PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Woo, AYH; Jozwiak, K; Toll, L; Tanga, MJ; Kozocas, JA; Jimenez, L; Huang, Y; Song, Y; Plazinska, A; Pajak, K; Paul, RK; Bernier, M; Wainer, IW; Xiao, RP				Woo, Anthony Yiu-Ho; Jozwiak, Krzysztof; Toll, Lawrence; Tanga, Mary J.; Kozocas, Joseph A.; Jimenez, Lucita; Huang, Ying; Song, Ying; Plazinska, Anita; Pajak, Karolina; Paul, Rajib K.; Bernier, Michel; Wainer, Irving W.; Xiao, Rui-Ping			Tyrosine 308 Is Necessary for Ligand-directed G(s) Protein-biased Signaling of beta(2)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-FIELD ANALYSIS; FUNCTIONAL SELECTIVITY; COUPLED RECEPTOR; CARDIAC MYOCYTES; KINASE-A; FENOTEROL DERIVATIVES; DRUG DISCOVERY; PHOSPHORYLATION; BINDING; G(I)	Interaction of a given G protein-coupled receptor to multiple different G proteins is a widespread phenomenon. For instance, beta(2)-adrenoceptor (beta(2)-AR) couples dually to G(s) and G(i) proteins. Previous studies have shown that cAMP-dependent protein kinase (PKA)-mediated phosphorylation of beta(2)-AR causes a switch in receptor coupling from G(s) to G(i). More recent studies have demonstrated that phosphorylation of beta(2)-AR byGproteincoupled receptor kinases, particularly GRK2, markedly enhances the G(i) coupling. Wehave previously shown that although most beta(2)-AR agonists cause both G(s) and G(i) activation, (R,R')fenoterol preferentially activates beta(2)-AR-G(s) signaling. However, the structural basis for this functional selectivity remains elusive. Here, using docking simulation and site-directed mutagenesis, we defined Tyr-308 as the key amino acid residue on beta(2)-AR essential for G(s)-biased signaling. Following stimulation with a beta(2)-AR-G(s)-biased agonist (R,R')-4'-aminofenoterol, the G(i) disruptor pertussis toxin produced no effects on the receptor-mediated ERK phosphorylation in HEK293 cells nor on the contractile response in cardiomyocytes expressing the wild-type beta(2)-AR. Interestingly, Y308F substitution on beta(2)-AR enabled (R,R')-4'-aminofenoterol to activate G(i) and to produce these responses in a pertussis toxin-sensitive manner without altering beta(2)-AR phosphorylation by PKA or G protein-coupled receptor kinases. These results indicate that, in addition to the phosphorylation status, the intrinsic structural feature of beta(2)-AR plays a crucial role in the receptor coupling selectivity to G proteins. We conclude that specific interactions between the ligand and the Tyr-308 residue of beta(2)-AR stabilize receptor conformations favoring the receptor-G(s) protein coupling and subsequently result in G(s)-biased agonism.	[Woo, Anthony Yiu-Ho; Huang, Ying; Song, Ying] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China; [Woo, Anthony Yiu-Ho; Huang, Ying; Song, Ying; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Ctr Life Sci, Beijing 100871, Peoples R China; [Woo, Anthony Yiu-Ho] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Paul, Rajib K.; Bernier, Michel; Wainer, Irving W.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Jozwiak, Krzysztof; Plazinska, Anita; Pajak, Karolina] Med Univ Lublin, Dept Chem, Lublin, Poland; [Toll, Lawrence] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Tanga, Mary J.; Kozocas, Joseph A.; Jimenez, Lucita] SRI Int, Menlo Pk, CA 94025 USA	Peking University; University Town of Shenzhen; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Lublin; Torrey Pines Institute for Molecular Studies, Florida; SRI International	Woo, AYH (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China.	yiuhowoo@pkusz.edu.cn; xiaor@pku.edu.cn	Woo, Anthony/D-4305-2014; Bernier, Michel/AAO-3983-2021; Xiao, Rui-Ping/AAE-2629-2019; Yimei, Wang/AAE-4083-2019; Bernier, Michel/Y-7139-2019	Woo, Anthony/0000-0003-0662-698X; Bernier, Michel/0000-0002-5948-368X; Jozwiak, Krzysztof/0000-0001-6018-5092; Plazinska, Anita/0000-0002-3698-2574	National Institutes of Health Intramural Research Program from NIA; National Institutes of Health from NIA [N01-AG31009]; National Basic Research Program of China [2012CB518000]; National Science Foundation of China [31221002]; National Major Scientific Research Program of China [2012CB910402]; National Scientific Technology Major Project of China [2013ZX09507001]; Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University; Foundation for Polish Science [TEAM 2009-4/5]	National Institutes of Health Intramural Research Program from NIA; National Institutes of Health from NIA; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific Research Program of China; National Scientific Technology Major Project of China; Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program from NIA (to A. Y. H. W., R. K. P., M. B., and I. W. W.) and by National Institutes of Health Grant N01-AG31009 from NIA. This work was also supported by National Basic Research Program of China Grant 2012CB518000 and National Science Foundation of China Project 31221002 (to R. P. X.), National Major Scientific Research Program of China Grant 2012CB910402, National Scientific Technology Major Project of China Grant 2013ZX09507001 (to A. Y. H. W.), Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, and Foundation for Polish Science Grant TEAM 2009-4/5 Programs (to K. J.).	Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Beigi F, 2006, CHIRALITY, V18, P822, DOI 10.1002/chir.20317; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Chakir K, 2011, J MOL CELL CARDIOL, V50, P1000, DOI 10.1016/j.yjmcc.2011.01.015; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Fowler JC, 2012, MOL PHARMACOL, V81, P820, DOI 10.1124/mol.111.075457; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; HAUSDORFF WP, 1990, SYM SOC EXP BIOL, V44, P225; Isogaya M, 1999, MOL PHARMACOL, V56, P875, DOI 10.1124/mol.56.5.875; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Jozwiak K, 2007, J MED CHEM, V50, P2903, DOI 10.1021/jm070030d; Jozwiak K, 2010, BIOORGAN MED CHEM, V18, P728, DOI 10.1016/j.bmc.2009.11.062; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Plazinska A, 2013, J MOL MODEL, V19, P4919, DOI 10.1007/s00894-013-1981-y; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Xiao RP, 1999, CIRC RES, V84, P43; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang SJ, 2000, J BIOL CHEM, V275, P21773, DOI 10.1074/jbc.M909484199; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zhu WZ, 2012, CIRC RES, V110, P265, DOI 10.1161/CIRCRESAHA.111.253260	48	35	38	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19351	19363		10.1074/jbc.M114.558882	http://dx.doi.org/10.1074/jbc.M114.558882			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831005	Green Published, hybrid			2022-12-25	WOS:000339326800012
J	Adamski, MG; Li, Y; Wagner, E; Yu, H; Seales-Bailey, C; Durkin, H; Hao, Q; Soper, SA; Murphy, M; Baird, AE				Adamski, Mateusz G.; Li, Yan; Wagner, Erin; Yu, Hua; Seales-Bailey, Chloe; Durkin, Helen; Hao, Qing; Soper, Steven A.; Murphy, Michael; Baird, Alison E.			Pre-Existing Hypertension Dominates gamma delta T Cell Reduction in Human Ischemic Stroke	PLOS ONE			English	Article							INTERFERON-GAMMA; ESCHERICHIA-COLI; GENE-EXPRESSION; BLOOD-PRESSURE; INTERLEUKIN-17; LYMPHOCYTES; AGE; MECHANISMS; GENERATION; INFECTION	T lymphocytes may play an important role in the evolution of ischemic stroke. Depletion of gamma delta T cells has been found to abrogate ischemia reperfusion injury in murine stroke. However, the role of gamma delta T cells in human ischemic stroke is unknown. We aimed to determine gamma delta T cell counts and gamma delta T cell interleukin 17A (IL-17A) production in the clinical setting of ischemic stroke. We also aimed to determine the associations of gamma delta T cell counts with ischemic lesion volume, measures of clinical severity and with major stroke risk factors. Peripheral blood samples from 43 acute ischemic stroke patients and 26 control subjects matched on race and gender were used for flow cytometry and complete blood count analyses. Subsequently, cytokine levels and gene expression were measured in gamma delta T cells. The number of circulating gamma delta T cells was decreased by almost 50% (p = 0.005) in the stroke patients. gamma delta T cell counts did not correlate with lesion volume on magnetic resonance diffusion-weighted imaging or with clinical severity in the stroke patients, but gamma delta T cells showed elevated levels of IL-17A (p = 0.048). Decreased gamma delta T cell counts were also associated with older age (p = 0.004), pre-existing hypertension (p = 0.0005) and prevalent coronary artery disease (p = 0.03), with pre-existing hypertension being the most significant predictor of gamma delta T cell counts in a multivariable analysis. gamma delta T cells in human ischemic stroke are reduced in number and show elevated levels of IL-17A. A major reduction in gamma delta T lymphocytes also occurs in hypertension and may contribute to the development of hypertension-mediated stroke and vascular disease.	[Adamski, Mateusz G.; Li, Yan; Wagner, Erin; Yu, Hua; Seales-Bailey, Chloe; Hao, Qing; Baird, Alison E.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Adamski, Mateusz G.] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Durkin, Helen] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Soper, Steven A.] Univ N Carolina, Chapel Hill, NC USA; [Murphy, Michael] Louisiana State Univ, Baton Rouge, LA 70803 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Jagiellonian University; Collegium Medicum Jagiellonian University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Louisiana State University System; Louisiana State University	Baird, AE (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	alison.baird@downstate.edu	Adamski, Mateusz G/K-7634-2016; Adamski, Mateusz/F-6274-2015	Adamski, Mateusz/0000-0002-8340-2181; Hao, Qing/0000-0002-1097-893X	National Institute of Biomedical Imaging and Bioengineering/NIH [R01-EB010087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010087] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering/NIH (R01-EB010087) to A. E. B., M. M., and S. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Andreu-Ballester JC, 2012, CYTOM PART B-CLIN CY, V82B, P238, DOI 10.1002/cyto.b.21020; Bhowmick S, 2009, J LEUKOCYTE BIOL, V86, P1275, DOI 10.1189/jlb.0209107; Bosch JA, 2003, BRAIN BEHAV IMMUN, V17, P251, DOI 10.1016/S0889-1591(03)00054-0; Brunetti ND, 2012, J THROMB THROMBOLYS, V34, P475, DOI 10.1007/s11239-012-0761-3; Chon H, 2004, HYPERTENSION, V43, P947, DOI 10.1161/01.HYP.0000123071.35142.72; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kengne AP, 2007, J HYPERTENS, V25, P1205; Kim CH, 2005, KIDNEY INT, V67, P1462, DOI 10.1111/j.1523-1755.2005.00223.x; Kolbus D, 2013, J INTERN MED, V274, P41, DOI 10.1111/joim.12038; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Nakamura R, 2008, J IMMUNOL, V181, P2071, DOI 10.4049/jimmunol.181.3.2071; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; RDevelopment C, 2012, R LANG ENV STAT COMP; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roux A, 2013, J IMMUNOL, V191, P1300, DOI 10.4049/jimmunol.1202940; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Touyz RM, 2012, CURR OPIN NEPHROL HY, V21, P119, DOI 10.1097/MNH.0b013e328350a50f; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Yu H, 2013, INT J STROKE, V8, pE57, DOI 10.1111/ijs.12175	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97755	10.1371/journal.pone.0097755	http://dx.doi.org/10.1371/journal.pone.0097755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840735	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600069
J	Chen, YA; Chi, WC; Trinh, NN; Huang, LY; Chen, YC; Cheng, KT; Huang, TL; Lin, CY; Huang, HJ				Chen, Yun-An; Chi, Wen-Chang; Ngoc Nam Trinh; Huang, Li-Yao; Chen, Ying-Chih; Cheng, Kai-Teng; Huang, Tsai-Lien; Lin, Chung-Yi; Huang, Hao-Jen			Transcriptome Profiling and Physiological Studies Reveal a Major Role for Aromatic Amino Acids in Mercury Stress Tolerance in Rice Seedlings	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; SIGNALING PATHWAYS; ENVIRONMENTAL-STRESSES; TRANSGENIC ARABIDOPSIS; PLASMA-MEMBRANE; GENE FAMILY; ROOT-GROWTH; EXPRESSION; KINASE; RESPONSES	Mercury (Hg) is a serious environmental pollution threat to the planet. The accumulation of Hg in plants disrupts many cellular-level functions and inhibits growth and development, but the mechanism is not fully understood. To gain more insight into the cellular response to Hg, we performed a large-scale analysis of the rice transcriptome during Hg stress. Genes induced with short-term exposure represented functional categories of cell-wall formation, chemical detoxification, secondary metabolism, signal transduction and abiotic stress response. Moreover, Hg stress upregulated several genes involved in aromatic amino acids (Phe and Trp) and increased the level of free Phe and Trp content. Exogenous application of Phe and Trp to rice roots enhanced tolerance to Hg and effectively reduced Hg-induced production of reactive oxygen species. Hg induced calcium accumulation and activated mitogen-activated protein kinase. Further characterization of the Hg-responsive genes we identified may be helpful for better understanding the mechanisms of Hg in plants.	[Chen, Yun-An; Chi, Wen-Chang; Ngoc Nam Trinh; Huang, Li-Yao; Chen, Ying-Chih; Cheng, Kai-Teng; Huang, Tsai-Lien; Lin, Chung-Yi; Huang, Hao-Jen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Chen, Yun-An] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	National Cheng Kung University; National Sun Yat Sen University	Huang, HJ (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	haojen@mail.ncku.edu.tw		Trinh, Ngoc Nam/0000-0002-7983-7270	National Science Council [NSC96-2311-B-006-001, NSC 101-2621-B-006-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Science Council (including NSC96-2311-B-006-001 and NSC 101-2621-B-006-001-MY3). The National Science Council is the main governmental promotion and funding body of the Republic of China for science research in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Agarwal PK, 2010, MOL BIOL REP, V37, P981, DOI 10.1007/s11033-009-9774-1; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; BEAUFORD W, 1977, PHYSIOL PLANTARUM, V39, P261, DOI 10.1111/j.1399-3054.1977.tb01880.x; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Bohm PAF, 2006, BIOL PLANTARUM, V50, P315, DOI 10.1007/s10535-006-0029-x; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen YA, 2012, PLANT PHYSIOL BIOCH, V55, P23, DOI 10.1016/j.plaphy.2012.03.008; Chi WC, 2011, PLANT MOL BIOL, V77, P591, DOI 10.1007/s11103-011-9841-6; Christensen JH, 1998, PLANT PHYSIOL, V118, P125, DOI 10.1104/pp.118.1.125; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Fu SF, 2002, PLANT CELL PHYSIOL, V43, P958, DOI 10.1093/pcp/pcf111; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; Heidenreich B, 2001, PLANT CELL ENVIRON, V24, P1227, DOI 10.1046/j.0016-8025.2001.00775.x; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Katiyar-Agarwal S, 2003, PLANT MOL BIOL, V51, P677, DOI 10.1023/A:1022561926676; Kim JA, 2003, BIOCHEM BIOPH RES CO, V300, P868, DOI 10.1016/S0006-291X(02)02944-3; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; Lin CY, 2013, PLANT MOL BIOL, V81, P507, DOI 10.1007/s11103-013-0020-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes MS, 2013, METALLOMICS, V5, P1305, DOI 10.1039/c3mt00084b; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Massot N, 2002, PLANT GROWTH REGUL, V37, P105, DOI 10.1023/A:1020511007138; Trinh NN, 2014, PHYSIOL PLANTARUM, V150, P205, DOI 10.1111/ppl.12088; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Pitorre D, 2010, PLANTA, V232, P1339, DOI 10.1007/s00425-010-1260-4; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Rea PA, 1999, J EXP BOT, V50, P895, DOI 10.1093/jexbot/50.suppl_1.895; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Ruiz ON, 2011, PLANT BIOTECHNOL J, V9, P609, DOI 10.1111/j.1467-7652.2011.00616.x; Sanjaya, 2008, PLANT CELL ENVIRON, V31, P1074, DOI 10.1111/j.1365-3040.2008.01819.x; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Song W, 1997, PLANT PHYSIOL, V114, P927, DOI 10.1104/pp.114.3.927; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yeh CM, 2007, J EXP BOT, V58, P659, DOI 10.1093/jxb/erl240; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Zabihi M, 2010, J HAZARD MATER, V174, P251, DOI 10.1016/j.jhazmat.2009.09.044; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849; Zhou ZS, 2007, J INORG BIOCHEM, V101, P1, DOI 10.1016/j.jinorgbio.2006.05.011	56	33	35	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e95163	10.1371/journal.pone.0095163	http://dx.doi.org/10.1371/journal.pone.0095163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840062	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600005
J	Govender, Y; Avenant, C; Verhoog, NJD; Ray, RM; Grantham, NJ; Africander, D; Hapgood, JP				Govender, Yashini; Avenant, Chanel; Verhoog, Nicolette J. D.; Ray, Roslyn M.; Grantham, Nicholas J.; Africander, Donita; Hapgood, Janet P.			The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; FEMALE GENITAL-TRACT; HORMONAL CONTRACEPTION; HIV ACQUISITION; IMMUNE-RESPONSES; DNA-BINDING; EXPRESSION; INFECTION; PROGESTINS	Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN). We investigated the differential effects, molecular mechanism of action and steroid receptor involvement in gene expression by MPA as compared to NET and progesterone (P4) in the End1/E6E7 cell line model for the endocervical epithelium, a key point of entry for pathogens in the female genital mucosa. MPA, unlike NET-acetate (NET-A) and P4, increases mRNA expression of the anti-inflammatory GILZ and I kappa B alpha genes. Similarly, MPA unlike NET-A, decreases mRNA expression of the proinflammatory IL-6, IL-8 and RANTES genes, and IL-6 and IL-8 protein levels. The predominant steroid receptor expressed in the End1/E6E7 and primary endocervical epithelial cells is the glucocorticoid receptor (GR), and GR knockdown experiments show that the anti-inflammatory effects of MPA are mediated by the GR. Chromatin-immunoprecipitation results suggest that MPA, unlike NET-A and P4, represses pro-inflammatory cytokine gene expression in cervical epithelial cells via a mechanism involving recruitment of the GR to cytokine gene promoters, like the GR agonist dexamethasone. This is at least in part consistent with direct effects on transcription, without a requirement for new protein synthesis. Dose response analysis shows that MPA has a potency of similar to 24 nM for transactivation of the anti-inflammatory GILZ gene and similar to 4-20 nM for repression of the pro-inflammatory genes, suggesting that these effects are likely to be relevant at injectable contraceptive doses of MPA. These findings suggest that in the context of the genital mucosa, these GR-mediated glucocorticoid-like effects of MPA in cervical epithelial cells are likely to play a critical role in discriminating between the effects on inflammation caused by different progestins and P4 and hence susceptibility to genital infections, given the predominant expression of the GR in primary endocervical epithelial cells.	[Govender, Yashini; Avenant, Chanel; Verhoog, Nicolette J. D.; Ray, Roslyn M.; Grantham, Nicholas J.; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Provinc, South Africa; [Africander, Donita] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Provinc, South Africa	University of Cape Town; Stellenbosch University	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Provinc, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018; Ray, Roslyn/AAB-2898-2019	Hapgood, Janet P/0000-0002-4414-4861; Africander, Donita/0000-0002-3429-7100; Verhoog, Nicolette/0000-0002-3786-6452	South African HIV/AIDS Research and Innovation Platform (SHARP)	South African HIV/AIDS Research and Innovation Platform (SHARP)	This work was supported by a grant from the South African HIV/AIDS Research and Innovation Platform (SHARP) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 1999, BRIT J PHARMACOL, V127, P1003, DOI 10.1038/sj.bjp.0702613; Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Al-Hendy A, 2006, FERTIL STERIL, V86, P686, DOI 10.1016/j.fertnstert.2006.01.052; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bamberger CM, 1999, J CLIN ENDOCR METAB, V84, P4055, DOI 10.1210/jc.84.11.4055; BARCLAY CG, 1993, AM J OBSTET GYNECOL, V169, P625, DOI 10.1016/0002-9378(93)90634-U; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Brabin L, 2002, AIDS PATIENT CARE ST, V16, P211, DOI 10.1089/10872910252972267; Bray JD, 2005, J STEROID BIOCHEM, V97, P328, DOI 10.1016/j.jsbmb.2005.06.032; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; Elovitz M, 2004, AM J OBSTET GYNECOL, V190, P693, DOI 10.1016/j.ajog.2003.10.693; fhi 360 website, EXP ACC INJ CONTR; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; FOTHERBY K, 1983, J STEROID BIOCHEM, V19, P817, DOI 10.1016/0022-4731(83)90017-1; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gray RH, 2012, LANCET INFECT DIS, V12, P507, DOI 10.1016/S1473-3099(12)70111-1; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hapgood JP, 2014, AM J REPROD IMMUNOL, V71, P505, DOI 10.1111/aji.12214; Hapgood JP, 2013, ENDOCRINOLOGY, V154, P985, DOI 10.1210/en.2013-1066; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Hapgood JP, 2013, J STEROID BIOCHEM, P1; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Hermoso M, 2003, IUBMB LIFE, V55, P497, DOI 10.1080/15216540310001642072; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Janeway C., 2012, IMMUNOBIOLOGY, V5th; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kaushic C, 2011, AM J REPROD IMMUNOL, V65, P253, DOI 10.1111/j.1600-0897.2010.00965.x; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; KIRTON KT, 1974, CONTRACEPTION, V10, P39, DOI 10.1016/0010-7824(74)90130-9; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Lavreys L, 2004, AIDS, V18, P695, DOI 10.1097/00002030-200403050-00017; Lee B, 1999, J LEUKOCYTE BIOL, V65, P552; Ma H, 2003, METHOD ENZYMOL, V364, P284; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MacLean R, 2005, INT FAM PLAN PERSPEC, V31, P45; McCoy SI, 2013, AIDS, V27, P1001, DOI 10.1097/QAD.0b013e32835da401; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Mosmann T., 1983, J IMMUNOL METHODS, V12, P16; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; PARR MB, 1994, LAB INVEST, V70, P369; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Sitruk-Ware R, 2004, MATURITAS, V47, P277, DOI 10.1016/j.maturitas.2004.01.001; Smit JA, 2013, JAIDS-J ACQ IMM DEF, V62, P363, DOI 10.1097/QAI.0b013e31827e818a; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; STANCZYK FZ, 1990, CONTRACEPTION, V42, P67, DOI 10.1016/0010-7824(90)90093-B; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; USAID website, TECHN BRIEF HORM CON; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Vladic-Stjernholm Y, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-116; Wand H, 2012, AIDS, V26, P375, DOI 10.1097/QAD.0b013e32834f990f; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; WOODWORTH CD, 1993, AM J PATHOL, V142, P1544; [No title captured]; [No title captured]	87	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96497	10.1371/journal.pone.0096497	http://dx.doi.org/10.1371/journal.pone.0096497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840644	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600008
J	Jajamovich, GH; Dyvorne, H; Donnerhack, C; Taouli, B				Jajamovich, Guido H.; Dyvorne, Hadrien; Donnerhack, Claudia; Taouli, Bachir			Quantitative Liver MRI Combining Phase Contrast Imaging, Elastography, and DWI: Assessment of Reproducibility and Postprandial Effect at 3.0 T	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; DIFFUSION-WEIGHTED MRI; CHRONIC HEPATITIS; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; PORTAL-HYPERTENSION; FLOW MEASUREMENTS; ENHANCED MRI; BLOOD-FLOW; FIBROSIS	Purpose: To quantify short-term reproducibility (in fasting conditions) and postprandial changes after a meal in portal vein (PV) flow parameters measured with phase contrast (PC) imaging, liver diffusion parameters measured with multiple b value diffusion-weighted imaging (DWI) and liver stiffness (LS) measured with MR elastography (MRE) in healthy volunteers and patients with liver disease at 3.0 T. Materials and Methods: In this IRB-approved prospective study, 30 subjects (11 healthy volunteers and 19 liver disease patients; 23 males, 7 females; mean age 46.5 y) were enrolled. Imaging included 2D PC imaging, multiple b value DWI and MRE. Subjects were initially scanned twice in fasting state to assess short-term parameter reproducibility, and then scanned 20 min. after a liquid meal. PV flow/velocity, LS, liver true diffusion coefficient (D), pseudodiffusion coefficient (D*), perfusion fraction (PF) and apparent diffusion coefficient (ADC) were measured in fasting and postprandial conditions. Short-term reproducibility was assessed in fasting conditions by measuring coefficients of variation (CV) and Bland-Altman limits of agreement. Differences in MR metrics before and after caloric intake and between healthy volunteers and liver disease patients were assessed. Results: PV flow parameters, D, ADC and LS showed good to excellent short-term reproducibility in fasting state (CV <16%), while PF and D* showed acceptable and poor reproducibility (CV = 20.4% and 51.6%, respectively). PV flow parameters and LS were significantly higher (p<0.04) in postprandial state while liver diffusion parameters showed no significant change (p>0.2). LS was significantly higher in liver disease patients compared to healthy volunteers both in fasting and postprandial conditions (p<0.001). Changes in LS were significantly correlated with changes in PV flow (Spearman rho = 0.48, p = 0.013). Conclusions: Caloric intake had no/minimal/large impact on diffusion/stiffness/portal vein flow, respectively. PC MRI and MRE but not DWI should be performed in controlled fasting state.	[Jajamovich, Guido H.; Dyvorne, Hadrien; Donnerhack, Claudia; Taouli, Bachir] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Taouli, B (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA.	bachir.taouli@mountsinai.org	Taouli, Bachir/ABB-5044-2020		National Institutes of Health [1R01DK087877, T32CA78207]; GE Healthcare; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grants 1R01DK087877 and T32CA78207, and by GE Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annet L, 2003, RADIOLOGY, V229, P409, DOI 10.1148/radiol.2292021128; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Bellis L, 2003, HEPATOLOGY, V37, P378, DOI 10.1053/jhep.2003.50053; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Bureau C, 2008, ALIMENT PHARM THER, V27, P1261, DOI 10.1111/j.1365-2036.2008.03701.x; BURKART DJ, 1995, RADIOLOGY, V194, P801, DOI 10.1148/radiology.194.3.7862982; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; DAUZAT M, 1994, EUR J APPL PHYSIOL, V68, P373, DOI 10.1007/BF00843732; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; GALLAVAN RH, 1985, AM J PHYSIOL, V249, pG301, DOI 10.1152/ajpgi.1985.249.3.G301; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Girometti R, 2007, RADIOL MED, V112, P394, DOI 10.1007/s11547-007-0149-1; Gouya H, 2011, RADIOLOGY, V261, P144, DOI 10.1148/radiol.11101541; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Hara AK, 1996, AM J ROENTGENOL, V166, P1311, DOI 10.2214/ajr.166.6.8633438; Hines CDG, 2011, J MAGN RESON IMAGING, V33, P239, DOI 10.1002/jmri.22354; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Hollingsworth KG, 2006, NMR BIOMED, V19, P231, DOI 10.1002/nbm.1028; Huwart L, 2008, GASTROEN CLIN BIOL, V32, P68, DOI 10.1016/S0399-8320(08)73995-2; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; KASHITANI N, 1995, ABDOM IMAGING, V20, P197, DOI 10.1007/BF00200392; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEE SS, 1988, HEPATOLOGY, V8, P647, DOI 10.1002/hep.1840080335; Lee YJ, 2013, J MAGN RESON IMAGING; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Ludwig D, 1998, J HEPATOL, V28, P631, DOI 10.1016/S0168-8278(98)80287-0; Lupsor M, 2008, J GASTROINTEST LIVER, V17, P155; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; OBRIEN S, 1992, GUT, V33, P364, DOI 10.1136/gut.33.3.364; Osman O, 2008, WORLD J GASTROENTERO, V14, P260, DOI 10.3748/wjg.14.260; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Pazahr S, 2013, INVEST RADIOL; Sadek AG, 1996, JMRI-J MAGN RESON IM, V6, P90, DOI 10.1002/jmri.1880060118; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Van Beers BE, 2003, MAGN RESON MED, V49, P692, DOI 10.1002/mrm.10420; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yin M, 2011, AM J ROENTGENOL, V197, P64, DOI 10.2214/AJR.10.5989; Yzet T, 2010, J MAGN RESON IMAGING, V31, P579, DOI 10.1002/jmri.22079	48	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97355	10.1371/journal.pone.0097355	http://dx.doi.org/10.1371/journal.pone.0097355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840288	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600026
J	Kopatz, A; Eiken, HG; Aspi, J; Kojola, I; Tobiassen, C; Tirronen, KF; Danilov, PI; Hagen, SB				Kopatz, Alexander; Eiken, Hans Geir; Aspi, Jouni; Kojola, Ilpo; Tobiassen, Camilla; Tirronen, Konstantin F.; Danilov, Pjotr I.; Hagen, Snorre B.			Admixture and Gene Flow from Russia in the Recovering Northern European Brown Bear (Ursus arctos)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MICROSATELLITE ANALYSIS; COMPUTER-PROGRAM; DIVERSITY; SOFTWARE; EXTINCTION; CARNIVORE; BEHAVIOR; EXAMPLE	Large carnivores were persecuted to near extinction during the last centuries, but have now recovered in some countries. It has been proposed earlier that the recovery of the Northern European brown bear is supported by migration from Russia. We tested this hypothesis by obtaining for the first time continuous sampling of the whole Finnish bear population, which is located centrally between the Russian and Scandinavian bear populations. The Finnish population is assumed to experience high gene flow from Russian Karelia. If so, no or a low degree of genetic differentiation between Finnish and Russian bears could be expected. We have genotyped bears extensively from all over Finland using 12 validated microsatellite markers and compared their genetic composition to bears from Russian Karelia, Sweden, and Norway. Our fine masked investigation identified two overlapping genetic clusters structured by isolation-by-distance in Finland (pairwise F-ST = 0.025). One cluster included Russian bears, and migration analyses showed a high number of migrants from Russia into Finland, providing evidence of eastern gene flow as an important driver during recovery. In comparison, both clusters excluded bears from Sweden and Norway, and we found no migrants from Finland in either country, indicating that eastern gene flow was probably not important for the population recovery in Scandinavia. Our analyses on different spatial scales suggest a continuous bear population in Finland and Russian Karelia, separated from Scandinavia.	[Kopatz, Alexander; Eiken, Hans Geir; Tobiassen, Camilla; Hagen, Snorre B.] Bioforsk Norwegian Inst Agr & Environm Res, Svanvik, Norway; [Aspi, Jouni] Univ Oulu, Dept Biol, Oulu, Finland; [Kojola, Ilpo] Finnish Game & Fisheries Res Inst, Oulu, Finland; [Tirronen, Konstantin F.; Danilov, Pjotr I.] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia	Bioforsk; University of Oulu; Natural Resources Institute Finland (Luke); Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS	Kopatz, A (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, Svanvik, Norway.	alexander.kopatz@bioforsk.no; snorre.hagen@bioforsk.no	Aspi, Jouni O/B-3087-2012; Kopatz, Alexander/AAC-3967-2022; Hagen, Snorre/O-5220-2015; Tirronen, Konstantin/AAV-9418-2021; Tirronen, Konstantin/A-9590-2014; Kopatz, Alexander/A-3174-2012	Kopatz, Alexander/0000-0002-9139-1179; Hagen, Snorre/0000-0001-8289-7752; Tirronen, Konstantin/0000-0002-8208-5460; Kopatz, Alexander/0000-0002-9139-1179; Eiken, Hans Geir/0000-0002-5368-3648; Aspi, Jouni/0000-0002-2451-3201	Bioforsk	Bioforsk(Bioforsk)	The study was funded by Bioforsk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 2012, FORENSIC SCI INT-GEN, V6, P798, DOI 10.1016/j.fsigen.2012.03.002; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Belkhir K., 1996, 5171 CNRS UMR; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chestin I, 1999, BEARS STATUS SURVEY; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520; Danilov PI, 1994, INT C BEAR RES MANAG, V9, P199; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eiken HG, 2009, FORENS SCI INT-GEN S, V2, P273, DOI 10.1016/j.fsigss.2009.07.007; Ermala Aslak, 2003, Acta Zoologica Lituanica, V13, P15; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kojola I, 2000, ANN ZOOL FENN, V37, P59; Kojola I, 2004, SUURPETOJEN LUKUMAAR, P1; Kojola I, 2006, ANN ZOOL FENN, V43, P258; Kojola L, 2003, URSUS-SERIES, V14, P17; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linacre A, 2011, Forensic Sci Int Genet, V5, P501, DOI 10.1016/j.fsigen.2010.10.017; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; Miller CR, 2003, P NATL ACAD SCI USA, V100, P4334, DOI 10.1073/pnas.0735531100; Mills L. Scott, 2003, P587, DOI 10.1017/CBO9780511615757.018; Nyholm Erik S., 1999, P63; Nyholm ES, 1995, SUOMEN SUURPETOKANNA, P1; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pelletier A, 2012, CAN J ZOOL, V90, P999, DOI 10.1139/Z2012-068; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; PULLIAINEN E, 1983, Z SAUGETIERKD, V48, P290; PULLIAINEN E, 1990, Aquilo Ser Zoologica, V27, P21; Pulliainen E, 1997, INT BEAR NEWS, V6, P10; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schregel J, 2012, MOL ECOL, V21, P3474, DOI 10.1111/j.1365-294X.2012.05631.x; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SWENSON JE, 1994, BIOL CONSERV, V70, P9, DOI 10.1016/0006-3207(94)90293-3; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wikman M, 2010, RIISTAKANNAT 2010 RI, P1	62	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97558	10.1371/journal.pone.0097558	http://dx.doi.org/10.1371/journal.pone.0097558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839968	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600044
J	Weaver, AJ; Shepard, JB; Wilkinson, RA; Watkins, RL; Walton, SK; Radke, AR; Wright, TJ; Awel, MB; Cooper, C; Erikson, E; Labib, ME; Voyich, JM; Teintze, M				Weaver, Alan J., Jr.; Shepard, Joyce B.; Wilkinson, Royce A.; Watkins, Robert L.; Walton, Sarah K.; Radke, Amanda R.; Wright, Thomas J.; Awel, Milat B.; Cooper, Catherine; Erikson, Elizabeth; Labib, Mohamed E.; Voyich, Jovanka M.; Teintze, Martin			Antibacterial Activity of THAM Trisphenylguanide against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							BIOCIDE POLYHEXAMETHYLENE BIGUANIDE; ACANTHAMOEBA-CASTELLANII; INFECTIONS; SUSCEPTIBILITY; ANTISEPTICS; CORECEPTOR; ENCYSTMENT; CXCR4; DRUGS; BIND	This study investigated the potential antibacterial activity of three series of compounds synthesized from 12 linear and branched polyamines with 2-8 amino groups, which were substituted to produce the corresponding guanides, biguanides, or phenylguanides, against Acinetobacter baumannii, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Antibacterial activity was measured for each compound by determining the minimum inhibitory concentration against the bacteria, and the toxicity towards mammalian cells was determined. The most effective compound, THAM trisphenylguanide, was studied in time-to-kill and cytoplasmic leakage assays against methicillin-resistant Staphylococcus aureus (MRSA, USA300) in comparison to chlorhexidine. Preliminary toxicity and MRSA challenge studies in mice were also conducted on this compound. THAM trisphenylguanide showed significant antibacterial activity (MIC similar to 1 mg/L) and selectivity against MRSA relative to all the other bacteria examined. In time-to-kill assays it showed increased antimicrobial activity against MRSA versus chlorhexidine. It induced leakage of cytoplasmic content at concentrations that did not reduce cell viability, suggesting the mechanism of action may involve membrane disruption. Using an intraperitoneal mouse model of invasive MRSA disease, THAM trisphenylguanide reduced bacterial burden locally and in deeper tissues. This study has identified a novel guanide compound with selective microbicidal activity against Staphylococcus aureus, including a methicillin-resistant (MRSA) strain.	[Weaver, Alan J., Jr.; Shepard, Joyce B.; Wilkinson, Royce A.; Walton, Sarah K.; Radke, Amanda R.; Wright, Thomas J.; Awel, Milat B.; Teintze, Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Wilkinson, Royce A.; Watkins, Robert L.; Cooper, Catherine; Erikson, Elizabeth; Voyich, Jovanka M.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Labib, Mohamed E.] Adv BioDevices, Princeton, NJ USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Teintze, M (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mteintze@montana.edu		Wilkinson, Royce/0000-0001-8831-2081	National Institute of Allergy and Infectious Diseases [AI076965]; National Center for Research Resources [P20RR024237, P20RR020185]; INBRE grant, National Center for Research Resources [P20RR016455]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237, P20RR016455, P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076965] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); INBRE grant, National Center for Research Resources; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional funds and by the following US Public Health Service grants: AI076965 (M. E. L.) from the National Institute of Allergy and Infectious Diseases, CoBRE grants P20RR024237 (M. T.) and P20RR020185 (C. C., E. E. and J.M.V.) from the National Center for Research Resources. S. K. W., R. L. W., and T.J.W. were supported by fellowships from INBRE grant P20RR016455 from the National Center for Research Resources. M. B. A. was supported by a fellowship funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2006, MICROBIOL-SGM, V152, P989, DOI 10.1099/mic.0.28643-0; Allen MJ, 2004, BIOCHEM BIOPH RES CO, V318, P397, DOI 10.1016/j.bbrc.2004.04.043; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buxbaum A, 2006, J ANTIMICROB CHEMOTH, V58, P193, DOI 10.1093/jac/dkl206; Chopra S, 2010, J ANTIMICROB CHEMOTH, V65, P2598, DOI 10.1093/jac/dkq353; DAVIES GE, 1954, BRIT J PHARM CHEMOTH, V9, P192, DOI 10.1111/j.1476-5381.1954.tb00840.x; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Grare M, 2010, CLIN MICROBIOL INFEC, V16, P432, DOI 10.1111/j.1469-0691.2009.02837.x; Khunkitti W, 1998, J INFECTION, V36, P43, DOI 10.1016/S0163-4453(98)93054-7; Khunkitti W, 1998, J APPL MICROBIOL, V84, P53; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kratzer C, 2006, J HOSP INFECT, V63, P316, DOI 10.1016/j.jhin.2006.01.024; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nde CW, 2009, ENVIRON SCI TECHNOL, V43, P8406, DOI 10.1021/es9015475; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shepard JB, 2013, ANTICANCER IN PRESS; Tien HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-95; Turner NA, 2004, J APPL MICROBIOL, V96, P1287, DOI 10.1111/j.1365-2672.2004.02260.x; Watkins RL, 2013, MICROBES INFECT, V15, P749, DOI 10.1016/j.micinf.2013.05.004; Watkins RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019939; Wilkinson RA, 2013, BIOORG MED CHEM LETT, V23, P2197, DOI 10.1016/j.bmcl.2013.01.107; Wilkinson RA, 2011, ANTIMICROB AGENTS CH, V55, P255, DOI 10.1128/AAC.00709-10; 2002, MMWR MORB MORTAL WKL, V51, P902	28	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97742	10.1371/journal.pone.0097742	http://dx.doi.org/10.1371/journal.pone.0097742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840307	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600067
J	Ovesen, JL; Fan, YX; Zhang, X; Chen, J; Medvedovic, M; Xia, Y; Puga, A				Ovesen, Jerald L.; Fan, Yunxia; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Xia, Ying; Puga, Alvaro			Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) Analysis Uncovers Broad Changes in Chromatin Structure Resulting from Hexavalent Chromium Exposure	PLOS ONE			English	Article							DNA CROSS-LINKING; TRANSCRIPTION FACTORS; REPAIR; TOXICITY; ADDUCTS; CANCER; CELLS; CARCINOGENICITY; EPIGENETICS; ACTIVATION	The ability of chromatin to switch back and forth from open euchromatin to closed heterochromatin is vital for transcriptional regulation and genomic stability, but its dynamic structure is subject to disruption by exposure to environmental agents such as hexavalent chromium. Cr(VI) exposure disrupts chromatin remodeling mechanisms and causes chromosomal damage through formation of free radicals, Cr-DNA adducts, and DNA-Cr-protein cross-links. In addition, acute, high-concentration, and chronic, low-concentration exposures to Cr(VI) lead to significantly different transcriptional and genomic stability outcomes. We used mouse hepatoma Hepa-1c1c7 cells to investigate how transcriptional responses to chromium treatment might correlate with structural chromatin changes. We used Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) analysis coupled with deep sequencing to identify regions of the genome that may switch between open and closed chromatin in response to exposure to varying Cr(VI) concentrations. At either Cr(VI) concentration, chromatin domains surrounding binding sites for AP-1 transcription factors become significantly open, whereas BACH2 and CTCF binding sites are open solely at the low and high concentrations, respectively. Parallel gene expression profiling using RNA-seq indicates that the structural chromatin changes caused by Cr(VI) affect gene expression levels in the target areas that vary depending on Cr(VI) concentration, but show no correlation between global changes in the overall transcriptional response and Cr(VI) concentration. Our results suggest that FAIRE may be a useful technique to map chromatin elements targeted by DNA damaging agents for which there is no prior knowledge of their specificity, and to identify subsequent transcriptomic changes induced by those agents.	[Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA	University of Cincinnati; University of Cincinnati	Puga, A (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Alvaro.Puga@uc.edu		Chen, Jing/0000-0002-6227-7393	National Institutes of Health [5 R01 ES010807, R21 ES020048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020048, R01ES010807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants 5 R01 ES010807 and R21 ES020048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchowsky A, 2003, FREE RADICAL BIO MED, V34, P1130, DOI 10.1016/S0891-5849(03)00059-5; Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062; Ding Min, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P129; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.0.CO;2-Y; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2006, CURR OPIN GENET DEV, V16, P171, DOI 10.1016/j.gde.2006.02.003; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kallies A, 2013, IMMUNOL CELL BIOL, V91, P491, DOI 10.1038/icb.2013.32; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Majumder S, 2003, J BIOL CHEM, V278, P26216, DOI 10.1074/jbc.M302887200; MANNING FCR, 1992, MOL CARCINOGEN, V6, P270, DOI 10.1002/mc.2940060409; Morse JL, 2013, CHEM RES TOXICOL, V26, P1591, DOI 10.1021/tx400293s; O'Brien T, 2001, MOL CELL BIOCHEM, V222, P173, DOI 10.1023/A:1017918330073; O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006; Ovesen JL, 2014, TOXICOLOGY, V316, P14, DOI 10.1016/j.tox.2013.12.001; Owen-Hughes T, 2012, CURR OPIN CELL BIOL, V24, P296, DOI 10.1016/j.ceb.2012.02.003; Reynolds M, 2004, J BIOL CHEM, V279, P30419, DOI 10.1074/jbc.M402486200; Schnekenburger M, 2007, MOL CELL BIOL, V27, P7089, DOI 10.1128/MCB.00838-07; Shumilla JA, 1999, J BIOL CHEM, V274, P36207, DOI 10.1074/jbc.274.51.36207; Tsai CC, 2004, VITAM HORM, V68, P93; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; WETTERHAHN KE, 1989, SCI TOTAL ENVIRON, V86, P113, DOI 10.1016/0048-9697(89)90199-X; XU J, 1994, CARCINOGENESIS, V15, P1443, DOI 10.1093/carcin/15.7.1443; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	35	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97849	10.1371/journal.pone.0097849	http://dx.doi.org/10.1371/journal.pone.0097849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837440	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800077
J	Suharti, S; Wang, MY; de Vries, S; Ferry, JG				Suharti, Suharti; Wang, Mingyu; de Vries, Simon; Ferry, James G.			Characterization of the RnfB and RnfG Subunits of the Rnf Complex from the Archaeon Methanosarcina acetivorans	PLOS ONE			English	Article							MEMBRANE-PROTEIN TOPOLOGY; IRON-SULFUR PROTEIN; ELECTRON-TRANSPORT; ECH HYDROGENASE; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; ACETOBACTERIUM-WOODII; DEPENDENT GROWTH; GENOME SEQUENCE; GENE-PRODUCTS	Rnf complexes are redox-driven ion pumps identified in diverse species from the domains Bacteria and Archaea, biochemical characterizations of which are reported for two species from the domain Bacteria. Here, we present characterizations of the redox-active subunits RnfG and RnfB from the Rnf complex of Methanosarcina acetivorans, an acetate-utilizing methane-producing species from the domain Archaea. The purified RnfG subunit produced in Escherichia coli fluoresced in SDS-PAGE gels under UV illumination and showed a UV-visible spectrum typical of flavoproteins. The Thr166Gly variant of RnfG was colorless and failed to fluoresce under UV illumination confirming a role for Thr166 in binding FMN. Redox titration of holo-RnfG revealed a midpoint potential of -129 mV for FMN with n = 2. The overproduced RnfG was primarily localized to the membrane of E. coli and the sequence contained a transmembrane helix. A topological analysis combining reporter protein fusion and computer predictions indicated that the C-terminal domain containing FMN is located on the outer aspect of the cytoplasmic membrane. The purified RnfB subunit produced in E. coli showed a UV-visible spectrum typical of iron-sulfur proteins. The EPR spectra of reduced RnfB featured a broad spectral shape with g values (2.06, 1.94, 1.90, 1.88) characteristic of magnetically coupled 3Fe-4S and 4Fe-4S clusters in close agreement with the iron and acid-labile sulfur content. The ferredoxin specific to the aceticlastic pathway served as an electron donor to RnfB suggesting this subunit is the entry point of electrons to the Rnf complex. The results advance an understanding of the organization and biochemical properties of the Rnf complex and lay a foundation for further understanding the overall mechanism in the pathway of methane formation from acetate.	[Suharti, Suharti; Wang, Mingyu; Ferry, James G.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Delft University of Technology	Ferry, JG (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	jgf3@psu.edu	Suharti, Suharti/ABB-7837-2020	Suharti, Suharti/0000-0002-9849-8083; Wang, Mingyu/0000-0003-1215-9556	NSF [0820734]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant number 0820734 to JGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG FA, 1988, FEBS LETT, V234, P107, DOI 10.1016/0014-5793(88)81313-9; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; CLEMENTS AP, 1994, J BACTERIOL, V176, P2689, DOI 10.1128/JB.176.9.2689-2693.1994; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; ESKELINEN S, 1983, SCAND J CLIN LAB INV, V43, P453; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Guss AM, 2009, J BACTERIOL, V191, P2826, DOI 10.1128/JB.00563-08; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hess V, 2013, J BIOL CHEM, V288, P31496, DOI 10.1074/jbc.M113.510255; Jasso-Chavez R, 2013, J BACTERIOL, V195, P3987, DOI 10.1128/JB.00581-13; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Kim J, 2004, FEMS MICROBIOL REV, V28, P455, DOI 10.1016/j.femsre.2004.03.001; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Li QB, 2006, J BACTERIOL, V188, P702, DOI 10.1128/JB.188.2.702-710.2006; Lu CH, 2004, BIOTECHNOL PROGR, V20, P1634, DOI 10.1021/bp049751l; LU WP, 1993, J BIOL CHEM, V268, P5605; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; Masepohl B, 1996, ARCH MICROBIOL, V165, P80, DOI 10.1007/s002030050301; MaupinFurlow J, 1996, J BACTERIOL, V178, P340, DOI 10.1128/jb.178.2.340-346.1996; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Melchers K, 1999, RES MICROBIOL, V150, P507, DOI 10.1016/S0923-2508(99)00106-0; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; Meyer B, 2014, ENV MICROBI IN PRESS; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Saeki K, 1998, ARCH MICROBIOL, V169, P464, DOI 10.1007/s002030050598; Schlegel K, 2013, BIOCHEM SOC T, V41, P421, DOI 10.1042/BST20120294; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Suharti, 2001, BIOCHEMISTRY-US, V40, P2632, DOI 10.1021/bi0020067; Suharti S, 2008, BIOCHEMISTRY-US, V47, P11528, DOI 10.1021/bi801012p; Tietze M, 2003, CHEMBIOCHEM, V4, P333, DOI 10.1002/cbic.200390053; TREMBLAY P, 2012, MBIO; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wang MY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-165; Welte C, 2013, BIOCH BIOPH IN PRESS; Welte C, 2011, METHOD ENZYMOL, V494, P257, DOI 10.1016/B978-0-12-385112-3.00013-5; Welte C, 2010, FEBS J, V277, P3396, DOI 10.1111/j.1742-4658.2010.07744.x; Welte C, 2010, J BACTERIOL, V192, P674, DOI 10.1128/JB.01307-09; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Worm P, 2011, MICROBIOL-SGM, V157, P280, DOI 10.1099/mic.0.043927-0	60	22	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97966	10.1371/journal.pone.0097966	http://dx.doi.org/10.1371/journal.pone.0097966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836163	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800093
J	Arachiche, A; de la Fuente, M; Nieman, MT				Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.			Platelet Specific Promoters Are Insufficient to Express Protease Activated Receptor 1 (PAR1) Transgene in Mouse Platelets	PLOS ONE			English	Article							FACTOR-VIII; THROMBIN; IDENTIFICATION; HEMATOPOIESIS; HEMOSTASIS; MICE	The in vivo study of protease activated receptors (PARs) in platelets is complicated due to species specific expression profiles. Human platelets express PAR1 and PAR4 whereas mouse platelets express PAR3 and PAR4. Further, PAR subtypes interact with one another to influence activation and signaling. The goal of the current study was to generate mice expressing PAR1 on their platelets using transgenic approaches to mimic PAR expression found in human platelets. This system would allow us to examine specific signaling from PAR1 and the PAR1-PAR4 heterodimer in vivo. Our first approach used the mouse GPIb alpha promoter to drive expression of mouse PAR1 in platelets (GPIb alpha-Tg-mPAR1). We obtained the expected frequency of founders carrying the transgene and had the expected Mendelian distribution of the transgene in multiple founders. However, we did not observe expression or a functional response of PAR1. As a second approach, we targeted human PAR1 with the same promoter (GPIb alpha-Tg-hPAR1). Once again we observed the expected frequency and distributing of the transgene. Human PAR1 expression was detected in platelets from the GPIb alpha-Tg-hPAR1 mice by flow cytometry, however, at a lower level than for human platelets. Despite a low level of PAR1 expression, platelets from the GPIb alpha-Tg-hPAR1 mice did not respond to the PAR1 agonist peptide (SFLLRN). In addition, they did not respond to thrombin when crossed to the PAR4(-/-) mice. Finally, we used an alternative platelet specific promoter, human a(IIb), to express human PAR1 (a(IIb)-Tg-hPAR1). Similar to our previous attempts, we obtained the expected number of founders but did not detect PAR1 expression or response in platelets from alpha(IIb)-Tg-hPAR1 mice. Although unsuccessful, the experiments described in this report provide a resource for future efforts in generating mice expressing PAR1 on their platelets. We provide an experimental framework and offer considerations that will save time and research funds.	[Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	nieman@case.edu			American Heart Association [10SDG2600021]; NIH [HL098217]; Cytometry and Light Microscopy Core Facility; Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Light Microscopy Core Facility; Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by grants from the American Heart Association (AHA Scientist Development Grant, 10SDG2600021) and the NIH (HL098217) to MTN. This research was also supported by the Cytometry and Light Microscopy Core Facility and the Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Arachiche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055740; Aronovich A, 2013, BLOOD, V122, P2562, DOI 10.1182/blood-2012-08-447458; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; DERIAN CK, 1995, THROMB RES, V78, P505, DOI 10.1016/0049-3848(95)00084-5; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; KOZAK M, 1978, CELL, V13, P201, DOI 10.1016/0092-8674(78)90150-2; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Sun HM, 2003, BLOOD, V102, P2856, DOI 10.1182/blood-2003-04-1225; Wilcox DA, 1999, P NATL ACAD SCI USA, V96, P9654, DOI 10.1073/pnas.96.17.9654; Yang TL, 2000, THROMB HAEMOSTASIS, V83, P70; Yarovoi HV, 2003, BLOOD, V102, P4006, DOI 10.1182/blood-2003-05-1519; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang Y, 2012, J THROMB HAEMOST, V10, P2149, DOI 10.1111/j.1538-7836.2012.04894.x	20	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97724	10.1371/journal.pone.0097724	http://dx.doi.org/10.1371/journal.pone.0097724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830314	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500106
J	Bregeon, F; Brioude, G; De Dominicis, F; Atieh, T; D'Journo, XB; Flaudrops, C; Rolain, JM; Raoult, D; Thomas, PA				Bregeon, Fabienne; Brioude, Geoffrey; De Dominicis, Florence; Atieh, Therese; D'Journo, Xavier Benoit; Flaudrops, Christophe; Rolain, Jean-Marc; Raoult, Didier; Thomas, Pascal Alexandre			MALDI-ToF Mass Spectrometry for the Rapid Diagnosis of Cancerous Lung Nodules	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; DIRECT IDENTIFICATION; PROTEOMIC ANALYSIS; FROZEN-SECTION; CLASSIFICATION	Recently, tissue-based methods for proteomic analysis have been used in clinical research and appear reliable for digestive, brain, lymphomatous, and lung cancers classification. However simple, tissue-based methods that couple signal analysis to tissue imaging are time consuming. To assess the reliability of a method involving rapid tissue preparation and analysis to discriminate cancerous from non-cancerous tissues, we tested 141 lung cancer/non-tumor pairs and 8 unique lung cancer samples among the stored frozen samples of 138 patients operated on during 2012. Samples were crushed in water, and 1.5 mu l was spotted onto a steel target for analysis with the Microflex LT analyzer (Bruker Daltonics). Spectra were analyzed using ClinProTools software. A set of samples was used to generate a random classification model on the basis of a list of discriminant peaks sorted with the k-nearest neighbor genetic algorithm. The rest of the samples (n = 43 cancerous and n = 41 non-tumoral) was used to verify the classification capability and calculate the diagnostic performance indices relative to the histological diagnosis. The analysis found 53 m/z valid peaks, 40 of which were significantly different between cancerous and non-tumoral samples. The selected genetic algorithm model identified 20 potential peaks from the training set and had 98.81% recognition capability and 89.17% positive predictive value. In the blinded set, this method accurately discriminated the two classes with a sensitivity of 86.7% and a specificity of 95.1% for the cancer tissues and a sensitivity of 87.8% and a specificity of 95.3% for the non-tumor tissues. The second model generated to discriminate primary lung cancer from metastases was of lower quality. The reliability of MALDI-ToF analysis coupled with a very simple lung preparation procedure appears promising and should be tested in the operating room on fresh samples coupled with the pathological examination.	[Bregeon, Fabienne; Brioude, Geoffrey; De Dominicis, Florence; Atieh, Therese; D'Journo, Xavier Benoit; Flaudrops, Christophe; Rolain, Jean-Marc; Raoult, Didier; Thomas, Pascal Alexandre] Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect, URMITE,UMR 63,CNRS 7278,IRD 3R198,INSERM,U1095, Marseille, France; [Bregeon, Fabienne] Explorat Fonct Resp Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Pole Thorac & Cardiovasc, Marseille, France; [Brioude, Geoffrey; De Dominicis, Florence; D'Journo, Xavier Benoit; Thomas, Pascal Alexandre] Aix Marseille Univ, Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Serv Chirurg Thorac & Malad Oesophage,Pole Thorac, Marseille, France; [Rolain, Jean-Marc; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Pole Malad Infect & Trop Clin & Biol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bregeon, F (corresponding author), Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect, URMITE,UMR 63,CNRS 7278,IRD 3R198,INSERM,U1095, Marseille, France.		Rolain, Jean-Marc/Y-3788-2019; D'journo, Xavier Benoit/AAJ-4457-2021; RAOULT, Didier/A-8434-2008; Thomas, Pascal/L-3355-2019; Thomas, Pascal A/E-5036-2010	Rolain, Jean-Marc/0000-0002-2402-4467; D'journo, Xavier Benoit/0000-0001-6747-4583; RAOULT, Didier/0000-0002-0633-5974; Thomas, Pascal/0000-0002-3305-6989; Thomas, Pascal A/0000-0002-3305-6989	URMITE	URMITE	A grant from the URMITE was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balluff B, 2010, J PROTEOME RES, V9, P6317, DOI 10.1021/pr100573s; Chatelain D, 2012, J VISC SURG, V149, pE134, DOI 10.1016/j.jviscsurg.2012.01.005; Eberlin LS, 2013, P NATL ACAD SCI USA, V110, P1611, DOI 10.1073/pnas.1215687110; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; James P, 1997, Q REV BIOPHYS, V30, P279, DOI 10.1017/S0033583597003399; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Le Faouder J, 2011, J PROTEOME RES, V10, P3755, DOI 10.1021/pr200372p; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; Marchevsky AM, 2004, ANN THORAC SURG, V78, P1755, DOI 10.1016/j.athoracsur.2004.05.003; Maygarden SJ, 2004, MODERN PATHOL, V17, P1080, DOI 10.1038/modpathol.3800154; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; Poon TCW, 2001, CLIN CHIM ACTA, V313, P231, DOI 10.1016/S0009-8981(01)00677-5; Rahman SMJ, 2011, CANCER RES, V71, P3009, DOI 10.1158/0008-5472.CAN-10-2510; Remmerbach TW, 2011, ORAL ONCOL, V47, P278, DOI 10.1016/j.oraloncology.2011.02.005; Rivera MP, 2003, CHEST, V123, p129S, DOI 10.1378/chest.123.1_suppl.129S; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	19	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97511	10.1371/journal.pone.0097511	http://dx.doi.org/10.1371/journal.pone.0097511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830707	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500071
J	Jafari, M; Xu, W; Pan, R; Sweeting, CM; Karunaratne, DN; Chen, P				Jafari, Mousa; Xu, Wen; Pan, Ran; Sweeting, Chad M.; Karunaratne, Desiree Nedra; Chen, Pu			Serum Stability and Physicochemical Characterization of a Novel Amphipathic Peptide C6M1 for SiRNA Delivery	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; RNA INTERFERENCE; NUCLEIC-ACIDS; STABILIZATION; SOLUBILITY; CARRIER; POTENT	The efficient delivery of nucleic acids as therapeutic agents is a major challenge in gene therapy. Peptides have recently emerged as a novel carrier for delivery of drugs and genes. C6M1 is a designed amphipathic peptide with the ability to form stable complexes with short interfering RNA (siRNA). The peptide showed a combination of random coil and helical structure in water but mainly adopted a helical conformation in the presence of anions or siRNA. Revealed by dynamic light scattering (DLS) and microscopy techniques, the interaction of C6M1 and siRNA in water and HEPES led to complexes of similar to 70 and similar to 155 nm in size, respectively, but showed aggregates as large as similar to 500 nm in PBS. The time-dependent aggregation of the complex in PBS was studied by DLS and fluorescence spectroscopy. At molar ratio of 15:1, C6M1 was able to completely encapsulate siRNA; however, higher molar ratios were required to obtain stable complexes. Naked siRNA was completely degraded in 4 h in the solution of 50% serum; however C6M1 protected siRNA against serum RNase over the period of 24 h. Western blotting experiment showed similar to 72% decrease in GAPDH protein level of the cells treated with C6M1-siRNA complexes while no significant knockdown was observed for the cells treated with naked siRNA.	[Jafari, Mousa; Xu, Wen; Pan, Ran; Sweeting, Chad M.; Karunaratne, Desiree Nedra; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Jafari, Mousa; Xu, Wen; Pan, Ran; Chen, Pu] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada; [Karunaratne, Desiree Nedra] Univ Peradeniya, Dept Chem, Peradeniya, Sri Lanka	University of Waterloo; University of Waterloo; University of Peradeniya	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Waterloo Institute for Nanotechnology fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Waterloo Institute for Nanotechnology fellowship	This research was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chairs (CRC) Program, and Waterloo Institute for Nanotechnology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEMAN C, 1995, INT J PEPT PROT RES, V46, P408; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P7698, DOI 10.1021/bi049298m; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elshereef R, 2006, BIOTECHNOL BIOENG, V95, P863, DOI 10.1002/bit.21039; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hao JG, 2009, ARCH PHARM RES, V32, P1045, DOI 10.1007/s12272-009-1710-3; Harutyunyan EH, 1996, EUR J BIOCHEM, V239, P220, DOI 10.1111/j.1432-1033.1996.0220u.x; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Jafari M, 2013, BIOCHEMISTRY-US, V52, P3428, DOI 10.1021/bi4001326; Jafari M, 2012, J PHYS CHEM B, V116, P13183, DOI 10.1021/jp3072553; Jarvert P, 2007, BIOCHEM SOC T, V35, P770; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Konate K, 2010, BIOCHEMISTRY-US, V49, P3393, DOI 10.1021/bi901791x; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lee SY, 2010, J CONTROL RELEASE, V141, P339, DOI 10.1016/j.jconrel.2009.10.007; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lundberg P, 2002, BIOCHEM BIOPH RES CO, V299, P85, DOI 10.1016/S0006-291X(02)02595-0; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mann RA, 2012, J CONTROL RELEASE, V157, P260, DOI 10.1016/j.jconrel.2011.09.081; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Paddison PJ, 2008, RNA INTERFERENCE; Rao NM, 2006, BIOSCIENCE REP, V26, P301, DOI 10.1007/s10540-006-9026-8; Shi ZS, 2001, BIOPOLYMERS, V60, P366, DOI 10.1002/1097-0282(2001)60:5<366::AID-BIP10177>3.0.CO;2-5; Veldhoen S, 2008, INT J MOL SCI, V9, P1276, DOI 10.3390/ijms9071276; Verma S, 2003, CHEM REC, V3, P51, DOI 10.1002/tcr.10047; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Xu PS, 2006, BIOTECHNOL BIOENG, V95, P893, DOI 10.1002/bit.21036; Zhang HY, 2006, CURR TOP MED CHEM, V6, P893, DOI 10.2174/156802606777303676	31	31	32	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97797	10.1371/journal.pone.0097797	http://dx.doi.org/10.1371/journal.pone.0097797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831131	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500117
J	Koutsoni, O; Barhoumi, M; Guizani, I; Dotsika, E				Koutsoni, Olga; Barhoumi, Mourad; Guizani, Ikram; Dotsika, Eleni			Leishmania Eukaryotic Initiation Factor (LeIF) Inhibits Parasite Growth in Murine Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; IFN-GAMMA; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; CC-CHEMOKINE; INFLAMMATORY PROTEIN-1-ALPHA; ACTIVATED MACROPHAGES; INTERLEUKIN (IL)-12; MAJOR AMASTIGOTES	The leishmaniases constitute neglected global public health problems that require adequate control measures, prophylactic clinical vaccines and effective and non-toxic drug treatments. In this study, we explored the potential of Leishmania infantum eukaryotic initiation factor (LieIF), an exosomal protein, as a novel anti-infective therapeutic molecule. More specifically, we assessed the efficacy of recombinant LieIF, in combination with recombinant IFN-gamma, in eliminating intracellular L. donovani parasites in an in vitro macrophage model. J774A.1 macrophages were initially treated with LieIF/IFN-gamma prior to in vitro infection with L. donovani stationary phase promastigotes (pre-infection treatment), and resistance to infection was observed 72 h after infection. J774A.1 macrophages were also treated with LieIF/IFN-gamma after L. donovani infection (post-infection treatment), and resistance to infection was also observed at both time points tested (19 h and 72 h) after infection. To elucidate the LieIF/IFN-gamma-induced mechanism(s) that mediate the reduction of intracellular parasite growth, we examined the generation of potent microbicidal molecules, such as nitric oxide (NO) and reactive oxygen species (ROS), within infected macrophages. Furthermore, macrophages pre-treated with LieIF/IFN-gamma showed a clear up-regulation in macrophage inflammatory protein 1 alpha (MIP-1 alpha) as well as tumor necrosis factor alpha (TNF-alpha) expression. However, significant different protein levels were not detected. In addition, macrophages pre-treated with LieIF/IFN-gamma combined with anti-TNF-alpha monoclonal antibody produced significantly lower amounts of ROS. These data suggest that during the pre-treatment state, LieIF induces intramacrophage parasite growth inhibition through the production of TNF-alpha, which induces microbicidal activity by stimulating NO and ROS production. The mechanisms of NO and ROS production when macrophages are treated with LieIF after infection are probably different. Overall, these results indicate that LieIF is a good candidate for use as an anti-leishmanial molecule.	[Koutsoni, Olga; Dotsika, Eleni] Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece; [Barhoumi, Mourad; Guizani, Ikram] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol Mol & Pathol Expt Appl Malad Infect, Tunis, Tunisia; [Koutsoni, Olga] Natl & Kapodistrian Univ, Med Sch Athens, Dept Microbiol, Athens, Greece	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; National & Kapodistrian University of Athens	Guizani, I (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol Mol & Pathol Expt Appl Malad Infect, Tunis, Tunisia.	ikram.guizani@pasteur.rns.tn; e.dotsika@pasteur.gr	Koutsoni, Olga/AAH-5511-2021; Barhoumi, Mourad/AAU-8031-2020; Dotsika, Elissavet/D-7260-2016	Dotsika, Elissavet/0000-0003-1858-2961; Guizani, Ikram/0000-0003-2763-8963	Institut Pasteur fellowship (programme Calmette et Yersin); Greek Ministry of Education, Religious Affairs, Culture and Sport; UNICEF/UNDP/World Bank/WHO; TDR [A30134]; Tunisian ministry of higher education and scientific research [LR00SP04, LR11IPT04]	Institut Pasteur fellowship (programme Calmette et Yersin); Greek Ministry of Education, Religious Affairs, Culture and Sport; UNICEF/UNDP/World Bank/WHO(World Health Organization); TDR; Tunisian ministry of higher education and scientific research	This work was conducted in the frame of an Institut Pasteur fellowship (programme Calmette et Yersin) granted to M. B. as post-doctoral fellow. O.K. received a PhD fellowship from the Greek Ministry of Education, Religious Affairs, Culture and Sport. Work in the HPI was funded by an internal grant. Work in IPT received support from the special program of the UNICEF/UNDP/World Bank/WHO for research and training on tropical diseases, TDR (A30134) and the Tunisian ministry of higher education and scientific research (LR00SP04 and LR11IPT04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Badaro R, 2001, Braz J Infect Dis, V5, P223; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Barhoumi M, 2013, PARASITE IMMUNOL, V35, P194, DOI 10.1111/pim.12026; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Barhoumi M, 2006, FEBS J, V273, P5086, DOI 10.1111/j.1742-4658.2006.05506.x; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhattacharyya S, 2002, J INFECT DIS, V185, P1704, DOI 10.1086/340820; Bisti S, 2006, MICROBES INFECT, V8, P1464, DOI 10.1016/j.micinf.2006.01.014; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brandonisio O, 2002, CLIN EXP MED, V2, P125, DOI 10.1007/s102380200017; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; CUNHA FQ, 1993, EUR J IMMUNOL, V23, P1385, DOI 10.1002/eji.1830230631; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Dey R, 2007, SCAND J IMMUNOL, V66, P671, DOI 10.1111/j.1365-3083.2007.02025.x; Dey R, 2005, INFECT IMMUN, V73, P8334, DOI 10.1128/IAI.73.12.8334-8344.2005; DING AH, 1988, J IMMUNOL, V141, P2407; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; EVANS TG, 1993, J IMMUNOL, V151, P907; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREEN SJ, 1990, J IMMUNOL, V144, P278; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kumar P, 2002, J MED MICROBIOL, V51, P832, DOI 10.1099/0022-1317-51-10-832; Kumar R, 2001, CLIN EXP IMMUNOL, V124, P262, DOI 10.1046/j.1365-2249.2001.01551.x; Kyriazis JD, 2013, PHYTOMEDICINE, V20, P275, DOI 10.1016/j.phymed.2012.11.013; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liew FY, 1999, IMMUNOL LETT, V65, P101, DOI 10.1016/S0165-2478(98)00131-X; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1990, J IMMUNOL, V144, P4794; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1982, J IMMUNOL, V129, P344; NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Panaro MA, 1999, INT J CLIN LAB RES, V29, P122, DOI 10.1007/s005990050076; Probst P, 1997, EUR J IMMUNOL, V27, P2634, DOI 10.1002/eji.1830271024; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Sakai S, 2010, VACCINE, V28, P2207, DOI 10.1016/j.vaccine.2009.12.055; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sato N, 1999, J IMMUNOL, V163, P5519; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Scott P, 2003, IMMUNOL RES, V27, P489, DOI 10.1385/IR:27:2-3:489; Sharma A, 2009, J IMMUNOL, V183, P7719, DOI 10.4049/jimmunol.0900132; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Strieter RM, 1996, J IMMUNOL, V156, P3583; Tsagozis P, 2003, PARASITE IMMUNOL, V25, P569, DOI 10.1111/j.0141-9838.2004.00672.x; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; von Stebut E, 2004, MICROBES INFECT, V6, P1102, DOI 10.1016/j.micinf.2004.05.024; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	76	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97319	10.1371/journal.pone.0097319	http://dx.doi.org/10.1371/journal.pone.0097319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830439	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500048
J	Santos, DA; Dawson, JA; Matias, CN; Rocha, PM; Minderico, CS; Allison, DB; Sardinha, LB; Silva, AM				Santos, Diana A.; Dawson, John A.; Matias, Catarina N.; Rocha, Paulo M.; Minderico, Claudia S.; Allison, David B.; Sardinha, Luis B.; Silva, Analiza M.			Reference Values for Body Composition and Anthropometric Measurements in Athletes	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; RESEARCH WORKING GROUP; SKELETAL-MUSCLE MASS; POSITION STATEMENT; PERFORMANCE; SPORT; DETERMINANTS; VALIDATION; AUSPICES; BEHALF	Background: Despite the importance of body composition in athletes, reference sex-and sport-specific body composition data are lacking. We aim to develop reference values for body composition and anthropometric measurements in athletes. Methods: Body weight and height were measured in 898 athletes (264 female, 634 male), anthropometric variables were assessed in 798 athletes (240 female and 558 male), and in 481 athletes (142 female and 339 male) with dual-energy X-ray absorptiometry (DXA). A total of 21 different sports were represented. Reference percentiles (5th, 25th, 50th, 75th, and 95th) were calculated for each measured value, stratified by sex and sport. Because sample sizes within a sport were often very low for some outcomes, the percentiles were estimated using a parametric, empirical Bayesian framework that allowed sharing information across sports. Results: We derived sex-and sport-specific reference percentiles for the following DXA outcomes: total (whole body scan) and regional (subtotal, trunk, and appendicular) bone mineral content, bone mineral density, absolute and percentage fat mass, fat-free mass, and lean soft tissue. Additionally, we derived reference percentiles for height-normalized indexes by dividing fat mass, fat-free mass, and appendicular lean soft tissue by height squared. We also derived sex-and sport-specific reference percentiles for the following anthropometry outcomes: weight, height, body mass index, sum of skinfold thicknesses (7 skinfolds, appendicular skinfolds, trunk skinfolds, arm skinfolds, and leg skinfolds), circumferences (hip, arm, midthigh, calf, and abdominal circumferences), and muscle circumferences (arm, thigh, and calf muscle circumferences). Conclusions: These reference percentiles will be a helpful tool for sports professionals, in both clinical and field settings, for body composition assessment in athletes.	[Santos, Diana A.; Matias, Catarina N.; Rocha, Paulo M.; Minderico, Claudia S.; Sardinha, Luis B.; Silva, Analiza M.] Univ Lisbon, Exercise & Hlth Lab, CIPER, Fac Motricidade Humana, Cruz Quebrada, Portugal; [Dawson, John A.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Off Energet, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Rocha, Paulo M.] Portuguese Inst Sport & Youth, Sport Med & Training Control Unit, Cruz Quebrada, Portugal	Universidade de Lisboa; University of Alabama System; University of Alabama Birmingham	Silva, AM (corresponding author), Univ Lisbon, Exercise & Hlth Lab, CIPER, Fac Motricidade Humana, Cruz Quebrada, Portugal.	analiza@fmh.ulisboa.pt	Manuel Rocha, Paulo/AAE-7124-2022; Sardinha, Luís Bettencourt/F-2641-2013; Santos, Diana A/H-9086-2013; Dawson, John/HDM-6702-2022; Sardinha, Luís B./ABG-5389-2020; Santos, Vanessa/AAP-4130-2020; Matias, Catarina N/I-7957-2014; Silva, Analiza M/C-9858-2010	Sardinha, Luís Bettencourt/0000-0002-6230-6027; Santos, Diana A/0000-0003-0429-3093; Sardinha, Luís B./0000-0002-6230-6027; Silva, Analiza M/0000-0002-8984-8600; Allison, David/0000-0003-3566-9399; Rocha, Paulo/0000-0001-8971-5501; Minderico, Claudia Sofia/0000-0002-3621-9501	Portuguese Foundation for Science and Technology [PTDC/DES/098963/2008, SFRH/BD/46503/2008]; National Institutes of Health (NIH) [T32HL072757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, P30DK079626] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Portuguese Foundation for Science and Technology (Grant: PTDC/DES/098963/2008). DAS was supported by a scholarship from the Portuguese Foundation for Science and Technology (SFRH/BD/46503/2008). JAD is supported National Institutes of Health (NIH) grant T32HL072757. The opinions expressed are those of the authors and not necessarily those of the NIH or any other organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; [Anonymous], 2007, MED SCI SPORT EXER, V39, P1867, DOI 10.1249/mss.0b013e318149f111; [Anonymous], 2005, CHAPTER 8 ANTHROPOME; Brun JF, 2011, CLIN HEMORHEOL MICRO, V49, P207, DOI 10.3233/CH-2011-1470; Granados C, 2008, MED SCI SPORT EXER, V40, P351, DOI 10.1249/mss.0b013e31815b4905; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Hogstrom GM, 2012, J STRENGTH COND RES, V26, P1799, DOI 10.1519/JSC.0b013e318237e8da; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jones MM, 2001, P SEOUL INT SPORT SC, P313; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malina R. M., 2005, HUMAN BODY COMPOSITI, P271; Malina RM, 2007, CLIN SPORT MED, V26, P37, DOI 10.1016/j.csm.2006.11.004; Midorikawa T, 2007, INT J SPORTS MED, V28, P100, DOI 10.1055/s-2006-924139; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; National Institutes of Health, 1998, CLIN GUID ID EV TREA; Pietrobelli A, 1998, AM J PHYSIOL-ENDOC M, V274, pE808, DOI 10.1152/ajpendo.1998.274.5.E808; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Prior BM, 2001, J APPL PHYSIOL, V90, P1523, DOI 10.1152/jappl.2001.90.4.1523; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Santos DA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-22; Santos DA, 2013, J SPORT SCI, V31, P405, DOI 10.1080/02640414.2012.734918; Shen W., 2005, HUMAN BODY COMPOSITI, P3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Silva AM, 2006, EUR J CLIN NUTR, V60, P955, DOI 10.1038/sj.ejcn.1602405; Silva AM, 2010, INT J SPORTS MED, V31, P737, DOI 10.1055/s-0030-1255115; Silva AM, 2011, J STRENGTH COND RES, V25, P2488, DOI 10.1519/JSC.0b013e3181fb3dfb; St-Onge MP, 2004, AM J PHYSIOL-ENDOC M, V287, pE842, DOI 10.1152/ajpendo.00361.2003; Sundgot-Borgen J, 2013, BRIT J SPORT MED, V47, P1012, DOI 10.1136/bjsports-2013-092966; TANNER J. M., 1962, Growth at adolescence. With a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity.; Toombs RJ, 2012, OBESITY, V20, P30, DOI 10.1038/oby.2011.211; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; World Medical Association (WMA), 2008, DECL HELS ETH PRINC	39	120	122	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97846	10.1371/journal.pone.0097846	http://dx.doi.org/10.1371/journal.pone.0097846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830292	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500125
J	Wang, SP; Wang, L; Shi, Z; Zhong, ZF; Chen, MW; Wang, YT				Wang, Shengpeng; Wang, Lu; Shi, Zhi; Zhong, Zhangfeng; Chen, Meiwan; Wang, Yitao			Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B ACTIVATION; MULTIDRUG-RESISTANCE; CELL-LINES; APOPTOSIS RESISTANCE; SIGNALING PATHWAYS; THERAPY RESISTANCE; DOWN-REGULATION; IN-VITRO; DEATH	Drug resistance is one of the main hurdles for the successful treatment of breast cancer. The synchronous targeting of apoptosis resistance and survival signal transduction pathways may be a promising approach to overcome drug resistance. In this study, we determined that evodiamine (EVO), a major constituent of the Chinese herbal medicine Evodiae Fructus, could induce apoptosis of doxorubicin (DOX)-sensitive MCF-7 and DOX-resistant MCF-7/ADR cells in a caspase-dependent manner, as confirmed by significant increases of cleaved poly(ADP-ribose) polymerase (PARP), caspase-7/9, and caspase activities. Notably, the reversed phenomenon of apoptosis resistance by EVO might be attributed to its ability to inhibit the Ras/MEK/ERK pathway and the expression of inhibitors of apoptosis (IAPs). Furthermore, our results indicated that EVO enhanced the apoptotic action of DOX by inhibiting the Ras/MEK/ERK cascade and the expression of IAPs without inhibiting the expression and activity of P-glycoprotein (P-gp). Taken together, our data indicate that EVO, a natural product, may be useful applied alone or in combination with DOX for the treatment of resistant breast cancer.	[Wang, Shengpeng; Wang, Lu; Zhong, Zhangfeng; Chen, Meiwan; Wang, Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Inst Biomed, Guangzhou, Guangdong, Peoples R China	University of Macau; Jinan University; Jinan University	Chen, MW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China.	mwchen@umac.mo; yo'wang@umac.mo	Wang, Yitao/O-5184-2016		Macao Science and Technology Development Fund [102/2012/A3, 077/2011/A3]; Research Fund of the University of Macau [MYRG 208 (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG005/CMW/2014/ICMS]	Macao Science and Technology Development Fund; Research Fund of the University of Macau	This study was supported by the Macao Science and Technology Development Fund (102/2012/A3, 077/2011/A3) and the Research Fund of the University of Macau (MYRG 208 (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG005/CMW/2014/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATIST G, 1986, J BIOL CHEM, V261, P5544; Blanc C, 2000, CANCER RES, V60, P4386; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen SY, 2013, ASIAN PAC J CANCER P, V14, P6135, DOI 10.7314/APJCP.2013.14.10.6135; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dai Y, 2009, AM J TRANSL RES, V1, P1; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Fei XF, 2003, CANCER SCI, V94, P92, DOI 10.1111/j.1349-7006.2003.tb01358.x; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kan SF, 2004, INT J CANCER, V110, P641, DOI 10.1002/ijc.20138; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khonkarn R, 2012, COLLOID SURFACE B, V94, P266, DOI 10.1016/j.colsurfb.2012.02.002; Kim TH, 2014, BBA-GEN SUBJECTS, V1840, P615, DOI 10.1016/j.bbagen.2013.10.023; KING CL, 1980, J NAT PROD, V43, P577, DOI 10.1021/np50011a008; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kruh GD, 2003, ONCOGENE, V22, P7262, DOI 10.1038/sj.onc.1206932; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; Ogasawara M, 2002, BIOL PHARM BULL, V25, P1491, DOI 10.1248/bpb.25.1491; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065; Rangwala F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-402; Rumjanek VM, 2013, BIOSCIENCE REP, V33, P875, DOI 10.1042/BSR20130067; Saha S, 2012, ANTICANCER RES, V32, P2567; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shyu KG, 2006, LIFE SCI, V78, P2234, DOI 10.1016/j.lfs.2005.09.027; Silva KL, 2013, LEUKEMIA RES, V37, P1350, DOI 10.1016/j.leukres.2013.06.014; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Vaux DL, 2005, CELL DEATH DIFFER, V12, P1205, DOI 10.1038/sj.cdd.4401696; Wang C, 2010, TOXICOL IN VITRO, V24, P898, DOI 10.1016/j.tiv.2009.11.019; Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Yamaguchi Y, 2005, ONCOL REP, V14, P1311; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Yu H, 2013, MOLECULES, V18, P1826, DOI 10.3390/molecules18021826	44	53	54	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97512	10.1371/journal.pone.0097512	http://dx.doi.org/10.1371/journal.pone.0097512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830744	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500072
J	Kraal, L; Abubucker, S; Kota, K; Fischbach, MA; Mitreva, M				Kraal, Laurens; Abubucker, Sahar; Kota, Karthik; Fischbach, Michael A.; Mitreva, Makedonka			The Prevalence of Species and Strains in the Human Microbiome: A Resource for Experimental Efforts	PLOS ONE			English	Article							GUT MICROBIOME; BACTEROIDES; DIET; DIVERSITY; GENOMES	Experimental efforts to characterize the human microbiota often use bacterial strains that were chosen for historical rather than biological reasons. Here, we report an analysis of 380 whole-genome shotgun samples from 100 subjects from the NIH Human Microbiome Project. By mapping their reads to 1,751 reference genome sequences and analyzing the resulting relative strain abundance in each sample we present metrics and visualizations that can help identify strains of interest for experimentalists. We also show that approximately 14 strains of 10 species account for 80% of the mapped reads from a typical stool sample, indicating that the function of a community may not be irreducibly complex. Some of these strains account for >20% of the sequence reads in a subset of samples but are absent in others, a dichotomy that could underlie biological differences among subjects. These data should serve as an important strain selection resource for the community of researchers who take experimental approaches to studying the human microbiota.	[Kraal, Laurens; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kraal, Laurens; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Abubucker, Sahar; Kota, Karthik; Mitreva, Makedonka] Washington Univ Sch Med, Genome Inst, St Louis, MO USA; [Mitreva, Makedonka] Washington Univ Sch Med, Dept Med, St Louis, MO USA; [Mitreva, Makedonka] Washington Univ Sch Med, Dept Genet, St Louis, MO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	fischbach@fischbachgroup.org; mmitreva@genome.wustl.edu		Mitreva, Makedonka/0000-0001-9572-3436; Fischbach, Michael/0000-0003-3079-8247	Medical Research award from the W.M. Keck Foundation; David and Lucile Packard Foundation; NIH [DP2 OD007290, U54HG004968]; UCSF Center for Systems and Synthetic Biology; NIGMS (NIGMS Systems Biology Center grant) [P50 GM081879]; ARCS Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Medical Research award from the W.M. Keck Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Center for Systems and Synthetic Biology; NIGMS (NIGMS Systems Biology Center grant); ARCS Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Medical Research award from the W.M. Keck Foundation (M.A.F.); a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.); NIH DP2 OD007290 (M.A.F.); the UCSF Center for Systems and Synthetic Biology (http://systemsbiology.ucsf.edu/), one of the NIGMS-funded National Centers for Systems Biology (http://www.systemscenters.org) (NIGMS Systems Biology Center grant P50 GM081879); and a fellowship from the ARCS Foundation (https://www.arcsfoundation.org/) (L.K.). Research at Washington University was supported by NIH U54HG004968 (G.M. Weinstock). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, FASEB J; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V107, P11976, DOI 10.1073/pnas.1005039107; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eggerth AH, 1933, J BACTERIOL, V25, P389, DOI 10.1128/JB.25.4.389-413.1933; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vos M, 2011, PLOS ONE, V7; Waters JL, 2012, J BACTERIOL, V194, P5228, DOI 10.1128/JB.00941-12; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	45	59	61	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97279	10.1371/journal.pone.0097279	http://dx.doi.org/10.1371/journal.pone.0097279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827833	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400072
J	Lee, DH; Lind, L; Jacobs, DR; Salihovic, S; van Bavel, B; Lind, PM				Lee, Duk-Hee; Lind, Lars; Jacobs, David R., Jr.; Salihovic, Samira; van Bavel, Bert; Lind, P. Monica			Does Mortality Risk of Cigarette Smoking Depend on Serum Concentrations of Persistent Organic Pollutants? Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study	PLOS ONE			English	Article							TELOMERE LENGTH; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; IN-VITRO; HORMESIS; ASSOCIATION; DICHLORODIPHENYLTRICHLOROETHANE; KERATINOCYTES; TRANSCRIPTION; PESTICIDES	Cigarette smoking is an important cause of preventable death globally, but associations between smoking and mortality vary substantially across country and calendar time. Although methodological biases have been discussed, it is biologically plausible that persistent organic pollutants (POPs) like polychlorinated biphenyls (PCBs) and organochlorine (OC) pesticides can affect this association. This study was performed to evaluate if associations of cigarette smoking with mortality were modified by serum concentrations of PCBs and OC pesticides. We evaluated cigarette smoking in 111 total deaths among 986 men and women aged 70 years in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) with mean follow-up for 7.7 years. The association between cigarette smoking and total mortality depended on serum concentration of PCBs and OC pesticides (P value for interaction = 0.02). Among participants in the highest tertile of the serum POPs summary score, former and current smokers had 3.7 (95% CI, 1.5-9.3) and 6.4 (95% CI, 2.3-17.7) times higher mortality hazard, respectively, than never smokers. In contrast, the association between cigarette smoking and total mortality among participants in the lowest tertile of the serum POPs summary score was much weaker and statistically nonsignificant. The strong smoking-mortality association observed among elderly people with high POPs was mainly driven by low risk of mortality among never smokers with high POPs. As smoking is increasing in many low-income and middle-income countries and POPs contamination is a continuing problem in these areas, the interactions between these two important health-related issues should be considered in future research.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Taegu, South Korea; [Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Taegu, South Korea; [Lind, Lars] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Salihovic, Samira; van Bavel, Bert] Univ Orebro, Sch Sci & Technol, MTM Res Ctr, SE-70182 Orebro, Sweden; [Lind, P. Monica] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Kyungpook National University; Kyungpook National University; Uppsala University; Uppsala University Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Orebro University; Uppsala University	Lind, PM (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden.	monica.lind@medsci.uu.se	van Bavel, Bert/K-1377-2015; Lind, Monica/B-6677-2017	van Bavel, Bert/0000-0001-6217-8857; Lind, Monica/0000-0002-8949-3555; Salihovic, Samira/0000-0001-5752-4196; Jacobs, David/0000-0002-7232-0543	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Korea Health technology RD Project; Ministry of Health & Welfare, Republic of Korea [A111716]; BK21 PLUS KNU Biomedical Convergence Program for Creative Talent	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Korea Health technology RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); BK21 PLUS KNU Biomedical Convergence Program for Creative Talent	This study was supported by the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111716), and BK21 PLUS KNU Biomedical Convergence Program for Creative Talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Carpenter David O., 2011, Reviews on Environmental Health, V26, P61, DOI 10.1515/REVEH.2011.009; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; DIWAN BA, 1994, TOXICOL PATHOL, V22, P430, DOI 10.1177/019262339402200409; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Hunt D, 2005, INT J EPIDEMIOL, V34, P1020, DOI 10.1093/ije/dyi139; HUTTON JJ, 1979, MUTAT RES, V66, P75, DOI 10.1016/0165-1218(79)90010-7; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee YM, 2013, J KOREAN MED SCI, V28, P1122, DOI 10.3346/jkms.2013.28.8.1122; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; PSATY BM, 1990, J CLIN EPIDEMIOL, V43, P961, DOI 10.1016/0895-4356(90)90079-5; Salihovic S, 2012, ENVIRON INT, V44, P59, DOI 10.1016/j.envint.2012.01.011; Sandau CD, 2003, ANAL CHEM, V75, P71, DOI 10.1021/ac026121u; Shin JY, 2010, MUTAGENESIS, V25, P511, DOI 10.1093/mutage/geq035; Shutoh Y, 2009, J TOXICOL SCI, V34, P469, DOI 10.2131/jts.34.469; Solomon GM, 2002, ENVIRON HEALTH PERSP, V110, pA339, DOI 10.1289/ehp.021100339; Someya M, 2010, ENVIRON INT, V36, P27, DOI 10.1016/j.envint.2009.09.003; Sukata T, 2002, INT J CANCER, V99, P112, DOI 10.1002/ijc.10312; Tanabe S, 2010, ECOTOXICOLOGY, V19, P463, DOI 10.1007/s10646-009-0445-8; Tuomisto Jouko, 2005, Dose-Response, V3, P332, DOI 10.2203/dose-response.003.03.004; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van de Mheen PJ, 1996, PUBLIC HLTH REP, V111, P427; van de Mheen PJ, 1996, PUBLIC HLTH REP, V111, P420; Viluksela M, 2000, CANCER RES, V60, P6911; Wong MH, 2005, CHEMOSPHERE, V60, P740, DOI 10.1016/j.chemosphere.2005.04.028; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yokoo S, 2004, J CELL BIOCHEM, V93, P588, DOI 10.1002/jcb.20208; Zhang TC, 2003, CARCINOGENESIS, V24, P1811, DOI 10.1093/carcin/bgg141	33	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95937	10.1371/journal.pone.0095937	http://dx.doi.org/10.1371/journal.pone.0095937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828407	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400019
J	Weber, ND; Stone, D; Sedlak, RH; Feelixge, HSD; Roychoudhury, P; Schiffer, JT; Aubert, M; Jerome, KR				Weber, Nicholas D.; Stone, Daniel; Sedlak, Ruth Hall; Feelixge, Harshana S. De Silva; Roychoudhury, Pavitra; Schiffer, Joshua T.; Aubert, Martine; Jerome, Keith R.			AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication	PLOS ONE			English	Article							FACTOR-IX; VIRAL TRANSCRIPTION; RNA INTERFERENCE; GENE-TRANSFER; IN-VIVO; DNA; HEMOPHILIA; LIVER; MUTAGENESIS; CLEAVAGE	Despite an existing effective vaccine, hepatitis B virus (HBV) remains a major public health concern. There are effective suppressive therapies for HBV, but they remain expensive and inaccessible to many, and not all patients respond well. Furthermore, HBV can persist as genomic covalently closed circular DNA (cccDNA) that remains in hepatocytes even during otherwise effective therapy and facilitates rebound in patients after treatment has stopped. Therefore, the need for an effective treatment that targets active and persistent HBV infections remains. As a novel approach to treat HBV, we have targeted the HBV genome for disruption to prevent viral reactivation and replication. We generated 3 zinc finger nucleases (ZFNs) that target sequences within the HBV polymerase, core and X genes. Upon the formation of ZFN-induced DNA double strand breaks (DSB), imprecise repair by non-homologous end joining leads to mutations that inactivate HBV genes. We delivered HBV-specific ZFNs using self-complementary adeno-associated virus (scAAV) vectors and tested their anti-HBV activity in HepAD38 cells. HBV-ZFNs efficiently disrupted HBV target sites by inducing site-specific mutations. Cytotoxicity was seen with one of the ZFNs. scAAV-mediated delivery of a ZFN targeting HBV polymerase resulted in complete inhibition of HBV DNA replication and production of infectious HBV virions in HepAD38 cells. This effect was sustained for at least 2 weeks following only a single treatment. Furthermore, high specificity was observed for all ZFNs, as negligible off-target cleavage was seen via high-throughput sequencing of 7 closely matched potential off-target sites. These results show that HBV-targeted ZFNs can efficiently inhibit active HBV replication and suppress the cellular template for HBV persistence, making them promising candidates for eradication therapy.	[Weber, Nicholas D.; Stone, Daniel; Feelixge, Harshana S. De Silva; Roychoudhury, Pavitra; Schiffer, Joshua T.; Aubert, Martine; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Weber, Nicholas D.; Sedlak, Ruth Hall; Jerome, Keith R.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Schiffer, Joshua T.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Schiffer, Joshua T.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jerome, Keith R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Jerome, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	kjerome@fhcrc.org	Roychoudhury, Pavitra/K-8841-2012	Roychoudhury, Pavitra/0000-0002-4567-8232; Stone, Daniel/0000-0003-1619-7541	NIH [U19 AI 096111]; NIH Interdisciplinary Training Grant postdoctoral fellowship [T32 CA080416]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Interdisciplinary Training Grant postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this work were funded by NIH supported Martin Delaney Collaboratory grant U19 AI 096111. NDW was supported by NIH Interdisciplinary Training Grant postdoctoral fellowship T32 CA080416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Aubert M, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.75; Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; BEASLEY RP, 1981, LANCET, V2, P1129; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chen CC, 2009, MOL THER, V17, P352, DOI 10.1038/mt.2008.245; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi V.W., 2007, CURR PROTOC MOL BIOL; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fagone P, 2012, HUM GENE THER METHOD, V23, P1, DOI 10.1089/hgtb.2011.104; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Grosse S, 2011, MOL THER, V19, P694, DOI 10.1038/mt.2010.302; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Harding TC, 2004, GENE THER, V11, P204, DOI 10.1038/sj.gt.3302142; Ho KJ, 2008, AM J PHYSIOL-GASTR L, V295, pG412, DOI 10.1152/ajpgi.00590.2007; Hoeksema KA, 2010, METHODS MOL BIOL, V649, P97, DOI 10.1007/978-1-60761-753-2_6; Hosel M, 2014, HEPATOLOGY, V59, P2110, DOI 10.1002/hep.26990; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Loeb KR, 2000, HEPATOLOGY, V32, P626, DOI 10.1053/jhep.2000.9878; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Schiffer JT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003131; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Sedlak RH, 2013, DIAGN MICR INFEC DIS, V75, P1, DOI 10.1016/j.diagmicrobio.2012.10.009; Shi LP, 2012, J VIROL, V86, P10059, DOI 10.1128/JVI.00535-12; Stone D, 2013, CURR OPIN HIV AIDS, V8, P217, DOI 10.1097/COH.0b013e32835f736c; Tanaka A, 2013, LEUKEMIA, V27, P1621, DOI 10.1038/leu.2013.46; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Weber ND, 2014, VIROLOGY, V454, P353, DOI 10.1016/j.virol.2013.12.037; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Zimmerman KA, 2008, J VIROL, V82, P8013, DOI 10.1128/JVI.00366-08; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	59	78	93	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97579	10.1371/journal.pone.0097579	http://dx.doi.org/10.1371/journal.pone.0097579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827459	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400109
J	Ye, WL; Du, JB; Zhang, BL; Na, R; Song, YF; Mei, QB; Zhao, MG; Zhou, SY				Ye, Wei-liang; Du, Jiang-bo; Zhang, Bang-le; Na, Ren; Song, Yan-feng; Mei, Qi-bing; Zhao, Ming-gao; Zhou, Si-yuan			Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles	PLOS ONE			English	Article							DRUG-DELIVERY; POLYMERIC MICELLES; CANCER; CONJUGATE; TUMOR; PH; BIODISTRIBUTION; NANOCARRIERS; ENDOCYTOSIS; RESVERATROL	A PEG-based, folate mediated, active tumor targeting drug delivery system using DOX-hyd-PEG-FA nanoparticles (NPs) were prepared. DOX-hyd-PEG-FA NPs showed a significantly faster DOX release in pH 5.0 medium than in pH 7.4 medium. Compared with DOX-hyd-PEG NPs, DOX-hyd-PEG-FA NPs increased the intracellular accumulation of DOX and showed a DOX translocation from lysosomes to nucleus. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was much higher than that of free DOX, DOX-ami-PEG-FA NPs and DOX-hyd-PEG NPs. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was attenuated in the presence of exogenous folic acid. The IC50 of DOX-hyd-PEG-FA NPs and DOX-hyd-PEG NPs on A549 cells showed no significant difference. After DOX-hyd-PEG-FA NPs were intravenously administered, the amount of DOX distributed in tumor tissue was significantly increased, while the amount of DOX distributed in heart was greatly decreased as compared with free DOX. Compared with free DOX, NPs yielded improved survival rate, prolonged life span, delayed tumor growth and reduced the cardiotoxicity in tumor bearing mice model. These results indicated that the acid sensitivity, passive and active tumor targeting abilities were likely to act synergistically to enhance the drug delivery efficiency of DOX-hyd-PEG-FA NPs. Therefore, DOX-hyd-PEG-FA NPs are a promising drug delivery system for targeted cancer therapy.	[Ye, Wei-liang; Du, Jiang-bo; Zhang, Bang-le; Song, Yan-feng; Zhou, Si-yuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Mei, Qi-bing; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Na, Ren] Fourth Mil Med Univ, West Changle Sanat Xian Army Retired Cadres, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhou, SY (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China.	zhousy@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887; Zhang, Bang-Le/0000-0001-9008-5391	Shaanxi Science and Technology Innovation Project [2012KTCL03-18]	Shaanxi Science and Technology Innovation Project	This research was supported by the Shaanxi Science and Technology Innovation Project (2012KTCL03-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Andersson L, 2005, BIOMACROMOLECULES, V6, P914, DOI 10.1021/bm049381p; Arote RB, 2010, BIOMATERIALS, V31, P2435, DOI 10.1016/j.biomaterials.2009.11.106; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; DEVERDIERE AC, 1994, CANCER CHEMOTH PHARM, V33, P504; Dhawan D, 2013, CANCER RES, V73, P875, DOI 10.1158/0008-5472.CAN-12-2101; Dosio F, 2010, CURR OPIN INVEST DR, V11, P1424; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fipula D, 2008, ADV DRUG DELIVER REV, V60, P29, DOI 10.1016/j.addr.2007.02.001; Ghaghada KB, 2005, J CONTROL RELEASE, V104, P113, DOI 10.1016/j.jconrel.2005.01.012; Guo X, 2013, BIOMATERIALS, V34, P4544, DOI 10.1016/j.biomaterials.2013.02.071; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Hu QY, 2013, BIOMATERIALS, V34, P5640, DOI 10.1016/j.biomaterials.2013.04.025; Huan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044116; Huang L, 2011, ANNU REV BIOMED ENG, V13, P507, DOI 10.1146/annurev-bioeng-071910-124709; Jayant S, 2007, PHARM RES, V24, P2120, DOI 10.1007/s11095-007-9406-1; Kim SH, 2005, J CONTROL RELEASE, V103, P625, DOI 10.1016/j.jconrel.2004.01.006; Koyama Junichi, 2011, Gan To Kagaku Ryoho, V38, P461; Lalatsa A, 2012, J CONTROL RELEASE, V161, P523, DOI 10.1016/j.jconrel.2012.04.046; Lancon A, 2004, BIOCHEM BIOPH RES CO, V316, P1132, DOI 10.1016/j.bbrc.2004.02.164; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; LEAMON CP, 1991, P NATL ACAD SCI USA, V88, P5572, DOI 10.1073/pnas.88.13.5572; Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018; Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1; Low PS, 2004, ADV DRUG DELIVER REV, V56, P1055, DOI 10.1016/j.addr.2004.02.003; Ma RJ, 2012, BIOMACROMOLECULES, V13, P3409, DOI 10.1021/bm3012715; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Minko T, 1998, J CONTROL RELEASE, V54, P223, DOI 10.1016/S0168-3659(98)00009-1; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Prabaharan M, 2009, BIOMATERIALS, V30, P6065, DOI 10.1016/j.biomaterials.2009.07.048; Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z; Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; van Steenis JH, 2003, J CONTROL RELEASE, V87, P167, DOI 10.1016/S0168-3659(02)00361-9; Xiong XB, 2010, BIOMATERIALS, V31, P757, DOI 10.1016/j.biomaterials.2009.09.080; Yang C, 2012, BIOMATERIALS, V33, P2971, DOI 10.1016/j.biomaterials.2011.11.035; Ye WL, 2013, J PHARM SCI-US, V102, P530, DOI 10.1002/jps.23381; Yoo HS, 2004, J CONTROL RELEASE, V100, P247, DOI 10.1016/j.jconrel.2004.08.017	44	43	45	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97358	10.1371/journal.pone.0097358	http://dx.doi.org/10.1371/journal.pone.0097358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828815	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400084
J	Rakotoniana, JS; Rakotomanga, JDM; Barennes, H				Rakotoniana, Jerry S.; Rakotomanga, Jean de Dieu M.; Barennes, Hubert			Can Churches Play a Role in Combating the HIV/AIDS Epidemic? A Study of the Attitudes of Christian Religious Leaders in Madagascar	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SEX WORKERS; CONDOM USE; RURAL MADAGASCAR; HIV; BEHAVIOR; WOMEN; PREVENTION; YOUTH; CARE	Introduction: Churches occupy an important social and cultural position in Madagascar. The sexual transmission of HIV raises controversies about the role that Churches can play in preventing HIV/AIDS. This cross-sectional survey investigated recommendations by religious leaders for condom use and other preventive strategies in the context of international guidelines. Methods: A questionnaire was self-administered to a random sample of religious leaders. The questions related to preventive methods against HIV/AIDS such as: condom use, marital fidelity, sexual abstinence before marriage, and HIV-testing. Associations with recommendations for condom use were evaluated using univariate and multivariate logistic regression analyses. Results: Of 231 religious leaders, 215 (93.1%) were willing to share their knowledge of HIV/AIDS with their congregations. The majority received their information from the media (N = 136, 58.9%), a minority from their church (N = 9, 3.9%), and 38 (16.4%) had received prior training on HIV. Nearly all (N = 212, 91.8%) knew that HIV could be sexually transmitted though only a few (N = 39, 16.9%) were aware of mother-to-child transmission or unsafe injections (N = 56, 24.2%). A total of 91 (39.4%) were willing to, or had recommended (N = 64, 27.7%), condom use, while 50 (21.6%) had undergone HIV testing. Only nine (3.9%) had ever cared for a person living with HIV/AIDS (PLHIV). Multivariable logistic regression shows that condom use recommendations by religious leaders were negatively associated with tertiary level education (OR: 0.3, 95% CI 0.1-0.7), and positively associated with knowing a person at risk (OR: 16.2, 95% CI 3.2-80.2), knowing of an ART center (OR: 2.6, 95% CI 1.4-4.8), and receiving information about HIV at school (OR: 2.6, 95% CI 1.2-5.6). Conclusions: Malagasy church leaders could potentially become key players in HIV/AIDS prevention if they improved their knowledge of the illness, their commitment to international recommendations, and extended their interaction with people most at risk.	[Rakotoniana, Jerry S.; Barennes, Hubert] Inst Francophone Med Trop, Viangchan, Laos; [Rakotoniana, Jerry S.; Rakotomanga, Jean de Dieu M.] Inst Natl Sante Publ & Communautaire INSPC Befela, Antananarivo, Madagascar; [Barennes, Hubert] Agence Natl Rech VIH & Hepatites, Phnom Penh, Cambodia; [Barennes, Hubert] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Barennes, H (corresponding author), Inst Francophone Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	This study was supported by Agence Universitaire de la Francophonie (AUF), Institut Francophone pour la Medecine Tropicale (IFMT). The findings and conclusions in this report are those of the authors, and do not necessarily represent the official position of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGRE H, 2004, FRANCE TRANSFUSE AFR; Behets F, 2001, TROP MED INT HEALTH, V6, P202, DOI 10.1046/j.1365-3156.2001.00690.x; Benton KW, 2008, J RELIG HEALTH, V47, P314, DOI 10.1007/s10943-007-9158-6; *DEM HLTH SURV, 2008, DEM HLTH SURV; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Frickmann H, 2013, TROP MED INT HEALTH, V18, P35, DOI 10.1111/tmi.12007; GREEN EC, 2013, RETHINKING AIDS PREV; Harijaona V, 2009, MED MALADIES INFECT, V39, P909, DOI 10.1016/j.medmal.2009.01.007; Kagimu M, 2012, AFR HEALTH SCI, V12, P119, DOI 10.4314/ahs.v12i2.7; Kanda K, 2013, GLOB PUBLIC HEALTH, V8, P159, DOI 10.1080/17441692.2012.745892; Khan MR, 2008, SEX TRANSM DIS, V35, P738, DOI 10.1097/OLQ.0b013e3181724383; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Lanouette NM, 2003, AM J PUBLIC HEALTH, V93, P917, DOI 10.2105/AJPH.93.6.917; Leutscher P, 2005, SEX TRANSM DIS, V32, P150, DOI 10.1097/01.olq.0000152820.17242.17; Leutscher PDC, 2003, SEX TRANSM DIS, V30, P262, DOI 10.1097/00007435-200303000-00017; Liebowitz J, 2006, RES GLOB CHILD ADVOC, P209; Manglos ND, 2011, J HEALTH SOC BEHAV, V52, P107, DOI 10.1177/0022146510395025; Meekers D, 2006, J BIOSOC SCI, V38, P365, DOI 10.1017/S0021932005007200; Rahamefy OH, 2008, SAHARA J-J SOC ASP H, V5, P28, DOI 10.1080/17290376.2008.9724899; Randrianasolo B, 2008, J BIOSOC SCI, V40, P879, DOI 10.1017/S0021932007002672; *SE CNLS, 2007, PLAN ACT MAD LUTT EF; Stoebenau K, 2009, AM J PUBLIC HEALTH, V99, P811, DOI 10.2105/AJPH.2007.118422; Szaflarski M, 2013, AIDS BEHAV, V17, P1839, DOI 10.1007/s10461-013-0455-7; Trinitapoli J, 2011, GLOB PUBLIC HEALTH, V6, P41, DOI 10.1080/17441692.2010.486764; Trinitapoli J, 2009, SOC SCI MED, V69, P199, DOI 10.1016/j.socscimed.2009.04.018; Watt MH, 2009, AIDS PATIENT CARE ST, V23, P389, DOI 10.1089/apc.2008.0195; *WHO, 2009, POS STAT; Xueref S, 2003, TROP MED INT HEALTH, V8, P60, DOI 10.1046/j.1365-3156.2003.00986.x; Zou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-75	29	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97131	10.1371/journal.pone.0097131	http://dx.doi.org/10.1371/journal.pone.0097131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824620	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200064
J	Zuloaga, KL; Krasnow, SM; Zhu, XX; Zhang, WR; Jouihan, SA; Shangraw, RE; Alkayed, NJ; Marks, DL				Zuloaga, Kristen L.; Krasnow, Stephanie M.; Zhu, Xinxia; Zhang, Wenri; Jouihan, Sari A.; Shangraw, Robert E.; Alkayed, Nabil J.; Marks, Daniel L.			Mechanism of Protection by Soluble Epoxide Hydrolase Inhibition in Type 2 Diabetic Stroke	PLOS ONE			English	Article							ISCHEMIC BRAIN-DAMAGE; EPOXYEICOSATRIENOIC ACIDS; POSTSTROKE HYPERGLYCEMIA; GLUCOSE CONTROL; INSULIN; OVEREXPRESSION; OBESITY; MODEL; DIET	Inhibition of soluble epoxide hydrolase (sEH) is a potential target of therapy for ischemic injury. sEH metabolizes neuroprotective epoxyeicosatrienoic acids (EETs). We recently demonstrated that sEH inhibition reduces infarct size after middle cerebral artery occlusion (MCAO) in type 1 diabetic mice. We hypothesized that inhibition of sEH would protect against ischemic injury in type 2 diabetic mice. Type 2 diabetes was produced by combined high-fat diet, nicotinamide and streptozotocin in male mice. Diabetic and control mice were treated with vehicle or the sEH inhibitor t-AUCB then subjected to 60-min MCAO. Compared to chow-fed mice, high fat diet-fed mice exhibited an upregulation of sEH mRNA and protein in brain, but no differences in brain EETs levels were observed between groups. Type 2 diabetic mice had increased blood glucose levels at baseline and throughout ischemia, decreased laser-Doppler perfusion of the MCA territory after reperfusion, and sustained larger cortical infarcts compared to control mice. t-AUCB decreased fasting glucose levels at baseline and throughout ischemia, improved cortical perfusion after MCAO and significantly reduced infarct size in diabetic mice. We conclude that sEH inhibition, as a preventative treatment, improves glycemic status, post-ischemic reperfusion in the ischemic territory, and stroke outcome in type 2 diabetic mice.	[Zuloaga, Kristen L.; Zhang, Wenri; Jouihan, Sari A.; Shangraw, Robert E.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Krasnow, Stephanie M.; Zhu, Xinxia; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009	Zuloaga, Kristen/0000-0002-5395-7362	National Institute of Neurological Disorders and Stroke [R01NS044313, R01NS070837, F32NS082017-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK70333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS082017, R01NS044313, R01NS070837] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the National Institute of Neurological Disorders and Stroke (R01NS044313 and R01NS070837 to Dr. Alkayed and F32NS082017-01 to Dr. Zuloaga) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK70333 to Dr. Marks). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Bergman M, 2013, ENDOCRINE, V43, P504, DOI 10.1007/s12020-012-9830-9; Cipolla MJ, 2010, TRANSL STROKE RES, V1, P127, DOI 10.1007/s12975-010-0014-8; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; Dave KR, 2011, STROKE, V42, P1404, DOI 10.1161/STROKEAHA.110.594937; De Taeye BM, 2010, OBESITY, V18, P489, DOI 10.1038/oby.2009.227; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fabian RH, 2012, TRANSL STROKE RES, V3, P482, DOI 10.1007/s12975-012-0210-9; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; HEIZER ML, 1991, STROKE, V22, P1389, DOI 10.1161/01.STR.22.11.1389; Iliff JJ, 2010, J NEUROCHEM, V115, P1530, DOI 10.1111/j.1471-4159.2010.07059.x; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Jouihan SA, 2013, J CEREB BLOOD FLOW M; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Liu JY, 2009, BRIT J PHARMACOL, V156, P284, DOI 10.1111/j.1476-5381.2008.00009.x; Luitse MJA, 2013, CEREBROVASC DIS, V35, P163, DOI 10.1159/000346588; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Ma B, 2013, ENDOCRINOLOGY, V154, P2843, DOI 10.1210/en.2012-2166; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Meng L, 2012, BMJ, V344; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Naramura T, 2006, BIOL PHARM BULL, V29, P1167, DOI 10.1248/bpb.29.1167; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Ntaios G, 2013, INT J STROKE; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prakash R, 2013, STROKE; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041710; WARNER DS, 1995, STROKE, V26, P655, DOI 10.1161/01.STR.26.4.655; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhang WR, 2009, J CEREBR BLOOD F MET, V29, P1475, DOI 10.1038/jcbfm.2009.65	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97529	10.1371/journal.pone.0097529	http://dx.doi.org/10.1371/journal.pone.0097529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824753	gold, Green Submitted, Green Published			2022-12-25	WOS:000336369200127
J	Dumitru, CA; Hemeda, H; Jakob, M; Lang, S; Brandau, S				Dumitru, Claudia A.; Hemeda, Hatim; Jakob, Mark; Lang, Stephan; Brandau, Sven			Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming	FASEB JOURNAL			English	Article						proinflammatory cytokines; interferon type I; biphasic cytokine response; functional polarization; Poly I:C	TOLL-LIKE RECEPTORS; STEM-CELLS; PATHWAY; PROTEIN; INDUCTION; MONOCYTES; THERAPY; REPAIR; BETA	Mesenchymal stem/stromal cells (MSCs) are emerging as important regulators of innate and adaptive immunity. In this context, both proinflammatory and anti-inflammatory effects have been described for MSCs. The mechanisms mediating this functional plasticity are poorly characterized at present. Here, we investigated the inflammatory responses of MSCs isolated from human nasal mucosa (nmMSCs) upon challenge with different Toll-like receptor (TLR) ligands. We found that TLR3 ligands induced the strongest release of both proinflammatory cytokines [interleukin (IL)-6 and IL-8] and type I interferon by nmMSCs compared with other TLR ligands. Notably, TLR3 ligands triggered a biphasic cytokine response, with an early peak of type I interferon at 4 h poststimulation and a late release of proinflammatory cytokines at 24 h poststimulation. While the early interferon response was subject to direct stimulation, the proinflammatory response was regulated by factors released during the early cytokine response, which subsequently enhanced sensitivity to TLR3 ligation and amplified the production of IL-6 and IL-8 but not that of interferon. Taken together, our findings indicate that TLR3 ligands polarize the inflammatory phenotype of MSCs in a time-dependent manner. Thus, our study proposes a novel model that helps to explain the strikingly dichotomous functionality of MSCs in inflammation and immunoregulation.	[Dumitru, Claudia A.; Hemeda, Hatim; Jakob, Mark; Lang, Stephan; Brandau, Sven] Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, D-45122 Essen, Germany	University of Duisburg Essen	Brandau, S (corresponding author), Univ Duisburg Essen, Dept Otorhinolaryngol, Hufelandstr 55, D-45122 Essen, Germany.	sven.brandau@uk-essen.de		Brandau, Sven/0000-0002-2702-4163	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Kirsten Bruderek and Sebastian Vollmer (Department of Otorhinolaryngology, University Hospital Essen) for excellent technical support. The authors are grateful to Dr. Karl S. Lang (Department of Immunology, University Hospital Essen), as well as to Dr. Ulf Dittmer and Dr. Katrin Gibbert (Department of Virology, University Hospital Essen) for the critical reading and helpful comments on our manuscript. This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) to S.B.	Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Cassatella MA, 2011, STEM CELLS, V29, P1001, DOI 10.1002/stem.651; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Maccario R, 2005, HAEMATOLOGICA, V90, P516; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nathan S, 2003, TISSUE ENG, V9, P733, DOI 10.1089/107632703768247412; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Stagg J, 2013, CURR MOL MED, V13, P856, DOI 10.2174/1566524011313050016; Tomchuck SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039592; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	31	29	30	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3856	3866		10.1096/fj.14-250159	http://dx.doi.org/10.1096/fj.14-250159			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24830384	Green Published			2022-12-25	WOS:000340845900005
J	Barcena-Uribarri, I; Thein, M; Barbot, M; Sans-Serramitjana, E; Bonde, M; Mentele, R; Lottspeich, F; Bergstrom, S; Benz, R				Barcena-Uribarri, Ivan; Thein, Marcus; Barbot, Mariam; Sans-Serramitjana, Eulalia; Bonde, Mari; Mentele, Reinhard; Lottspeich, Friedrich; Bergstrom, Sven; Benz, Roland			Study of the Protein Complex, Pore Diameter, and Pore-forming Activity of the Borrelia burgdorferi P13 Porin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; LYME-DISEASE SPIROCHETE; COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; BINDING-SITE; INSERTIONAL INACTIVATION; MOLECULAR-BASIS; ION CHANNELS; PERMEABILITY; ELIMINATION	P13 is one of the major outer membrane proteins of Borrelia burgdorferi. Previous studies described P13 as a porin. In the present study some structure and function aspects of P13 were studied. P13 showed according to lipid bilayer studies a channel-forming activity of 0.6 nanosiemens in 1 M KCl. Single channel and selectivity measurements demonstrated that P13 had no preference for either cations or anions and showed no voltage-gating up to +/-100 mV. Blue native polyacrylamide gel electrophoresis was used to isolate and characterize the P13 protein complex in its native state. The complex had a high molecular mass of about 300 kDa and was only composed of P13 monomers. The channel size was investigated using non-electrolytes revealing an apparent diameter of about 1.4 nm with a 400-Da molecular mass cut-off. Multichannel titrations with different substrates reinforced the idea that P13 forms a general diffusion channel. The identity of P13 within the complex was confirmed by second dimension SDS-PAGE, Western blotting, mass spectrometry, and the use of a p13 deletion mutant strain. The results suggested that P13 is the protein responsible for the 0.6-nanosiemens pore-forming activity in the outer membrane of B. burgdorferi.	[Barcena-Uribarri, Ivan; Thein, Marcus; Barbot, Mariam; Sans-Serramitjana, Eulalia; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Barcena-Uribarri, Ivan; Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Bonde, Mari; Bergstrom, Sven] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Mentele, Reinhard; Lottspeich, Friedrich] Max Planck Inst Biochem, Prot Anal Dept, D-82152 Martinsried, Germany	University of Wurzburg; Jacobs University; Umea University; Max Planck Society	Barcena-Uribarri, I (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campusring 1, D-28759 Bremen, Germany.	i.barcenauribarri@jacobs-university.de		Benz, Roland/0000-0002-9510-9265	Stint (Sweden); Deutscher Akademischer Austauschdienst (DAAD) (Germany); Deutsche Forschungsgemeinschaft [Be 864/15-1, Wi 933]; Swedish Medical Research Council Grant [07922]; Alfonso Martin Escudero Foundation	Stint (Sweden); Deutscher Akademischer Austauschdienst (DAAD) (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Medical Research Council Grant; Alfonso Martin Escudero Foundation	This work was supported by a joint project between Stint (Sweden) and Deutscher Akademischer Austauschdienst (DAAD) (Germany) (to S. B. and R. B.), the Deutsche Forschungsgemeinschaft (Be 864/15-1; to R. B.), Wi 933 (to Mathias Winterhalter), and Swedish Medical Research Council Grant 07922 (to S. B.).; Supported by the Alfonso Martin Escudero Foundation.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barcena-Uribarri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078272; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; Benz R., 2001, PORINS STRUCTURE FUN; Benz R., 1994, BACTERIAL CELL WALL, P397; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BURGDORFER W, 1984, YALE J BIOL MED, V57, P515; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Cluss RG, 2004, INFECT IMMUN, V72, P6279, DOI 10.1128/IAI.72.11.6279-6286.2004; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; HANCOCK REW, 1986, BIOCHIM BIOPHYS ACTA, V860, P699, DOI 10.1016/0005-2736(86)90569-9; HANCOCK REW, 1988, EUR J CLIN MICROBIOL, V7, P713, DOI 10.1007/BF01975036; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Kim BH, 2001, MOL MICROBIOL, V41, P665, DOI 10.1046/j.1365-2958.2001.02544.x; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Lide D.R., 1998, CRC HDB CHEM PHYS, P99; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; Mahendran KR, 2010, J PHYS CHEM B, V114, P5170, DOI 10.1021/jp911485k; MAIER C, 1988, J BIOL CHEM, V263, P2493; Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x; MARK JE, 1965, J AM CHEM SOC, V87, P1415, DOI 10.1021/ja01085a001; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Obermeier O. H. F., 1873, ENTDECKUNG FADENFORM; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Pinne M, 2004, MICROBIOL-SGM, V150, P549, DOI 10.1099/mic.0.26728-0; Pinne M, 2006, J BACTERIOL, V188, P4207, DOI 10.1128/JB.00302-06; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; Rempp P., 1957, J CHIM PHYS PCB, V54, P432; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sicklinger M, 2003, J CLIN MICROBIOL, V41, P1791, DOI 10.1128/JCM.41.4.1791-1793.2003; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; SKARE JT, 1995, J CLIN INVEST, V96, P2380, DOI 10.1172/JCI118295; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; Thein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036523; Tristram-Nagle S, 2010, CHEM PHYS LIPIDS, V163, P630, DOI 10.1016/j.chemphyslip.2010.04.011; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	59	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18614	18624		10.1074/jbc.M113.539528	http://dx.doi.org/10.1074/jbc.M113.539528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24825899	Green Published, hybrid			2022-12-25	WOS:000339062900001
J	Borthakur, S; Lee, H; Kim, S; Wang, BC; Buck, M				Borthakur, Susmita; Lee, HyeongJu; Kim, SoonJeung; Wang, Bing-Cheng; Buck, Matthias			Binding and Function of Phosphotyrosines of the Ephrin A2 (EphA2) Receptor Using Synthetic Sterile alpha Motif (SAM) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION SITES; CELL-MIGRATION; SH2 DOMAIN; SIGNAL-TRANSDUCTION; LIPID PHOSPHATASE; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; BREAST-CANCER; PROTEIN; GRB7	The sterile alpha motif (SAM) domain of the ephrin receptor tyrosine kinase, EphA2, undergoes tyrosine phosphorylation, but the effect of phosphorylation on the structure and interactions of the receptor is unknown. Studies to address these questions have been hindered by the difficulty of obtaining site-specifically phosphorylated proteins in adequate amounts. Here, we describe the use of chemically synthesized and specifically modified domain-length peptides to study the behavior of phosphorylated EphA2 SAM domains. We show that tyrosine phosphorylation of any of the three tyrosines, Tyr(921), Tyr(930), and Tyr(960), has a surprisingly small effect on the EphA2 SAM structure and stability. However, phosphorylation at Tyr(921) and Ty(r)9(30) enables differential binding to the Src homology 2 domain of the adaptor protein Grb7, which we propose will lead to distinct functional outcomes. Setting up different signaling platforms defined by selective interactions with adaptor proteins thus adds another level of regulation to EphA2 signaling.	[Borthakur, Susmita; Lee, HyeongJu; Kim, SoonJeung; Wang, Bing-Cheng; Buck, Matthias] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Bing-Cheng] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Wang, Bing-Cheng; Buck, Matthias] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Bing-Cheng] MetroHlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH 44109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System	Buck, M (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	matthias.buck@case.edu	Buck, Matthias/B-2106-2017	Buck, Matthias/0000-0002-2958-0403	National Institutes of Health [R01GM092851, R01CA152371, R01CA155676, R01DK077876]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA152371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092851 and R01CA152371 (to M. B.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to S. B.).; Supported by National Institutes of Health Grants R01CA155676 and R01DK077876.	Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balasubramaniam D, 2011, PROTEIN SCI, V20, P1172, DOI 10.1002/pro.646; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Edimo WE, 2012, BIOESSAYS, V34, P634, DOI 10.1002/bies.201100195; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Ivancic M, 2005, PROTEIN SCI, V14, P1556, DOI 10.1110/ps.041102305; Ivancic M, 2003, J BIOMOL NMR, V27, P205, DOI 10.1023/A:1025498409113; Janes PW, 1997, J BIOL CHEM, V272, P8490, DOI 10.1074/jbc.272.13.8490; Jehle J, 2012, BRIT J PHARMACOL, V167, P1563, DOI 10.1111/j.1476-5381.2012.02117.x; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lee H, 2013, MOL CELL BIOL, V33, P1430, DOI 10.1128/MCB.01708-12; Lee HJ, 2012, STRUCTURE, V20, P41, DOI 10.1016/j.str.2011.11.013; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Paavilainen S, 2013, PROTEIN EXPRES PURIF, V92, P112, DOI 10.1016/j.pep.2013.08.016; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peterson TA, 2012, J MOL RECOGNIT, V25, P427, DOI 10.1002/jmr.2205; Pias SC, 2010, CRIT REV IMMUNOL, V30, P299, DOI 10.1615/CritRevImmunol.v30.i3.70; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Ramachander R, 2004, J MOL BIOL, V342, P1353, DOI 10.1016/j.jmb.2004.08.011; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schultz J, 1997, PROTEIN SCI, V6, P249; Singla N, 2011, CHEM BIOL, V18, P361, DOI 10.1016/j.chembiol.2011.01.011; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Timsah Z, 2014, NAT STRUCT MOL BIOL, V21, P180, DOI 10.1038/nsmb.2752; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Zhang LQ, 2013, BIOPHYS J, V105, P2412, DOI 10.1016/j.bpj.2013.09.052; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	53	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19694	19703		10.1074/jbc.M114.567602	http://dx.doi.org/10.1074/jbc.M114.567602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24825902	Green Published, hybrid			2022-12-25	WOS:000339326800041
J	Lu, ZK; Ma, XN; Zhang, HM; Ji, HH; Ding, H; Zhang, J; Luo, D; Sun, YJ; Li, XD				Lu, Zekuan; Ma, Xiao-Nan; Zhang, Hai-Man; Ji, Huan-Hong; Ding, Hao; Zhang, Jie; Luo, Dan; Sun, Yujie; Li, Xiang-dong			Mouse Myosin-19 Is a Plus-end-directed, High-duty Ratio Molecular Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; REGULATORY LIGHT-CHAIN; GLOBULAR TAIL DOMAIN; MEDIATED DIMERIZATION; UNCONVENTIONAL MYOSIN; DEPENDENT REGULATION; KINETIC MECHANISM; PROCESSIVE MOTOR; VI MOTOR; 2 HEADS	Class XIX myosin (Myo19) is a vertebrate-specific unconventional myosin, responsible for the transport of mitochondria. To characterize biochemical properties of Myo19, we prepared recombinant mouse Myo19-truncated constructs containing the motor domain and the IQ motifs using the baculovirus/Sf9 expression system. We identified regulatory light chain (RLC) of smooth muscle/non-muscle myosin-2 as the light chain of Myo19. The actin-activated ATPase activity and the actin-gliding velocity of Myo19-truncated constructs were about onethird and one-sixth as those of myosin-5a, respectively. The apparent affinity of Myo19 to actin was about the same as that of myosin-5a. The RLCs bound to Myo19 could be phosphorylated by myosin light chain kinase, but this phosphorylation had little effect on the actin-activated ATPase activity and the actin-gliding activity of Myo19-truncated constructs. Using dual fluorescence-labeled actin filaments, we determined that Myo19 is a plus-end-directed molecular motor. We found that, similar to that of the high-duty ratio myosin, such as myosin-5a, ADP release rate was comparable with the maximal actin-activated ATPase activity of Myo19, indicating that ADP release is a ratelimiting step for the ATPase cycle of acto-Myo19. ADP strongly inhibited the actin-activated ATPase activity and actin-gliding activity of Myo19-truncated constructs. Based on the above results, we concluded that Myo19 is a high-duty ratio molecular motor moving to the plus-end of the actin filament.	[Lu, Zekuan; Ma, Xiao-Nan; Zhang, Hai-Man; Ji, Huan-Hong; Ding, Hao; Zhang, Jie; Luo, Dan; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China; [Sun, Yujie] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Sch Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802]; National Natural Science Foundation of China [31201071, 31171367]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2013CB932802 and National Natural Science Foundation of China Grants 31201071 and 31171367.	Adikes RC, 2013, CYTOSKELETON, V70, P281, DOI 10.1002/cm.21110; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cremo C. R., 2008, PROTEINS CELL REGULA, p[125, 169]; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Cull MG, 2000, METHOD ENZYMOL, V326, P430; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1994, J BIOL CHEM, V269, P28165; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Li XD, 2000, BIOCHEMISTRY-US, V39, P2254, DOI 10.1021/bi9924617; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Ma RN, 2013, BIOCHEMISTRY-US, V52, P6240, DOI 10.1021/bi400554s; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nitzsche B, 2008, NAT NANOTECHNOL, V3, P552, DOI 10.1038/nnano.2008.216; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	50	29	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18535	18548		10.1074/jbc.M114.569087	http://dx.doi.org/10.1074/jbc.M114.569087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825904	Green Published, hybrid			2022-12-25	WOS:000338042000050
J	Raina, M; Moghal, A; Kano, A; Jerums, M; Schnier, PD; Luo, S; Deshpande, R; Bondarenko, PV; Lin, H; Ibba, M				Raina, Medha; Moghal, Adil; Kano, Amanda; Jerums, Mathew; Schnier, Paul D.; Luo, Shun; Deshpande, Rohini; Bondarenko, Pavel V.; Lin, Henry; Ibba, Michael			Reduced Amino Acid Specificity of Mammalian Tyrosyl-tRNA Synthetase Is Associated with Elevated Mistranslation of Tyr Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; TRANSLATIONAL FIDELITY; GENETIC-CODE; CELL-LINES; IN-VITRO; SEQUENCE; ERRORS; MECHANISMS; INHIBITORS; SB-219383	Quality control operates at different steps in translation to limit errors to approximately one mistranslated codon per 10,000 codons during mRNA-directed protein synthesis. Recent studies have suggested that error rates may actually vary considerably during translation under different growth conditions. Here we examined the misincorporation of Phe at Tyr codons during synthesis of a recombinant antibody produced in tyrosine-limited Chinese hamster ovary (CHO) cells. Tyr to Phe replacements were previously found to occur throughout the antibody at a rate of up to 0.7% irrespective of the identity or context of the Tyr codon translated. Despite this comparatively high mistranslation rate, no significant change in cellular viability was observed. Monitoring of Phe and Tyr levels revealed that changes in error rates correlated with changes in amino acid pools, suggesting that mischarging of tRNA(Tyr) with noncognate Phe by tyrosyl-tRNA synthetase was responsible for mistranslation. Steady-state kinetic analyses of CHO cytoplasmic tyrosyl-tRNA synthetase revealed a 25-fold lower specificity for Tyr over Phe as compared with previously characterized bacterial enzymes, consistent with the observed increase in translation error rates during tyrosine limitation. Functional comparisons of mammalian and bacterial tyrosyl-tRNA synthetase revealed key differences at residues responsible for amino acid recognition, highlighting differences in evolutionary constraints for translation quality control.	[Raina, Medha; Moghal, Adil; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Raina, Medha; Moghal, Adil; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Kano, Amanda; Jerums, Mathew; Schnier, Paul D.; Luo, Shun; Deshpande, Rohini; Bondarenko, Pavel V.; Lin, Henry] Amgen Inc, Thousand Oaks, CA 91320 USA	Ohio State University; Ohio State University; Amgen	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Raina, Medha/J-5154-2019	Raina, Medha/0000-0001-9690-6576; Moghal, Adil/0000-0003-4097-331X	National Science Foundation (NSF) [MCB-1052344]; NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship; NIH [GM008512, GM086252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086252, T32GM008512] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) Grant MCB-1052344 (to M. I.) an NSF-Grant Opportunities for Academic Liaison with Industry (NSF-GOALI) fellowship (to M. R) and NIH training grant fellowships (GM008512 and GM086252 to A.M.).	Austin J, 2002, J BIOL CHEM, V277, P20243, DOI 10.1074/jbc.M201923200; Berge JM, 2000, J ANTIBIOT, V53, P1282, DOI 10.7164/antibiotics.53.1282; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Feeney L, 2013, BIOTECHNOL BIOENG, V110, P1087, DOI 10.1002/bit.24759; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HARRIS RJ, 1993, BIO-TECHNOL, V11, P1293; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jarvest RL, 2001, BIOORG MED CHEM LETT, V11, P715, DOI 10.1016/S0960-894X(01)00040-3; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Polycarpo C, 2003, MOL CELL, V12, P287, DOI 10.1016/S1097-2765(03)00280-6; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wen DY, 2009, J BIOL CHEM, V284, P32686, DOI 10.1074/jbc.M109.059360; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c	39	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17780	17790		10.1074/jbc.M114.564609	http://dx.doi.org/10.1074/jbc.M114.564609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828507	Green Published, hybrid			2022-12-25	WOS:000338018100041
J	Bobashev, G; Norton, J; Wechsberg, W; Toussova, O				Bobashev, Georgiy; Norton, Jacob; Wechsberg, Wendee; Toussova, Olga			Are You HIV Invincible? A Probabilistic Study of Discordant Couples in the Context of HIV Transmission	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; VIRAL LOAD; INFECTIVITY; INFECTIOUSNESS	A number of factors have been identified that are related to sexual and injecting HIV transmission. We developed a probabilistic mathematical model to put these factors together and interpret risks in the context of individual behavior among injecting drug-using (IDU) couples in St. Petersburg, Russia. Some HIV-discordant couples have unprotected sex and sometimes inject drugs together but stay discordant for a long time, while some individuals acquire HIV on the first encounter. We considered existing estimates of HIV transmission risks through injecting and sexual contacts to develop a predictive survival model for an individual who is exposed to HIV through intimate relationships. We computed simulated survival curves for a number of behavioral scenarios and discussed sources of simulated uncertainty. We then applied the model to a longitudinal study of HIV-discordant couples and validated the model's forecast. Although individual prediction of seroconversion time appeared impossible, the ability to rank behavioral patterns in terms of HIV risk and to estimate the probability of survival HIV-free will be important to educators and counselors.	[Bobashev, Georgiy; Wechsberg, Wendee] RTI Int, Durham, NC 27703 USA; [Norton, Jacob] N Carolina State Univ, Raleigh, NC 27695 USA; [Toussova, Olga] Pavlov Med Univ, St Petersburg, Russia	Research Triangle Institute; University of North Carolina; North Carolina State University; Pavlov First Saint Petersburg State Medical University	Bobashev, G (corresponding author), RTI Int, Durham, NC 27703 USA.	bobashev@rti.org	Toussova, Olga/AAE-5470-2022	Toussova, Olga/0000-0002-2657-9634; Wechsberg, Wendee/0000-0002-5146-6463	University of North Carolina Social and Behavioral Science Research Core (UNC CFAR) [P30 AI50410]; NIH/NIDA [1R01DA025163-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025163] Funding Source: NIH RePORTER	University of North Carolina Social and Behavioral Science Research Core (UNC CFAR); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The pilot study in St. Petersburg was funded by the University of North Carolina Social and Behavioral Science Research Core (UNC CFAR) P30 AI50410. The current study was funded in part by NIH/NIDA grant 1R01DA025163-01. No additional internal or external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, BMJ, V304, P809; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; CHIN J, 1992, SCIENCE CHALLENGING AIDS, P33; Hudgens MG, 2001, J ROY STAT SOC C-APP, V50, P1, DOI 10.1111/1467-9876.00216; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Weller SC, 2011, CONDOM EFFECTIVENESS; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Zule WA, 2013, INT J DRUG POLICY, V24, P1, DOI 10.1016/j.drugpo.2012.07.002	15	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e94799	10.1371/journal.pone.0094799	http://dx.doi.org/10.1371/journal.pone.0094799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839972	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600004
J	Huang, TC; Wang, YC; Chiou, YR; Kao, CH				Huang, Tzung-Chi; Wang, Yao-Ching; Chiou, Yu-Rou; Kao, Chia-Hung			Respiratory Motion Reduction in PET/CT Using Abdominal Compression for Lung Cancer Patients	PLOS ONE			English	Article							ATTENUATION CORRECTION; RADIATION-THERAPY; TUMOR MOTION; CT; IMAGES; THORAX; IMPACT; DELINEATION	Purpose: Respiratory motion causes substantial artifacts in reconstructed PET images when using helical CT as the attenuation map in PET/CT imaging. In this study, we aimed to reduce the respiratory artifacts in PET/CT images of patients with lung tumors using an abdominal compression device. Methods: Twelve patients with lung cancer located in the middle or lower lobe of the lung were recruited. The patients were injected with 370 MBq of F-18-FDG. During PET, the patients assumed two bed positions for 1.5 min/bed. After conducting free-breathing imaging, we obtained images of the patients with abdominal compression by applying the same setup used in the free-breathing scan. The differences in the standardized uptake value (SUV)(max), SUVmean, tumor volume, and the centroid of the tumors between PET and various CT schemes were measured. Results: The SUVmax and SUVmean derived from PET/CT imaging using an abdominal compression device increased for all the lesions, compared with those obtained using the conventional approach. The percentage increases were 18.1% +/- 14% and 17% +/- 16.8% for SUVmax and SUVmean, respectively. PET/CT imaging combined with abdominal compression generally reduced the tumor mismatch between CT and the corresponding attenuation corrected PET images, with an average decrease of 1.9 +/- 1.7 mm over all the cases. Conclusions: PET/CT imaging combined with abdominal compression reduces respiratory artifacts and PET/CT misregistration, and enhances quantitative SUV in tumor. Abdominal compression is easy to set up and is an effective method used in PET/CT imaging for clinical oncology, especially in the thoracic region.	[Huang, Tzung-Chi; Chiou, Yu-Rou] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		National Science Council of Taiwan [NSC 102-2221-E-039-010-MY3]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was financially supported by National Science Council of Taiwan (NSC 102-2221-E-039-010-MY3) and by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristophanous M, 2010, INT J RADIAT ONCOL, V82, pe99; Bissonnette JP, 2009, INT J RADIAT ONCOL, V75, P688, DOI 10.1016/j.ijrobp.2008.11.066; Boucher L, 2004, J NUCL MED, V45, P214; Bouilhol G, 2013, PHYS MEDICA, V29, P333, DOI 10.1016/j.ejmp.2012.04.006; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Callahan J, 2011, AUSTRALAS PHYS ENG S, V34, P489, DOI 10.1007/s13246-011-0109-x; Cervino LI, 2009, PHYS MED BIOL, V54, P3529, DOI 10.1088/0031-9155/54/11/017; Erdi YE, 2004, J NUCL MED, V45, P1287; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; Hamill JJ, 2008, MED PHYS, V35, P576, DOI 10.1118/1.2829875; Heinzerling JH, 2008, INT J RADIAT ONCOL, V70, P1571, DOI 10.1016/j.ijrobp.2007.12.023; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Liu C, 2009, PHYS MED BIOL, V54, P7345, DOI 10.1088/0031-9155/54/24/007; Mok GSP, 2013, IEEE T BIO-MED ENG, V60, P1927, DOI 10.1109/TBME.2013.2245132; Nagamachi S, 2010, ANN NUCL MED, V24, P171, DOI 10.1007/s12149-010-0352-3; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Nehmeh SA, 2002, J NUCL MED, V43, P876; Nehmeh SA, 2007, J NUCL MED, V48, P22; Pan TS, 2005, J NUCL MED, V46, P1481; Sun T, 2013, MED PHYS, V40, DOI 10.1118/1.4820976; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064665	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98033	10.1371/journal.pone.0098033	http://dx.doi.org/10.1371/journal.pone.0098033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837352	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800100
J	Ku, PI; Bendjennat, M; Ballew, J; Landesman, MB; Saffarian, S				Ku, Pei-I; Bendjennat, Mourad; Ballew, Jeff; Landesman, Michael B.; Saffarian, Saveez			ALIX Is Recruited Temporarily into HIV-1 Budding Sites at the End of Gag Assembly	PLOS ONE			English	Article							LATE-DOMAIN; ESCRT-III; HELICAL STRUCTURES; STRUCTURAL BASIS; BINDING PARTNER; BRO1 DOMAIN; IN-VITRO; PROTEIN; UBIQUITIN; RELEASE	Polymerization of Gag on the inner leaflet of the plasma membrane drives the assembly of Human Immunodeficiency Virus 1 (HIV-1). Gag recruits components of the endosomal sorting complexes required for transport (ESCRT) to facilitate membrane fission and virion release. ESCRT assembly is initiated by recruitment of ALIX and TSG101/ESCRT-I, which bind directly to the viral Gag protein and then recruit the downstream ESCRT-III and VPS4 factors to complete the budding process. In contrast to previous models, we show that ALIX is recruited transiently at the end of Gag assembly, and that most ALIX molecules are recycled into the cytosol as the virus buds, although a subset remains within the virion. Our experiments imply that ALIX is recruited to the neck of the assembling virion and is mostly recycled after virion release.	[Ku, Pei-I; Bendjennat, Mourad; Ballew, Jeff; Landesman, Michael B.; Saffarian, Saveez] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Saffarian, Saveez] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT USA; [Saffarian, Saveez] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Saffarian, S (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	saffarian@physics.utah.edu			NSF [1121972]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants 1121972 (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Balasubramaniam M, 2011, PHYSIOLOGY, V26, P236, DOI 10.1152/physiol.00051.2010; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bodon G, 2011, J BIOL CHEM, V286, P40276, DOI 10.1074/jbc.M111.283671; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Effantin G, 2013, CELL MICROBIOL, V15, P213, DOI 10.1111/cmi.12041; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Joshi A, 2008, TRAFFIC, V9, P1972, DOI 10.1111/j.1600-0854.2008.00817.x; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Katoh K, 2004, ARCH BIOCHEM BIOPHYS, V421, P159, DOI 10.1016/j.abb.2003.09.038; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Ku PI, 2013, BIOPHYS J, V105, P2262, DOI 10.1016/j.bpj.2013.09.047; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Sette P, 2010, J VIROL, P00634; Sette P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-79; Sette P, 2012, J VIROL, V86, P11608, DOI 10.1128/JVI.01260-12; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; Sundquist WI, 2012, COLD SPRING HARBOR P, P2; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Yoo L, 2012, BIOMATERIALS, V33, P6194, DOI 10.1016/j.biomaterials.2012.05.028; Zhai Q, 2011, J VIROL; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhou X, 2009, BIOCHEM J, V418, P277, DOI 10.1042/BJ20081388	68	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96950	10.1371/journal.pone.0096950	http://dx.doi.org/10.1371/journal.pone.0096950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834918	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800023
J	Zhang, L; Meng, S; Tu, QS; Yu, LM; Tang, Y; Dard, MM; Kim, SH; Valverde, P; Zhou, XD; Chen, JK				Zhang, Lan; Meng, Shu; Tu, Qisheng; Yu, Liming; Tang, Yin; Dard, Michel M.; Kim, Sung-Hoon; Valverde, Paloma; Zhou, Xuedong; Chen, Jake			Adiponectin Ameliorates Experimental Periodontitis in Diet-Induced Obesity Mice	PLOS ONE			English	Article							MAPK SIGNALING PATHWAY; INSULIN-RESISTANCE; OXIDATIVE STRESS; PLASMA-CONCENTRATIONS; GLOBULAR ADIPONECTIN; METABOLIC SYNDROME; HUMAN OSTEOBLASTS; BONE LOSS; EXPRESSION; PROTEIN	Adiponectin is an adipokine that sensitizes the body to insulin. Low levels of adiponectin have been reported in obesity, diabetes and periodontitis. In this study we established experimental periodontitis in male adiponectin knockout and diet-induced obesity mice, a model of obesity and type 2 diabetes, and aimed at evaluating the therapeutic potential of adiponectin. We found that systemic adiponectin infusion reduced alveolar bone loss, osteoclast activity and infiltration of inflammatory cells in both periodontitis mouse models. Furthermore, adiponectin treatment decreased the levels of pro-inflammatory cytokines in white adipose tissue of diet-induced obesity mice with experimental periodontitis. Our in vitro studies also revealed that forkhead box O1, a key transcriptional regulator of energy metabolism, played an important role in the direct signaling of adiponectin in osteoclasts. Thus, adiponectin increased forkhead box O1 mRNA expression and its nuclear protein level in osteoclast-precursor cells undergoing differentiation. Inhibition of c-Jun N-terminal kinase signaling decreased nuclear protein levels of forkhead box O1. Furthermore, over-expression of forkhead box O1 inhibited osteoclastogenesis and led to decreased nuclear levels of nuclear factor of activated T cells c1. Taken together, this study suggests that systemic adiponectin application may constitute a potential intervention therapy to ameliorate type 2 diabetes-associated periodontitis. It also proposes that adiponectin inhibition of osteoclastogenesis involves forkhead box O1.	[Zhang, Lan; Meng, Shu; Tu, Qisheng; Yu, Liming; Tang, Yin; Chen, Jake] Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA; [Zhang, Lan; Meng, Shu; Tang, Yin; Zhou, Xuedong] Sichuan Univ, West China Hosp Stomatol, Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Dard, Michel M.] NYU, Coll Dent, New York, NY USA; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Valverde, Paloma] Wentworth Inst Technol, Dept Sci, Boston, MA USA; [Chen, Jake] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Anat & Cell Biol, Boston, MA 02111 USA	Tufts University; Sichuan University; New York University; Kyung Hee University; Kyung Hee University; Tufts University	Tu, QS (corresponding author), Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA.	qisheng.tu@tufts.edu; jk.chen@tufts.edu	ZHOU, XUE/F-6129-2013; tang, yin/GXZ-6989-2022; tang, yin/AAR-2123-2021	Zhang, Lan/0000-0002-9714-999X; Chen, Jake/0000-0001-8829-7504; Tu, Qisheng/0000-0003-0639-8761; kim, sunghoon/0000-0002-1570-3230; Zhou, Xuedong/0000-0002-9319-7302	National Institutes of Health (NIH) [R01DE16710, R01DE21464]; International Association of Dental Research (IADR); Academy of Osseointegration (AO) Innovation in Implant Science Award; Ministry of Education, Science and Technology (MEST) in South Korea [2007-0054931]; NIH [DK080344]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Association of Dental Research (IADR); Academy of Osseointegration (AO) Innovation in Implant Science Award; Ministry of Education, Science and Technology (MEST) in South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grants R01DE16710 and R01DE21464, and the International Association of Dental Research (IADR) and the Academy of Osseointegration (AO) Innovation in Implant Science Award (to J.C.); Ministry of Education, Science and Technology (MEST) grant 2007-0054931 in South Korea (to S. H. K.); NIH grant DK080344 (to L. Q. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Bartell S, 2012, ASBMR 2012 ANN M, P284; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bobbert P, 2008, J MOL CELL CARDIOL, V44, P388, DOI 10.1016/j.yjmcc.2007.10.018; Bullon P, 2009, J DENT RES, V88, P503, DOI 10.1177/0022034509337479; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Galli C, 2011, J PERIODONTAL RES, V46, P397, DOI 10.1111/j.1600-0765.2011.01354.x; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Li H, 2013, STEROIDS, V78, P115, DOI 10.1016/j.steroids.2012.10.015; Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076; Nakanishi S, 2005, METABOLISM, V54, P194, DOI 10.1016/j.metabol.2004.08.012; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; Ren WH, 2006, PROG BIOCHEM BIOPHYS, V33, P846; Saito T, 2008, J DENT RES, V87, P319, DOI 10.1177/154405910808700416; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Subedi A, 2013, FEBS LETT, V587, P1556, DOI 10.1016/j.febslet.2013.03.040; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toker H, 2009, J PERIODONTOL, V80, P672, DOI 10.1902/jop.2009.080509; Tu Q, 2008, J CELL PHYSIOL, V217, P40, DOI 10.1002/jcp.21472; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zimmermann GS, 2013, J PERIODONTOL, V84, P624, DOI 10.1902/jop.2012.120254	47	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97824	10.1371/journal.pone.0097824	http://dx.doi.org/10.1371/journal.pone.0097824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836538	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800072
J	Chioccioli, M; Hankamer, B; Ross, IL				Chioccioli, Maurizio; Hankamer, Ben; Ross, Ian L.			Flow Cytometry Pulse Width Data Enables Rapid and Sensitive Estimation of Biomass Dry Weight in the Microalgae Chlamydomonas reinhardtii and Chlorella vulgaris	PLOS ONE			English	Article							REFRACTIVE-INDEX; CELL-DIVISION; LIGHT SCATTER; SINGLE-CELL; ALGAE; SIZE; GROWTH; PHYTOPLANKTON; BACTERIA; ATLANTIC	Dry weight biomass is an important parameter in algaculture. Direct measurement requires weighing milligram quantities of dried biomass, which is problematic for small volume systems containing few cells, such as laboratory studies and high throughput assays in microwell plates. In these cases indirect methods must be used, inducing measurement artefacts which vary in severity with the cell type and conditions employed. Here, we utilise flow cytometry pulse width data for the estimation of cell density and biomass, using Chlorella vulgaris and Chlamydomonas reinhardtii as model algae and compare it to optical density methods. Measurement of cell concentration by flow cytometry was shown to be more sensitive than optical density at 750 nm (OD750) for monitoring culture growth. However, neither cell concentration nor optical density correlates well to biomass when growth conditions vary. Compared to the growth of C. vulgaris in TAP (tris-acetate-phosphate) medium, cells grown in TAP + glucose displayed a slowed cell division rate and a 2-fold increased dry biomass accumulation compared to growth without glucose. This was accompanied by increased cellular volume. Laser scattering characteristics during flow cytometry were used to estimate cell diameters and it was shown that an empirical but nonlinear relationship could be shown between flow cytometric pulse width and dry weight biomass per cell. This relationship could be linearised by the use of hypertonic conditions (1 M NaCl) to dehydrate the cells, as shown by density gradient centrifugation. Flow cytometry for biomass estimation is easy to perform, sensitive and offers more comprehensive information than optical density measurements. In addition, periodic flow cytometry measurements can be used to calibrate OD750 measurements for both convenience and accuracy. This approach is particularly useful for small samples and where cellular characteristics, especially cell size, are expected to vary during growth.	[Chioccioli, Maurizio; Hankamer, Ben; Ross, Ian L.] Univ Queensland, Inst Mol Biosci IMB, Brisbane, Qld, Australia	University of Queensland	Ross, IL (corresponding author), Univ Queensland, Inst Mol Biosci IMB, Brisbane, Qld, Australia.	i.ross@imb.uq.edu.au	Ross, Ian/A-8622-2011; Hankamer, Ben D/C-9688-2015	Ross, Ian/0000-0002-2389-4292; Hankamer, Ben D/0000-0001-9284-4929	Australian Research Council (ARC) [LP0883380]; University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship; University of Queensland International Research Award (UQIRTA)	Australian Research Council (ARC)(Australian Research Council); University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship; University of Queensland International Research Award (UQIRTA)	This work was supported by Australian Research Council (ARC) grant LP0883380 (www.arc.gov.au). MC was supported by a University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship and a University of Queensland International Research Award (UQIRTA) Tuition Fees Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwa OK, 2013, INT J BIOCH BIOTECH, V2, P289; Alcaraz M, 2003, MAR BIOL, V143, P307, DOI 10.1007/s00227-003-1094-8; Altenburger R, 2008, J ENVIRON QUAL, V37, P16, DOI 10.2134/jeq2006.0556; Alvarez E, 2012, J PLANKTON RES, V34, P454, DOI 10.1093/plankt/fbs017; Collier JL, 2000, J PHYCOL, V36, P628, DOI 10.1046/j.1529-8817.2000.99215.x; Foladori P, 2008, WATER RES, V42, P3757, DOI 10.1016/j.watres.2008.06.026; Gerashchenko BI, 2000, CYTOMETRY, V41, P209, DOI 10.1002/1097-0320(20001101)41:3<209::AID-CYTO8>3.0.CO;2-U; Gerashchenko Bogdan I, 2010, Curr Protoc Cytom, VChapter 11, DOI 10.1002/0471142956.cy1119s52; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gray AJ, 2002, J APPL PHYCOL, V14, P193, DOI 10.1023/A:1019976310527; Green RE, 2003, APPL OPTICS, V42, P526, DOI 10.1364/AO.42.000526; GRIFFITHS D, 1961, ANN BOT-LONDON, V25, P85, DOI 10.1093/oxfordjournals.aob.a083746; GRIFFITHS DJ, 1963, ANN BOT-LONDON, V27, P493, DOI 10.1093/oxfordjournals.aob.a083865; Hoffman RA, 2009, CURR PROTOC CYTOM; Jahnke J, 2011, J APPL PHYCOL, V23, P655, DOI 10.1007/s10811-010-9557-z; Lorenzen H., 1974, ALGAL PHYSL BIOCH, P894; Madrid RE, 2005, CRIT REV BIOTECHNOL, V25, P97, DOI 10.1080/07388550500248563; Mahlmann DM, 2008, EUR J PHYCOL, V43, P355, DOI 10.1080/09670260802168625; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Pearsall WH, 1936, P ROY SOC          B, V121, P451; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Quirantes A, 2004, J QUANT SPECTROSC RA, V89, P311, DOI 10.1016/j.jqsrt.2004.05.031; Reckermann M, 2000, SCI MAR, V64, P235, DOI 10.3989/scimar.2000.64n2235; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; Robertson BR, 2001, CURR PROTOC CYTOM; SHARPLESS TK, 1977, J HISTOCHEM CYTOCHEM, V25, P845, DOI 10.1177/25.7.330734; SHARPLESS TK, 1976, J HISTOCHEM CYTOCHEM, V24, P257, DOI 10.1177/24.1.1254921; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Stramski D, 1999, DEEP-SEA RES PT I, V46, P335, DOI 10.1016/S0967-0637(98)00065-X; SYRETT PJ, 1963, BIOCHEM J, V89, P308, DOI 10.1042/bj0890308; Tanaka JY, 2001, CRYOBIOLOGY, V42, P286, DOI 10.1006/cryo.2001.2334; Toepel J, 2005, J PHYCOL, V41, P1099, DOI 10.1111/j.1529-8817.2005.00137.x; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Umorin M, 2005, BIOTECHNOL LETT, V27, P347, DOI 10.1007/s10529-005-1010-z; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; WITKOWSKI K, 1993, LIMNOL OCEANOGR, V38, P1365, DOI 10.4319/lo.1993.38.7.1365; Wood A., 2005, ALGAL CULTURING TECH, P253; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	41	60	61	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97269	10.1371/journal.pone.0097269	http://dx.doi.org/10.1371/journal.pone.0097269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832156	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500044
J	Kurtyka, CA; Chen, L; Cress, WD				Kurtyka, Courtney A.; Chen, Lu; Cress, W. Douglas			E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; S-PHASE; TRANSCRIPTIONAL REPRESSION; RB/E2F PATHWAY; RB PROTEIN; PD 0332991; CYCLE; PROLIFERATION; INACTIVATION; EXPRESSION	The CDK/Rb/E2F pathway is commonly disrupted in lung cancer, and thus, it is predicted that blocking the E2F pathway would have therapeutic potential. To test this hypothesis, we have examined the activity of HLM006474 (a small molecule pan-E2F inhibitor) in lung cancer cell lines as a single agent and in combination with other compounds. HLM006474 reduces the viability of both SCLC and NSCLC lines with a biological IC50 that varies between 15 and 75 mu M, but with no significant difference between the groups. Combination of HLM006474 with cisplatin and gemcitabine demonstrate little synergy; however, HLM006474 synergizes with paclitaxel. Surprisingly, we discovered that brief treatment of cells with HLM006474 led to an increase of E2F3 protein levels (due to de-repression of these promoter sites). Since paclitaxel sensitivity has been shown to correlate with E2F3 levels, we hypothesized that HLM006474 synergy with paclitaxel may be mediated by transient induction of E2F3. To test this, H1299 cells were depleted of E2F3a and E2F3b with siRNA and treated with paclitaxel. Assays of proliferation showed that both siRNAs significantly reduced paclitaxel sensitivity, as expected. Taken together, these results suggest that HLM006474 may have efficacy in lung cancer and may be useful in combination with taxanes.	[Kurtyka, Courtney A.; Chen, Lu; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Biol & Evolut, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Biol & Evolut, Tampa, FL 33612 USA.	douglas.cress@moffitt.org			National Cancer Institute [CA119997]; Bankhead Coley Cancer Research Program of the Florida Department of Health [FDH 08BB-05]; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, P50CA119997] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bankhead Coley Cancer Research Program of the Florida Department of Health; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (CA119997), the Bankhead Coley Cancer Research Program of the Florida Department of Health (FDH 08BB-05) and the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2010, CANC FACTS FIG 2010, P1; Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Guha M, 2013, NAT BIOTECHNOL, V31, P187, DOI 10.1038/nbt0313-187a; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200; He S, 2000, MOL CELL BIOL, V20, P363, DOI 10.1128/MCB.20.1.363-371.2000; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Humbert PO, 2000, GENE DEV, V14, P690; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; KELLEY MJ, 1995, JNCI-J NATL CANCER I, V87, P756, DOI 10.1093/jnci/87.10.756; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Ma YH, 2010, J BIOL CHEM, V285, P9813, DOI 10.1074/jbc.M109.091496; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matsumura N, 2009, MOL CANCER RES, V7, P210, DOI 10.1158/1541-7786.MCR-08-0255; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; OTTERSON GA, 1994, ONCOGENE, V9, P3375; Porlan E, 2013, NAT NEUROSCI, V16, P1567, DOI 10.1038/nn.3545; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; SHAPIRO GI, 1995, CANCER RES, V55, P6200; SHAPIRO GI, 1995, CANCER RES, V55, P505; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHIMIZU E, 1994, ONCOGENE, V9, P2441; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tordai A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2088; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; XU HJ, 1991, CANCER RES, V51, P2735; Zheng YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070371; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	52	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96357	10.1371/journal.pone.0096357	http://dx.doi.org/10.1371/journal.pone.0096357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831239	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500017
J	Zhai, H; Lu, SX; Wang, YQ; Chen, X; Ren, HX; Yang, JY; Cheng, W; Zong, CM; Gu, HP; Qiu, HM; Wu, HY; Zhang, XZ; Cui, TT; Xia, ZJ				Zhai, Hong; Lu, Shixiang; Wang, Yueqiang; Chen, Xin; Ren, Haixiang; Yang, Jiayin; Cheng, Wen; Zong, Chunmei; Gu, Heping; Qiu, Hongmei; Wu, Hongyan; Zhang, Xingzheng; Cui, Tingting; Xia, Zhengjun			Allelic Variations at Four Major Maturity E Genes and Transcriptional Abundance of the E1 Gene Are Associated with Flowering Time and Maturity of Soybean Cultivars	PLOS ONE			English	Article							RESIDUAL HETEROZYGOUS LINE; MAP-BASED CLONING; PHOTOPERIOD-SENSITIVITY; GLYCINE-MAX; LOCUS-T; INHERITANCE; LANDRACES; MARKERS; GROWTH; TRAIT	The time to flowering and maturity are ecologically and agronomically important traits for soybean landrace and cultivar adaptation. As a typical short-day crop, long day conditions in the high-latitude regions require soybean cultivars with photoperiod insensitivity that can mature before frost. Although the molecular basis of four major E loci (E1 to E4) have been deciphered, it is not quite clear whether, or to what degree, genetic variation and the expression level of the four E genes are associated with the time to flowering and maturity of soybean cultivars. In this study, we genotyped 180 cultivars at E1 to E4 genes, meanwhile, the time to flowering and maturity of those cultivars were investigated at six geographic locations in China from 2011 to 2012 and further confirmed in 2013. The percentages of recessive alleles at E1, E2, E3 and E4 loci were 38.34%, 84.45%, 36.33%, and 7.20%, respectively. Statistical analysis showed that allelic variations at each of four loci had a significant effect on flowering time as well as maturity. We classified the 180 cultivars into eight genotypic groups based on allelic variations of the four major E loci. The genetic group of e1-nf representing dysfunctional alleles at the E1 locus flowered earliest in all the geographic locations. In contrast, cultivars in the E1E2E3E4 group originated from the southern areas flowered very late or did not flower before frost at high latitude locations. The transcriptional abundance of functional E1 gene was significantly associated with flowering time. However, the ranges of time to flowering and maturity were quite large within some genotypic groups, implying the presence of some other unknown genetic factors that are involved in control of flowering time or maturity. Known genes (e. g. E3 and E4) and other unknown factors may function, at least partially, through regulation of the expression of the E1 gene.	[Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Xingzheng; Cui, Tingting; Xia, Zhengjun] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Lu, Shixiang; Zhang, Xingzheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Yueqiang; Qiu, Hongmei] Jilin Acad Agr Sci, Soybean Res Inst, Changchun, Peoples R China; [Chen, Xin; Gu, Heping] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China; [Ren, Haixiang; Zong, Chunmei] Heilongjiang Acad Agr Sci, Mudanjiang Branch, Mudanjiang, Peoples R China; [Yang, Jiayin] Huaiyin Inst Agr Sci Xuhuai Reg Jiangsu, Huaian, Peoples R China; [Cheng, Wen] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Shandong Normal University	Xia, ZJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.	xiazhj@iga.ac.cn		Chen, Xin/0000-0002-8292-7699	Chinese Academy of Sciences [KZCX2-EW-303, XDA08010105]; National Natural Science Foundation of China [31271742, 31301338]; Natural Science Foundation of Heilongjiang Province of China [ZD201120]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Chinese Academy of Sciences (Grant KZCX2-EW-303 and Hundred Talents Program, Grant XDA08010105), and National Natural Science Foundation of China (31271742 and 31301338), and Natural Science Foundation of Heilongjiang Province of China (ZD201120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, CROP SCI, V43, P1300, DOI 10.2135/cropsci2003.1300; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; Gai J., 2001, ACTA AGRONOMICA SINI, V27, P286; Garner WW, 1919, J AGRIC RES, V18, P0553; Hartwig E. E., 1973, AGRONOMY, P187; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Kumudini SV, 2007, CROP SCI, V47, P1510, DOI 10.2135/cropsci2006.10.0662; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Norman A.G., 1978, SOYBEAN PHYSL AGRONO; Owen FV, 1927, GENETICS, V12, P519; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Sayama T, 2010, BREEDING SCI, V60, P380, DOI 10.1270/jsbbs.60.380; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shin JH, 2012, MOL BREEDING, V30, P1793, DOI 10.1007/s11032-012-9743-6; Stupar RM, 2013, ADV AGRON, V118, P177, DOI 10.1016/B978-0-12-405942-9.00004-9; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang JL, 1961, SCI AGR SIN, V2, P24; Wang YS, 2006, GENET RESOUR CROP EV, V53, P803, DOI 10.1007/s10722-004-5731-y; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Xia ZJ, 2013, SCI WORLD J, DOI 10.1155/2013/281367; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Yamanaka N, 2005, THEOR APPL GENET, V110, P634, DOI 10.1007/s00122-004-1886-3; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	41	33	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97636	10.1371/journal.pone.0097636	http://dx.doi.org/10.1371/journal.pone.0097636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830458	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500090
J	Bjornstrom, K; Turina, D; Strid, T; Sundqvist, T; Eintrei, C				Bjornstrom, Karin; Turina, Dean; Strid, Tobias; Sundqvist, Tommy; Eintrei, Christina			Orexin A Inhibits Propofol-Induced Neurite Retraction by a Phospholipase D/Protein Kinase C-epsilon-Dependent Mechanism in Neurons	PLOS ONE			English	Article							GABA(A) RECEPTOR; PKC-EPSILON; RHO-KINASE; GENERAL-ANESTHESIA; MYOSIN PHOSPHATASE; BETA-SUBUNIT; RAT NEURONS; CELLS; ACTIVATION; MODULATION	Background: The intravenous anaesthetic propofol retracts neurites and reverses the transport of vesicles in rat cortical neurons. Orexin A (OA) is an endogenous neuropeptide regulating wakefulness and may counterbalance anaesthesia. We aim to investigate if OA interacts with anaesthetics by inhibition of the propofol-induced neurite retraction. Methods: In primary cortical cell cultures from newborn rats' brains, live cell light microscopy was used to measure neurite retraction after propofol (2 mu M) treatment with or without OA (10 nM) application. The intracellular signalling involved was tested using a protein kinase C (PKC) activator [phorbol 12-myristate 13-acetate (PMA)] and inhibitors of Rho-kinase (HA-1077), phospholipase D (PLD) [5-fluoro-2-indolyl des-chlorohalopemide (FIPI)], PKC (staurosporine), and a PKC epsilon translocation inhibitor peptide. Changes in PKC epsilon Ser(729) phosphorylation were detected with Western blot. Results: The neurite retraction induced by propofol is blocked by Rho-kinase and PMA. OA blocks neurite retraction induced by propofol, and this inhibitory effect could be prevented by FIPI, staurosporine and PKC epsilon translocation inhibitor peptide. OA increases via PLD and propofol decreases PKC epsilon Ser(729) phosphorylation, a crucial step in the activation of PKC epsilon. Conclusions: Rho-kinase is essential for propofol-induced neurite retraction in cortical neuronal cells. Activation of PKC inhibits neurite retraction caused by propofol. OA blocks propofol-induced neurite retraction by a PLD/PKC epsilon-mediated pathway, and PKC epsilon maybe the key enzyme where the wakefulness and anaesthesia signal pathways converge.	[Bjornstrom, Karin; Turina, Dean; Strid, Tobias; Eintrei, Christina] Linkoping Univ, Fac Hlth Sci, Div Anaesthesiol, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundqvist, Tommy] Linkoping Univ, Fac Hlth Sci, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Bjornstrom, Karin; Turina, Dean; Eintrei, Christina] Ostergotland Cty Council UHL, Clin Anaesthesiol, Linkoping, Sweden	Linkoping University; Linkoping University; City Council Ostergotland	Bjornstrom, K (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Anaesthesiol, Dept Med & Hlth Sci, Linkoping, Sweden.	karin.bjornstrom-karlsson@liu.se			Ostergotland County Council research foundation; Henry and Ella Stahl Foundation; Linkoping Society of Medicine	Ostergotland County Council research foundation; Henry and Ella Stahl Foundation; Linkoping Society of Medicine	This study was funded by the Ostergotland County Council research foundation, the Henry and Ella Stahl Foundation and Linkoping Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Bjornstrom K, 2008, J PHYSIOL PHARMACOL, V59, P617; Bjorklund U, 2010, NEUROCHEM RES, V35, P1733, DOI 10.1007/s11064-010-0236-x; Bjornstrom K, 2003, ACTA ANAESTH SCAND, V47, P157, DOI 10.1034/j.1399-6576.2003.00007.x; Bjornstrom K, 2002, ACTA PHYSIOL SCAND, V175, P227, DOI 10.1046/j.1365-201X.2002.00991.x; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Hansson E., 1989, DISSECTION TISSUE CU, P92; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; JENSEN AG, 1994, ANESTHESIOLOGY, V81, P1220, DOI 10.1097/00000542-199411000-00016; Johansson L, 2008, CELL MOL LIFE SCI, V65, P1948, DOI 10.1007/s00018-008-8206-z; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krasowski MD, 1997, NEUROPHARMACOLOGY, V36, P941, DOI 10.1016/S0028-3908(97)00074-9; Kushikata T, 2003, NEUROSCIENCE, V121, P855, DOI 10.1016/S0306-4522(03)00554-2; Kushikata T, 2010, BRIT J ANAESTH, V104, P723, DOI 10.1093/bja/aeq098; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Ling M, 2004, EXP CELL RES, V292, P135, DOI 10.1016/j.yexcr.2003.08.013; Mashour GA, 2004, ANESTHESIOLOGY, V100, P428, DOI 10.1097/00000542-200402000-00035; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nagumo H, 2000, AM J PHYSIOL-CELL PH, V278, pC57, DOI 10.1152/ajpcell.2000.278.1.C57; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Satoh SI, 2011, BRAIN RES BULL, V84, P174, DOI 10.1016/j.brainresbull.2010.11.013; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Tose R, 2009, ANESTH ANALG, V108, P491, DOI 10.1213/ane.0b013e31819000c8; Turina D, 2008, BRIT J ANAESTH, V101, P374, DOI 10.1093/bja/aen185; Turina D, 2011, J PHYSIOL PHARMACOL, V62, P119; Wickley PJ, 2010, PROPOFOL MODULATES A; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Yasuda Y, 2003, ANESTH ANALG, V97, P1663, DOI 10.1213/01.ANE.0000089964.85834.EF; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97129	10.1371/journal.pone.0097129	http://dx.doi.org/10.1371/journal.pone.0097129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828410	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400058
J	Eichner, J; Wrzodek, C; Romer, M; Ellinger-Ziegelbauer, H; Zell, A				Eichner, Johannes; Wrzodek, Clemens; Roemer, Michael; Ellinger-Ziegelbauer, Heidrun; Zell, Andreas			Evaluation of Toxicogenomics Approaches for Assessing the Risk of Nongenotoxic Carcinogenicity in Rat Liver	PLOS ONE			English	Article							DNA-DAMAGE; EXPRESSION PROFILES; CELL-PROLIFERATION; CANCER; PREDICTION; INDUCTION; HEPATOCARCINOGENICITY; CLASSIFICATION; GENOTOXICITY; MICROARRAY	The current gold-standard method for cancer safety assessment of drugs is a rodent two-year bioassay, which is associated with significant costs and requires testing a high number of animals over lifetime. Due to the absence of a comprehensive set of short-term assays predicting carcinogenicity, new approaches are currently being evaluated. One promising approach is toxicogenomics, which by virtue of genome-wide molecular profiling after compound treatment can lead to an increased mechanistic understanding, and potentially allow for the prediction of a carcinogenic potential via mathematical modeling. The latter typically involves the extraction of informative genes from omics datasets, which can be used to construct generalizable models allowing for the early classification of compounds with unknown carcinogenic potential. Here we formally describe and compare two novel methodologies for the reproducible extraction of characteristic mRNA signatures, which were employed to capture specific gene expression changes observed for nongenotoxic carcinogens. While the first method integrates multiple gene rankings, generated by diverse algorithms applied to data from different subsamplings of the training compounds, the second approach employs a statistical ratio for the identification of informative genes. Both methods were evaluated on a dataset obtained from the toxicogenomics database TG-GATEs to predict the outcome of a two-year bioassay based on profiles from 14-day treatments. Additionally, we applied our methods to datasets from previous studies and showed that the derived prediction models are on average more accurate than those built from the original signatures. The selected genes were mostly related to p53 signaling and to specific changes in anabolic processes or energy metabolism, which are typically observed in tumor cells. Among the genes most frequently incorporated into prediction models were Phlda3, Cdkn1a, Akr7a3, Ccng1 and Abcb4.	[Eichner, Johannes; Wrzodek, Clemens; Roemer, Michael; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Ellinger-Ziegelbauer, Heidrun] Bayer Pharma AG, Global Early Dev, Wuppertal, Germany	Eberhard Karls University of Tubingen; Bayer AG; Bayer Healthcare Pharmaceuticals	Eichner, J (corresponding author), Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany.	johannes.eichner@uni-tuebingen.de		Romer, Michael/0000-0003-2821-4425; Wrzodek, Clemens/0000-0003-4995-780X	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]; Deutsche Forschungsgemeinschaft; Tuebingen University	Innovative Medicine Initiative Joint Undertaking (IMI JU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Albrethsen J, 2011, BBA-PROTEINS PROTEOM, V1814, P1367, DOI 10.1016/j.bbapap.2011.05.018; Amundson SA, 2001, COMP BIOCHEM PHYS B, V129, P703, DOI 10.1016/S1096-4959(01)00389-X; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CATTLEY RC, 1989, CANCER RES, V49, P3246; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deutsch WA, 2001, MUTAGENESIS, V16, P439, DOI 10.1093/mutage/16.5.439; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; ELLIOTT BM, 1987, CARCINOGENESIS, V8, P1213, DOI 10.1093/carcin/8.9.1213; Fielden MR, 2007, TOXICOL SCI, V99, P90, DOI 10.1093/toxsci/kfm156; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLAUERT HP, 1986, CANCER RES, V46, P4601; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Kuncheva LI, STABILITY INDEX FEAT, P390; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Mally A, 2002, TOXICOLOGY, V180, P233, DOI 10.1016/S0300-483X(02)00393-1; Manuppello J, 2008, ENVIRON HEALTH PERSP, V116, pA516, DOI 10.1289/ehp.11964; Nakayama K, 2006, TOXICOL APPL PHARM, V217, P299, DOI 10.1016/j.taap.2006.09.008; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; REDDY JK, 1989, MUTAT RES, V214, P63, DOI 10.1016/0027-5107(89)90198-X; Silva-Neto JP, 2010, TOXICON, V55, P105, DOI 10.1016/j.toxicon.2009.07.007; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; TURNER NT, 1987, MUTAT RES, V189, P285, DOI 10.1016/0165-1218(87)90060-7; Uehara T, 2008, TOXICOLOGY, V250, P15, DOI 10.1016/j.tox.2008.05.013; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wang RX, 2011, CURR PHARM BIOTECHNO, V12, P636, DOI 10.2174/138920111795163986; Warfel NA, 2012, CURR OPIN ONCOL; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wrzodek C, 2013, BIOINFORMATICS, V29, P506, DOI 10.1093/bioinformatics/bts709; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhao L, 2003, MOL CANCER RES, V1, P195	52	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97678	10.1371/journal.pone.0097678	http://dx.doi.org/10.1371/journal.pone.0097678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828355	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400118
J	Huang, HL				Huang, Hui-Ling			Propensity Scores for Prediction and Characterization of Bioluminescent Proteins from Sequences	PLOS ONE			English	Article							PHOTOPROTEIN AEQUORIN; CRYSTAL-STRUCTURE; FLUORESCENT; DATABASE; MACHINE; CELLS	Bioluminescent proteins (BLPs) are a class of proteins with various mechanisms of light emission such as bioluminescence and fluorescence from luminous organisms. While valuable for commercial and medical applications, identification of BLPs, including luciferases and fluorescent proteins (FPs), is rather challenging, owing to their high variety of protein sequences. Moreover, characterization of BLPs facilitates mutagenesis analysis to enhance bioluminescence and fluorescence. Therefore, this study proposes a novel methodological approach to estimating the propensity scores of 400 dipeptides and 20 amino acids in order to design two prediction methods and characterize BLPs based on a scoring card method (SCM). The SCMBLP method for predicting BLPs achieves an accuracy of 90.83% for 10-fold cross-validation higher than existing support vector machine based methods and a test accuracy of 82.85%. A dataset consisting of 269 luciferases and 216 FPs is also established to design the SCMLFP prediction method, which achieves training and test accuracies of 97.10% and 96.28%, respectively. Additionally, four informative physicochemical properties of 20 amino acids are identified using the estimated propensity scores to characterize BLPs as follows: 1) high transfer free energy from inside to the protein surface, 2) high occurrence frequency of residues in the transmembrane regions of the protein, 3) large hydrophobicity scale from the native protein structure, and 4) high correlation coefficient (R = 0.921) between the amino acid compositions of BLPs and integral membrane proteins. Further analyzing BLPs reveals that luciferases have a larger value of R (0.937) than FPs (0.635), suggesting that luciferases tend to locate near the cell membrane location rather than FPs for convenient receipt of extracellular ions. Importantly, the propensity scores of dipeptides and amino acids and the identified properties facilitate efforts to predict, characterize, and apply BLPs, including luciferases, photoproteins, and FPs. The web server is available at http://iclab.life.nctu.edu.tw/SCMBLP/index.html.	[Huang, Hui-Ling] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hui-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw			National Science Council of Taiwan [NSC-102-2221-E-009-169]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [102W962]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This work was funded by National Science Council of Taiwan, under the contract number NSC-102-2221-E-009-169, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C., for the project 102W962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cainarca S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008882; CAMPBELL AK, 1974, BIOCHEM J, V143, P411, DOI 10.1042/bj1430411; CASARI G, 1992, J MOL BIOL, V224, P725, DOI 10.1016/0022-2836(92)90556-Y; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Charoenkwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072368; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DEGLIESPOSTI M, 1990, EUR J BIOCHEM, V190, P207, DOI 10.1111/j.1432-1033.1990.tb15566.x; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Eglen RM, 2008, ASSAY DRUG DEV TECHN, V6, P659, DOI 10.1089/adt.2008.160; Fan GL, 2013, J THEOR BIOL, V334, P45, DOI 10.1016/j.jtbi.2013.06.003; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Ho SY, 2004, IEEE T EVOLUT COMPUT, V8, P522, DOI 10.1109/TEVC.2004.835176; Huang HL, 2012, IEEE INT C BIOINF BI, P40; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Huang HL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S3; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kandaswamy KK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-345; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Nakashima H, 2013, J BIOMEDICAL SCI ENG, V6, P36, DOI [DOI 10.4236/jbise.2013.61006, 10.4236/jbise.2013.61006]; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Titushin MS, 2011, PROTEIN CELL, V2, P957, DOI 10.1007/s13238-011-1118-y; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Vidi PA, 2009, MOL PHARMACOL, V75, P733, DOI 10.1124/mol.108.053819; Weast RC, 1974, EDITOR HDB CHEM PHYS; WHITE E H, 1971, Bioorganic Chemistry, V1, P92, DOI 10.1016/0045-2068(71)90009-5; WILSON T, 1995, PHOTOCHEM PHOTOBIOL, V62, P601, DOI 10.1111/j.1751-1097.1995.tb08706.x; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Zhao XW, 2012, INT J MOL SCI, V13, P3650, DOI 10.3390/ijms13033650	34	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97158	10.1371/journal.pone.0097158	http://dx.doi.org/10.1371/journal.pone.0097158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828431	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400060
J	Noguchi-Shinohara, M; Yuki, S; Dohmoto, C; Ikeda, Y; Samuraki, M; Iwasa, K; Yokogawa, M; Asai, K; Komai, K; Nakamura, H; Yamada, M				Noguchi-Shinohara, Moeko; Yuki, Sohshi; Dohmoto, Chiaki; Ikeda, Yoshihisa; Samuraki, Miharu; Iwasa, Kazuo; Yokogawa, Masami; Asai, Kimiko; Komai, Kiyonobu; Nakamura, Hiroyuki; Yamada, Masahito			Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline	PLOS ONE			English	Article							ALZHEIMER TRANSGENIC MICE; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; PRECURSOR PROTEIN; DIETARY-INTAKE; IMPAIRMENT; CAFFEINE; DISEASE; DEMENTIA; CATECHIN; ANTIOXIDANTS	Our objective was to determine whether the consumption of green tea, coffee, or black tea influences the incidence of dementia and mild cognitive impairment (MCI) in older people. We conducted a population-based prospective study with Japanese residents aged >60 years from Nakajima, Japan (the Nakajima Project). Participants received an evaluation of cognitive function and blood tests. The consumption of green tea, coffee, and black tea was also evaluated at baseline. Of 723 participants with normal cognitive function at a baseline survey (2007-2008), 490 completed the follow up survey in 2011-2013. The incidence of dementia during the follow-up period (mean +/- SD: 4.9 +/- 0.9 years) was 5.3%, and that of MCI was 13.1%. The multiple-adjusted odds ratio for the incidence of overall cognitive decline (dementia or MCI) was 0.32 (95% CI: 0.16-0.64) among individuals who consumed green tea every day and 0.47 (95% CI: 0.25-0.86) among those who consumed green tea 1-6 days per week compared with individuals who did not consume green tea at all. The multiple-adjusted odds ratio for the incidence of dementia was 0.26 (95% CI: 0.06-1.06) among individuals who consumed green tea every day compared with those who did not consume green tea at all. No association was found between coffee or black tea consumption and the incidence of dementia or MCI. Our results indicate that green tea consumption is significantly associated with reduced risk of cognitive decline, even after adjustment for possible confounding factors.	[Noguchi-Shinohara, Moeko; Yuki, Sohshi; Dohmoto, Chiaki; Ikeda, Yoshihisa; Samuraki, Miharu; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Yokogawa, Masami] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Dept Phys Therapy, Kanazawa, Ishikawa, Japan; [Asai, Kimiko] Bishoen Geriatr Hlth Serv Facil, Suzu, Japan; [Komai, Kiyonobu] Natl Hosp Org, Ioh Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.	m-yamada@med.kanazawa-u.ac.jp			Grant for the Hokuriku Innovation Cluster for Health Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Grant for the Hokuriku Innovation Cluster for Health Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Grant for the Hokuriku Innovation Cluster for Health Science (to M.Y.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. In addition, this work was also supported from the Research on Dementia, Health and Labour Sciences Research Grants (to M.Y.) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Bastianetto S, 2006, EUR J NEUROSCI, V23, P55, DOI 10.1111/j.1460-9568.2005.04532.x; Choi YT, 2001, LIFE SCI, V70, P603, DOI 10.1016/S0024-3205(01)01438-2; Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KAMBOH MI, 1988, J LIPID RES, V29, P1535; Khokhar S, 2002, J AGR FOOD CHEM, V50, P565, DOI 10.1021/jf010153l; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Landau SM, 2012, ARCH NEUROL-CHICAGO, V69, P623, DOI 10.1001/archneurol.2011.2748; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; LYKKESFELDT J, 1995, ANAL BIOCHEM, V229, P329, DOI 10.1006/abio.1995.1421; Morris J. C., 1993, NEUROLOGY, V43, P2411, DOI [10.1212/WNL.43.11.24118232970, DOI 10.1212/WNL.43.11.24118232970]; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679; Noguchi-Shinohara M, 2013, J ALZHEIMERS DIS, V37, P691, DOI 10.3233/JAD-130398; Ogawa Keiko, 2002, J Epidemiol, V12, P1; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Peterson J, 2005, J FOOD COMPOS ANAL, V18, P487, DOI 10.1016/j.jfca.2004.05.006; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c; Science and Technology Agency, 2010, STAND TABL FOOD COMP; Sugano K, 2012, DEMENT GER COGN D EX, V2, P69, DOI 10.1159/000337224; van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	39	90	96	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96013	10.1371/journal.pone.0096013	http://dx.doi.org/10.1371/journal.pone.0096013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828424	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400020
J	Carl, C; de Nys, R; Lawton, RJ; Paul, NA				Carl, Christina; de Nys, Rocky; Lawton, Rebecca J.; Paul, Nicholas A.			Methods for the Induction Reproduction in a Species of Filamentous Ulva	PLOS ONE			English	Article							ALGA ENTEROMORPHA; GAMETE RELEASE; FLOATING ULVA; GREEN TIDE; CHLOROPHYTA; MUTABILIS; SPORULATION; ZOOSPORES; SETTLEMENT; PROLIFERA	The green seaweed Ulva is a major fouling organism but also an edible aquaculture product in Asia. This study quantified for the first time the effect of key factors on the reproduction of a tropical species of filamentous Ulva (Ulva sp. 3). The controlled timing of release of swarmers (motile reproductive bodies) was achieved when experiments were initiated in the early afternoon by exposing the thalli to a temperature shock (4 degrees C) for 10 min and subsequently placing them into autoclaved filtered seawater under a 12 h light: 12 h dark photoperiod at 25 degrees C. The release of swarmers then peaked two days after initiation. In contrast, segmentation, dehydration, salinity or time of initiation of experiments had no effect of any magnitude on reproduction. The released swarmers were predominantly biflagellate (95%), negatively phototactic and germinated without complementary gametes. This indicates that Ulva sp. 3 has a simple asexual life history dominated by biflagellate zoids.	[Carl, Christina] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Carl, C (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	tine.carl@jcu.edu.au	Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Praeger, Christina/A-7224-2013	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Praeger, Christina/0000-0002-1947-122X; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRATEN T, 1973, J CELL SCI, V13, P69; Callow JA, 2006, BIOLOGICAL ADHESIVES, P63, DOI 10.1007/978-3-540-31049-5_4; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; CALLOW ME, 1986, BOT MAR, V29, P351, DOI 10.1515/botm.1986.29.4.351; CHRISTIE AO, 1962, NATURE, V193, P193, DOI 10.1038/193193a0; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Corradi MG, 2006, AQUAT BOT, V84, P144, DOI 10.1016/j.aquabot.2005.08.007; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Cruz-Suarez LE, 2010, AQUACULTURE, V301, P64, DOI 10.1016/j.aquaculture.2010.01.021; EVANS LV, 1970, ANN BOT-LONDON, V34, P451, DOI 10.1093/oxfordjournals.aob.a084382; FLETCHER RL, 1989, INT BIODETERIOR, V25, P407, DOI 10.1016/0265-3036(89)90067-5; Forbord S, 2012, J APPL PHYCOL, V24, P393, DOI 10.1007/s10811-011-9784-y; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Godwin LS, 2003, BIOFOULING, V19, P123, DOI 10.1080/0892701031000061750; Graham LE, 2000, ALGAE; Han TJ, 2005, AQUAT TOXICOL, V75, P202, DOI 10.1016/j.aquatox.2005.08.003; Han TJ, 2003, J EXP MAR BIOL ECOL, V290, P115, DOI 10.1016/S0022-0981(03)00068-6; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2004.tb00311.x; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2003, PHYCOLOGIA, V42, P275, DOI 10.2216/i0031-8884-42-3-275.1; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; Hiraoka Masanori, 2003, Phycological Research, V51, P29; Hiraoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019371; Hiraoka M, 2010, J PHYCOL, V46, P882, DOI 10.1111/j.1529-8817.2010.00873.x; Hiraoka Masanori, 1998, Phycological Research, V46, P199, DOI 10.1111/j.1440-1835.1998.tb00114.x; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Imchen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032651; Kalita TL, 2011, RUSS J MAR BIOL+, V37, P52, DOI 10.1134/S106307401101007X; Kawashima Y, 2013, FISHERIES SCI, V79, P521, DOI 10.1007/s12562-013-0610-0; Kuwano K, 2012, J PHYCOL, V48, P394, DOI 10.1111/j.1529-8817.2011.01110.x; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; LERSTEN NELS R., 1960, BOT GAZ, V122, P33, DOI 10.1086/336083; Long CJ, 2010, BIOFOULING, V26, P411, DOI 10.1080/08927011003628849; Luning K, 2008, J PHYCOL, V44, P866, DOI 10.1111/j.1529-8817.2008.00535.x; LUNING K, 1988, MAR ECOL PROG SER, V45, P137, DOI 10.3354/meps045137; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Mantri VA, 2011, J APPL PHYCOL, V23, P243, DOI 10.1007/s10811-010-9544-4; MCARTHUR DM, 1979, BRIT PHYCOL J, V14, P43, DOI 10.1080/00071617900650071; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; NIESENBAUM RA, 1988, AQUAT BOT, V32, P155, DOI 10.1016/0304-3770(88)90095-2; NILSEN G, 1975, PLANTA, V125, P127, DOI 10.1007/BF00388699; NORDBY O, 1974, J CELL SCI, V15, P443; NORDBY O, 1977, BOT MAR, V20, P19, DOI 10.1515/botm.1977.20.1.19; NORDBY O, 1972, EXP CELL RES, V75, P321, DOI 10.1016/0014-4827(72)90436-3; Ohno M, 1993, SEAWEED CULTIVATION, P7; Pandey RS, 1985, REP US MAR BIOL I, V7, P21; Pickett-Heaps JD, 1975, GREEN ALGAE, P167; Poole LJ, 1997, PROG PHYCOL RES, V12, P1; Ruangchuay R., 2012, Songklanakarin Journal of Science and Technology, V34, P501; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936; Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Shin HW, 2008, J ENVIRON BIOL, V29, P613; Shokita S, 1991, AQUACULTURE TROPICAL, P31; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; SMITH GM, 1947, AM J BOT, V34, P80, DOI 10.2307/2437232; Stratmann J, 1996, J PHYCOL, V32, P1009, DOI 10.1111/j.0022-3646.1996.01009.x; THIADENS AJ, 1967, PLANTA, V72, P60; Thome I, 2012, BIOFOULING, V28, P501, DOI 10.1080/08927014.2012.689288; Thompson SEM, 2007, PLANT CELL ENVIRON, V30, P733, DOI 10.1111/j.1365-3040.2007.01661.x; Titlyanov EA, 1996, EUR J PHYCOL, V31, P181, DOI 10.1080/09670269600651361; Wichard T, 2010, J PHYCOL, V46, P248, DOI 10.1111/j.1529-8817.2010.00816.x; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018	69	29	30	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97396	10.1371/journal.pone.0097396	http://dx.doi.org/10.1371/journal.pone.0097396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824896	Green Accepted, gold, Green Published			2022-12-25	WOS:000336369200107
J	Cui, JD; Cui, LL; Zhang, SP; Zhang, YF; Su, ZG; Ma, GH				Cui, Jian dong; Cui, Li li; Zhang, Song ping; Zhang, Yu fei; Su, Zhi guo; Ma, Guang hui			Hybrid Magnetic Cross-Linked Enzyme Aggregates of Phenylalanine Ammonia Lyase from Rhodotorula glutinis	PLOS ONE			English	Article							PENICILLIN-G ACYLASE; SILICA; BIOCATALYSTS; CLEAS; IMMOBILIZATION; COAGGREGATION; ENHANCEMENT; METHODOLOGY; POLYMERS; LIPASE	Novel hybrid magnetic cross-linked enzyme aggregates of phenylalanine ammonia lyase (HM-PAL-CLEAs) were developed by co-aggregation of enzyme aggregates with magnetite nanoparticles and subsequent crosslinking with glutaraldehyde. The HM-PAL-CLEAs can be easily separated from the reaction mixture by using an external magnetic field. Analysis by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) indicated that PAL-CLEAs were inlayed in nanoparticle aggregates. The HM-PAL-CLEAs revealed a broader limit in optimal pH compared to free enzyme and PAL-CLEAs. Although there is no big difference in K-m of enzyme in CLEAs and HM-PAL-CLEAs, V-max of HM-PAL-CLEAs is about 1.75 times higher than that of CLEAs. Compared with free enzyme and PAL-CLEAs, the HM-PAL-CLEAs also exhibited the highest thermal stability, denaturant stability and storage stability. The HM-PAL-CLEAs retained 30% initial activity even after 11 cycles of reuse, whereas PAL-CLEAs retained 35% of its initial activity only after 7 cycles. These results indicated that hybrid magnetic CLEAs technology might be used as a feasible and efficient solution for improving properties of immobilized enzyme in industrial application.	[Cui, Jian dong; Cui, Li li] Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China; [Cui, Jian dong; Cui, Li li; Zhang, Song ping; Zhang, Yu fei; Su, Zhi guo; Ma, Guang hui] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Cui, Jian dong] Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Tai Da Dev Area, Minist Educ, Tianjin, Peoples R China; [Zhang, Song ping] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin, Peoples R China	Hebei University of Science & Technology; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tianjin University Science & Technology	Cui, JD (corresponding author), Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China.	cjd007cn@163.com; spzhang@home.ipe.ac.cn	Zhang, yufei/HHC-7375-2022	cui, jian dong/0000-0002-2809-530X	National Natural Science Foundation of China [21072041, 21106164, 21376249]; Open Funding Project of the National Key Laboratory of Biochemical Engineering [KF2010-12]; Foundation of Key Laboratory of Industry Microbiology [2012IM004]; Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology); Foundation of Hebei University of Science and Technology [SW10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the National Key Laboratory of Biochemical Engineering; Foundation of Key Laboratory of Industry Microbiology; Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology); Foundation of Hebei University of Science and Technology	The project was partially supported by the National Natural Science Foundation of China (project no. 21072041, 21106164, 21376249). Dr. J.D. Cui also thanks supports from Open Funding Project of the National Key Laboratory of Biochemical Engineering (no. KF2010-12) and the Foundation (no. 2012IM004) of Key Laboratory of Industry Microbiology, Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology), (Tianjin University of Science & Technology), People's Republic of China, the Natural Science Foundation of Hebei Province, China (project no. B2014208054), and the Foundation of Hebei University of Science and Technology (project no. SW10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytar BS, 2008, PROCESS BIOCHEM, V43, P125, DOI 10.1016/j.procbio.2007.11.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabana H, 2009, BIOTECHNOL BIOENG, V102, P1582, DOI 10.1002/bit.22198; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Cui JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080581; Cui JD, 2013, APPL BIOCHEM BIOTECH, V170, P1827, DOI 10.1007/s12010-013-0317-9; Cui JD, 2012, APPL BIOCHEM BIOTECH, V167, P835, DOI 10.1007/s12010-012-9738-0; Dong T, 2010, BIORESOURCE TECHNOL, V101, P6569, DOI 10.1016/j.biortech.2010.03.061; Jung D, 2009, J MATER SCI, V44, P6747, DOI 10.1007/s10853-009-3917-6; Kim MI, 2007, BIOTECHNOL BIOENG, V96, P210, DOI 10.1002/bit.21107; Lee J, 2009, J MATER CHEM, V19, P7864, DOI 10.1039/b909109b; Li Y, 2010, J MOL CATAL B-ENZYM, V66, P182, DOI 10.1016/j.molcatb.2010.05.007; Mateo C, 2004, BIOTECHNOL BIOENG, V86, P273, DOI 10.1002/bit.20033; Matijosyte I, 2010, J MOL CATAL B-ENZYM, V62, P142, DOI 10.1016/j.molcatb.2009.09.019; Montoro-Garcia S, 2010, BIORESOURCE TECHNOL, V101, P331, DOI 10.1016/j.biortech.2009.08.016; Park JM, 2013, INT J BIOL MACROMOL, V54, P37, DOI 10.1016/j.ijbiomac.2012.11.025; Park JM, 2012, BIOMACROMOLECULES, V13, P3780, DOI 10.1021/bm3012264; Park JM, 2010, PROCESS BIOCHEM, V45, P259, DOI 10.1016/j.procbio.2009.09.015; Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097; Rees DG, 1996, ENZYME MICROB TECH, V19, P282; Reshmi R, 2013, J MOL CATAL B-ENZYM, V85-86, P111, DOI 10.1016/j.molcatb.2012.08.007; Talekar S, 2013, RSC ADV, V3, P12485, DOI 10.1039/c3ra40818c; Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044; Wang MF, 2010, BIOCHEM ENG J, V52, P168, DOI 10.1016/j.bej.2010.08.003; Wilson L, 2004, BIOTECHNOL BIOENG, V86, P558, DOI 10.1002/bit.20107; Wilson L, 2004, BIOMACROMOLECULES, V5, P852, DOI 10.1021/bm0343895; Wilson L, 2006, ENZYME MICROB TECH, V39, P750, DOI 10.1016/j.enzmictec.2005.12.011; YAMADA S, 1981, APPL ENVIRON MICROB, V42, P773, DOI 10.1128/AEM.42.5.773-778.1981; Yang XE, 2012, J BIOTECHNOL, V161, P27, DOI 10.1016/j.jbiotec.2012.05.014; Zhang BZ, 2010, J AGR FOOD CHEM, V58, P2795, DOI 10.1021/jf9036744; Zhang S, 2012, BIOTECHNOL BIOTEC EQ, V26, P3418, DOI 10.5504/BBEQ.2012.0106; Zheng MQ, 2013, J BIOTECHNOL, V168, P212, DOI 10.1016/j.jbiotec.2013.05.016; Zheng MQ, 2011, J BIOTECHNOL, V154, P274, DOI 10.1016/j.jbiotec.2011.04.013	33	40	43	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97221	10.1371/journal.pone.0097221	http://dx.doi.org/10.1371/journal.pone.0097221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825453	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200072
J	Wang, HB; Gutierrez-Uzquiza, A; Garg, R; Barrio-Real, L; Abera, MB; Lopez-Haber, C; Rosemblit, C; Lu, HS; Abba, M; Kazanietz, MG				Wang, HongBin; Gutierrez-Uzquiza, Alvaro; Garg, Rachana; Barrio-Real, Laura; Abera, Mahlet B.; Lopez-Haber, Cynthia; Rosemblit, Cinthia; Lu, Huaisheng; Abba, Martin; Kazanietz, Marcelo G.			Transcriptional Regulation of Oncogenic Protein Kinase C epsilon (PKC epsilon) by STAT1 and Sp1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; CYCLIN D1; ESTROGEN-RECEPTOR; OXIDATIVE-STRESS; PROSTATE-CANCER; EPIGENETIC REPRESSION; INSULIN-RESISTANCE; DRUG ACTIVITY; GROWTH-FACTOR	Overexpression of PKC epsilon, a kinase associated with tumor aggressiveness and widely implicated in malignant transformation and metastasis, is a hallmark of multiple cancers, including mammary, prostate, and lung cancer. To characterize the mechanisms that control PKC epsilon expression and its up-regulation in cancer, we cloned an similar to 1.6-kb promoter segment of the human PKC epsilon gene (PRKCE) that displays elevated transcriptional activity in cancer cells. A comprehensive deletional analysis established two regions rich in Sp1 and STAT1 sites located between -777 and -105 bp (region A) and -921 and -796 bp (region B), respectively, as responsible for the high transcriptional activity observed in cancer cells. A more detailed mutagenesis analysis followed by EMSA and ChIP identified Sp1 sites in positions -668/-659 and -269/-247 as well as STAT1 sites in positions -880/-869 and -793/-782 as the elements responsible for elevated promoter activity in breast cancer cells relative to normal mammary epithelial cells. RNAi silencing of Sp1 and STAT1 in breast cancer cells reduced PKC epsilon mRNA and protein expression, as well as PRKCE promoter activity. Moreover, a strong correlation was found between PKC epsilon and phospho-Ser-727 (active) STAT1 levels in breast cancer cells. Our results may have significant implications for the development of approaches to target PKC epsilon and its effectors in cancer therapeutics.	[Wang, HongBin; Gutierrez-Uzquiza, Alvaro; Garg, Rachana; Barrio-Real, Laura; Abera, Mahlet B.; Lopez-Haber, Cynthia; Rosemblit, Cinthia; Lu, Huaisheng; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Abba, Martin] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, RA-1900 La Plata, Argentina	University of Pennsylvania; Pennsylvania Medicine; National University of La Plata	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Uzquiza, Alvaro Gutierrez/E-4073-2012; Garg, Rachana/AAQ-9518-2020	Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Lopez Haber, Cynthia/0000-0001-9106-543X; Garg, Rachana/0000-0002-7808-1053; Abba, Martin/0000-0002-9206-2369	National Institutes of Health [R01-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; CACACE AM, 1993, ONCOGENE, V8, P2095; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; CHEN YY, 1994, ONCOGENE, V9, P2269; Cheng MB, 2010, CELL SIGNAL, V22, P1206, DOI 10.1016/j.cellsig.2010.03.012; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; Dann S. G., 2013, ONCOGENE; Finkenzeller Gunter, 2004, Angiogenesis, V7, P59, DOI 10.1023/B:AGEN.0000037332.66411.f0; Franci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058183; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Greenwood C, 2012, J PROTEOMICS, V75, P3031, DOI 10.1016/j.jprot.2011.11.033; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hagiwara K, 2012, GENE CHROMOSOME CANC, V51, P1024, DOI 10.1002/gcc.21985; Han W, 2013, MOL CARCINOGEN, V52, P959, DOI 10.1002/mc.21936; Hix LM, 2013, J BIOL CHEM, V288, P11676, DOI 10.1074/jbc.M112.441402; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Khodarev NN, 2012, CLIN CANCER RES, V18, P3015, DOI 10.1158/1078-0432.CCR-11-3225; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Lee AM, 2011, P NATL ACAD SCI USA, V108, P16080, DOI 10.1073/pnas.1106277108; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lopez-Haber C, 2013, MOL PHARMACOL, V83, P1141, DOI 10.1124/mol.112.084293; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Magkou C, 2012, HISTOPATHOLOGY, V60, P1125, DOI 10.1111/j.1365-2559.2011.04143.x; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mesquita RFDS, 2014, MOL CELL BIOL, V34, P574, DOI 10.1128/MCB.01098-13; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Perletti GP, 1996, ONCOGENE, V12, P847; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Rajski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029743; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Rickardson L, 2006, CANCER CHEMOTH PHARM, V58, P749, DOI 10.1007/s00280-006-0216-7; Salvatori L, 2011, BIOMED PHARMACOTHER, V65, P307, DOI 10.1016/j.biopha.2011.03.007; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Su T., 2013, ISRN ONCOL, V2013; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang Xiao-Bing, 2007, Ai Zheng, V26, P996; Wu DF, 2012, J CLIN INVEST, V122, P1306, DOI 10.1172/JCI61934; Wu DQ, 2002, CANCER RES, V62, P2423; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Zannetti A, 2000, CANCER RES, V60, P1546; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19823	19838		10.1074/jbc.M114.548446	http://dx.doi.org/10.1074/jbc.M114.548446			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24825907	Green Published, hybrid			2022-12-25	WOS:000339326800053
J	Wisniewska, M; Happonen, L; Kahn, F; Varjosalo, M; Malmstrom, L; Rosenberger, G; Karlsson, C; Cazzamali, G; Pozdnyakova, I; Frick, IM; Bjorck, L; Streicher, W; Malmstrom, J; Wikstrom, M				Wisniewska, Magdalena; Happonen, Lotta; Kahn, Fredrik; Varjosalo, Markku; Malmstroem, Lars; Rosenberger, George; Karlsson, Christofer; Cazzamali, Giuseppe; Pozdnyakova, Irina; Frick, Inga-Maria; Bjorck, Lars; Streicher, Werner; Malmstrom, Johan; Wikstrom, Mats			Functional and Structural Properties of a Novel Protein and Virulence Factor (Protein sHIP) in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GROUP-A STREPTOCOCCUS; SERUM OPACITY FACTOR; GENOME SEQUENCE; SURFACE; STRAIN; IDENTIFICATION; BACTERIA; SYSTEM; SERVER	Streptococcus pyogenes is a significant bacterial pathogen in the human population. The importance of virulence factors for the survival and colonization of S. pyogenes is well established, and many of these factors are exposed to the extracellular environment, enabling bacterial interactions with the host. In the present study, we quantitatively analyzed and compared S. pyogenes proteins in the growth medium of a strain that is virulent to mice with a non-virulent strain. Particularly, one of these proteins was present at significantly higher levels in stationary growth medium from the virulent strain. We determined the three-dimensional structure of the protein that showed a unique tetrameric organization composed of four helix-loop-helix motifs. Affinity pull-down mass spectrometry analysis in human plasma demonstrated that the protein interacts with histidine-rich glycoprotein (HRG), and the name sHIP (streptococcal histidine-rich glycoprotein-interacting protein) is therefore proposed. HRG has antibacterial activity, and when challenged by HRG, sHIP was found to rescue S. pyogenes bacteria. This and the finding that patients with invasive S. pyogenes infection respond with antibody production against sHIP suggest a role for the protein in S. pyogenes pathogenesis.	[Wisniewska, Magdalena; Cazzamali, Giuseppe; Pozdnyakova, Irina; Streicher, Werner; Wikstrom, Mats] Univ Copenhagen, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Happonen, Lotta; Kahn, Fredrik; Karlsson, Christofer; Frick, Inga-Maria; Bjorck, Lars; Malmstrom, Johan] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; [Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Malmstroem, Lars; Rosenberger, George] ETH, Dept Biol, CH-8093 Zurich, Switzerland	Novo Nordisk Foundation; University of Copenhagen; Lund University; University of Helsinki; Swiss Federal Institutes of Technology Domain; ETH Zurich	Malmstrom, J (corresponding author), Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden.	mats.wikstrom@cpr.ku.dk	Malmström, Lars/R-4991-2019; Happonen, Lotta J./AAI-2032-2021; Rosenberger, George/S-7458-2019; Malmström, Johan A/B-7660-2009; Kahn, Fredrik/X-5338-2018; Rosenberger, George/C-1412-2017; Varjosalo, Markku/K-6424-2015	Malmström, Lars/0000-0001-9885-9312; Happonen, Lotta J./0000-0002-5922-4549; Malmström, Johan A/0000-0002-2889-7169; Kahn, Fredrik/0000-0001-5566-6350; Rosenberger, George/0000-0002-1655-6789; Varjosalo, Markku/0000-0002-1340-9732; Streicher, Werner/0000-0002-2425-5839	Swedish Research Council [7480, 2008, 3356, 621-2012-3559]; Swedish Foundation for Strategic Research [FFL4]; Crafoord Foundation [20100892]; Wallenberg Academy [KAW 2012.0178]; European Research Council [ERC-2012-StG-309831]; Swedish Government Funds for Clinical Research; Knut and Alice Wallenberg Foundation; Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Crafoord Foundation; Wallenberg Academy; European Research Council(European Research Council (ERC)European Commission); Swedish Government Funds for Clinical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University	This work was supported by Swedish Research Council Projects 7480, 2008: 3356, and 621-2012-3559); Swedish Foundation for Strategic Research Grant FFL4; Crafoord Foundation Grant 20100892; Wallenberg Academy Fellowship KAW 2012.0178; European Research Council Starting Grant ERC-2012-StG-309831; Swedish Government Funds for Clinical Research (ALF); and the Knut and Alice Wallenberg Foundation.; Recipient of a MIMS Clinical Research Fellowship from the Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University.	ABE J, 1991, J IMMUNOL, V146, P3747; AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2004, J INFECT DIS, V189, P797, DOI 10.1086/381982; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamezawa Y, 1997, INFECT IMMUN, V65, P3828, DOI 10.1128/IAI.65.9.3828-3833.1997; Karlsson C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2297; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KREIKEMEYER B, 1995, MOL MICROBIOL, V17, P137, DOI 10.1111/j.1365-2958.1995.mmi_17010137.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; MOLLICK JA, 1993, J CLIN INVEST, V92, P710, DOI 10.1172/JCI116641; Niclasen LM, 2011, BIOCHEM J, V434, P123, DOI 10.1042/BJ20100984; Nithianantham S, 2009, J BIOL CHEM, V284, P3865, DOI 10.1074/jbc.M805503200; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; NORRBYTEGLUND A, 1994, INFECT IMMUN, V62, P5227, DOI 10.1128/IAI.62.12.5227-5233.1994; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; RAJU R, 1976, AM J SURG, V132, P64, DOI 10.1016/0002-9610(76)90292-0; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Rocha CL, 1999, INFECT IMMUN, V67, P2720, DOI 10.1128/IAI.67.6.2720-2728.1999; Rosales C, 2009, BIOCHEMISTRY-US, V48, P8070, DOI 10.1021/bi901087z; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Sjoholm K, 2014, MOL BIOSYST, V10, P1698, DOI 10.1039/c3mb70555b; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; SWANSON J, 1969, J EXP MED, V130, P1063, DOI 10.1084/jem.130.5.1063; TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TOMAI MA, 1992, INFECT IMMUN, V60, P701, DOI 10.1128/IAI.60.2.701-705.1992; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waldetoft KW, 2014, MICROBIOL-SGM, V160, P279, DOI 10.1099/mic.0.071332-0; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Weisser H, 2013, J PROTEOME RES, V12, P1628, DOI 10.1021/pr300992u; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	72	5	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18175	18188		10.1074/jbc.M114.565978	http://dx.doi.org/10.1074/jbc.M114.565978			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825900	hybrid, Green Published			2022-12-25	WOS:000338042000020
J	Yin, MM; Wang, XR; Yao, GD; Lu, MR; Liang, M; Sun, YP; Sun, F				Yin, Mianmian; Wang, Xiaorong; Yao, Guidong; Lu, Mingrong; Liang, Meng; Sun, Yingpu; Sun, Fei			Transactivation of MicroRNA-320 by MicroRNA-383 Regulates Granulosa Cell Functions by Targeting E2F1 and SF-1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; TRANSCRIPTION FACTOR E2F-1; PROSTATE-CANCER CELLS; GROWTH-FACTOR-BETA; FACTOR-I; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROLIFERATION; APOPTOSIS; OVARY	Our previous studies have shown that microRNA-320 (miR-320) is one of the most down-regulated microRNAs (miRNA) in mouse ovarian granulosa cells (GCs) after TGF-beta 1 treatment. However, the underlying mechanisms of miR-320 involved in GC function during follicular development remain unknown. In this study, we found that pregnant mare serum gonadotropin treatment resulted in the suppression of miR-320 expression in a time-dependent manner. miR-320 was mainly expressed in GCs and oocytes of mouse ovarian follicles in follicular development. Over-expression of miR-320 inhibited estradiol synthesis and proliferation of GCs through targeting E2F1 and SF-1. E2F1/SF-1 mediated miR-320-induced suppression of GC proliferation and of GC steroidogenesis. FSH down-regulated the expression of miR-320 and regulated the function of miR-320 in mouse GCs. miR-383 promoted the expression of miR-320 and enhanced miR-320-mediated suppression of GC proliferation. Injection of miR-320 into the ovaries of mice partially promoted the production of testosterone and progesterone but inhibited estradiol release in vivo. Moreover, the expression of miR-320 and miR-383 was up-regulated in the follicular fluid of polycystic ovarian syndrome patients, although the expression of E2F1 and SF-1 was down-regulated in GCs. These data demonstrated that miR-320 regulates the proliferation and steroid production by targeting E2F1 and SF-1 in the follicular development. Understanding the regulation of miRNA biogenesis and function in the follicular development will potentiate the usefulness of miRNA in the treatment of reproduction and some steroid-related disorders.	[Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Inst Immunol, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Innate Immun & Chron Dis, Innovat Ctr Cell Biol,Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Univ Sci & Technol China, Med Ctr, Hefei 230026, Anhui, Peoples R China; [Yin, Mianmian; Wang, Xiaorong; Lu, Mingrong; Liang, Meng; Sun, Fei] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Yao, Guidong; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Henan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhengzhou University	Sun, YP (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	syp2008@vip.sina.com; feisun@ustc.edu.cn	Yin, Mianmian/AAG-4192-2019; Sun, Fei/N-2850-2013; wang, xiao/HGB-7081-2022	Yin, Mianmian/0000-0001-5573-8991; wang, xiao/0000-0002-4088-3341	National Natural Science Foundation of China [31171379, 81125005, 31271605]; National Basic Research Program of China [2014CB943100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31171379 and 81125005 (to F. S.), 31271605 (to Y. S.), and National Basic Research Program of China Grant 2014CB943100.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Amsterdam A, 1997, ENDOCR REV, V18, P435, DOI 10.1210/er.18.4.435; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Cutolo M, 2005, ARTHRITIS RES THER, V7, pR1124, DOI 10.1186/ar1791; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLO RV, 1981, BIOL REPROD, V24, P100, DOI 10.1095/biolreprod24.1.100; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; Holmberg C, 1998, ONCOGENE, V17, P143, DOI 10.1038/sj.onc.1201915; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Jamnongjit M, 2006, CELL CYCLE, V5, P1178, DOI 10.4161/cc.5.11.2803; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jongen V H W M, 2006, Minerva Endocrinol, V31, P47; Kim BM, 2012, BIOCHEM BIOPH RES CO, V426, P183, DOI 10.1016/j.bbrc.2012.08.058; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lee KH, 1996, BIOTECHNOL BIOENG, V50, P273, DOI 10.1002/(SICI)1097-0290(19960505)50:3<273::AID-BIT6>3.0.CO;2-D; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Macklon NS, 2001, ARCH MED RES, V32, P595, DOI 10.1016/S0188-4409(01)00327-7; Majors BS, 2008, J BIOTECHNOL, V138, P103, DOI 10.1016/j.jbiotec.2008.08.003; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; MONDSCHEIN JS, 1988, ENDOCRINOLOGY, V123, P1970, DOI 10.1210/endo-123-4-1970; Moore RK, 2005, MOL CELL ENDOCRINOL, V234, P67, DOI 10.1016/j.mce.2004.10.012; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; Noel JC, 2010, APPL IMMUNOHISTO M M, V18, P258, DOI 10.1097/PAI.0b013e3181c06948; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; ROBINSON S, 1993, CLIN ENDOCRINOL, V39, P351, DOI 10.1111/j.1365-2265.1993.tb02376.x; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE604, DOI 10.1152/ajpendo.00350.2006; Shen LC, 2013, J CLIN ENDOCR METAB, V98, P1575, DOI 10.1210/jc.2012-3010; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Stefani G, 2006, COLD SPRING HARB SYM, V71, P129, DOI 10.1101/sqb.2006.71.032; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; VANDERHYDEN BC, 1993, ENDOCRINOLOGY, V133, P423, DOI 10.1210/en.133.1.423; Vitt UA, 1998, BIOL REPROD, V59, P854, DOI 10.1095/biolreprod59.4.854; Wang W, 2011, REPRODUCTION, V141, P643, DOI 10.1530/REP-10-0098; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984; Xu SY, 2011, ENDOCRINOLOGY, V152, P3941, DOI 10.1210/en.2011-1147; Yang G, 2011, J MOL MED, V89, P1037, DOI 10.1007/s00109-011-0775-x; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004; Yang XK, 2012, REPRODUCTION, V144, P235, DOI 10.1530/REP-11-0371; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yin MM, 2012, MOL ENDOCRINOL, V26, P1129, DOI 10.1210/me.2011-1341	80	100	112	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18239	18257		10.1074/jbc.M113.546044	http://dx.doi.org/10.1074/jbc.M113.546044			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828505	Green Published, hybrid			2022-12-25	WOS:000338042000025
J	Barais, M; Morio, N; Breton, AC; Barraine, P; Calvez, A; Stolper, E; Van Royen, P; Lietard, C				Barais, Marie; Morio, Nathalie; Breton, Amelie Cuzon; Barraine, Pierre; Calvez, Amelie; Stolper, Erik; Van Royen, Paul; Lietard, Claire			"I Can't Find Anything Wrong: It Must Be a Pulmonary Embolism": Diagnosing Suspected Pulmonary Embolism in Primary Care, a Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE; GUT FEELINGS; ERROR; CONSENSUS; MEDICINE; RULES	Background: Before using any prediction rule oriented towards pulmonary embolism (PE), family physicians (FPs) should have some suspicion of this diagnosis. The diagnostic reasoning process leading to the suspicion of PE is not well described in primary care. Objective: to explore the diagnostic reasoning of FPs when pulmonary embolism is suspected. Method: Semi-structured qualitative interviews with 28 FPs. The regional hospital supplied data of all their cases of pulmonary embolism from June to November 2011. The patient's FP was identified where he/she had been the physician who had sent the patient to the emergency unit. The first consecutive 14 FPs who agreed to participate made up the first group. A second group was chosen using a purposeful sampling method. The topic guide focused on the circumstances leading to the suspicion of PE. A thematic analysis was performed, by three researchers, using a grounded theory coding paradigm. Results: In the FPs' experience, the suspicion of pulmonary embolism arose out of four considerations: the absence of indicative clinical signs for diagnoses other than PE, a sudden change in the condition of the patient, a gut feeling that something was seriously wrong and an earlier failure to diagnose PE. The FPs interviewed did not use rules in their diagnostic process. Conclusion: This study illustrated the diagnostic role of gut feelings in the specific context of suspected pulmonary embolism in primary care. The FPs used the sense of alarm as a tool to prevent the diagnostic error of missing a PE. The diagnostic accuracy of gut feelings has yet to be evaluated.	[Barais, Marie; Morio, Nathalie; Breton, Amelie Cuzon; Barraine, Pierre; Calvez, Amelie] Univ Bretagne Occidentale, Fac Med & Sci Sante Brest, Dept Univ Med Gen, Brest, France; [Stolper, Erik] Maastricht Univ, Fac Hlth Med & Life Sci, Caphri Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Stolper, Erik; Van Royen, Paul] Univ Antwerp, Dept Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Lietard, Claire] Univ Europeenne Bretagne, Fac Med & Sci Sante Brest, Lab Sante Publ, Brest, France	CHU Brest; Universite de Bretagne Occidentale; Maastricht University; University of Antwerp; Universite de Bretagne Occidentale	Barais, M (corresponding author), Univ Bretagne Occidentale, Fac Med & Sci Sante Brest, Dept Univ Med Gen, Brest, France.	marie.barais@gmail.com	, Van Royen Paul/H-7315-2015; barais, marie/H-2888-2018	, Van Royen Paul/0000-0002-9554-1680; 				Abu Hani M, 2007, FAM PRACT, V24, P622, DOI 10.1093/fampra/cmm053; Allen J, 2002, BRIT J GEN PRACT, V52, P526; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Buntinx F, 2011, BRIT J GEN PRACT, V61, P43, DOI 10.3399/bjgp11X548974; Campbell IA, 2003, THORAX, V58, P470; Cook C, 2009, J MAN MANIP THER, V17, P6, DOI 10.1179/106698109790818223; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; Feddock CA, 2007, AM J MED, V120, P374, DOI 10.1016/j.amjmed.2007.01.023; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Geersing GJ, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6564; Gigerenzer G., 2000, SIMPLE HEURISTICS MA; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Innes AD, 2005, BRIT J GEN PRACT, V55, P47; Koontz NA, 2008, AM J ROENTGENOL, V190, P1156, DOI 10.2214/AJR.07.3268; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Le Reste JY, 2013, EUR J GEN PRACT, V19, P237, DOI 10.3109/13814788.2013.779662; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Meyer G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1421; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P, 2002, AFFECT HEURISTIC, P1333; Stolper CF, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-1; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-66; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-17; Thorne S., 2000, EVIDENCE BASED NURS, V3, P68, DOI [DOI 10.1136/EBN.3.3.68, 10.1136/ebn.3.3.68]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Woolley A, 2013, ANN FAM MED, V11, P60, DOI 10.1370/afm.1433	39	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98112	10.1371/journal.pone.0098112	http://dx.doi.org/10.1371/journal.pone.0098112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24840333	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600107
J	Brady, MT; Hilchey, SP; Hyrien, O; Spence, SA; Bernstein, SH				Brady, Michael T.; Hilchey, Shannon P.; Hyrien, Ollivier; Spence, Stephen A.; Bernstein, Steven H.			Mesenchymal Stromal Cells Support the Viability and Differentiation of Follicular Lymphoma-Infiltrating Follicular Helper T-Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; ACTIVATING FACTOR; GROWTH; EXPRESSION; PROLIFERATION; FIBROBLASTS; CANCER; NICHE; BCL6	The biology of follicular lymphoma (FL) is largely dictated by the immune-effector and stromal cells that comprise its tumor microenvironment. FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg). These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment. Whereas MSCs have been shown to support FL B-cell and Treg viability, their effects on FL-infiltrating TFH and TFR cells have not been described. Herein we show that MSCs support the viability of FL-infiltrating TFH and TFR, as well as Tregs, in part through an IL-6-dependent mechanism. We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells. Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.	[Brady, Michael T.; Hilchey, Shannon P.; Spence, Stephen A.; Bernstein, Steven H.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Bernstein, SH (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA.	steven_bernstein@urmc.rochester.edu		Brady, Michael/0000-0002-0711-0435	University of Rochester Human Immunology Center Pilot Project Grant [5-29712]; Leukemia and Lymphoma Society Translational Grant [6344-11]; U.S. Public Health Service Grants [RO1-CA122645]; SPORE in Lymphoma Grant [P50-CA130805]; T32 training grant [5T32HL007152-35]; NATIONAL CANCER INSTITUTE [R01CA122645, P50CA130805] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007152] Funding Source: NIH RePORTER	University of Rochester Human Immunology Center Pilot Project Grant; Leukemia and Lymphoma Society Translational Grant(Leukemia and Lymphoma Society); U.S. Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); SPORE in Lymphoma Grant; T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a University of Rochester Human Immunology Center Pilot Project Grant 5-29712, a Leukemia and Lymphoma Society Translational Grant 6344-11, U.S. Public Health Service Grants RO1-CA122645 and a SPORE in Lymphoma Grant P50-CA130805. The authors would also like to acknowledge the generous support of Peter and Kathy Landers and Gary and Laura Haseley. MTB is a recipient of a T32 training grant 5T32HL007152-35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Guilloton F, 2012, BLOOD, V119, P2556, DOI 10.1182/blood-2011-08-370908; Hilchey SP, 2007, J IMMUNOL, V178, P4051, DOI 10.4049/jimmunol.178.7.4051; Hilchey SP, 2011, BLOOD, V118, P3591, DOI 10.1182/blood-2011-03-340646; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lwin T, 2009, LEUKEMIA, V23, P170, DOI 10.1038/leu.2008.266; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Mourcin F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00280; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	30	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97597	10.1371/journal.pone.0097597	http://dx.doi.org/10.1371/journal.pone.0097597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836297	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800056
J	Chen, K; Ciannelli, L; Decker, MB; Ladd, C; Cheng, W; Zhou, ZQ; Chan, KS				Chen, Kun; Ciannelli, Lorenzo; Decker, Mary Beth; Ladd, Carol; Cheng, Wei; Zhou, Ziqian; Chan, Kung-Sik			Reconstructing Source-Sink Dynamics in a Population with a Pelagic Dispersal Phase	PLOS ONE			English	Article							EASTERN BERING-SEA; SETTLEMENT PREFERENCES; MARINE POPULATIONS; LARVAL DISPERSAL; LIFE-HISTORY; NORTH-SEA; IN-SITU; CONNECTIVITY; JELLYFISH; MODEL	For many organisms, the reconstruction of source-sink dynamics is hampered by limited knowledge of the spatial assemblage of either the source or sink components or lack of information on the strength of the linkage for any source-sink pair. In the case of marine species with a pelagic dispersal phase, these problems may be mitigated through the use of particle drift simulations based on an ocean circulation model. However, when simulated particle trajectories do not intersect sampling sites, the corroboration of model drift simulations with field data is hampered. Here, we apply a new statistical approach for reconstructing source-sink dynamics that overcomes the aforementioned problems. Our research is motivated by the need for understanding observed changes in jellyfish distributions in the eastern Bering Sea since 1990. By contrasting the source-sink dynamics reconstructed with data from the pre-1990 period with that from the post-1990 period, it appears that changes in jellyfish distribution resulted from the combined effects of higher jellyfish productivity and longer dispersal of jellyfish resulting from a shift in the ocean circulation starting in 1991. A sensitivity analysis suggests that the source-sink reconstruction is robust to typical systematic and random errors in the ocean circulation model driving the particle drift simulations. The jellyfish analysis illustrates that new insights can be gained by studying structural changes in source-sink dynamics. The proposed approach is applicable for the spatial source-sink reconstruction of other species and even abiotic processes, such as sediment transport.	[Chen, Kun] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Decker, Mary Beth] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Ladd, Carol; Cheng, Wei] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Cheng, Wei] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98195 USA; [Zhou, Ziqian; Chan, Kung-Sik] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA	University of Connecticut; Oregon State University; Yale University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; University of Iowa	Chan, KS (corresponding author), Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA.	kung-sik-chan@uiowa.edu	Ladd, Carol/M-6159-2014; Chen, Kun/C-2975-2015; Cheng, Wei/J-1030-2017	Ladd, Carol/0000-0003-1065-430X; Chen, Kun/0000-0003-3579-5467; Cheng, Wei/0000-0002-5892-2177	US National Science Foundation [NSF-0934617, 0934727, 0934961, DMS-1021292]	US National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge the US National Science Foundation(NSF-0934617, 0934727, 0934961 and DMS-1021292) for financial support. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Bailey KM, 2008, FISH FISH, V9, P44, DOI 10.1111/j.1467-2979.2007.00268.x; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Brodeur RD, 1998, MAR ECOL PROG SER, V163, P11, DOI 10.3354/meps163011; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Brodeur RD, 1999, FISH OCEANOGR, V8, P296, DOI 10.1046/j.1365-2419.1999.00115.x; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Brown PJ, 2002, J R STAT SOC B, V64, P519, DOI 10.1111/1467-9868.00348; Chatterjee A, 2011, J AM STAT ASSOC, V106, P608, DOI 10.1198/jasa.2011.tm10159; Chen K, 2014, J AM STAT A IN PRESS; Chen K, 2012, J R STAT SOC B, V74, P203, DOI 10.1111/j.1467-9868.2011.01002.x; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; COYLE KO, 1993, CONT SHELF RES, V13, P803, DOI 10.1016/0278-4343(93)90028-V; Crowder LB, 2000, B MAR SCI, V66, P799; Curchitser EN, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002902; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Decker Mary Beth, 2014, P153; Decker MB, 2013, MAR ECOL PROG SER, V494, P179, DOI 10.3354/meps10545; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Harden-Jones FR, 1968, FISH MIGRATION; Hoff GR, 2006, FISH B-NOAA, V104, P226; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Holst S, 2012, HYDROBIOLOGIA, V690, P127, DOI 10.1007/s10750-012-1043-y; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Liu H, 2011, J AGR BIOL ENVIR ST, V16, P185, DOI 10.1007/s13253-010-0044-4; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Purcell JE, 2009, MAR ECOL PROG SER, V375, P139, DOI 10.3354/meps07785; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; See KE, 2010, BIOL INVASIONS, V12, P1305, DOI 10.1007/s10530-009-9548-7; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sohn D, 2010, FISH OCEANOGR, V19, P339, DOI 10.1111/j.1365-2419.2010.00549.x; Stabeno PJ, 2006, SEA, P1177; Thomas GH, 1996, J N AMER BENTHOL SOC, V15, P564; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Yu HS, 2009, J MARINE SYST, V76, P369, DOI 10.1016/j.jmarsys.2007.07.010; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	45	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95316	10.1371/journal.pone.0095316	http://dx.doi.org/10.1371/journal.pone.0095316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835251	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800006
J	Geffner, L; Basile, JI; Yokobori, N; Kviatcovsky, D; Garcia, CSY; Ritacco, V; Lopez, B; Sasiain, MD; de la Barrera, S				Geffner, Laura; Ignacio Basile, Juan; Yokobori, Noemi; Kviatcovsky, Denise; Sabio y Garcia, Carmen; Ritacco, Viviana; Lopez, Beatriz; del Carmen Sasiain, Maria; de la Barrera, Silvia			Mycobacterium tuberculosis Multidrug Resistant Strain M Induces an Altered Activation of Cytotoxic CD8(+) T Cells	PLOS ONE			English	Article							HUMAN NK-CELLS; GENE-EXPRESSION; ANTIMICROBIAL ACTIVITY; PLASMA-MEMBRANE; CD8+T CELLS; PERFORIN; INFECTION; GRANULYSIN; ANTIGENS; GRANZYME	In human tuberculosis (TB), CD8(+) T cells contribute to host defense by the release of Th1 cytokines and the direct killing of Mycobacterium tuberculosis (Mtb)-infected macrophages via granule exocytosis pathway or the engagement of receptors on target cells. Previously we demonstrated that strain M, the most prevalent multidrug-resistant (MDR) Mtb strain in Argentine, is a weak inducer of IFN-gamma and elicits a remarkably low CD8-dependent cytotoxic T cell activity (CTL). In contrast, the closely related strain 410, which caused a unique case of MDR-TB, elicits a CTL response similar to H37Rv. In this work we extend our previous study investigating some parameters that can account for this discrepancy. We evaluated the expressions of the lytic molecules perforin, granzyme B and granulysin and the chemokine CCL5 in CD8(+) T cells as well as activation markers CD69 and CD25 and IL-2 expression in CD4(+) and CD8(+) T cells stimulated with strains H37Rv, M and 410. Our results demonstrate that M-stimulated CD8(+) T cells from purified protein derivative positive healthy donors show low intracellular expression of perforin, granzyme B, granulysin and CCL5 together with an impaired ability to form conjugates with autologous M-pulsed macrophages. Besides, M induces low CD69 and IL-2 expression in CD4+ and CD8(+) T cells, being CD69 and IL-2 expression closely associated. Furthermore, IL-2 addition enhanced perforin and granulysin expression as well as the degranulation marker CD107 in M-stimulated CD8(+) T cells, making no differences with cells stimulated with strains H37Rv or 410. Thus, our results highlight the role of IL-2 in M-induced CTL activity that drives the proper activation of CD8(+) T cells as well as CD4(+) T cells collaboration.	[Geffner, Laura; Ignacio Basile, Juan; Yokobori, Noemi; Kviatcovsky, Denise; Sabio y Garcia, Carmen; del Carmen Sasiain, Maria; de la Barrera, Silvia] Natl Acad Med Buenos Aires, CONICET, Inst Expt Med, Lab Inmunol Enfermedades Resp, Buenos Aires, DF, Argentina; [Ritacco, Viviana; Lopez, Beatriz] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas, Lab Micobacterias, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	de la Barrera, S (corresponding author), Natl Acad Med Buenos Aires, CONICET, Inst Expt Med, Lab Inmunol Enfermedades Resp, Buenos Aires, DF, Argentina.	sdelab@hematologia.anm.edu.ar	Yokobori, Noemí Kaoru/S-9139-2019; Ritacco, Viviana/E-8135-2011	Yokobori, Noemí Kaoru/0000-0001-8966-0491; Ritacco, Viviana/0000-0003-1217-0229; de la Barrera, Silvia/0000-0003-0644-1686; Kviatcovsky, Denise/0000-0002-9697-0380	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0599, PICT 2011-0572]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0599 and PICT 2011-0572). The funder has no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001; Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Antas PRZ, 2002, MEM I OSWALDO CRUZ, V97, P1097, DOI 10.1590/S0074-02762002000800005; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Cox MA, 2011, TRENDS IMMUNOL, V32, P180, DOI 10.1016/j.it.2011.01.004; Dagur PK, 2010, MOL IMMUNOL, V47, P943, DOI 10.1016/j.molimm.2009.11.009; DAMBROSIO D, 1993, EUR J IMMUNOL, V23, P2993, DOI 10.1002/eji.1830231140; De la Barrera SS, 2003, CLIN EXP IMMUNOL, V132, P450, DOI 10.1046/j.1365-2249.2003.02176.x; DEIS, 2011, AN 2010 BUEN AIR DIE; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Geffner L, 2009, INFECT IMMUN, V77, P5025, DOI 10.1128/IAI.00224-09; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kumar MM, 2010, CELL IMMUNOL, V265, P146, DOI 10.1016/j.cellimm.2010.08.004; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; MARTIN A, 2007, TUBERCULOSIS 2007 BA; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Quintero-Macias L, 2012, IMMUNOL INVEST, V41, P51, DOI 10.3109/08820139.2011.580408; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Rolph MS, 2001, EUR J IMMUNOL, V31, P1944, DOI 10.1002/1521-4141(200106)31:6<1944::AID-IMMU1944>3.0.CO;2-R; Sanchez-Ruiz Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027057; Schierlohl P, 2009, EUR J IMMUNOL, V39, P2450, DOI 10.1002/eji.200939515; Smith SM, 2000, INFECT IMMUN, V68, P7144, DOI 10.1128/IAI.68.12.7144-7148.2000; Stegelmann F, 2005, J IMMUNOL, V175, P7474, DOI 10.4049/jimmunol.175.11.7474; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TESTI R, 1989, J IMMUNOL, V143, P1123; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; WHO, 2012, GLOB TUB REP 2012 GE; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Yokobori N, 2013, INFECT GENET EVOL, V16, P151, DOI 10.1016/j.meegid.2013.01.007; Yokobori N, 2012, FEMS IMMUNOL MED MIC, V66, P363, DOI 10.1111/j.1574-695X.2012.01024.x	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97837	10.1371/journal.pone.0097837	http://dx.doi.org/10.1371/journal.pone.0097837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836916	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800074
J	Leung, YK; Chan, QKY; Ng, CF; Ma, FMT; Tse, HM; To, KF; Maranchie, J; Ho, SM; Lau, KM				Leung, Yuet-Kin; Chan, Queeny Kwan-Yi; Ng, Chi-Fai; Ma, Fanny Man-Ting; Tse, Ho-Man; To, Ka-Fai; Maranchie, Jodi; Ho, Shuk-Mei; Lau, Kin-Mang			Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; IN-SITU HYBRIDIZATION; HIGH-DOSE TAMOXIFEN; GROUP PROTEIN I(Y); PHASE-II TRIAL; GENE-EXPRESSION; ANDROGEN RECEPTOR; NOBLE RATS; ER-BETA; TRANSDERMAL ESTRADIOL	Fulvestrant (ICI-182,780) has recently been shown to effectively suppress prostate cancer cell growth in vitro and in vivo. But it is unclear whether microRNAs play a role in regulating oncogene expression in fulvestrant-treated prostate cancer. Here, this study reports hsa-miR-765 as the first fulvestrant-driven, ERb-regulated miRNA exhibiting significant tumor suppressor activities like fulvestrant, against prostate cancer cell growth via blockage of cell-cycle progression at the G2/M transition, and cell migration and invasion possibly via reduction of filopodia/intense stress-fiber formation. Fulvestrant was shown to upregulate hsa-miR-765 expression through recruitment of ERb to the 59-regulatory-region of hsa-miR-765. HMGA1, an oncogenic protein in prostate cancer, was identified as a downstream target of hsa-miR-765 and fulvestrant in cell-based experiments and a clinical study. Both the antiestrogen and the hsa-miR-765 mimic suppressed HMGA1 protein expression. In a neo-adjuvant study, levels of hsa-miR-765 were increased and HMGA1 expression was almost completely lost in prostate cancer specimens from patients treated with a single dose (250 mg) of fulvestrant 28 days before prostatectomy. These findings reveal a novel fulvestrant signaling cascade involving ER beta-mediated transcriptional upregulation of hsa-miR-765 that suppresses HMGA1 protein expression as part of the mechanism underlying the tumor suppressor action of fulvestrant in prostate cancer.	[Leung, Yuet-Kin; Ho, Shuk-Mei] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Ho, Shuk-Mei] Univ Cincinnati, Med Ctr, Inst Canc, Cincinnati, OH 45267 USA; [Chan, Queeny Kwan-Yi; Ma, Fanny Man-Ting; Tse, Ho-Man; To, Ka-Fai; Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Chi-Fai] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai; Lau, Kin-Mang] Chinese Univ Hong Kong, State Key Lab Southern China Oncol, Hong Kong, Hong Kong, Peoples R China; [Maranchie, Jodi] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA; [Ho, Shuk-Mei] Cincinnati Veteran Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Med Ctr, Ctr Environm Genet, Dept Environm Hlth, Cincinnati, OH 45267 USA.	hosm@uc.edu; kmlau@cuhk.edu.hk	Maranchie, Jodi/AAG-1035-2020; Chi-fai, NG/AAV-8270-2021; Ng, Chi-Fai/E-5134-2011; Leung, Ricky/H-5958-2019	Ng, Chi-Fai/0000-0002-1723-9646; Leung, Ricky/0000-0003-2063-277X; Maranchie, Jodi/0000-0002-8534-9468	Hong Kong University Grant Council [M469107]; Chinese University of Hong Kong Direct Research Grants [CU2041252, CU2041563]; Veterans Affairs Merit Award [I01BX000675]; National Institutes of Health [ES019480, ES020956, ES015584, ES006096, CA112570, CA015776]; Investigator-Sponsored Study Program of AstraZeneca; NATIONAL CANCER INSTITUTE [R01CA112570, R01CA015776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480, P30ES006096, R01ES015584] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000675] Funding Source: NIH RePORTER	Hong Kong University Grant Council; Chinese University of Hong Kong Direct Research Grants; Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator-Sponsored Study Program of AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by Hong Kong University Grant Council-General Research Fund (M469107 to KML) and Chinese University of Hong Kong Direct Research Grants (CU2041252 and CU2041563 to KML), a Veterans Affairs Merit Award (I01BX000675 to SMH) and grants from National Institutes of Health (ES019480, ES020956, ES015584, ES006096, CA112570, CA015776 to SMH) and a grant from the Investigator-Sponsored Study Program of AstraZeneca (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergan RC, 1999, CLIN CANCER RES, V5, P2366; Bhattacharyya RS, 2006, MOL CANCER THER, V5, P1539, DOI 10.1158/1535-7163.MCT-06-0065; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C; Chadha MK, 2008, PROSTATE, V68, P1461, DOI 10.1002/pros.20813; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fernandes SAF, 2011, INT J ANDROL, V34, P486, DOI 10.1111/j.1365-2605.2010.01109.x; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Blesa JMG, 2010, ANN ONCOL, V21, P1131, DOI 10.1093/annonc/mdq010; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hamilton M, 2003, ACTA ONCOL, V42, P195, DOI 10.1080/02841860310010718; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho SM, 2008, NEOPLASIA, V10, P20, DOI 10.1593/neo.07889; Ho SM, 2011, ENDOCRIN METAB CLIN, V40, P591, DOI 10.1016/j.ecl.2011.05.002; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai JS, 2004, UROLOGY, V64, P814, DOI 10.1016/j.urology.2004.05.036; Lane KE, 1997, CARCINOGENESIS, V18, P1505, DOI 10.1093/carcin/18.8.1505; Langley RE, 2008, BJU INT, V102, P442, DOI 10.1111/j.1464-410X.2008.07583.x; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lau KM, 2012, ACTA NEUROPATHOL, V123, P553, DOI 10.1007/s00401-011-0934-8; Lau KM, 2000, CANCER RES, V60, P3175; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Nakajima Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001551; Ockrim JL, 2004, J UROLOGY, V172, P2203, DOI 10.1097/01.ju.0000145511.56476.00; Oh William K, 2002, Clin Prostate Cancer, V1, P81, DOI 10.3816/CGC.2002.n.009; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Saini S, 2010, PHARM RES-DORDR, V27, P1014, DOI 10.1007/s11095-010-0086-x; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Shazer RL, 2006, BJU INT, V97, P691, DOI 10.1111/j.1464-410X.2006.05974.x; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Stein M, 2012, MED SCI MONITOR, V18, pCR260, DOI 10.12659/MSM.882626; Stein S, 2001, AM J CLIN ONCOL-CANC, V24, P283, DOI 10.1097/00000421-200106000-00015; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tam NNC, 2010, MOL ENDOCRINOL, V24, P2207, DOI 10.1210/me.2010-0179; Tamimi Y, 1996, BRIT J CANCER, V74, P573, DOI 10.1038/bjc.1996.403; TAMIMI Y, 1993, CANCER RES, V53, P5512; Thompson CJ, 2002, ENDOCRINOLOGY, V143, P2093, DOI 10.1210/en.143.6.2093; von SB, 1989, PROSTATE, V14, P389; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1; Zou AH, 1999, MOL ENDOCRINOL, V13, P418, DOI 10.1210/me.13.3.418	56	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98037	10.1371/journal.pone.0098037	http://dx.doi.org/10.1371/journal.pone.0098037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837491	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000339614800101
J	Sawa, Y; Takata, S; Hatakeyama, Y; Ishikawa, H; Tsuruga, E				Sawa, Yoshihiko; Takata, Shunsuke; Hatakeyama, Yuji; Ishikawa, Hiroyuki; Tsuruga, Eichi			Expression of Toll-Like Receptor 2 in Glomerular Endothelial Cells and Promotion of Diabetic Nephropathy by Porphyromonas gingivalis Lipopolysaccharide	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROINFLAMMATORY STATE; EPITHELIAL-CELLS; INNATE IMMUNITY; PATHWAY; INFLAMMATION; MACROPHAGES; INHIBITION; MECHANISMS; FIBROSIS	The toll-like receptor (TLR) has been suggested as a candidate cause for diabetic nephropathy. Recently, we have reported the TLR4 expression in diabetic mouse glomerular endothelium. The study here investigates the effects of the periodontal pathogen Porphyromonas gingivalis lipopolysaccharide (LPS) which is a ligand for TLR2 and TLR4 in diabetic nephropathy. In laser-scanning microscopy of glomeruli of streptozotocin-and a high fat diet feed-induced type I and type II diabetic mice, TLR2 localized on the glomerular endothelium and proximal tubule epithelium. The TLR2 mRNA was detected in diabetic mouse glomeruli by in situ hybridization and in real-time PCR of the renal cortex, the TLR2 mRNA amounts were larger in diabetic mice than in non-diabetic mice. All diabetic mice subjected to repeated LPS administrations died within the survival period of all of the diabetic mice not administered LPS and of all of the non-diabetic LPS-administered mice. The LPS administration promoted the production of urinary protein, the accumulation of type I collagen in the glomeruli, and the increases in IL-6, TNF-alpha, and TGF-beta in the renal cortex of the glomeruli of the diabetic mice. It is thought that blood TLR ligands like Porphyromonas gingivalis LPS induce the glomerular endothelium to produce cytokines which aid glomerulosclerosis. Periodontitis may promote diabetic nephropathy.	[Sawa, Yoshihiko; Hatakeyama, Yuji; Tsuruga, Eichi] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan; [Takata, Shunsuke; Ishikawa, Hiroyuki] Fukuoka Dent Coll, Dept Oral Growth & Dev, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sawa, Y (corresponding author), Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan.	ysawa@college.fdcnet.ac.jp			Japan Society for the Promotion of Science [25670803]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Exploratory Research 25670803 grants from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Cheng A, 2013, INT J BIOL SCI, V9, P94, DOI 10.7150/ijbs.5246; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Fan MHM, 2010, J PERIODONTAL RES, V45, P100, DOI 10.1111/j.1600-0765.2009.01206.x; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Herminajeng E, 2001, J PERIODONTOL, V72, P1527, DOI 10.1902/jop.2001.72.11.1527; Hornigold N, 2013, LAB INVEST, V93, P553, DOI 10.1038/labinvest.2013.42; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kaur H, 2012, AM J PHYSIOL-RENAL, V303, pF1145, DOI 10.1152/ajprenal.00319.2012; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071849; Li CL, 2002, CELL GROWTH DIFFER, V13, P27; Li FL, 2010, AM J NEPHROL, V32, P179, DOI 10.1159/000317023; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sherry CL, 2007, J IMMUNOL, V178, P663, DOI 10.4049/jimmunol.178.2.663; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Takata S, 2013, ACTA HISTOCHEM CYTOC, V46, P35, DOI 10.1267/ahc.13002; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wong FS, 2008, ANN NY ACAD SCI, V1150, P123, DOI 10.1196/annals.1447.063; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	36	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97165	10.1371/journal.pone.0097165	http://dx.doi.org/10.1371/journal.pone.0097165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835775	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800029
J	Arab, HH; Al-Shorbagy, MY; Abdallah, DM; Nassar, NN				Arab, Hany H.; Al-Shorbagy, Muhammad Y.; Abdallah, Dalaal M.; Nassar, Noha N.			Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease	PLOS ONE			English	Article							TNBS-INDUCED COLITIS; ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAYS; ACID-INDUCED COLITIS; PPAR-GAMMA; SUPEROXIDE-DISMUTASE; ULCERATIVE-COLITIS; GENE-EXPRESSION; INTERLEUKIN-10	Accumulating evidence has indicated the implication of angiotensin II in the pathogenesis of inflammatory bowel diseases (IBD) via its proinflammatory features. Telmisartan (TLM) is an angiotensin II receptor antagonist with marked anti-inflammatory and antioxidant actions that mediated its cardio-, reno- and hepatoprotective actions. However, its impact on IBD has not been previously explored. Thus, we aimed to investigate the potential alleviating effects of TLM in tri-nitrobenezene sulphonic acid (TNBS)-induced colitis in rats. Pretreatment with TLM (10 mg/kg p.o.) attenuated the severity of colitis as evidenced by decrease of disease activity index (DAI), colon weight/length ratio, macroscopic damage, histopathological findings and leukocyte migration. TLM suppressed the inflammatory response via attenuation of tumor necrosis factor-alpha (TNF-alpha), prostaglandin E-2 (PGE(2)) and myeloperoxidase (MPO) activity as a marker of neutrophil infiltration besides restoration of interleukin-10 (IL-10). TLM also suppressed mRNA and protein expression of nuclear factor kappa B (NF-kappa B) p65 and mRNA of cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) proinflammatory genes with concomitant upregulation of PPAR-gamma. The alleviation of TLM to colon injury was also associated with inhibition of oxidative stress as evidenced by suppression of lipid peroxides and nitric oxide (NO) besides boosting glutathione (GSH), total anti-oxidant capacity (TAC) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx). With respect to apoptosis, TLM downregulated the increased mRNA, protein expression and activity of caspase-3. It also suppressed the elevation of cytochrome c and Bax mRNA besides the upregulation of Bcl-2. Together, these findings highlight evidences for the beneficial effects of TLM in IBD which are mediated through modulation of colonic inflammation, oxidative stress and apoptosis.	[Arab, Hany H.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Al-Shorbagy, Muhammad Y.; Abdallah, Dalaal M.; Nassar, Noha N.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Arab, HH (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	hany.arab@pharma.cu.edu.eg	Arab, Hany/AAF-3652-2020; Abdallah, Dalaal/GVT-0783-2022; Al-Shorbagy, Muhammad/R-3968-2019	Arab, Hany/0000-0002-4195-6901; Al-Shorbagy, Muhammad/0000-0002-5104-6821				Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Attia YM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-199; Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6; Barada KA, 2007, CYTOKINE, V37, P236, DOI 10.1016/j.cyto.2007.04.005; Becker C, 2013, GASTROENTEROLOGY, V144, P283, DOI 10.1053/j.gastro.2012.11.035; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bobin-Dubigeon C, 2001, EUR J PHARMACOL, V431, P103, DOI 10.1016/S0014-2999(01)01410-8; Bregonzio C, 2003, AM J PHYSIOL-GASTR L, V285, pG414, DOI 10.1152/ajpgi.00058.2003; Buege J A, 1978, Methods Enzymol, V52, P302; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cianchetti S, 2008, ATHEROSCLEROSIS, V198, P22, DOI 10.1016/j.atherosclerosis.2007.09.013; COOPER HS, 1993, LAB INVEST, V69, P238; Crespo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050407; Destro M, 2011, EXPERT OPIN PHARMACO, V12, P2719, DOI 10.1517/14656566.2011.632367; Dey I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061891; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fujita H, 2012, HYPERTENS RES, V35, P213, DOI 10.1038/hr.2011.176; Galvez J, 2001, ALIMENT PHARM THERAP, V15, P2027, DOI 10.1046/j.1365-2036.2001.01133.x; Gillberg L, 2013, ACTA PHYSIOL, V207, P326, DOI 10.1111/apha.12017; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Goyal S, 2010, CHEM-BIOL INTERACT, V185, P271, DOI 10.1016/j.cbi.2010.03.030; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Hume Georgia E, 2008, Expert Rev Gastroenterol Hepatol, V2, P645, DOI 10.1586/17474124.2.5.645; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Kushwaha S, 2013, MUTAT RES-GEN TOX EN, V755, P11, DOI 10.1016/j.mrgentox.2013.04.013; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mizushima T, 2010, AM J PHYSIOL-GASTR L, V298, pG255, DOI 10.1152/ajpgi.00264.2009; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nagib MM, 2013, TOXICOL APPL PHARM, V271, P106, DOI 10.1016/j.taap.2013.04.026; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Qin HY, 2012, WORLD J GASTROENTERO, V18, P2481, DOI 10.3748/wjg.v18.i20.2481; Remuzzi A, 2006, J RENIN-ANGIO-ALDO S, V7, P185, DOI 10.3317/jraas.2006.036; Sanchez-Hidalgo M, 2007, EUR J PHARMACOL, V562, P247, DOI 10.1016/j.ejphar.2007.01.047; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Santiago OI, 2008, REGUL PEPTIDES, V146, P250, DOI 10.1016/j.regpep.2007.10.004; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Sukumaran V, 2011, EUR J PHARMACOL, V652, P126, DOI 10.1016/j.ejphar.2010.10.081; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Thoene-Reineke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023646; Toba H, 2012, EUR J PHARMACOL, V685, P91, DOI 10.1016/j.ejphar.2012.01.026; Tomoyose M, 1998, SCAND J GASTROENTERO, V33, P435; Tsune I, 2003, GASTROENTEROLOGY, V125, P775, DOI 10.1016/S0016-5085(03)01067-9; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Wang RQ, 1999, AM J PHYSIOL-LUNG C, V277, pL1245, DOI 10.1152/ajplung.1999.277.6.L1245; Wang YH, 2011, INT IMMUNOPHARMACOL, V11, P1620, DOI 10.1016/j.intimp.2011.05.024; Witaicenis A, 2012, CHEM-BIOL INTERACT, V195, P76, DOI 10.1016/j.cbi.2011.11.004; Yamagishi SI, 2007, CURR MOL MED, V7, P463; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013	61	85	90	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97193	10.1371/journal.pone.0097193	http://dx.doi.org/10.1371/journal.pone.0097193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831514	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500039
J	Duelli, A; Kiss, B; Lundholm, I; Bodor, A; Petoukhov, MV; Svergun, DI; Nyitray, L; Katona, G				Duelli, Annette; Kiss, Bence; Lundholm, Ida; Bodor, Andrea; Petoukhov, Maxim V.; Svergun, Dmitri I.; Nyitray, Laszlo; Katona, Gergely			The C-Terminal Random Coil Region Tunes the Ca2+-Binding Affinity of S100A4 through Conformational Activation	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEIN; CALCIUM-BINDING PROTEIN; NONMUSCLE MYOSIN-IIA; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MTS1 S100A4; SCATTERING; COMPLEX; PLASMIN; TARGET	S100A4 interacts with many binding partners upon Ca2+ activation and is strongly associated with increased metastasis formation. In order to understand the role of the C-terminal random coil for the protein function we examined how small angle X-ray scattering of the wild-type S100A4 and its C-terminal deletion mutant (residues 1-88, Delta 13) changes upon Ca2+ binding. We found that the scattering intensity of wild-type S100A4 changes substantially in the 0.15-0.25 angstrom(-1) q-range whereas a similar change is not visible in the C-terminus deleted mutant. Ensemble optimization SAXS modeling indicates that the entire C-terminus is extended when Ca2+ is bound. Pulsed field gradient NMR measurements provide further support as the hydrodynamic radius in the wild-type protein increases upon Ca2+ binding while the radius of Delta 13 mutant does not change. Molecular dynamics simulations provide a rational explanation of the structural transition: the positively charged C-terminal residues associate with the negatively charged residues of the Ca2+-free EF-hands and these interactions loosen up considerably upon Ca2+-binding. As a consequence the Delta 13 mutant has increased Ca2+ affinity and is constantly loaded at Ca2+ concentration ranges typically present in cells. The activation of the entire C-terminal random coil may play a role in mediating interaction with selected partner proteins of S100A4.	[Duelli, Annette; Lundholm, Ida; Katona, Gergely] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Kiss, Bence; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Bodor, Andrea] Eotvos Lorand Univ, Lab Struct Chem & Biol, Inst Chem, Budapest, Hungary; [Petoukhov, Maxim V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany	University of Gothenburg; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Nyitray, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu; gergely.katona@cmb.gu.se	Nyitray, László/AAE-5910-2020; Bodor, Andrea/AAL-7854-2020; Kiss, Bence/AAF-1808-2020; Bodor, Andrea/G-1797-2018; Katona, Gergely/B-3491-2008; Petoukhov, Maxim V/R-7371-2016	Nyitray, László/0000-0003-4717-5994; Bodor, Andrea/0000-0002-7422-298X; Bodor, Andrea/0000-0002-7422-298X; Katona, Gergely/0000-0002-2031-8716; Petoukhov, Maxim V/0000-0001-6760-4595; Svergun, Dmitri/0000-0003-0830-5696; Lundholm, Ida/0000-0003-4342-990X; Kiss, Bence/0000-0001-5810-5858	Swedish Research Council; Harald and Greta Jeanssons Foundation; Hungarian Scientific Research Fund [OTKA K108437, NK81950, OTKANK101072]; German Ministry of Education andScience (BMBF) project BIOSCAT [05K20912]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald and Greta Jeanssons Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Ministry of Education andScience (BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF))	The work was supported by the Swedish Research Council, Harald and Greta Jeanssons Foundation, Hungarian Scientific Research Fund (OTKA K108437, NK81950, OTKANK101072). DIS and MVP acknowledge support from the German Ministry of Education andScience (BMBF) project BIOSCAT, contract 05K20912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Dutta K, 2002, BIOCHEMISTRY-US, V41, P4239, DOI 10.1021/bi012061v; Dutta K, 2008, BIOCHEMISTRY-US, V47, P7637, DOI 10.1021/bi8005048; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Gingras AR, 2008, FEBS LETT, V582, P1651, DOI 10.1016/j.febslet.2008.04.017; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Linegar KL, 2010, COLLOID J+, V72, P279, DOI 10.1134/S1061933X10020195; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pathuri P, 2008, J MOL BIOL, V383, P62, DOI 10.1016/j.jmb.2008.04.076; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ramagopal UA, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-31; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97654	10.1371/journal.pone.0097654	http://dx.doi.org/10.1371/journal.pone.0097654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830809	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500095
J	Himsworth, CG; Parsons, KL; Feng, AYT; Kerr, T; Jardine, CM; Patrick, DM				Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Kerr, Thomas; Jardine, Claire M.; Patrick, David M.			A Mixed Methods Approach to Exploring the Relationship between Norway Rat (Rattus norvegicus) Abundance and Features of the Urban Environment in an Inner-City Neighborhood of Vancouver, Canada	PLOS ONE			English	Article								Urban rats (Rattus spp.) are among the most ubiquitous pest species in the world. Previous research has shown that rat abundance is largely determined by features of the environment; however, the specific urban environmental factors that influence rat population density within cities have yet to be clearly identified. Additionally, there are no well described tools or methodologies for conducting an in-depth evaluation of the relationship between urban rat abundance and the environment. In this study, we developed a systematic environmental observation tool using methods borrowed from the field of systematic social observation. This tool, which employed a combination of quantitative and qualitative methodologies, was then used to identify environmental factors associated with the relative abundance of Norway rats (Rattus norvegicus) in an inner-city neighborhood of Vancouver, Canada. Using a multivariate zero-inflated negative binomial model, we found that a variety of factors, including specific land use, building condition, and amount of refuse, were related to rat presence and abundance. Qualitative data largely supported and further clarified observed statistical relationships, but also identified conflicting and unique situations not easily captured through quantitative methods. Overall, the tool helped us to better understand the relationship between features of the urban environment and relative rat abundance within our study area and may useful for studying environmental determinants of zoonotic disease prevalence/distribution among urban rat populations in the future.	[Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Himsworth, Chelsea G.] British Columbia Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Kerr, Thomas] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Guelph	Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	Chelsea.Himsworth@gov.bc.ca			Canadian Institutes of Health Research [MOP - 119530, CGV - 104833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research [MOP - 119530 and CGV - 104833]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bricki N., 2007, MED FRONT; Caughy MO, 2001, HEALTH PLACE, V7, P225, DOI 10.1016/S1353-8292(01)00012-0; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; Dohoo I, 2007, VET EPIDEMIOLOGIC RE; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; EMLEN JT, 1949, ECOLOGY, V30, P430, DOI 10.2307/1932446; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Figgs LW, 2011, INT J PEST MANAGE, V57, P217, DOI 10.1080/09670874.2011.567307; Frantz SC, 1976, P 7 VERT PEST C; Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794; Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Krebs Charles J., 1999, ACIAR Monograph Series, V59, P33; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Nagorsen D.W, 2002, IDENTIFICATION MANUA; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Parsons JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-6; Promkerd P, 2008, INTEGR ZOOL, V3, P11, DOI 10.1111/j.1749-4877.2008.00069.x; RAND Corperation, 2011, ANG FAM NEIGHB SURV; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Smith H. A., 2000, WORLDS COLLIDE SOCIA; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; Vadell MV, 2010, INT J PEST MANAGE, V56, P327, DOI 10.1080/09670874.2010.499479; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3; Yin Jia-Xiang, 2008, BMC Ecology, V8, P18, DOI 10.1186/1472-6785-8-18	26	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97776	10.1371/journal.pone.0097776	http://dx.doi.org/10.1371/journal.pone.0097776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830847	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500115
J	Jackson, AM; Semmens, BX; de Mitcheson, YS; Nemeth, RS; Heppell, SA; Bush, PG; Aguilar-Perera, A; Claydon, JAB; Calosso, MC; Sealey, KS; Scharer, MT; Bernardi, G				Jackson, Alexis M.; Semmens, Brice X.; de Mitcheson, Yvonne Sadovy; Nemeth, Richard S.; Heppell, Scott A.; Bush, Phillippe G.; Aguilar-Perera, Alfonso; Claydon, John A. B.; Calosso, Marta C.; Sealey, Kathleen S.; Schaerer, Michelle T.; Bernardi, Giacomo			Population Structure and Phylogeography in Nassau Grouper (Epinephelus striatus), a Mass-Aggregating Marine Fish	PLOS ONE			English	Article							SNAPPER LUTJANUS-ANALIS; SPAWNING AGGREGATION; BRACHIDONTES-EXUSTUS; GENETIC-STRUCTURE; LARVAL DISPERSAL; SCORCHED MUSSEL; OCEAN CURRENTS; CARIBBEAN SEA; REEF FISHES; CONNECTIVITY	To address patterns of genetic connectivity in a mass-aggregating marine fish, we analyzed genetic variation in mitochondrial DNA (mtDNA), microsatellites, and single nucleotide polymorphisms (SNPs) for Nassau grouper (Epinephelus striatus). We expected Nassau grouper to exhibit genetic differentiation among its subpopulations due to its reproductive behavior and retentive oceanographic conditions experienced across the Caribbean basin. All samples were genotyped for two mitochondrial markers and 9 microsatellite loci, and a subset of samples were genotyped for 4,234 SNPs. We found evidence of genetic differentiation in a Caribbean-wide study of this mass-aggregating marine fish using mtDNA (F-ST = 0.206, p<0.001), microsatellites (F-ST = 0.002, p = 0.004) and SNPs (F-ST = 0.002, p = 0.014), and identified three potential barriers to larval dispersal. Genetically isolated regions identified in our work mirror those seen for other invertebrate and fish species in the Caribbean basin. Oceanographic regimes in the Caribbean may largely explain patterns of genetic differentiation among Nassau grouper subpopulations. Regional patterns observed warrant standardization of fisheries management and conservation initiatives among countries within genetically isolated regions.	[Jackson, Alexis M.; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Semmens, Brice X.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [de Mitcheson, Yvonne Sadovy] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Nemeth, Richard S.] Univ Virgin Isl, Dept Zool Marine Biol, St Thomas, VI USA; [Heppell, Scott A.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Bush, Phillippe G.] Cayman Isl Dept Environm, Protect & Conservat Unit, Grand Cayman, British West In, Iceland; [Aguilar-Perera, Alfonso] Univ Autonoma Yucatan, Dept Biol Marina, Merida, Yucatan, Mexico; [Claydon, John A. B.; Calosso, Marta C.] Ctr Marine Resource Studies, Sch Field Studies, South Caicos, Turks & Caicos, Iceland; [Sealey, Kathleen S.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Schaerer, Michelle T.] Univ Puerto Rico, Mayaguez, PR USA	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hong Kong; University of the Virgin Islands; Oregon State University; Universidad Autonoma de Yucatan; University of Miami; University of Puerto Rico; University of Puerto Rico Mayaguez	Jackson, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	almjacks@ucsc.edu	Bernardi, Giacomo/F-6346-2011; Schärer-Umpierre, Michelle/R-2318-2019; Sealey, Kathleen Sullivan/A-8112-2019; Aguilar-Perera, Alfonso/D-6327-2012	Bernardi, Giacomo/0000-0002-8249-4678; Schärer-Umpierre, Michelle/0000-0002-0068-4049; Sealey, Kathleen Sullivan/0000-0003-4470-0909; Aguilar-Perera, Alfonso/0000-0002-7579-2183	National Geographic [8928-11]; Reef Environmental Education Foundation (REEF); Lenfest Ocean Program, Puerto Rico Sea Grant [R-31-1-06]; USGS State Partnership Program [07ERAG0078]; Caribbean Coral Reef Institute of the University of Puerto Rico; Friends of Long Marine Lab	National Geographic(National Geographic Society); Reef Environmental Education Foundation (REEF); Lenfest Ocean Program, Puerto Rico Sea Grant; USGS State Partnership Program; Caribbean Coral Reef Institute of the University of Puerto Rico; Friends of Long Marine Lab	Sample collection and lab work was funded by National Geographic (Young Explorers Grant #8928-11), the Reef Environmental Education Foundation (REEF), the Lenfest Ocean Program, Puerto Rico Sea Grant (#R-31-1-06), the USGS State Partnership Program (07ERAG0078), the Caribbean Coral Reef Institute of the University of Puerto Rico and grant from the Friends of Long Marine Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello P, 2012, MOL ECOL RESOUR, V12, P972, DOI 10.1111/j.1755-0998.2012.03173.x; Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Avise John C., 2004, P1; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; Bolden SK, 2000, FISH B-NOAA, V98, P642; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Carson EW, 2011, FISH B-NOAA, V109, P416; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Cherubin LM, 2011, ECOL MODEL, V222, P3132, DOI 10.1016/j.ecolmodel.2011.05.031; Cheung WWL, 2013, ENDANGER SPECIES RES, V20, P27, DOI 10.3354/esr00472; COLIN PL, 1992, ENVIRON BIOL FISH, V34, P357, DOI 10.1007/BF00004740; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Diaz-Ferguson E, 2012, J MOLLUS STUD, V78, P112, DOI 10.1093/mollus/eyr050; Diaz-Ferguson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012675; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Domeier ML, 1997, B MAR SCI, V60, P698; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ersts PJ, 2012, GEOGRAPHIC DISTANCE; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Froese R., 2012, FISHBASE; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haney RA, 2007, HEREDITY, V98, P294, DOI 10.1038/sj.hdy.6800940; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hellberg ME, 2002, B MAR SCI, V70, P273; Heppell SA, 2012, BIOL CONSERV, V155, P119, DOI 10.1016/j.biocon.2012.06.002; Heyman WD, 2008, B MAR SCI, V83, P531; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones KMM, 2005, J FISH BIOL, V66, P150, DOI 10.1111/j.0022-1112.2005.00589.x; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Lavery S, 1996, MOL ECOL, V5, P557; Lee T, 2004, MOL ECOL, V13, P3527, DOI 10.1111/j.1365-294X.2004.02337.x; Lee T, 2005, EVOLUTION, V59, P2139; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; Murphy SJ, 1999, J GEOPHYS RES-OCEANS, V104, P1431, DOI 10.1029/1998JC900010; Nemeth RS, 2012, FISH FISH SER, V35, P21, DOI 10.1007/978-94-007-1980-4_2; Nemeth RS, 2009, P GULF CARIB FISH I, V61, P329; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL AB, 1992, B MAR SCI, V50, P171; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Puebla O, 2009, ECOLOGY, V90, P3087, DOI 10.1890/08-0859.1; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Richardson PL, 2005, DEEP-SEA RES PT II, V52, P429, DOI 10.1016/j.dsr2.2004.11.001; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Sadovy Y, 1999, SYNOPSIS BIOL DATA N, V146; Salas E, 2010, MAR BIOL, V157, P437, DOI 10.1007/s00227-009-1330-y; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Scharsack JP, 2012, ECOL EVOL, V2, P1122, DOI 10.1002/ece3.232; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Semmens BX, 2006, CARIBBEAN CONNECTIVI, V9, P186; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Shulzitski K, 2009, FISH B-NOAA, V107, P501; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Sluka R, 1998, B MAR SCI, V62, P219; SMITH CL, 1972, T AM FISH SOC, V101, P257, DOI 10.1577/1548-8659(1972)101<257:ASAONG>2.0.CO;2; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Stevenson DE, 1997, STOCK IDENTIFICATION, P727; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; TUCKER JW, 1993, B MAR SCI, V52, P961; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERON JEN, 1995, CORALS SPACE TIME BI; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214	89	36	41	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97508	10.1371/journal.pone.0097508	http://dx.doi.org/10.1371/journal.pone.0097508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830641	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500070
J	Sueur, C; Maire, A				Sueur, Cedric; Maire, Anais			Modelling Animal Group Fission Using Social Network Dynamics	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; FUSION DYNAMICS; MACACA-SYLVANUS; PRIMATE GROUPS; TROOP FISSION; GROUP-SIZE; MACAQUES; POPULATION; EVOLUTION; BEHAVIOR	Group life involves both advantages and disadvantages, meaning that individuals have to compromise between their nutritional needs and their social links. When a compromise is impossible, the group splits in order to reduce conflict of interests and favour positive social interactions between its members. In this study we built a dynamic model of social networks to represent a succession of temporary fissions involving a change in social relations that could potentially lead to irreversible group fission (i.e. no more group fusion). This is the first study that assesses how a social network changes according to group fission-fusion dynamics. We built a model that was based on different parameters: the group size, the influence of nutritional needs compared to social needs, and the changes in the social network after a temporary fission. The results obtained from this theoretical data indicate how the percentage of social relation transfer, the number of individuals and the relative importance of nutritional requirements and social links influence the average number of days before irreversible fission occurs. The greater the nutritional needs and the higher the transfer of social relations during temporary fission, the fewer days will be observed before an irreversible fission. It is crucial to bridge the gap between the individual and the population level if we hope to understand how simple, local interactions may drive ecological systems.	[Sueur, Cedric; Maire, Anais] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Sueur, Cedric; Maire, Anais] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Sueur, Cedric] Univ Libre Brussels, Unit Social Ecol, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles	Sueur, C (corresponding author), CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France.	cedric.sueur@iphc.cnrs.fr	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Fyssen foundation; USIAS (University of Strasbourg Institute for Advanced Study)	Fyssen foundation; USIAS (University of Strasbourg Institute for Advanced Study)	CS is granted by the Fyssen foundation and the USIAS (University of Strasbourg Institute for Advanced Study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Asensio N, 2009, BEHAV ECOL SOCIOBIOL, V63, P649, DOI 10.1007/s00265-008-0699-9; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baigger A, 2013, NATURWISSENSCHAFTEN, V100, P895, DOI 10.1007/s00114-013-1090-x; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DITTUS WPJ, 1988, ANIM BEHAV, V36, P1626, DOI 10.1016/S0003-3472(88)80104-0; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hood LC, 1995, INT J PRIMATOL, V16, P997, DOI 10.1007/BF02696113; Jacobs A, 2011, INT J PRIMATOL, V32, P721, DOI 10.1007/s10764-011-9497-8; Jacobs A, 2010, BEHAV PROCESS, V84, P678, DOI 10.1016/j.beproc.2010.03.004; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2009, BEHAV ECOL, V20, P1039, DOI 10.1093/beheco/arp095; Krause J, 2002, LIVING GROUPS; Lefebvre D, 2003, BEHAV ECOL SOCIOBIOL, V53, P402, DOI 10.1007/s00265-002-0578-8; Lehmann J, 2009, P ROY SOC B-BIOL SCI, V276, P4417, DOI 10.1098/rspb.2009.1409; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Martin-Ordas G, 2013, CURR BIOL, V23, P1438, DOI 10.1016/j.cub.2013.06.017; MELNICK DJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P229, DOI 10.1007/BF00290775; MENARD N, 1993, INT J PRIMATOL, V14, P479, DOI 10.1007/BF02192778; Morrell LJ, 2008, ANIM BEHAV, V76, P855, DOI 10.1016/j.anbehav.2008.02.015; OI T, 1988, PRIMATES, V29, P1, DOI 10.1007/BF02380846; Okamoto K, 2001, INT J PRIMATOL, V22, P481, DOI 10.1023/A:1010711813637; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; PRUDHOMME J, 1991, PRIMATES, V32, P9, DOI 10.1007/BF02381597; R Development Core Team, 2009, R FDN STAT COMP; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Romey WL, 2008, BEHAV ECOL, V19, P338, DOI 10.1093/beheco/arm138; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Sueur C, 2011, P ROY SOC B-BIOL SCI, V278, P1697, DOI 10.1098/rspb.2010.2084; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032566; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Tisue S., 2004, NETLOGO SIMPLE ENV M; Van Horn RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1823, DOI 10.1007/s00265-007-0415-1; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; YAMAGIWA J, 1985, Primates, V26, P105, DOI 10.1007/BF02382011	63	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97813	10.1371/journal.pone.0097813	http://dx.doi.org/10.1371/journal.pone.0097813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831471	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500119
J	Sundstrom, K; Wahlstrom, H; Ivarsson, S; Lewerin, SS				Sundstrom, Kristian; Wahlstrom, Helene; Ivarsson, Sofie; Lewerin, Susanna Sternberg			Economic Effects of Introducing Alternative Salmonella Control Strategies in Sweden	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; WILLINGNESS-TO-PAY; BACTERIAL GASTROENTERITIS; RISK; CAMPYLOBACTER; REDUCTIONS; OUTBREAK; DISEASE	The objective of the study was to analyse the economic effects of introducing alternative Salmonella control strategies in Sweden. Current control strategies in Denmark and the Netherlands were used as benchmarks. The true number of human Salmonella cases was estimated by reconstructing the reporting pyramids for the various scenarios. Costs were calculated for expected changes in human morbidity (Salmonella and two of its sequelae), for differences in the control programmes and for changes in cattle morbidity. The net effects (benefits minus costs) were negative in all scenarios ((sic) -5 to -105 million), implying that it would not be cost-effective to introduce alternative control strategies in Sweden. This result was mainly due to an expected increase in the incidence of Salmonella in humans (6035-57108 reported and unreported new cases/year), with expected additional costs of (sic) 5-55 million. Other increased costs were due to expected higher incidences of sequelae ((sic) 3-49 million) and a higher cattle morbidity ((sic) 4-8 million). Benefits in terms of lower control costs amounted to (sic) 4-7 million.	[Sundstrom, Kristian] Lund Univ, Inst Food & Agr Econ, Lund, Sweden; [Wahlstrom, Helene] Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Lund University; National Veterinary Institute SVA; Swedish Institute for Infectious Disease Control; Swedish University of Agricultural Sciences	Sundstrom, K (corresponding author), Lund Univ, Inst Food & Agr Econ, Lund, Sweden.	kristian.sundstrom@agrifood.lu.se	Lewerin, Susanna Sternberg/C-1621-2015	Lewerin, Susanna Sternberg/0000-0001-7907-8377				Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Brouwer R, 2005, J HEALTH ECON, V24, P591, DOI 10.1016/j.jhealeco.2004.09.004; CDC, 1981, JINFECTDIS, V143; Danish Ministry of Food A and Fisheries, SALM CONTR; de Jong B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-4; Engvall A, 1992, EC SWEDISH SALMONELL; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Falkenhorst G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-523; Haagsma J, 2012, EPIDEMIOLOGY INFECT, V1, P1; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P553, DOI 10.1046/j.1365-2036.1997.00160.x; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI 10.3201/eid1410.071042; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Havelaar A, 2012, EPIDEMIOLOGY INFECT, V1, P1; Henson S, 1996, J AGR ECON, V47, P403, DOI 10.1111/j.1477-9552.1996.tb00701.x; Jung IS, 2009, J CLIN GASTROENTEROL, V43, P534, DOI 10.1097/MCG.0b013e31818c87d7; Kahng LS, 2009, GASTROENTEROLOGY, V137, P415, DOI 10.1053/j.gastro.2009.06.019; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Mangen MJJ, 2006, EUR J PUBLIC HEALTH, V16, P11; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1053/j.gastro.2005.04.012; Nilsson J, 2011, 20114 AGRIFOOD; Osterberg E, 2000, SCAND J GASTROENTERO, V35, P264; Osterberg J, 2006, ACTA VET SCAND, V47, P13, DOI 10.1186/1751-0147-47-13; Parry SD, 2003, AM J GASTROENTEROL, V98, P1970, DOI 10.1016/S0002-9270(03)00627-0; Pettersson L., 2010, 20102 SJV; Rodriguez LAG, 1999, BRIT MED J, V318, P565, DOI 10.1136/bmj.318.7183.565; SANCO, 2010, SANCO2008E2036; SIKA, 2008, 20083 SIKA PM; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Wahlstrom H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089833; Wang LH, 2004, GUT, V53, P1390, DOI 10.1136/gut.2003.021154corr1; Wierup M, 2006, SALMONELLA CONTAMINA, P1	34	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96446	10.1371/journal.pone.0096446	http://dx.doi.org/10.1371/journal.pone.0096446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831797	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500020
J	Chi, W; Dao, D; Lau, TC; Henriksbo, BD; Cavallari, JF; Foley, KP; Schertzer, JD				Chi, Wendy; Dao, Dyda; Lau, Trevor C.; Henriksbo, Brandyn D.; Cavallari, Joseph F.; Foley, Kevin P.; Schertzer, Jonathan D.			Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; ACTIVATION; INFLAMMATION; RECOGNITION; MICROBIOTA; ENDOTOXEMIA; MECHANISM; OBESITY; EXPRESSION	Obesity is associated with inflammation that can drive metabolic defects such as hyperlipidemia and insulin resistance. Specific metabolites can contribute to inflammation, but nutrient intake and obesity are also associated with altered bacterial load in metabolic tissues (i.e. metabolic endotoxemia). These bacterial cues can contribute to obesity-induced inflammation. The specific bacterial components and host receptors that underpin altered metabolic responses are emerging. We previously showed that Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) activation with bacterial peptidoglycan (PGN) caused insulin resistance in mice. We now show that PGN induces cell-autonomous lipolysis in adipocytes via NOD1. Specific bacterial PGN motifs stimulated lipolysis in white adipose tissue (WAT) explants from WT, but not NOD1(-/-) mice. NOD1-activating PGN stimulated mitogen activated protein kinases (MAPK), protein kinase A (PKA), and NF-kappa B in 3T3-L1 adipocytes. The NOD1-mediated lipolysis response was partially reduced by inhibition of ERK1/2 or PKA alone, but not c-Jun N-terminal kinase (JNK). NOD1-stimulated lipolysis was partially dependent on NF-kappa B and was completely suppressed by inhibiting ERK1/2 and PKA simultaneously or hormone sensitive lipase (HSL). Our results demonstrate that bacterial PGN stimulates lipolysis in adipocytes by engaging a stress kinase, PKA, NF-kappa B-dependent lipolytic program. Bacterial NOD1 activation is positioned as a component of metabolic endotoxemia that can contribute to hyperlipidemia, systemic inflammation and insulin resistance by acting directly on adipocytes.	[Schertzer, Jonathan D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Schertzer, JD (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	schertze@mcmaster.ca	; Schertzer, Jonathan/P-3395-2017	Chi, Wendy/0000-0003-2973-7084; Dao, Dyda/0000-0003-2941-8374; Schertzer, Jonathan/0000-0002-1547-5856; Dao, Dyda/0000-0002-8261-5361	Canadian Diabetes Association (CDA) [SC-5-12-3891-JS, OG-3-12-3745-JS]; Canadian Institutes of Health Research (CIHR) [MOP 130432]	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Diabetes Association (CDA) [SC-5-12-3891-JS and OG-3-12-3745-JS] and Canadian Institutes of Health Research (CIHR) [MOP 130432]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Balwani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046528; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Carneiro LAM, 2004, MICROBES INFECT, V6, P609, DOI 10.1016/j.micinf.2004.01.012; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Correa RG, 2011, CHEM BIOL, V18, P825, DOI 10.1016/j.chembiol.2011.06.009; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Grisouard J, 2012, INNATE IMMUN-LONDON, V18, P25, DOI 10.1177/1753425910386632; HARDARDOTTIR I, 1992, BIOCHEM BIOPH RES CO, V186, P237, DOI 10.1016/S0006-291X(05)80798-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Inouye K., 2006, J CLIN INVEST; Khan PM, 2011, ACS MED CHEM LETT, V2, P780, DOI 10.1021/ml200158b; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Purohit JS, 2013, BIOCHEM CELL BIOL, V91, P428, DOI 10.1139/bcb-2013-0049; Rickard DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069619; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Schertzer JD, 2004, ACTA PHYSIOL SCAND, V180, P195, DOI 10.1046/j.0001-6772.2003.01227.x; Schertzer JD, 2011, AM J PHYSIOL-ENDOC M, V301, pE585, DOI 10.1152/ajpendo.00362.2011; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Zhao L, 2011, AM J PHYSIOL-ENDOC M, V301, pE587, DOI 10.1152/ajpendo.00709.2010; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	46	46	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97675	10.1371/journal.pone.0097675	http://dx.doi.org/10.1371/journal.pone.0097675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828250	gold, Green Submitted, Green Published			2022-12-25	WOS:000336857400117
J	Junca, P; Carcaud, J; Moulin, S; Garnery, L; Sandoz, JC				Junca, Pierre; Carcaud, Julie; Moulin, Sibyle; Garnery, Lionel; Sandoz, Jean-Christophe			Genotypic Influence on Aversive Conditioning in Honeybees, Using a Novel Thermal Reinforcement Procedure	PLOS ONE			English	Article							DOPAMINE-LIKE IMMUNOREACTIVITY; PROBOSCIS EXTENSION RESPONSE; DIVISION-OF-LABOR; APIS-MELLIFERA; GUSTATORY RESPONSIVENESS; SUCROSE RESPONSIVENESS; LEARNING-PERFORMANCE; MEMORY FORMATION; BEE; TACTILE	In Pavlovian conditioning, animals learn to associate initially neutral stimuli with positive or negative outcomes, leading to appetitive and aversive learning respectively. The honeybee (Apis mellifera) is a prominent invertebrate model for studying both versions of olfactory learning and for unraveling the influence of genotype. As a queen bee mates with about 15 males, her worker offspring belong to as many, genetically-different patrilines. While the genetic dependency of appetitive learning is well established in bees, it is not the case for aversive learning, as a robust protocol was only developed recently. In the original conditioning of the sting extension response (SER), bees learn to associate an odor (conditioned stimulus CS) with an electric shock (unconditioned stimulus - US). This US is however not a natural stimulus for bees, which may represent a potential caveat for dissecting the genetics underlying aversive learning. We thus first tested heat as a potential new US for SER conditioning. We show that thermal stimulation of several sensory structures on the bee's body triggers the SER, in a temperature-dependent manner. Moreover, heat applied to the antennae, mouthparts or legs is an efficient US for SER conditioning. Then, using microsatellite analysis, we analyzed heat sensitivity and aversive learning performances in ten worker patrilines issued from a naturally inseminated queen. We demonstrate a strong influence of genotype on aversive learning, possibly indicating the existence of a genetic determinism of this capacity. Such determinism could be instrumental for efficient task partitioning within the hive.	[Junca, Pierre; Carcaud, Julie; Moulin, Sibyle; Garnery, Lionel; Sandoz, Jean-Christophe] CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sandoz, JC (corresponding author), CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France.	sandoz@legs.cnrs-gif.fr	Sandoz, Jean-Christophe/A-6085-2012; Carcaud, Julie/AAF-3453-2019	Sandoz, Jean-Christophe/0000-0002-5423-9645; Carcaud, Julie/0000-0003-3672-9963				Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BHAGAVAN S, 1994, ANIM BEHAV, V48, P1357, DOI 10.1006/anbe.1994.1372; Biergans SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039349; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BRANDES C, 1988, ANIM BEHAV, V36, P981, DOI 10.1016/S0003-3472(88)80056-3; BRANDES C, 1991, BEHAV GENET, V21, P271, DOI 10.1007/BF01065820; BRANDES C, 1990, COMP BIOCHEM PHYS C, V97, P53, DOI 10.1016/0742-8413(90)90171-5; Chapman NC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1185, DOI 10.1007/s00265-006-0348-0; Cox MD, 2003, J THEOR BIOL, V223, P179, DOI 10.1016/S0022-5193(03)00085-7; Eckholm BJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1037, DOI 10.1007/s00265-010-1108-8; Erber J, 2006, BEHAV BRAIN RES, V174, P174, DOI 10.1016/j.bbr.2006.07.023; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; ESTOUP A, 1995, GENETICS, V140, P679; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; FRUMHOFF PC, 1988, NATURE, V333, P358, DOI 10.1038/333358a0; Furey TS, 2013, SCIENCE, V342, P705, DOI 10.1126/science.1246755; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Garnery L, 1998, GENET SEL EVOL, V30, P1, DOI DOI https://doi.org/10.1186/1297-9686-30-S1-S31; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2006, CURR BIOL, V16, pR892, DOI 10.1016/j.cub.2006.09.021; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Guzman-Novoa E, 2005, J HERED, V96, P376, DOI 10.1093/jhered/esi038; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Kryger P, 2000, ETHOLOGY, V106, P769, DOI 10.1046/j.1439-0310.2000.00571.x; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Laloi D, 2010, APIDOLOGIE, V41, P436, DOI 10.1051/apido/2009080; Lenoir JC, 2006, INSECT SOC, V53, P80, DOI 10.1007/s00040-005-0838-5; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Matsumoto Y, 2014, LEARN MEM IN PRESS; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Muller U, 2012, APIDOLOGIE, V43, P322, DOI 10.1007/s13592-011-0115-8; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Newland PL, 1997, J INSECT PHYSIOL, V43, P107, DOI 10.1016/S0022-1910(96)00081-9; Nishino H, 2009, J COMP NEUROL, V515, P161, DOI 10.1002/cne.22064; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Paratore S, 2006, GENES BRAIN BEHAV, V5, P209, DOI 10.1111/j.1601-183X.2005.00159.x; Perez M, 2013, LEARN MEMORY, V20, P417, DOI 10.1101/lm.031427.113; ROBINSON GE, 1989, WESTV STUD, P61; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; SCHAFER S, 1989, J COMP NEUROL, V280, P43, DOI 10.1002/cne.902800105; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Scheiner R, 2010, APIDOLOGIE, V41, P29, DOI 10.1051/apido/2009040; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Ugajin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032902; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	75	13	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97333	10.1371/journal.pone.0097333	http://dx.doi.org/10.1371/journal.pone.0097333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828422	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400079
J	Munshi, SU; Panda, H; Holla, P; Rewari, BB; Jameel, S				Munshi, Saif Ullah; Panda, Harekrushna; Holla, Prasida; Rewari, Bharat Bhushan; Jameel, Shahid			MicroRNA-150 Is a Potential Biomarker of HIV/AIDS Disease Progression and Therapy	PLOS ONE			English	Article							T-CELL COUNT; CERAMIDE PRODUCTION; VIRAL LOAD; HIV-1; EXPRESSION; PLASMA; MECHANISMS; SERUM; PCR; MIR-150	Background: The surrogate markers of HIV/AIDS progression include CD4 T cell count and plasma viral load. But, their reliability has been questioned in patients on anti-retroviral therapy (ART). Five microRNAs (miRNAs) - miR-16, miR-146b-5p, miR-150, miR-191 and miR-223 in peripheral blood mononuclear cells (PBMCs) were earlier found to assign HIV/AIDS patients into groups with varying CD4 T cell counts and viral loads. In this pilot study, we profiled the expression of these five miRNAs in PBMCs, and two of these miRNAs (miR-146b-5p and miR-150) in the plasma of HIV/AIDS patients, including those on ART and those who developed ART resistance, to evaluate if these are biomarkers of disease progression and therapy. Results: We quantified miRNA levels by quantitative reverse transcription polymerase chain reaction (qRT-PCR) using RNA isolated from PBMCs and plasma of healthy persons or HIV-infected patients who were (1) asymptomatic; (2) symptomatic and ART naive; (3) on ART; and (4) failing ART. Our results show miR-150 (p<0.01) and to a lesser extent miR-146b-5p (p<0.05) levels in PBMCs to reliably distinguish between ART-naive AIDS patients, those on ART, and those developing drug resistance and failing ART. The plasma levels of these two miRNAs also varied significantly between patients in these groups and between patients and healthy controls (p values <0.05). Conclusions: We report for the first time that PBMC and plasma levels of miR-150 and miR-146b-5p are predictive of HIV/AIDS disease progression and therapy.	[Munshi, Saif Ullah; Holla, Prasida; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Panda, Harekrushna] Int Ctr Genet Engn & Biotechnol, ICGEB Emory Vaccine Ctr, New Delhi, India; [Rewari, Bharat Bhushan] Natl AIDS Control Org, ART Dept, New Delhi, India; [Rewari, Bharat Bhushan] Dr Ram Manohar Lohia Hosp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	shahid@icgeb.res.in			Department of Biotechnology, Government of India; Indian Council of Medical Research; Emory Vaccine Center; ICGEB	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Emory Vaccine Center; ICGEB(Department of Biotechnology (DBT) India)	This work was supported by grants from the Department of Biotechnology, Government of India and the Indian Council of Medical Research. It also received support from the Emory Vaccine Center through a grant to the ICGEB-Emory Vaccine Centre. S.U.M. received a Pre-Doctoral Fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Corbeau P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000162; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Gupta V, 2004, Indian J Med Microbiol, V22, P7; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kamat A, 2007, J CLIN VIROL, V39, P9, DOI 10.1016/j.jcv.2006.12.026; Kanekar Amar, 2010, J Clin Med Res, V2, P55, DOI 10.4021/jocmr2010.03.255w; Kawado M, 2006, J EPIDEMIOL, V16, P101, DOI 10.2188/jea.16.101; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; Swaminathan S, 2012, J IMMUNOL, V188, P6238, DOI 10.4049/jimmunol.1101196; Swaminathan S, 2009, BLOOD, V113, P5029, DOI 10.1182/blood-2009-01-196741; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; TSOUKAS CM, 1994, CLIN MICROBIOL REV, V7, P14, DOI 10.1128/CMR.7.1.14-28.1994; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	49	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95920	10.1371/journal.pone.0095920	http://dx.doi.org/10.1371/journal.pone.0095920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828336	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400018
J	Sirvente, RA; Irigoyen, MC; Souza, LE; Mostarda, C; La Fuente, RN; Candido, GO; Souza, PRM; Medeiros, A; Mady, C; Salemi, VMC				Sirvente, Raquel A.; Irigoyen, Maria C.; Souza, Leandro E.; Mostarda, Cristiano; La Fuente, Raquel N.; Candido, Georgia O.; Souza, Pamella R. M.; Medeiros, Alessandra; Mady, Charles; Salemi, Vera M. C.			Cardiac Impairment Evaluated by Transesophageal Echocardiography and Invasive Measurements in Rats Undergoing Sinoaortic Denervation	PLOS ONE			English	Article							BAROREFLEX SENSITIVITY; AMERICAN-SOCIETY; EUROPEAN-ASSOCIATION; EXERCISE; RECOMMENDATIONS; GUIDELINES; VARIABILITY; ADJUSTMENTS; BRANCH; HEART	Background: Sympathetic hyperactivity may be related to left ventricular (LV) dysfunction and baro- and chemoreflex impairment in hypertension. However, cardiac function, regarding the association of hypertension and baroreflex dysfunction, has not been previously evaluated by transesophageal echocardiography (TEE) using intracardiac echocardiographic catheter. Methods and Results: We evaluated exercise tests, baroreflex sensitivity and cardiovascular autonomic control, cardiac function, and biventricular invasive pressures in rats 10 weeks after sinoaortic denervation (SAD). The rats (n = 32) were divided into 4 groups: 16 Wistar (W) with (n = 8) or without SAD (n = 8) and 16 spontaneously hypertensive rats (SHR) with (n = 8) or without SAD (SHRSAD) (n = 8). Blood pressure (BP) and heart rate (HR) did not change between the groups with or without SAD; however, compared to W, SHR groups had higher BP levels and BP variability was increased. Exercise testing showed that SHR had better functional capacity compared to SAD and SHRSAD. Echocardiography showed left ventricular (LV) concentric hypertrophy; segmental systolic and diastolic biventricular dysfunction; indirect signals of pulmonary arterial hypertension, mostly evident in SHRSAD. The end-diastolic right ventricular (RV) pressure increased in all groups compared to W, and the end-diastolic LV pressure increased in SHR and SHRSAD groups compared to W, and in SHRSAD compared to SAD. Conclusions: Our results suggest that baroreflex dysfunction impairs cardiac function, and increases pulmonary artery pressure, supporting a role for baroreflex dysfunction in the pathogenesis of hypertensive cardiac disease. Moreover, TEE is a useful and feasible noninvasive technique that allows the assessment of cardiac function, particularly RV indices in this model of cardiac disease.	[Sirvente, Raquel A.; Mady, Charles; Salemi, Vera M. C.] Univ Sao Paulo, Fac Med, Cardiomyopathy Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil; [Sirvente, Raquel A.; Irigoyen, Maria C.; Souza, Leandro E.; Mostarda, Cristiano; La Fuente, Raquel N.; Candido, Georgia O.; Souza, Pamella R. M.] Univ Sao Paulo, Fac Med, Hypertens Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil; [Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Sirvente, RA (corresponding author), Univ Sao Paulo, Fac Med, Cardiomyopathy Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil.	raquelsirvente@hotmail.com	IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; Medeiros, Alessandra/E-8132-2012; Mostarda, Cristiano/AAG-4087-2019; Salemi, Vera/AAY-5024-2020; Salemi, Vera MC/C-9104-2013; Mady, Charles/C-8870-2012; Medeiros, Alessandra/F-6149-2014	IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; Medeiros, Alessandra/0000-0002-7962-7185; Salemi, Vera MC/0000-0002-7152-1810; Mady, Charles/0000-0002-8838-199X; Medeiros, Alessandra/0000-0002-7962-7185; Mostarda, Cristiano Teixeira/0000-0002-1305-1697	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce CJ, 1999, J AM SOC ECHOCARDIOG, V12, P596, DOI 10.1016/S0894-7317(99)70008-8; Brum PC, 2000, HYPERTENSION, V36, P1018, DOI 10.1161/01.HYP.36.6.1018; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Farah VMA, 1999, BRAZ J MED BIOL RES, V32, P361, DOI 10.1590/S0100-879X1999000300018; Gao ZH, 2005, J AM SOC ECHOCARDIOG, V18, P626, DOI 10.1016/j.echo.2004.08.032; IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111, DOI 10.1161/01.HYP.26.6.1111; Jorge L, 2011, EUR HEART J, V32, P904, DOI 10.1093/eurheartj/ehq244; KRIEGER EM, 1963, AM J PHYSIOL, V205, P771, DOI 10.1152/ajplegacy.1963.205.4.771; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li P, 2002, J AM SOC ECHOCARDIOG, V15, P349, DOI 10.1067/mje.2002.116312; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Miao CY, 2003, AM J HYPERTENS, V16, P585, DOI 10.1016/S0895-7061(03)00866-5; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007; Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; NORMAN RA, 1981, HYPERTENSION, V3, P119, DOI 10.1161/01.HYP.3.1.119; Ramires FJA, 2006, J RENIN-ANGIO-ALDO S, V7, P162, DOI 10.3317/jraas.2006.026; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Salemi Vera M C, 2005, Eur J Echocardiogr, V6, P41, DOI 10.1016/j.euje.2004.06.001; Sebbag I, 2001, AM J CARDIOL, V88, P1060, DOI 10.1016/S0002-9149(01)01995-6; Shanewise JS, 1999, J AM SOC ECHOCARDIOG, V12, P884, DOI 10.1016/S0894-7317(99)70199-9; Silva GJJ, 1997, HYPERTENSION, V30, P714, DOI 10.1161/01.HYP.30.3.714; Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002; Tei C, 1995, J Cardiol, V26, P357; Van Vliet BN, 1999, J PHYSIOL-LONDON, V516, P885, DOI 10.1111/j.1469-7793.1999.0885u.x; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14	30	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e87935	10.1371/journal.pone.0087935	http://dx.doi.org/10.1371/journal.pone.0087935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828834	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400001
J	Sundberg, T; Petzold, M; Kohls, N; Falkenberg, T				Sundberg, Tobias; Petzold, Max; Kohls, Niko; Falkenberg, Torkel			Opposite Drug Prescription and Cost Trajectories following Integrative and Conventional Care for Pain - A Case-Control Study	PLOS ONE			English	Article							MEDICINE; THERAPY; BACK	Objectives: Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of this study were to compare prescribed defined daily doses (DDD) and cost of first line drugs for pain patients referred to conventional or anthroposophic IC in Stockholm County, Sweden. Methods: In this retrospective high quality registry case-control study, IC and conventional care patients were identified through inpatient care registries and matched on pain diagnosis (ICD-10: M79), age, gender and socio-demographics. National drug registry data was used to investigate changes in DDD and costs from 90/180 days before, to 90/180 days after, index visits to IC and conventional care. The primary selected drug category was analgesics, complemented by musculo-skeletal system drugs (e.g. anti-inflammatories, muscle relaxants) and psycholeptics (e.g. hypnotics, sedatives). Results: After index care visits, conventional care pain patients (n = 1050) compared to IC patients (n = 213), were prescribed significantly more analgesics. The average (95% CI) group difference was 15.2 (6.0 to 24.3), p = 0.001, DDD/patient after 90 days; and 21.5 (7.4 to 35.6), p = 0.003, DDD/patient after 180 days. The cost of the prescribed and sold analgesics was significantly higher for conventional care after 90 days: euro/patient 10.7 (1.3 to 20.0), p = 0.025. Changes in drug prescription and costs for the other drug categories were not significantly different between groups. Conclusions: Drug prescriptions and costs of analgesics increased following conventional care and decreased following IC, indicating potentially fewer adverse drug events and beneficial societal cost savings with IC.	[Sundberg, Tobias; Falkenberg, Torkel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Res Grp Integrat Care, Huddinge, Sweden; [Sundberg, Tobias; Falkenberg, Torkel] I C Integrat Care Sci Ctr, Jarna, Sweden; [Petzold, Max] Univ Gothenburg, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Kohls, Niko] Univ Appl Sci & Arts, Div Integrat Hlth Promot, Coburg, Germany; [Kohls, Niko] Univ Munich, Generat Res Program, Bad Tolz, Germany; [Kohls, Niko] Samueli Inst, Brain Mind & Healing Program, Alexandria, VA USA	Karolinska Institutet; University of Gothenburg; Klinikum Coburg; University of Munich	Sundberg, T (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Res Grp Integrat Care, Huddinge, Sweden.	tobias.sundberg@ki.se		Falkenberg, Torkel/0000-0002-8150-9380	Mahle (Germany); Ekhaga (Sweden); Vidar (Sweden); Jochnick (the Netherlands); Gyllenberg (Finland); Samueli Institute (USA)	Mahle (Germany); Ekhaga (Sweden); Vidar (Sweden); Jochnick (the Netherlands); Gyllenberg (Finland); Samueli Institute (USA)	Financial support: The study was partly funded by the Mahle (Germany), Ekhaga (Sweden), Vidar (Sweden), Jochnick (the Netherlands), Gyllenberg (Finland) and Samueli Institute (USA) charitable non-profit foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2012, ALTERN THER HEALTH M, V18, P25; Arman Maria, 2011, Complement Ther Clin Pract, V17, P170, DOI 10.1016/j.ctcp.2010.11.001; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; CAMbrella, 2013, ROADMAP EUR CAM RES; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; European Commission, 2014, FULL LIST OF HUMAN M; Experian AB, 2013, EXPERIAN MOSAIC LIVS; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Hamre HJ, 2005, WIEN KLIN WOCHENSCHR, V117, P256, DOI 10.1007/s00508-005-0344-9; Kienle GS, 2006, COSTS ANTHROPOSOPHIC, P319; Kienle GS, 2006, ANTHROPOSOPHIC MED E, P1; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; National Institute for Health and Clinical Excellence (NICE), CG90 DEPR AD NICE GU; NCCAM, 2013, COMPL ALT INT HLTH W; NICE, 2009, CG88 LOW BACK PAIN N; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; SBU, 2010, REH LANGV SMART; SBU, 2006, MET BEH LANGV SM; Stockholm County Council, 2013, VISS MED ADM STOD PR; Stockholm County Council, 2013, AVENZA MAPUBLISHER W; Sundberg T, 2013, EUR J INTEGR MED; Sundberg T, 2012, EUR J INTEGR MED S1, V4, P38; Sundberg T, 2013, ACCEPT PUBL FORSCHE; Sundberg T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-107; Sundberg T, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-33; Sveriges Kommuner och Landsting, 2012, LAG VALFR LOV; Swedish National Board of Health and Welfare, 2013, LAKEMEDELSREGISTRET; Vidarkliniken, 2012, ANTROPOSOFISK MEDICI; Vidarkliniken, 2012, VID ANTR SJUKH JAM; World Health Organization, TRAD MED; World Health Organization (WHO), 2013, ICD 10 VERSION 2010	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96717	10.1371/journal.pone.0096717	http://dx.doi.org/10.1371/journal.pone.0096717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827981	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400034
J	von Jonquieres, G; Froud, KE; Klugmann, CB; Wong, ACY; Housley, GD; Klugmann, M				von Jonquieres, Georg; Froud, Kristina E.; Klugmann, Claudia B.; Wong, Ann C. Y.; Housley, Gary D.; Klugmann, Matthias			Loss of Central Auditory Processing in a Mouse Model of Canavan Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; A-DEFICIENT MICE; SPONGY DEGENERATION; METACHROMATIC LEUKODYSTROPHY; COCHLEAR FUNCTION; WHITE-MATTER; BRAIN; ASPARTOACYLASE; RESPONSES; HEARING	Canavan Disease (CD) is a leukodystrophy caused by homozygous null mutations in the gene encoding aspartoacylase (ASPA). ASPA-deficiency is characterized by severe psychomotor retardation, and excessive levels of the ASPA substrate N-acetylaspartate (NAA). ASPA is an oligodendrocyte marker and it is believed that CD has a central etiology. However, ASPA is also expressed by Schwann cells and ASPA-deficiency in the periphery might therefore contribute to the complex CD pathology. In this study, we assessed peripheral and central auditory function in the Aspa(lacZ/lacZ) rodent model of CD using auditory brainstem response (ABR). Increased ABR thresholds and the virtual loss of waveform peaks 4 and 5 from Aspa(lacZ/lacZ) mice, indicated altered central auditory processing in mutant mice compared with Aspa(wt/wt) controls and altered central auditory processing. Analysis of ABR latencies recorded from Aspa(lacZ/lacZ) mice revealed that the speed of nerve conduction was unchanged in the peripheral part of the auditory pathway, and impaired in the CNS. Histological analyses confirmed that ASPA was expressed in oligodendrocytes and Schwann cells of the auditory system. In keeping with our physiological results, the cellular organization of the cochlea, including the organ of Corti, was preserved and the spiral ganglion nerve fibres were normal in ASPA-deficientmice. In contrast, we detected substantial hypomyelination in the central auditory systemof Aspa(lacZ/lacZ) mice. In summary, our data suggest that the lack of ASPA in the CNS is responsible for the observed hearing deficits, while ASPA-deficiency in the cochlear nerve fibres is tolerated both morphologically and functionally.	[Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Translat Neurosci Facil, Sydney, NSW, Australia; Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Klugmann, M (corresponding author), Univ New S Wales, Sch Med Sci, Translat Neurosci Facil, Sydney, NSW, Australia.	m.klugmann@unsw.edu.au	von Jonquieres, Georg/W-1781-2019	von Jonquieres, Georg/0000-0002-7423-3355; Parley, Kristina E/0000-0002-5710-915X; Wong, Ann CY/0000-0001-7011-0369; Housley, Gary/0000-0002-8413-588X	EU FP7 LeukoTreat; Australian Research Council (ARC)	EU FP7 LeukoTreat; Australian Research Council (ARC)(Australian Research Council)	This work was supported by a project grant of the EU FP7 LeukoTreat and an Australian Research Council (ARC) Future Fellowship to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2013, MOL THER, V21, P2136, DOI 10.1038/mt.2013.138; BANKER BQ, 1964, NEUROLOGY, V14, P981, DOI 10.1212/WNL.14.11.981; BROWN FR, 1981, NEUROLOGY, V31, P980, DOI 10.1212/WNL.31.8.980; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cederholm JME, 2012, HEARING RES, V292, P71, DOI 10.1016/j.heares.2012.08.010; D'Hooge R, 1999, BRAIN RES, V847, P352, DOI 10.1016/S0006-8993(99)02085-5; ELKHATEEB I, 1988, BRAIN DEV-JPN, V10, P243; Fishman MA, 2006, OSKIS PEDIAT PRINCIP, P2378; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Ishiyama G, 2003, NEUROLOGY, V60, P1702, DOI 10.1212/01.WNL.0000065893.60879.D3; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Klugmann M, 2003, NEUROREPORT, V14, P1837, DOI 10.1097/00001756-200310060-00016; Klugmann Matthias, 2006, P303, DOI 10.1016/B978-012397632-1/50024-1; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kuan CC, 2008, ACTA OTO-LARYNGOL, V128, P539, DOI 10.1080/00016480701258713; Leuzzi V, 2000, NEUROLOGY, V54, P2325, DOI 10.1212/WNL.54.12.2325; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Matalon R, 2000, J GENE MED, V2, P165; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; Mersmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020336; MIKAELIAN DO, 1979, LARYNGOSCOPE, V89, P1; OCHS R, 1979, NEUROLOGY, V29, P1089, DOI 10.1212/WNL.29.8.1089; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; SACKS O, 1965, NEUROLOGY, V15, P165, DOI 10.1212/WNL.15.2.165; SUZUKI K, 1968, ACTA NEUROPATHOL, V10, P95, DOI 10.1007/BF00690515; Toriello H. V., 2004, HEREDITARY HEARING L; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; van Bogaert L., 1949, ACTA NEUROL BELG, V49, P572; VANDERKNAAP MS, 1991, DEV MED CHILD NEUROL, V33, P849; von Jonquieres G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065646; Zafeiriou DI, 1999, BRAIN DEV-JPN, V21, P205, DOI 10.1016/S0387-7604(99)00003-0	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97374	10.1371/journal.pone.0097374	http://dx.doi.org/10.1371/journal.pone.0097374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826990	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400087
J	Xu, XL; Li, QK; Wang, JY; Zhang, LM; Tian, SN; Zhi, L; Li, QR; Sun, Y				Xu, Xingliang; Li, Qingkang; Wang, Jingyuan; Zhang, Leiming; Tian, Shengni; Zhi, Lin; Li, Qianru; Sun, Yue			Inorganic and Organic Nitrogen Acquisition by a Fern Dicranopteris dichotoma in a Subtropical Forest in South China	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; N UPTAKE; RAIN-FOREST; MAUNA-LOA; PLANTS; SOIL; ROOTS; NUTRITION; LINEARIS; AVAILABILITY	The fern Dicranopteris dichotoma is an important pioneer species of the understory in Masson pine (Pinus massoniana) forests growing on acidic soils in the subtropical and tropical China. To improve our understanding of the role of D. dichotoma in nitrogen (N) uptake of these forests, a short-term N-15 experiment was conducted at mountain ridge (MR, with low N level) and mountain foot (MF, with high N level). We injected N-15 tracers as 15 NH4, (NO3)-N-15 or N-15-glycine into the soil surrounding each plant at both MR and MF sites. Three hours after tracer injection, the fern D. dichotoma took up (NH4+)-N-15 significantly faster at MF than at MR, but it showed significantly slower uptake of (NO3-)-N-15 at MF than at MR. Consequently, (NO3-)-N-15 made greater contribution to the total N uptake (50% to the total N uptake) at MR than at MF, but N-15-glycine only contributed around 11% at both sites. Twenty-four hours after tracer injection, D. dichotoma preferred (NH4+)-N-15 (63%) at MR, whereas it preferred (NO3-)-N-15 (47%) at MF. We concluded that the D. dichotoma responds distinctly in its uptake pattern for three available N species over temporal and spatial scales, but mainly relies on inorganic N species in the subtropical forest. This suggests that the fern employs different strategies to acquire available N which depends on N levels and time.	[Xu, Xingliang; Li, Qingkang; Wang, Jingyuan; Zhang, Leiming; Li, Qianru; Sun, Yue] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Li, Qianru; Sun, Yue] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tian, Shengni; Zhi, Lin] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China; [Zhi, Lin] Xikou Jr Middle Sch, Xikou City, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui Agricultural University	Li, QK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	liqk@igsnrr.ac.cn	Xu, Xingliang/P-9916-2015; wang, jingyuan/H-8917-2013	Xu, Xingliang/0000-0003-2869-4932; wang, jingyuan/0000-0001-7904-4695; Sun, Yue/0000-0002-2207-6423	National Basic Research Program of China [2012CB416903]; National Natural Science Foundation of China [41071209, 30970484]; National Key Technologies R D Program [2012BAC11B05-3]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R D Program(National Key Technology R&D Program)	This study was supported by National Basic Research Program of China (2012CB416903) and the National Natural Science Foundation of China (41071209 and 30970484) and National Key Technologies R & D Program (2012BAC11B05-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2013, J ECOL, V101, P819, DOI 10.1111/1365-2745.12070; BARBER SA, 1963, J AGR FOOD CHEM, V11, P204, DOI 10.1021/jf60127a017; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Cohen AL, 1995, RESTOR ECOL, V3, P261, DOI 10.1111/j.1526-100X.1995.tb00093.x; Dahlman L, 2004, PLANTA, V219, P459, DOI 10.1007/s00425-004-1247-0; GRAY JT, 1983, J ECOL, V71, P43, DOI 10.2307/2259962; Hietz P, 1999, PLANT CELL ENVIRON, V22, P1435, DOI 10.1046/j.1365-3040.1999.00502.x; Hou Xue-Yu, 1983, ANN MISSOURI BOT GAR, V70, P509; Inselsbacher E, 2012, NEW PHYTOL, V195, P329, DOI 10.1111/j.1469-8137.2012.04169.x; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leadley PW, 1997, ECOL MONOGR, V67, P1, DOI 10.1890/0012-9615(1997)067[0001:AMONUB]2.0.CO;2; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LI ZC, 1990, PLANT PHYSIOL, V94, P268, DOI 10.1104/pp.94.1.268; LI ZC, 1991, PLANT PHYSIOL, V96, P1338, DOI 10.1104/pp.96.4.1338; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; NASHOLM T, 1987, J CHROMATOGR, V396, P225, DOI 10.1016/S0021-9673(01)94060-9; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Russell AE, 1997, J TROP ECOL, V13, P579, DOI 10.1017/S0266467400010737; Russell AE, 1998, J ECOL, V86, P765, DOI 10.1046/j.1365-2745.1998.8650765.x; Schmidt S, 2003, PLANT SOIL, V248, P157, DOI 10.1023/A:1022352415728; Schmidt S, 1997, PLANT CELL ENVIRON, V20, P1231, DOI 10.1046/j.1365-3040.1997.d01-20.x; Schmidt S, 1999, AUST J PLANT PHYSIOL, V26, P253, DOI 10.1071/PP98116; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; vonWiren N, 1997, PLANT SOIL, V196, P191, DOI 10.1023/A:1004241722172; Wanek W, 2002, FUNCT PLANT BIOL, V29, P733, DOI 10.1071/PP01238; Wanek W, 2008, FUNCT PLANT BIOL, V35, P51, DOI 10.1071/FP07191; Warren CR, 2006, FUNCT PLANT BIOL, V33, P653, DOI 10.1071/FP06045; Warren CR, 2007, TREE PHYSIOL, V27, P413, DOI 10.1093/treephys/27.3.413; Warren CR, 2009, TREE PHYSIOL, V29, P401, DOI 10.1093/treephys/tpn037; Watkins Jr J.E., 2006, THESIS; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zheng H, 2008, J HYDROL, V356, P174, DOI 10.1016/j.jhydrol.2008.04.007	41	4	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e90075	10.1371/journal.pone.0090075	http://dx.doi.org/10.1371/journal.pone.0090075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829044	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400003
J	Zhang, MX; Zhao, XY; Cheng, H; Wang, L; Xi, B; Shen, Y; Hou, DQ; Mi, J				Zhang, Meixian; Zhao, Xiaoyuan; Cheng, Hong; Wang, Liang; Xi, Bo; Shen, Yue; Hou, Dongqing; Mi, Jie			Age- and Sex-Dependent Association between FTO rs9939609 and Obesity-Related Traits in Chinese Children and Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; FAT MASS; GENE VARIANT; CHILDHOOD; HERITABILITY; OVERWEIGHT; TIME; RISK; BMI	Background: The associations between common variants in the fat mass- and obesity-associated (FTO) gene and obesity-related traits may be age-dependent and may differ by sex. The present study aimed to assess the association of FTO rs9939609 with body mass index (BMI) and the risk of obesity from childhood to adolescence, and to determine the age at which the association becomes evident. Methods: Totally 757 obese and 2,746 non-obese Chinese children aged 6-18 years were genotyped for FTO rs9939609. Of these, a young sub-cohort (n = 777) aged 6-11 years was reexamined 6 years later. Obesity was defined using the sex- and age-specific BMI cut-offs recommended by the International Obesity Task Force. Results: The associations of FTO rs9939609 with BMI and obesity did not appear until children reached 12-14 years. The variant was associated with an increased BMI in boys (beta = 1.50, P = 0.004) and girls (beta = 0.97, P = 0.018), respectively. Thereafter, the magnitude of association increased in girls at ages 15-18 years (beta = 2.02, P < 0.001), but not boys (beta = 0.10, P > 0.05). Age was found to interact with the variant on BMI (P < 0.001) and obesity (P = 0.042) only in girls. In the sub-cohort, the associations of FTO rs9939609 with BMI (beta = 1.07, P = 0.008) and obesity (OR = 2.09, 95% CI: 1.12, 3.91) were only observed 6 years later (ages 12-18 years) in girls, even after adjusting for baseline BMI. Conclusions: The association between FTO rs9939609 and obesity-related traits may change from childhood to adolescence in Chinese individuals, and the association may start as early as age 12 years, especially in girls.	[Zhang, Meixian; Zhao, Xiaoyuan; Cheng, Hong; Shen, Yue; Hou, Dongqing; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Zhang, Meixian; Mi, Jie] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Liang] E Tennessee State Univ, Dept Biostat & Epidemiol, Coll Publ Hlth, Johnson City, TN 37614 USA; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China	Capital Institute of Pediatrics (CIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; East Tennessee State University; Shandong University	Mi, J (corresponding author), Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China.	jiemi@vip.163.com			National Basic Research Program of China (973 Program) [2013CB530605]; Beijing Municipal Science and Technology Key Project [D111100000611002, H030930030031]; Beijing Training Project for the Leading Talents in S T [2011LJ07]; Beijing Health System Leading Talent Grant [2009-1-08]; Capital Institute of Pediatrics	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Science and Technology Key Project; Beijing Training Project for the Leading Talents in S T; Beijing Health System Leading Talent Grant; Capital Institute of Pediatrics	This work was supported by grants from National Basic Research Program of China (973 Program, 2013CB530605), Beijing Municipal Science and Technology Key Project (D111100000611002, H030930030031), Beijing Training Project for the Leading Talents in S & T (2011LJ07), Beijing Health System Leading Talent Grant (2009-1-08) and Capital Institute of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Germer Soren, 2003, Methods Mol Biol, V212, P197; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hallman DM, 2012, INT J OBESITY, V36, P61, DOI 10.1038/ijo.2011.190; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Marshall WA, 1986, HUMAN GROWTH, P171, DOI DOI 10.1007/978-1-4899-0522-2_8; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107	24	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97545	10.1371/journal.pone.0097545	http://dx.doi.org/10.1371/journal.pone.0097545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827155	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400108
J	Mattioli, TA; Leduc-Pessah, H; Skelhorne-Gross, G; Nicol, CJB; Milne, B; Trang, T; Cahill, CM				Mattioli, Theresa Alexandra; Leduc-Pessah, Heather; Skelhorne-Gross, Graham; Nicol, Chris J. B.; Milne, Brian; Trang, Tuan; Cahill, Catherine M.			Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence	PLOS ONE			English	Article							PRIMARY ASTROGLIAL CULTURES; PERIPHERAL-NERVE INJURY; ADENYLATE-CYCLASE; INDUCED ANALGESIA; OPIATE RECEPTORS; IMMUNE-RESPONSES; MU; MICROGLIA; LIPOPOLYSACCHARIDE; ACTIVATION	The innate immune system modulates opioid-induced effects within the central nervous system and one target that has received considerable attention is the toll-like receptor 4 (TLR4). Here, we examined the contribution of TLR4 in the development of morphine tolerance, hyperalgesia, and physical dependence in two inbred mouse strains: C3H/HeJ mice which have a dominant negative point mutation in the Tlr4 gene rendering the receptor non-functional, and B10ScNJ mice which are TLR4 null mutants. We found that neither acute antinociceptive response to a single dose of morphine, nor the development of analgesic tolerance to repeated morphine treatment, was affected by TLR4 genotype. Likewise, opioid induced hyperalgesia and opioid physical dependence (assessed by naloxone precipitated withdrawal) were not altered in TLR4 mutant or null mice. We also examined the behavioural consequence of two stereoisomers of naloxone: (-) naloxone, an opioid receptor antagonist, and (+) naloxone, a purported antagonist of TLR4. Both stereoisomers of naloxone suppressed opioid induced hyperalgesia in wild-type control, TLR4 mutant, and TLR4 null mice. Collectively, our data suggest that TLR4 is not required for opioid-induced analgesic tolerance, hyperalgesia, or physical dependence.	[Mattioli, Theresa Alexandra; Nicol, Chris J. B.; Milne, Brian; Cahill, Catherine M.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Leduc-Pessah, Heather; Trang, Tuan] Univ Calgary, Hotchkiss Brain Inst, Dept Comparat Biol & Expt Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Skelhorne-Gross, Graham; Nicol, Chris J. B.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Skelhorne-Gross, Graham; Nicol, Chris J. B.] Queens Univ, Canc Res Inst, Canc Biol & Genet Div, Kingston, ON, Canada; [Milne, Brian] Queens Univ, Dept Anaesthesiol & Perioperat Med, Kingston, ON, Canada; [Cahill, Catherine M.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA	Queens University - Canada; University of Calgary; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of California System; University of California Irvine	Cahill, CM (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	cmcahill@uci.edu	Cahill, Catherine M/J-6524-2019; Leduc-Pessah, Heather/HCH-2964-2022		Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation; National Sciences and Engineering Research Council (NSERC); Ontario Graduate Scholarship (OGS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Foundation for Innovation awarded to CMC, and from the National Sciences and Engineering Research Council (NSERC) awarded to TAM. TT was supported by grants from NSERC and the Canadian Foundation for Innovation. GSG was supported in part by an Ontario Graduate Scholarship (OGS). CMC was a Canadian Research Chair in chronic pain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELBASSET E, 1995, J NEUROSCI RES, V41, P222, DOI 10.1002/jnr.490410210; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Cheng PY, 1997, BRAIN RES, V778, P367, DOI 10.1016/S0006-8993(97)00891-3; Cicero TJ, 1996, J PHARMACOL EXP THER, V279, P767; Cook CD, 2000, PSYCHOPHARMACOLOGY, V150, P430, DOI 10.1007/s002130000453; Crain SM, 2000, BRAIN RES, V856, P227, DOI 10.1016/S0006-8993(99)02446-4; DOBRENIS K, 1995, BRAIN RES, V686, P239, DOI 10.1016/0006-8993(95)00452-V; Elmer GI, 1998, PAIN, V75, P129, DOI 10.1016/S0304-3959(97)00215-7; ERIKSSON PS, 1991, NEUROPHARMACOLOGY, V30, P1233, DOI 10.1016/0028-3908(91)90170-G; ERIKSSON PS, 1990, NEUROCHEM RES, V15, P1123, DOI 10.1007/BF01101714; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Fukagawa H, 2013, J ANESTH, V27, P93, DOI 10.1007/s00540-012-1469-4; Hamann SR, 2004, RECEPTOR CHANNEL, V10, P73, DOI 10.1080/10606820490464334; Hameed H, 2010, CURR PAIN HEADACHE R, V14, P96, DOI 10.1007/s11916-010-0093-y; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018190; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kest B, 1999, J PHARMACOL EXP THER, V289, P1370; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu L, 2011, BRAIN BEHAV IMMUN, V25, P1223, DOI 10.1016/j.bbi.2011.03.016; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mattioli TAM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-22; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Mogil JS, 1996, J PHARMACOL EXP THER, V276, P532; Peckham EM, 2005, BRAIN RES, V1058, P137, DOI 10.1016/j.brainres.2005.07.060; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raghavendra V, 2004, NEUROPSYCHOPHARMACOL, V29, P327, DOI 10.1038/sj.npp.1300315; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rivat C, 2014, BRAIN BEHAV IMMUN, V38, P38, DOI 10.1016/j.bbi.2013.11.010; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; SEMENOVA S, 1995, PHARMACOL BIOCHEM BE, V50, P17, DOI 10.1016/0091-3057(94)00221-4; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Terner JM, 2006, PAIN, V122, P90, DOI 10.1016/j.pain.2006.01.019; Trang T, 2006, PAIN, V126, P256, DOI 10.1016/j.pain.2006.07.008; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wu HE, 2007, EUR J PHARMACOL, V571, P145, DOI 10.1016/j.ejphar.2007.06.012; Yoon SY, 2012, NEUROSCIENCE, V221, P214, DOI 10.1016/j.neuroscience.2012.06.024; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063	55	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97361	10.1371/journal.pone.0097361	http://dx.doi.org/10.1371/journal.pone.0097361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824631	gold, Green Published			2022-12-25	WOS:000336369200103
J	Sarkar, S; Zhang, L; Subramaniam, P; Lee, KB; Garfunkel, E; Strickland, PAO; Mainelis, G; Lioy, PJ; Tetley, TD; Chung, KF; Zhang, JF; Ryan, M; Porter, A; Schwander, S				Sarkar, Srijata; Zhang, Lin; Subramaniam, Prasad; Lee, Ki-Bum; Garfunkel, Eric; Strickland, Pamela A. Ohman; Mainelis, Gediminas; Lioy, Paul J.; Tetley, Teresa D.; Chung, Kian Fan; Zhang, Junfeng; Ryan, Mary; Porter, Alex; Schwander, Stephan			Variability in Bioreactivity Linked to Changes in Size and Zeta Potential of Diesel Exhaust Particles in Human Immune Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; PARTICULATE MATTER; ALVEOLAR MACROPHAGES; INFLAMMATORY MEDIATORS; ULTRAFINE PARTICLES; AIR-POLLUTION; INFECTION; CYTOKINE; SUPPRESSION; INHALATION	Acting as fuel combustion catalysts to increase fuel economy, cerium dioxide (ceria, CeO2) nanoparticles have been used in Europe as diesel fuel additives (Envirox (TM)). We attempted to examine the effects of particles emitted from a diesel engine burning either diesel (diesel exhaust particles, DEP) or diesel doped with various concentrations of CeO2 (DEP-Env) on innate immune responses in THP-1 and primary human peripheral blood mononuclear cells (PBMC). Batches of DEP and DEP-Env were obtained on three separate occasions using identical collection and extraction protocols with the aim of determining the reproducibility of particles generated at different times. However, we observed significant differences in size and surface charge (zeta potential) of the DEP and DEP-Env across the three batches. We also observed that exposure of THP-1 cells and PBMC to identical concentrations of DEP and DEP-Env from the three batches resulted in statistically significant differences in bioreactivity as determined by IL-1 beta, TNF-alpha, IL-6, IFN-gamma, and IL-12p40 mRNA (by qRT-PCR) and protein expression (by ELISPOT assays). Importantly, bioreactivity was noted in very tight ranges of DEP size (60 to 120 nm) and zeta potential (-37 to -41 mV). Thus, these physical properties of DEP and DEP-Env were found to be the primary determinants of the bioreactivity measured in this study. Our findings also point to the potential risk of over-or under-estimation of expected bioreactivity effects (and by inference of public health risks) from bulk DEP use without taking into account potential batch-to-batch variations in physical (and possibly chemical) properties.	[Sarkar, Srijata; Zhang, Lin; Schwander, Stephan] Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA; [Subramaniam, Prasad; Lee, Ki-Bum; Garfunkel, Eric] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Strickland, Pamela A. Ohman] Rutgers Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Mainelis, Gediminas] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; [Mainelis, Gediminas; Lioy, Paul J.; Schwander, Stephan] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Tetley, Teresa D.; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tetley, Teresa D.; Chung, Kian Fan] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Ryan, Mary] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Ryan, Mary] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Schwander, Stephan] Rutgers Sch Publ Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA; [Lioy, Paul J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Imperial College London; Duke University; Duke University; Imperial College London; Imperial College London; University of London; University College London; Rutgers State University New Brunswick; Rutgers State University Medical Center	Schwander, S (corresponding author), Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA.	schwansk@sph.rutgers.edu	Lioy, Paul J/F-6148-2011; Lee, Ki-Bum/G-7503-2015; Tetley, Teresa D/B-3288-2016; Mainelis, Gediminas/A-9340-2013; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019; Subramaniam, Prasad/C-1746-2015	Mainelis, Gediminas/0000-0002-5837-0413; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Subramaniam, Prasad/0000-0002-4460-3773; LEE, Ki-Bum/0000-0002-8164-0047	US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials [EPA-G2008-STRAT-R1]; NIEHS [R01ES020382-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020382] Funding Source: NIH RePORTER	US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: Joint US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials (EPA-G2008-STRAT-R1) and NIEHS R01ES020382-02 (S. Schwander). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amakawa K, 2003, EXP LUNG RES, V29, P149, DOI 10.1080/01902140303770; Bayram H, 1998, AM J RESP CELL MOL, V18, P441, DOI 10.1165/ajrcmb.18.3.2882; Becker S, 1999, J TOXICOL ENV HEAL A, V57, P445, DOI 10.1080/009841099157539; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Cassee FR, 2012, ENVIRON RES, V115, P1, DOI 10.1016/j.envres.2012.03.004; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001; Finkelman FD, 2004, J IMMUNOL, V172, P3808, DOI 10.4049/jimmunol.172.6.3808; Furuyama A, 2009, ARCH TOXICOL, V83, P429, DOI 10.1007/s00204-008-0371-1; Gillespie P, 2013, NEUROTOXICOLOGY, V36, P112, DOI 10.1016/j.neuro.2011.10.006; Health Effects Institute (HEI), 2001, EV HUM HLTH RISK CER; Hiramatsu K, 2005, EXP LUNG RES, V31, P405, DOI 10.1080/01902140590918786; Jung HJ, 2005, COMBUST FLAME, V142, P276, DOI 10.1016/j.combustflame.2004.11.015; Katterman ME, 2007, CHEMOSPHERE, V66, P567, DOI 10.1016/j.chemosphere.2006.05.037; Kreyling WG, 2013, ACCOUNTS CHEM RES, V46, P714, DOI 10.1021/ar300043r; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Manchester-Neesvig JB, 2003, J AIR WASTE MANAGE, V53, P1065, DOI 10.1080/10473289.2003.10466265; Mundandhara SD, 2006, TOXICOL IN VITRO, V20, P614, DOI 10.1016/j.tiv.2005.10.018; Ohtani T, 2005, J IMMUNOL, V174, P2412, DOI 10.4049/jimmunol.174.4.2412; Pacheco KA, 2001, CLIN EXP IMMUNOL, V126, P374, DOI 10.1046/j.1365-2249.2001.01698.x; Park B, 2008, INHAL TOXICOL, V20, P547, DOI [10.1080/08958370801915309, 10.1080/08958370801915309 ]; Park Barry, 2007, Part Fibre Toxicol, V4, P12, DOI 10.1186/1743-8977-4-12; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901; Sawyer K, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037019; Saxena RK, 2003, TOXICOL SCI, V73, P66, DOI 10.1093/toxsci/kfg048; Seagrave J, 2004, INHAL TOXICOL, V16, P93, DOI 10.1080/08958370490443178; Totlandsdal AI, 2013, ENVIRON TOXICOL, DOI [10.1002/tox, DOI 10.1002/T0X]; United States Pharmacopia, 2011, BACT END, P78; Veronesi B, 2002, TOXICOL APPL PHARM, V178, P144, DOI 10.1006/taap.2001.9341; Vogel CFA, 2005, ENVIRON HEALTH PERSP, V113, P1536, DOI 10.1289/ehp.8094; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zhang JF, 2013, ENVIRON SCI TECHNOL, V47, P13077, DOI 10.1021/es402140u; Zhao JZ, 2013, OCCUP ENVIRON MED, V70, P426, DOI 10.1136/oemed-2012-100864	37	8	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97304	10.1371/journal.pone.0097304	http://dx.doi.org/10.1371/journal.pone.0097304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825358	Green Published, gold			2022-12-25	WOS:000336369200091
J	Spyridaki, K; Matsoukas, MT; Cordomi, A; Gkountelias, K; Papadokostaki, M; Mavromoustakos, T; Logothetis, DE; Margioris, AN; Pardo, L; Liapakis, G				Spyridaki, Katerina; Matsoukas, Minos-Timotheos; Cordomi, Arnau; Gkountelias, Kostas; Papadokostaki, Maria; Mavromoustakos, Thomas; Logothetis, Diomedes E.; Margioris, Andrew N.; Pardo, Leonardo; Liapakis, George			Structural-Functional Analysis of the Third Transmembrane Domain of the Corticotropin-releasing Factor Type 1 Receptor ROLE IN ACTIVATION AND ALLOSTERIC ANTAGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; SCANNING MUTAGENESIS; BINDING; FAMILY; ASTRESSIN; ALIGNMENT; UROCORTIN; RESIDUES; PEPTIDE	The corticotropin-releasing factor (CRF) type 1 receptor (CRF1R) for the 41-amino acid peptide CRF is a class B G protein-coupledreceptor, which plays a key role in the response of our body to stressful stimuli and the maintenance of homeostasis by regulating neural and endocrine functions. CRF and related peptides, such as sauvagine, bind to the extracellular regions of CRF1R and activate the receptor. In contrast, small nonpeptide antagonists, which are effective against stress-related disorders, such as depression and anxiety, have been proposed to interact with the helical transmembrane domains (TMs) of CRF1R and allosterically antagonize peptide binding and receptor activation. Here, we aimed to elucidate the role of the third TM(TM3) in the molecular mechanisms underlying activation of CRF1R. TM3 was selected because its tilted orientation, relative to the membrane, allows its residues to establish key interactions with ligands, other TM helices, and the G protein. Using a combination of pharmacological, biochemical, and computational approaches, we found that Phe-203(3.40) and Gly-210(3.47) in TM3 play an important role in receptor activation. Our experimental findings also suggest that Phe-203(3.40) interacts with nonpeptide antagonists.	[Spyridaki, Katerina; Gkountelias, Kostas; Papadokostaki, Maria; Liapakis, George] Univ Crete, Dept Pharmacol, Sch Med, Iraklion 71003, Greece; [Margioris, Andrew N.] Univ Crete, Dept Clin Chem, Sch Med, Iraklion 71003, Greece; [Matsoukas, Minos-Timotheos; Cordomi, Arnau; Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Fac Med, Bellaterra 08193, Spain; [Mavromoustakos, Thomas] Univ Athens, Dept Chem, Organ Chem Lab, Athens 11571, Greece; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of Crete; University of Crete; Autonomous University of Barcelona; National & Kapodistrian University of Athens; Virginia Commonwealth University	Liapakis, G (corresponding author), Univ Crete, Dept Pharmacol, Sch Med, Voutes 71003, Crete, Greece.	liapakis@med.uoc.gr	Mavromoustakos, Thomas/C-4696-2017; Matsoukas, Minos-Timotheos/B-8746-2012; Cordomí, Arnau/A-1686-2009	Mavromoustakos, Thomas/0000-0001-5309-992X; Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Cordomí, Arnau/0000-0002-3848-2928; Pardo, Leonardo/0000-0003-1778-7420	National Alliance for Research on Schizophrenia and Depression; Greek Ministry of Health; Ministerio de Ciencia e Innovacion [SAF2013-48271-C2-2-R]; ISCIII	National Alliance for Research on Schizophrenia and Depression(NARSAD); Greek Ministry of Health(Greek Ministry of Development-GSRT); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ISCIII(Instituto de Salud Carlos III)	This work was supported in part by a National Alliance for Research on Schizophrenia and Depression grant (to G. L.), a grant from the Greek Ministry of Health (to G. L.), and Grant SAF2013-48271-C2-2-R from Ministerio de Ciencia e Innovacion (to L. P.).; Recipient of a contract grant from ISCIII.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Ersoy BA, 2012, NAT CHEM BIOL, V8, P725, DOI [10.1038/nchembio.1008, 10.1038/NCHEMBIO.1008]; George L, 2012, CURR PHARM DESIGN, V18, P175, DOI 10.2174/138161212799040529; Gkountelias K, 2010, MOL PHARMACOL, V78, P785, DOI 10.1124/mol.110.065474; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Grigoriadis Dimitri E., 2001, Current Medicinal Chemistry - Central Nervous System Agents, V1, P63, DOI 10.2174/1568015013358734; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Liapakis G, 2011, CURR MED CHEM, V18, P2583, DOI 10.2174/092986711795933704; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perlman JH, 1996, BIOCHEMISTRY-US, V35, P7643, DOI 10.1021/bi952202r; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WINSLOW JT, 1989, PHARMACOL BIOCHEM BE, V32, P919, DOI 10.1016/0091-3057(89)90059-2; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	31	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18966	18977		10.1074/jbc.M113.544460	http://dx.doi.org/10.1074/jbc.M113.544460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838244	Green Published, hybrid			2022-12-25	WOS:000339062900029
J	Aghajanian, H; Choi, C; Ho, VC; Gupta, M; Singh, MK; Epstein, JA				Aghajanian, Haig; Choi, Connie; Ho, Vivienne C.; Gupta, Mudit; Singh, Manvendra K.; Epstein, Jonathan A.			Semaphorin 3d and Semaphorin 3e Direct Endothelial Motility through Distinct Molecular Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE COLLAPSE; VASCULAR DEVELOPMENT; CANCER CELLS; ANGIOGENESIS; NEUROPILIN-1; BRAIN; ATTRACTION; INHIBITION; EXPRESSION; RECEPTORS	Class 3 semaphorins were initially described as axonal growth cone guidance molecules that signal through plexin and neuropilin coreceptors and since then have been established to be regulators of vascular development. Semaphorin 3e (Sema3e) has been shown previously to repel endothelial cells and is the only class 3 semaphorin known to be capable of signaling via a plexin receptor without a neuropilin coreceptor. Sema3e signals through plexin D1 (Plxnd1) to regulate vascular patterning by modulating the cytoskeleton and focal adhesion structures. We showed recently that semaphorin 3d (Sema3d) mediates endothelial cell repulsion and pulmonary vein patterning during embryogenesis. Here we show that Sema3d and Sema3e affect human umbilical vein endothelial cells similarly but through distinct molecular signaling pathways. Time-lapse imaging studies show that both Sema3d and Sema3e can inhibit cell motility and migration, and tube formation assays indicate that both can impede tubulogenesis. Endothelial cells incubated with either Sema3d or Sema3e demonstrate a loss of actin stress fibers and focal adhesions. However, the addition of neuropilin 1 (Nrp1)-blocking antibody or siRNA knockdown of Nrp1 inhibits Sema3d-mediated, but not Sema3e-mediated, cytoskeletal reorganization, and siRNA knockdown of Nrp1 abrogates Sema3d-mediated, but not Sema3e-mediated, inhibition of tubulogenesis. On the other hand, endothelial cells deficient in Plxnd1 are resistant to endothelial repulsion mediated by Sema3e but not Sema3d. Unlike Sema3e, Sema3d incubation results in phosphorylation of Akt in human umbilical vein endothelial cells, and inhibition of the PI3K/Akt pathway blocks the endothelial guidance and cytoskeletal reorganization functions of Sema3d but not Sema3e.	Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Epstein, JA (corresponding author), Smilow Translat Res Ctr 9-105,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	epsteinj@upenn.edu		Aghajanian, Haig/0000-0002-8317-0157; Epstein, Jonathan/0000-0001-8637-4465; Singh, Manvendra K./0000-0002-2884-0074	National Institutes of Health [R01HL118768]; American Heart Association [13PRE16940111]; Spain Fund for Cardiovascular Research; W. W. Smith endowed chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Spain Fund for Cardiovascular Research; W. W. Smith endowed chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL118768 (to J. A. E.). This work was also supported by American Heart Association Grant 13PRE16940111 (to H. A.), by the Spain Fund for Cardiovascular Research (to J. A. E.), and by the W. W. Smith endowed chair (to J. A. E.).	Atwal JK, 2003, J NEUROSCI, V23, P7602; Auerbach R, 1997, AM J PATHOL, V151, P1183; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; BOUGERET C, 1992, J IMMUNOL, V148, P318; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; Feiner L, 2001, DEVELOPMENT, V128, P3061; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Meadows SM, 2012, CIRC RES, V110, P34, DOI 10.1161/CIRCRESAHA.111.249847; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Parker MW, 2013, J MOL BIOL, V425, P4405, DOI 10.1016/j.jmb.2013.07.017; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Sabag AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042912; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yamamizu K, 2011, CIRC J, V75, P253, DOI 10.1253/circj.CJ-10-0915; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	34	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					17971	17979		10.1074/jbc.M113.544833	http://dx.doi.org/10.1074/jbc.M113.544833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825896	hybrid, Green Published			2022-12-25	WOS:000338042000002
J	Pasqualetti, V; Altomare, A; Guarino, MPL; Locato, V; Cocca, S; Cimini, S; Palma, R; Alloni, R; De Gara, L; Cicala, M				Pasqualetti, Valentina; Altomare, Annamaria; Guarino, Michele Pier Luca; Locato, Vittoria; Cocca, Silvia; Cimini, Sara; Palma, Rossella; Alloni, Rossana; De Gara, Laura; Cicala, Michele			Antioxidant Activity of Inulin and Its Role in the Prevention of Human Colonic Muscle Cell Impairment Induced by Lipopolysaccharide Mucosal Exposure	PLOS ONE			English	Article							IN-VITRO; FRUCTO-OLIGOSACCHARIDES; OXIDATIVE STRESS; NITRIC-OXIDE; TUMOR-CELLS; CONTRACTILITY; PREBIOTICS; ACID; OLIGOFRUCTOSE; FERMENTATION	Background: Fructans, such as inulin, are dietary fibers which stimulate gastro-intestinal (GI) function acting as prebiotics. Lipopolysaccharide (LPS) impairs GI motility, through production of reactive oxygen species. The antioxidant activity of various fructans was tested and the protective effect of inulin on colonic smooth muscle cell (SMC) impairment, induced by exposure of human mucosa to LPS, was assessed in an ex vivo experimental model. Methods: The antioxidant capacity of fructans was measured in an in vitro system that simulates cooking and digestion processes. Human colonic mucosa and submucosa, obtained from disease-free margins of resected segments for cancer, were sealed between two chambers, with the mucosal side facing upwards with Krebs solution with or without purified LPS from a pathogenic strain of Escherichia coli (O111:B4) and inulin (Frutafit IQ), and the submucosal side facing downwards into Krebs solution. The solutions on the submucosal side were collected following mucosal exposure to Krebs in the absence (N-undernatant) or presence of LPS (LPS-undernatant) or LPS+ inulin (LPS+INU-undernatant). Undernatants were tested for their antioxidant activity and the effects on SMCs contractility. Inulin protective effects on mucosa and submucosa layers were assessed measuring the protein oxidation level in the experimental conditions analyzed. Results: Antioxidant activity of inulin, which was significantly higher compared to simple sugars, remained unaltered despite cooking and digestion processes. Inulin protected the mucosal and submucosal layers against protein oxidation. Following exposure to LPS-undernatant, a significant decrease in maximal acetylcholine (Ach)-induced contraction was observed when compared to the contraction induced in cells incubated with the N-undernatant (4 +/- 1% vs 25 +/- 5% respectively, P<0.005) and this effect was completely prevented by pre-incubation of LPS with Inulin (35 +/- 5%). Conclusions: Inulin protects the human colon mucosa from LPS-induced damage and this effect appears to be related to the protective effect of inulin against LPS-induced oxidative stress.	[Pasqualetti, Valentina; Locato, Vittoria; Cimini, Sara; De Gara, Laura] Univ Campus Biomed Rome, Food Sci & Human Nutr Unit, Rome, Italy; [Altomare, Annamaria; Guarino, Michele Pier Luca; Cocca, Silvia; Palma, Rossella; Cicala, Michele] Univ Campus Biomed Rome, Gastroenterol Unit, Rome, Italy; [Alloni, Rossana] Univ Campus Biomed Rome, Surg Unit, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy	De Gara, L (corresponding author), Univ Campus Biomed Rome, Food Sci & Human Nutr Unit, Rome, Italy.	l.degara@unicampus.it	Locato, Vittoria/K-8747-2016; Campos, Gustavo R C Ribeiro/O-3981-2017; De Gara, Laura/Y-8420-2019; cimini, sara/ABC-3518-2020; Cicala, Michele/AAC-1681-2019	Locato, Vittoria/0000-0003-0267-5039; Cicala, Michele/0000-0002-5370-2642; Pasqualetti, Valentina/0000-0002-8558-0731; De Gara, Laura/0000-0001-5938-7113; Altomare, Annamaria/0000-0001-8630-7836; CIMINI, Sara/0000-0002-0139-0755; Guarino, Michele Pier Luca/0000-0003-3325-9425; ALLONI, ROSSANA/0000-0001-8877-2141; Cocca, Silvia/0000-0002-0642-8054	University Campus Bio-Medico of Rome	University Campus Bio-Medico of Rome	University Campus Bio-Medico of Rome provided internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles MS, 1996, BRIT J NUTR, V76, P211, DOI 10.1079/BJN19960026; Ammoscato F, 2013, NEUROGASTROENT MOTIL, V25, P984, DOI 10.1111/nmo.12232; Arrizon J, 2010, FOOD CHEM, V122, P123, DOI 10.1016/j.foodchem.2010.02.028; Avila-Fernandez A, 2011, FOOD CHEM, V129, P380, DOI 10.1016/j.foodchem.2011.04.088; Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; Bercik P, 2004, GASTROENTEROLOGY, V127, P179, DOI 10.1053/j.gastro.2004.04.006; Bouhnik Y, 1996, NUTR CANCER, V26, P21, DOI 10.1080/01635589609514459; Bouhnik Y, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-42; Buddington RK, 1996, AM J CLIN NUTR, V63, P709, DOI 10.1093/ajcn/63.5.709; Busserolles J, 2003, J NUTR, V133, P1903, DOI 10.1093/jn/133.6.1903; Cao W, 2005, AM J PHYSIOL-CELL PH, V289, pC1408, DOI 10.1152/ajpcell.00073.2005; Cullen JJ, 1999, SURGERY, V125, P339, DOI 10.1016/S0039-6060(99)70246-1; De Winter BY, 2010, WORLD J GASTROENTERO, V16, P5523, DOI 10.3748/wjg.v16.i44.5523; De Winter BY, 2005, NEUROGASTROENT MOTIL, V17, P251, DOI 10.1111/j.1365-2982.2004.00618.x; Euler AR, 2005, J PEDIATR GASTR NUTR, V40, P157, DOI 10.1097/00005176-200502000-00014; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Guarino MPL, 2013, DIGEST LIVER DIS, V45, P1011, DOI 10.1016/j.dld.2013.06.001; Guarner F, 2005, BRIT J NUTR, V93, pS61, DOI 10.1079/BJN20041345; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Han JS, 2004, J AGR FOOD CHEM, V52, P6516, DOI 10.1021/jf0493270; Hidaka H, 1991, BIFIDOBACT MICROFLOR, V10, P65, DOI DOI 10.12938/BIFIDUS1982.10.1_65; Kelly G, 2009, ALTERN MED REV, V14, P36; Kelly G, 2008, ALTERN MED REV, V13, P315; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Kroyer G, 2010, J VERBRAUCH LEBENSM, V5, P225, DOI 10.1007/s00003-010-0557-3; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Li XM, 2007, J PHARMACEUT BIOMED, V43, P364, DOI 10.1016/j.jpba.2006.06.041; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Locato V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00152; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mellado-Mojica E, 2012, J AGR FOOD CHEM, V60, P11704, DOI 10.1021/jf303332n; Munjal U, 2009, BRIT J NUTR, V102, P663, DOI 10.1017/S0007114509274770; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rebollar E, 2002, NEUROGASTROENT MOTIL, V14, P633, DOI 10.1046/j.1365-2982.2002.00364.x; Rishi P, 2009, FEMS MICROBIOL ECOL, V69, P222, DOI 10.1111/j.1574-6941.2009.00703.x; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Roman C, 1984, GASTROINTESTINAL MOT, P549; RUMESSEN JJ, 1990, AM J CLIN NUTR, V52, P675, DOI 10.1093/ajcn/52.4.675; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sayar S, 2005, J AGR FOOD CHEM, V53, P8797, DOI 10.1021/jf051380g; Serpen A, 2008, J CEREAL SCI, V48, P816, DOI 10.1016/j.jcs.2008.06.002; Shi XZ, 2003, GASTROENTEROLOGY, V124, P1369, DOI 10.1016/S0016-5085(03)00263-4; Stoyanova S, 2011, INT J FOOD SCI NUTR, V62, P207, DOI 10.3109/09637486.2010.523416; Takakura K, 1997, ANESTHESIOLOGY, V87, P652, DOI 10.1097/00000542-199709000-00027; Tattoli I, 2004, DIGEST LIVER DIS, V36, P735, DOI 10.1016/j.dld.2004.06.016; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; Van den Ende W, 2011, TRENDS FOOD SCI TECH, V22, P689, DOI 10.1016/j.tifs.2011.07.005; Wechsung E, 1996, Verh K Acad Geneeskd Belg, V58, P711	50	46	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98031	10.1371/journal.pone.0098031	http://dx.doi.org/10.1371/journal.pone.0098031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837182	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800099
J	Comas, M; Arrospide, A; Mar, J; Sala, M; Vilaprinyo, E; Hernandez, C; Cots, F; Martinez, J; Castells, X				Comas, Merce; Arrospide, Arantzazu; Mar, Javier; Sala, Maria; Vilaprinyo, Ester; Hernandez, Cristina; Cots, Francesc; Martinez, Juan; Castells, Xavier			Budget Impact Analysis of Switching to Digital Mammography in a Population-Based Breast Cancer Screening Program: A Discrete Event Simulation Model	PLOS ONE			English	Article							FILM MAMMOGRAPHY; COST-EFFECTIVENESS; IMPLEMENTATION; TRANSITION; REDUCTION; INTERVAL	Objective: To assess the budgetary impact of switching from screen-film mammography to full-field digital mammography in a population-based breast cancer screening program. Methods: A discrete-event simulation model was built to reproduce the breast cancer screening process (biennial mammographic screening of women aged 50 to 69 years) combined with the natural history of breast cancer. The simulation started with 100,000 women and, during a 20-year simulation horizon, new women were dynamically entered according to the aging of the Spanish population. Data on screening were obtained from Spanish breast cancer screening programs. Data on the natural history of breast cancer were based on US data adapted to our population. A budget impact analysis comparing digital with screen-film screening mammography was performed in a sample of 2,000 simulation runs. A sensitivity analysis was performed for crucial screening-related parameters. Distinct scenarios for recall and detection rates were compared. Results: Statistically significant savings were found for overall costs, treatment costs and the costs of additional tests in the long term. The overall cost saving was 1,115,857(sic) (95%CI from 932,147 to 1,299,567) in the 10th year and 2,866,124(sic) (95% CI from 2,492,610 to 3,239,638) in the 20th year, representing 4.5% and 8.1% of the overall cost associated with screen-film mammography. The sensitivity analysis showed net savings in the long term. Conclusions: Switching to digital mammography in a population-based breast cancer screening program saves long-term budget expense, in addition to providing technical advantages. Our results were consistent across distinct scenarios representing the different results obtained in European breast cancer screening programs.	[Comas, Merce; Sala, Maria; Hernandez, Cristina; Castells, Xavier] Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Comas, Merce; Sala, Maria; Hernandez, Cristina; Cots, Francesc; Castells, Xavier] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Comas, Merce; Arrospide, Arantzazu; Mar, Javier; Sala, Maria; Vilaprinyo, Ester; Cots, Francesc; Castells, Xavier] Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain; [Arrospide, Arantzazu; Mar, Javier] Hosp Alto Deba, Gipuzkoa Oeste Res Unit, Arrasate Mondragon, Spain; [Vilaprinyo, Ester] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida, Spain; [Cots, Francesc] Hosp del Mar, Management Control Dept, Barcelona, Spain; [Martinez, Juan] Hosp del Mar, Dept Radiol, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat de Lleida; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Comas, M (corresponding author), Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain.	mcomas@parcdesalutmar.cat	Castells, Xavier/S-7798-2016; Serrano, Merce Comas/O-3825-2014; Sala, Maria/H-2562-2013; Vilaprinyo, Ester/A-6702-2010; Serra, Maria Sala/O-9420-2019	Castells, Xavier/0000-0002-2528-0382; Serrano, Merce Comas/0000-0003-1926-2740; Sala, Maria/0000-0002-9955-8746; Vilaprinyo, Ester/0000-0002-5787-5890; Serra, Maria Sala/0000-0002-9955-8746; Sala Serra, Maria/0000-0002-5516-5967; Arrospide, Arantzazu/0000-0003-3537-6588; Cots, Francesc/0000-0003-0238-8902	Health Ministry of Spain (Fondo de Investigacion Sanitaria) [PI07/90357]	Health Ministry of Spain (Fondo de Investigacion Sanitaria)	This was supported by grants from the Health Ministry of Spain (Fondo de Investigacion Sanitaria PI07/90357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce N, 2010, ANN ONCOL, V21, piii43; Baltussen R, 1999, PHARMACOECONOMICS, V16, P449, DOI 10.2165/00019053-199916050-00003; Bluekens AMJ, 2012, RADIOLOGY, V265, P707, DOI 10.1148/radiol.12111461; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Ciatto S, 2006, EUR J RADIOL, V57, P69, DOI 10.1016/j.ejrad.2005.08.010; Corral J, 2009, GAC SANIT, V23, P189; Cots F, 2012, GEST EVALUACION COST, V13, P369; Domingo L, 2011, EUR RADIOL, V21, P2020, DOI 10.1007/s00330-011-2143-1; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Glynn CG, 2011, RADIOLOGY, V260, P664, DOI 10.1148/radiol.11110159; Hoff SR, 2012, RADIOLOGY, V264, P378, DOI 10.1148/radiol.12112074; Iared W, 2011, SAO PAULO MED J, V129, P250, DOI 10.1590/S1516-31802011000400009; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Lee SJ, 1998, J AM STAT ASSOC, V93, P1271, DOI 10.2307/2670042; Mar J, 2010, VALUE HEALTH, V13, P69, DOI 10.1111/j.1524-4733.2009.00655.x; Martinez-Cantarero JF, 2006, REV ESP EC SALUD, V5, P230; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Mauskopf Josephine A, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P65, DOI 10.1586/14737167.5.1.65; Nederend J, 2012, ANN ONCOL, V23, P3098, DOI 10.1093/annonc/mds146; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Roman R, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052639; Rue M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-326; Sala M, 2011, RADIOLOGY, V258, P388, DOI 10.1148/radiol.10100874; Sala M, 2009, RADIOLOGY, V252, P31, DOI 10.1148/radiol.2521080696; Sarriugarte G, 2012, ESTUDIO COSTES PROGR; Skaane P, 2009, ACTA RADIOL, V50, P3, DOI 10.1080/02841850802563269; Timmers JM, 2011, EUR J PUBLIC HLTH; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; Trueman P, 2001, PHARMACOECONOMICS, V19, P609, DOI 10.2165/00019053-200119060-00001; van de Wetering G, 2013, EUR J HEALTH ECON, V14, P911, DOI 10.1007/s10198-012-0435-2; Vilaprinyo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030157; Vilaprinyo E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-98; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; von Karsa L., 2008, CANC SCREENING EUROP; Wang SH, 2009, AUST NZ J PUBL HEAL, V33, P430, DOI 10.1111/j.1753-6405.2009.00424.x; White J, 2000, J NATL CANCER I, V92, P442, DOI 10.1093/jnci/92.6.442	38	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97459	10.1371/journal.pone.0097459	http://dx.doi.org/10.1371/journal.pone.0097459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24832200	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500062
J	Fourati, Z; Kolesnikova, O; Back, R; Keller, J; Charenton, C; Taverniti, V; Plesse, CG; Lazar, N; Durand, D; van Tilbeurgh, H; Seraphin, B; Graille, M				Fourati, Zaineb; Kolesnikova, Olga; Back, Regis; Keller, Jenny; Charenton, Clement; Taverniti, Valerio; Plesse, Claudine Gaudon; Lazar, Noureddine; Durand, Dominique; van Tilbeurgh, Herman; Seraphin, Bertrand; Graille, Marc			The C-Terminal Domain from S. cerevisiae Pat1 Displays Two Conserved Regions Involved in Decapping Factor Recruitment	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SM-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; LSM1-7-PAT1 COMPLEX; PROCESSING-BODIES; DIFFRACTION DATA; YEAST; DEADENYLATION; DEGRADATION; MULTIPLE	Eukaryotic mRNA decay is a highly regulated process allowing cells to rapidly modulate protein production in response to internal and environmental cues. Mature translatable eukaryotic mRNAs are protected from fast and uncontrolled degradation in the cytoplasm by two cis-acting stability determinants: a methylguanosine (m(7)G) cap and a poly(A) tail at their 5' and 3' extremities, respectively. The hydrolysis of the m(7)G cap structure, known as decapping, is performed by the complex composed of the Dcp2 catalytic subunit and its partner Dcp1. The Dcp1-Dcp2 decapping complex has a low intrinsic activity and requires accessory factors to be fully active. Among these factors, Pat1 is considered to be a central scaffolding protein involved in Dcp2 activation but also in inhibition of translation initiation. Here, we present the structural and functional study of the C-terminal domain from S. cerevisiae Pat1 protein. We have identified two conserved and functionally important regions located at both extremities of the domain. The first region is involved in binding to Lsm1-7 complex. The second patch is specific for fungal proteins and is responsible for Pat1 interaction with Edc3. These observations support the plasticity of the protein interaction network involved in mRNA decay and show that evolution has extended the C-terminal alpha-helical domain from fungal Pat1 proteins to generate a new binding platform for protein partners.	[Fourati, Zaineb; Back, Regis; Charenton, Clement; Graille, Marc] Ecole Polytech, CNRS, UMR 7654, Biochim Lab, F-91128 Palaiseau, France; [Fourati, Zaineb; Keller, Jenny; Lazar, Noureddine; Durand, Dominique; van Tilbeurgh, Herman; Graille, Marc] Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France; [Kolesnikova, Olga; Taverniti, Valerio; Plesse, Claudine Gaudon; Seraphin, Bertrand] Univ Strasbourg, INSERM, U964, CNRS,UMR 7104,IGBMC,Equipe Labellisee La Ligue, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Seraphin, B (corresponding author), Univ Strasbourg, INSERM, U964, CNRS,UMR 7104,IGBMC,Equipe Labellisee La Ligue, Illkirch Graffenstaden, France.	seraphin@igbmc.fr; marc.graille@polytechnique.edu	Charenton, Clement/ABF-8608-2021; GRAILLE, Marc/D-3242-2014	Charenton, Clement/0000-0002-8959-7012; GRAILLE, Marc/0000-0002-7853-5852; Valerio, Taverniti/0000-0002-6233-8416; Seraphin, Bertrand/0000-0002-5168-1921; Fourati, Zaineb/0000-0002-2316-4142	Centre National pour la Recherche Scientifique; ATIP-AVENIR program; Agence Nationale pour la Recherche [ANR-11-BSV800902, ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; European Union [LSHG-CT-2005-512028]; Human Frontiers Science Program [RGP0018]; Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; INSERM; Fondation pour la Recherche Medicale (FRM); French Ministere de l'Enseignement Superieur et de la Recherche (MESR); ENS Cachan	Centre National pour la Recherche Scientifique; ATIP-AVENIR program; Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Union(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); ENS Cachan	This work was supported by the Centre National pour la Recherche Scientifique [B. S. and M. G.] including a specific support by the ATIP-AVENIR program [to M. G.], the Agence Nationale pour la Recherche [grant ANR-11-BSV800902 to B. S. and M. G., study ANR-10-LABX-0030-INRT performed under the programme Investissements d'Avenir ANR-10-IDEX-0002-02 to B. S.], the European Union Sixth Framework program "3D-Repertoire" [LSHG-CT-2005-512028 to B. S. and M. G.], the Human Frontiers Science Program [grant RGP0018 to M. G.], the Ligue Contre le Cancer (Equipe Labellisee 2014) [to B. S.], and the CERBM-IGBMC and INSERM [to B. S.]. Z.F. was supported by the Fondation pour la Recherche Medicale (FRM). C. C. holds a PhD fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche (MESR) and ENS Cachan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Braun JE, 2010, EMBO J, V29, P2368, DOI 10.1038/emboj.2010.124; Chang CT, 2014, NUCL ACIDS RES; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Chowdhury A, 2009, RNA, V15, P1837, DOI 10.1261/rna.1650109; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dong SY, 2007, MOL CELL, V25, P559, DOI 10.1016/j.molcel.2007.01.012; Dong SY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000360; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fromm SA, 2012, EMBO J, V31, P279, DOI 10.1038/emboj.2011.408; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Harigaya Y, 2010, MOL CELL BIOL, V30, P1446, DOI 10.1128/MCB.01305-09; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kolesnikova O, 2013, NUCLEIC ACIDS RES, V41, P9514, DOI 10.1093/nar/gkt607; Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; Ling SH, 2010, WILEY INTERDISCIP RE, V2, P193; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Marnef A, 2012, MOL BIOL CELL, V23, P213, DOI 10.1091/mbc.E11-05-0415; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Ozgur S, 2013, RNA BIOL, V10, P528, DOI 10.4161/rna.24086; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Rajyaguru P, 2012, MOL CELL, V45, P244, DOI 10.1016/j.molcel.2011.11.026; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwartz D, 2003, RNA, V9, P239, DOI 10.1261/rna.2171203; Sharif H, 2013, CELL REP, V5, P283, DOI 10.1016/j.celrep.2013.10.004; Sharif H, 2013, NUCLEIC ACIDS RES, V41, P8377, DOI 10.1093/nar/gkt600; SIKORSKI RS, 1989, GENETICS, V122, P19; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2009, RNA BIOL, V6, P228, DOI 10.4161/rna.6.3.8282; Tritschler F, 2009, MOL CELL, V33, P661, DOI 10.1016/j.molcel.2009.02.014; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wu D, 2013, J MED RES DEV, V2, P1; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000	70	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96828	10.1371/journal.pone.0096828	http://dx.doi.org/10.1371/journal.pone.0096828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830408	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500027
J	Tan, CL; Lui, PPY; Lee, YW; Wong, YM				Tan, Chunlai; Lui, Pauline Po Yee; Lee, Yuk Wa; Wong, Yin Mei			Scx-Transduced Tendon-Derived Stem Cells (TDSCs) Promoted Better Tendon Repair Compared to Mock-Transduced Cells in a Rat Patellar Tendon Window Injury Model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SCLERAXIS; MARROW STROMAL CELLS; BONE-MARROW; RABBIT MODEL; EXTRACELLULAR-MATRIX; MOUSE EMBRYOGENESIS; EXPRESSION; DIFFERENTIATION; TENOCYTES; HISTOLOGY	We hypothesized that the transplantation of Scx-transduced tendon-derived stem cells (TDSCs) promoted better tendon repair compared to the transplantation of mock-transduced cells. This study thus aimed to investigate the effect of Scx transduction on the expression of lineage markers in TDSCs and the effect of the resulting cell line in the promotion of tendon repair. Rat non-GFP or GFP-TDSCs were transduced with Scx or empty lentiviral vector (Mock) and selected by blasticidin. The mRNA expressions of Scx and different lineage markers were examined by qRT-PCR. The effect of the transplantation of GFP-TDSC-Scx on tendon repair was then tested in a rat unilateral patellar tendon window injury model. The transplantation of GFP-TDSC-Mock and scaffold-only served as controls. At week 2, 4 and 8 post-transplantation, the repaired patellar tendon was harvested for ex vivo fluorescent imaging, vivaCT imaging, histology, immunohistochemistry and biomechanical test. GFP-TDSC-Scx consistently showed higher expressions of most of tendon-and cartilage-related markers compared to the GFP-TDSC-Mock. However, the effect of Scx transduction on the expressions of bone-related markers was inconclusive. The transplanted GFP-TDSCs could be detected in the window wound at week 2 but not at week 4. Ectopic mineralization was detected in some samples at week 8 but there was no difference among different groups. The GFP-TDSC-Scx group only statistically significantly improved tendon repair histologically and biomechanically compared to the Scaffold-only group and the GFP-TDSC-Mock group at the early stage of tendon repair. There was significant higher expression of collagen type I in the window wound in the GFP-TDSC-Scx group compared to the other two groups at week 2. The transplantation of GFP-TDSC-Scx promoted healing at the early stage of tendon repair in a rat patellar tendon window injury model.	[Tan, Chunlai; Lee, Yuk Wa; Wong, Yin Mei] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tan, Chunlai; Lee, Yuk Wa; Wong, Yin Mei] Chinese Univ Hong Kong, Fac Med, Hong Kong Jockey Club Sports Med & Hlth Sci Ctr, Hong Kong, Hong Kong, Peoples R China; [Lui, Pauline Po Yee] Hosp Author, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lui, PPY (corresponding author), Hosp Author, Hong Kong, Hong Kong, Peoples R China.	paulinelui00@gmail.com	Tan, Chunlai/D-3038-2016; Lee, Wayne YW/H-8298-2013; Lui, Pauline Po Yee/AAU-9823-2020	Tan, Chunlai/0000-0003-0800-1190; Lee, Wayne YW/0000-0002-0486-360X; Lui, Pauline Po Yee/0000-0003-2446-6203	Research Grants Council of the Hong Kong Special Administrative Region, China [460710]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work is supported by the General Research Fund (project number: 460710) from the Research Grants Council of the Hong Kong Special Administrative Region, China (http://www.ugc.edu.hk/eng/rgc/grf/grf.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Brown D, 1999, DEVELOPMENT, V126, P4317; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chan BP, 1998, J ORTHOP RES, V16, P597, DOI 10.1002/jor.1100160512; Chen JM, 2011, TISSUE ENG PT A, V17, P2037, DOI [10.1089/ten.TEA.2010.0492, 10.1089/ten.tea.2010.0492]; Chen X, 2012, SCI REP-UK, V2, DOI 10.1038/srep00977; Crovace A, 2008, VET COMP ORTHOPAED, V21, P329, DOI 10.3415/VCOT-07-05-0050; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; He M, 2013, J PLAST SURG HAND SU, V47, P509, DOI 10.3109/2000656X.2013.789037; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369; Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448; Kawa-uchi T, 1998, J CELL BIOCHEM, V70, P468, DOI 10.1002/(SICI)1097-4644(19980915)70:4<468::AID-JCB4>3.0.CO;2-H; Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu Y, 1997, J BIOL CHEM, V272, P29880, DOI 10.1074/jbc.272.47.29880; Lui PPY, 2011, J TISSUE ENG REGEN M, V5, pE144, DOI 10.1002/term.424; Lui PPY, 2007, WOUND REPAIR REGEN, V15, P702, DOI 10.1111/j.1524-475X.2007.00276.x; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Lui PPY, TISSUE EN A IN PRESS; Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534; Ouyang HW, 2004, CELL TRANSPLANT, V13, P649, DOI 10.3727/000000004783983549; Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Rui YF, 2013, STEM CELLS DEV, V22, P1076, DOI 10.1089/scd.2012.0555; Rui YF, 2011, J ORTHOP RES, V29, P390, DOI 10.1002/jor.21218; Rui YF, 2011, CHINESE MED J-PEKING, V124, P606, DOI 10.3760/cma.j.issn.0366-6999.2011.04.022; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Sugiura F, 2004, BIOCHEM BIOPH RES CO, V316, P233, DOI 10.1016/j.bbrc.2004.02.038; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.tea.2011.0362, 10.1089/ten.TEA.2011.0362]; Tan Q, 2012, STEM CELLS DEV, V21, P790, DOI 10.1089/scd.2011.0160; Tasso R, 2009, CARCINOGENESIS, V30, P150, DOI 10.1093/carcin/bgn234; Terraz C, 2002, J BIOL CHEM, V277, P19019, DOI 10.1074/jbc.M200125200; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	51	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97453	10.1371/journal.pone.0097453	http://dx.doi.org/10.1371/journal.pone.0097453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831949	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500060
J	Hetzel, MW; Page-Sharp, M; Bala, N; Pulford, J; Betuela, I; Davis, TME; Lavu, EK				Hetzel, Manuel W.; Page-Sharp, Madhu; Bala, Nancy; Pulford, Justin; Betuela, Inoni; Davis, Timothy M. E.; Lavu, Evelyn K.			Quality of Antimalarial Drugs and Antibiotics in Papua New Guinea: A Survey of the Health Facility Supply Chain	PLOS ONE			English	Article							MALARIA CASE-MANAGEMENT; SOUTHEAST-ASIA; ANTI-MALARIALS; HPLC METHOD; PRIMAQUINE; SUBSTANDARD; MEDICINES; COUNTERFEIT; PHARMACOKINETICS; PYRIMETHAMINE	Background: Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the development of drug resistance. In the case of malaria, concerns relate to implications for the efficacy of artemisinin-based combination therapies (ACT). In Papua New Guinea (PNG), Plasmodium falciparum and P. vivax are both endemic and health facilities are the main source of treatment. ACT has been introduced as first-line treatment but other drugs, such as primaquine for the treatment of P. vivax hypnozoites, are widely available. This study investigated the quality of antimalarial drugs and selected antibiotics at all levels of the health facility supply chain in PNG. Methods and Findings: Medicines were obtained from randomly sampled health facilities and selected warehouses and hospitals across PNG and analysed for API content using validated high performance liquid chromatography (HPLC). Of 360 tablet/capsule samples from 60 providers, 9.7% (95% CI 6.9, 13.3) contained less, and 0.6% more, API than pharmacopoeial reference ranges, including 29/37 (78.4%) primaquine, 3/70 (4.3%) amodiaquine, and one sample each of quinine, artemether, sulphadoxine-pyrimethamine and amoxicillin. According to the package label, 86.5% of poor-quality samples originated from India. Poor-quality medicines were found in 48.3% of providers at all levels of the supply chain. Drug quality was unrelated to storage conditions. Conclusions: This study documents the presence of poor-quality medicines, particularly primaquine, throughout PNG. Primaquine is the only available transmission-blocking antimalarial, likely to become important to prevent the spread of artemisinin-resistant P. falciparum and eliminating P. vivax hypnozoites. The availability of poor-quality medicines reflects the lack of adequate quality control and regulatory mechanisms. Measures to stop the availability of poor-quality medicines should include limiting procurement to WHO prequalified products and implementing routine quality testing.	[Hetzel, Manuel W.; Pulford, Justin] Papua New Guinea Inst Med Res, Goroka, Ehp, Papua N Guinea; [Hetzel, Manuel W.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hetzel, Manuel W.] Univ Basel, Basel, Switzerland; [Page-Sharp, Madhu] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Bala, Nancy; Lavu, Evelyn K.] Cent Publ Hlth Lab, Boroko, Ncd, Papua N Guinea; [Pulford, Justin] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Betuela, Inoni] Papua New Guinea Inst Med Res, Madang, Mdg, Papua N Guinea; [Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia	PNG Institute Of Medical Research; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Curtin University; University of Queensland; PNG Institute Of Medical Research; University of Western Australia	Hetzel, MW (corresponding author), Papua New Guinea Inst Med Res, POB 60, Goroka, Ehp, Papua N Guinea.	manuel.hetzel@unibas.ch	Davis, Timothy ME/M-5144-2014	Hetzel, Manuel W./0000-0002-5285-3254; Pulford, Justin/0000-0003-4756-8480	Global Fund to Fight AIDS, Tuberculosis and Malaria through the Papua New Guinea National Malaria Control Program; National Health and Medical Research Council (NHMRC) of Australia [634343]; NHMRC; research fund (Forschungsfonds) of the University of Basel	Global Fund to Fight AIDS, Tuberculosis and Malaria through the Papua New Guinea National Malaria Control Program; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); research fund (Forschungsfonds) of the University of Basel	This study was financially supported by a Global Fund to Fight AIDS, Tuberculosis and Malaria round 8 grant through the Papua New Guinea National Malaria Control Program (http://www.theglobalfund.org/). The chemical assays for this study were conducted in a facility supported by National Health and Medical Research Council (NHMRC) of Australia Project Grant 634343. TMED is supported by a NHMRC Practitioner Fellowship, MWH in 2013 by the research fund (Forschungsfonds) of the University of Basel (http://www.unibas.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Ahmed M, 2011, INT J CHEM TECH RES, V3, P1037; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; Angwin A, 2014, P N G MED J IN PRESS, V56; [Anonymous], 2011, INT J PHARM BIOMED R; [Anonymous], 2012, T3 TEST TREAT TRACK; [Anonymous], QUALITY ANTIMALARIAL; [Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], COCHRANE DATABASE SY; [Anonymous], COCHRANE DATABASE SY; Arayne MS, 2010, MED CHEM RES, V19, P1043, DOI 10.1007/s00044-009-9250-4; Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Bate R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-157; Carmona-Fonseca J, 2009, AM J TROP MED HYG, V80, P188, DOI 10.4269/ajtmh.2009.80.188; Chaccour CJ, 2012, LANCET, V380, P1120, DOI 10.1016/S0140-6736(12)60649-7; Cruz AP, 2008, LAT AM J PHARM, V27, P415; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Department of Health Government of Papua New Guinea, 2012, HLTH SERVICE DELIVER; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Evans L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-203; Faucon B, 2013, WALL STREET J; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Gaudiano MC, 2006, J PHARMACEUT BIOMED, V42, P132, DOI 10.1016/j.jpba.2006.01.059; Gostin LO, 2013, JAMA-J AM MED ASSOC, V309, P1693, DOI 10.1001/jama.2013.3048; Hehonah NT, 2010, PACIFIC J MED SCI, V7, P4; Hetzel MW, 2010, PAPUA NEW GUINEA GLO; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; Kazura JW, 2012, ACTA TROP, V121, P274, DOI 10.1016/j.actatropica.2011.08.002; Kogawa AC, 2013, J CHROMATOGR SCI, V51, P919, DOI 10.1093/chromsci/bms190; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Nair A, 2011, J PHARM SCI-US, V100, P5059, DOI 10.1002/jps.22691; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Paediatric Society of Papua New Guinea, 2005, STAND TREATM COMM IL; Page-Sharp M, 2012, J CHROMATOGR B, V902, P142, DOI 10.1016/j.jchromb.2012.06.019; Papua New Guinea Department of Health, 2012, PAP NEW GUIN PHARM C; Papua New Guinea Department of Health, 2009, NAT MAL TREATM PROT; Papua New Guinea Department of Health, 2012, NAT MED FORM; Papua New Guinea Department of Health, 2005, STAND TREATM COMM IL; Phanouvong S, 2013, SE ASIAN J TROP MED, V44, P363; Phanouvong S, 2013, SE ASIAN J TROP MED, V44, P349; Pribluda VS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-202; Pulford J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-433; Pulford J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-157; Ranher SS, 2010, J ANAL CHEM+, V65, P507, DOI 10.1134/S1061934810050126; Salman S, 2011, ANTIMICROB AGENTS CH, V55, P5306, DOI 10.1128/AAC.05136-11; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; The Global Fund, 2013, MAL CONTR PAP NEW GU; United States Pharmacopeia Drug Quality and Information Program, 2007, ENS QUAL MED RES LTD; White NJ, 2013, LANCET INFECT DIS, V13, P175, DOI 10.1016/S1473-3099(12)70198-6; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2010, GUID TREATM MAL, V2nd; WHO Malaria Policy Advisory Committee and Secretariat, 2012, Malar J, V11, P424, DOI 10.1186/1475-2875-11-424; World Health Organization, 2013, WHO LIST PREQ MED PR; World Health Organization (WHO), 2006, COUNT MED	63	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96810	10.1371/journal.pone.0096810	http://dx.doi.org/10.1371/journal.pone.0096810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828338	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336857400038
J	Lindblad, AC; Rosenhall, U; Olofsson, A; Hagerman, B				Lindblad, Ann-Cathrine; Rosenhall, Ulf; Olofsson, Ake; Hagerman, Bjorn			Tinnitus and Other Auditory Problems - Occupational Noise Exposure below Risk Limits May Cause Inner Ear Dysfunction	PLOS ONE			English	Article							HAIR CELL LOSS; BLUE MOUNTAINS HEARING; OTOACOUSTIC EMISSIONS; OLDER-ADULTS; CHINCHILLAS; MUSICIANS; AMPLITUDES; DISORDERS; THRESHOLD; SYSTEM	The aim of the investigation was to study if dysfunctions associated to the cochlea or its regulatory system can be found, and possibly explain hearing problems in subjects with normal or near-normal audiograms. The design was a prospective study of subjects recruited from the general population. The included subjects were persons with auditory problems who had normal, or near-normal, pure tone hearing thresholds, who could be included in one of three subgroups: teachers, Education; people working with music, Music; and people with moderate or negligible noise exposure, Other. A fourth group included people with poorer pure tone hearing thresholds and a history of severe occupational noise, Industry. N-total = 193. The following hearing tests were used: 2 pure tone audiometry with Bekesy technique, 2 transient evoked otoacoustic emissions and distortion product otoacoustic emissions, without and with contralateral noise; 2 psychoacoustical modulation transfer function, 2 forward masking, 2 speech recognition in noise, 2 tinnitus matching. A questionnaire about occupations, noise exposure, stress/anxiety, muscular problems, medication, and heredity, was addressed to the participants. Forward masking results were significantly worse for Education and Industry than for the other groups, possibly associated to the inner hair cell area. Forward masking results were significantly correlated to louder matched tinnitus. For many subjects speech recognition in noise, left ear, did not increase in a normal way when the listening level was increased. Subjects hypersensitive to loud sound had significantly better speech recognition in noise at the lower test level than subjects not hypersensitive. Self-reported stress/anxiety was similar for all groups. In conclusion, hearing dysfunctions were found in subjects with tinnitus and other auditory problems, combined with normal or near-normal pure tone thresholds. The teachers, mostly regarded as a group exposed to noise below risk levels, had dysfunctions almost identical to those of the more exposed Industry group.	[Lindblad, Ann-Cathrine; Olofsson, Ake; Hagerman, Bjorn] Karolinska Inst, Unit Tech & Expt Audiol, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Inst, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Univ Hosp, Dept Audiol & Neurotol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lindblad, AC (corresponding author), Karolinska Inst, Unit Tech & Expt Audiol, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.		Hagerman, Björn C/H-6720-2014		AFA Insurance [T-50:05]; Swedish Council for Working Life and Social Research [20030154]	AFA Insurance; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This project was supported by AFA Insurance, T-50:05, www.afaforsakring.se; and by the Swedish Council for Working Life and Social Research (20030154), www.fasarbetsliv.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias J, 1996, ACTA OTO-LARYNGOL, V116, P534, DOI 10.3109/00016489609137885; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Berninger E, 1999, SCAND AUDIOL, V28, P117, DOI 10.1080/010503999424842; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Davis RI, 2009, EAR HEARING, V30, P628, DOI 10.1097/AUD.0b013e3181b527a8; Duan M L, 1996, Audiol Neurootol, V1, P309; Duan M L, 1996, Audiol Neurootol, V1, P320; El-Badry MM, 2007, BRAIN RES, V1134, P122, DOI 10.1016/j.brainres.2006.11.078; El-Badry MM, 2009, HEARING RES, V255, P84, DOI 10.1016/j.heares.2009.06.003; Hagerman B, 2002, INT J AUDIOL, V41, P321, DOI 10.3109/14992020209090406; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; ISO, 2000, ISO7029; *ISO, 1990, ISO1999; Jacobson M, 2003, LARYNGOSCOPE, V113, P1707, DOI 10.1097/00005537-200310000-00009; Jansen EJM, 2009, INT ARCH OCC ENV HEA, V82, P153, DOI 10.1007/s00420-008-0317-1; Kahari K, 2003, INT J AUDIOL, V42, P279, DOI 10.3109/14992020309078347; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kumar UA, 2012, NOISE HEALTH, V14, P100, DOI 10.4103/1463-1741.97252; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lindblad AC, 1999, ACUSTICA, V85, P870; Lindblad AC, 2011, NOISE HEALTH, V13, P423, DOI 10.4103/1463-1741.90310; Lindblad AC, 2011, NOISE HEALTH, V13, P392, DOI 10.4103/1463-1741.90293; Liu LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049550; McAllister AM, 2009, J VOICE, V23, P587, DOI 10.1016/j.jvoice.2007.10.017; McFadden SL, 1998, HEARING RES, V120, P121, DOI 10.1016/S0378-5955(98)00052-5; Qiu CX, 2000, HEARING RES, V139, P153, DOI 10.1016/S0378-5955(99)00171-9; Schmuziger N, 2006, EAR HEARING, V27, P321, DOI 10.1097/01.aud.0000224737.34907.5e; Shi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081566; Sindhusake D, 2003, INT J AUDIOL, V42, P289, DOI 10.3109/14992020309078348; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Sjodin F, 2012, NOISE HEALTH, V14, P72, DOI 10.4103/1463-1741.95135; Sztuka A, 2010, AURIS NASUS LARYNX, V37, P55, DOI 10.1016/j.anl.2009.05.001; Walton J, 1999, HEARING RES, V127, P86, DOI 10.1016/S0378-5955(98)00175-0; Wang J, 1997, HEARING RES, V107, P67, DOI 10.1016/S0378-5955(97)00020-8; Wang Y, 2012, JARO-J ASSOC RES OTO, V13, P505, DOI 10.1007/s10162-012-0329-0; Zhao F, 2010, INT J AUDIOL, V49, P54, DOI 10.3109/14992020903202520	36	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97377	10.1371/journal.pone.0097377	http://dx.doi.org/10.1371/journal.pone.0097377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827149	gold, Green Submitted, Green Published			2022-12-25	WOS:000336857400088
J	Zhang, QS; Lu, GH; Wang, XB; Li, J				Zhang, Qian-Shi; Lu, Guo-Hua; Wang, Xiao-Bin; Li, Jing			The Significance of Removing Ruptured Intervertebral Discs for Interbody Fusion in Treating Thoracic or Lumbar Type B and C Spinal Injuries through a One-Stage Posterior Approach	PLOS ONE			English	Article							THORACOLUMBAR BURST FRACTURES; INSTRUMENTATION; STABILIZATION	Objectives: To identify the negative effect on treatment results of reserving damaged intervertebral discs when treating type B and type C spinal fracture-dislocations through a one-stage posterior approach. Methods: This is a retrospective review of 53 consecutive patients who were treated in our spine surgery center from January 2005 to May 2012 due to severe thoracolumbar spinal fracture-dislocation. The patients in Group A (24 patients) underwent long-segment instrumentation laminectomy with pedicle screw-rod fixators for neural decompression. In Group B (29 patients), the patients underwent long-segment instrumentation laminectomy with pedicle screw-rod fixators for neural decompression evacuating of the ruptured disc and inserting of a bone graft into the evacuated disc space for interbody fusion. The mean time between injury and operation was 4.1 days (range 2-15 days). The clinical, radiologic and complication outcomes were analyzed retrospectively. Results: Periodic follow-ups were carried out until an affirmative union or treatment failure took place. A progressive kyphosis angle larger than 10(u), loss of disc height, pseudoarthrosis, recurrence of dislocation or subluxation, or instrument failure before fusion were considered treatment failures. Treatment failures were detected in 13 cases in Group A (failure rate was 54.2%). In Group B, there were 28 cases in which definitive bone fusion was demonstrated on CT scans, and CT scans of the other cases demonstrated undefined pseudoarthrosis without hardware failure. There were statistically significant differences between the two groups (p<0.001 chi-square test). The neurologic recoveries, assessed by the ASIA scoring system, were not satisfactory for the neural deficit patients in either group, indicating there was no significant difference with regard to neurologic recovery between the two groups (p>0.05 Fisher's exact test). Conclusion: Intervertebral disc damage is a common characteristic in type B and C spinal fracture-dislocation injuries. The damaged intervertebral disc should be removed and substituted with a bone graft because reserving the damaged disc in situ increases the risk of treatment failure.	[Zhang, Qian-Shi; Lu, Guo-Hua; Wang, Xiao-Bin; Li, Jing] Cent S Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China	Central South University	Li, J (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China.	jingli1969@126.com						Alanay A, 2001, SPINE, V26, P213, DOI 10.1097/00007632-200101150-00017; Ayberk G, 2008, NEUROL MED-CHIR, V48, P8, DOI 10.2176/nmc.48.8; DANIAUX H, 1991, SPINE, V16, pS125, DOI 10.1097/00007632-199103001-00018; Elgafy H, 2007, SPINE, V32, pE785, DOI 10.1097/BRS.0b013e31815b60fd; Inamasu J, 2008, NEUROL MED-CHIR, V48, P15, DOI 10.2176/nmc.48.15; Knop C, 2002, EUR SPINE J, V11, P251, DOI 10.1007/s00586-001-0360-z; Knop C, 2001, SPINE, V26, P88, DOI 10.1097/00007632-200101010-00016; Ma Yi, 2013, Zhonghua Yi Xue Za Zhi, V93, P2112; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424, DOI 10.5435/00124635-200411000-00007; Moore TA, 2011, J NEUROSURG-SPINE, V15, P675, DOI 10.3171/2011.8.SPINE1129; MUMFORD J, 1993, SPINE, V18, P955, DOI 10.1097/00007632-199306150-00003; Oner FC, 1998, J BONE JOINT SURG BR, V80B, P833, DOI 10.1302/0301-620X.80B5.8830; Oner FC, 1999, EUR SPINE J, V8, P194, DOI 10.1007/s005860050156; P Oprel Pim, 2010, Open Orthop J, V4, P93, DOI 10.2174/1874325001004010093; Przybyla A, 2006, CLIN BIOMECH, V21, P1013, DOI 10.1016/j.clinbiomech.2006.07.003; SPETH MJGM, 1995, ACTA ORTHOP SCAND, V66, P406, DOI 10.3109/17453679508995575; WILLEN JAG, 1989, SPINE, V14, P1316, DOI 10.1097/00007632-198912000-00008; Xia Qun, 2009, Orthop Surg, V1, P28, DOI 10.1111/j.1757-7861.2008.00006.x; Xu Bao-shan, 2009, Orthop Surg, V1, P85, DOI 10.1111/j.1757-7861.2009.00022.x; Yu Shang-Won, 2002, Chang Gung Med J, V25, P253	21	2	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97275	10.1371/journal.pone.0097275	http://dx.doi.org/10.1371/journal.pone.0097275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827733	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400071
J	Romero-Geraldo, RDJ; Garcia-Lagunas, N; Hernandez-Saavedra, NY				de Jesus Romero-Geraldo, Reyna; Garcia-Lagunas, Norma; Yolanda Hernandez-Saavedra, Norma			Effects of In Vitro Exposure to Diarrheic Toxin Producer Prorocentrum lima on Gene Expressions Related to Cell Cycle Regulation and Immune Response in Crassostrea gigas	PLOS ONE			English	Article							SHELLFISH POISONING TOXINS; OKADAIC ACID; PACIFIC OYSTER; MOLECULAR-IDENTIFICATION; MYTILUS-EDULIS; ALGAL TOXINS; DNA-DAMAGE; MARINE; PHOSPHORYLATION; ARREST	Background: Crassostrea gigas accumulates diarrheic shellfish toxins (DSP) associated to Prorocentrum lima of which Okadaic acid (OA) causes specific inhibitions of serine and threonine phosphatases 1 and 2A. Its toxic effects have been extensively reported in bivalve mollusks at cellular and physiological levels, but genomic approaches have been scarcely studied. Methodology/Principal Findings: Acute and sub-chronic exposure effects of P. lima were investigated on farmed juvenile C. gigas (3-5 mm). The Pacific oysters were fed with three dinoflagellate concentrations: 0.3, 3, and 30X10(3) cells mL(-1) along with a nontoxic control diet of Isochrysis galbana. The effects of P. lima on C. gigas were followed by analyzing expression levels of a total of four genes, three involved in cell cycle regulation and one in immune response by polymerase chain reaction and real time quantitative PCR, where changes in time and cell concentration were found. The highest expression levels were found in oysters fed 3X10(3) cells mL(-1) at 168 h for the cycle regulator p21 protein (9 fold), chromatin assembly factor 1 p55 subunit (8 fold), elongation factor 2 (2 fold), and lipopolysaccharide/beta-1, 3 glucan binding protein (13 fold above base line). Additionally, the transcript level of all the genes decreased in oysters fed wich the mixed diet 30X10(3) cells mL(-1) of dinoflagellate after 72 h and was lowest in the chromatin assembly factor 1 p55 subunit (0.9 fold below baseline). Conclusions: On C. gigas the whole cell ingestion of P lima caused a clear mRNA modulation expression of the genes involved in cell cycle regulation and immune system. Over- expression could be related to DNA damage, disturbances in cell cycle continuity, probably a genotoxic effect, as well as an activation of its innate immune system as first line of defense.	[de Jesus Romero-Geraldo, Reyna; Garcia-Lagunas, Norma; Yolanda Hernandez-Saavedra, Norma] Ctr Invest Biol Noroeste, Mol Genet Lab, Baja California Sur, Mexico; [de Jesus Romero-Geraldo, Reyna] Inst Tecnol La Paz, Dept Engn, Baja California Sur, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Hernandez-Saavedra, NY (corresponding author), Ctr Invest Biol Noroeste, Mol Genet Lab, Baja California Sur, Mexico.	nhernan04@cibnor.mx	Hernandez Saavedra, Norma Yolanda/ABB-4249-2021	Hernandez Saavedra, Norma Yolanda/0000-0002-7004-299X	CONACyT [CB07 083442]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this project was by CONACyT CB07 083442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 1999, ONCOGENE, V18, P2846, DOI 10.1038/sj.onc.1202462; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; Bauder AG, 2000, J SHELLFISH RES, V19, P321; Bauder AG, 2001, MAR ECOL PROG SER, V213, P39, DOI 10.3354/meps213039; Beninger PG, 1999, MAR ECOL PROG SER, V178, P259, DOI 10.3354/meps178259; Bougrier S, 1997, AQUACULTURE, V150, P123, DOI 10.1016/S0044-8486(96)01457-3; Boutet I, 2004, BBA-GENE STRUCT EXPR, V1679, P29, DOI 10.1016/j.bbaexp.2004.04.001; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cognie B, 2001, ESTUARIES, V24, P126, DOI 10.2307/1352819; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; Doucet E, 2007, ANAL BIOANAL CHEM, V389, P335, DOI 10.1007/s00216-007-1489-3; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Fujiki H, 1997, J ENVIRON SCI HEAL C, V15, P1, DOI 10.1080/10590509709373488; Gainey LF., 1988, J SHELLFISH RES, V7, P623; Galimany E, 2008, HARMFUL ALGAE, V7, P630, DOI 10.1016/j.hal.2008.01.001; Garcia-Lagunas N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072323; GERDES D, 1983, AQUACULTURE, V31, P195, DOI 10.1016/0044-8486(83)90313-7; Gifford D.J., 2000, P193, DOI 10.1016/B978-012327645-2/50006-2; Gonzalez-Romero R, 2012, COMP BIOCHEM PHYS C, V155, P175, DOI 10.1016/j.cbpc.2011.09.003; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haberkorn H, 2010, AQUAT TOXICOL, V97, P96, DOI 10.1016/j.aquatox.2009.12.006; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Heredia-Tapia A, 2002, TOXICON, V40, P1121, DOI 10.1016/S0041-0101(02)00111-3; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Keppler CJ, 2005, HARMFUL ALGAE, V4, P275, DOI 10.1016/j.hal.2004.05.002; Li SC, 2001, J EXP MAR BIOL ECOL, V263, P65, DOI 10.1016/S0022-0981(01)00294-5; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Mello DF, 2012, MAR DRUGS, V10, P583, DOI 10.3390/md10030583; Mello DF, 2010, TOXINS, V2, P1166, DOI 10.3390/toxins2051166; Milczarek GJ, 1999, CARCINOGENESIS, V20, P1043, DOI 10.1093/carcin/20.6.1043; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Nunez-Vazquez E., 2003, P HAB TECH 2003 WORK, P64; Ochoa JL, 1997, MORTANDAD MAMIFEROS; Paul VJ, 2007, BIOL BULL-US, V213, P226, DOI 10.2307/25066642; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistocchi R, 2012, MAR DRUGS, V10, P140, DOI 10.3390/md10010140; Prego-Faraldo MV, 2013, MAR DRUGS, V11, P2829, DOI 10.3390/md11082829; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; Romero-Geraldo R. J., 2012, AQUAC RES, P1; Sar A, 2002, FLORACIONES ALGALES, P311; SCHONTHAL AH, 1998, FRONT BIOSCI, V3, P1262; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Souto C, 2001, SCI MAR, V65, P269, DOI 10.3989/scimar.2001.65s1269; Su JJ, 2004, WORLD J GASTROENTERO, V10, P3559, DOI 10.3748/wjg.v10.i24.3559; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P4370, DOI 10.3390/md11114370; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Suzuki T, 2011, ANAL SCI, V27, P571, DOI 10.2116/analsci.27.571; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Tanguy A, 2003, MAR ECOL PROG SER, V257, P87, DOI 10.3354/meps257087; Valdiglesias V, 2011, J ENVIRON MONITOR, V13, P1831, DOI 10.1039/c0em00771d; Valdiglesias V, 2010, MUTAT RES-FUND MOL M, V689, P74, DOI 10.1016/j.mrfmmm.2010.05.004; Vale C, 2008, FEBS J, V275, P6060, DOI 10.1111/j.1742-4658.2008.06711.x; Van Dolah FM, 2003, N P TOX ENV, P247; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vieites JM, 2000, SEAFOOD FRESHWATER T, P741; Wikfors GH, 2005, HARMFUL ALGAE, V4, P585, DOI 10.1016/j.hal.2004.08.008; Windust AJ, 1996, MAR BIOL, V126, P19, DOI 10.1007/BF00571373; Yasumoto T, 1984, DIARRHETIC SHELLFISH, P207; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	64	21	22	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97181	10.1371/journal.pone.0097181	http://dx.doi.org/10.1371/journal.pone.0097181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825133	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200070
J	Kaza, N; Kohli, L; Graham, CD; Klocke, BJ; Carroll, SL; Roth, KA				Kaza, Niroop; Kohli, Latika; Graham, Christopher D.; Klocke, Barbara J.; Carroll, Steven L.; Roth, Kevin A.			BNIP3 Regulates AT101 [(-)-Gossypol] Induced Death in Malignant Peripheral Nerve Sheath Tumor Cells	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; BCL-XL; SCHWANN-CELLS; GLIOMA-CELLS; PHASE I/II; GOSSYPOL; EXPRESSION; AUTOPHAGY; APOPTOSIS; PROTEIN	Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective, resulting in a high rate of MPNST recurrence and poor five-year patient survival. This necessitates the exploration of alternative chemotherapeutic options for MPNST patients. This study sought to assess the cytotoxic effect of the BH3-mimetic AT101 [(-)-gossypol] on MPNST cells in vitro and to identify key regulators of AT101-induced MPNST cell death. We found that AT101 caused caspase-independent, non-apoptotic MPNST cell death, which was accompanied by autophagy and was mediated through HIF-1 alpha induced expression of the atypical BH3-only protein BNIP3. These effects were mediated by intracellular iron chelation, a previously unreported mechanism of AT101 cytotoxicity.	[Kaza, Niroop; Kohli, Latika; Graham, Christopher D.; Klocke, Barbara J.; Carroll, Steven L.; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Roth, KA (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	karoth@uab.edu		Kaza, Niroop/0000-0002-7584-1379; Roth, Kevin/0000-0002-0643-995X	National Cancer Institute [CA134773, CA122804]; National Institute of Neurological Disorders and Stroke [NS41962]; Department of Defense [X81XWH-09-1-0086, W81XWH-12-1-0164]; NATIONAL CANCER INSTITUTE [R01CA122804, R01CA134773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041962] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute grants CA134773 (KAR, SLC) and CA122804 (SLC), National Institute of Neurological Disorders and Stroke grant NS41962 (KAR), and Department of Defense grants X81XWH-09-1-0086 and W81XWH-12-1-0164 (SLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; ADAMS R, 1960, CHEM REV, V60, P555, DOI 10.1021/cr60208a002; Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brossier NM, 2012, BRAIN RES BULL, V88, P58, DOI 10.1016/j.brainresbull.2011.08.005; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2002, CANCER RES, V62, P1573; FLORIDI A, 1983, EXP MOL PATHOL, V38, P322, DOI 10.1016/0014-4800(83)90072-2; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heist RS, 2010, J THORAC ONCOL, V5, P1637, DOI 10.1097/JTO.0b013e3181e8f4dc; Hu WB, 2012, J BIOL CHEM, V287, P68, DOI 10.1074/jbc.M111.271205; Jan CR, 2000, BBA-MOL CELL RES, V1496, P270, DOI 10.1016/S0167-4889(00)00033-1; Jiang JH, 2004, ANTICANCER RES, V24, P91; Jiang JH, 2012, CLIN EXP METASTAS, V29, P165, DOI 10.1007/s10585-011-9439-z; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; KIM SH, 1985, CANCER RES, V45, P6338; King AA, 2000, MALIGNANT PERIPHERAL; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Ko CH, 2007, INT J CANCER, V121, P1670, DOI 10.1002/ijc.22910; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SJ, 2012, INT J MOL MED, V30, P443, DOI 10.3892/ijmm.2012.1013; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Lian JQ, 2010, AUTOPHAGY, V6, P1201, DOI [10.1038/cdd.2010.74, 10.4161/auto.6.8.13549]; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Mego M, 2002, Bratisl Lek Listy, V103, P378; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; Oliver CL, 2005, MOL CANCER THER, V4, P23; Park HJ, 2013, INT J ONCOL, V42, P657, DOI 10.3892/ijo.2012.1751; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Ready N, 2011, J THORAC ONCOL, V6, P781, DOI 10.1097/JTO.0b013e31820a0ea6; REYES J, 1988, AM J PHYSIOL, V254, pC564, DOI 10.1152/ajpcell.1988.254.4.C564; Santos JEP, 2005, J DAIRY SCI, V88, P3563, DOI 10.3168/jds.S0022-0302(05)73041-1; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sikora MJ, 2008, CANCER BIOL THER, V7, P767, DOI 10.4161/cbt.7.5.5767; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Triantafyllou A, 2007, FREE RADICAL RES, V41, P342, DOI 10.1080/10715760601055324; VERMEL E M, 1965, Fed Proc Transl Suppl, V24, P106; VERMEL' E. M., 1963, VOPR ONKOL, V9, P39; Volate SR, 2010, MOL CANCER THER, V9, P461, DOI 10.1158/1535-7163.MCT-09-0507; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Waites GMH, 1998, INT J ANDROL, V21, P8; Walls KC, 2009, J NEUROPATH EXP NEUR, V68, P1326, DOI 10.1097/NEN.0b013e3181c3b9be; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; WANG YC, 1984, CANCER RES, V44, P35; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Yu ZH, 1998, INT J ANDROL, V21, P2, DOI 10.1046/j.1365-2605.1998.00091.x; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhang ZF, 2011, FEBS J, V278, P134, DOI 10.1111/j.1742-4658.2010.07939.x; Zhong H, 2000, CANCER RES, V60, P1541	68	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96733	10.1371/journal.pone.0096733	http://dx.doi.org/10.1371/journal.pone.0096733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824755	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200028
J	Salavirta, H; Oksanen, I; Kuuskeri, J; Makela, M; Laine, P; Paulin, L; Lundell, T				Salavirta, Heikki; Oksanen, Ilona; Kuuskeri, Jaana; Makela, Miia; Laine, Pia; Paulin, Lars; Lundell, Taina			Mitochondrial Genome of Phlebia radiata Is the Second Largest (156 kbp) among Fungi and Features Signs of Genome Flexibility and Recent Recombination Events	PLOS ONE			English	Article							LIGNIN-MODIFYING ENZYMES; GROUP-I INTRON; HOMING ENDONUCLEASES; DEGRADING BASIDIOMYCETE; TRANSFER-RNAS; PROTEIN; GENE; MANGANESE; EVOLUTION; SEQUENCE	Mitochondria are eukaryotic organelles supporting individual life-style via generation of proton motive force and cellular energy, and indispensable metabolic pathways. As part of genome sequencing of the white rot Basidiomycota species Phlebia radiata, we first assembled its mitochondrial genome (mtDNA). So far, the 156 348 bp mtDNA is the second largest described for fungi, and of considerable size among eukaryotes. The P. radiata mtDNA assembled as single circular dsDNA molecule containing genes for the large and small ribosomal RNAs, 28 transfer RNAs, and over 100 open reading frames encoding the 14 fungal conserved protein subunits of the mitochondrial complexes I, III, IV, and V. Two genes (atp6 and tRNA-Ile(GAU)) were duplicated within 6.1 kbp inverted region, which is a unique feature of the genome. The large mtDNA size, however, is explained by the dominance of intronic and intergenic regions (sum 80% of mtDNA sequence). The intergenic DNA stretches harness short (<= 200 nt)repetitive, dispersed and overlapping sequence elements in abundance. Long self-splicing introns of types I and II interrupt eleven of the conserved genes (cox1,2,3; cob; nad1,2,4,4L, 5; rnl; rns). The introns embrace a total of 57 homing endonucleases with LAGLIDADGD and GYI-YIG core motifs, which makes P. radiata mtDNA to one of the largest known reservoirs of intron-homing endonucleases. The inverted duplication, intergenic stretches, and intronic features are indications of dynamics and genetic flexibility of the mtDNA, not fully recognized to this extent in fungal mitochondrial genomes previously, thus giving new insights for the evolution of organelle genomes in eukaryotes.	[Salavirta, Heikki; Oksanen, Ilona; Kuuskeri, Jaana; Makela, Miia; Lundell, Taina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Laine, Pia; Paulin, Lars] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland	University of Helsinki; University of Helsinki	Lundell, T (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	taina.lundell@helsinki.fi	Lundell, Taina/ABA-8393-2021; Mäkelä, Miia R./F-2181-2011; Lundell, Taina/P-6623-2016	Lundell, Taina/0000-0003-3899-1658; Mäkelä, Miia R./0000-0003-0771-2329; Lundell, Taina/0000-0003-3899-1658; Laine, Pia/0000-0002-3727-8749; Kuuskeri, Jaana/0000-0002-5838-2086	Academy of Finland [AF-138331 (Ox-Red), AF-129869]; Department of Food and Environmental Sciences, University of Helsinki	Academy of Finland(Academy of Finland); Department of Food and Environmental Sciences, University of Helsinki	This study was supported by the Academy of Finland research project grants AF-138331 (Ox-Red) and AF-129869, and a Master's thesis grant from the Department of Food and Environmental Sciences, University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; [Anonymous], NCBI ORG GEN RES; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendich AJ, 2010, MOL CELL, V39, P831, DOI 10.1016/j.molcel.2010.09.005; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Caprara MG, 2007, RNA, V13, P211, DOI 10.1261/rna.307907; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Costa GGL, 2012, FUNGAL BIOL-UK, V116, P551, DOI 10.1016/j.funbio.2012.01.008; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferandon C, 2008, FUNGAL GENET BIOL, V45, P292, DOI 10.1016/j.fgb.2007.10.012; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Forget L, 2002, MOL BIOL EVOL, V19, P310, DOI 10.1093/oxfordjournals.molbev.a004084; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Gu SQ, 2010, RNA, V16, P732, DOI 10.1261/rna.2007310; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hilden KS, 2008, MICROBIOL-SGM, V154, P2371, DOI 10.1099/mic.0.2008/018747-0; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kim EK, 2000, CURR GENET, V38, P283, DOI 10.1007/s002940000157; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Litter J, 2005, ANTON LEEUW INT J G, V88, P249, DOI 10.1007/s10482-005-8544-x; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; LUNDELL T, 1990, APPL ENVIRON MICROB, V56, P2623, DOI 10.1128/AEM.56.9.2623-2629.1990; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Makela MR, 2013, FUNGAL BIOL-UK, V117, P62, DOI 10.1016/j.funbio.2012.11.006; MARGULIS L, 1970, P349; MICHEL F, 1985, NATURE, V316, P641, DOI 10.1038/316641a0; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Moilanen AM, 1996, APPL MICROBIOL BIOT, V45, P792, DOI 10.1007/s002530050764; Mouhamadou B, 2007, FEMS MICROBIOL LETT, V272, P276, DOI 10.1111/j.1574-6968.2007.00771.x; NAKASONE KK, 1993, MYCOLOGIA, V85, P996, DOI 10.2307/3760683; PAQUIN B, 1994, P NATL ACAD SCI USA, V91, P11807, DOI 10.1073/pnas.91.25.11807; Petersen RF, 2002, J MOL BIOL, V318, P627, DOI 10.1016/S0022-2836(02)00037-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, P5189, DOI 10.1093/nar/gks226; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	70	46	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97141	10.1371/journal.pone.0097141	http://dx.doi.org/10.1371/journal.pone.0097141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824642	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200065
J	Cheng, JH; Zhang, LF; Gao, F; Bai, YG; Boscolo, M; Huang, XF; Zhang, X				Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang; Boscolo, Marco; Huang, Xiao-Feng; Zhang, Xiang			Mechanics and Composition of Middle Cerebral Arteries from Simulated Microgravity Rats with and without 1-h/d-Gx Gravitation	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; DAILY -G(X) GRAVITATION; ORTHOSTATIC INTOLERANCE; MYOGENIC TONE; SPACEFLIGHT; HYPERTENSION; VASOCONSTRICTOR; REACTIVITY; RESISTANCE; PERFUSION	Background: To elucidate further from the biomechanical aspect whether microgravity-induced cerebral vascular maladaptation might be a contributing factor to postflight orthostatic intolerance and the underlying mechanism accounting for the potential effectiveness of intermittent artificial gravity (IAG) in preventing this adverse effect. Methodology/Principal Findings: Middle cerebral arteries (MCAs) were isolated from 28-day SUS (tail-suspended, head-down tilt rats to simulate microgravity effect), S+D (SUS plus 1-h/d-G(x) gravitation by normal standing to simulate IAG), and CON (control) rats. Vascular myogenic reactivity and circumferential stress-strain and axial force-pressure relationships and overall stiffness were examined using pressure arteriography and calculated. Acellular matrix components were quantified by electron microscopy. The results demonstrate that myogenic reactivity is susceptible to previous pressure-induced, serial constrictions. During the first-run of pressure increments, active MCAs from SUS rats can strongly stiffen their wall and maintain the vessels at very low strains, which can be prevented by the simulated IAG countermeasure. The strains are 0.03 and 0.14 respectively for SUS and S+D, while circumferential stress being kept at 0.5 (10(6) dyn/cm(2)). During the second-run pressure steps, both the myogenic reactivity and active stiffness of the three groups declined. The distensibility of passive MCAs from S+D is significantly higher than CON and SUS, which may help to attenuate the vasodilatation impairment at low levels of pressure. Collagen and elastin percentages were increased and decreased, respectively, in MCAs from SUS and S+D as compared with CON; however, elastin was higher in S+D than SUS rats. Conclusions: Susceptibility to previous myogenic constrictions seems to be a self-limiting protective mechanism in cerebral small resistance arteries to prevent undue cerebral vasoconstriction during orthostasis at 1-G environment. Alleviating of active stiffening and increasing of distensibility of cerebral resistance arteries may underlie the countermeasure effectiveness of IAG.	[Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang] Fourth Mil Med Univ, Dept Aerosp Physiol, Minist Educ, Xian 710032, Peoples R China; [Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang] Fourth Mil Med Univ, Minist Educ, Key Lab Aerosp Med, Xian 710032, Peoples R China; [Huang, Xiao-Feng] Fourth Mil Med Univ, Sch Basic Med Sci, Cent Lab, Xian 710032, Peoples R China; [Boscolo, Marco; Zhang, Xiang] Cranfield Univ, Dept Aerosp Engn, Cranfield MK43 0AL, Beds, England	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Cranfield University	Zhang, LF (corresponding author), Fourth Mil Med Univ, Dept Aerosp Physiol, Minist Educ, Xian 710032, Peoples R China.	zhanglf@fmmu.edu.cn	Zhang, Xiang/ABI-2024-2020	Zhang, Xiang/0000-0001-8454-3931	National Natural Science Foundation of China [30470649, 31070839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos: 30470649 and 31070839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Cheng Jiu-Hua, 2009, Shengli Xuebao, V61, P386; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Delp MD, 2000, AM J PHYSIOL-HEART C, V278, pH1866, DOI 10.1152/ajpheart.2000.278.6.H1866; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Gao Fang, 2012, Shengli Xuebao, V64, P107; GAZENKO OG, 1981, ACTA ASTRONAUT, V8, P907, DOI 10.1016/0094-5765(81)90061-8; Geary GG, 1998, J APPL PHYSIOL, V85, P1615, DOI 10.1152/jappl.1998.85.5.1615; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hargens AR, 2012, EUR J APPL PHYSL, DOI [10.1007/s00421-00012-02523-00425, DOI 10.1007/S00421-00012-02523-00425]; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; HEISTAD DD, 1992, J HYPERTENS, V10, pS71; HUMPHREY J, 2001, CARDIOVASCULAR SOLID; Intengan HD, 1999, HYPERTENSION, V33, P569, DOI 10.1161/01.HYP.33.1.569; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Lin Le-Jian, 2009, Shengli Xuebao, V61, P27; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; Rowell L, 1993, HUMAN CARDIOVASCULAR; Sides MB, 2005, AVIAT SPACE ENVIR MD, V76, P877; Sun B, 2004, J APPL PHYSIOL, V97, P1022, DOI 10.1152/japplphysiol.00188.2004; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Timoshenko SP, 1934, THEORY ELASTICITY; WATENPAUGH DE, 1996, HDB PHYSIOL SECT 4, V1, P631; Wilkerson MK, 2005, AM J PHYSIOL-HEART C, V288, pH1652, DOI 10.1152/ajpheart.00925.2004; Wilkerson MK, 2002, AM J PHYSIOL-HEART C, V282, pH328, DOI 10.1152/ajpheart.00727.2001; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Young L., 2009, ARTIFICIAL GRAVITY R, P1; Zhang LF, 2003, J APPL PHYSIOL, V95, P207, DOI 10.1152/japplphysiol.00969.2002; Zhang LF, 2001, AVIAT SPACE ENVIR MD, V72, P567; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2013, EUR J APPL PHYSL, DOI [10.1007/s00421-00013-02597-00428, DOI 10.1007/S00421-00013-02597-00428]; Zhang LN, 2001, J APPL PHYSIOL, V90, P2296, DOI 10.1152/jappl.2001.90.6.2296; Zuj KA, 2012, AM J PHYSIOL-HEART C, V302, pH2592, DOI 10.1152/ajpheart.00029.2012	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97737	10.1371/journal.pone.0097737	http://dx.doi.org/10.1371/journal.pone.0097737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840155	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600066
J	Xue, P; Crum, CM; Thibodeau, PH				Xue, Peng; Crum, Chelsea M.; Thibodeau, Patrick H.			Regulation of ABCC6 Trafficking and Stability by a Conserved C-terminal PDZ-Like Sequence	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CAUSE PSEUDOXANTHOMA ELASTICUM; RESISTANCE-ASSOCIATED PROTEIN; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; ATP-BINDING; CRYSTAL-STRUCTURE; APICAL MEMBRANE; CELL-SURFACE; CFTR	Mutations in the ABCC6 ABC-transporter are causative of pseudoxanthoma elasticum (PXE). The loss of functional ABCC6 protein in the basolateral membrane of the kidney and liver is putatively associated with altered secretion of a circulatory factor. As a result, systemic changes in elastic tissues are caused by progressive mineralization and degradation of elastic fibers. Premature arteriosclerosis, loss of skin and vascular tone, and a progressive loss of vision result from this ectopic mineralization. However, the identity of the circulatory factor and the specific role of ABCC6 in disease pathophysiology are not known. Though recessive loss-of-function alleles are associated with alterations in ABCC6 expression and function, the molecular pathologies associated with the majority of PXE-causing mutations are also not known. Sequence analysis of orthologous ABCC6 proteins indicates the C-terminal sequences are highly conserved and share high similarity to the PDZ sequences found in other ABCC subfamily members. Genetic testing of PXE patients suggests that at least one disease-causing mutation is located in a PDZ-like sequence at the extreme C-terminus of the ABCC6 protein. To evaluate the role of this C-terminal sequence in the biosynthesis and trafficking of ABCC6, a series of mutations were utilized to probe changes in ABCC6 biosynthesis, membrane stability and turnover. Removal of this PDZ-like sequence resulted in decreased steady-state ABCC6 levels, decreased cell surface expression and stability, and mislocalization of the ABCC6 protein in polarized cells. These data suggest that the conserved, PDZ-like sequence promotes the proper biosynthesis and trafficking of the ABCC6 protein.	[Xue, Peng; Crum, Chelsea M.; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	thibodea@pitt.edu		Thibodeau, Patrick/0000-0002-6790-144X	University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NIH/NIDDK [DK083284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER	University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by faculty development funding from the University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology and by support from the NIH/NIDDK to PHT (DK083284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlanov R, 2012, HUM MUTAT, V33, P750, DOI 10.1002/humu.22041; Azim AC, 1995, GENOMICS, V30, P613, DOI 10.1006/geno.1995.1286; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Emi Y, 2012, J CELL SCI, V125, P3133, DOI 10.1242/jcs.099549; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Faletra F, 2012, GENE; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Germain DP, 2003, ARTERIOSCL THROM VAS, V23, P836, DOI 10.1161/01.ATV.0000067428.19031.28; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harris MJ, 2001, J BIOL CHEM, V276, P20876, DOI 10.1074/jbc.M010566200; Hayashi H, 2012, J BIOL CHEM, V287, P15054, DOI 10.1074/jbc.M111.337931; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hu XF, 2003, EUR J HUM GENET, V11, P215, DOI 10.1038/sj.ejhg.5200953; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jiang QJ, 2006, J INVEST DERMATOL, V126, P1440, DOI 10.1038/sj.jid.5700267; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kocher O, 1999, LAB INVEST, V79, P1161; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; LEBWOHL M, 1993, NEW ENGL J MED, V329, P1240; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Maday S, 2008, TRAFFIC, V9, P1915, DOI 10.1111/j.1600-0854.2008.00805.x; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Milewski MI, 2001, J CELL SCI, V114, P719; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Plomp AS, 2008, MOL VIS, V14, P118; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Schulz V, 2005, HUM BIOL, V77, P367, DOI 10.1353/hub.2005.0054; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun RH, 2012, J BIOL CHEM, V287, P37564, DOI 10.1074/jbc.M112.394585; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Wegman JJ, 2005, INT J CARDIOL, V100, P389, DOI 10.1016/j.ijcard.2004.07.012; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilken S, 1996, MOL MICROBIOL, V22, P655, DOI 10.1046/j.1365-2958.1996.d01-1724.x; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97360	10.1371/journal.pone.0097360	http://dx.doi.org/10.1371/journal.pone.0097360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840500	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000340948600027
J	Bechah, Y; Verneau, J; Ben Amara, A; Barry, AO; Lepolard, C; Achard, V; Panicot-Dubois, L; Textoris, J; Capo, C; Ghigo, E; Mege, JL				Bechah, Yassina; Verneau, Johanna; Ben Amara, Amira; Barry, Abdoulaye O.; Lepolard, Catherine; Achard, Vincent; Panicot-Dubois, Laurence; Textoris, Julien; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis			Persistence of Coxiella burnetii, the Agent of Q Fever, in Murine Adipose Tissue	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TARGET-CELL; ADIPOCYTE; INFECTION; EXPRESSION	Coxiella burnetii, the agent of Q fever, is known to persist in humans and rodents but its cellular reservoir in hosts remains undetermined. We hypothesized that adipose tissue serves as a C. burnetii reservoir during bacterial latency. BALB/c and C57BL/6 mice were infected with C. burnetii by the intraperitoneal route or the intracheal route. Adipose tissue was tested for the presence of C. burnetii several months after infection. C. burnetii was detected in abdominal, inguinal and dorsal adipose tissue 4 months post-infection, when no bacteria were detected in blood, liver, lungs and spleen, regardless of the inoculation route and independently of mouse strain. The transfer of abdominal adipose tissue from convalescent BALB/c mice to naive immunodeficient mice resulted in the infection of the recipient animals. It is likely that C. burnetii infects adipocytes in vivo because bacteria were found in adipocytes within adipose tissue and replicated within in vitro-differentiated adipocytes. In addition, C. burnetii induced a specific transcriptional program in in-vivo and in vitro-differentiated adipocytes, which was enriched in categories associated with inflammatory response, hormone response and cytoskeleton. These changes may account for bacterial replication in in-vitro and chronic infection in-vivo. Adipose tissue may be the reservoir in which C. burnetii persists for prolonged periods after apparent clinical cure. The mouse model of C. burnetii infection may be used to understand the relapses of Q fever and provide new perspectives to the follow-up of patients.	[Bechah, Yassina; Verneau, Johanna; Ben Amara, Amira; Barry, Abdoulaye O.; Lepolard, Catherine; Textoris, Julien; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis] Aix Marseille Univ, Unite Rech Malad Infect Transmissibles & Emergent, UMR CNRS 7278, IRD 198,INSERM U1095, Marseille, France; [Achard, Vincent] Aix Marseille Univ, UMR S INSERM, Marseille, France; [Panicot-Dubois, Laurence] Aix Marseille Univ UMR S1076, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Bechah, Y (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect Transmissibles & Emergent, UMR CNRS 7278, IRD 198,INSERM U1095, Marseille, France.	yassina.bechah@univ-amu.fr	Textoris, Julien/H-3317-2019; Panicot-Dubois, Laurence/E-3030-2016; MEGE, JEAN-LOUIS/O-6063-2016; catherine, lepolard/P-5653-2016; Eric, Ghigo/N-9427-2016	Textoris, Julien/0000-0002-3821-9337; Panicot-Dubois, Laurence/0000-0003-0848-5009; 				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adamczak M, 2013, SEMIN NEPHROL, V33, P2, DOI 10.1016/j.semnephrol.2012.12.008; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Bechah Y, 2008, J INFECT DIS, V197, P142, DOI 10.1086/523649; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Ben Amara A, 2010, PLOS ONE, V12; Benslimani A, 2005, EMERG INFECT DIS, V11, P216, DOI 10.3201/eid1102.040668; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Darbousset R, 2012, BLOOD, V120, P2133, DOI 10.1182/blood-2012-06-437772; DESLEX S, 1987, INT J OBESITY, V11, P19; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Erol A, 2008, MED HYPOTHESES, V71, P222, DOI 10.1016/j.mehy.2008.03.028; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Hanses F, 2011, ENDOCRINOLOGY, V152, P4148, DOI 10.1210/en.2011-0103; Harris RJ, 2000, EPIDEMIOL INFECT, V124, P543, DOI 10.1017/S0950268899003763; Hazan U, 2002, FASEB J, V16, P1254, DOI 10.1096/fj.01-0947fje; Ikeoka D, 2010, CYTOKINE, V50, P284, DOI 10.1016/j.cyto.2010.02.015; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; Maurin T, 2005, EXP CELL RES, V304, P544, DOI 10.1016/j.yexcr.2004.12.003; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Million M, 2010, LANCET INFECT DIS, V10, P527, DOI 10.1016/S1473-3099(10)70135-3; Morguet AJ, 2007, CLIN RES CARDIOL, V96, P519, DOI 10.1007/s00392-007-0522-z; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagajyothi F, 2009, MEM I OSWALDO CRUZ, V104, P219, DOI 10.1590/S0074-02762009000900028; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; ONG JM, 1992, ENDOCRINOLOGY, V130, P2310, DOI 10.1210/en.130.4.2310; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Sashinami H, 2010, CYTOKINE, V50, P170, DOI 10.1016/j.cyto.2009.12.005; SIDWELL RW, 1964, AM J HYG, V79, P320, DOI 10.1093/oxfordjournals.aje.a120386; SIDWELL RW, 1966, AM J EPIDEMIOL, V84, P132, DOI 10.1093/oxfordjournals.aje.a120618; SIDWELL RW, 1964, AM J HYG, V79, P113, DOI 10.1093/oxfordjournals.aje.a120359; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Tissot-Dupont H, 2008, INFECT DIS CLIN N AM, V22, P505, DOI 10.1016/j.idc.2008.03.002	41	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97503	10.1371/journal.pone.0097503	http://dx.doi.org/10.1371/journal.pone.0097503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835240	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800047
J	Davoodi-Bojd, E; Chopp, M; Soltanian-Zadeh, H; Wang, SY; Ding, GL; Jiang, Q				Davoodi-Bojd, Esmaeil; Chopp, Michael; Soltanian-Zadeh, Hamid; Wang, Shiyang; Ding, Guangliang; Jiang, Quan			An Analytical Model for Estimating Water Exchange Rate in White Matter Using Diffusion MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXON DIAMETER DISTRIBUTION; FIELD GRADIENT NMR; IN-VIVO; RESTRICTED DIFFUSION; SPIN-ECHO; STROKE; TENSOR; DIFFRACTION; FIBERS	Substantial effort is being expended on using micro-structural modeling of the white matter, with the goal of relating diffusion weighted magnetic resonance imaging (DWMRI) to the underlying structure of the tissue, such as axonal density. However, one of the important parameters affecting diffusion is the water exchange rate between the intra-and extra-axonal space, which has not been fully investigated and is a crucial marker of brain injury such as multiple sclerosis (MS), stroke, and traumatic brain injury (TBI). To our knowledge, there is no diffusion analytical model which includes the Water eXchange Rate (WXR) without the requirement of short gradient pulse (SGP) approximation. We therefore propose a new analytical model by deriving the diffusion signal for a permeable cylinder, assuming a clinically feasible pulse gradient spin echo (PGSE) sequence. Simulations based on Markov Random Walk confirm that the exchange parameter included in our model has a linear correlation (R-2>0.88) with the actual WXR. Moreover, increasing WXR causes the estimated values of diameter and volume fraction of the cylinders to increase and decrease, respectively, which is consistent with our findings from histology measurements in tissues near TBI regions. This model was also applied to the diffusion signal acquired from ex vivo brains of 14 male (10 TBI and 4 normal) rats using hybrid diffusion imaging. The estimated values of axon diameter and axonal volume fraction are in agreement with their corresponding histological measurements in normal brains, with 0.96 intra-class correlation coefficient value resulting from consistency analysis. Moreover, a significant increase (p = 0.001) in WXR and diameter and decrease in axonal volume fraction in the TBI boundary were detected in the TBI rats compared with the normal rats.	[Davoodi-Bojd, Esmaeil; Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, Tehran, Iran; [Davoodi-Bojd, Esmaeil; Chopp, Michael; Ding, Guangliang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael; Wang, Shiyang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA	University of Tehran; Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Ding, Guangliang/0000-0003-1286-5901	NIH [RO1 NS64134, RO1 AG037506, RO1 EB013227]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants RO1 NS64134, RO1 AG037506, and RO1 EB013227. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2004, COMP Q BALL PASMRI S, V90; Aslund I, 2009, J MAGN RESON, V200, P291, DOI 10.1016/j.jmr.2009.07.015; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2005, MEASUREMENT AXON DIA, V842; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Avram L, 2004, J MAGN RESON, V169, P30, DOI 10.1016/j.jmr.2004.03.020; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; CALLAGHAN PT, 1995, J MAGN RESON SER A, V113, P53, DOI 10.1006/jmra.1995.1055; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; Davoodi-Bojd E, 2011, MAGN RESON IMAGING, V29, P1175, DOI 10.1016/j.mri.2011.07.006; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hagslatt H, 2003, J MAGN RESON, V161, P138, DOI 10.1016/S1090-7807(02)00039-3; Harkins KD, 2009, MAGN RESON MED, V62, P1414, DOI 10.1002/mrm.22155; Hwang SN, 2003, MAGNET RESON MED, V50, P373, DOI 10.1002/mrm.10536; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; KARGER J, 1988, ADV MAGN RESON, P1; Karimi-Ashtiani S, 2010, I S BIOMED IMAGING, P1149, DOI 10.1109/ISBI.2010.5490197; Komlosh ME, 2011, J MAGN RESON, V208, P128, DOI 10.1016/j.jmr.2010.10.014; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; LEIBIG M, 1993, J PHYS A-MATH GEN, V26, P3349, DOI 10.1088/0305-4470/26/14/005; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Meier C, 2003, MAGN RESON MED, V50, P500, DOI 10.1002/mrm.10557; Momot KI, 2011, EUR BIOPHYS J BIOPHY, V40, P81, DOI 10.1007/s00249-010-0629-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEUMAN CH, 1974, J CHEM PHYS, V60, P4508, DOI 10.1063/1.1680931; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; Sen PN, 2005, MAGN RESON IMAGING, V23, P215, DOI 10.1016/j.mri.2004.11.014; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Torres AM, 1998, MAGN RESON IMAGING, V16, P423, DOI 10.1016/S0730-725X(98)00005-8; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Xu JZ, 2007, PHYS MED BIOL, V52, pN111, DOI 10.1088/0031-9155/52/7/N01; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084; Zhou W, 2009, P 17 ANN M ISMRM HON, V17, P263	61	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95921	10.1371/journal.pone.0095921	http://dx.doi.org/10.1371/journal.pone.0095921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836290	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800012
J	Kline, KA; Schwartz, DJ; Gilbert, NM; Lewis, AL				Kline, Kimberly A.; Schwartz, Drew J.; Gilbert, Nicole M.; Lewis, Amanda L.			Impact of Host Age and Parity on Susceptibility to Severe Urinary Tract Infection in a Murine Model	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; GROUP-B STREPTOCOCCUS; SIALIC-ACID; ASYMPTOMATIC BACTERIURIA; O-ACETYLATION; NEUTROPHIL RECRUITMENT; PREMENOPAUSAL WOMEN; RISK-FACTORS; ESTROGEN; MICE	The epidemiology and bacteriology of urinary tract infection (UTI) varies across the human lifespan, but the reasons for these differences are poorly understood. Using established monomicrobial and polymicrobial murine UTI models caused by uropathogenic Escherichia coli (UPEC) and/or Group B Streptococcus (GBS), we demonstrate age and parity as inter-related factors contributing to UTI susceptibility. Young nulliparous animals exhibited 10-100-fold higher bacterial titers compared to older animals. In contrast, multiparity was associated with more severe acute cystitis in older animals compared to age-matched nulliparous controls, particularly in the context of polymicrobial infection where UPEC titers were similar to 1000-fold higher in the multiparous compared to the nulliparous host. Multiparity was also associated with significantly increased risk of chronic high titer UPEC cystitis and ascending pyelonephritis. Further evidence is provided that the increased UPEC load in multiparous animals required TLR4-signaling. Together, these data strongly suggest that the experience of childbearing fundamentally and permanently changes the urinary tract and its response to pathogens in a manner that increases susceptibility to severe UTI. Moreover, this murine model provides a system for dissecting these and other lifespan-associated risk factors contributing to severe UTI in at-risk groups.	[Kline, Kimberly A.] Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Kline, Kimberly A.; Schwartz, Drew J.; Gilbert, Nicole M.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Washington University (WUSTL)	Kline, KA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore.	kkline@ntu.edu.sg; allewis@wustl.edu	Schwartz, Drew/AAN-7742-2021; Kline, Kimberly/H-1589-2011	Schwartz, Drew/0000-0003-1568-7733; Kline, Kimberly/0000-0002-5472-3074; Gilbert, Nicole/0000-0003-4830-3257	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme; National Research Foundation under its Singapore NRF Fellowship programme; American Heart Association postdoctoral fellowship; NIH [R21DK092586, P50 DK064540-11]; NCRR [C06RR012466];  [F30 DK096751]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, F30DK096751, R21DK092586] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme(Ministry of Education, Singapore); National Research Foundation under its Singapore NRF Fellowship programme(National Research Foundation, Singapore); American Heart Association postdoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and the National Research Foundation under its Singapore NRF Fellowship programme (K. A. K.). This work was also supported by a predoctoral fellowship F30 DK096751 (D.J.S.), an American Heart Association postdoctoral fellowship (N.G.), and NIH grants R21DK092586 (to A. L.) and P50 DK064540-11 (A. L. Co-Investigator). Finally, the animal work performed in this manuscript was performed in a facility supported by NCRR grant C06RR012466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; BACHMAN JW, 1993, JAMA-J AM MED ASSOC, V270, P1971, DOI 10.1001/jama.270.16.1971; BERNSTEIN L, 1985, J NATL CANCER I, V74, P741; Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Curran EM, 2007, J INFECT DIS, V195, P680, DOI 10.1086/511275; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; DORGAN JF, 1995, CANCER EPIDEM BIOMAR, V4, P381; Dwyer PL, 2002, CURR OPIN OBSTET GYN, V14, P537, DOI 10.1097/00001703-200210000-00016; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Fonti Ylenia, 2009, J Prenat Med, V3, P57; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2001, J CLIN EPIDEMIOL, V54, P710, DOI 10.1016/S0895-4356(00)00352-8; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Grandadam F, 1999, BJU INT, V84, P861; Griebling T, 2007, URINARY TRACT INFECT; Guiton PS, 2012, ANTIMICROB AGENTS CH, V56, P4738, DOI 10.1128/AAC.00447-12; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Haider G, 2010, J PAK MED ASSOC, V60, P213; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; Hextall A, 2000, MATURITAS, V36, P83, DOI 10.1016/S0378-5122(00)00143-2; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jackson SL, 2004, AM J MED, V117, P903, DOI 10.1016/j.amjmed.2004.07.045; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kline KA, 2012, INFECT IMMUN, V80, P4186, DOI 10.1128/IAI.00684-12; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Luthje P, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005574; Matthews SJ, 2011, AM J GERIATR PHARMAC, V9, P286, DOI 10.1016/j.amjopharm.2011.07.002; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; OLD DC, 1970, J BACTERIOL, V103, P447, DOI 10.1128/JB.103.2.447-456.1970; ORLANDER JD, 1992, J AM GERIATR SOC, V40, P817, DOI 10.1111/j.1532-5415.1992.tb01855.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raz R, 2011, KOREAN J UROL, V52, P801, DOI 10.4111/kju.2011.52.12.801; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08; Rozenberg S, 2004, INT J FERTIL WOMEN M, V49, P71; RYHAMMER AM, 1995, DIS COLON RECTUM, V38, P1206, DOI 10.1007/BF02048338; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Sheiner E, 2009, J MATERN-FETAL NEO M, V22, P423, DOI 10.1080/14767050802360783; Stamm WE, 1999, CLIN INFECT DIS, V28, P723, DOI 10.1086/515209; Sunden F, 2006, INT J ANTIMICROB AG, V28, pS26, DOI 10.1016/j.ijantimicag.2006.05.007; TERPENNING MS, 1991, GERIATRICS, V46, P77; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Trivalle C, 1998, J MED MICROBIOL, V47, P649, DOI 10.1099/00222615-47-7-649; Wang CH, 2013, INFECT IMMUN, V81, P733, DOI 10.1128/IAI.01234-12; Weiman S, 2010, BIOCHEM J, V428, P163, DOI 10.1042/BJ20100232; WEISSENBACHER ER, 1993, CURR OPIN OBSTET GYN, V5, P513; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Wullt B, 2003, INT J ANTIMICROB AG, V21, P604, DOI 10.1016/S0924-8579(02)00327-8	65	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97798	10.1371/journal.pone.0097798	http://dx.doi.org/10.1371/journal.pone.0097798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835885	Green Published, gold			2022-12-25	WOS:000339614800069
J	Nofiele, JT; Cheng, HLM				Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret			Establishment of a Lung Metastatic Breast Tumor Xenograft Model in Nude Rats	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MRI	Objective: Larger animal models provide relevant tumor burden in the development of advanced clinical imaging methods for non-invasive cancer detection and diagnosis, and are especially valuable for studying metastatic disease. Most available experimental models, however, are based on immune-compromised mice. To lay the foundation for studying spontaneous metastasis using non-invasive magnetic resonance imaging (MRI), this study aims to establish a highly metastatic breast cancer xenograft model in nude rats. Materials and Methods: A highly metastatic variant of human adenocarcinoma MDA-MB-231 known as LM2 was inoculated into nude rats. Orthotopic and subcutaneous (flank) sites were compared, with half of the orthotopic injections guided by ultrasound imaging. MRI with gadolinium contrast administration was performed weekly beginning on Day 6 and ending on Day 104. Excised tumors were assessed on histology using hematoxylin and eosin and CD34. Fisher's exact test was used to compare successful tumor induction amongst different inoculation methods. Results: Primary LM2 tumors were established orthotopically in all cases under ultrasound-guided injection, and none otherwise (p = 0.0028). Contrast-enhanced MRI revealed rapidly progressing tumors that reached critical size (15 mm diameter) in 2 to 3 weeks after inoculation. MRI and histology findings were consistent: LM2 tumors were characterized by low vascularity confined to the tumor rim and large necrotic cores with increasing interstitial fluid pressure. Conclusions: The metastatic LM2 breast tumor model was successfully established in the mammary fat pads of nude rats, using ultrasound needle guidance as a non-invasive alternative to surgery. This platform lays the foundation for future development and application of MRI to study spontaneous metastasis and different stages throughout the metastatic cascade.	[Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst & Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Cheng, HLM (corresponding author), Hosp Sick Children, Res Inst & Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hailing.cheng@utoronto.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	Natural Sciences and Engineering Research Council of Canada [355795]; Garron Family Cancer Centre Grant through the SickKids Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Garron Family Cancer Centre Grant through the SickKids Foundation	This study was supported by funding from the Natural Sciences and Engineering Research Council of Canada (#355795) and the Garron Family Cancer Centre Grant through the SickKids Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-83; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P736, DOI 10.1002/jmri.21489; Cheng HLM, 2009, J MAGN RESON IMAGING, V30, P864, DOI 10.1002/jmri.21916; Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791; Daenen LG, 2009, MOL CANCER THER, V8, P2872, DOI 10.1158/1535-7163.MCT-09-0583; Dickinson L, 2013, J MAGN RESON IMAGING, V37, P48, DOI 10.1002/jmri.23689; Guo Y, 2011, AM J TRANSL RES, V3, P114; HUGGINS C, 1961, NATURE, V189, P204, DOI 10.1038/189204a0; Lederle W, 2012, CURR PHARM BIOTECHNO, V13, P595, DOI 10.2174/138920112799436348; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; MEHTA RR, 1993, BREAST CANCER RES TR, V25, P65, DOI 10.1007/BF00662402; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Olsen OE, 2013, ACTA RADIOL, V54, P1030, DOI 10.1177/0284185113494038; Punwani S, 2011, EUR J RADIOL, V78, P2, DOI 10.1016/j.ejrad.2010.03.010; RUSSO J, 1990, LAB INVEST, V62, P244; Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758; Thompson SM, 2013, CARDIOVASC INTER RAD, V36, P198, DOI 10.1007/s00270-012-0466-1	17	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97950	10.1371/journal.pone.0097950	http://dx.doi.org/10.1371/journal.pone.0097950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835641	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800091
J	Postnikoff, CK; Pintwala, R; Williams, S; Wright, AM; Hileeto, D; Gorbet, MB				Postnikoff, Cameron K.; Pintwala, Robert; Williams, Sara; Wright, Ann M.; Hileeto, Denise; Gorbet, Maud B.			Development of a Curved, Stratified, In Vitro Model to Assess Ocular Biocompatibility	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; AIR-LIQUID INTERFACE; LENS CARE SOLUTIONS; END-POINT ANALYSIS; MULTIPURPOSE SOLUTIONS; DRUG ABSORPTION; CULTURE MODEL; EYE IRRITATION; BENZALKONIUM CHLORIDE; CASPASE ACTIVATION	Purpose: To further improve in vitro models of the cornea, this study focused on the creation of a three-dimensional, stratified, curved epithelium; and the subsequent characterization and evaluation of its suitability as a model for biocompatibility testing. Methods: Immortalized human corneal epithelial cells were grown to confluency on curved cellulose filters for seven days, and were then differentiated and stratified using an air-liquid interface for seven days before testing. Varying concentrations of a commercial ophthalmic solution containing benzalkonium chloride (BAK), a known cytotoxic agent, and two relevant ocular surfactants were tested on the model. A whole balafilcon A lens soaked in phosphate buffered saline (BA PBS) was also used to assess biocompatibility and verify the validity of the model. Viability assays as well as flow cytometry were performed on the cells to investigate changes in cell death and integrin expression. Results: The reconstructed curved corneal epithelium was composed of 3-5 layers of cells. Increasing concentrations of BAK showed dose-dependent decreased cell viability and increased integrin expression and cell death. No significant change in viability was observed in the presence of the surfactants. As expected, the BA PBS combination appeared to be very biocompatible with no adverse change in cell viability or integrin expression. Conclusions: The stratified, curved, epithelial model proved to be sensitive to distinct changes in cytotoxicity and is suitable for continued assessment for biocompatibility testing of contact lenses. Our results showed that flow cytometry can provide a quantitative measure of the cell response to biomaterials or cytotoxic compounds for both the supernatant and adherent cell populations. As a specifically designed in vitro model of the corneal epithelium, this quantitative model for biocompatibility at the ocular surface may help improve our understanding of cell-material interactions and reduce the use of animal testing.	[Postnikoff, Cameron K.; Pintwala, Robert; Williams, Sara; Gorbet, Maud B.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Williams, Sara] Alcon CIBAVis, Duluth, GA USA; [Hileeto, Denise; Gorbet, Maud B.] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Gorbet, MB (corresponding author), Univ Waterloo, Waterloo, ON N2L 3G1, Canada.	mgorbet@uwaterloo.ca			Natural Sciences and Engineering Council (NSERC) of Canada; Alcon	Natural Sciences and Engineering Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alcon(Novartis)	This work was supported by a Collaborative Research and Development grant from the Natural Sciences and Engineering Council (NSERC) of Canada and CIBA Vision (now known as Alcon). NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. M. W. from CIBA participated in the study design but did not have a decision role. CIBA Vision/Alcon had no role in data collection and analysis, decision to publish or preparation of the manuscript.	Altman F P, 1976, Prog Histochem Cytochem, V9, P1; ALTMAN FP, 1974, HISTOCHEMISTRY, V38, P155, DOI 10.1007/BF00499663; Andrasko Gary, 2008, Optometry, V79, P444, DOI 10.1016/j.optm.2008.04.097; [Anonymous], 2013, BIOLUMINESCENT CELL; [Anonymous], 2004, BASF TECHNICAL B; ARAIE M, 1987, EXP EYE RES, V44, P73, DOI 10.1016/S0014-4835(87)80027-1; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Ban Y, 2003, EXP EYE RES, V76, P735, DOI 10.1016/S0014-4835(03)00033-2; Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI 10.1517/17425247.5.5.567 ; Bradbury DA, 2000, J IMMUNOL METHODS, V240, P79, DOI 10.1016/S0022-1759(00)00178-2; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carnt N, 2007, CORNEAL STAINING IER; Castro-Munozledo F, 2008, EXP EYE RES, V86, P459, DOI 10.1016/j.exer.2007.11.017; Cavet ME, 2009, CONTACT LENS ANTERIO, V32, P171, DOI 10.1016/j.clae.2009.05.002; Chang JE, 2000, PHARMACEUT RES, V17, P670, DOI 10.1023/A:1007569929765; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choy CKM, 2012, CLIN EXP OPTOM, V95, P198, DOI 10.1111/j.1444-0938.2011.00687.x; Choy CKM, 2009, OPTOMETRY VISION SCI, V86, P447; Debbasch C, 2005, FOOD CHEM TOXICOL, V43, P155, DOI 10.1016/j.fct.2004.09.004; Diaz G, 2007, EUR J HISTOCHEM, V51, P213; Doucet O, 2006, TOXICOL IN VITRO, V20, P499, DOI 10.1016/j.tiv.2005.09.005; Doucet O, 1996, TOXICOL IN VITRO, V10, P305, DOI 10.1016/0887-2333(96)00011-2; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Geerling G, 2001, INVEST OPHTH VIS SCI, V42, P948; GEGGEL HS, 1985, INVEST OPHTH VIS SCI, V26, P901; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Glick R, 2006, COMPOSITIONS METHODS; Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5; Gorbet MB, 2011, MOL VIS, V17, P3458; Gorbet MB, 2010, MOL VIS, V16, P272; Gorbet M, 2013, EYE CONTACT LENS, V39, P42, DOI 10.1097/ICL.0b013e318279bf8c; Greco D, 2010, MOL VIS, V16, P2109; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hahne M, 2012, J PHARM SCI-US, V101, P2976, DOI 10.1002/jps.23190; HE YG, 1991, CURR EYE RES, V10, P851, DOI 10.3109/02713689109013881; ImmunoChemistry Technologies LLC, 2012, FAM FLICA IN VITR CA; JOHNSON LG, 1993, AM J PHYSIOL, V264, pL560, DOI 10.1152/ajplung.1993.264.6.L560; Jones L, 2013, EYE CONTACT LENS, V39, P29, DOI 10.1097/ICL.0b013e31827d4f25; Khoh-Reiter S, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-5; Kondo M, 1997, AM J RESP CELL MOL, V16, P62, DOI 10.1165/ajrcmb.16.1.8998080; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Liang H, 2011, BRIT J OPHTHALMOL, V95, P869, DOI 10.1136/bjo.2010.189449; Lim MJ, 2009, EYE CONTACT LENS, V35, P287, DOI 10.1097/ICL.0b013e3181b9e92c; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; McCanna DJ, 2008, EYE CONTACT LENS, V34, P6, DOI 10.1097/ICL.0b013e31804fa141; Meloni M, 2011, MOL VIS, V17, P113; Meloni M, 2010, TOXICOL IN VITRO, V24, P276, DOI 10.1016/j.tiv.2009.08.016; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Molinari BL, 2005, MICRON, V36, P177, DOI 10.1016/j.micron.2004.08.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nguyen DH, 2003, ALTERNATIVE TOXICOLO, P147; Noecker R, 2001, ADV THER, V18, P205, DOI 10.1007/BF02853166; OHJI M, 1994, INVEST OPHTH VIS SCI, V35, P479; Owen GR, 2006, SUSPENSION FORMULATI; PAALLYSAHO T, 1992, ACTA OPHTHALMOL, V70, P22; Pauly A, 2011, MOL VIS, V17, P745; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Petrali JP, 2000, J APPL TOXICOL, V21, pS173; Powell CH, 2010, CONTACT LENS ANTERIO, V33, P9, DOI 10.1016/j.clae.2009.10.006; Reichl S, 2005, EUR J PHARM BIOPHARM, V60, P305, DOI 10.1016/j.ejpb.2004.09.016; Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225; Reichl S, 2006, P 5 WORLD M PHARM BI; Reichl S, 2008, J PHARM PHARMACOL, V60, P299, DOI 10.1211/jpp.60.3.0004; Reichl S, 2011, EXPERT OPIN DRUG MET, V7, P559, DOI 10.1517/17425255.2011.562195; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Santodomingo-Rubido J, 2006, OPHTHAL PHYSL OPT, V26, P476, DOI 10.1111/j.1475-1313.2006.00393.x; Schotanus MR, 2011, EXP EYE RES, V93, P735, DOI 10.1016/j.exer.2011.09.005; Smolewski P, 2002, J IMMUNOL METHODS, V265, P111, DOI 10.1016/S0022-1759(02)00074-1; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Stepp MA, 1997, J HISTOCHEM CYTOCHEM, V45, P189, DOI 10.1177/002215549704500205; STJOHN JB, 1970, ANAL BIOCHEM, V37, P409, DOI 10.1016/0003-2697(70)90066-7; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tanti NC, 2011, OPTOMETRY VISION SCI, V88, P483, DOI 10.1097/OPX.0b013e3182045967; Toropainen E, 2003, EUR J PHARM SCI, V20, P99, DOI 10.1016/S0928-0987(03)00173-8; Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; Xiang CD, 2009, DRUG METAB DISPOS, V37, P992, DOI 10.1124/dmd.108.026286; Yamasaki K, 2009, INVEST OPHTH VIS SCI, V50, P604, DOI 10.1167/iovs.08-2239; York M, 1998, J APPL TOXICOL, V18, P233, DOI 10.1002/(SICI)1099-1263(199807/08)18:4<233::AID-JAT496>3.0.CO;2-Y; Zhao M, 2012, OPHTHALMIC RES, V48, P124, DOI 10.1159/000334981; ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300	85	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96448	10.1371/journal.pone.0096448	http://dx.doi.org/10.1371/journal.pone.0096448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837074	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800017
J	Velsko, IM; Chukkapalli, SS; Rivera, MF; Lee, JY; Chen, H; Zheng, DH; Bhattacharyya, I; Gangula, PR; Lucas, AR; Kesavalu, L				Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera, Mercedes F.; Lee, Ju-Youn; Chen, Hao; Zheng, Donghang; Bhattacharyya, Indraneel; Gangula, Pandu R.; Lucas, Alexandra R.; Kesavalu, Lakshmyya			Active Invasion of Oral and Aortic Tissues by Porphyromonas gingivalis in Mice Causally Links Periodontitis and Atherosclerosis	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; ATHEROMATOUS PLAQUES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; DIRECT VISUALIZATION; IMMUNE-RESPONSE; NITRIC-OXIDE; RAT MODEL; PATHOGENS; INFLAMMATION	Atherosclerotic vascular disease is a leading cause of myocardial infarction and cerebrovascular accident, and independent associations with periodontal disease (PD) are reported. PD is caused by polymicrobial infections and aggressive immune responses. Genomic DNA of Porphyromonas gingivalis, the best-studied bacterial pathogen associated with severe PD, is detected within atherosclerotic plaque. We examined causal relationships between chronic P. gingivalis oral infection, PD, and atherosclerosis in hyperlipidemic ApoE(null) mice. ApoE(null) mice (n = 24) were orally infected with P. gingivalis for 12 and 24 weeks. PD was assessed by standard clinical measurements while the aorta was examined for atherosclerotic lesions and inflammatory markers by array. Systemic inflammatory markers serum amyloid A, nitric oxide, and oxidized low-density lipoprotein were analyzed. P. gingivalis infection elicited specific antibodies and alveolar bone loss. Fluorescent in situ hybridization detected viable P. gingivalis within oral epithelium and aorta, and genomic DNA was detected within systemic organs. Aortic plaque area was significantly increased in P. gingivalis-infected mice at 24 weeks (P<0.01). Aortic RNA and protein arrays indicated a strong Th2 response. Chronic oral infection with P. gingivalis results in a specific immune response, significant increases in oral bone resorption, aortic inflammation, viable bacteria in oral epithelium and aorta, and plaque development.	[Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera, Mercedes F.; Kesavalu, Lakshmyya] Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, South Korea; [Chen, Hao; Zheng, Donghang; Lucas, Alexandra R.] Univ Florida, Dept Cardiovasc Med & Mol Genet & Microbiol, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Dept Oral Diagnost Sci, Gainesville, FL USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Physiol Oral Biol & Res, Nashville, TN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University; Pusan National University Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College	Kesavalu, L (corresponding author), Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Stefanadis, Christodoulos/ABH-2232-2020; Bhattacharyya, Indraneel/U-7752-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; 	NIH National Institute for Dental and Craniofacial Research [R01DE020820]; NIH National Center for Research Resources [1U54RR026140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	NIH National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH National Institute for Dental and Craniofacial Research (R01DE020820; Dr. Kesavalu); NIH National Center for Research Resources (1U54RR026140-01; Dr. Gangula). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; Allen JD, 2012, NITRIC OXIDE-BIOL CH, V26, P217, DOI 10.1016/j.niox.2012.03.003; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Brodala N, 2005, ARTERIOSCL THROM VAS, V25, P1446, DOI 10.1161/01.ATV.0000167525.69400.9c; Cairo F, 2004, J PERIODONTAL RES, V39, P442, DOI 10.1111/j.1600-0765.2004.00761.x; Carrion J, 2012, J IMMUNOL, V189, P3178, DOI 10.4049/jimmunol.1201053; Cavrini F, 2005, J MED MICROBIOL, V54, P93, DOI 10.1099/jmm.0.45845-0; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Fuchs BM., 2007, METHODS GEN MOL MICR, V5, P886; Fukasawa A, 2012, IMMUNOPHARM IMMUNOT, V34, P470, DOI 10.3109/08923973.2011.627866; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Haraszthy VI, 2000, J PERIODONTOL, V71, P1; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Manz W, 1999, METHOD ENZYMOL, V310, P79; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Progulske-Fox A, 2004, J PERIODONTAL RES, P1; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Rudney JD, 2005, J DENT RES, V84, P59, DOI 10.1177/154405910508400110; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Trevisan M, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.030; Vasquez EC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-22; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; Wada K, 2010, PERIODONTOL 2000, V54, P222, DOI 10.1111/j.1600-0757.2009.00336.x; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x	38	107	110	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97811	10.1371/journal.pone.0097811	http://dx.doi.org/10.1371/journal.pone.0097811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836175	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800070
J	Xia, CQ; Zhang, PC; Li, SW; Yuan, LH; Xia, TN; Xie, C; Clare-Salzler, MJ				Xia, Chang-Qing; Zhang, Pengcheng; Li, Shiwu; Yuan, Lihui; Xia, Tina; Xie, Chao; Clare-Salzler, Michael J.			C-Abl Inhibitor Imatinib Enhances Insulin Production by beta Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GASTROINTESTINAL STROMAL TUMORS; MESYLATE GLEEVEC; PDX-1; SENSITIVITY; NKX6.1; BINDING; GENE; MAFA; AMELIORATION	Chronic myelogenous leukemia patients treated with tyrosine kinase inhibitor, Imatinib, were shown to have increased serum levels of C-peptide. Imatinib specifically inhibits the tyrosine kinase, c-Abl. However, the mechanism of how Imatinib treatment can lead to increased insulin level is unclear. Specifically, there is little investigation into whether Imatinib directly affects beta cells to promote insulin production. In this study, we showed that Imatinib significantly induced insulin expression in both glucose-stimulated and resting beta cells. In line with this finding, c-Abl knockdown by siRNA and overexpression of c-Abl markedly enhanced and inhibited insulin expression in beta cells, respectively. Unexpectedly, high concentrations of glucose significantly induced c-Abl expression, suggesting c-Abl may play a role in balancing insulin production during glucose stimulation. Further studies demonstrated that c-Abl inhibition did not affect the major insulin gene transcription factor, pancreatic and duodenal homeobox-1 (PDX-1) expression. Of interest, inhibition of c-Abl enhanced NKx2.2 and overexpression of c-Abl in beta cells markedly down-regulated NKx2.2, which is a positive regulator for insulin gene expression. Additionally, we found that c-Abl inhibition significantly enhanced the expression of glucose transporter GLUT2 on beta cells. Our study demonstrates a previously unrecognized mechanism that controls insulin expression through c-Abl-regulated NKx2.2 and GLUT2. Therapeutic targeting beta cell c-Abl could be employed in the treatment of diabetes or beta cell tumor, insulinoma.	[Xia, Chang-Qing] Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China; [Xia, Chang-Qing; Zhang, Pengcheng; Li, Shiwu; Yuan, Lihui; Xia, Tina; Xie, Chao; Clare-Salzler, Michael J.] Univ Florida, Diabet Ctr Excellence, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Capital Medical University; State University System of Florida; University of Florida	Xia, CQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China.	cqx65@yahoo.com	Xie, Chao/ABA-7345-2021	Xie, Chao/0000-0001-7645-1922	JDRF academic RD award [17-2008-1036]; National Natural Science Foundation of China [81172854, 81241015]	JDRF academic RD award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by JDRF academic R&D award (17-2008-1036 to CQX) and National Natural Science Foundation of China (81172854 and 81241015 to CQX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Chang LJ, 2010, METHODS MOL BIOL, V614, P161, DOI 10.1007/978-1-60761-533-0_11; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Fitter S, 2010, J CLIN ENDOCR METAB, V95, P3763, DOI 10.1210/jc.2010-0086; Frasca F, 2007, J BIOL CHEM, V282, P26077, DOI 10.1074/jbc.M705008200; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Hagerkvist R, 2008, CLIN SCI, V114, P65, DOI 10.1042/CS20070122; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hagerkvist R, 2006, CELL BIOL INT, V30, P1013, DOI 10.1016/j.cellbi.2006.08.006; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hill JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-62; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Kaneto H, 2008, FRONT BIOSCI-LANDMRK, V13, P6406, DOI 10.2741/3162; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Mokhtari D, 2013, DIABETOLOGIA; Nielsen K, 2004, DIABETOLOGIA, V47, P2185, DOI 10.1007/s00125-004-1578-1; Ono K, 2012, INTERNAL MED, V51, P2763, DOI 10.2169/internalmedicine.51.8314; Paronen J, 2003, ANN NY ACAD SCI, V1005, P205, DOI 10.1196/annals.1288.027; Saito S, 2013, DIGESTION, V87, P47, DOI 10.1159/000343938; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Tsapas A, 2008, LEUKEMIA RES, V32, P674, DOI 10.1016/j.leukres.2007.08.014; Veneri D, 2005, NEW ENGL J MED, V352, P1049, DOI 10.1056/NEJM200503103521023; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Yeung David T., 2012, Critical Reviews in Oncogenesis, V17, P17	32	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97694	10.1371/journal.pone.0097694	http://dx.doi.org/10.1371/journal.pone.0097694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835010	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800064
J	Dutta, S; Warshall, C; Bandyopadhyay, C; Dutta, D; Chandran, B				Dutta, Sujoy; Warshall, Case; Bandyopadhyay, Chirosree; Dutta, Dipanjan; Chandran, Bala			Interactions between Exosomes from Breast Cancer Cells and Primary Mammary Epithelial Cells Leads to Generation of Reactive Oxygen Species Which Induce DNA Damage Response, Stabilization of p53 and Autophagy in Epithelial Cells	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; CARCINOMA IN-SITU; OF-THE-ART; INTERCELLULAR-COMMUNICATION; MEMBRANE-VESICLES; FIBROBLASTS; GROWTH; MICROENVIRONMENT; PROGRESSION; MICROVESICLES	Exosomes are nanovesicles originating from multivesicular bodies and are released by all cell types. They contain proteins, lipids, microRNAs, mRNAs and DNA fragments, which act as mediators of intercellular communications by inducing phenotypic changes in recipient cells. Tumor-derived exosomes have been shown to play critical roles in different stages of tumor development and metastasis of almost all types of cancer. One of the ways by which exosomes affect tumorigenesis is to manipulate the tumor microenvironments to create tumor permissive "niches". Whether breast cancer cell secreted exosomes manipulate epithelial cells of the mammary duct to facilitate tumor development is not known. To address whether and how breast cancer cell secreted exosomes manipulate ductal epithelial cells we studied the interactions between exosomes isolated from conditioned media of 3 different breast cancer cell lines (MDA-MB-231, T47DA18 and MCF7), representing three different types of breast carcinomas, and normal human primary mammary epithelial cells (HMECs). Our studies show that exosomes released by breast cancer cell lines are taken up by HMECs, resulting in the induction of reactive oxygen species (ROS) and autophagy. Inhibition of ROS by N-acetyl-L-cysteine (NAC) led to abrogation of autophagy. HMEC-exosome interactions also induced the phosphorylation of ATM, H2AX and Chk1 indicating the induction of DNA damage repair (DDR) responses. Under these conditions, phosphorylation of p53 at serine 15 was also observed. Both DDR responses and phosphorylation of p53 induced by HMEC-exosome interactions were also inhibited by NAC. Furthermore, exosome induced autophagic HMECs were found to release breast cancer cell growth promoting factors. Taken together, our results suggest novel mechanisms by which breast cancer cell secreted exosomes manipulate HMECs to create a tumor permissive microenvironment.	[Dutta, Sujoy; Warshall, Case; Bandyopadhyay, Chirosree; Dutta, Dipanjan; Chandran, Bala] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Dutta, S (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA.	sujoy.dutta@rosalindfranklin.edu			H. M. Bligh Cancer Research; RFUMS (CMS)-ALGH pilot research grant	H. M. Bligh Cancer Research; RFUMS (CMS)-ALGH pilot research grant	This work was supported by H. M. Bligh Cancer Research support to BC and RFUMS (CMS)-ALGH pilot research grant to BC and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Chazotte B, 2011, COLD SPRING HARB PRO, V2011; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Cho JA, 2012, INT J ONCOL, V40, P130, DOI 10.3892/ijo.2011.1193; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; FOIDART JM, 1994, B ACAD NAT MED PARIS, V178, P533; Fontana S, 2013, PROTEOMICS, V13, P1581, DOI 10.1002/pmic.201200398; Gangadhara S, 2012, FUTURE ONCOL, V8, P1427, DOI [10.2217/FON.12.134, 10.2217/fon.12.134]; Ge R, 2012, CANCER MICROENVIRON, V5, P323, DOI 10.1007/s12307-012-0110-2; Gusachenko ON, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1, DOI 10.1134/S000629791301001X; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Hoffman RM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3426; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Howlader N, 2012, SEER CANC STAT REV 1; Inal JM, 2013, BBA-PROTEINS PROTEOM, V1834, P2317, DOI 10.1016/j.bbapap.2013.04.005; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kaur P, 2008, TOXICOL IN VITRO, V22, P1392, DOI 10.1016/j.tiv.2008.01.017; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kotzerke K, 2013, EXP DERMATOL, V22, P650, DOI 10.1111/exd.12230; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marcucci F, 2014, INT J CANCER, V135, P1265, DOI 10.1002/ijc.28572; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; MURPHY CS, 1990, CANCER RES, V50, P7285; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Paltridge JL, 2013, BBA-PROTEINS PROTEOM, V1834, P2233, DOI 10.1016/j.bbapap.2013.03.014; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Principe S, 2013, PROTEOMICS, V13, P1608, DOI 10.1002/pmic.201200533; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; ROSE HN, 1975, SCIENCE, V190, P673, DOI 10.1126/science.1188362; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Sui XB, 2011, AUTOPHAGY, V7, P565, DOI 10.4161/auto.7.6.14073; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Svensson KJ, 2013, BIOCHEM SOC T, V41, P273, DOI 10.1042/BST20120248; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wendler F, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22390; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	74	100	105	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97580	10.1371/journal.pone.0097580	http://dx.doi.org/10.1371/journal.pone.0097580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831807	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500081
J	Ji, ZH; Wang, TC; Shao, ZJ; Huang, DH; Wang, AH; Guo, ZW; Long, Y; Zhang, L; Su, HX; Zhang, Q; Yan, YP; Fan, DM				Ji, Zhaohua; Wang, Tingcai; Shao, Zhongjun; Huang, Dahong; Wang, Anhui; Guo, Zhiwen; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping; Fan, Daiming			A Population-Based Study Examining Hepatitis B Virus Infection and Immunization Rates in Northwest China	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; VACCINATION; PREVENTION; IMPACT	Background and Aim: Current baseline data regarding the prevalence of hepatitis B virus (HBV) infections and the immune status in hyperendemic areas is necessary in evaluating the effectiveness of ongoing HBV prevention and control programs in northwest China. This study aims to determine the prevalence of chronic HBV infections, past exposure rates, and immune response profiles in Wuwei City, northwest China in 2010. Methods: Cross-sectional household survey representative of the Wuwei City population. 28,579 participants were interviewed in the seroepidemiological survey >= 1 year of age. House to house screening was conducted using a standard questionnaire. All serum samples were screened by enzyme-linked immunoassays for the presence of hepatitis B surface antigen, antibodies against HBV surface antigen, and antibodies to the hepatitis B core antigen. Results: Among individuals >= 1 year of age, 7.2% (95% CI: 6.3-8.1%) had chronic HBV infections, 43.9% (CI: 40.4-47.4%) had been exposed to HBV, and 23.49% (CI: 21.6-25.3%) had vaccine-induced immunity. Multi-factor weighted logistic regression analysis showed that having household contact with HBV carriers (OR = 2.6, 95% CI: 2.3-3.0) and beauty treatments in public places (OR = 1.2, 95% CI: 1.1-1.3) were the risk factors of HBV infection in whole population. Having household contact with HBV carriers (OR = 3.8, 95% CI: 2.2-6.5) and lack of hepatitis vaccination (OR = 2.0, 95% CI: 1.4-3.3) were the risk factors for HBV infection in children aged 1-14 years. Conclusions: Hepatitis B infection remains a serious public health problem in northwest China. Having household contact with HBV carriers and beauty treatments in public places represented HBV infection risk factors. Hepatitis B vaccine immunization strategies need further improvement, particularly by targeting the immunization of rural migrant workers.	[Ji, Zhaohua; Shao, Zhongjun; Wang, Anhui; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Ji, Zhaohua; Shao, Zhongjun; Wang, Anhui; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Wang, Tingcai; Huang, Dahong; Guo, Zhiwen] Wuwei Municipal Ctr Dis Control & Prevent, Chongzuo, Gansu, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yanyping@fmmu.edu.cn; fandaim@fmmu.edu.cn	Yan, Yongping/K-9634-2019	Su, Haixia/0000-0002-1154-8077	China Special Grant for the Prevention and Control of Infectious Diseases [2009ZX10002-027, 2012ZX10004907]	China Special Grant for the Prevention and Control of Infectious Diseases	This study was supported by the China Special Grant for the Prevention and Control of Infectious Diseases (2009ZX10002-027 and 2012ZX10004907): Infectious disease prevention and control in endemic areas and epidemiological studies of viral hepatitis B in Wuwei City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1990, MED CLIN N AM, V74, P1529, DOI 10.1016/S0025-7125(16)30493-X; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P441; [Anonymous], REP INC RAT HEP B CH; [Anonymous], 2009, CHIN HLTH STAT DIG; Cui F, 2008, CHINESE J VACCINES I, P413; Cui FQ, 2007, VACCINE, V25, P664, DOI 10.1016/j.vaccine.2006.08.027; Ding X, 2001, INTERVIROLOGY, V44, P43, DOI 10.1159/000050029; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Ioannou GN, 2011, ANN INTERN MED, V154, P319, DOI 10.7326/0003-4819-154-5-201103010-00006; Li C, 2012, J TRANSL MED, V10, P2214; Li F, 2012, VACCINE, V30, P7118, DOI 10.1016/j.vaccine.2012.09.031; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Li Z, 2012, CHINESE J EPIDEMIOLO, V33, P305; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu C, 2011, WORLD J GASTROENTERO, V17, P3054, DOI 10.3748/wjg.v17.i25.3054; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Liu L, 2011, INT J CANCER, V128, P1692, DOI 10.1002/ijc.25488; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Shao ZJ, 2011, J MED VIROL, V83, P791, DOI 10.1002/jmv.22043; Sun ZT, 2002, J MED VIROL, V67, P447, DOI 10.1002/jmv.10094; Wang FZ, 2007, CHINESE J VACCINES I, V13, P309; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Xin D, 2003, JPN J INFECT DIS, V56, P19; Yongri T, 2005, CLIN HEPATOLOGY, V21, P28; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149; Zhang L, 2010, INT J INFECT DIS, V14, pE483, DOI 10.1016/j.ijid.2009.08.005; Zhang Wei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P767; Zhang Wei, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P918	34	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97474	10.1371/journal.pone.0097474	http://dx.doi.org/10.1371/journal.pone.0097474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832483	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500063
J	Nakao, R; Kikushima, K; Higuchi, H; Obana, N; Nomura, N; Bai, DY; Ohnishi, M; Senpuku, H				Nakao, Ryoma; Kikushima, Kenji; Higuchi, Hideo; Obana, Nozomu; Nomura, Nobuhiko; Bai, Dongying; Ohnishi, Makoto; Senpuku, Hidenobu			A Novel Approach for Purification and Selective Capture of Membrane Vesicles of the Periodontopathic Bacterium, Porphyromonas gingivalis: Membrane Vesicles Bind to Magnetic Beads Coated with Epoxy Groups in a Noncovalent, Species-Specific Manner	PLOS ONE			English	Article							ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; BACTEROIDES-GINGIVALIS; PSEUDOMONAS-AERUGINOSA; PORIN PORB; FIMA GENE; CELLS; LIPOPOLYSACCHARIDE; PERIODONTITIS; W50	Membrane vesicles (MVs) of Porphyromonas gingivalis are regarded as an offensive weapon of the bacterium, leading to tissue deterioration in periodontal disease. Therefore, isolation of highly purified MVs is indispensable to better understand the pathophysiological role of MVs in the progression of periodontitis. MVs are generally isolated by a conventional method based on ultracentrifugation of the bacterial culture supernatant. However, the resulting MVs are often contaminated with co-precipitating bacterial appendages sheared from the live bacteria. Here, we report an intriguing property of P. gingivalis MVs-their ability to bind superparamagnetic beads coated with epoxy groups (SB-Epoxy). Analysis of fractions collected during the purification revealed that all MVs of five tested P. gingivalis stains bound to SB-Epoxy. In contrast, free fimbriae in the crude MV preparation did not bind to the SB-Epoxy. The SB-Epoxy-bound MVs were easily dissociated from the SB-Epoxy using a mild denaturation buffer. These results suggest that the surface chemistry conferred by epoxy on the beads is responsible for the binding, which is mediated by noncovalent bonds. Both the structural integrity and purity of the isolated MVs were confirmed by electron microscopy. The isolated MVs also caused cell detachment from culture dishes at a physiologically relevant concentration. Assays of competitive binding between the SB-Epoxy and mixtures of MVs from five bacterial species demonstrated that only P. gingivalis MVs could be selectively eliminated from the mixtures. We suggest that this novel approach enables efficient purification and selective elimination of P. gingivalis MVs.	[Nakao, Ryoma; Ohnishi, Makoto; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Kikushima, Kenji; Higuchi, Hideo] Univ Tokyo, Dept Sci, Tokyo, Japan; [Obana, Nozomu; Nomura, Nobuhiko] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Bai, Dongying] Tokyo Med & Dent Univ, Grad Sch, Dept Gerodontol, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; University of Tsukuba; Tokyo Medical & Dental University (TMDU)	Nakao, R (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan.	ryoma73@nih.go.jp	Nomura, Nobuhiko/AAR-1915-2021; SENPUKU, HIDENOBU/ABC-6160-2021	Nomura, Nobuhiko/0000-0003-1103-9157; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22791822, 24659821]; Ministry of Health, Labor and Welfare [H22 Iryo-Ippan-026]; Naito Foundation; Grants-in-Aid for Scientific Research [13J00321, 23247022] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid from the Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22791822 and 24659821); the Ministry of Health, Labor and Welfare (H22 Iryo-Ippan-026); and The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Fan Q, 2001, ORAL MICROBIOL IMMUN, V16, P144, DOI 10.1034/j.1399-302X.2001.016003144.x; Fan Q, 2000, ORAL MICROBIOL IMMUN, V15, P158, DOI 10.1034/j.1399-302x.2000.150303.x; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kimura Y, 1978, Kokubyo Gakkai Zasshi, V45, P20; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909, DOI 10.1128/JCM.38.5.1909-1914.2000; Nakagawa I, 2002, J PERIODONTAL RES, V37, P425, DOI 10.1034/j.1600-0765.2002.01637.x; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; RIVERA M, 1988, J BACTERIOL, V170, P512, DOI 10.1128/jb.170.2.512-521.1988; Rudel T, 1996, CELL, V85, P391, DOI 10.1016/S0092-8674(00)81117-4; SCHLEIN RA, 1991, AM J ORTHOD DENTOFAC, V99, P466, DOI 10.1016/S0889-5406(05)81580-X; van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065157; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WEEL JFL, 1991, J EXP MED, V174, P705, DOI 10.1084/jem.174.3.705	43	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95137	10.1371/journal.pone.0095137	http://dx.doi.org/10.1371/journal.pone.0095137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830438	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500008
J	O'Farrill, G; Schampaert, KG; Rayfield, B; Bodin, O; Calme, S; Sengupta, R; Gonzalez, A				O'Farrill, Georgina; Schampaert, Kim Gauthier; Rayfield, Bronwyn; Bodin, Orjan; Calme, Sophie; Sengupta, Raja; Gonzalez, Andrew			The Potential Connectivity of Waterhole Networks and the Effectiveness of a Protected Area under Various Drought Scenarios	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; HABITAT AVAILABILITY; CRITICAL THRESHOLDS; HOME-RANGE; FRAGMENTATION; POPULATIONS; PERSISTENCE; DYNAMICS; CALAKMUL; RESERVE	Landscape connectivity is considered a priority for ecosystem conservation because it may mitigate the synergistic effects of climate change and habitat loss. Climate change predictions suggest changes in precipitation regimes, which will affect the availability of water resources, with potential consequences for landscape connectivity. The Greater Calakmul Region of the Yucatan Peninsula (Mexico) has experienced a 16% decrease in precipitation over the last 50 years, which we hypothesise has affected water resource connectivity. We used a network model of connectivity, for three large endangered species (Baird's tapir, white-lipped peccary and jaguar), to assess the effect of drought on waterhole availability and connectivity in a forested landscape inside and adjacent to the Calakmul Biosphere Reserve. We used reported travel distances and home ranges for our species to establish movement distances in our model. Specifically, we compared the effects of 10 drought scenarios on the number of waterholes (nodes) and the subsequent changes in network structure and node importance. Our analysis revealed that drought dramatically influenced spatial structure and potential connectivity of the network. Our results show that waterhole connectivity and suitable habitat (area surrounding waterholes) is lost faster inside than outside the reserve for all three study species, an outcome that may drive them outside the reserve boundaries. These results emphasize the need to assess how the variability in the availability of seasonal water resource may affect the viability of animal populations under current climate change inside and outside protected areas.	[O'Farrill, Georgina] Univ Toronto, Ecol & Evolutionary Biol Dept, Toronto, ON, Canada; [Rayfield, Bronwyn; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Schampaert, Kim Gauthier; Calme, Sophie] Univ Sherbrooke, Dept Geomat KGS, Dept Biol SC, Sherbrooke, PQ J1K 2R1, Canada; [Bodin, Orjan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Calme, Sophie] Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Sengupta, Raja] McGill Univ, Dept Geog, Montreal, PQ, Canada	University of Toronto; McGill University; University of Sherbrooke; Stockholm University; El Colegio de la Frontera Sur (ECOSUR); McGill University	O'Farrill, G (corresponding author), Univ Toronto, Ecol & Evolutionary Biol Dept, Toronto, ON, Canada.	georgina.ofarrill@gmail.com	Bodin, Örjan/A-5098-2010; Calmé, Sophie/ABC-9684-2021; Gonzalez, Andrew/F-2247-2010; Calmé, Sophie/J-5723-2013; Rayfield, Bronwyn/ABB-8306-2021	Bodin, Örjan/0000-0002-8218-1153; Calmé, Sophie/0000-0003-0818-3932; Gonzalez, Andrew/0000-0001-6075-8081; Calmé, Sophie/0000-0003-0818-3932; Rayfield, Bronwyn/0000-0003-1768-1300; Sengupta, Raja/0000-0003-4914-5844	Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); National Science and Engineering Research Council from Canada (NSERC); Canada Research Chair Program; Global Environmental and Climate Change Center (GEC3); Swedish Foundation for Strategic Environmental Research (MISTRA); Stockholm University; NASA-LCLUC program [NAG5-6046, NAG5-11134]	Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); National Science and Engineering Research Council from Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Global Environmental and Climate Change Center (GEC3); Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research); Stockholm University; NASA-LCLUC program	This study was carried out with the support of the Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT-doctoral fellowship) and Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT-postdoctoral fellowship) to GO, the National Science and Engineering Research Council from Canada (NSERC) Discovery Grants program to AG and RS, the Canada Research Chair Program (to AG), the Global Environmental and Climate Change Center (GEC3), the Swedish Foundation for Strategic Environmental Research (MISTRA), the strategic research program Ekoklim at Stockholm University, and the NASA-LCLUC program(NAG5-6046 and NAG5-11134) to the Southern Yucatan Peninsular Region(SYPR) project. The Walter Hitschfeld Geographic Information Centre in the Geography Department at McGill University provided the authors with the Quick Bird images. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2009, ECOGRAPHY, V32, P123, DOI 10.1111/j.1600-0587.2008.05435.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bodin O, 2007, LANDSCAPE ECOL, V22, P31, DOI 10.1007/s10980-006-9015-0; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Caso A, 2008, IUCN RED LIST THREAT; Castellanos A, 2008, IUCN 2009 IUCN RED L; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chavez Tovar JC, 2010, THESIS U GRANADA; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Cote D, 2009, LANDSCAPE ECOL, V24, P101, DOI 10.1007/s10980-008-9283-y; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; Fall A, 2001, ECOL MODEL, V141, P1, DOI 10.1016/S0304-3800(01)00334-9; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; García Gil Gerardo, 2002, Invest. Geog, P7; Gomez-Rodriguez C, 2009, AQUAT ECOL, V43, P1179, DOI 10.1007/s10452-009-9235-x; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hetherington DA, 2008, MAMMAL REV, V38, P285, DOI 10.1111/j.1365-2907.2008.00117.x; Kadoya T, 2009, POPUL ECOL, V51, P5, DOI 10.1007/s10144-008-0120-6; Larson BD, 2004, ENVIRON MODELL SOFTW, V19, P7, DOI 10.1016/S1364-8152(03)00098-7; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Márdero Sofía, 2012, Invest. Geog, P19; Martuinez E., 2002, B SOC BOT MEX, V71, P7, DOI DOI 10.17129/B0TSCI.1660; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; Naranjo Eduardo J., 2002, Tapir Conservation, V11, P25; Neeti N, 2012, REMOTE SENS LETT, V3, P433, DOI 10.1080/01431161.2011.616238; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Pereira M, 2011, LANDSCAPE URBAN PLAN, V100, P67, DOI 10.1016/j.landurbplan.2010.11.009; Perez-Cortez S, 2012, REV MEX BIODIVERS, V83, P753, DOI 10.7550/rmb.25095; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Reyna-Hurtado R, 2008, IUCN 2012 IUCN RED L; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Reyna-Hurtado R, 2009, J MAMMAL, V90, P1199, DOI 10.1644/08-MAMM-A-246.1; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Solomon S, 2007, CLIMATE CHANGE 2001; Stevens VM, 2008, CONSERV BIOL, V22, P1194, DOI 10.1111/j.1523-1739.2008.00990.x; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Tobler M, 2008, THESIS TEXAS A M U; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Valeix M, 2008, ANIM CONSERV, V11, P391, DOI 10.1111/j.1469-1795.2008.00194.x; Vester HFM, 2007, ECOL APPL, V17, P989, DOI 10.1890/05-1106; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Wright CK, 2010, ECOLOGY, V91, P1924, DOI 10.1890/09-0865.1	53	19	26	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95049	10.1371/journal.pone.0095049	http://dx.doi.org/10.1371/journal.pone.0095049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830392	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500007
J	Zayas-Santiago, A; Agte, S; Rivera, Y; Benedikt, J; Ulbricht, E; Karl, A; Davila, J; Savvinov, A; Kucheryavykh, Y; Inyushin, M; Cubano, LA; Pannicke, T; Veh, RW; Francke, M; Verkhratsky, A; Eaton, MJ; Reichenbach, A; Skatchkov, SN				Zayas-Santiago, Astrid; Agte, Silke; Rivera, Yomarie; Benedikt, Jan; Ulbricht, Elke; Karl, Anett; Davila, Jose; Savvinov, Alexey; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Pannicke, Thomas; Veh, Ruediger W.; Francke, Mike; Verkhratsky, Alexei; Eaton, Misty J.; Reichenbach, Andreas; Skatchkov, Serguei N.			Unidirectional Photoreceptor-to-Muller Glia Coupling and Unique K+ Channel Expression in Caiman Retina	PLOS ONE			English	Article							RECTIFYING POTASSIUM CHANNEL; SENSORINEURAL DEAFNESS; GLUTAMATE UPTAKE; ELECTRORETINOGRAM COMPONENTS; CONNEXIN43 IMMUNOREACTIVITY; EXTRACELLULAR K; CELL DIFFUSION; GAP-JUNCTIONS; ATP-CHANNELS; KIR4.1	Background: Muller cells, the principal glial cells of the vertebrate retina, are fundamental for the maintenance and function of neuronal cells. In most vertebrates, including humans, Muller cells abundantly express Kir4.1 inwardly rectifying potassium channels responsible for hyperpolarized membrane potential and for various vital functions such as potassium buffering and glutamate clearance; inter-species differences in Kir4.1 expression were, however, observed. Localization and function of potassium channels in Muller cells from the retina of crocodiles remain, hitherto, unknown. Methods: We studied retinae of the Spectacled caiman (Caiman crocodilus fuscus), endowed with both diurnal and nocturnal vision, by (i) immunohistochemistry, (ii) whole-cell voltage-clamp, and (iii) fluorescent dye tracing to investigate K+ channel distribution and glia-to-neuron communications. Results: Immunohistochemistry revealed that caiman Muller cells, similarly to other vertebrates, express vimentin, GFAP, S100 beta, and glutamine synthetase. In contrast, Kir4.1 channel protein was not found in Muller cells but was localized in photoreceptor cells. Instead, 2P-domain TASK-1 channels were expressed in Muller cells. Electrophysiological properties of enzymatically dissociated Muller cells without photoreceptors and isolated Muller cells with adhering photoreceptors were significantly different. This suggests ion coupling between Muller cells and photoreceptors in the caiman retina. Sulforhodamine-B injected into cones permeated to adhering Muller cells thus revealing a uni-directional dye coupling. Conclusion: Our data indicate that caiman Muller glial cells are unique among vertebrates studied so far by predominantly expressing TASK-1 rather than Kir4.1 K+ channels and by bi-directional ion and uni-directional dye coupling to photoreceptor cells. This coupling may play an important role in specific glia-neuron signaling pathways and in a new type of K+ buffering.	[Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Pathol, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Biochem, Bayamon, PR USA; [Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR USA; [Agte, Silke; Ulbricht, Elke; Karl, Anett; Pannicke, Thomas; Francke, Mike; Reichenbach, Andreas] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Agte, Silke] Univ Leipzig, Dept Phys, Div Soft Matter Phys, D-04109 Leipzig, Germany; [Savvinov, Alexey] Univ Puerto Rico, Dept Phys Sci, Rio Piedras, PR 00931 USA; [Ulbricht, Elke] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Veh, Ruediger W.] Charite, Berlin, Germany; [Francke, Mike] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Verkhratsky, Alexei] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Leipzig University; Leipzig University; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Cambridge; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Manchester	Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Pathol, Bayamon, PR 00960 USA.	sergueis50@yahoo.com	Pannicke, Thomas/A-5078-2017; Verkhratsky, Alexei/J-4527-2013; Francke, Mike/A-7505-2017; Inyushin, Mikhail/B-2459-2016; Reichenbach, Andreas/B-2510-2017	Pannicke, Thomas/0000-0001-7435-9540; Verkhratsky, Alexei/0000-0003-2592-9898; Inyushin, Mikhail/0000-0003-3253-7307; Zayas-Santiago, Astrid/0000-0003-4028-0564; Veh, Rudiger/0000-0002-6253-9808	National Institutes of Health from NINDS [R01-NS065201-02 03]; Title-V PPOHA, RCMI-SRDU from NIMHD; NIGMS [SC1-GM 088019-02, SC2 GM095410]; NIMHD [G12-RR03035, 8G12-MD007583-27 G12-RR03035]; FIPI-NSF-UPR; Deutsche Forschungsgemeinschaft [FOR 748, GRK 1097, RE 849/16-1, SPP 1172, PA 615/2-1]; German Federal Ministry of Education and Research: BMBF [1315883]; European Community [FP7-SPP 1172]; EU FP 7 Program EduGlia [237956]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM088019, SC2GM095410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Title-V PPOHA, RCMI-SRDU from NIMHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD; FIPI-NSF-UPR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research: BMBF(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); EU FP 7 Program EduGlia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This publication was made possible by grants from the National Institutes of Health: R01-NS065201-02 03 from NINDS (to SNS); Title-V PPOHA, RCMI-SRDU from NIMHD (to LC and AZ); SC1-GM 088019-02 from NIGMS (to MJE); SC2 GM095410 from NIGMS (to YK); G12-RR03035-Project-A from NIMHD (to MI); 8G12-MD007583-27 G12-RR03035 from NIMHD (for core facilities at UCC); FIPI-NSF-UPR (to AS); From the Deutsche Forschungsgemeinschaft: FOR 748, GRK 1097, RE 849/16-1 and SPP 1172(to AR); PA 615/2-1 (to TP). From the German Federal Ministry of Education and Research: BMBF 1315883 (to MF), From the European Community: FP7-SPP 1172 (to AR); and EU FP 7 Program EduGlia 237956 (to AR and AV). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; [Anonymous], 1851, Z WISS ZOOL; Ball AK, 1998, J COMP NEUROL, V393, P48, DOI 10.1002/(SICI)1096-9861(19980330)393:1<48::AID-CNE5>3.0.CO;2-Q; BANK M, 1992, J NEUROSCI, V12, P2960, DOI 10.1523/JNEUROSCI.12-08-02960.1992; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; Biedermann B, 1998, GLIA, V23, P209, DOI 10.1002/(SICI)1098-1136(199807)23:3<209::AID-GLIA4>3.0.CO;2-#; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bringmann A, 1999, EUR J NEUROSCI, V11, P2883, DOI 10.1046/j.1460-9568.1999.00706.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; BYKOV K A, 1984, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V70, P1381; Chao TI, 1997, J NEUROCYTOL, V26, P439, DOI 10.1023/A:1018525222826; CONNER JD, 1985, J PHYSIOL-LONDON, V362, P79, DOI 10.1113/jphysiol.1985.sp015664; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; DICK E, 1985, J GEN PHYSIOL, V85, P885, DOI 10.1085/jgp.85.6.885; DICK E, 1985, J GEN PHYSIOL, V85, P911, DOI 10.1085/jgp.85.6.911; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; DREHER Z, 1994, J COMP NEUROL, V350, P96, DOI 10.1002/cne.903500107; Du GZ, 2011, ANESTHESIOLOGY, V115, P1003, DOI 10.1097/ALN.0b013e3182343660; Eaton MJ, 2004, NEUROREPORT, V15, P321, DOI 10.1097/00001756-200402090-00022; Eaton MJ, 2002, NEUROREPORT, V13, P57, DOI 10.1097/00001756-200201210-00016; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ettaiche M, 2001, BRAIN RES, V890, P118, DOI 10.1016/S0006-8993(00)03152-8; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Giblin LJ, 1997, BRAIN RES, V755, P146, DOI 10.1016/S0006-8993(97)00174-1; Glukhov AV, 2013, J MOL CELL CARDIOL, V62, P90, DOI 10.1016/j.yjmcc.2013.04.016; Govardovski VI, 1987, SENS SYST, V1, P28; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hibino H, 1997, J NEUROSCI, V17, P4711; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Iandiev I, 2006, NEUROSCI LETT, V396, P97, DOI 10.1016/j.neulet.2005.11.016; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Iandiev L, 2008, NEUROSCI LETT, V434, P317, DOI 10.1016/j.neulet.2008.02.026; IMANAGA I, 1987, AM J PHYSIOL, V252, pH223, DOI 10.1152/ajpheart.1987.252.1.H223; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Jons T, 2006, J CELL SCI, V119, P3087, DOI 10.1242/jcs.03041; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Krishnamoorthy V, 2008, INVEST OPHTH VIS SCI, V49, P2643, DOI 10.1167/iovs.07-1471; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Laurens H, 1921, J EXP ZOOL, V32, P207, DOI 10.1002/jez.1400320204; LEDAIN AC, 1994, J MEMBRANE BIOL, V141, P239, DOI 10.1007/BF00235133; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Linn DM, 1998, VISUAL NEUROSCI, V15, P449; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; MALCHOW RP, 1989, P NATL ACAD SCI USA, V86, P4326, DOI 10.1073/pnas.86.11.4326; Morton MJ, 2005, AM J PHYSIOL-RENAL, V288, pF162, DOI 10.1152/ajprenal.00248.2004; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1985, J NEUROSCI, V5, P2225; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1987, J NEUROSCI, V7, P2423; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; NEWMAN EA, 1988, GLIA, V1, P275, DOI 10.1002/glia.440010406; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, VISION RES, V45, P1781, DOI 10.1016/j.visres.2005.01.016; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Raap M, 2002, NEUROREPORT, V13, P1037, DOI 10.1097/00001756-200206120-00012; REICHELT W, 1993, NEUROSCI LETT, V155, P15, DOI 10.1016/0304-3940(93)90663-6; REICHELT W, 1993, NEUROSCIENCE, V57, P599, DOI 10.1016/0306-4522(93)90009-5; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; ROBINSON SR, 1993, SCIENCE, V262, P1072; SAFRANYOS RGA, 1987, P NATL ACAD SCI USA, V84, P2272, DOI 10.1073/pnas.84.8.2272; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schopf S, 2004, NEUROSCI LETT, V365, P167, DOI 10.1016/j.neulet.2004.04.074; SCHWARTZ EA, 1993, NEURON, V10, P1141, DOI 10.1016/0896-6273(93)90062-V; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Skatchkov SN, 2006, GLIA, V53, P266, DOI 10.1002/glia.20280; Skatchkov SN, 2002, GLIA, V38, P256, DOI 10.1002/glia.10073; Skatchkov SN, 2001, NEUROREPORT, V12, P1437, DOI 10.1097/00001756-200105250-00028; SKATCHKOV SN, 1995, GLIA, V15, P54, DOI 10.1002/glia.440150107; Solessio E, 2000, J NEUROPHYSIOL, V83, P418, DOI 10.1152/jn.2000.83.1.418; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Thompson DA, 2011, J PHYSIOL-LONDON, V589, P1681, DOI 10.1113/jphysiol.2010.198531; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; WAGNER EC, 1991, EXP EYE RES, V53, P583, DOI 10.1016/0014-4835(91)90216-2; WALD G, 1957, J GEN PHYSIOL, V40, P703, DOI 10.1085/jgp.40.5.703; Walls G., 1967, VERTEBRATE EYE ITS A; Walls GL, 1942, CRANBROOK I SCI B; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Zahs KR, 2006, VISUAL NEUROSCI, V23, P1, DOI 10.1017/S0952523806231018; Zahs KR, 2003, J COMP NEUROL, V455, P531, DOI 10.1002/cne.10524; Zahs KR, 1998, GLIA, V24, P85, DOI 10.1002/(SICI)1098-1136(199809)24:1<85::AID-GLIA9>3.3.CO;2-C; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zayas-Santiago A, 2013, 32008 SOC NEUR; Zayas-Santiago A, 2012, 56612 SOC NEUR; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; ZHU H, 1994, J NEUROSCI, V14, P6886	108	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97155	10.1371/journal.pone.0097155	http://dx.doi.org/10.1371/journal.pone.0097155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831221	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500037
J	Bouyer, C; Forestier, L; Renand, G; Oulmouden, A				Bouyer, Claire; Forestier, Lionel; Renand, Gilles; Oulmouden, Ahmad			Deep Intronic Mutation and Pseudo Exon Activation as a Novel Muscular Hypertrophy Modifier in Cattle	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; MYOSTATIN GENE; GROWTH; MICE; EXPRESSION; SERUM; MYOD; LOOP	Myostatin is essential for proper regulation of myogenesis, and inactivation of Myostatin results in muscle hypertrophy. Here, we identified an unexpected mutation in the myostatin gene which is almost fixed in Blonde d'Aquitaine cattle. In skeletal muscle, the mutant allele was highly expressed leading to an abnormal transcript consisting of a 41-bp inclusion and premature termination codons and to residual levels of a correctly spliced transcript. This expression pattern, caused by a leaky intronic mutation with regard to spliceosome activity and its apparent stability with regard to surveillance mechanisms, could contribute to the moderate muscle hypertrophy in this cattle breed. This finding is of importance for genetic counseling for meat quantity and quality in livestock production and possibly to manipulate myostatin pre-mRNA in human muscle diseases.	[Bouyer, Claire; Forestier, Lionel; Oulmouden, Ahmad] Univ Limoges, INRA, UMR 1061, Unite Genet Mol Anim, Limoges, France; [Renand, Gilles] INRA, UMR 1313, Unite Genet Anim & Biol Integrat, Jouy En Josas, France	INRAE; Universite de Limoges; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Oulmouden, A (corresponding author), Univ Limoges, INRA, UMR 1061, Unite Genet Mol Anim, Limoges, France.	ahmad.oulmouden@unilim.fr		Ahmad, oulmouden/0000-0002-2920-2226	Universite de Limoges; Region Limousin; INRA, France	Universite de Limoges; Region Limousin; INRA, France	This work was funded by the Universite de Limoges, Region Limousin and INRA, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 1999, DOMEST ANIM ENDOCRIN, V17, P191, DOI 10.1016/S0739-7240(99)00036-3; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Forbes D, 2006, J CELL PHYSIOL, V206, P264, DOI 10.1002/jcp.20477; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hu SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058521; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Karim L, 2000, ANIM GENET, V31, P396, DOI 10.1046/j.1365-2052.2000.00684.x; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Oldham JM, 2001, AM J PHYSIOL-REG I, V280, pR1488, DOI 10.1152/ajpregu.2001.280.5.R1488; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	25	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97399	10.1371/journal.pone.0097399	http://dx.doi.org/10.1371/journal.pone.0097399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827585	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400090
J	Peel, D; Miller, BS; Kelly, N; Dawson, S; Slooten, E; Double, MC				Peel, David; Miller, Brian S.; Kelly, Natalie; Dawson, Steve; Slooten, Elisabeth; Double, Michael C.			A Simulation Study of Acoustic-Assisted Tracking of Whales for Mark-Recapture Surveys	PLOS ONE			English	Article							MALE SPERM-WHALES; PACIFIC; BLUE; KAIKOURA; ABUNDANCE; BEHAVIOR; DESIGN; CALLS	Collecting enough data to obtain reasonable abundance estimates of whales is often difficult, particularly when studying rare species. Passive acoustics can be used to detect whale sounds and are increasingly used to estimate whale abundance. Much of the existing effort centres on the use of acoustics to estimate abundance directly, e. g. analysing detections in a distance sampling framework. Here, we focus on acoustics as a tool incorporated within mark-recapture surveys. In this context, acoustic tools are used to detect and track whales, which are then photographed or biopsied to provide data for mark-recapture analyses. The purpose of incorporating acoustics is to increase the encounter rate beyond using visual searching only. While this general approach is not new, its utility is rarely quantified. This paper predicts the "acoustically-assisted'' encounter rate using a discrete-time individual-based simulation of whales and survey vessel. We validate the simulation framework using existing data from studies of sperm whales. We then use the framework to predict potential encounter rates in a study of Antarctic blue whales. We also investigate the effects of a number of the key parameters on encounter rate. Mean encounter rates from the simulation of sperm whales matched well with empirical data. Variance of encounter rate, however, was underestimated. The simulation of Antarctic blue whales found that passive acoustics should provide a 1.7-3.0 fold increase in encounter rate over visual-only methods. Encounter rate was most sensitive to acoustic detection range, followed by vocalisation rate. During survey planning and design, some indication of the relationship between expected sample size and effort is paramount; this simulation framework can be used to predict encounter rates and establish this relationship. For a case in point, the simulation framework indicates unequivocally that real-time acoustic tracking should be considered for quantifying the abundance of Antarctic blue whales via mark-recapture methods.	[Peel, David; Kelly, Natalie] CSIRO Computat Informat, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia; [Peel, David; Miller, Brian S.; Kelly, Natalie; Double, Michael C.] Australian Marine Mammal Ctr, Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia; [Dawson, Steve; Slooten, Elisabeth] Univ Otago, Dunedin, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Antarctic Division; University of Otago	Peel, D (corresponding author), CSIRO Computat Informat, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia.	David.peel@csiro.au	Peel, David/E-8888-2010; Kelly, Natalie/B-3481-2010	Peel, David/0000-0002-1413-3168; Dawson, Stephen/0000-0003-3182-0186; Kelly, Nat/0000-0002-9664-354X; Miller, Brian/0000-0001-7615-3044	Australian Government; Australian Antarctic Science Project [4102]	Australian Government(Australian GovernmentCGIAR); Australian Antarctic Science Project	This work was supported by the Australian Government, and contributes to Australian Antarctic Science Project 4102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Buckland S.T., 2001, pi; CHILDERHOUSE SJ, 1995, CAN J ZOOL, V73, P723, DOI 10.1139/z95-084; Dawson S.M., 1995, REP INT WHAL COMM, V45, P431; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Double MC, 2013, CRUISE REPORT 2013 A, P1; Douglas LA, 2005, J ACOUST SOC AM, V118, P523, DOI 10.1121/1.1937283; Ensor P, 2006, 2005 2006 INT WHALIN; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; Jaquet N, 2001, J ACOUST SOC AM, V109, P2254, DOI 10.1121/1.1360718; Jaquet N, 2000, CAN J ZOOL, V78, P407, DOI 10.1139/cjz-78-3-407; Langrock R, 2014, METHODS ECOL EVOL, V5, P190, DOI 10.1111/2041-210X.12155; Leaper R., 1992, DEV PRACTICAL TECHNI; Lettevall E, 2002, CAN J ZOOL, V80, P1189, DOI 10.1139/Z02-102; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; McDonald MA, 2001, J ACOUST SOC AM, V109, P1728, DOI 10.1121/1.1353593; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; Miller BS, 2012, P AC 2012; Miller BS, 2012, SCI COMM INT WHAL CO; Miller BS, 2013, SCI COMM INT WHAL CO, P17; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Development Core Team, 2012, R LANG ENV STAT COMP; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Rone BK, 2012, MAR MAMMAL SCI, V28, pE528, DOI 10.1111/j.1748-7692.2012.00573.x; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Thomas L., 2012, ACOUST TODAY, V8, P35, DOI [10.1121/1.4753915, DOI 10.1121/1.4753915]; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Turchin Peter, 1998; Wade P, 2006, BIOL LETTERS, V2, P417, DOI 10.1098/rsbl.2006.0460; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H., 1986, REPORTS INT WHALING, V8, P149; Whitehead H, 2008, MAR ECOL PROG SER, V361, P291, DOI 10.3354/meps07412; Yochem P. K., 1985, HDB MARINE MAMMALS, V3, P193	37	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95602	10.1371/journal.pone.0095602	http://dx.doi.org/10.1371/journal.pone.0095602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827919	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400013
J	Potamitis, I				Potamitis, Ilyas			Automatic Classification of a Taxon-Rich Community Recorded in the Wild	PLOS ONE			English	Article							BIODIVERSITY	There is a rich literature on automatic species identification of a specific target taxon as regards various vocalizing animals. Research usually is restricted to specific species - in most cases a single one. It is only very recently that the number of monitored species has started to increase for certain habitats involving birds. Automatic acoustic monitoring has not yet been proven to be generic enough to scale to other taxa and habitats than the ones described in the original research. Although attracting much attention, the acoustic monitoring procedure is neither well established yet nor universally adopted as a biodiversity monitoring tool. Recently, the multi-instance multi-label framework on bird vocalizations has been introduced to face the obstacle of simultaneously vocalizing birds of different species. We build on this framework to integrate novel, image-based heterogeneous features designed to capture different aspects of the spectrum. We applied our approach to a taxon-rich habitat that included 78 birds, 8 insect species and 1 amphibian. This dataset constituted the Multi-label Bird Species Classification Challenge-NIPS 2013 where the proposed approach achieved an average accuracy of 91.25% on unseen data.	Technol Educ Inst Crete, Dept Mus Technol & Acoust, Iraklion, Greece	Hellenic Mediterranean University	Potamitis, I (corresponding author), Technol Educ Inst Crete, Dept Mus Technol & Acoust, Iraklion, Greece.	potamitis@staff.teicrete.gr		Potamitis, Ilyas/0000-0002-7111-3331	Project AMIBIO	Project AMIBIO	This work was funded by Project AMIBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeli R, 2010, PATTERN RECOGN LETT, V31, P1524, DOI 10.1016/j.patrec.2009.09.014; Bas Y., 2013, P NEUR INF PROC SCAL; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Brandes TS, 2006, J ACOUST SOC AM, V120, P2950, DOI 10.1121/1.2355479; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs F., 2013, IEEE INT WORKSH MACH; Briggs F, 2012, J ACOUST SOC AM, V131, P4640, DOI 10.1121/1.4707424; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Fodor G, 2013, IEEE INT WORKS MACH, DOI 10.1109/MLSP.2013.6661932; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Glotin H., 2013, P NIPS INT C; Glotin H, 2013, P 1 INT WORKSH MACH; Grimsley Jasmine M S, 2012, Front Behav Neurosci, V6, P89, DOI 10.3389/fnbeh.2012.00089; Halkias XC, 2013, J ACOUST SOC AM, V134, P3496, DOI 10.1121/1.4821203; Keen S, 2014, ECOLOGICAL INFORM; Kottege N, 2012, WUWNET 12 P 7 ACM IN; Lasseck M., 2013, P NEUR INF PROC SCAL; Lundy M, 2013, BIOACOUSTICS, V20, P101; Potamitis I, 2014, APPL ACOUST, V80, P1, DOI 10.1016/j.apacoust.2014.01.001; Riede K., 1997, P442; RIEDE K, 1993, AMBIO, V22, P546; Shih F., 2009, IMAGE PROCESSING MAT; Skowronski MD, 2006, J ACOUST SOC AM, V119, P1817, DOI 10.1121/1.2166948; Slimani T, 2010, P 11 C LUS ESP HERP, P148; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065	25	49	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96936	10.1371/journal.pone.0096936	http://dx.doi.org/10.1371/journal.pone.0096936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826989	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400047
J	Ritz, U; Spies, V; Mehling, I; Gruszka, D; Rommens, PM; Hofmann, A				Ritz, Ulrike; Spies, Volker; Mehling, Isabella; Gruszka, Dominik; Rommens, Pol Maria; Hofmann, Alexander			Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW; CD34(+) CELLS; MUSCULOSKELETAL TRAUMA; CD34-POSITIVE CELLS; PERIPHERAL-BLOOD; MULTIPLE TRAUMA; PRECURSOR CELLS; SKIN BURNS; NEOVASCULARIZATION	Circulating CD34+ progenitor cells () gained importance in the field of regenerative medicine due to their potential to home in on injury sites and differentiate into cells of both endothelial and osteogenic lineages. In this study, we analyzed the mobilization kinetics and the numbers of CD34+, CD31+, CD45+, and CD133+ cells in twenty polytrauma patients (n = 13 male, n = 7 female, mean age 46.5 +/- 17.2 years, mean injury severity score (ISS) 35.8 +/- 12.5 points). In addition, the endothelial differentiation capacity of enriched CD34+ cells was assessed by analyzing DiI-ac-LDL/ lectin uptake, the expression of endothelial markers, and the morphological characteristics of these cells in Matrigel and spheroid cultures. We found that on days 1, 3, and 7 after a major trauma, the number of CD34+ cells increased from 6-up to 12-fold (p < 0.0001) over the number of CD34+ cells from a control population of healthy, age-matched volunteers. The numbers of CD31+ cells were consistently higher on days 1 (1.4-fold, p, 0.01) and 7 (1.3-fold, p, 0.01), whereas the numbers of CD133+ cell did not change during the time course of investigation. Expression of endothelial marker molecules in CD34+ cells was significantly induced in the polytrauma patients. In addition, we show that the CD34+ cell levels in severely injured patients were not correlated with clinical parameters, such as the ISS score, the acute physiology and chronic health evaluation II score (APACHE II), as well as the sequential organ failure assessment score (SOFA-2). Our results clearly indicate that proangiogenic cells are systemically mobilized after polytrauma and that their numbers are sufficient for the development of novel therapeutic models in regenerative medicine.	[Ritz, Ulrike; Spies, Volker; Mehling, Isabella; Gruszka, Dominik; Rommens, Pol Maria; Hofmann, Alexander] Johannes Gutenberg Univ Mainz, Ctr Orthopaed & Trauma Surg, Univ Med Ctr, BiomaT Grp, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Hofmann, A (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Orthopaed & Trauma Surg, Univ Med Ctr, BiomaT Grp, D-55122 Mainz, Germany.	hofmann.trauma-surgery@gmx.net	Hofmann, Alexander/C-3943-2013; Gruszka, Dominik/AAB-7785-2020; Gruszka, Dominik/ABE-5001-2020; Ritz, Ulrike/N-6871-2016	Gruszka, Dominik/0000-0001-8360-9441; Ritz, Ulrike/0000-0001-8936-3227	German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III) [HO 4309/1-1]; MAIFOR (University Medical Centre Mainz) [111]	German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III); MAIFOR (University Medical Centre Mainz)	Funds were received in total support of the research presented in this article. The funding agencies were the German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III, HO 4309/1-1) and MAIFOR No. 111 (University Medical Centre Mainz). No benefits of any kind have been received or will be received by the authors from a commercial party related directly or indirectly to the subject of this article. No competing financial interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Busuioc CJ, 2013, ROM J MORPHOL EMBRYO, V54, P163; Casamassimi A, 2007, J BIOCHEM, V141, P503, DOI 10.1093/jb/mvm060; Chang HW, 2010, TRANSL RES, V156, P251, DOI 10.1016/j.trsl.2010.07.010; Chen JL, 1997, STEM CELLS, V15, P368, DOI 10.1002/stem.150368; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Foresta C, 2011, J TRAUMA, V70, P459, DOI 10.1097/TA.0b013e3181fcf83c; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; German Trauma Society, 2002, S3 GUID TREATM PAT S; Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kuroda R, 2014, TISSUE ENG B; Kuroda R, 2011, CELL TRANSPLANT, V20, P1491, DOI 10.3727/096368910X550189; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Li R, 2012, J ORTHOP TRAUMA, V26, P689, DOI 10.1097/BOT.0b013e318266eb7e; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Musialek P, 2011, J NUCL CARDIOL, V18, P104, DOI 10.1007/s12350-010-9326-z; Pasquet S, 2009, CYTOTHERAPY, V11, P1002, DOI 10.3109/14653240903164963; Patschan SA, 2011, CRIT CARE, V15, DOI 10.1186/cc10100; Qi YY, 2010, INFLAMM RES, V59, P889, DOI 10.1007/s00011-010-0201-9; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Schuh A, 2013, CURR PHARM DES; Shantsila E, 2012, J THROMB HAEMOST, V10, P1252, DOI 10.1111/j.1538-7836.2012.04753.x; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; TSCHERNE H, 1987, CHIRURG, V58, P631; van Ierssel SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069499; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wara AK, 2011, BLOOD; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xin-Long M, 2012, J ORTHOP RES	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97369	10.1371/journal.pone.0097369	http://dx.doi.org/10.1371/journal.pone.0097369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826895	Green Published, gold			2022-12-25	WOS:000336857400086
J	Trott, M; Weiss, S; Antoni, S; Koch, J; von Briesen, H; Hust, M; Dietrich, U				Trott, Maria; Weiss, Svenja; Antoni, Sascha; Koch, Joachim; von Briesen, Hagen; Hust, Michael; Dietrich, Ursula			Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3-and a Trimer-Specific gp41 Antibody	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENVELOPE GLYCOPROTEIN TRIMERS; B-CELL RESPONSES; PBL-SCID MICE; V3 LOOP; RECOMBINANT ANTIBODIES; PASSIVE-IMMUNIZATION; PHAGE DISPLAY	HIV neutralizing antibodies (nAbs) represent an important tool in view of prophylactic and therapeutic applications for HIV-1 infection. Patients chronically infected by HIV-1 represent a valuable source for nAbs. HIV controllers, including long-term non-progressors (LTNP) and elite controllers (EC), represent an interesting subgroup in this regard, as here nAbs can develop over time in a rather healthy immune system and in the absence of any therapeutic selection pressure. In this study, we characterized two particular antibodies that were selected as scFv antibody fragments from a phage immune library generated from an LTNP with HIV neutralizing antibodies in his plasma. The phage library was screened on recombinant soluble gp140 envelope (Env) proteins. Sequencing the selected peptide inserts revealed two major classes of antibody sequences. Binding analysis of the corresponding scFv-Fc derivatives to various trimeric and monomeric Env constructs as well as to peptide arrays showed that one class, represented by monoclonal antibody (mAb) A2, specifically recognizes an epitope localized in the pocket binding domain of the C heptad repeat (CHR) in the ectodomain of gp41, but only in the trimeric context. Thus, this antibody represents an interesting tool for trimer identification. MAb A7, representing the second class, binds to structural elements of the third variable loop V3 and neutralizes tier 1 and tier 2 HIV-1 isolates of different subtypes with matching critical amino acids in the linear epitope sequence. In conclusion, HIV controllers are a valuable source for the selection of functionally interesting antibodies that can be selected on soluble gp140 proteins with properties from the native envelope spike.	[Trott, Maria; Weiss, Svenja; Antoni, Sascha; Koch, Joachim; Dietrich, Ursula] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany; [von Briesen, Hagen] Fraunhofer Inst Biomed Engn, HIV Specimen Cryorepository HSC, St Ingbert, Germany; [Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany	Octapharma; Fraunhofer Gesellschaft; Braunschweig University of Technology	Dietrich, U (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany.	ursula.dietrich@gsh.uni-frankfurt.de	Dietrich, Ursula/AAD-5704-2020	Hust, Michael/0000-0003-3418-6045; Dietrich, Ursula/0000-0003-2491-4758	Dr. Bodo Sponholz-Foundation	Dr. Bodo Sponholz-Foundation	This work was supported by the Dr. Bodo Sponholz-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Andrabi R, 2013, VIROLOGY, V439, P81, DOI 10.1016/j.virol.2012.12.010; Antoni S, 2007, AIDS RES HUM RETROV, V23, P1377, DOI 10.1089/aid.2007.0113; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Derby NR, 2007, VIROLOGY, V366, P433, DOI 10.1016/j.virol.2007.05.020; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gorny MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027780; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoorelbeke B, 2013, FEBS LETT, V587, P860, DOI 10.1016/j.febslet.2013.02.037; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Izumi Kazuki, 2011, Antiviral Chemistry & Chemotherapy, V22, P51, DOI 10.3851/IMP1836; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; PARREN PWHI, 1995, AIDS, V9, pF1, DOI 10.1097/00002030-199506000-00001; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Ruprecht Ruth M., 2009, V525, P559, DOI 10.1007/978-1-59745-554-1_31; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Schultz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051715; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; TILLEY SA, 1992, AIDS RES HUM RETROV, V8, P461, DOI 10.1089/aid.1992.8.461; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Veselinovic M, 2012, VIROLOGY, V432, P505, DOI 10.1016/j.virol.2012.06.025; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zahn RC, 2008, GENE THER, V15, P1210, DOI 10.1038/gt.2008.73; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou MK, 2013, EUR J IMMUNOL, V43, P499, DOI 10.1002/eji.201242974; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	87	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97478	10.1371/journal.pone.0097478	http://dx.doi.org/10.1371/journal.pone.0097478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828352	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400098
J	Warren, CJ; Griffin, LM; Little, AS; Huang, IC; Farzan, M; Pyeon, D				Warren, Cody J.; Griffin, Laura M.; Little, Alexander S.; Huang, I-Chueh; Farzan, Michael; Pyeon, Dohun			The Antiviral Restriction Factors IFITM1, 2 and 3 Do Not Inhibit Infection of Human Papillomavirus, Cytomegalovirus and Adenovirus	PLOS ONE			English	Article							INTERFERON-ALPHA; IMMUNE-RESPONSES; NATURAL-HISTORY; CERVICAL-CANCER; E7 ONCOPROTEIN; PROTEIN; CELLS; ENTRY; REPLICATION; PREVALENCE	Type I interferons (IFN-alpha and beta) induce dynamic host defense mechanisms to inhibit viral infections. It has been recently recognized that the interferon-inducible transmembrane proteins (IFITM) 1, 2 and 3 can block entry of a broad spectrum of RNA viruses. However, no study to date has focused on the role of IFITM proteins in DNA virus restriction. Here, we demonstrate that IFN-alpha or -beta treatment of keratinocytes substantially decreases human papillomavirus 16 (HPV16) infection while robustly inducing IFITM1, 2 and 3 expression. However, IFITM1, 2 and 3 overexpression did not inhibit HPV16 infection; rather, IFITM1 and IFITM3 modestly enhanced HPV16 infection in various cell types including primary keratinocytes. Moreover, IFITM1, 2 and 3 did not inhibit infection by two other DNA viruses, human cytomegalovirus (HCMV) and adenovirus type 5 (Ad5). Taken together, we reveal that the entry of several DNA viruses, including HPV, HCMV, and Ad5 is not affected by IFITM1, 2 and 3 expression. These results imply that HPV, and other DNA viruses, may bypass IFITM restriction during intracellular trafficking.	[Warren, Cody J.; Griffin, Laura M.; Little, Alexander S.; Pyeon, Dohun] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Pyeon, Dohun] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Huang, I-Chueh] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Riverside; Scripps Research Institute	Pyeon, D (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA.	Dohun.Pyeon@ucdenver.edu		Warren, Cody/0000-0003-4101-2705; Pyeon, Dohun/0000-0003-1970-844X; Farzan, Michael/0000-0002-2990-5319	NIH [R01 AI091968, T32 AI052066]; University of Colorado Health Sciences Library Open Access Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, R01AI091968, R01AI100953, T32AI052066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Health Sciences Library Open Access Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants, R01 AI091968 (D. P.) and T32 AI052066 (L. G.). Publication of this article was funded in part by the University of Colorado Health Sciences Library Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Barnard P, 1999, VIROLOGY, V259, P305, DOI 10.1006/viro.1999.9771; Beglin M, 2009, J INTERF CYTOK RES, V29, P629, DOI 10.1089/jir.2009.0075; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRANCA AA, 1981, NATURE, V294, P768, DOI 10.1038/294768a0; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; GARBE C, 1990, J INVEST DERMATOL, V95, pS231, DOI 10.1111/1523-1747.ep12875837; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2001, CURR OPIN ONCOL, V13, P183, DOI 10.1097/00001622-200105000-00009; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Ryckman BJ, 2006, J VIROL, V80, P710, DOI 10.1128/JVI.80.2.710-722.2006; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2009, INDIAN J MED RES, V130, P266; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	55	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96579	10.1371/journal.pone.0096579	http://dx.doi.org/10.1371/journal.pone.0096579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827144	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400028
J	Baldwin, CC; Johnson, GD				Baldwin, Carole C.; Johnson, G. David			Connectivity across the Caribbean Sea: DNA Barcoding and Morphology Unite an Enigmatic Fish Larva from the Florida Straits with a New Species of Sea Bass from Deep Reefs off Curacao	PLOS ONE			English	Article							TELEOSTEI; DIVERSITY	Integrative taxonomy, in which multiple disciplines are combined to address questions related to biological species diversity, is a valuable tool for identifying pelagic marine fish larvae and recognizing the existence of new fish species. Here we combine data from DNA barcoding, comparative morphology, and analysis of color patterns to identify an unusual fish larva from the Florida Straits and demonstrate that it is the pelagic larval phase of a previously undescribed species of Liopropoma sea bass from deep reefs off Curacao, southern Caribbean. The larva is unique among larvae of the teleost family Serranidae, Tribe Liopropomini, in having seven elongate dorsal-fin spines. Adults of the new species are similar to the golden bass, Liopropoma aberrans, with which they have been confused, but they are distinct genetically and morphologically. The new species differs from all other western Atlantic liopropomins in having IX, 11 dorsal-fin rays and in having a unique color pattern-most notably the predominance of yellow pigment on the dorsal portion of the trunk, a pale to white body ventrally, and yellow spots scattered across both the dorsal and ventral portions of the trunk. Exploration of deep reefs to 300 m using a manned submersible off Curacao is resulting in the discovery of numerous new fish species, improving our genetic databases, and greatly enhancing our understanding of deep-reef fish diversity in the southern Caribbean. Oh the mother and child reunion is only a moment away. Paul Simon.	[Baldwin, Carole C.; Johnson, G. David] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Baldwin, CC (corresponding author), Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA.	baldwinc@si.edu		Johnson, G D/0000-0003-4339-6589	Consortium for Understanding and Sustaining a Biodiverse Planet; National Geographic Society's Committee for Research and Exploration [9102-12]; Evelyn Axelrod Endowment Fund for systematic ichthyology	Consortium for Understanding and Sustaining a Biodiverse Planet; National Geographic Society's Committee for Research and Exploration(National Geographic Society); Evelyn Axelrod Endowment Fund for systematic ichthyology	Funding for the Smithsonian Institution's Deep Reef Observation Project was provided internally by the Consortium for Understanding and Sustaining a Biodiverse Planet and by National Geographic Society's Committee for Research and Exploration to CCB (Grant # 9102-12). Additional funding for this study was provided to both authors through the generous support of the Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CC, 2013, ZOOL J LINN SOC-LOND, V168, P496, DOI 10.1111/zoj.12033; Baldwin CC, 2013, ZOOKEYS, P71, DOI 10.3897/zookeys.306.5198; Baldwin CC, 2012, COPEIA, P23, DOI 10.1643/CG-11-035; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Baldwin CC, 2009, ZOOTAXA, P1; BALDWIN CC, 1993, B MAR SCI, V52, P240; BALDWIN CC, 1991, B MAR SCI, V48, P67; Baldwin CC, ZOOKEYS IN PRESS; Baldwin CC, 2001, ZOOTAXA, V3133, P1; Chakrabarty P, 2014, ZOOKEYS IN PRESS; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Eschmeyer WN, 2010, ZOOTAXA, P19; Eschmeyer WN, GENERA SPECIES REFER; Frable BW, 2013, FISH B-NOAA, V111, P122, DOI 10.7755/FB.111.2.2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; JOHNSON GD, 1983, COPEIA, P777; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P499; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lagler KF, 1958, FISHES GREAT LAKES R; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moser HG, 1981, MARINE FISH LARVAE M, P90; Moser HG, 1984, ONTOGENY SYSTEMATICS, V1; Neira FJ, 1998, LARVAE TEMPERATE AUS; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Poey F., 1860, MEMORIAS HIST NATURA, V2, P115; Randall JE, 1963, STUD FAUNA CURACAO, V19, P77; Randall John E., 1988, Indo-Pacific Fishes, V16, P1; ROBINS CR, 1967, COPEIA, P591; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHULTZ LEONARD P., 1958, PROC U S NATL MUS, V108, P321; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tornabene Luke, 2010, Aqua, V16, P141; Uiblein F, 2014, MAR BIOL RES, V10, P655, DOI 10.1080/17451000.2013.850515; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Victor BC, 2009, ZOOTAXA, P24; Weigt Lee A, 2012, Methods Mol Biol, V858, P109, DOI 10.1007/978-1-61779-591-6_6; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Winterbottom R, 2014, ZOOKEYS, P79, DOI 10.3897/zookeys.381.6445	42	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97661	10.1371/journal.pone.0097661	http://dx.doi.org/10.1371/journal.pone.0097661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825118	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200131
J	Boltjes, A; Groothuismink, ZM; van Oord, GW; Janssen, HLA; Woltman, AM; Boonstra, A				Boltjes, Arjan; Groothuismink, Zwier M.; van Oord, Gertine W.; Janssen, Harry L. A.; Woltman, Andrea M.; Boonstra, Andre			Monocytes from Chronic HBV Patients React In Vitro to HBsAg and TLR by Producing Cytokines Irrespective of Stage of Disease	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RECOMBINANT HBSAG; BLOOD MONOCYTES; SURFACE-ANTIGEN; SERUM-LEVELS; EXPRESSION; INTERLEUKIN-10; ACTIVATION; INFECTION; MACROPHAGES	Individuals who are chronically infected with the hepatitis B virus (HBV) are highly heterogenous with respect to serum levels of HBV DNA, HBV particles and viral proteins. Since circulating leukocytes, such as monocytes, are constantly exposed to these viral components, it is likely that the functionality of these cells is affected. However, at present, little information is available on the consequences of the interaction between monocytes and viral components. Therefore, we examined the in vitro effects of HBV surface antigen (HBsAg) on monocytes and evaluated whether these effects were reflected in vivo. We observed that in vitro HBsAg exposure of monocytes induced robust production of IL-6 and TNF. However, between chronic HBV patients with distinct levels of serum HBsAg, HBV early antigen (HBeAg), and HBV DNA, TLR-induced monocyte cytokine production did not differ. Importantly, HBsAg-induced cytokine production by monocytes was similar between patients and healthy controls showing that earlier in vivo exposure to HBsAg does not affect the in vitro response. Additionally, we show that IL-10 is able to inhibit cytokine production by HBsAg-induced monocytes. In conclusion, we demonstrate that monocytes can recognize and respond to HBsAg, resulting in vigorous pro-inflammatory cytokine production in vitro. However, phenotype and function of the monocyte compartment in chronic HBV patients are not influenced by differences in levels of serum viral components, suggesting that regulatory mechanisms are active to avoid excessive in vivo monocyte activation.	[Boltjes, Arjan; Groothuismink, Zwier M.; van Oord, Gertine W.; Janssen, Harry L. A.; Woltman, Andrea M.; Boonstra, Andre] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Janssen, Harry L. A.] Univ Toronto, Div Gastroenterol, Univ Hlth Network, Liver Clin, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Boonstra, A (corresponding author), Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751; Boltjes, Arjan/0000-0002-6338-051X; Boonstra, Andre/0000-0001-8607-1616	Dutch government [FES0908]; Netherlands Genomics Initiative [050-060-452]; Netherlands Organization for Scientific Research (NWO VIDI) [91712329]	Dutch government; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908, by the Netherlands Genomics Initiative (NGI; http://www.genomics.nl/) project number 050-060-452, and by The Netherlands Organization for Scientific Research (NWO VIDI Grant 91712329 to A. M. W.; http://www.nwo.nl/en/funding/our-funding-instruments/nwo/innovational-research-incentives-scheme/vidi/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DD, 2011, VACCINE, V29, P3558, DOI 10.1016/j.vaccine.2011.02.092; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Bozkaya H, 2000, HEPATO-GASTROENTEROL, V47, P1675; Cheng JD, 2005, J HEPATOL, V43, P465, DOI 10.1016/j.jhep.2005.02.033; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gehring AJ, 2013, J CLIN INVEST, V123, P3766, DOI 10.1172/JCI66043; JOCHUM C, 1990, J VIROL, V64, P1956, DOI 10.1128/JVI.64.5.1956-1963.1990; Liu BS, 2012, EUR J IMMUNOL, V42, P2431, DOI 10.1002/eji.201142360; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; Nockher WA, 1998, INFECT IMMUN, V66, P2782, DOI 10.1128/IAI.66.6.2782-2790.1998; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Peng C, 2011, MOL IMMUNOL, V48, P1505, DOI 10.1016/j.molimm.2011.04.008; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Riordan SM, 2006, CLIN VACCINE IMMUNOL, V13, P972, DOI 10.1128/CVI.00396-05; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Tulek N, 2000, HEPATO-GASTROENTEROL, V47, P828; Vanlandschoot P, 2002, BIOCHEM BIOPH RES CO, V297, P486, DOI 10.1016/S0006-291X(02)02243-X; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Vanlandschoot P, 2002, J GEN VIROL, V83, P2279, DOI 10.1099/0022-1317-83-9-2279; Visvanathan K, 2007, HEPATOLOGY, V45, P102, DOI 10.1002/hep.21482; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Wu JF, 2010, GASTROENTEROLOGY, V138, P165, DOI 10.1053/j.gastro.2009.09.018; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484	34	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97006	10.1371/journal.pone.0097006	http://dx.doi.org/10.1371/journal.pone.0097006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824830	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200049
J	Chao, THH; Chen, JH; Yen, CT				Chao, Tzu-Hao Harry; Chen, Jyh-Horng; Yen, Chen-Tung			Repeated BOLD-fMRI Imaging of Deep Brain Stimulation Responses in Rats	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SOMATOSENSORY CORTEX; FUNCTIONAL MRI; FOREPAW STIMULATION; ANESTHETIZED RATS; NEURONAL-ACTIVITY; ALPHA-CHLORALOSE; SENSORY STIMULATION; NEURAL ACTIVITY; ACTIVATION	Functional magnetic resonance imaging (fMRI) provides a picture of the global spatial activation pattern of the brain. Interest is growing regarding the application of fMRI to rodent models to investigate adult brain plasticity. To date, most rodent studies used an electrical forepaw stimulation model to acquire fMRI data, with a-chloralose as the anesthetic. However, a-chloralose is harmful to animals, and not suitable for longitudinal studies. Moreover, peripheral stimulation models enable only a limited number of brain regions to be studied. Processing between peripheral regions and the brain is multisynaptic, and renders interpretation difficult and uncertain. In the present study, we combined the medetomidine-based fMRI protocol (a noninvasive rodent fMRI protocol) with chronic implantation of an MRI-compatible stimulation electrode in the ventroposterior (VP) thalamus to repetitively sample thalamocortical responses in the rat brain. Using this model, we scanned the forebrain responses evoked by the VP stimulation repeatedly of individual rats over 1 week. Cortical BOLD responses were compared between the 2 profiles obtained at day1 and day8. We discovered reproducible frequency- and amplitude-dependent BOLD responses in the ipsilateral somatosensory cortex (S1). The S1 BOLD responses during the 2 sessions were conserved in maximal response amplitude, area size (size ratio from 0.88 to 0.91), and location (overlap ratio from 0.61 to 0.67). The present study provides a long-term chronic brain stimulation protocol for studying the plasticity of specific neural circuits in the rodent brain by BOLD-fMRI.	[Chao, Tzu-Hao Harry; Yen, Chen-Tung] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Yen, CT (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan.	ctyen@ntu.edu.tw		Yen, Chen-Tung/0000-0002-0076-4487	National Science Council, Taiwan [NSC100-2311-B002-002-MY3, NSC102-2311-B002-034-MY3]; National Health Research Institutes, Taiwan [NHRI-EX102-10104NI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Science Council, Taiwan (NSC100-2311-B002-002-MY3 & NSC102-2311-B002-034-MY3), and the National Health Research Institutes, Taiwan (NHRI-EX102-10104NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso BD, 2011, J NEUROSCI METH, V195, P236, DOI 10.1016/j.jneumeth.2010.12.010; Alvarez-Salvado E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0152; Antognini JF, 1999, ANESTHESIOLOGY, V91, P1064, DOI 10.1097/00000542-199910000-00027; Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BONVENTO G, 1994, BRAIN RES, V665, P213, DOI 10.1016/0006-8993(94)91340-4; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Detre JA, 1998, BRAIN RES, V796, P91, DOI 10.1016/S0006-8993(98)00322-9; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dunn JF, 2009, MAGN RESON MED, V61, P222, DOI 10.1002/mrm.21803; Duong TQ, 2000, MAGN RESON MED, V44, P231, DOI 10.1002/1522-2594(200008)44:2<231::AID-MRM10>3.0.CO;2-T; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; Hau J, 2011, HDB LAB ANIMAL SCI; HYDER F, 1994, J CEREBR BLOOD F MET, V14, P649, DOI 10.1038/jcbfm.1994.81; Kim T, 2010, NEUROIMAGE, V52, P224, DOI 10.1016/j.neuroimage.2010.03.064; Krautwald K, 2013, NEUROIMAGE; Kuo CC, 2005, CHINESE J PHYSIOL, V48, P200; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Lu HB, 2004, MAGN RESON MED, V52, P1060, DOI 10.1002/mrm.20265; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Matsuura T, 2001, NEUROSCI RES, V40, P281, DOI 10.1016/S0168-0102(01)00236-X; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Niskanen J-P, 2012, J NEUROTRAUMA; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PARKER JL, 1978, LAB ANIM SCI, V28, P575; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G, 1998, RAT BRAIN IN STEREOT; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Pelled G, 2009, P NATL ACAD SCI USA, V106, P14114, DOI 10.1073/pnas.0903153106; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pikkemaat J, 2002, IMPROVED ANESTHESIA; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Schafer JR, 2005, MAGN RESON MED, V54, P443, DOI 10.1002/mrm.20588; Schmidt C, 2011, ANESTHESIOLOGY; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Shih Y-YI, 2013, BRAIN STIMULATION; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; SILVERMAN J, 1993, LAB ANIM SCI, V43, P210; Sinclair MD, 2003, CAN VET J, V44, P885; UEKI M, 1988, J CEREBR BLOOD F MET, V8, P486, DOI 10.1038/jcbfm.1988.89; Ureshi M, 2004, NEUROSCI RES, V48, P147, DOI 10.1016/j.neures.2003.10.014; Ward B, 2000, ALPHASIM; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Yang PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066821; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604; Yu X, 2012, NEURON, V74, P731, DOI 10.1016/j.neuron.2012.04.024; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zong X, 2013, EFFECTS OF THE A2 AD	64	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97305	10.1371/journal.pone.0097305	http://dx.doi.org/10.1371/journal.pone.0097305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825464	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200092
J	Kishino, Y; Seki, T; Fujita, J; Yuasa, S; Tohyama, S; Kunitomi, A; Tabei, R; Nakajima, K; Okada, M; Hirano, A; Kanazawa, H; Fukuda, K				Kishino, Yoshikazu; Seki, Tomohisa; Fujita, Jun; Yuasa, Shinsuke; Tohyama, Shugo; Kunitomi, Akira; Tabei, Ryota; Nakajima, Kazuaki; Okada, Marina; Hirano, Akinori; Kanazawa, Hideaki; Fukuda, Keiichi			Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions	PLOS ONE			English	Article							EFFICIENT GENE-TRANSFER; SENDAI-VIRUS; HUMAN FIBROBLASTS; GENERATION; MAINTENANCE; INDUCTION; VECTOR; LINES; SYSTEM; BLOOD	Recently, induced pluripotent stem cells (iPSCs) were established as promising cell sources for revolutionary regenerative therapies. The initial culture system used for iPSC generation needed fetal calf serum in the culture medium and mouse embryonic fibroblast as a feeder layer, both of which could possibly transfer unknown exogenous antigens and pathogens into the iPSC population. Therefore, the development of culture systems designed to minimize such potential risks has become increasingly vital for future applications of iPSCs for clinical use. On another front, although donor cell types for generating iPSCs are wide-ranging, T cells have attracted attention as unique cell sources for iPSCs generation because T cell-derived iPSCs (TiPSCs) have a unique monoclonal T cell receptor genomic rearrangement that enables their differentiation into antigen-specific T cells, which can be applied to novel immunotherapies. In the present study, we generated transgene-free human TiPSCs using a combination of activated human T cells and Sendai virus under defined culture conditions. These TiPSCs expressed pluripotent markers by quantitative PCR and immunostaining, had a normal karyotype, and were capable of differentiating into cells from all three germ layers. This method of TiPSCs generation is more suitable for the therapeutic application of iPSC technology because it lowers the risks associated with the presence of undefined, animal-derived feeder cells and serum. Therefore this work will lead to establishment of safer iPSCs and extended clinical application.	[Kishino, Yoshikazu; Seki, Tomohisa; Fujita, Jun; Yuasa, Shinsuke; Tohyama, Shugo; Kunitomi, Akira; Tabei, Ryota; Nakajima, Kazuaki; Okada, Marina; Kanazawa, Hideaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Seki, Tomohisa; Tohyama, Shugo] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science; Keio University	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	kfukuda@a2.keio.jp	Fukuda, Keiichi/L-3777-2013; Seki, Tomohisa/L-3524-2013	Kishino, Yoshikazu/0000-0003-3291-2795; Seki, Tomohisa/0000-0002-4281-135X; Yuasa, Shinsuke/0000-0001-5593-7552	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine	This work was partly supported by the Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome, the Highway Program for the Realization of Regenerative Medicine, and a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Ikeda Y, 2002, EXP EYE RES, V75, P39, DOI 10.1006/exer.2002.1177; Kim HT, 2013, BIOMATERIALS, V34, P1041, DOI 10.1016/j.biomaterials.2012.10.064; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520; Masaki I, 2001, FASEB J, V15, P1294, DOI 10.1096/fj.00-0460fje; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Ohnuki M, 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Sato H, 2007, TISSUE ENG, V13, P1539, DOI 10.1089/ten.2006.0383; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006	33	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97397	10.1371/journal.pone.0097397	http://dx.doi.org/10.1371/journal.pone.0097397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824994	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200108
J	Murhekar, MV; Ahmad, M; Shukla, H; Abhishek, K; Perry, RT; Bose, AS; Shimpi, R; Kumar, A; Kaliaperumal, K; Sethi, R; Selvaraj, V; Kamaraj, P; Routray, S; Das, VN; Menabde, N; Bahl, S				Murhekar, Manoj V.; Ahmad, Mohammad; Shukla, Hemant; Abhishek, Kunwar; Perry, Robert T.; Bose, Anindya S.; Shimpi, Rahul; Kumar, Arun; Kaliaperumal, Kanagasabai; Sethi, Raman; Selvaraj, Vadivoo; Kamaraj, Pattabi; Routray, Satyabrata; Das, Vidya Nand; Menabde, Nata; Bahl, Sunil			Measles Case Fatality Rate in Bihar, India, 2011-12	PLOS ONE			English	Article							MORTALITY REDUCTION GOAL; COMMUNITY; SURVEILLANCE; INFECTION; MODEL	Background: Updated estimates of measles case fatality rates (CFR) are critical for monitoring progress towards measles elimination goals. India accounted for 36% of total measles deaths occurred globally in 2011. We conducted a retrospective cohort study to estimate measles CFR and identify the risk factors for measles death in Bihar-one of the north Indian states historically known for its low vaccination coverage. Methods: We systematically selected 16 of the 31 laboratory-confirmed measles outbreaks occurring in Bihar during 1 October 2011 to 30 April 2012. All households of the villages/urban localities affected by these outbreaks were visited to identify measles cases and deaths. We calculated CFR and used multivariate analysis to identify risk factors for measles death. Results: The survey found 3670 measles cases and 28 deaths (CFR: 0.78, 95% confidence interval: 0.47-1.30). CFR was higher among under-five children (1.22%) and children belonging to scheduled castes/tribes (SC/ST, 1.72%). On multivariate analysis, independent risk factors associated with measles death were age,5 years, SC/ST status and non-administration of vitamin A during illness. Outbreaks with longer interval between the occurrence of first case and notification of the outbreak also had a higher rate of deaths. Conclusions: Measles CFR in Bihar was low. To further reduce case fatality, health authorities need to ensure that SC/ST are targeted by the immunization programme and that outbreak investigations target for vitamin A treatment of cases in high risk groups such as SC/ST and young children and ensure regular visits by health-workers in affected villages to administer vitamin A to new cases.	[Murhekar, Manoj V.; Kaliaperumal, Kanagasabai; Selvaraj, Vadivoo; Kamaraj, Pattabi] ICMR, Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Ahmad, Mohammad; Shukla, Hemant; Abhishek, Kunwar; Bose, Anindya S.; Shimpi, Rahul; Kumar, Arun; Sethi, Raman; Routray, Satyabrata; Menabde, Nata; Bahl, Sunil] WHO, Country Off India, Natl Polio Surveillance Project, New Delhi, India; [Shukla, Hemant; Perry, Robert T.] WHO, CH-1211 Geneva, Switzerland; [Bose, Anindya S.] Bill & Melinda Gates Fdn, New Delhi, India; [Das, Vidya Nand] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); World Health Organization; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Murhekar, MV (corresponding author), ICMR, Natl Inst Epidemiol, Madras, Tamil Nadu, India.	mmurhekar@gmail.com	Murhekar, Manoj/ABG-2389-2020	Murhekar, Manoj/0000-0002-1720-7628; Bose, Anindya Sekhar/0000-0002-7657-8648	WHO (World Health Organization) [2013-297450-0]	WHO (World Health Organization)	The authors received funding from WHO (World Health Organization). The Reference Number associated with this funding is 2013-297450-0. The authors (MA, HS, KA, RTP, ASB, RS, AK, RS, SR, NM, SB) received salary from WHO during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; Cairns KL, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-4; Chen S, 2012, J R STAT SOC C-APPL, V61, P117, DOI 10.1111/j.1467-9876.2011.01001.x; Coronado F, 2006, J TROP PEDIATRICS, V52, P329, DOI 10.1093/tropej/fml026; D'Souza R. M., 2002, COCHRANE DB SYST REV, V1; Govt of India, ANN HLTH SURV 2010 2; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF, V1, P227; Joshi AB, 2009, B WORLD HEALTH ORGAN, V87, P456, DOI 10.2471/BLT.07.050427; MANCHANDA KS, 1980, TROP GEOGR MED, V32, P70; Ministry of Health and Family Welfare Government of India, 2005, MEASL SURV OUTBR INV; Ministry of Health and Family Welfare Govt of India, 2010, MEASL CATCH UP IMM C; Ministry of Social Justice and Empowerment Govt of India, 1965, REP ADV COMM REV LIS; Murhekar MV, 2011, J INFECT DIS, V204, pS427, DOI 10.1093/infdis/jir062; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Perry RT, 2013, MMWR-MORBID MORTAL W, V62, P27; Samb B, 1997, AM J EPIDEMIOL, V145, P51, DOI 10.1093/oxfordjournals.aje.a009031; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh M B, 1994, Indian Pediatr, V31, P340; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Sudfeld CR, 2009, INDIAN PEDIATR, V46, P983; UNICEF, COV EV SURV 2009; WHO, 1993, WHOEPIGEN9303; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224	24	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96668	10.1371/journal.pone.0096668	http://dx.doi.org/10.1371/journal.pone.0096668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824641	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200027
J	Suarez, SC; Toffton, SM; McCulloch, SD				Suarez, Samuel C.; Toffton, Shannon M.; McCulloch, Scott D.			Biochemical Analysis of DNA Polymerase eta Fidelity in the Presence of Replication Protein A	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; THYMINE-THYMINE DIMER; ACCESSORY PROTEINS; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; HUMAN-CELLS; 8-OXO-GUANINE BYPASS; SITE; PROCESSIVITY; ALPHA	DNA polymerase g (pol eta) synthesizes across from damaged DNA templates in order to prevent deleterious consequences like replication fork collapse and double-strand breaks. This process, termed translesion synthesis (TLS), is an overall positive for the cell, as cells deficient in pol g display higher mutation rates. This outcome occurs despite the fact that the in vitro fidelity of bypass by pol eta alone is moderate to low, depending on the lesion being copied. One possible means of increasing the fidelity of pol eta is interaction with replication accessory proteins present at the replication fork. We have previously utilized a bacteriophage based screening system to measure the fidelity of bypass using purified proteins. Here we report on the fidelity effects of a single stranded binding protein, replication protein A (RPA), when copying the oxidative lesion 7,8-dihydro-8-oxo-guanine(8-oxoG) and the UV-induced cis-syn thymine-thymine cyclobutane pyrimidine dimer (T-T CPD). We observed no change in fidelity dependent on RPA when copying these damaged templates. This result is consistent in multiple position contexts. We previously identified single amino acid substitution mutants of pol eta that have specific effects on fidelity when copying both damaged and undamaged templates. In order to confirm our results, we examined the Q38A and Y52E mutants in the same full-length construct. We again observed no difference when RPA was added to the bypass reaction, with the mutant forms of pol eta displaying similar fidelity regardless of RPA status. We do, however, observe some slight effects when copying undamaged DNA, similar to those we have described previously. Our results indicate that RPA by itself does not affect pol g dependent lesion bypass fidelity when copying either 8-oxoG or T-T CPD lesions.	[Suarez, Samuel C.; Toffton, Shannon M.; McCulloch, Scott D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [McCulloch, Scott D.] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	McCulloch, SD (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	scott_mcculloch@ncsu.edu			National Institute of Environmental Health Sciences [R01 ES016942];  [T32 ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016942, T32ES007046] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/). R01 ES016942 to SM, supporting SM and SS. T32 ES007046 supporting SM and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beardslee RA, 2013, ENVIRON MOL MUTAGEN, V54, P638, DOI 10.1002/em.21807; Bebenek A, 2005, GENETICS, V169, P1815, DOI 10.1534/genetics.104.037630; Bebenek A, 2002, GENETICS, V162, P1003; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; CARTY MP, 1992, MUTAT RES, V274, P29, DOI 10.1016/0921-8777(92)90041-Z; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Frank EG, 2012, ANAL BIOCHEM, V429, P132, DOI 10.1016/j.ab.2012.07.016; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hashimoto K, 2003, BIOCHEMISTRY-US, V42, P14207, DOI 10.1021/bi0348359; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kroutil LC, 1998, J MOL BIOL, V278, P135, DOI 10.1006/jmbi.1998.1676; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; KUNKEL TA, 1991, MUTAT RES, V250, P175, DOI 10.1016/0027-5107(91)90174-M; Lee DH, 2008, MUTAT RES-FUND MOL M, V641, P19, DOI 10.1016/j.mrfmmm.2008.02.006; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; MAHER VM, 1976, BIOCHEM BIOPH RES CO, V71, P228, DOI 10.1016/0006-291X(76)90272-2; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2007, BIOCHEMISTRY-US, V46, P8888, DOI 10.1021/bi700234t; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SRD, 2006, METHOD ENZYMOL, V408, P341, DOI 10.1016/S0076-6879(06)08021-9; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Mozzherin DJ, 1996, J BIOL CHEM, V271, P31711, DOI 10.1074/jbc.271.49.31711; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Perales C, 2003, NUCLEIC ACIDS RES, V31, P6473, DOI 10.1093/nar/gkg865; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; ROBERTS JD, 1990, PROG CLIN BIOL RES, V340, P91; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; SUZUKI M, 1994, J BIOL CHEM, V269, P10225; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97382	10.1371/journal.pone.0097382	http://dx.doi.org/10.1371/journal.pone.0097382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824831	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200106
J	Chen, YY; Chen, JY; Yu, JJ; Yang, GZ; Temple, E; Harbinski, F; Gao, H; Wilson, C; Pagliarini, R; Zhou, WL				Chen, Yaoyu; Chen, Jinyun; Yu, Jianjun; Yang, Guizhi; Temple, Emilia; Harbinski, Fred; Gao, Hui; Wilson, Christopher; Pagliarini, Raymond; Zhou, Wenlai			Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 METHYLTRANSFERASE ACTIVITY; MLL; GENE; COMPLEX; MENIN; EXPRESSION; HSF1; PHOSPHORYLATION; DEGRADATION; EXECUTION	Heat shock protein 90 (HSP90) inhibition inhibits cancer cell proliferation through depleting client oncoproteins and shutting down multiple oncogenic pathways. Therefore, it is an attractive strategy for targeting human cancers. Several HSP90 inhibitors, including AUY922 and STA9090, show promising effects in clinical trials. However, the efficacy of HSP90 inhibitors may be limited by heat shock factor 1 (HSF1)-mediated feedback mechanisms. Here, we identify, through an siRNA screen, that the histone H3 lysine 4 methyltransferase MLL1 functions as a coactivator of HSF1 in response to HSP90 inhibition. MLL1 is recruited to the promoters of HSF1 target genes and regulates their expression in response to HSP90 inhibition. In addition, a striking combination effect is observed when MLL1 depletion is combined with HSP90 inhibition in various human cancer cell lines and tumor models. Thus, targeting MLL1 may block a HSF1-mediated feedback mechanism induced by HSP90 inhibition and provide a new avenue to enhance HSP90 inhibitor activity in human cancers.	[Chen, Yaoyu; Chen, Jinyun; Yang, Guizhi; Gao, Hui; Pagliarini, Raymond; Zhou, Wenlai] Novartis Inst Biomed Res, Dept Oncol, Cambridge, MA 02139 USA; [Temple, Emilia; Harbinski, Fred] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA; [Wilson, Christopher] Novartis Inst Biomed Res, Dept Neurosci, Cambridge, MA 02139 USA; [Yu, Jianjun] Novartis Inst Biomed Res, Dept Oncol, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis; Novartis	Zhou, WL (corresponding author), Novartis Inst Biomed Res, Dept Oncol, 250 Mass Ave, Cambridge, MA 02139 USA.	wenlai.zhou@novartis.com			Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This work was supported by a presidential postdoctoral fellowship from Novartis Institutes for Biomedical Research (to Y. C.).	Ansari KI, 2013, ONCOGENE, V32, P3359, DOI 10.1038/onc.2012.352; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chen YY, 2013, ONCOTARGET, V4, P816, DOI 10.18632/oncotarget.991; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; de Billy E, 2009, CELL CYCLE, V8, P3806, DOI 10.4161/cc.8.23.10423; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; GENUA MI, 1980, J PHARM SCI, V69, P1282, DOI 10.1002/jps.2600691113; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Heddleston JM, 2012, CELL DEATH DIFFER, V19, P428, DOI 10.1038/cdd.2011.109; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Liu H, 2008, CELL CYCLE, V7, P428, DOI 10.4161/cc.7.4.5426; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Menezes DL, 2012, MOL CANCER THER, V11, P730, DOI 10.1158/1535-7163.MCT-11-0667; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munster PN, 2002, CANCER RES, V62, P3132; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ozdemir Oner, 2003, Cytometry, V56A, P53, DOI 10.1002/cyto.a.10081; Piper PW, 2011, PHARMACEUTICALS, V4, P1400, DOI 10.3390/ph4111400; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Timothy D., 2013, RSC DRUG DISCOVERY; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	50	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18914	18927		10.1074/jbc.M114.574053	http://dx.doi.org/10.1074/jbc.M114.574053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831003	Green Published, hybrid			2022-12-25	WOS:000339062900025
J	No, YR; He, PJ; Yoo, BK; Yun, CC				No, Yi Ran; He, Peijian; Yoo, Byong Kwon; Yun, C. Chris			Unique Regulation of Human Na+/H+ Exchanger 3 (NHE3) by Nedd4-2 Ligase That Differs from Non-primate NHE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; UBIQUITIN LIGASES; PROXIMAL TUBULE; BLOOD-PRESSURE; ISOFORM NHE3; WW DOMAINS; ACTIVATION; PHOSPHORYLATION; HYPERTENSION; DEGRADATION	Na+/H+ exchanger NHE3 expressed in the intestine and kidney plays a major role in NaCl and HCO3- absorption that is closely linked to fluid absorption and blood pressure regulation. The Nedd4 family of E3 ubiquitin ligases interacts with a number of transporters and channels via PY motifs. A comparison of NHE3 sequences revealed the presence of PY motifs in NHE3s from human and several non-human primates but not in non-primate NHE3s. In this study we evaluated the differences between human and non-primate NHE3s in ubiquitination and interaction with Nedd4-2. We found that Nedd4-2 ubiquitinated human NHE3 (hNHE3) and altered its expression and activity. Surprisingly, rat NHE3 coimmunoprecipitated Nedd4-2, but its expression and activity were not altered by silencing of Nedd4-2. Ubiquitination by Nedd4-2 rendered hNHE3 to undergo internalization at a significantly greater rate than non-primate NHE3s without altering protein stability. Insertion of a PY motif in rabbit NHE3 recapitulated the interaction with Nedd4-2 and enhanced internalization. Thus, we propose a new model where disruption of Nedd4-2 interaction elevates hNHE3 expression and activity.	[No, Yi Ran; He, Peijian; Yoo, Byong Kwon; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Whitehead Bldg Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu		He, Peijian/0000-0002-9526-8004; Yoo, Brian/0000-0003-0683-1887	National Institutes of Health [R24DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK061418, T32DK007771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The microscopy core was supported by National Institutes of Health Grant R24DK064399.	Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Bobulescu IA, 2005, CURR OPIN NEPHROL HY, V14, P485, DOI 10.1097/01.mnh.0000174146.52915.5d; Cabado AG, 1996, J BIOL CHEM, V271, P3590; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Fouladkou F, 2004, AM J PHYSIOL-RENAL, V287, pF550, DOI 10.1152/ajprenal.00353.2003; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Gill RK, 2005, GASTROENTEROLOGY, V128, P962, DOI 10.1053/j.gastro.2005.02.011; Girardi ACC, 2012, AM J PHYSIOL-CELL PH, V302, pC1569, DOI 10.1152/ajpcell.00017.2012; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; LaPointe MS, 2002, KIDNEY INT, V62, P157, DOI 10.1046/j.1523-1755.2002.00406.x; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Noonan WT, 2005, AM J PHYSIOL-REG I, V288, pR685, DOI 10.1152/ajpregu.00209.2004; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pankow JS, 2005, AM J HYPERTENS, V18, P672, DOI 10.1016/j.amjhyper.2004.12.004; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Simonin A, 2010, J BIOL CHEM, V285, P38293, DOI 10.1074/jbc.M110.115089; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Yip KP, 1998, AM J PHYSIOL-RENAL, V275, pF565, DOI 10.1152/ajprenal.1998.275.4.F565; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	53	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18360	18372		10.1074/jbc.M113.541706	http://dx.doi.org/10.1074/jbc.M113.541706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831004	Green Published, hybrid			2022-12-25	WOS:000338042000035
J	Jiang, JF; Lu, YF; Li, JG; Li, L; He, X; Shao, HL; Dong, YH				Jiang, Jiafeng; Lu, Yufang; Li, Jiangang; Li, Ling; He, Xin; Shao, Hanliang; Dong, Yuanhua			Effect of Seed Treatment by Cold Plasma on the Resistance of Tomato to Ralstonia solanacearum (Bacterial Wilt)	PLOS ONE			English	Article							CALCIUM NUTRITION; STEM ROT; GERMINATION; GROWTH; BORON; SUSCEPTIBILITY; INACTIVATION; SEVERITY; ROOT	This study investigated the effect of cold plasma seed treatment on tomato bacterial wilt, caused by Ralstonia solanacearum (R. solanacearum), and the regulation of resistance mechanisms. The effect of cold plasma of 80W on seed germination, plant growth, nutrient uptake, disease severity, hydrogen peroxide (H2O2) concentration and activities of peroxidase (POD; EC 1.11.1.7), polyphenol oxidase (PPO; EC 1.10.3.2) and phenylalanine ammonia lyase (PAL; EC 4.3.1.5) were examined in tomato plants. Plasma treatment increased tomato resistance to R. solanacearum with an efficacy of 25.0%. Plasma treatment significantly increased both germination and plant growth in comparison with the control treatment, and plasma- treated plants absorbed more calcium and boron than the controls. In addition, H2O2 levels in treated plants rose faster and reached a higher peak, at 2.579 mu M gFW(-1), 140% greater than that of the control. Activities of POD (421.3 U gFW(-1)), PPO (508.8 U gFW(-1)) and PAL (707.3 U gFW(-1)) were also greater in the treated plants than in the controls (103.0 U gFW(-1), 166.0 U gFW(-1) and 309.4 U gFW(-1), respectively). These results suggest that plasma treatment affects the regulation of plant growth, H2O2 concentration, and POD, PPO and PAL activity in tomato, resulting in an improved resistance to R. solanacearum. Consequently, cold plasma seed treatment has the potential to control tomato bacterial wilt caused by R. solanacearum.	[Jiang, Jiafeng; Li, Jiangang; Li, Ling; He, Xin; Dong, Yuanhua] Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Lu, Yufang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Jiang, Jiafeng; Lu, Yufang; Li, Ling; He, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shao, Hanliang] Changzhou ZhongKe ChangTai Plasma Technol Co Ltd, Changzhou, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, YH (corresponding author), Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	yhdong@issas.ac.cn			Chinese academy of sciences [KSCX2-EW-B-6]; National Science & Technology Pillar Program [2012BAD05B04]; Jiangsu Province Science and Technology Support Program, China [BE2013452]	Chinese academy of sciences(Chinese Academy of Sciences); National Science & Technology Pillar Program; Jiangsu Province Science and Technology Support Program, China	This research was supported by the innovation key program of the Chinese academy of sciences (KSCX2-EW-B-6), National Science & Technology Pillar Program (2012BAD05B04) and Jiangsu Province Science and Technology Support Program, China (BE2013452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios N.G., 2005, PLANT PATHOLOGY; BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P734; Bormashenko E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00741; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2; Deora A, 2011, CAN J PLANT PATHOL, V33, P475, DOI 10.1080/07060661.2011.620630; FINGER A, 1994, J SCI FOOD AGR, V66, P293, DOI 10.1002/jsfa.2740660306; Goodman R. N., 1994, HYPERSENSITIVE REACT; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heller LC, 2012, LETT APPL MICROBIOL, V54, P126, DOI 10.1111/j.1472-765X.2011.03186.x; Henselova M, 2012, BIOLOGIA, V67, P490, DOI 10.2478/s11756-012-0046-5; Hury S, 1998, LETT APPL MICROBIOL, V26, P417; Jiang JF, 2013, EUR J PLANT PATHOL, V136, P547, DOI 10.1007/s10658-013-0186-7; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; KAR RK, 1987, PHYSIOL PLANTARUM, V70, P729, DOI 10.1111/j.1399-3054.1987.tb04331.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li JG, 2013, ANTON LEEUW INT J G, V103, P11, DOI 10.1007/s10482-012-9781-4; Li SM, 2008, ANN MICROBIOL, V58, P573, DOI 10.1007/BF03175560; McGarvey JA, 1999, PHYTOPATHOLOGY, V89, P1233, DOI 10.1094/PHYTO.1999.89.12.1233; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NELSON CL, 1989, CURR MICROBIOL, V18, P275, DOI 10.1007/BF01570305; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rivard CL, 2010, PLANT DIS, V94, P1015, DOI 10.1094/PDIS-94-8-1015; ROBERTS DP, 1988, J BACTERIOL, V170, P1445, DOI 10.1128/jb.170.4.1445-1451.1988; Rose S, 2003, PLANT DIS, V87, P1462, DOI 10.1094/PDIS.2003.87.12.1462; Ruiz JM, 1999, PHYSIOL PLANTARUM, V106, P151, DOI 10.1034/j.1399-3054.1999.106201.x; Sera B, 2010, IEEE T PLASMA SCI, V38, P2963, DOI 10.1109/TPS.2010.2060728; Sera B, 2009, PLASMA SCI TECHNOL, V11, P750, DOI 10.1088/1009-0630/11/6/22; Simoglou KB, 2006, CROP PROT, V25, P657, DOI 10.1016/j.cropro.2005.09.007; Sugimoto T, 2008, PLANT DIS, V92, P1559, DOI 10.1094/PDIS-92-11-1559; Tensmeyer L G, 1981, J Parenter Sci Technol, V35, P93; van Elsas JD, 2001, CAN J MICROBIOL, V47, P842, DOI 10.1139/cjm-47-9-842; VOLPIN H, 1991, PHYTOPATHOLOGY, V81, P1390, DOI 10.1094/Phyto-81-1390; Yamazaki H, 1996, SOIL SCI PLANT NUTR, V42, P203, DOI 10.1080/00380768.1996.10414705; Yin MQ, 2005, PLASMA SCI TECHNOL, V7, P3143, DOI 10.1088/1009-0630/7/6/017; Zivkovic S, 2004, SEED SCI TECHNOL, V32, P693	36	67	70	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97753	10.1371/journal.pone.0097753	http://dx.doi.org/10.1371/journal.pone.0097753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840508	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600068
J	Ito, G; Fujimoto, T; Kamikawaji, S; Kuwahara, T; Iwatsubo, T				Ito, Genta; Fujimoto, Tetta; Kamikawaji, Shogo; Kuwahara, Tomoki; Iwatsubo, Takeshi			Lack of Correlation between the Kinase Activity of LRRK2 Harboring Kinase-Modifying Mutations and Its Phosphorylation at Ser910, 935, and Ser955	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; 14-3-3 BINDING; GTP-BINDING; INHIBITION; POTENT; DOMAIN; GENE	Leucine-rich repeat kinase 2 (LRRK2) is extensively phosphorylated in cells within a region amino-terminal to the leucine-rich repeat domain. Since phosphorylation in this region of LRRK2, including Ser910, Ser935, Ser955, and Ser973, is significantly downregulated upon treatment with inhibitors of LRRK2, it has been hypothesized that signaling pathways downstream of the kinase activity of LRRK2 are involved in regulating the phosphorylation of LRRK2, although the precise mechanism has remained unknown. Here we examined the effects of LRRK2 inhibitors on the phosphorylation state at Ser910, Ser935, and Ser955 in a series of kinase-inactive mutants of LRRK2. We found that the responses of LRRK2 to the inhibitors varied among mutants, in a manner not consistent with the above-mentioned hypothesis. Notably, one of the kinase-inactive mutants, T2035A LRRK2, underwent phosphorylation, as well as the inhibitor-induced dephosphorylation, at Ser910, Ser935, and Ser955, to a similar extent to those observed with wild-type LRRK2. These results suggest that the kinase activity of LRRK2 is not involved in the common mechanism of inhibitor-induced dephosphorylation of LRRK2.	[Ito, Genta; Fujimoto, Tetta; Kuwahara, Tomoki; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan; [Kamikawaji, Shogo; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan	University of Tokyo; University of Tokyo	Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan.	iwatsubo@m.u-tokyo.ac.jp	Ito, Genta/L-2581-2015; Kuwahara, Tomoki/AAT-7119-2021; Kuwahara, Tomoki/AAX-2459-2020	Ito, Genta/0000-0001-6370-1099; Kuwahara, Tomoki/0000-0003-1788-7018; 	Japan Society for the Promotion of Science [22790058, 24790068]; Ministry of Education, Culture, Sports, Science and Technology [17025009]; Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI]; Elan Pharmaceuticals (Innovation Program)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI]; Elan Pharmaceuticals (Innovation Program)	This work was supported by the Japan Society for the Promotion of Science [grant number 22790058 and 24790068 for GI] [Grant-in-Aid for Young Scientists (B)], by the Ministry of Education, Culture, Sports, Science and Technology [grant number 17025009 for TI] (Grant-in-Aid for Scientific Research on Priority Areas-Research on Pathomechanism of Brain Disorders, and Global Center of Excellence Program), by the Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI] and by Elan Pharmaceuticals (Innovation Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Delbroek L, 2013, J PHARMACEUT BIOMED, V76, P49, DOI 10.1016/j.jpba.2012.12.002; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Doggett EA, 2012, J NEUROCHEM, V120, P37, DOI 10.1111/j.1471-4159.2011.07537.x; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Franzini M, 2013, BIOORG MED CHEM LETT, V23, P1967, DOI 10.1016/j.bmcl.2013.02.043; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hermanson SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043580; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Lobbestael E, 2013, BIOCH J; Lobbestael E, 2012, BIOCHEM SOC T, V40, P1102, DOI 10.1042/BST20120128; Luerman GC, 2013, J NEUROCHEM, P1; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Vancraenenbroeck R, 2012, BBA-PROTEINS PROTEOM, V1824, P450, DOI 10.1016/j.bbapap.2011.12.009; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zhao J, 2012, BIOCHEM SOC T, V40, P1158, DOI 10.1042/BST20120137; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	40	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97988	10.1371/journal.pone.0097988	http://dx.doi.org/10.1371/journal.pone.0097988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836358	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800094
J	Roda, MA; Sadik, M; Gaggar, A; Hardison, MT; Jablonsky, MJ; Braber, S; Blalock, JE; Redegeld, FA; Folkerts, G; Jackson, PL				Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Jablonsky, Michael J.; Braber, Saskia; Blalock, James Edwin; Redegeld, Frank A.; Folkerts, Gert; Jackson, Patricia L.			Targeting Prolyl Endopeptidase with Valproic Acid as a Potential Modulator of Neutrophilic Inflammation	PLOS ONE			English	Article							CHEMOATTRACTANT; INHIBITION; MECHANISM; MANIA	A novel neutrophil chemoattractant derived from collagen, proline-glycine-proline (PGP), has been recently characterized in chronic obstructive pulmonary disease (COPD). This peptide is derived via the proteolytic activity of matrix metalloproteases (MMP's)-8/9 and PE, enzymes produced by neutrophils and present in COPD serum and sputum. Valproic acid (VPA) is an inhibitor of PE and could possibly have an effect on the severity of chronic inflammation. Here the interaction site of VPA to PE and the resulting effect on the secondary structure of PE is investigated. Also, the potential inhibition of PGP-generation by VPA was examined in vitro and in vivo to improve our understanding of the biological role of VPA. UV-visible, fluorescence spectroscopy, CD and NMR were used to determine kinetic information and structural interactions between VPA and PE. In vitro, PGP generation was significantly inhibited by VPA. In vivo, VPA significantly reduced cigarette-smoke induced neutrophil influx. Investigating the molecular interaction between VPA and PE showed that VPA modified the secondary structure of PE, making substrate binding at the catalytic side of PE impossible. Revealing the molecular interaction VPA to PE may lead to a better understanding of the involvement of PE and PGP in inflammatory conditions. In addition, the model of VPA interaction with PE suggests that PE inhibitors have a great potential to serve as therapeutics in inflammatory disorders.	[Roda, Mojtaba Abdul; Sadik, Mariam; Braber, Saskia; Folkerts, Gert] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Fac Sci, Utrecht, Netherlands; [Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Blalock, James Edwin; Redegeld, Frank A.; Jackson, Patricia L.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Blalock, James Edwin; Redegeld, Frank A.; Jackson, Patricia L.] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Jablonsky, Michael J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	Utrecht University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Roda, MA (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Fac Sci, Utrecht, Netherlands.	m.abdulroda@uu.nl	Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960; Blalock, J. Edwin/0000-0001-5303-8123	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands) [017.008.029]; University of Alabama Clinical Investigator Fellowship Award; Cystic Fibrosis Foundation [GAGGAR07A0, R464-CR11]; NIH/NHLBI [HL07783, HL090999, HL087824, HL102371-01A1]; NIH/NIDDK [P30 DKO72482]; NIH [RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, P30 DK079337]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114439, R01HL110950, R01HL090999, R01HL077783, R01HL087824, R01HL102371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); University of Alabama Clinical Investigator Fellowship Award; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.A.R. recieved a Mosaic grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands; grant (017.008.029). A. G was supported by the University of Alabama Clinical Investigator Fellowship Award, the Cystic Fibrosis Foundation (Grant GAGGAR07A0 to AG) and NIH/NHLBI (HL07783, HL090999, and HL087824 (to JEB) and HL102371-01A1 (to AG). PLJ is supported by Cystic Fibrosis Foundation R464-CR11 "Research Development Program-Component II'', and NIH/NIDDK P30 DKO72482. The Univ. of Alabama Birmingham (UAB) Lung Health Center Pulmonary Proteomics Laboratory is funded through the NIH (by grants RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, and P30 DK079337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BAKKER AV, 1990, BIOCHEM J, V271, P559, DOI 10.1042/bj2710559; Bellemere G, 2003, J NEUROCHEM, V84, P919, DOI 10.1046/j.1471-4159.2003.01536.x; Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Brodie SA, 2014, CANCER PREV RES, V7, P351, DOI 10.1158/1940-6207.CAPR-13-0254; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Cheng LL, 2005, MOL CELL NEUROSCI, V29, P155, DOI 10.1016/j.mcn.2004.12.003; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Hsieh CL, 2014, CLIN EXP PHARMACOL P, V41, P210, DOI 10.1111/1440-1681.12205; Hsieh CL, 2013, ROM J MORPHOL EMBRYO, V54, P993; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; O'Reilly PJ, 2009, J NEUROIMMUNOL, V217, P51, DOI 10.1016/j.jneuroim.2009.09.020; Papi A, 2010, ANTICANCER RES, V30, P535; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Shen YF, 2014, COPD, V11, P351, DOI 10.3109/15412555.2013.858315; Shinoda M, 1999, BEHAV BRAIN RES, V99, P17, DOI 10.1016/S0166-4328(98)00005-9; Thanacoody RHK, 2009, CLIN TOXICOL, V47, P609, DOI 10.1080/15563650903167772; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WHO, 2008, WORLD HLTH STAT 2013; WILK S, 1983, J NEUROCHEM, V41, P69, DOI 10.1111/j.1471-4159.1983.tb11815.x; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97594	10.1371/journal.pone.0097594	http://dx.doi.org/10.1371/journal.pone.0097594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835793	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800054
J	Rodrigues, RS; Brum, ALG; Paes, MV; Povoa, TF; Basilio-de-Oliveira, CA; Marchiori, E; Borghi, DP; Ramos, GV; Bozza, FA				Rodrigues, Rosana Souza; Garcia Brum, Ana Livia; Paes, Marciano Viana; Povoa, Tiago Fajardo; Basilio-de-Oliveira, Carlos Alberto; Marchiori, Edson; Borghi, Danielle Provencano; Ramos, Grazielle Viana; Bozza, Fernando Augusto			Lung in Dengue: Computed Tomography Findings	PLOS ONE			English	Article							DIFFUSE ALVEOLAR HEMORRHAGE; IMMUNOCOMPETENT PATIENTS; VIRUS-INFECTION; PLASMA LEAKAGE; FEVER; MANIFESTATIONS; LEPTOSPIROSIS; AMERICA	Background: Dengue is the most important mosquito-borne viral disease in the world. Dengue virus infection may be asymptomatic or lead to undifferentiated fever, dengue fever with or without warning signs, or severe dengue. Lower respiratory symptoms are unusual and lung-imaging data in patients with dengue are scarce. Methodology/Principal Findings: To evaluate lung changes associated with dengue infection, we retrospectively analyzed 2,020 confirmed cases of dengue. Twenty-nine of these patients (11 females and 18 males aged 16-90 years) underwent chest computed tomography (CT), which yielded abnormal findings in 17 patients: 16 patients had pleural effusion (the sole finding in six patients) and 11 patients had pulmonary abnormalities. Lung parenchyma involvement ranged from subtle to moderate unilateral and bilateral abnormalities. The most common finding was ground-glass opacity in eight patients, followed by consolidation in six patients. Less common findings were airspace nodules (two patients), interlobular septal thickening (two patients), and peribronchovascular interstitial thickening (one patient). Lung histopathological findings in four fatal cases showed thickening of the alveolar septa, hemorrhage, and interstitial edema. Conclusions/Significance: In this largest series involving the use of chest CT to evaluate lung involvement in patients with dengue, CT findings of lower respiratory tract involvement were uncommon. When abnormalities were present, pleural effusion was the most frequent finding and lung involvement was often mild or moderate and bilateral. Extensive lung abnormalities are infrequent even in severe disease and when present should lead physicians to consider other diagnostic possibilities.	[Rodrigues, Rosana Souza; Garcia Brum, Ana Livia; Ramos, Grazielle Viana; Bozza, Fernando Augusto] DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil; [Rodrigues, Rosana Souza; Marchiori, Edson] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Paes, Marciano Viana; Povoa, Tiago Fajardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Basilio-de-Oliveira, Carlos Alberto] Fed Univ State Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Borghi, Danielle Provencano] Corpo Bombeiros Mil Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Ramos, Grazielle Viana; Bozza, Fernando Augusto] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas IPEC, Rio De Janeiro, RJ, Brazil	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Rodrigues, RS (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil.	rosana.souzarodrigues@gmail.com; bozza.fernando@gmail.com	Marchiori, Edson/C-1205-2013; Rodrigues, Rosana Souza/N-9866-2013; Bozza, Fernando A/A-2618-2013	Rodrigues, Rosana Souza/0000-0002-9952-3834; Bozza, Fernando A/0000-0003-4878-0256; Marchiori, Edson/0000-0001-8797-7380; Paes, Marciano/0000-0002-2266-2801	D'Or Institute for Research and Education	D'Or Institute for Research and Education	D'Or Institute for Research and Education has supported the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Ejaz K, 2011, SAUDI MED J, V32, P46; Elicker BM, 2010, EMERG RADIOL, V17, P299, DOI 10.1007/s10140-010-0859-x; Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Gluecker T, 1999, RADIOGRAPHICS, V19, P1507, DOI 10.1148/radiographics.19.6.g99no211507; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Marchiori E, 2002, J THORAC IMAG, V17, P151, DOI 10.1097/00005382-200204000-00007; Marchiori E, 2012, RESP MED, V106, P1807, DOI 10.1016/j.rmed.2012.07.014; Marchiori E, 2011, EUR J RADIOL, V77, P80, DOI 10.1016/j.ejrad.2009.06.017; Marchiori E, 2011, LUNG, V189, P1, DOI 10.1007/s00408-010-9273-0; Marchiori E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-8; Mergo PJ, 1999, J THORAC IMAG, V14, P122, DOI 10.1097/00005382-199904000-00011; Mustafa B, 2010, Med J Malaysia, V65, P291; PRAMULJO HS, 1991, PEDIATR RADIOL, V21, P100, DOI 10.1007/BF02015615; Sharma S K, 2007, J Assoc Physicians India, V55, P729; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; von Ranke FM, 2013, LUNG, V191, P9, DOI 10.1007/s00408-012-9431-7; Wang CC, 2007, AM J TROP MED HYG, V77, P291, DOI 10.4269/ajtmh.2007.77.291; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2009, DENGUE GUIDELINES DI	31	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96313	10.1371/journal.pone.0096313	http://dx.doi.org/10.1371/journal.pone.0096313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836605	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800014
J	Schaller-Schonitz, M; Barzan, D; Williamson, AJK; Griffiths, JR; Dallmann, I; Battmer, K; Ganser, A; Whetton, AD; Scherr, M; Eder, M				Schaller-Schoenitz, Michael; Barzan, David; Williamson, Andrew J. K.; Griffiths, John R.; Dallmann, Iris; Battmer, Karin; Ganser, Arnold; Whetton, Anthony D.; Scherr, Michaela; Eder, Matthias			BCR-ABL Affects STAT5A and STAT5B Differentially	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GENE-EXPRESSION; REQUIRES PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; LYMPHOID DEVELOPMENT; SEXUAL-DIMORPHISM; BCR/ABL; ROLES; MAINTENANCE; MECHANISMS	Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors linking extracellular signals to target gene transcription. Hematopoietic cells express two highly conserved STAT5-isoforms (STAT5A/STAT5B), and STAT5 is directly activated by JAK2 downstream of several cytokine receptors and the oncogenic BCR-ABL tyrosine kinase. Using an IL-3-dependent cell line with inducible BCR-ABL-expression we compared STAT5-activation by IL-3 and BCR-ABL in a STAT5-isoform specific manner. RNAi targeting of STAT5B strongly inhibits BCR-ABL-dependent cell proliferation, and STAT5B but not STAT5A is essential for BCL-X-L-expression in the presence of BCR-ABL. Although BCR-ABL induces STAT5-tyrosine phosphorylation independent of JAK2-kinase activity, BCR-ABL is less efficient in inducing active STAT5A: STAT5B-heterodimerization than IL-3, leaving constitutive STAT5A and STAT5B-homodimerization unaffected. In comparison to IL-3, nuclear accumulation of a STAT5A-eGFP fusion protein is reduced by BCR-ABL, and BCR-ABL tyrosine kinase activity induces STAT5A-eGFP translocation to the cell membrane and co-localization with the IL-3 receptor. Furthermore, BCR-ABL-dependent phosphorylation of Y682 in STAT5A was detected by mass-spectrometry. Finally, RNAi targeting STAT5B but not STAT5A sensitizes human BCR-ABL-positive cell lines to imatinib-treatment. These data demonstrate differences between IL-3 and BCR-ABL-mediated STAT5-activation and isoform-specific effects, indicating therapeutic options for isoform-specific STAT5-inhibition in BCR-ABL-positive leukemia.	[Schaller-Schoenitz, Michael; Barzan, David; Dallmann, Iris; Battmer, Karin; Ganser, Arnold; Scherr, Michaela; Eder, Matthias] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Williamson, Andrew J. K.; Griffiths, John R.; Whetton, Anthony D.] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England	Hannover Medical School; University of Manchester	Eder, M (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	Eder.Matthias@MH-Hannover.de		WHETTON, ANTHONY D/0000-0002-1098-3878	Deutsche Forschungsgemeinschaft [SFB 566]; H. W. & J. Hector-Stiftung; Cancer Research UK; Leukaemia Lymphoma Research UK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. W. & J. Hector-Stiftung; Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research UK	This work was supported in part by grants of the Deutsche Forschungsgemeinschaft (SFB 566), the H. W. & J. Hector-Stiftung (MS and ME), Cancer Research UK (ADW), and Leukaemia Lymphoma Research UK (AJKW, ADW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Chatain N, 2013, ONCOGENE, V32, P3587, DOI 10.1038/onc.2012.369; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Furqan M, 2013, J HEMATOL ONCOL, V6; Furqan M, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-5; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; John S, 1999, MOL CELL BIOL, V19, P1910; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Scherr M, 2002, BLOOD, V99, P709, DOI 10.1182/blood.V99.2.709; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Scherr Michaela, 2009, V506, P207, DOI 10.1007/978-1-59745-409-4_15; Shuai K, 1996, ONCOGENE, V13, P247; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Warsch W, 2012, ONCOTARGET, V3, P1669; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850	48	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97243	10.1371/journal.pone.0097243	http://dx.doi.org/10.1371/journal.pone.0097243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836440	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800032
J	Altermann, S; Leavitt, SD; Goward, T; Nelsen, MP; Lumbsch, HT				Altermann, Susanne; Leavitt, Steven D.; Goward, Trevor; Nelsen, Matthew P.; Lumbsch, H. Thorsten			How Do You Solve a Problem like Letharia? A New Look at Cryptic Species in Lichen-Forming Fungi Using Bayesian Clustering and SNPs from Multilocus Sequence Data	PLOS ONE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC ANALYSIS; REPRODUCTIVE MODE; DELIMITATION; COALESCENT; INFERENCE; ACCURACY; PARMELIACEAE; BOUNDARIES; SOFTWARE	The inclusion of molecular data is increasingly an integral part of studies assessing species boundaries. Analyses based on predefined groups may obscure patterns of differentiation, and population assignment tests provide an alternative for identifying population structure and barriers to gene flow. In this study, we apply population assignment tests implemented in the programs STRUCTURE and BAPS to single nucleotide polymorphisms from DNA sequence data generated for three previous studies of the lichenized fungal genus Letharia. Previous molecular work employing a gene genealogical approach circumscribed six species-level lineages within the genus, four putative lineages within the nominal taxon L. columbiana (Nutt.) J.W. Thomson and two sorediate lineages. We show that Bayesian clustering implemented in the program STRUCTURE was generally able to recover the same six putative Letharia lineages. Population assignments were largely consistent across a range of scenarios, including: extensive amounts of missing data, the exclusion of SNPs from variable markers, and inferences based on SNPs from as few as three gene regions. While our study provided additional evidence corroborating the six candidate Letharia species, the equivalence of these genetic clusters with species-level lineages is uncertain due, in part, to limited phylogenetic signal. Furthermore, both the BAPS analysis and the ad hoc Delta K statistic from results of the STRUCTURE analysis suggest that population structure can possibly be captured with fewer genetic groups. Our findings also suggest that uneven sampling across taxa may be responsible for the contrasting inferences of population substructure. Our results consistently supported two distinct sorediate groups, 'L. lupina' and L. vulpina, and subtle morphological differences support this distinction. Similarly, the putative apotheciate species 'L. lucida' was also consistently supported as a distinct genetic cluster. However, additional studies will be required to elucidate the relationships of other L. columbiana s.l. populations with the two sorediate genetic clusters.	[Altermann, Susanne] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Leavitt, Steven D.; Nelsen, Matthew P.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Leavitt, Steven D.; Nelsen, Matthew P.; Lumbsch, H. Thorsten] Field Museum, Chicago, IL USA; [Goward, Trevor] Univ British Columbia, Beaty Biodivers Museum, Vancouver, BC V5Z 1M9, Canada	Whitman College; University of Chicago; Field Museum of Natural History (Chicago); University of British Columbia	Leavitt, SD (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sleavitt@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Nelsen, Matthew/0000-0002-6866-815X; Lumbsch, Thorsten/0000-0003-1512-835X	National Science Foundation [DEB-0949147]; California Lichen Society; Northwest Scientific Association; Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution; STEPS Institute; University of California, Santa Cruz	National Science Foundation(National Science Foundation (NSF)); California Lichen Society; Northwest Scientific Association; Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution; STEPS Institute; University of California, Santa Cruz(University of California System)	This research is based upon work supported by the National Science Foundation under Grant No. DEB-0949147. Molecular work by the first author was supported by the California Lichen Society, the Northwest Scientific Association, the Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution, and the STEPS Institute. Additional funding, workspace and equipment were provided by Dr. Lynda Goff at University of California, Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann S, 2009, GEOGRAPHIC STRUCTURE; Arnerup J, 2004, MYCOL RES, V108, P311, DOI 10.1017/S0953756204009360; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Del-Prado R, 2010, MOL PHYLOGENET EVOL, V56, P125, DOI 10.1016/j.ympev.2010.04.014; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fu YX, 1997, GENETICS, V147, P915; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GAMS HELMUT, 1955, SVENSK BOT TIDSKR, V49, P29; Geml J, 2012, FUNGAL BIOL-UK, V116, P388, DOI 10.1016/j.funbio.2011.12.009; Geml J, 2010, J BIOGEOGR, V37, P1529, DOI 10.1111/j.1365-2699.2010.02287.x; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hogberg N, 2002, MOL ECOL, V11, P1191, DOI 10.1046/j.1365-294X.2002.01513.x; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johannesson HS, 2000, MOL ECOL, V9, P375, DOI 10.1046/j.1365-294x.2000.00874-6.x; Jovan S, 2007, ENVIRON MONIT ASSESS, V129, P243, DOI 10.1007/s10661-006-9357-8; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kroken S, 2000, BRYOLOGIST, V103, P645, DOI 10.1639/0007-2745(2000)103[0645:PSRMAS]2.0.CO;2; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Kroken S, 2001, FUNGAL GENET BIOL, V34, P83, DOI 10.1006/fgbi.2001.1291; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Leavitt SD, 2013, BRYOLOGIST, V116, P337, DOI 10.1639/0007-2745-116.4.337; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; MAYR E, 1970, P453; McCune B, 2009, BRYOLOGIST, V112, P375, DOI 10.1639/0007-2745-112.2.375; McMurray JA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1487-3; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Nelson MF, 2013, ECOL EVOL, V3, P3455, DOI 10.1002/ece3.725; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Poelt J, 1970, VORTRAGE GESAMTGEBIE, V4, P187; POELT VJ, 1972, BOT NOTISER, V125, P77; Price TD, 2002, EVOLUTION, V56, P2083; Printzen C, 2002, LICHENOLOGIST, V34, P101, DOI 10.1006/lich.2002.0381; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2008, FIGTREE VERSION 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 2003, GENETICS, V164, P1645; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rowe G, 2007, MOL ECOL, V16, P785, DOI 10.1111/j.1365-294X.2006.03188.x; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Sites JJ, 2013, SPECIES PROBLEM ONGO, P225, DOI DOI 10.5772/52664; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TONSBERG T, 1996, SOMMERFELTIA, V23, P1; Vitikainen O, 1997, NORRLINIA, V6, P1; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	87	39	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97556	10.1371/journal.pone.0097556	http://dx.doi.org/10.1371/journal.pone.0097556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831224	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500077
J	Enyedi, P; Veres, I; Braun, G; Czirjak, G				Enyedi, Peter; Veres, Iren; Braun, Gabriella; Czirjak, Gabor			Tubulin Binds to the Cytoplasmic Loop of TRESK Background K+ Channel In Vitro	PLOS ONE			English	Article							POTASSIUM CHANNEL; C-TERMINUS; DEPENDENT ACTIVATION; FUNCTIONAL-ANALYSIS; GLYCINE RECEPTOR; MESSENGER-RNAS; ALPHA-TUBULIN; BETA-TUBULIN; TASK-1 KCNK3; MIGRAINE	The cytoplasmic loop between the second and third transmembrane segments is pivotal in the regulation of TRESK (TWIK-related spinal cord K+ channel, K2P18.1, KCNK18). Calcineurin binds to this region and activates the channel by dephosphorylation in response to the calcium signal. Phosphorylation-dependent anchorage of 14-3-3 adaptor protein also modulates TRESK at this location. In the present study, we identified molecular interacting partners of the intracellular loop. By an affinity chromatography approach using the cytoplasmic loop as bait, we have verified the specific association of calcineurin and 14-3-3 to the channel. In addition to these known interacting proteins, we observed substantial binding of tubulin to the intracellular loop. Successive truncation of the polypeptide and pull-down experiments from mouse brain cytosol narrowed down the region sufficient for the binding of tubulin to a 16 amino acid sequence: LVLGRLSYSIISNLDE. The first six residues of this sequence are similar to the previously reported tubulin-binding region of P2X2 purinergic receptor. The tubulin-binding site of TRESK is located close to the protein kinase A (PKA)-dependent 14-3-3-docking motif of the channel. We provide experimental evidence suggesting that 14-3-3 competes with tubulin for the binding to the cytoplasmic loop of TRESK. It is intriguing that the 16 amino acid tubulin-binding sequence includes the serines, which were previously shown to be phosphorylated by microtubule-affinity regulating kinases (MARK kinases) and contribute to channel inhibition. Although tubulin binds to TRESK in vitro, it remains to be established whether the two proteins also interact in the living cell.	[Enyedi, Peter; Veres, Iren; Braun, Gabriella; Czirjak, Gabor] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary	Semmelweis University	Czirjak, G (corresponding author), Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary.	czirjak.gabor@med.semmelweis-univ.hu	Braun, Gabriella/D-7494-2015	Braun, Gabriella/0000-0002-1762-7622; Czirjak, Gabor/0000-0002-5485-2327	Hungarian National Research Fund [OTKA K108496]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian National Research Fund OTKA K108496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Enguix I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00237; BEST D, 1981, ANAL BIOCHEM, V114, P281, DOI 10.1016/0003-2697(81)90481-4; Bista P, 2012, PFLUG ARCH EUR J PHY, V463, P89, DOI 10.1007/s00424-011-1056-9; Braun G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028119; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Callejo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064471; Canman JC, 1997, J CELL SCI, V110, P1907; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Cid LP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00198; Cotten JF, 2013, ANESTH ANALG, V116, P810, DOI 10.1213/ANE.0b013e318284469d; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gendreau S, 2003, J CHROMATOGR B, V786, P311, DOI 10.1016/S1570-0232(02)00743-2; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Goswami C, 2012, J NEUROCHEM, V123, P1, DOI 10.1111/j.1471-4159.2012.07892.x; Guimaraes MZP, 2008, NEUROCHEM INT, V52, P314, DOI 10.1016/j.neuint.2007.06.032; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; JESSUS C, 1987, J CELL SCI, V87, P705; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kreneisz O, 2009, J PHYSIOL-LONDON, V587, P5819, DOI 10.1113/jphysiol.2009.180372; Lafreniere RG, 2011, INT J BIOCHEM CELL B, V43, P1533, DOI 10.1016/j.biocel.2011.08.002; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maher BH, 2013, GENE, V528, P343, DOI 10.1016/j.gene.2013.07.030; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Penton D, 2012, ENDOCRINOLOGY, V153, P4740, DOI 10.1210/en.2012-1527; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Pottosin II, 2008, PFLUG ARCH EUR J PHY, V456, P1037, DOI 10.1007/s00424-008-0481-x; Rahm AK, 2013, ARCH PHARM, V387, P291; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Sanchez-Miguel DS, 2013, BIOCHEM BIOPH RES CO, V434, P273, DOI 10.1016/j.bbrc.2013.02.115; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wright PD, 2013, BIOCHEM BIOPH RES CO, V441, P463, DOI 10.1016/j.bbrc.2013.10.090; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zhou J, 2012, MOL MED REP, V5, P1049, DOI 10.3892/mmr.2012.778; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	65	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97854	10.1371/journal.pone.0097854	http://dx.doi.org/10.1371/journal.pone.0097854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830385	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500127
J	Moreno, M; Puig, J; Serrano, M; Moreno-Navarrete, JM; Ortega, F; Ricart, W; Fernandez-Real, JM				Moreno, Maria; Puig, Josep; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects	PLOS ONE			English	Article							MAST-CELL TRYPTASE; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; SERUM TRYPTASE; ARTERY-DISEASE; CHOLESTEROL; PROTEASES; PLAQUES; STROKE	Introduction: Mast cells participate in atherogenesis by releasing cytokines to induce vascular cell protease expression. Tryptase is expressed highly in human atherosclerotic lesions and the inhibition of tryptase activity hampers its capacity to maintain cholesterol inside macrophague foam cells. We aimed to investigate the association between circulating tryptase levels and subclinical atherosclerosis through estimation of carotid intima-media thickness (c-IMT) as surrogate marker for increased cardiovascular risk in obese and non-obese subjects. Methods: Circulating tryptase levels (ELISA) and metabolic parameters were analyzed in 228 subjects. Atherosclerosis (c-IMT>0.9 mm) was evaluated ultrasonographically. Results: Significant positive associations were evident between circulating tryptase levels and BMI, fat mass, glycated haemoglobin, fasting insulin, HOMAIR, fasting triglycerides and ultrasensitive PCR (p<0.05 from linear-trend ANOVA). The positive association between tryptase levels and insulin resistance parameters, suggested a glucose homeostasis impairment in individuals with higher tryptase levels. The negative asociation between tryptase levels and HDL-cholesterol supports the proatherogenic role of this protease (p<0.0001). Circulating tryptase levels were strongly associated with c-IMT measurements (p<0.0001 from linear-trend ANOVA), and were higher in subjects with presence of carotid plaque (p<0.0001). Tryptase levels (beta = 0.015, p = 0.001) contributed independently to subclinical atherosclerosis variance after controlling for cardiovascular risk factors (BMI, blood pressure, LDL-cholesterol). Conclusions: Circulating tryptase level is associated to obesity related parameters and has a close relation with various metabolic risk factors. Moreover, serum tryptase level was independently associated with c-IMT, suggesting its potential use as a surrogate marker for subclinical atherosclerosis in obese subjects.	[Moreno, Maria; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno, Maria; Puig, Josep; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III ISCIII, Girona, Spain; [Puig, Josep] CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Radiol, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Fernandez-Real, JM (corresponding author), CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfreal@idibgi.org	Fernandez-Real, Jose Manuel/L-5897-2014; Moreno-Navarrete, José María/ABG-5548-2021; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016	Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Fernandez-Real, Jose Manuel/0000-0002-7442-9323; Ricart, Wifredo/0000-0002-3452-9098	Spanish Ministry of Health [FIS 2011-00214]; CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	This study was supported by the Spanish Ministry of Health (FIS 2011-00214), and CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn). The CIBER de la Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative from the Instituto de Salud Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; Deliargyris EN, 2005, ATHEROSCLEROSIS, V178, P381, DOI 10.1016/j.atherosclerosis.2004.09.008; Divoux A, 2012, J CLIN ENDOCR METAB, V97, pE1677, DOI 10.1210/jc.2012-1532; Fenger RV, 2012, INT ARCH ALLERGY IMM, V157, P151, DOI 10.1159/000327535; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Johnson JL, 1998, ARTERIOSCL THROM VAS, V18, P1707, DOI 10.1161/01.ATV.18.11.1707; KAARTINEN M, 1994, ARTERIOSCLER THROMB, V14, P966, DOI 10.1161/01.ATV.14.6.966; Kelley JL, 2000, MOL MED TODAY, V6, P304, DOI 10.1016/S1357-4310(00)01747-0; Kervinen H, 2005, INT J CARDIOL, V104, P138, DOI 10.1016/j.ijcard.2004.10.023; KOVANEN PT, 1990, EUR HEART J, V11, P238, DOI 10.1093/eurheartj/11.suppl_E.238; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P2086, DOI 10.1161/01.ATV.0000041405.07367.B5; Lehtonen-Smeds EMP, 2005, CEREBROVASC DIS, V19, P291, DOI 10.1159/000084497; Lindstedt KA, 1998, BBA-GEN SUBJECTS, V1425, P617, DOI 10.1016/S0304-4165(98)00115-9; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ramalho LS, 2013, ANN DIAGN PATHOL, V17, P28, DOI 10.1016/j.anndiagpath.2012.04.007; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1990, J ALLERGY CLIN IMMUN, V86, P594, DOI 10.1016/S0091-6749(05)80222-2; Thomas VA, 1998, BIOCHEMISTRY-US, V37, P2291, DOI 10.1021/bi972119z; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Wang Z, 2013, ANN MED, V45, P220, DOI 10.3109/07853890.2012.732234; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; Willems S, 2013, EUR HEART J, V34, P3699, DOI 10.1093/eurheartj/eht186; Xiang MX, 2011, ATHEROSCLEROSIS, V215, P494, DOI 10.1016/j.atherosclerosis.2011.01.006; Zhi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060960	32	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97014	10.1371/journal.pone.0097014	http://dx.doi.org/10.1371/journal.pone.0097014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830464	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500029
J	Sudarshan, S; Kodathala, SB; Mahadik, AC; Mehta, I; Beck, BW				Sudarshan, Sanjana; Kodathala, Sasi B.; Mahadik, Amruta C.; Mehta, Isha; Beck, Brian W.			Protein-Protein Interface Detection Using the Energy Centrality Relationship (ECR) Characteristic of Proteins	PLOS ONE			English	Article							HOT-SPOTS; PREDICTION; BINDING; CLASSIFICATION; CONSERVATION; DIVERSITY; COMPLEXES; CONTACTS; DATABASE	Specific protein interactions are responsible for most biological functions. Distinguishing Functionally Linked Interfaces of Proteins (FLIPs), from Functionally uncorrelated Contacts (FunCs), is therefore important to characterizing these interactions. To achieve this goal, we have created a database of protein structures called FLIPdb, containing proteins belonging to various functional sub-categories. Here, we use geometric features coupled with Kortemme and Baker's computational alanine scanning method to calculate the energetic sensitivity of each amino acid at the interface to substitution, identify hotspots, and identify other factors that may contribute towards an interface being FLIP or FunC. Using Principal Component Analysis and K-means clustering on a training set of 160 interfaces, we could distinguish FLIPs from FunCs with an accuracy of 76%. When these methods were applied to two test sets of 18 and 170 interfaces, we achieved similar accuracies of 78% and 80%. We have identified that FLIP interfaces have a stronger central organizing tendency than FunCs, due, we suggest, to greater specificity. We also observe that certain functional sub-categories, such as enzymes, antibody-heavy-light, antibody-antigen, and enzyme-inhibitors form distinct sub-clusters. The antibody-antigen and enzyme-inhibitors interfaces have patterns of physical characteristics similar to those of FunCs, which is in agreement with the fact that the selection pressures of these interfaces is differently evolutionarily driven. As such, our ECR model also successfully describes the impact of evolution and natural selection on protein-protein interfaces. Finally, we indicate how our ECR method may be of use in reducing the false positive rate of docking calculations.	[Sudarshan, Sanjana; Kodathala, Sasi B.; Mahadik, Amruta C.; Mehta, Isha; Beck, Brian W.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Beck, Brian W.] Texas Womans Univ, Dept Math & Comp Sci, Denton, TX 76204 USA; [Beck, Brian W.] Texas Womans Univ, Dept Chem & Biochem, Denton, TX 76204 USA	Texas Womans University; Texas Womans University; Texas Womans University	Beck, BW (corresponding author), Texas Womans Univ, Dept Biol, Denton, TX 76204 USA.	bbeck@twu.edu	Mehta, Isha/AFA-1627-2022; Beck, Brian/H-5530-2018	Beck, Brian/0000-0002-7731-3457	TWU (Research Enhancement Program); TWU (Multidisciplinary Research Program); TWU (Art & Sciences Research Development Fund)	TWU (Research Enhancement Program); TWU (Multidisciplinary Research Program); TWU (Art & Sciences Research Development Fund)	The work of SS, ACM, SBK and IM for specific portions of this project were supported by internal funding from TWU (Research Enhancement Program, Multidisciplinary Research Program, and Art & Sciences Research Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HARTIGAN JA, 1973, ANNU REV BIOPHYS BIO, V2, P81, DOI 10.1146/annurev.bb.02.060173.000501; Havranek JJ, 2010, J BIOL CHEM, V285, P31095, DOI 10.1074/jbc.R110.157685; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; Janin J, 2005, PROTEIN SCI, V14, P278, DOI 10.1110/ps.041081905; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Liu SY, 2006, PROTEINS, V64, P68, DOI 10.1002/prot.20954; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Moretti R, 2013, PROTEINS; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Ponstingl H, 2000, PROTEINS, V41, P47; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schrodinger L., PYMOL MOL GRAPHICS S; Schwartz GW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00357; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, PROTEINS, V42, P108; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97115	10.1371/journal.pone.0097115	http://dx.doi.org/10.1371/journal.pone.0097115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830938	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500035
J	Xu, ZF; Zhu, WY; Liu, YC; Liu, X; Chen, QS; Peng, M; Wang, XZ; Shen, GM; He, L				Xu, Zhifeng; Zhu, Wenyi; Liu, Yanchao; Liu, Xing; Chen, Qiushuang; Peng, Miao; Wang, Xiangzun; Shen, Guangmao; He, Lin			Analysis of Insecticide Resistance-Related Genes of the Carmine Spider Mite Tetranychus cinnabarinus Based on a De Novo Assembled Transcriptome	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SODIUM-CHANNEL GENE; DROSOPHILA-MELANOGASTER; URTICAE KOCH; ACARI; EVOLUTION; IDENTIFICATION; ANNOTATION; TOXICOLOGY; MUTATIONS	The carmine spider mite (CSM), Tetranychus cinnabarinus, is an important pest mite in agriculture, because it can develop insecticide resistance easily. To gain valuable gene information and molecular basis for the future insecticide resistance study of CSM, the first transcriptome analysis of CSM was conducted. A total of 45,016 contigs and 25,519 unigenes were generated from the de novo transcriptome assembly, and 15,167 unigenes were annotated via BLAST querying against current databases, including nr, SwissProt, the Clusters of Orthologous Groups (COGs), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO). Aligning the transcript to Tetranychus urticae genome, the 19255 (75.45%) of the transcripts had significant (e-value <10(-5)) matches to T. urticae DNA genome, 19111 sequences matched to T. urticae proteome with an average protein length coverage of 42.55%. Core Eukaryotic Genes Mapping Approach (CEGMA) analysis identified 435 core eukaryotic genes (CEGs) in the CSM dataset corresponding to 95% coverage. Ten gene categories that relate to insecticide resistance in arthropod were generated from CSM transcriptome, including 53 P450-, 22 GSTs-, 23 CarEs-, 1 AChE-, 7 GluCls-, 9 nAChRs-, 8 GABA receptor-, 1 sodium channel-, 6 ATPase-and 12 Cyt b genes. We developed significant molecular resources for T. cinnabarinus putatively involved in insecticide resistance. The transcriptome assembly analysis will significantly facilitate our study on the mechanism of adapting environmental stress (including insecticide) in CSM at the molecular level, and will be very important for developing new control strategies against this pest mite.	[Xu, Zhifeng; Zhu, Wenyi; Liu, Yanchao; Liu, Xing; Chen, Qiushuang; Peng, Miao; Wang, Xiangzun; Shen, Guangmao; He, Lin] Southwest Univ, Key Lab Entomol & Pest Control Engn Chongqing, Coll Plant Protect, Chongqing, Peoples R China	Southwest University - China	He, L (corresponding author), Southwest Univ, Key Lab Entomol & Pest Control Engn Chongqing, Coll Plant Protect, Chongqing, Peoples R China.	helinok@vip.tom.com			Ministry of Education Program for New Century Excellent Talents [NCET-10-0700]; Fundamental Research Funds for the Central Universities [XDJK2013A007]; National Nature Sciences Foundation [31071984, 31272059]; Special Fund for Agro-scientific Research in the Public Interest [201103020]	Ministry of Education Program for New Century Excellent Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Sciences Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This research was funded in part by the Ministry of Education Program for New Century Excellent Talents (NCET-10-0700), the Fundamental Research Funds for the Central Universities (XDJK2013A007), the National Nature Sciences Foundation (31071984, 31272059) and the Special Fund for Agro-scientific Research in the Public Interest (201103020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bolland H.R., 1998, WORLD CATALOGUE SPID; BOUDREAUX H. BRUCE, 1956, ANN ENT SOC AMER, V49, P43, DOI 10.1093/aesa/49.1.43; BRANDENBURG R L, 1981, International Journal of Acarology, V7, P231; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; DUPONT LM, 1979, ENTOMOL EXP APPL, V25, P297, DOI 10.1007/BF00302791; Eddy S, 2010, HMMER3 NEW GENERATIO; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehara S, 1989, SHOKUBUTU BOEKI, V43, P358; Feng YN, 2011, PEST MANAG SCI, V67, P904, DOI 10.1002/ps.2129; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Goka K, 1996, EXP APPL ACAROL, V20, P683, DOI 10.1007/BF00051553; Gotoh Tetsuo, 1996, Japanese Journal of Entomology, V64, P215; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; He L, 2009, PESTIC BIOCHEM PHYS, V93, P47, DOI 10.1016/j.pestbp.2008.11.001; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; [贾福丽 Jia Fuli], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P286; JORDAAN LC, 1977, J ENTOMOL SOC S AFR, V40, P147; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Konanz S, 2004, PESTIC BIOCHEM PHYS, V79, P49, DOI 10.1016/J.PESTBP.2004.03.004; KUANG H-Y, 1990, Acta Entomologica Sinica, V33, P109; Li T, 2009, ANN ENTOMOL SOC AM, V102, P674, DOI 10.1603/008.102.0412; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; [梁为 LIANG Wei], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P68; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Lu WC, 2009, EFFECTS ABAMECTIN HE; Ma Y, 2004, CHIN J PUBLIC HLTH, V20, P1440; Ma Y, 2006, CHIN J PUBLIC HLTH, V22, P1080; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Qiu Xing-Hui, 2005, Acta Entomologica Sinica, V48, P960; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; ROBINSON DM, 1961, NATURE, V189, P857, DOI 10.1038/189857a0; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; Smith F. F., 1969, P155; Sugasawa J, 2002, APPL ENTOMOL ZOOL, V37, P127, DOI 10.1303/aez.2002.127; Sun Qing-tian, 2001, Journal of Jilin Agricultural University, V23, P24; Sun W, 2010, INSECT SCI, V17, P91, DOI 10.1111/j.1744-7917.2009.01302.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhai Qihui, 1995, Acta Entomologica Sinica, V38, P493; Zhang Jian-Ping, 2003, Acta Arachnologica Sinica, V12, P95; Zhang Zhi-Qiang, 2000, Systematic and Applied Acarology, V5, P69; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	65	34	38	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94779	10.1371/journal.pone.0094779	http://dx.doi.org/10.1371/journal.pone.0094779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830288	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500005
J	Pelletreau, KN; Weber, APM; Weber, KL; Rumpho, ME				Pelletreau, Karen N.; Weber, Andreas P. M.; Weber, Katrin L.; Rumpho, Mary E.			Lipid Accumulation during the Establishment of Kleptoplasty in Elysia chlorotica	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; GENE-EXPRESSION; CODIUM-FRAGILE; SEA SLUGS; SYMBIOTIC ZOOXANTHELLAE; EICOSAPENTAENOIC ACID; DIGESTIVE GLAND; CHLOROPLASTS; DROPLETS	The establishment of kleptoplasty (retention of "stolen plastids") in the digestive tissue of the sacoglossan Elysia chlorotica Gould was investigated using transmission electron microscopy. Cellular processes occurring during the initial exposure to plastids were observed in laboratory raised animals ranging from 1 - 14 days post metamorphosis (dpm). These observations revealed an abundance of lipid droplets (LDs) correlating to plastid abundance. Starvation of animals resulted in LD and plastid decay in animals,5 dpm that had not yet achieved permanent kleptoplasty. Animals allowed to feed on algal prey (Vaucheria litorea C. Agardh) for 7 d or greater retained stable plastids resistant to cellular breakdown. Lipid analysis of algal and animal samples supports that these accumulating LDs may be of plastid origin, as the often algal- derived 20:5 eicosapentaenoic acid was found in high abundance in the animal tissue. Subsequent culturing of animals in dark conditions revealed a reduced ability to establish permanent kleptoplasty in the absence of photosynthetic processes, coupled with increased mortality. Together, these data support an important role of photosynthetic lipid production in establishing and stabilizing this unique animal kleptoplasty.	[Pelletreau, Karen N.; Rumpho, Mary E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Weber, Andreas P. M.; Weber, Katrin L.] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, Inst Plant Biochem, Dusseldorf, Germany	University of Connecticut; Heinrich Heine University Dusseldorf; University of Cologne	Pelletreau, KN (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	karen.pelletreau@uconn.edu	Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011	Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672	National Science Foundation [IOS-0726178]; University of Maine - High End Instrumentation Research Grant; University of Connecticut; Deutsche Forschungsgemeinschaft [IRTG 1525-2, EXC 1028]; Direct For Biological Sciences [1265171] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Maine - High End Instrumentation Research Grant; University of Connecticut; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant IOS-0726178 (www.nsf.gov); by a University of Maine - High End Instrumentation Research Grant (www.umaine.edu); by the University of Connecticut (www.uconn.edu); and by the Deutsche Forschungsgemeinschaft grants IRTG 1525-2 and EXC 1028 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, J NUTR, V132, P3566, DOI 10.1093/jn/132.12.3566; Bachok Z, 2006, CORAL REEFS, V25, P545, DOI 10.1007/s00338-006-0130-9; BAJPAI P, 1993, J BIOTECHNOL, V30, P161, DOI 10.1016/0168-1656(93)90111-Y; BATTEY JF, 1984, MAR BIOL, V79, P27, DOI 10.1007/BF00404982; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; BISHOP DG, 1980, LIPIDS, V15, P799, DOI 10.1007/BF02534368; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CHANG HR, 1992, METABOLISM, V41, P1, DOI 10.1016/0026-0495(92)90181-9; CHEN LY, 1994, THROMB RES, V76, P317, DOI 10.1016/0049-3848(94)90160-0; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Christa G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2493; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Cirulis JT, 2012, CYTOM PART A, V81A, P618, DOI 10.1002/cyto.a.22066; CLARK KB, 1990, VELIGER, V33, P339; D'Avila H, 2012, MEDIAT INFLAMM, V2012, P1, DOI [10.1017/S1431927611012098., DOI 10.1017/S1431927611012098]; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; de Pablo MA, 2000, FEMS IMMUNOL MED MIC, V29, P323, DOI 10.1016/S0928-8244(00)00224-8; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Ehrt S, 2007, NAT MED, V13, P284, DOI 10.1038/nm0307-284; Fan CN, 2013, CURR OPIN CLIN NUTR, V16, P124, DOI 10.1097/MCO.0b013e32835c02c8; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Garrett TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057975; GILES KL, 1980, IN VITRO CELL DEV B, V16, P581; Gong YM, 2013, J BASIC MICROB, V53, P29, DOI 10.1002/jobm.201100487; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Green BJ, 2005, SYMBIOSIS, V40, P31; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HARLAND AD, 1991, MAR BIOL, V110, P13, DOI 10.1007/BF01313087; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Hirose E, 2005, ZOOL SCI, V22, P905, DOI 10.2108/zsj.22.905; HUBBARD NE, 1991, J LEUKOCYTE BIOL, V49, P592, DOI 10.1002/jlb.49.6.592; Imbs AB, 2014, PHYTOCHEMISTRY, V101, P76, DOI 10.1016/j.phytochem.2014.02.012; Irons R, 2003, J NUTR, V133, P1163, DOI 10.1093/jn/133.4.1163; KELLOGG RB, 1983, MAR BIOL, V75, P137, DOI 10.1007/BF00405996; Khozin-Goldberg I, 2011, BIOCHIMIE, V93, P91, DOI 10.1016/j.biochi.2010.07.020; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Mondy WL, 2003, INVERTEBR BIOL, V122, P126; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Mujer CV, 1996, P NATL ACAD SCI USA, V93, P12333, DOI 10.1073/pnas.93.22.12333; Muniain C, 2001, MAR BIOL, V139, P687; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; PATTON JS, 1983, MAR BIOL, V75, P131, DOI 10.1007/BF00405995; Pelletreau KN, 2012, SYMBIOSIS, V58, P221, DOI 10.1007/s13199-012-0192-0; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pierce SK, 2006, MOLLUSCAN RES, V26, P23; Puertollano MA, 2002, CLIN DIAGN LAB IMMUN, V9, P352, DOI 10.1128/CDLI.9.2.352-357.2002; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Rumpho Mary E., 2006, V23, P451; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Rumpho ME, 2001, ZOOL-ANAL COMPLEX SY, V104, P303, DOI 10.1078/0944-2006-00036; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schmidt S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-45; Schwerbrock NMJ, 2009, J NUTR, V139, P1588, DOI 10.3945/jn.109.108027; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sipka S, 1996, CLIN IMMUNOL IMMUNOP, V79, P224, DOI 10.1006/clin.1996.0072; Stehr M, 2012, MICROBES INFECT, V14, P1227, DOI 10.1016/j.micinf.2012.08.001; TAYLOR DL, 1968, J MAR BIOL ASSOC UK, V48, P1, DOI 10.1017/S0025315400032380; Trench R.K., 1975, Symposia Soc exp Biol, VNo. 29, P229; TRENCH RK, 1973, PROC R SOC SER B-BIO, V184, P63, DOI 10.1098/rspb.1973.0031; TRENCH RK, 1969, NATURE, V222, P1071, DOI 10.1038/2221071a0; TRENCH RK, 1973, PROC R SOC SER B-BIO, V184, P51, DOI 10.1098/rspb.1973.0030; TRENCH RK, 1976, NEW PHYTOL, V76, P99, DOI 10.1111/j.1469-8137.1976.tb01442.x; TRENCH RK, 1974, PROC R SOC SER B-BIO, V185, P453, DOI 10.1098/rspb.1974.0029; TRENCH RK, 1969, J CELL BIOL, V42, P404, DOI 10.1083/jcb.42.2.404; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wu DY, 1998, P NUTR SOC, V57, P503, DOI 10.1079/PNS19980074; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002	86	25	25	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97477	10.1371/journal.pone.0097477	http://dx.doi.org/10.1371/journal.pone.0097477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828251	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400097
J	Hamalainen, S; Solovieva, S; Vehmas, T; Luoma, K; Leino-Arjas, P; Hirvonen, A				Hamalainen, Satu; Solovieva, Svetlana; Vehmas, Tapio; Luoma, Katariina; Leino-Arjas, Paivi; Hirvonen, Ari			Genetic Influences on Hand Osteoarthritis in Finnish Women - A Replication Study of Candidate Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RADIOGRAPHIC HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; SUSCEPTIBILITY LOCUS; JOINT OSTEOARTHRITIS; POSTMENOPAUSAL WOMEN; CHROMOSOME 7Q22; FEMALE DENTISTS; SCAN; DISEASE	Objectives: Our aims were to replicate some previously reported associations of single nucleotide polymorphisms (SNPs) in five genes (A2BP1, COG5, GDF5, HFE, ESR1) with hand osteoarthritis (OA), and to examine whether genes (BCAP29, DIO2, DUS4L, DVWA, HLA, PTGS2, PARD3B, TGFB1 and TRIB1) associated with OA at other joint sites were associated with hand OA among Finnish women. Design: We examined the bilateral hand radiographs of 542 occupationally active Finnish female dentists and teachers aged 45 to 63 and classified them according to the presence of OA by using reference images. Data regarding finger joint pain and other risk factors were collected using a questionnaire. We defined two hand OA phenotypes: radiographic OA in at least three joints (ROA) and symptomatic DIP OA. The genotypes were determined by PCR-based methods. In statistical analysis, we used SNPStats software, the chi-square test and logistic regression. Results: Of the SNPs, rs716508 in A2BP1 was associated with ROA (OR = 0.7, 95% CI 0.5-0.9) and rs1800470 in TGFB1 with symptomatic DIP OA (1.8, 1.2-2.9). We found an interaction between ESR1 (rs9340799) and occupation: teachers with the minor allele were at an increased risk of symptomatic DIP OA (2.8, 1.3-6.5). We saw no association among the dentists. We also found that the carriage of the COG5 rs3757713 C allele increased the risk of ROA only among women with the BCAP29 rs10953541 CC genotype (2.6; 1.1-6.1). There was also a suggestive interaction between the HFE rs179945 and the ESR1 rs9340799, and the carriage of the minor allele of either of these SNPs was associated with an increased risk of symptomatic DIP OA (2.1, 1.3-2.5). Conclusions: Our results support the earlier findings of A2BP1 and TBGF1 being OA susceptibility genes and provide evidence of a possible gene-gene interaction in the genetic influence on hand OA predisposition.	[Hamalainen, Satu; Solovieva, Svetlana; Vehmas, Tapio; Leino-Arjas, Paivi; Hirvonen, Ari] Ctr Expertise Hlth & Work Abil, Finnish Inst Occupat Hlth, Helsinki, Finland; [Luoma, Katariina] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital	Hamalainen, S (corresponding author), Ctr Expertise Hlth & Work Abil, Finnish Inst Occupat Hlth, Helsinki, Finland.	satu.hamalainen@ttl.fi		Leino-Arjas, Paivi/0000-0001-9534-7071; Vehmas, Tapio/0000-0002-4761-9826	Finnish Work Environment Fund [101334]	Finnish Work Environment Fund	The study was financially supported by a grant (101334) from the Finnish Work Environment Fund (http:// www. tsr. fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh BZ, 2007, ANN RHEUM DIS, V66, P1436, DOI 10.1136/ard.2006.063099; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Carroll GJ, 2006, J RHEUMATOL, V33, P741; Cicuttini FM, 1996, ANN RHEUM DIS, V55, P665, DOI 10.1136/ard.55.9.665; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Demissie S, 2002, ARTHRITIS RHEUM, V46, P946, DOI 10.1002/art.10149; Ding H, 2010, SCAND J RHEUMATOL, V39, P84, DOI 10.3109/03009740903201834; Driban JB, 2010, CLIN RHEUMATOL, V29, P123, DOI 10.1007/s10067-009-1301-1; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Fahlgren A, 2001, OSTEOARTHR CARTILAGE, V9, P195, DOI 10.1053/joca.2000.0376; Gonzalez A, 2013, OSTEOARTHR CARTILAGE, V21, P1443, DOI 10.1016/j.joca.2013.07.001; Greig C, 2006, ANN RHEUM DIS, V65, P1131, DOI 10.1136/ard.2005.048165; Gu X, 2012, DIGEST DIS SCI, V57, P2901, DOI 10.1007/s10620-012-2238-9; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Hirsch R, 2000, OSTEOARTHR CARTILAGE, V8, pS16; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang X, 2008, BLOOD CELL MOL DIS, V41, P265, DOI 10.1016/j.bcmd.2008.06.009; Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906; Hunter DJ, 2004, ARTHRITIS RHEUM, V50, P2489, DOI 10.1002/art.20445; Husar-Memmer E, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0393-4; Ikegawa S, 2013, ANNU REV GENOM HUM G, V14, P245, DOI 10.1146/annurev-genom-091212-153427; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Jin SY, 2004, ARTHRITIS RES THER, V6, pR415, DOI 10.1186/ar1207; Kalichman L, 2010, SEMIN ARTHRITIS RHEU, V39, P465, DOI 10.1016/j.semarthrit.2009.03.001; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kloppenburg M, 2012, NAT REV RHEUMATOL, V8, P22, DOI 10.1038/nrrheum.2011.170; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Lian K, 2007, OSTEOARTHR CARTILAGE, V15, P972, DOI 10.1016/j.joca.2007.02.020; Livshits G, 2007, ANN RHEUM DIS, V66, P623, DOI 10.1136/ard.2006.060236; Loughlin John, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009257; Ma LJ, 2010, DIABETES, V59, P2837, DOI 10.2337/db09-1604; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Meulenbelt I, 2008, HUM MOL GENET, V17, P1867, DOI 10.1093/hmg/ddn082; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Raine EVA, 2012, ANN RHEUM DIS, V71, P2020, DOI 10.1136/annrheumdis-2012-201304; Riancho JA, 2010, OSTEOARTHR CARTILAGE, V18, P927, DOI 10.1016/j.joca.2010.04.002; Ross JM, 2003, J RHEUMATOL, V30, P121; Ryder JJ, 2008, ANN RHEUM DIS, V67, P584, DOI 10.1136/ard.2007.073874; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Solovieva S, 2005, RHEUMATOLOGY, V44, P521, DOI 10.1093/rheumatology/keh534; Spector TD, 1996, BRIT MED J, V312, P940; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Ushiyama T, 1998, J RHEUMATOL, V25, P134; Vaes RBA, 2009, ANN RHEUM DIS, V68, P1754, DOI 10.1136/ard.2008.099655; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Wise BL, 2009, J RHEUMATOL, V36, P2772, DOI 10.3899/jrheum.081208; Yamada Y, 2000, MECH AGEING DEV, V116, P113, DOI 10.1016/S0047-6374(00)00131-7; Zhai G, 2009, J MED GENET, V46, P614, DOI 10.1136/jmg.2009.067314	62	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97417	10.1371/journal.pone.0097417	http://dx.doi.org/10.1371/journal.pone.0097417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825461	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200111
J	Arya, VB; Senniappan, S; Demirbilek, H; Alam, S; Flanagan, SE; Ellard, S; Hussain, K				Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Alam, Syeda; Flanagan, Sarah E.; Ellard, Sian; Hussain, Khalid			Pancreatic Endocrine and Exocrine Function in Children following Near-Total Pancreatectomy for Diffuse Congenital Hyperinsulinism	PLOS ONE			English	Article							SULFONYLUREA RECEPTOR SUR1; 95-PERCENT PANCREATECTOMY; GLUCOSE-METABOLISM; HYPOGLYCEMIA; INFANCY; NESIDIOBLASTOSIS; MUTATIONS; MANAGEMENT; GENE	Context: Congenital hyperinsulinism (CHI), the commonest cause of persistent hypoglycaemia, has two main histological subtypes: diffuse and focal. Diffuse CHI, if medically unresponsive, is managed with near-total pancreatectomy. Post-pancreatectomy, in addition to persistent hypoglycaemia, there is a very high risk of diabetes mellitus and pancreatic exocrine insufficiency. Setting: International referral centre for the management of CHI. Patients: Medically unresponsive diffuse CHI patients managed with near-total pancreatectomy between 1994 and 2012. Intervention: Near-total pancreatectomy. Main Outcome Measures: Persistent hypoglycaemia post near-total pancreatectomy, insulin-dependent diabetes mellitus, clinical and biochemical (faecal elastase 1) pancreatic exocrine insufficiency. Results: Of more than 300 patients with CHI managed during this time period, 45 children had medically unresponsive diffuse disease and were managed with near-total pancreatectomy. After near-total pancreatectomy, 60% of children had persistent hypoglycaemia requiring medical interventions. The incidence of insulin dependent diabetes mellitus was 96% at 11 years after surgery. Thirty-two patients (72%) had biochemical evidence of severe pancreatic exocrine insufficiency (Faecal elastase 1,100 mg/g). Clinical exocrine insufficiency was observed in 22 (49%) patients. No statistically significant difference in weight and height standard deviation score (SDS) was found between untreated subclinical pancreatic exocrine insufficiency patients and treated clinical pancreatic exocrine insufficiency patients. Conclusions: The outcome of diffuse CHI patients after near-total pancreatectomy is very unsatisfactory. The incidence of persistent hypoglycaemia and insulin-dependent diabetes mellitus is very high. The presence of clinical rather than biochemical pancreatic exocrine insufficiency should inform decisions about pancreatic enzyme supplementation.	[Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Alam, Syeda; Hussain, Khalid] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Endocrinol, London, England; [Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Hussain, Khalid] UCL, Inst Child Hlth, London, England; [Demirbilek, Huseyin] Ankara Pediat Hematol & Oncol Training Hosp, Dept Paediat Endocrinol, Ankara, Turkey; [Flanagan, Sarah E.; Ellard, Sian] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Exeter	Hussain, K (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Endocrinol, London, England.	Khalid.Hussain@ucl.ac.uk	Demirbilek, Huseyin/AAK-6434-2021	Ellard, Sian/0000-0002-7620-5526; Flanagan, Sarah/0000-0002-8670-6340	Medical Research Council [G1001821] Funding Source: Medline; MRC [G1001821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aynsley-Green A, 2000, ARCH DIS CHILD-FETAL, V82, pF98, DOI 10.1136/fn.82.2.F98; Beltrand J, 2012, DIABETES CARE, V35, P198, DOI 10.2337/dc11-1296; Cade A, 1998, ARCH DIS CHILD, V79, P435, DOI 10.1136/adc.79.5.435; Cherian MP, 2005, J PEDIATR ENDOCR MET, V18, P1441; DUNGER DB, 1988, J PEDIATR SURG, V23, P112, DOI 10.1016/S0022-3468(88)80136-2; Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Keller J, 2009, BEST PRACT RES CL GA, V23, P425, DOI 10.1016/j.bpg.2009.02.013; LANGER JC, 1984, J PEDIATR SURG, V19, P786, DOI 10.1016/S0022-3468(84)80369-3; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Loser C, 1996, GUT, V39, P580, DOI 10.1136/gut.39.4.580; Lovvorn HN, 1999, J PEDIATR SURG, V34, P786, DOI 10.1016/S0022-3468(99)90374-3; Ludwig A, 2011, SEMIN PEDIATR SURG, V20, P45, DOI 10.1053/j.sempedsurg.2010.10.005; MacMullen CM, 2011, DIABETES, V60, P1797, DOI 10.2337/db10-1631; Meissner T, 2003, EUR J ENDOCRINOL, V149, P43, DOI 10.1530/eje.0.1490043; Rahier J, 2000, ARCH DIS CHILD-FETAL, V82, pF108, DOI 10.1136/fn.82.2.F108; Rother K I, 2001, Pediatr Diabetes, V2, P115, DOI 10.1034/j.1399-5448.2001.002003115.x; Shilyansky J, 1997, J PEDIATR SURG, V32, P342, DOI 10.1016/S0022-3468(97)90207-4; Stein J, 1996, CLIN CHEM, V42, P222; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Verkarre V, 1998, J CLIN INVEST, V102, P1286, DOI 10.1172/JCI4495	21	52	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98054	10.1371/journal.pone.0098054	http://dx.doi.org/10.1371/journal.pone.0098054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840042	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600105
J	Danion, F; Bongers, RM; Bootsma, RJ				Danion, Frederic; Bongers, Raoul M.; Bootsma, Reinoud J.			The Trade-Off between Spatial and Temporal Variabilities in Reciprocal Upper-Limb Aiming Movements of Different Durations	PLOS ONE			English	Article							GRIP FORCE ADJUSTMENTS; INFORMATION CAPACITY; DIRECTED MOVEMENTS; REACHING MOVEMENTS; TIMING VARIABILITY; TASK CONSTRAINTS; HAND MOVEMENTS; MOVING TARGET; DRAWING TASKS; MOTOR CONTROL	The spatial and temporal aspects of movement variability have typically been studied separately. As a result the relationship between spatial and temporal variabilities remains largely unknown. In two experiments we examined the evolution and covariation of spatial and temporal variabilities over variations in the duration of reciprocal aiming movements. Experiments differed in settings: In Experiment 1 participants moved unperturbed whereas in Experiment 2 they were confronted with an elastic force field. Different movement durations-for a constant inter-target distance-were either evoked by imposing spatial accuracy constraints while requiring participants to move as fast as possible, or prescribed by means of an auditory metronome while requiring participants to maximize spatial accuracy. Analyses focused on absolute and relative variabilities, respectively captured by the standard deviation (SD) and the coefficient of variation (CV = SD/mean). Spatial variability (both SDspace and CVspace) decreased with movement duration, while temporal variability (both SDtime and CVtime) increased with movement duration. We found strong negative correlations between spatial and temporal variabilities over variations in movement duration, whether the variability examined was absolute or relative. These findings observed at the level of the full movement contrasted with the findings observed at the level of the separate acceleration and deceleration phases of movement. During the separate acceleration and deceleration phases both spatial and temporal variabilities (SD and CV) were found to increase with their respective durations, leading to positive correlations between them. Moreover, variability was generally larger at the level of the constituent movement phases than at the level of the full movement. The general pattern of results was robust, as it emerged in both tasks in each of the two experiments. We conclude that feedback mechanisms operating to maximize task performance are subjected to a form of competition between spatial and temporal variabilities.	[Danion, Frederic] Aix Marseille Univ, CNRS, Inst Neurosci Timone UMR 7289, Marseille, France; [Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Sci, Groningen, Netherlands; [Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Danion, F (corresponding author), Aix Marseille Univ, CNRS, Inst Neurosci Timone UMR 7289, Marseille, France.	frederic.danion@univ-amu.fr	Bootsma, Reinoud/B-1254-2008; Danion, Frederic/ABS-1799-2022; Bongers, Raoul/C-1094-2012	Bootsma, Reinoud/0000-0002-3719-7586; Danion, Frederic/0000-0003-4296-7300; Bongers, Raoul/0000-0002-3518-7464				BARTLETT NR, 1959, PSYCHOL REV, V66, P203, DOI 10.1037/h0046490; BEEK PJ, 1995, BIOL CYBERN, V73, P499, DOI 10.1007/BF00199542; Bella SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020518; Billon M, 2000, NEUROSCI LETT, V286, P49, DOI 10.1016/S0304-3940(00)01089-2; Bongers RM, 2009, J EXP PSYCHOL HUMAN, V35, P1443, DOI 10.1037/a0015783; BONNARD M, 1997, MOTOR CONTROL, V1, P247; Bootsma RJ, 2004, INT J HUM-COMPUT ST, V61, P811, DOI 10.1016/j.ijhcs.2004.09.004; Bootsma RJ, 2004, ECOL PSYCHOL, V16, P55, DOI 10.1207/s15326969eco1601_7; Bootsma RJ, 2002, NEUROSCI LETT, V333, P141, DOI 10.1016/S0304-3940(02)01003-0; Brouwer AM, 2005, EXP BRAIN RES, V165, P28, DOI 10.1007/s00221-005-2277-y; Casiez G, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1709; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Ciofani G, 2010, MICROGRAVITY SCI TEC, V22, P123, DOI 10.1007/s12217-009-9163-3; Danion F, 2006, GAIT POSTURE, V23, P173, DOI 10.1016/j.gaitpost.2005.01.005; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Danion F, 2007, J NEUROSCI, V27, P12839, DOI 10.1523/JNEUROSCI.3110-07.2007; Danion F, 2010, J EXP PSYCHOL HUMAN, V36, P1684, DOI 10.1037/a0020672; Doumas M, 2007, J EXP PSYCHOL HUMAN, V33, P442, DOI 10.1037/0096-1523.33.2.442; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fernandez L, 2004, EXP BRAIN RES, V159, P458, DOI 10.1007/s00221-004-1964-4; Fernandez L, 2008, ACTA PSYCHOL, V129, P217, DOI 10.1016/j.actpsy.2008.06.001; Fernandez L, 2006, HUM MOVEMENT SCI, V25, P695, DOI 10.1016/j.humov.2006.05.001; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 1997, J NEUROSCI, V17, P1519; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Guigon E, 2008, EUR J NEUROSCI, V27, P1003, DOI 10.1111/j.1460-9568.2008.06028.x; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hancock P.A., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [10.1007/978-3-642-69749-4_5, DOI 10.1007/978-3-642-69749-4_5]; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; MacKenzie KM, 1987, AM J OPTOMETRY PHYSL, V64, P186; Mackey DC, 2002, EXP BRAIN RES, V142, P409, DOI 10.1007/s00221-001-0946-z; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Mottet D, 2001, HUM MOVEMENT SCI, V20, P213, DOI 10.1016/S0167-9457(01)00038-0; Newell K.M, 1993, VARIABILITY MOTOR CO; NEWELL KM, 1980, J MOTOR BEHAV, V12, P47; NEWELL KM, 1979, J MOTOR BEHAV, V11, P49; NEWELL KM, 1982, J MOTOR BEHAV, V14, P24; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Sarlegna FR, 2010, J NEUROPHYSIOL, V104, P641, DOI 10.1152/jn.00174.2010; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Semjen A, 2000, PSYCHOL RES-PSYCH FO, V63, P137, DOI 10.1007/PL00008172; Shafir T, 2010, J MOTOR BEHAV, V42, P71, DOI 10.1080/00222890903397137; Spencer RMC, 2003, J MOTOR BEHAV, V35, P371, DOI 10.1080/00222890309603157; Spiegel J, 2007, ZBL NEUROCHIR, V68, P67, DOI 10.1055/s-2007-977739; Sternad D, 2000, J MOTOR BEHAV, V32, P249, DOI 10.1080/00222890009601376; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tresilian JR, 2006, EXP BRAIN RES, V171, P421, DOI 10.1007/s00221-005-0286-5; Tresilian JR, 2004, EXP BRAIN RES, V155, P509, DOI 10.1007/s00221-003-1793-x; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; Woodworth R. S., 1899, PSYCHOL REV MONOGR S, V3, pi, DOI DOI 10.1037/H0092992; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; ZELAZNIK HN, 1988, J EXP PSYCHOL HUMAN, V14, P221, DOI 10.1037/0096-1523.14.2.221	67	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97447	10.1371/journal.pone.0097447	http://dx.doi.org/10.1371/journal.pone.0097447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835236	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800046
J	Fujii, S; Watanabe, H; Oohashi, H; Hirashima, M; Nozaki, D; Taga, G				Fujii, Shinya; Watanabe, Hama; Oohashi, Hiroki; Hirashima, Masaya; Nozaki, Daichi; Taga, Gentaro			Precursors of Dancing and Singing to Music in Three- to Four-Months-Old Infants	PLOS ONE			English	Article							SPEECH; BEAT; SYNCHRONIZATION; EVOLUTION; ENTRAINMENT; MOVEMENTS; RESPONSES; RHYTHM; PERCEPTION; IMITATION	Dancing and singing to music involve auditory-motor coordination and have been essential to our human culture since ancient times. Although scholars have been trying to understand the evolutionary and developmental origin of music, early human developmental manifestations of auditory-motor interactions in music have not been fully investigated. Here we report limb movements and vocalizations in three- to four-months-old infants while they listened to music and were in silence. In the group analysis, we found no significant increase in the amount of movement or in the relative power spectrum density around the musical tempo in the music condition compared to the silent condition. Intriguingly, however, there were two infants who demonstrated striking increases in the rhythmic movements via kicking or arm-waving around the musical tempo during listening to music. Monte-Carlo statistics with phase-randomized surrogate data revealed that the limb movements of these individuals were significantly synchronized to the musical beat. Moreover, we found a clear increase in the formant variability of vocalizations in the group during music perception. These results suggest that infants at this age are already primed with their bodies to interact with music via limb movements and vocalizations.	[Fujii, Shinya] Heart & Stroke Fdn Canadian Partnership Stroke Re, Sunnybrook Res Inst, Toronto, ON, Canada; [Watanabe, Hama; Oohashi, Hiroki; Hirashima, Masaya; Nozaki, Daichi; Taga, Gentaro] Univ Tokyo, Bunkyo Ku, Grad Sch Educ, Tokyo 113, Japan; [Fujii, Shinya; Oohashi, Hiroki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Tokyo; Japan Society for the Promotion of Science	Fujii, S (corresponding author), Heart & Stroke Fdn Canadian Partnership Stroke Re, Sunnybrook Res Inst, Toronto, ON, Canada.	sfujii@sri.utoronto.ca		Nozaki, Daichi/0000-0002-1338-8337	Japan Society for the Promotion of Science [22-7777, 23700682, 20670001, 24119002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by a Grant for the Fellows of the Japan Society for the Promotion of Science (No. 22-7777) awarded to S. F., a Grant-in-Aid for Scientific Research (No. 23700682) awarded to H. W., and a Grant-in-Aid for Scientific Research (No. 20670001 and 24119002) awarded to G. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma P., 2020, PRAAT DOING PHONETIC; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; Darwin G., 1871, P423; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Ellis DPW, 2007, J NEW MUSIC RES, V36, P51, DOI 10.1080/09298210701653344; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Fujioka T, 2010, J NEUROSCI, V30, P3458, DOI 10.1523/JNEUROSCI.3086-09.2010; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; HADDERSALGRA M, 1992, EARLY HUM DEV, V28, P201, DOI 10.1016/0378-3782(92)90167-F; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Kato M., 2013, J MOTOR LEARNING DEV, V1, P79, DOI [10.1123/jmld.1.4.79, DOI 10.1123/JMLD.1.4.79]; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kotilahti K, 2010, HUM BRAIN MAPP, V31, P595, DOI 10.1002/hbm.20890; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Kung SJ, 2013, J COGNITIVE NEUROSCI, V25, P401, DOI 10.1162/jocn_a_00325; Masataka N, 2007, DEVELOPMENTAL SCI, V10, P35, DOI 10.1111/j.1467-7687.2007.00561.x; Masataka N, 2009, PHYS LIFE REV, V6, P11, DOI 10.1016/j.plrev.2008.08.003; Mase M, 2005, PHYSIOL MEAS, V26, P911, DOI 10.1088/0967-3334/26/6/003; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MICHEL GF, 1986, DEV PSYCHOBIOL, V19, P247, DOI 10.1002/dev.420190310; Mithen S., 2005, SINGING NEANDERTHALS; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Patel AD, 2009, ANN NY ACAD SCI, V1169, P459, DOI 10.1111/j.1749-6632.2009.04581.x; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Perani D, 2010, P NATL ACAD SCI USA, V107, P4758, DOI 10.1073/pnas.0909074107; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; PRECHTL HFR, 1986, EARLY HUM DEV, V14, P233, DOI 10.1016/0378-3782(86)90184-2; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Stefanics G, 2009, CLIN NEUROPHYSIOL, V120, P304, DOI 10.1016/j.clinph.2008.11.020; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; TREHUB SE, 1989, CAN J PSYCHOL, V43, P217, DOI 10.1037/h0084223; TREHUB SE, 1993, ADV CHILD DEV BEHAV, V24, P1, DOI 10.1016/S0065-2407(08)60298-0; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Watanabe H, 2011, J EXP PSYCHOL HUMAN, V37, P1157, DOI 10.1037/a0021936; Watanabe H, 2009, INFANT BEHAV DEV, V32, P79, DOI 10.1016/j.infbeh.2008.10.003; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	58	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97680	10.1371/journal.pone.0097680	http://dx.doi.org/10.1371/journal.pone.0097680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24837135	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800061
J	Gonzalez-Ruiz, V; Pascua, I; Fernandez-Marcelo, T; Ribelles, P; Bianchini, G; Sridharan, V; Iniesta, P; Ramos, MT; Olives, AI; Martin, MA; Menendez, JC				Gonzalez-Ruiz, Victor; Pascua, Irene; Fernandez-Marcelo, Tamara; Ribelles, Pascual; Bianchini, Giulia; Sridharan, Vellaisamy; Iniesta, Pilar; Teresa Ramos, M.; Olives, Ana I.; Antonia Martin, M.; Carlos Menendez, J.			B-Ring-Aryl Substituted Luotonin A Analogues with a New Binding Mode to the Topoisomerase 1-DNA Complex Show Enhanced Cytotoxic Activity	PLOS ONE			English	Article							CERIUM(IV) AMMONIUM-NITRATE; ALKALOID LUOTONIN; CAMPTOTHECINS; FRIEDLANDER; DERIVATIVES; CATALYST	Topoisomerase 1 inhibition is an important strategy in targeted cancer chemotherapy. The drugs currently in use acting on this enzyme belong to the family of the camptothecins, and suffer severe limitations because of their low stability, which is associated with the hydrolysis of the delta-lactone moiety in their E ring. Luotonin A is a natural camptothecin analogue that lacks this functional group and therefore shows a much-improved stability, but at the cost of a lower activity. Therefore, the development of luotonin A analogues with an increased potency is important for progress in this area. In the present paper, a small library of luotonin A analogues modified at their A and B rings was generated by cerium(IV) ammonium nitrate-catalyzed Friedlander reactions. All analogues showed an activity similar or higher than the natural luotonin A in terms of topoisomerase 1 inhibition and some compounds had an activity comparable to that of camptothecin. Furthermore, most compounds showed a better activity than luotonin A in cell cytotoxicity assays. In order to rationalize these results, the first docking studies of luotonin-topoisomerase 1-DNA ternary complexes were undertaken. Most compounds bound in a manner similar to luotonin A and to standard topoisomerase poisons such as topotecan but, interestingly, the two most promising analogues, bearing a 3,5-dimethylphenyl substituent at ring B, docked in a different orientation. This binding mode allows the hydrophobic moiety to be shielded from the aqueous environment by being buried between the deoxyribose belonging to the G(+1) guanine and Arg364 in the scissile strand and the surface of the protein and a hydrogen bond between the D-ring carbonyl and the basic amino acid. The discovery of this new binding mode and its associated higher inhibitory potency is a significant advance in the design of new topoisomerase 1 inhibitors.	[Gonzalez-Ruiz, Victor; Olives, Ana I.; Antonia Martin, M.] Univ Complutense, Fac Farm, Secc Dept Quim Analit, E-28040 Madrid, Spain; [Gonzalez-Ruiz, Victor; Ribelles, Pascual; Bianchini, Giulia; Teresa Ramos, M.; Olives, Ana I.; Antonia Martin, M.; Carlos Menendez, J.] Univ Complutense, Fac Farm, BIOHET Biol Relevant Heterocycles Grp, E-28040 Madrid, Spain; [Pascua, Irene; Fernandez-Marcelo, Tamara; Iniesta, Pilar] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Pascua, Irene; Fernandez-Marcelo, Tamara; Iniesta, Pilar] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Ribelles, Pascual; Bianchini, Giulia; Sridharan, Vellaisamy; Teresa Ramos, M.; Carlos Menendez, J.] Univ Complutense, Fac Farm, Dept Quim Organ & Farmaceut, E-28040 Madrid, Spain; [Sridharan, Vellaisamy] SASTRA Univ, Dept Chem & Biotechnol, Thanjavur, India	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid; Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Menendez, JC (corresponding author), Univ Complutense, Fac Farm, BIOHET Biol Relevant Heterocycles Grp, E-28040 Madrid, Spain.	josecm@farm.ucm.es	Fernández-Marcelo, Tamara/N-9196-2018; González-Ruiz, Víctor/C-4990-2009; Menéndez, J. Carlos/B-7529-2014; González-Ruiz, Víctor/M-3500-2019; Ramos, M Teresa/H-8552-2015; Fernández-Marcelo, Tamara/Y-9067-2019; Martin, M. Antonia/H-4794-2015	Fernández-Marcelo, Tamara/0000-0001-6550-3838; González-Ruiz, Víctor/0000-0001-7204-2363; Menéndez, J. Carlos/0000-0002-0560-8416; González-Ruiz, Víctor/0000-0001-7204-2363; Fernández-Marcelo, Tamara/0000-0001-6550-3838; Olives, Ana Isabel/0000-0002-5535-1700; Martin, M. Antonia/0000-0001-5525-8621; Ramos, M Teresa/0000-0001-9225-9316; Sridharan, Vellaisamy/0000-0002-3099-4734	MICINN [CTQ 2009-11312]; Santander-UCM [PR6/13-18859]; Fundacion de Investigacion Medica Mutua Madrilena; MINECO [CTQ 2012-33272-BQU]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Santander-UCM; Fundacion de Investigacion Medica Mutua Madrilena; MINECO(Spanish Government)	MICINN (grant CTQ 2009-11312), www.micinn.es; Santander-UCM PR6/13-18859, www.ucm.es; Fundacion de Investigacion Medica Mutua Madrilena, www.fundacionmutua.es; MINECO (CTQ 2012-33272-BQU), www.mineco.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atechian S, 2007, TETRAHEDRON, V63, P2811, DOI 10.1016/j.tet.2007.01.050; Avendano C, 2008, MED CHEM ANTICANCER; Boisse T, 2011, TETRAHEDRON LETT, V52, P1592, DOI 10.1016/j.tetlet.2011.01.105; Cagir A, 2003, J AM CHEM SOC, V125, P13628, DOI 10.1021/ja0368857; Castelli S, 2012, BIOL CHEM, V393, P1327, DOI 10.1515/hsz-2012-0240; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Dallavalle S, 2004, BIOORG MED CHEM LETT, V14, P5757, DOI 10.1016/j.bmcl.2004.09.039; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Ferlay J, 2013, IARC CANCERBASE; Golubev AS, 2011, RUSS CHEM B INT EDIT, V59, P209; Gonzalez-Ruiz V, 2010, J SEP SCI, V33, P2086, DOI 10.1002/jssc.201000175; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; Kacprzak K., 2013, NATURAL PRODUCTS, P643, DOI [10.1007/978-3-642-22144-6_26, DOI 10.1007/978-3-642-22144-6_26]; Levin B, 2008, WORLD CANC REPORT; Liang JL, 2011, MOLECULES, V16, P4861, DOI 10.3390/molecules16064861; Ma ZZ, 1997, HETEROCYCLES, V46, P541; Marco-Contelles J, 2009, CHEM REV, V109, P2652, DOI 10.1021/cr800482c; Marszall MP, 2011, J PHARM SCI-US, V100, P1142, DOI 10.1002/jps.22318; Molina P, 2000, SYNTHESIS-STUTTGART, P1523; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Politzer P, 2013, PHYS CHEM CHEM PHYS, V15, P11178, DOI 10.1039/c3cp00054k; Pommier Y., 2011, DNA TOPOISOMERASES C; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rahman AFMM, 2008, B KOREAN CHEM SOC, V29, P1988; Sridharan V, 2010, CHEM REV, V110, P3805, DOI 10.1021/cr100004p; Sridharan V, 2009, J ORG CHEM, V74, P5715, DOI 10.1021/jo900965f; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng MC, 2011, ORG LETT, V13, P920, DOI 10.1021/ol1029707; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Verma RP, 2009, CHEM REV, V109, P213, DOI 10.1021/cr0780210; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wadkins Randy M., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P327, DOI 10.2174/1568011043352894; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	37	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95998	10.1371/journal.pone.0095998	http://dx.doi.org/10.1371/journal.pone.0095998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830682	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500011
J	Hiremath, P; Bauer, M; Aguirre, AD; Cheng, HW; Unno, K; Patel, RB; Harvey, BW; Chang, WT; Groarke, JD; Liao, R; Cheng, S				Hiremath, Pranoti; Bauer, Michael; Aguirre, Aaron D.; Cheng, Hui-Wen; Unno, Kazumasa; Patel, Ravi B.; Harvey, Bethany W.; Chang, Wei-Ting; Groarke, John D.; Liao, Ronglih; Cheng, Susan			Identifying Early Changes in Myocardial Microstructure in Hypertensive Heart Disease	PLOS ONE			English	Article							B-MODE ULTRASOUND; INTEGRATED BACKSCATTER; BLOOD-PRESSURE; GRAY-LEVEL; CYCLIC VARIATION; TIME-DELAY; FIBROSIS; PATTERNS; RECOMMENDATIONS; HYPOTHYROIDISM	The transition from healthy myocardium to hypertensive heart disease is characterized by a series of poorly understood changes in myocardial tissue microstructure. Incremental alterations in the orientation and integrity of myocardial fibers can be assessed using advanced ultrasonic image analysis. We used a modified algorithm to investigate left ventricular myocardial microstructure based on analysis of the reflection intensity at the myocardial-pericardial interface on B-mode echocardiographic images. We evaluated the extent to which the novel algorithm can differentiate between normal myocardium and hypertensive heart disease in humans as well as in a mouse model of afterload resistance. The algorithm significantly differentiated between individuals with uncomplicated essential hypertension (N = 30) and healthy controls (N = 28), even after adjusting for age and sex (P = 0.025). There was a trend in higher relative wall thickness in hypertensive individuals compared to controls (P = 0.08), but no difference between groups in left ventricular mass (P = 0.98) or total wall thickness (P = 0.37). In mice, algorithm measurements (P = 0.026) compared with left ventricular mass (P = 0.053) more clearly differentiated between animal groups that underwent fixed aortic banding, temporary aortic banding, or sham procedure, on echocardiography at 7 weeks after surgery. Based on sonographic signal intensity analysis, a novel imaging algorithm provides an accessible, non-invasive measure that appears to differentiate normal left ventricular microstructure from myocardium exposed to chronic afterload stress. The algorithm may represent a particularly sensitive measure of the myocardial changes that occur early in the course of disease progression.	[Hiremath, Pranoti] Harvard Univ, Sch Med, Boston, MA USA; [Patel, Ravi B.; Harvey, Bethany W.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bauer, Michael; Aguirre, Aaron D.; Cheng, Hui-Wen; Unno, Kazumasa; Chang, Wei-Ting; Groarke, John D.; Liao, Ronglih; Cheng, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cheng, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA.	scheng@rics.bwh.harvard.edu	Unno, Kazumasa/M-5065-2014	Patel, Ravi/0000-0001-5037-5554; Liao, Ronglih/0000-0002-9598-9020; Cheng, Susan/0000-0002-4977-036X	National Institutes of Health (NIH) [HL088533, HL071775, HL093148, HL099073]; American Heart Association; Ellison Foundation; American Medical Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093148, R01HL099073, R01HL088533, R01HL071775] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ellison Foundation(Lawrence Ellison Foundation); American Medical Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by funding from the National Institutes of Health (NIH) - HL088533, HL071775, HL093148, and HL099073 (R. L.). M. B. was a recipient of an American Heart Association founder affiliate postdoctoral fellowship award. S. C. was supported by an award from the Ellison Foundation. K. U. is a recipient of an American Heart Association founders affiliate postdoctoral fellowship award. P. H. is a recipient of the American Medical Association Medical Student Seed Grant and the American Heart Association Student Scholarship in Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghini-Lombardi F, 2006, EUR J ENDOCRINOL, V155, P3, DOI 10.1530/eje.1.02174; Baroldi Giorgio, 2007, Cardiovasc Ultrasound, V5, P5, DOI 10.1186/1476-7120-5-5; Bauer M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053956, 10.1371/journal.pone.0059915]; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Cheng S, 2012, HYPERTENSION, V60, P1393, DOI 10.1161/HYPERTENSIONAHA.112.201780; Ciulla M, 1997, J AM SOC ECHOCARDIOG, V10, P657, DOI 10.1016/S0894-7317(97)70028-2; Di Bello V, 2000, J AM SOC ECHOCARDIOG, V13, P832, DOI 10.1067/mje.2000.106397; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Finch-Johnston AE, 2000, J AM SOC ECHOCARDIOG, V13, P9, DOI 10.1067/mje.2000.102695; Franklin SS, 1997, CIRCULATION, V96, P308; Hadi AM, 2011, CELL ONCOL, V34, P343, DOI 10.1007/s13402-011-0035-7; Hiremath P BM, 2013, J EXP VIS IN PRESS; Hunt KJ, 2001, ULTRASOUND MED BIOL, V27, P357, DOI 10.1016/S0301-5629(00)00353-7; Hunt KJ, 2001, STROKE, V32, P1120, DOI 10.1161/01.STR.32.5.1120; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maceira AM, 2002, HYPERTENSION, V39, P923, DOI 10.1161/01.HYP.0000014616.48920.8F; Marini C, 1996, EUR HEART J, V17, P472; MEUNIER J, 1995, IEEE T BIO-MED ENG, V42, P403, DOI 10.1109/10.376133; Mizuno R, 2007, CARDIOLOGY, V108, P11, DOI 10.1159/000095595; MOHR GA, 1989, ULTRASONIC IMAGING, V11, P245, DOI 10.1016/0161-7346(89)90078-3; OBRIEN PD, 1995, CIRCULATION, V91, P171, DOI 10.1161/01.CIR.91.1.171; OLSHANSKY B, 1984, CIRCULATION, V70, P972, DOI 10.1161/01.CIR.70.6.972; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Yamada S, 2006, CURR OPIN CARDIOL, V21, P433, DOI 10.1097/01.hco.0000240578.05053.f9	26	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97424	10.1371/journal.pone.0097424	http://dx.doi.org/10.1371/journal.pone.0097424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831515	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500057
J	Masala, S; Cossu, D; Palermo, M; Sechi, LA				Masala, Speranza; Cossu, Davide; Palermo, Mario; Sechi, Leonardo Antonio			Recognition of Zinc Transporter 8 and MAP3865c Homologous Epitopes by Hashimoto's Thyroiditis Subjects from Sardinia: A Common Target with Type 1 Diabetes?	PLOS ONE			English	Article							AVIUM-SUBSPECIES-PARATUBERCULOSIS; MULTIPLE-SCLEROSIS; INFECTION	Mycobacterium avium subspecies paratuberculosis (MAP) asymptomatic infection has been previously linked to Type 1 diabetes (T1D) and Multiple Sclerosis. An association between MAP infection and Hashimoto's thyroiditis (HT) was also proposed only in a case report. This study aimed to investigate the robustness of the latter association, testing a large cohort of HT and healthy control (HCs) subjects, all from Sardinia. Prevalence of anti-MAP3865c Abs was assessed by indirect enzyme-linked immunosorbent assay (ELISA). Moreover, given that human ZnT8 is specifically expressed in the pancreatic beta-cells, in the follicle epithelial cells and in the parafollicular cells of the thyroid gland, we also tested ZnT8 epitopes homologues to the MAP3865c immunodominant peptides previously identified. Indeed, Abs targeting MAP3865c and ZnT8 homologous regions display similar frequencies in patients and controls, thus suggesting that Abs recognizing these epitopes could be cross-reactive. A statistically significant difference was found between HT patients and HCs when analyzing the humoral response mounted against MAP3865c/ZnT8 homologues epitopes. To our knowledge, this is the first report, which provides statistically significant evidence sustaining the existence of an association between MAP sero-reactivity and HT. Further studies are required to investigate the relevance of MAP to HT, aimed at deciphering if this pathogen can be at play in triggering this autoimmune disease. Likewise, genetic polymorphism of the host, and other environmental factors need to be investigated.	[Masala, Speranza; Cossu, Davide; Sechi, Leonardo Antonio] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Palermo, Mario] Azienda Sanit Locale ASL 1, Dept Endocrinol, Sassari, Italy	University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	sechila@uniss.it	Cossu, Davide/C-4452-2013; Cossu, Davide/AAD-7958-2019; Sechi, Leonardo Antonio/Y-3109-2018	Cossu, Davide/0000-0002-0557-9467; sechi, leonardo antonio/0000-0003-0566-2049	Sardinian Region [L.R.7]; Progetti di ricerca di base-; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale; P.O.R. Sardinia F.S.E.; Axis IV human capitals, Line of Business I.3.1;  [RF-2009-1545765]	Sardinian Region(Regione Sardegna); Progetti di ricerca di base-; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)); P.O.R. Sardinia F.S.E.; Axis IV human capitals, Line of Business I.3.1; 	This research was supported by the Sardinian Region L.R.7 2009 and 2010 Progetti di ricerca di base-, PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale, <Bando PRIN 2009>. Protocollo: 2009ZYECWZ and Italian Minister of Health, "Finalized Research" Protocollo: RF-2009-1545765, to LAS. The present publication was produced as part of the RAS research project selection code 06/A3-10, developed at Sassari University by Speranza Masala and supported by P.O.R. Sardinia F.S.E. 2007-2013; Axis IV human capitals, Line of Business I.3.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2012, ADV ANAT PATHOL, V19, P181, DOI 10.1097/PAP.0b013e3182534868; Bitti MLM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/785262; Burek CL, 2009, J AUTOIMMUN, V33, P183, DOI 10.1016/j.jaut.2009.09.001; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Cossu D, 2013, FUTURE MICROBIOL, V8, P223, DOI [10.2217/fmb.12.135, 10.2217/FMB.12.135]; Cossu D, 2012, MULT SCLER J, V18, P1181, DOI 10.1177/1352458511433430; D'Amore M, 2010, J MED MICROBIOL, V59, P137, DOI 10.1099/jmm.0.013474-0; Derbinski J, 2005, PROMISCUOUS GENE EXP, V202, P33; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-24; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Naser SA, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-14; Pozzato N, 2011, PREV VET MED, V102, P83, DOI 10.1016/j.prevetmed.2011.07.001; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sisto M, 2010, SCAND J INFECT DIS, V42, P787, DOI 10.3109/00365541003762306	18	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97621	10.1371/journal.pone.0097621	http://dx.doi.org/10.1371/journal.pone.0097621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830306	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500086
J	Moussu, L; Saint-Pierre, P; Panayotopoulos, V; Couderc, R; Amat, F; Just, J				Moussu, Lise; Saint-Pierre, Philippe; Panayotopoulos, Virginie; Couderc, Remy; Amat, Flore; Just, Jocelyne			Determinants of Allergic Rhinitis in Young Children with Asthma	PLOS ONE			English	Article							ATOPIC-DERMATITIS; RISK; SENSITIZATION; IMPACT; ASSOCIATION; POPULATION; HEALTH; PREVALENCE; PHENOTYPES; DISEASES	Background: In the preschool period, allergic rhinitis (AR) is infrequent and thus under-diagnosed. However, recent works have highlighted the occurrence of AR in toddlers although the causes of AR in this young population remain unknown. The objective of this study was to identify determinants of AR in young children with asthma. Methods: We carried out a case-control study of 227 children with active asthma and enrolled in the Trousseau Asthma Program. AR and other allergic diseases (asthma, food allergy and eczema) were diagnosed by medical doctors using standardized questionnaires. Parental history of AR and asthma, biological markers of atopy (total IgE, blood eosinophilia, allergic sensitization towards food and aeroallergens) and environmental parameters were also collected. Results: Forty one of the children (18.1%) had AR. By univariate logistic regression analysis, AR was mainly associated with peanut sensitization (OR = 6.75; p = 0.002); food allergy (OR = 4.31; p = 0.026); mold exposure (OR = 3.81 p<0.01) and parental history of AR (OR = 1.42; p = 0.046). Due to the strong link between food allergy and peanut sensitization three models of multivariate logistic regression were performed and confirmed that AR is associated with peanut sensitization but also food allergy and mold exposure. A random forest analysis was also performed to explain AR. The results reinforced the logistic analysis that peanut sensitization and mold exposure were the principal determinants of AR. Conclusions & Clinical Relevance: These results stress the importance of investigating AR in young children with asthma to potentially diagnose a particularly severe allergic asthmatic phenotype. Moreover, these data evoke the hypothesis that peanut could be an aeroallergen.	[Moussu, Lise; Panayotopoulos, Virginie; Amat, Flore; Just, Jocelyne] Univ Paris 06, Hop Enfants Armand Trousseau, AP HP, Allergol Dept,Ctr Asthme & Allergies, Paris, France; [Saint-Pierre, Philippe] Univ Paris 06, Lab Stat Theor & Appl, Paris, France; [Couderc, Remy] Hop Enfants Armand Trousseau, AP HP, Serv Biochim & Biol Mol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Just, J (corresponding author), Univ Paris 06, Hop Enfants Armand Trousseau, AP HP, Allergol Dept,Ctr Asthme & Allergies, Paris, France.	jocelyne.just@trs.aphp.fr	Amat, Flore/GPF-4655-2022					Annesi-Maesano I, 2002, ALLERGY, V57, P107, DOI 10.1034/j.1398-9995.2002.1o3170.x; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Biagini JM, 2006, PEDIAT ALLERG IMM-UK, V17, P278, DOI 10.1111/j.1399-3038.2006.00386.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Clarisse B, 2009, PEDIAT ALLERG IMM-UK, V20, P126, DOI 10.1111/j.1399-3038.2008.00743.x; de Groot EP, 2012, THORAX, V67, P582, DOI 10.1136/thoraxjnl-2011-201168; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Hellings PW, 2006, ALLERGY, V61, P656, DOI 10.1111/j.1398-9995.2006.01109.x; Herr M, 2011, ALLERGY, V66, P214, DOI 10.1111/j.1398-9995.2010.02467.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Husman T, 1996, SCAND J WORK ENV HEA, V22, P5, DOI 10.5271/sjweh.103; Jaakkola JJK, 2010, AM J EPIDEMIOL, V172, P451, DOI 10.1093/aje/kwq110; Just J, 2008, CLIN EXP ALLERGY, V38, P767, DOI 10.1111/j.1365-2222.2008.02966.x; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Kim SW, 2013, AM J RHINOL ALLERGY, V27, pE63, DOI 10.2500/ajra.2013.27.3877; Kjaer HF, 2008, PEDIAT ALLERG IMM-UK, V19, P737, DOI 10.1111/j.1399-3038.2008.00733.x; Kulig M, 1998, PEDIAT ALLERG IMM-UK, V9, P61, DOI 10.1111/j.1399-3038.1998.tb00305.x; Kulig M, 2000, J ALLERGY CLIN IMMUN, V106, P832, DOI 10.1067/mai.2000.110098; Lee JT, 2004, ANN ACAD MED SINGAP, V33, P71; Lohia S, 2013, ALLERGY, V68, P569, DOI 10.1111/all.12124; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; O'Sullivan MM, 2012, J ASTHMA, V49, P911, DOI 10.3109/02770903.2012.724131; Peroni DG, 2003, CLIN EXP ALLERGY, V33, P1349, DOI 10.1046/j.1365-2222.2003.01766.x; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Schroeder A, 2009, CLIN EXP ALLERGY, V39, P261, DOI 10.1111/j.1365-2222.2008.03160.x; Silva CHM da, BRAZ J OTORHINOLARYN, V75, P642; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Strachan D, 1997, PEDIAT ALLERGY IMMUN, V8, P161; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; Wang WC, ZHONGHUA MIN GUO XIA, V39, P314; Westman M, 2012, J ALLERGY CLIN IMMUN, V129, P403, DOI 10.1016/j.jaci.2011.09.036; WRIGHT AL, 1994, PEDIATRICS, V94, P895; Zacharasiewicz A, 2000, ALLERGY, V55, P945, DOI 10.1034/j.1398-9995.2000.00575.x	43	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97236	10.1371/journal.pone.0097236	http://dx.doi.org/10.1371/journal.pone.0097236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831804	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500041
J	Machado, MN; Nakazone, MA; Maia, LN				Machado, Mauricio N.; Nakazone, Marcelo A.; Maia, Lilia N.			Prognostic Value of Acute Kidney Injury after Cardiac Surgery according to Kidney Disease: Improving Global Outcomes Definition and Staging (KDIGO) Criteria	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; REPLACEMENT THERAPY; SERUM CREATININE; RIFLE CRITERIA; RISK-FACTORS; BYPASS; MORTALITY; DYSFUNCTION; PREDICTION; NETWORK	Objectives: The definition of acute renal failure has been recently reviewed, and the term acute kidney injury (AKI) was proposed to cover the entire spectrum of the syndrome, ranging from small changes in renal function markers to dialysis needs. This study was aimed to evaluate the incidence, morbidity and mortality associated with AKI (based on KDIGO criteria) in patients after cardiac surgery (coronary artery bypass grafting or cardiac valve surgery) and to determine the value of this feature as a predictor of hospital mortality (30 days). Methods: From January 2003 to June 2013, a total of 2,804 patients underwent cardiac surgery in our service. Cox proportional hazard models were used to determine the association between the development of AKI and 30-day mortality. Results: A total of 1,175 (42%) patients met the diagnostic criteria for AKI based on KDIGO classification during the first 7 postoperative days: 978 (35%) patients met the diagnostic criteria for stage 1 while 100 (4%) patients met the diagnostic criteria for stage 2 and 97 (3%) patients met the diagnostic criteria for stage 3. A total of 63 (2%) patients required dialysis treatment. Overall, the 30-day mortality was 7.1% (2.2%) for patients without AKI and 8.2%, 31% and 55% for patients with AKI at stages 1, 2 and 3, respectively. The KDIGO stage 3 patients who did not require dialysis had a mortality rate of 41%, while the mortality of dialysis patients was 62%. The adjusted Cox regression analysis revealed that AKI based on KDIGO criteria (stages 1-3) was an independent predictor of 30-day mortality (P<0.001 for all. Hazard ratio = 3.35, 11.94 and 24.85). Conclusion: In the population evaluated in the present study, even slight changes in the renal function based on KDIGO criteria were considered as independent predictors of 30-day mortality after cardiac surgery.	[Machado, Mauricio N.; Nakazone, Marcelo A.] Hosp Base, Div Cardiac Surg, Intens Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil; [Machado, Mauricio N.; Nakazone, Marcelo A.] Hosp Base, Coronary Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil; [Nakazone, Marcelo A.; Maia, Lilia N.] Hosp Base, Div Ctr Integrado Pesquisa CIP, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil		Nakazone, MA (corresponding author), Hosp Base, Div Cardiac Surg, Intens Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil.	naka_med@yahoo.com	Nakazone, Marcelo Arruda/H-2719-2012; Maia, Lilia Nigro/AAV-6938-2021; Machado, Mauricio/B-7012-2008	Nakazone, Marcelo Arruda/0000-0002-0449-7056; Machado, Mauricio/0000-0002-9581-5215				Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0; Arnaoutakis GJ, 2007, J THORAC CARDIOV SUR, V134, P1554, DOI 10.1016/j.jtcvs.2007.08.039; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2011, SEMIN RESP CRIT CARE, V32, P639, DOI 10.1055/s-0031-1287872; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Dardashti A, 2013, J THORAC CA IN PRESS; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; De Santo LS, 2010, J HEART VALVE DIS, V19, P139; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Englberger L, 2011, CRIT CARE, V15, DOI 10.1186/cc9960; Ghavidel AA, 2014, J THORACIC IN PRESS; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Han SS, 2012, NEPHROL DIAL TRANSPL, V27, P161, DOI 10.1093/ndt/gfr312; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Mickleborough LL, 2003, J THORAC CARDIOV SUR, V126, P950, DOI 10.1016/S0022-5223(02)73596-4; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Olivero Juan Jose, 2012, Methodist Debakey Cardiovasc J, V8, P31; Robert AM, 2010, ANN THORAC SURG, V90, P1939, DOI 10.1016/j.athoracsur.2010.08.018; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Sampaio MC, 2013, ARQ BRAS CARDIOL, V101, P18, DOI 10.5935/abc.20130115; Schneider AG, 2012, J CRIT CARE, V27, P488, DOI 10.1016/j.jcrc.2012.02.008; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Tolpin DA, 2012, J THORAC CARDIOV SUR, V143, P682, DOI 10.1016/j.jtcvs.2011.09.044; Toumpoulis IK, 2006, J THORAC CARDIOV SUR, V131, P343, DOI 10.1016/j.jtcvs.2005.08.056; Trienekens MP, 2014, J CARDIOVAS IN PRESS; Uchino S, 2006, CURR OPIN CRIT CARE, V12, P538, DOI 10.1097/01.ccx.0000247448.94252.5a; Wang TKM, 2013, NEW ZEAL MED J, V126, P25; Xu Jia-rui, 2012, Zhonghua Nei Ke Za Zhi, V51, P943; Yehia M, 2005, NEPHROLOGY, V10, P541, DOI 10.1111/j.1440-1797.2005.00496.x	41	93	102	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e98028	10.1371/journal.pone.0098028	http://dx.doi.org/10.1371/journal.pone.0098028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826910	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400126
J	Smith, D; Leary, P; Bendall, M; Flach, E; Jones, R; Sweet, M				Smith, David; Leary, Peter; Bendall, Mark; Flach, Edmund; Jones, Rachel; Sweet, Michael			A Novel Investigation of a Blister-Like Syndrome in Aquarium Echinopora lamellosa	PLOS ONE			English	Article							BLACK BAND DISEASE; GEL-ELECTROPHORESIS DGGE; GROWTH ANOMALIES; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; METAGENOMIC ANALYSIS; ASPERGILLUS-SYDOWII; TURTLE HERPESVIRUS; CHELONIA-MYDAS; CORAL	This study investigates potential causes of a novel blister-like syndrome in the plating coral Echinopora lamellosa. Visual inspections of this novel coral syndrome showed no obvious signs of macroparasites and the blisters themselves manifested as fluid-filled sacs on the surface of the coral, which rose from the coenosarc between the coral polyps. Histological analysis of the blisters showed that there was no associated necrosis with the epidermal or gastrodermal tissues. The only difference between blistered areas and apparently healthy tissues was the presence of proliferated growth (possible mucosal cell hyperplasia) directly at the blister interface (area between where the edge of the blister joined apparently healthy tissue). No bacterial aggregates were identified in any histological samples, nor any sign of tissue necrosis identified. We conclude, that the blister formations are not apparently caused by a specific microbial infection, but instead may be the result of irritation following growth anomalies of the epidermis. However, future work should be conducted to search for other potential casual agents, including viruses.	[Smith, David; Leary, Peter; Bendall, Mark; Sweet, Michael] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, David] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Flach, Edmund; Jones, Rachel] Zool Soc London, London, Greater London, England; [Sweet, Michael] Univ Derby, Biol Sci Res Grp, Derby DE22 1GB, England	Newcastle University - UK; Queens University Belfast; Zoological Society of London; University of Derby	Smith, D (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	dsmith37@qub.ac.uk	Smith, David/AAH-4738-2020; Sweet, Michael/E-9661-2012	Smith, David/0000-0002-5158-0522; Sweet, Michael/0000-0003-4983-8333	Natural Environment Research Council [NE/H020616/1]; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by funding from a Natural Environment Research Council grant (NE/H020616/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bettarel Y, 2013, J MAR BIOL ASSOC UK, V93, P909, DOI 10.1017/S0025315411002062; Bjorndahl L, 2003, HUM REPROD, V18, P813, DOI 10.1093/humrep/deg199; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruno JF, 2011, ECOL MONOGR, V81, P123, DOI 10.1890/09-1178.1; Burns JHR, 2011, CORAL REEFS, V30, P819, DOI 10.1007/s00338-011-0761-3; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cheney D P, 1975, Adv Exp Med Biol, V64, P77; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coffee LL, 2013, VET PATHOL, V50, P390, DOI 10.1177/0300985813480529; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2006, DIS AQUATIC ORAGNISM, V69; Croquer A, 2012, ENV MICROBIOLOGY REP; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; Ein-Gil N, 2009, ISME J, V3, P752, DOI 10.1038/ismej.2009.18; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Irikawa A, 2011, MAR POLLUT BULL, V62, P1702, DOI 10.1016/j.marpolbul.2011.05.033; Kang KI, 2008, J COMP PATHOL, V139, P218, DOI 10.1016/j.jcpa.2008.07.003; Klaus JS, 2011, B MAR SCI, V87, P795, DOI 10.5343/bms.2010.1050; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Lema KA, 2012, APPL ENVIRON MICROB, V78, P3136, DOI 10.1128/AEM.07800-11; Lenz DH, 2000, INFECT IMMUN, V68, P956, DOI 10.1128/IAI.68.2.956-959.2000; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Palmer CV, 2010, CORAL REEFS, V29, P469, DOI 10.1007/s00338-010-0597-2; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Robert J, 2010, DEV COMP IMMUNOL, V34, P915, DOI 10.1016/j.dci.2010.05.011; Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26; Shen WY, 2011, EUR J CELL BIOL, V90, P323, DOI 10.1016/j.ejcb.2010.10.013; Soffer N, 2014, ISME J, V8, P271, DOI 10.1038/ismej.2013.137; Sweet M, 2012, ENV MICROBIOLOGY; Sweet M, 2011, J MAR BIOL ASSOC UK, P1, DOI DOI 10.1017/S0025315411001688; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Thurber RLV, 2011, J EXP MAR BIOL ECOL, V408, P102, DOI 10.1016/j.jembe.2011.07.030; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Weir-Brush J. R., 2004, Aerobiologia, V20, P119, DOI 10.1023/B:AERO.0000032949.14023.3a; Williams GJ, 2013, DIS AQUAT ORGAN, V106, P181, DOI 10.3354/dao02652; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2009, J GEN VIROL, V90, P1943, DOI 10.1099/vir.0.011650-0; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x; Zhao BY, 2011, CAN J MICROBIOL, V57, P115, DOI 10.1139/w10-107	63	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97018	10.1371/journal.pone.0097018	http://dx.doi.org/10.1371/journal.pone.0097018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827734	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400051
J	Conway, KW; Baldwin, C; White, MD				Conway, Kevin W.; Baldwin, Carole; White, Macaulay D.			Cryptic Diversity and Venom Glands in Western Atlantic Clingfishes of the Genus Acyrtus (Teleostei: Gobiesocidae)	PLOS ONE			English	Article							CRYPTOBENTHIC FISH ASSEMBLAGES; ENNEANECTES; EVOLUTION; PACIFIC	Examination of genetic data (mitochondrial cytochrome c oxidase I) for western Atlantic clingfishes revealed two distinct lineages within a group of individuals originally identified as Acyrtus artius. Subsequent investigation of preserved voucher specimens was conducted to reconcile the genetic data and the existing classification, which is based on morphology. In addition to discovering that one of the genetic lineages is an undescribed species, which we describe as Acyrtus lanthanum, new species, we found that the nominal species Acyrtus artius has a putative venom gland associated with the subopercle that has been overlooked since the species was described nearly 60 years ago. The new species lacks the subopercular gland as does Acyrtus rubiginosus, but one is present in the related Arcos nudus. Venom glands have not been reported previously for the Gobiesocidae, and the venom gland described herein for Acyrtus and Arcos represents the first example in teleost fishes of a venom gland associated with the subopercle.	[Conway, Kevin W.] Texas A&M Univ, Dept Wildlife & Fisheries Sci & Biodivers Res & T, College Stn, TX 77843 USA; [Baldwin, Carole] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [White, Macaulay D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Undergrad Degree Program, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Smithsonian Institution; Smithsonian National Museum of Natural History; Texas A&M University System; Texas A&M University College Station	Conway, KW (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci & Biodivers Res & T, College Stn, TX 77843 USA.	kevin.conway@tamu.edu			National Science Foundation [IOS 1256793]; Texas A&M Agrilife Research [TEX09452]; Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program; Direct For Biological Sciences [1256793] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Texas A&M Agrilife Research; Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation (IOS 1256793 to KWC), Texas A&M Agrilife Research (TEX09452 to KWC), and several Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program grants (to CCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2003, OECOLOGIA, V136, P137, DOI 10.1007/s00442-003-1244-1; Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Ahmadia GN, 2012, AQUAT BIOL, V16, P125, DOI 10.3354/ab00440; Baldwin CC, 2012, COPEIA, P23, DOI 10.1643/CG-11-035; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; BALDWIN CC, 1993, B MAR SCI, V52, P240; Bohlke JE, 1968, FISHES BAHAMAS ADJAC; Briggs J. C., 1969, Copeia, V1969, P774, DOI 10.2307/1441801; BRIGGS JOHN C., 1955, STANFORD ICHTHYOL BULL, V6, P1; CAMERON AM, 1973, TOXICON, V11, P401, DOI 10.1016/0041-0101(73)90115-3; Chakrabarty P, 2013, ZOOKEYS, P29, DOI 10.3897/zookeys.346.5753; Conway KW, 2012, J MORPHOL, V273, P1127, DOI 10.1002/jmor.20049; Craig MT, 2008, COPEIA, P68, DOI 10.1643/CI-07-025; Craig MT, 2009, ZOOTAXA, P64, DOI 10.11646/zootaxa.2271.1.6; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERNHOLM B, 1983, ZOOL J LINN SOC-LOND, V78, P199, DOI 10.1111/j.1096-3642.1983.tb00867.x; FISHELSON L, 1974, COPEIA, P386; Frable BW, 2013, FISH B-NOAA, V111, P122, DOI 10.7755/FB.111.2.2; Gemballa Sven, 1998, American Museum Novitates, V3241, P1; Greenfield DW, 2012, ZOOTAXA, P33, DOI 10.11646/zootaxa.3572.1.5; Halstead BW, 1970, POISONOUS VENOMOUS M, V3; Halstead BW., 1967, POISONOUS VENOMOUS M, VII; Harborne AR, 2012, CORAL REEFS, V31, P977, DOI 10.1007/s00338-012-0938-4; HORI K, 1979, TOXICON, V17, P418, DOI 10.1016/0041-0101(79)90271-X; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; JOHNSON R K, 1983, Northeast Gulf Science, V6, P33; Konstantinidis P, 2010, J MORPHOL, V271, P215, DOI 10.1002/jmor.10792; Lavett C., 2003, ATOLL RES B, V497, P1, DOI [10.5479/si.00775630.497.1, DOI 10.5479/SI.00775630.497.1]; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; Maddison WP., 2000, MACCLADE ANAL PHYLOG; McEachran JD, 2002, LIVING MARINE RESOUR, P1773; Perez M. H.Sabaj, 2010, STANDARD SYMBOLIC CO; Rosenblatt RH, 2013, ZOOTAXA, V3636, P361, DOI 10.11646/zootaxa.3636.2.7; Sampaio Claudio L. S., 2004, Neotropical Ichthyology, V2, P205; Schultz Leonard P., 1944, PROC U S NATION MUS, V96, P47; SHIOGAKI M, 1983, JPN J ICHTHYOL, V30, P111; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Smith-Vaniz W.F., 1971, Copeia, V1971, P291, DOI 10.2307/1442829; Smith-Vaniz WF., 1976, MONOGR ACAD NAT SCI, V19, P1; Smith-Vaniz WF, 2006, B MAR SCI, V79, P17; Springer V. G., 1968, Bulletin United States National Museum, VNo. 284, P1; Suzuki Toshiyuki, 2014, Aqua, V20, P11; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR W R, 1985, Cybium, V9, P107; TEYTAUD A R, 1971, Caribbean Journal of Science, V11, P41; Tornabene Luke, 2010, Aqua, V16, P141; Victor Benjamin C., 2013, Journal of the Ocean Science Foundation, V7, P44; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Williams Jeffrey T., 2003, Smithsonian Contributions to Zoology, V621, P1; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282	54	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97664	10.1371/journal.pone.0097664	http://dx.doi.org/10.1371/journal.pone.0097664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825326	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200132
J	Gu, JM; Yang, JS; Chang, Q; Lu, XQ; Wang, JY; Chen, MJ; Ghayur, T; Gu, JJ				Gu, Jinming; Yang, Jinsong; Chang, Qing; Lu, Xiaoqing; Wang, Jieyi; Chen, Mingjiu; Ghayur, Tariq; Gu, Jijie			Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig (TM)) Proteins with Unique Activities	PLOS ONE			English	Article							HER2-POSITIVE BREAST-CANCER; BISPECIFIC ANTIBODY; MONOCLONAL-ANTIBODY; TARGETED THERAPY; PI3K INHIBITOR; ERBB FAMILY; TRASTUZUMAB; GROWTH; MOLECULES; COMPLEX	Inhibiting ErbB2 signaling with monoclonal antibodies (mAbs) or small molecules is an established therapeutic strategy in oncology. We have developed anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig) proteins that capture the function of a combination of two anti-ErbB2 antibodies. In addition, some of the anti-ErbB2 DVD-Ig proteins gain the new functions of enhancing ErbB2 signaling and cell proliferation in N87 cells. We further found that two DVD-Ig proteins, DVD687 and DVD688, have two distinct mechanisms of actions in Calu-3 and N87 cells. DVD687 enhances cell cycle progression while DVD688 induces apoptosis in N87 cells. Using a half DVD687, we found that avidity may play a key role in the agonist activity of DVD687 in N87 cells.	[Gu, Jinming; Yang, Jinsong; Chang, Qing; Lu, Xiaoqing; Chen, Mingjiu; Ghayur, Tariq; Gu, Jijie] AbbVie Biores Ctr, R&D, Worcester, MA 01609 USA; [Wang, Jieyi] AbbVie Inc, Canc Res, R&D, N Chicago, IL USA	AbbVie; AbbVie	Gu, JJ (corresponding author), AbbVie Biores Ctr, R&D, Worcester, MA 01609 USA.	jijie.gu@abbvie.com			AbbVie, Inc	AbbVie, Inc(AbbVie)	This study was supported by fundings from AbbVie, Inc. The funder provided support in the form of salaries for all authors and contributed to the study design, participated in the collection, analysis and interpretation of the data, and in the writing, reviewing, and approval of this publication. The specific roles of these authors are articulated in the 'author contributions' section (JG, JY, and JG designed the study, QC did assays in Fig. 5, other authors analyzed the data).	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baselga J., 2010, ANN ONCOL; Cai Z, 2010, SEMIN CELL DEV BIOL, V21, P961, DOI 10.1016/j.semcdb.2010.09.005; Campbell CI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-235; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chien AJ, 2009, CANCER TREAT RES, P197, DOI 10.1007/978-0-387-75115-3_13; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Correia I, 2013, MABS-AUSTIN, V5, P364, DOI 10.4161/mabs.24258; Craig RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046778; DiGiammarino Enrico, 2012, Methods Mol Biol, V899, P145, DOI 10.1007/978-1-61779-921-1_9; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; English DP, 2013, MOL DIAGN THER, V17, P85, DOI 10.1007/s40291-013-0024-9; Frampton JE, 2009, DRUGS, V69, P2125, DOI 10.2165/11203240-000000000-00000; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Gu JJ, 2012, METHOD ENZYMOL, V502, P25, DOI 10.1016/B978-0-12-416039-2.00002-1; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ioannou N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-41; Jakob CG, 2013, MABS-AUSTIN, V5, P358, DOI 10.4161/mabs.23977; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Khurana A, 2013, CURR PHARM DES; Konecny GE, 2013, CURR OPIN OBSTET GYN, V25, P55, DOI 10.1097/GCO.0b013e32835c5e90; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Kulig Jan, 2013, J Oncol Pharm Pract, V19, P75, DOI 10.1177/1078155212449030; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu J, 2012, Patent No. [US20120201746, 20120201746]; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Sendur MAN, 2012, CURR MED RES OPIN, V28, P1709, DOI 10.1185/03007995.2012.728132; Shak S, 1999, SEMIN ONCOL, V26, P71; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stern HM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3001539; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Wang SH, 2012, CANCER LETT, V325, P214, DOI 10.1016/j.canlet.2012.07.007; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wu CB, 2009, MABS, V1, P339, DOI 10.4161/mabs.1.4.8755; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	47	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97292	10.1371/journal.pone.0097292	http://dx.doi.org/10.1371/journal.pone.0097292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824849	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200087
J	Weis, B; Schmidt, J; Maamar, H; Raj, A; Lin, H; Toth, C; Riedmann, K; Raddatz, G; Seitz, HK; Ho, AD; Lyko, F; Linhart, HG				Weis, B.; Schmidt, J.; Maamar, H.; Raj, A.; Lin, H.; Toth, C.; Riedmann, K.; Raddatz, G.; Seitz, H-K; Ho, A. D.; Lyko, F.; Linhart, H. G.			Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a	ONCOGENE			English	Article							DE-NOVO METHYLATION; IN-VIVO; DNMT3A; CANCER; MOUSE; GENE; HYPOMETHYLATION; OVEREXPRESSION; EXPRESSION; 3B	Aberrant de novo methylation of DNA is considered an important mediator of tumorigenesis. To investigate the role of de novo DNA methyltransferase 3a (Dnmt3a) in intestinal tumor development, we analyzed the expression of Dnmt3a in murine colon crypts, murine colon adenomas and human colorectal cancer using RNA fluorescence in situ hybridization (FISH), quantitative PCR and immunostaining. Following conditional deletion of Dnmt3a in the colon of APC((Min/+)) mice, we analyzed tumor numbers, genotype of macroadenomas and laser dissected microadenomas, global and regional DNA methylation and gene expression. Our results showed increased Dnmt3a expression in colon adenomas of APC((Min/+)) mice and human colorectal cancer samples when compared with control tissue. Interestingly, in tumor tissue, RNA FISH analysis showed highest Dnmt3a expression in Lgr5-positive stem/progenitor cells. Deletion of Dnmt3a in APC((Min/+)) mice reduced colon tumor numbers by similar to 40%. Remaining adenomas and microadenomas almost exclusively contained the non-recombined Dnmt3a allele; no tumors composed of the inactivated Dnmt3a allele were detected. DNA methylation was reduced at the Oct4, Nanog, Tff2 and Cdkn1c promoters and expression of the tumor-suppressor genes Tff2 and Cdkn1c was increased. In conclusion, our results show that Dnmt3a is predominantly expressed in the stem/progenitor cell compartment of tumors and that deletion of Dnmt3a inhibits the earliest stages of intestinal tumor development.	[Weis, B.; Schmidt, J.; Riedmann, K.; Raddatz, G.; Lyko, F.; Linhart, H. G.] German Canc Res Ctr, Div Epigenet A130, D-69120 Heidelberg, Germany; [Maamar, H.; Raj, A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Lin, H.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Toth, C.] Heidelberg Univ, Dept Pathol, Natl Ctr Tumor Dis NCT, Tissue Bank, Heidelberg, Germany; [Toth, C.] Univ Dusseldorf, Dept Pathol, Dusseldorf, Germany; [Seitz, H-K; Linhart, H. G.] Heidelberg Univ, Dept Med, Salem Med Ctr, Alcohol Res Ctr, Heidelberg, Germany; [Ho, A. D.; Linhart, H. G.] Heidelberg Univ, Dept Hematol Oncol, Med Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Linhart, HG (corresponding author), German Canc Res Ctr, Div Epigenet A130, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	heinz.linhart@nct-heidelberg.de		Lin, Haijiang/0000-0003-2931-468X; Raj, Arjun/0000-0002-2915-6960	DKFZ Light Microscopy Facility; Helmholtz International Graduate School for Cancer Research; Burroughs-Wellcome Fund Career Award at the Scientific Interface; NIH [1DP2OD008514-01]; Lautenschlager foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	DKFZ Light Microscopy Facility; Helmholtz International Graduate School for Cancer Research; Burroughs-Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lautenschlager foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support by the DKFZ Light Microscopy Facility is gratefully acknowledged. We also thank E Herpel and the tissue bank of the NCT Heidelberg for providing human tissue samples and for technical support in histology and immunohistochemistry. We also thank J Gutekunst for bioinformatical support and R Jaenisch for critical discussions. This study was supported by a graduate scholarship from the Helmholtz International Graduate School for Cancer Research (B Weis), a Burroughs-Wellcome Fund Career Award at the Scientific Interface (A Raj, H Maamar), a NIH Director's New Innovator award (1DP2OD008514-01 to A Raj) and the Lautenschlager foundation (HK Seitz).	Bai XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040024; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Fujimoto K, 2002, GASTROENTEROLOGY, V123, P1941, DOI 10.1053/gast.2002.37065; Gao Q, 2011, P NATL ACAD SCI USA, V108, P18061, DOI 10.1073/pnas.1114946108; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Katoh M, 2003, INT J MOL MED, V12, P3; Kavanagh E, 2011, BBA-REV CANCER, V1816, P50, DOI 10.1016/j.bbcan.2011.03.002; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Luczak MW, 2012, INT J ONCOL, V40, P860, DOI 10.3892/ijo.2011.1183; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Raddatz G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003146; Rahman MM, 2010, HUM PATHOL, V41, P1069, DOI 10.1016/j.humpath.2010.01.011; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Samuel MS, 2009, GASTROENTEROLOGY, V137, P902, DOI 10.1053/j.gastro.2009.05.042; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Tang YA, 2012, CLIN CANCER RES, V18, P4325, DOI 10.1158/1078-0432.CCR-11-2617; Weis B, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-75; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	38	18	18	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1822	1830		10.1038/onc.2014.114	http://dx.doi.org/10.1038/onc.2014.114			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24837369				2022-12-25	WOS:000352158000009
J	Hans, F; Fiesel, FC; Strong, JC; Jackel, S; Rasse, TM; Geisler, S; Springer, W; Schulz, JB; Voigt, A; Kahle, PJ				Hans, Friederike; Fiesel, Fabienne C.; Strong, Jennifer C.; Jaeckel, Sandra; Rasse, Tobias M.; Geisler, Sven; Springer, Wolfdieter; Schulz, Joerg B.; Voigt, Aaron; Kahle, Philipp J.			UBE2E Ubiquitin-conjugating Enzymes and Ubiquitin Isopeptidase Y Regulate TDP-43 Protein Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HISTONE DEACETYLASE 6; MESSENGER-RNA; PROTEASOME SYSTEM; MOLECULAR-BASIS; DEGRADATION; COMPLEX; ALS; CLEARANCE	Trans-activation element DNA-binding protein of 43 kDa (TDP-43) characterizes insoluble protein aggregates in distinct subtypes of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. TDP-43 mediates many RNA processing steps within distinct protein complexes. Here we identify novel TDP-43 protein interactors found in a yeast two-hybrid screen using an adult human brain cDNA library. We confirmed the TDP-43 interaction of seven hits by co-immunoprecipitation and assessed their co-localization in HEK293E cells. As pathological TDP-43 is ubiquitinated, we focused on the ubiquitin- conjugating enzyme UBE2E3 and the ubiquitin isopeptidase Y (UBPY). When cells were treated with proteasome inhibitor, ubiquitinated and insoluble TDP-43 species accumulated. All three UBE2E family members could enhance the ubiquitination of TDP-43, whereas catalytically inactive UBE2E3(C145S) was much less efficient. Conversely, silencing of UBE2E3 reduced TDP-43 ubiquitination. We examined 15 of the 48 known disease-associated TDP-43 mutants and found that one was excessively ubiquitinated. This strong TDP-43(K263E) ubiquitination was further enhanced by proteasomal inhibition as well as UBE2E3 expression. Conversely, UBE2E3 silencing and expression of UBPY reduced TDP-43(K263E) ubiquitination. Moreover, wild-type but not active site mutant UBPY reduced ubiquitination of TDP-43 C-terminal fragments and of a nuclear import-impaired mutant. In Drosophila melanogaster, UBPY silencing enhanced neurodegenerative TDP-43 phenotypes and the accumulation of insoluble high molecular weight TDP-43 and ubiquitin species. Thus, UBE2E3 and UBPY participate in the regulation of TDP-43 ubiquitination, solubility, and neurodegeneration.	[Hans, Friederike; Kahle, Philipp J.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72076 Tubingen, Germany; [Hans, Friederike; Springer, Wolfdieter; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, Lab Funct Neurogenet, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Hans, Friederike; Fiesel, Fabienne C.; Strong, Jennifer C.; Jaeckel, Sandra; Geisler, Sven; Springer, Wolfdieter; Kahle, Philipp J.] Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Rasse, Tobias M.] Hertie Inst Clin Brain Res, Synapt Plast Grp, D-72076 Tubingen, Germany; [Schulz, Joerg B.; Voigt, Aaron] Univ Med Ctr, Dept Neurol, D-52074 Aachen, Germany; [Schulz, Joerg B.] JARA, Translat Brain Med, D-52074 Aachen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, German Ctr Neurodegenerat Dis, Dept Neurodegenerat, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de	Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593; Fiesel, Fabienne/0000-0002-1919-9676; Springer, Wolfdieter/0000-0002-1178-3149	German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; DZNE Ph.D. stipend; DZNE Virtual Institute; German Research Foundation (Deutsche Forschungsgemeinschaft) [KA1675/3-1, KA1675/3-2]; German Competence Network; Hertie Foundation	German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; DZNE Ph.D. stipend; DZNE Virtual Institute; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Competence Network; Hertie Foundation	This work was supported by the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, specifically a DZNE Ph.D. stipend (to F. H.) and the DZNE Virtual Institute "RNA Dysmetabolism in ALS"; German Research Foundation (Deutsche Forschungsgemeinschaft) Grants KA1675/3-1 and KA1675/3-2; the German Competence Network "Degenerative Dementias"; and the Hertie Foundation.	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gibson TJ, 2012, FEBS LETT, V586, P2787, DOI 10.1016/j.febslet.2012.04.048; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hong S, 2008, BIOCHEM BIOPH RES CO, V371, P256, DOI 10.1016/j.bbrc.2008.04.066; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seiberlich V, 2012, BBA-MOL CELL RES, V1823, P2057, DOI 10.1016/j.bbamcr.2012.04.011; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Yu ZP, 2012, J BIOL CHEM, V287, P22560, DOI 10.1074/jbc.M112.357582; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	69	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19164	19179		10.1074/jbc.M114.561704	http://dx.doi.org/10.1074/jbc.M114.561704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24825905	Green Published, hybrid			2022-12-25	WOS:000339062900045
J	Henriksen, OM; Jensen, LT; Krabbe, K; Guldberg, P; Teerlink, T; Rostrup, E				Henriksen, Otto M.; Jensen, Lars T.; Krabbe, Katja; Guldberg, Per; Teerlink, Tom; Rostrup, Egill			Resting Brain Perfusion and Selected Vascular Risk Factors in Healthy Elderly Subjects	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ASYMMETRIC DIMETHYLARGININE; ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; HOMOCYSTEINE; PLASMA; METAANALYSIS; DEMENTIA; QUANTIFICATION; VARIABILITY	Background and Purpose: Both cerebral hypoperfusion and vascular risk factors have been implicated in early aging of the brain and the development of neurodegenerative disease. However, the current knowledge of the importance of cardiovascular health on resting brain perfusion is limited. The aim of the present study was to elucidate the relation between brain perfusion variability and risk factors of endothelial dysfunction and atherosclerosis in healthy aged subjects. Methods: Thirty-eight healthy subjects aged 50-75 years old were included. Mean global brain perfusion was measured using magnetic resonance phase contrast mapping and regional brain perfusion by use of arterial spin labeling. Results: Mean global brain perfusion was inversely correlated with caffeine and hematocrit, and positively with end-tidal P-CO2. Furthermore, the mean global brain perfusion was inversely correlated with circulating homocysteine, but not with asymmetric dimethylarginine, dyslipidemia or the carotid intima-media thickness. The relative regional brain perfusion was associated with circulating homocysteine, with a relative parietal hypoperfusion and a frontal hyperperfusion. No effect on regional brain perfusion was observed for any of the other risk factors. A multiple regression model including homocysteine, caffeine, hematocrit and end-tidal P-CO2, explained nearly half of the observed variability. Conclusion: Both intrinsic and extrinsic factors influenced global cerebral perfusion variation between subjects. Further, the results suggest that the inverse relation between homocysteine and brain perfusion is owing to other mechanisms, than reflected by asymmetric dimethylarginine, and that homocysteine may be a marker of cerebral perfusion in aging brains.	[Henriksen, Otto M.; Rostrup, Egill] Copenhagen Univ Hosp, Glostrup Hosp, Sect Clin Physiol & Nucl Med, Funct Imaging Unit,Dept Diagnost, Glostrup, Denmark; [Henriksen, Otto M.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Henriksen, Otto M.; Rostrup, Egill] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Jensen, Lars T.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark; [Krabbe, Katja] Copenhagen Univ Hosp, Glostrup Hosp, Sect Radiol, Dept Diagnost, Glostrup, Denmark; [Guldberg, Per] Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; [Teerlink, Tom] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Lab, Amsterdam, Netherlands	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Danish Cancer Society; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Henriksen, OM (corresponding author), Copenhagen Univ Hosp, Glostrup Hosp, Sect Clin Physiol & Nucl Med, Funct Imaging Unit,Dept Diagnost, Glostrup, Denmark.	ohen0009@regionh.dk	Rostrup, Egill/D-8622-2017	Rostrup, Egill/0000-0001-5015-5244	Danish Council for Independent Research - Medical Sciences; Center of Healthy Aging grant from Nordeafonden	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Center of Healthy Aging grant from Nordeafonden	This work was supported by the Danish Council for Independent Research - Medical Sciences (http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-medical-sciences) and by the Center of Healthy Aging grant from the Nordeafonden (https://www.nordeafonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2013, J CEREB BLOOD FLOW M; Blackwell S, 2010, ANN CLIN BIOCHEM, V47, P17, DOI 10.1258/acb.2009.009196; Cacciapuoti F, 2011, J THROMB THROMBOLYS, V32, P82, DOI 10.1007/s11239-011-0550-4; Chappell MA, 2013, MAGN RESON MED, V69, P1466, DOI 10.1002/mrm.24372; Cherbuin N, 2007, DEMENT GERIATR COGN, V24, P348, DOI 10.1159/000109150; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Demuth K, 2002, ATHEROSCLEROSIS, V165, P167, DOI 10.1016/S0021-9150(02)00205-8; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, pS167, DOI 10.3233/JAD-2010-1404; Henriksen OM, 2013, CLIN PHYSL IN PRESS; Henriksen OM, 2013, J CEREBR BLOOD F MET, V33, P787, DOI 10.1038/jcbfm.2013.17; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Jennings JR, 2013, STROKE, V44, P2480, DOI 10.1161/STROKEAHA.113.001716; Lim MH, 2009, STROKE, V40, P3216, DOI 10.1161/STROKEAHA.109.558403; Nilsson K, 2000, AGING-CLIN EXP RES, V12, P199, DOI 10.1007/BF03339837; Norager CB, 2006, CLIN ENDOCRINOL, V65, P223, DOI 10.1111/j.1365-2265.2006.02579.x; Notsu Y, 2009, AM J HYPERTENS, V22, P257, DOI 10.1038/ajh.2008.346; Ostergaard L, 2013, NEUROBIOL AGING, V34, P1018, DOI 10.1016/j.neurobiolaging.2012.09.011; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pase MP, 2012, STROKE, V43, P2803, DOI 10.1161/STROKEAHA.112.666727; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Rocha MS, 2012, ATHEROSCLEROSIS, V222, P509, DOI 10.1016/j.atherosclerosis.2012.03.009; RUBBA P, 1993, STROKE, V24, P1154, DOI 10.1161/01.STR.24.8.1154; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Sojkova J, 2010, STROKE, V41, P273, DOI 10.1161/STROKEAHA.109.566810; Stuhlinger MC, 2003, CIRCULATION, V108, P933, DOI 10.1161/01.CIR.0000085067.55901.89; TANG C, 1993, JMRI-J MAGN RESON IM, V3, P377, DOI 10.1002/jmri.1880030213; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; ten Dam VH, 2005, STROKE, V36, P1633, DOI 10.1161/01.STR.0000173162.88600.29; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Wald DS, 2011, ALZHEIMERS DEMENT, V7, P412, DOI 10.1016/j.jalz.2010.08.234; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wendell CR, 2009, STROKE, V40, P3180, DOI 10.1161/STROKEAHA.109.557280; Zhang FY, 1998, AM J PHYSIOL-REG I, V274, pR1704, DOI 10.1152/ajpregu.1998.274.6.R1704	39	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97363	10.1371/journal.pone.0097363	http://dx.doi.org/10.1371/journal.pone.0097363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840730	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600028
J	Wille, S; Schumacher, P; Paas, J; Tenholte, D; Eminaga, O; Muller, U; Muthen, N; Mehner, J; Cornely, O; Engelmann, U				Wille, Sebastian; Schumacher, Pauline; Paas, Jenny; Tenholte, Dirk; Eminaga, Okyaz; Mueller, Ute; Muthen, Noemi; Mehner, Jan; Cornely, Oliver; Engelmann, Udo			Catheterless Long-Term Ambulatory Urodynamic Measurement Using a Novel Three-Device System	PLOS ONE			English	Article							DETRUSOR OVERACTIVITY; BLADDER; PRESSURE; BIOCOMPATIBILITY; SYMPTOMS	Aims: Long-term urodynamics are required because bladder-emptying disorders are often not clearly revealed by conventional urodynamics. Patients with severe clinical overactive bladder symptoms, for instance, often show normal results. This may be due to the short evaluation time and psychological factors that complicate conventional urodynamics. This study aimed to develop an ambulatory three-component urodynamic measurement system that is easy to operate, registers urodynamic parameters for several days, and has no negative impact on the patient. Methods: We developed an intravesical capsule combined with a hand-held device to register voiding desire and micturition, and an alarm pad device that detects urine loss. Recently, the intravesical capsule and its proven function were detailed in the literature. Here, we present detailed in vitro results using a female bladder model. The flexible capsule was C-shaped to minimize the risk of expulsion from the bladder during micturition. Results of biocompatibility evaluation of the intravesical capsule, which is called Wille Capsule (WiCa) are described. Results: The WiCa with an oval nose and a maximum outer diameter of 5.5 mm was easily inserted through a 25-French cystoscope. Removing the WiCa by grasping the nose using the female model with bladder was easily conducted. Expulsion of the WiCa during voiding was avoided through a novel C-shaped device design. Based on in vitro cytotoxicity studies, the capsule is a promising and safe device. Conclusion: Our novel system is an innovative minimally-invasive tool for accurate long-term urodynamic measurement, and does not require inserting a transurethral catheter.	[Wille, Sebastian; Paas, Jenny; Eminaga, Okyaz; Engelmann, Udo] Univ Cologne, Dept Urol, D-50931 Cologne, Germany; [Schumacher, Pauline; Muthen, Noemi; Cornely, Oliver] ZKS Koln Zentrum Klin Studien, Cologne, Germany; [Tenholte, Dirk; Mehner, Jan] Tech Univ Chemnitz, Fac Elect Engn & Informat Technol, Chemnitz, Germany; [Mueller, Ute] BMP Lab Med Mat Prufung GmbH, Aachen, Germany; [Cornely, Oliver] Univ Cologne, Fac Med, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; University of Cologne; Technische Universitat Chemnitz; University of Cologne	Wille, S (corresponding author), Univ Cologne, Dept Urol, D-50931 Cologne, Germany.	sebastian.wille@uk-koeln.de	Eminaga, Okyaz/ABH-7208-2020; Cornely, Oliver A./J-5095-2013	Cornely, Oliver A./0000-0001-9599-3137; /0000-0003-0861-3138	German Federal Ministry of Research and Education (BMBF) [01KN1106]; Center for Clinical Trial Cologne (ZKS Koln)	German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Center for Clinical Trial Cologne (ZKS Koln)	SW, PS, JP, NM, and OAC are supported by the German Federal Ministry of Research and Education (BMBF grant 01KN1106). The project was supported by the Center for Clinical Trial Cologne (ZKS Koln). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050; Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x; BMP GmbH, 2012, INV REP B0343 12 CYT, P1; BMP GmbH, 2013, INV REP B0133 13 CYT, P1; Braden M, 1995, Eur J Prosthodont Restor Dent, V3, P163; Clasbrummel B, 2005, CHIR GASTROENTEROL, V21, P38, DOI 10.1159/000089346; Digesu GA, 2003, NEUROUROL URODYNAM, V22, P105, DOI 10.1002/nau.10099; Hashim H, 2006, J UROLOGY, V175, P191, DOI 10.1016/S0022-5347(05)00067-4; Jourand P, 2010, SENSOR ACTUAT A-PHYS, V162, P160, DOI 10.1016/j.sna.2010.01.035; Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7; Radley SC, 2001, J UROLOGY, V166, P2253, DOI 10.1016/S0022-5347(05)65545-0; Schnakenberg U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P191, DOI 10.1515/bmte.2002.47.s1a.191; Vijayananthan A, 2008, BIOMED IMAGING INTER, V4, P5; Wang CC, 2008, IEEE T BIOMED CIRC S, V2, P44, DOI 10.1109/TBCAS.2008.921601; Wille S, 2013, EUR UROL, V63, P966, DOI 10.1016/j.eururo.2013.01.029	15	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96280	10.1371/journal.pone.0096280	http://dx.doi.org/10.1371/journal.pone.0096280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840482	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600007
J	Krogh-Jespersen, S; Woodward, AL				Krogh-Jespersen, Sheila; Woodward, Amanda L.			Making Smart Social Judgments Takes Time: Infants' Recruitment of Goal Information When Generating Action Predictions	PLOS ONE			English	Article							DIRECTED ACTIONS; GAZE; ATTRIBUTION; PERCEPTION; ABILITY; OTHERS; OBJECT	Previous research has shown that young infants perceive others' actions as structured by goals. One open question is whether the recruitment of this understanding when predicting others' actions imposes a cognitive challenge for young infants. The current study explored infants' ability to utilize their knowledge of others' goals to rapidly predict future behavior in complex social environments and distinguish goal-directed actions from other kinds of movements. Fifteen-month-olds (N = 40) viewed videos of an actor engaged in either a goal-directed (grasping) or an ambiguous (brushing the back of her hand) action on a Tobii eye-tracker. At test, critical elements of the scene were changed and infants' predictive fixations were examined to determine whether they relied on goal information to anticipate the actor's future behavior. Results revealed that infants reliably generated goal-based visual predictions for the grasping action, but not for the back-of-hand behavior. Moreover, response latencies were longer for goal-based predictions than for location-based predictions, suggesting that goal-based predictions are cognitively taxing. Analyses of areas of interest indicated that heightened attention to the overall scene, as opposed to specific patterns of attention, was the critical indicator of successful judgments regarding an actor's future goal-directed behavior. These findings shed light on the processes that support "smart'' social behavior in infants, as it may be a challenge for young infants to use information about others' intentions to inform rapid predictions.	[Krogh-Jespersen, Sheila; Woodward, Amanda L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Krogh-Jespersen, S (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.			Woodward, Amanda/0000-0002-9383-9969	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [P01HD064653]; National Science Foundation [DLS 0951489]; Direct For Social, Behav & Economic Scie [0951489] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064653] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by grants to the second author from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P01HD064653 ( http://www.nichd.nih.gov) and the National Science Foundation under award number DLS 0951489 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067916; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Brandone AC, 2014, DEVELOPMENTAL SCI, V17, P23, DOI 10.1111/desc.12095; Brandone AC, 2009, PSYCHOL SCI, V20, P85, DOI 10.1111/j.1467-9280.2008.02246.x; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Gerson SA, 2012, COGNITION, V122, P181, DOI 10.1016/j.cognition.2011.10.014; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Guajardo JJ, 2004, INFANCY, V6, P361, DOI 10.1207/s15327078in0603_3; Hamlin JK, 2008, DEVELOPMENTAL SCI, V11, P487, DOI 10.1111/j.1467-7687.2008.00694.x; Henrichs I, 2014, DEV PSYCHOL, V50, P100, DOI 10.1037/a0032664; Kanakogi Y, 2010, JPN PSYCHOL RES, V52, P121, DOI 10.1111/j.1468-5884.2010.00429.x; Kiraly I, 2003, CONSCIOUS COGN, V12, P752, DOI 10.1016/S1053-8100(03)00084-9; Luo Y, 2007, COGNITION, V105, P489, DOI 10.1016/j.cognition.2006.10.007; Paulus M, 2011, DEVELOPMENTAL SCI, V14, P1301, DOI 10.1111/j.1467-7687.2011.01076.x; Paulus M, 2011, DEV PSYCHOL, V47, P976, DOI 10.1037/a0023785; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P625, DOI 10.1111/j.1467-7687.2007.00604.x; Wentworth N, 1998, DEV PSYCHOL, V34, P247, DOI 10.1037/0012-1649.34.2.247; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Woodward AL, 2009, PSYCHOL LEARN MOTIV, V51, P187, DOI 10.1016/S0079-7421(09)51006-7	23	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98085	10.1371/journal.pone.0098085	http://dx.doi.org/10.1371/journal.pone.0098085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835053	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800104
J	Singh, S; Sharma, A; Arora, SK				Singh, Sukhvinder; Sharma, Aman; Arora, Sunil K.			High Producer Haplotype (CAG) of-863C/A,-308G/A and-238G/A Polymorphisms in the Promoter Region of TNF-alpha Gene Associate with Enhanced Apoptosis of Lymphocytes in HIV-1 Subtype C Infected Individuals from North India	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VIRUS-INFECTION; LIPODYSTROPHY; RISK; SUSCEPTIBILITY; PATHOGENESIS; CHEMOKINES; SECRETION; ALLELE; COHORT	Introduction: The natural history of HIV-1 infection and its progression towards AIDS vary considerably among individuals. Host genetic factors may be one of the possible reasons for variable HIV-1 disease progression. Single nucleotide polymorphisms (SNPs) in the promoter region of TNF-alpha gene can influence its production. The aim of the present study was to determine the association of functional TNF-alpha SNPs and its associated parameters related to apoptosis that may influence the rate of HIV-1 disease progression. Methods: Therapy naive, 100 HIV slow progressors (SPs), 100 HIV fast progressors (FPs), 50 HIV exposed but seronegative individuals (ESNs) and 260 healthy controls from same ethnic origin were recruited. Genotyping of TNF-alpha variants (-863C/A, -308G/A and -238G/A) was done using PCR-RFLP. CD4 counts were determined by flow cytometry. Plasma viral load was estimated by COBAS AMPLICOR HIV-1 monitor test. Plasma TNF-alpha concentration was estimated by Human CBA Th1/Th2 cytokine kit. The lymphocyte mitochondrial membrane potential was measured by JC-1 dye by flow cytometry. Results: Genotype and allele frequency of TNF-alpha. -238G/A and -863C/A was not significantly different in HIV-1-infected patients when compared to controls, while that of TNF-alpha -308G/A variant (high TNF-alpha producer) was significantly higher in FPs compared to SPs (p<0.01, OR=3.43). Haplotype analyses also showed that carriers of high TNF-alpha producing haplotype CAG was significantly more common among FPs compared to SPs (p<0.01, OR=3). The circulating TNF-alpha levels in blood also correlated well with genotypes. The lymphocyte mitochondrial membrane potential of FPs having CAG haplotype was significantly low as compared to wild type (CGG) haplotype (417 +/- 22 vs 571 +/- 28, p<0.01). Conclusion: High producer haplotype, CAG of TNF-alpha gene associates with enhanced apoptosis of lymphocytes in HIV-1 infected individuals, hence faster progression to ADS. However, further functional studies are needed to confirm this association and this knowledge may help clinicians to better understand the disease outcome.	[Singh, Sukhvinder; Arora, Sunil K.] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Arora, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India.	arora.sunil@pgimer.edu.in	Arora, Sunil K/V-9083-2019; Singh, Sukhvinder/I-8846-2019		Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The authors gratefully acknowledge Indian Council of Medical Research, New Delhi, India for providing senior research fellowship to Mr. Sukhvinder Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Barrett S, 2003, J MED VIROL, V71, P212, DOI 10.1002/jmv.10472; Brinkman BMN, 1997, J INFECT DIS, V175, P188, DOI 10.1093/infdis/175.1.188; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Chaudhari DV, 2013, INDIAN J MED MICROBI, V31, P166, DOI 10.4103/0255-0857.115250; Deghaide NHS, 2009, AIDS, V23, P1641, DOI 10.1097/QAD.0b013e32832e5591; Delgado JC, 2003, IMMUNOGENETICS, V55, P497, DOI 10.1007/s00251-003-0604-7; Erikstrup C, 2007, AIDS, V21, P2283, DOI 10.1097/QAD.0b013e3282f153ed; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Fernandez-Ortega C, 2004, BIOCHEM BIOPH RES CO, V325, P1075, DOI 10.1016/j.bbrc.2004.10.142; Heijmans BT, 2002, GENES IMMUN, V3, P225, DOI 10.1038/sj.gene.6363859; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Hornung F, 2000, J IMMUNOL, V164, P6180, DOI 10.4049/jimmunol.164.12.6180; Jang WH, 2001, CANCER LETT, V166, P41, DOI 10.1016/S0304-3835(01)00438-4; Kim YJ, 2003, HUM MOL GENET, V12, P2541, DOI 10.1093/hmg/ddg262; Knuchel MC, 1998, AIDS RES HUM RETROV, V14, P305, DOI 10.1089/aid.1998.14.305; Kumar N, 2012, HUM IMMUNOL, V73, P566, DOI 10.1016/j.humimm.2012.01.012; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; Marzocchetti A, 2011, AIDS RES HUM RETROV, V27, P1300, DOI 10.1089/aid.2010.0172; Maxwell JR, 2008, HUM MOL GENET, V17, P3532, DOI 10.1093/hmg/ddn245; Merino AM, 2013, IMMUNOGENETICS, V65, P543, DOI 10.1007/s00251-013-0700-2; Nolan D, 2003, AIDS, V17, P121, DOI 10.1097/00002030-200301030-00017; Sachdeva Naresh, 2005, MedGenMed, V7, P68, DOI 10.1186/1758-2652-7-3-68; Sharma S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-165; Silva MM, 2010, INT J IMMUNOGENET, V37, P379, DOI 10.1111/j.1744-313X.2010.00937.x; Simpson PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040100; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Tayebi S., 2012, HEPATITIS RES TREATM, V24, P1, DOI DOI 10.1155/2012/493219; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Veloso S, 2010, BMC MED GENET, V11, P63; Werth VP, 2002, J INVEST DERMATOL, V119, P617, DOI 10.1046/j.1523-1747.2002.01869.x; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	33	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98020	10.1371/journal.pone.0098020	http://dx.doi.org/10.1371/journal.pone.0098020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837009	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800098
J	Kinlock, BL; Wang, YD; Turner, TM; Wang, CL; Liu, BD				Kinlock, Ballington L.; Wang, Yudi; Turner, Tiffany M.; Wang, Chenliang; Liu, Bindong			Transcytosis of HIV-1 through Vaginal Epithelial Cells Is Dependent on Trafficking to the Endocytic Recycling Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; INTRAVAGINAL INOCULATION; TYPE-1 TRANSCYTOSIS; INFECTION; TRANSMISSION; MUCOSAL; TISSUE; MODEL; MECHANISMS	Background: While it is accepted that viruses can enter epithelial cells by endocytosis, the lack of an established biological mechanism for the trafficking of infectious virions through vaginal epithelial cells and their release from the plasma membrane has contributed to ongoing controversy about whether endocytosis is a mere artifact of some cell culture systems and whether squamous vaginal epithelial cells are even relevant as it pertains to HIV-1 transmission. Methodology/Principal Findings: In this study, we investigated the intracellular trafficking pathway that HIV-1 exploits to transcytose vaginal epithelial cells. The reduction of endosome tubulation by recycling endosome inhibitors blocked transcytosis of HIV-1 in a cell culture and transwell system. In addition, we demonstrate that although heat-inactivated virus was endocytosed as efficiently as native virus, heat-inactivated virus was trafficked exclusively to the lysosomal pathway for degradation following endocytosis. Lysosomal protease-specific inhibitors blocked the degradation of inactivated virions. Immunofluorescence analysis not only demonstrated that HIV-1 was inside the cells but the different colocalization pattern of native vs. heat inactivated virus with transferrin provided conclusive evidence that HIV-1 uses the recycling pathway to get across vaginal epithelial cells. Conclusions/Significance:Altogether, our findings demonstrate the precise intracellular trafficking pathway utilized by HIV-1 in epithelial cells, confirms that HIV-1 transcytosis through vaginal epithelial cells is a biological phenomenon and brings to light the differential intracellular trafficking of native vs heat-inactivated HIV-1 which with further exploration could prove to provide valuable insights that could be used in the prevention of transcytosis/transmission of HIV-1 across the mucosal epithelia.	[Kinlock, Ballington L.; Wang, Yudi; Turner, Tiffany M.; Wang, Chenliang; Liu, Bindong] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Kinlock, Ballington L.; Turner, Tiffany M.; Liu, Bindong] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Wang, Chenliang] Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chenliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Meharry Medical College; Meharry Medical College; Sun Yat Sen University; Sun Yat Sen University	Liu, BD (corresponding author), Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA.	bliu@mmc.edu		wang, chenliang/0000-0003-4388-681X	National Institutes of Health (NIH) [5C1GM089269, G12MD007586, U54MD007593, P30A1054999, UL1TR000445]; NIH [T32HL007737, T32A1007281]; NATIONAL CANCER INSTITUTE [U54CA163069, U54CA163072, U54CA163066] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281, P30AI054999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM089269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partially supported by National Institutes of Health (NIH) grants 5C1GM089269, G12MD007586, U54MD007593, P30A1054999 and UL1TR000445 to BL. BLK and TMT are supported by NIH training grant T32HL007737 and T32A1007281 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Anukam KC, 2009, SEX HEALTH, V6, P67, DOI 10.1071/SH08037; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BOURINBAIAR AS, 1991, J ACQ IMMUN DEF SYND, V4, P56; Bouschbacher M, 2008, AIDS, V22, P1257, DOI 10.1097/QAD.0b013e3282f736f4; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; CDC, 2007, HIV AIDS SURVEILLANC; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Drosten C, 2005, J MOL DIAGN, V7, P219, DOI 10.1016/S1525-1578(10)60548-X; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; FURUTA Y, 1994, P NATL ACAD SCI USA, V91, P12559, DOI 10.1073/pnas.91.26.12559; Ganor Y, 2013, MUCOSAL IMMUNOL, V6, P776, DOI 10.1038/mi.2012.116; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Jain S, 2010, VACCINE, V28, P7070, DOI 10.1016/j.vaccine.2010.08.009; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Khatua AK, 2010, VIROLOGY, V408, P119, DOI 10.1016/j.virol.2010.09.005; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mikulak J, 2009, VIROLOGY, V385, P105, DOI 10.1016/j.virol.2008.11.029; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Modi M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-158; Mossop H, 2011, OBSTET GYNECOL, V118, P840, DOI 10.1097/AOG.0b013e31822da9e9; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Salle B, 2010, J INFECT DIS, V202, P337, DOI 10.1086/653619; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Timmons CL, 2013, J INFECT DIS, V207, P1171, DOI 10.1093/infdis/jit001; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vacharaksa A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-66; Wang YD, 2011, J VIROL, V85, P4510, DOI 10.1128/JVI.01925-10; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	70	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96760	10.1371/journal.pone.0096760	http://dx.doi.org/10.1371/journal.pone.0096760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830293	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500025
J	Llop, S; Engstrom, K; Ballester, F; Franforte, E; Alhamdow, A; Pisa, F; Tratnik, JS; Mazej, D; Murcia, M; Rebagliato, M; Bustamante, M; Sunyer, J; Sofianou-Katsoulis, A; Prasouli, A; Antonopoulou, E; Antoniadou, I; Nakou, S; Barbone, F; Horvat, M; Broberg, K				Llop, Sabrina; Engstrom, Karin; Ballester, Ferran; Franforte, Elisa; Alhamdow, Ayman; Pisa, Federica; Tratnik, Janja Snoj; Mazej, Datja; Murcia, Mario; Rebagliato, Marisa; Bustamante, Mariona; Sunyer, Jordi; Sofianou-Katsoulis, Aikaterini; Prasouli, Alexia; Antonopoulou, Eleni; Antoniadou, Ioanna; Nakou, Sheena; Barbone, Fabio; Horvat, Milena; Broberg, Karin			Polymorphisms in ABC Transporter Genes and Concentrations of Mercury in Newborns - Evidence from Two Mediterranean Birth Cohorts	PLOS ONE			English	Article							FISH CONSUMPTION; ELEMENTAL MERCURY; EXPOSURE; BLOOD; WOMEN; VAPOR; MRP2	Background: The genetic background may influence methylmercury (MeHg) metabolism and neurotoxicity. ATP binding cassette (ABC) transporters actively transport various xenobiotics across biological membranes. Objective: To investigate the role of ABC polymorphisms as modifiers of prenatal exposure to MeHg. Methods: The study population consisted of participants (n = 1651) in two birth cohorts, one in Italy and Greece (PHIME) and the other in Spain (INMA). Women were recruited during pregnancy in Italy and Spain, and during the perinatal period in Greece. Total mercury concentrations were measured in cord blood samples by atomic absorption spectrometry. Maternal fish intake during pregnancy was determined from questionnaires. Polymorphisms (n = 5) in the ABC genes ABCA1, ABCB1, ABCC1 and ABCC2 were analysed in both cohorts. Results: ABCB1 rs2032582, ABCC1 rs11075290, and ABCC2 rs2273697 modified the associations between maternal fish intake and cord blood mercury concentrations. The overall interaction coefficient between rs2032582 and log2-transformed fish intake was negative for carriers of GT (beta = -0.29, 95%CI -0.47, -0.12) and TT (beta = -0.49, 95%CI -0.71, -0.26) versus GG, meaning that for a doubling in fish intake of the mothers, children with the rs2032582 GG genotype accumulated 35% more mercury than children with TT. For rs11075290, the interaction coefficient was negative for carriers of TC (beta = -0.12, 95%CI -0.33, 0.09), and TT (beta = -0.28, 95%CI -0.51, -0.06) versus CC. For rs2273697, the interaction coefficient was positive when combining GA+AA (beta = 0.16, 95%CI 0.01, 0.32) versus GG. Conclusion: The ABC transporters appear to play a role in accumulation of MeHg during early development.	[Llop, Sabrina; Ballester, Ferran; Murcia, Mario] FISABIO, Fdn Promot Hlth & Biomed Res Valencian Reg, Valencia, Spain; [Llop, Sabrina; Ballester, Ferran; Murcia, Mario; Rebagliato, Marisa; Bustamante, Mariona; Sunyer, Jordi] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Engstrom, Karin; Franforte, Elisa; Alhamdow, Ayman; Broberg, Karin] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Ballester, Ferran] Univ Valencia, Sch Nursing, Valencia, Spain; [Pisa, Federica; Barbone, Fabio] Univ Udine, Unit Hyg & Epidemiol, I-33100 Udine, Italy; [Tratnik, Janja Snoj; Mazej, Datja; Horvat, Milena] Jozef Stefan Inst, Dept Environm Sci, Ljubljana, Slovenia; [Rebagliato, Marisa] Jaume I Univ, Dept Med, Castellon de La Plana, Spain; [Bustamante, Mariona; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Sunyer, Jordi] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona] Ctr Genom Regulat CRG, Barcelona, Spain; [Sunyer, Jordi] Pompeu Fabra Univ UPF, Barcelona, Spain; [Sofianou-Katsoulis, Aikaterini; Prasouli, Alexia; Antonopoulou, Eleni; Antoniadou, Ioanna; Nakou, Sheena] Inst Child Hlth, Dept Social & Dev Paediat, Athens, Greece; [Broberg, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Lund University; University of Valencia; University of Udine; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Universitat Jaume I; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Karolinska Institutet	Broberg, K (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	karin.broberg@ki.se	Sunyer, Jordi/G-6909-2014; Murcia, Mario/B-5477-2019; Bustamante, Mariona/M-7277-2015; Barbone, Fabio/K-1755-2014; Llop, Sabrina/L-2122-2015; Bustamante, Mariona/ABB-9142-2021; Rebagliato, Marisa/L-6116-2018	Sunyer, Jordi/0000-0002-2602-4110; Murcia, Mario/0000-0001-6996-1158; Bustamante, Mariona/0000-0003-0127-2860; Barbone, Fabio/0000-0001-8795-9959; Llop, Sabrina/0000-0002-6784-4211; Bustamante, Mariona/0000-0003-0127-2860; Rebagliato, Marisa/0000-0001-5825-0190; Pisa, Federica Edith/0000-0003-0459-2616; Barbone, Fabio/0000-0003-1337-5111; Broberg, Karin/0000-0002-5862-468X	European Union; Swedish Research Council for Health, Working Life and Welfare; Swedish Research Council FORMAS; Instituto de Salud Carlos III (Red INMA) [G03/176, CB06/02/0031]; UE [282957, HEALTH.2010.2.4.5-1]; Spanish Ministry of Health (FIS-FEDER) [03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/02591, 04/1436, 04/2018, 09/02311, 06/0867, 08/1151, 11/02038, CP11/00178]; Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT) [1999SGR 00241]; Fundacio La marato de TV3 [090430]; European Union [NEWGENERIS FP6-2003-Food-3-A-016320]; ARRS [P1-0143]	European Union(European Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Instituto de Salud Carlos III (Red INMA)(Instituto de Salud Carlos III); UE; Spanish Ministry of Health (FIS-FEDER)(Instituto de Salud Carlos IIISpanish GovernmentEuropean Commission); Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT); Fundacio La marato de TV3; European Union(European Commission); ARRS(Slovenian Research Agency - Slovenia)	This study was funded by The European Union 6th and 7th framework projects PHIME NEWGENERIS, the Swedish Research Council for Health, Working Life and Welfare, the Swedish Research Council FORMAS. The INMA study was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176 and CB06/02/0031), UE (FP7-ENV-2011 DENAMIC cod 282957 and HEALTH.2010.2.4.5-1), Spanish Ministry of Health (FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/02591, 04/1436, 04/2018, 09/02311, 06/0867, 08/1151, 11/02038, CP11/00178), Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT 1999SGR 00241), Fundacio La marato de TV3 (090430) and European Union Sixth Framework Project (NEWGENERIS FP6-2003-Food-3-A-016320). National funding for the PHIME project in Slovenia was provided by the programme ARRS P1-0143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bjornberg KA, 2003, ENVIRON HEALTH PERSP, V111, P637, DOI [10.1289/ehp.5618, 10.1289/ehp.111-1241457]; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Bridges CC, 2011, TOXICOL APPL PHARM, V251, P50, DOI 10.1016/j.taap.2010.11.015; Custodio HM, 2005, ARCH ENVIRON HEALTH, V60, P17, DOI 10.3200/AEOH.60.1.17-23; Engstrom K, 2013, ENVIRON HEALTH PERSP, V121, P85, DOI 10.1289/ehp.1204951; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Engstrom KS, 2008, ENVIRON HEALTH PERSP, V116, P734, DOI 10.1289/ehp.10804; Gundacker C, 2010, MUTAT RES-REV MUTAT, V705, P130, DOI 10.1016/j.mrrev.2010.06.003; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Harari R, 2012, TOXICOL LETT, V213, P75, DOI 10.1016/j.toxlet.2011.09.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirrlinger J, 2005, METHOD ENZYMOL, V400, P395, DOI 10.1016/S0076-6879(05)00023-6; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liu J, 2003, TOXICOL SCI, V74, P174, DOI 10.1093/toxsci/kfg091; Liu J, 2002, TOXICOLOGY, V170, P55, DOI 10.1016/S0300-483X(01)00532-7; Miklavcic A, 2013, ENVIRON RES, V120, P7, DOI 10.1016/j.envres.2012.08.010; Ni ZL, 2011, CURR PHARM BIOTECHNO, V12, P674, DOI 10.2174/138920111795164057; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Ramon R, 2011, ENVIRON INT, V37, P597, DOI 10.1016/j.envint.2010.12.004; Rentschler G, 2013, ENVIRON HEALTH PERSP, V121, P467, DOI 10.1289/ehp.1205672; Scinicariello F, 2007, ENVIRON HEALTH PERSP, V115, P35, DOI 10.1289/ehp.9448; Steuerwald U, 2000, J PEDIATR-US, V136, P599, DOI 10.1067/mpd.2000.102774; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Toyama T, 2011, ENVIRON HEALTH PERSP, V119, P1117, DOI 10.1289/ehp.1003123; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Valent F, 2013, J EPIDEMIOL, V23, P146, DOI 10.2188/jea.JE20120030; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; WHO (World Health Organization), 2007, HLTH RISKS HEAV MET; World Health Organization (WHO), 2010, CHILDR EXP MERC COMP	31	33	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97172	10.1371/journal.pone.0097172	http://dx.doi.org/10.1371/journal.pone.0097172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831289	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500038
J	Zhu, LJ; Liu, MY; Li, H; Liu, X; Chen, C; Han, Z; Wu, HY; Jing, X; Zhou, HH; Suh, H; Zhu, DY; Zhou, QG				Zhu, Li-Juan; Liu, Meng-Ying; Li, Huan; Liu, Xiao; Chen, Chen; Han, Zhou; Wu, Hai-Yin; Jing, Xing; Zhou, Hai-Hui; Suh, Hoonkyo; Zhu, Dong-Ya; Zhou, Qi-Gang			The Different Roles of Glucocorticoids in the Hippocampus and Hypothalamus in Chronic Stress-Induced HPA Axis Hyperactivity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MAJOR DEPRESSION; NEUROGENESIS; PHYSIOLOGY; NEUROBIOLOGY; MODULATION; HEALTH	Hypothalamus-pituitary-adrenal (HPA) hyperactivity is observed in many patients suffering from depression and the mechanism underling the dysfunction of HPA axis is not well understood. Chronic stress has a causal relationship with the hyperactivity of HPA axis. Stress induces the over-synthesis of glucocorticoids, which will arrive at all the body containing the brain. It is still complicated whether glucocorticoids account for chronic stress-induced HPA axis hyperactivity and in which part of the brain the glucocorticoids account for chronic stress-induced HPA axis hyperactivity. Here, we demonstrated that glucocorticoids were indispensable and sufficient for chronic stress-induced hyperactivity of HPA axis. Although acute glucocorticoids elevation in the hippocampus and hypothalamus exerted a negative regulation of HPA axis, we found that chronic glucocorticoids elevation in the hippocampus but not in the hypothalamus accounted for chronic stress-induced hyperactivity of HPA axis. Chronic glucocorticoids exposure in the hypothalamus still exerted a negative regulation of HPA axis activity. More importantly, we found mineralocorticoid receptor (MR) - neuronal nitric oxide synthesis enzyme (nNOS) - nitric oxide (NO) pathway mediated the different roles of glucocorticoids in the hippocampus and hypothalamus in regulating HPA axis activity. This study suggests that the glucocorticoids in the hippocampus play an important role in the development of HPA axis hyperactivity and the glucocorticoids in the hypothalamus can't induce hyperactivity of HPA axis, revealing new insights into understanding the mechanism of depression.	[Zhu, Li-Juan; Liu, Meng-Ying; Chen, Chen; Han, Zhou; Wu, Hai-Yin; Zhou, Hai-Hui; Zhu, Dong-Ya; Zhou, Qi-Gang] Nanjing Med Univ, Dept Pharmacol, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Li, Huan; Liu, Xiao] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Suh, Hoonkyo; Zhou, Qi-Gang] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Zhu, Li-Juan] Coochow Univ, Inst Neurosci, Suzhou, Peoples R China; [Jing, Xing] Nanjing Med Univ, Suzhou Hosp, Suzhou, Peoples R China; [Li, Huan] Temasek Polytech, Sch Appl Sci, Singapore, Singapore	Nanjing Medical University; Nanjing University of Chinese Medicine; Cleveland Clinic Foundation; Nanjing Medical University	Zhu, DY (corresponding author), Nanjing Med Univ, Dept Pharmacol, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	dyzhu@njmu.edu.cn; qigangzhou@gmail.com		Suh, Hoonkyo/0000-0002-4227-2982	National Natural Science Foundation of China [81000586, 81370033]; Natural Science Foundation of Jiangsu Province [10KJB31008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from National Natural Science Foundation of China (81000586 and 81370033 to QG Zhou) and Natural Science Foundation of Jiangsu Province (10KJB31008 to QG Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004265; Belmaker RH, 2009, NEW ENGL J MED, V358, P1855; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Chen JJ, 2004, DEV BIOL, V269, P165, DOI 10.1016/j.ydbio.2004.01.024; Conrad C D, 2001, Stress, V4, P305; Coryell W, 2006, PSYCHIAT RES, V142, P99, DOI 10.1016/j.psychres.2005.08.009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Herman JP, 2008, PROG BRAIN RES, V170, P353, DOI 10.1016/S0079-6123(08)00429-9; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; KATHOL RG, 1989, AM J PSYCHIAT, V146, P311; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schimmer B, 1996, GOODMAN GILMANS PHAR, P1459; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Zhou QG, 2007, J NEUROCHEM, V103, P1843, DOI 10.1111/j.1471-4159.2007.04914.x; Zhou QG, 2011, J NEUROSCI, V31, P7579, DOI 10.1523/JNEUROSCI.0004-11.2011; Zhu XJ, 2006, NEUROSCIENCE, V141, P827, DOI 10.1016/j.neuroscience.2006.04.032	30	53	56	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97689	10.1371/journal.pone.0097689	http://dx.doi.org/10.1371/journal.pone.0097689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831808	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500102
J	Chang, CW; Lai, YS; Lamb, LS; Townes, TM				Chang, Chia-Wei; Lai, Yi-Shin; Lamb, Lawrence S., Jr.; Townes, Tim M.			Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; STROMAL CELLS; FETAL THYMUS; HUMAN ES; GENERATION; FIBROBLASTS; COMMITMENT; ACTIVATION; PRECURSORS; EXPRESSION	Human induced pluripotent stem cells (hiPSCs) have enormous potential for the treatment of inherited and acquired disorders. Recently, antigen-specific T lymphocytes derived from hiPSCs have been reported. However, T lymphocyte populations with broad T cell receptor (TCR) diversity have not been generated. We report that hiPSCs derived from skin biopsy are capable of producing T lymphocyte populations with a broad TCR repertoire. In vitro T cell differentiation follows a similar developmental program as observed in vivo, indicated by sequential expression of CD7, intracellular CD3 and surface CD3. The gamma delta TCR locus is rearranged first and is followed by rearrangement of the alpha beta locus. Both gamma delta and alpha beta T cells display a diverse TCR repertoire. Upon activation, the cells express CD25, CD69, cytokines (TNF-alpha, IFN-gamma, IL-2) and cytolytic proteins (Perforin and Granzyme-B). These results suggest that most, if not all, mechanisms required to generate functional T cells with a broad TCR repertoire are intact in our in vitro differentiation protocol. These data provide a foundation for production of patient-specific T cells for the treatment of acquired or inherited immune disorders and for cancer immunotherapy.	[Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35205 USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Dent, Dept Med, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Med, Cell Therapy Lab, Birmingham, AL USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Dent, Cell Therapy Lab, Birmingham, AL 35294 USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Med, UAB Stem Cell Inst, Birmingham, AL USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Dent, UAB Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Townes, TM (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35205 USA.	ttownes@uab.edu		Lamb, Lawrence/0000-0001-7180-0994	NIH [R01HL057619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01HL057619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; BARCENA A, 1993, BLOOD, V82, P3401; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beck RC, 2003, AM J CLIN PATHOL, V120, P785, DOI 10.1309/835B04QXGNNFNRJU; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; KRANGEL MS, 1990, J EXP MED, V172, P847, DOI 10.1084/jem.172.3.847; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lei FY, 2009, CELL IMMUNOL, V260, P1, DOI 10.1016/j.cellimm.2009.09.005; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Ohnuki M., 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9]; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramsdell F., 2006, CURRENT PROTOCOLS IM; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; YEOMAN H, 1993, P NATL ACAD SCI USA, V90, P10778, DOI 10.1073/pnas.90.22.10778; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522	40	19	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97335	10.1371/journal.pone.0097335	http://dx.doi.org/10.1371/journal.pone.0097335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828440	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400080
J	Heng, YJJ; Pennell, CE; Chua, HN; Perkins, JE; Lye, SJ				Heng, Yujing Jan; Pennell, Craig Edward; Chua, Hon Nian; Perkins, Jonathan Edward; Lye, Stephen James			Whole Blood Gene Expression Profile Associated with Spontaneous Preterm Birth in Women with Threatened Preterm Labor	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; CERVICOVAGINAL FETAL FIBRONECTIN; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTENATAL CORTICOSTEROIDS; LATE PREGNANCY; IMMUNOHISTOCHEMICAL LOCALIZATION; MULTIPLE COURSES; HUMAN TERM; ACTIVATION; INFLAMMATION	Threatened preterm labor (TPTL) is defined as persistent premature uterine contractions between 20 and 37 weeks of gestation and is the most common condition that requires hospitalization during pregnancy. Most of these TPTL women continue their pregnancies to term while only an estimated 5% will deliver a premature baby within ten days. The aim of this work was to study differential whole blood gene expression associated with spontaneous preterm birth (sPTB) within 48 hours of hospital admission. Peripheral blood was collected at point of hospital admission from 154 women with TPTL before any medical treatment. Microarrays were utilized to investigate differential whole blood gene expression between TPTL women who did (n = 48) or did not have a sPTB (n = 106) within 48 hours of admission. Total leukocyte and neutrophil counts were significantly higher (35% and 41% respectively) in women who had sPTB than women who did not deliver within 48 hours (p<0.001). Fetal fibronectin (fFN) test was performed on 62 women. There was no difference in the urine, vaginal and placental microbiology and histopathology reports between the two groups of women. There were 469 significant differentially expressed genes (FDR<0.05); 28 differentially expressed genes were chosen for microarray validation using qRT-PCR and 20 out of 28 genes were successfully validated (p<0.05). An optimal random forest classifier model to predict sPTB was achieved using the top nine differentially expressed genes coupled with peripheral clinical blood data (sensitivity 70.8%, specificity 75.5%). These differentially expressed genes may further elucidate the underlying mechanisms of sPTB and pave the way for future systems biology studies to predict sPTB.	[Heng, Yujing Jan; Perkins, Jonathan Edward; Lye, Stephen James] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pennell, Craig Edward] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Chua, Hon Nian] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Heng, YJJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	heng@lunenfeld.ca	Lye, Stephen J/E-7269-2013; Pennell, Craig/ABD-6902-2020	Lye, Stephen J/0000-0002-3305-4406; Pennell, Craig/0000-0002-0937-6165; Heng, Yu Jing Jan/0000-0002-8930-817X	Canadian Institutes of Health Research fellowship; March of Dimes [21-Fy04-171, 21-Fy10-204]	Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); March of Dimes(March of Dimes)	Dr Heng is a Canadian Institutes of Health Research fellowship recipient. This study was funded by March of Dimes (#21-Fy04-171 and #21-Fy10-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos EV, 2010, PEDIATRICS, V126, pE1045, DOI 10.1542/peds.2010-0857; Baumgart F, 2010, BBA-BIOMEMBRANES, V1798, P592, DOI 10.1016/j.bbamem.2010.01.002; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRUMMER HC, 1972, PROSTAGL, V2, P185, DOI 10.1016/S0090-6980(72)80022-4; Campbell MK, 2005, J CLIN EPIDEMIOL, V58, P304, DOI 10.1016/j.jclinepi.2004.06.015; Canadian Institute for Health Information, 2009, TOO EARL TOO SMALL P; Chaiworapongsa T, 2013, J PERINAT MED, V41, P485, DOI 10.1515/jpm-2013-0082; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chim SSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034328; COPPER RL, 1990, AM J OBSTET GYNECOL, V162, P748, DOI 10.1016/0002-9378(90)91000-3; Crowley P, 2003, BJOG-INT J OBSTET GY, V110, P77, DOI 10.1016/S1470-0328(03)00041-7; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DeFranco EA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.015; DELGADO I, 1994, GYNECOL OBSTET INVES, V38, P227, DOI 10.1159/000292487; EFRATI P, 1964, OBSTET GYNECOL, V23, P429; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681; Giannoulias D, 2002, J CLIN ENDOCR METAB, V87, P1345, DOI 10.1210/jc.87.3.1345; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Goffinet F, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2005.00583.x; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2013, AM J REPROD IMMUNOL, V69, P212, DOI 10.1111/aji.12074; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Hua RY, 2013, AM J REPROD IMMUNOL, V69, P21, DOI 10.1111/aji.12025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iams J. D., 2004, MATERNAL FETAL MED P; Institute of Medicine (US), 2007, PRETERM BIRTH CAUSES; Johnson RF, 2004, J CLIN ENDOCR METAB, V89, P5639, DOI 10.1210/jc.2004-0540; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; KARIM SMMM, 1968, BRIT MED J, V4, P618, DOI 10.1136/bmj.4.5631.618; KATZ M, 1990, AM J OBSTET GYNECOL, V162, P1150, DOI 10.1016/0002-9378(90)90004-Q; Kaukola T, 2011, CYTOKINE, V54, P85, DOI 10.1016/j.cyto.2011.01.002; Kawakami Y, 2013, J NUTRIGENET NUTRIGE, V6, P154, DOI 10.1159/000354247; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Krupa FG, 2006, INT J GYNECOL OBSTET, V94, P5, DOI 10.1016/j.ijgo.2006.03.022; Larma JD, 2012, CLIN OBSTET GYNECOL, V55, P324, DOI 10.1097/GRF.0b013e3182487e96; Lartey J, 2009, REPRODUCTION, V138, P407, DOI 10.1530/REP-09-0160; Leitich H, 1999, AM J OBSTET GYNECOL, V180, P1169, DOI 10.1016/S0002-9378(99)70612-5; Lim Gillian, 2009, Healthc Q, V12, P20; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105163; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Lucovnik M, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.046; Luppi P, 2002, J LEUKOCYTE BIOL, V72, P874; Lyndon A, 2006, J PERINAT NEONAT NUR, V20, P82, DOI 10.1097/00005237-200601000-00024; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Markovic D, 2013, J CLIN ENDOCR METAB, V98, P2864, DOI 10.1210/jc.2013-1094; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Mitchell JA, 2004, AM J PHYSIOL-ENDOC M, V287, pE439, DOI 10.1152/ajpendo.00275.2003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Murphy KE, 2012, OBSTET GYNECOL, V119, P917, DOI 10.1097/AOG.0b013e31825189dc; Murphy KE, 2011, J OBSTET GYNAECOL CA, V33, P909, DOI 10.1016/S1701-2163(16)35016-2; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nicholson WK, 2000, OBSTET GYNECOL, V96, P95, DOI 10.1016/S0029-7844(00)00863-2; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; Sabra S, 2011, REPROD SCI, V18; Sabra S, 2012, REPROD SCI, V19, p119A; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shynlova O, 2009, REPROD SCI, V16, p222A; SIEGEL I, 1981, DIAGN GYNECOL OBSTET, V3, P123; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Torbe A, 2007, EUR CYTOKINE NETW, V18, P102, DOI 10.1684/ecn.2007.0092; Tornblom SA, 2004, J CLIN ENDOCR METAB, V89, P2909, DOI 10.1210/jc.2003-031149; Unal ER, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanMeir CA, 1997, J CLIN ENDOCR METAB, V82, P969, DOI 10.1210/jc.82.3.969; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Versleijen MWJ, 2009, CLIN NUTR, V28, P59, DOI 10.1016/j.clnu.2008.09.001; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Ward RM, 2003, BJOG-INT J OBSTET GY, V110, P8, DOI 10.1016/S1470-0328(03)00012-0; Welsh T, 2012, REPROD SCI, V19, P1099, DOI 10.1177/1933719112442247; Yellon SM, 2003, J SOC GYNECOL INVEST, V10, P323, DOI 10.1016/S1071-5576(03)00116-3; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	94	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96901	10.1371/journal.pone.0096901	http://dx.doi.org/10.1371/journal.pone.0096901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828675	Green Published, gold			2022-12-25	WOS:000336857400044
J	Kour, A; Boone, AM; Vodkin, LO				Kour, Anupreet; Boone, Anne M.; Vodkin, Lila O.			RNA-Seq Profiling of a Defective Seed Coat Mutation in Glycine max Reveals Differential Expression of Proline-Rich and Other Cell Wall Protein Transcripts	PLOS ONE			English	Article							GENE FAMILY; ARABIDOPSIS; BIOSYNTHESIS; LIGNIN; POLLEN; ACCUMULATE; EXPANSION; THALIANA; CLONING; AUXIN	The plant cell wall performs a number of essential functions including providing shape to many different cell types and serving as a defense against potential pathogens. The net pattern mutation creates breaks in the seed coat of soybean (Glycine max) because of ruptured cell walls. Using RNA-Seq, we examined the seed coat transcriptome from three stages of immature seed development in two pairs of isolines with normal or defective seed coat phenotypes due to the net pattern. The genome-wide comparative study of the transcript profiles of these isolines revealed 364 differentially expressed genes in common between the two varieties that were further divided into different broad functional categories. Genes related to cell wall processes accounted for 19% of the differentially expressed genes in the middle developmental stage of 100200 mg seed weight. Within this class, the cell wall proline-rich and glycine-rich protein genes were highly differentially expressed in both genetic backgrounds. Other genes that showed significant expression changes in each of the isoline pairs at the 100-200 mg seed weight stage were xylem serine proteinase, fasciclin-related genes, auxin and stress response related genes, TRANSPARENT TESTA 1 (TT1) and other transcription factors. The mutant appears to shift the timing of either the increase or decrease in the levels of some of the transcripts. The analysis of these data sets reveals the physiological changes that the seed coat undergoes during the formation of the breaks in the cell wall.	[Kour, Anupreet; Boone, Anne M.; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; United States Department of Agriculture (USDA)	United Soybean Board; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	The research was funded by support from the United Soybean Board and the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; BAILEY RW, 1978, AM J CLIN NUTR, V31, pS77, DOI 10.1093/ajcn/31.10.S77; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bewley JD, 2000, BIOCH MOL BIOL PLANT, P988; Chou YH, 2012, PLANT PHYSIOL, V159, P1355, DOI 10.1104/pp.112.199356; CORNER E. J. H., 1951, PHYTOMORPHOLOGY [DELHI], V1, P117; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; EVANS ML, 1985, CRC CR REV PLANT SCI, V2, P317, DOI 10.1080/07352688509382200; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gibalova A, 2009, PLANT MOL BIOL, V70, P581, DOI 10.1007/s11103-009-9493-y; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; HONG JC, 1989, PLANT CELL, V1, P937, DOI 10.1105/tpc.1.9.937; HONG JC, 1987, J BIOL CHEM, V262, P8367; HONG JC, 1990, J BIOL CHEM, V265, P2470; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Lamport DTA, 2011, METHODS MOL BIOL, V715, P209, DOI 10.1007/978-1-61779-008-9_15; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasserre E, 2008, PLANT PHYSIOL BIOCH, V46, P1051, DOI 10.1016/j.plaphy.2008.07.003; LINDSTROM JT, 1991, PLANT CELL, V3, P561, DOI 10.1105/tpc.3.6.561; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; MARCUS A, 1991, PHYSIOL PLANTARUM, V81, P273; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; Miller SS, 1999, ANN BOT-LONDON, V84, P297, DOI 10.1006/anbo.1999.0915; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NICHOLAS CD, 1993, PLANT MOL BIOL, V21, P145, DOI 10.1007/BF00039625; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Percy JD, 1999, PLANT MOL BIOL, V40, P603, DOI 10.1023/A:1006221115522; Pestana-Calsa MC, 2012, GENET MOL BIOL, V35, P322, DOI 10.1590/S1415-47572012000200013; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Ringli C, 2001, CELL MOL LIFE SCI, V58, P1430, DOI 10.1007/PL00000786; Ritchie SW, 1996, SOYBEAN PLANT DEV; RYSER U, 1992, PLANT CELL, V4, P773, DOI 10.1105/tpc.4.7.773; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHMIDT JS, 1994, PLANT J, V6, P177, DOI 10.1046/j.1365-313X.1994.6020177.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tsukaya H, 2006, J PLANT RES, V119, P1, DOI 10.1007/s10265-005-0254-y; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; WILLIAMS LF, 1950, SOYBEANS SOYBEAN PRO, P111; WU HM, 1993, P NATL ACAD SCI USA, V90, P6829, DOI 10.1073/pnas.90.14.6829; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang XY, 2008, J EXP BOT, V59, P3661, DOI 10.1093/jxb/ern214; Zabala G, 2003, GENETICS, V163, P295; Zhao CS, 2000, PLANT PHYSIOL, V123, P1185, DOI 10.1104/pp.123.3.1185; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	71	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96342	10.1371/journal.pone.0096342	http://dx.doi.org/10.1371/journal.pone.0096342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828743	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400025
J	Valletta, JJ; Chipperfield, AJ; Clough, GF; Byrne, CD				Valletta, John Joseph; Chipperfield, Andrew J.; Clough, Geraldine F.; Byrne, Christopher D.			Daily Energy Expenditure, Cardiorespiratory Fitness and Glycaemic Control in People with Type 1 Diabetes	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; DAILY-LIFE; EXERCISE; MEN; ADOLESCENTS; PREDICTORS; MORTALITY; CAPACITY	Objective: Encouraging daily physical activity improves cardiorespiratory fitness and many cardiovascular risk factors. However, increasing physical activity often creates a challenge for people with type 1 diabetes, because of difficulties maintaining euglycemia in the face of altered food intake and adjustments to insulin doses. Our aim was to examine the triangular relationship between glucose control measured by continuous glucose monitoring system (CGMS), objective measures of total daily energy expenditure (TEE) recorded by a multi-sensory monitoring device, and cardiorespiratory fitness (CRF), in free-living subjects with type 1 diabetes. Research Design and Methods: Twenty-three individuals (12 women) with type 1 diabetes who were free from micro- and macrovascular complications were recruited. TEE and glucose control were monitored simultaneously for up to 12 days, using a multi-sensory device and CGMS respectively. CRF was recorded as V02 max from a maximal treadmill test with the Bruce protocol. Results: Subjects (mean +/- SD) were aged 37 +/- 11 years, with BMI = 26.5 +/- 5.1 kg.m(-2), HbA(1c) = 7.7 +/- 1.3% (61 +/- 14 mmol/mol) and V02 max (ml.min(-1).kg(-1)) = 39.9 +/- 8.4 (range 22.4 - 58.6). TEE (36.3 +/- 5.5 kcal.kg(-1).day(-1)) was strongly associated with CRF(39.9 +/- 8.4 ml.min(-1).kg(-1)) independently of sex (r = 0.63, p < 0.01). However, neither TEE (r = -0.20, p = 0.36) nor CRF (r = -0.20, p = 0.39; adjusted for sex), were significantly associated with mean glycaemia measured by CGMS. Conclusion: Higher levels of energy expenditure (due to a more active lifestyle) are associated with increased cardiorespiratory fitness, but not necessarily better glycaemic control. Since increased levels of energy expenditure and good glycaemic control are both needed to protect against diabetes-related complications our data suggest they need to be achieved independently.	[Valletta, John Joseph; Clough, Geraldine F.; Byrne, Christopher D.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Valletta, John Joseph; Chipperfield, Andrew J.] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Chipperfield, AJ (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	A.J.Chipperfield@soton.ac.uk	Chipperfield, Andrew J/B-7001-2009	Byrne, Christopher D/0000-0001-6322-7753; Chipperfield, Andrew/0000-0002-3026-9890	Diabetes UK [BDA: RD06/0003306]; UK EPSRC PhD plus programme	Diabetes UK(Diabetes UK); UK EPSRC PhD plus programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Diabetes UK funded this work under grant BDA: RD06/0003306. JJV also gratefully acknowledges the support of the UK EPSRC PhD plus programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Benevento D, 2010, Diabetes Res Clin Pract, V88, pe32, DOI 10.1016/j.diabres.2010.03.016; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; den Hoed M, 2008, INT J OBESITY, V32, P1264, DOI 10.1038/ijo.2008.72; den Hoed M, 2008, J APPL PHYSIOL, V105, P561, DOI 10.1152/japplphysiol.00091.2008; Ekelund U, 2005, AM J CLIN NUTR, V81, P964; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737; Harmer AR, 2007, DIABETES CARE, V30, P1269, DOI 10.2337/dc06-1790; Herbst A, 2006, ARCH PEDIAT ADOL MED, V160, P573, DOI 10.1001/archpedi.160.6.573; Kavookjian J, 2007, DIABETES EDUCATOR, V33, P962, DOI 10.1177/0145721707308411; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; Lakoski SG, 2011, AM J CARDIOL, V108, P34, DOI 10.1016/j.amjcard.2011.02.338; Lehmann R, 1997, DIABETES CARE, V20, P1603, DOI 10.2337/diacare.20.10.1603; Ligtenberg PC, 1999, NETH J MED, V55, P59, DOI 10.1016/S0300-2977(99)00039-X; McAuley P, 2009, DIABETES RES CLIN PR, V85, pE30, DOI 10.1016/j.diabres.2009.05.012; Michaliszyn SF, 2010, RES NURS HEALTH, V33, P441, DOI 10.1002/nur.20393; Mittermayer F, 2005, WIEN KLIN WOCHENSCHR, V117, P816, DOI 10.1007/s00508-005-0476-y; Mosher PE, 1998, ARCH PHYS MED REHAB, V79, P652, DOI 10.1016/S0003-9993(98)90039-9; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Ramalho AC, 2006, DIABETES RES CLIN PR, V72, P271, DOI 10.1016/j.diabres.2005.11.011; Riazi A, 2004, DIABETES RES CLIN PR, V66, P237, DOI 10.1016/j.diabres.2004.04.001; Rigla M, 2000, METABOLISM, V49, P640, DOI 10.1016/S0026-0495(00)80041-4; Roberts L, 2002, J PEDIATR ENDOCR MET, V15, P621; Ross R, 2011, MED SCI SPORT EXER, V43, P2189, DOI 10.1249/MSS.0b013e31821e4ff2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Trout KK, 2007, DIABETES TECHNOL THE, V9, P176, DOI 10.1089/dia.2006.0004; Waden J, 2005, DIABETES CARE, V28, P777, DOI 10.2337/diacare.28.4.777; Wallymahmed M, 2007, PRACTICAL DIABETES I, V24, P418; Wallymahmed ME, 2007, DIABETIC MED, V24, P1296, DOI 10.1111/j.1464-5491.2007.02257.x; Wiesinger GF, 2001, WIEN KLIN WOCHENSCHR, V113, P670; Wiesli P, 2005, DIABETES CARE, V28, P1910, DOI 10.2337/diacare.28.8.1910; Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003	41	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97534	10.1371/journal.pone.0097534	http://dx.doi.org/10.1371/journal.pone.0097534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826899	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000336857400106
J	Im, YK; La Selva, R; Gandin, V; Ha, JR; Sabourin, V; Sonenberg, N; Pawson, T; Topisirovic, I; Ursini-Siegel, J				Im, Y. K.; La Selva, R.; Gandin, V.; Ha, J. R.; Sabourin, V.; Sonenberg, N.; Pawson, T.; Topisirovic, I.; Ursini-Siegel, J.			The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER CELLS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; FACTOR EIF-4E; INITIATION; EXPRESSION; RECEPTOR; DISTINCT; MTOR	The ShcA adaptor protein is engaged by numerous receptor tyrosine kinases (RTKs) in breast cancer cells. Once activated, RTKs phosphorylate three key tyrosine phosphorylation sites (Y239, Y240 and Y317) within ShcA that creates a docking site for Grb2/SOS and Grb2/Gab-containing complexes to activate the MAPK and AKT signaling pathways, respectively. We previously demonstrated that a tyrosine to phenylalanine substitution of the ShcA tyrosine phosphorylation sites (Shc3F-Y239/240/313F) significantly impairs breast tumor growth and angiogenesis in transgenic mouse models, in part, through the regulation of vascular endothelial growth factor (VEGF) production. Despite this fact, the underlying molecular mechanisms by which ShcA transduces pro-tumorigenic signals in breast cancer cells remain poorly defined. In this study, we demonstrate that ShcA-dependent activation of AKT, but not the RAS/MAPK pathway, induces VEGF production by bolstering VEGF mRNA translation. Accordingly, ShcA drives breast tumor growth and angiogenesis in vivo in a 4E-BP-dependent manner. These findings establish ShcA as a biological bridge that links AKT activation downstream of RTKs to cap-dependent VEGF mRNA translation in order to promote mammary tumorigenesis.	[Im, Y. K.; La Selva, R.; Gandin, V.; Ha, J. R.; Sabourin, V.; Topisirovic, I.; Ursini-Siegel, J.] McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Sonenberg, N.] Goodman Canc Res Ctr, Montreal, PQ, Canada; [Pawson, T.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Lady Davis Institute; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Ursini-Siegel, J (corresponding author), McGill Univ, Lady Davis Inst Med Res, Dept Oncol, 3999 Cote St Catherine Rd,Room F528-1, Montreal, PQ H3T 1E2, Canada.	giuseppina.ursini-siegel@mcgill.ca	Pawson, Tony J/E-4578-2013; Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762; Gandin, Valentina/0000-0003-2627-1303	Canadian Institutes of Health Research (CIHR) grant [MOP-111143]; TD/LDI; McGill Integrated Research Training Program; CIHR	Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); TD/LDI; McGill Integrated Research Training Program; CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr Peter Siegel for critical reading of the manuscript and Dr Sonia del Rincon for the VEGF antibody. This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MOP-111143) to JU-S. YKI is the recipient of a TD/LDI studentship. JRH is the recipient of a McGill Integrated Research Training Program studentship. JU-S and IT are recipients of a CIHR New Investigator Salary Support award.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Casanova ML, 2002, CANCER RES, V62, P3402; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Davol PA, 2003, CANCER RES, V63, P6772; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Flowers A, 2009, SURGERY, V146, P220, DOI 10.1016/j.surg.2009.05.010; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Li CH, 2011, CANCER BIOL THER, V12, P872, DOI 10.4161/cbt.12.10.17672; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Maity A, 2000, CANCER RES, V60, P5879; Miller TW, 2009, CLIN CANCER RES, V15, P7266, DOI 10.1158/1078-0432.CCR-09-1665; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; SALCINI AE, 1994, ONCOGENE, V9, P2827; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; Shama Silvian, 1995, Gene Expression, V4, P241; Tcherkezian JCM, 2014, GENES DEV, V28; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2007, MOL CELL BIOL, V27, P6361, DOI 10.1128/MCB.00686-07; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Xiong SB, 2001, CANCER RES, V61, P1727; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	48	17	18	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 26	2015	34	13					1729	1735		10.1038/onc.2014.110	http://dx.doi.org/10.1038/onc.2014.110			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE5CS	24837366				2022-12-25	WOS:000351848400013
J	Cheung, CT; Singh, R; Kalra, RS; Kaul, SC; Wadhwa, R				Cheung, Caroline T.; Singh, Rumani; Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu			Collaborator of ARF (CARF) Regulates Proliferative Fate of Human Cells by Dose-dependent Regulation of DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; ERK; P53; ACTIVATION; APOPTOSIS; PROTEIN; ARREST; ATM; CHECKPOINT; SENESCENCE	Collaborator of ARF (CARF) has been shown to directly bind to and regulate p53, a central protein that controls tumor suppression via cellular senescence and apoptosis. However, the cellular functions of CARF and the mechanisms governing its effect on senescence, apoptosis, or proliferation are still unknown. Our previous studies have shown that (i) CARF is up-regulated during replicative and stress-induced senescence, and its exogenous overexpression caused senescence-like growth arrest of cells, and (ii) suppression of CARF induces aneuploidy, DNA damage, and mitotic catastrophe, resulting in apoptosis via the ATR/CHK1 pathway. In the present study, we dissected the cellular role of CARF by investigating the molecular pathways triggered by its overexpression in vitro and in vivo. We found that the dosage of CARF is a critical factor in determining the proliferation potential of cancer cells. Most surprisingly, although a moderate level of CARF overexpression induced senescence, a very high level of CARF resulted in increased cell proliferation. We demonstrate that the level of CARF is crucial for DNA damage and checkpoint response of cells through ATM/CHK1/CHK2, p53, and ERK pathways that in turn determine the proliferative fate of cancer cells toward growth arrest or proproliferative and malignant phenotypes. To the best of our knowledge, this is the first report that demonstrates the capability of a fundamental protein, CARF, in controlling cell proliferation in two opposite directions and hence may play a key role in tumor biology and cancer therapeutics.	[Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Kalra, Rajkumar S.; Kaul, Sunil C.; Wadhwa, Renu] Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Wadhwa, Renu/L-8898-2018; Kalra, RAJKUMAR S/L-6944-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kalra, RAJKUMAR S/0000-0002-8181-457X; Kaul, Sunil C/0000-0002-0046-3916	Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan; Japan Society for Promotion of Science; Canadian Institutes of Health Research; La Ligue Contre le Cancer; Fondation de France; Grants-in-Aid for Scientific Research [13F03918] Funding Source: KAKEN	Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for Promotion of Science, New Energy & Industrial Technology Development Organization of Japan.; Supported by fellowships from the Japan Society for Promotion of Science, Canadian Institutes of Health Research, La Ligue Contre le Cancer, and Fondation de France. Present address: Institute of Molecular Genetics of Montpellier/University of Montpellier I & II/CNRS, 1919 Route de Mende, Montpellier 34293, France.; Supported by a fellowship from the Japan Society for Promotion of Science.	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Cheung CT, 2011, CELL DEATH DIFFER, V18, P589, DOI 10.1038/cdd.2010.129; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dai BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1404; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Hasan MK, 2008, INT J ONCOL, V32, P663; Hasan MK, 2009, J BIOL CHEM, V284, P1664, DOI 10.1074/jbc.M805778200; Hasan MK, 2004, BIOCHEM J, V380, P605, DOI 10.1042/BJ20040337; Hasan MK, 2002, J BIOL CHEM, V277, P37765, DOI 10.1074/jbc.M204177200; Heo JI, 2012, MOL BIOL REP, V39, P8007, DOI 10.1007/s11033-012-1647-3; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khalil A, 2011, CELL CYCLE, V10, P481, DOI 10.4161/cc.10.3.14713; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Lee SJ, 2013, NEOPLASIA, V15, P727, DOI 10.1593/neo.121862; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Marchetti A, 2004, CELL DEATH DIFFER, V11, P596, DOI 10.1038/sj.cdd.4401368; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singh R, 2014, EXP CELL RES, V322, P324, DOI 10.1016/j.yexcr.2014.01.022; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tentner AR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.1; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	25	26	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18258	18269		10.1074/jbc.M114.547208	http://dx.doi.org/10.1074/jbc.M114.547208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825908	Green Published, hybrid			2022-12-25	WOS:000338042000026
J	Cho, HJ; Hwang, YS; Mood, K; Ji, YJ; Lim, J; Morrison, DK; Daar, IO				Cho, Hee Jun; Hwang, Yoo-Seok; Mood, Kathleen; Ji, Yon Ju; Lim, Junghwa; Morrison, Deborah K.; Daar, Ira O.			EphrinB1 Interacts with CNK1 and Promotes Cell Migration through c-Jun N-terminal Kinase (JNK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; EPH-RECEPTOR; TRANSMEMBRANE LIGANDS; SCAFFOLD PROTEIN; GASTRIC-CANCER; MORPHOGENESIS; SIGNALS; RHO; ANGIOGENESIS; MAINTENANCE	The Eph receptors and their membrane-bound ligands, ephrins, play important roles in various biological processes such as cell adhesion and movement. The transmembrane ephrinBs transduce reverse signaling in a tyrosine phosphorylation-dependent or -independent, as well as PDZ-dependent manner. Here, we show that ephrinB1 interacts with Connector Enhancer of KSR1 (CNK1) in an EphB receptor-independent manner. In cultured cells, cotransfection of ephrinB1 with CNK1 increases JNK phosphorylation. EphrinB1/CNK1-mediated JNK activation is reduced by overexpression of dominant-negative RhoA. Overexpression of CNK1 alone is sufficient for activation of RhoA; however, both ephrinB1 and CNK1 are required for JNK phosphorylation. Co-immunoprecipitation data showed that ephrinB1 and CNK1 act as scaffold proteins that connect RhoA and JNK signaling components, such as p115RhoGEF and MKK4. Furthermore, adhesion to fibronectin or active Src overexpression increases ephrinB1/CNK1 binding, whereas blocking Src activity by a pharmacological inhibitor decreases not only ephrinB1/CNK1 binding, but also JNK activation. EphrinB1 overexpression increases cell motility, however, CNK1 depletion by siRNA abrogates ephrinB1-mediated cell migration and JNK activation. Moreover, Rho kinase inhibitor or JNK inhibitor treatment suppresses ephrinB1-mediated cell migration. Taken together, our findings suggest that CNK1 is required for ephrinB1-induced JNK activation and cell migration.	[Cho, Hee Jun; Hwang, Yoo-Seok; Mood, Kathleen; Ji, Yon Ju; Lim, Junghwa; Morrison, Deborah K.; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Daar, IO (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov		Daar, Ira/0000-0003-2657-526X	Intramural Research Program of the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE [ZIABC010958, ZIABC010006, ZIABC011107] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, NCI.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Bong YS, 2004, BIOCHEM J, V377, P499, DOI 10.1042/BJ20031449; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Dravis C, 2011, DEV BIOL, V355, P138, DOI 10.1016/j.ydbio.2011.04.020; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Fritz RD, 2011, BBA-MOL CELL RES, V1813, P1971, DOI 10.1016/j.bbamcr.2011.02.008; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hwang YS, 2013, GENE DEV, V27, P491, DOI 10.1101/gad.208355.112; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kandouz M., CANC METASTASIS REV, V31, P353; Kataoka H, 2002, J CANCER RES CLIN, V128, P343, DOI 10.1007/s00432-002-0355-0; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lee HS, 2009, MOL BIOL CELL, V20, P124, DOI 10.1091/mbc.E08-06-0662; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Tanaka M, 2010, CANCER SCI, V101, P87, DOI 10.1111/j.1349-7006.2009.01352.x; Uyen HD, 2002, J CELL SCI, V115, P3073; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Wu C, 2009, J NEUROSCI, V29, P7404, DOI 10.1523/JNEUROSCI.5841-08.2009; Xu Z, 2003, J BIOL CHEM, V278, P24767, DOI 10.1074/jbc.M302454200; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Ziogas A, 2005, J BIOL CHEM, V280, P24205, DOI 10.1074/jbc.M413327200	52	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18556	18568		10.1074/jbc.M114.558809	http://dx.doi.org/10.1074/jbc.M114.558809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825906	Green Published, hybrid			2022-12-25	WOS:000338042000052
J	Doppler, H; Bastea, LI; Borges, S; Spratley, SJ; Pearce, SE; Storz, P				Doeppler, Heike; Bastea, Ligia I.; Borges, Sahra; Spratley, Samantha J.; Pearce, Sarah E.; Storz, Peter			Protein Kinase D Isoforms Differentially Modulate Cofilin-Driven Directed Cell Migration	PLOS ONE			English	Article							INVASIVE TUMOR-CELLS; NF-KAPPA-B; PROSTATE-CANCER; PHOSPHATASE SLINGSHOT; ACTIN REORGANIZATION; MEDIATED ACTIVATION; LIM-KINASE; IN-VIVO; PHOSPHORYLATION; MOTILITY	Background: Protein kinase D (PKD) enzymes regulate cofilin-driven actin reorganization and directed cell migration through both p21-activated kinase 4 (PAK4) and the phosphatase slingshot 1L (SSH1L). The relative contributions of different endogenous PKD isoforms to both signaling pathways have not been elucidated, sufficiently. Methodology/Principal Findings: We here analyzed two cell lines (HeLa and MDA-MB-468) that express the subtypes protein kinase D2 (PKD2) and protein kinase D3 (PKD3). We show that under normal growth conditions both isoforms can form a complex, in which PKD3 is basally-active and PKD2 is inactive. Basal activity of PKD3 mediates PAK4 activity and downstream signaling, but does not significantly inhibit SSH1L. This signaling constellation was required for facilitating directed cell migration. Activation of PKD2 and further increase of PKD3 activity leads to additional phosphorylation and inhibition of endogenous SSH1L. Net effect is a dramatic increase in phospho-cofilin and a decrease in cell migration, since now both PAK4 and SSH1L are regulated by the active PKD2/PKD3 complex. Conclusions/Significance: Our data suggest that PKD complexes provide an interface for both cofilin regulatory pathways. Dependent on the activity of involved PKD enzymes signaling can be balanced to guarantee a functional cofilin activity cycle and increase cell migration, or imbalanced to decrease cell migration. Our data also provide an explanation of how PKD isoforms mediate different effects on directed cell migration.	[Doeppler, Heike; Bastea, Ligia I.; Borges, Sahra; Spratley, Samantha J.; Pearce, Sarah E.; Storz, Peter] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			NIH [GM086435, CA140182]; Mayo Clinic Center for Individualized Medicine; Breast Cancer SPORE DRP award [CA116201-08-DRP5]; NATIONAL CANCER INSTITUTE [R01CA140182, P50CA116201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; Breast Cancer SPORE DRP award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants GM086435 and CA140182, and a grant from the Mayo Clinic Center for Individualized Medicine, as well as a Breast Cancer SPORE DRP award (CA116201-08-DRP5) - all to PS. The content is solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bastea LI, 2013, BIOCHEM J, V455, P251, DOI 10.1042/BJ20130281; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Christoforides C, 2012, DEV CELL, V23, P560, DOI 10.1016/j.devcel.2012.08.008; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Doeppler HR, 2013, J BIOL CHEM; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullin MJ, 2006, J BIOL CHEM, V281, P25089, DOI 10.1074/jbc.M603591200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Onishi Y, 2012, INT J ONCOL, V40, P1839, DOI 10.3892/ijo.2012.1400; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2009, CELL CYCLE, V8, P1975; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Tania N, 2011, BIOPHYS J, V100, P1883, DOI 10.1016/j.bpj.2011.02.036; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	52	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98090	10.1371/journal.pone.0098090	http://dx.doi.org/10.1371/journal.pone.0098090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840177	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600106
J	Mora, L; de Zamaroczy, M				Mora, Liliana; de Zamaroczy, Miklos			In Vivo Processing of DNase Colicins E2 and E7 Is Required for Their Import into the Cytoplasm of Target Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; CELLULAR FUNCTIONS; CRYSTAL-STRUCTURE; IMMUNITY PROTEIN; R-DOMAIN; D TRNASE; IDENTIFICATION; TRANSLOCATION; OMPT	DNase colicins E2 and E7, both of which appropriate the BtuB/Tol translocation machinery to cross the outer membrane, undergo a processing step as they enter the cytoplasm. This endoproteolytic cleavage is essential for their killing action. A processed form of the same size, 18.5 kDa, which corresponds to the C-terminal catalytic domain, was detected in the cytoplasm of bacteria treated with either of the two DNase colicins. The inner-membrane protease FtsH is necessary for the processing that allows the translocation of the colicin DNase domain into the cytoplasm. The processing occurs near residue D420, at the same position as the FtsH-dependent cleavage in RNase colicins E3 and D. The cleavage site is located 30 amino acids upstream of the DNase domain. In contrast, the previously reported periplasm-dependent colicin cleavage, located at R452 in colicin E2, was shown to be generated by the outer-membrane protease OmpT and we show that this cleavage is not physiologically relevant for colicin import. Residue R452, whose mutated derivatives led to toxicity defect, was shown to have no role in colicin processing and translocation, but it plays a key role in the catalytic activity, as previously reported for other DNase colicins. Membrane associated forms of colicins E2 and E7 were detected on target cells as proteinase K resistant peptides, which include both the receptor-binding and DNase domains. A similar, but much less proteinase K-resistant form was also detected with RNase colicin E3. These colicin forms are not relevant for colicin import, but their detection on the cell surface indicates that whole nuclease-colicin molecules are found in a stable association with the outer-membrane receptor BtuB of the target cells.	[Mora, Liliana; de Zamaroczy, Miklos] CNRS, Inst Biol Physicochim, UPR 9073, Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), CNRS, Inst Biol Physicochim, UPR 9073, Paris, France.	zamaroczy@ibpc.fr			Centre National de la Recherche Scientifique (CNRS, Paris, France) [UPR 9073]	Centre National de la Recherche Scientifique (CNRS, Paris, France)(Centre National de la Recherche Scientifique (CNRS))	The work was supported by UPR 9073 funds from the Centre National de la Recherche Scientifique (CNRS, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ayuso-Tejedor S, 2010, J STRUCT BIOL, V171, P117, DOI 10.1016/j.jsb.2010.05.001; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; COLE ST, 1985, MOL GEN GENET, V198, P465, DOI 10.1007/BF00332940; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; de Zamaroczy M, 2012, BIOCHEM SOC T, V40, P1486, DOI 10.1042/BST20120173; de Zamaroczy M, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P255, DOI 10.1007/978-1-4419-7692-5_14; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; DUCHE D, 1995, J BACTERIOL, V177, P4935, DOI 10.1128/jb.177.17.4935-4939.1995; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Duche D, 2009, J BIOCHEM, V145, P95, DOI 10.1093/jb/mvn149; Duquesne K, 2010, METHODS MOL BIOL, V601, P205, DOI 10.1007/978-1-60761-344-2_13; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kolade OO, 2002, BIOCHIMIE, V84, P439, DOI 10.1016/S0300-9084(02)01451-7; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; KRONE WJA, 1986, J BACTERIOL, V166, P260, DOI 10.1128/jb.166.1.260-268.1986; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lazdunski C, 2000, INT J MED MICROBIOL, V290, P337; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; Mora L, 2008, J BIOL CHEM, V283, P4993, DOI 10.1074/jbc.M706846200; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sharma O, 2007, J BACTERIOL, V189, P363, DOI 10.1128/JB.01344-06; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tan Y, 1997, MOL BIOL EVOL, V14, P666, DOI 10.1093/oxfordjournals.molbev.a025806; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; Walker DC, 2002, NUCLEIC ACIDS RES, V30, P3225, DOI 10.1093/nar/gkf420; WATSON R, 1981, J BACTERIOL, V147, P569, DOI 10.1128/JB.147.2.569-577.1981	53	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96549	10.1371/journal.pone.0096549	http://dx.doi.org/10.1371/journal.pone.0096549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840776	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600009
J	Boualem, A; Fleurier, S; Troadec, C; Audigier, P; Kumar, APK; Chatterjee, M; Alsadon, AA; Sadder, MT; Wahb-Allah, MA; Al-Doss, AA; Bendahmane, A				Boualem, Adnane; Fleurier, Sebastien; Troadec, Christelle; Audigier, Pascal; Kumar, Anish P. K.; Chatterjee, Manash; Alsadon, Abdullah A.; Sadder, Monther T.; Wahb-Allah, Mahmoud A.; Al-Doss, Abdullah A.; Bendahmane, Abdelhafid			Development of a Cucumis sativus TILLinG Platform for Forward and Reverse Genetics	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; BIOSYNTHESIS ENZYME LEADS; SEX DETERMINATION; MELO L; ARABIDOPSIS-THALIANA; MUTANT POPULATION; ETHYLENE; EXPRESSION; PLANTS; IDENTIFICATION	Background: Cucumber (Cucumis sativus) belongs to the Cucurbitaceae family that includes more than 800 species. The cucumber genome has been recently sequenced and annotated. Transcriptomics and genome sequencing of many plant genomes are providing information on candidate genes potentially related to agronomically important traits. To accelerate functional characterization of these genes in cucumber we have generated an EMS mutant population that can be used as a TILLinG platform for reverse genetics. Principal Findings: A population of 3,331 M2 mutant seed families was generated using two EMS concentrations (0.5% and 0.75%). Genomic DNA was extracted from M2 families and eight-fold pooled for mutation detection by ENDO1 nuclease. To assess the quality of the mutant collection, we screened for induced mutations in five genes and identified 26 mutations. The average mutation rate was calculated as 1/1147 Kb giving rise to approximately 320 mutations per genome. We focused our characterization on three missense mutations, G33C, S238F and S249F identified in the CsACS2 sex determination gene. Protein modeling and crystallography studies predicted that mutation at G(33) may affect the protein function, whereas mutations at S-238 and S-249 may not impair the protein function. As predicted, detailed phenotypic evaluation showed that the S238F and the S249F mutant lines had no sexual phenotype. In contrast, plants homozygous for the G33C mutation showed a complete sexual transition from monoecy to andromonoecy. This result demonstrates that TILLinG is a valuable tool for functional validation of gene function in crops recalcitrant to transgenic transformation. Conclusions: We have developed a cucumber mutant population that can be used as an efficient reverse genetics tool. The cucumber TILLinG collection as well as the previously described melon TILLinG collection will prove to be a valuable resource for both fundamental research and the identification of agronomically-important genes for crop improvement in cucurbits in general.	[Boualem, Adnane; Fleurier, Sebastien; Troadec, Christelle; Audigier, Pascal; Bendahmane, Abdelhafid] Saclay Plant Sci, INRA URGV, UMR1165, Unite Rech Genom Vegetale, Evry, France; [Kumar, Anish P. K.; Chatterjee, Manash] Jai Res Fdn, Bench Bio Pvt Ltd, Vapi, Gujarat, India; [Chatterjee, Manash] Natl Univ Ireland Univ Coll Galway, Plant & AgriBiosci Res Ctr PABC, Galway, Ireland; [Alsadon, Abdullah A.; Sadder, Monther T.; Wahb-Allah, Mahmoud A.; Al-Doss, Abdullah A.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ollscoil na Gaillimhe-University of Galway; King Saud University	Bendahmane, A (corresponding author), Saclay Plant Sci, INRA URGV, UMR1165, Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr	Sadder, Monther T./AAH-4484-2021; Boualem, Adnane/ABC-5019-2021; Sadder, Monther/B-9081-2015; Al-Doss, Abdullah/AAL-7883-2021; Al-Doss, Abdullah A/F-8539-2016	Sadder, Monther T./0000-0001-6651-0423; Boualem, Adnane/0000-0003-4428-6496; Sadder, Monther/0000-0001-6651-0423; Al-Doss, Abdullah/0000-0003-3828-2384; Abady, Mahmoud/0000-0002-7169-3751; TROADEC, Christelle/0000-0003-1927-7352; fleurier, sebastien/0000-0003-2334-7835	INRA-KSU Plant biotechnology network; Program LABEX Saclay Plant Sciences (SPS) [ANR-10-LABX-40]; ANR MELODY [ANR-11-BSV7-0024]; European Research Council (ERCSEXYPARTH)	INRA-KSU Plant biotechnology network; Program LABEX Saclay Plant Sciences (SPS); ANR MELODY(French National Research Agency (ANR)); European Research Council (ERCSEXYPARTH)(European Research Council (ERC))	This work was supported by INRA-KSU Plant biotechnology network, the Program LABEX Saclay Plant Sciences (SPS, ANR-10-LABX-40), the ANR MELODY (ANR-11-BSV7-0024), and the European Research Council (ERCSEXYPARTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Belouchi A, 1996, P NATL ACAD SCI USA, V93, P121, DOI 10.1073/pnas.93.1.121; Bentley A, 2000, GENETICS, V156, P1169; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boualem A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006144; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; Haritatos E, 1996, PLANTA, V198, P614, DOI 10.1007/BF00262649; Huai Q, 2001, J BIOL CHEM, V276, P38210; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jeffrey C., 1990, BIOL UTILIZATION CUC, P3; KUBICKI B, 1969, GENET POL, V10, P101; KUBICKI B, 1969, GENET POL, V10, P69; Kumar APK, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-38; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Rashid M, 2011, AUST J CROP SCI, V5, P411; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; Staub Jack E., 2008, V1, P241; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	42	29	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97963	10.1371/journal.pone.0097963	http://dx.doi.org/10.1371/journal.pone.0097963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835852	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800092
J	Liu, T; Zhang, WN; Cao, LJ; Zhang, Y				Liu, Ting; Zhang, Wei-Nan; Cao, Liujuan; Zhang, Yu			Question Popularity Analysis and Prediction in Community Question Answering Services	PLOS ONE			English	Article								With the blooming of online social media applications, Community Question Answering (CQA) services have become one of the most important online resources for information and knowledge seekers. A large number of high quality question and answer pairs have been accumulated, which allow users to not only share their knowledge with others, but also interact with each other. Accordingly, volumes of efforts have been taken to explore the questions and answers retrieval in CQA services so as to help users to finding the similar questions or the right answers. However, to our knowledge, less attention has been paid so far to question popularity in CQA. Question popularity can reflect the attention and interest of users. Hence, predicting question popularity can better capture the users' interest so as to improve the users' experience. Meanwhile, it can also promote the development of the community. In this paper, we investigate the problem of predicting question popularity in CQA. We first explore the factors that have impact on question popularity by employing statistical analysis. We then propose a supervised machine learning approach to model these factors for question popularity prediction. The experimental results show that our proposed approach can effectively distinguish the popular questions from unpopular ones in the Yahoo! Answers question and answer repository.	[Liu, Ting; Zhang, Wei-Nan; Zhang, Yu] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin 150006, Heilongjiang, Peoples R China; [Cao, Liujuan] Xiamen Univ, Sch Informat Sci & Technol, Dept Comp Sci, Xiamen, Fujian, Peoples R China	Harbin Institute of Technology; Xiamen University	Cao, LJ (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Dept Comp Sci, Xiamen, Fujian, Peoples R China.	caoliujuan@gmail.com; zhangyu@ir.hit.edu.cn			Natural Science Foundation of China [61133012, 61073129, 61073126]; Fundamental Research Funds for the Central Universities [2013121026, 2011121052]; Xiamen University 985 Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen University 985 Project	This work was supported by the Natural Science Foundation of China (Grant No. 61133012, 61073129, 61073126) and the Fundamental Research Funds for the Central Universities (No. 2013121026 and No. 2011121052) and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agichtein E., 2008, PROC INT C WEB SEARC, P183; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Bian J., 2008, P 17 INT C WORLD WID, P467, DOI DOI 10.1145/1367497.1367561; Bian Jiang, 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526717; Chen BC, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P781; Freund Y., 1996, ICML 13 INT C INT C; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Yue, 2010, P INT C MULT, P123; GUPTA M, 2012, 75 ANN M AM SOC INF; Hong L., 2011, P 20 INT C COMP WORL, DOI DOI 10.1145/1963192.1963222; JEON J, 2006, P 29 ANN INT ACM SIG, P228, DOI DOI 10.1145/1148170.1148212; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Lerman K., 2010, P 19 INT C WORLD WID, P621, DOI DOI 10.1145/1772690.1772754; Lerman K, 2007, IEEE INTERNET COMPUT, V11, P16, DOI 10.1109/MIC.2007.136; Li B., 2012, WWW, P775, DOI DOI 10.1145/2187980.2188200; QUAN X, 2012, 11 INT C COGN INF CO, P109; Richardson M., 2007, P 16 INT C WORLD WID, P521, DOI [DOI 10.1145/1242572.1242643, 10.1145/1242572.1242643]; RODGERS JL, 1988, 13 WAYS LOOK CORRELA, V42, P59; Suryanto MA, 2009, P 2 ACM INT C WEB SE, P142, DOI DOI 10.1145/1498759.1498820; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Wang XJ, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P179, DOI 10.1145/1571941.1571974; Witten I.H., 2002, ACM SIGMOD REC, V31, P76, DOI 10.1145/507338.507355; Yang J., 2010, ICWSM; Yu B, 2011, LECT NOTES COMPUT SC, V6589, P317; ZHANG WN, 2012, COLING 2012, P3105; ZHANG WN, 2013, PLOS ONE; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]	28	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e85236	10.1371/journal.pone.0085236	http://dx.doi.org/10.1371/journal.pone.0085236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837851	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800001
J	Crotty, FV; Fychan, R; Theobald, VJ; Sanderson, R; Chadwick, DR; Marley, CL				Crotty, Felicity V.; Fychan, Rhun; Theobald, Vince J.; Sanderson, Ruth; Chadwick, David R.; Marley, Christina L.			The Impact of Using Alternative Forages on the Nutrient Value within Slurry and Its Implications for Forage Productivity in Agricultural Systems	PLOS ONE			English	Article							NITROGEN MINERALIZATION; METHANE EMISSIONS; MILK-PRODUCTION; LEGUME SILAGES; PIG MANURE; GRASSLAND; SOIL; PHOSPHORUS; LOSSES; CATTLE	Alternative forages can be used to provide valuable home-grown feed for ruminant livestock. Utilising these different forages could affect the manure value and the implications of incorporating these forages into farming systems, needs to be better understood. An experiment tested the hypothesis that applying slurries from ruminants, fed ensiled red clover (Trifolium pratense), lucerne (Medicago sativa) or kale (Brassica oleracea) would improve the yield of hybrid ryegrass (Lolium hybridicum), compared with applying slurries from ruminants fed ensiled hybrid ryegrass, or applying inorganic N alone. Slurries from sheep offered one of four silages were applied to ryegrass plots (at 35 t ha(-1)) with 100 kg N ha(-1) inorganic fertiliser; dry matter (DM) yield was compared to plots only receiving ammonium nitrate at rates of 0, 100 and 250 kg N ha(-1) year(-1). The DM yield of plots treated with 250 kg N, lucerne or red clover slurry was significantly higher than other treatments (P<0.001). The estimated relative fertiliser N equivalence (FNE) (fertiliser-N needed to produce same yield as slurry N), was greatest for lucerne (114 kg) >red clover (81 kg) >kale (44 kg) >ryegrass (26 kg ha(-1) yr(-1)). These FNE values represent relative efficiencies of 22% (ryegrass), 52% (kale), 47% (red clover) and 60% for lucerne slurry, with the ryegrass slurry efficiency being lowest (P = 0.005). Soil magnesium levels in plots treated with legume slurry were higher than other treatments (P<0.001). Overall, slurries from ruminants fed alternative ensiled forages increased soil nutrient status, forage productivity and better N efficiency than slurries from ruminants fed ryegrass silage. The efficiency of fertiliser use is one of the major factors influencing the sustainability of farming systems, these findings highlight the cascade in benefits from feeding ruminants alternative forages, and the need to ensure their value is effectively captured to reduce environmental risks.	[Crotty, Felicity V.; Fychan, Rhun; Theobald, Vince J.; Sanderson, Ruth; Marley, Christina L.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Chadwick, David R.] Bangor Univ, Sch Environm Nat Resources & Geog, Environm Ctr Wales, Bangor, Gwynedd, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Bangor University	Marley, CL (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cvm@aber.ac.uk	Crotty, Felicity/D-4931-2013	Crotty, Felicity/0000-0002-7363-224X; Sanderson, Ruth/0000-0001-5569-5493	Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom [LS3642]	Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	The authors acknowledge the Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom, (LS3642) for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfield A, 2013, AGR SYST, V115, P41, DOI 10.1016/j.agsy.2012.10.001; Begum F, 2013, INT J BIODIV SCI ECO, V9, P1; Berry PM, 2003, SOIL USE MANAGE, V19, P112, DOI 10.1079/SUM2003176; Butler TJ, 2012, CROP SCI, V52, P1931, DOI 10.2135/cropsci2011.11.0611; Cardenas LM, 2007, ATMOS ENVIRON, V41, P7096, DOI 10.1016/j.atmosenv.2007.04.055; Chadwick D, 2011, ANIM FEED SCI TECH, V166-67, P514, DOI 10.1016/j.anifeedsci.2011.04.036; Chadwick DR, 2000, J AGR SCI, V134, P159, DOI 10.1017/S0021859699007510; Chambers BJ, 1999, SOIL USE MANAGE, V15, P137, DOI 10.1111/j.1475-2743.1999.tb00079.x; CUSHNAHAN A, 1994, ANIM PROD, V59, P415, DOI 10.1017/S0003356100007935; DEFRA, 2018, NITRATE VULNERABLE Z; DEFRA, 2013, GOOD AGR PRACT NUTR; Defra, 2010, FERT MAN RB209, P252; DEFRA, 2020, AGR UK; Dewhurst RJ, 2003, J DAIRY SCI, V86, P2598, DOI 10.3168/jds.S0022-0302(03)73855-7; Dewhurst RJ, 2003, J DAIRY SCI, V86, P2612, DOI 10.3168/jds.S0022-0302(03)73856-9; DuPont ST, 2010, AGR ECOSYST ENVIRON, V137, P25, DOI 10.1016/j.agee.2009.12.021; FAO, 2010, CURR WORLD FERT TREN; FAO, 2004, AN PROD HLTH P; Fortune S, 2005, SOIL USE MANAGE, V21, P370, DOI 10.1079/SUM2005338; Fortune S, 2000, SUSTAINABLE MANAGEME, P286; Fraser MD, 2001, GRASS FORAGE SCI, V56, P218, DOI 10.1046/j.1365-2494.2001.00268.x; Groot JCJ, 2007, NJAS-WAGEN J LIFE SC, V54, P235, DOI 10.1016/S1573-5214(07)80017-0; Jarvis SC, 1996, ADV AGRON, V57, P187, DOI 10.1016/S0065-2113(08)60925-6; Kanneganti VR, 1996, 1996 RES SUMMARIES, P26; Kirkham FW, 2001, J ECOL, V89, P1041, DOI 10.1111/j.1365-2745.2001.00626.x; Komiyama T, 2013, J MATER CYCLES WASTE, V15, P106, DOI 10.1007/s10163-012-0089-2; Kyvsgaard P, 2000, NUTR CYCL AGROECOSYS, V57, P207, DOI 10.1023/A:1009874500769; MacLeod M, 2010, AGR SYST, V103, P198, DOI 10.1016/j.agsy.2010.01.002; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Marley CL, 2007, GRASS FORAGE SCI, V62, P1, DOI 10.1111/j.1365-2494.2007.00556.x; Marley CL, 2009, ADV ANIMAL BIOSCIENC, P162; Misselbrook TH, 1998, J AGR SCI, V130, P183, DOI 10.1017/S0021859697005194; Murray P. J., 2012, SOIL ECOLOGY ECOSYST, P424; Nicholson FA, 2003, J AGR SCI, V140, P53, DOI 10.1017/S0021859602002848; O'Brien D, 2012, AGR SYST, V107, P33, DOI 10.1016/j.agsy.2011.11.004; Payne RW, 2011, INTRO GENSTAT WINDOW, P150; Powell JM, 2009, AGRON J, V101, P747, DOI 10.2134/agronj2008.0193x; Powell JM, 2009, J DAIRY SCI, V92, P1765, DOI 10.3168/jds.2008-1738; Powell JM, 2006, SOIL SCI SOC AM J, V70, P786, DOI 10.2136/sssaj2005.0286; Powell JM, 1999, NUTR CYCL AGROECOSYS, V54, P215, DOI 10.1023/A:1009762900258; Rochon JJ, 2004, GRASS FORAGE SCI, V59, P197, DOI 10.1111/j.1365-2494.2004.00423.x; Shrestha RK, 2013, GEODERMA, V197, P177, DOI 10.1016/j.geoderma.2013.01.005; Sokal RR, 1995, BIOMETRY PRINCIPLES, P240; Sorensen P, 1998, BIOL FERT SOILS, V28, P56, DOI 10.1007/s003740050463; Thomsen IK, 2001, EUR J AGRON, V15, P31, DOI 10.1016/S1161-0301(01)00096-X; UNWIN RJ, 1986, AGR WASTES, V15, P253, DOI 10.1016/0141-4607(86)90023-5; van Eekeren N, 2009, BIOL FERT SOILS, V45, P595, DOI 10.1007/s00374-009-0370-2; Velthof GL, 2005, J ENVIRON QUAL, V34, P698, DOI 10.2134/jeq2005.0698; Velthof GL, 2000, GREEN WORLD RES, P42; Vos J, 2000, NUTR CYCL AGROECOSYS, V56, P87, DOI 10.1023/A:1009807504178; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wiens MJ, 2008, AGR SYST, V98, P74, DOI 10.1016/j.agsy.2008.03.008; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	53	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97516	10.1371/journal.pone.0097516	http://dx.doi.org/10.1371/journal.pone.0097516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830777	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500073
J	Tsuchiya, M; Hashimoto, M; Takenaka, Y; Motoike, IN; Yoshikawa, K				Tsuchiya, Masa; Hashimoto, Midori; Takenaka, Yoshiko; Motoike, Ikuko N.; Yoshikawa, Kenichi			Global Genetic Response in a Cancer Cell: Self-Organized Coherent Expression Dynamics	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; MOLECULAR-INTERACTIONS; CHROMATIN; DNA; NOISE; TRANSITION; DIFFERENTIATION; NORMALIZATION; CHROMOSOMES; SWITCHES	Understanding the basic mechanism of the spatio-temporal self-control of genome-wide gene expression engaged with the complex epigenetic molecular assembly is one of major challenges in current biological science. In this study, the genome-wide dynamical profile of gene expression was analyzed for MCF-7 breast cancer cells induced by two distinct ErbB receptor ligands: epidermal growth factor (EGF) and heregulin (HRG), which drive cell proliferation and differentiation, respectively. We focused our attention to elucidate how global genetic responses emerge and to decipher what is an underlying principle for dynamic self-control of genome-wide gene expression. The whole mRNA expression was classified into about a hundred groups according to the root mean square fluctuation (rmsf). These expression groups showed characteristic time-dependent correlations, indicating the existence of collective behaviors on the ensemble of genes with respect to mRNA expression and also to temporal changes in expression. All-or-none responses were observed for HRG and EGF (biphasic statistics) at around 10-20 min. The emergence of time-dependent collective behaviors of expression occurred through bifurcation of a coherent expression state (CES). In the ensemble of mRNA expression, the self-organized CESs reveals distinct characteristic expression domains for biphasic statistics, which exhibits notably the presence of criticality in the expression profile as a route for genomic transition. In time-dependent changes in the expression domains, the dynamics of CES reveals that the temporal development of the characteristic domains is characterized as autonomous bistable switch, which exhibits dynamic criticality (the temporal development of criticality) in the genome-wide coherent expression dynamics. It is expected that elucidation of the biophysical origin for such critical behavior sheds light on the underlying mechanism of the control of whole genome.	[Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Takenaka, Yoshiko] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki, Japan; [Motoike, Ikuko N.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Keio University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; keyoshik@mail.doshisha.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Tsuruoka City; Yamagata prefectural government; GCOE program of Keio University; KAKENHI [23240044, 25103012]	Tsuruoka City(Tsuruoka City Government); Yamagata prefectural government; GCOE program of Keio University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Tsuruoka City, the Yamagata prefectural government, and the GCOE program of Keio University, and was supported in part by Grants-in-Aid, KAKENHI (Nos. 23240044 and 25103012). The funders had no role in study design, data collection and analysis, decision to publish.	Akitaya T, 2007, BIOMACROMOLECULES, V8, P273, DOI 10.1021/bm060634j; Assaf M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058102; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erenpreisa J, 1992, P LATV ACAD SCI B, V3, P64; Felli N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-85; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landau L. D., 1937, ZH EXPER THEOR FIZ, V7, P627, DOI DOI 10.1038/138840A0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Makita N, 1999, FEBS LETT, V460, P333, DOI 10.1016/S0014-5793(99)01368-X; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Nagahara H, 2010, CHEM PHYS LETT, V494, P88, DOI 10.1016/j.cplett.2010.05.083; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ryabov Y, 2008, NUCLEIC ACIDS RES, V36, P2756, DOI 10.1093/nar/gkn086; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Shu GP, 2003, COMP FUNCT GENOM, V4, P287, DOI 10.1002/cfg.290; Sims RJ, 2009, NATURE, V460, P802, DOI 10.1038/460802a; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Takagi S, 1999, LANGMUIR, V15, P4143, DOI 10.1021/la981158o; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; Tsuchiya M., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P744, DOI 10.1109/ICCME.2012.6275649; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsumoto K, 1999, BIOPHYS CHEM, V82, P1, DOI 10.1016/S0301-4622(99)00098-8; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; YANAGIDA M, 1982, COLD SPRING HARB SYM, V47, P177; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Yoshikawa K, 2001, ADV DRUG DELIVER REV, V52, P235, DOI 10.1016/S0169-409X(01)00210-1; Yoshikawa K, 1996, PHYS REV LETT, V76, P3029, DOI 10.1103/PhysRevLett.76.3029; Yoshikawa K., 2002, PHARM PROPERTIES NUC, P137; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zinchenko A.A., 2008, DNA INTERACTIONS POL, P59, DOI DOI 10.1002/9780470286364.CH3	56	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97411	10.1371/journal.pone.0097411	http://dx.doi.org/10.1371/journal.pone.0097411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831017	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500053
J	Grzymski, JJ; Marsh, AG				Grzymski, Joseph J.; Marsh, Adam G.			Protein Languages Differ Depending on Microorganism Lifestyle	PLOS ONE			English	Article							MYCOPLASMA-GENITALIUM; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCES; BIOLOGICAL-SYSTEMS; COST-MINIMIZATION; GENOME; INFORMATION; COMPLEXITY; EVOLUTION; BACTERIUM	Few quantitative measures of genome architecture or organization exist to support assumptions of differences between microorganisms that are broadly defined as being free-living or pathogenic. General principles about complete proteomes exist for codon usage, amino acid biases and essential or core genes. Genome-wide shifts in amino acid usage between free-living and pathogenic microorganisms result in fundamental differences in the complexity of their respective proteomes that are size and gene content independent. These differences are evident across broad phylogenetic groups-a result of environmental factors and population genetic forces rather than phylogenetic distance. A novel comparative analysis of amino acid usage-utilizing linguistic analyses of word frequency in language and text-identified a global pattern of higher peptide word repetition in 376 free-living versus 421 pathogen genomes across broad ranges of genome size, G+C content and phylogenetic ancestry. This imprint of repetitive word usage indicates free-living microorganisms have a bias for repetitive sequence usage compared to pathogens. These findings quantify fundamental differences in microbial genomes relative to life-history function.	[Grzymski, Joseph J.] Univ Nevada, Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89506 USA; [Marsh, Adam G.] Univ Delaware, Ctr Bioinformat & Computat Biol, Lewes, DE 19958 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; University of Delaware	Grzymski, JJ (corresponding author), Univ Nevada, Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89506 USA.	joeg@dri.edu; amarsh@udel.edu		Grzymski, Joseph/0000-0003-2646-8958	U.S. National Science Foundation, Office of Polar Programs [02-38281, 06-32278]	U.S. National Science Foundation, Office of Polar Programs(National Science Foundation (NSF))	This work was supported by the U.S. National Science Foundation, Office of Polar Programs (#02-38281 to AGM and #06-32278 to JJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2012, ANN NY ACAD SCI, V1256, P49, DOI 10.1111/j.1749-6632.2011.06422.x; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; BARRAI I, 1995, INT J PEPT PROT RES, V45, P326; Boneca IG, 1997, J BIOL CHEM, V272, P29053, DOI 10.1074/jbc.272.46.29053; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; DEJONGE BLM, 1993, ANTIMICROB AGENTS CH, V37, P342, DOI 10.1128/AAC.37.2.342; Denton M, 2001, NATURE, V410, P417, DOI 10.1038/35068645; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Dufton MJ, 1997, J THEOR BIOL, V187, P165, DOI 10.1006/jtbi.1997.0443; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forster AC, 2007, GENOME RES, V17, P1, DOI 10.1101/gr.5776007; Frank SA, 2009, J EVOLUTION BIOL, V22, P231, DOI 10.1111/j.1420-9101.2008.01647.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grzymski JJ, 2012, ISME J, V6, P71, DOI 10.1038/ismej.2011.72; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Liu ZD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-509; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V6, P1013, DOI 10.1080/07391102.1989.10506528; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V6, P1027, DOI 10.1080/07391102.1989.10506529; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P197, DOI 10.1093/nar/24.1.197; Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sadovsky MG, 2008, THEOR BIOSCI, V127, P69, DOI 10.1007/s12064-008-0032-1; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340	44	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96910	10.1371/journal.pone.0096910	http://dx.doi.org/10.1371/journal.pone.0096910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828817	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400045
J	Li, ZJ; Xu, XB; Meng, LX; Zhang, Q; Cao, LY; Li, WX; Wu, YL; Cao, ZJ				Li, Zhongjie; Xu, Xiaobo; Meng, Lanxia; Zhang, Qian; Cao, Luyang; Li, Wenxin; Wu, Yingliang; Cao, Zhijian			Hp1404, a New Antimicrobial Peptide from the Scorpion Heterometrus petersii	PLOS ONE			English	Article							OPISTHACANTHUS-MADAGASCARIENSIS; FUNCTIONAL-CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; PANDINUS-IMPERATOR; VENOM PEPTIDES; LYTIC PEPTIDES; CDNA SEQUENCES; LIPID-BILAYER; MODEL; MICROORGANISMS	Antimicrobial peptides have attracted much interest as a novel class of antibiotics against a variety of microbes including antibiotics resistant strains. In this study, a new cationic antimicrobial peptide Hp1404 was identified from the scorpion Heterometrus petersii, which is an amphipathic alpha-helical peptide and has a specific inhibitory activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus. Hp1404 can penetrate the membrane of S. aureus at low concentration, and disrupts the cellular membrane directly at super high concentration. S. aureus does not develop drug resistance after multiple treatments with Hp1404 at sub MIC concentration, which is possibly associated with the antibacterial mechanism of the peptide. In addition, Hp1404 has low toxicity to both mammalian cells (HC50 = 226.6 mu g/mL and CC50 > 100 mu g/mL) and balb-c mice (Non-toxicity at 80 mg/Kg by intraperitoneal injection and LD50 = 89.8 mg/Kg by intravenous injection). Interestingly, Hp1404 can improve the survival rate of the MRSA infected balb-c mice in the peritonitis model. Taken together, Hp1404 may have potential applications as an antibacterial agent.	[Li, Zhongjie; Xu, Xiaobo; Meng, Lanxia; Zhang, Qian; Cao, Luyang; Li, Wenxin; Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn		FCCN, Bogus/0000-0001-6282-8004	National Key Basic Research Program in China [2010CB529800, 2010CB530100]	National Key Basic Research Program in China(National Basic Research Program of China)	This work is supported by the grants from National Key Basic Research Program in China (http://www.973.gov.cn/English/AreaList.aspx): Nos. 2010CB529800, and 2010CB530100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Banerjee Tarun K., 1993, Biomedical and Environmental Sciences, V6, P31; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Cao LY, 2012, PEPTIDES, V36, P213, DOI 10.1016/j.peptides.2012.04.010; Cassone M, 2010, EXPERT REV ANTI-INFE, V8, P703, DOI [10.1586/eri.10.38, 10.1586/ERI.10.38]; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dai L, 2002, BIOCHEM BIOPH RES CO, V293, P1514, DOI 10.1016/S0006-291X(02)00423-0; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005; Domenech A, 2004, MICROB DRUG RESIST, V10, P346, DOI 10.1089/mdr.2004.10.346; FITTON JE, 1980, FEBS LETT, V115, P209, DOI 10.1016/0014-5793(80)81170-7; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Hernandez-Aponte CA, 2011, TOXICON, V57, P84, DOI 10.1016/j.toxicon.2010.10.008; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; JACOB L, 1994, CIBA F SYMP, V186, P197; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Morassutti C, 2002, FEBS LETT, V519, P141, DOI 10.1016/S0014-5793(02)02741-2; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park S, 2001, FEBS LETT, V507, P95, DOI 10.1016/S0014-5793(01)02956-8; Phadke SM, 2003, PEPTIDES, V24, P1099, DOI 10.1016/j.peptides.2003.07.001; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yamaguchi S, 2001, BIOPHYS J, V81, P2203, DOI 10.1016/S0006-3495(01)75868-7; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yuan WY, 2010, PEPTIDES, V31, P22, DOI 10.1016/j.peptides.2009.10.008; Zeh DW, 1990, BIOL SCORPIONS, pxxvi; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zeng XC, 2013, PEPTIDES, V45, P28, DOI 10.1016/j.peptides.2013.03.026	48	24	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97539	10.1371/journal.pone.0097539	http://dx.doi.org/10.1371/journal.pone.0097539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826994	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400107
J	Mischler, JA; Taylor, PG; Townsend, AR				Mischler, John A.; Taylor, Philip G.; Townsend, Alan R.			Nitrogen Limitation of Pond Ecosystems on the Plains of Eastern Colorado	PLOS ONE			English	Article							FRESH-WATER; NUTRIENT LIMITATION; PHYTOPLANKTON GROWTH; CONTROLLING EUTROPHICATION; PHOSPHORUS LIMITATION; NITRATE UPTAKE; N-2 FIXATION; ARCTIC LAKES; RIVER-BASIN; DENITRIFICATION	Primary production in freshwater ecosystems is often limited by the availability of phosphorus (P), nitrogen (N), or a combination of both (NP co-limitation). While N fixation via heterocystous cyanobacteria can supply additional N, no comparable mechanism for P exists; hence P is commonly considered to be the predominant and ultimate limiting nutrient in freshwater ecosystems. However, N limitation can be maintained if P is supplied in stoichiometric excess of N (including N fixation). The main objective of this study was to examine patterns in nutrient limitation across a series of 21 vernal ponds in Eastern Colorado where high P fluxes are common. Across all ponds, water column dissolved inorganic N steadily decreased throughout the growth season due to biological demand while total dissolved P remained stable. The water column dissolved inorganic N to total dissolved P ratios suggested a transition from NP co-limitation to N limitation across the growth season. Periphyton and phytoplankton %C was strongly correlated with %N while %P was assimilated in excess of %N and %C in many ponds. Similarly, in nutrient addition bottle assays algae responded more strongly to N additions (11 out of 18 water bodies) than P additions (2 out of 18 water bodies) and responded most strongly when N and P were added in concert (12 out of 18 water bodies). Of the ponds that responded to nutrient addition, 92% exhibited some sort of N limitation while less than 8% were limited by P alone. Despite multiple lines of evidence for N limitation or NP co-limitation, N fixation rates were uniformly low across most ponds, most likely due to inhibition by water column nitrate. Within this set of 18 water bodies, N limitation or NP co-limitation is widespread due to the combination high anthropogenic P inputs and constrained N fixation rates.	[Mischler, John A.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Mischler, JA (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	john.mischler@colorado.edu	Townsend, Alan/AAE-9602-2019		National Science Foundation [DGE-0802270]; U.S. Environmental Protection Agency's Science; University of Colorado Boulder	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency's Science(United States Environmental Protection Agency); University of Colorado Boulder	This work was funded by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-0802270, a grant from the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program, and grants from the University of Colorado Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleinikoff JN, 1999, GEOL SOC AM BULL, V111, P1876, DOI 10.1130/0016-7606(1999)111<1876:LQLINC>2.3.CO;2; ANDERSEN FO, 1992, HYDROBIOLOGIA, V228, P71; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Association APH, 1999, STANDARD METHODS EXA; Axler RP, 1996, LIMNOL OCEANOGR, V41, P659, DOI 10.4319/lo.1996.41.4.0659; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; BERGMANN MA, 1990, CAN J FISH AQUAT SCI, V47, P1545, DOI 10.1139/f90-174; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Bradburn MJ, 2012, FRESHWATER BIOL, V57, P1042, DOI 10.1111/j.1365-2427.2012.02765.x; Bunting L, 2005, INT VER THEOR ANGEW, V29, P1005; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Council NR, 1992, REST AQ EC SCI TECHN; Cronin G, 2007, FRESHWATER BIOL, V52, P1587, DOI 10.1111/j.1365-2427.2007.01790.x; Pinto PD, 2010, OIKOS, V119, P567, DOI 10.1111/j.1600-0706.2009.17924.x; Dennehy KF, 2007, USGS CIRCULAR, V1167, P37; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DILLON PJ, 1974, LIMNOL OCEANOGR, V19, P767, DOI 10.4319/lo.1974.19.5.0767; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; DOYLE RD, 1994, BIOGEOCHEMISTRY, V26, P41, DOI 10.1007/BF02180403; EINSELE WILHELM, 1941, ZEITSCHR FISCH U HILFSW, V39, P407; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; FLETT RJ, 1976, CAN J MICROBIOL, V22, P43, DOI 10.1139/m76-006; Forshay KJ, 2005, BIOGEOCHEMISTRY, V75, P43, DOI 10.1007/s10533-004-6016-4; Galloway JN, 1998, ENVIRON POLLUT, V102, P15, DOI 10.1016/S0269-7491(98)80010-9; Golterman HL, 1975, PHYSL LIMNOLOGY APPR; Hauer FR, 2006, METHODS STREAM ECOLO, V2; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HENRIKSEN A, 1970, ANALYST, V95, P514, DOI 10.1039/an9709500514; Hillebrand H, 1999, LIMNOL OCEANOGR, V44, P440, DOI 10.4319/lo.1999.44.2.0440; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Howarth R, 2012, FRONT ECOL ENVIRON, V10, P37, DOI 10.1890/100178; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Hutchinson GE, 1957, TREATISE LIMNOLOGY, P1015; James C, 2003, ARCH HYDROBIOL, V158, P249, DOI 10.1127/0003-9136/2003/0158-0249; Jones John R., 1993, Lake and Reservoir Management, V8, P17; Keck F, 2012, FRESHWATER BIOL, V57, P1410, DOI 10.1111/j.1365-2427.2012.02802.x; Kemp MJ, 2002, ECOL APPL, V12, P998, DOI 10.1890/1051-0761(2002)012[0998:CONADI]2.0.CO;2; Kemp PF, 1993, HDB METHODS AQUATIC, P5; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; Knopf Fritz L., 1990, P47; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; LARSEN DP, 1979, WATER RES, V13, P1259, DOI 10.1016/0043-1354(79)90170-2; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; LEVINE SN, 1992, LIMNOL OCEANOGR, V37, P917, DOI 10.4319/lo.1992.37.5.0917; Lewis WM, 2008, LAKE RESERV MANAGE, V24, P41, DOI 10.1080/07438140809354049; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Lewis WM, 2002, INT VER THEOR ANGEW, V28, P210; Liu Y, 2008, J IND ECOL, V12, P229, DOI 10.1111/j.1530-9290.2008.00025.x; Marcarelli AM, 2008, J N AM BENTHOL SOC, V27, P186, DOI 10.1899/07-027.1; McCormick PV, 2006, ECOL ENG, V27, P279, DOI 10.1016/j.ecoleng.2006.05.018; McCutchan JH, 2008, INT VER THEOR ANGEW, V30, P323; MIYACHI S, 1964, BIOCHIM BIOPHYS ACTA, V93, P625, DOI 10.1016/0304-4165(64)90345-9; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Mugidde R, 2003, J GREAT LAKES RES, V29, P76, DOI 10.1016/S0380-1330(03)70540-1; MULHOLLAND PJ, 1992, J N AM BENTHOL SOC, V11, P405, DOI 10.2307/1467561; Nichols S.A., 2005, RESTORATION MANAGEME, VThird edition; NRC (National Research Council), 2004, END THREAT FISH KLAM; Ogbebo FE, 2009, CAN J FISH AQUAT SCI, V66, P247, DOI 10.1139/F08-202; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; PAERL HW, 1982, ADV MICROB ECOL, V6, P75; Paterson MJ, 2011, LIMNOL OCEANOGR, V56, P1545, DOI 10.4319/lo.2011.56.4.1545; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; Pocernich M, 1997, 33 USGS; PRAIRIE YT, 1989, CAN J FISH AQUAT SCI, V46, P1176, DOI 10.1139/f89-153; Pribyl AL, 2005, BIOGEOCHEMISTRY, V73, P439, DOI 10.1007/s10533-004-0565-4; REDFIELD AC, 1958, AM SCI, V46, P205; Ryding SO, 1989, MAN BIOSPHERE, V1; Sakamoto M., 1966, ARCH HYDROBIOL, V62, P1, DOI 10.1371/journal.pone.0095757; Saunders DL, 2001, WATER RES, V35, P1897, DOI 10.1016/S0043-1354(00)00479-6; Saunders JF, 2003, J AM WATER RESOUR AS, V39, P33, DOI 10.1111/j.1752-1688.2003.tb01559.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; SCHINDLER DW, 1987, CAN J FISH AQUAT SCI, V44, P26; Schindler DW, 1998, ECOSYSTEMS, V1, P323, DOI 10.1007/s100219900026; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2007, BIOGEOCHEMISTRY, V84, P207, DOI 10.1007/s10533-007-9119-x; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Scott JT, 2005, WETLANDS, V25, P439, DOI 10.1672/18; Sharpley AN, 2003, J SOIL WATER CONSERV, V58, P137; Sjodin AL, 1997, BIOGEOCHEMISTRY, V39, P327, DOI 10.1023/A:1005884117467; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P7; SMITH VH, 1982, LIMNOL OCEANOGR, V27, P1101, DOI 10.4319/lo.1982.27.6.1101; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sprague Lisa, 2002, NHPF Issue Brief, P1; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Talling Jack F., 1992, Revue d'Hydrobiologie Tropicale, V25, P87; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vollenweider RA, 1968, D91 SECURESCM; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Wurtsbaugh W.A., 1988, VERHANDLUNGEN INT VE, V23, P121, DOI [10.1080/03680770.1987.11897913, DOI 10.1080/03680770.1987.11897913]; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	106	21	22	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95757	10.1371/journal.pone.0095757	http://dx.doi.org/10.1371/journal.pone.0095757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824838	gold, Green Submitted, Green Published			2022-12-25	WOS:000336369200008
J	Boyer, A; Dumans, A; Beaumont, E; Etienne, L; Roingeard, P; Meunier, JC				Boyer, Audrey; Dumans, Amelie; Beaumont, Elodie; Etienne, Loic; Roingeard, Philippe; Meunier, Jean-Christophe			The Association of Hepatitis C Virus Glycoproteins with Apolipoproteins E and B Early in Assembly Is Conserved in Lipoviral Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY; CULTURE; DETERMINANTS; LOCALIZATION; SECRETION; INTERACTS; CELLS; GENE	In patients chronically infected with hepatitis C virus and in the HCV cell culture system (HCVcc), it is known that highly infectious virus particles have low to very low buoyant densities. These low densities have been attributed to the association of HCV with lipoprotein components, which occur during the viral morphogenesis. The resulting hybrid particles are known as lipoviral particles (LVP); however, very little is known about how these particles are created. In our study, we used Huh7.5 cells to investigate the intracellular association between envelope proteins and apolipoproteins B and E (ApoB and ApoE, respectively). In particular, we were interested in the role of this association in initiating LVP morphogenesis. Co-immunoprecipitation assays revealed that ApoB, ApoE, and HCV glycoproteins formed a protein complex early in the HCV lifecycle. Confocal analyses of naive, E1E2-transduced and HCVcc-infected cells showed that HCV glycoproteins, ApoB and ApoE were found strongly colocalized only in the endoplasmic reticulum. We also found that HCV glycoproteins, ApoB and ApoE were already associated with intracellular infectious viral particles and, furthermore, that the protein complex was conserved in the infectious viral particles present in the supernatant of infected Huh7.5 cells. The association of HCV glycoproteins with ApoE was also evidenced in the HCVpp system, using the non-hepatic HEK293T cell line. We suggest that the complex formed by HCV E1E2, ApoB, and ApoE may initiate lipoviral particle morphogenesis.	Univ Tours, INSERM, U966, F-37032 Tours, France; CHRU Tours, F-37032 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Meunier, JC (corresponding author), Univ Tours, INSERM, U966, Morphogenese & Antigenicite VIH & Virus Hepatites, 10 Bvd Tonnelle BP3223, F-37032 Tours 1, France.	Jean.meunier@univ-tours.fr			"APOVIR" grant from Region Centre; INSERM-Region Centre; Cluster Infectiologie (Region Centre)	"APOVIR" grant from Region Centre(Region Centre-Val de Loire); INSERM-Region Centre(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Centre-Val de Loire); Cluster Infectiologie (Region Centre)(Region Centre-Val de Loire)	This work was supported by the "APOVIR" grant from Region Centre.; Supported by a PhD fellowship from INSERM-Region Centre.; Supported by a fellowship from the Cluster Infectiologie (Region Centre).	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang K. S., 2007, J VIROL; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Mazumdar B, 2011, HEPATOLOGY, V54, P1149, DOI 10.1002/hep.24523; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pecheur EI, 2010, J BIOL CHEM, V285, P25802, DOI 10.1074/jbc.M110.131664; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; SMITH JD, 1988, J BIOL CHEM, V263, P8300; Steinmann E, 2013, J VIROL, V87, P13297, DOI 10.1128/JVI.01708-13; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301	37	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18904	18913		10.1074/jbc.M113.538256	http://dx.doi.org/10.1074/jbc.M113.538256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838241	Green Published, hybrid			2022-12-25	WOS:000339062900024
J	Dong, NZ; Zhou, TT; Zhang, Y; Liu, M; Li, H; Huang, XY; Liu, ZZ; Wu, Y; Fukuda, K; Qin, J; Wu, QY				Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Huang, Xiaoyi; Liu, Zhenzhen; Wu, Yi; Fukuda, Koichi; Qin, Jun; Wu, Qingyu			Corin Mutations K317E and S472G from Preeclamptic Patients Alert Zymogen Activation and Cell Surface Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; SERINE-PROTEASE CORIN; PLASMA SOLUBLE CORIN; FAMILIAL HYPERCHOLESTEROLEMIA; TROPHOBLAST INVASION; RECEPTOR GENE; VARIANT; HYPERTENSION; EXPRESSION; HEART	Corin is a membrane-bound serine protease that acts as the atrial natriuretic peptide (ANP) convertase in the heart. Recent studies show that corin also activates ANP in the pregnant uterus to promote spiral artery remodeling and prevent pregnancy-induced hypertension. Two CORIN gene mutations, K317E and S472G, were identified in preeclamptic patients and shown to have reduced activity in vitro. In this study, we carried out molecular modeling and biochemical experiments to understand how these mutations impair corin function. By molecular modeling, the mutation K317E was predicted to alter corin LDL receptor-2 module conformation. Western blot analysis of K317E mutant in HEK293 cells showed that the mutation did not block corin expression on the cell surface but inhibited corin zymogen activation. In contrast, the mutation S472G was predicted to abolish a beta-sheet critical for corin frizzled-2 module structure. In Western blot analysis and flow cytometry, S472G mutant was not detected on the cell surface in transfected HEK293cells. By immunostaining, the S472G mutant was found in the ER, indicating that the mutation S472G disrupted the beta-sheet, causing corin misfolding and ER retention. Thus, these results show that mutations in the CORIN gene may impair corin function by entirely different mechanisms. Together, our data provide important insights into the molecular basis underlying corin mutations that may contribute to preeclampsia in patients.	[Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Liu, Zhenzhen; Wu, Yi; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Liu, Meng; Li, Hui; Liu, Zhenzhen; Wu, Yi; Wu, Qingyu] Soochow Univ, MOE Engn Ctr Hematol Dis, Suzhou 215123, Peoples R China; [Dong, Ningzheng] Soochow Univ, MOH Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Wu, Yi; Wu, Qingyu] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215123, Peoples R China; [Huang, Xiaoyi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China; [Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Shanghai Jiao Tong University; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL089298, HD064634]; National Natural Science Foundation of China [81170247, 81370718, 31161130356]; Chinese Ministry of Education [213016A]; Danish-Chinese Center for Proteases and Cancer; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Danish-Chinese Center for Proteases and Cancer; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (HL089298 and HD064634) and grants from the National Natural Science Foundation of China (81170247, 81370718, and 31161130356), the Key Project of Chinese Ministry of Education (213016A), the Danish-Chinese Center for Proteases and Cancer, and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Barbato E, 2012, J AM COLL CARDIOL, V59, P1763, DOI 10.1016/j.jacc.2012.02.017; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cootauco AC, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.019; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dechend R, 2008, NAT MED, V14, P1187, DOI 10.1038/nm1108-1187; Dong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033263; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Dong NZ, 2012, CLIN CHIM ACTA, V413, P378, DOI 10.1016/j.cca.2011.10.032; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GILILLAND JL, 1992, J CLIN ENDOCR METAB, V75, P547, DOI 10.1210/jc.75.2.547; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Hatta K, 2011, REPROD SCI, V18, P383, DOI 10.1177/1933719110385136; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; ITOH H, 1994, BIOCHEM BIOPH RES CO, V203, P602, DOI 10.1006/bbrc.1994.2225; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lynch AI, 2009, CURR HYPERTENS REP, V11, P35, DOI 10.1007/s11906-009-0008-7; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Parikh SM, 2008, NAT MED, V14, P810, DOI 10.1038/nm0808-810; Peleg A, 2013, EUR HEART J-ACUTE CA, V2, P159, DOI 10.1177/2048872613483588; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reis AM, 1997, J ENDOCRINOL, V153, P345, DOI 10.1677/joe.0.1530345; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Zhou Y, 2013, PLACENTA, V34, P89, DOI 10.1016/j.placenta.2012.11.016	51	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17909	17916		10.1074/jbc.M114.551424	http://dx.doi.org/10.1074/jbc.M114.551424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828501	Green Published, hybrid			2022-12-25	WOS:000338018100051
J	Spencer, B; Verma, I; Desplats, P; Morvinski, D; Rockenstein, E; Adame, A; Masliah, E				Spencer, Brian; Verma, Inder; Desplats, Paula; Morvinski, Dinorah; Rockenstein, Ed; Adame, Anthony; Masliah, Eliezer			A Neuroprotective Brain-penetrating Endopeptidase Fusion Protein Ameliorates Alzheimer Disease Pathology and Restores Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; DENSITY-LIPOPROTEIN RECEPTOR; NEPRILYSIN GENE-TRANSFER; APP TRANSGENIC MICE; A-BETA; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; NEUTRAL ENDOPEPTIDASE; PLAQUE-FORMATION; PREMATURE DEATH	Alzheimer disease (AD) is characterized by widespread neurodegeneration throughout the association cortex and limbic system, deposition of amyloid-beta peptide (A beta) in the neuropil and around the blood vessels, and formation of neurofibrillary tangles. The endopeptidase neprilysin has been successfully used to reduce the accumulation of A beta following intracranial viral vector delivery or ex vivo manipulated intracranial delivery. These therapies have relied on direct injections into the brain, whereas a clinically desirable therapy would involve i.v. infusion of a recombinant enzyme. We previously characterized a recombinant neprilysin that contained a 38-amino acid brain-targeting domain. Recombinant cell lines have been generated expressing this brain-targeted enzyme (ASN12). In this report, we characterize the ASN12 recombinant protein for pharmacology in a mouse as well as efficacy in two APPtg mouse models of AD. The recombinant ASN12 transited to the brain with a t(1/2) of 24 h and accumulated to 1.7% of injected dose at 24 h following i.v. delivery. We examined pharmacodynamics in the tg2576 APPtg mouse with the prion promoter APP695 SWE mutation and in the Line41 mThy1 APP751 mutation mouse. Treatment of either APPtg mouse resulted in reduced A beta, increased neuronal synapses, and improved learning and memory. In addition, the Line41 APPtg mice showed increased levels of C-terminal neuropeptide Y fragments and increased neurogenesis. These results suggest that the recombinant brain-targeted neprilysin, ASN12, may be an effective treatment for AD and warrant further investigation in clinical trials.	[Spencer, Brian] NeuroTransit Inc, San Diego, CA 92121 USA; [Verma, Inder; Morvinski, Dinorah] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Desplats, Paula; Rockenstein, Ed; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Spencer, B (corresponding author), NeuroTransit Inc, San Diego, CA 92121 USA.	spencer@neurotransit.com	Desplats, Paula/AFW-5030-2022	Lipton, Stuart/0000-0002-3490-1259; Desplats, Paula/0000-0002-4758-4280	National Institutes of Health [AG5131, AG022074, AG188440, AG010435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, P50AG005131, P01AG010435, R37AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG022074, AG188440, and AG010435. B. S. was the principal investigator at NeuroTransit, Inc., during the course of these studies. The pharmacokinetics and the pharmacodynamics in the APPtg2576 line were completed at NeuroTransit.	Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cuello AC, 2008, NEURODEGENER DIS, V5, P146, DOI 10.1159/000113686; Cuello AC, 2005, BRAIN PATHOL, V15, P66; Decressac M, 2011, HIPPOCAMPUS, V21, P233, DOI 10.1002/hipo.20765; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Fan QW, 2001, J AM AGING ASSOC, V24, P1, DOI 10.1007/s11357-001-0001-9; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Gerenu G, 2013, BBA-MOL BASIS DIS, V1832, P837, DOI 10.1016/j.bbadis.2013.02.018; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hong CS, 2006, GENE THER, V13, P1068, DOI 10.1038/sj.gt.3302719; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Li CW, 1996, ANN NY ACAD SCI, V780, P145, DOI 10.1111/j.1749-6632.1996.tb15118.x; Liu YX, 2007, PEPTIDES, V28, P2348, DOI 10.1016/j.peptides.2007.09.015; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Mandler M, 2012, J ALZHEIMERS DIS, V28, P783, DOI 10.3233/JAD-2011-111208; Marr RA, 2010, CURR ALZHEIMER RES, V7, P223, DOI 10.2174/156720510791050849; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Misra S, 2013, NEUROL SCI, V34, P831, DOI 10.1007/s10072-013-1316-x; Mordenti J, 1996, TOXICOL APPL PHARM, V136, P75, DOI 10.1006/taap.1996.0008; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Skidgel RA, 2004, PEPTIDES, V25, P521, DOI 10.1016/j.peptides.2003.12.010; Spencer B. J., 2007, P NATL ACAD SCI US; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; SRIVASTAVA RAK, 1995, J LIPID RES, V36, P1434; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Terry Robert D., 1994, P179; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; Zhou QH, 2012, DRUG METAB DISPOS, V40, P329, DOI 10.1124/dmd.111.042903	64	30	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17917	17931		10.1074/jbc.M114.557439	http://dx.doi.org/10.1074/jbc.M114.557439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24825898	hybrid, Green Published			2022-12-25	WOS:000338018100052
J	Kim, YJ; Cho, HJ; Shin, WC; Song, HA; Yoon, JH; Kim, CH				Kim, Yoon-Ju; Cho, Hyung-Ju; Shin, Woo-Chul; Song, Hyun-Ah; Yoon, Joo-Heon; Kim, Chang-Hoon			Hypoxia-Mediated Mechanism of MUC5AC Production in Human Nasal Epithelia and Its Implication in Rhinosinusitis	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; MUCIN GENE-EXPRESSION; GROWTH-FACTOR GENE; RETINOIC ACID; TRANSCRIPTIONAL ACTIVATION; CHRONIC SINUSITIS; FACTOR-1; CELLS; STIMULATION; PHENOTYPE	Background: Excessive mucus production is typical in various upper airway diseases. In sinusitis, the expression of MUC5AC, a major respiratory mucin gene, increases. However, the mechanisms leading to mucus hypersecretion in sinusitis have not been characterized. Hypoxia due to occlusion of the sinus ostium is one of the major pathologic mechanisms of sinusitis, but there have been no reports regarding the mechanism of hypoxia-induced mucus hypersecretion. Methods and Findings: This study aims to identify whether hypoxia may induce mucus hypersecretion and elucidate its mechanism. Normal human nasal epithelial (NHNE) cells and human lung mucoepidermoid carcinoma cell line (NCI-H292) were used. Sinus mucosa from patients was also tested. Anoxic condition was in an anaerobic chamber with a 95% N-2/5% CO2 atmosphere. The regulatory mechanism of MUC5AC by anoxia was investigated using RT-PCR, real-time PCR, western blot, ChIP, electrophoretic mobility shift, and luciferase assay. We show that levels of MUC5AC mRNA and the corresponding secreted protein increase in anoxic cultured NHNE cells. The major transcription factor for hypoxia-related signaling, HIF-1 alpha, is induced during hypoxia, and transfection of a mammalian expression vector encoding HIF-1 alpha results in increased MUC5AC mRNA levels under normoxic conditions. Moreover, hypoxia-induced expression of MUC5AC mRNA is down-regulated by transfected HIF-1 alpha siRNA. We found increased MUC5AC promoter activity under anoxic conditions, as indicated by a luciferase reporter assay, and mutation of the putative hypoxia-response element in MUC5AC promoter attenuated this activity. Binding of over-expressed HIF-1 alpha to the hypoxia-response element in the MUC5AC promoter was confirmed. In human sinusitis mucosa, which is supposed to be hypoxic, expression of MUC5AC and HIF-1 alpha is higher than in control mucosa. Conclusion: The results indicate that anoxia up-regulates MUC5AC by the HIF-1 alpha signaling pathway in human nasal epithelia and suggest that hypoxia might be a pathogenic mechanism of mucus hypersecretion in sinusitis.	[Cho, Hyung-Ju; Yoon, Joo-Heon; Kim, Chang-Hoon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Cho, Hyung-Ju; Yoon, Joo-Heon; Kim, Chang-Hoon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Kim, Yoon-Ju; Yoon, Joo-Heon] Yonsei Univ, Coll Med, BK Project Med Sci 21, Seoul, South Korea; [Kim, Yoon-Ju; Song, Hyun-Ah; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea; [Shin, Woo-Chul] Hana ENT Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, CH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	entman@yuhs.ac	Kim, Chang-Hoon/D-7205-2016; rchnds, rchnds/D-7595-2016; Yoon, Joo-Heon/E-5781-2016	Kim, Chang-Hoon/0000-0003-1238-6396; Yoon, Joo-Heon/0000-0003-2404-7156	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0008442, 2012R1A1A2042476, 2012-0000803]; Yonsei University College of Medicine [6-2011-0140]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Yonsei University College of Medicine(General Electric)	This research was supported by grants 2010-0008442 and 2012R1A1A2042476 to C. H. Kim, and 2012-0000803 to J.H. Yoon, from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology. This study was also supported by a faculty research grant from the Yonsei University College of Medicine for 2011 (6-2011-0140) to C. H. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenmyr L, 2011, CLIN PHYSIOL FUNCT I, V31, P435, DOI 10.1111/j.1475-097X.2011.01039.x; Ali MS, 2005, OTOLARYNG HEAD NECK, V133, P423, DOI 10.1016/j.otohns.2005.06.005; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; AUST R, 1974, ACTA OTO-LARYNGOL, V78, P264, DOI 10.3109/00016487409126354; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Ding GQ, 2007, AM J RHINOL, V21, P359, DOI 10.2500/ajr.2007.21.3037; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Georgy Mary S, 2012, Allergy Asthma Proc, V33 Suppl 1, P24, DOI 10.2500/aap.2012.33.3538; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Matsune S, 2003, ACTA OTO-LARYNGOL, V123, P519, DOI 10.1080/0036554021000028113; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Neruntarat C, 2003, OTOLARYNG HEAD NECK, V129, P353, DOI 10.1016/S0194-5998(03)00636-3; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Steinke JW, 2008, CURR OPIN ALLERGY CL, V8, P16, DOI 10.1097/ACI.0b013e3282f3f488; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu Li, 2002, Biological Procedures Online, V4, P1, DOI 10.1251/bpo28	32	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98136	10.1371/journal.pone.0098136	http://dx.doi.org/10.1371/journal.pone.0098136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840724	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600109
J	Parolini, C; Vik, R; Busnelli, M; Bjorndal, B; Holm, S; Brattelid, T; Manzini, S; Ganzetti, GS; Dellera, F; Halvorsen, B; Aukrust, P; Sirtori, CR; Nordrehaug, JE; Skorve, J; Berge, RK; Chiesa, G				Parolini, Cinzia; Vik, Rita; Busnelli, Marco; Bjorndal, Bodil; Holm, Sverre; Brattelid, Trond; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Halvorsen, Bente; Aukrust, Pal; Sirtori, Cesare R.; Nordrehaug, Jan E.; Skorve, Jon; Berge, Rolf K.; Chiesa, Giulia			A Salmon Protein Hydrolysate Exerts Lipid-Independent Anti-Atherosclerotic Activity in ApoE-Deficient Mice	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE ACTIVITY; N-3 FATTY-ACIDS; FISH-PROTEIN; CARDIOVASCULAR-DISEASE; TRANSGENIC MICE; HDL CHOLESTEROL; ADIPOSE-TISSUE; LIVER; PLASMA; INFLAMMATION	Fish consumption is considered health beneficial as it decreases cardiovascular disease (CVD)-risk through effects on plasma lipids and inflammation. We investigated a salmon protein hydrolysate (SPH) that is hypothesized to influence lipid metabolism and to have anti-atherosclerotic and anti-inflammatory properties. 24 female apolipoprotein (apo) E-/- mice were divided into two groups and fed a high-fat diet with or without 5% (w/w) SPH for 12 weeks. The atherosclerotic plaque area in aortic sinus and arch, plasma lipid profile, fatty acid composition, hepatic enzyme activities and gene expression were determined. A significantly reduced atherosclerotic plaque area in the aortic arch and aortic sinus was found in the 12 apoE(-/-) mice fed 5% SPH for 12 weeks compared to the 12 casein-fed control mice. Immunohistochemical characterization of atherosclerotic lesions in aortic sinus displayed no differences in plaque composition between mice fed SPH compared to controls. However, reduced mRNA level of Icam1 in the aortic arch was found. The plasma content of arachidonic acid (C20:4n-6) and oleic acid (C18:1n-9) were increased and decreased, respectively. SPH-feeding decreased the plasma concentration of IL-1 beta, IL-6, TNF-alpha and GM-CSF, whereas plasma cholesterol and triacylglycerols (TAG) were unchanged, accompanied by unchanged mitochondrial fatty acid oxidation and acyl-CoA: cholesterol acyltransferase (ACAT)-activity. These data show that a 5% (w/w) SPH diet reduces atherosclerosis in apoE(-/-) mice and attenuate risk factors related to atherosclerotic disorders by acting both at vascular and systemic levels, and not directly related to changes in plasma lipids or fatty acids.	[Parolini, Cinzia; Busnelli, Marco; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Sirtori, Cesare R.; Chiesa, Giulia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Vik, Rita; Bjorndal, Bodil; Skorve, Jon; Berge, Rolf K.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Holm, Sverre; Halvorsen, Bente; Aukrust, Pal] Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Brattelid, Trond] NIFES, Natl Inst Nutr & Seafood Res, Bergen, Norway; [Nordrehaug, Jan E.; Berge, Rolf K.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Milan; University of Bergen; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital	Parolini, C (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	cinzia.parolini@unimi.it; rita.vik@k2.uib.no	Busnelli, Marco/AAO-6981-2021; Parolini, Cinzia/G-8984-2012; Manzini, Stefano/H-7123-2014; Bjørndal, Bodil/H-6143-2017; Bjørndal, Bodil/HDN-4287-2022; Chiesa, Giulia/G-8987-2012	Busnelli, Marco/0000-0003-3245-2872; Parolini, Cinzia/0000-0002-5699-0918; Manzini, Stefano/0000-0002-1232-2635; Bjørndal, Bodil/0000-0001-9718-5117; Chiesa, Giulia/0000-0001-5553-1210; Holm, Sverre/0000-0003-1064-3926	NordForsk [070010]; Research Council of Norway [190287/110]; European Community [201668]	NordForsk; Research Council of Norway(Research Council of Norway); European Community(European Commission)	This work was supported by grants from NordForsk, grant no. 070010, MitoHealth; the Research Council of Norway, grant no. 190287/110; and the European Community's Seventh Framework Programme (FP7/2007-2013) AtheroRemo, grant no. 201668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Bjorndal B, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-143; Bjorndal B, 2012, METABOLISM, V61, P1461, DOI 10.1016/j.metabol.2012.03.012; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Chalamaiah M, 2012, FOOD CHEM, V135, P3020, DOI 10.1016/j.foodchem.2012.06.100; Chen W, 2004, LIFE SCI, V74, P1889, DOI 10.1016/j.lfs.2003.08.041; Cinq-Mars CD, 2008, J AGR FOOD CHEM, V56, P410, DOI 10.1021/jf072277p; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; DEMBINSKAKIEC A, 1986, WIEN KLIN WOCHENSCHR, V98, P198; Duarte J, 2006, IMMUNOBIOLOGY, V211, P341, DOI 10.1016/j.imbio.2005.12.002; Elvevoll EO, 2008, ATHEROSCLEROSIS, V200, P396, DOI 10.1016/j.atherosclerosis.2007.12.021; FIELD FJ, 1991, LIPIDS, V26, P1; Grimstad T, 2012, J NUTR SCI, V1, P1; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Harnedy PA, 2012, J FUNCT FOODS, V4, P6, DOI 10.1016/j.jff.2011.09.001; JACQUES H, 1995, CAN J CARDIOL, V11, pG63; Jung UJ, 2008, AM J CLIN NUTR, V87, p2003S, DOI 10.1093/ajcn/87.6.2003S; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kleemann R., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P441, DOI 10.2174/156800605774962077; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Murakami S, 1998, LIFE SCI, V64, P83, DOI 10.1016/S0024-3205(98)00536-0; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; Raatz SK, 2013, NUTRIENTS, V5, P1081, DOI 10.3390/nu5041081; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; SABESIN SM, 1981, CIRCULATION, V64, P72; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; SKORVE J, 1993, J LIPID RES, V34, P1177; Strand E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-82; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Vigerust NF, 2013, EUR J NUTR, V52, P1315, DOI 10.1007/s00394-012-0441-2; Wergedahl H, 2004, J NUTR, V134, P1320, DOI 10.1093/jn/134.6.1320; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; ZHANG XZ, 1993, BRIT J NUTR, V69, P767, DOI 10.1079/BJN19930077; Zhu CF, 2010, APPL PHYSIOL NUTR ME, V35, P797, DOI 10.1139/H10-075	39	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97598	10.1371/journal.pone.0097598	http://dx.doi.org/10.1371/journal.pone.0097598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840793	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600049
J	Canning, KL; Brown, RE; Jamnik, VK; Salmon, A; Ardern, CI; Kuk, JL				Canning, Karissa L.; Brown, Ruth E.; Jamnik, Veronica K.; Salmon, Art; Ardern, Chris I.; Kuk, Jennifer L.			Individuals Underestimate Moderate and Vigorous Intensity Physical Activity	PLOS ONE			English	Article							MAXIMAL HEART-RATE; HEALTH; INACTIVITY; AGE	Background: It is unclear whether the common physical activity (PA) intensity descriptors used in PA guidelines worldwide align with the associated percent heart rate maximum method used for prescribing relative PA intensities consistently between sexes, ethnicities, age categories and across body mass index (BMI) classifications. Objectives: The objectives of this study were to determine whether individuals properly select light, moderate and vigorous intensity PA using the intensity descriptions in PA guidelines and determine if there are differences in estimation across sex, ethnicity, age and BMI classifications. Methods: 129 adults were instructed to walk/jog at a "light,'' "moderate'' and "vigorous effort'' in a randomized order. The PA intensities were categorized as being below, at or above the following %HRmax ranges of: 50-63% for light, 64-76% for moderate and 77-93% for vigorous effort. Results: On average, people correctly estimated light effort as 51.5 +/- 8.3%HRmax but underestimated moderate effort as 58.7 +/- 10.7%HRmax and vigorous effort as 69.9 +/- 11.9%HRmax. Participants walked at a light intensity (57.4 +/- 10.5%HRmax) when asked to walk at a pace that provided health benefits, wherein 52% of participants walked at a light effort pace, 19% walked at a moderate effort and 5% walked at a vigorous effort pace. These results did not differ by sex, ethnicity or BMI class. However, younger adults underestimated moderate and vigorous intensity more so than middle-aged adults (P<0.05). Conclusion: When the common PA guideline descriptors were aligned with the associated %HRmax ranges, the majority of participants underestimated the intensity of PA that is needed to obtain health benefits. Thus, new subjective descriptions for moderate and vigorous intensity may be warranted to aid individuals in correctly interpreting PA intensities.	[Canning, Karissa L.; Brown, Ruth E.; Jamnik, Veronica K.; Ardern, Chris I.; Kuk, Jennifer L.] York Univ, Sch Kinesiol, Toronto, ON M3J 2R7, Canada; [Salmon, Art] Ontario Minist Tourism Culture & Sport, Toronto, ON, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol, Toronto, ON M3J 2R7, Canada.	jennkuk@yorku.ca			Heart and Stroke Foundation; Faculty of Health, York University, Canada	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Faculty of Health, York University, Canada	This study was supported in part by a research grant to JL Kuk from the Heart and Stroke Foundation and from the Faculty of Health, York University, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Australian Government Department of Health, 2013, AUSTR PHYS ACT SED B; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Braham R, 2012, J SCI MED SPORT, V15, P322, DOI 10.1016/j.jsams.2011.11.252; Canadian Society for Exercise Physiology, 2011, CAN PHYS ACT GUID; Colley Rachel C, 2011, Health Rep, V22, P7; Engels HJ, 1998, RES Q EXERCISE SPORT, V69, P94, DOI 10.1080/02701367.1998.10607673; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Health Canada, 1998, CAN PHYS ACT HLTH AC; Jamnik VK, 2011, APPL PHYSIOL NUTR ME, V36, pS3, DOI [10.1139/h11-044, 10.1139/H11-044]; Kesaniemi A, 2001, MED SCI SPORTS EXERC, pS351; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Macfarlane D, 2010, PUBLIC HEALTH NUTR, V14, P1; National Center for Disease Control and Prevention, 2011, MUCH PHYS ACT AD NEE; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Public Health Agency of Canada, 2007, BEN PHYS ACT; Public Health Agency of Canada, 2011, PHYS ACT GUID; Ready AE, 2009, APPL PHYSIOL NUTR ME, V34, P172, DOI 10.1139/H08-143; Spackman M. B., 2001, Measurement in Physical Education and Exercise Science, V5, P1, DOI 10.1207/S15327841MPEE0501_1; SPELMAN CC, 1993, MED SCI SPORT EXER, V25, P1174; US Department of Human and Health Services, 2008, PHYS ACT GUID AM; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHALEY MH, 1992, MED SCI SPORT EXER, V24, P1173; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WILMORE J, 2004, PHYSL SPORT EXERCISE; World Health Organization, 2012, PHYS IN GLOB PUBL HL	27	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97927	10.1371/journal.pone.0097927	http://dx.doi.org/10.1371/journal.pone.0097927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835105	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800084
J	Pai, VJ; Wang, B; Li, XY; Wu, L; Kang, JX				Pai, Victor J.; Wang, Bin; Li, Xiangyong; Wu, Lin; Kang, Jing X.			Transgenic Mice Convert Carbohydrates to Essential Fatty Acids	PLOS ONE			English	Article							OMEGA-3; RATIO	Transgenic mice (named "Omega mice'') were engineered to carry both optimized fat-1 and fat-2 genes from the roundworm Caenorhabditis elegans and are capable of producing essential omega-6 and omega-3 fatty acids from saturated fats or carbohydrates. When maintained on a high-saturated fat diet lacking essential fatty acids or a high-carbohydrate, no-fat diet, the Omega mice exhibit high tissue levels of both omega-6 and omega-3 fatty acids, with a ratio of similar to 1:1. This study thus presents an innovative technology for the production of both omega-6 and omega-3 essential fatty acids, as well as a new animal model for understanding the true impact of fat on human health.	[Pai, Victor J.; Wang, Bin; Li, Xiangyong; Kang, Jing X.] Massachusetts Gen Hosp, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Pai, Victor J.; Wang, Bin; Li, Xiangyong; Wu, Lin; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Lin] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Kang, JX (corresponding author), Massachusetts Gen Hosp, Lab Lipid Med & Technol, Boston, MA 02114 USA.	kang.jing@mgh.harvard.edu		Pai, Victor/0000-0001-9710-7821	Fortune Education Foundation; Sansun Life Sciences	Fortune Education Foundation; Sansun Life Sciences	This study was supported by funding from the Fortune Education Foundation and Sansun Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB, P335; Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER, V916, P81; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2007, NAT BIOTECHNOL, V25, P505, DOI 10.1038/nbt0507-505; Kang JX, 2011, WORLD REV NUTR DIET, V102, P22, DOI 10.1159/000327787; Kang JX, 2011, BIOTECHNOL ADV, V29, P388, DOI 10.1016/j.biotechadv.2011.02.003; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; LEAF A, 1987, AM J CLIN NUTR, V45, P1048, DOI 10.1093/ajcn/45.5.1048; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; VOLPE JJ, 1976, PHYSIOL REV, V56, P339, DOI 10.1152/physrev.1976.56.2.339; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	18	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97637	10.1371/journal.pone.0097637	http://dx.doi.org/10.1371/journal.pone.0097637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836606	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800058
J	Wang, X; Fu, YF; Wang, RY; Li, L; Cao, YH; Chen, YQ; Zhao, HZ; Zhang, QQ; Wu, JQ; Weng, XH; Cheng, XJ; Zhu, LP				Wang, Xuan; Fu, Yong-Feng; Wang, Rui-Ying; Li, Li; Cao, Ya-Hui; Chen, Yan-Qiong; Zhao, Hua-Zhen; Zhang, Qiang-Qiang; Wu, Ji-Qin; Weng, Xin-Hua; Cheng, Xun-Jia; Zhu, Li-Ping			Identification of Clinically Relevant Fungi and Prototheca Species by rRNA Gene Sequencing and Multilocus PCR Coupled with Electrospray Ionization Mass Spectrometry	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MEDICALLY IMPORTANT YEASTS; BLOOD-STREAM INFECTIONS; RAPID IDENTIFICATION; BASIDIOMYCETOUS YEASTS; ASCOMYCETOUS YEASTS; DNA; ASPERGILLUS; REGION; MOLDS	Background: Multilocus PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) is a new strategy for pathogen identification, but information about its application in fungal identification remains sparse. Methods: One-hundred and twelve strains and isolates of clinically important fungi and Prototheca species were subjected to both rRNA gene sequencing and PCR/ESI-MS. Three regions of the rRNA gene were used as targets for sequencing: the 5' end of the large subunit rRNA gene (D1/D2 region), and the internal transcribed spacers 1 and 2 (ITS1 and ITS2 regions). Microbial identification (Micro ID), acquired by combining results of phenotypic methods and rRNA gene sequencing, was used to evaluate the results of PCR/ESI-MS. Results: For identification of yeasts and filamentous fungi, combined sequencing of the three regions had the best performance (species-level identification rate of 93.8% and 81.8% respectively). The highest species-level identification rate was achieved by sequencing of D1/D2 for yeasts (92.2%) and ITS2 for filamentous fungi (75.8%). The two Prototheca species could be identified to species level by D1/D2 sequencing but not by ITS1 or ITS2. For the 102 strains and isolates within the coverage of PCR/ESI-MS identification, 87.3% (89/102) achieved species-level identification, 100% (89/89) of which were concordant to Micro ID on species/complex level. The species-level identification rates for yeasts and filamentous fungi were 93.9% (62/66) and 75% (27/36) respectively. Conclusions: rRNA gene sequencing provides accurate identification information, with the best results obtained by a combination of ITS1, ITS2 and D1/D2 sequencing. Our preliminary data indicated that PCR/ESI-MS method also provides a rapid and accurate identification for many clinical relevant fungi.	[Wang, Xuan; Wang, Rui-Ying; Cao, Ya-Hui; Chen, Yan-Qiong; Zhao, Hua-Zhen; Wu, Ji-Qin; Weng, Xin-Hua; Zhu, Li-Ping] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Fu, Yong-Feng; Cheng, Xun-Jia] Fudan Univ, Shanghai Med Coll, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China; [Li, Li; Zhang, Qiang-Qiang] Fudan Univ, Huashan Hosp, Dept Dermatol, Mycol Lab, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Cheng, XJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China.	xjcheng@shmu.edu.cn; zhulp@fudan.edu.cn	付, 永鋒/Q-2449-2019	付, 永鋒/0000-0002-9867-9722; Wang, Ruiying/0000-0002-3638-4582	Chinese Major Infectious Disease Fund [2013ZX10004612]	Chinese Major Infectious Disease Fund	This work was supported by the Chinese Major Infectious Disease Fund (grant number: 2013ZX10004612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balajee SA, 2007, STUD MYCOL, P39, DOI 10.3114/sim.2007.59.05; Balajee SA, 2009, J CLIN MICROBIOL, V47, P877, DOI 10.1128/JCM.01685-08; Balajee SA, 2007, MED MYCOL, V45, P475, DOI 10.1080/13693780701449425; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Caston-Osorio JJ, 2008, INT J ANTIMICROB AG, V32, pS103, DOI 10.1016/S0924-8579(08)70009-8; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Chen YC, 2000, J CLIN MICROBIOL, V38, P2302; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Ciardo DE, 2007, DIAGN MICR INFEC DIS, V59, P49, DOI 10.1016/j.diagmicrobio.2007.04.020; Ciardo DE, 2010, J CLIN MICROBIOL, V48, P2809, DOI 10.1128/JCM.00289-10; Cuenca-Estrella M, 2008, INT J ANTIMICROB AG, V32, pS143, DOI 10.1016/S0924-8579(08)70016-5; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Carolis E, 2012, CLIN MICROBIOL INFEC, V18, P475, DOI 10.1111/j.1469-0691.2011.03599.x; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Eberhardt Ursula, 2012, Methods Mol Biol, V858, P183, DOI 10.1007/978-1-61779-591-6_9; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gu ZM, 2012, MED MYCOL, V50, P259, DOI 10.3109/13693786.2011.600341; Juhasz A, 2007, ANTON LEEUW INT J G, V91, P209, DOI 10.1007/s10482-006-9110-x; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09; Kriengkauykiat Jane, 2011, Clin Epidemiol, V3, P175, DOI 10.2147/CLEP.S12502; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Massire C, 2013, J CLIN MICROBIOL, V51, P959, DOI 10.1128/JCM.02621-12; McTaggart L, 2011, J CLIN MICROBIOL, V49, P2522, DOI 10.1128/JCM.00502-11; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shendure JA, 2011, CURR PROTOC MOL BIOL, V81, P711; Shin JH, 2013, J CLIN MICROBIOL, V51, P136, DOI 10.1128/JCM.01907-12; Simner PJ, 2013, J CLIN MICROBIOL, V51, P1699, DOI 10.1128/JCM.03282-12; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Verweij PE, 1999, J CLIN PATHOL, V52, P271, DOI 10.1136/jcp.52.4.271; Wolk DM, 2009, J CLIN MICROBIOL, V47, P3129, DOI 10.1128/JCM.00709-09	42	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98110	10.1371/journal.pone.0098110	http://dx.doi.org/10.1371/journal.pone.0098110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835205	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800105
J	Obermayer, A; Stoiber, W; Krautgartner, WD; Klappacher, M; Kofler, B; Steinbacher, P; Vitkov, L; Grabcanovic-Musija, F; Studnicka, M				Obermayer, Astrid; Stoiber, Walter; Krautgartner, Wolf-Dietrich; Klappacher, Michaela; Kofler, Barbara; Steinbacher, Peter; Vitkov, Ljubomir; Grabcanovic-Musija, Fikreta; Studnicka, Michael			New Aspects on the Structure of Neutrophil Extracellular Traps from Chronic Obstructive Pulmonary Disease and In Vitro Generation	PLOS ONE			English	Article							ELASTASE; IMMUNITY; INFILTRATION; INFLAMMATION; CHROMATIN; BACTERIA; NETOSIS; SMOKE; DNA	Polymorphonuclear neutrophils have in recent years attracted new attention due to their ability to release neutrophil extracellular traps (NETs). These web-like extracellular structures deriving from nuclear chromatin have been depicted in ambiguous roles between antimicrobial defence and host tissue damage. NETs consist of DNA strands of varying thickness and are decorated with microbicidal and cytotoxic proteins. Their principal structure has in recent years been characterised at molecular and ultrastructural levels but many features that are of direct relevance to cytotoxicity are still incompletely understood. These include the extent of chromatin decondensation during NET formation and the relative amounts and spatial distribution of the microbicidal components within the NET. In the present work, we analyse the structure of NETs found in induced sputum of patients with acutely exacerbated chronic obstructive pulmonary disease (COPD) using confocal laser microscopy and electron microscopy. In vitro induced NETs from human neutrophils serve for purposes of comparison and extended analysis of NET structure. Results demonstrate that COPD sputa are characterised by the pronounced presence of NETs and NETotic neutrophils. We provide new evidence that chromatin decondensation during NETosis is most extensive and generates substantial amounts of double-helix DNA in 'beads-on-a-string' conformation. New information is also presented on the abundance and location of neutrophil elastase (NE) and citrullinated histone H3 (citH3). NE occurs in high densities in nearly all non-fibrous constituents of the NETs while citH3 is much less abundant. We conclude from the results that (i) NETosis is an integral part of COPD pathology; this is relevant to all future research on the etiology and therapy of the disease; and that (ii) release of 'beads-on-a-string' DNA studded with non-citrullinated histones is a common feature of in vivo NETosis; this is of relevance to both the antimicrobial and the cytotoxic effects of NETs.	[Obermayer, Astrid; Stoiber, Walter; Krautgartner, Wolf-Dietrich; Klappacher, Michaela; Steinbacher, Peter; Vitkov, Ljubomir] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Vitkov, Ljubomir] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Grabcanovic-Musija, Fikreta; Studnicka, Michael] Paracelsus Med Univ, Univ Clin Pneumol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Saarland University; Paracelsus Private Medical University	Obermayer, A (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	astrid.obermayer@sbg.ac.at	Vitkov, Ljubomir/H-5873-2019	Vitkov, Ljubomir/0000-0002-1249-0161; Steinbacher, Peter/0000-0001-8033-5190; Kofler, Barbara/0000-0002-1198-4776	Austrian Research Promotion Agency (FFG) [822782/THERAPEP]	Austrian Research Promotion Agency (FFG)	Parts of the study were supported by the Austrian Research Promotion Agency (FFG, 822782/THERAPEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arazna M, 2013, RESP PHYSIOL NEUROBI, V187, P74, DOI 10.1016/j.resp.2013.03.002; Baraldo S, 2004, THORAX, V59, P308, DOI 10.1136/thx.2003.012146; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Bock CT, 2007, PROTEINS, P105; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Daban JR, 2011, MICRON, V42, P733, DOI 10.1016/j.micron.2011.05.002; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Marcos V, 2009, BLOOD, V114, P4908, DOI 10.1182/blood-2009-09-242388; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Mehrzad J., 2012, RECENT ADV IMMUNOLOG, P383; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Ohbayashi Ohji, 2011, Nihon Rinsho, V69, P1741; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Pratesi F., 2013, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2012-202765; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Radic M, 2013, SEMIN IMMUNOPATHOL, V35, P465, DOI 10.1007/s00281-013-0376-6; Rattner JB, 1981, ELECT MICROSCOPY BIO, P31; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sandhaus RA, 2013, COPD, V10, P60, DOI 10.3109/15412555.2013.764403; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Ungurs MJ, 2014, AM J PHYSIOL-LUNG C, V306, pL80, DOI 10.1152/ajplung.00221.2013; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Weier HUG, 2001, J HISTOCHEM CYTOCHEM, V49, P939, DOI 10.1177/002215540104900802; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Zhang XJ, 2011, CYTOKINE, V56, P717, DOI 10.1016/j.cyto.2011.09.010	48	57	63	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97784	10.1371/journal.pone.0097784	http://dx.doi.org/10.1371/journal.pone.0097784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831032	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500116
J	Ren, T; Wang, JG; Chen, Q; Zhang, FS; Lu, SC				Ren, Tao; Wang, Jingguo; Chen, Qing; Zhang, Fusuo; Lu, Shuchang			The Effects of Manure and Nitrogen Fertilizer Applications on Soil Organic Carbon and Nitrogen in a High-Input Cropping System	PLOS ONE			English	Article							VEGETABLE PRODUCTION; MATTER FRACTIONS; WATER-USE; MANAGEMENT; MINERALIZATION; DYNAMICS; EMISSIONS; GRASSLAND; QUALITY; YIELD	With the goal of improving N fertilizer management to maximize soil organic carbon (SOC) storage and minimize N losses in high-intensity cropping system, a 6-years greenhouse vegetable experiment was conducted from 2004 to 2010 in Shouguang, northern China. Treatment tested the effects of organic manure and N fertilizer on SOC, total N (TN) pool and annual apparent N losses. The results demonstrated that SOC and TN concentrations in the 0-10cm soil layer decreased significantly without organic manure and mineral N applications, primarily because of the decomposition of stable C. Increasing C inputs through wheat straw and chicken manure incorporation couldn't increase SOC pools over the 4 year duration of the experiment. In contrast to the organic manure treatment, the SOC and TN pools were not increased with the combination of organic manure and N fertilizer. However, the soil labile carbon fractions increased significantly when both chicken manure and N fertilizer were applied together. Additionally, lower optimized N fertilizer inputs did not decrease SOC and TN accumulation compared with conventional N applications. Despite the annual apparent N losses for the optimized N treatment were significantly lower than that for the conventional N treatment, the unchanged SOC over the past 6 years might limit N storage in the soil and more surplus N were lost to the environment. Consequently, optimized N fertilizer inputs according to root-zone N management did not influence the accumulation of SOC and TN in soil; but beneficial in reducing apparent N losses. N fertilizer management in a greenhouse cropping system should not only identify how to reduce N fertilizer input but should also be more attentive to improving soil fertility with better management of organic manure.	[Ren, Tao; Wang, Jingguo; Chen, Qing; Zhang, Fusuo] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Ren, Tao] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Lu, Shuchang] Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China	China Agricultural University; Huazhong Agricultural University; Tianjin Agricultural University	Chen, Q (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	qchen@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021; Ren, Tao/P-1434-2014	Ren, Tao/0000-0003-1986-7985; Ren, Tao/0000-0002-7147-3775	National Natural Science Foundation of China [31071858]; Innovative Research Team of Beijing Fruit Vegetable Industry; NSFC [30821003]; Basic Application and Cutting-edge Technology Research Projects of Tianjin City [09JCYBJC08600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Beijing Fruit Vegetable Industry; NSFC(National Natural Science Foundation of China (NSFC)); Basic Application and Cutting-edge Technology Research Projects of Tianjin City	The authors are grateful to the National Natural Science Foundation of China (No. 31071858), Innovative Research Team of Beijing Fruit Vegetable Industry, the innovative group grant of NSFC (No. 30821003) and Basic Application and Cutting-edge Technology Research Projects of Tianjin City (09JCYBJC08600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoe F, 2004, SOIL BIOL BIOCHEM, V36, P2075, DOI 10.1016/j.soilbio.2004.06.006; Adani F, 2007, WASTE MANAGE, V27, P319, DOI 10.1016/j.wasman.2006.04.004; AJWA HA, 1994, BIOL FERT SOILS, V18, P175, DOI 10.1007/BF00647664; [Anonymous], AGR WATER MANAGE, V96, P23; Antil RS, 2005, J PLANT NUTR SOIL SC, V168, P108, DOI 10.1002/jpln.200421461; Bird JA, 2002, SOIL SCI SOC AM J, V66, P478, DOI 10.2136/sssaj2002.0478; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Blair N, 2006, SOIL TILL RES, V91, P30, DOI 10.1016/j.still.2005.11.002; Cayuela ML, 2010, GEODERMA, V157, P235, DOI 10.1016/j.geoderma.2010.04.026; Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Christopher SF, 2007, CRIT REV PLANT SCI, V26, P45, DOI 10.1080/07352680601174830; Compton JE, 2002, SOIL BIOL BIOCHEM, V34, P933, DOI 10.1016/S0038-0717(02)00025-1; Constantin J, 2010, AGR ECOSYST ENVIRON, V135, P268, DOI 10.1016/j.agee.2009.10.005; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; Feller C, 2002, ACTA HORTIC, P195, DOI 10.17660/ActaHortic.2002.571.23; Fonte SJ, 2009, SOIL SCI SOC AM J, V73, P961, DOI 10.2136/sssaj2008.0204; Ge XiaoGuang, 2004, Acta Horticulturae Sinica, V31, P34; Gundersen P, 1998, ENVIRON POLLUT, V102, P403, DOI 10.1016/S0269-7491(98)80060-2; Guo RY, 2008, PLANT SOIL, V313, P55, DOI 10.1007/s11104-008-9679-0; Hagedorn F, 2003, SOIL BIOL BIOCHEM, V35, P1683, DOI 10.1016/j.soilbio.2003.08.015; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; He FF, 2009, ENVIRON POLLUT, V157, P1666, DOI 10.1016/j.envpol.2008.12.017; Jagadamma S, 2007, SOIL TILL RES, V95, P348, DOI 10.1016/j.still.2007.02.006; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Lei BK, 2010, SOIL SCI SOC AM J, V74, P1320, DOI 10.2136/sssaj2009.0222; [雷宝坤 LEI Baokun], 2008, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V14, P914; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; Li ZP, 2010, SOIL TILL RES, V106, P268, DOI 10.1016/j.still.2009.12.008; Lin Y, 2010, THESIS CHINA AGR U B; Liu J, 2012, J PLANT NUTR SOIL SC, V175, P698, DOI 10.1002/jpln.201100172; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Mao XS, 2003, AGR WATER MANAGE, V61, P219, DOI 10.1016/S0378-3774(03)00022-2; McLauchlan KK, 2004, SOIL SCI SOC AM J, V68, P1616, DOI 10.2136/sssaj2004.1616; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oborn I, 2003, EUR J AGRON, V20, P211, DOI 10.1016/S1161-0301(03)00080-7; Pare MC, 2013, GLOBAL CHANGE BIOL, V19, P1126, DOI 10.1111/gcb.12125; Piccolo A, 2004, CLIMATIC CHANGE, V67, P329, DOI 10.1007/s10584-004-1822-1; Plaza C, 2005, AGROCHIMICA, V49, P87; Ren T, 2010, SCI HORTIC-AMSTERDAM, V125, P25, DOI 10.1016/j.scienta.2010.02.014; RYDEN JC, 1980, SOIL SCI SOC AM J, V44, P505, DOI 10.2136/sssaj1980.03615995004400030013x; SCHIMEL DS, 1986, BIOGEOCHEMISTRY, V2, P345, DOI 10.1007/BF02180325; Sieling K, 2006, AGR ECOSYST ENVIRON, V115, P261, DOI 10.1016/j.agee.2006.01.011; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Song XZ, 2009, CR BIOL, V332, P385, DOI 10.1016/j.crvi.2008.11.005; Swanston C, 2004, BIOGEOCHEMISTRY, V70, P227, DOI 10.1023/B:BIOG.0000049341.37579.86; Wang Xiao-juan, 2012, Yingyong Shengtai Xuebao, V23, P159; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; [曾希柏 ZENG Xi-Bai], 2009, [生态学报, Acta Ecologica Sinica], V29, P3737; Zhao XC, 2011, THESIS CHINA AGR U B; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	59	50	51	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97732	10.1371/journal.pone.0097732	http://dx.doi.org/10.1371/journal.pone.0097732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830463	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500109
J	Asaoka, Y; Hata, S; Namae, M; Furutani-Seiki, M; Nishina, H				Asaoka, Yoichi; Hata, Shoji; Namae, Misako; Furutani-Seiki, Makoto; Nishina, Hiroshi			The Hippo Pathway Controls a Switch between Retinal Progenitor Cell Proliferation and Photoreceptor Cell Differentiation in Zebrafish	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; WW DOMAIN; SIGNALING PATHWAY; TRANSCRIPTIONAL ACTIVATOR; NEURONAL DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; NEGATIVE REGULATION; FATE DETERMINATION; MAMMALIAN RETINA; SELF-RENEWAL	The precise regulation of numbers and types of neurons through control of cell cycle exit and terminal differentiation is an essential aspect of neurogenesis. The Hippo signaling pathway has recently been identified as playing a crucial role in promoting cell cycle exit and terminal differentiation in multiple types of stem cells, including in retinal progenitor cells. When Hippo signaling is activated, the core Mst1/2 kinases activate the Lats1/2 kinases, which in turn phosphorylate and inhibit the transcriptional cofactor Yap. During mouse retinogenesis, overexpression of Yap prolongs progenitor cell proliferation, whereas inhibition of Yap decreases this proliferation and promotes retinal cell differentiation. However, to date, it remains unknown how the Hippo pathway affects the differentiation of distinct neuronal cell types such as photoreceptor cells. In this study, we investigated whether Hippo signaling regulates retinogenesis during early zebrafish development. Knockdown of zebrafish mst2 induced early embryonic defects, including altered retinal pigmentation and morphogenesis. Similar abnormal retinal phenotypes were observed in zebrafish embryos injected with a constitutively active form of yap [(yap (5SA)]. Loss of Yap's TEAD-binding domain, two WW domains, or transcription activation domain attenuated the retinal abnormalities induced by yap (5SA), indicating that all of these domains contribute to normal retinal development. Remarkably, yap (5SA)-expressing zebrafish embryos displayed decreased expression of transcription factors such as otx5 and crx, which orchestrate photoreceptor cell differentiation by activating the expression of rhodopsin and other photoreceptor cell genes. Co-immunoprecipitation experiments revealed that Rx1 is a novel interacting partner of Yap that regulates photoreceptor cell differentiation. Our results suggest that Yap suppresses the differentiation of photoreceptor cells from retinal progenitor cells by repressing Rx1-mediated transactivation of photoreceptor cell genes during zebrafish retinogenesis.	[Asaoka, Yoichi; Hata, Shoji; Namae, Misako; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Tokyo Medical & Dental University (TMDU); University of Bath	Asaoka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan.	y-asaoka.dbio@mri.tmd.ac.jp; nishina.dbio@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [25460358, 26114005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, and a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Dowling JE, 2012, RETINA APPROACHABLE, Vxvi; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hata S, 2012, J BIOL CHEM, V287, P22089, DOI 10.1074/jbc.M111.334714; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hu JY, 2013, INT J BIOL SCI, V9, P267, DOI 10.7150/ijbs.4887; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nejigane S, 2013, INT J DEV BIOL, V57, P407, DOI 10.1387/ijdb.130010st; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pan Y, 2010, DEV BIOL, V339, P494, DOI 10.1016/j.ydbio.2009.12.032; Pellissier LP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003976; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Shimomura T, 2014, BIOCHEM BIOPH RES CO, V443, P917, DOI 10.1016/j.bbrc.2013.12.100; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Whitaker SL, 2004, J BIOL CHEM, V279, P49010, DOI 10.1074/jbc.M406080200; Xiang MQ, 2013, CELL MOL LIFE SCI, V70, P2519, DOI 10.1007/s00018-012-1183-2; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	55	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97365	10.1371/journal.pone.0097365	http://dx.doi.org/10.1371/journal.pone.0097365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828882	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400085
J	Fehrholz, M; Speer, CP; Kunzmann, S				Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen			Caffeine and Rolipram Affect Smad Signalling and TGF-beta 1 Stimulated CTGF and Transgelin Expression in Lung Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHODIESTERASE-4 INHIBITION; ANTENATAL INFLAMMATION; PULMONARY INFLAMMATION; GENE-EXPRESSION; HYPEROXIA; PROTEIN; INJURY; MICE; ALVEOLARIZATION	Caffeine administration is an important part of the therapeutic treatment of bronchopulmonary dysplasia (BPD) in preterm infants. However, caffeine mediated effects on airway remodelling are still undefined. The TGF-beta/Smad signalling pathway is one of the key pathways involved in airway remodelling. Connective tissue growth factor (CTGF), a downstream mediator of TGF-beta, and transgelin, a binding and stabilising protein of the cytoskeleton, are both regulated by TGF-beta 1 and play an important role in airway remodelling. Both have also been implicated in the pathogenesis of BPD. The aim of the present study was to clarify whether caffeine, an unspecific phosphodiesterase (PDE) inhibitor, and rolipram, a prototypical PDE-4 selective inhibitor, were both able to affect TGF-beta 1-induced Smad signalling and CTGF/transgelin expression in lung epithelial cells. Furthermore, the effect of transgelin knock-down on Smad signalling was studied. The pharmacological effect of caffeine and rolipram on Smad signalling was investigated by means of a luciferase assay via transfection of a TGF-beta 1-inducible reporter plasmid in A549 cells. The regulation of CTGF and transgelin expression by caffeine and rolipram were studied by promoter analysis, real-time PCR and Western blot. Endogenous transgelin expression was down-regulated by lentiviral transduction mediating transgelin-specific shRNA expression. The addition of caffeine and rolipram inhibited TGF-beta 1 induced reporter gene activity in a concentration-related manner. They also antagonized the TGF-beta 1 induced up-regulation of CTGF and transgelin on the promoter-, the mRNA-, and the protein-level. Functional analysis showed that transgelin silencing reduced TGF-beta 1 induced Smad-signalling and CTGF induction in lung epithelial cells. The present study highlights possible new molecular mechanisms of caffeine and rolipram including an inhibition of Smad signalling and of TGF-beta 1 regulated genes involved in airway remodelling. An understanding of these mechanisms might help to explain the protective effects of caffeine in prevention of BPD and suggests rolipram to be a potent replacement for caffeine.	[Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Kunzmann, S (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	kunzmann_s@ukw.de						Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Alapati D, 2011, AM J RESP CELL MOL, V45, P1169, DOI 10.1165/rcmb.2011-0023OC; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Assinder S, 2011, MED HYPOTHESES, V76, P802, DOI 10.1016/j.mehy.2011.02.021; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR; Barnes Peter J, 2004, Discov Med, V4, P421; Barnes PJ, 2004, NAT REV DRUG DISCOV, V3, P831, DOI 10.1038/nrd1524; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Burgess JK, 2006, J ALLERGY CLIN IMMUN, V118, P649, DOI 10.1016/j.jaci.2006.05.019; Chen SY, 2011, AM J PHYSIOL-LUNG C, V300, pL330, DOI 10.1152/ajplung.00270.2010; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Collins JJP, 2013, AM J PHYSIOL-LUNG C, V304, pL438, DOI 10.1152/ajplung.00251.2012; Leon AEC, 2007, AM J PERINAT, V24, P39, DOI 10.1055/s-2006-958163; de Visser YP, 2008, EUR RESPIR J, V31, P633, DOI 10.1183/09031936.00071307; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, pL56, DOI 10.1152/ajplung.00041.2011; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dent G, 1998, PULM PHARMACOL THER, V11, P47, DOI 10.1006/pupt.1998.0115; Fehrholz M, 2014, AM J PHYSIOL-LUNG C, V306, pL101, DOI 10.1152/ajplung.00257.2013; Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Homer L, 2012, J PHARMACOL EXP THER, V340, P620, DOI 10.1124/jpet.111.179085; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; HOWELL RE, 1995, J PHARMACOL EXP THER, V275, P703; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kunzmann S, 2007, AM J PHYSIOL-LUNG C, V292, pL223, DOI 10.1152/ajplung.00159.2006; Kunzmann S, 2013, AM J OBSTET GYNECOL, V208, P429, DOI 10.1016/j.ajog.2013.01.008; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Kuss H, 2003, J PHARMACOL EXP THER, V307, P373, DOI 10.1124/jpet.103.053942; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; LEESMILLER JP, 1987, BIOCHEM J, V244, P705, DOI 10.1042/bj2440705; Li J, 2011, EUR J PHARMACOL, V654, P295, DOI 10.1016/j.ejphar.2010.12.040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Chouly CAE, 2004, LIFE SCI, V75, P823, DOI 10.1016/j.lfs.2004.01.021; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mehats C, 2009, EUR RESPIR J, V33, P1236, DOI 10.1183/09031936.00002809; Mehats C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003445; Miotla JM, 1998, AM J RESP CELL MOL, V18, P411, DOI 10.1165/ajrcmb.18.3.2913; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohta A, 2007, J IMMUNOL, V179, P7431, DOI 10.4049/jimmunol.179.11.7431; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; SHAPLAND C, 1993, J CELL BIOL, V121, P1065, DOI 10.1083/jcb.121.5.1065; Soto FJ, 2005, CURR OPIN PULM MED, V11, P129; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051; Weichelt U, 2013, EUR RESPIR J, V41, P966, DOI 10.1183/09031936.00012412; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Yano Y, 2006, BIOCHEM BIOPH RES CO, V341, P684, DOI 10.1016/j.bbrc.2006.01.018; Yu HY, 2008, FASEB J, V22, P1778, DOI 10.1096/fj.07-083857; Zhang RF, 2014, AM J PHYSIOL-LUNG C, V306, pL574, DOI 10.1152/ajplung.00327.2013; Zhang RF, 2009, AM J RESP CELL MOL, V41, P467, DOI 10.1165/rcmb.2008-0333OC; Zinke M, 2009, J VIROL, V83, P9423, DOI 10.1128/JVI.00846-09	64	27	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97357	10.1371/journal.pone.0097357	http://dx.doi.org/10.1371/journal.pone.0097357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828686	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400083
J	Simonetto, C; Azizova, TV; Grigoryeva, ES; Kaiser, JC; Schollnberger, H; Eidemuller, M				Simonetto, Cristoforo; Azizova, Tamara V.; Grigoryeva, Evgenia S.; Kaiser, Jan C.; Schoellnberger, Helmut; Eidemueller, Markus			Ischemic Heart Disease in Workers at Mayak PA: Latency of Incidence Risk after Radiation Exposure	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; LEVEL IONIZING-RADIATION; CIRCULATORY DISEASE; CARDIOVASCULAR-DISEASES; APOE(-/-) MICE; CEREBROVASCULAR DISEASES; PRODUCTION-ASSOCIATION; MULTIMODEL INFERENCE; DOSE-RESPONSES; BREAST-CANCER	We present an updated analysis of incidence and mortality from atherosclerotic induced ischemic heart diseases in the cohort of workers at the Mayak Production Association (PA). This cohort constitutes one of the most important sources for the assessment of radiation risk. It is exceptional because it comprises information on several other risk factors. While most of the workers have been exposed to external gamma radiation, a large proportion has additionally been exposed to internal radiation from inhaled plutonium. Compared to a previous study by Azizova et al. 2012, the updated dosimetry system MWDS-2008 has been applied and methods of analysis have been revised. We extend the analysis of the significant incidence risk and observe that main detrimental effects of external radiation exposure occur after more than about 30 years. For mortality, significant risk was found in males with an excess relative risk per dose of 0.09 (95% CI: 0.02; 0.16) Gy(-1) while risk was insignificant for females. With respect to internal radiation exposure no association to risk could be established.	[Simonetto, Cristoforo; Kaiser, Jan C.; Schoellnberger, Helmut; Eidemueller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.; Grigoryeva, Evgenia S.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	cristoforo.simonetto@helmholtz-muenchen.de	Grigoryeva, Evgeniya S./B-9142-2016; Azizova, Tamara V./R-5295-2019; Kaiser, Jan Christian/M-9852-2014; Simonetto, Cristoforo/AAE-7124-2020; Schöllnberger, Helmut/K-1446-2016	Grigoryeva, Evgeniya S./0000-0003-1806-9922; Azizova, Tamara V./0000-0001-6954-2674; Simonetto, Cristoforo/0000-0003-4816-3514; Schöllnberger, Helmut/0000-0002-4398-6565; Kaiser, Jan Christian/0000-0003-0359-2251	Federal Office of Radiation Protection [3611S30022]; EU project ProCardio [295823]	Federal Office of Radiation Protection; EU project ProCardio	This work was supported by a project of the Federal Office of Radiation Protection (contract 3611S30022) and by the EU project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Group on Ionising Radiation, 2010, RCE16 HPA ADV GROUP, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; Azizova T. V., 2012, Radiatsionnaya Biologiya Radioekologiya, V52, P158; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Azizova TV, 2012, HEALTH PHYS, V103, P3, DOI 10.1097/HP.0b013e3182243a62; Azizova TV, 2011, RADIAT ENVIRON BIOPH, V50, P539, DOI 10.1007/s00411-011-0377-6; Bess JD, 2007, HEALTH PHYS, V93, P207, DOI 10.1097/01.HP.0000266741.42070.e8; BOLOTNIKOVA MG, 1994, SCI TOTAL ENVIRON, V142, P29, DOI 10.1016/0048-9697(94)90070-1; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Committee on Health Risks of Exposure to Radon (BEIR VI) National Research Council, 1999, HLTH EFF EXP RAD BEI; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Krestinina LY, 2013, RADIAT ENVIRON BIOPH, V52, P47, DOI 10.1007/s00411-012-0438-5; Kreuzer M, 2013, RADIAT ENVIRON BIOPH, V52, P37, DOI 10.1007/s00411-012-0446-5; Kumarathasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065486; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Little MP, 2012, ENVIRON HEALTH PERSP, V120, pA453, DOI 10.1289/ehp.1206046R; Little MP, 2012, INT J RADIAT ONCOL, V84, P1101, DOI 10.1016/j.ijrobp.2012.01.053; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; Little MP, 2013, RADIAT ENVIRON BIOPH, V51, P165; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mitchel REJ, 2013, RADIAT RES, V179, P190, DOI 10.1667/RR3140.1; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057052; Mothersill C, 2013, J ENVIRON RADIOACTIV, DOI [10.1016/j.jenvrad.2013.04.002, DOI 10.1016/J.JENVRAD.2013.04.002.]; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Roedel F, 2012, CURR MED CHEM, V19, P1741, DOI 10.2174/092986712800099866; Rodel F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00120; Schollnberger H, 2013, RADIAT ENVIRON BIOPH, V52, P161, DOI 10.1007/s00411-012-0454-5; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; Schollnberger H, 2012, ENVIRON HEALTH PERSP, V120, pA452, DOI 10.1289/ehp.1206046; Schollnberger, RAD ENV BIOPHYS, V52, P157; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tretyakov FD, 2012, RADIOACTIVE SOURCE 4, P4; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Vrijheid M, 2007, INT J EPIDEMIOL, V36, P1126, DOI 10.1093/ije/dym138; WHO Regional Office for Europe, 2006, HIGHL HLTH RUSS FED; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183	48	32	35	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96309	10.1371/journal.pone.0096309	http://dx.doi.org/10.1371/journal.pone.0096309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828606	gold, Green Submitted, Green Published			2022-12-25	WOS:000336857400024
J	Wong, VL; Ellison, CE; Eisen, MB; Pachter, L; Brem, RB				Wong, Valerie L.; Ellison, Christopher E.; Eisen, Michael B.; Pachter, Lior; Brem, Rachel B.			Structural Variation among Wild and Industrial Strains of Penicillium chrysogenum	PLOS ONE			English	Article							TANDEM REPEATS; GENE-CLUSTER	Strain selection and strain improvement are the first, and arguably most important, steps in the industrial production of biological compounds by microorganisms. While traditional methods of mutagenesis and selection have been effective in improving production of compounds at a commercial scale, the genetic changes underpinning the altered phenotypes have remained largely unclear. We utilized high-throughput Illumina short read sequencing of a wild Penicillium chrysogenum strain in order to make whole genome comparisons to a sequenced improved strain (WIS 54-1255). We developed an assembly-free method of identifying chromosomal rearrangements and validated the in silico predictions with a PCR-based assay and Sanger sequencing. Despite many rounds of mutagen treatment and artificial selection, WIS 54-1255 differs from its wild progenitor at only one of the identified rearrangements. We suggest that natural variants predisposed for high penicillin production were instrumental in the success of WIS 54-1255 as an industrial strain. In addition to finding a previously published inversion in the penicillin biosynthesis cluster, we located several genes related to penicillin production associated with these rearrangements. By comparing the configuration of rearrangement events among several historically important strains known to be high penicillin producers to a collection of recently isolated wild strains, we suggest that wild strains with rearrangements similar to those in known high penicillin producers may be viable candidates for further improvement efforts.	[Wong, Valerie L.; Ellison, Christopher E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.; Brem, Rachel B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wong, VL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	vwong@umn.edu		Pachter, Lior/0000-0002-9164-6231; Eisen, Michael/0000-0002-7528-738X				Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chain E, 1940, LANCET, V2, P226; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; DIEZ B, 1990, J BIOL CHEM, V265, P16358; Eland RP, 1976, IND MICROBIOLOGY, P192; Elander RP, 1967, INDUCED MUTATIONS TH, P403; FIERRO F, 1995, P NATL ACAD SCI USA, V92, P6200, DOI 10.1073/pnas.92.13.6200; Fierro F, 2006, FUNGAL GENET BIOL, V43, P618, DOI 10.1016/j.fgb.2006.03.001; Fleming A, 1929, BR J EXP PATHOL, V10, P185; GORDON M, 1953, SCIENCE, V118, P43, DOI 10.1126/science.118.3054.43; Harris DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-75; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Jami MS, 2010, MOL CELL PROTEOMICS, V9, P1182, DOI 10.1074/mcp.M900327-MCP200; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; Lein J., 1986, OVERPRODUCTION MICRO, P105; Martin JF, 2010, MICROB BIOTECHNOL, V3, P285, DOI 10.1111/j.1751-7915.2009.00123.x; MOYER AJ, 1946, J BACTERIOL, V51, P79, DOI 10.1128/JB.51.1.79-93.1946; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Muniz C. C., 2007, REV LATINOAM MICROBI, V49, P88; Raper KB, 1944, J BACTERIOL, V48, P639, DOI 10.1128/JB.48.6.639-659.1944; Raper Kenneth B., 1945, JOUR ELISHA MITCHELL SCI SOC, V61, P74; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498	24	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96784	10.1371/journal.pone.0096784	http://dx.doi.org/10.1371/journal.pone.0096784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824901	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000336369200031
J	Kumar, S; Tepper, K; Kaniyappan, S; Biernat, J; Wegmann, S; Mandelkow, EM; Muller, DJ; Mandelkow, E				Kumar, Satish; Tepper, Katharina; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Wegmann, Susanne; Mandelkow, Eva-Maria; Mueller, Daniel J.; Mandelkow, Eckhard			Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; PATHOLOGICAL TAU; ENDOGENOUS-TAU; BETA-STRUCTURE; MOUSE MODEL; PROTEIN-TAU; IN-VITRO; OLIGOMERS	Several neurodegenerative diseases are characterized by the aggregation and posttranslational modifications of Tau protein. Its "repeat domain" (TauRD) is mainly responsible for the aggregation properties, and oligomeric forms are thought to dominate the toxic effects of Tau. Here we investigated the conformational transitions of this domain during oligomerization and aggregation in different states of beta-propensity and pseudophosphorylation, using several complementary imaging and spectroscopic methods. Although the repeat domain generally aggregates more readily than full-length Tau, its aggregation was greatly slowed down by phosphorylation or pseudo-phosphorylation at the KXGS motifs, concomitant with an extended phase of oligomerization. Analogous effects were observed with pro-aggregant variants of TauRD. Oligomers became most evident in the case of the pro-aggregant mutant TauRD Delta K280, as monitored by atomic force microscopy, and the fluorescence lifetime of Alexa-labeled Tau (time-correlated single photon counting (TCSPC)), consistent with its pronounced toxicity in mouse models. In cell models or primary neurons, neither oligomers nor fibrils of TauRD or TauRD Delta K280 had a toxic effect, as seen by assays with lactate dehydrogenase and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, respectively. However, oligomers of pro-aggregant TauRD Delta K280 specifically caused a loss of spine density in differentiated neurons, indicating a locally restricted impairment of function.	[Kumar, Satish; Tepper, Katharina; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Tepper, Katharina; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Ctr Adv European Studies & Res CAESAR, D-53175 Bonn, Germany; [Kumar, Satish; Kaniyappan, Senthilvelrajan; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] DESY, Max Planck Inst Neurol Res, Hamburg Outstn, D-22607 Hamburg, Germany; [Wegmann, Susanne; Mueller, Daniel J.] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mandelkow, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany.	Eckhard.Mandelkow@dzne.de	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665; Kaniyappan, Senthilvelrajan/0000-0002-0606-2769	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft (MPG); Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program); Wellcome Trust/MRC; Tau Consortium	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft (MPG)(Max Planck Society); Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Tau Consortium	This work was supported by the German Center for Neurodegenerative Diseases, Max-Planck-Gesellschaft (MPG), Bundesministerium fur Bildung und Forschung (BMBF; Kompetenznetz Neurodegenerative Demenzen (KNDD program), the Wellcome Trust/MRC, and the Tau Consortium.	Akoury E, 2013, J AM CHEM SOC, V135, P2853, DOI 10.1021/ja312471h; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Blair LJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt207; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Fath T, 2002, J NEUROSCI, V22, P9733; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Giurleo JT, 2008, J MOL BIOL, V381, P1332, DOI 10.1016/j.jmb.2008.06.043; Gotz J, 2010, NEURODEGENER DIS, V7, P10, DOI 10.1159/000283475; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guzman-Martinez L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00167; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lakowicz JR, 2006, PLASMONICS, V1, P5, DOI 10.1007/s11468-005-9002-3; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Ren Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00102; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Sahoo B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2969110; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Trojanowski JQ, 2005, NAT NEUROSCI, V8, P1136, DOI 10.1038/nn0905-1136; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang YP, 2012, BIOCHEM SOC T, V40, P644, DOI 10.1042/BST20120071; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	81	53	54	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20318	20332		10.1074/jbc.M114.554725	http://dx.doi.org/10.1074/jbc.M114.554725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24825901	Green Published, hybrid			2022-12-25	WOS:000339395200043
J	Touhara, KK; Nihira, T; Kitaoka, M; Nakai, H; Fushinobu, S				Touhara, Kouki K.; Nihira, Takanori; Kitaoka, Motomitsu; Nakai, Hiroyuki; Fushinobu, Shinya			Structural Basis for Reversible Phosphorolysis and Hydrolysis Reactions of 2-O-alpha-Glucosylglycerol Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GLUCOSYLGLYCEROL; THERMOANAEROBACTER-BROCKII; MALTOSE PHOSPHORYLASE; DIRECTED EVOLUTION; TREHALOSE; THERMOSTABILITY; RECOGNITION; ENZYMES; CLONING; GENE	2-O-alpha-Glucosylglycerol phosphorylase (GGP) from Bacillus selenitireducens catalyzes both the reversible phosphorolysis of 2-O-alpha-glucosylglycerol (GG) and the hydrolysis of beta-D-glucose 1-phosphate (beta Glc1P). GGP belongs to the glycoside hydrolase (GH) family 65 and can efficiently and specifically produce GG. However, its structural basis has remained unclear. In this study, the crystal structures of GGP complexed with glucose and the glucose analog isofagomine and glycerol were determined. Subsite -1 of GGP is similar to those of other GH65 enzymes, maltose phosphorylase and kojibiose phosphorylase, whereas subsite +1 is largely different and is well designed for GG recognition. An automated docking analysis was performed to complement these crystal structures, beta Glc1P being docked at an appropriate position. To investigate the importance of residues at subsite +1 in the bifunctionality of GGP, we constructed mutants at these residues. Y327F and K587A did not show detectable activities for either reverse phosphorolysis or beta Glc1P hydrolysis. Y572F also showed significantly reduced activities for both of these reactions. In contrast, W381F showed significantly reduced reverse phosphorolytic activity but retained beta Glc1P hydrolysis. The mode of substrate recognition and the reaction mechanisms of GGP were proposed based on these analyses. Specifically, an extensive hydrogen bond network formed by Tyr-327, Tyr-572, Lys-587, and water molecules contributes to fixing the acceptor molecule in both reverse phosphorolysis( glycerol) and beta Glc1P hydrolysis(water) for a glycosyl transfer reaction. This study will contribute to the development of a large scale production system of GG by facilitating the rational engineering of GGP.	[Touhara, Kouki K.; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nihira, Takanori; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019	Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838; Touhara, Kouki/0000-0003-3167-9784	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; MEXT; NISR; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NISR; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and in part by the MEXT program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology, a NISR Young Investigator Research Grant in 2012, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Cerdobbel A, 2011, PROTEIN ENG DES SEL, V24, P829, DOI 10.1093/protein/gzr042; De Groeve MRM, 2009, PROTEIN ENG DES SEL, V22, P393, DOI 10.1093/protein/gzp017; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FITTING C, 1952, J BIOL CHEM, V199, P153; Fushinobu S, 2007, J APPL GLYCOSCI, V54, P95; Hagemann M, 1998, MICR EXTREM UNUSUAL, P177; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Koyama Y, 2013, PROTEIN ENG DES SEL, V26, P755, DOI 10.1093/protein/gzt049; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Luley-Goedl C, 2010, FOOD TECHNOL BIOTECH, V48, P276; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1736, DOI 10.1016/j.carres.2010.05.022; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1492, DOI 10.1016/j.carres.2010.03.035; Maruta K, 2002, BIOSCI BIOTECH BIOCH, V66, P1976, DOI 10.1271/bbb.66.1976; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakai H, 2010, PROTEIN ENG DES SEL, V23, P781, DOI 10.1093/protein/gzq055; Nihira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086548; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nishimoto M, 2012, J MOL CATAL B-ENZYM, V74, P97, DOI 10.1016/j.molcatb.2011.09.004; Okada S, 2014, FEBS J, V281, P778, DOI 10.1111/febs.12622; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sawangwan T, 2010, BIOTECHNOL J, V5, P187, DOI 10.1002/biot.200900197; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P1821, DOI 10.1271/bbb.64.1821; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P378, DOI 10.1271/bbb.64.378; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamamoto T, 2004, J BIOSCI BIOENG, V98, P99, DOI 10.1263/jbb.98.99; Yamamoto T, 2006, J BIOSCI BIOENG, V101, P427, DOI 10.1263/jbb.101.427	36	14	15	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18067	18075		10.1074/jbc.M114.573212	http://dx.doi.org/10.1074/jbc.M114.573212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828502	Green Published, hybrid			2022-12-25	WOS:000338042000010
J	van der Hagen, EAE; Tudpor, K; Verkaart, S; Lavrijsen, M; van der Kemp, A; van Zeeland, F; Bindels, RJM; Hoenderop, JGJ				van der Hagen, Eline A. E.; Tudpor, Kukiat; Verkaart, Sjoerd; Lavrijsen, Marla; van der Kemp, Annemiete; van Zeeland, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.			beta 1-Adrenergic Receptor Signaling Activates the Epithelial Calcium Channel, Transient Receptor Potential Vanilloid Type 5 (TRPV5), via the Protein Kinase A Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; CONVOLUTED TUBULE CELLS; BETA-ADRENERGIC-RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; PARATHYROID-HORMONE; CA2+ TRANSPORT; RAT-KIDNEY; EXPRESSION; EPINEPHRINE; MODULATION	Epinephrine and norepinephrine are present in the pro-urine. beta-Adrenergic receptor (beta-AR) blockers administered to counteract sympathetic overstimulation in patients with congestive heart failure have a negative inotropic effect, resulting in reduced cardiac contractility. Positive inotropes, beta 1-AR agonists, are used to improve cardiac functions. Active Ca2+ reabsorption in the late distal convoluted and connecting tubules (DCT2/CNT) is initiated by Ca2+ influx through the transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel. Although it was reported that beta-ARs are present in the DCT2/CNT region, their role in active Ca2+ reabsorption remains elusive. Here we revealed that beta 1-AR, but not beta 2-AR, is localized with TRPV5 in DCT2/CNT. Subsequently, treatment of TRPV5-expressing mouse DCT2/CNT primary cell cultures with the beta 1-AR agonist dobutamine showed enhanced apical-to-basolateral transepithelial Ca2+ transport. In human embryonic kidney (HEK293) cells, dobutamine was shown to stimulate cAMP production, signifying functional beta 1-AR expression. Fura-2 experiments demonstrated increased activity of TRPV5 in response to dobutamine, which could be prevented by the PKA inhibitor H89. Moreover, nonphosphorylable T709A-TRPV5 and phosphorylation-mimicking T709D-TRPV5 mutants were unresponsive to dobutamine. Surface biotinylation showed that dobutamine did not affect plasma membrane abundance of TRPV5. In conclusion, activation of beta 1-AR stimulates active Ca2+ reabsorption in DCT2/CNT; an increase in TRPV5 activity via PKA phosphorylation of residue Thr-709 possibly plays an important role. These data explicate a calciotropic role in addition to the inotropic property of beta 1-AR.	[van der Hagen, Eline A. E.; Tudpor, Kukiat; Verkaart, Sjoerd; Lavrijsen, Marla; van der Kemp, Annemiete; van Zeeland, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Joost.Hoenderop@radboudumc.nl	Tudpor, Kukiat/GSM-7368-2022; Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Tudpor, Kukiat/0000-0002-8533-5891	Netherlands Organization for Scientific Research (NWO-ALW) [819.02.012]	Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research (NWO-ALW) Grant 819.02.012.	Alsafwah S, 2007, CLIN MED RES, V5, P238, DOI 10.3121/cmr.2007.737; Boivin V, 2001, KIDNEY INT, V59, P515, DOI 10.1046/j.1523-1755.2001.059002515.x; Bollano E, 2003, HEART, V89, P621, DOI 10.1136/heart.89.6.621; Borkowski BJ, 2011, EUR HEART J, V32, P1846, DOI 10.1093/eurheartj/ehr063; Bylund DB, 2007, AM J PHYSIOL-ENDOC M, V293, pE1479, DOI 10.1152/ajpendo.00664.2007; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Charoenphandhu N, 2006, AM J PHYSIOL-GASTR L, V291, pG446, DOI 10.1152/ajpgi.00108.2006; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; ELALOUF JM, 1993, J CLIN INVEST, V91, P264, DOI 10.1172/JCI116180; Erraji-Benchekroun L, 2005, AM J PHYSIOL-ENDOC M, V288, pE715, DOI 10.1152/ajpendo.00113.2004; Evans BA, 1998, BRIT J PHARMACOL, V124, P763, DOI 10.1038/sj.bjp.0701867; FURCHGOTT RF, 1959, PHARMACOL REV, V11, P429; GEFFNER DL, 1992, AM J MED, V93, P61, DOI 10.1016/0002-9343(92)90681-Z; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; Gesek FA, 1997, AM J PHYSIOL-RENAL, V272, pF712, DOI 10.1152/ajprenal.1997.272.6.F712; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; HAYES JR, 1983, IRISH J MED SCI, V152, P422, DOI 10.1007/BF02958811; Hellgren I, 2000, BIOL PHARM BULL, V23, P700; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, BBA-PROTEINS PROTEOM, V1600, P6, DOI 10.1016/S1570-9639(02)00438-7; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Kang HS, 2000, AM J PHYSIOL-RENAL, V279, pF1116, DOI 10.1152/ajprenal.2000.279.6.F1116; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; MALLIANI A, 1983, EUR HEART J, V4, P49, DOI 10.1093/eurheartj/4.suppl_A.49; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Motoyama HI, 2002, AM J PHYSIOL-RENAL, V283, pF399, DOI 10.1152/ajprenal.00346.2001; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6; Shane E, 1997, AM J MED, V103, P197, DOI 10.1016/S0002-9343(97)00142-3; SNAVELY MD, 1985, ENDOCRINOLOGY, V117, P2182, DOI 10.1210/endo-117-5-2182; Taylor SH, 1996, EUR HEART J, V17, P43, DOI 10.1093/eurheartj/17.suppl_B.43; Topala CN, 2009, CELL CALCIUM, V45, P331, DOI 10.1016/j.ceca.2008.12.003; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Zannad F, 2001, HYPERTENSION, V38, P1227, DOI 10.1161/hy1101.099484; Ziegler MG, 1997, KIDNEY INT, V51, P324, DOI 10.1038/ki.1997.40	40	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18489	18496		10.1074/jbc.M113.491274	http://dx.doi.org/10.1074/jbc.M113.491274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828496	hybrid, Green Published			2022-12-25	WOS:000338042000045
J	Ye, F; Kim, SJ; Kim, C				Ye, Feng; Kim, Se-Jong; Kim, Chungho			Intermolecular Transmembrane Domain Interactions Activate Integrin alpha IIb beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; MECHANISM; AFFINITY; BINDING; ROLES	Integrins are the major cell adhesion molecules responsible for cell attachment to the extracellular matrix. The strength of integrin-mediated adhesion is controlled by the affinity of individual integrins (integrin activation) as well as by the number of integrins involved in such adhesion. The positive correlation between integrin activation and integrin clustering had been suggested previously, but several trials to induce integrin clustering by dimerization of the transmembrane domain or tail region of integrin alpha subunits failed to demonstrate any change in integrin activation. Here, using platelet integrin alpha IIb beta 3 as a model system, we showed that there is intermolecular lateral interaction between integrins through the transmembrane domains, and this interaction can enhance the affinity state of integrins. In addition, when integrin clustering was induced through heteromeric lateral interactions using bimolecular fluorescence complementation, we could observe a significant increase in the number of active integrin molecules. Because the possibility of intermolecular interaction would be increased by a higher local concentration of integrins, we propose that integrin clustering can shift the equilibrium in favor of integrin activation.	[Ye, Feng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Se-Jong; Kim, Chungho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	University of California System; University of California San Diego; Korea University	Kim, C (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	chungho@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A1007773]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Education Grant NRF-2013R1A1A1007773.	Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim CH, 2012, J CELL BIOL, V197, P605, DOI 10.1083/jcb.201112141; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	21	8	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18507	18513		10.1074/jbc.M113.541888	http://dx.doi.org/10.1074/jbc.M113.541888			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838247	Green Published, hybrid			2022-12-25	WOS:000338042000047
J	Mummalaneni, S; Qian, J; Phan, THT; Rhyu, MR; Heck, GL; DeSimone, JA; Lyall, V				Mummalaneni, Shobha; Qian, Jie; Phan, Tam-Hao T.; Rhyu, Mee-Ra; Heck, Gerard L.; DeSimone, John A.; Lyall, Vijay			Effect of ENaC Modulators on Rat Neural Responses to NaCl	PLOS ONE			English	Article							TASTE RECEPTOR CELL; EPITHELIAL NA+ CHANNEL; CHORDA TYMPANI RESPONSES; SODIUM TASTE; AMILORIDE; CAMP; SWEET; SALTY; KCL; PH	The effects of small molecule ENaC activators N,N,N-trimethyl-2-((4-methyl-2-((4-methyl-1H-indol-3-yl)thio) pentanoyl)oxy)ethanaminium iodide (Compound 1) and N-(2-hydroxyethyl)-4-methyl-2-((4-methyl-1H-indol-3-yl) thio) pentanamide (Compound 2), were tested on the benzamil (Bz)-sensitive NaCl chorda tympani (CT) taste nerve response under open-circuit conditions and under +/- 60 mV applied lingual voltage-clamp, and compared with the effects of known physiological activators (8-CPT-cAMP, BAPTA-AM, and alkaline pH), and an inhibitor (ionomycin+Ca2+) of ENaC. The NaCl CT response was enhanced at -60 mV and suppressed at +60 mV. In every case the CT response (r) versus voltage (V) curve was linear. All ENaC activators increased the open-circuit response (r(o)) and the voltage sensitivity (kappa, negative of the slope of the r versus V curve) and ionomycin+Ca2+ decreased r(o) and kappa to zero. Compound 1 and Compound 2 expressed a sigmoidal-saturating function of concentration (0.25-1 mM) with a half-maximal response concentration (k) of 0.49 and 1.05 mM, respectively. Following treatment with 1 mM Compound 1, 8-CPT-cAMP, BAPTA-AM and pH 10.3, the Bz-sensitive NaCl CT response to 100 mM NaCl was enhanced and was equivalent to the Bz-sensitive CT response to 300 mM NaCl. Plots of kappa versus r(o) in the absence and presence of the activators or the inhibitor were linear, suggesting that changes in the affinity of Na+ for ENaC under different conditions are fully compensated by changes in the apical membrane potential difference, and that the observed changes in the Bz-sensitive NaCl CT response arise exclusively from changes in the maximum CT response (r(m)). The results further suggest that the agonists enhance and ionomycin+Ca2+ decreases ENaC function by increasing or decreasing the rate of release of Na+ from its ENaC binding site to the receptor cell cytosol, respectively. Irrespective of agonist type, the Bz-sensitive NaCl CT response demonstrated a maximum response enhancement limit of about 75% over control value.	[Mummalaneni, Shobha; Qian, Jie; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Rhyu, Mee-Ra] Korea Food Res Inst, Songnam, Gyeonggi Do, South Korea	Virginia Commonwealth University; Korea Food Research Institute (KFRI)	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	vlyall@vcu.edu			NIDCD [DC-005981, DC-011569]; Korea Food Research Institute (KFRI) [E094101, E0111501]; Senomyx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569, R01DC005981] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Korea Food Research Institute (KFRI); Senomyx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by NIDCD grants DC-005981 (V. L.), DC-011569 (V. L.), Korea Food Research Institute (KFRI) grants E094101 (M. R.), E0111501 (M. R.) and research support from Senomyx (J.A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chraibi A, 2001, J MEMBRANE BIOL, V183, P15, DOI 10.1007/s00232-001-0049-6; Coleman J, 2011, J NEUROPHYSIOL, V106, P2606, DOI 10.1152/jn.00196.2010; DeSimone JA, 2001, J NEUROPHYSIOL, V86, P2638, DOI 10.1152/jn.2001.86.5.2638; DeSimone JA, 2008, SENSES COMPREHENSIVE, V4, P281; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3221, DOI 10.1152/jn.00129.2012; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3206, DOI 10.1152/jn.00916.2011; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Halpern BP, 1998, CHEM SENSES, V23, P501, DOI 10.1093/chemse/23.5.501; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hendricks SJ, 2000, J NEUROPHYSIOL, V84, P1531, DOI 10.1152/jn.2000.84.3.1531; HERNESS MS, 1992, COMP BIOCHEM PHYS A, V103, P269, DOI 10.1016/0300-9629(92)90578-E; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089062; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2004, J PHYSIOL-LONDON, V556, P159, DOI 10.1113/jphysiol.2003.057745; Lyall V, 2002, J GEN PHYSIOL, V120, P793, DOI 10.1085/jgp.20028656; Lyall V, 2002, J NEUROPHYSIOL, V87, P399, DOI 10.1152/jn.00331.2001; Lyall V, 1999, AM J PHYSIOL-CELL PH, V277, pC800, DOI 10.1152/ajpcell.1999.277.4.C800; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Lyall V, 2009, J NEUROPHYSIOL, V102, P1591, DOI 10.1152/jn.91301.2008; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; OSSEBAARD CA, 1995, CHEM SENSES, V20, P37, DOI 10.1093/chemse/20.1.37; Robins GG, 2013, J PHYSIOL BIOCHEM, V69, P419, DOI 10.1007/s13105-012-0223-6; ROTHERMEL JD, 1983, J BIOL CHEM, V258, P2125; Schnizler M, 2000, PFLUG ARCH EUR J PHY, V439, P579, DOI 10.1007/s004240050981; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Sturz GR, 2011, CHEM SENSES, V36, P375, DOI 10.1093/chemse/bjq146; Tahara Y, 2013, European Patent Application, Patent No. [10857834.5, 108578345]; YE Q, 1991, SCIENCE, V254, P724, DOI 10.1126/science.1948054; Yusuke A, 2012, Salty taste enhancer, Patent No. [WO 2012121273 A1, 2012121273]	40	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98049	10.1371/journal.pone.0098049	http://dx.doi.org/10.1371/journal.pone.0098049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839965	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600104
J	Sepulveda, M; Sabat, P; Porter, WP; Farina, JM				Sepulveda, Maritza; Sabat, Pablo; Porter, Warren P.; Miguel Farina, Jose			One Solution for Two Challenges: The Lizard Microlophus atacamensis Avoids Overheating by Foraging in Intertidal Shores	PLOS ONE			English	Article							RUIN LIZARDS; BODY-SIZE; GEOGRAPHIC-VARIATION; SCELOPORUS-MERRIAMI; LIFE-HISTORIES; BEHAVIORAL THERMOREGULATION; THERMAL CONSTRAINTS; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; ACTIVITY PATTERNS	In lizards, one of the most important behavioral mechanisms to cope with spatial and temporal variations in thermal resources observed is activity time. The longer a lizard can maintain activity, the more time it has to forage and reach larger adult body size. We studied the behavioral adjustments to different climatic regimens on daily and seasonal scales in three natural populations of the lizard Microlophus atacamensis along a latitudinal temperature and rainfall gradient. We also used Niche Mapper to determinate the amount of thermally suitable time for activity for this species. Abundance and daily activity patterns varied greatly over the year for the three populations. In summer and spring, the daily activity times were greater, and were reduced in fall and winter seasons. In summer, when stressful heat loads should prohibit activity over a midday gap, lizards did not show bimodal patterns of activity. Instead, they move to the cooler intertidal habitat. Abundance and thermal quality in the southernmost coolest site was lower, and the potential annual activity time decreases with latitude. Contrary to expectations, lizards from this locality showed the largest body sizes possibly due to diet and/or time to sexual maturation. Our results indicate that the intertidal habitat is a key factor that influences daily and seasonal activity of M. atacamensis lizards. While this habitat is not climatically optimal for lizards, it allows them to behaviorally extend their activity window and gain access to food in the intertidal areas.	[Sepulveda, Maritza] Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile; [Sabat, Pablo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Miguel Farina, Jose] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Miguel Farina, Jose] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Universidad de Valparaiso; Universidad de Chile; University of Wisconsin System; University of Wisconsin Madison; Pontificia Universidad Catolica de Chile; Brown University	Sepulveda, M (corresponding author), Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile.	maritza.sepulveda@uv.cl	Sabat, Pablo/E-8829-2012		Beca Universidad de Chile [PG/3/2006]; Fondecyt [1040783, 105096]	Beca Universidad de Chile; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by funding from Beca Universidad de Chile PG/3/2006 to MS, Fondecyt Grant number 1040783 to JMF, and Fondecyt Grant number 105096 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Adolph SC, 1996, OIKOS, V77, P267, DOI 10.2307/3546065; ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Angilletta MJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P11; Avery R.A., 1982, Biology of Reptilia, V12, P93; Bertolucci C, 2002, HORM BEHAV, V41, P414, DOI 10.1006/hbeh.2002.1781; Bertolucci C, 1999, BEHAV ECOL SOCIOBIOL, V46, P200, DOI 10.1007/s002650050610; Carothers JH, 1998, REV CHIL HIST NAT, V71, P39; Catenazzi A, 2005, COPEIA, P713, DOI 10.1643/0045-8511(2005)005[0713:SAGEIA]2.0.CO;2; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; DIAZ JA, 1991, J BIOGEOGR, V18, P291, DOI 10.2307/2845399; Diaz JA, 2004, FUNCT ECOL, V18, P867, DOI 10.1111/j.0269-8463.2004.00916.x; Donoso-Barros R., 1966, REPTILES CHILE; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Ellis DJ, 2007, J COMP PHYSIOL A, V193, P695, DOI 10.1007/s00359-007-0224-z; Farina JM, 2008, J ANIM ECOL, V77, P458, DOI 10.1111/j.1365-2656.2008.01361.x; Farina JM, 2003, ECOL APPL, V13, P1533, DOI 10.1890/02-5216; Foa A, 2003, FRONT BIOSCI, V8, pS236, DOI 10.2741/1037; FOA A, 1994, BEHAV ECOL SOCIOBIOL, V34, P267; Foa A, 2001, J BIOL RHYTHM, V16, P574, DOI 10.1177/074873001129002268; GRANT BW, 1990, ECOLOGY, V71, P2323, DOI 10.2307/1938643; GRANT BW, 1992, AM ZOOL, V32, P154; GRANT BW, 1988, ECOLOGY, V69, P167, DOI 10.2307/1943171; GRANT BW, 1990, ECOLOGY, V71, P1765, DOI 10.2307/1937584; Gunderson AR, 2012, FUNCT ECOL, V26, P783, DOI 10.1111/j.1365-2435.2012.01987.x; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Huey R.B., 1982, Biology of Reptilia, V12, P25; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kerr GD, 2008, J ZOOL, V275, P79, DOI 10.1111/j.1469-7998.2008.00413.x; Labra A, 2001, ECOSCIENCE, V8, P413, DOI 10.1080/11956860.2001.11682669; MCCULLOUGH EC, 1971, ECOLOGY, V52, P1008, DOI 10.2307/1933806; NAGY KA, 1984, ECOLOGY, V65, P588, DOI 10.2307/1941421; Niewiarowski PH, 2001, AM NAT, V157, P421, DOI 10.1086/319321; Ortiz JC, 1980, ACTAS PRIMERA REUNIO, P355; Porter W.P., 2006, METHOD SYSTEM CALCUL; PORTER WP, 1973, OECOLOGIA, V13, P1, DOI 10.1007/BF00379617; Sears MW, 2004, INTEGR COMP BIOL, V44, P433, DOI 10.1093/icb/44.6.433; Sears MW, 2005, OECOLOGIA, V143, P25, DOI 10.1007/s00442-004-1767-0; Sepulveda M, 2008, J THERM BIOL, V33, P141, DOI 10.1016/j.jtherbio.2007.07.002; SINERVO B, 1994, ECOLOGY, V75, P776, DOI 10.2307/1941734; *STATS INC, 2001, STATISTICA; Tracy CR, 1999, ECOLOGY, V80, P259, DOI 10.1890/0012-9658(1999)080[0259:DIBSAC]2.0.CO;2; Vidal M, 2002, REV CHIL HIST NAT, V75, P283; Vitt LJ, 1999, FUNCT ECOL, V13, P670, DOI 10.1046/j.1365-2435.1999.00357.x; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Wikelski M, 2000, OECOLOGIA, V124, P107, DOI 10.1007/s004420050030; Winne CT, 2004, FUNCT ECOL, V18, P314, DOI 10.1111/j.0269-8463.2004.00819.x; Zar JH, 1999, BIOSTATISTICAL ANAL	50	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97735	10.1371/journal.pone.0097735	http://dx.doi.org/10.1371/journal.pone.0097735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839969	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600064
J	Carrera, S; Senra, J; Acosta, MI; Althubiti, M; Hammond, EM; de Verdier, PJ; Macip, S				Carrera, Samantha; Senra, Joana; Acosta, Maria Isabel; Althubiti, Mohammad; Hammond, Ester M.; de Verdier, Petra J.; Macip, Salvador			The Role of the HIF-1 alpha Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; FACTOR 1-ALPHA; CANCER CELLS; DNA-DAMAGE; HIF-1; P53; ACTIVATION; PATHWAYS; GROWTH	HIF-1 is a transcription factor that mediates the cellular responses to low oxygen environments, mainly as a result of having an oxygen-labile subunit, HIF-1 alpha. HIF-1 alpha has been carefully studied in the context of severe hypoxic stresses (<1% O-2), but it is also known to be present at oxygen tensions commonly found in normal tissues in vivo (similar to 1-13% O-2), albeit at much lower levels. Its role under these physiological conditions is not fully understood. Here, we show that a transcriptionally active HIF-1 alpha was up-regulated at 5% O-2, both in normal and cancer cells, but only some of its target genes were elevated as a result. HIF-1 alpha induction was in part dependent on the activation of the ERK1/2 MAPK signalling pathway, which we have previously shown is active at 5% O-2. We also found that HIF-1 alpha does not contribute to the protection against DNA damage that can be observed in low oxygen environments, and that there are certain DNA damaging agents, such as doxorubicin and actinomycin D, that prevent HIF-1 alpha induction independently of p53. Moreover, absence of HIF-1 alpha significantly reduced the growth advantage of cells cultured at 5% O-2. In view of these data, we conclude that HIF-1 alpha can be induced and activated at physiological oxygen tensions in a MAPK-dependent manner and that, although this does not lead to pro-survival responses to stress, it determines the increased cell proliferation rates that are common under these conditions.	[Carrera, Samantha; Acosta, Maria Isabel; Althubiti, Mohammad; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Senra, Joana; Hammond, Ester M.] Univ Oxford, MRC, Gray Inst Radiat Oncol & Biol, Dept Oncol,Canc Res UK, Oxford, England; [de Verdier, Petra J.] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Urol Lab, Stockholm, Sweden; [de Verdier, Petra J.] Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden	University of Leicester; Cancer Research UK; University of Oxford; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	sm460@le.ac.uk	Macip, Salvador/P-4233-2019; Macip, Salvador/S-6358-2019; Macip, Salvador/K-5985-2014	Macip, Salvador/0000-0003-1963-8840; Althubiti, Mohammad/0000-0002-9738-3188; Hammond, Ester/0000-0002-2335-3146	MRC; CONACYT [200721]; Stockholm County Council; Karolinska Institutet; CRUK; Cancer Research UK [19276] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by the MRC (www.mrc.ac.uk, New Blood Lectureship Research Support Funding). SC held a pre-doctoral fellowship from CONACYT (www.conacyt.mx, fellow #200721). PJDV held financial support through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. EMH and JMS are supported by a CRUK grant awarded to EMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2002, BRIT J CANCER, V87, P1173, DOI 10.1038/sj.bjc.6600576; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Cao Y, 2013, CANC RES; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; DOROSHOW JH, 1981, J CLIN INVEST, V68, P1053, DOI 10.1172/JCI110328; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Hall E.J, 2006, RADIOBIOLOGY RADIOLO, V6, P576; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Ravi R, 2000, GENE DEV, V14, P34; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Zhong H, 1999, CANCER RES, V59, P5830	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97938	10.1371/journal.pone.0097938	http://dx.doi.org/10.1371/journal.pone.0097938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835245	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800087
J	Dermitzaki, E; Liapakis, G; Androulidaki, A; Venihaki, M; Melissas, J; Tsatsanis, C; Margioris, AN				Dermitzaki, Eirini; Liapakis, George; Androulidaki, Ariadne; Venihaki, Maria; Melissas, John; Tsatsanis, Christos; Margioris, Andrew N.			Corticotrophin-Releasing Factor (CRF) and the Urocortins Are Potent Regulators of the Inflammatory Phenotype of Human and Mouse White Adipocytes and the Differentiation of Mouse 3T3L1 Pre-Adipocytes	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; ADIPOSE-TISSUE; DEHYDROGENASE TYPE-1; MESSENGER-RNA; INTERLEUKIN-6; OBESITY; EXPRESSION; MACROPHAGE; SECRETION; INSULIN	Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipose tissue expresses a complete CRF system. The aim of this study was to examine the role of CRF neuropeptides in the immune phenotype of adipocytes assessed by their expression of the toll-like receptor-4 (TLR4), the production of inflammatory cytokines IL-6, TNF-alpha and IL-1 beta, chemokines IL-8, monocyte attractant protein-1 (MCP-1) and of the adipokines adiponectin, resistin and leptin. Our data are as follows: (a) CRF, UCN2 and UCN3 are expressed in human white adipocytes as well as CRFR1a, CRFR2a and CRFR2b but not CRFR2c. 3T3L1 pre-adipocytes and differentiated adipocytes expressed both CRF1 and CRF2 receptors and UCN3, while UCN2 was detected only in differentiated adipocytes. CRF2 was up-regulated in mouse mature adipocytes. (b) CRF1 agonists suppressed media- and LPS-induced pre-adipocyte differentiation while CRF2 receptor agonists had no effect. (c) In mouse pre-adipocytes, CRF2 agonists suppressed TLR4 expression and the production of IL-6, CXCL1 and adiponectin while CRF1 agonists had no effect. (d) In mature mouse adipocytes LPS induced IL-6 and CXCL1 production and suppressed leptin. (e) In human visceral adipocytes LPS induced IL-6, TNF-alpha, IL-8, MCP-1 and leptin production and suppressed adiponectin and resistin. (f) In mouse mature adipocytes CRF1 and CRF2 agonists suppressed basal and LPS-induced production of inflammatory cytokines, TLR4 expression and adiponectin production, while in human visceral adipocytes CRF and UCN1 suppressed basal and LPS-induced IL-6, TNF-alpha, IL-8 and MCP-1 production. In conclusion, the effects of the activation of CRF1 and CRF2 may be significant in ameliorating the pro-inflammatory activity of adipocytes in obesity.	[Dermitzaki, Eirini; Androulidaki, Ariadne; Venihaki, Maria; Tsatsanis, Christos; Margioris, Andrew N.] Univ Crete, Sch Med, Dept Lab Med, Lab Clin Chem Biochem, Iraklion, Crete, Greece; [Liapakis, George] Univ Crete, Sch Med, Dept Basic Sci, Pharmacol Lab, Iraklion, Crete, Greece; [Melissas, John] Univ Crete, Sch Med, Dept Surg Oncol, Bariatr Unit, Iraklion, Crete, Greece	University of Crete; University of Crete; University of Crete	Margioris, AN (corresponding author), Univ Crete, Sch Med, Dept Lab Med, Lab Clin Chem Biochem, Iraklion, Crete, Greece.	andym@med.uoc.gr	Tsatsanis, Christos/AAM-9362-2020; Tsatsanis, Christos/C-2516-2018	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151	Hellenic Secretariat for Research and Technology [KA296/KA3330]; EU; program THALIS-FAT-VESSEL [379527]	Hellenic Secretariat for Research and Technology; EU(European Commission); program THALIS-FAT-VESSEL	This work was partly funded by Hellenic Secretariat for Research and Technology (Contract grant number: KA296/KA3330) and by the EU and national funds under the action "Education and lifelong learning'', program THALIS-FAT-VESSEL (No 379527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Ahima RS, 2008, J CLIN INVEST, V118, P2380, DOI 10.1172/JCI36284; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Charalampopoulos I, 2006, NEUROENDOCRINOLOGY, V84, P49, DOI 10.1159/000096827; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Ciardi C, 2012, BRIT J NUTR, V107, P826, DOI 10.1017/S0007114511003680; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dermitzaki E, 2001, ENDOCRINOLOGY, V142, P2022, DOI 10.1210/en.142.5.2022; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Friedberg M, 2003, J CLIN ENDOCR METAB, V88, P385, DOI 10.1210/jc.2002-020510; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hiroi N, 2001, MOL PSYCHIATR, V6, P540, DOI 10.1038/sj.mp.4000908; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; PEKALA PH, 1981, J BIOL CHEM, V256, P4871; Rentsch J, 1996, FEBS LETT, V379, P55, DOI 10.1016/0014-5793(95)01485-3; Seres J, 2004, J CLIN ENDOCR METAB, V89, P965, DOI 10.1210/jc.2003-031299; Shi HF, 2005, AM J PHYSIOL-REG I, V288, pR1028, DOI 10.1152/ajpregu.00648.2004; Sonti G, 1996, AM J PHYSIOL-REG I, V270, pR1394, DOI 10.1152/ajpregu.1996.270.6.R1394; STOUTHARD JML, 1995, AM J PHYSIOL-ENDOC M, V268, pE813, DOI 10.1152/ajpendo.1995.268.5.E813; Tomlinson JW, 2003, J CLIN ENDOCR METAB, V88, P2113, DOI 10.1210/jc.2002-021894; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Tsatsanis C, 2007, J CELL PHYSIOL, V210, P774, DOI 10.1002/jcp.20900; Tsigos C, 1997, NEUROENDOCRINOLOGY, V66, P54, DOI 10.1159/000127219; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turner JJ, CLIN EXP IMMUNOL, V162, P487; Vicennati V, 2002, INT J OBESITY, V26, P905, DOI 10.1038/sj.ijo.0802035; Vitseva OI, 2008, OBESITY, V16, P932, DOI 10.1038/oby.2008.25; Wabitsch M, 1996, DIABETES, V45, P1435, DOI 10.2337/diabetes.45.10.1435	36	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97060	10.1371/journal.pone.0097060	http://dx.doi.org/10.1371/journal.pone.0097060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835211	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800025
J	Noh, JW; Jo, M; Huh, T; Cheon, J; Kwon, YD				Noh, Jin-Won; Jo, Minkyung; Huh, Taewook; Cheon, Jooyoung; Kwon, Young Dae			Gender Differences and Socioeconomic Status in Relation to Overweight among Older Korean People	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CENTRAL OBESITY; PREVALENCE; ASSOCIATION; POPULATION; ADULTS; MEN; CONSUMPTION; INEQUALITY	Background: The ever-increasing older population and its association with serious overweight problems have garnered much attention. The correlation between being overweight and socioeconomic status factors could be helpful for understanding the inequalities among the overweight population. We examined the correlation between being overweight and some key variables, such as demographics, socioeconomic status, general health status, and health behavior in a large sample of older individuals, by each gender. Methods: We used data from the 2008 Korean Longitudinal Study of Aging and it included 8,157 participants who were 45 years or older. To understand the relationship between the overweight participants in accordance to demographic and socioeconomic characteristics, health status, and health behaviors, a weighted chi-square test and logistic regression analysis were conducted by separating variables related to overweight, according to the genders. Results: The number of people in the normal group was 6,347 (77.8%), while the people who were considered overweight were 1,810 (22.2%). Women (n = 4,583) constituted 52.7% of the subject, 24.9% of whom were classified as overweight. Meanwhile, 20.6% of the 47.3% (n = 3,574) of the sample who were men were classified as overweight. Participants between the ages of 45 and 64 with chronic diseases were more likely to be overweight. Men in the 4th quartile of household income were more likely to be overweight than those who were in the 1st quartile, in contrast, while unemployed women with lower education levels and urban residents were at greater risk for being overweight. Conclusions: Among the men, health status and health behavior appeared to show a correlation with being overweight; however, among women, socioeconomic status factors were strongly related to being overweight. These findings appear to support the association of gender-specifics with the prevalence of being overweight.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Songnam, South Korea; [Jo, Minkyung] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Huh, Taewook] Korean Womens Dev Inst, Strategy Dept Women Friendly Policy, Seoul, South Korea; [Cheon, Jooyoung] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Eulji University; Korea University; Korea University Medicine (KU Medicine); University System of Maryland; University of Maryland Baltimore; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832; Cheon, Jooyoung/0000-0001-9622-0937				Ball K, 2003, INT J OBESITY, V27, P394, DOI 10.1038/sj.ijo.0802237; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Ball K, 2002, INT J OBESITY, V26, P559, DOI 10.1038/sj.ijo.0801960; Cho Juhee, 2006, Prev Chronic Dis, V3, pA79; Grujic V, 2009, VOJNOSANIT PREGL, V66, P705, DOI 10.2298/VSP0909705G; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x; Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu20100060, 10.3390/nu2010060]; Kim IH, 2011, J KOREAN MED SCI, V26, P250, DOI 10.3346/jkms.2011.26.2.250; Kim JY, 2010, J KOREAN MED SCI, V25, P1560, DOI 10.3346/jkms.2010.25.11.1560; Kim O, 2012, PSYCHOL REP, V111, P963, DOI 10.2466/18.06.13.PR0.111.6.963-970; Korean National Statistical Office, 2012, POP PROJ KOR; KweonGuYoung, 2005, [Korean Journal of Social Welfare, 한국사회복지학], V57, P93; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; 김미영, 2012, Journal of Obesity & Metabolic Syndrome, V21, P18; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Padez C, 2006, PUBLIC HEALTH, V120, P946, DOI 10.1016/j.puhe.2006.05.023; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park H, 2011, MATURITAS, V70, P65, DOI 10.1016/j.maturitas.2011.05.014; Reas DL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-269; Martin AR, 2008, APPETITE, V51, P266, DOI 10.1016/j.appet.2008.02.021; Rodriguez-Martin A, 2009, NUTR HOSP, V24, P144; Roskam AJR, 2008, PUBLIC HEALTH NUTR, V11, P1256, DOI 10.1017/S1368980008002747; Sabanayagam C, 2009, ASIA-PAC J PUBLIC HE, V21, P487, DOI 10.1177/1010539509343957; Santos R, 2008, AM J HUM BIOL, V20, P78, DOI 10.1002/ajhb.20680; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2009, OBESITY, V17, P2223, DOI 10.1038/oby.2009.64; Sund ER, 2010, SOC SCI MED, V70, P1194, DOI 10.1016/j.socscimed.2010.01.007; Tchicaya Anastase, 2012, BMC Res Notes, V5, P467, DOI 10.1186/1756-0500-5-467; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97990	10.1371/journal.pone.0097990	http://dx.doi.org/10.1371/journal.pone.0097990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836697	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800096
J	Yaita, K; Aoki, K; Suzuki, T; Nakaharai, K; Yoshimura, Y; Harada, S; Ishii, Y; Tachikawa, N				Yaita, Kenichiro; Aoki, Kotaro; Suzuki, Takumitsu; Nakaharai, Kazuhiko; Yoshimura, Yukihiro; Harada, Sohei; Ishii, Yoshikazu; Tachikawa, Natsuo			Epidemiology of Extended-Spectrum beta-Lactamase Producing Escherichia coli in the Stools of Returning Japanese Travelers, and the Risk Factors for Colonization	PLOS ONE			English	Article							GRAM-NEGATIVE BACILLI; ENTEROBACTERIACEAE; PREVALENCE; DISSEMINATION; ENVIRONMENT; EMERGENCE; HEALTH; GENES; SMART	Objective: Travel overseas has recently been considered a risk factor for colonization with drug-resistant bacteria. The purpose of this study was to establish the epidemiology and risk factors associated with the acquisition of drug-resistant bacteria by Japanese travelers. Methods: Between October 2011 and September 2012, we screened the stools of 68 Japanese returning travelers for extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. All specimens were sampled for clinical reasons. Based on the results, the participants were divided into an ESBL-producing E. coli positive group (18 cases; 26%) and an ESBL-producing E. coli negative group (50 cases; 74%), and a case-control study was performed. Microbiological analyses of ESBL-producing strains, including susceptibility tests, screening tests for metallo-beta-lactamase, polymerase chain reaction amplification and sequencing of bla(CTX-M) genes, multilocus sequence typing, and whole genome sequencing, were also conducted. Results: In a univariate comparison, travel to India was a risk factor (Odds Ratio 13.6, 95% Confidence Interval 3.0-75.0, p<0.0001). There were no statistical differences in the characteristics of the travel, such as backpacking, purpose of travel, interval between travel return and sampling stool, and duration of travel. Although 10 of 13 analyzed strains (77%) produced CTX-M-15, no ST131 clone was detected. Conclusion: We must be aware of the possibilities of acquiring ESBL-producing E. coli during travel in order to prevent the spread of these bacteria not only in Japan but globally.	[Yaita, Kenichiro; Suzuki, Takumitsu; Nakaharai, Kazuhiko; Yoshimura, Yukihiro; Tachikawa, Natsuo] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan; [Aoki, Kotaro; Ishii, Yoshikazu] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Tokyo, Japan; [Harada, Sohei] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Infect Dis, Tokyo, Japan	Toho University; Japanese Foundation for Cancer Research	Yaita, K (corresponding author), Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan.	kyaita81@gmail.com		Harada, Sohei/0000-0003-3073-6564	Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Brink AJ, 2012, SURG INFECT, V13, P43, DOI 10.1089/sur.2011.074; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; Clinical and Laboratory Standards Institute, 2011, M7A9 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Deresinski S, 2011, CLIN INFECT DIS, V52, pI; Donnenberg MS, 2009, MANDELL DOUGLAS BENN, P2815; Ensor VM, 2006, J ANTIMICROB CHEMOTH, V58, P1260, DOI 10.1093/jac/dkl422; Freeman JT, 2008, CLIN INFECT DIS, V47, P689, DOI 10.1086/590941; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hawser SP, 2009, ANTIMICROB AGENTS CH, V53, P3280, DOI 10.1128/AAC.00426-09; Islam S, 2012, PEDIATR INFECT DIS J, V31, P1103, DOI 10.1097/INF.0b013e3182610e20; Kanda Y., 2012, BONE MARROW TRANSPL, V47, P1; Kimura S, 2005, DIAGN MICR INFEC DIS, V53, P241, DOI 10.1016/j.diagmicrobio.2005.05.017; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Luvsansharav UO, 2011, J INFECT CHEMOTHER, V17, P722, DOI 10.1007/s10156-011-0225-2; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2539, DOI 10.1128/AAC.00061-09; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Tham J, 2012, SCAND J INFECT DIS, V44, P573, DOI 10.3109/00365548.2011.653582; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Weisenberg SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045141; Woodford N, 2011, J TRAVEL MED, V18, P297, DOI 10.1111/j.1708-8305.2011.00541.x; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0	30	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98000	10.1371/journal.pone.0098000	http://dx.doi.org/10.1371/journal.pone.0098000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836896	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800097
J	Zhang, L; Zhang, C; Wu, PZ; Chen, YP; Li, MR; Jiang, HW; Wu, GJ				Zhang, Lin; Zhang, Chao; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Jiang, Huawu; Wu, Guojiang			Global Analysis of Gene Expression Profiles in Physic Nut (Jatropha curcas L.) Seedlings Exposed to Salt Stress	PLOS ONE			English	Article							ARABINOGALACTAN PROTEINS; ABIOTIC STRESS; TRANSCRIPTOME ANALYSIS; SIGNAL-TRANSDUCTION; SALINITY TOLERANCE; ARABIDOPSIS ROOTS; DROUGHT; MECHANISMS; RESPONSES; ETHYLENE	Background: Salt stress interferes with plant growth and production. Plants have evolved a series of molecular and morphological adaptations to cope with this abiotic stress, and overexpression of salt response genes reportedly enhances the productivity of various crops. However, little is known about the salt responsive genes in the energy plant physic nut (Jatropha curcas L.). Thus, excavate salt responsive genes in this plant are informative in uncovering the molecular mechanisms for the salt response in physic nut. Methodology/Principal Findings: We applied next-generation Illumina sequencing technology to analyze global gene expression profiles of physic nut plants (roots and leaves) 2 hours, 2 days and 7 days after the onset of salt stress. A total of 1,504 and 1,115 genes were significantly up and down-regulated in roots and leaves, respectively, under salt stress condition. Gene ontology (GO) analysis of physiological process revealed that, in the physic nut, many "biological processes'' were affected by salt stress, particular those categories belong to "metabolic process'', such as "primary metabolism process'', "cellular metabolism process'' and "macromolecule metabolism process''. The gene expression profiles indicated that the associated genes were responsible for ABA and ethylene signaling, osmotic regulation, the reactive oxygen species scavenging system and the cell structure in physic nut. Conclusions/Significance: The major regulated genes detected in this transcriptomic data were related to trehalose synthesis and cell wall structure modification in roots, while related to raffinose synthesis and reactive oxygen scavenger in leaves. The current study shows a comprehensive gene expression profile of physic nut under salt stress. The differential expression genes detected in this study allows the underling the salt responsive mechanism in physic nut with the aim of improving its salt resistance in the future.	[Zhang, Lin; Zhang, Chao; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Jiang, Huawu; Wu, Guojiang] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Zhang, Lin; Zhang, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, GJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	wugj@scbg.ac.cn	zhang, chao/C-4732-2012	zhang, chao/0000-0001-5287-4701	National Basic Research Program of China (973 Program) [2010CB126603]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-28]; CAS/SAFEA International Partnership Program for Creative Research Teams	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	The work was supported by grants from the National Basic Research Program of China (973 Program) (2010CB126603) (http://www.973.gov.cn/), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28) (http://www.cas.cn/), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2008, BIOMASS BIOENERG, V32, P1063, DOI 10.1016/j.biombioe.2008.03.003; Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; da Silva EN, 2011, SCI AGR, V68, P62, DOI 10.1590/S0103-90162011000100010; da Silva EN, 2009, PESQUI AGROPECU BRAS, V44, P437, DOI 10.1590/S0100-204X2009000500002; da Silva EN, 2009, REV CIENC AGRON, V40, P240; Diaz-Lopez L, 2012, PLANT PHYSIOL BIOCH, V54, P34, DOI 10.1016/j.plaphy.2012.02.005; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Farrokhi N, 2006, PLANT BIOTECHNOL J, V4, P145, DOI 10.1111/j.1467-7652.2005.00169.x; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Geilfus CM, 2011, PLANT SIGNAL BEHAV, V6, P1279, DOI 10.4161/psb.6.9.16760; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jiang HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036522; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jithesh MN, 2006, J GENET, V85, P237, DOI 10.1007/BF02935340; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Kwon Y, 2007, PLANT J, V49, P184, DOI 10.1111/j.1365-313X.2006.02950.x; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Neto MCL, 2014, J PLANT PHYSIOL, V171, P23, DOI 10.1016/j.jplph.2013.09.002; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mohsenzadeh S, 2011, AFR J BIOTECHNOL, V10, P8160; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; OOMS JJJ, 1993, PLANT PHYSIOL, V102, P1185, DOI 10.1104/pp.102.4.1185; Peters S, 2007, J EXP BOT, V58, P1947, DOI 10.1093/jxb/erm056; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Silva EN, 2010, J ARID ENVIRON, V74, P1130, DOI 10.1016/j.jaridenv.2010.05.036; Singh K, 2011, OMICS, V15, P913, DOI 10.1089/omi.2011.0098; van Hengel AJ, 2001, PLANT PHYSIOL, V125, P1880, DOI 10.1104/pp.125.4.1880; Vandenbussche F, 2012, NEW PHYTOL, V194, P895, DOI 10.1111/j.1469-8137.2012.04100.x; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Xiong Liming, 2002, Arabidopsis Book, V1, pe0048, DOI 10.1199/tab.0048; Xiong WD, 2013, GENE, V524, P124, DOI 10.1016/j.gene.2013.04.047; Xu XJ, 2009, MOL CELLS, V27, P423, DOI 10.1007/s10059-009-0060-9; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472	70	43	47	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97878	10.1371/journal.pone.0097878	http://dx.doi.org/10.1371/journal.pone.0097878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837971	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800080
J	Lindh, JD; Andersson, ML; Mannheimer, B				Lindh, Jonatan D.; Andersson, Marine L.; Mannheimer, Buster			Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SEROTONIN REUPTAKE INHIBITORS; PHARMACOEPIDEMIOLOGIC RESEARCH; POTENTIAL INTERACTION; HIGH-RISK; TRAMADOL; HEMORRHAGE; DATABASE; PHARMACOKINETICS; PHARMACODYNAMICS	Purpose: To investigate the extent to which clinicians avoid well-established drug-drug interactions associated with warfarin. We hypothesised that clinicians would avoid combining non-steroidal anti-inflammatory drugs (NSAIDs), tramadol and sulfamethoxazole with warfarin. Methods: A cross-sectional analysis of nationwide dispensing data was performed in Swedish individuals 18 years or older (n = 7 563 649). Odds ratios of interacting NSAIDs, tramadol and sulfamethoxazole versus respective prevalence of comparator drugs codeine, and ciprofloxacin in patients co-dispensed interacting warfarin versus patients unexposed was calculated. Results: The odds of receiving an interacting NSAID versus the comparator codeine was markedly lower in patients with warfarin than in the remaining population (adjusted OR 0.21; 95% CI 0.20 - 0.22). Also, the interacting drugs tramadol and sulfamethoxazole were less common among patients dispensed warfarin as compared to the remaining population, although the decrease was much more modest (adjusted OR 0.83; CI 0.80-0.87 and 0.81; CI 0.73 - 0.90). Conclusions: In conclusion, Swedish doctors in the vast majority of cases refrain from prescribing NSAIDs to patients already on warfarin. Tramadol and sulfamethoxazole are however rarely avoided.	[Lindh, Jonatan D.; Andersson, Marine L.] Karolinska Inst, Karolinska Univ Hosp, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital	Mannheimer, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden.	buster.mannheimer@sodersjukhuset.se			Swedish Society for Medical Research	Swedish Society for Medical Research	The work was supported financially by the Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn MD, 2003, MED J AUSTRALIA, V179, P34, DOI 10.5694/j.1326-5377.2003.tb05415.x; Battistella M, 2005, ARCH INTERN MED, V165, P189, DOI 10.1001/archinte.165.2.189; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Bottiger Y, 2009, EUR J CLIN PHARMACOL, V65, P627, DOI 10.1007/s00228-008-0612-5; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; Fischer HD, 2010, ARCH INTERN MED, V170, P617, DOI 10.1001/archinternmed.2010.37; Fitzmaurice DA, 2002, BMJ-BRIT MED J, V325, P828, DOI 10.1136/bmj.325.7368.828; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gagne JJ, 2008, J CLIN PHARM THER, V33, P141, DOI 10.1111/j.1365-2710.2007.00891.x; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Ghaswalla PK, 2012, AM J GERIATR PHARMAC, V10, P352, DOI 10.1016/j.amjopharm.2012.09.006; Glassman PA, 2006, MED CARE, V44, P250, DOI 10.1097/01.mlr.0000199849.08389.91; Glassman PA, 2002, MED CARE, V40, P1161, DOI 10.1097/00005650-200212000-00004; HASSALL C, 1975, LANCET, V2, P1155; Israel DS, 1996, CLIN INFECT DIS, V22, P251, DOI 10.1093/clinids/22.2.251; Johnell K, 2007, DRUG SAFETY, V30, P911, DOI 10.2165/00002018-200730100-00009; Jonsson AK, 2007, PHARMACOEPIDEM DR S, V16, P309, DOI 10.1002/pds.1291; Juel J, 2013, EUR J CLIN PHARMACOL, V69, P291, DOI 10.1007/s00228-012-1325-3; Klotz U, 2003, ARZNEIMITTELFORSCH, V53, P681; Lane MA, 2012, J CLIN PHARM THER, V37, P157, DOI 10.1111/j.1365-2710.2011.01270.x; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Malone DC, 2005, AM J HEALTH-SYST PH, V62, P1983, DOI 10.2146/ajhp040567; Mannheimer B, 2010, BRIT J CLIN PHARMACO, V69, P411, DOI 10.1111/j.1365-2125.2009.03598.x; Mannheimer B, 2008, EUR J CLIN PHARMACOL, V64, P1209, DOI 10.1007/s00228-008-0547-x; PIPPc Marie Eliasson, 2011, COMMUNICATION; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rane A, 2010, HUM GENOMICS PROTEOM, V2010, DOI DOI 10.4061/2010/754919; Sabbe JR, 1998, PHARMACOTHERAPY, V18, P871; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P581, DOI 10.1038/clpt.2008.150; Scher ML, 1997, ANN PHARMACOTHER, V31, P646, DOI 10.1177/106002809703100523; Settergren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069545; van Dijk KN, 2004, THROMB HAEMOSTASIS, V91, P95, DOI 10.1160/TH03-05-0325; Washington C, 2007, J CLIN PHARMACOL, V47, P1320, DOI 10.1177/0091270007305504; Wen X, 2002, DRUG METAB DISPOS, V30, P631, DOI 10.1124/dmd.30.6.631; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Williams D, 2000, BRIT J CLIN PHARMACO, V49, P369, DOI 10.1046/j.1365-2125.2000.00177.x	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97388	10.1371/journal.pone.0097388	http://dx.doi.org/10.1371/journal.pone.0097388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830709	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500051
J	Pang, S; Pokomo, L; Chen, K; Kamata, M; Mao, SH; Zhang, H; Razi, E; An, DS; Chen, ISY				Pang, Shen; Pokomo, Lauren; Chen, Kevin; Kamata, Masakazu; Mao, Si-Hua; Zhang, Hong; Razi, Elliot; An, Dong Sung; Chen, Irvin S. Y.			High-Throughput Screening of Effective siRNAs Using Luciferase-Linked Chimeric mRNA	PLOS ONE			English	Article							SMALL INTERFERING RNAS; SECONDARY STRUCTURE; MAMMALIAN-CELLS; TARGET SITES; HAIRPIN RNAS; EXPRESSION; HIV-1; VECTOR; CCR5; TRANSFECTION	The use of siRNAs to knock down gene expression can potentially be an approach to treat various diseases. To avoid siRNA toxicity the less transcriptionally active H1 pol III promoter, rather than the U6 promoter, was proposed for siRNA expression. To identify highly efficacious siRNA sequences, extensive screening is required, since current computer programs may not render ideal results. Here, we used CCR5 gene silencing as a model to investigate a rapid and efficient screening approach. We constructed a chimeric luciferase-CCR5 gene for high-throughput screening of siRNA libraries. After screening approximately 900 shRNA clones, 12 siRNA sequences were identified. Sequence analysis demonstrated that most (11 of the 12 sequences) of these siRNAs did not match those identified by available siRNA prediction algorithms. Significant inhibition of CCR5 in a T-lymphocyte cell line and primary T cells by these identified siRNAs was confirmed using the siRNA lentiviral vectors to infect these cells. The inhibition of CCR5 expression significantly protected cells from R5 HIV-1(JRCSF) infection. These results indicated that the high-throughput screening method allows efficient identification of siRNA sequences to inhibit the target genes at low levels of expression.	[Pang, Shen; Razi, Elliot] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Pokomo, Lauren; An, Dong Sung] Univ Calif Los Angeles, David Geffen Sch Med, Sch Nursing, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Pokomo, Lauren; An, Dong Sung] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Chen, Kevin; Kamata, Masakazu; Mao, Si-Hua; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Zhang, Hong] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhang, Hong] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Orthodont, Guangzhou 510275, Guangdong, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Sun Yat Sen University	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet & Med, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Kamata, Masakazu/0000-0003-0323-3742; Chen, Irvin/0000-0003-1199-2415	UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID) [AI028697]; National Institutes of Health [AI39975, AI28697, R01 HL086409, 3R01HL086409-03S1]; CIRM [RS1-00172-01]; Intramural Research Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, R01AI039975, P30AI028697] Funding Source: NIH RePORTER	UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID AI028697), the National Institutes of Health (AI39975 and AI28697 (to ISYC) and R01 HL086409 and 3R01HL086409-03S1 (to DSA)), CIRM (RS1-00172-01 (to ISYC)), and partially by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Chung NJ, 2008, J BIOMOL SCREEN, V13, P142, DOI 10.1177/1087057107312032; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; KIEFER J, 1953, P AM MATH SOC, V4, P502, DOI 10.2307/2032161; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Orita M, 2009, DRUG DISCOV TODAY, V14, P321, DOI 10.1016/j.drudis.2008.10.006; Pang S, 2001, CLIN CANCER RES, V7, P3567; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Scherer L, 2004, CURR PHARM BIOTECHNO, V5, P355, DOI 10.2174/1389201043376724; Scherer LJ, 2004, MOL THER, V10, P597, DOI 10.1016/j.ymthe.2004.05.003; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Snove O, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-231; Stevenson M, 2003, NAT REV IMMUNOL, V3, P851, DOI 10.1038/nri1227; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Ui-Tei Kumiko, 2007, Methods Mol Biol, V361, P201; van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhao HF, 2005, NAT METHODS, V2, P967, DOI 10.1038/NMETH812; Zheng XJ, 2011, J BIOTECHNOL, V155, P135, DOI 10.1016/j.jbiotec.2011.05.004	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96445	10.1371/journal.pone.0096445	http://dx.doi.org/10.1371/journal.pone.0096445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831610	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500019
J	Abreu, CM; Price, SL; Shirk, EN; Cunha, RD; Pianowski, LF; Clements, JE; Tanuri, A; Gama, L				Abreu, Celina M.; Price, Sarah L.; Shirk, Erin N.; Cunha, Rodrigo D.; Pianowski, Luiz F.; Clements, Janice E.; Tanuri, Amilcar; Gama, Lucio			Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; P-TEFB; DEACETYLASE INHIBITORS; BIOLOGICAL-ACTIVITY; LATENT RESERVOIR; EXPRESSION; PROSTRATIN; KINASE; TYPE-1	HIV infection is not cleared by antiretroviral drugs due to the presence of latently infected cells that are not eliminated with current therapies and persist in the blood and organs of infected patients. New compounds to activate these latent reservoirs have been evaluated so that, along with HAART, they can be used to activate latent virus and eliminate the latently infected cells resulting in eradication of viral infection. Here we describe three novel diterpenes isolated from the sap of Euphorbia tirucalli, a tropical shrub. These molecules, identified as ingenols, were modified at carbon 3 and termed ingenol synthetic derivatives (ISD). They activated the HIV-LTR in reporter cell lines and human PBMCs with latent virus in concentrations as low as 10 nM. ISDs were also able to inhibit the replication of HIV-1 subtype B and C in MT-4 cells and human PBMCs at concentrations of EC50 0.02 and 0.09 mu M respectively, which are comparable to the EC50 of some antiretroviral currently used in AIDS treatment. Control of viral replication may be caused by downregulation of surface CD4, CCR5 and CXCR4 observed after ISD treatment in vitro. These compounds appear to be less cytotoxic than other diterpenes such as PMA and prostratin, with effective dose versus toxic dose TI> 400. Although the mechanisms of action of the three ISDs are primarily attributed to the PKC pathway, downregulation of surface receptors and stimulation of the viral LTR might be differentially modulated by different PKC isoforms.	[Abreu, Celina M.; Cunha, Rodrigo D.; Clements, Janice E.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Abreu, Celina M.; Price, Sarah L.; Shirk, Erin N.; Gama, Lucio] Johns Hopkins Univ Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Pianowski, Luiz F.] Kyolab, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Johns Hopkins University	Gama, L (corresponding author), Johns Hopkins Univ Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	lucio@jhmi.edu	Tanuri, Amilcar/AAM-8601-2021; Abreu, Celina Monteiro/AAT-7447-2020	Gama, Lucio/0000-0001-9511-012X; Price, Sarah/0000-0002-4392-7506	NIH [R01 NS077869, P01 MH070306, U19 AI096113]; Brazilian agency CNPq; Brazilian agency FAPERJ; Brazilian agency CAPES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (www.nih.gov) grants R01 NS077869, P01 MH070306 and U19 AI096113 (JEC). It also received financial assistance from the Brazilian agencies CNPq, FAPERJ and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FR, 2012, DERMATOLOGY THER, V2, DOI 10.1007/s13555-012-0008-4; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Blanco-Molina M, 2001, CHEM BIOL, V8, P767, DOI 10.1016/S1074-5521(01)00048-5; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BOTO WMO, 1991, CELL REGUL, V2, P95, DOI 10.1091/mbc.2.2.95; Bouchat S, 2012, AIDS, V26, P1473, DOI 10.1097/QAD.0b013e32835535f5; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buss N, 2001, ANTIVIR THER, V6, P1; Capo C, 2000, IMPACT HIGHLY ACTIVE; Cherrier T, 2013, P NATL ACAD SCI USA, V110, P12655, DOI 10.1073/pnas.1220136110; Chiang Peter K., 1996, Journal of Biomedical Science, V3, P78, DOI 10.1007/BF02255534; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cimo AM, 2013, BIOCHEM J, V454, P109, DOI 10.1042/BJ20130485; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ersvaer E, 2010, TOXINS, V2, P174, DOI 10.3390/toxins2010174; Fernandez G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-266; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; Fujiwara M, 1998, ARCH VIROL, V143, P2003, DOI 10.1007/s007050050436; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hampson P, 2005, DRUG FUTURE, V30, P1003, DOI 10.1358/dof.2005.030.10.942816; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hashemi BB, 1999, FASEB J, V13, P2071, DOI 10.1096/fasebj.13.14.2071; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Hong Kee-Jong, 2011, Osong Public Health Res Perspect, V2, P109, DOI 10.1016/j.phrp.2011.07.001; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026677; Huet T, 2010, ANTIMICROB AGENTS CH, V54, P134, DOI 10.1128/AAC.00827-09; Jassbi AR, 2006, PHYTOCHEMISTRY, V67, P1977, DOI 10.1016/j.phytochem.2006.06.030; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347; McNamara LA, 2012, J VIROL, V86, P9337, DOI 10.1128/JVI.00895-12; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nirmala M. J., 2011, Research in Plant Biology, V1, P1; Norman R, 2013, JAMA DERMATOL, V149, P666, DOI [10.1001/jamadermatol.2013.2766, DOI 10.1001/JAMADERMATOL.2013.2766]; Pedersen OS, 1999, ANTIVIR CHEM CHEMOTH, V10, P285, DOI 10.1177/095632029901000601; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rullas J, 2004, ANTIVIR THER, V9, P545; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Vandergeeten C, 2012, CYTOKINE GROWTH F R, V23, P143, DOI 10.1016/j.cytogfr.2012.05.001; Visseaux B, 2012, ANTIMICROB AGENTS CH, V56, P137, DOI 10.1128/AAC.05313-11; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wender PA, 2011, P NATL ACAD SCI USA, V108, P6721, DOI 10.1073/pnas.1015270108; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yoshida M, 2003, INT J CANCER, V105, P601, DOI 10.1002/ijc.11157; ZAYED S, 1977, EXPERIENTIA, V33, P1554, DOI 10.1007/BF01933991; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	79	62	66	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97257	10.1371/journal.pone.0097257	http://dx.doi.org/10.1371/journal.pone.0097257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827152	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400068
J	Bala, S; Marcos, M; Gattu, A; Catalano, D; Szabo, G				Bala, Shashi; Marcos, Miguel; Gattu, Arijeet; Catalano, Donna; Szabo, Gyongyi			Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals	PLOS ONE			English	Article							LIVER-DISEASE; ALCOHOL; ACTIVATION; ETHANOL; PROTEIN	Binge drinking, the most common form of alcohol consumption, is associated with increased mortality and morbidity; yet, its biological consequences are poorly defined. Previous studies demonstrated that chronic alcohol use results in increased gut permeability and increased serum endotoxin levels that contribute to many of the biological effects of chronic alcohol, including alcoholic liver disease. In this study, we evaluated the effects of acute binge drinking in healthy adults on serum endotoxin levels. We found that acute alcohol binge resulted in a rapid increase in serum endotoxin and 16S rDNA, a marker of bacterial translocation from the gut. Compared to men, women had higher blood alcohol and circulating endotoxin levels. In addition, alcohol binge caused a prolonged increase in acute phase protein levels in the systemic circulation. The biological significance of the in vivo endotoxin elevation was underscored by increased levels of inflammatory cytokines, TNF alpha and IL-6, and chemokine, MCP-1, measured in total blood after in vitro lipopolysaccharide stimulation. Our findings indicate that even a single alcohol binge results in increased serum endotoxin levels likely due to translocation of gut bacterial products and disturbs innate immune responses that can contribute to the deleterious effects of binge drinking.	[Bala, Shashi; Marcos, Miguel; Gattu, Arijeet; Catalano, Donna; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Marcos, Miguel/B-3550-2008	Marcos, Miguel/0000-0003-1269-4487	NIH [AA 011576]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant AA 011576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, J LEUKOCYTE BIOL, V92, P611, DOI 10.1189/jlb.0112050; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005; Hartmann P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00402; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Levy O, 2003, PEDIATR INFECT DIS J, V22, P978, DOI 10.1097/01.inf.0000095196.19606.d2; Massey VL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00193; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG1252, DOI 10.1152/ajpgi.1998.275.6.G1252; Schnabl B, 2013, CURR OPIN GASTROEN, V29, P264, DOI 10.1097/MOG.0b013e32835ff948; Shukla SD, 2013, ALCOHOL CLIN EXP RES, V37, P550, DOI 10.1111/acer.12011; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Szabo G, 2010, ALCOHOL CLIN EXP RES, V34, P1675, DOI 10.1111/j.1530-0277.2010.01255.x; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	21	189	192	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96864	10.1371/journal.pone.0096864	http://dx.doi.org/10.1371/journal.pone.0096864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828436	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400041
J	Sjovall, F; Morota, S; Frostner, EA; Hansson, MJ; Elmer, E				Sjovall, Fredrik; Morota, Saori; Frostner, Eleonor Asander; Hansson, Magnus J.; Elmer, Eskil			Cytokine and Nitric Oxide Levels in Patients with Sepsis - Temporal Evolvement and Relation to Platelet Mitochondrial Respiratory Function	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; OXIDATIVE-PHOSPHORYLATION; INFLAMMATORY RESPONSE; BIOGENESIS; DYSFUNCTION; METABOLISM; ACTIVATION; MORTALITY; SURVIVAL; MARKERS	Background: The levels of nitric oxide (NO) and various cytokines are known to be increased during sepsis. These signaling molecules could potentially act as regulators and underlie the enhancement of mitochondrial function described in the later phase of sepsis. Therefore, we investigated the correlation between observed changes in platelet mitochondrial respiration and a set of pro- and anti-inflammatory cytokines as well as NO plasma levels in patients with sepsis. Methods and Results: Platelet mitochondrial respiration and levels of TNF alpha, MCP-1 (monocyte chemotactic protein-1), INF gamma (interferon-gamma), IL-1 beta, IL-4, IL-5, IL-6, IL-8, IL-10 and IL-17 and NO were analyzed in 38 patients with severe sepsis or septic shock at three time points during one week following admission to the ICU. Citrate synthase, mitochondrial DNA and cytochrome c were measured as markers of cellular mitochondrial content. All mitochondrial respiratory states increased over the week analyzed (p < 0.001). IL-8 levels correlated with maximal mitochondrial respiration on day 6-7 (p = 0.02, r(2) = 0.22) and was also higher in non-survivors compared to survivors on day 3-4 and day 6-7 (p = 0.03 respectively). Neither NO nor any of the other cytokines measured correlated with respiration or mortality. Cytochrome c levels were decreased at day 1-2 by 24 +/- 5% (p = 0.03) and returned towards values of the controls at the last two time points. Citrate synthase activity and mitochondrial DNA levels were similar to controls and remained constant throughout the week. Conclusions: Out of ten analyzed cytokines and nitric oxide, IL-8 correlated with the observed increase in mitochondrial respiration. This suggests that cytokines as well as NO do not play a prominent role in the regulation of platelet mitochondrial respiration in sepsis. Further, the respiratory increase was not accompanied by an increase in markers of mitochondrial content, suggesting a possible role for post-translational enhancement of mitochondrial respiration rather than augmented mitochondrial mass.	[Sjovall, Fredrik; Morota, Saori; Frostner, Eleonor Asander; Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Lund, Sweden; [Sjovall, Fredrik] Univ Copenhagen Hosp, Rigshosp, Intens Care Unit 4131, DK-2100 Copenhagen, Denmark; [Hansson, Magnus J.] Lund Univ, Dept Clin Physiol, Skane Univ Hosp, Lund, Sweden; [Elmer, Eskil] Lund Univ, Dept Clin Neurophysiol, Skane Univ Hosp, Lund, Sweden	Lund University; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Sjovall, F (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	fredrik.sjovall@med.lu.se	Elmér, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014	Elmér, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638; Asander Frostner, Eleonor/0000-0001-8426-4836; Sjovall, Fredrik/0000-0001-5612-0325	Swedish Research Council [2011-3470]; Royal Physiographic Society; Swedish Society of Medicine; Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab; Lippman foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society; Swedish Society of Medicine; Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab; Lippman foundation	This work was supported by the Swedish Research Council (Reference number 2011-3470), the Royal Physiographic Society, the Swedish Society of Medicine, Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab, and the Lippman foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; Boczkowski J, 2001, BIOL SIGNAL RECEPT, V10, P66; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brealey David, 2003, Curr Infect Dis Rep, V5, P365, DOI 10.1007/s11908-003-0015-9; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Drabarek B, 2012, INT J BIOCHEM CELL B, V44, P1390, DOI 10.1016/j.biocel.2012.05.022; Fry DE, 2012, AM SURGEON, V78, P1; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Gnaiger E, 2000, LIFE IN THE COLD, P431; HACK CE, 1992, INFECT IMMUN, V60, P2835, DOI 10.1128/IAI.60.7.2835-2842.1992; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hoogerwerf JJ, 2010, INTENS CARE MED, V36, P630, DOI 10.1007/s00134-010-1773-0; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KILBOURN RG, 1992, J NATL CANCER I, V84, P827, DOI 10.1093/jnci/84.11.827; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Reynolds CM, 2009, FREE RADICAL BIO MED, V46, P564, DOI 10.1016/j.freeradbiomed.2008.11.007; Ricart-Jane D, 2002, NITRIC OXIDE-BIOL CH, V6, P178, DOI 10.1006/niox.2001.0392; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Sjovall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97673	10.1371/journal.pone.0097673	http://dx.doi.org/10.1371/journal.pone.0097673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828117	Green Published, gold			2022-12-25	WOS:000336857400116
J	Sun, JH; Peng, Y; Duan, XM; Yu, T; Zhang, QF; Liu, Y; Hu, D				Sun, Jihang; Peng, Yun; Duan, Xiaomin; Yu, Tong; Zhang, Qifeng; Liu, Yong; Hu, Di			Image Quality in Children with Low-Radiation Chest CT Using Adaptive Statistical Iterative Reconstruction and Model-Based Iterative Reconstruction	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; LOW-DOSE CT; HELICAL CT; REDUCTION; OPTIMIZATION; FEASIBILITY; ABDOMEN	Objective: To evaluate noise reduction and image quality improvement in low-radiation dose chest CT images in children using adaptive statistical iterative reconstruction (ASIR) and a full model-based iterative reconstruction (MBIR) algorithm. Methods: Forty-five children (age ranging from 28 days to 6 years, median of 1.8 years) who received low-dose chest CT scans were included. Age-dependent noise index (NI) was used for acquisition. Images were retrospectively reconstructed using three methods: MBIR, 60% of ASIR and 40% of conventional filtered back-projection (FBP), and FBP. The subjective quality of the images was independently evaluated by two radiologists. Objective noises in the left ventricle (LV), muscle, fat, descending aorta and lung field at the layer with the largest cross-section area of LV were measured, with the region of interest about one fourth to half of the area of descending aorta. Optimized signal-to-noise ratio (SNR) was calculated. Result: In terms of subjective quality, MBIR images were significantly better than ASIR and FBP in image noise and visibility of tiny structures, but blurred edges were observed. In terms of objective noise, MBIR and ASIR reconstruction decreased the image noise by 55.2% and 31.8%, respectively, for LV compared with FBP. Similarly, MBIR and ASIR reconstruction increased the SNR by 124.0% and 46.2%, respectively, compared with FBP. Conclusion: Compared with FBP and ASIR, overall image quality and noise reduction were significantly improved by MBIR. MBIR image could reconstruct eligible chest CT images in children with lower radiation dose.	[Sun, Jihang; Peng, Yun; Duan, Xiaomin; Yu, Tong; Zhang, Qifeng; Liu, Yong; Hu, Di] Capital Med Univ, Beijing Childrens Hosp, Imaging Ctr, Beijing, Peoples R China	Capital Medical University	Peng, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Imaging Ctr, Beijing, Peoples R China.	ppengyun@yahoo.com	Sun, Jihang/AAG-2811-2020		National Science and Technology Major Project of the Ministry of Science and Technology of China; Application Research of Clinical Characteristics of Beijing [Z141107002514005]	National Science and Technology Major Project of the Ministry of Science and Technology of China; Application Research of Clinical Characteristics of Beijing	This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China and The Application Research of Clinical Characteristics of Beijing (Z141107002514005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GE BLUEPR GUID CT RA; Bongartz G, 2000, 16262 EUR EN; Cornfeld D, 2011, AM J ROENTGENOL, V196, pW336, DOI 10.2214/AJR.10.4573; Diel J, 2000, J COMPUT ASSIST TOMO, V24, P795, DOI 10.1097/00004728-200009000-00023; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Kalra MK, 2003, RADIOLOGY, V228, P251, DOI 10.1148/radiol.2281020693; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Peng Y, 2009, ACTA RADIOL, V50, P1175, DOI 10.3109/02841850903241914; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Vorona GA, 2011, PEDIATR RADIOL, V41, P1174, DOI 10.1007/s00247-011-2063-x; Xu X, 2011, ZHONG GUO YI XUE YIN, V27, P1633; Yoon MA, 2012, J COMPUT ASSIST TOMO, V36, P596, DOI 10.1097/RCT.0b013e31826092be; Yu Z, 2011, IEEE T IMAGE PROCESS, V20, P161, DOI 10.1109/TIP.2010.2058811	23	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96045	10.1371/journal.pone.0096045	http://dx.doi.org/10.1371/journal.pone.0096045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828429	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400021
J	Sanchez-Osuna, M; Garcia-Belinchon, M; Iglesias-Guimarais, V; Gil-Guinon, E; Casanelles, E; Yuste, VJ				Sanchez-Osuna, Maria; Garcia-Belinchon, Merce; Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Casanelles, Elisenda; Yuste, Victor J.			Caspase-activated DNase Is Necessary and Sufficient for Oligonucleosomal DNA Breakdown, but Not for Chromatin Disassembly during Caspase-dependent Apoptosis of LN-18 Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENTATION FACTOR; DFF40/CAD ENDONUCLEASE; NEUROBLASTOMA-CELLS; NUCLEAR APOPTOSIS; 40-KDA SUBUNIT; DEATH; CONDENSATION; CLEAVAGE; INHIBITOR; PROTEIN	Caspase-dependent apoptosis is a controlled type of cell death characterized by oligonucleosomal DNA breakdown and major nuclear morphological alterations. Other kinds of cell death do not share these highly distinctive traits because caspase-activated DNase (DFF40/CAD) remains inactive. Here, we report that human glioblastoma multiforme-derived LN-18 cells do not hydrolyze DNA into oligonucleosomal fragments after apoptotic insult. Furthermore, their chromatin remains packaged into a single mass, with no signs of nuclear fragmentation. However, ultrastructural analysis reveals that nuclear disassembly occurs, although compacted chromatin does not localize into apoptotic nuclear bodies. Caspases become properly activated, and ICAD, the inhibitor of DFF40/CAD, is correctly processed. Using cell-free in vitro assays, we show that chromatin from isolated nuclei of LN-18 cells is suitable for hydrolysis into oligonuclesomal fragments by staurosporine-pretreated SH-SY5Y cytoplasms. However, staurosporine-pretreated LN-18 cytoplasms do not induce DNA laddering in isolated nuclei from either LN-18 or SH-SY5Y cells because LN-18 cells express lower amounts of DFF40/CAD. DFF40/CAD overexpression makes LN-18 cells fully competent to degrade their DNA into oligonucleosome-sized fragments, and yet they remain unable to arrange their chromatin into nuclear clumps after apoptotic insult. Indeed, isolated nuclei from LN-18 cells were resistant to undergoing apoptotic nuclear morphology in vitro. The use of LN-18 cells has uncovered a previously unsuspected cellular model, whereby a caspase-dependent chromatin package is DFF40/CAD-independent, and DFF40/CAD-mediated double-strand DNA fragmentation does not warrant the distribution of the chromatin into apoptotic nuclear bodies. The studies highlight a not-yet reported DFF40/CAD-independent mechanism driving conformational nuclear changes during caspase-dependent cell death.	Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08193, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; CIBERNED	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Gil, Estel/B-9786-2015; Yuste, Victor J./C-7071-2008	Yuste, Victor J./0000-0001-5322-9261; Gil, Estel/0000-0003-4502-4623	Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant [SAF2012-31485]; Generalitat de Catalunya Grant [SGR2009-346]; Ministerio de Ciencia e Innovacion [BES-2099-028572, TRA2009-0185]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Ramon y Cajal Program (Ministerio de Educacion y Ciencia)	Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant; Generalitat de Catalunya Grant(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ramon y Cajal Program (Ministerio de Educacion y Ciencia)(German Research Foundation (DFG))	This work was supported by Ministerio de Economia y Competitividad/Fondo Europeo de Desarrollo Regional (MINECO/FEDER) Grant SAF2012-31485 and Generalitat de Catalunya Grant SGR2009-346.; Recipient of Formacion de Personal Investigador Fellowship BES-2099-028572 from the Ministerio de Ciencia e Innovacion).; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya).; Held Postdoctoral Contract TRA2009-0185 from the Ministerio de Ciencia e Innovacion.; Supported by the Ramon y Cajal Program (Ministerio de Educacion y Ciencia).	Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dini L, 1996, EXP CELL RES, V223, P340, DOI 10.1006/excr.1996.0089; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Glebova K, 2015, CANCER LETT, V356, P22, DOI 10.1016/j.canlet.2013.09.005; Gozzelino R, 2008, CELL RES, V18, P1020, DOI 10.1038/cr.2008.76; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Joselin AP, 2006, J BIOL CHEM, V281, P12475, DOI 10.1074/jbc.M509859200; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kuribayashi N, 1996, ANTICANCER RES, V16, P1225; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Majczak A, 2004, J ELECTRON MICROSC, V53, P635, DOI 10.1093/jmicro/dfh086; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Perez-Alvarez S, 2011, PHARMACOL RES, V63, P352, DOI 10.1016/j.phrs.2010.12.001; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Widlak P, 2002, J BIOL CHEM, V277, P21683, DOI 10.1074/jbc.M201027200; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450	47	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18752	18769		10.1074/jbc.M114.550020	http://dx.doi.org/10.1074/jbc.M114.550020			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24838313	Green Published, hybrid			2022-12-25	WOS:000339062900012
J	Sugeno, N; Hasegawa, T; Tanaka, N; Fukuda, M; Wakabayashi, K; Oshima, R; Konno, M; Miura, E; Kikuchi, A; Baba, T; Anan, T; Nakao, M; Geisler, S; Aoki, M; Takeda, A				Sugeno, Naoto; Hasegawa, Takafumi; Tanaka, Nobuyuki; Fukuda, Mitsunori; Wakabayashi, Koichi; Oshima, Ryuji; Konno, Masashi; Miura, Emiko; Kikuchi, Akio; Baba, Toru; Anan, Tadashi; Nakao, Mitsuyoshi; Geisler, Sven; Aoki, Masashi; Takeda, Atsushi			Lys-63-linked Ubiquitination by E3 Ubiquitin Ligase Nedd4-1 Facilitates Endosomal Sequestration of Internalized alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODIES; ALZHEIMERS-DISEASE; WW DOMAINS; MEMBRANE; DEGRADATION; BINDING; PHOSPHORYLATION; LOCALIZATION; PENETRATION; AGGREGATION	alpha-Synuclein (aS) is a major constituent of Lewy bodies, which are not only a pathological marker for Parkinson disease but also a trigger for neurodegeneration. Cumulative evidence suggests that aS spreads from cell to cell and thereby propagates neurodegeneration to neighboring cells. Recently, Nedd4-1 (neural precursor cell expressed developmentally down-regulated protein 4-1), an E3 ubiquitin ligase, was shown to catalyze the Lys-63-linked polyubiquitination of intracellular aS and thereby facilitate aS degradation by the endolysosomal pathway. Because Nedd4-1 exerts its activity in close proximity to the inner leaflet of the plasma membrane, we speculate that after the internalization of aS the membrane resident aS is preferentially ubiquitinated by Nedd4-1. To clarify the role of Nedd4-1 in aS internalization and endolysosomal sequestration, we generated aS mutants, including Delta PR1(1-119 and 129-140), Delta C(1-119), and Delta PR2(1-119 and 134-140), that lack the proline-rich sequence, a putative Nedd4-1 recognition site. We show that wild type aS, but not Delta PR1, Delta PR2, or Delta C aS, is modified by Nedd4-1 in vitro, acquiring a Lys-63-linked ubiquitin chain. Compared with the mutants lacking the proline-rich sequence, wild type-aS is preferentially internalized and translocated to endosomes. The overexpression of Nedd4-1 increased aS in endosomes, whereas RNAi-mediated silencing of Nedd4-1 decreased endosomal aS. Although aS freely passes through plasma membranes within minutes, a pulse-chase experiment revealed that the overexpression of Nedd4-1 markedly decreased the re-secretion of internalized aS. Together, these findings demonstrate that Nedd4-1-linked Lys-63 ubiquitination specifies the fate of extrinsic and de novo synthesized aS by facilitating their targeting to endosomes.	[Sugeno, Naoto; Hasegawa, Takafumi; Oshima, Ryuji; Konno, Masashi; Miura, Emiko; Kikuchi, Akio; Baba, Toru; Aoki, Masashi; Takeda, Atsushi] Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi 9808574, Japan; [Tanaka, Nobuyuki; Oshima, Ryuji] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi 9811293, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9808578, Japan; [Wakabayashi, Koichi] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Anan, Tadashi] Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 860, Japan; [Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Geisler, Sven] Univ Tubingen, German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Lab Funct Neurogenet,Dept Neurodegenerat Dis, D-72076 Tubingen, Germany	Tohoku University; Miyagi Cancer Center; Tohoku University; Hirosaki University; Kumamoto University; Kumamoto University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hasegawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi 9808574, Japan.	thasegawa@med.tohoku.ac.jp	Hasegawa, Takafumi/I-6668-2017; Perry, George/A-8611-2009; Fukuda, MItsunori/I-1511-2015	Perry, George/0000-0002-6547-0172; Fukuda, MItsunori/0000-0002-8620-5853; Baba, Toru/0000-0003-0936-2510	Ministry of Education, Culture, Sports, Science and Technology [25461264, 23591228, 24390219, 24659423, 24111502]; Research Committee for Ataxic Diseases; Ministry of Health, Labor, and Welfare, Japan; Symposium on Catecholamine and Neurological Disorders; 17th Takeda Science Foundation Symposium on Bioscience; Grants-in-Aid for Scientific Research [26461263] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee for Ataxic Diseases; Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Symposium on Catecholamine and Neurological Disorders; 17th Takeda Science Foundation Symposium on Bioscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (C) 25461264 and 23591228, Grant-in-aid for Scientific Research (B) 24390219, Grant-in-aid for Exploratory Research 24659423, Grant-in-aid for Scientific Research on Innovative Areas (Brain Environment) 24111502 from the Ministry of Education, Culture, Sports, Science and Technology, a grant from the Research Committee for Ataxic Diseases, the Ministry of Health, Labor, and Welfare, Japan, a grant from the Symposium on Catecholamine and Neurological Disorders, and a grant from the 17th Takeda Science Foundation Symposium on Bioscience.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hara S, 2013, MOL BIOL CELL, V24, P1649, DOI 10.1091/mbc.E12-12-0903; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; HAYASHIDA K, 1993, ACTA NEUROPATHOL, V85, P445, DOI 10.1007/BF00334457; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kurashige T, 2013, NEUROPATHOLOGY, V33, P237, DOI 10.1111/j.1440-1789.2012.01346.x; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Tanikawa S, 2012, NEUROSCI LETT, V527, P16, DOI 10.1016/j.neulet.2012.08.035; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	50	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18137	18151		10.1074/jbc.M113.529461	http://dx.doi.org/10.1074/jbc.M113.529461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831002	hybrid, Green Published			2022-12-25	WOS:000338042000017
J	Elziere, L; Sar, C; Venteo, S; Bourane, S; Puech, S; Sonrier, C; Boukhadaoui, H; Fichard, A; Pattyn, A; Valmier, J; Carroll, P; Mechaly, I				Elziere, Lucie; Sar, Chamroeun; Venteo, Stephanie; Bourane, Steeve; Puech, Sylvie; Sonrier, Corinne; Boukhadaoui, Hassan; Fichard, Agnes; Pattyn, Alexandre; Valmier, Jean; Carroll, Patrick; Mechaly, Ilana			CaMKK-CaMK1a, a New Post-Traumatic Signalling Pathway Induced in Mouse Somatosensory Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; KINASE-I; RECEPTOR COMPONENTS; AXONAL REGENERATION; NEUROPATHIC PAIN; GENE-EXPRESSION; GDNF; AXOTOMY	Neurons innervating peripheral tissues display complex responses to peripheral nerve injury. These include the activation and suppression of a variety of signalling pathways that together influence regenerative growth and result in more or less successful functional recovery. However, these responses can be offset by pathological consequences including neuropathic pain. Calcium signalling plays a major role in the different steps occurring after nerve damage. As part of our studies to unravel the roles of injury-induced molecular changes in dorsal root ganglia (DRG) neurons during their regeneration, we show that the calcium calmodulin kinase CaMK1a is markedly induced in mouse DRG neurons in several models of mechanical peripheral nerve injury, but not by inflammation. Intrathecal injection of NRTN or GDNF significantly prevents the post-traumatic induction of CaMK1a suggesting that interruption of target derived factors might be a starter signal in this de novo induction. Inhibition of CaMK signalling in injured DRG neurons by pharmacological means or treatment with CaMK1a siRNA resulted in decreased velocity of neurite growth in vitro. Altogether, the results suggest that CaMK1a induction is part of the intrinsic regenerative response of DRG neurons to peripheral nerve injury, and is thus a potential target for therapeutic intervention to improve peripheral nerve regeneration.	[Elziere, Lucie; Sar, Chamroeun; Venteo, Stephanie; Puech, Sylvie; Sonrier, Corinne; Boukhadaoui, Hassan; Fichard, Agnes; Pattyn, Alexandre; Valmier, Jean; Carroll, Patrick; Mechaly, Ilana] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Fichard, Agnes; Valmier, Jean; Mechaly, Ilana] Univ Montpellier 2, Dept BioMV, Montpellier, France; [Bourane, Steeve] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Salk Institute	Mechaly, I (corresponding author), INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	imechaly@univ-montp2.fr	Carroll, Patrick/C-2933-2012; Alexandre, Pattyn/ABF-1346-2020; Carroll, Patrick/AAL-7773-2021; Bourane, Steeve/AAI-6143-2020	Carroll, Patrick/0000-0003-3287-8195; Bourane, Steeve/0000-0002-9805-2196; Pattyn, Alexandre/0000-0003-1215-1482	AFM (Association Francaise contre les Myopathies); MESR (Ministere de l'enseignement superieur et de la recherche)	AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); MESR (Ministere de l'enseignement superieur et de la recherche)(Ministry of Research, France)	This work was supported by grants from AFM (Association Francaise contre les Myopathies) and MESR (Ministere de l'enseignement superieur et de la recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Averill S, 2004, EUR J NEUROSCI, V19, P1437, DOI 10.1111/j.1460-9568.2004.03241.x; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Eddleman CS, 1998, J NEUROSCI, V18, P4029; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Gold BG, 1997, NEUROSCIENCE, V76, P1153, DOI 10.1016/S0306-4522(96)00416-2; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hirata A, 2002, BRAIN RES, V944, P146, DOI 10.1016/S0006-8993(02)02739-7; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Ivanavicius SP, 2007, PAIN, V128, P272, DOI 10.1016/j.pain.2006.12.022; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kamata A, 2007, NEUROSCI RES, V57, P86, DOI 10.1016/j.neures.2006.09.013; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mohiuddin L, 1999, NEUROSCIENCE, V91, P265, DOI 10.1016/S0306-4522(98)00582-X; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Neal AP, 2010, J NEUROSCI, V30, P2807, DOI 10.1523/JNEUROSCI.5984-09.2010; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; Patodia S, 2012, CELL TISSUE RES, V349, P15, DOI 10.1007/s00441-012-1416-6; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Smith DS, 1997, J NEUROSCI, V17, P646; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Szpara ML, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-100; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venteo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029852; Vogelaar CF, 2003, EUR J PHARMACOL, V480, P233, DOI 10.1016/j.ejphar.2003.08.110; Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3; Wang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028908; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	69	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97736	10.1371/journal.pone.0097736	http://dx.doi.org/10.1371/journal.pone.0097736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840036	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600065
J	Lambrechts, D; Roeffaers, M; Goossens, K; Hofkens, J; Van de Putte, T; Schrooten, J; Van Oosterwyck, H				Lambrechts, Dennis; Roeffaers, Maarten; Goossens, Karel; Hofkens, Johan; Van de Putte, Tom; Schrooten, Jan; Van Oosterwyck, Hans			A Causal Relation between Bioluminescence and Oxygen to Quantify the Cell Niche	PLOS ONE			English	Article							FIREFLY LUCIFERASE; PARTICLES; SUBSTRATE; HYPOXIA; LUMINESCENCE; FLUORESCENCE; GENE	Bioluminescence imaging assays have become a widely integrated technique to quantify effectiveness of cell-based therapies by monitoring fate and survival of transplanted cells. To date these assays are still largely qualitative and often erroneous due to the complexity and dynamics of local micro-environments (niches) in which the cells reside. Here, we report, using a combined experimental and computational approach, on oxygen that besides being a critical niche component responsible for cellular energy metabolism and cell-fate commitment, also serves a primary role in regulating bioluminescent light kinetics. We demonstrate the potential of an oxygen dependent Michaelis-Menten relation in quantifying intrinsic bioluminescence intensities by resolving cell-associated oxygen gradients from bioluminescent light that is emitted from three-dimensional (3D) cell-seeded hydrogels. Furthermore, the experimental and computational data indicate a strong causal relation of oxygen concentration with emitted bioluminescence intensities. Altogether our approach demonstrates the importance of oxygen to evolve towards quantitative bioluminescence and holds great potential for future microscale measurement of oxygen tension in an easily accessible manner.	[Lambrechts, Dennis; Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium; [Lambrechts, Dennis; Schrooten, Jan; Van Oosterwyck, Hans] Katholieke Univ Leuven, Div Skeletal Tissue Engn Leuven, Leuven, Belgium; [Roeffaers, Maarten] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Leuven, Belgium; [Goossens, Karel] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Hofkens, Johan] Katholieke Univ Leuven, Leuven, Belgium; [Van de Putte, Tom] TiGenix NV, Leuven, Belgium; [Van Oosterwyck, Hans] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Texas System; University of Texas Austin; KU Leuven; KU Leuven	Schrooten, J (corresponding author), Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium.	Jan.Schrooten@mtm.kuleuven.be; Hans.VanOosterwyck@mech.kuleuven.be	Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/AAL-4204-2020; Van Oosterwyck, Hans/C-2528-2016; Velde, Greetje Vande/O-9161-2016; Roeffaers, Maarten/AAB-8874-2020; Roeffaers, Maarten/D-9328-2011; Hofkens, Johan/D-4284-2017	Van Oosterwyck, Hans/0000-0002-2142-9717; Velde, Greetje Vande/0000-0002-5633-3993; Roeffaers, Maarten/0000-0001-6582-6514; Lambrechts, Dennis/0000-0002-2373-2795; Hofkens, Johan/0000-0002-9101-0567	agency for Innovation by Science and Technology (IWT-Vlaanderen) [090727]; Research Foundation-Flanders (FWO-Vlaanderen) [G.0858.12]; Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant); Hercules Foundation [HER/08/021]; Research Foundation Flanders (FWO-Vlaanderen); Belgian American Educational Foundation (BAEF)	agency for Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant); Hercules Foundation; Research Foundation Flanders (FWO-Vlaanderen)(FWO); Belgian American Educational Foundation (BAEF)	This work was supported by the agency for Innovation by Science and Technology (IWT-Vlaanderen, project number 090727) and the Research Foundation-Flanders (FWO-Vlaanderen, project number G.0858.12). The authors also gratefully acknowledge financial support from the Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant) and from the Hercules Foundation (HER/08/021). KG acknowledges the Research Foundation Flanders (FWO-Vlaanderen) and the Belgian American Educational Foundation (BAEF) for postdoctoral research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Berthold F, 2011, CHEMILUMINESCENCE AND BIOLUMINESCENCE: PAST, PRESENT AND FUTURE, P113; BOGUSH GH, 1988, J NON-CRYST SOLIDS, V104, P95, DOI 10.1016/0022-3093(88)90187-1; Chen SL, 1996, J COLLOID INTERF SCI, V180, P237, DOI 10.1006/jcis.1996.0295; Crank J, 1979, MATH DIFFUSION, P28; DENBURG JL, 1969, ARCH BIOCHEM BIOPHYS, V134, P381, DOI 10.1016/0003-9861(69)90297-5; Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005; Fraga H, 2005, FEBS J, V272, P5206, DOI 10.1111/j.1742-4658.2005.04895.x; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GANDELMAN O, 1994, J BIOLUM CHEMILUM, V9, P363, DOI 10.1002/bio.1170090603; GANDELMAN OA, 1993, J PHOTOCH PHOTOBIO B, V19, P187, DOI 10.1016/1011-1344(93)87083-Y; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; KOPELMAN R, 1988, SCIENCE, V241, P1620, DOI 10.1126/science.241.4873.1620; Lambrechts D, 2013, BIOMATERIALS, V34, P922, DOI 10.1016/j.biomaterials.2012.10.019; Leskovac V, 2003, COMPREHENSIVE ENZYME, P11; Masalov VM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/27/275718; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Moriyama EH, 2008, PHOTOCH PHOTOBIO SCI, V7, P675, DOI 10.1039/b719231b; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Shinde R, 2006, BIOCHEMISTRY-US, V45, P11103, DOI 10.1021/bi060475o; Timmins GS, 2001, J EXP BIOL, V204, P2795; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Weiss MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014026; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	40	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97572	10.1371/journal.pone.0097572	http://dx.doi.org/10.1371/journal.pone.0097572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840204	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600046
J	Murakami, H; Tomaru, T; Nishiyama, Y; Moriyama, T; Niizato, T; Gunji, YP				Murakami, Hisashi; Tomaru, Takenori; Nishiyama, Yuta; Moriyama, Toru; Niizato, Takayuki; Gunji, Yukio-Pegio			Emergent Runaway into an Avoidance Area in a Swarm of Soldier Crabs	PLOS ONE			English	Article							INFORMATION; MICTYRIDAE; BRACHYURA; BEHAVIOR	Emergent behavior that arises from a mass effect is one of the most striking aspects of collective animal groups. Investigating such behavior would be important in order to understand how individuals interact with their neighbors. Although there are many experiments that have used collective animals to investigate social learning or conflict between individuals and society such as that between a fish and a school, reports on mass effects are rare. In this study, we show that a swarm of soldier crabs could spontaneously enter a water pool, which are usually avoided, by forming densely populated part of a swarm at the edge of the water pool. Moreover, we show that the observed behavior can be explained by the model of collective behavior based on inherent noise that is individuals' different velocities in a directed group. Our results suggest that inherent noise, which is widely seen in collective animals, can contribute to formation and/or maintenance of a swarm and that the dense swarm can enter the pool by means of enhanced inherent noise.	[Murakami, Hisashi; Tomaru, Takenori] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan; [Nishiyama, Yuta] Osaka Univ, Sci & Technol Entrepreneurship Lab E Square, Osaka, Japan; [Moriyama, Toru] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan; [Niizato, Takayuki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Gunji, Yukio-Pegio] Waseda Univ, Sch Fundamental Sci & Engn, Dept Intermedia Art & Sci, Tokyo, Japan	Kobe University; Osaka University; Shinshu University; University of Tsukuba; Waseda University	Murakami, H (corresponding author), Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan.	hssh415@gmail.com	Moriyama, Toru/AAX-9780-2020	Moriyama, Toru/0000-0001-8711-5676	Kobe University;  [JSPS24320008]; Grants-in-Aid for Scientific Research [13J03561, 25280091] Funding Source: KAKEN	Kobe University; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kobe University funding and JSPS24320008 (organized by Hiroyuki Miyoshi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Bradshaw C, 1999, MAR BIOL, V135, P83, DOI 10.1007/s002270050604; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2013, P R SOC B, V280, P1471, DOI DOI 10.1098/RSPB.2012.2484); Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davie PJF, 2010, CRUSTACEANA MONOGR, V11, P83; Dunlop R, 2006, APPL ANIM BEHAV SCI, V97, P255, DOI 10.1016/j.applanim.2005.06.018; Goldstone RL, 2009, TOP COGN SCI, V1, P412, DOI 10.1111/j.1756-8765.2009.01038.x; Gunji YP, 2012, PASSIVELY ACTIVE ACT, P169; Gunji YP, 2011, ADV ARTIFICIAL LIFE, P294; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Helbing D, 1997, PHYS REV E, V56, P2527, DOI 10.1103/PhysRevE.56.2527; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Murakami H, 2012, IJALR, V3, P35; Niizato T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035615; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Pike TW, 2010, BEHAV ECOL, V21, P570, DOI 10.1093/beheco/arq025; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; SHIH JT, 1995, ZOOL STUD, V34, P96; Shirakawa T., 2011, NANO COMMUN NETW, V2, P99, DOI [10.1016/j.nancom.2011.05.002, DOI 10.1016/J.NANCOM.2011.05.002]; Strandburg-Peshkin A, 2010, CURR BIOL, V23, P711; Takeda S, 2005, J ZOOL, V266, P197, DOI 10.1017/S0952836905006783; Takeda S, 2004, J CRUSTACEAN BIOL, V24, P327, DOI 10.1651/C-2436; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	33	23	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97870	10.1371/journal.pone.0097870	http://dx.doi.org/10.1371/journal.pone.0097870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839970	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600084
J	Amendola, E; Zhan, Y; Mattucci, C; Castroflorio, E; Calcagno, E; Fuchs, C; Lonetti, G; Silingardi, D; Vyssotski, AL; Farley, D; Ciani, E; Pizzorusso, T; Giustetto, M; Gross, CT				Amendola, Elena; Zhan, Yang; Mattucci, Camilla; Castroflorio, Enrico; Calcagno, Eleonora; Fuchs, Claudia; Lonetti, Giuseppina; Silingardi, Davide; Vyssotski, Alexei L.; Farley, Dominika; Ciani, Elisabetta; Pizzorusso, Tommaso; Giustetto, Maurizio; Gross, Cornelius T.			Mapping Pathological Phenotypes in a Mouse Model of CDKL5 Disorder	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; CPG-BINDING PROTEIN-2; RETT-SYNDROME; MECP2; EXPRESSION; MUTATIONS; MICE; RECOMBINASE; POTENTIALS; DEFICIENCY	Mutations in cyclin-dependent kinase-like 5 (CDKL5) cause early-onset epileptic encephalopathy, a neurodevelopmental disorder with similarities to Rett Syndrome. Here we describe the physiological, molecular, and behavioral phenotyping of a Cdkl5 conditional knockout mouse model of CDKL5 disorder. Behavioral analysis of constitutive Cdkl5 knockout mice revealed key features of the human disorder, including limb clasping, hypoactivity, and abnormal eye tracking. Anatomical, physiological, and molecular analysis of the knockout uncovered potential pathological substrates of the disorder, including reduced dendritic arborization of cortical neurons, abnormal electroencephalograph (EEG) responses to convulsant treatment, decreased visual evoked responses (VEPs), and alterations in the Akt/rpS6 signaling pathway. Selective knockout of Cdkl5 in excitatory and inhibitory forebrain neurons allowed us to map the behavioral features of the disorder to separable cell-types. These findings identify physiological and molecular deficits in specific forebrain neuron populations as possible pathological substrates in CDKL5 disorder.	[Amendola, Elena; Zhan, Yang; Mattucci, Camilla; Farley, Dominika; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Castroflorio, Enrico; Calcagno, Eleonora; Giustetto, Maurizio] Univ Turin, Dept Neurosci, Turin, Italy; [Castroflorio, Enrico; Calcagno, Eleonora; Giustetto, Maurizio] Univ Turin, Natl Inst Neurosci, Turin, Italy; [Fuchs, Claudia; Ciani, Elisabetta] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Lonetti, Giuseppina; Silingardi, Davide; Pizzorusso, Tommaso] CNR, Inst Neurosci, Pisa, Italy; [Lonetti, Giuseppina; Pizzorusso, Tommaso] Univ Florence, NEUROFARBA, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Vyssotski, Alexei L.] ETH, Swiss Fed Inst Technol, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); University of Turin; University of Turin; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	CASTROFLORIO, ENRICO/I-6767-2019; giustetto, maurizio/D-6606-2011; Farley, Dominika/S-5391-2018; Amendola, Elena/P-2434-2016; Ciani, Elisabetta/AAL-6462-2020; Pizzorusso, Tommaso/D-1399-2013	CASTROFLORIO, ENRICO/0000-0002-6953-5420; giustetto, maurizio/0000-0003-1323-4060; Farley, Dominika/0000-0001-9173-324X; Pizzorusso, Tommaso/0000-0001-5614-0668; Vyssotski, Alexei/0000-0002-9021-1471; ciani, elisabetta/0000-0003-3130-5168; Zhan, Yang/0000-0002-1150-6344	EMBL; Italian Telethon Foundation [GGP09196, GGP10162]; Epigenomics Flagship Project EPIGEN; MIUR-CNR; AIRETT onlus; International Rett Syndrome Foundation (ISRF); International Foundation for CDKL5 Research (IFCR); ISRF	EMBL; Italian Telethon Foundation(Fondazione Telethon); Epigenomics Flagship Project EPIGEN; MIUR-CNR(Ministry of Education, Universities and Research (MIUR)); AIRETT onlus; International Rett Syndrome Foundation (ISRF); International Foundation for CDKL5 Research (IFCR); ISRF	The research was supported by EMBL (E. A. and C. T. G.), the Italian Telethon Foundation (grant GGP09196, T. P. and M. G.; grant GGP10162, E. C., T. P., and M. G.), Epigenomics Flagship Project EPIGEN, MIUR-CNR to T. P., AIRETT onlus (T. P. and M. G.), the International Rett Syndrome Foundation (ISRF, M. G.), and a fellowship from the International Foundation for CDKL5 Research (IFCR) in collaboration with ISRF (E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang Q, 2010, NEURON, V49, P341; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grosso S, 2007, BRAIN DEV-JPN, V29, P239, DOI 10.1016/j.braindev.2006.09.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kishi N, 2005, J CHILD NEUROL, V20, P753; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pizzorusso T, 1999, EUR J NEUROSCI, V11, P204, DOI 10.1046/j.1460-9568.1999.00417.x; Pizzorusso T, 1997, VISION RES, V37, P389, DOI 10.1016/S0042-6989(96)00172-1; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rogers DC, 1999, MAMM GENOME, V8, P711; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Russo S, 2009, NEUROGENETICS, V10, P241, DOI 10.1007/s10048-009-0177-1; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Stuss DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031896; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	41	104	109	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e91613	10.1371/journal.pone.0091613	http://dx.doi.org/10.1371/journal.pone.0091613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24838000	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339614800002
J	Han, GZ; Worobey, M				Han, Guan-Zhu; Worobey, Michael			Endogenous Viral Sequences from the Cape Golden Mole (Chrysochloris asiatica) Reveal the Presence of Foamy Viruses in All Major Placental Mammal Clades	PLOS ONE			English	Article							PHYLOGENIES	Endogenous retroviruses provide important insights into the deep history of this viral lineage. Endogenous foamy viruses are thought to be very rare and only a few cases have been identified to date. Here we report a novel endogenous foamy virus (CaEFV) within the genome of the Cape golden mole (Chrysochloris asiatica). The identification of CaEFV reveals the presence of foamy virus in the placental mammal superorder Afrotheria. Phylogenetic analyses place CaEFV basal to other foamy viruses of Eutherian origin, suggesting an ancient codivergence between foamy virus and placental mammals. These findings have implications for understanding the long-term evolution, diversity, and biology of retroviruses.	[Han, Guan-Zhu; Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Han, GZ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	guanzhu@email.arizona.edu; worobey@email.arizona.edu	Han, Guan-Zhu/A-6818-2011; Han, Guan-Zhu/P-4188-2019	Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726	NIAID [R01 AI084691]; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084691] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grant R01 AI084691 and the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths DJ, 2001, GENOME BIOL, V2; Han GZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002790; Han GZ, 2012, J VIROL, V86, P7696, DOI 10.1128/JVI.00650-12; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Katzourakis A, 2009, SCIENCE, V325, P1512, DOI 10.1126/science.1174149; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-41; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12	19	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97931	10.1371/journal.pone.0097931	http://dx.doi.org/10.1371/journal.pone.0097931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835242	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800086
J	Matheson, AI; Manhart, LE; Pavlinac, PB; Means, AR; Akullian, A; Levine, GA; Jacobson, J; Shutes, E; Walson, JL				Matheson, Alastair I.; Manhart, Lisa E.; Pavlinac, Patricia B.; Means, Arianna R.; Akullian, Adam; Levine, Gillian A.; Jacobson, Julie; Shutes, Erin; Walson, Judd L.			Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin	PLOS ONE			English	Article							UPDATED SYSTEMATIC ANALYSIS; NATIONAL CAUSES; TRACHOMA; HEALTH; TRENDS	Background: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. Methodology/Principal Findings: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. Conclusions/Significance: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources.	[Matheson, Alastair I.; Manhart, Lisa E.; Pavlinac, Patricia B.; Means, Arianna R.; Akullian, Adam; Levine, Gillian A.; Walson, Judd L.] Univ Washington, Seattle, WA 98195 USA; [Jacobson, Julie; Shutes, Erin] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Matheson, AI (corresponding author), Univ Washington, Seattle, WA 98195 USA.	alastair.matheson@gmail.com	Walson, Judd/HGC-4359-2022; Walson, Judd/R-7269-2019	Walson, Judd/0000-0003-4836-720X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was completed by Strategic Analysis, Research, and Training Program (START) at the University of Washington. START is a collaborative effort with, and is funded by, the Bill & Melinda Gates Foundation. The funder commissioned the study but did not have exclusive control of the design, data collection and analysis, decision to pursue publication, conclusions, or preparation of the manuscript.	[Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2013, 2013 GLOB PEAC IND; [Anonymous], 2012, FIN GLOB HLTH 2012 E; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carter Center, 2010, PLANN TRACH EL DISTR; Feldbaum H, 2010, EPIDEMIOL REV, V32, P82, DOI 10.1093/epirev/mxq006; Hermes E, 2013, EULER HERMES COUNTRY; International Coalition for Trachoma Control, 2011, 2020 INSIGHT; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malhotra-Kumar S, 2009, LANCET, V374, P449, DOI 10.1016/S0140-6736(09)61447-1; McCoy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034749; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Transparency International, 2013, CORR PERC IND 2013; UNICEF, 2013, PNEUM CONJ VACC CURR; UNICEF, 2013, ROT VACC CURR SUPPL; United Nations (Department of Economic and Social Affairs), 2013, TOT POP BOTH SEX WOR; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2006, TRACH CONTR GUID PRO; World Health Organisation, 2013, NEGL TROP DIS PREV C; World Health Organization, 2013, IMM COV; Zaric GS, 2007, MED DECIS MAKING, V27, P71, DOI 10.1177/0272989X06297395	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96658	10.1371/journal.pone.0096658	http://dx.doi.org/10.1371/journal.pone.0096658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837459	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800019
J	Shan, GG; Wilding, GE				Shan, Guogen; Wilding, Gregory E.			Powerful Exact Unconditional Tests for Agreement between Two Raters with Binary Endpoints	PLOS ONE			English	Article							DETECTING TRENDS; WEIGHTED KAPPA; MATCHED-PAIRS; RELIABILITY; COEFFICIENT; STATISTICS; PARADOXES	Asymptotic and exact conditional approaches have often been used for testing agreement between two raters with binary outcomes. The exact conditional approach is guaranteed to respect the test size as compared to the traditionally used asymptotic approach based on the standardized Cohen's kappa coefficient. An alternative to the conditional approach is an unconditional strategy which relaxes the restriction of fixed marginal totals as in the conditional approach. Three exact unconditional hypothesis testing procedures are considered in this article: an approach based on maximization, an approach based on the conditional p-value and maximization, and an approach based on estimation and maximization. We compared these testing procedures based on the commonly used Cohen's kappa with regards to test size and power. We recommend the following two exact approaches for use in practice due to power advantages: the approach based on conditional p-value and maximization and the approach based on estimation and maximization.	[Shan, Guogen] Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Wilding, Gregory E.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shan, GG (corresponding author), Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.	guogen.shan@unlv.edu	Shan, Guogen/GQI-3293-2022					Andres AM, 2008, COMMUN STAT-THEOR M, V37, P760, DOI 10.1080/03610920701669884; BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; BASU D, 1977, J AM STAT ASSOC, V72, P355, DOI 10.2307/2286800; Boschloo RD, 1970, STAT NEERL, V24, P1, DOI [10.1111/j.1467-9574.1970.tb00104.x, DOI 10.1111/J.1467-9574.1970.TB00104.X]; Brusco MJ, 2008, BRIT J MATH STAT PSY, V61, P439, DOI 10.1348/000711007X227058; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fang K.T., 2001, ORTHOGONAL UNIFORM E; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fisher R., 1970, STAT METHODS RES WOR; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fleiss JL, 2013, STAT METHODS RATES P; Fleiss JL, 2003, BOOK SERIES WILEY SE, V3rd, DOI [10.1002/0471445428, DOI 10.1198/TECH.2004.S812, DOI 10.1002/0471445428]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lloyd CJ, 2008, BIOMETRICS, V64, P716, DOI 10.1111/j.1541-0420.2007.00936.x; Lloyd CJ, 2008, STAT MED, V27, P3540, DOI 10.1002/sim.3229; Lloyd CJ, 2008, AUST NZ J STAT, V50, P329, DOI 10.1111/j.1467-842X.2008.00520.x; Mehta CR, 1998, BIOMETRICS, V54, P1615, DOI 10.2307/2533685; Shan GG, 2014, STAT PROBABIL LETT, V85, P129, DOI 10.1016/j.spl.2013.11.010; Shan GG, 2013, HUM HERED, V76, P10, DOI 10.1159/000353205; Shan GG, 2013, COMPUT STAT DATA AN, V57, P246, DOI 10.1016/j.csda.2012.04.021; Shan GG, 2012, STAT MED, V31, P155, DOI 10.1002/sim.4411; Shoukri MM, 1996, STAT MED, V15, P1409; Smedmark V, 2000, MANUAL THER, V5, P97, DOI 10.1054/math.2000.0234; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; UMESH UN, 1989, EDUC PSYCHOL MEAS, V49, P835, DOI 10.1177/001316448904900407	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97386	10.1371/journal.pone.0097386	http://dx.doi.org/10.1371/journal.pone.0097386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837970	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800041
J	Blome, MA; Bjorkman, P; Molnegren, V; Hoglund, P; Widell, A				Blome, Marianne Alanko; Bjorkman, Per; Molnegren, Vilma; Hoglund, Peter; Widell, Anders			Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; VIRUS-INFECTION; NATURAL-HISTORY; HCV; USERS; TRANSMISSION; REINFECTION; PREVALENCE; PRISONERS; DIAGNOSIS	Objectives: To assess HCV viremia levels just before, during and one year after anti-HCV seroconversion in people who inject drugs (PWID). Methods: PWID enrolling into a needle exchange program in Malmo, Sweden, 1997-2005 constituted the source population. Sera were obtained at enrolment and at approximately 3-4 monthly intervals afterwards, and were initially tested for anti-HIV, HBsAg/anti-HBc and anti-HCV and thereafter for markers previously negative. Seroconversion to anti-HCV had occurred during the study period in 186 out of 332 seronegative subjects. In these anti-HCV seroconverters, quantitative HCV RNA PCR was retrospectively performed on frozen sera to determine viremia levels in the last anti-HCV negative, the first anti-HCV positive and in one year follow-up samples. Results: Among 150 subjects seroconverting to anti-HCV with samples available from all three defined time-points, eight different patterns of viremia were observed. Spontaneous clearance at one year was noted in 48 cases (32%) and was associated with female gender (p = 0.03, CI 0.17-1.00). In 13 cases HCV-RNA was not detected in any study sample. Among 61 subjects with pre-seroconversion viremia, viral load was significantly higher in the pre-seroconversion samples compared to subsequent samples. For the whole group, viral load declined to undetectable levels at seroconversion in 28% of cases (but with recurrent viremia in 15%). Conclusions: Different patterns of HCV RNA kinetics were observed among PWID with documented seroconversion to anti-HCV. The frequently observed absence of detectable HCV RNA in the first anti-HCV positive sample (irrespective of subsequent viremia) demonstrates the importance of repeated sampling and RNA testing for determination of the outcome of acute infection.	[Blome, Marianne Alanko; Bjorkman, Per] Lund Univ, Div Clin Sci, Infect Dis Unit, Malmo, Sweden; [Molnegren, Vilma; Widell, Anders] Lund Univ, Div Sci Lab, Dept Clin Microbiol, Malmo, Sweden; [Hoglund, Peter] Res & Dev Ctr Skane, Med Stat & Epidemiol Unit, Lund, Sweden	Lund University; Lund University	Widell, A (corresponding author), Lund Univ, Div Sci Lab, Dept Clin Microbiol, Malmo, Sweden.	anders.widell@med.lu.se	Höglund, Peter/H-4774-2014	Höglund, Peter/0000-0002-8395-922X	Region Skane, Lund University; Malmo City Donation funds; Osterlund Foundation	Region Skane, Lund University; Malmo City Donation funds; Osterlund Foundation	This study was funded in part by Region Skane, Lund University (ALF grant), Malmo City Donation funds and the Osterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Aberle JH, 2006, J CLIN VIROL, V36, P24, DOI 10.1016/j.jcv.2005.12.010; Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Amini M, 2012, VIRAL IMMUNOL, V25, P241, DOI 10.1089/vim.2011.0052; Blome MA, 2011, J VIRAL HEPATITIS, V18, P831, DOI 10.1111/j.1365-2893.2010.01400.x; Chemaitelly H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069803; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Dale CH, 2009, CAN J GASTROENTEROL, V23, P265, DOI 10.1155/2009/912848; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; de Almeida BS, 2011, J VIRAL HEPATITIS, V18, P692, DOI 10.1111/j.1365-2893.2010.01429.x; Doyle JS, 2012, BEST PRACT RES CL GA, V26, P413, DOI 10.1016/j.bpg.2012.09.004; Duberg A, 2008, Euro Surveill, V13; Fabris P, 2008, CURR PHARM DESIGN, V14, P1661, DOI 10.2174/138161208784746789; Gutierrez-Moreno M, 2012, TRANSPL P, V44, P2100, DOI 10.1016/j.transproceed.2012.07.074; Hajarizadeh B, 2012, J HEPATOL, V57, P1349, DOI 10.1016/j.jhep.2012.07.007; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Jarlais DCD, 2005, AIDS, V19, pS20, DOI 10.1097/01.aids.0000192066.86410.8c; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mansson AS, 2000, SCAND J INFECT DIS, V32, P253, DOI 10.1080/00365540050165875; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Mathei C, 2001, J INFECT DIS, V184, P659, DOI 10.1086/322795; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, INT J INFECT DIS, V13, P201, DOI 10.1016/j.ijid.2008.06.011; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Olsson B, 2001, MAX PROJECT CENTRLAF, V3, P61; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Wawrzynowicz-Syczewska M, 2004, INFECTION, V32, P138, DOI 10.1007/s15010-004-3062-8; Widell A, 2002, TRANSFUSION MED, V12, P107, DOI 10.1046/j.1365-3148.2002.00359.x	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97022	10.1371/journal.pone.0097022	http://dx.doi.org/10.1371/journal.pone.0097022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830647	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500030
J	Briones, A; Coats, E; Brinkman, C				Briones, Aurelio; Coats, Erik; Brinkman, Cynthia			Should We Build "Obese'' or "Lean'' Anaerobic Digesters?	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CORE	Conventional anaerobic digesters (ADs) treating dairy manure are fed with raw or fermented manure rich in volatile fatty acids (VFAs). In contrast, pre-fermented AD (PF-AD) is fed with the more recalcitrant, fiber-rich fraction of manure that has been pre-fermented and depleted of VFAs. Thus, the substrate of PF-AD may be likened to a lean diet rich in fibers while the pre-fermentation stage fermenter is fed a relatively rich diet containing labile organic substances. Previous results have shown that conventional and pre-fermented ADs fed with raw or pre-fermented manure, respectively, produced comparable methane yields. The primary objective of this study was to characterize, using next-generation DNA sequencing, the bacterial communities in various bioreactors (pre-fermentation stage fermenter; various operational arrangements PF-AD; conventional single-stage AD; and a full scale AD) and compare the Firmicutes to Bacteroidetes (F/B) ratios in these different systems. Firmicutes and Bacteroidetes constituted the two most abundant phyla in all AD samples analyzed, as well as most of the samples analyzed in the fermenters and manure samples. Higher relative abundance of Bacteroidetes, ranging from 26% to 51% of bacteria, tended to be associated with PF-AD samples, while the highest relative abundance of Firmicutes occurred in the fermenter (maximum of 76% of bacteria) and manure (maximum of 66% of bacteria) samples. On average, primary stage fermenters exhibited microbiological traits linked to obesity: higher F/B ratios and a 'diet' that is less fibrous and more labile compared to that fed to PF-AD. On the other hand, microbial characteristics associated with leanness (lower F/B ratios combined with fibrous substrate) were associated with PF-AD. We propose that bacterial communities in AD shift depending on the quality of substrate, which ultimately results in maintaining VFA yields in PF-AD, similar to the role of bacterial communities and a high fiber diet in lean mice.	[Briones, Aurelio] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Coats, Erik; Brinkman, Cynthia] Univ Idaho, Dept Civil Engn, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Briones, A (corresponding author), Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA.	abriones@uidaho.edu	Coats, Erik/C-2887-2008	Coats, Erik/0000-0003-2796-9949	Idaho Center for Advanced Energy Studies (CAES) [00042246-00074]	Idaho Center for Advanced Energy Studies (CAES)	The authors gratefully acknowledge the Idaho Center for Advanced Energy Studies (CAES) for funding the project (Contract No. 00042246-00074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; Coats ER, 2013, BIOFUEL BIOPROD BIOR, V7, P459, DOI 10.1002/bbb.1408; Coats ER, 2012, BIORESOURCE TECHNOL, V107, P205, DOI 10.1016/j.biortech.2011.12.077; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lee SH, 2012, J ENVIRON MONITOR, V14, P1893, DOI 10.1039/c2em10958a; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Ziganshin AM, 2013, APPL MICROBIOL BIOT, V97, P5161, DOI 10.1007/s00253-013-4867-0	28	21	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97252	10.1371/journal.pone.0097252	http://dx.doi.org/10.1371/journal.pone.0097252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831948	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500042
J	Ciarleglio, CM; Resuehr, HES; Axley, JC; Deneris, ES; McMahon, DG				Ciarleglio, Christopher M.; Resuehr, Holly E. S.; Axley, John C.; Deneris, Evan S.; McMahon, Douglas G.			Pet-1 Deficiency Alters the Circadian Clock and Its Temporal Organization of Behavior	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; BIOLOGICAL CLOCK; IN-VITRO; INTERGENICULATE LEAFLET; SEROTONERGIC AGONISTS; PERIPHERAL-TISSUES; 5-HT7 RECEPTORS; BINDING-SITES; RETINAL INPUT; PHASE-SHIFTS	The serotonin and circadian systems are two important interactive regulatory networks in the mammalian brain that regulate behavior and physiology in ways that are known to impact human mental health. Previous work on the interaction between these two systems suggests that serotonin modulates photic input to the central circadian clock (the suprachiasmatic nuclei; SCN) from the retina and serves as a signal for locomotor activity, novelty, and arousal to shift the SCN clock, but effects of disruption of serotonergic signaling from the raphe nuclei on circadian behavior and on SCN function are not fully characterized. In this study, we examined the effects on diurnal and circadian behavior, and on ex vivo molecular rhythms of the SCN, of genetic deficiency in Pet-1, an ETS transcription factor that is necessary to establish and maintain the serotonergic phenotype of raphe neurons. Pet-1(-/-) mice exhibit loss of rhythmic behavioral coherence and an extended daily activity duration, as well as changes in the molecular rhythms expressed by the clock, such that ex vivo SCN from Pet-1(-/-) mice exhibit period lengthening and sex-dependent changes in rhythmic amplitude. Together, our results indicate that Pet-1 regulation of raphe neuron serotonin phenotype contributes to the period, precision and light/dark partitioning of locomotor behavioral rhythms by the circadian clock through direct actions on the SCN clock itself, as well as through non-clock effects.	[Ciarleglio, Christopher M.; Resuehr, Holly E. S.; McMahon, Douglas G.] Vanderbilt Univ, Silvio O Conte Ctr Neurosci Res, Nashville, TN 37235 USA; [Ciarleglio, Christopher M.; Resuehr, Holly E. S.; McMahon, Douglas G.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA; [Resuehr, Holly E. S.; Axley, John C.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Deneris, Evan S.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University	McMahon, DG (corresponding author), Vanderbilt Univ, Silvio O Conte Ctr Neurosci Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	douglas.g.mcmahon@vanderbilt.edu	Ciarleglio, Christopher M/D-8463-2013	Ciarleglio, Christopher M/0000-0002-8490-8715; Axley, John/0000-0002-4207-7984	NIMH [P50 MH096972, R01 MH062723]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723, P50MH096972] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH P50 MH096972 (R. Blakely, ESD and DGM), and by NIMH R01 MH062723 (ESD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2005, EUR J NEUROSCI, V21, P1536, DOI 10.1111/j.1460-9568.2005.03964.x; Amir S, 1998, NEUROSCIENCE, V84, P1059, DOI 10.1016/S0306-4522(97)00575-7; Antle MC, 2000, J NEUROSCI, V20, P9326; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Belenky MA, 2001, J COMP NEUROL, V432, P371, DOI 10.1002/cne.1109; BOSLER O, 1985, J NEUROCYTOL, V14, P749, DOI 10.1007/BF01170826; BOSLER O, 1989, J NEUROCYTOL, V18, P105, DOI 10.1007/BF01188429; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; EDGAR DM, 1991, AM J PHYSIOL, V261, pR928, DOI 10.1152/ajpregu.1991.261.4.R928; Edgar DM, 1997, AM J PHYSIOL-REG I, V273, pR265, DOI 10.1152/ajpregu.1997.273.1.R265; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Glass JD, 2003, J NEUROSCI, V23, P7451; Glickman G, 2010, NEUROSCI BIOBEHAV R, V34, P755, DOI 10.1016/j.neubiorev.2009.11.017; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5640, DOI 10.1210/en.2007-1083; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kawakami F, 1995, NEUROSCI LETT, V200, P171, DOI 10.1016/0304-3940(95)12130-V; KISS J, 1984, NEUROSCI LETT, V44, P119, DOI 10.1016/0304-3940(84)90068-5; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Kriegsfeld LJ, 2006, HORM BEHAV, V49, P557, DOI 10.1016/j.yhbeh.2005.12.011; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; LEVITT P, 1982, DEV BRAIN RES, V4, P35, DOI 10.1016/0165-3806(82)90095-5; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Malhi GS, 2013, ACTA PSYCHIAT SCAND, V128, P2, DOI 10.1111/acps.12173; MANRIQUE C, 1994, BRAIN RES, V663, P93, DOI 10.1016/0006-8993(94)90466-9; MANRIQUE C, 1993, BRAIN RES, V623, P345, DOI 10.1016/0006-8993(93)91452-X; Marchant EG, 1997, J NEUROSCI, V17, P7974; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MeyerBernstein EL, 1996, J NEUROSCI, V16, P2097; Mintz EM, 1997, NEUROSCIENCE, V79, P563, DOI 10.1016/S0306-4522(96)00696-3; Mistlberger RE, 1998, BEHAV BRAIN RES, V96, P93, DOI 10.1016/S0166-4328(98)00007-2; Mistlberger RE, 1998, BRAIN RES, V786, P31, DOI 10.1016/S0006-8993(97)01269-9; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; MORIN LP, 1977, PSYCHONEUROENDOCRINO, V2, P73, DOI 10.1016/0306-4530(77)90035-X; MORIN LP, 1977, SCIENCE, V196, P305, DOI 10.1126/science.557840; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Paulus EV, 2013, CHRONOBIOL INT, V30, P1251, DOI 10.3109/07420528.2013.815198; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; Pickard GE, 1999, J NEUROSCI, V19, P4034; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Prosser RA, 2003, BRAIN RES, V966, P110, DOI 10.1016/S0006-8993(02)04206-3; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; Quintero JE, 1999, J NEUROPHYSIOL, V82, P533, DOI 10.1152/jn.1999.82.2.533; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Smith BN, 2001, J BIOL RHYTHM, V16, P25, DOI 10.1177/074873040101600104; Sokal RR, 1995, BIOMETRY PRINCIPLES, Vxix; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	66	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97412	10.1371/journal.pone.0097412	http://dx.doi.org/10.1371/journal.pone.0097412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831114	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500054
J	Goode, D; Aravantinou, M; Jarl, S; Truong, R; Derby, N; Guerra-Perez, N; Kenney, J; Blanchard, J; Gettie, A; Robbiani, M; Martinelli, E				Goode, Diana; Aravantinou, Meropi; Jarl, Sebastian; Truong, Rosaline; Derby, Nina; Guerra-Perez, Natalia; Kenney, Jessica; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa; Martinelli, Elena			Sex Hormones Selectively Impact the Endocervical Mucosal Microenvironment: Implications for HIV Transmission	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; FEMALE REPRODUCTIVE-TRACT; SIV VAGINAL TRANSMISSION; T-CELLS; CONTRACEPTIVE USE; INTEGRIN ALPHA(4)BETA(7); RECEPTOR EXPRESSION; ADAPTIVE IMMUNITY; ESTROGEN PROTECTS; GENITAL-TRACT	Several studies suggest that progesterone and estrogens may affect HIV transmission in different, possibly opposing ways. Nonetheless, a direct comparison of their effects on the mucosal immune system has never been done. We hypothesize that sex hormones might impact the availability of cells and immune factors important in early stages of mucosal transmission, and, in doing so influence the risk of HIV acquisition. To test this hypothesis, we employed 15 ovarectomized rhesus macaques: 5 were treated with Depot Medroxy Progesterone Acetate (DMPA), 6 with 17-beta estradiol (E2) and 4 were left untreated. All animals were euthanized 5 weeks after the initiation of hormone treatment, a time post-DMPA injection associated with high susceptibility to SIV infection. We found that DMPA-treated macaques exhibited higher expression of integrin alpha(4)beta(7) (alpha(4)beta(7)) on CD4(+) T cells, the gut homing receptor and a marker of cells highly susceptible to HIV, in the endocervix than did the E2-treated animals. In contrast, the frequency of CCR5(+) CD4(+) T cells in DMPA-treated macaques was higher than in the E2-treated group in vaginal tissue, but lower in endocervix. alpha(4)beta(7) expression on dendritic cells (DCs) was higher in the DMPA-treated group in the endocervical tissue, but lower in vaginal tissue and on blood DCs compared with the E2-treated animals. Soluble MAdCAM-1, the alpha(4)beta(7) ligand, was present in the vaginal fluids of the control and E2-treated groups, but absent in the fluids from DMPA-treated animals. Both hormones modulated the expression and release of inflammatory factors and modified the distribution of sialomucins in the endocervix. In summary, we found that sex hormones profoundly impact mucosal immune factors that are directly implicated in HIV transmission. The effect is particularly significant in the endocervix. This may increase our understanding of the potential hormone-driven modulation of HIV susceptibility and potentially guide contraceptive policies in high-risk settings.	[Goode, Diana; Aravantinou, Meropi; Jarl, Sebastian; Truong, Rosaline; Derby, Nina; Guerra-Perez, Natalia; Kenney, Jessica; Robbiani, Melissa; Martinelli, Elena] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Ctr Sci, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; Tulane University; Rockefeller University	Martinelli, E (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	emartinelli@popcouncil.org	Guerra-Pérez, Natalia/I-1879-2017	Guerra-Pérez, Natalia/0000-0002-4851-3361; Martinelli, Elena/0000-0002-3416-9627; Jarl, Sebastian/0000-0003-3584-7079	United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; National Institutes of Health (NIH) [R01 AI098456-01]; National Cancer Institute, NIH [HHSN261200800001E]; USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with the support of the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, the National Institutes of Health (NIH) base grant R01 AI098456-01 and with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. This research is made possible by the generous support of the American people through the USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Baxter MG, 2013, NEUROBIOL AGING, V34, P1882, DOI 10.1016/j.neurobiolaging.2012.12.017; Brahmbhatt H, 2013, J FAM PLANN REPROD H; Campbell DE, 2010, CLIN VACCINE IMMUNOL, V17, P1148, DOI 10.1128/CVI.00533-09; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Clendenen TV, 2011, CYTOKINE, V56, P769, DOI 10.1016/j.cyto.2011.09.013; DCRUZ OJ, 1993, FERTIL STERIL, V60, P1011; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Foulk RA, 2007, J ASSIST REPROD GEN, V24, P316, DOI 10.1007/s10815-007-9151-8; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gipson IK, 2005, E SCHERING RES FDN W, V52, P219; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Kader M, 2009, J MED PRIMATOL, V38, P24, DOI 10.1111/j.1600-0684.2009.00372.x; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kawashima H, 2012, ANN NY ACAD SCI, V1253, P112, DOI 10.1111/j.1749-6632.2011.06356.x; Kelly KA, 2001, J INFECT DIS, V184, P885, DOI 10.1086/323341; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Kiddugavu M, 2003, AIDS, V17, P233, DOI 10.1097/00002030-200301240-00014; Kim KC, 2012, PULM PHARMACOL THER, V25, P415, DOI 10.1016/j.pupt.2011.12.003; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; Leung E, 2004, IMMUNOL CELL BIOL, V82, P400, DOI 10.1111/j.0818-9641.2004.01247.x; Leung E, 2003, IMMUNOL CELL BIOL, V81, P320, DOI 10.1046/j.1440-1711.2003.t01-1-01175.x; Lutalo T, 2013, AIDS, V27, pS27, DOI 10.1097/QAD.0000000000000045; Margarit L, 2009, HUM REPROD, V24, P2767, DOI 10.1093/humrep/dep247; Martinelli E, 2013, J ACQUIR IMMUNE DEFI; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mishell DR, 1996, J REPROD MED, V41, P381; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Nejatbakhsh R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-46; Prakash M, 2004, BJOG-INT J OBSTET GY, V111, P1468, DOI 10.1111/j.1471-0528.2004.00283.x; Sanchez MG, 2013, J NEUROENDOCRINOL, V25, P560, DOI 10.1111/jne.12034; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Szabo MC, 1997, J IMMUNOL, V158, P5584; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Teleshova N, 2013, ADV EXP MED BIOL, V762, P155, DOI 10.1007/978-1-4614-4433-6_6; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2000, ENDOCRINOLOGY, V141, P2877, DOI 10.1210/en.141.8.2877; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	61	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97767	10.1371/journal.pone.0097767	http://dx.doi.org/10.1371/journal.pone.0097767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830732	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500112
J	Shao, ZR; Zhang, PY; Li, QY; Wang, XL; Duan, DL				Shao, Zhanru; Zhang, Pengyan; Li, Qiuying; Wang, Xiuliang; Duan, Delin			Characterization of Mannitol-2-Dehydrogenase in Saccharina japonica: Evidence for a New Polyol-Specific Long-Chain Dehydrogenases/Reductase	PLOS ONE			English	Article							FLUORESCENS MANNITOL 2-DEHYDROGENASE; SWISS-MODEL; MANNITOL-1-PHOSPHATE DEHYDROGENASE; CARBON METABOLISM; LACTIC-ACID; BROWN; PURIFICATION; EVOLUTION; INSIGHTS; PHOTOSYNTHESIS	Mannitol plays a crucial role in brown algae, acting as carbon storage, organic osmolytes and antioxidant. Transcriptomic analysis of Saccharina japonica revealed that the relative genes involved in the mannitol cycle are existent. Full-length sequence of mannitol-2-dehydrogenase (M2DH) gene was obtained, with one open reading frame of 2,007 bp which encodes 668 amino acids. Cis-regulatory elements for response to methyl jasmonic acid, light and drought existed in the 5'-upstream region. Phylogenetic analysis indicated that SjM2DH has an ancient prokaryotic origin, and is probably acquired by horizontal gene transfer event. Multiple alignment and spatial structure prediction displayed a series of conserved functional residues, motifs and domains, which favored that SjM2DH belongs to the polyol-specific long-chain dehydrogenases/reductase (PSLDR) family. Expressional profiles of SjM2DH in the juvenile sporophytes showed that it was influenced by saline, oxidative and desiccative factors. SjM2DH was over-expressed in Escherichia coli, and the cell-free extracts with recombinant SjM2DH displayed high activity on D-fructose reduction reaction. The analysis on SjM2DH gene structure and biochemical parameters reached a consensus that activity of SjM2DH is NADH-dependent and metal ion-independent. The characterization of SjM2DH showed that M2DH is a new member of PSLDR family and play an important role in mannitol metabolism in S. japonica.	[Shao, Zhanru; Zhang, Pengyan; Li, Qiuying; Wang, Xiuliang; Duan, Delin] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Shao, Zhanru; Zhang, Pengyan; Li, Qiuying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, DL (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	dlduan@qdio.ac.cn	Duan, Delin/G-9002-2011	Wang, Xiuliang/0000-0003-4262-0083	National High Tech 863 Project [2012AA10A406]; National Key Technology Research & Development Program [2013BAB01B01]; Ocean Public Welfare Scientific Research Project [201405040]; Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project	National High Tech 863 Project(National High Technology Research and Development Program of China); National Key Technology Research & Development Program; Ocean Public Welfare Scientific Research Project; Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project	This research was supported by the National High Tech 863 Project (2012AA10A406), Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project, National Key Technology Research & Development Program (2013BAB01B01), and Ocean Public Welfare Scientific Research Project (201405040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BIDWELL R. G. S., 1958, CANADIAN JOUR BOT, V36, P581; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Delavault P, 2002, PHYSIOL PLANTARUM, V115, P48, DOI 10.1034/j.1399-3054.2002.1150105.x; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Dittami SM, 2011, PLANT SIGNAL BEHAV, V6, P1237, DOI 10.4161/psb.6.8.16404; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; EKLUND H, 1985, BIOCHEMISTRY-US, V24, P8005, DOI 10.1021/bi00348a025; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gravot A, 2010, NEW PHYTOL, V188, P98, DOI 10.1111/j.1469-8137.2010.03400.x; Groisillier A, 2014, J EXP BOT, V65, P559, DOI 10.1093/jxb/ert405; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Horer S, 2001, J BIOL CHEM, V276, P27555, DOI 10.1074/jbc.M102850200; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Iwamoto K, 2003, PLANT PHYSIOL, V133, P893, DOI 10.1104/pp.103.026906; Ji MH, 1980, OCEANOL LIMNOL SINIC, V11, P229; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karsten U, 1997, PLANTA, V201, P173, DOI 10.1007/BF01007701; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Korakli M, 2003, FEMS MICROBIOL LETT, V220, P281, DOI 10.1016/S0378-1097(03)00129-0; Krahulec S, 2011, FEBS J, V278, P1264, DOI 10.1111/j.1742-4658.2011.08047.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; KULKARNI RK, 1990, APPL ENVIRON MICROB, V56, P250, DOI 10.1128/AEM.56.1.250-253.1990; Lee JK, 2003, APPL ENVIRON MICROB, V69, P4438, DOI 10.1128/AEM.69.8.4438-4447.2003; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu SQ, 2005, APPL BIOCHEM BIOTECH, V121, P391, DOI 10.1385/ABAB:121:1-3:0391; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Moulin P, 1999, J PHYCOL, V35, P1237, DOI 10.1046/j.1529-8817.1999.3561237.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Rousvoal S, 2011, PLANTA, V233, P261, DOI 10.1007/s00425-010-1295-6; RUMPHO ME, 1983, PLANT PHYSIOL, V73, P869, DOI 10.1104/pp.73.4.869; Saha BC, 2011, APPL MICROBIOL BIOT, V89, P879, DOI 10.1007/s00253-010-2979-3; Saha BC, 2004, BIOTECHNOL PROGR, V20, P537, DOI 10.1021/bp034277p; Salamov AA, 1997, COMPUT APPL BIOSCI, V13, P23; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schwarz E, 1994, ULLMANS ENCY IND CHE, P423; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shao ZR, 2014, CHIN J OCEANOL LIMN, V32, P377, DOI 10.1007/s00343-014-3130-6; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Soetaert W., 1995, Agro Food Industry hi-tech, V6, P41; Stoop JMH, 1998, PLANT SCI, V131, P43, DOI 10.1016/S0168-9452(97)00243-4; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Suvarna K, 2000, MICROBIOL-SGM, V146, P2705, DOI 10.1099/00221287-146-10-2705; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenhaken R, 2011, J BIOL CHEM, V286, P16707, DOI 10.1074/jbc.M111.230979; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Den Daele K, 2006, EUROPEAN JOURNAL OF, V41, P1; WILLIAMSON JD, 1995, P NATL ACAD SCI USA, V92, P7148, DOI 10.1073/pnas.92.16.7148; Wisselink HW, 2002, INT DAIRY J, V12, P151, DOI 10.1016/S0958-6946(01)00153-4; YAMAGUCH.T, 1969, PLANT CELL PHYSIOL, V10, P425; YAMAGUCHI T, 1966, PLANT CELL PHYSIOL, V7, P217	63	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97935	10.1371/journal.pone.0097935	http://dx.doi.org/10.1371/journal.pone.0097935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830763	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500133
J	Jiang, H; Clise-Dwyer, K; Ruisaard, KE; Fan, XJ; Tian, WH; Gumin, J; Lamfers, ML; Kleijn, A; Lang, FF; Yung, WKA; Vence, LM; Gomez-Manzano, C; Fueyo, J				Jiang, Hong; Clise-Dwyer, Karen; Ruisaard, Kathryn E.; Fan, Xuejun; Tian, Weihua; Gumin, Joy; Lamfers, Martine L.; Kleijn, Anne; Lang, Frederick F.; Yung, Wai-Kwan Alfred; Vence, Luis M.; Gomez-Manzano, Candelaria; Fueyo, Juan			Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model	PLOS ONE			English	Article							MHC CLASS-I; SYRIAN-HAMSTER; ANTIGEN; CELLS; AUTOPHAGY; INNATE; REPLICATION; EFFICACY; VIRUSES; GAMMA	Background: Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect induced by oncolytic viruses. Here we investigate the effect of Delta-24-RGD oncolytic adenovirus on innate and adaptive anti-glioma immunity. Design: Mouse GL261-glioma model was set up in immunocompetent C57BL/6 mouse for Delta-24-RGD treatment. The changes of the immune cell populations were analyzed by immunohistochemistry and flow cytometry. The antiglioma immunity was evaluated with functional study of the splenocytes isolated from the mice. The efficacy of the virotherapy was assessed with animal survival analysis. The direct effect of the virus on the tumor-associated antigen presentation to CD8+ T cells was analyzed with an in vitro ovalbumin (OVA) modeling system. Results: Delta-24-RGD induced cytotoxic effect in mouse glioma cells. Viral treatment in GL261-glioma bearing mice caused infiltration of innate and adaptive immune cells, instigating a Th1 immunity at the tumor site which resulted in specific anti-glioma immunity, shrunken tumor and prolonged animal survival. Importantly, viral infection and IFN gamma increased the presentation of OVA antigen in OVA-expressing cells to CD8+ T-cell hybridoma B3Z cells, which is blocked by brefeldin A and proteasome inhibitors, indicating the activity is through the biosynthesis and proteasome pathway. Conclusions: Our results demonstrate that Delta-24-RGD induces anti-glioma immunity and offers the first evidence that viral infection directly enhances presentation of tumor-associated antigens to immune cells.	[Jiang, Hong; Fan, Xuejun; Tian, Weihua; Gumin, Joy; Lang, Frederick F.; Yung, Wai-Kwan Alfred; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Clise-Dwyer, Karen; Ruisaard, Kathryn E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Vence, Luis M.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lamfers, Martine L.; Kleijn, Anne] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Erasmus University Rotterdam; Erasmus MC	Jiang, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	hjiang@mdanderson.org	Lamfers, Martine/C-6246-2016; Yung, W.K. Alfred/W-5016-2019	Lamfers, Martine/0000-0001-7745-9029; Fueyo, Juan/0000-0001-6941-2335; Gomez-Manzano, Candelaria/0000-0002-1259-2133	National Institutes of Health [P50CA127001]; Institutional U.T. M.D. Anderson's Cancer Center Support Grant [CA016672]; Marnie Rose Foundation; Will Power Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional U.T. M.D. Anderson's Cancer Center Support Grant; Marnie Rose Foundation; Will Power Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institutes of Health (P50CA127001), the Institutional U.T. M.D. Anderson's Cancer Center Support Grant (CA016672; Flow Cytometry and Cellular Imaging Facility; Research Animal Support Facility Sequencing, and Microarray Facility), the Marnie Rose Foundation, and the Will Power Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JF, CGM, and WKAY are shareholders of DNAtrix, Inc. The authors confirm here that the Financial Disclosure in the first submission does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Cerullo V, 2012, MOL THER, V20, P2076, DOI 10.1038/mt.2012.137; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Falkeholm L, 2001, LAB INVEST, V81, P1213, DOI 10.1038/labinvest.3780335; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Hallden G, 2003, MOL THER, V8, P412, DOI 10.1016/S1525-0016(03)00199-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang H, 2006, REPLICATING VIRUSES, P293; Jiang H, 2011, J VIROL; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Melcher A, 2011, MOL THER, V19, P1008, DOI 10.1038/mt.2011.65; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Park HJ, 2011, VACCINE, V29, P3476, DOI 10.1016/j.vaccine.2011.02.061; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Thomas MA, 2008, MOL THER, V16, P1665, DOI 10.1038/mt.2008.162; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wold WSM, 2012, ADV CANCER RES, V115, P69, DOI 10.1016/B978-0-12-398342-8.00003-3; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	38	74	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97407	10.1371/journal.pone.0097407	http://dx.doi.org/10.1371/journal.pone.0097407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827739	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400091
J	Karusisi, N; Thomas, F; Meline, J; Brondeel, R; Chaix, B				Karusisi, Noella; Thomas, Frederique; Meline, Julie; Brondeel, Ruben; Chaix, Basile			Environmental Conditions around Itineraries to Destinations as Correlates of Walking for Transportation among Adults: The RECORD Cohort Study	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; RESEARCH AGENDA; BLOOD-PRESSURE; RISK-FACTORS; BODY-WEIGHT; NEIGHBORHOOD; HEALTH; URBAN	Introduction: Assessing the contextual factors that influence walking for transportation is important to develop more walkable environments and promote physical activity. To advance previous research focused on residential environments and overall walking for transportation, the present study investigates objective environmental factors assessed around the residence, the workplace, the home - work itinerary, and the home - supermarket itinerary, and considered overall walking for transportation but also walking to work and to shops. Methods: Data from the RECORD Study involving 7290 participants recruited in 2007-2008, aged 30-79 years, and residing in the Paris metropolitan area were analyzed. Multilevel ordinal regression analyses were conducted to investigate environmental characteristics associated with self-reported overall walking for transportation, walking to work, and walking to shops. Results: High individual education was associated with overall walking for transportation, with walking to work, and walking to shops. Among workers, a high residential neighborhood education was associated with increased overall walking for transportation, while a high workplace neighborhood education was related to an increased time spent walking to work. The residential density of destinations was positively associated with overall walking for transportation, with walking to work, and with walking to shops, while the workplace density of destinations was positively associated with overall walking for transportation among workers. Environmental factors assessed around the itineraries were not associated with walking to work or to the shops. Conclusion: This research improves our understanding of the role of the environments on walking for transportation by accounting for some of the environments visited beyond the residential neighborhood. It shows that workers' walking habits are more influenced by the density of destinations around the workplace than around the residence. These results provide insight for the development of policies and programs to encourage population level active commuting.	[Karusisi, Noella; Meline, Julie; Brondeel, Ruben; Chaix, Basile] INSERM, U707, Paris, France; [Karusisi, Noella; Meline, Julie; Brondeel, Ruben; Chaix, Basile] Univ Paris 06, UMR S 707, Paris, France; [Thomas, Frederique] Ctr Invest Prevent & Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Karusisi, N (corresponding author), INSERM, U707, Paris, France.	karusisi@u707.jussieu.fr	Chaix, Basile/B-8625-2014; Brondeel, Ruben/F-1086-2018; Brondeel, Ruben/L-3419-2019	Brondeel, Ruben/0000-0002-9876-4150; Brondeel, Ruben/0000-0002-9876-4150	Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); French Ministry of Research; French Ministry of Health; National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, CODDIM); National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program); Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante); City of Paris (Ville de Paris); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale)	Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ministry of Health; National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT)(Region Ile-de-France); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, CODDIM)(Region Ile-de-France); National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program)(French National Research Agency (ANR)); Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante)(Region Ile-de-France); City of Paris (Ville de Paris)(Region Ile-de-France); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale)(Region Ile-de-France)	The RECORD project received support from the Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); the National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante) (Prevention Program 2007; 2010-2011 financial support; and 2011-2013 financial support); the National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); the French Ministries of Research and Health (Epidemiologic Cohorts Grant 2008); the National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); the Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); the National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program 2005); the Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante); the City of Paris (Ville de Paris); and the Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badland HM, 2012, SOC SCI MED, V75, P1469, DOI 10.1016/j.socscimed.2012.05.029; Beckman A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-71; BIDDLE SJH, 2001, PSYCHOL PHYS ACTIVIT; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Cerin E, 2009, SOC SCI MED, V68, P1013, DOI 10.1016/j.socscimed.2009.01.008; Chaix B, 2002, REV EPIDEMIOL SANTE, V50, P489; Chaix B, 2011, INT J EPIDEMIOL; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Chaix B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032908; Chaix B, 2011, SOC SCI MED, V73, P1543, DOI 10.1016/j.socscimed.2011.09.009; Chaix B, 2011, EPIDEMIOLOGY, V22, P18, DOI 10.1097/EDE.0b013e3181fd2961; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Dalton AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067575; Drewnowski A, 2013, INT J OBES LOND; Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009; Evans G., 2009, BUILD ENVIRON, V35, P366, DOI DOI 10.2148/BENV.35.3.366; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Haskell WL, 2009, PREV MED, V49, P280, DOI 10.1016/j.ypmed.2009.05.002; Johansson K, 2012, EUR J PUBLIC HEALTH, V22, P209, DOI 10.1093/eurpub/ckr042; Karusisi N, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-48; Karusisi N, 2012, PREV MED, V55, P50, DOI 10.1016/j.ypmed.2012.04.018; Kerr J, 2013, J PHYS ACT HEALTH, V10, P581, DOI 10.1123/jpah.10.4.581; Larsen J, 2010, QUARTER MILE REEXAMI; Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leal C, 2012, AM J EPIDEMIOL, V175, P1152, DOI 10.1093/aje/kwr434; Leal C, 2011, EPIDEMIOLOGY, V22, P694, DOI 10.1097/EDE.0b013e3182257784; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Oyeyemi AL, 2013, INT J HLTH GEOGRAAPH; Panter J, 2013, PREV MED, V56, P211, DOI 10.1016/j.ypmed.2013.01.014; Popham F, 2007, PREV MED, V45, P182, DOI 10.1016/j.ypmed.2007.06.012; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Stigell E, 2011, ASSESSMENT ACTIVE CO; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Turrell G, 2013, HEALTH PLACE, V19, P89, DOI 10.1016/j.healthplace.2012.10.008; Van Hulst A, 2012, J HYPERTENS, V30, P1336, DOI 10.1097/HJH.0b013e3283544863; van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030	49	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e88929	10.1371/journal.pone.0088929	http://dx.doi.org/10.1371/journal.pone.0088929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828890	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400002
J	Wagner, AL; Sun, XD; Montgomery, JP; Huang, ZY; Boulton, ML				Wagner, Abram L.; Sun, Xiaodong; Montgomery, JoLynn P.; Huang, Zhuoying; Boulton, Matthew L.			The Impact of Residency and Urbanicity on Haemophilus influenzae Type b and Pneumococcal Immunization in Shanghai Children: A Retrospective Cohort Study	PLOS ONE			English	Article							CHINA; VACCINATION; TIMELINESS; VACCINES; YOUNGER; DISEASE	Background: Haemophilus influenzae type b (Hib) vaccine and pneumococcal conjugate vaccine (PCV) are relatively expensive, newly introduced vaccines in China. This study evaluates the impact of residency and urbanicity on Hib vaccine and PCV coverage for children aged 2 to 7 years living in Shanghai, China, in August 2012. Methods: In this exploratory cohort study, a sample of children aged 2 to 7 years, all of whom were eligible to have received the complete series of Hib vaccine and PCV, was obtained from the Shanghai Immunization Program Information System. Three measures of vaccination coverage for Hib vaccine and PCV were examined: dose 1 coverage, series completion, and timeliness of dose 1 vaccination. Multivariable binomial regression was used to estimate the difference in vaccination coverage between locals and the floating population. Results: Dose 1 coverage was 50.9% for Hib vaccine and 11.4% for PCV for the 28,141 abstracted pediatric records. For both vaccines, dose 1 coverage was higher in locals than in the floating population. The disparity in coverage between locals and the floating population was greater in suburban areas than urban areas. Of all children who received dose 1, 79.7% completed the Hib vaccine series, and 91.3% completed the PCV series. Timely dose 1 coverage was 8.2% for Hib vaccine and 0.5% for PCV. Conclusion: Low vaccination coverage and extremely low levels of timely dose 1 vaccination indicate that current vaccination efforts are inadequate to reduce the burden of Hib and pneumococcal disease among Chinese children, especially infants. Government funding of the Hib vaccine and PCV through the Expanded Program on Immunization would increase uptake and could also ensure that improvement in the timeliness of administration and series completion is targeted for all demographic groups.	[Wagner, Abram L.; Montgomery, JoLynn P.; Boulton, Matthew L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Sun, Xiaodong; Huang, Zhuoying] Shanghai Municipal Ctr Dis Control & Prevent, Dept Immunizat Program, Shanghai, Peoples R China; [Boulton, Matthew L.] Univ Michigan, Div Infect Dis, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Shanghai Center for Disease Control & Prevention; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Boulton, Matthew/0000-0002-0565-9010				Akmatov MK, 2008, VACCINE, V26, P3805, DOI 10.1016/j.vaccine.2008.05.031; [Anonymous], 2012, WKLY EPIDEMIOL REC; Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Bian H, 2012, MED LAB SCI, V4, P82; Bolton P, 1998, PUBLIC HEALTH REP, V113, P527; Centers for Disease Control and Prevention, 2012, HAEM INFL EP PREV VA, P87; Centers for Disease Control and Prevention, 2012, PNEUM DIS EP PREV VA, P233; Centers for Disease Control and Prevention, 2012, GEN REC IMM EP PREV, P9; Chen Peng, 2010, Modern Preventive Medicine, V37, P2041; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027333; Cui Q, 2012, ZHEJIANG PREVENTIVE, V24, P32; Freeman III C. W., 2009, CHINAS CAPACITY MANA; Gates Foundation, 2013, PNEUM STRAT OV; GAVI Alliance, 2013, HAEM INFL TYP B VACC; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Han C, 2012, ZHEJIANG PREVENTIVE, V24, P24; Irigoyen M, 2004, AMBUL PEDIATR, V4, P199, DOI 10.1367/A03-138R1.1; Kalies H, 2006, PEDIATR INFECT DIS J, V25, P507, DOI 10.1097/01.inf.0000222413.47344.23; Lin N, 2006, MED IND INFORM, V3, P142; Qi H, 2012, CHINESE FOREIGN MED, V10, P144; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Shanghai Municipal Statistics Bureau, 2011, SHANGH STAT YB; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sun J, 2012, MED LAB SCI, V3, P117; Sun MP, 2010, VACCINE, V28, P1264, DOI 10.1016/j.vaccine.2009.11.015; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; The Government of the People's Republic of China, 2013, GLOB ALL VACC UNPUB; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; WHO, 2012, EST HIB PNEUM DEATHS; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; Xiao H, 2012, HEILONGJIANG MED PHA, V35, P55; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yu HJ, 2012, HEALTH AFFAIR, V31, P2545, DOI 10.1377/hlthaff.2011.1272; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; Zheng JS., 2012, CHIN J VACCINES IMMU, V18, P233, DOI 10.13683/j.wph.2017.06.014	38	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97800	10.1371/journal.pone.0097800	http://dx.doi.org/10.1371/journal.pone.0097800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828814	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400124
J	Castillo-Rodriguez, RA; Arango-Rodriguez, ML; Escobedo, L; Hernandez-Baltazar, D; Gompel, A; Forgez, P; Martinez-Fong, D				Castillo-Rodriguez, Rosa A.; Arango-Rodriguez, Martha L.; Escobedo, Lourdes; Hernandez-Baltazar, Daniel; Gompel, Anne; Forgez, Patricia; Martinez-Fong, Daniel			Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice	PLOS ONE			English	Article							CELL-LINES; NONVIRAL VECTOR; RECEPTOR 1; BYSTANDER; THERAPY; APOPTOSIS; PATHWAY; MODELS; DNA; PROLIFERATION	The human breast adenocarcinoma cell line MDA-MB-231 has the triple-negative breast cancer (TNBC) phenotype, which is an aggressive subtype with no specific treatment. MDA-MB-231 cells express neurotensin receptor type 1 (NTSR1), which makes these cells an attractive target of therapeutic genes that are delivered by the neurotensin (NTS)-polyplex nanocarrier via the bloodstream. We addressed the relevance of this strategy for TNBC treatment using NTS-polyplex nanoparticles harboring the herpes simplex virus thymidine kinase (HSVtk) suicide gene and its complementary prodrug ganciclovir (GCV). The reporter gene encoding green fluorescent protein (GFP) was used as a control. NTS-polyplex successfully transfected both genes in cultured MDA-MB-231 cells. The transfection was demonstrated pharmacologically to be dependent on activation of NTSR1. The expression of HSVtk gene decreased cell viability by 49% (P<0.0001) and induced apoptosis in cultured MDA-MB-231 cells after complementary GCV treatment. In the MDA-MB-231 xenograft model, NTS-polyplex nanoparticles carrying either the HSVtk gene or GFP gene were injected into the tumors or via the bloodstream. Both routes of administration allowed the NTS-polyplex nanoparticles to reach and transfect tumorous cells. HSVtk expression and GCV led to apoptosis, as shown by the presence of cleaved caspase-3 and Apostain immunoreactivity, and significantly inhibited the tumor growth (55-60%) (P<0.001). At the end of the experiment, the weight of tumors transfected with the HSVtk gene was 55% less than that of control tumors (P<0.05). The intravenous transfection did not induce apoptosis in peripheral organs. Our results offer a promising gene therapy for TNBC using the NTS-polyplex nanocarrier.	[Castillo-Rodriguez, Rosa A.; Escobedo, Lourdes; Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Programa Nanociencias & Nanotecnol, Mexico City, DF, Mexico; [Arango-Rodriguez, Martha L.] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias, Santiago, Chile; [Gompel, Anne] Univ Paris 05, Port Royal Cochin, AP HP, Unite Gynecol, Paris, France; [Forgez, Patricia] Univ Paris 05, INSERM, Dept Cellular Homeostasis & Canc, UMR S 1007, Paris, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad del Desarrollo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Martinez-Fong, D (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	dmartine@fisio.cinvestav.mx	FORGEZ, Patricia/N-2960-2018; Gompel, Anne/AAV-3132-2020; BALTAZAR, DANIEL HERNANDEZ/S-9655-2019	BALTAZAR, DANIEL HERNANDEZ/0000-0002-3658-4808; Castillo-Rodriguez, Rosa Angelica/0000-0003-4117-6689	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Agence Internationale de la Recherche Blanc International [ANR-10-INTB-1503]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [142947]; Evaluation-orientation de la Cooperation Scientifique (ECOS Nord) [M07-S01]	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Agence Internationale de la Recherche Blanc International; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Evaluation-orientation de la Cooperation Scientifique (ECOS Nord)	This work was supported by Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF), and Agence Internationale de la Recherche Blanc International (ANR-10-INTB-1503) NTS-Polyplex. Consejo Nacional de Ciencia y Tecnologia (CONACYT) # 142947, supported the fellowships of RC-R and DH-B. Evaluation-orientation de la Cooperation Scientifique (ECOS Nord) # M07-S01 supported travel missions and RC-R travel fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Asklund T, 2003, EXP CELL RES, V284, P185, DOI 10.1016/S0014-4827(02)00052-6; Bayraktar S, 2013, BREAST CANCER RES TR, V138, P21, DOI 10.1007/s10549-013-2421-5; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Boyle P, 2012, ANN ONCOL S6, V23, pvi7; Carroll JL, 2001, MOL CANCER THER, V1, P49; Chiu SH, 2004, J CONTROL RELEASE, V97, P357, DOI 10.1016/j.jconrel.2004.03.019; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Dachs GU, 2009, MOLECULES, V14, P4517, DOI 10.3390/molecules14114517; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dilber MS, 1996, BLOOD, V88, P2192, DOI 10.1182/blood.V88.6.2192.bloodjournal8862192; Drake RR, 2000, MOL THER, V2, P515, DOI 10.1006/mthe.2000.0192; Duarte S, 2012, CANCER LETT, V324, P160, DOI 10.1016/j.canlet.2012.05.023; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Eastman A, 2013, ANN SURG ONCOL, V20, P1880, DOI 10.1245/s10434-012-2835-z; Orozco-Barrios CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008268; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1993, CANCER RES, V53, P5274; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Hamel W, 1996, CANCER RES, V56, P2697; Heakal Y, 2009, MOL CANCER RES, V7, P724, DOI 10.1158/1541-7786.MCR-08-0322; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hernandez-Baltazar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051341; Hernandez-Gutierrez M, 2013, NANOMEDICINE NANOTEC; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huang HL, 2010, BIOMATERIALS, V31, P1830, DOI 10.1016/j.biomaterials.2009.11.012; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Li XG, 2001, CANCER GENE THER, V8, P555, DOI 10.1038/sj.cgt.7700337; Lim KI, 2012, BMB REP, V45, P207, DOI 10.5483/BMBRep.2012.45.4.207; LOOKINGBILL DP, 1993, J AM ACAD DERMATOL, V29, P228, DOI 10.1016/0190-9622(93)70173-Q; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Martinez-Fong D, 1999, MOL BRAIN RES, V69, P249, DOI 10.1016/S0169-328X(99)00114-X; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mendez M, 1997, J MOL NEUROSCI, V9, P93, DOI 10.1007/BF02736853; Merkel OM, 2009, J CONTROL RELEASE, V138, P148, DOI 10.1016/j.jconrel.2009.05.016; Mesnil M, 2000, CANCER RES, V60, P3989; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pan JG, 2012, MED ONCOL, V29, P1938, DOI 10.1007/s12032-011-0091-x; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Princen F, 1999, CLIN CANCER RES, V5, P3639; Reis JS, 2006, J PATHOL, V209, P445, DOI 10.1002/path.2004; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; Schade B, 2013, CANCER RES, V73, P4474, DOI 10.1158/0008-5472.CAN-12-3925; Shy BR, 2013, CELL REP, V4, P1, DOI 10.1016/j.celrep.2013.06.001; Somai S, 2002, BIOCHEM BIOPH RES CO, V295, P482, DOI 10.1016/S0006-291X(02)00703-9; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; SPENCER PS, 1987, CUTIS, V39, P119; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tomicic MT, 2002, MUTAT RES-FUND MOL M, V505, P1, DOI 10.1016/S0027-5107(02)00105-7; Vyas VK, 2013, ANTI-CANCER AGENT ME, V13, P433; Ward CM, 2001, BLOOD, V97, P2221, DOI 10.1182/blood.V97.8.2221; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu Zherui, 2012, Front Endocrinol (Lausanne), V3, P184, DOI 10.3389/fendo.2012.00184; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	68	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97151	10.1371/journal.pone.0097151	http://dx.doi.org/10.1371/journal.pone.0097151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824754	gold, Green Published, Green Submitted			2022-12-25	WOS:000336369200066
J	Lin, YC; Li, L; Makarova, AV; Burgers, PM; Stone, MP; Lloyd, RS				Lin, Ying-Chih; Li, Liang; Makarova, Alena V.; Burgers, Peter M.; Stone, Michael P.; Lloyd, R. Stephen			Error-prone Replication Bypass of the Primary Aflatoxin B-1 DNA Adduct, AFB(1)-N7-Gua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; POLYMERASE-ZETA; RAT-LIVER; P53 GENE; MUTATIONS; IDENTIFICATION; SUBSTITUTION; EXONUCLEASE; MUTAGENESIS; FIDELITY	Hepatocellular carcinomas (HCCs) are the third leading cause of cancer deaths worldwide. The highest rates of early onset HCCs occur in geographical regions with high aflatoxin B-1 (AFB(1)) exposure, concomitant with hepatitis B infection. Although the carcinogenic basis of AFB1 has been ascribed to its mutagenic effects, the mutagenic property of the primary AFB(1)-DNA adduct, AFB(1)-N7-Gua, in mammalian cells has not been studied extensively. Taking advantage of the ability to create vectors containing a site-specific DNA adduct, the mutagenic potential was determined in primate cells. This adduct was highly mutagenic following replication in COS-7 cells, with a mutation frequency of 45%. The spectrum of mutations was predominantly G to T base substitutions, a result that is consistent with previous mutation data derived from aflatoxin-associated HCCs. To assess which DNA polymerases (pol) might contribute to the mutational outcome, in vitro replication studies were performed. Unexpectedly, replicative pol delta and the error-prone translesion synthesis pol sigma were able to accurately bypass AFB(1)-N7-Gua. In contrast, replication bypass using pol kappa was shown to occur with low fidelity and could account for the commonly detected G to T transversions.	[Lin, Ying-Chih] Oregon Hlth & Sci Univ, Canc Biol Program, Portland, OR 97239 USA; [Lin, Ying-Chih; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Li, Liang; Stone, Michael P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Makarova, Alena V.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Vanderbilt University; Washington University (WUSTL)	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA.	lloydst@ohsu.edu	Makarova, Alena Vladimirovna/I-1338-2014; Burgers, Peter M/AAW-6621-2021	Lloyd, R. Stephen/0000-0001-7273-372X; Stone, Michael/0000-0002-0922-0216	National Institutes of Health [R01 CA055678, GM032431, P30 ES00267]; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA055678, P30CA068485, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA055678 (to M. P. S. and R. S. L.), GM032431 (to P. M. B.), and P30 ES00267 (to M. P. S.) and by the OHSU Knight Cancer Institute graduate fellowship (to Y.-C. L.).	AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; BAERTSCHI SW, 1988, J AM CHEM SOC, V110, P7929, DOI 10.1021/ja00231a083; Bailey EA, 1996, P NATL ACAD SCI USA, V93, P1535, DOI 10.1073/pnas.93.4.1535; Banerjee S, 2011, J AM CHEM SOC, V133, P12556, DOI 10.1021/ja2015668; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Brown KL, 2006, J AM CHEM SOC, V128, P15188, DOI 10.1021/ja063781y; CROY RG, 1981, CANCER RES, V41, P197; CROY RG, 1978, P NATL ACAD SCI USA, V75, P1745, DOI 10.1073/pnas.75.4.1745; ESSIGMANN JM, 1977, P NATL ACAD SCI USA, V74, P1870, DOI 10.1073/pnas.74.5.1870; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandes PH, 2007, MUTAT RES-FUND MOL M, V625, P40, DOI 10.1016/j.mrfmmm.2007.05.003; FORRESTER LM, 1990, P NATL ACAD SCI USA, V87, P8306, DOI 10.1073/pnas.87.21.8306; FOSTER PL, 1983, P NATL ACAD SCI-BIOL, V80, P2695, DOI 10.1073/pnas.80.9.2695; GOPALAKRISHNAN S, 1990, BIOCHEMISTRY-US, V29, P10438, DOI 10.1021/bi00498a002; GROOPMAN JD, 1981, P NATL ACAD SCI-BIOL, V78, P5445, DOI 10.1073/pnas.78.9.5445; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Johnston DS, 2000, CHEM RES TOXICOL, V13, P1158, DOI 10.1021/tx000129m; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; LEVY DD, 1992, CANCER RES, V52, P5668; Lin Y.-C., 2014, CARCINOGENE IN PRESS; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Maddukuri L, 2012, J BIOL CHEM, V287, P42312, DOI 10.1074/jbc.M112.410332; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Mao H, 1998, BIOCHEMISTRY-US, V37, P4374, DOI 10.1021/bi9718292; MARTIN CN, 1977, NATURE, V267, P863, DOI 10.1038/267863a0; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Roze LV, 2013, ANNU REV FOOD SCI T, V4, P293, DOI 10.1146/annurev-food-083012-123702; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Smela ME, 2002, P NATL ACAD SCI USA, V99, P6655, DOI 10.1073/pnas.102167699; Yamanaka K, 2013, DNA REPAIR AND CANCER: FROM BENCH TO CLINIC, P325; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10	35	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18497	18506		10.1074/jbc.M114.561563	http://dx.doi.org/10.1074/jbc.M114.561563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838242	Green Published, hybrid			2022-12-25	WOS:000338042000046
J	Valentin-Hansen, L; Park, M; Huber, T; Grunbeck, A; Naganathan, S; Schwartz, TW; Sakmar, TP				Valentin-Hansen, Louise; Park, Minyoung; Huber, Thomas; Grunbeck, Amy; Naganathan, Saranga; Schwartz, Thue W.; Sakmar, Thomas P.			Mapping Substance P Binding Sites on the Neurokinin-1 Receptor Using Genetic Incorporation of a Photoreactive Amino Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; NK-1 RECEPTOR; CRYSTAL-STRUCTURE; NK1 RECEPTOR; TACHYKININ RECEPTOR; COVALENT ATTACHMENT; AGONIST; SEPTIDE; COMPLEX; DOMAIN	Substance P (SP) is a neuropeptide that mediates numerous physiological responses, including transmission of pain and inflammation through the neurokinin-1 (NK1) receptor, a G protein-coupled receptor. Previous mutagenesis studies and photoaffinity labeling using ligand analogues suggested that the binding site for SP includes multiple domains in the N-terminal (Nt) segment and the second extracellular loop (ECLII) of NK1. To map precisely the NK1 residues that interact with SP, we applied a novel receptor-based targeted photocross-linking approach. We used amber codon suppression to introduce the photoreactive unnatural amino acid p-benzoyl-L-phenylalanine (BzF) at 11 selected individual positions in the Nt tail (residues 11-21) and 23 positions in the ECLII (residues 170(C-10)-193(C+13)) of NK1. The 34 NK1 variants were expressed in mammalian HEK293 cells and retained the ability to interact with a fluorescently labeled SP analog. Notably, 10 of the receptor variants with BzF in the Nt tail and 4 of those with BzF in ECLII cross-linked efficiently to SP, indicating that these 14 sites are juxtaposed to SP in the ligand-bound receptor. These results show that two distinct regions of the NK1 receptor possess multiple determinants for SP binding and demonstrate the utility of genetically encoded photocross-linking to map complex multitopic binding sites on G protein-coupled receptors in a cell-based assay format.	[Valentin-Hansen, Louise; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Park, Minyoung; Schwartz, Thue W.; Sakmar, Thomas P.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, DK-2200 Copenhagen, Denmark; [Park, Minyoung; Huber, Thomas; Grunbeck, Amy; Naganathan, Saranga; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10065 USA.	sakmar@rockefeller.edu	Sakmar, Thomas P/D-1833-2015; Huber, Thomas/A-8016-2008	Sakmar, Thomas P/0000-0002-2836-8953; Huber, Thomas/0000-0002-1844-262X; Schwartz, Thue W./0000-0002-0261-6904	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank the Proteomic Resource Center at the Rockefeller University for the synthesis of the F-SP and F-SP(BzF8) peptide analogues. The Novo Nordisk Foundation Center for Basic Metabolic Research is supported by an unconditional grant from the Novo Nordisk Foundation to the University of Copenhagen.	BOYD ND, 1995, ANN NY ACAD SCI, V757, P405, DOI 10.1111/j.1749-6632.1995.tb17498.x; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; FONG TM, 1993, NATURE, V362, P350; FONG TM, 1993, REGUL PEPTIDES, V46, P43, DOI 10.1016/0167-0115(93)90010-6; Gayen A, 2011, BBA-BIOMEMBRANES, V1808, P127, DOI 10.1016/j.bbamem.2010.09.023; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; Grunbeck A, 2013, BIOCHEMISTRY-US, V52, P8625, DOI 10.1021/bi401300y; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HUANG RRC, 1994, BIOCHEMISTRY-US, V33, P3007, DOI 10.1021/bi00176a033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lequin O, 2002, J BIOL CHEM, V277, P22386, DOI 10.1074/jbc.M110614200; Li HZ, 2001, J BIOL CHEM, V276, P10589, DOI 10.1074/jbc.M007397200; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Maggi CA, 2000, REGUL PEPTIDES, V93, P53, DOI 10.1016/S0167-0115(00)00177-4; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nguyen ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067302; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pellegrini M, 2001, J BIOL CHEM, V276, P22862, DOI 10.1074/jbc.M101057200; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; PRADIER L, 1994, MOL PHARMACOL, V45, P287; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; REGOLI D, 1994, PHARMACOL REV, V46, P551; Riitano D, 1997, J BIOL CHEM, V272, P7646, DOI 10.1074/jbc.272.12.7646; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Sachon E, 2002, J BIOL CHEM, V277, P50409, DOI 10.1074/jbc.M207242200; Sachon E, 2002, J PEPT RES, V59, P232, DOI 10.1034/j.1399-3011.2002.01977.x; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Turcatti G, 1997, J BIOL CHEM, V272, P21167, DOI 10.1074/jbc.272.34.21167; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wijkhuisen A, 1999, FEBS LETT, V447, P155, DOI 10.1016/S0014-5793(99)00298-7; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200	48	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18045	18054		10.1074/jbc.M113.527085	http://dx.doi.org/10.1074/jbc.M113.527085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831006	hybrid, Green Published			2022-12-25	WOS:000338042000008
J	Yokoyama, A; Igarashi, K; Sato, T; Takagi, K; Otsuka, IM; Shishido, Y; Baba, T; Ito, R; Kanno, J; Ohkawa, Y; Morohashi, K; Sugawara, A				Yokoyama, Atsushi; Igarashi, Katsuhide; Sato, Tetsuya; Takagi, Kiyoshi; Otsuka, Maky, I; Shishido, Yurina; Baba, Takashi; Ito, Ryo; Kanno, Jun; Ohkawa, Yasuyuki; Morohashi, Ken-ichirou; Sugawara, Akira			Identification of Myelin Transcription Factor 1 (MyT1) as a Subunit of the Neural Cell Type-specific Lysine-specific Demethylase 1 (LSD1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE DEMETHYLASE; ZINC-FINGER; DEPENDENT TRANSCRIPTION; NERVOUS-SYSTEM; BREAST-CANCER; PROTEIN PHOSPHATASE; NUCLEAR RECEPTORS; TUMOR-SUPPRESSOR; GENE ACTIVATION	Regulation of spatiotemporal gene expression in higher eukaryotic cells is critical for the precise and orderly development of undifferentiated progenitors into committed cell types of the adult. It is well known that dynamic epigenomic regulation (including chromatin remodeling and histone modifications by transcriptional coregulator complexes) is involved in transcriptional regulation. Precisely how these coregulator complexes exert their cell type and developing stage-specific activity is largely unknown. In this study we aimed to isolate the histone demethylase lysine-specific demethylase 1 (LSD1) complex from neural cells by biochemical purification. In so doing, we identified myelin transcription factor 1 (MyT1) as a novel LSD1 complex component. MyT1 is a neural cell-specific zinc finger factor, and it forms a stable multiprotein complex with LSD1 through direct interaction. Target gene analysis using microarray and ChIP assays revealed that the Pten gene was directly regulated by the LSD1-MyT1 complex. Knockdown of either LSD1 or MyT1 derepressed the expression of endogenous target genes and inhibited cell proliferation of a neuroblastoma cell line, Neuro2a. We propose that formation of tissue-specific combinations of coregulator complexes is a critical mechanism for tissue-specific transcriptional regulation.	[Yokoyama, Atsushi; Ito, Ryo; Sugawara, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yokoyama, Atsushi; Ito, Ryo] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Igarashi, Katsuhide; Otsuka, Maky, I; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Igarashi, Katsuhide; Otsuka, Maky, I] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 1428501, Japan; [Sato, Tetsuya] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Higashi Ku, Fukuoka 8128582, Japan; [Takagi, Kiyoshi] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Shishido, Yurina; Baba, Takashi; Morohashi, Ken-ichirou] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Div Epigenet,Higashi Ku, Fukuoka 8128582, Japan	Tohoku University; University of Tokyo; National Institute of Health Sciences - Japan; Hoshi University; Kyushu University; Tohoku University; Kyushu University; Kyushu University	Yokoyama, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ayokoyama@med.tohoku.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Baba, Takashi/ABI-2727-2020; Yokoyama, Atsushi/W-3519-2019; Ito, Ryo/F-8571-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Sugawara, Akira/0000-0003-4511-8101; Yokoyama, Atsushi/0000-0003-2842-4334	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a research fellowship for young scientists from the Japan Society for the Promotion of Science (to A. Y.).	Blasie CA, 2000, INORG CHEM, V39, P348, DOI 10.1021/ic990913y; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Fiaschi T, 2001, J BIOL CHEM, V276, P49156, DOI 10.1074/jbc.M107538200; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Jones KA, 2007, GENE DEV, V21, P2113, DOI 10.1101/gad.1598007; Kanno J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-64; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Kimura M, 2001, CYTOGENET CELL GENET, V95, P177, DOI 10.1159/000059342; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lucentini L, 2003, INT J BIOCHEM CELL B, V35, P1378, DOI 10.1016/S1357-2725(03)00099-2; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2006, CURR OPIN GENET DEV, V16, P513, DOI 10.1016/j.gde.2006.08.013; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sanosaka T, 2008, NEUROSCIENCE, V155, P780, DOI 10.1016/j.neuroscience.2008.06.039; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Yokoyama A, 2011, COLD SH Q B, V76, P165, DOI 10.1101/sqb.2011.76.010736; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Yokoyama A, 2010, GENES CELLS, V15, P867, DOI 10.1111/j.1365-2443.2010.01424.x; Zhang YZ, 2010, NEUROSCI RES, V68, P66, DOI 10.1016/j.neures.2010.06.002; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	65	29	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18152	18162		10.1074/jbc.M114.566448	http://dx.doi.org/10.1074/jbc.M114.566448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828497	Green Published, hybrid			2022-12-25	WOS:000338042000018
J	Wang, BY; Pfeiffer, MJ; Schwarzer, C; Arauzo-Bravo, MJ; Boiani, M				Wang, Bingyuan; Pfeiffer, Martin J.; Schwarzer, Caroline; Arauzo-Bravo, Marcos J.; Boiani, Michele			DNA Replication Is an Integral Part of the Mouse Oocyte's Reprogramming Machinery	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; GENE-EXPRESSION; POLYMERASE-ALPHA; SOMATIC-CELLS; EMBRYOS; PLURIPOTENCY; APHIDICOLIN; OCT4; CHROMATIN; FUSION	Many of the structural and mechanistic requirements of oocyte-mediated nuclear reprogramming remain elusive. Previous accounts that transcriptional reprogramming of somatic nuclei in mouse zygotes may be complete in 24-36 hours, far more rapidly than in other reprogramming systems, raise the question of whether the mere exposure to the activated mouse ooplasm is sufficient to enact reprogramming in a nucleus. We therefore prevented DNA replication and cytokinesis, which ensue after nuclear transfer, in order to assess their requirement for transcriptional reprogramming of the key pluripotency genes Oct4 (Pou5f1) and Nanog in cloned mouse embryos. Using transcriptome and allele-specific analysis, we observed that hundreds of mRNAs, but not Oct4 and Nanog, became elevated in nucleus-transplanted oocytes without DNA replication. Progression through the first round of DNA replication was essential but not sufficient for transcriptional reprogramming of Oct4 and Nanog, whereas cytokinesis and thereby cell-cell interactions were dispensable for transcriptional reprogramming. Responses similar to clones also were observed in embryos produced by fertilization in vitro. Our results link the occurrence of reprogramming to a previously unappreciated requirement of oocyte-mediated nuclear reprogramming, namely DNA replication. Nuclear transfer alone affords no immediate transition from a somatic to a pluripotent gene expression pattern unless DNA replication is also in place. This study is therefore a resource to appreciate that the quest for always faster reprogramming methods may collide with a limit that is dictated by the cell cycle.	[Wang, Bingyuan; Pfeiffer, Martin J.; Schwarzer, Caroline; Boiani, Michele] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian, Spain; [Arauzo-Bravo, Marcos J.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain	Max Planck Society; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science	Boiani, M (corresponding author), Max Planck Inst Mol Biomed, D-48149 Munster, Germany.	mboiani@mpi-muenster.mpg.de	Schwarzer, Caroline/I-2435-2013; Pfeiffer, Martin Johannes/A-9332-2011; Marcos, Arauzo-Bravo/A-1706-2011; Boiani, Michele/M-3519-2015	Pfeiffer, Martin Johannes/0000-0001-9264-9218; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Boiani, Michele/0000-0003-2765-2781	Deutsche Forschungsgemeinschaft (DFG) [1356, BO2540/3-2]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This study was financially supported by the special priority program (Schwerpunktprogramm) no. 1356 of the Deutsche Forschungsgemeinschaft, http://www.dfg.de (DFG grant BO2540/3-2) and by the Max Planck Society (https://www.mpg.de/). The funder (DFG) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; BERGER NA, 1979, BIOCHEM BIOPH RES CO, V89, P218, DOI 10.1016/0006-291X(79)90966-5; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choi I, 2010, MOL REPROD DEV, V77, P876, DOI 10.1002/mrd.21230; Choi I, 2010, REPROD FERT DEVELOP, V22, P1000, DOI 10.1071/RD09144; de Vries WN, 2008, COLD SH Q B, V73, P33, DOI 10.1101/sqb.2008.73.016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Gurdon JB, 2013, DEVELOPMENT, V140, P2449, DOI 10.1242/dev.097170; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Iqbal K, 2007, BIOCHEM BIOPH RES CO, V358, P727, DOI 10.1016/j.bbrc.2007.04.155; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; KROKAN H, 1981, NUCLEIC ACIDS RES, V9, P4709, DOI 10.1093/nar/9.18.4709; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; PETZOLDT U, 1984, CELL DIFFER DEV, V15, P163, DOI 10.1016/0045-6039(84)90069-1; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; Samake S, 1996, J EXP ZOOL, V274, P111, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;111::AID-JEZ4&gt;3.0.CO;2-S; Schwarzer C, 2012, HUM REPROD, V27, P2627, DOI 10.1093/humrep/des223; Sebastiano V, 2005, MOL REPROD DEV, V70, P146, DOI 10.1002/mrd.20144; Solter D, 2002, GENE DEV, V16, P1163, DOI 10.1101/gad.998302; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Vassena R, 2007, MOL REPROD DEV, V74, P1548, DOI 10.1002/mrd.20723; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Xu YY, 2013, J BIOL CHEM, V288, P9767, DOI 10.1074/jbc.M112.403881; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97199	10.1371/journal.pone.0097199	http://dx.doi.org/10.1371/journal.pone.0097199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836291	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800031
J	Aceto, S; Sica, M; De Paolo, S; D'Argenio, V; Cantiello, P; Salvatore, F; Gaudio, L				Aceto, Serena; Sica, Maria; De Paolo, Sofia; D'Argenio, Valeria; Cantiello, Piergiuseppe; Salvatore, Francesco; Gaudio, Luciano			The Analysis of the Inflorescence miRNome of the Orchid Orchis italica Reveals a DEF-Like MADS-Box Gene as a New miRNA Target	PLOS ONE			English	Article							PI/GLO-LIKE LOCUS; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS; EXPRESSION; MICRORNA; FLOWER; IDENTIFICATION; HOMEOSTASIS; EVOLUTION; MIR168A	Plant microRNAs (miRNAs) are small, regulatory non-coding RNAs involved in a wide range of biological processes, from organ development to response to stimuli. In recent years, an increasing number of studies on model plant species have highlighted the evolutionary conservation of a high number of miRNA families and the existence of taxon-specific ones. However, few studies have examined miRNAs in non-model species such as orchids, which are characterized by highly diversified floral structures and pollination strategies. Therefore, we analysed a small RNA library of inflorescence tissue of the Mediterranean orchid Orchis italica to increase the knowledge on miRNAs in a non-model plant species. The high-throughput sequencing and analysis of a small RNA library of inflorescence of O. italica revealed 23 conserved and 161 putative novel miRNA families. Among the putative miRNA targets, experimental validation demonstrated that a DEF-like MADS-box transcript is cleaved by the homolog of miR5179 of O. italica. The presence of conserved miRNA families in the inflorescence of O. italica indicates that the basic developmental flower regulatory mechanisms mediated by miRNAs are maintained through evolution. Because, according to the "orchid code" theory, DEF-like genes exert a key function in the diversification of tepals and lip, the cleavage-mediated inhibitory activity of miR5179 on a OitaDEF-like transcript suggests that, in orchids, miRNAs play an important role in the diversification of the perianth organs.	[Aceto, Serena; Sica, Maria; De Paolo, Sofia; Gaudio, Luciano] Univ Naples Federico II, Dept Biol, Naples, Italy; [D'Argenio, Valeria; Cantiello, Piergiuseppe; Salvatore, Francesco] CEINGE Biotecnol Avanzate, Naples, Italy; [D'Argenio, Valeria; Salvatore, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	D'Argenio, Valeria/K-9345-2016; Aceto, Serena/E-5350-2010; Gaudio, Luciano/AAF-4322-2020; Salvatore, Francesco/A-1966-2011	D'Argenio, Valeria/0000-0001-9273-3698; Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872; Salvatore, Francesco/0000-0002-2346-3564	Regione Campania Grant [L.R. N5/2002]	Regione Campania Grant(Regione Campania)	This work was supported by the 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Cantone C, 2009, GENE, V434, P9, DOI 10.1016/j.gene.2008.12.015; Cantone C, 2011, GENE, V481, P48, DOI 10.1016/j.gene.2011.04.004; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kanno A, 2007, THESCIENTIFICWORLDJO, V7, P268, DOI 10.1100/tsw.2007.86; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Manavella PA, 2013, PLANT PHYSIOL, V161, P805, DOI 10.1104/pp.112.207068; Miyashima S, 2013, PLANT CELL PHYSIOL, V54, P375, DOI 10.1093/pcp/pcs188; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Pan ZJ, 2011, PLANT CELL PHYSIOL, V52, P1515, DOI 10.1093/pcp/pcr092; Salemme M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077454; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Shi Rui, 2012, Methods Mol Biol, V822, P53, DOI 10.1007/978-1-61779-427-8_4; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhu J, 2013, PLANT CELL REP	57	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97839	10.1371/journal.pone.0097839	http://dx.doi.org/10.1371/journal.pone.0097839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832004	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500123
J	Carr, RM; Peralta, G; Yin, XY; Ahima, RS				Carr, Rotonya M.; Peralta, Giselle; Yin, Xiaoyan; Ahima, Rexford S.			Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; CHRONIC ETHANOL-CONSUMPTION; FATTY LIVER; INSULIN-RESISTANCE; LIPID-METABOLISM; TRIGLYCERIDE; TIP47; HOMEOSTASIS; HEPATOSTEATOSIS; PATHOGENESIS	Background: Perilipin 2 (Plin2) is a lipid droplet protein that has roles in both lipid and glucose homeostasis. An increase in Plin2 in liver is associated with the development of steatosis, glucose intolerance, and ceramide accumulation in alcoholic liver disease. We investigated the role of Plin2 on energy balance and glucose and lipid homeostasis in wildtype and Plin2 knockout (Plin2KO) mice chronically fed a Lieber-DeCarli liquid ethanol or control diet for six weeks. Methods: We performed in vivo measurements of energy intake and expenditure; body composition; and glucose tolerance. After sacrifice, liver was dissected for histology and lipid analysis. Results: We found that neither genotype nor diet had a significant effect on final weight, body composition, or energy intake between WT and Plin2KO mice fed alcohol or control diets. Additionally, alcohol feeding did not affect oxygen consumption or carbon dioxide production in Plin2KO mice. We performed glucose tolerance testing and observed that alcohol feeding failed to impair glucose tolerance in Plin2KO mice. Most notably, absence of Plin2 prevented hepatic steatosis and ceramide accumulation in alcohol-fed mice. These changes were related to downregulation of genes involved in lipogenesis and triglyceride synthesis. Conclusions: Plin2KO mice chronically fed alcohol are protected from hepatic steatosis, glucose intolerance, and hepatic ceramide accumulation, suggesting a critical pathogenic role of Plin2 in experimental alcoholic liver disease.	[Carr, Rotonya M.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Peralta, Giselle; Yin, Xiaoyan; Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Carr, RM (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	Rotonya.Carr@uphs.upenn.edu	Ahima, Rexford/W-1394-2019		National Institutes of Health Grant (NIH) [K08-AA021424]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores; NIH [P01-DK-049210]; Diabetes Research Center Mouse Metabolic Phenotyping Core [P30-DK-19525]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA021424] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center Mouse Metabolic Phenotyping Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by National Institutes of Health Grant (NIH) grant K08-AA021424; and in part by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and its pilot and feasibility grant award, as well as the Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores (to RMC); NIH grant P01-DK-049210 (to RSA), Diabetes Research Center Mouse Metabolic Phenotyping Core (grant P30-DK-19525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434; Carr RM, 2013, ALCOHOL CLIN EXP RES, V37, P1091, DOI 10.1111/acer.12075; Carr RM, 2012, AM J PHYSIOL-REG I, V302, pR996, DOI 10.1152/ajpregu.00177.2011; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen J, 2012, J CHROMATOGR B, V883, P136, DOI 10.1016/j.jchromb.2011.11.017; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; de la Monte SM, 2008, J GASTROEN HEPATOL, V23, pE477, DOI 10.1111/j.1440-1746.2008.05339.x; de la Monte SM, 2011, HEPATOL RES, V41, P386, DOI 10.1111/j.1872-034X.2011.00775.x; Deaciuc IV, 2000, ALCOHOL CLIN EXP RES, V24, P1557, DOI 10.1111/j.1530-0277.2000.tb04575.x; Denucci SM, 2010, GASTROENTEROLOGY RES, V2010; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; HOLLEY DC, 1981, METABOLISM, V30, P894, DOI 10.1016/0026-0495(81)90068-8; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lizarazo D, 2013, J GASTROEN HEPATOL, V28, P1660, DOI 10.1111/jgh.12291; Longato L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/479348; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; McVicker BL, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/978136; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; National Institute on Alcohol Abuse and Alcoholism (U.S.), 2005, ALCOHOL ALERT; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Pastorino JG, 2000, HEPATOLOGY, V31, P1141, DOI 10.1053/he.2000.7013; Ramirez T, 2013, J GASTROEN HEPATOL, V28, P179, DOI 10.1111/j.1440-1746.2012.07256.x; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; TIENGO A, 1981, DIABETES, V30, P705, DOI 10.2337/diabetes.30.9.705; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; WATSON CG, 1987, J CLIN PSYCHOL, V43, P404, DOI 10.1002/1097-4679(198705)43:3<404::AID-JCLP2270430315>3.0.CO;2-4; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zhao ZW, 2011, ALCOHOL CLIN EXP RES, V35, P229, DOI 10.1111/j.1530-0277.2010.01338.x	60	70	73	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97118	10.1371/journal.pone.0097118	http://dx.doi.org/10.1371/journal.pone.0097118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831094	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500036
J	Li, S; Zhang, JM; Lu, SY; Huang, WK; Geng, L; Shen, QC; Zhang, J				Li, Shuai; Zhang, Jingmiao; Lu, Shaoyong; Huang, Wenkang; Geng, Lv; Shen, Qiancheng; Zhang, Jian			The Mechanism of Allosteric Inhibition of Protein Tyrosine Phosphatase 1B	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PTP1B INHIBITORS; STRUCTURAL BASIS; LOOP DYNAMICS; BINDING; PHOSPHORYLATION; RECOGNITION; RESIDUES; INSIGHTS; KINASE	As the prototypical member of the PTP family, protein tyrosine phosphatase 1B (PTP1B) is an attractive target for therapeutic interventions in type 2 diabetes. The extremely conserved catalytic site of PTP1B renders the design of selective PTP1B inhibitors intractable. Although discovered allosteric inhibitors containing a benzofuran sulfonamide scaffold offer fascinating opportunities to overcome selectivity issues, the allosteric inhibitory mechanism of PTP1B has remained elusive. Here, molecular dynamics (MD) simulations, coupled with a dynamic weighted community analysis, were performed to unveil the potential allosteric signal propagation pathway from the allosteric site to the catalytic site in PTP1B. This result revealed that the allosteric inhibitor compound-3 induces a conformational rearrangement in helix alpha 7, disrupting the triangular interaction among helix alpha 7, helix alpha 3, and loop11. Helix alpha 7 then produces a force, pulling helix alpha 3 outward, and promotes Ser190 to interact with Tyr176. As a result, the deviation of Tyr176 abrogates the hydrophobic interactions with Trp179 and leads to the downward movement of the WPD loop, which forms an H-bond between Asp181 and Glu115. The formation of this H-bond constrains the WPD loop to its open conformation and thus inactivates PTP1B. The discovery of this allosteric mechanism provides an overall view of the regulation of PTP1B, which is an important insight for the design of potent allosteric PTP1B inhibitors.	[Li, Shuai; Zhang, Jingmiao; Lu, Shaoyong; Huang, Wenkang; Geng, Lv; Shen, Qiancheng; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Med Bioinformat Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med SJTU SM, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X	National Basic Research Program of China (973 Program) [2011CB504001]; National Natural Science Foundation of China [81322046, 21002062, 21102090]; Shanghai Rising-Star Program [13QA1402300]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for New Century Excellent Talents in University [NCET-12-0355]; Ph.D. Programs Foundation of Ministry of Education of China [20120073110070]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program) (2011CB504001); National Natural Science Foundation of China (81322046, 21002062, 21102090); Shanghai Rising-Star Program (13QA1402300); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the Program for New Century Excellent Talents in University (NCET-12-0355); the Ph.D. Programs Foundation of Ministry of Education of China (20120073110070). This work has also been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala PJ, 2006, J BIOL CHEM, V281, P38013, DOI 10.1074/jbc.M607913200; [Anonymous], 2001, VERS S 6 8; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Baskaran SK, 2012, J CHEM INF MODEL, V52, P2004, DOI 10.1021/ci200581g; Case D.A., 2022, AMBER 2020; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cui W, 2013, J CHEM INF MODEL, V53, P1157, DOI 10.1021/ci300526u; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; Huang WK, 2013, BIOINFORMATICS, V29, P2357, DOI 10.1093/bioinformatics/btt399; Huang ZM, 2014, NUCLEIC ACIDS RES, V42, pD510, DOI 10.1093/nar/gkt1247; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ivan R, 2012, P NATL ACAD SCI USA, V22, pE1428; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juszczak LJ, 1997, BIOCHEMISTRY-US, V36, P2227, DOI 10.1021/bi9622130; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamerlin SCL, 2006, BIOCHEM BIOPH RES CO, V345, P1161, DOI 10.1016/j.bbrc.2006.04.181; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Kumar R, 2010, J CHEM INF MODEL, V50, P1147, DOI 10.1021/ci900484g; Li XB, 2013, J MOL GRAPH MODEL, V40, P30, DOI 10.1016/j.jmgm.2012.12.011; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Lu SY, 2012, J CHEM INF MODEL, V52, P2398, DOI 10.1021/ci300172r; Kamerlin SCL, 2007, BIOCHEM BIOPH RES CO, V356, P1011, DOI 10.1016/j.bbrc.2007.03.093; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Olmez EO, 2011, J BIOMOL STRUCT DYN, V28, P675, DOI 10.1080/07391102.2011.10508599; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Peters GH, 2000, BIOPHYS J, V78, P2191, DOI 10.1016/S0006-3495(00)76768-3; Peters GH, 1999, BIOPHYS J, V77, P505, DOI 10.1016/S0006-3495(99)76907-9; Picha KM, 2007, J BIOL CHEM, V282, P2911, DOI 10.1074/jbc.M610096200; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Schneider R, 2013, J AM CHEM SOC, V135, P6838, DOI 10.1021/ja4030484; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Wang F, 2011, J CHEM INF MODEL, V51, P2821, DOI 10.1021/ci200264h; Wang Q, 2012, J MOL GRAPH MODEL, V38, P324, DOI 10.1016/j.jmgm.2012.07.006; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhang J, 2005, J AM CHEM SOC, V127, P11709, DOI 10.1021/ja051199o; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006304; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	59	12	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97668	10.1371/journal.pone.0097668	http://dx.doi.org/10.1371/journal.pone.0097668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831294	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500099
J	Omae, Y; Sekimizu, K; Kaito, C				Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara			Identification of Staphylococcus aureus Colony-Spreading Stimulatory Factors from Mammalian Serum	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; PULMONARY SURFACTANT; VIRULENCE; LIPOPROTEINS; ACTIVATION; EXPRESSION; ALBUMIN; GENE	Staphylococcus aureus forms giant colonies on soft-agar surfaces, which is called colony-spreading. In the present study, we searched for host factors that influence S. aureus colony-spreading activity. The addition of calf serum, porcine serum, or silkworm hemolymph to soft-agar medium stimulated S. aureus colony-spreading activity. Gel filtration column chromatography of calf serum produced a high molecular weight fraction and a low molecular weight fraction, both of which exhibited colony-spreading stimulatory activity. In the low molecular weight fraction, we identified the stimulatory factor as bovine serum albumin. The stimulatory fraction in the high molecular weight fraction was identified as high-density lipoprotein (HDL) particles. Delipidation of HDL abolished the stimulatory activity of HDL. Phosphatidylcholine, which is the major lipid component in HDL particles, stimulated the colony-spreading activity. Other phosphatidylcholine-containing lipoprotein particles, low-density lipoprotein and very low-density lipoprotein, also showed colony-spreading stimulatory activity. These findings suggest that S. aureus colony-spreading activity is stimulated by albumin and lipoprotein particles in mammalian serum.	[Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Genome Pharmaceutical Institute;  [23249009];  [24590519];  [25117507]	Genome Pharmaceutical Institute; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (23249009, 24590519, 25117507). This study was supported in part by the Genome Pharmaceutical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLOF E, 1991, BIOCHEMISTRY-US, V30, P8986; BRUMLEY GW, 1967, J CLIN INVEST, V46, P863, DOI 10.1172/JCI105586; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Nguyen D, 2013, BIOCHEMISTRY-US, V52, P1963, DOI 10.1021/bi400032y; NOBLE RP, 1968, J LIPID RES, V9, P693; Omae Y, 2012, J BIOL CHEM, V287, P15570, DOI 10.1074/jbc.M112.357848; Piknova B, 2002, CURR OPIN STRUC BIOL, V12, P487, DOI 10.1016/S0959-440X(02)00352-4; Schmidt HHJ, 1997, CLIN CHIM ACTA, V268, P41, DOI 10.1016/S0009-8981(97)00155-1; SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Tsompanidou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044646; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	23	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97670	10.1371/journal.pone.0097670	http://dx.doi.org/10.1371/journal.pone.0097670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831518	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500100
J	Been, RA; Linden, MA; Hager, CJ; DeCoursin, KJ; Abrahante, JE; Landman, SR; Steinbach, M; Sarver, AL; Largaespada, DA; Starr, TK				Been, Raha A.; Linden, Michael A.; Hager, Courtney J.; DeCoursin, Krista J.; Abrahante, Juan E.; Landman, Sean R.; Steinbach, Michael; Sarver, Aaron L.; Largaespada, David A.; Starr, Timothy K.			Genetic Signature of Histiocytic Sarcoma Revealed by a Sleeping Beauty Transposon Genetic Screen in Mice	PLOS ONE			English	Article							IDENTIFIES GENES; STEM-CELLS; CANCER; LYMPHOMA; MUTAGENESIS; EXPRESSION; MUTATIONS; BACH2; SUSCEPTIBILITY; PROTEIN	Histiocytic sarcoma is a rare, aggressive neoplasm that responds poorly to therapy. Histiocytic sarcoma is thought to arise from macrophage precursor cells via genetic changes that are largely undefined. To improve our understanding of the etiology of histiocytic sarcoma we conducted a forward genetic screen in mice using the Sleeping Beauty transposon as a mutagen to identify genetic drivers of histiocytic sarcoma. Sleeping Beauty mutagenesis was targeted to myeloid lineage cells using the Lysozyme2 promoter. Mice with activated Sleeping Beauty mutagenesis had significantly shortened lifespan and the majority of these mice developed tumors resembling human histiocytic sarcoma. Analysis of transposon insertions identified 27 common insertion sites containing 28 candidate cancer genes. Several of these genes are known drivers of hematological neoplasms, like Raf1, Fli1, and Mitf, while others are well-known cancer genes, including Nf1, Myc, Jak2, and Pten. Importantly, several new potential drivers of histiocytic sarcoma were identified and could serve as targets for therapy for histiocytic sarcoma patients.	[Been, Raha A.; Hager, Courtney J.; DeCoursin, Krista J.; Abrahante, Juan E.; Sarver, Aaron L.; Largaespada, David A.; Starr, Timothy K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Been, Raha A.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Been, Raha A.] Univ Minnesota, Dept Comparat & Mol Biosci, St Paul, MN 55108 USA; [Abrahante, Juan E.; Starr, Timothy K.] Univ Minnesota, Minneapolis, MN USA; [Linden, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Largaespada, David A.; Starr, Timothy K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Landman, Sean R.; Steinbach, Michael] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Starr, TK (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	star0044@umn.edu	Starr, Tim/AAX-9342-2021	Linden, Michael/0000-0002-7433-1676; Burnett, Courtney/0000-0003-4779-0049; Starr, Timothy/0000-0002-6308-3451; Steinbach, Michael/0000-0002-7309-6395; Abrahante, Juan/0000-0002-9074-4307	NCI [R01 CA113636]; Leukemia and Lymphoma Society [LLS 7019-04]; NIH [T32EB008389, 4R00CA151672-02]; Integrative Training in Neuroimaging; University of Minnesota Interdisciplinary Doctoral Fellowship; Masonic Cancer Center; American Cancer Society [PF-06-282-01-MGO]; Masonic Cancer Center shared resources [NIH P30 CA077598]; NATIONAL CANCER INSTITUTE [R01CA113636, P30CA077598, R00CA151672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB008389] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Training in Neuroimaging; University of Minnesota Interdisciplinary Doctoral Fellowship; Masonic Cancer Center; American Cancer Society(American Cancer Society); Masonic Cancer Center shared resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	RAB and DAL were supported by grants from the NCI (R01 CA113636) and the Leukemia and Lymphoma Society (LLS 7019-04). SL was supported by NIH Grant T32EB008389, Integrative Training in Neuroimaging, and by a University of Minnesota Interdisciplinary Doctoral Fellowship. JEA was supported by an SP3 grant from the Masonic Cancer Center. TKS was supported by a grant from the American Cancer Society (PF-06-282-01-MGO), the NIH (4R00CA151672-02), Masonic Cancer Center shared resources (NIH P30 CA077598) and generous assistance from the Masonic Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AT, 1981, CANCER RES, V41, P2063; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; AGRAWAL R, 1993, IEEE T KNOWL DATA EN, V5, P914, DOI 10.1109/69.250074; Agrawal R., 1994, P 20 INT C VER LARG, P487; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alonso-Dominguez JM, 2012, CASE REP HEMATOL, V2012, DOI 10.1155/2012/428279; ARAI E, 1993, J CUTAN PATHOL, V20, P115, DOI 10.1111/j.1600-0560.1993.tb00226.x; Berger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056408; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bie L, 2012, CLIN NEUROL NEUROSUR, V114, P356, DOI 10.1016/j.clineuro.2011.11.005; Carpenter B, 2004, MOL CELL BIOL, V24, P537, DOI 10.1128/MCB.24.2.537-549.2004; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Castro ECC, 2010, PEDIATR DEVEL PATHOL, V13, P225, DOI 10.2350/09-03-0622-OA.1; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copie-Bergman C, 1998, AM J SURG PATHOL, V22, P1386, DOI 10.1097/00000478-199811000-00009; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Eischen CM, 2002, CANCER RES, V62, P2184; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faust N, 2000, BLOOD, V96, P719; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hornick JL, 2004, AM J SURG PATHOL, V28, P1133, DOI 10.1097/01.pas.0000131541.95394.23; Huang CX, 2014, BLOOD, V123, P1012, DOI 10.1182/blood-2013-07-518605; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Keng VW, 2012, HEPATOLOGY; Kornblau SM, 2011, BLOOD, V118, P5604, DOI 10.1182/blood-2011-04-348052; Koso H, 2012, P NATL ACAD SCI USA, V109, pE2998, DOI 10.1073/pnas.1215899109; Kumar R, 2011, PEDIATR BLOOD CANCER, V56, P307, DOI 10.1002/pbc.22810; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NATURE GENETICS; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mashima R, 2010, LAB INVEST; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McGrail M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018826; Mori M, 2010, INT J HEMATOL, V92, P168, DOI 10.1007/s12185-010-0603-z; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; O'Donnell KA, 2012, P NATL ACAD SCI US; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Quintana RM, 2012, J INVESTIGATIVE DERM; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Sakane-Ishikawa E, 2005, J CLIN ONCOL, V23, P8012, DOI 10.1200/JCO.2005.02.1626; Sarver AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-154; Shearin AL, 2012, CANCER EPIDEM BIOMAR, V21, P1019, DOI 10.1158/1055-9965.EPI-12-0190-T; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH, 2008, WHO CLASSIFICATION T, V15, P439; TCGARN, 2013, NEW ENGLAND J MED; Vieira SAD, 2001, GENE CHROMOSOME CANC, V32, P353, DOI 10.1002/gcc.1200; Vos JA, 2005, MODERN PATHOL, V18, P693, DOI 10.1038/modpathol.3800346; Wang ED, 2010, LEUKEMIA LYMPHOMA, V51, P802, DOI 10.3109/10428191003699845; Ward JM, 2004, TOXICOL PATHOL, V32, P710, DOI 10.1080/01926230490885706; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yang J, 2010, CANCER BIOL THER, V9, P967, DOI 10.4161/cbt.9.12.11635; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu XD, 2002, J NATL CANCER I, V94, P504; Zaki M. J., 1998, 3 ACM SIGMOD WORKSH, P71; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	78	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97280	10.1371/journal.pone.0097280	http://dx.doi.org/10.1371/journal.pone.0097280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827933	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400073
J	Kouba, M; Bartos, L; Zarybnicka, M				Kouba, Marek; Bartos, Ludek; Zarybnicka, Marketa			Perching of Tengmalm's Owl (Aegolius funereus) Nestlings at the Nest Box Entrance: Effect of Time of the Day, Age, Wing Length and Body Weight	PLOS ONE			English	Article							SIBLING COMPETITION; REPRODUCTIVE SUCCESS; BEGGING BEHAVIOR; SEX-DIFFERENCES; FOOD ABUNDANCE; BOREAL OWLS; TYTO-ALBA; BUDGERIGARS; MOUNTAINS; VIGILANCE	The behaviour of the nestlings of nocturnal cavity-nesting species has relatively rarely been studied in detail because of problems connected with use of the technical devices required to provide long-term monitoring of individuals. However, long-term observation of nestling behaviour is crucial in order to identify different types of behaviour which may be caused by sibling competition at the end of nesting period. We studied behaviour of 43 Tengmalm's owl (Aegolius funereus) nestlings at 14 nests using a camera and a chip system. The nestlings perched at the nest box entrance from an average age of 28 days from hatching (range 24-34 days) until fledging, spending around 2 hours per day here in total, in periods ranging from a few seconds to 147 min (7.6 +/- 10.9 min, mean +/- SD). We found that individual duration of perching at the nest box entrance was significantly influenced by nestlings' age and wing length and that the duration of perching at the nest box entrance significantly decreased with time of night. However, during daylight hours, time of day had no effect on either probability or duration of nestlings' perching. We suggest daylight perching at the nest box entrance results from nestlings' preparation for fledging, while individuals perching here during the night may gain an advantageous position for obtaining food from the parents; another possibility at all times of day is that nestlings can reaffirm their social dominance status by monopolizing the nest box entrance.	[Kouba, Marek; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Suchdol, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Fac Agrobiol Food & Nat Resources, Suchdol, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Suchdol, Czech Republic.	marekkouba8@gmail.com	Kouba, Marek/A-1350-2019; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Kouba, Marek/0000-0003-2262-5733; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague (CIGA) [20104205, 20144203]; Ministry of Education, Youth and Sports of the Czech Republic [MSMT 1321/213205]; Ministry of Agriculture of the Czech Republic [MZERO 0714]	Czech University of Life Sciences Prague (CIGA); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech University of Life Sciences Prague (CIGA Grant No. 20104205 and 20144203), the Ministry of Education, Youth and Sports of the Czech Republic (MSMT 1321/213205), and Ministry of Agriculture of the Czech Republic (MZERO 0714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; BEZOUSKA V, 2005, ITCE 2005 C, P173; Ctyroky P, 1971, SYLVIA, V19, P83; Drdakova Marketa, 2003, Sylvia, V39, P35; Drdakova-Zarybnicka M., 2005, BUTEO, V14, P37; Dreiss AN, 2014, J EVOLUTION BIOL, V27, P63, DOI 10.1111/jeb.12277; Dreiss A, 2010, ANIM BEHAV, V80, P1049, DOI 10.1016/j.anbehav.2010.09.012; Dreiss AN, 2013, J AVIAN BIOL, V44, P359, DOI 10.1111/j.1600-048X.2013.00066.x; Dreiss AN, 2013, BEHAV ECOL, V24, P717, DOI 10.1093/beheco/ars210; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; GLUTZ BUN, 1980, HDB VOGEL MITTELEURO, V9; GOTTLANDER K, 1987, ORNIS SCAND, V18, P269, DOI 10.2307/3676895; HAYWARD GD, 1993, WILDLIFE MONOGR, P1; Hofstetter SH, 1998, WILSON BULL, V110, P86; KACELNIK A, 1995, P ROY SOC B-BIOL SCI, V259, P259, DOI 10.1098/rspb.1995.0038; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kilner RM, 2002, BEHAV ECOL SOCIOBIOL, V52, P400, DOI 10.1007/s00265-002-0533-8; Klaus S., 1975, Zoologische Jb (Syst), V102, P485; Kloubec B., 1990, TICHODROMA, V3, P103; Konig C, 2008, OWLS WORLD; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1984, Ornis Fennica, V61, P80; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; Korpimaki E, 1981, BIOL, V13, P1; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Kouba Marek, 2012, Sylvia, V48, P115; Lopez BC, 2010, J RAPTOR RES, V44, P40, DOI 10.3356/JRR-09-32.1; MCRAE SB, 1993, BEHAV ECOL SOCIOBIOL, V33, P101; Mock D. W., 1997, EVOLUTION SIBLING RI; Ostreiher R, 2001, BEHAV ECOL SOCIOBIOL, V49, P340, DOI 10.1007/s002650000308; Pedersen D, 2013, ORNIS FENNICA, V90, P117; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Pokorny J., 2000, Buteo, V11, P107; Pykal Jiri, 1994, P537; RICKLEFS RE, 1966, WILSON BULL, V78, P47; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P459, DOI 10.1098/rspb.2000.1022; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Roulin A, 2007, ANIM BEHAV, V74, P1099, DOI 10.1016/j.anbehav.2007.01.027; Roulin A, 2009, ANIM BEHAV, V77, P717, DOI 10.1016/j.anbehav.2008.12.004; RYDEN O, 1980, Z TIERPSYCHOL, V53, P209; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V29, P307, DOI 10.1007/BF00163989; STAMPS J, 1989, ETHOLOGY, V81, P177; STAMPS J, 1985, BEHAVIOUR, V94, P1, DOI 10.1163/156853985X00253; Stein MF, 1986, THESIS U MICHIGAN MI; Tanner M, 2007, ANIM BEHAV, V74, P977, DOI 10.1016/j.anbehav.2006.11.034; Tao J., 2002, MIXED MODEL ANAL USI; TEATHER KL, 1992, BEHAV ECOL SOCIOBIOL, V31, P81, DOI 10.1007/BF00166340; Vacik R, 1991, SYLVIA, V28, P95; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916; Wuntke B, 2003, J ORNITHOL, V144, P81, DOI 10.1007/BF02465519; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka Marketa, 2008, Sylvia, V44, P51; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, FOLIA ZOOL, V58, P104; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	57	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97504	10.1371/journal.pone.0097504	http://dx.doi.org/10.1371/journal.pone.0097504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828567	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400103
J	Liu, XB; Ma, L; Zhang, AH; Zhang, YH; Jiang, J; Ma, W; Zhang, LM; Ren, WC; Kong, XJ				Liu, Xiu-Bo; Ma, Ling; Zhang, Ai-Hua; Zhang, Yan-He; Jiang, Jing; Ma, Wei; Zhang, Lei-Ming; Ren, Wei-Chao; Kong, Xiang-Jun			High-Throughput Analysis and Characterization of Astragalus membranaceus Transcriptome Using 454 GS FLX	PLOS ONE			English	Article							RESPONSES; CHINA	Astragalus membranaceus (Fisch.) Bge (AR), one of the most important medicinal plants in Asia, was found to exhibit various bioactivities. Due to limited genomic and transcriptomic data, the biosynthetic pathway of the major bioactive compound in AR, is currently unclear. In this study, 454 GS FLX technology was employed to produce a substantial expressed sequence tag (EST) dataset from the AR. In all, 742721 high-quality reads from the AR were produced using Roche GS FLX Titanium. A total of 9893 unique sequences were obtained and annotated by a similarity search against the public databases, and involved in the secondary metabolic pathway, which would facilitate deciphering the molecular mechanism of secondary metabolism in AR. The assembled sequences were annotated with gene names and Gene Ontology (GO) terms. GO revealed the unique sequences that could be assigned to 34 vocabularies. In the KEGG mapping, unique sequences were established as associated with 46 biochemical pathways. These results provided the largest EST collections in AR and will contribute to biosynthetic and biochemical studies that lead to drug improvement. With respect to the genes related to metabolism and biosynthesis pathway were also found. Our work demonstrated the utility of 454 GS FLX as a method for the rapid and cost-effective identification of AR transcriptome, and this EST dataset will be a powerful resource for further studies such as taxonomy, molecular breeding, and secondary metabolism in AR.	[Liu, Xiu-Bo; Zhang, Ai-Hua; Zhang, Yan-He; Ma, Wei; Zhang, Lei-Ming; Ren, Wei-Chao] Heilongjiang Univ Chinese Med, Harbin, Peoples R China; [Liu, Xiu-Bo; Jiang, Jing; Ma, Wei] Northeast Forestry Univ, Minist Educ, Key Lab Forest Tree Genet Improvement & Biotechno, Harbin, Peoples R China; [Ma, Ling] Northeast Forestry Univ, Harbin, Peoples R China; [Kong, Xiang-Jun] Qiqihar Med Univ, Affiliated Hosp 1, Qiqihar, Peoples R China	Heilongjiang University of Chinese Medicine; Northeast Forestry University - China; Northeast Forestry University - China; Qiqihar Medical University	Ma, W (corresponding author), Heilongjiang Univ Chinese Med, Harbin, Peoples R China.	88788891@qq.com	ma, wei/GVU-3235-2022		Key Program of Natural Science Foundation of State [81274010]; Heilongjiang province outstanding youth fund [JC201101]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); Heilongjiang province outstanding youth fund	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 81274010) and Heilongjiang province outstanding youth fund (Grant No. JC201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045541; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Du HW, 2014, J CHROMATOGR SCI, V52, P226, DOI 10.1093/chromsci/bmt016; Du XG, 2012, INT IMMUNOPHARMACOL, V14, P463, DOI 10.1016/j.intimp.2012.09.006; Gad HA, 2013, PHYTOCHEM ANALYSIS, V24, P1, DOI 10.1002/pca.2378; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; Hong MJ, 2013, J PHARM PHARMACOL, V65, P142, DOI 10.1111/j.2042-7158.2012.01570.x; Kang SC, 2013, BIOL TRACE ELEM RES, V151, P68, DOI 10.1007/s12011-012-9527-1; Lai PKK, 2014, PHYTOTHER RES, V28, P395, DOI 10.1002/ptr.5002; Lee DY, 2013, MOLECULES, V18, P3725, DOI 10.3390/molecules18043725; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liu J, 2013, ACTA PHARMACOL SIN, V34, P137, DOI 10.1038/aps.2012.133; Liu YM, 2013, PHARMACOGN MAG, V9, P331, DOI 10.4103/0973-1296.117829; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Qin QJ, 2012, INT J MOL SCI, V13, P8379, DOI 10.3390/ijms13078379; Stanton-Geddes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065688; Sun H, 2012, CHIN J NAT MEDICINES, V10, P196, DOI 10.3724/SP.J.1009.2012.00196; Wei XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064481; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yao MC, 2000, J CHROMATOGR SCI, V38, P325, DOI 10.1093/chromsci/38.8.325; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200	23	12	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95831	10.1371/journal.pone.0095831	http://dx.doi.org/10.1371/journal.pone.0095831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828103	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400016
J	Pan, XB; Lu, TT; Wu, F; Jin, LG; Zhang, Y; Shi, LH; Li, XK; Lin, ZF				Pan, Xuebo; Lu, Tingting; Wu, Fan; Jin, Leigang; Zhang, Yi; Shi, Lihua; Li, Xiaokun; Lin, Zhuofeng			Circulating Complement-C1q TNF-Related Protein 1 Levels Are Increased in Patients with Type 2 Diabetes and Are Associated with Insulin Sensitivity in Chinese Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENDER-DIFFERENCES; GLUCOSE-TOLERANCE; ADIPONECTIN; CTRP1; HOMEOSTASIS; PROGRESSION; EXPRESSION; RESISTANCE; ADIPOKINE	Background: Complement-C1q TNF-related protein 1 (CTRP1), a member of the CTRP superfamily, possesses anti-inflammatory and anti-diabetic effects in mice. However, the clinical relevance of CTRP1 has been seldom explored. The current study aimed to investigate the association of circulating CTRP1 and type 2 diabetes mellitus (T2DM) in a Chinese population. Design and Methods: Serum CTRP1 and adiponectin levels of 96 T2DM patients and 85 healthy subjects were determined by ELISA, and their associations with adiposity, glucose and lipid profiles were studied. In a subgroup of this study, the 75-g oral glucose tolerance test (OGTT) was performed in 20 healthy and 20 T2DM subjects to evaluate the relationship among serum levels of CTRP1 and adiponectin, insulin secretion and insulin sensitivity. Results: Serum CTRP1 levels were significantly increased in patients with T2DM, compared with healthy controls (p<0.001). Similar to adiponectin, serum levels of CTRP1 were significantly correlated to several parameters involved in glucose metabolism and insulin resistance, and independently associated with fasting glucose levels (p<0.05) after BMI and gender adjustments. Furthermore, CTRP1 levels were positively correlated to insulin secretion, while negatively to insulin sensitivity, as measured by OGTT. Conclusion: CTRP1 is a novel adipokine associated with T2DM in humans. The paradoxical increase of serum CTRP1 levels in T2DM subjects may be due to a compensatory response to the adverse glucose and lipid metabolism, which warrants further investigation.	[Pan, Xuebo; Lu, Tingting; Jin, Leigang; Zhang, Yi; Shi, Lihua; Li, Xiaokun; Lin, Zhuofeng] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China; [Wu, Fan; Li, Xiaokun] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Changchun, Peoples R China	Wenzhou Medical University; Jilin Agricultural University	Lin, ZF (corresponding author), Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China.	zhuofenglin@wzmc.edu.cn		Leigang, Jin/0000-0002-6916-4009	Key Project in New drug discovery of MOST, China [2011ZX0 9102-004-03]; Natural Science Project of Zhejiang Province [Y2110339]; Scientific Technological Projects of Wenzhou [H20100026, Y20090016]	Key Project in New drug discovery of MOST, China; Natural Science Project of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Technological Projects of Wenzhou	The work has been supported Key Project in New drug discovery of MOST, China (grant No. 2011ZX0 9102-004-03); Natural Science Project of Zhejiang Province (Grant No: Y2110339) and Scientific Technological Projects of Wenzhou (H20100026 and Y20090016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Fernandez-Real JM, 2004, DIABETES CARE, V27, P739, DOI 10.2337/diacare.27.3.739; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hwang YC, 2014, INT J OBESITY, V38, P1207, DOI 10.1038/ijo.2013.242; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Li YJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/981896; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Saltevo J, 2009, GENDER MED, V6, P463, DOI 10.1016/j.genm.2009.09.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Woo YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036868; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744	30	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e94478	10.1371/journal.pone.0094478	http://dx.doi.org/10.1371/journal.pone.0094478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827430	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400009
J	Carpenter, RE; Maruska, KP; Becker, L; Fernald, RD				Carpenter, Russ E.; Maruska, Karen P.; Becker, Lisa; Fernald, Russell D.			Social Opportunity Rapidly Regulates Expression of CRF and CRF Receptors in the Brain during Social Ascent of a Teleost Fish, Astatotilapia burtoni	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AFRICAN CICHLID FISH; DORSAL RAPHE NUCLEUS; BASS DICENTRARCHUS-LABRAX; PITUITARY-GONADAL AXIS; MEDIAL PREOPTIC AREA; MESSENGER-RNA LEVELS; SEROTONERGIC NEURONS; HAPLOCHROMIS-BURTONI; FEMALE RAT	In social animals, hierarchical rank governs food availability, territorial rights and breeding access. Rank order can change rapidly and typically depends on dynamic aggressive interactions. Since the neuromodulator corticotrophin releasing factor (CRF) integrates internal and external cues to regulate the hypothalamic-pituitary adrenal (HPA) axis, we analyzed the CRF system during social encounters related to status. We used a particularly suitable animal model, African cichlid fish, Astatotilapia burtoni, whose social status regulates reproduction. When presented with an opportunity to rise in rank, subordinate A. burtoni males rapidly change coloration, behavior, and their physiology to support a new role as dominant, reproductively active fish. Although changes in gonadotropin-releasing hormone (GnRH1), the key reproductive molecular actor, have been analyzed during social ascent, little is known about the roles of CRF and the HPA axis during transitions. Experimentally enabling males to ascend in social rank, we measured changes in plasma cortisol and the CRF system in specific brain regions 15 minutes after onset of social ascent. Plasma cortisol levels in ascending fish were lower than subordinate conspecifics, but similar to levels in dominant animals. In the preoptic area (POA), where GnRH1 cells are located, and in the pituitary gland, CRF and CRF1 receptor mRNA levels are rapidly down regulated in ascending males compared to subordinates. In the Vc/Vl, a forebrain region where CRF cell bodies are located, mRNA coding for both CRFR1 and CRFR2 receptors is lower in ascending fish compared to stable subordinate conspecifics. The rapid time course of these changes (within minutes) suggests that the CRF system is involved in the physiological changes associated with shifts in social status. Since CRF typically has inhibitory effects on the neuroendocrine reproductive axis in vertebrates, this attenuation of CRF activity may allow rapid activation of the reproductive axis and facilitate the transition to dominance.	[Carpenter, Russ E.; Maruska, Karen P.; Becker, Lisa; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Carpenter, RE (corresponding author), Program Writing & Rhetor, Stanford, CA 94305 USA.	russ1@stanford.edu			National Institutes of Health (NIH) [F32HD063234, F32NS061431, NS034950]; National Science Foundation (NSF) [IOS-0923588]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD063234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034950, R37NS034950, F32NS061431, R56NS034950] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) Grants F32HD063234 (REC), F32NS061431 (KPM), NS034950 (RDF), and National Science Foundation (NSF) IOS-0923588 (RDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au TM, 2006, BEHAV BRAIN RES, V170, P342, DOI 10.1016/j.bbr.2006.02.027; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Breen KM, 2008, ENDOCRINOLOGY, V149, P767, DOI 10.1210/en.2007-0773; Burmeister SS, 2007, HORM BEHAV, V51, P164, DOI 10.1016/j.yhbeh.2006.09.008; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Bushnik TL, 1995, BRAIN BEHAV EVOLUT, V46, P371, DOI 10.1159/000113287; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Campbell RE, 2007, ENDOCRINOLOGY, V148, P5884, DOI 10.1210/en.2007-0854; Carpenter RE, 2007, HORM BEHAV, V52, P600, DOI 10.1016/j.yhbeh.2007.07.012; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cerda-Reverter JM, 2001, J MORPHOL, V247, P217, DOI 10.1002/1097-4687(200103)247:3<217::AID-JMOR1013>3.0.CO;2-U; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Clements S, 2003, HORM BEHAV, V43, P214, DOI 10.1016/S0018-506X(02)00027-2; Clotfelter ED, 2010, FISH PHYSIOL BIOCHEM, V36, P933, DOI 10.1007/s10695-009-9370-2; Cooper MA, 2009, NEUROSCIENCE, V161, P680, DOI 10.1016/j.neuroscience.2009.03.084; Cooper MA, 2007, PSYCHOPHARMACOLOGY, V194, P297, DOI 10.1007/s00213-007-0849-1; Dahlbom SJ, 2012, BEHAV BRAIN RES, V228, P333, DOI 10.1016/j.bbr.2011.12.011; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Densmore VS, 2003, J CLIN ENDOCR METAB, V88, P2126, DOI 10.1210/jc.2002-021359; Desjardins JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032781; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Doyon C, 2003, GEN COMP ENDOCR, V133, P260, DOI 10.1016/S0016-6480(03)00195-3; Dudas B, 2006, J NEUROENDOCRINOL, V18, P79, DOI 10.1111/j.1365-2826.2005.01398.x; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Ferin M, 2006, STRESS, V62, P2627; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Flett P, 1994, ONCORHYNCHUS MYKISS, P399; Fox HE, 1997, J NEUROSCI, V17, P6463; GOLDSMITH PC, 1994, ENDOCRINOLOGY, V134, P858, DOI 10.1210/en.134.2.858; Grone BP, 2012, HORM BEHAV, V62, P18, DOI 10.1016/j.yhbeh.2012.04.012; Hoffman CS, 2002, BRAIN RES, V946, P96, DOI 10.1016/S0006-8993(02)02867-6; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Jasoni CL, 2005, NEUROENDOCRINOLOGY, V82, P320, DOI 10.1159/000093155; Li XF, 2011, J NEUROENDOCRINOL, V23, P3, DOI 10.1111/j.1365-2826.2010.02071.x; LIPOSITS Z, 1987, HISTOCHEMISTRY, V86, P541, DOI 10.1007/BF00489545; Lorenzi V, 2009, PHYSIOL BEHAV, V97, P476, DOI 10.1016/j.physbeh.2009.03.026; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Lowry CA, 2000, J NEUROSCI, V20, P7728; MACLUSKY NJ, 1988, BRAIN RES, V439, P391, DOI 10.1016/0006-8993(88)91501-6; Majzoub JA, 2006, EUR J ENDOCRINOL, V155, pS71, DOI 10.1530/eje.1.02247; MALER L, 1991, J CHEM NEUROANAT, V4, P1, DOI 10.1016/0891-0618(91)90030-G; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; Maruska KP, 2011, ENDOCRINOLOGY, V152, P291, DOI 10.1210/en.2010-0876; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maruska KP, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-58; Maruska KP, 2013, INTEGR COMP BIOL, P1; Mitter K, 2009, COMP BIOCHEM PHYS B, V153, P340, DOI 10.1016/j.cbpb.2009.04.009; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; NIKOLARAKIS KE, 1986, BRAIN RES, V377, P388, DOI 10.1016/0006-8993(86)90887-5; Parent AS, 2005, ENDOCRINE, V28, P281, DOI 10.1385/ENDO:28:3:281; Pepels PPLM, 2004, GEN COMP ENDOCR, V139, P251, DOI 10.1016/j.ygcen.2004.09.013; PLANT TM, 1989, P NATL ACAD SCI USA, V86, P2506, DOI 10.1073/pnas.86.7.2506; RIVEST S, 1993, NEUROENDOCRINOLOGY, V57, P236, DOI 10.1159/000126365; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Rodaros D, 2007, NEUROSCIENCE, V150, P8, DOI 10.1016/j.neuroscience.2007.09.043; Rupp B, 1996, ANAT EMBRYOL, V194, P187; SAPOLSKY RM, 1989, ARCH GEN PSYCHIAT, V46, P1047; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; SAWCHENKO PE, 1985, FED PROC, V44, P221; SIRINATHSINGHJI DJS, 1985, BRAIN RES, V336, P45, DOI 10.1016/0006-8993(85)90414-7; SIRINATHSINGHJI DJS, 1986, BRAIN RES, V375, P49, DOI 10.1016/0006-8993(86)90957-1; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; SUH BY, 1988, J CLIN ENDOCR METAB, V66, P733, DOI 10.1210/jcem-66-4-733; Summers CH, 2005, PHYSIOL BIOCHEM ZOOL, V78, P679, DOI 10.1086/432139; SUTER DE, 1988, AM J PHYSIOL, V254, pE595, DOI 10.1152/ajpendo.1988.254.5.E595; Teles MC, 2013, BEHAV BRAIN RES, V253, P17, DOI 10.1016/j.bbr.2013.07.012; TRUDEAU VL, 1993, J NEUROENDOCRINOL, V5, P129, DOI 10.1111/j.1365-2826.1993.tb00372.x; VANDENPOL AN, 1993, J BIOL RHYTHM, V8, pS11; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014; WILLIAMS CL, 1990, NEUROENDOCRINOLOGY, V52, P133, DOI 10.1159/000125563; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; Winberg S, 1997, BRAIN BEHAV EVOLUT, V49, P230, DOI 10.1159/000112994; Yamamoto N, 1998, NEUROSCI RES, V31, P31, DOI 10.1016/S0168-0102(98)00022-4; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao S, 2010, AM J PHYSIOL-ENDOC M, V298, pE524, DOI 10.1152/ajpendo.00597.2009	84	27	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96632	10.1371/journal.pone.0096632	http://dx.doi.org/10.1371/journal.pone.0096632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824619	gold, Green Submitted, Green Published			2022-12-25	WOS:000336369200026
J	Fontana, JM; Christos, PJ; Michelini, Z; Negri, D; Cara, A; Salvatore, M				Fontana, Judith M.; Christos, Paul J.; Michelini, Zuleika; Negri, Donatella; Cara, Andrea; Salvatore, Mirella			Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; A VIRUS; IMMUNE-RESPONSES; GENE-TRANSFER; NUCLEOPROTEIN GENE; IN-VITRO; VACCINE; CELLS; INDUCTION; DELIVERY	Recent reports highlight the potential for integrase-defective lentiviral vectors (IDLV) to be developed as vaccines due to their ability to elicit cell-mediated and humoral immune responses after intramuscular administration. Differently from their integrase-competent counterpart, whose utility for vaccine development is limited by the potential for insertional mutagenesis, IDLV possess a mutation in their integrase gene that prevents genomic integration. Instead, they are maintained as episomal DNA circles that retain the ability to stably express functional proteins. Despite their favorable profile, it is unknown whether IDLV elicit immune responses after intranasal administration, a route that could be advantageous in the case of infection with a respiratory agent. Using influenza as a model, we constructed IDLV expressing the influenza virus nucleoprotein (IDLV-NP), and tested their ability to generate NP-specific immune responses and protect from challenge in vivo. We found that administration of IDLV-NP elicited NP-specific T cell and antibody responses in BALB/c mice. Importantly, IDLV-NP was protective against homologous and heterosubtypic influenza virus challenge only when given by the intranasal route. This is the first report demonstrating that IDLV can induce protective immunity after intranasal administration, and suggests that IDLV may represent a promising vaccine platform against infectious agents.	[Fontana, Judith M.; Christos, Paul J.; Salvatore, Mirella] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Salvatore, Mirella] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [Michelini, Zuleika; Cara, Andrea] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Negri, Donatella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Cornell University; Cornell University; Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Salvatore, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA.	mis2053@med.cornell.edu	Michelini, Zuleika/J-9003-2016; Cara, Andrea/M-4865-2015; Cara, Andrea/AAA-4238-2021; Negri, Donatella/M-4362-2015; Salvatore, Mirella/K-6691-2016; michelini, zuleika/Q-4383-2019	Michelini, Zuleika/0000-0001-6841-7396; Cara, Andrea/0000-0003-4967-1895; Cara, Andrea/0000-0003-4967-1895; Negri, Donatella/0000-0002-3437-9288; Salvatore, Mirella/0000-0002-8296-0376; michelini, zuleika/0000-0001-6841-7396; Minkoff, Judith/0000-0002-7379-2753	National Institute of Allergy and Infectious Diseases [1R21AI073926-01A2]; Feldstein Medical Foundation; Stony Wold-Herbert Fund Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073926] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Feldstein Medical Foundation; Stony Wold-Herbert Fund Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (1R21AI073926-01A2) and from the Feldstein Medical Foundation to M.S. J.M.F. is a recipient of a Stony Wold-Herbert Fund Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Banasik MB, 2010, GENE THER, V17, P150, DOI 10.1038/gt.2009.135; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; Brave A, 2007, MOL PHARMACEUT, V4, P18, DOI 10.1021/mp060098+; Buffa V, 2006, VIRAL IMMUNOL, V19, P690, DOI 10.1089/vim.2006.19.690; Buffa V, 2006, J GEN VIROL, V87, P1625, DOI 10.1099/vir.0.81706-0; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Cmielewski P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-84; Copreni E, 2010, VIRUSES-BASEL, V2, P1577, DOI 10.3390/v2081577; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062684; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 1997, J IMMUNOL, V158, P1222; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gillirn-Ross L, 2005, J GEN VIROL, V86, P765, DOI 10.1099/vir.0.80570-0; Goldman MJ, 1997, HUM GENE THER, V8, P2261, DOI 10.1089/hum.1997.8.18-2261; Grasso F, 2013, INT J CANCER, V132, P335, DOI 10.1002/ijc.27676; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; He YK, 2005, J IMMUNOL, V174, P3808, DOI 10.4049/jimmunol.174.6.3808; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Li Z, 2013, J VIROL, V87, P5985, DOI 10.1128/JVI.00120-13; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Luo J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-286; Mbawuike IN, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-44; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Negri DRM, 2011, EXPERT OPIN BIOL TH, V11, P739, DOI 10.1517/14712598.2011.571670; Negri DRM, 2010, HUM GENE THER, V21, P1029, DOI 10.1089/hum.2009.200; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Suda T, 2011, ANTIVIR RES, V91, P252, DOI 10.1016/j.antiviral.2011.06.008; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P23, DOI 10.1007/BF02123574; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	55	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97270	10.1371/journal.pone.0097270	http://dx.doi.org/10.1371/journal.pone.0097270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824623	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200084
J	Behrens, M; Frank, O; Rawel, H; Ahuja, G; Potting, C; Hofmann, T; Meyerhof, W; Korsching, S				Behrens, Maik; Frank, Oliver; Rawel, Harshadrai; Ahuja, Gaurav; Potting, Christoph; Hofmann, Thomas; Meyerhof, Wolfgang; Korsching, Sigrun			ORA1, a Zebrafish Olfactory Receptor Ancestral to All Mammalian V1R Genes, Recognizes 4-Hydroxyphenylacetic Acid, a Putative Reproductive Pheromone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOMERONASAL RECEPTOR; TASTE RECEPTORS; BITTER TASTE; FUNCTIONAL EXPRESSION; SENSORY NEURONS; ODORANT; BULB; FAMILIES; COMBINATORIAL; SPECIFICITY	The teleost v1r-related ora genes are a small, highly conserved olfactory receptor gene family of only six genes, whose direct orthologues can be identified in lineages as far as that of cartilaginous fish. However, no ligands for fish olfactory receptor class A related genes (ORA) had been uncovered so far. Here we have deorphanized the ORA1 receptor using heterologous expression and calcium imaging. We report that zebrafish ORA1 recognizes with high specificity and sensitivity 4-hydroxyphenylacetic acid. The carboxyl group of this compound is required in a particular distance from the aromatic ring, whereas the hydroxyl group in the para-position is not essential, but strongly enhances the binding efficacy. Low concentrations of 4-hydroxyphenylacetic acid elicit increases in oviposition frequency in zebrafish mating pairs. This effect is abolished by naris closure. We hypothesize that 4-hydroxyphenylacetic acid might function as a pheromone for reproductive behavior in zebrafish. ORA1 is ancestral to mammalian V1Rs, and its putative function as pheromone receptor is reminiscent of the role of several mammalian V1Rs as pheromone receptors.	[Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, D-14558 Nuthetal, Germany; [Frank, Oliver; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany; [Rawel, Harshadrai] Univ Potsdam, Inst Nutr Sci, D-14558 Nuthetal, Germany; [Ahuja, Gaurav; Potting, Christoph; Korsching, Sigrun] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Technical University of Munich; University of Potsdam; University of Cologne	Korsching, S (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	sigrun.korsching@uni-koeln.de	/ABE-5591-2020; Frank, Oliver/AAO-9888-2021; Rawel, Harshadrai/AFL-5307-2022; Behrens, Maik/B-6753-2016	/0000-0002-2837-9361; Frank, Oliver/0000-0003-0437-5005; Rawel, Harshadrai/0000-0003-2768-1531; Behrens, Maik/0000-0003-2082-8860				Ahuja G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04037; Ahuja G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02063; Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DETTNER K, 1980, BIOCHEM SYST ECOL, V8, P89, DOI 10.1016/0305-1978(80)90032-0; Friedrich RW, 2013, ANNU REV NEUROSCI, V36, P383, DOI 10.1146/annurev-neuro-062111-150504; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Fuss SH, 2001, J NEUROSCI, V21, P8396, DOI 10.1523/JNEUROSCI.21-21-08396.2001; Gossauer A., 2006, STRUKTUR REAKTIVITAE; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hussain A, 2013, P NATL ACAD SCI USA, V110, P19579, DOI 10.1073/pnas.1318596110; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ko HS, 2009, CURR MICROBIOL, V59, P608, DOI 10.1007/s00284-009-9481-0; Kreuzer OJ, 2001, J NEUROENDOCRINOL, V13, P279, DOI 10.1046/j.1365-2826.2001.00630.x; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ohtani K, 2011, Z NATURFORSCH C, V66, P31; Oka Y, 2012, CHEM SENSES, V37, P219, DOI 10.1093/chemse/bjr095; Oka Y, 2011, CHEM SENSES, V36, P357, DOI 10.1093/chemse/bjq138; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Pageat P, 2003, VET CLIN N AM-SMALL, V33, P187, DOI 10.1016/S0195-5616(02)00128-6; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Schack HB, 2008, J EXP BIOL, V211, P2079, DOI 10.1242/jeb.015081; Stacey N.E., 2005, FISH PHYSIOL, P359; Takahama U, 2002, FEBS LETT, V518, P116, DOI 10.1016/S0014-5793(02)02659-5; Ueda T, 2003, J NEUROSCI, V23, P7376; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633	40	26	28	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19778	19788		10.1074/jbc.M114.573162	http://dx.doi.org/10.1074/jbc.M114.573162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831010	Green Published, hybrid			2022-12-25	WOS:000339326800049
J	Niu, L; Li, GL; Lin, SL				Niu, Liang; Li, Guoliang; Lin, Shili			Statistical Models for Detecting Differential Chromatin Interactions Mediated by a Protein	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSCRIPTION; PROMOTER; ORGANIZATION; AGREEMENT; LOCUS; GENE	Chromatin interactions mediated by a protein of interest are of great scientific interest. Recent studies show that protein-mediated chromatin interactions can have different intensities in different types of cells or in different developmental stages of a cell. Such differences can be associated with a disease or with the development of a cell. Thus, it is of great importance to detect protein-mediated chromatin interactions with different intensities in different cells. A recent molecular technique, Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET), which uses formaldehyde cross-linking and paired-end sequencing, is able to detect genome-wide chromatin interactions mediated by a protein of interest. Here we proposed two models (One-Step Model and Two-Step Model) for two sample ChIA-PET count data (one biological replicate in each sample) to identify differential chromatin interactions mediated by a protein of interest. Both models incorporate the data dependency and the extent to which a fragment pair is related to a pair of DNA loci of interest to make accurate identifications. The One-Step Model makes use of the data more efficiently but is more computationally intensive. An extensive simulation study showed that the models can detect those differentially interacted chromatins and there is a good agreement between each classification result and the truth. Application of the method to a two-sample ChIA-PET data set illustrates its utility. The two models are implemented as an R package MDM (available at http://www.stat.osu.edu/similar to statgen/SOFTWARE/MDM).	[Niu, Liang; Lin, Shili] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Li, Guoliang] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Ctr Syst Biol,Ctr Bioinformat,Coll Life Sci & Tec, Wuhan, Hubei, Peoples R China	University System of Ohio; Ohio State University; Huazhong Agricultural University	Lin, SL (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	shili@stat.osu.edu	Li, Guoliang/D-8014-2012	Li, Guoliang/0000-0003-1601-6640	National Science Foundation [DMS-1042946]; Fundamental Research Funds for the Central Universities [2662014PY001]	National Science Foundation(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	LN and SL were supported by the National Science Foundation grant DMS-1042946. GL was supported by the Fundamental Research Funds for the Central Universities [2662014PY001]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Jiang HM, 2008, MOL CELL BIOL, V28, P907, DOI 10.1128/MCB.00909-07; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Junier I, 2012, NUCLEIC ACIDS RES, V40, P7718, DOI 10.1093/nar/gks536; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Niu L, 2013, 876 OH STAT U DEP ST; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Raftery A. E., 1995, PRACTICAL MARKOV CHA, P115; Rousseau M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-414; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97560	10.1371/journal.pone.0097560	http://dx.doi.org/10.1371/journal.pone.0097560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835279	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800051
J	Bertolini, M; Zilio, F; Rossi, A; Kleditzsch, P; Emelianov, VE; Gilhar, A; Keren, A; Meyer, KC; Wang, E; Funk, W; McElwee, K; Paus, R				Bertolini, Marta; Zilio, Federica; Rossi, Alfredo; Kleditzsch, Patrick; Emelianov, Vladimir E.; Gilhar, Amos; Keren, Aviad; Meyer, Katja C.; Wang, Eddy; Funk, Wolfgang; McElwee, Kevin; Paus, Ralf			Abnormal Interactions between Perifollicular Mast Cells and CD8+T-Cells May Contribute to the Pathogenesis of Alopecia Areata	PLOS ONE			English	Article							CLASS-I EXPRESSION; GROWTH-FACTOR-BETA; HAIR FOLLICLE; T-CELLS; IMMUNE PRIVILEGE; COSTIMULATORY MOLECULES; GENE-EXPRESSION; CD30 LIGAND; PERIPHERAL TOLERANCE; AUTOIMMUNE-DISEASE	Alopecia areata (AA) is a CD8+ T-cell dependent autoimmune disease of the hair follicle (HF) in which the collapse of HF immune privilege (IP) plays a key role. Mast cells (MCs) are crucial immunomodulatory cells implicated in the regulation of T cell-dependent immunity, IP, and hair growth. Therefore, we explored the role of MCs in AA pathogenesis, focusing on MC interactions with CD8+ T-cells in vivo, in both human and mouse skin with AA lesions. Quantitative (immuno)histomorphometry revealed that the number, degranulation and proliferation of perifollicular MCs are significantly increased in human AA lesions compared to healthy or non-lesional control skin, most prominently in subacute AA. In AA patients, perifollicular MCs showed decreased TGF beta 1 and IL-10 but increased tryptase immunoreactivity, suggesting that MCs switch from an immuno-inhibitory to a pro-inflammatory phenotype. This concept was supported by a decreased number of IL-10+ and PD-L1+ MCs, while OX40L+, CD30L+, 4-1BBL+ or ICAM-1+ MCs were increased in AA. Lesional AA-HFs also displayed significantly more peri-and intrafollicular-CD8+ T-cells as well as more physical MC/CD8+ T-cell contacts than healthy or non-lesional human control skin. During the interaction with CD8+ T-cells, AA MCs prominently expressed MHC class I and OX40L, and sometimes 4-1BBL or ICAM-1, suggesting that MC may present autoantigens to CD8+ T-cells and/or co-stimulatory signals. Abnormal MC numbers, activities, and interactions with CD8+ T-cells were also seen in the grafted C3H/HeJ mouse model of AA and in a new humanized mouse model for AA. These phenomenological in vivo data suggest the novel AA pathobiology concept that perifollicular MCs are skewed towards pro-inflammatory activities that facilitate cross-talk with CD8+ T-cells in this disease, thus contributing to triggering HF-IP collapse in AA. If confirmed, MCs and their CD8+ T-cell interactions could become a promising new therapeutic target in the future management of AA.	[Bertolini, Marta; Zilio, Federica; Meyer, Katja C.; Paus, Ralf] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Bertolini, Marta; Paus, Ralf] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Rossi, Alfredo] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Kleditzsch, Patrick] Univ Rostock, Dept Obstet & Gynaecol, D-18055 Rostock, Germany; [Emelianov, Vladimir E.] Chuvash State Univ, Dept Pharmacol Clin Pharmacol & Biochem, Sch Med, Cheboksary, Russia; [Gilhar, Amos; Keren, Aviad] Technion Israel Inst Technol, Rappaport Fac Med, Lab Skin Res, Haifa, Israel; [Gilhar, Amos] Flieman Med Ctr, Haifa, Israel; [Wang, Eddy; McElwee, Kevin] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Funk, Wolfgang] Klin Dr Koslowski, Munich, Germany; [Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	University of Lubeck; University of Munster; Sapienza University Rome; University of Rostock; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of British Columbia; University of Manchester	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	ralf.paus@manchester.ac.uk	Wang, Eddy Hsi Chun/AAD-2759-2019; Paus, Ralf/B-5279-2015; Rossi, Alfredo/K-1725-2018	Wang, Eddy Hsi Chun/0000-0001-7785-1442; Paus, Ralf/0000-0002-3492-9358; Rossi, Alfredo/0000-0002-7442-3423; McElwee, Kevin/0000-0003-1020-3832; Emelianov, Vladimir/0000-0003-1720-1741; Bertolini, Marta/0000-0002-5927-6998	DFG [GRK1727/1]; University of Manchester; Associazione Associazione Nazionale Mediterranea Alopecia Areata	DFG(German Research Foundation (DFG)); University of Manchester; Associazione Associazione Nazionale Mediterranea Alopecia Areata	This project was supported in part by a grant from DFG to RP and a PhD fellowship to MB (GRK1727/1) as well as by faculty funds to RP from the University of Manchester and by funds from the Associazione Associazione Nazionale Mediterranea Alopecia Areata funds to RP and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Algermissen B, 1994, Exp Dermatol, V3, P290, DOI 10.1111/j.1600-0625.1994.tb00291.x; Alli R, 2012, J IMMUNOL, V188, P477, DOI 10.4049/jimmunol.1100657; BACCAREDDA-BOY A., 1959, PANMINERVA MED, V1, P198; Bertolini M, 2013, EXP DERMATOL, V22, P593, DOI 10.1111/exd.12205; Bodemer C, 2000, J INVEST DERMATOL, V114, P112, DOI 10.1046/j.1523-1747.2000.00828.x; BOTCHKAREV VA, 1995, ARCH DERMATOL RES, V287, P683, DOI 10.1007/BF00371743; Brown MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00147; Buckley MG, 1999, J PATHOL, V189, P138, DOI 10.1002/(SICI)1096-9896(199909)189:1<138::AID-PATH400>3.0.CO;2-H; Cabrera CM, 2013, SCAND J IMMUNOL, V78, P306, DOI 10.1111/sji.12088; Catley MC, 2011, PHARMACOL THERAPEUT, V132, P333, DOI 10.1016/j.pharmthera.2011.09.005; Cetin ED, 2009, AM J DERMATOPATH, V31, P53, DOI 10.1097/DAD.0b013e318185a66e; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Crilly A, 2012, ANN RHEUM DIS, V71, P1049, DOI 10.1136/annrheumdis-2011-200703; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; D'Ovidio R, 1988, G Ital Dermatol Venereol, V123, P569; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; de Vries VC, 2009, CURR OPIN ORGAN TRAN, V14, P332, DOI 10.1097/MOT.0b013e32832ce87a; Diaconu NC, 2007, CANCER IMMUNOL IMMUN, V56, P1407, DOI 10.1007/s00262-007-0290-7; dos Santos RV, 2010, BRIT J DERMATOL, V162, P674, DOI 10.1111/j.1365-2133.2009.09516.x; Finn DF, 2013, BRIT J PHARMACOL, V170, P23, DOI 10.1111/bph.12138; FINZI A F, 1964, Minerva Dermatol, V39, P99; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Freyschmidt-Paul P, 2006, BRIT J DERMATOL, V155, P515, DOI 10.1111/j.1365-2133.2006.07377.x; Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gan PY, 2012, J AM SOC NEPHROL, V23, P1955, DOI 10.1681/ASN.2012060572; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gilhar A, 1998, J CLIN INVEST, V101, P62, DOI 10.1172/JCI551; Gilhar A, 2013, J INVEST DERMATOL, V133, P2088, DOI 10.1038/jid.2013.141; Gilhar A, 2013, J INVEST DERMATOL, V133, P844, DOI 10.1038/jid.2012.365; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Gizinski AM, 2010, BEST PRACT RES CL RH, V24, P463, DOI 10.1016/j.berh.2009.12.015; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Gri G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00120; Groux H, 1998, J IMMUNOL, V160, P3188; Gruss HJ, 1996, AM J PATHOL, V149, P469; Gupta MA, 1997, ACTA DERM-VENEREOL, V77, P296; Harries MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3671; Harries MJ, 2013, J PATHOL, V231, P236, DOI 10.1002/path.4233; Harvima IT, 2011, ACTA DERM-VENEREOL, V91, P644, DOI 10.2340/00015555-1197; Hernandez-Hernandez L, 2012, ALLERGOL IMMUNOPATH, V40, P385, DOI 10.1016/j.aller.2012.04.004; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Hugle T, 2011, ARTHRITIS RHEUM-US, V63, P795, DOI 10.1002/art.30190; Ilves T, 2013, J EUR ACAD DERMATOL, V27, pE197, DOI 10.1111/j.1468-3083.2012.04587.x; Inui S, 2007, J DERMATOL, V34, P852, DOI 10.1111/j.1346-8138.2007.00401.x; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387; Ito T, 2005, BRIT J DERMATOL, V152, P623, DOI 10.1111/j.1365-2133.2005.06453.x; Ito T, 2004, AM J PATHOL, V164, P623, DOI 10.1016/S0002-9440(10)63151-3; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Ito T, 2013, J DERMATOL SCI, V72, P327, DOI 10.1016/j.jdermsci.2013.07.014; Ito T, 2013, J DERMATOL SCI, V72, P68, DOI 10.1016/j.jdermsci.2013.04.029; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kang H, 2010, J INVEST DERMATOL, V130, P2677, DOI 10.1038/jid.2010.180; Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; King Lloyd E. Jr., 2008, V10, P280, DOI 10.1159/000131749; Kinori M, 2011, INVEST OPHTH VIS SCI, V52, P4447, DOI 10.1167/iovs.10-7154; Kloepper JE, 2013, J INVEST DERMATOL, V133, P1666, DOI 10.1038/jid.2013.17; Kober J, 2008, EUR J IMMUNOL, V38, P2678, DOI 10.1002/eji.200838250; Kumamoto T, 2003, BLOOD, V102, P1654, DOI 10.1182/blood-2003-02-0449; Li QY, 2014, CELL BIOCHEM FUNCT, V32, P183, DOI 10.1002/cbf.2991; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Matzer F, 2011, ACTA DERM-VENEREOL, V91, P318, DOI 10.2340/00015555-1031; Maurer M, 1997, LAB INVEST, V77, P319; Maurer M, 2003, EXP DERMATOL, V12, P886, DOI 10.1111/j.0906-6705.2003.0109a.x; Maurer M, 1995, Exp Dermatol, V4, P266, DOI 10.1111/j.1600-0625.1995.tb00256.x; McElwee KJ, 2013, EXP DERMATOL, V22, P609, DOI 10.1111/exd.12209; McElwee KJ, 1996, BRIT J DERMATOL, V135, P211, DOI 10.1111/j.1365-2133.1996.tb01149.x; McElwee KJ, 2005, J INVEST DERMATOL, V124, P947, DOI 10.1111/j.0022-202X.2005.23692.x; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Molin D, 2001, BRIT J HAEMATOL, V114, P616, DOI 10.1046/j.1365-2141.2001.02977.x; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nagai H, 2006, ARCH DERMATOL RES, V298, P131, DOI 10.1007/s00403-006-0668-y; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Ohyama M, 2010, J DERMATOL SCI, V58, P154, DOI 10.1016/j.jdermsci.2010.03.009; PAUS R, 1993, YALE J BIOL MED, V66, P541; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; PAUS R, 1994, DEV BIOL, V163, P230, DOI 10.1006/dbio.1994.1139; Paus R, 2009, J INVEST DERMATOL, V129, P1324, DOI 10.1038/jid.2009.111; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Podojil JR, 2013, BIODRUGS, V27, P1, DOI 10.1007/s40259-012-0001-6; RANKI A, 1984, J INVEST DERMATOL, V83, P7, DOI 10.1111/1523-1747.ep12261627; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Ruckert R, 1998, J INVEST DERMATOL, V111, P25, DOI 10.1046/j.1523-1747.1998.00228.x; Rygiel TF, 2012, CURR OPIN IMMUNOL, V24, P233, DOI 10.1016/j.coi.2012.01.002; Saresella M, 2012, CURR MOL MED, V12, P259, DOI 10.2174/156652412799218903; Sayama Koichi, 2002, BMC Immunol, V3, P5, DOI 10.1186/1471-2172-3-5; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Spath U, 1970, Z Haut Geschlechtskr, V45, P435; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Tete S, 2012, J BIOL REG HOMEOS AG, V26, P193; Theoharides TC, 2007, ADV EXP MED BIOL, V601, P423; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Tsuboi Hiromi, 1999, Journal of Dermatology (Tokyo), V26, P797; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Waldmann H, 2006, NATURE, V442, P987, DOI 10.1038/nature05165; Walker ME, 2012, BBA-MOL BASIS DIS, V1822, P57, DOI 10.1016/j.bbadis.2011.02.009; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062935; Wang XJ, 2014, J INVEST DERMATOL, V134, P736, DOI 10.1038/jid.2013.368; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Whiting DA, 2003, ARCH DERMATOL, V139, P1555, DOI 10.1001/archderm.139.12.1555; Wu CX, 2011, CELL IMMUNOL, V271, P118, DOI 10.1016/j.cellimm.2011.06.013; Wu YL, 2012, INT J BIOL SCI, V8, P1420, DOI 10.7150/ijbs.5273; Yano S, 2002, ACTA DERM-VENEREOL, V82, P82, DOI 10.1080/00015550252948077; Zhang ZL, 2013, DIGEST DIS SCI, V58, P1497, DOI 10.1007/s10620-013-2599-8	130	77	79	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94260	10.1371/journal.pone.0094260	http://dx.doi.org/10.1371/journal.pone.0094260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832234	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500003
J	Chen, YK; Yang, XB; Yang, Q; Li, DH; Long, WX; Luo, WQ				Chen, Yukai; Yang, Xiaobo; Yang, Qi; Li, Donghai; Long, Wenxing; Luo, Wenqi			Factors Affecting the Distribution Pattern of Wild Plants with Extremely Small Populations in Hainan Island, China	PLOS ONE			English	Article							THREATENED PLANTS; SPECIES-DIVERSITY; LAND-USE; ROADS; CONSERVATION; COMMUNITIES; TOPOGRAPHY; GRADIENT; REINTRODUCTION; MOUNTAINS	Understanding which factors affect the distribution pattern of extremely small populations is essential to the protection and propagation of rare and endangered plant species. In this study, we established 108 plots covering the entire Hainan Island, and measured the appearance frequency and species richness of plant species with extremely small populations, as well as the ecological environments and human disturbances during 2012-2013. We explored how the ecological environments and human activities affected the distribution pattern of these extremely small populations. Results showed that the extremely small populations underwent human disturbances and threats, and they were often found in fragmental habitats. The leading factors changing the appearance frequency of extremely small populations differed among plant species, and the direct factors making them susceptible to extinction were human disturbances. The peak richness of extremely small populations always occurred at the medium level across environmental gradients, and their species richness always decreased with increasing human disturbances. However, the appearance frequencies of three orchid species increased with the increasing human disturbances. Our study thus indicate that knowledge on how the external factors, such as the ecological environment, land use type, roads, human activity, etc., affect the distribution of the extremely small populations should be taken for the better protecting them in the future.	[Chen, Yukai; Yang, Xiaobo; Yang, Qi; Li, Donghai; Long, Wenxing; Luo, Wenqi] Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Coll Hort & Landscapes, Haikou 570228, Hainan, Peoples R China	Hainan University	Yang, XB (corresponding author), Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Coll Hort & Landscapes, Haikou 570228, Hainan, Peoples R China.	yanfengxb@163.com	; Long, Wenxing/P-1440-2018	Luo, Wenqi/0000-0002-7454-0961; Long, Wenxing/0000-0002-9195-5878	National Natural Science Foundation of China [31060073]; Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province [201207002-03]; Second national key protected plant resources survey in Hainan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province; Second national key protected plant resources survey in Hainan province	This work was financially supported by grants from the National Natural Science Foundation of China (31060073), the Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province (201207002-03), and the Second national key protected plant resources survey in Hainan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2010, RESTOR ECOL, V18, P235, DOI 10.1111/j.1526-100X.2009.00584.x; Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Amat ME, 2013, J NAT CONSERV, V21, P262, DOI 10.1016/j.jnc.2013.02.001; Amat ME, 2013, J HERED, V104, P692, DOI 10.1093/jhered/est042; BEERS TW, 1966, J FOREST, V64, P691; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Compilation Group of China's Biodiversity, 1998, CHINAS BIODIVERSITY; [崔艳 CUI Yan], 2006, [广西植物, Guihaia], V26, P660; Fiedler P. L., 1992, Conservation biology: the theory and practice of nature conservation, preservation, and management., P23; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frazer G.W., 1999, GAP LIGHT ANALYZER V; [高建国 Gao Jianguo], 2012, [生态学报, Acta Ecologica Sinica], V32, P5287; Garcia MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044657; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Guo ZM, 2006, AGROFOREST SYST, V66, P117, DOI 10.1007/s10457-005-4676-2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN (International Union for Conservation of Nature), 2013, THE IUCN RED LIST OF; Jiang HY, 2011, TROPICAL FORESTRY, V39, P40; Jiang Mingxi, 2002, Yingyong Shengtai Xuebao, V13, P1373; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2001, J BIOGEOGR, V28, P611, DOI 10.1046/j.1365-2699.2001.00577.x; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; Lauterbach D, 2011, PLANT BIOLOGY, V13, P667, DOI 10.1111/j.1438-8677.2010.00418.x; Lenzen M, 2009, CONSERV BIOL, V23, P294, DOI 10.1111/j.1523-1739.2008.01126.x; Leps J, 2003, MULTIVARIATE ANAL EC; Levine JM, 2010, ECOLOGY, V91, P130, DOI 10.1890/08-2039.1; Martens SN, 2000, ECOL MODEL, V126, P79, DOI 10.1016/S0304-3800(99)00188-X; Mason Herbert L., 1946, MADROnO, V8, P209; Neel MC, 2013, CONSERV BIOL, V27, P385, DOI 10.1111/cobi.12008; ODUM E P, 1971, P574; [乔琦 QIAO Qi], 2011, [生态学报, Acta Ecologica Sinica], V31, P4709; Qiu Y, 2001, J HYDROL, V240, P243, DOI 10.1016/S0022-1694(00)00362-0; Reckinger C, 2010, RESTOR ECOL, V18, P904, DOI 10.1111/j.1526-100X.2009.00522.x; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Reid T., 2013, OPEN J FORESTRY, V3, P70, DOI DOI 10.4236/OJF.2013.32012; Ren H, 2012, AMBIO, V41, P913, DOI 10.1007/s13280-012-0284-3; Ren H, 2010, PLANT SPEC BIOL, V25, P43, DOI 10.1111/j.1442-1984.2009.00261.x; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Singh KN, 2008, J MT SCI-ENGL, V5, P73, DOI 10.1007/s11629-008-0073-4; [宋萍 Song Ping], 2005, [山地学报, Journal of Mountain Science], V23, P631; Spooner PG, 2005, BIOL CONSERV, V122, P231, DOI 10.1016/j.biocon.2004.07.012; State Forestry Administration of China, 2011, THE SAVING AND CONSE; Tokuchi N, 1999, ECOL RES, V14, P361, DOI 10.1046/j.1440-1703.1999.00309.x; Tong Yuewei, 2013, Shengwu Duoyangxing, V21, P269, DOI 10.3724/SP.J.1003.2013.09008; Victor JE, 2003, S AFR J SCI, V99, P437; [王伯荪 WANG BoSun], 2007, [生态学报, Acta Ecologica Sinica], V27, P1690; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Watkins RZ, 2003, CONSERV BIOL, V17, P411, DOI 10.1046/j.1523-1739.2003.01285.x; WHITTAKER RH, 1965, ECOLOGY, V46, P429, DOI 10.2307/1934875; Xu Xiao, 2005, Ying Yong Sheng Tai Xue Bao, V16, P985; Yuan Jin-Feng, 2011, Bulletin of Botanical Research, V31, P61; Zang RG, 2009, ACTA OECOL, V35, P462, DOI 10.1016/j.actao.2008.12.006; Zhang HD, 2001, ECOLOGIC SCI, V20, P1; [张文辉 Zhang Wenhui], 2002, [生态学报, Acta Ecologica Sinica], V22, P1512; Zhang YB, 2008, BIODIVERS CONSERV, V17, P1783, DOI 10.1007/s10531-008-9384-6	60	21	27	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97751	10.1371/journal.pone.0097751	http://dx.doi.org/10.1371/journal.pone.0097751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830683	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500111
J	Hallstrom, H; Wolk, A; Glynn, A; Michaelsson, K; Byberg, L				Hallstrom, Helena; Wolk, Alicja; Glynn, Anders; Michaelsson, Karl; Byberg, Liisa			Coffee Consumption and Risk of Fracture in the Cohort of Swedish Men (COSM)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TOTAL PHYSICAL-ACTIVITY; HIGH-TRAUMA FRACTURES; HIP FRACTURE; CALCIUM ECONOMY; OLDER WOMEN; CAFFEINE; OSTEOPOROSIS; HEALTH; QUESTIONNAIRE	Background: Recent research in a large cohort of women showed that coffee consumption is not associated with increased risk of fracture. Whether this is the case also among men is less clear. Methods: In the Cohort of Swedish Men (COSM) study, 42,978 men aged 45-79 years old at baseline in 1997 answered a self-administered food frequency questionnaire covering coffee consumption and a medical and lifestyle questionnaire covering potential confounders. Our main outcomes first fracture at any site and first hip fracture were collected from the National Patient Registry in Sweden. The association between coffee consumption and fracture risk was investigated using Cox's proportional hazards regression. Results: During a mean follow-up of 11.2 years, 5,066 men had a first fracture at any site and of these, 1,186 (23%) were hip fractures. There was no association between increasing coffee consumption (per 200 ml) and rate of any fracture (hazard ratio [HR] 1.00; 95% confidence interval [CI] 0.99-1.02) or hip fracture (HR 1.02; 95% CI 0.99-1.06) after adjustment for potential confounders. For men consuming >= 4 cups of coffee/day compared to those consuming <1 cup of coffee/day, HR for any type of fracture was 0.91 (95% CI 0.80-1.02) and for hip fracture: 0.89 (95% CI 0.70-1.14). Conclusions: High coffee consumption was not associated with an increased risk of fractures in this large cohort of Swedish men.	[Hallstrom, Helena; Michaelsson, Karl; Byberg, Liisa] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Glynn, Anders] Natl Food Agcy, Risk & Benefit Assessment Dept, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Swedish National Food Agency	Byberg, L (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden.	liisa.byberg@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2004, TEMANORD, V2004, P565; BARGERLUX MJ, 1995, OSTEOPOROSIS INT, V5, P97, DOI 10.1007/BF01623310; Bergstrom L., 1991, Var Foda, V43, P439; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen Z, 2003, AM J EPIDEMIOL, V158, P772, DOI 10.1093/aje/kwg214; Discacciati A, 2013, ANN ONCOL, V24, P1912, DOI 10.1093/annonc/mdt105; Dy CJ, 2011, CLIN ORTHOP RELAT R, V469, P1906, DOI 10.1007/s11999-011-1849-3; European Coffee Federation, 2013, EUR COFF REP 2012 13; Fenton TR, 2009, J BONE MINER RES, V24, P1835, DOI [10.1359/jbmr.090515, 10.1359/JBMR.090515]; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Hallstrom H, 2013, AM J EPIDEMIOL, V178, P898, DOI 10.1093/aje/kwt062; Hallstrom H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-12; Hanley DA, 2013, J CLIN DENSITOM, V16, P420, DOI 10.1016/j.jocd.2013.08.014; Hansson LM, 2000, NUTR CANCER, V36, P1, DOI 10.1207/S15327914NC3601_1; Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7; Hegarty VM, 2000, AM J CLIN NUTR, V71, P1003; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI [10.1007/s00198-004-1734-y, 10.1007/s00198-004-1640-3]; KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Liu HF, 2012, ARCH MED SCI, V8, P776, DOI 10.5114/aoms.2012.31612; Lu PZ, 2008, INT J MOL SCI, V9, P698, DOI 10.3390/ijms9050698; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Mandel HG, 2002, FOOD CHEM TOXICOL, V40, P1231, DOI 10.1016/S0278-6915(02)00093-5; Mangano KM, 2014, CURR OPIN CLIN NUTR, V17, P69, DOI 10.1097/MCO.0000000000000013; MASSEY LK, 1990, NUTR RES, V10, P741, DOI 10.1016/S0271-5317(05)80823-1; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Meyer HE, 1997, AM J EPIDEMIOL, V145, P117, DOI 10.1093/oxfordjournals.aje.a009082; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Norman A, 2002, INT J OBESITY, V26, P670, DOI 10.1038/sj.ijo.0801955; Norman A, 2001, INT J OBESITY, V25, P682, DOI 10.1038/sj.ijo.0801597; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rapuri PB, 2007, J STEROID BIOCHEM, V103, P368, DOI 10.1016/j.jsbmb.2006.12.037; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; Tsuang Yang-Hwei, 2006, J Orthop Surg Res, V1, P7, DOI 10.1186/1749-799X-1-7; Wagner H, 2009, AM J EPIDEMIOL, V169, P143, DOI 10.1093/aje/kwn379; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wu CH, 2002, ARCH INTERN MED, V162, P1001, DOI 10.1001/archinte.162.9.1001; Zhou Y, 2010, BRIT J PHARMACOL, V161, P1542, DOI 10.1111/j.1476-5381.2010.00998.x	46	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97770	10.1371/journal.pone.0097770	http://dx.doi.org/10.1371/journal.pone.0097770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830750	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500113
J	Miyoshi, K; Kasahara, K; Murakami, S; Takeshima, M; Kumamoto, N; Sato, A; Miyazaki, I; Matsuzaki, S; Sasaoka, T; Katayama, T; Asanuma, M				Miyoshi, Ko; Kasahara, Kyosuke; Murakami, Shinki; Takeshima, Mika; Kumamoto, Natsuko; Sato, Asako; Miyazaki, Ikuko; Matsuzaki, Shinsuke; Sasaoka, Toshikuni; Katayama, Taiichi; Asanuma, Masato			Lack of Dopaminergic Inputs Elongates the Primary Cilia of Striatal Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; ADENYLYL-CYCLASE; INTRAFLAGELLAR TRANSPORT; BASAL GANGLIA; LOCALIZATION; DISEASE; LENGTH; BRAIN; IDENTIFICATION; INTERNEURONS	In the rodent brain, certain G protein-coupled receptors and adenylyl cyclase type 3 are known to localize to the neuronal primary cilium, a primitive sensory organelle protruding singly from almost all neurons. A recent chemical screening study demonstrated that many compounds targeting dopamine receptors regulate the assembly of Chlamydomonas reinhardtii flagella, structures which are analogous to vertebrate cilia. Here we investigated the effects of dopaminergic inputs loss on the architecture of neuronal primary cilia in the rodent striatum, a brain region that receives major dopaminergic projections from the midbrain. We first analyzed the lengths of neuronal cilia in the dorsolateral striatum of hemi-parkinsonian rats with unilateral lesions of the nigrostriatal dopamine pathway. In these rats, the striatal neuronal cilia were significantly longer on the lesioned side than on the non-lesioned side. In mice, the repeated injection of reserpine, a dopamine-depleting agent, elongated neuronal cilia in the striatum. The combined administration of agonists for dopamine receptor type 2 (D2) with reserpine attenuated the elongation of striatal neuronal cilia. Repeated treatment with an antagonist of D2, but not of dopamine receptor type 1 (D1), elongated the striatal neuronal cilia. In addition, D2-null mice displayed longer neuronal cilia in the striatum compared to wild-type controls. Reserpine treatment elongated the striatal neuronal cilia in D1-null mice but not in D2-null mice. Repeated treatment with a D2 agonist suppressed the elongation of striatal neuronal cilia on the lesioned side of hemi-parkinsonian rats. These results suggest that the elongation of striatal neuronal cilia following the lack of dopaminergic inputs is attributable to the absence of dopaminergic transmission via D2 receptors. Our results provide the first evidence that the length of neuronal cilia can be modified by the lack of a neurotransmitter's input.	[Miyoshi, Ko; Matsuzaki, Shinsuke; Katayama, Taiichi] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Miyoshi, Ko; Matsuzaki, Shinsuke] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Miyoshi, Ko; Kasahara, Kyosuke; Murakami, Shinki; Takeshima, Mika; Miyazaki, Ikuko; Asanuma, Masato] Okayama Univ, Dept Brain Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Kumamoto, Natsuko] Nagoya City Univ, Grad Sch Med Sci, Dept Neurobiol & Anat, Nagoya, Aichi, Japan; [Sato, Asako] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 228, Japan; [Matsuzaki, Shinsuke] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Suita, Osaka, Japan; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Comparat & Expt Med, Niigata, Japan	Osaka University; Osaka University; Okayama University; Nagoya City University; Kitasato University; Osaka University; Niigata University	Miyoshi, K (corresponding author), Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan.	miyoshi@ugscd.osaka-u.ac.jp	, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394	Japanese Ministry of Education, Culture, Sports, Science and Technology [24111533, 21591082, 22590934, 25461279]; Grants-in-Aid for Scientific Research [24659431] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment'' (KAKENHI #24111533; MA) and for Scientific Research (C) (KAKENHI #21591082; MA and #22590934, #25461279; IM) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara AA, 2003, BRAIN RES, V986, P22, DOI 10.1016/S0006-8993(03)03165-2; Avasthi P, 2012, ACS CHEM BIOL, V7, P911, DOI 10.1021/cb200349v; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Hamon M, 1999, NEUROPSYCHOPHARMACOL, V21, pS68, DOI 10.1038/sj.npp.1395368; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P225, DOI 10.2220/biomedres.32.225; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Miyazaki I, 2000, NEUROSCI LETT, V293, P65, DOI 10.1016/S0304-3940(00)01488-9; Miyoshi K, 2011, ACTA MED OKAYAMA, V65, P279; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Soetedjo L, 2013, BIOL OPEN, V2, DOI 10.1242/bio.20134747; Stanic D, 2009, BRAIN RES, V1249, P101, DOI 10.1016/j.brainres.2008.10.024; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Whitfield JF, 2009, CELL SIGNAL, V21, P1351, DOI 10.1016/j.cellsig.2009.02.013; Yamaguchi H, 1996, GENES CELLS, V1, P253, DOI 10.1046/j.1365-2443.1996.d01-238.x	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97918	10.1371/journal.pone.0097918	http://dx.doi.org/10.1371/journal.pone.0097918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830745	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500132
J	Saenz, FR; Ory, V; AlOtaiby, M; Rosenfield, S; Furlong, M; Cavalli, LR; Johnson, MD; Liu, XF; Schlegel, R; Wellstein, A; Riegel, AT				Saenz, Francisco R.; Ory, Virginie; AlOtaiby, Maram; Rosenfield, Sonia; Furlong, Mary; Cavalli, Luciane R.; Johnson, Michael D.; Liu, Xuefeng; Schlegel, Richard; Wellstein, Anton; Riegel, Anna T.			Conditionally Reprogrammed Normal and Transformed Mouse Mammary Epithelial Cells Display a Progenitor-Cell-Like Phenotype	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; MESENCHYMAL TRANSITION; ROCK INHIBITOR; SELF-RENEWAL; TUMORIGENESIS; SENESCENCE; GENERATION; INSIGHTS; DISEASE	Mammary epithelial (ME) cells cultured under conventional conditions senesce after several passages. Here, we demonstrate that mouse ME cells isolated from normal mammary glands or from mouse mammary tumor virus (MMTV)-Neu-induced mammary tumors, can be cultured indefinitely as conditionally reprogrammed cells (CRCs) on irradiated fibroblasts in the presence of the Rho kinase inhibitor Y-27632. Cell surface progenitor-associated markers are rapidly induced in normal mouse ME-CRCs relative to ME cells. However, the expression of certain mammary progenitor subpopulations, such as CD49f(+) ESA(+) CD44(+), drops significantly in later passages. Nevertheless, mouse ME-CRCs grown in a three-dimensional extracellular matrix gave rise to mammary acinar structures. ME-CRCs isolated from MMTV-Neu transgenic mouse mammary tumors express high levels of HER2/neu, as well as tumor-initiating cell markers, such as CD44(+), CD49f(+), and ESA(+) (EpCam). These patterns of expression are sustained in later CRC passages. Early and late passage ME-CRCs from MMTV-Neu tumors that were implanted in the mammary fat pads of syngeneic or nude mice developed vascular tumors that metastasized within 6 weeks of transplantation. Importantly, the histopathology of these tumors was indistinguishable from that of the parental tumors that develop in the MMTV-Neu mice. Application of the CRC system to mouse mammary epithelial cells provides an attractive model system to study the genetics and phenotype of normal and transformed mouse epithelium in a defined culture environment and in vivo transplant studies.	[Saenz, Francisco R.; Ory, Virginie; AlOtaiby, Maram; Rosenfield, Sonia; Cavalli, Luciane R.; Johnson, Michael D.; Wellstein, Anton; Riegel, Anna T.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Furlong, Mary; Liu, Xuefeng; Schlegel, Richard] Georgetown Univ, Dept Pathol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Riegel, AT (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	ariege01@georgetown.edu	Saenz, Francisco/ABE-7477-2020; Cavalli, Luciane R/J-6100-2012; Al-Otaiby, Maram/AAX-4283-2021	Saenz, Francisco/0000-0003-4738-4710; Al-Otaiby, Maram/0000-0002-6383-2301; Wellstein, Anton/0000-0002-0570-4950; Cavalli, Luciane Regina/0000-0001-5619-9037	National Institutes of Health/National Cancer Institute [CA113477]; Development Grant under CCSG National Cancer Institute [P30CA051008]; Cherry Blossom Breast Cancer Foundation Grant; Susan G Komen Training Grant [PBTDR12228366];  [CA177466];  [CA180524]; NATIONAL CANCER INSTITUTE [T32CA009686, R33CA177466, P30CA051008, R01CA113477] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Development Grant under CCSG National Cancer Institute; Cherry Blossom Breast Cancer Foundation Grant; Susan G Komen Training Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by National Institutes of Health/National Cancer Institute grants CA113477 (ATR), Development Grant (ATR) under CCSG Number P30CA051008 from the National Cancer Institute, CA177466 (RS and AW), CA180524 (XL) and by the Cherry Blossom Breast Cancer Foundation Grant (XL). FS is supported by Susan G Komen Training Grant PBTDR12228366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batts TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027841; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Owens TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00225; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Rosenfield SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047876; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Stingl J, 2006, NATURE, V5; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055	32	24	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97666	10.1371/journal.pone.0097666	http://dx.doi.org/10.1371/journal.pone.0097666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831228	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500098
J	Wang, SG; Hibberd, ML; Pettersson, S; Lee, YK				Wang, Shugui; Hibberd, Martin Lloyd; Pettersson, Sven; Lee, Yuan Kun			Enterococcus faecalis from Healthy Infants Modulates Inflammation through MAPK Signaling Pathways	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTESTINAL EPITHELIAL-CELLS; LACTIC-ACID BACTERIA; FACTOR 4E EIF4E; PRETERM INFANTS; GUT MICROBIOTA; KINASE; COLONIZATION; NEUTROPHILS; MICROFLORA	Colonizing commensal bacteria after birth are required for the proper development of the gastrointestinal tract. It is believed that bacterial colonization pattern in neonatal gut affects gut barrier function and immune system maturation. Studies on the development of faecal microbiota in infants showed that the neonatal gut was first colonized with enterococci followed by other microbiota such as Bifidobacterium. Other studies showed that babies who developed allergy were less often colonized with Enterococcus during the first month of life as compared to healthy infants. Many studies have been conducted to elucidate how bifidobacteria or lactobacilli, some of which are considered probiotic, regulate infant gut immunity. However, fewer studies have been focused on enterococi. In our study, we demonstrate that E. faecalis, isolated from healthy newborns, suppress inflammatory responses activated in vivo and in vitro. We found E. faecalis attenuates proinflammatory cytokine secretions, especially IL-8, through JNK and p38 signaling pathways. This finding shed light on how the first colonizer, E. faecalis, regulates inflammatory responses in the host.	[Wang, Shugui; Lee, Yuan Kun] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Wang, Shugui; Pettersson, Sven] Natl Canc Ctr Singapore, Div Cellular & Mol Res, Singapore, Singapore; [Hibberd, Martin Lloyd] Genome Inst Singapore, Singapore, Singapore; [Pettersson, Sven] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden	National University of Singapore; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet	Lee, YK (corresponding author), Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.	yuan_kun_lee@nuhs.edu.sg	Pettersson, Sven/F-9511-2015	Hibberd, Martin/0000-0001-8587-1849	National Research Foundation EWI Incentive for Research and Innovation Scheme	National Research Foundation EWI Incentive for Research and Innovation Scheme	The work is supported by National Research Foundation EWI Incentive for Research and Innovation Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; Carey CM, 2013, CAN J MICROBIOL, V59, P9, DOI 10.1139/cjm-2012-0446; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chen LL, 2009, WORLD J GASTROENTERO, V15, P321, DOI 10.3748/wjg.15.321; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; DJEU JY, 1990, J IMMUNOL, V144, P2205; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Hufnagel M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-107; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; ISEKI K, 1987, Hokkaido Journal of Medical Science, V62, P895; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Jijon HB, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/207398; Kalliomaki M, 2012, J PEDIATR GASTR NUTR, V54, P727, DOI 10.1097/MPG.0b013e318241cfa8; Lin HY, 2013, J FORMOS MED ASS; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; Nueno-Palop C, 2011, INT J FOOD MICROBIOL, V145, P390, DOI 10.1016/j.ijfoodmicro.2010.12.029; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Pinholt M, 2013, CLIN MICROBIOL INFEC; Rafferty BJ, 2012, CELL IMMUNOL, V280, P148, DOI 10.1016/j.cellimm.2012.12.003; Robyn J, 2012, BENEF MICROBES, V3, P299, DOI 10.3920/BM2012.0021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Shon WJ, 2005, J ENDODONT, V31, P369, DOI 10.1097/01.don.0000145420.29539.78; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Wang SG, 2008, WORLD J GASTROENTERO, V14, P1067, DOI 10.3748/wjg.14.1067; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wolf A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029256; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zhou S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-231	44	67	75	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97523	10.1371/journal.pone.0097523	http://dx.doi.org/10.1371/journal.pone.0097523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830946	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336789500075
J	Yung, LC; Fei, CC; Mandeep, JS; Abdullah, HB; Wee, LK				Yung, Lai Chin; Fei, Cheong Choke; Mandeep, J. S.; Abdullah, Huda Binti; Wee, Lai Khin			Synthesis of a Nano-Silver Metal Ink for Use in Thick Conductive Film Fabrication Applied on a Semiconductor Package	PLOS ONE			English	Article							EPOXY MOLDING COMPOUND; AG-TI; TEMPERATURE; ADHESION	The success of printing technology in the electronics industry primarily depends on the availability of metal printing ink. Various types of commercially available metal ink are widely used in different industries such as the solar cell, radio frequency identification (RFID) and light emitting diode (LED) industries, with limited usage in semiconductor packaging. The use of printed ink in semiconductor IC packaging is limited by several factors such as poor electrical performance and mechanical strength. Poor adhesion of the printed metal track to the epoxy molding compound is another critical factor that has caused a decline in interest in the application of printing technology to the semiconductor industry. In this study, two different groups of adhesion promoters, based on metal and polymer groups, were used to promote adhesion between the printed ink and the epoxy molding substrate. The experimental data show that silver ink with a metal oxide adhesion promoter adheres better than silver ink with a polymer adhesion promoter. This result can be explained by the hydroxyl bonding between the metal oxide promoter and the silane grouping agent on the epoxy substrate, which contributes a greater adhesion strength compared to the polymer adhesion promoter. Hypotheses of the physical and chemical functions of both adhesion promoters are described in detail.	[Yung, Lai Chin; Fei, Cheong Choke] Infineon Technol Malaysia Sdn Bhd 56645D, Melaka Operat, Free Trade Zone, Batu Berendam, Melaka, Malaysia; [Yung, Lai Chin; Mandeep, J. S.; Abdullah, Huda Binti] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi 43600, Selangor, Malaysia; [Wee, Lai Khin] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Yung, LC (corresponding author), Infineon Technol Malaysia Sdn Bhd 56645D, Melaka Operat, Free Trade Zone, Batu Berendam, Melaka, Malaysia.	ChinYung.Lai@infineon.com	singh, mandeep/W-7242-2019; Lai, Khin Wee/A-2997-2011; Singh, Mandeep/AAC-8680-2020	Lai, Khin Wee/0000-0002-8602-0533; 	National University of Malaysia; Infineon Technologies (Malaysia) Sdn Bhd; Infineon Technologies (Malaysia)	National University of Malaysia; Infineon Technologies (Malaysia) Sdn Bhd; Infineon Technologies (Malaysia)	This evaluation work was support by National University of Malaysia and Infineon Technologies (Malaysia) Sdn Bhd. Infineon Technologies (Malaysia) only provided the scholarship for their employee, Lai Chin Yung but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbary A., 2004, ALEXANDRIA ENG J, V43, P615; ASHBY MF, 1974, ACTA METALL MATER, V22, P275, DOI 10.1016/0001-6160(74)90167-9; Chen SW, 2005, MATER TRANS, V46, P2536, DOI 10.2320/matertrans.46.2536; Ding LF, 2009, COMP MATER SCI, V45, P247, DOI 10.1016/j.commatsci.2008.09.021; Fischer P, 2004, THIN SOLID FILMS, V453, P139, DOI 10.1016/j.tsf.2003.11.152; Greer JR, 2007, ACTA MATER, V55, P6345, DOI 10.1016/j.actamat.2007.07.040; Hang T, 2007, J ELECTRON MATER, V36, P1594, DOI 10.1007/s11664-007-0292-4; Ismagilov ZR, 2009, RUSS CHEM REV+, V78, P873, DOI 10.1070/RC2009v078n09ABEH004082; Kamyshny A., 2011, OPEN APPL PHYS J, V4, P19, DOI [10.2174/1874183501104010019, DOI 10.2174/1874183501104010019]; Knoerr M., 2010, P 2010 6 INT C INTEG, P1; Krebs FC, 2009, ORG ELECTRON, V10, P761, DOI 10.1016/j.orgel.2009.03.009; Kumpulainen T, 2011, OPT LASER TECHNOL, V43, P570, DOI 10.1016/j.optlastec.2010.08.002; Moon KS, 2005, J ELECTRON MATER, V34, P168, DOI 10.1007/s11664-005-0229-8; Ni MZ, 2012, MICROELECTRON RELIAB, V52, P206, DOI 10.1016/j.microrel.2011.07.095; Perelaer J, 2008, J MATER CHEM, V18, P3209, DOI 10.1039/b720032c; Perelaer J, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165303; Qi WH, 2002, J MATER SCI LETT, V21, P1743, DOI 10.1023/A:1020904317133; Schroder K. A., 2011, NAN C EXP 2011, V2, P220; Thierry C, 2002, Substrate with a photocatalytic coating based on titanium dioxide and organic dispersions based on titanium dioxide, Patent No. [US 6362121 B1, 6362121]; van der Eijk C, 2008, SCRIPTA MATER, V58, P779, DOI 10.1016/j.scriptamat.2007.12.017; Wang T, 2007, J ELECTRON MATER, V36, P1333, DOI 10.1007/s11664-007-0230-5; Wong CKY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3167358; Xie GQ, 2003, METALL MATER TRANS A, V34A, P2655, DOI 10.1007/s11661-003-0024-1	23	13	13	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97484	10.1371/journal.pone.0097484	http://dx.doi.org/10.1371/journal.pone.0097484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830317	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500066
J	Ascenzi, P; Leboffe, L; Pesce, A; Ciaccio, C; Sbardella, D; Bolognesi, M; Coletta, M				Ascenzi, Paolo; Leboffe, Loris; Pesce, Alessandra; Ciaccio, Chiara; Sbardella, Diego; Bolognesi, Martino; Coletta, Massimo			Nitrite-Reductase and Peroxynitrite Isomerization Activities of Methanosarcina acetivorans Protoglobin	PLOS ONE			English	Article							GLOBIN-COUPLED SENSORS; MYCOBACTERIUM-LEPRAE; ANAEROBIC CONDITIONS; OXYGEN-AFFINITY; CARBON-MONOXIDE; LIGAND-BINDING; HEMOGLOBIN; OXIDE; REACTIVITY; MECHANISM	Within the globin superfamily, protoglobins (Pgb) belong phylogenetically to the same cluster of two-domain globin-coupled sensors and single-domain sensor globins. Multiple functional roles have been postulated for Methanosarcina acetivorans Pgb (Ma-Pgb), since the detoxification of reactive nitrogen and oxygen species might co-exist with enzymatic activity(ies) to facilitate the conversion of CO to methane. Here, the nitrite-reductase and peroxynitrite isomerization activities of the CysE20Ser mutant of Ma-Pgb (Ma-Pgb*) are reported and analyzed in parallel with those of related heme-proteins. Kinetics of nitrite-reductase activity of ferrous Ma-Pgb* (Ma-Pgb*-Fe(II)) is biphasic and values of the second-order rate constant for the reduction of NO2- to NO and the concomitant formation of nitrosylated Ma-Pgb*-Fe(II) (Ma-Pgb*-Fe(II)-NO) are k(app1) = 9.6 +/- 0.2 M-1 s(-1) and k(app2) = 1.2 +/- 0.1 M-1 s(-1) (at pH 7.4 and 20 degrees C). The k(app1) and k(app2) values increase by about one order of magnitude for each pH unit decrease, between pH 8.3 and 6.2, indicating that the reaction requires one proton. On the other hand, kinetics of peroxynitrite isomerization catalyzed by ferric Ma-Pgb* (Ma-Pgb*-Fe(III)) is monophasic and values of the second order rate constant for peroxynitrite isomerization by Ma-Pgb*-Fe(III) and of the first order rate constant for the spontaneous conversion of peroxynitrite to nitrate are h(app) = 3.8x10(4) M-1 s(-1) and h(0) = 2.86 x 10(-1) s(-1) (at pH 7.4 and 20 degrees C). The pH-dependence of h(on) and h(0) values reflects the acid-base equilibrium of peroxynitrite (pK(a) = 6.7 and 6.9, respectively; at 20 degrees C), indicating that HOONO is the species that reacts preferentially with the heme-Fe(III) atom. These results highlight the potential role of Pgbs in the biosynthesis and scavenging of reactive nitrogen and oxygen species.	[Ascenzi, Paolo; Leboffe, Loris] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Ascenzi, Paolo] Natl Inst Biostruct & Biosyst, Rome, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Ciaccio, Chiara; Sbardella, Diego; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Sbardella, Diego; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy	Roma Tre University; University of Genoa; University of Rome Tor Vergata; University of Milan	Ascenzi, P (corresponding author), Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy.	ascenzi@uniroma3.it	Sbardella, Diego/N-9187-2015; Bolognesi, Martino/B-7924-2017; Coletta, Massimo/N-9049-2015; Pesce, Alessandra/A-3660-2015; Sbardella, Diego/K-7519-2016; Coletta, Massimiliano/GSN-5927-2022; Leboffe, Loris/K-7838-2016	Bolognesi, Martino/0000-0002-9253-5170; Sbardella, Diego/0000-0002-9924-7761; Leboffe, Loris/0000-0001-8272-1896; COLETTA, Massimiliano/0000-0002-5489-9467	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [PRIN 20109MXHMR_001]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CAL)	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CAL)	This work was partially supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN 20109MXHMR_001 and Universita Roma Tre, CAL 2013) to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V380, P392, DOI 10.1016/j.bbrc.2009.01.088; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V351, P528, DOI 10.1016/j.bbrc.2006.10.060; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Ascenzi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069762; Ascenzi P, 2013, BIOCHEM BIOPH RES CO, V430, P1301, DOI 10.1016/j.bbrc.2012.11.122; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V415, P463, DOI 10.1016/j.bbrc.2011.10.094; Ascenzi P, 2011, J BIOL INORG CHEM, V16, P97, DOI 10.1007/s00775-010-0706-2; Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736; Bikiel DE, 2010, J PHYS CHEM B, V114, P8536, DOI 10.1021/jp102135p; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Ciaccio C, 2013, BBA-PROTEINS PROTEOM, V1834, P1813, DOI 10.1016/j.bbapap.2013.02.026; Coppola D, 2013, BBA-PROTEINS PROTEOM, V1834, P1923, DOI 10.1016/j.bbapap.2013.02.018; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Forti F, 2011, J PHYS CHEM B, V115, P13771, DOI 10.1021/jp208562b; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; Herold S, 2001, J AM CHEM SOC, V123, P4085, DOI 10.1021/ja010111d; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Oelgeschlager E, 2008, ARCH MICROBIOL, V190, P257, DOI 10.1007/s00203-008-0382-6; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P79, DOI 10.1016/B978-0-12-407693-8.00003-0; Pesce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066144; Pesce A, 2011, IUBMB LIFE, V63, P287, DOI 10.1002/iub.484; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021	55	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95391	10.1371/journal.pone.0095391	http://dx.doi.org/10.1371/journal.pone.0095391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827820	Green Published, gold			2022-12-25	WOS:000336857400012
J	Garza, MC; Monzon, M; Marin, B; Badiola, JJ; Monleon, E				Carmen Garza, Maria; Monzon, Marta; Marin, Belen; Jose Badiola, Juan; Monleon, Eva			Distribution of Peripheral PrPSc in Sheep with Naturally Acquired Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CELLULAR PRION PROTEIN; CERVUS-ELAPHUS-NELSONI; MAMMARY-GLAND; TISSUE DISTRIBUTION; LYMPHOID-TISSUES; SUFFOLK SHEEP; ACCUMULATION; PATHOGENESIS; DISEASE	Accumulation of prion protein (PrPSc) in the central nervous system is the hallmark of transmissible spongiform encephalopathies. However, in some of these diseases such as scrapie or chronic wasting disease, the PrPSc can also accumulate in other tissues, particularly in the lymphoreticular system. In recent years, PrPSc in organs other than nervous and lymphoid have been described, suggesting that distribution of this protein in affected individuals may be much larger than previously thought. In the present study, 11 non-nervous/non-lymphoid organs from 16 naturally scrapie infected sheep in advanced stages of the disease were examined for the presence of PrPSc. Fourteen infected sheep were of the ARQ/ARQ PRNP genotype and 2 of the VRQ/VRQ, where the letters A, R, Q, and V represent the codes for amino-acids alanine, arginine, glutamine and valine, respectively. Adrenal gland, pancreas, heart, skin, urinary bladder and mammary gland were positive for PrPSc by immunohistochemistry and IDEXX HerdChek scrapie/BSE Antigen EIA Test in at least one animal. Lung, liver, kidney and skeletal muscle exhibited PrPSc deposits by immunohistochemistry only. To our knowledge, this is the first report regarding the presence of PrPSc in the heart, pancreas and urinary bladder in naturally acquired scrapie infections. In some other organs examined, in which PrPSc had been previously detected, PrPSc immunolabeling was observed to be associated with new structures within those organs. The results of the present study illustrate a wide dissemination of PrPSc in both ARQ/ARQ and VRQ/VRQ infected sheep, even when the involvement of the lymphoreticular system is scarce or absent, thus highlighting the role of the peripheral nervous system in the spread of PrPSc.	[Carmen Garza, Maria; Monzon, Marta; Marin, Belen; Jose Badiola, Juan; Monleon, Eva] Univ Zaragoza, Ctr Encefalopatias Espongiformes & Enfermedades E, Zaragoza, Spain; [Carmen Garza, Maria] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M7, Canada; [Monleon, Eva] Univ Zaragoza, Dept Anat & Histol Humanas, Zaragoza, Spain	University of Zaragoza; University of Alberta; University of Zaragoza	Monleon, E (corresponding author), Univ Zaragoza, Ctr Encefalopatias Espongiformes & Enfermedades E, Zaragoza, Spain.	emonleon@unizar.es	Garza, M Carmen/ABI-8266-2020; MONZÓN, MARTA/R-6162-2017	Garza, M Carmen/0000-0001-7098-2327; MONZÓN, MARTA/0000-0002-2787-9671	Gobierno de Aragon [218-315/3]; FEDER [CONCOTSA EFA205/11]; FPU doctoral grant from the Spanish Ministry of Education [AP2007-03842]	Gobierno de Aragon(Gobierno de Aragon); FEDER(European Commission); FPU doctoral grant from the Spanish Ministry of Education(German Research Foundation (DFG))	This study was supported by the Gobierno de Aragon (grant 218-315/3) and FEDER (CONCOTSA EFA205/11). Dr. Garza was supported by a FPU doctoral grant from the Spanish Ministry of Education (grant AP2007-03842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin C, 2004, J GEN VIROL, V85, P2103, DOI 10.1099/vir.0.80047-0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bessen RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028026; Caplazi P, 2004, J VET DIAGN INVEST, V16, P489, DOI 10.1177/104063870401600601; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; Didier A, 2008, BIOCHEM BIOPH RES CO, V369, P841, DOI 10.1016/j.bbrc.2008.02.108; Didier A, 2006, J HISTOCHEM CYTOCHEM, V54, P1255, DOI 10.1369/jhc.5A6880.2006; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Everest SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019737; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Groschup MH, 1999, ACTA NEUROPATHOL, V98, P453, DOI 10.1007/s004010051108; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; KIMBERLIN RH, 1983, J NEUROL SCI, V61, P315, DOI 10.1016/0022-510X(83)90165-X; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Lee AM, 2011, VIROLOGY, V411, P1, DOI 10.1016/j.virol.2010.12.012; Lezmi S, 2006, ACTA BIOCHIM POL, V53, P399; Lezmi S, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-41; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Maestrale C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062830; McGovern G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058620; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Monleon E, 2011, VET MICROBIOL, V147, P237, DOI 10.1016/j.vetmic.2010.06.028; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okada H, 2012, J HISTOCHEM CYTOCHEM, V60, P290, DOI 10.1369/0022155412437218; PATTISON I. H., 1960, JOUR COMP PATHOL AND THERAP, V70, P182, DOI 10.1016/S0368-1742(60)80018-5; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Salazar E, 2010, VET RES, V41, DOI 10.1051/vetres/2010030; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; Trifilo MJ, 2006, SCIENCE, V313, P94, DOI 10.1126/science.1128635; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; van Keulen LJM, 2000, ARCH VIROL, P57; Vargas F, 2005, VET REC, V156, P318, DOI 10.1136/vr.156.10.318; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; World Health Organization, 2010, WHO GUID TISS INF DI	51	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97768	10.1371/journal.pone.0097768	http://dx.doi.org/10.1371/journal.pone.0097768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828439	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400120
J	Craig, VJ; Polverino, F; Laucho-Contreras, ME; Shi, YY; Liu, YS; Osorio, JC; Tesfaigzi, Y; Pinto-Plata, V; Gochuico, BR; Rosas, IO; Owen, CA				Craig, Vanessa J.; Polverino, Francesca; Laucho-Contreras, Maria E.; Shi, Yuanyuan; Liu, Yushi; Osorio, Juan C.; Tesfaigzi, Yohannes; Pinto-Plata, Victor; Gochuico, Bernadette R.; Rosas, Ivan O.; Owen, Caroline A.			Mononuclear Phagocytes and Airway Epithelial Cells: Novel Sources of Matrix Metalloproteinase-8 (MMP-8) in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							HUMAN NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR; EXPRESSION; INFLAMMATION; DISEASE; MICE; FIBROBLASTS; SARCOIDOSIS; APOPTOSIS; INJURY	Objectives: Matrix metalloproteinase-8 (MMP-8) promotes lung fibrotic responses to bleomycin in mice. Although prior studies reported that MMP-8 levels are increased in plasma and bronchoalveolar lavage fluid (BALF) samples from IPF patients, neither the bioactive forms nor the cellular sources of MMP-8 in idiopathic pulmonary fibrosis (IPF) patients have been identified. It is not known whether MMP-8 expression is dys-regulated in IPF leukocytes or whether MMP-8 plasma levels correlate with IPF outcomes. Our goal was to address these knowledge gaps. Methods: We measured MMP-8 levels and forms in blood and lung samples from IPF patients versus controls using ELISAs, western blotting, and qPCR, and assessed whether MMP-8 plasma levels in 73 IPF patients correlate with rate of lung function decline and mortality. We used immunostaining to localize MMP-8 expression in IPF lungs. We quantified MMP-8 levels and forms in blood leukocytes from IPF patients versus controls. Results: IPF patients have increased BALF, whole lung, and plasma levels of soluble MMP-8 protein. Active MMP-8 is the main form elevated in IPF lungs. MMP-8 mRNA levels are increased in monocytes from IPF patients, but IPF patients and controls have similar levels of MMP-8 in PMNs. Surprisingly, macrophages and airway epithelial cells are the main cells expressing MMP-8 in IPF lungs. Plasma and BALF MMP-8 levels do not correlate with decline in lung function and/or mortality in IPF patients. Conclusion: Blood and lung MMP-8 levels are increased in IPF patients. Active MMP-8 is the main form elevated in IPF lungs. Surprisingly, blood monocytes, lung macrophages, and airway epithelial cells are the main cells in which MMP-8 is upregulated in IPF patients. Plasma and BALF MMP-8 levels are unlikely to serve as a prognostic biomarker for IPF patients. These results provide new information about the expression patterns of MMP-8 in IPF patients.	[Craig, Vanessa J.; Polverino, Francesca; Laucho-Contreras, Maria E.; Shi, Yuanyuan; Liu, Yushi; Osorio, Juan C.; Pinto-Plata, Victor; Rosas, Ivan O.; Owen, Caroline A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Polverino, Francesca] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Polverino, Francesca; Shi, Yuanyuan; Liu, Yushi; Rosas, Ivan O.; Owen, Caroline A.] Lovelace Resp Res Inst, Pulm Fibrosis Program, Albuquerque, NM USA; [Tesfaigzi, Yohannes; Owen, Caroline A.] Lovelace Resp Res Inst, Chron Obstruct Pulm Dis Program, Albuquerque, NM USA; [Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Parma; University Hospital of Parma; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Owen, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	cowen@rics.bwh.harvard.edu	Polverino, Francesca/AAL-7997-2020; Liu, Yushi/A-1533-2014; Polverino, Francesca/F-3816-2017	Liu, Yushi/0000-0003-4185-4187; Polverino, Francesca/0000-0001-9686-5698; Osorio, Juan C/0000-0001-8090-1551	Public Health Service, National Heart, Lung, and Blood Institute Grants [HL63137, HL086814, HL111835]; NIH [2T32 HL007633-26, 5T32 HD007466-15]; American Thoracic Society/Pulmonary Fibrosis Foundation; Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111835, P01HL114501, T32HL007633, R01HL063137, R01HL086814] Funding Source: NIH RePORTER	Public Health Service, National Heart, Lung, and Blood Institute Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society/Pulmonary Fibrosis Foundation; Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Public Health Service, National Heart, Lung, and Blood Institute Grants HL63137, HL086814, HL111835, NIH 2T32 HL007633-26, NIH 5T32 HD007466-15 (www.grants.gov); the American Thoracic Society/Pulmonary Fibrosis Foundation (www.thoracic.org); and the Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium (http://brighamandwomens.org and http://www.lrri.org). This work was supported, in part, by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante CL, 2007, CLIN CHIM ACTA, V379, P48, DOI 10.1016/j.cca.2006.12.006; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Craig VJ, 2013, J IMMUNOL, V190, P4283, DOI 10.4049/jimmunol.1201043; Decock J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-77; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gunther A, 2012, EUR RESPIR REV, V21, P152, DOI 10.1183/09059180.00001012; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HARRIS ED, 1984, COLLAGEN REL RES, V4, P493; HASTY KA, 1987, J BIOL CHEM, V262, P10048; HASTY KA, 1986, J BIOL CHEM, V261, P5645; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Kato R, 2005, CIRC J, V69, P1035, DOI 10.1253/circj.69.1035; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Knolle MD, 2013, J IMMUNOL, V190, P6434, DOI 10.4049/jimmunol.1202329; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; MURPHY G, 1977, BIOCHEM J, V162, P195, DOI 10.1042/bj1620195; National Heart Lung and Blood Institute, 2012, EV EFF PREDN AZ N AC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Overbeek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055612; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Prikk K, 2001, J PATHOL, V194, P232, DOI 10.1002/path.849; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Salminen HJ, 2002, ANN RHEUM DIS, V61, P591, DOI 10.1136/ard.61.7.591; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMYTHE G, 2005, BIOINFORMATICS COMPU; Stijn W, 2013, ANN THORAC MED, V8, P38, DOI 10.4103/1817-1737.105718; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Zhou T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044818	45	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97485	10.1371/journal.pone.0097485	http://dx.doi.org/10.1371/journal.pone.0097485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828408	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400099
J	Elhaddad, NS; Hunt, L; Sloan, J; Gray, JE				Elhaddad, Nagat S.; Hunt, Lee; Sloan, Jennifer; Gray, Julie E.			Light-Induced Stomatal Opening Is Affected by the Guard Cell Protein Kinase APK1b	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PHOSPHORYLATION; TRANSFORMATION; CO2	Guard cells allow land plants to survive under restricted or fluctuating water availability. They control the exchange of gases between the external environment and the interior of the plant by regulating the aperture of stomatal pores in response to environmental stimuli such as light intensity, and are important regulators of plant productivity. Their turgor driven movements are under the control of a signalling network that is not yet fully characterised. A reporter gene fusion confirmed that the Arabidopsis APK1b protein kinase gene is predominantly expressed in guard cells. Infrared gas analysis and stomatal aperture measurements indicated that plants lacking APK1b are impaired in their ability to open their stomata on exposure to light, but retain the ability to adjust their stomatal apertures in response to darkness, abscisic acid or lack of carbon dioxide. Stomatal opening was not specifically impaired in response to either red or blue light as both of these stimuli caused some increase in stomatal conductance. Consistent with the reduction in maximum stomatal conductance, the relative water content of plants lacking APK1b was significantly increased under both well-watered and drought conditions. We conclude that APK1b is required for full stomatal opening in the light but is not required for stomatal closure.	[Elhaddad, Nagat S.; Hunt, Lee; Sloan, Jennifer; Gray, Julie E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Gray, JE (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	j.e.gray@sheffield.ac.uk	Gray, Julie E/B-4271-2014; Hunt, Lee/A-1279-2008	Gray, Julie E/0000-0001-9972-5156; Hunt, Lee/0000-0001-6781-0540; Sloan, Jennifer/0000-0003-0334-3722	Libyan government; Biotechnology and Biological Sciences Research Council [BB/I002154/1]; BBSRC [BB/I002154/1] Funding Source: UKRI	Libyan government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a studentship from the Libyan government and Biotechnology and Biological Sciences Research Council grant BB/I002154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Desclos-Theveniau M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002513; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Goring DR, 2004, SCIENCE, V303, P1474, DOI 10.1126/science.1095764; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hayashi M, 2011, PLANT CELL PHYSIOL, V52, P1238, DOI 10.1093/pcp/pcr072; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li XM, 2011, J CHEM ECOL, V37, P779, DOI 10.1007/s10886-011-9975-7; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Pandey S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.28; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	23	16	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97161	10.1371/journal.pone.0097161	http://dx.doi.org/10.1371/journal.pone.0097161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828466	gold, Green Published, Green Accepted			2022-12-25	WOS:000336857400061
J	Logue, EC; Bloch, N; Dhuey, E; Zhang, RN; Cao, P; Herate, C; Chauveau, L; Hubbard, SR; Landau, NR				Logue, Eric C.; Bloch, Nicolin; Dhuey, Erica; Zhang, Ruonan; Cao, Ping; Herate, Cecile; Chauveau, Lise; Hubbard, Stevan R.; Landau, Nathaniel R.			A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity	PLOS ONE			English	Article							BIOCHEMICAL-ANALYSIS; HIV-1 RESTRICTION; CRYSTAL-STRUCTURE; VIRUS; DEAMINASE; RNA; FAMILY; GAG; HYPERMUTATION; PROTEINS	APOBEC3A (A3A), one of the seven-member APOBEC3 family of cytidine deaminases, lacks strong antiviral activity against lentiviruses but is a potent inhibitor of adeno-associated virus and endogenous retroelements. In this report, we characterize the biochemical properties of mammalian cell-produced and catalytically active E. coli-produced A3A. The enzyme binds to single-stranded DNA with a K-d of 150 nM and forms dimeric and monomeric fractions. A3A, unlike APOBEC3G (A3G), deaminates DNA substrates nonprocessively. Using a panel of oligonucleotides that contained all possible trinucleotide contexts, we identified the preferred target sequence as TC (A/G). Based on a three-dimensional model of A3A, we identified a putative binding groove that contains residues with the potential to bind substrate DNA and to influence target sequence specificity. Taking advantage of the sequence similarity to the catalytic domain of A3G, we generated A3A/A3G chimeric proteins and analyzed their target site preference. We identified a recognition loop that altered A3A sequence specificity, broadening its target sequence preference. Mutation of amino acids in the predicted DNA binding groove prevented substrate binding, confirming the role of this groove in substrate binding. These findings shed light on how APOBEC3 proteins bind their substrate and determine which sites to deaminate.	[Logue, Eric C.; Bloch, Nicolin; Dhuey, Erica; Zhang, Ruonan; Herate, Cecile; Chauveau, Lise; Landau, Nathaniel R.] NYU Sch Med, Dept Microbiol, New York, NY 10003 USA; [Cao, Ping; Hubbard, Stevan R.] NYU Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Hubbard, Stevan R.] NYU Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University; New York University; New York University	Landau, NR (corresponding author), NYU Sch Med, Dept Microbiol, New York, NY 10003 USA.	nathaniel.landau@med.nyu.edu	Chauveau, Lise/AAC-4598-2020	Chauveau, Lise/0000-0002-2671-4488; Hubbard, Stevan/0000-0002-2707-9383; Dhuey, Erica/0000-0002-5961-0722	NIH [AI074967-06, AI058864]; Cancer Research Institute; Vilcek Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074967, R01AI058864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Vilcek Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH grant AI074967-06 and AI058864, and by a postdoctoral fellowship to ECL from the Cancer Research Institute. NB is supported by a fellowship from the Vilcek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Ellinger P, 2012, J STRUCT BIOL, V178, P350, DOI 10.1016/j.jsb.2012.04.006; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pham P, 2013, J BIOL CHEM, V288, P29294, DOI 10.1074/jbc.M113.504175; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schmitt K, 2011, VIROLOGY, V419, P24, DOI 10.1016/j.virol.2011.07.017; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Wang T, 2008, VIROLOGY, V377, P71, DOI 10.1016/j.virol.2008.04.012; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	47	34	36	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97062	10.1371/journal.pone.0097062	http://dx.doi.org/10.1371/journal.pone.0097062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827831	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400052
J	Chang, FMJ; Coyne, HJ; Cubillas, C; Vinuesa, P; Fang, XY; Ma, Z; Ma, DJ; Helmann, JD; Garcia-de los Santos, A; Wang, YX; Dann, CE; Giedroc, DP				Chang, Feng-Ming James; Coyne, H. Jerome; Cubillas, Ciro; Vinuesa, Pablo; Fang, Xianyang; Ma, Zhen; Ma, Dejian; Helmann, John D.; Garcia-de los Santos, Alejandro; Wang, Yun-Xing; Dann, Charles E., III; Giedroc, David P.			Cu(I)-mediated Allosteric Switching in a Copper-sensing Operon Repressor (CsoR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI RCNR; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; STREPTOMYCES-LIVIDANS; STAPHYLOCOCCUS-AUREUS; PROTEIN; HOMEOSTASIS; RESISTANCE	The copper-sensing operon repressor (CsoR) is representative of a major Cu(I)-sensing family of bacterial metalloregulatory proteins that has evolved to prevent cytoplasmic copper toxicity. It is unknown how Cu(I) binding to tetrameric CsoRs mediates transcriptional derepression of copper resistance genes. A phylogenetic analysis of 227 DUF156 protein members, including biochemically or structurally characterized CsoR/RcnR repressors, reveals that Geobacillus thermodenitrificans (Gt) CsoR characterized here is representative of CsoRs from pathogenic bacilli Listeria monocytogenes and Bacillus anthracis. The 2.56 structure of Cu(I)-bound Gt CsoR reveals that Cu(I) binding induces a kink in the alpha 2-helix between two conserved copper-ligating residues and folds an N-terminal tail (residues 12-19) over the Cu(I) binding site. NMR studies of Gt CsoR reveal that this tail is flexible in the apo-state with these dynamics quenched upon Cu(I) binding. Small angle x-ray scattering experiments on an N-terminally truncated Gt CsoR (Delta 2-10) reveal that the Cu(I)-bound tetramer is hydrodynamically more compact than is the apo-state. The implications of these findings for the allosteric mechanisms of other CsoR/RcnR repressors are discussed.	[Chang, Feng-Ming James; Coyne, H. Jerome; Ma, Dejian; Dann, Charles E., III; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Cubillas, Ciro; Vinuesa, Pablo; Garcia-de los Santos, Alejandro] Univ Nacl Autonoma Mexico, Programa Ingn Genom, Ctr Ciencias Genom, Cuernavaca 04510, Morelos, Mexico; [Fang, Xianyang; Wang, Yun-Xing] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Ma, Zhen; Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Indiana University System; Indiana University Bloomington; Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Santos, Alejandro García-de los/AAQ-1047-2020; Giedroc, David/A-8608-2018; Vinuesa, Pablo/AAJ-1851-2020; Dann, Charles E/C-2747-2018	Giedroc, David/0000-0002-2342-1620; Vinuesa, Pablo/0000-0001-6119-2956; Fang, Xianyang/0000-0001-9432-9736; Cubillas, Ciro/0000-0002-2238-8048	National Institutes of Health [GM042569]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [CVU 269108]; Ciencia Basica Grant [179133]; Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica) [IN201112]; Lilly Endowment, Inc.; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, 22978]; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042569, R29GM042569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencia Basica Grant; Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica); Lilly Endowment, Inc.; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM042569 (to D. P. G.). This work was also supported by Consejo Nacional de Ciencia y Tecnologia (Mexico) Ph.D. Scholarship CVU 269108 (to C. C.), Ciencia Basica Grant 179133 (to P. V.), and Universidad Nacional Autonoma de Mexico/PAPIIT (Programa de Apoyo a Projectos de Investigacion e Innovacion Tecnologica) Grant IN201112 (to A. G. S.). The NMR instrumentation at Indiana University was supported by the Indiana METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357 and under Partner User Proposal 22978.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Chang FMJ, 2011, ANAL CHEM, V83, P9092, DOI 10.1021/ac202154r; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coyne HJ, 2013, BIOMOL NMR ASSIGN, V7, P279, DOI 10.1007/s12104-012-9428-4; Cubillas C, 2013, METALLOMICS, V5, P1634, DOI 10.1039/c3mt00204g; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Higgins KA, 2014, CHEM LETT, V43, P20, DOI 10.1246/cl.130965; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Luebke JL, 2013, METALLOMICS, V5, P335, DOI 10.1039/c3mt20205d; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tan BG, 2014, NUCLEIC ACIDS RES, V42, P1326, DOI 10.1093/nar/gkt902; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	55	42	42	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19204	19217		10.1074/jbc.M114.556704	http://dx.doi.org/10.1074/jbc.M114.556704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831014	hybrid, Green Published			2022-12-25	WOS:000339062900048
J	Singh, R; Brewer, MK; Mashburn, CB; Lou, DY; Bondada, V; Graham, B; Geddes, JW				Singh, Ranjana; Brewer, M. Kathryn; Mashburn, Charles B.; Lou, Dingyuan; Bondada, Vimala; Graham, Brantley; Geddes, James W.			Calpain 5 Is Highly Expressed in the Central Nervous System (CNS), Carries Dual Nuclear Localization Signals, and Is Associated with Nuclear Promyelocytic Leukemia Protein Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBCELLULAR-LOCALIZATION; IMPORTIN BETA; GENE; CLEAVAGE; DOMAINS; IDENTIFICATION; HUNTINGTIN; INHIBITION; BRAIN	Calpain 5 (CAPN5) is a non-classical member of the calpain family. It lacks the EF hand motif characteristic of classical calpains but retains catalytic and Ca2+ binding domains, and it contains a unique C-terminal domain. TRA-3, an ortholog of CAPN5, has been shown to be involved in necrotic cell death in Caenorhabditis elegans. CAPN5 is expressed throughout the CNS, but its expression relative to other calpains and subcellular distribution has not been investigated previously. Based on relative mRNA levels, Capn5 is the second most highly expressed calpain in the rat CNS, with Capn2 mRNA being the most abundant. Unlike classical calpains, CAPN5 is a non-cytosolic protein localized to the nucleus and extra-nuclear locations. CAPN5 possesses two nuclear localization signals (NLS): an N-terminal monopartite NLS and a unique bipartite NLS closer to the C terminus. The C-terminal NLS contains a SUMO-interacting motif that contributes to nuclear localization, and mutation or deletion of both NLS renders CAPN5 exclusively cytosolic. Dual NLS motifs are common among transcription factors. Interestingly, CAPN5 is found in punctate domains associated with promyelocytic leukemia (PML) protein within the nucleus. PML nuclear bodies are implicated in transcriptional regulation, cell differentiation, cellular response to stress, viral defense, apoptosis, and cell senescence as well as protein sequestration, modification, and degradation. The roles of nuclear CAPN5 remain to be determined.	[Singh, Ranjana; Brewer, M. Kathryn; Mashburn, Charles B.; Lou, Dingyuan; Bondada, Vimala; Graham, Brantley; Geddes, James W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Singh, Ranjana; Geddes, James W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone St, Lexington, KY 40536 USA.	jgeddes@uky.edu		Brewer, M. Kathryn/0000-0001-5089-3570	National Institutes of Health [P01NS058484, P30NS051220]; Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS051220, P01NS058484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01NS058484 and P30NS051220. This work was also supported by the Kentucky Spinal Cord and Head Injury Research Trust.	Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Barnes TM, 1996, EMBO J, V15, P4477, DOI 10.1002/j.1460-2075.1996.tb00825.x; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bhat RV, 1996, GLIA, V17, P169; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franz T, 2004, MOL CELL BIOL, V24, P1649, DOI 10.1128/MCB.24.4.1649-1654.2004; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonzalez A, 2006, HUM REPROD, V21, P943, DOI 10.1093/humrep/dei443; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hubener J, 2013, HUM MOL GENET, V22, P508, DOI 10.1093/hmg/dds449; Joyce PI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002602; KAGEYAMA GH, 1982, NEUROSCIENCE, V7, P2337, DOI 10.1016/0306-4522(82)90199-3; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Mahajan VB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003001; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matena K, 1998, GENOMICS, V48, P117, DOI 10.1006/geno.1997.5133; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Moore MW, 2005, E SCHERING RES FDN W, V50, P27; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURAYAMA A, 1984, J BIOCHEM-TOKYO, V95, P1697, DOI 10.1093/oxfordjournals.jbchem.a134783; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091025; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; Penna I, 2008, MOL HUM REPROD, V14, P613, DOI 10.1093/molehr/gan055; Raynaud F, 2008, INT J DEV BIOL, V52, P383, DOI 10.1387/ijdb.072448fr; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Saez ME, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-23; Saez ME, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-1; Santiago A, 2009, CELL CYCLE, V8, P76, DOI 10.4161/cc.8.1.7493; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seilhean D, 2004, ACTA NEUROPATHOL, V108, P81, DOI 10.1007/s00401-004-0855-x; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shin SJ, 2004, PROTEOMICS, V4, P3359, DOI 10.1002/pmic.200400961; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; STUURMAN N, 1992, J CELL SCI, V101, P773; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Takahashi J, 2003, NEUROBIOL DIS, V13, P230, DOI 10.1016/S0969-9961(03)00080-9; Takahashi J, 2002, BRAIN, V125, P1534, DOI 10.1093/brain/awf154; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Truant R, 1999, MOL CELL BIOL, V19, P1210; Waghray A, 2004, BIOCHEM BIOPH RES CO, V324, P46, DOI 10.1016/j.bbrc.2004.09.012; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565; Yeurl PL, 2008, J CELL BIOCHEM, V103, P456, DOI 10.1002/jcb.21408; YOSHIMURA N, 1984, J BIOL CHEM, V259, P9847	86	32	34	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19383	19394		10.1074/jbc.M114.575159	http://dx.doi.org/10.1074/jbc.M114.575159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24838245	hybrid, Green Published			2022-12-25	WOS:000339326800015
J	Buness, A; Roth, A; Herrmann, A; Schmitz, O; Kamp, H; Busch, K; Suter, L				Buness, Andreas; Roth, Adrian; Herrmann, Annika; Schmitz, Oliver; Kamp, Hennicke; Busch, Kristina; Suter, Laura			Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; KIDNEY INJURY; BIOMARKERS; METABOLOMICS; NEPHROTOXICITY; DISCOVERY; TOXICITY; PROTEIN; EGR-1	Early and accurate pre-clinical and clinical biomarkers of hepatotoxicity facilitate the drug development process and the safety monitoring in clinical studies. We selected eight known model compounds to be administered to male Wistar rats to identify biomarkers of drug induced liver injury (DILI) using transcriptomics, metabolite profiling (metabolomics) and conventional endpoints. We specifically explored early biomarkers in serum and liver tissue associated with histopathologically evident acute hepatotoxicity. A tailored data analysis strategy was implemented to better differentiate animals with no treatment-related findings in the liver from animals showing evident hepatotoxicity as assessed by histopathological analysis. From the large number of assessed parameters, our data analysis strategy allowed us to identify five metabolites in serum and five in liver tissue, 58 transcripts in liver tissue and seven clinical chemistry markers in serum that were significantly associated with acute hepatotoxicity. The identified markers comprised metabolites such as taurocholic acid and putrescine (measured as sum parameter together with agmatine), classical clinical chemistry markers like AST (aspartate aminotransferase), ALT (alanine aminotransferase), and bilirubin, as well as gene transcripts like Igfbp1 (insulin-like growth factor-binding protein 1) and Egr1 (early growth response protein 1). The response pattern of the identified biomarkers was concordant across all types of parameters and sample matrices. Our results suggest that a combination of several of these biomarkers could significantly improve the robustness and accuracy of an early diagnosis of hepatotoxicity.	[Buness, Andreas; Roth, Adrian; Herrmann, Annika; Suter, Laura] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Schmitz, Oliver] Metanomics GmbH, Berlin, Germany; [Busch, Kristina] Metan Hlth GmbH, Berlin, Germany; [Kamp, Hennicke] BASF SE, Ludwigshafen, Germany	Roche Holding; BASF	Buness, A (corresponding author), F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland.	a.buness@gmx.de	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913	F. Hoffmann-La Roche Ltd; Metanomics Health GmbH	F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Metanomics Health GmbH	This work was funded by Non-Clinical Safety, F. Hoffmann-La Roche Ltd, and Metanomics Health GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi J, 2005, XENOBIOTICA, V35, P839, DOI 10.1080/00498250500297940; BERK PD, 1978, AM J MED, V64, P311, DOI 10.1016/0002-9343(78)90061-X; Bollard ME, 2001, ANAL BIOCHEM, V295, P194, DOI 10.1006/abio.2001.5211; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144; Friedman S L, 1996, Prog Liver Dis, V14, P101; Goodsaid FM, 2009, CLIN PHARMACOL THER, V86, P490, DOI 10.1038/clpt.2009.149; Huang J, 2010, PHARMACOGENOMICS J, V10, P267, DOI 10.1038/tpj.2010.33; Kamp H, 2012, BIOANALYSIS, V4, P2291, DOI [10.4155/BIO.12.214, 10.4155/bio.12.214]; Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Ravenzwaay B, 2010, USE METABOLOMICS CAN, P141, DOI [10.1007/978-90-481-2675-0_8, DOI 10.1007/978-90-481-2675-0_]; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Strauss V, 2009, TOXICOL LETT, V191, P88, DOI 10.1016/j.toxlet.2009.08.004; Sun J., 2013, J MOL BIOMARKERS DIA, pS1; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Xu YL, 2010, J BIOL CHEM, V285, P23231, DOI 10.1074/jbc.M110.117457; Zhang AH, 2012, PHARMAZIE, V67, P99, DOI 10.1691/ph.2012.1104	27	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97249	10.1371/journal.pone.0097249	http://dx.doi.org/10.1371/journal.pone.0097249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836604	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800033
J	Jamil, T; Kruk, C; ter Braak, CJF				Jamil, Tahira; Kruk, Carla; ter Braak, Cajo J. F.			A Unimodal Species Response Model Relating Traits to Environment with Application to Phytoplankton Communities	PLOS ONE			English	Article							BAYESIAN VARIABLE SELECTION; CLIMATE-CHANGE; LAKE; STRATEGIES; HABITAT; CLASSIFICATION; VARIABILITY; REGRESSION; DIVERSITY; ECOLOGY	In this paper we attempt to explain observed niche differences among species (i.e. differences in their distribution along environmental gradients) by differences in trait values (e.g. volume) in phytoplankton communities. For this, we propose the trait-modulated Gaussian logistic model in which the niche parameters (optimum, tolerance and maximum) are made linearly dependent on species traits. The model is fitted to data in the Bayesian framework using OpenBUGS (Bayesian inference Using Gibbs Sampling) to identify according to which environmental variables there is niche differentiation among species and traits. We illustrate the method with phytoplankton community data of 203 lakes located within four climate zones and associated measurements on 11 environmental variables and six morphological species traits of 60 species. Temperature and chlorophyll-a (with opposite signs) described well the niche structure of all species. Results showed that about 25% of the variance in the niche centres with respect to chlorophyll-a were accounted for by traits, whereas niche width and maximum could not be predicted by traits. Volume, mucilage, flagella and siliceous exoskeleton are found to be the most important traits to explain the niche centres. Species were clustered in two groups with different niches structures, group 1 high temperature-low chlorophyll-a species and group 2 low temperature-high chlorophyll-a species. Compared to group 2, species in group 1 had larger volume but lower surface area, had more often flagella but neither mucilage nor siliceous exoskeleton. These results might help in understanding the effect of environmental changes on phytoplankton community. The proposed method, therefore, can also apply to other aquatic or terrestrial communities for which individual traits and environmental conditioning factors are available.	[Jamil, Tahira; ter Braak, Cajo J. F.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Jamil, Tahira] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Kruk, Carla] Fac deCiencias, Lab Ethol Ecol & Evolut, IIBCE Funct Ecol Aquat Syst, Montevideo, Uruguay	Wageningen University & Research; COMSATS University Islamabad (CUI); Instituto de Investigaciones Biologicas Clemente Estable Uruguay	ter Braak, CJF (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Braak, Cajo J. F. ter/G-7006-2011	Braak, Cajo J. F. ter/0000-0002-0414-8745; Kruk, Carla/0000-0003-0760-1186	Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands	Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands(Netherlands Government)	Tahira Jamil is funded by Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown PJ, 1998, J R STAT SOC B, V60, P627, DOI 10.1111/1467-9868.00144; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Falkowski PG, 2003, GLO CH IGBP, P99; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Ferber LR, 2004, FRESHWATER BIOL, V49, P690, DOI 10.1111/j.1365-2427.2004.01218.x; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gimenez O, 2009, ENVIRON ECOL STAT SE, V3, P883, DOI 10.1007/978-0-387-78151-8_41; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; GREEN RH, 1971, ECOLOGY, V52, P543, DOI 10.2307/1934142; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Huang YX, 2011, ANN APPL STAT, V5, P551, DOI 10.1214/10-AOAS376; Hubbell SP, 2008, UNIFIED NEUTRAL THEO; Jamil T, 2013, J VEG SCI, V24, P988, DOI 10.1111/j.1654-1103.2012.12036.x; Jamil T, 2013, PEERJ, V1, DOI 10.7717/peerj.95; Jongman RHG, 1995, DATA ANAL COMMUNITY; KEDDY PA, 1992, FUNCT ECOL, V6, P621, DOI 10.2307/2389954; Kirk J.T.O, 1996, LIGHT PHOTOSYNTHESIS; Kosten S, 2011, GLOBAL CHANGE BIOL; Kosten S, 2009, ECOSYSTEMS, V12, P1117, DOI 10.1007/s10021-009-9277-x; Kosten S, 2009, ECOL APPL, V19, P1791, DOI 10.1890/08-0906.1; Kruk C, 2011, LIMNOL OCEANOGR, V56, P110, DOI 10.4319/lo.2011.56.1.0110; Kruk C, 2012, HYDROBIOLOGIA, V698, P191, DOI 10.1007/s10750-012-1072-6; Kruk C, 2010, FRESHWATER BIOL, V55, P614, DOI 10.1111/j.1365-2427.2009.02298.x; Kruk C, 2009, FRESHWATER BIOL, V54, P2628, DOI 10.1111/j.1365-2427.2009.02274.x; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lahoz-Monfort JJ, 2011, METHODS ECOL EVOL, V2, P116, DOI 10.1111/j.2041-210X.2010.00050.x; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lehman J.T., 1988, P369; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; LURling M, 2012, FRESHWATER BIOL; MALTHUS TJ, 1989, FRESHWATER BIOL, V22, P383, DOI 10.1111/j.1365-2427.1989.tb01112.x; Margalef R, 1978, OCEANOLOGICA ACTA, V1; Mazzeo N, 2003, HYDROBIOLOGIA, V506, P591, DOI 10.1023/B:HYDR.0000008571.40893.77; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Naselli-Flores L, 2007, HYDROBIOLOGIA, V578, P87, DOI 10.1007/s10750-006-0436-1; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J, 2001, ECOLOGY, V82, P1191, DOI 10.2307/2679914; OKSANEN J, 1988, Journal of Paleolimnology, V1, P39; Padisak J, 2003, HYDROBIOLOGIA, V501, P219, DOI 10.1023/A:1026255328741; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pearsall WH, 1950, MOUNTAINS MOORLANDS; Pinheiro J, 2001, MIXED EFFECTS MODELS; Reynolds C, 2006, FRESHWATER BIOL, V14, P111; Reynolds C.S., 1988, P388; Reynolds C. S., 1997, VEGETATION PROCESS P; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Reynolds CS, 1998, HYDROBIOLOGIA, V370, P11, DOI 10.1023/A:1017062213207; REYNOLDS CS, 1987, SCHWEIZ Z HYDROL, V49, P220, DOI 10.1007/BF02538504; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; REYNOLDS CS, 1984, FRESHWATER BIOL, V14, P111, DOI 10.1111/j.1365-2427.1984.tb00027.x; Reynolds CS, 1997, HYDROBIOLOGIA, V349, P5, DOI 10.1023/A:1003020823129; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Segura AM, 2011, P ROY SOC B-BIOL SCI, V278, P2355, DOI 10.1098/rspb.2010.2464; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2011, R2OPENBUGS PACKAGE R; Tansley AG, 1939, BRIT ISLANDS THEIR V; Ter Braak C. J. F., 1988, Classification and Related Methods of Data Analysis. Proceedings of the First Conference of the International Federation of Classification Societies (IFCS), P551; ter Braak CJF, 2012, ECOLOGY, V93, P1525, DOI 10.1890/12-0126.1; TERBRAAK CJF, 1986, VEGETATIO, V65, P3; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TILMAN D, 1986, ARCH HYDROBIOL, V106, P473; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Van Buuren S., 2011, MICE MULTIVARIATE IM; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; VOLLENWEIDER R A, 1976, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V33, P53; Weithoff G, 2003, FRESHWATER BIOL, V48, P1669, DOI 10.1046/j.1365-2427.2003.01116.x; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Yuan M, 2005, J AM STAT ASSOC, V100, P1215, DOI 10.1198/016214505000000367	94	19	19	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97583	10.1371/journal.pone.0097583	http://dx.doi.org/10.1371/journal.pone.0097583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835582	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800053
J	Melamed, D				Melamed, David			Community Structures in Bipartite Networks: A Dual-Projection Approach	PLOS ONE			English	Article							COMPLEX NETWORKS	Identifying communities or clusters in networked systems has received much attention across the physical and social sciences. Most of this work focuses on single layer or one-mode networks, including social networks between people or hyperlinks between websites. Multilayer or multi-mode networks, such as affiliation networks linking people to organizations, receive much less attention in this literature. Common strategies for discovering the community structure of multi-mode networks identify the communities of each mode simultaneously. Here I show that this combined approach is ineffective at discovering community structures when there are an unequal number of communities between the modes of a multi-mode network. I propose a dual-projection alternative for detecting communities in multi-mode networks that overcomes this shortcoming. The evaluation of synthetic networks with known community structures reveals that the dual-projection approach outperforms the combined approach when there are a different number of communities in the various modes. At the same time, results show that the dual-projection approach is as effective as the combined strategy when the number of communities is the same between the modes.	Univ S Carolina, Dept Sociol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Melamed, D (corresponding author), Univ S Carolina, Dept Sociol, Columbia, SC 29208 USA.	melamed@mailbox.sc.edu						[Anonymous], [No title captured], DOI DOI 10.1145/1772690.1772853; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Carley KM, 2003, CITESEER, P133; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Everett MG, 2013, SOC NETWORKS, V35, P204, DOI 10.1016/j.socnet.2012.05.004; FARARO TJ, 1984, SOC NETWORKS, V6, P141, DOI 10.1016/0378-8733(84)90015-7; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeman LC, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P39; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Jensen Kurt, 2007, International Journal on Software Tools for Technology Transfer, V9, P213, DOI 10.1007/s10009-007-0038-x; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Melamed D, 2013, CONNECTIONS, V33, P18; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Wang XH, 2009, PHYSICA A, V388, P5045, DOI 10.1016/j.physa.2009.08.032; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Zhan WH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066120; Zhang P, 2008, PHYSICA A, V387, P6869, DOI 10.1016/j.physa.2008.09.006; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023	29	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97823	10.1371/journal.pone.0097823	http://dx.doi.org/10.1371/journal.pone.0097823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836376	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800071
J	Valdez, DJ; Cortez, MV; Della Costa, NS; Leche, A; Hansen, C; Navarro, JL; Martella, MB				Valdez, Diego J.; Vera Cortez, Marilina; Della Costa, Natalia S.; Leche, Alvina; Hansen, Cristian; Navarro, Joaquin L.; Martella, Monica B.			Seasonal Changes in Plasma Levels of Sex Hormones in the Greater Rhea (Rhea americana), a South American Ratite with a Complex Mating System	PLOS ONE			English	Article							EMU DROMAIUS-NOVAEHOLLANDIAE; STRUTHIO-CAMELUS; BIRDS; TESTOSTERONE; CORTICOSTERONE; INCUBATION; SIZE; ENVIRONMENT; CHALLENGE; ENDOCRINE	Seasonal rhythm in sex hormones has been extensively studied in birds, as well as its relationship with the type of mating system. The Greater Rhea (Rhea americana), a South American ratite species, reproduces seasonally and has a complex mating system: female-defense polygyny and sequential polyandry. The present study aimed at analyzing the endocrine basis of reproduction in this species and its relationship with its mating system. We used HPLC and electrochemiluminescence techniques to identify and measure plasma testosterone and estradiol levels. Annual oscillations in sex hormones, testosterone and estradiol, in adult males and females were observed. Lower levels of these hormones were exhibited during the non reproductive season (February to July), whereas their maximum values were reached in September for males and November-December for females. These fluctuations reflect the seasonal changes in gonadal function. By contrast, no significant sex hormones oscillations were observed in juvenile males and females (negative control of seasonal changes). Greater rheas maintain high testosterone and estradiol levels throughout the reproductive period. The high testosterone levels during incubation and chick rearing did not inhibit parental behavior in males, which appears not to conform to the "Challenge Hypothesis". In females, the high estradiol levels throughout the reproductive season would be needed to sustain their long egg-laying period.	[Valdez, Diego J.; Vera Cortez, Marilina; Della Costa, Natalia S.; Leche, Alvina; Navarro, Joaquin L.; Martella, Monica B.] Univ Nacl Cordoba, Ctr Zool Aplicada, Inst Diversidad & Ecol Anim IDEA CONICET, RA-5000 Cordoba, Argentina; [Hansen, Cristian] Lab Anal Clin Especializados, Cordoba, Argentina	National University of Cordoba	Valdez, DJ (corresponding author), Univ Nacl Cordoba, Ctr Zool Aplicada, Inst Diversidad & Ecol Anim IDEA CONICET, RA-5000 Cordoba, Argentina.	dvaldez@efn.uncor.edu		Leche, Alvina/0000-0002-8667-3374; Valdez, Diego Javier/0000-0002-4467-6761	Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT [PROYECTO 1170]; Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina	Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT(FONCyT); Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina(ANPCyT)	Funding was provided by grants from the Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC), and Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT 2012, No PROYECTO 1170, Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina, to M. B. Martella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blache D, 2001, J NEUROENDOCRINOL, V13, P998, DOI 10.1046/j.1365-2826.2001.00722.x; Blas J, 2010, GEN COMP ENDOCR, V168, P22, DOI 10.1016/j.ygcen.2010.03.020; BRUNING D F, 1974, Living Bird, V13, P251; COCKREM JF, 1994, GEN COMP ENDOCR, V94, P113, DOI 10.1006/gcen.1994.1065; Codenotti TL, 2001, WILSON BULL, V113, P85, DOI 10.1676/0043-5643(2001)113[0085:MBOTMG]2.0.CO;2; DEGEN AA, 1994, GEN COMP ENDOCR, V93, P21, DOI 10.1006/gcen.1994.1003; di Rienzo J., 2011, INFOSTAT STAT SOFTWA; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Fernandez GJ, 1995, J AVIAN BIOL, V26, P321, DOI 10.2307/3677047; Fernandez GJ, 2003, WILSON BULL, V115, P467, DOI 10.1676/03-060; Fernandez GJ, 2003, AUK, V120, P418, DOI 10.1093/auk/120.2.418; Fernandez GJ, 1998, AUK, V115, P340, DOI 10.2307/4089192; Fraire HJR, 2006, BRIT POULTRY SCI, V47, P375, DOI 10.1080/00071660600753805; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; Giordano PF, 2008, BIRD CONSERV INT, V18, P63, DOI 10.1017/S0959270908000075; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; HANDFORD P, 1985, BIOL J LINN SOC, V25, P77, DOI 10.1111/j.1095-8312.1985.tb00387.x; Hillgarth Nigella, 1997, P143; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; IUCN, 2013, IUCN RED LIST THREAT; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kimwele CN, 2003, MOL ECOL, V12, P229, DOI 10.1046/j.1365-294X.2003.01727.x; Koren L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032496; Labaque MC, 2010, BRIT POULTRY SCI, V51, P838, DOI 10.1080/00071668.2010.528376; Leche A, 2009, GEN COMP ENDOCR, V162, P188, DOI 10.1016/j.ygcen.2009.03.014; Leska A, 2007, REPROD BIOL, V7, P99; Malecki IA, 1998, ANIM REPROD SCI, V53, P143, DOI 10.1016/S0378-4320(98)00110-9; Martella M. B., 2006, PROYECTO NANDU MANEJ; Martella MB, 1994, J ORNITHOL, V135, P123; Martella MB, 1998, OSTRICH, V69, P259; McQueen SM, 1999, GEN COMP ENDOCR, V114, P11, DOI 10.1006/gcen.1998.7229; Melmed S., 2011, WILLIAMS TXB ENDOCRI, V12th; MENAKER M, 1968, P NATL ACAD SCI USA, V60, P146, DOI 10.1073/pnas.60.1.146; Nakane Y, 2010, CELL TISSUE RES, V342, P341, DOI 10.1007/s00441-010-1073-6; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Navarro JL, 2002, ARCH GEFLUGELKD, V66, P124; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; POTTER MA, 1992, GEN COMP ENDOCR, V87, P416, DOI 10.1016/0016-6480(92)90049-P; RAMOS C, 1992, HORM BEHAV, V26, P586, DOI 10.1016/0018-506X(92)90024-P; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Sales J, 2000, ARCH GEFLUGELKD, V64, P207; Sales J., 2009, Journal of Threatened Taxa, V1, P9; Sales J, 2006, AVIAN POULT BIOL REV, V17, P105, DOI 10.3184/147020606783438759; Taylor EL, 2000, BEHAV ECOL SOCIOBIOL, V47, P359, DOI 10.1007/s002650050677; Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x	47	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97334	10.1371/journal.pone.0097334	http://dx.doi.org/10.1371/journal.pone.0097334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837464	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800038
J	Ruggiero, A; Dattelbaum, JD; Staiano, M; Berisio, R; D'Auria, S; Vitagliano, L				Ruggiero, Alessia; Dattelbaum, Jonathan D.; Staiano, Maria; Berisio, Rita; D'Auria, Sabato; Vitagliano, Luigi			A Loose Domain Swapping Organization Confers a Remarkable Stability to the Dimeric Structure of the Arginine Binding Protein from Thermotoga maritima	PLOS ONE			English	Article							RIBONUCLEASE-A; CRYSTAL-STRUCTURES; CLOSED FORMS; TRANSPORTER; DYNAMICS; RECEPTOR; SYSTEMS; REVEAL; MODEL; RNASE	The arginine binding protein from Thermatoga maritima (TmArgBP), a substrate binding protein (SBP) involved in the ABC system of solute transport, presents a number of remarkable properties. These include an extraordinary stability to temperature and chemical denaturants and the tendency to form multimeric structures, an uncommon feature among SBPs involved in solute transport. Here we report a biophysical and structural characterization of the TmArgBP dimer. Our data indicate that the dimer of the protein is endowed with a remarkable stability since its full dissociation requires high temperature as well as SDS and urea at high concentrations. In order to elucidate the atomic level structural properties of this intriguing protein, we determined the crystallographic structures of the apo and the arginine-bound forms of TmArgBP using MAD and SAD methods, respectively. The comparison of the liganded and unliganded models demonstrates that TmArgBP tertiary structure undergoes a very large structural re-organization upon arginine binding. This transition follows the Venus Fly-trap mechanism, although the entity of the re-organization observed in TmArgBP is larger than that observed in homologous proteins. Intriguingly, TmArgBP dimerizes through the swapping of the C-terminal helix. This dimer is stabilized exclusively by the interactions established by the swapping helix. Therefore, the TmArgBP dimer combines a high level of stability and conformational freedom. The structure of the TmArgBP dimer represents an uncommon example of large tertiary structure variations amplified at quaternary structure level by domain swapping. Although the biological relevance of the dimer needs further assessments, molecular modelling suggests that the two TmArgBP subunits may simultaneously interact with two distinct ABC transporters. Moreover, the present protein structures provide some clues about the determinants of the extraordinary stability of the biomolecule. The availability of an accurate 3D model represents a powerful tool for the design of new TmArgBP suited for biotechnological applications.	[Ruggiero, Alessia; Berisio, Rita; Vitagliano, Luigi] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Dattelbaum, Jonathan D.] Univ Richmond, Dept Chem, Richmond, VA 23173 USA; [Staiano, Maria; D'Auria, Sabato] IBP CNR, Lab Mol Sensing, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Richmond; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Berisio, R (corresponding author), CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy.	rita.berisio@unina.it; luigi.vitagliano@unina.it	d'auria, sabato/C-3565-2015; Ruggiero, Alessia/GRJ-9538-2022; STAIANO, MARIA/B-9584-2015	d'auria, sabato/0000-0001-9320-494X; Ruggiero, Alessia/0000-0002-3508-385X; STAIANO, MARIA/0000-0003-0223-1825; Berisio, Rita/0000-0001-5025-6483	Regione Campania; Progetto POR	Regione Campania(Regione Campania); Progetto POR	This study was supported by Regione Campania and Progetto POR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicea I, 2011, J MOL BIOL, V414, P356, DOI 10.1016/j.jmb.2011.09.047; Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; Ausili A, 2013, J PHOTOCH PHOTOBIO B, V118, P66, DOI 10.1016/j.jphotobiol.2012.11.004; Ausili Alessio, 2013, Life-Basel, V3, P149, DOI 10.3390/life3010149; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bulut H, 2012, EUR J CELL BIOL, V91, P318, DOI 10.1016/j.ejcb.2011.12.004; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; Cuneo MJ, 2008, J BIOL CHEM, V283, P32812, DOI 10.1074/jbc.M803595200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deacon LJ, 2014, BIOCHIMIE, V99, P208, DOI 10.1016/j.biochi.2013.12.011; Deignan JL, 2008, MOL GENET METAB, V93, P7, DOI 10.1016/j.ymgme.2007.08.123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito L, 2000, PROTEIN SCI, V9, P2038; Esposito L, 2005, J MOL BIOL, V347, P483, DOI 10.1016/j.jmb.2005.01.065; Esposito L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326914; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Gotte G, 2006, BBA-PROTEINS PROTEOM, V1764, P44, DOI 10.1016/j.bbapap.2005.10.011; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Luchansky MS, 2010, MOL BIOSYST, V6, P142, DOI 10.1039/b908412f; Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058; MAO B, 1982, J BIOL CHEM, V257, P1131; MAZZARELLA L, 1995, P NATL ACAD SCI USA, V92, P3799, DOI 10.1073/pnas.92.9.3799; Merlino A, 2005, BIOPHYS J, V88, P2003, DOI 10.1529/biophysj.104.048611; Merlino A, 2004, BIOPHYS J, V86, P2383, DOI 10.1016/S0006-3495(04)74295-2; Nenci A, 2001, PROTEIN SCI, V10, P2017, DOI 10.1110/ps.14101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Ruggiero A, 2011, ACTA CRYSTALLOGR F, V67, P1462, DOI 10.1107/S1744309111037341; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Scire A, 2010, MOL BIOSYST, V6, P687, DOI 10.1039/b922092e; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Stamp AL, 2011, PROTEINS, V79, P2352, DOI 10.1002/prot.23060; Vahedi-Faridi A, 2008, J MOL BIOL, V375, P448, DOI 10.1016/j.jmb.2007.10.049; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	42	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96560	10.1371/journal.pone.0096560	http://dx.doi.org/10.1371/journal.pone.0096560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832102	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500023
J	Whelan, MC; Casey, G; Larkin, JO; Guinn, BA; O'Sullivan, GC; Tangney, M				Whelan, Maria C.; Casey, Garrett; Larkin, John O.; Guinn, Barbara-Ann; O'Sullivan, Gerald C.; Tangney, Mark			Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition	PLOS ONE			English	Article							IMMUNE TOLERANCE; IMMUNOTHERAPY; ESOPHAGEAL; INDUCTION; SURVIVAL	Oral administration of tumour cells induces an immune hypo-responsiveness known as oral tolerance. We have previously shown that oral tolerance to a cancer is tumour antigen specific, non-cross-reactive and confers a tumour growth advantage. We investigated the utilisation of regulatory T cell (Treg) depletion on oral tolerance to a cancer and its ability to control tumour growth. Balb/C mice were gavage fed homogenised tumour tissue - JBS fibrosarcoma (to induce oral tolerance to a cancer), or PBS as control. Growth of subcutaneous JBS tumours were measured; splenic tissue excised and flow cytometry used to quantify and compare systemic Tregs and T effector (Teff) cell populations. Prior to and/or following tumour feeding, mice were intraperitoneally administered anti-CD25, to inactivate systemic Tregs, or given isotype antibody as a control. Mice which were orally tolerised prior to subcutaneous tumour induction, displayed significantly higher systemic Treg levels (14% vs 6%) and faster tumour growth rates than controls (p<0.05). Complete regression of tumours were only seen after Treg inactivation and occurred in all groups - this was not inhibited by tumour feeding. The cure rates for Treg inactivation were 60% during tolerisation, 75% during tumour growth and 100% during inactivation for both tolerisation and tumour growth. Depletion of Tregs gave rise to an increased number of Teff cells. Treg depletion post-tolerisation and post-tumour induction led to the complete regression of all tumours on tumour bearing mice. Oral administration of tumour tissue, confers a tumour growth advantage and is accompanied by an increase in systemic Treg levels. The administration of anti-CD25 Ab decreased Treg numbers and caused an increase in Teffs. Most notably Treg cell inhibition overcame established oral tolerance with consequent tumor regression, especially relevant to foregut cancers where oral tolerance is likely to be induced by the shedding of tumour tissue into the gut.	[Whelan, Maria C.; Casey, Garrett; Larkin, John O.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork Canc Res Ctr, Cork, Ireland; [Guinn, Barbara-Ann] Univ Bedfordshire, Dept Life Sci, Luton, Beds, England	University College Cork; University of Bedfordshire	Tangney, M (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork Canc Res Ctr, Cork, Ireland.	m.tangney@ucc.ie	Guinn, Barbara/AAB-7403-2021; Guinn, Barbara-Ann/AHC-8282-2022	Guinn, Barbara/0000-0003-0639-4541; Guinn, Barbara-Ann/0000-0003-0639-4541; Tangney, Mark/0000-0002-6314-1260	Cancer Research Ireland [CRI06OSUG]; Royal College of Surgeons Edinburgh; Royal College of Surgeons Ireland; Cork Cancer Research Centre	Cancer Research Ireland; Royal College of Surgeons Edinburgh; Royal College of Surgeons Ireland; Cork Cancer Research Centre	This work was funded through a research grant to GOS and MT from Cancer Research Ireland (CRI06OSUG). MW was funded by a fellowship from the Royal College of Surgeons Edinburgh and the Royal College of Surgeons Ireland. The authors also acknowledge support from the Cork Cancer Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boncheva V, 2013, CANCER GENE THER, V20, P157, DOI 10.1038/cgt.2013.5; Castro AB, 2012, CELL IMMUNOL, V280, P171, DOI 10.1016/j.cellimm.2012.12.004; Castro-Sanchez P, 2013, BRIT J NUTR, V109, pS3, DOI 10.1017/S0007114512005223; Chen L, 2007, MOL THER, V15, P2194, DOI 10.1038/sj.mt.6300310; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Collins SA, 2008, CURR GENE THER, V8, P66, DOI 10.2174/156652308784049345; Curiel T.J., 2006, CANC IMMUNITY, V6, P20; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; KHARE SD, 1995, J IMMUNOL, V155, P3653; Larkin J, 2006, MED HYPOTHESES, V66, P541, DOI 10.1016/j.mehy.2005.09.021; Micheli A, 2003, ANN ONCOL, V14, pV28, DOI 10.1093/annonc/mdg752; Murphy J, 2000, AM J GASTROENTEROL, V95, P3607; Needham DJ, 2006, BIOCHEM BIOPH RES CO, V343, P684, DOI 10.1016/j.bbrc.2006.03.018; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; NUSSENBLATT RB, 1990, J IMMUNOL, V144, P1689; O'Brien MG, 2003, DIS ESOPHAGUS, V16, P218, DOI 10.1046/j.1442-2050.2003.00332.x; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang XM, 2013, ADV DRUG DELIVER REV, V65, P759, DOI 10.1016/j.addr.2012.10.013; Weiner HL, 1997, ANNU REV MED, V48, P341; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Whelan MC, 2010, CANCER GENE THER, V17, P501, DOI 10.1038/cgt.2010.8; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	22	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97602	10.1371/journal.pone.0097602	http://dx.doi.org/10.1371/journal.pone.0097602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832130	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500084
J	Zhang, SC; Dong, ZQ; Peng, ZS; Lu, F				Zhang, Shengchang; Dong, Ziqing; Peng, Zhangsong; Lu, Feng			Anti-Aging Effect of Adipose-Derived Stem Cells in a Mouse Model of Skin Aging Induced by D-Galactose	PLOS ONE			English	Article							ADVANCED GLYCATION; STROMAL CELLS; GROWTH-FACTOR; MYOCARDIAL-INFARCTION; ANGIOGENIC EFFICACY; OXIDATIVE STRESS; DIFFERENTIATION; TISSUE; IMPROVEMENT; EXPRESSION	Introduction: Glycation products accumulate during aging of slowly renewing tissue, including skin, and are suggested as an important mechanism underlying the skin aging process. Adipose-derived cells are widely used in the clinic to treat ischemic diseases and enhance wound healing. Interestingly, adipose-derived stem cells (ASCs) are also effective in anti-aging therapy, although the mechanism underlying their effects remains unknown. The purpose of the present study was to examine the anti-aging effect of ASCs in a D-galactose-induced aging animal model and to clarify the underlying mechanism. Materials and Methods: Six-week-old nude mice were subcutaneously injected with D-gal daily for 8 weeks. Two weeks after completion of treatment, mice were randomized to receive subcutaneous injections of 10(6) green fluorescent protein (GFP)-expressing ASCs, aminoguanidine (AG) or phosphate-buffered saline (PBS). Control mice received no treatment. We examined tissue histology and determined the activity of senescence-associated molecular markers such as superoxide dismutase (SOD) and malondialdehyde (MDA). Results: Transplanted ASCs were detectable for 14 days and their GFP signal disappeared at day 28 after injection. ASCs inhibited advanced glycation end product (AGE) levels in our animal model as well as increased the SOD level and decreased the MDA level, all of which act to reverse the aging phenotype in a similar way to AG, an inhibitor of AGE formation. Furthermore, ASCs released angiogenic factors in vivo such as vascular endothelial growth factor, suggesting a skin trophic effect. Conclusions: These results demonstrate that ASCs may contribute to the regeneration of skin during aging. In addition, the data shows that ASCs provide a functional benefit by glycation suppression, antioxidation, and trophic effects in a mouse model of aging.	[Zhang, Shengchang; Dong, Ziqing; Peng, Zhangsong; Lu, Feng] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Lu, F (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China.	doctorlufeng@hotmail.com			National Nature Science Foundation of China [81171834, 81071589]; Medical Scientific Research Foundation of Guangdong Province [A2013449, A2011453]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province	This work was financially supported by the National Nature Science Foundation of China (81171834, 81071589), Medical Scientific Research Foundation of Guangdong Province (A2013449, A2011453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Baregamian N, 2006, J SURG RES, V136, P31, DOI 10.1016/j.jss.2006.04.028; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Bonta M, 2013, ROM J MORPHOL EMBRYO, V54, P797; Cassino TR, 2012, TISSUE ENG PT A, V18, P1101, DOI [10.1089/ten.tea.2011.0285, 10.1089/ten.TEA.2011.0285]; Chen HY, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-33; Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gil P, 2002, GERONTOLOGY, V48, P209, DOI 10.1159/000058352; Glogau RG, 1997, DERMATOL CLIN, V15, P555, DOI 10.1016/S0733-8635(05)70465-4; Huebschmann AG, 2006, DIABETES CARE, V29, P1420, DOI 10.2337/dc05-2096; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kim WS, 2009, J DERMATOL SCI, V53, P96, DOI 10.1016/j.jdermsci.2008.08.007; Konno M, 2010, BIOCHEM BIOPH RES CO, V400, P461, DOI 10.1016/j.bbrc.2010.08.029; Kraus A, 2013, PLAST RECONSTR SURG, V132, p754E, DOI 10.1097/PRS.0b013e3182a48b46; Lee TJ, 2012, MICROVASC RES, V84, P1, DOI 10.1016/j.mvr.2012.04.004; Leslie SK, 2013, BIOMATERIALS, V34, P8172, DOI 10.1016/j.biomaterials.2013.07.017; Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Mojallal A, 2009, PLAST RECONSTR SURG, V124, P765, DOI 10.1097/PRS.0b013e3181b17b8f; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Nauta A, 2013, MOL THER, V21, P445, DOI 10.1038/mt.2012.234; Ramos GA, 2007, CELL TRANSPLANT, V16, P951, DOI 10.3727/096368907783338208; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Sell DR, 2000, FASEB J, V14, P145, DOI 10.1096/fasebj.14.1.145; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Shibuki H, 2002, INVEST OPHTH VIS SCI, V43, P528; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Suga H, 2014, ANN PLAS SURG, V72, P234, DOI 10.1097/SAP.0b013e318264fd6a; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	59	69	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97573	10.1371/journal.pone.0097573	http://dx.doi.org/10.1371/journal.pone.0097573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831697	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500080
J	Garcia, JE; Greentree, AD; Shrestha, M; Dorin, A; Dyer, AG				Garcia, Jair E.; Greentree, Andrew D.; Shrestha, Mani; Dorin, Alan; Dyer, Adrian G.			Flower Colours through the Lens: Quantitative Measurement with Visible and Ultraviolet Digital Photography	PLOS ONE			English	Article							SIGNALS; POLLINATORS; REFLECTANCE; VEGETATION; SELECTION; PATTERN; VISION	Background: The study of the signal-receiver relationship between flowering plants and pollinators requires a capacity to accurately map both the spectral and spatial components of a signal in relation to the perceptual abilities of potential pollinators. Spectrophotometers can typically recover high resolution spectral data, but the spatial component is difficult to record simultaneously. A technique allowing for an accurate measurement of the spatial component in addition to the spectral factor of the signal is highly desirable. Methodology/Principal findings: Consumer-level digital cameras potentially provide access to both colour and spatial information, but they are constrained by their non-linear response. We present a robust methodology for recovering linear values from two different camera models: one sensitive to ultraviolet (UV) radiation and another to visible wavelengths. We test responses by imaging eight different plant species varying in shape, size and in the amount of energy reflected across the UV and visible regions of the spectrum, and compare the recovery of spectral data to spectrophotometer measurements. There is often a good agreement of spectral data, although when the pattern on a flower surface is complex a spectrophotometer may underestimate the variability of the signal as would be viewed by an animal visual system. Conclusion: Digital imaging presents a significant new opportunity to reliably map flower colours to understand the complexity of these signals as perceived by potential pollinators. Compared to spectrophotometer measurements, digital images can better represent the spatio-chromatic signal variability that would likely be perceived by the visual system of an animal, and should expand the possibilities for data collection in complex, natural conditions. However, and in spite of its advantages, the accuracy of the spectral information recovered from camera responses is subject to variations in the uncertainty levels, with larger uncertainties associated with low radiance levels.	[Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Greentree, Andrew D.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Shrestha, Mani; Dorin, Alan] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Monash University	Garcia, JE (corresponding author), RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia.	jair.garcia@rmit.edu.au	Greentree, Andrew D/A-8503-2008; Shrestha, Mani/P-7045-2015	Greentree, Andrew D/0000-0002-3505-9163; Garcia, Jair/0000-0001-8456-4759; Shrestha, Mani/0000-0002-6165-8418; Dorin, Alan/0000-0002-5456-4835	Australian Research Council [DP0878968, DP130100015]	Australian Research Council(Australian Research Council)	AGD was supported by Australian Research Council DP0878968/DP130100015. AD was supported by Australian Research Council DP130100015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2005, TECHNICAL REPORT; Alsam A, 2007, J OPT SOC AM A, V24, P2505, DOI 10.1364/JOSAA.24.002505; AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Barnard K, 2002, COLOR RES APPL, V27, P152, DOI 10.1002/col.10050; Barth FG, 1985, INSECTS OWNERS BIOL; Bischoff M, 2013, NEW ZEAL J BOT, V51, P181, DOI 10.1080/0028825X.2013.806933; Chiao CC, 2009, J EXP BIOL, V212, P2269, DOI 10.1242/jeb.030734; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darwin CR, 1876, EFFECTS CROSS SELF F; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Dyer AG, 1996, J BIOMEDICAL IMAGING, V2, P6; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Endler JA, 2012, BIOL J LINN SOC, V107, P233, DOI 10.1111/j.1095-8312.2012.01937.x; Gao F, 2003, REMOTE SENS ENVIRON, V86, P198, DOI 10.1016/S0034-4257(03)00100-7; Garcia JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079534; Garcia JE, 2014, J FORENSIC SCI, V59, P117, DOI 10.1111/1556-4029.12274; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Holst GC., 2007, CMOS CCD SENSORS CAM; Indsto JO, 2000, MONOCOTS SYSTEMATICS, P326; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; KEVAN PG, 1979, AM J BOT, V66, P749, DOI 10.2307/2442421; Kevan PG, 2001, J EXP BIOL, V204, P2571; Knuth P., 1891, BOT CENTRALBL, V48, P160; Kuhn A., 1927, Z VERGL PHYSIOL, V5, P762, DOI DOI 10.1007/BF00302277; Lubbock SJ, 1881, J LINN SOC LOND ZOOL, V16, P110; Lutz FE, 1924, ANN NY ACAD SCI, V29, P233; Lythgoe J.N., 1979, ECOLOGY VISION; Martinez-Verdu F, 2002, J IMAGING SCI TECHN, V46, P15; Menzel R, 1990, COLOR VISION OWNER V; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Myers RD, 2010, TECHNICAL REPORT; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Ray S, 2011, MANUAL PHOTOGRAPHY, P43; Richtmyer FK, 1923, J OPT SOC AM REV SCI, V7, P151, DOI 10.1364/JOSA.7.000151; ROUJEAN JL, 1992, J GEOPHYS RES-ATMOS, V97, P20455, DOI 10.1029/92JD01411; Salvaggio N., 2009, BASIC PHOTOGRAPHIC M; Shrestha M, 2014, J ECOL, V102, P126, DOI 10.1111/1365-2745.12185; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Strutt JW, 1874, NATURE, V11, P6; Vignolini S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0394; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P93, DOI 10.1080/07929978.1997.10676676; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Waddington K.D., 1983, P213; Westland S, 2012, COLOR SCI USING MATL; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Williams S, 2007, J OPHTHALMIC PHOTOGR, V29, P10; Wyszecki G., 2000, COLOR SCI CONCEPTS M; Young MJ, 2011, J ANIM ECOL, V80, P183, DOI 10.1111/j.1365-2656.2010.01759.x	61	31	32	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96646	10.1371/journal.pone.0096646	http://dx.doi.org/10.1371/journal.pone.0096646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827828	Green Published, gold			2022-12-25	WOS:000336857400032
J	Weddell, JC; Imoukhuede, PI				Weddell, Jared C.; Imoukhuede, P. I.			Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling	PLOS ONE			English	Article								Cell population heterogeneity can affect cellular response and is a major factor in drug resistance. However, there are few techniques available to represent and explore how heterogeneity is linked to population response. Recent high-throughput genomic, proteomic, and cellomic approaches offer opportunities for profiling heterogeneity on several scales. We have recently examined heterogeneity in vascular endothelial growth factor receptor (VEGFR) membrane localization in endothelial cells. We and others processed the heterogeneous data through ensemble averaging and integrated the data into computational models of anti-angiogenic drug effects in breast cancer. Here we show that additional modeling insight can be gained when cellular heterogeneity is considered. We present comprehensive statistical and computational methods for analyzing cellomic data sets and integrating them into deterministic models. We present a novel method for optimizing the fit of statistical distributions to heterogeneous data sets to preserve important data and exclude outliers. We compare methods of representing heterogeneous data and show methodology can affect model predictions up to 3.9-fold. We find that VEGF levels, a target for tuning angiogenesis, are more sensitive to VEGFR1 cell surface levels than VEGFR2; updating VEGFR1 levels in the tumor model gave a 64% change in free VEGF levels in the blood compartment, whereas updating VEGFR2 levels gave a 17% change. Furthermore, we find that subpopulations of tumor cells and tumor endothelial cells (tEC) expressing high levels of VEGFR (>35,000 VEGFR/cell) negate anti-VEGF treatments. We show that lowering the VEGFR membrane insertion rate for these subpopulations recovers the anti-angiogenic effect of anti-VEGF treatment, revealing new treatment targets for specific tumor cell subpopulations. This novel method of characterizing heterogeneous distributions shows for the first time how different representations of the same data set lead to different predictions of drug efficacy.	[Weddell, Jared C.; Imoukhuede, P. I.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Weddell, JC (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	Jwedde3@illinois.edu	Imoukhuede, P I/T-7580-2017	Imoukhuede, P I/0000-0002-4257-1085	NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant	NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant(American Cancer Society)	This work was supported by: NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; [Anonymous], 2010, MOL SYST BIOL, V41, P369; [Anonymous], 2003, B CHIN ACAD SCI, V18, P9; [Anonymous], 2006, MIGRATION NEWS, V13, P9; Berthaut A, 2009, MOL VIS, V15, P1997; Bishop JE, 1997, BD BIOSCIENCES; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Booth PJ, 2004, J MOL BIOL, V344, P1109; Brinkman RR, 2009, ADV BIOINFORMAT, V2009; Chiu CS, 2002, J NEUROSCI, V22, P10251; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; DEBRABANDER HF, 1994, ANALYST, V119, P2581, DOI 10.1039/an9941902581; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eo Soo-Heang, 2012, BMC Res Notes, V5, P236, DOI 10.1186/1756-0500-5-236; Finley SD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00196; Finley SD, 2013, JNCI-J NATL CANCER I, V105, P802, DOI 10.1093/jnci/djt093; Finley SD, 2012, AAPS J, V14, P500, DOI 10.1208/s12248-012-9363-4; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; GABHANN F, 2010, MICROCIRCULATION, V17, P333; Ghosh D, 2009, BIOSTATISTICS, V10, P60, DOI 10.1093/biostatistics/kxn015; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; He B, 2013, IEEE T BIO-MED ENG, V60, P589, DOI 10.1109/TBME.2013.2244886; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Imoukhuede PI, 2013, AM J PHYSIOL-HEART C, V304, pH1085, DOI 10.1152/ajpheart.00514.2012; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Imoukhuede PI, 2014, CANCER MED-US, V3, P225, DOI 10.1002/cam4.188; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Le Meur N, 2013, CURR OPIN BIOTECH, V24, P105, DOI 10.1016/j.copbio.2012.09.003; Lee-Montiel FT, 2013, J MATER CHEM B, V1, P6434, DOI 10.1039/c3tb20904k; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Peel D, 2004, FINITE MIXTURE MODEL; Popel AS, 2013, PLOS ONE, V8; Popel AS, 2012, PLOS ONE, V7; POSNER I, 1992, J BIOL CHEM, V267, P20638; Quinn G, 2000, BIOCHEM BIOPH RES CO, V276, P1089, DOI 10.1006/bbrc.2000.3602; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; SATERBAK A, 1993, BIOPHYS J, V65, P243, DOI 10.1016/S0006-3495(93)81077-4; Sato T, 2014, J GASTROENTEROL, V49, P455, DOI 10.1007/s00535-013-0869-z; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Seely JF, 1997, AM STAT, V51, P55, DOI 10.2307/2684696; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tan WH, 2013, CELL SIGNAL, V25, P2496, DOI 10.1016/j.cellsig.2013.08.015; Trieglaff O, 2009, BIODATA MINING, V2; Tsentralfarband fun die bundistishe organisatsyonen in Amerika, 1905, KEMFER, V1, P1; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu FT, 2008, BMC SYST BIOL, V2; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200; Zhang LJ, 2001, CAN J FOREST RES, V31, P1654, DOI 10.1139/x01-086; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zimmerman N, 2009, ADV BIOINFORMAT, V2009	76	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97271	10.1371/journal.pone.0097271	http://dx.doi.org/10.1371/journal.pone.0097271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827582	gold, Green Submitted, Green Published			2022-12-25	WOS:000336857400070
J	Xu, H; Zhang, YM; Sun, H; Chen, SH; Wang, FM				Xu, Hong; Zhang, Yamin; Sun, Hua; Chen, Suhui; Wang, Fuming			Effects of Acupuncture at GV20 and ST36 on the Expression of Matrix Metalloproteinase 2, Aquaporin 4, and Aquaporin 9 in Rats Subjected to Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; ARTERY OCCLUSION; EDEMA; ELECTROACUPUNCTURE; DAMAGE; MODEL; MICE	Background/Purpose: Ischemic stroke is characterized by high morbidity and mortality worldwide. Matrix metalloproteinase 2 (MMP2), aquaporin (AQP) 4, and AQP9 are linked to permeabilization of the blood-brain barrier (BBB) in cerebral ischemia/reperfusion injury (CIRI). BBB disruption, tissue inflammation, and MMP/AQP upregulation jointly provoke brain edema/swelling after CIRI, while acupuncture and electroacupuncture can alleviate CIRI symptoms. This study evaluated the hypothesis that acupuncture and electroacupuncture can similarly exert neuroprotective actions in a rat model of middle cerebral artery occlusion (MCAO) by modulating MMP2/AQP4/APQ9 expression and inflammatory cell infiltration. Methods: Eighty 8-week-old Sprague-Dawley rats were randomly divided into sham group S, MCAO model group M, acupuncture group A, electroacupuncture group EA, and edaravone group ED. The MCAO model was established by placement of a suture to block the middle carotid artery, and reperfusion was triggered by suture removal in all groups except group S. Acupuncture and electroacupuncture were administered at acupoints GV20 (governing vessel-20) and ST36 (stomach-36). Rats in groups A, EA, and ED received acupuncture, electroacupuncture, or edaravone, respectively, immediately after MCAO. Neurological function (assessed using the Modified Neurological Severity Score), infarct volume, MMP2/AQP4/AQP9 mRNA and protein expression, and inflammatory cell infiltration were all evaluated at 24 h post-reperfusion. Results: Acupuncture and electroacupuncture significantly decreased infarct size and improved neurological function. Furthermore, target mRNA and protein levels and inflammatory cell infiltration were significantly reduced in groups A, EA, and ED vs. group M. However, MMP2/AQP levels and inflammatory cell infiltration were generally higher in groups A and EA than in group ED except MMP2 mRNA levels. Conclusions: Acupuncture and electroacupuncture at GV20 and ST36 both exercised neuroprotective actions in a rat model of MCAO, with no clear differences between groups A and EA. Therefore, acupuncture and electroacupuncture might find utility as adjunctive and complementary treatments to supplement conventional therapy for ischemic stroke.	[Xu, Hong; Zhang, Yamin; Sun, Hua; Chen, Suhui; Wang, Fuming] Chinese Acad Med Sci, PUMC, PUMCH, Dept Tradit Chinese Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Sun, H (corresponding author), Chinese Acad Med Sci, PUMC, PUMCH, Dept Tradit Chinese Med, Beijing 100730, Peoples R China.	sunhuahe@vip.sina.com			The National Natural Science Foundation of China [81273850]; Peking Union Medical College Hospital [2010150]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Hospital	This work was supported by: 1. The National Natural Science Foundation of China (No. 81273850) http://www.nsfc.gov.cn/.2. Peking Union Medical College Hospital (No. 2010150 http://www.pumch.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Beck K, 2012, CELL TISSUE RES, V347, P187, DOI 10.1007/s00441-011-1228-0; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Chen Shi-xin, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P784; Chen Su-Hui, 2012, Zhen Ci Yan Jiu, V37, P470; Feng Hao-rong, 2010, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V26, P12; Feng HR, 2010, ZHONGGUO YING YONG S, V26, P18; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Hwang IK, 2010, J VET MED SCI, V72, P279, DOI 10.1292/jvms.09-0374; Inoue I, 2009, ACUPUNCT MED, V27, P155, DOI 10.1136/aim.2009.000430; Isahaya K, 2012, J STROKE CEREBROVASC, V21, P102, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.009; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056736; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; Kurzepa J, 2013, INT J NEUROSCI; Lan L, 2013, INT J MOL MED, V31, P75, DOI 10.3892/ijmm.2012.1184; Lapergue B, 2013, STROKE, V44, P699, DOI 10.1161/STROKEAHA.112.667832; Lee JY, 2014, NEUROPHARMACOLOGY, V79, P161, DOI 10.1016/j.neuropharm.2013.11.011; Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028; Li Zhan-Biao, 2013, Zhen Ci Yan Jiu, V38, P106; Liu SY, 2009, AM J CHINESE MED, V37, P483, DOI 10.1142/S0192415X09006990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nagahiro Shinji, 1998, Journal of Medical Investigation, V45, P57; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Pandian JD, 2007, INT J STROKE, V2, P17, DOI 10.1111/j.1747-4949.2007.00089.x; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Shehadah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054083; Shen PF, 2012, AM J CHINESE MED, V40, P685, DOI 10.1142/S0192415X12500516; Tian GH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/482947; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wong V, 2013, COCHRANE DB SYST REV, V1, pD7968; Wu Y, 2012, J MOL NEUROSCI, V46, P483, DOI 10.1007/s12031-011-9620-5; Xu DY, 2008, PLANTA MED, V74, P816, DOI 10.1055/s-2008-1074557; [徐虹 Xu Hong], 2010, [基础医学与临床, Basic & Clinical Medicine], V30, P731; Xu Neng-gui, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P295; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yang Y, 2011, METHODS MOL BIOL, V762, P333, DOI 10.1007/978-1-61779-185-7_24; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zeng XW, 2012, BRAIN RES, V1437, P127, DOI 10.1016/j.brainres.2011.12.012	45	33	43	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97488	10.1371/journal.pone.0097488	http://dx.doi.org/10.1371/journal.pone.0097488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828425	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400100
J	Schultz, AL; Malcolm, HA; Bucher, DJ; Linklater, M; Smith, SDA				Schultz, Arthur L.; Malcolm, Hamish A.; Bucher, Daniel J.; Linklater, Michelle; Smith, Stephen D. A.			Depth and Medium-Scale Spatial Processes Influence Fish Assemblage Structure of Unconsolidated Habitats in a Subtropical Marine Park	PLOS ONE			English	Article							GREAT-BARRIER-REEF; UNDERWATER VIDEO STATIONS; DEMERSAL FISH; COMMUNITY STRUCTURE; CONTINENTAL-SHELF; TROPICAL FISH; ROCKY SHORES; EAST-COAST; SURF-ZONE; BIODIVERSITY	Where biological datasets are spatially limited, abiotic surrogates have been advocated to inform objective planning for Marine Protected Areas. However, this approach assumes close correlation between abiotic and biotic patterns. The Solitary Islands Marine Park, northern NSW, Australia, currently uses a habitat classification system (HCS) to assist with planning, but this is based only on data for reefs. We used Baited Remote Underwater Videos (BRUVs) to survey fish assemblages of unconsolidated substrata at different depths, distances from shore, and across an along-shore spatial scale of 10 s of km (2 transects) to examine how well the HCS works for this dominant habitat. We used multivariate regression modelling to examine the importance of these, and other environmental factors (backscatter intensity, fine-scale bathymetric variation and rugosity), in structuring fish assemblages. There were significant differences in fish assemblages across depths, distance from shore, and over the medium spatial scale of the study: together, these factors generated the optimum model in multivariate regression. However, marginal tests suggested that backscatter intensity, which itself is a surrogate for sediment type and hardness, might also influence fish assemblages and needs further investigation. Species richness was significantly different across all factors: however, total MaxN only differed significantly between locations. This study demonstrates that the pre-existing abiotic HCS only partially represents the range of fish assemblages of unconsolidated habitats in the region.	[Schultz, Arthur L.; Smith, Stephen D. A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Malcolm, Hamish A.] New South Wales Dept Primary Ind, Coffs Harbour, NSW, Australia; [Schultz, Arthur L.; Bucher, Daniel J.; Smith, Stephen D. A.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW, Australia; [Linklater, Michelle] Off Environm & Heritage, Div Sci, Coastal & Marine Unit, Woolongong, NSW, Australia	Southern Cross University; NSW Department of Primary Industries; Southern Cross University; Office of Environment & Heritage - New South Wales	Schultz, AL (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	a.schultz.22@student.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441; Bucher, Daniel/0000-0002-7640-4496; Linklater, Michelle/0000-0003-1995-6689	Southern Cross University	Southern Cross University	Funding was supplied by a postgraduate (PhD) research budget from Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; AYVAZIAN SG, 1995, MAR BIOL, V122, P527, DOI 10.1007/BF00350675; Beentjes MP, 2002, NEW ZEAL J MAR FRESH, V36, P197, DOI 10.1080/00288330.2002.9517080; Blamey LK, 2009, AQUAT CONSERV, V19, P645, DOI 10.1002/aqc.1014; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Connell SD, 1999, ESTUAR COAST SHELF S, V48, P483, DOI 10.1006/ecss.1998.0438; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Garcia CB, 1998, MAR ECOL PROG SER, V174, P13, DOI 10.3354/meps174013; Gladstone W, 2002, BIOL CONSERV, V104, P211, DOI 10.1016/S0006-3207(01)00167-7; Gladstone W, 2007, AQUAT CONSERV, V17, P71, DOI 10.1002/aqc.759; GRAY CA, 1994, AUST J MAR FRESH RES, V45, P665; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Harrison M, 2012, MAR BIODIVERS, V42, P203, DOI 10.1007/s12526-011-0105-0; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Hyndes GA, 1999, MAR BIOL, V134, P335, DOI 10.1007/s002270050551; Hyndes GA, 2005, ESTUAR COAST SHELF S, V63, P633, DOI 10.1016/j.ecss.2005.01.008; Jordan A., 2010, SEABED HABITAT MAPPI, P209; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Long BG, 1997, SEABED CURRENT STRES; Malcolm HA, 2012, OCEAN COAST MANAGE, V59, P1, DOI 10.1016/j.ocecoaman.2011.12.001; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; Malcolm HA, 2011, DEEP-SEA RES PT II, V58, P616, DOI 10.1016/j.dsr2.2010.09.030; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; Mau R, 1998, DISTRIBUTION SELECTE; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; NSW Marine Park Authority, 2010, SEAB HAB MAPP SOL IS; Owen V, 2010, 2010 M AUSTR MAR SCI; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Roberts CM, 2003, ECOL APPL, V13, pS215; ROBERTSON AI, 1984, J EXP MAR BIOL ECOL, V84, P265, DOI 10.1016/0022-0981(84)90185-0; Roff JC, 2002, AQUAT CONSERV, V12, P635, DOI 10.1002/aqc.513; Roughan M, 2002, CONT SHELF RES, V22, P2551, DOI 10.1016/S0278-4343(02)00101-2; Rule MJ, 2007, J EXP MAR BIOL ECOL, V345, P38, DOI 10.1016/j.jembe.2007.01.006; Schultz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049437; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Smith SDA, 2005, BIODIVERS CONSERV, V14, P3565, DOI 10.1007/s10531-004-0828-3; Smith SDA, 1996, AUST J ECOL, V21, P144, DOI 10.1111/j.1442-9993.1996.tb00595.x; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Snelgrove P, 1997, AMBIO, V26, P578; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Stevens T, 2002, COAST MANAGE, V30, P237, DOI 10.1080/08920750290042183; Travers MJ, 2010, J BIOGEOGR, V37, P148, DOI 10.1111/j.1365-2699.2009.02183.x; Travers MJ, 2012, MAR ECOL PROG SER, V446, P221, DOI 10.3354/meps09501; Ward TJ, 1999, ECOL APPL, V9, P691; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Wright D.J., 2005, ARCGIS BENTHIC TERRA; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x; Zann LP, 2000, MAR POLLUT BULL, V41, P188, DOI 10.1016/S0025-326X(00)00110-7	71	27	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96798	10.1371/journal.pone.0096798	http://dx.doi.org/10.1371/journal.pone.0096798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824998	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200032
J	Johansson, P; Jeffery, J; Al-Ejeh, F; Schulz, RB; Callen, DF; Kumar, R; Khanna, KK				Johansson, Pegah; Jeffery, Jessie; Al-Ejeh, Fares; Schulz, Renee B.; Callen, David F.; Kumar, Raman; Khanna, Kum Kum			SCF-FBXO31 E3 Ligase Targets DNA Replication Factor Cdt1 for Proteolysis in the G(2) Phase of Cell Cycle to Prevent Re-replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF UBIQUITIN LIGASE; LICENSING FACTOR CDT1; F-BOX PROTEINS; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; GEMININ BINDING; D1 DEGRADATION; S-PHASE; CANCER	FBXO31 was originally identified as a putative tumor suppressor gene in breast, ovarian, hepatocellular, and prostate cancers. By screening a set of cell cycle-regulated proteins as potential FBXO31 interaction partners, we have now identified Cdt1 as a novel substrate. Cdt1 DNA replication licensing factor is part of the pre-replication complex and essential for the maintenance of genomic integrity. We show that FBXO31 specifically interacts with Cdt1 and regulates its abundance by ubiquitylation leading to subsequent degradation. We also show that Cdt1 regulation by FBXO31 is limited to the G(2) phase of the cell cycle and is independent of the pathways previously described for Cdt1 proteolysis in S and G(2) phase. FBXO31 targeting of Cdt1 is mediated through the N terminus of Cdt1, a region previously shown to be responsible for its cell cycle regulation. Finally, we show that Cdt1 stabilization due to FBXO31 depletion results in re-replication. Our data present an additional pathway that contributes to the FBXO31 function as a tumor suppressor.	[Johansson, Pegah] Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden; [Schulz, Renee B.; Callen, David F.] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA 5000, Australia; [Schulz, Renee B.; Callen, David F.] Univ Adelaide, Discipline Med, Adelaide, SA 5000, Australia; [Kumar, Raman] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia; [Kumar, Raman] Univ Adelaide, Discipline Med, Adelaide, SA 5006, Australia; [Kumar, Raman] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Jeffery, Jessie; Al-Ejeh, Fares; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld 4006, Australia	Sahlgrenska University Hospital; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; QIMR Berghofer Medical Research Institute	Kumar, R (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia.	raman.sharma@adelaide.edu.au; KumKum.Khanna@qimrberghofer.edu.au	Kumar, Raman/AHE-0538-2022; Al-Ejeh, Fares/M-7032-2016	Kumar, Raman/0000-0001-7976-8386; Al-Ejeh, Fares/0000-0002-1553-0077; Callen, David/0000-0002-6189-9991; Khanna, Kum Kum/0000-0001-8650-5381	Cancer Council of South Australia; Swedish Research Council; National Breast Cancer Foundation; Cancer Council Queensland, Australia	Cancer Council of South Australia(Cancer Council South Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Breast Cancer Foundation; Cancer Council Queensland, Australia(Cancer Council Queensland)	This work was supported by the Cancer Council of South Australia, the Swedish Research Council, the National Breast Cancer Foundation, and the Cancer Council Queensland, Australia.	Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Harkonen P, 2005, PROSTATE, V62, P267, DOI 10.1002/pros.20147; Huang HL, 2010, ONCOL REP, V24, P715, DOI 10.3892/or_00000912; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Klotz-Noack K, 2012, J CELL SCI, V125, P2436, DOI 10.1242/jcs.100883; Kogo R, 2011, INT J ONCOL, V39, P155, DOI 10.3892/ijo.2011.1018; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launonen V, 2000, CANCER GENET CYTOGEN, V122, P49, DOI 10.1016/S0165-4608(00)00279-X; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin YW, 2001, INT J CANCER, V93, P74, DOI 10.1002/ijc.1287; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Schwartz AL, 1999, ANNU REV MED, V50, P57; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	46	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18514	18525		10.1074/jbc.M114.559930	http://dx.doi.org/10.1074/jbc.M114.559930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828503	Green Published, hybrid			2022-12-25	WOS:000338042000048
J	Amaral, ACKB; Holder, MW				Amaral, Andre C. K. B.; Holder, Michael W.			Timing of Antimicrobial Therapy after Identification of Ventilator-Associated Condition Is Not Associated with Mortality in Patients with Ventilator-Associated Pneumonia: A Cohort Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; SURVEILLANCE DEFINITIONS; ANTIBIOTIC-TREATMENT; IMPACT; APPROPRIATENESS; MANAGEMENT; INITIATION; INFECTION; EVENTS	Purpose: Delays in antimicrobial therapy increase mortality in ventilator-associated pneumonia (VAP). The more objective ventilator-associated complications (VAC) are increasingly used for quality reporting. It is unknown if delays in antimicrobial administration, after patients meet VAC criteria, leads to worse outcomes. Materials and Methods: Cohort of 81 episodes of antimicrobial treatment for VAP. We compared mortality, superinfections and treatment failures conditional on the timing of identification of VAC. Results: 60% of patients with VAC had an identifiable episode at least 48 before the initiation of antimicrobials. Antimicrobial administration after the identification of VAC was not associated with intensive care unit (ICU) mortality (OR 0.71, 95% CI 0.11-4.48, p = 0.701) compared to immediate antimicrobial administration. Similarly, the risk of treatment failure or superinfection was not affected by the timing of administration of antimicrobials in VAC (HR 0.95, 95% CI 0.42-2.19, p = 0.914). Conclusions: We observed no signal of harm associated with the timing to initiate antimicrobials after the identification of a VAC. The identification of VAC should not lead clinicians to start antimicrobials before a diagnosis of VAP can be established.	[Amaral, Andre C. K. B.; Holder, Michael W.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Amaral, Andre C. K. B.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Holder, Michael W.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Aberdeen	Amaral, ACKB (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	andrecarlos.amaral@sunnybrook.ca		Holder, Michael/0000-0001-9828-9153				AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Baker A. M., 2003, Journal of Bronchology, V10, P7, DOI 10.1097/00128594-200301000-00003; Bekaert M, 2011, AM J RESP CRIT CARE; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2013, CURR OPIN CRIT CARE, V19, P424, DOI 10.1097/MCC.0b013e3283636bc9; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003; Kollef MH, 1998, CHEST, V113, P412, DOI 10.1378/chest.113.2.412; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; Luna CM, 2006, EUR RESPIR J, V27, P158, DOI 10.1183/09031936.06.00049105; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Magill SS, 2012, CLIN INFECT DIS, V54, P378, DOI 10.1093/cid/cir833; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Mueller EW, 2005, J TRAUMA, V58, P94, DOI 10.1097/01.TA.0000141890.29032.9A; Muller MP, 2010, JAMA-J AM MED ASSOC, V304, P1116, DOI 10.1001/jama.2010.1301; Muscedere J, 2008, J CRIT CARE, V23, P126, DOI 10.1016/j.jcrc.2007.11.014; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; Stevens J P, 2013, CRIT CARE MED; TORRES A, 1990, AM REV RESPIR DIS, V142, P523, DOI 10.1164/ajrccm/142.3.523; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84	33	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97575	10.1371/journal.pone.0097575	http://dx.doi.org/10.1371/journal.pone.0097575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840503	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600047
J	Zhi, JJ; Jing, CW; Lin, SP; Zhang, C; Liu, QK; DeGloria, SD; Wu, JP				Zhi, Junjun; Jing, Changwei; Lin, Shengpan; Zhang, Cao; Liu, Qiankun; DeGloria, Stephen D.; Wu, Jiaping			Estimating Soil Organic Carbon Stocks and Spatial Patterns with Statistical and GIS-Based Methods	PLOS ONE			English	Article							PADDY SOILS; LAND-USE; STORAGE; MANAGEMENT; NITROGEN; DATABASE; CHINA	Accurately quantifying soil organic carbon (SOC) is considered fundamental to studying soil quality, modeling the global carbon cycle, and assessing global climate change. This study evaluated the uncertainties caused by up- scaling of soil properties from the county scale to the provincial scale and from lower- level classification of Soil Species to Soil Group, using four methods: the mean, median, Soil Profile Statistics (SPS), and pedological professional knowledge based (PKB) methods. For the SPS method, SOC stock is calculated at the county scale by multiplying the mean SOC density value of each soil type in a county by its corresponding area. For the mean or median method, SOC density value of each soil type is calculated using provincial arithmetic mean or median. For the PKB method, SOC density value of each soil type is calculated at the county scale considering soil parent materials and spatial locations of all soil profiles. A newly constructed 1:50,000 soil survey geographic database of Zhejiang Province, China, was used for evaluation. Results indicated that with soil classification levels up- scaling from Soil Species to Soil Group, the variation of estimated SOC stocks among different soil classification levels was obviously lower than that among different methods. The difference in the estimated SOC stocks among the four methods was lowest at the Soil Species level. The differences in SOC stocks among the mean, median, and PKB methods for different Soil Groups resulted from the differences in the procedure of aggregating soil profile properties to represent the attributes of one soil type. Compared with the other three estimation methods (i.e., the SPS, mean and median methods), the PKB method holds significant promise for characterizing spatial differences in SOC distribution because spatial locations of all soil profiles are considered during the aggregation procedure.	[Zhi, Junjun; Lin, Shengpan; Zhang, Cao; Liu, Qiankun] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jing, Changwei; Wu, Jiaping] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China; [DeGloria, Stephen D.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	Zhejiang University; Zhejiang University; Cornell University	Wu, JP (corresponding author), Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China.	jw67@zju.edu.cn	Zhi, Junjun/GVU-3721-2022; DeGloria, Stephen D/B-8513-2015; Wu, Jiaping/AAD-8800-2022; Zhi, Junjun/GVU-3746-2022	DeGloria, Stephen D/0000-0002-3343-6607; Lin, Shengpan/0000-0002-7458-7559	National Natural Science Foundation of China [30771253]; Key Project of the Science and Technology Department of Zhejiang Province [2006C22026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Science and Technology Department of Zhejiang Province	This study was supported by the National Natural Science Foundation of China (No. 30771253) and the Key Project of the Science and Technology Department of Zhejiang Province (No. 2006C22026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Fuentes J, 2014, PLANT SOIL, V376, P31, DOI 10.1007/s11104-012-1167-x; Arnold R. W., 1995, SOILS GLOBAL CHANGE, P257; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Batjes NH, 2000, GEODERMA, V97, P135, DOI 10.1016/S0016-7061(00)00031-8; Batjes NH, 2006, GEODERMA, V132, P361, DOI 10.1016/j.geoderma.2005.05.013; BOHN HL, 1976, SOIL SCI SOC AM J, V40, P468, DOI 10.2136/sssaj1976.03615995004000030045x; BOLIN B, 1977, SCIENCE, V196, P613, DOI 10.1126/science.196.4290.613; Cole C.V., 1998, POTENTIAL US CROPLAN; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Fang JY, 1996, STUDY KEY ISSUES MOD, P251; Homann PS, 1998, SOIL SCI SOC AM J, V62, P789, DOI 10.2136/sssaj1998.03615995006200030036x; Janzen HH, 2004, AGR ECOSYST ENVIRON, V104, P399, DOI 10.1016/j.agee.2004.01.040; Jin Feng, 2001, Acta Pedologica Sinica, V38, P522; Leifeld J, 2005, AGR ECOSYST ENVIRON, V105, P255, DOI 10.1016/j.agee.2004.03.006; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Liebens J, 2003, SOIL USE MANAGE, V19, P364, DOI 10.1079/SUM2003215; Liu QH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002731; Morisada K, 2004, GEODERMA, V119, P21, DOI 10.1016/S0016-7061(03)00220-9; *NAT SOIL SURV OFF, 1993, SOIL SPEC CHIN, V1; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Pan GX., 1999, B SCI TECHNOL, V15, P330, DOI DOI 10.13774/J.CNKI.KJTB.1999.05.002; Rapalee G, 1998, GLOBAL BIOGEOCHEM CY, V12, P687, DOI 10.1029/98GB02336; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Shi X.Z., 2004, SOIL SURVEY HORIZONS, V45, P111; SUN WX, 2003, SOILS, V35, P236; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Uri ND, 2000, SCI TOTAL ENVIRON, V256, P23, DOI 10.1016/S0048-9697(00)00462-9; Wang S., 1999, GEOGRAPHICAL RES, V18, P349, DOI [10.11821/yj1999040003, DOI 10.3321/J.ISSN:1000-0585.1999.04.003]; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wu J, 2001, SOIL SCI SOC AM J, V65, P169, DOI 10.2136/sssaj2001.651169x; Wu JiaPing, 2013, Acta Pedologica Sinica, V50, P30; Xu SX, 2013, CATENA, V104, P67, DOI 10.1016/j.catena.2012.10.017; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Yu Lian-jun, 2008, Yingyong Shengtai Xuebao, V19, P1058; Zhang Y, 2008, GEODERMA, V146, P449, DOI 10.1016/j.geoderma.2008.06.015; Zhao YC, 2005, PEDOSPHERE, V15, P293; Zhao YC, 2006, SOIL SCI SOC AM J, V70, P1377, DOI 10.2136/sssaj2004.0165; Zhejiang Soil Survey Office, 1994, SOILS ZHEJ PROV; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042927	40	10	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97757	10.1371/journal.pone.0097757	http://dx.doi.org/10.1371/journal.pone.0097757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840890	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600070
J	Tann, CJ; Nkurunziza, P; Nakakeeto, M; Oweka, J; Kurinczuk, JJ; Were, J; Nyombi, N; Hughes, P; Willey, BA; Elliott, AM; Robertson, NJ; Klein, N; Harris, KA				Tann, Cally J.; Nkurunziza, Peter; Nakakeeto, Margaret; Oweka, James; Kurinczuk, Jennifer J.; Were, Jackson; Nyombi, Natasha; Hughes, Peter; Willey, Barbara A.; Elliott, Alison M.; Robertson, Nicola J.; Klein, Nigel; Harris, Kathryn A.			Prevalence of Bloodstream Pathogens Is Higher in Neonatal Encephalopathy Cases vs. Controls Using a Novel Panel of Real-Time PCR Assays	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; BRAIN; INJURY	Background: In neonatal encephalopathy (NE), infectious co-morbidity is difficult to diagnose accurately, but may increase the vulnerability of the developing brain to hypoxia-ischemia. We developed a novel panel of species-specific real-time PCR assays to identify bloodstream pathogens amongst newborns with and without NE in Uganda. Methodology: Multiplex real-time PCR assays for important neonatal bloodstream pathogens (gram positive and gram negative bacteria, cytomegalovirus (CMV), herpes simplex virus(HSV) and P. falciparum) were performed on whole blood taken from 202 encephalopathic and 101 control infants. Automated blood culture (BACTEC) was performed for all cases and unwell controls. Principal Findings: Prevalence of pathogenic bacterial species amongst infants with NE was 3.6%, 6.9% and 8.9%, with culture, PCR and both tests in combination, respectively. More encephalopathic infants than controls had pathogenic bacterial species detected (8.9%vs2.0%, p = 0.028) using culture and PCR in combination. PCR detected bacteremia in 11 culture negative encephalopathic infants (3 Group B Streptococcus, 1 Group A Streptococcus, 1 Staphylococcus aureus and 6 Enterobacteriacae). Coagulase negative staphylococcus, frequently detected by PCR amongst case and control infants, was considered a contaminant. Prevalence of CMV, HSV and malaria amongst cases was low (1.5%, 0.5% and 0.5%, respectively). Conclusion/Significance: This real-time PCR panel detected more bacteremia than culture alone and provides a novel tool for detection of neonatal bloodstream pathogens that may be applied across a range of clinical situations and settings. Significantly more encephalopathic infants than controls had pathogenic bacterial species detected suggesting that infection may be an important risk factor for NE in this setting.	[Tann, Cally J.; Willey, Barbara A.; Elliott, Alison M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Nkurunziza, Peter; Oweka, James; Were, Jackson; Elliott, Alison M.] MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda; [Hughes, Peter; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Klein, Nigel; Harris, Kathryn A.] UCL, Inst Child Hlth, London, England; [Tann, Cally J.; Nakakeeto, Margaret; Nyombi, Natasha] Mulago Univ Hosp, Kampala, Uganda; [Kurinczuk, Jennifer J.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Klein, Nigel; Harris, Kathryn A.] Great Ormond St Hosp Sick Children, Dept Microbiol Virol & Infect Control, London WC1N 3JH, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; Mulago National Referral Hospital; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tann, CJ (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.	cally.tann@lshtm.ac.uk	Tann, Cally/ABE-3184-2020; Robertson, Nicola/GWR-2021-2022	Tann, Cally/0000-0003-0131-4952; Elliott, Alison/0000-0003-2818-9549; Harris, Kathryn/0000-0003-3807-9749; Klein, Nigel/0000-0003-3925-9258	Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme [094016/Z/10/Z]	Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme	This work was supported by the Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme [grant 094016/Z/10/Z to CT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Eklind S, 2005, PEDIATR RES, V58, P112, DOI 10.1203/01.PDR.0000163513.03619.8D; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Harris KA, 2008, J CLIN MICROBIOL, V46, P2751, DOI 10.1128/JCM.02462-07; Mallard C, 2003, NEUROCHEM RES, V28, P215, DOI 10.1023/A:1022368915400; Mallard C, 2012, ISRN NEUROLOGY, V2012, P19; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; McAdams RM, 2012, ROLE CYTOKINES INFLA; Pammi M, 2011, PEDIATRICS, V128, pE973, DOI 10.1542/peds.2011-1208; Peebles D. M., 2007, INTRAUTERINE INFECT; Stridh L, 2013, J NEUROSCI, V33, P12041, DOI 10.1523/JNEUROSCI.0673-13.2013; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492	15	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97259	10.1371/journal.pone.0097259	http://dx.doi.org/10.1371/journal.pone.0097259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836781	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800034
J	Ball, CB; Rodriguez, KF; Stumpo, DJ; Ribeiro-Neto, F; Korach, KS; Blackshear, PJ; Birnbaumer, L; Ramos, SBV				Ball, Christopher B.; Rodriguez, Karina F.; Stumpo, Deborah J.; Ribeiro-Neto, Fernando; Korach, Kenneth S.; Blackshear, Perry J.; Birnbaumer, Lutz; Ramos, Silvia B. V.			The RNA-Binding Protein, ZFP36L2, Influences Ovulation and Oocyte Maturation	PLOS ONE			English	Article							LUTEINIZING-HORMONE RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; EARLY EMBRYONIC-DEVELOPMENT; MESSENGER-RIBONUCLEIC-ACID; OVARIAN FOLLICULAR-FLUID; TO-CELL COMMUNICATION; MEIOTIC ARREST; CYCLIC-AMP; IN-VITRO; GRAAFIAN-FOLLICLES	ZFP36L2 protein destabilizes AU-rich element-containing transcripts and has been implicated in female fertility. In the C57BL/6NTac mouse, a mutation in Zfp36l2 that results in the decreased expression of a form of ZFP36L2 in which the 29 N-terminal amino acid residues have been deleted, Delta N-ZFP36L2, leads to fertilized eggs that arrest at the two-cell stage. Interestingly, homozygous Delta N-Zfp36l2 females in the C57BL/6NTac strain release 40% fewer eggs than the WT littermates (Ramos et al., 2004), suggesting an additional defect in ovulation and/or oocyte maturation. Curiously, the same Delta N-Zfp36l2 mutation into the SV129 strain resulted in anovulation, prompting us to investigate a potential problem in ovulation and oocyte maturation. Remarkably, only 20% of Delta N-Zfp36l2 oocytes in the 129S6/SvEvTac strain matured ex vivo, suggesting a defect on the oocyte meiotic maturation process. Treatment of Delta N-Zfp36l2 oocytes with a PKA inhibitor partially rescued the meiotic arrested oocytes. Furthermore, cAMP levels were increased in Delta N-Zfp36l2 oocytes, linking the cAMP/PKA pathway and Delta N-Zfp36l2 with meiotic arrest. Since ovulation and oocyte maturation are both triggered by LHR signaling, the downstream pathway was investigated. Adenylyl cyclase activity was increased in Delta N-Zfp36l2 ovaries only upon LH stimulation. Moreover, we discovered that ZFP36L2 interacts with the 3'UTR of LHR mRNA and that decreased expression levels of Zfp36l2 correlates with higher levels of LHR mRNA in synchronized ovaries. Furthermore, overexpression of ZFP36L2 decreases the endogenous expression of LHR mRNA in a cell line. Therefore, we propose that lack of the physiological down regulation of LHR mRNA levels by ZFP36L2 in the ovaries is associated with anovulation and oocyte meiotic arrest.	[Ball, Christopher B.; Ramos, Silvia B. V.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27515 USA; [Rodriguez, Karina F.; Korach, Kenneth S.] NIEHS, Lab Reprod & Dev Toxicol, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Stumpo, Deborah J.; Ribeiro-Neto, Fernando; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Ramos, SBV (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27515 USA.	sramos@med.unc.edu	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529; Korach, Kenneth/0000-0002-7765-418X	National Institutes of Health [K08 HD069597]; Institute for Biological Recognition and Catalysis, Inc.; UNC TraCS [550KR11128]; NIH, NIEHS [Z01-ES70065, Z01-ES090080-15, Z01-ES101643]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, ZIAES101643, Z01ES090080, Z01ES070065, ZIAES070065, Z01ES101643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biological Recognition and Catalysis, Inc.; UNC TraCS; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grant K08 HD069597 (to S. B. R.); Institute for Biological Recognition and Catalysis, Inc. (to S. B. R.), UNC TraCS grant # 550KR11128 (to S. B. R.) and by the Intramural Research Program of the NIH, NIEHS Z01-ES70065 (to K. S. K.), Z01-ES090080-15 (to P.J.B.) and Z01-ES101643 (to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM A, 1975, J CELL BIOL, V67, P894, DOI 10.1083/jcb.67.3.894; BOCKAERT J, 1976, J BIOL CHEM, V251, P2653; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; CHO WK, 1974, J EXP ZOOL, V187, P383, DOI 10.1002/jez.1401870307; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; DEKEL N, 1978, P NATL ACAD SCI USA, V75, P4369, DOI 10.1073/pnas.75.9.4369; DOWNS SM, 1984, ENDOCRINOLOGY, V114, P418, DOI 10.1210/endo-114-2-418; Edry I, 2006, MOL CELL ENDOCRINOL, V252, P102, DOI 10.1016/j.mce.2006.03.009; EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77; EPPIG JJ, 1985, BIOL REPROD, V33, P1041, DOI 10.1095/biolreprod33.5.1041; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; GRANOT I, 1994, J BIOL CHEM, V269, P30502; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; HOFFMAN YM, 1991, ENDOCRINOLOGY, V128, P388, DOI 10.1210/endo-128-1-388; HSUEH AJW, 1984, ENDOCR REV, V5, P76, DOI 10.1210/edrv-5-1-76; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAPOLT PS, 1990, ENDOCRINOLOGY, V126, P3277, DOI 10.1210/endo-126-6-3277; Maclean KN, 1998, BRIT J BIOMED SCI, V55, P184; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; Menon KMJ, 2007, MOL CELL ENDOCRINOL, V260, P109, DOI 10.1016/j.mce.2006.03.046; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nair AK, 2002, J BIOL CHEM, V277, P21468, DOI 10.1074/jbc.M111653200; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; OLSIEWSKI PJ, 1983, DEV BIOL, V100, P287, DOI 10.1016/0012-1606(83)90223-3; Pakarainen T, 2005, MOL ENDOCRINOL, V19, P2591, DOI 10.1210/me.2005-0075; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS228; Puett D, 2005, ANN NY ACAD SCI, V1061, P41, DOI 10.1196/annals.1336.006; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Ramos SBV, 2012, J BIOL CHEM, V287, P13116, DOI 10.1074/jbc.M111.330837; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rodriguez KF, 2002, REPRODUCTION, V123, P799, DOI 10.1530/reprod/123.6.799; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHROEDER AC, 1989, GAMETE RES, V24, P81, DOI 10.1002/mrd.1120240111; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Treguer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054550; TSAFRIRI A, 1976, ENDOCRINOLOGY, V98, P655, DOI 10.1210/endo-98-3-655; URNER F, 1983, ENDOCRINOLOGY, V113, P1170, DOI 10.1210/endo-113-3-1170; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zegers-Hochschild F, 2008, INFERTILITY INT ENCY, P576; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215	48	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97324	10.1371/journal.pone.0097324	http://dx.doi.org/10.1371/journal.pone.0097324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830504	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500049
J	Chen, JH; Chen, YC; Mao, CL; Chiou, JM; Tsao, CK; Tsai, KS				Chen, Jen-Hau; Chen, Yen-Ching; Mao, Chien-Lin; Chiou, Jeng-Min; Tsao, Chwen Keng; Tsai, Keh-Sung			Association between Secreted Phosphoprotein-1 (SPP1) Polymorphisms and Low Bone Mineral Density in Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNRELATED INDIVIDUALS; SEQUENCE VARIANTS; CELL-SURVIVAL; HIP FRACTURE; IN-VITRO; OSTEOPONTIN; OSTEOPOROSIS; RISK; MASS	Background: A recent meta-analysis found that secreted phosphoprotein-1 (SPP1) can predict the risk of both osteoporosis and fracture. No study has explored the association of SPP1 haplotype-tagging single nucleotide polymorphisms (htSNPs) and haplotypes with bone mineral density (BMD). Methods: This is a cross-sectional study. A total of 1,313 healthy Taiwanese women aged 40 to 55 years were recruited from MJ Health Management Institute from 2009 to 2010. BMD was dichotomized into high and low BMD groups. Three common (allele frequency >= 5%) htSNPs were selected to examine the association between sequence variants of SPP1 and BMD. Results: Homozygosity for the T allele of rs4754 were protective from low BMD [TT vs. CC: adjusted OR (AOR) = 0.58, 95% confidence interval (CI) = 0.83-0.89]. A protective effect was also found for women carrying 2 copies of Hap3 TCT (AOR = 0.57, 95% CI = 0.34-0.95). Menopausal status marginally interacted with SPP1 rs6839524 on BMD (p = 0.049). Postmenopausal women carrying variant rs6839524 (GG+GC vs. CC: AOR = 2.35, 95% CI = 1.06-5.20) or Hap1 TGC (AOR = 2.36, 95% CI = 1.06-5.24) were associated with 2.4-fold risk of low BMD. For women with low BMI (<18.5 kg/m(2)), variant rs6839524 (AOR = 7.64) and Hap1 (AOR = 6.42) were associated with increased risk of low BMD. These findings did not reach statistical significance after correction for multiple tests. Conclusions: SPP1 htSNP protected against low BMD in middle-aged women. SPP1 genetic markers may be important for the prediction of osteoporosis at an early age.	[Chen, Jen-Hau; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chen, Jen-Hau; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Jen-Hau; Chen, Yen-Ching; Mao, Chien-Lin] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiou, Jeng-Min] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Tsai, KS (corresponding author), Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan.	kstsaimd1128@ntuh.gov.tw	Chen, Jen-Hau/AFP-2878-2022; Chiou, Jeng-Min/AAQ-3736-2021; Chen, Yen-Ching/D-1098-2010	Chen, Yen-Ching/0000-0002-8159-7202; TSAI, KEH-SUNG/0000-0001-8528-1566; Chiou, Jeng-Min/0000-0003-4554-9454	National Science Council [98-2314-B-002-081, 99-2314-B-002-128, 101-2118-M-001-011-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 98-2314-B-002-081, 99-2314-B-002-128, and 101-2118-M-001-011-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NAT GENET, V29, P353; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidoli E, 1998, EUR J EPIDEMIOL, V14, P153, DOI 10.1023/A:1007496126098; Castro Jonathan P, 2005, Nutr Metab (Lond), V2, P9, DOI 10.1186/1743-7075-2-9; Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Dawson-Hughes B, 2011, OSTEOPOROS INT; Denhardt D, 1993, FASEB J; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Feng Y, 2005, OSTEOPOROSIS INT, V16, P1917, DOI 10.1007/s00198-005-1962-9; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Kanis JA, 2000, BONE, V27, P585, DOI 10.1016/S8756-3282(00)00381-1; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Moore M, 1991, BIOCHEMISTRY; Morin S, 2009, OSTEOPOROSIS INT, V20, P363, DOI 10.1007/s00198-008-0688-x; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Nock NL, 2011, INT J CANCER, V129, P956, DOI 10.1002/ijc.25722; O'Regan AW, 1999, J IMMUNOL, V162, P1024; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Saarelainen J, 2011, J BONE MINER METAB; Sanchez-Riera L, 2010, BEST PRACT RES CL RH, V24, P793, DOI 10.1016/j.berh.2010.10.003; SATOH Y, 1995, CALCIFIED TISSUE INT, V57, P258, DOI 10.1007/BF00298880; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Standal T, 2004, EXP ONCOL, V26, P179; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; SUGIMOTO T, 1992, J BONE MINER RES, V7, P153; Taylor BC, 2005, HUM GENET, V116, P525, DOI 10.1007/s00439-005-1258-3; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; You YS, 2013, J BONE MINERAL RES; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97428	10.1371/journal.pone.0097428	http://dx.doi.org/10.1371/journal.pone.0097428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831687	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500058
J	Menezes, K; Nascimento, MA; Goncalves, JP; Cruz, AS; Lopes, DV; Curzio, B; Bonamino, M; de Menezes, JRL; Borojevic, R; Rossi, MID; Coelho-Sampaio, T				Menezes, Karla; Nascimento, Marcos Assis; Goncalves, Juliana Pena; Cruz, Aline Silva; Lopes, Daiana Vieira; Curzio, Bianca; Bonamino, Martin; Lacerda de Menezes, Joao Ricardo; Borojevic, Radovan; Doria Rossi, Maria Isabel; Coelho-Sampaio, Tatiana			Human Mesenchymal Cells from Adipose Tissue Deposit Laminin and Promote Regeneration of Injured Spinal Cord in Rats	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; FUNCTIONAL RECOVERY; STROMAL CELLS; TRANSPLANTATION; PRECURSOR; BRAIN; GENE; COMBINATION; ACTIVATION	Cell therapy is a promising strategy to pursue the unmet need for treatment of spinal cord injury (SCI). Although several studies have shown that adult mesenchymal cells contribute to improve the outcomes of SCI, a descripton of the pro-regenerative events triggered by these cells is still lacking. Here we investigated the regenerative properties of human adipose tissue derived stromal cells (hADSCs) in a rat model of spinal cord compression. Cells were delivered directly into the spinal parenchyma immediately after injury. Human ADSCs promoted functional recovery, tissue preservation, and axonal regeneration. Analysis of the cord tissue showed an abundant deposition of laminin of human origin at the lesion site and spinal midline; the appearance of cell clusters composed of neural precursors in the areas of laminin deposition, and the appearance of blood vessels with separated basement membranes along the spinal axis. These effects were also observed after injection of hADSCs into non-injured spinal cord. Considering that laminin is a well-known inducer of axonal growth, as well a component of the extracellular matrix associated to neural progenitors, we propose that it can be the paracrine factor mediating the pro-regenerative effects of hADSCs in spinal cord injury.	[Menezes, Karla; Cruz, Aline Silva; Lopes, Daiana Vieira; Lacerda de Menezes, Joao Ricardo; Doria Rossi, Maria Isabel; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Nascimento, Marcos Assis; Goncalves, Juliana Pena] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Curzio, Bianca; Bonamino, Martin] Natl Canc Inst, Rio De Janeiro, Brazil; [Borojevic, Radovan] Excellion, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Rossi, Maria Isabel D/J-4802-2012; Borojevic, Radovan/V-8500-2019; Menezes, João R. L./D-5668-2012	Rossi, Maria Isabel D/0000-0003-3432-8453; Borojevic, Radovan/0000-0002-2393-7280; Assis Nascimento, Marcos/0000-0002-9830-9801; Vieira Lopes Alves, Daiana/0000-0002-1936-1952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ). KM and JPG are recipients of fellowships from CNPq, and MAN and DVL received fellowships from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) and FAPERJ, respectively. ASC received an undergraduate fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; Baptista L. S., 2007, J STEM CELLS, P73; Baptista LS, 2009, OBES SURG, V19, P1304, DOI 10.1007/s11695-009-9899-2; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bonamino M, 2004, GENE THER, V11, P85, DOI 10.1038/sj.gt.3302141; Bradbury EJ, 2002, EXP NEUROL, V235, P1; Burns AS, 2012, J SPINAL CORD MED, V35, P3, DOI 10.1179/2045772311Y.0000000043; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Carlson KB, 2011, GLIA, V59, P267, DOI 10.1002/glia.21099; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Chen X, 2003, INVEST OPHTH VIS SCI, V44, P2834, DOI 10.1167/iovs.02-1333; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Fuhrmann T, 2010, NEUROSCI LETT, V474, P37, DOI 10.1016/j.neulet.2010.03.002; Fukada S, 2008, EXP CELL RES, V314, P193, DOI 10.1016/j.yexcr.2007.09.020; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Ideguchi M, 2010, J NEUROSCI, V30, P894, DOI 10.1523/JNEUROSCI.4318-09.2010; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lebkowski Jane, 2011, Regen Med, V6, P11, DOI 10.2217/rme.11.77; Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; McDonald JW, 2002, PROG BRAIN RES, V137, P299; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Mercier F, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P109, DOI 10.1007/978-4-431-53933-9_4; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Pal R, 2010, CYTOTHERAPY, V12, P792, DOI 10.3109/14653249.2010.487899; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Pedram MS, 2010, SPINAL CORD, V48, P457, DOI 10.1038/sc.2009.153; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Siler U, 2000, BLOOD, V96, P4194; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Wyatt TJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/207230; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f	68	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96020	10.1371/journal.pone.0096020	http://dx.doi.org/10.1371/journal.pone.0096020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830794	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500013
J	Smith, MW; Ghindilis, AL; Seoudi, IA; Smith, K; Billharz, R; Simon, HM				Smith, Maria W.; Ghindilis, Andrei L.; Seoudi, Ihab A.; Smith, Kenneth; Billharz, Rosalind; Simon, Holly M.			A New Restriction Endonuclease-Based Method for Highly-Specific Detection of DNA Targets from Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							TIME PCR ASSAY; UNITED-STATES; ELECTROCHEMICAL DETECTION; RAPID DETECTION; MRSA DETECTION; IDENTIFICATION; INFECTIONS; HYBRIDIZATION; RECOGNITION; DIAGNOSTICS	PCR multiplexing has proven to be challenging, and thus has provided limited means for pathogen genotyping. We developed a new approach for analysis of PCR amplicons based on restriction endonuclease digestion. The first stage of the restriction enzyme assay is hybridization of a target DNA to immobilized complementary oligonucleotide probes that carry a molecular marker, horseradish peroxidase (HRP). At the second stage, a target-specific restriction enzyme is added, cleaving the target-probe duplex at the corresponding restriction site and releasing the HRP marker into solution, where it is quantified colorimetrically. The assay was tested for detection of the methicillin-resistant Staphylococcus aureus (MRSA) pathogen, using the mecA gene as a target. Calibration curves indicated that the limit of detection for both target oligonucleotide and PCR amplicon was approximately 1 nM. Sequences of target oligonucleotides were altered to demonstrate that (i) any mutation of the restriction site reduced the signal to zero; (ii) double and triple point mutations of sequences flanking the restriction site reduced restriction to 50-80% of the positive control; and (iii) a minimum of a 16-bp target-probe dsDNA hybrid was required for significant cleavage. Further experiments showed that the assay could detect the mecA amplicon from an unpurified PCR mixture with detection limits similar to those with standard fluorescence-based qPCR. Furthermore, addition of a large excess of heterologous genomic DNA did not affect amplicon detection. Specificity of the assay is very high because it involves two biorecognition steps. The proposed assay is low-cost and can be completed in less than 1 hour. Thus, we have demonstrated an efficient new approach for pathogen detection and amplicon genotyping in conjunction with various end-point and qPCR applications. The restriction enzyme assay may also be used for parallel analysis of multiple different amplicons from the same unpurified mixture in broad-range PCR applications.	[Smith, Maria W.; Simon, Holly M.] Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Portland, OR 97201 USA; [Smith, Maria W.; Simon, Holly M.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97201 USA; [Smith, Maria W.; Ghindilis, Andrei L.; Smith, Kenneth] Cascade Biosyst Inc, Colfax, WI USA; [Seoudi, Ihab A.] Hamad Med Corp, Doha, Qatar; [Billharz, Rosalind] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA	Oregon Health & Science University; Oregon Health & Science University; Hamad Medical Corporation; Pacific Lutheran University	Smith, MW (corresponding author), Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Portland, OR 97201 USA.	mariyasmit@hotmail.com	Ghindilis, Andrey/AAT-6810-2021	Gindilis, Andrei/0000-0002-1931-6422; Smit, Mariya/0000-0001-7458-4545	Qatar National Research Fund (a member of the Qatar Foundation) [NPRP 5-593-3-149]; National Science Foundation [OCE 0424602]	Qatar National Research Fund (a member of the Qatar Foundation); National Science Foundation(National Science Foundation (NSF))	This publication was made possible by NPRP 5-593-3-149 grant from the Qatar National Research Fund (a member of the Qatar Foundation. The statements made herein are solely the responsibility of the authors. Support was provided by the National Science Foundation, grant OCE 0424602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; Becker K, 2013, J CLIN MICROBIOL, V51, P1917, DOI 10.1128/JCM.00075-13; Bekkaoui F, 1999, DIAGN MICR INFEC DIS, V34, P83, DOI 10.1016/S0732-8893(99)00012-7; Desjardins M, 2006, J CLIN MICROBIOL, V44, P1219, DOI 10.1128/JCM.44.4.1219-1223.2006; Dill K, 2004, BIOSENS BIOELECTRON, V20, P736, DOI 10.1016/j.bios.2004.06.049; Evertsson U, 2000, APMIS, V108, P385, DOI 10.1034/j.1600-0463.2000.d01-73.x; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P3677; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; Jonas D, 2002, J CLIN MICROBIOL, V40, P1821, DOI 10.1128/JCM.40.5.1821-1823.2002; Kelley K, 2013, J CLIN MICROBIOL, V51, P2033, DOI 10.1128/JCM.00196-13; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Levi K, 2003, J CLIN MICROBIOL, V41, P3890, DOI 10.1128/JCM.41.8.3890-3892.2003; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; McDonald RR, 2005, J CLIN MICROBIOL, V43, P6147, DOI 10.1128/JCM.43.12.6147-6149.2005; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Soge OO, 2009, J ANTIMICROB CHEMOTH, V64, P1148, DOI 10.1093/jac/dkp368; van Hal SJ, 2007, J CLIN MICROBIOL, V45, P2486, DOI 10.1128/JCM.00139-07; Wolk D, 2001, INFECT DIS CLIN N AM, V15, P1157, DOI 10.1016/S0891-5520(05)70190-2; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	31	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97826	10.1371/journal.pone.0097826	http://dx.doi.org/10.1371/journal.pone.0097826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831802	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500121
J	Tai, TS; Pai, SY; Ho, IC				Tai, Tzong-Shyuan; Pai, Sung-Yun; Ho, I-Cheng			Itm2a, a Target Gene of GATA-3, Plays a Minimal Role in Regulating the Development and Function of T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; DIFFERENTIATION; EXPRESSION; MAINTENANCE; ACTIVATION; BRITISH; CD8	The integral membrane protein 2a (Itm2a) is one of the BRICHOS domain-containing proteins and is structurally related to Itm2b and Itm2c. It is expressed preferentially in the T lineage among hematopoietic cells and is induced by MHC-mediated positive selection. However, its transcriptional regulation and function are poorly understood. Here we showed Itm2a to be a target gene of GATA-3, a T cell-specific transcription factor. Deficiency of Itm2a had little impact on the development and function of polyclonal T cells but resulted in a partial defect in the development of thymocytes bearing a MHC class I-restricted TCR, OT-I. In addition, Itm2a-deficient mice displayed an attenuated T helper cell-dependent immune response in vivo. We further demonstrated that Itm2b but not Itm2c was also expressed in T cells, and was induced upon activation, albeit following a kinetic different from that of Itm2a. Thus, functional redundancy between Itm2a and Itm2b may explain the minimal phenotype of Itm2a deficiency.	[Tai, Tzong-Shyuan; Ho, I-Cheng] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Tai, Tzong-Shyuan; Pai, Sung-Yun; Ho, I-Cheng] Harvard Univ, Sch Med, Boston, MA USA; [Tai, Tzong-Shyuan] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Pai, Sung-Yun] Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; E-Da Hospital; I Shou University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Ho, IC (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	iho@partners.org	Pai, Sung-Yun/AAH-7762-2019	Pai, Sung-Yun/0000-0002-0158-8147	National Institutes of Health [AI097725, AI050601]; Charles H. Hood Foundation Child Health Research Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation Child Health Research Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a R03 grant (AI097725 to ICH) and a K08 award (AI050601 to SYP) from National Institutes of Health, and an award (to SYP) from Charles H. Hood Foundation Child Health Research Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Lagha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063143; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96535	10.1371/journal.pone.0096535	http://dx.doi.org/10.1371/journal.pone.0096535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831988	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500022
J	Todros-Dawda, I; Kveberg, L; Vaage, JT; Inngjerdingen, M				Todros-Dawda, Izabela; Kveberg, Lise; Vaage, John T.; Inngjerdingen, Marit			The Tetraspanin CD53 Modulates Responses from Activating NK Cell Receptors, Promoting LFA-1 Activation and Dampening NK Cell Effector Functions	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATITIS-C VIRUS; RAT LYMPHOCYTES-T; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; HOMOTYPIC ADHESION; CD81 TAPA-1; EXPRESSION; ANTIGEN; ASSOCIATION	NK cells express several tetraspanin proteins, which differentially modulate NK cell activities. The tetraspanin CD53 is expressed by all resting NK cells and was previously shown to decrease NK cell cytotoxicity upon ligation. Here, we show that CD53 ligation reduced degranulation of rat NK cells in response to tumour target cells, evoked redirected inhibition of killing of Fc-bearing targets, and reduced the IFN-gamma response induced by plate-bound antibodies towards several activating NK cell receptors (Ly49s3, NKR-P1A, and NKp46). CD53 induced activation of the beta 2 integrin LFA-1, which was further enhanced upon co-stimulation with activating NK cell receptors. Concordant with a role for CD53 in increasing NK cell adhesiveness, CD53 ligation induced a strong homotypic adhesion between NK cells. Further, the proliferative capacity of NK cells to a suboptimal dose of IL-2 was enhanced by CD53 ligation. Taken together, these data suggest that CD53 may shift NK cell responses from effector functions towards a proliferation phase.	[Inngjerdingen, Marit] Univ Oslo, Rikshosp, Dept Immunol, Oslo Univ Hosp, N-0027 Oslo, Norway; Univ Oslo, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Inngjerdingen, M (corresponding author), Univ Oslo, Rikshosp, Dept Immunol, Oslo Univ Hosp, N-0027 Oslo, Norway.	mariti@medisin.uio.no	Kveberg, Lise/AAG-1739-2019	Kveberg, Lise/0000-0001-9308-0641; Vaage, John T./0000-0003-0988-5768	South-Eastern Norway Regional Health Authority [2008100 BT]	South-Eastern Norway Regional Health Authority	This work was supported by the South-Eastern Norway Regional Health Authority grant number 2008100 BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrena S, 2005, LEUKEMIA, V19, P1376, DOI 10.1038/sj.leu.2403822; BELL GM, 1992, J EXP MED, V175, P527, DOI 10.1084/jem.175.2.527; Bos SD, 2010, EUR J HUM GENET, V18, P953, DOI 10.1038/ejhg.2010.52; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Cao L, 1997, IMMUNOBIOLOGY, V197, P70, DOI 10.1016/S0171-2985(97)80058-7; CARMO AM, 1995, EUR J IMMUNOL, V25, P2090, DOI 10.1002/eji.1830250743; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; CLARK SJ, 1988, J EXP MED, V167, P1861, DOI 10.1084/jem.167.6.1861; Crotta S, 2006, EUR J IMMUNOL, V36, P919, DOI 10.1002/eji.200535527; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; DAWE CJ, 1957, AM J PATHOL, V33, P603; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; Inngjerdingen M, 2011, TISSUE ANTIGENS, V78, P81, DOI 10.1111/j.1399-0039.2011.01714.x; Jockers JJ, 2006, ALLERGY, V61, P1419, DOI 10.1111/j.1398-9995.2006.01191.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim EO, 2010, J BIOL CHEM, V285, P41755, DOI 10.1074/jbc.M110.137976; Kim TR, 2004, MOL CELLS, V17, P125; Konstandin MH, 2007, J IMMUNOL METHODS, V327, P30, DOI 10.1016/j.jim.2007.07.005; Kramer B, 2009, EUR J IMMUNOL, V39, P3447, DOI 10.1002/eji.200939234; Kveberg L, 2006, IMMUNOGENETICS, V58, P905, DOI 10.1007/s00251-006-0154-x; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Lazo PA, 1997, CELL IMMUNOL, V178, P132, DOI 10.1006/cimm.1997.1139; Lee H, 2013, BBA-GEN SUBJECTS, V1830, P3011, DOI 10.1016/j.bbagen.2012.12.030; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Mannion BA, 1996, J IMMUNOL, V157, P2039; MASELLISSMITH A, 1990, J IMMUNOL, V144, P1607; Mollinedo F, 1997, CLIN DIAGN LAB IMMUN, V4, P229, DOI 10.1128/CDLI.4.2.229-231.1997; Naper C, 2002, J IMMUNOL, V169, P22, DOI 10.4049/jimmunol.169.1.22; OLWEUS J, 1993, J IMMUNOL, V151, P707; Pedersen-Lane JH, 2007, J LEUKOCYTE BIOL, V81, P934, DOI 10.1189/jlb.0806533; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Puls KL, 2002, INT IMMUNOL, V14, P249, DOI 10.1093/intimm/14.3.249; RASMUSSEN AM, 1994, J IMMUNOL, V153, P4997; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; SCHMIDT RE, 1988, J IMMUNOL, V140, P991; SEAMAN WE, 1987, P NATL ACAD SCI USA, V84, P4239, DOI 10.1073/pnas.84.12.4239; Shibagaki N, 1999, EUR J IMMUNOL, V29, P4081, DOI 10.1002/(SICI)1521-4141(199912)29:12<4081::AID-IMMU4081>3.3.CO;2-9; SLUPSKY JR, 1989, J BIOL CHEM, V264, P12289; Todd SC, 1996, J EXP MED, V184, P2055, DOI 10.1084/jem.184.5.2055; VAAGE JT, 1994, J EXP MED, V180, P641, DOI 10.1084/jem.180.2.641; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Yunta M, 2003, ONCOGENE, V22, P1219, DOI 10.1038/sj.onc.1206183; Zhuo M, 2010, EUR J IMMUNOL, V40, P1748, DOI 10.1002/eji.200939779	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97844	10.1371/journal.pone.0097844	http://dx.doi.org/10.1371/journal.pone.0097844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832104	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500124
J	Xu, J; Meng, KX; Zhang, R; Yang, H; Liao, C; Zhu, WL; Jiao, JD				Xu, Jia; Meng, Kexin; Zhang, Rui; Yang, He; Liao, Chang; Zhu, Wenliang; Jiao, Jundong			The Use of Functional Chemical-Protein Associations to Identify Multi-Pathway Renoprotectants	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; MULTITARGET DRUGS; OXIDATIVE STRESS; RENAL ISCHEMIA; CURCUMIN; AUTOPHAGY; MECHANISMS; KIDNEY; INJURY; DISCOVERY	Typically, most nephropathies can be categorized as complex human diseases in which the cumulative effect of multiple minor genes, combined with environmental and lifestyle factors, determines the disease phenotype. Thus, multi-target drugs would be more likely to facilitate comprehensive renoprotection than single-target agents. In this study, functional chemical-protein association analysis was performed to retrieve multi-target drugs of high pathway wideness from the STITCH 3.1 database. Pathway wideness of a drug evaluated the efficiency of regulation of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in quantity. We identified nine experimentally validated renoprotectants that exerted remarkable impact on KEGG pathways by targeting a limited number of proteins. We selected curcumin as an illustrative compound to display the advantage of multi-pathway drugs on renoprotection. We compared curcumin with hemin, an agonist of heme oxygenase-1 (HO-1), which significantly affects only one KEGG pathway, porphyrin and chlorophyll metabolism (adjusted p = 1.5x10(-5)). At the same concentration (10 mu M), both curcumin and hemin equivalently mitigated oxidative stress in H2O2-treated glomerular mesangial cells. The benefit of using hemin was derived from its agonistic effect on HO-1, providing relief from oxidative stress. Selective inhibition of HO-1 completely blocked the action of hemin but not that of curcumin, suggesting simultaneous multi-pathway intervention by curcumin. Curcumin also increased cellular autophagy levels, enhancing its protective effect; however, hemin had no effects. Based on the fact that the dysregulation of multiple pathways is implicated in the etiology of complex diseases, we proposed a feasible method for identifying multi-pathway drugs from compounds with validated targets. Our efforts will help identify multi-pathway agents capable of providing comprehensive protection against renal injuries.	[Xu, Jia; Meng, Kexin; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Xu, Jia] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin, Peoples R China; [Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China.	jiaojundong@163.com			National Nature Science Foundation of China [31071016]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (31071016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernd A, 2014, PHYTOCHEM REV, V13, P183, DOI 10.1007/s11101-013-9296-2; Bolisetty S, 2010, J AM SOC NEPHROL, V21, P1702, DOI 10.1681/ASN.2010030238; Chargui A, 2011, TOXICOL SCI, V121, P31, DOI 10.1093/toxsci/kfr031; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Dulbecco P, 2013, WORLD J GASTROENTERO, V19, P9256, DOI 10.3748/wjg.v19.i48.9256; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2013, MOL CELL ENDOCRINOL, V365, P231, DOI 10.1016/j.mce.2012.10.024; Jacob A, 2013, IMMUNOLOGY, V139, P328, DOI 10.1111/imm.12079; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lee H, 2013, BRIT J NUTR, V110, P69, DOI 10.1017/S0007114512004734; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li CW, 2013, EXP BIOL MED, V238, P744, DOI 10.1177/1535370213493705; Li D, 2013, KIDNEY BLOOD PRESS R, V38, P61, DOI 10.1159/000355755; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma XH, 2010, PHARM RES-DORDR, V27, P739, DOI 10.1007/s11095-010-0065-2; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Morsy MA, 2013, ADV PHARM SCI, V2013, DOI DOI 10.1155/2013/387071; Mueller TF, 2012, J NEPHROL, V25, P589, DOI 10.5301/jn.5000205; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Paccosi S, 2012, PHARMACOL RES, V66, P526, DOI 10.1016/j.phrs.2012.09.006; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Petrelli A, 2008, CURR MED CHEM, V15, P422; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salahudeen AK, 2011, TRANSPLANTATION, V91, P176, DOI 10.1097/TP.0b013e3181fffff2; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sraer JD, 1996, KIDNEY INT, V49, P267, DOI 10.1038/ki.1996.38; Tapia E, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/269039; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Ueki M, 2013, J BIOSCI BIOENG, V115, P547, DOI 10.1016/j.jbiosc.2012.11.007; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wang XJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003119; Waseem M, 2013, CELL BIOCHEM FUNCT, V31, P678, DOI 10.1002/cbf.2955; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yeh JH, 2013, TRANSPL P, V45, P3542, DOI 10.1016/j.transproceed.2013.09.004; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang DM, 2012, FOOD CHEM, V134, P2184, DOI 10.1016/j.foodchem.2012.04.026; Zhang DW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/636053; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	51	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97906	10.1371/journal.pone.0097906	http://dx.doi.org/10.1371/journal.pone.0097906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830678	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500131
J	Cosentino, RO; Aguero, F				Cosentino, Raul O.; Agueero, Fernan			Genetic Profiling of the Isoprenoid and Sterol Biosynthesis Pathway Genes of Trypanosoma cruzi	PLOS ONE			English	Article							CHAGAS-DISEASE; NUCLEOTIDE-SEQUENCES; CRYSTAL-STRUCTURES; ERGOSTEROL BIOSYNTHESIS; POPULATION-STRUCTURE; MULTIPLE-ALIGNMENT; SQUALENE SYNTHASE; BRUCEI-GAMBIENSE; STRUCTURAL BASIS; INHIBITORS	In Trypanosoma cruzi the isoprenoid and sterol biosynthesis pathways are validated targets for chemotherapeutic intervention. In this work we present a study of the genetic diversity observed in genes from these pathways. Using a number of bioinformatic strategies, we first identified genes that were missing and/or were truncated in the T. cruzi genome. Based on this analysis we obtained the complete sequence of the ortholog of the yeast ERG26 gene and identified a non-orthologous homolog of the yeast ERG25 gene (sterol methyl oxidase, SMO), and we propose that the orthologs of ERG25 have been lost in trypanosomes (but not in Leishmanias). Next, starting from a set of 16 T. cruzi strains representative of all extant evolutionary lineages, we amplified and sequenced similar to 24 Kbp from 22 genes, identifying a total of 975 SNPs or fixed differences, of which 28% represent non-synonymous changes. We observed genes with a density of substitutions ranging from those close to the average (similar to 2.5/100 bp) to some showing a high number of changes (11.4/100 bp, for the putative lathosterol oxidase gene). All the genes of the pathway are under apparent purifying selection, but genes coding for the sterol C14-demethylase, the HMG-CoA synthase, and the HMG-CoA reductase have the lowest density of missense SNPs in the panel. Other genes (TcPMK, TcSMO-like) have a relatively high density of non-synonymous SNPs (2.5 and 1.9 every 100 bp, respectively). However, none of the non-synonymous changes identified affect a catalytic or ligand binding site residue. A comparative analysis of the corresponding genes from African trypanosomes and Leishmania shows similar levels of apparent selection for each gene. This information will be essential for future drug development studies focused on this pathway.	[Cosentino, Raul O.; Agueero, Fernan] Univ San Martin, CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Aguero, F (corresponding author), Univ San Martin, CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina.	fernan@unsam.edu.ar	Filho, Fernando C/Q-8021-2018; Aguero, Fernan/F-5606-2013	Cosentino, Raul Oscar/0000-0003-2124-8198; Aguero, Fernan/0000-0003-1331-5741	National Agency for the Promotion of Science and Technology of Argentina [PICT-2005-38209, PICT-2010-1479]; National Research Council of Argentina (CONICET) [PIP-5454]; Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank) [A50830]; University of San Martin	National Agency for the Promotion of Science and Technology of Argentina(ANPCyT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank); University of San Martin	This work was supported by grants from the National Agency for the Promotion of Science and Technology of Argentina (Grants PICT-2005-38209 and PICT-2010-1479, http://www.agencia.gob.ar), the National Research Council of Argentina (CONICET, Grant PIP-5454, http://www.conicet.gob.ar), and the Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank, Grant A50830, http://www.who.int/tdr). ROC is now a fellow of CONICET and was also supported during this work by a fellowship from the University of San Martin. FA is a member of the Research Career of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ackermann AA, 2009, NUCLEIC ACIDS RES, V37, pD544, DOI 10.1093/nar/gkn874; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2010, MEM I OSWALDO CRUZ, V105, P834, DOI 10.1590/S0074-02762010000600018; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Braga MV, 2005, MICROSC MICROANAL, V11, P506, DOI 10.1017/S143192760505035X; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Buckner FS, 2012, INT J PARASITOL-DRUG, V2, P236, DOI 10.1016/j.ijpddr.2011.12.002; Buckner FS, 2003, MOL BIOCHEM PARASIT, V132, P75, DOI 10.1016/j.molbiopara.2003.07.004; Buckner FS, 2001, ANTIMICROB AGENTS CH, V45, P1210, DOI 10.1128/AAC.45.4.1210-1215.2001; Buscaglia CA, 2003, MICROBES INFECT, V5, P419, DOI 10.1016/S1286-4579(03)00050-9; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; Castillo Ramirez S, 2011, PLOS PATHOG, V7; Chang Q, 2008, PROTEINS, V73, P254, DOI 10.1002/prot.22151; Chen CK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000651; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coppens I, 2000, ANNU REV MICROBIOL, V54, P129, DOI 10.1146/annurev.micro.54.1.129; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; Delye C, 1997, APPL ENVIRON MICROB, V63, P2966; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Duffy CW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002526; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; FLORINCHRISTENSEN M, 1990, BIOCHEM BIOPH RES CO, V166, P1441, DOI 10.1016/0006-291X(90)91028-Q; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Gerpe A, 2008, BIOORGAN MED CHEM, V16, P569, DOI 10.1016/j.bmc.2007.07.031; Gerpe A, 2009, BIOORGAN MED CHEM, V17, P7500, DOI 10.1016/j.bmc.2009.09.013; Gordon D, 2003, CURR PROTOC BIOINFOR, V2, P43, DOI DOI 10.1002/0471250953.BI1102S02; Houten SM, 2001, MOL GENET METAB, V72, P273, DOI 10.1006/mgme.2000.3133; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurtado-Guerrrero R, 2002, FEBS LETT, V510, P141, DOI 10.1016/S0014-5793(01)03238-0; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly SL, 1999, FEMS MICROBIOL LETT, V180, P171, DOI 10.1111/j.1574-6968.1999.tb08792.x; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055497; Koffi M, 2009, P NATL ACAD SCI USA, V106, P209, DOI 10.1073/pnas.0811080106; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kursula P, 2005, J MOL BIOL, V347, P189, DOI 10.1016/j.jmb.2005.01.018; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lorente SO, 2004, ANTIMICROB AGENTS CH, V48, P2937, DOI 10.1128/AAC.48.8.2937-2950.2004; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Magaraci F, 2003, J MED CHEM, V46, P4714, DOI 10.1021/jm021114j; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Nes CR, 2012, BIOCHEM J, V443, P267, DOI 10.1042/BJ20111849; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Oliaro-Bosso S, 2004, LIPIDS, V39, P1007, DOI 10.1007/s11745-004-1323-2; Oliaro-Bosso S, 2007, CHEMMEDCHEM, V2, P226, DOI 10.1002/cmdc.200600234; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Park WKC, 2008, BIOORG MED CHEM LETT, V18, P1151, DOI 10.1016/j.bmcl.2007.11.124; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pojer F, 2006, P NATL ACAD SCI USA, V103, P11491, DOI 10.1073/pnas.0604935103; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rodrigues-Poveda CA, 2012, ANTIMICROB AGENTS CH, V56, P4483, DOI 10.1128/AAC.00796-12; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rosso VS, 2011, BIOORGAN MED CHEM, V19, P2211, DOI 10.1016/j.bmc.2011.02.037; Sealey-Cardona M, 2007, ANTIMICROB AGENTS CH, V51, P2123, DOI 10.1128/AAC.01454-06; Sgraja T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-20; Silva DT, 2006, INT J ANTIMICROB AG, V27, P530, DOI 10.1016/j.ijantimicag.2005.12.012; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Tibayrenc M, 2013, TRENDS PARASITOL, V29, P264, DOI 10.1016/j.pt.2013.03.007; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vacchina P, 2012, MOL BIOCHEM PARASIT, V184, P29, DOI 10.1016/j.molbiopara.2012.04.005; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Wolf YI, 2012, GENOME BIOL EVOL, V4, P1286, DOI 10.1093/gbe/evs100; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	100	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96762	10.1371/journal.pone.0096762	http://dx.doi.org/10.1371/journal.pone.0096762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828104	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400036
J	Harriff, MJ; Cansler, ME; Toren, KG; Canfield, ET; Kwak, S; Gold, MC; Lewinsohn, DM				Harriff, Melanie J.; Cansler, Meghan E.; Toren, Katelynne Gardner; Canfield, Elizabeth T.; Kwak, Stephen; Gold, Marielle C.; Lewinsohn, David M.			Human Lung Epithelial Cells Contain Mycobacterium tuberculosis in a Late Endosomal Vacuole and Are Efficiently Recognized by CD8(+) T Cells	PLOS ONE			English	Article							PHAGOSOME MATURATION; INTERFERON-GAMMA; ANTIGEN; LYMPHOCYTES; ARREST; IRON; RAB5	Mycobacterium tuberculosis (Mtb) is transmitted via inhalation of aerosolized particles. While alveolar macrophages are thought to play a central role in the acquisition and control of this infection, Mtb also has ample opportunity to interact with the airway epithelium. In this regard, we have recently shown that the upper airways are enriched with a population of non-classical, MR1-restricted, Mtb-reactive CD8(+) T cells (MAIT cells). Additionally, we have demonstrated that Mtb-infected epithelial cells lining the upper airways are capable of stimulating IFN gamma production by MAIT cells. In this study, we demonstrate that airway epithelial cells efficiently stimulate IFN gamma release by MAIT cells as well as HLA-B45 and HLA-E restricted T cell clones. Characterization of the intracellular localization of Mtb in epithelial cells indicates that the vacuole occupied by Mtb in epithelial cells is distinct from DC in that it acquires Rab7 molecules and does not retain markers of early endosomes such as Rab5. The Mtb vacuole is also heterogeneous as there is a varying degree of association with Lamp1 and HLA-I. Although the Mtb vacuole shares markers associated with the late endosome, it does not acidify, and the bacteria are able to replicate within the cell. This work demonstrates that Mtb infected lung epithelial cells are surprisingly efficient at stimulating IFN gamma release by CD8(+) T cells.	[Harriff, Melanie J.; Gold, Marielle C.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR 97239 USA; [Harriff, Melanie J.; Canfield, Elizabeth T.; Kwak, Stephen; Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Cansler, Meghan E.; Toren, Katelynne Gardner] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Harriff, MJ (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	harriffm@ohsu.edu; lewinsod@ohsu.edu	; Lewinsohn, David/I-4936-2013	Slater, Marielle/0000-0003-2505-3291; Lewinsohn, David/0000-0001-9906-9494	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Portland VA Medical Center; National Institutes of Health (NIH) [AI048090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Portland VA Medical Center(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, with resources and the use of facilities at the Portland VA Medical Center (Merit Review, DM Lewinsohn; Career Development Award, MJH), and the National Institutes of Health (NIH) grant, AI048090 (DM Lewinsohn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Fine KL, 2012, CELL MICROBIOL, V14, P1402, DOI 10.1111/j.1462-5822.2012.01804.x; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Grotzke JE, 2010, J IMMUNOL, V185, P4336, DOI 10.4049/jimmunol.1000801; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Reichman LB, 2000, LUNG BIOL HLTH DIS T, P898; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Sharma M, 2007, IMMUNOL CELL BIOL, V85, P229, DOI 10.1038/sj.icb.7100037; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Wong J, 2007, AM J PHYSIOL-LUNG C, V293, pL1385, DOI 10.1152/ajplung.00207.2007	36	64	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97515	10.1371/journal.pone.0097515	http://dx.doi.org/10.1371/journal.pone.0097515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828674	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400104
J	Sreekumar, V; Dennis, S; Doxas, I; Zhuang, YW; Belkin, M				Sreekumar, Vishnu; Dennis, Simon; Doxas, Isidoros; Zhuang, Yuwen; Belkin, Mikhail			The Geometry and Dynamics of Lifelogs: Discovering the Organizational Principles of Human Experience	PLOS ONE			English	Article							RECURRENCE PLOTS	A correlation dimension analysis of people's visual experiential streams captured by a smartphone shows that visual experience is two-scaled with a smaller dimension at shorter length scales than at longer length scales. The bend between the two scales is a phase transition point where the lower scale primarily captures relationships within the same context and the higher dimensional scale captures relationships between different contexts. The dimensionality estimates are confirmed using Takens' delay embedding procedure on the image stream, while the randomly permuted stream is shown to be space-filling thereby establishing that the two-scaled structure is a consequence of the dynamics. We note that the structure of visual experience closely resembles the structure of another domain of experience: natural language discourse. The emergence of an identical structure across different domains of human experience suggests that the two-scaled geometry reflects a general organizational principle.	[Sreekumar, Vishnu] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Dennis, Simon] Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia; [Doxas, Isidoros] Univ Colorado, Ctr Integrated Plasma Studies, Boulder, CO 80309 USA; [Zhuang, Yuwen; Belkin, Mikhail] Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Newcastle; University of Colorado System; University of Colorado Boulder; University System of Ohio; Ohio State University	Dennis, S (corresponding author), Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia.	simon.dennis@gmail.com	Sreekumar, Vishnu/I-9516-2016	Sreekumar, Vishnu/0000-0002-5366-1633; Dennis, Simon/0000-0002-1890-1187	Air Force Office of Scientific Research (AFOSR) [FA9550-09-1-0614]	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was partially supported by Air Force Office of Scientific Research (AFOSR) grant FA9550-09-1-0614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrew AH, 2013, INT CONF PER COMP, P408, DOI 10.4108/icst.pervasivehealth.2013.252134; Chiu GS, 2002, THESIS S FRASER U; Doxas I, 2010, P NATL ACAD SCI USA, V107, P4866, DOI 10.1073/pnas.0908315107; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Huang J, 1997, PROC CVPR IEEE, P762, DOI 10.1109/CVPR.1997.609412; Kintsch W, 2006, HDB LATENT SEMANTIC; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Moskowitz DS, 2006, J PSYCHIATR NEUROSCI, V31, P13; Schreiber T., 1999, PHYS REP, V308, P1; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Sreekumar V, 2010, P 32 ANN M COGN SCI; Swan M, 2009, INT J ENV RES PUB HE, V6, P492, DOI 10.3390/ijerph6020492; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802	21	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97166	10.1371/journal.pone.0097166	http://dx.doi.org/10.1371/journal.pone.0097166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824825	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200067
J	Zhang, H; von Gise, A; Liu, QZ; Hu, TY; Tian, XY; He, LJ; Pu, WJ; Huang, XZ; He, L; Cai, CL; Camargo, FD; Pu, WT; Zhou, B				Zhang, Hui; von Gise, Alexander; Liu, Qiaozhen; Hu, Tianyuan; Tian, Xueying; He, Lingjuan; Pu, Wenjuan; Huang, Xiuzhen; He, Liang; Cai, Chen-Leng; Camargo, Fernando D.; Pu, William T.; Zhou, Bin			Yap1 Is Required for Endothelial to Mesenchymal Transition of the Atrioventricular Cushion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; GROWTH-FACTOR-BETA; CONGENITAL HEART-DISEASE; HOLT-ORAM-SYNDROME; CELL-TRANSFORMATION; CARDIOMYOCYTE PROLIFERATION; EMBRYONIC HEART; TRANSCRIPTION FACTORS; PATHWAY; DOMAIN	Cardiac malformations due to aberrant development of the atrioventricular (AV) valves are among the most common forms of congenital heart diseases. Normally, heart valve mesenchyme is formed from an endothelial to mesenchymal transition (EMT) of endothelial cells of the endocardial cushions. Yes-associated protein 1 (YAP1) has been reported to regulate EMT in vitro, in addition to its known role as a major regulator of organ size and cell proliferation in vertebrates, leading us to hypothesize that YAP1 is required for heart valve development. We tested this hypothesis by conditional inactivation of YAP1 in endothelial cells and their derivatives. This resulted in markedly hypocellular endocardial cushions due to impaired formation of heart valve mesenchyme by EMT and to reduced endocardial cell proliferation. In endothelial cells, TGF beta induces nuclear localization of Smad2/3/4 complex, which activates expression of Snail, Twist1, and Slug, key transcription factors required for EMT. YAP1 interacts with this complex, and loss of YAP1 disrupts TGF beta-induced up-regulation of Snail, Twist1, and Slug. Together, our results identify a role of YAP1 in regulating EMT through modulation of TGF beta-Smad signaling and through proliferative activity during cardiac cushion development.	[Zhang, Hui; Liu, Qiaozhen; Hu, Tianyuan; Tian, Xueying; He, Lingjuan; Pu, Wenjuan; Huang, Xiuzhen; He, Liang; Pu, William T.; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [von Gise, Alexander] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Ctr Mol Cardiol, Child Hlth & Dev Inst,Black Family Stem Cell Inst, New York, NY 10029 USA; [Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [von Gise, Alexander] MHH Hannover Med Sch, Dept Pediat Cardiol & Intens Care, D-30669 Hannover, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Hannover Medical School	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn	von Gise, Alexander/C-3997-2016; Pu, William/AAJ-8301-2020	von Gise, Alexander/0000-0001-7886-3031; Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [2013CB945302, 2012CB945102]; National Natural Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship [SIBS-2013KIP311, China-2013M541561]; National Institutes of Health [R01 HL094683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic Research Key Project; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca(AstraZeneca); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Basic Research Program of China (2013CB945302 and 2012CB945102), National Natural Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), Organization Department of the CPC Central Committee Bajian Talents Program, AstraZeneca, Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship, and Postdoc Fund (SIBS-2013KIP311, China-2013M541561).; Supported by funding from National Institutes of Health R01 HL094683.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MARKWALD RR, 1981, SCAN ELECTRON MICROS, P261; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Onuzo OC, 2006, ARCH DIS CHILD-FETAL, V91, pF236, DOI 10.1136/adc.2006.094789; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Song LY, 2011, DEV DYNAM, V240, P211, DOI 10.1002/dvdy.22493; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	54	112	117	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18681	18692		10.1074/jbc.M114.554584	http://dx.doi.org/10.1074/jbc.M114.554584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831012	Green Published, hybrid			2022-12-25	WOS:000339062900007
J	Chen, L; Zhou, Y; Qu, MB; Zhao, Y; Yang, Q				Chen, Lei; Zhou, Yong; Qu, Mingbo; Zhao, Yong; Yang, Qing			Fully Deacetylated Chitooligosaccharides Act as Efficient Glycoside Hydrolase Family 18 Chitinase Inhibitors.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOCLADIUM SP FTD-0668; SERRATIA-MARCESCENS; PRODUCT; ALLOSAMIDIN; COMPLEX; MECHANISM; ARGIFIN; BINDING; CLONING; CHITOTRIOSIDASE	Small molecule inhibitors against chitinases have potential applications as pesticides, fungicides, and antiasthmatics. Here, we report that a series of fully deacetylated chitooligosaccharides (GlcN)(2-7) can act as inhibitors against the insect chitinase OfChtI, the human chitinase HsCht, and the bacterial chitinases SmChiA and SmChiB with IC50 values at micromolar to millimolar levels. The injection of mixed (GlcN)(2-7) into the fifth instar larvae of the insect Ostrinia furnacalis resulted in 85% of the larvae being arrested at the larval stage and death after 10 days, also suggesting that (GlcN)(2-7) might inhibit OfChtI in vivo. Crystal structures of the catalytic domain of OfChtI (OfChtI-CAD) complexed with (GlcN)(5,6) were obtained at resolutions of 2.0 angstrom. These structures, together with mutagenesis and thermodynamic analysis, suggested that the inhibition was strongly related to the interaction between the -1 GlcN residue of the inhibitor and the catalytic Glu(148) of the enzyme. Structure-based comparison showed that the fully deacetylated chitooligosaccharides mimic the substrate chitooligosaccharides by binding to the active cleft. This work first reports the inhibitory activity and proposed inhibitory mechanism of fully deacetylated chitooligosaccharides. Because the fully deacetylated chitooligosaccharides can be easily derived from chitin, one of the most abundant materials in nature, this work also provides a platform for developing eco-friendly inhibitors against chitinases.	[Chen, Lei; Qu, Mingbo; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Liaoning, Peoples R China; [Zhou, Yong] Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Liaoning, Peoples R China.	qingyang@dlut.edu.cn	Qu, Mingbo/L-6231-2016; Qu, Mingbo/F-5037-2014; Yang, Qing/GZK-2526-2022	Qu, Mingbo/0000-0003-0397-1630; Qu, Mingbo/0000-0003-0397-1630; Yang, Qing/0000-0001-8623-7532	National High Technology Research and Development Program of China [2011AA10A204]; National Key Project for Basic Research Grant [2010CB126100]; National Natural Science Foundation of China [61202252]; National Key Technology RD Program Grant [2011BAE06B05]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120041120052]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Project for Basic Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program Grant(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National High Technology Research and Development Program of China Grant 2011AA10A204; National Key Project for Basic Research Grant 2010CB126100; National Natural Science Foundation of China Grant 61202252; National Key Technology R&D Program Grant 2011BAE06B05; and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20120041120052.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Arai N, 2000, J ANTIBIOT, V53, P609, DOI 10.7164/antibiotics.53.609; Arai N, 2000, CHEM PHARM BULL, V48, P1442, DOI 10.1248/cpb.48.1442; Barone R, 2003, CLIN CHIM ACTA, V331, P79, DOI 10.1016/S0009-8981(03)00089-5; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Cederkvist F, 2006, ANGEW CHEM INT EDIT, V45, P2429, DOI 10.1002/anie.200503168; Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020; Cederkvist FH, 2007, BIOCHEMISTRY-US, V46, P12347, DOI 10.1021/bi701029u; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dixon MJ, 2005, BIOORG MED CHEM LETT, V15, P4717, DOI 10.1016/j.bmcl.2005.07.068; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUCHS RL, 1986, APPL ENVIRON MICROB, V51, P504, DOI 10.1128/AEM.51.3.504-509.1986; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Genta FA, 2006, INSECT BIOCHEM MOLEC, V36, P789, DOI 10.1016/j.ibmb.2006.07.007; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, BIOCHEM J, V368, P23, DOI 10.1042/BJ20021034; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; JONES JDG, 1986, EMBO J, V5, P467, DOI 10.1002/j.1460-2075.1986.tb04235.x; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Labadaridis I, 2005, ARCH DIS CHILD-FETAL, V90, pF531, DOI 10.1136/adc.2004.051284; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Omura S, 2000, J ANTIBIOT, V53, P603, DOI 10.7164/antibiotics.53.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2003, ACTA CRYSTALLOGR D, V59, P400, DOI 10.1107/S0907444902021923; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Qu MB, 2011, BIOCHEM BIOPH RES CO, V404, P302, DOI 10.1016/j.bbrc.2010.11.111; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Rush CL, 2010, CHEM BIOL, V17, P1275, DOI 10.1016/j.chembiol.2010.07.018; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2475, DOI 10.1016/S0040-4039(00)84560-8; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P27278, DOI 10.1074/jbc.M604048200; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Wu QY, 2013, INSECT SCI, V20, P147, DOI 10.1111/j.1744-7917.2012.01512.x	46	42	47	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17932	17940		10.1074/jbc.M114.564534	http://dx.doi.org/10.1074/jbc.M114.564534			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828498	Green Published, hybrid			2022-12-25	WOS:000338018100053
J	Fabrick, JA; Ponnuraj, J; Singh, A; Tanwar, RK; Unnithan, GC; Yelich, AJ; Li, XC; Carriere, Y; Tabashnik, BE				Fabrick, Jeffrey A.; Ponnuraj, Jeyakumar; Singh, Amar; Tanwar, Raj K.; Unnithan, Gopalan C.; Yelich, Alex J.; Li, Xianchun; Carriere, Yves; Tabashnik, Bruce E.			Alternative Splicing and Highly Variable Cadherin Transcripts Associated with Field-Evolved Resistance of Pink Bollworm to Bt Cotton in India	PLOS ONE			English	Article							ARMIGERA LEPIDOPTERA-NOCTUIDAE; THURINGIENSIS TOXIN CRY1AC; EUROPEAN CORN-BORER; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; TRANSGENIC COTTON; PECTINOPHORA-GOSSYPIELLA; CROSS-RESISTANCE; CONFERRING RESISTANCE; OSTRINIA-NUBILALIS	Evolution of resistance by insect pests can reduce the benefits of insecticidal proteins from Bacillus thuringiensis (Bt) that are used extensively in sprays and transgenic crops. Despite considerable knowledge of the genes conferring insect resistance to Bt toxins in laboratory-selected strains and in field populations exposed to Bt sprays, understanding of the genetic basis of field-evolved resistance to Bt crops remains limited. In particular, previous work has not identified the genes conferring resistance in any cases where field-evolved resistance has reduced the efficacy of a Bt crop. Here we report that mutations in a gene encoding a cadherin protein that binds Bt toxin Cry1Ac are associated with field-evolved resistance of pink bollworm (Pectinophora gossypiella) in India to Cry1Ac produced by transgenic cotton. We conducted laboratory bioassays that confirmed previously reported resistance to Cry1Ac in pink bollworm from the state of Gujarat, where Bt cotton producing Cry1Ac has been grown extensively. Analysis of DNA from 436 pink bollworm from seven populations in India detected none of the four cadherin resistance alleles previously reported to be linked with resistance to Cry1Ac in laboratory-selected strains of pink bollworm from Arizona. However, DNA sequencing of pink bollworm derived from resistant and susceptible field populations in India revealed eight novel, severely disrupted cadherin alleles associated with resistance to Cry1Ac. For these eight alleles, analysis of complementary DNA (cDNA) revealed a total of 19 transcript isoforms, each containing a premature stop codon, a deletion of at least 99 base pairs, or both. Seven of the eight disrupted alleles each produced two or more different transcript isoforms, which implicates alternative splicing of messenger RNA (mRNA). This represents the first example of alternative splicing associated with field-evolved resistance that reduced the efficacy of a Bt crop.	[Fabrick, Jeffrey A.] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA; [Ponnuraj, Jeyakumar] Natl Inst Plant Hlth Management, Hyderabad, Andhra Pradesh, India; [Singh, Amar; Tanwar, Raj K.] Indian Agr Res Inst, Natl Ctr Integrated Pest Management, Delhi, India; [Unnithan, Gopalan C.; Yelich, Alex J.; Li, Xianchun; Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	United States Department of Agriculture (USDA); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Research Centre for Integrated Pest Management; University of Arizona	Fabrick, JA (corresponding author), ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA.	jeff.fabrick@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545	U.S. Department of Agriculture [5347-22620-021-00D]; U.S. Department of Agriculture Agriculture and Food Research Initiative [2008-35302-0390]; Biotechnology Risk Assessment Research Grants Program [2011-33522-30729]; Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Department of Agriculture Agriculture and Food Research Initiative; Biotechnology Risk Assessment Research Grants Program; Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship(Department of Science & Technology (India))	This work was funded by U.S. Department of Agriculture base funding (Project Number 5347-22620-021-00D) to J.A.F., research grants from the U.S. Department of Agriculture Agriculture and Food Research Initiative (2008-35302-0390) and Biotechnology Risk Assessment Research Grants Program (2011-33522-30729) to B. E. T., and the Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship to J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2001, J ECON ENTOMOL, V94, P935, DOI 10.1603/0022-0493-94.4.935; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Choudhary B., 2013, BT COTTON INDIA COUN; Coates BS, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2101; Coates BS, 2013, INSECT BIOCHEM MOLEC, V43, P1152, DOI 10.1016/j.ibmb.2013.09.003; Coates BS, 2005, INSECT BIOCHEM MOLEC, V35, P129, DOI 10.1016/j.ibmb.2004.10.008; Desh Gujarat, 2013, STAT WIS FIG COTT PR; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Fabrick JA, 2011, INSECT MOL BIOL, V20, P651, DOI 10.1111/j.1365-2583.2011.01095.x; Fabrick JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035658; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FFRENCHCONSTANT RH, 1993, J NEUROCHEM, V60, P2323, DOI 10.1111/j.1471-4159.1993.tb03523.x; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hernandez-Martinez P, 2012, APPL ENVIRON MICROB, V78, P6759, DOI 10.1128/AEM.01689-12; Herring RJ, 2007, J DEV STUD, V43, P130, DOI 10.1080/00220380601055601; Higginson DM, 2005, EVOLUTION, V59, P915, DOI 10.1111/j.0014-3820.2005.tb01765.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lalitha N, 2009, ROUTL EXPLOR ENVIRON, V19, P135; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Mahon RJ, 2010, J ECON ENTOMOL, V103, P472, DOI 10.1603/EC09225; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Monsanto, 2010, COTT IND; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nair R, 2013, CURR SCI INDIA, V104, P215; National Research Council, 2010, IMP GEN ENG CROPS FA; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Rinkevich FD, 2010, INVERTEBR NEUROSCI, V10, P25, DOI 10.1007/s10158-010-0102-1; Roy SW, 2009, TRENDS ECOL EVOL, V24, P447, DOI 10.1016/j.tree.2009.04.005; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stone GD, 2014, HUM ORGAN, V63, P127; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik B., 2012, GM CROPS FOOD, V3, P1; Tabashnik BE, 2000, APPL ENVIRON MICROB, V66, P4582, DOI 10.1128/AEM.66.10.4582-4584.2000; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2004, J ECON ENTOMOL, V97, P721, DOI 10.1603/0022-0493(2004)097[0721:SGBORT]2.0.CO;2; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P2125, DOI 10.1603/0022-0493-99.6.2125; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]; Zhang X, 2013, INSECT BIOCHEM MOLEC, V43, P712, DOI 10.1016/j.ibmb.2013.05.007; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	84	109	116	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97900	10.1371/journal.pone.0097900	http://dx.doi.org/10.1371/journal.pone.0097900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840729	gold, Green Published			2022-12-25	WOS:000340948600089
J	Duan, CX; Li, DD; Sun, SL; Wang, XM; Zhu, ZD				Duan, Can-xing; Li, Dan-dan; Sun, Su-li; Wang, Xiao-ming; Zhu, Zhen-dong			Rapid Development of Microsatellite Markers for Callosobruchus chinensis Using Illumina Paired-End Sequencing	PLOS ONE			English	Article							EST-SSR MARKERS; TRANSCRIPTOME ANALYSIS; HUMAN GENOME; COLEOPTERA; L.; TRINUCLEOTIDE; REVEALS; BEETLE; PLANTS; GENES	Background: The adzuki bean weevil, Callosobruchus chinensis L., is one of the most destructive pests of stored legume seeds such as mungbean, cowpea, and adzuki bean, which usually cause considerable loss in the quantity and quality of stored seeds during transportation and storage. However, a lack of genetic information of this pest results in a series of genetic questions remain largely unknown, including population genetic structure, kinship, biotype abundance, and so on. Co-dominant microsatellite markers offer a great resolving power to determine these events. Here, we report rapid microsatellite isolation from C. chinensis via high-throughput sequencing. Principal Findings: In this study, 94,560,852 quality-filtered and trimmed reads were obtained for the assembly of genome using Illumina paired-end sequencing technology. In total, the genome with total length of 497,124,785 bp, comprising 403,113 high quality contigs was generated with de novo assembly. More than 6800 SSR loci were detected and a suit of 6303 primer pair sequences were designed and 500 of them were randomly selected for validation. Of these, 196 pair of primers, i.e. 39.2%, produced reproducible amplicons that were polymorphic among 8 C. chinensis genotypes collected from different geographical regions. Twenty out of 196 polymorphic SSR markers were used to analyze the genetic diversity of 18 C. chinensis populations. The results showed the twenty SSR loci were highly polymorphic among these populations. Conclusions: This study presents a first report of genome sequencing and de novo assembly for C. chinensis and demonstrates the feasibility of generating a large scale of sequence information and SSR loci isolation by Illumina paired-end sequencing. Our results provide a valuable resource for C. chinensis research. These novel markers are valuable for future genetic mapping, trait association, genetic structure and kinship among C. chinensis.	[Duan, Can-xing; Li, Dan-dan; Sun, Su-li; Wang, Xiao-ming; Zhu, Zhen-dong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhu, ZD (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	zhuzhendong@caas.cn			Institute of Crop Sciences, CAAS [2060302-2-13]; Modern Agro-industry Technology Research System, Ministry of Agriculture of China [CARS-09]	Institute of Crop Sciences, CAAS; Modern Agro-industry Technology Research System, Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Public Welfare Special Fund (2060302-2-13) from Institute of Crop Sciences, CAAS and Modern Agro-industry Technology Research System (CARS-09) from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chaubey MK, 2008, J OLEO SCI, V57, P171, DOI 10.5650/jos.57.171; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kageyama D, 2010, J STORED PROD RES, V46, P13, DOI 10.1016/j.jspr.2009.07.003; KIMURA M, 1964, GENETICS, V49, P725; Kondo N, 1999, ZOOL SCI, V16, P955, DOI 10.2108/zsj.16.955; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Mishra Dheeraj, 2006, J Oleo Sci, V56, P1; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nahdy MS, 1998, J STORED PROD RES, V34, P207, DOI 10.1016/S0022-474X(97)00043-X; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ott J., 1991, ANAL HUMAN GENETIC L; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shahin Arwa, 2012, BMC Res Notes, V5, P79, DOI 10.1186/1756-0500-5-79; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHINODA K, 1991, APPL ENTOMOL ZOOL, V26, P91; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Talekar NS, 1988, P 2 INT S MUNGB AVRD, P329; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuda M, 2004, B ENTOMOL RES, V94, P75, DOI 10.1079/BER2003277; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; XuJ J, 2007, THESIS YANGZHOU U YA; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	54	18	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95458	10.1371/journal.pone.0095458	http://dx.doi.org/10.1371/journal.pone.0095458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835431	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800008
J	Gardiner, RZ; Doran, E; Strickland, K; Carpenter-Bundhoo, L; Frere, C				Gardiner, Riana Zanarivero; Doran, Erik; Strickland, Kasha; Carpenter-Bundhoo, Luke; Frere, Celine			A Face in the Crowd: A Non-Invasive and Cost Effective Photo-Identification Methodology to Understand the Fine Scale Movement of Eastern Water Dragons	PLOS ONE			English	Article							HOME-RANGE SIZE; ELK CERVUS-ELAPHUS; HABITAT USE; BODY TEMPERATURES; MICROHABITAT USE; LIZARD; DIMORPHISM; PATTERNS; OVERLAP; FIELD	Ectothermic vertebrates face many challenges of thermoregulation. Many species rely on behavioral thermoregulation and move within their landscape to maintain homeostasis. Understanding the fine-scale nature of this regulation through tracking techniques can provide a better understanding of the relationships between such species and their dynamic environments. The use of animal tracking and telemetry technology has allowed the extensive collection of such data which has enabled us to better understand the ways animals move within their landscape. However, such technologies do not come without certain costs: they are generally invasive, relatively expensive, can be too heavy for small sized animals and unreliable in certain habitats. This study provides a cost-effective and non-invasive method through photo-identification, to determine fine scale movements of individuals. With our methodology, we have been able to find that male eastern water dragons (Intellagama leuseurii) have home ranges one and a half times larger than those of females. Furthermore, we found intraspecific differences in the size of home ranges depending on the time of the day. Lastly, we found that location mostly influenced females' home ranges, but not males and discuss why this may be so. Overall, we provide valuable information regarding the ecology of the eastern water dragon, but most importantly demonstrate that non-invasive photo-identification can be successfully applied to the study of reptiles.	[Gardiner, Riana Zanarivero; Doran, Erik; Strickland, Kasha; Frere, Celine] Univ Sunshine Coast, GeneCol Res Ctr, Maroochydore, Qld, Australia; [Carpenter-Bundhoo, Luke] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Falmouth, Cornwall, England; [Frere, Celine] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of the Sunshine Coast; University of Exeter; University of Queensland	Frere, C (corresponding author), Univ Sunshine Coast, GeneCol Res Ctr, Maroochydore, Qld, Australia.	cfrere@usc.edu.au	Frere, Celine Henria/B-4905-2013; Gardiner, Riana/X-2362-2019; Strickland, Kasha/AAR-5132-2021; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; Gardiner, Riana/0000-0001-7782-8664; Carpenter-Bundhoo, Luke/0000-0002-9637-5231	biosciences department of the University of Exeter	biosciences department of the University of Exeter	The authors received internal funding from the biosciences department of the University of Exeter (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Baird TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041819; Beck DD, 2003, HERPETOL MONOGR, V17, P111, DOI 10.1655/0733-1347(2003)017[0111:HUBGMT]2.0.CO;2; Biebouw K, 2009, INT J PRIMATOL, V30, P367, DOI 10.1007/s10764-009-9349-y; BUTTEMER WA, 1993, OECOLOGIA, V96, P56, DOI 10.1007/BF00318031; Cabrera MP, 2013, ZOOL ANZ, V252, P299, DOI 10.1016/j.jcz.2012.08.003; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Carter AJ, 2009, ANIM BEHAV, V77, P839, DOI 10.1016/j.anbehav.2008.12.007; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cook R., 2004, TERRAPENE C CAROLINA, V1, P197, DOI DOI 10.1163/157075403323012197; Dubey S, 2011, AUSTRAL ECOL, V36, P68, DOI 10.1111/j.1442-9993.2010.02119.x; ERLINGE S, 1990, J MAMMAL, V71, P597, DOI 10.2307/1381799; Firth BT, 1998, PHYSIOL ZOOL, V71, P303, DOI 10.1086/515919; Fisher DO, 1999, ANIM BEHAV, V58, P121, DOI 10.1006/anbe.1999.1119; Fitzgerald LA, 2011, J THERM BIOL, V36, P160, DOI 10.1016/j.jtherbio.2011.01.003; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Georges A, 2013, ANIM CONSERV, V16, P493, DOI 10.1111/acv.12080; Gifford ME, 2012, J THERM BIOL, V37, P496, DOI 10.1016/j.jtherbio.2012.05.003; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; GRANT BW, 1990, ECOLOGY, V71, P2323, DOI 10.2307/1938643; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Harlow Henry J., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/921371; Jachowski DS, 2010, WILDLIFE BIOL, V16, P66, DOI 10.2981/09-034; Kasper CB, 2012, MAMM BIOL, V77, P358, DOI 10.1016/j.mambio.2012.03.006; Kelley EA, 2013, AM J PHYS ANTHROPOL, V150, P122, DOI 10.1002/ajpa.22184; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Knapp C, 2005, ANIM CONSERV, V8, P239; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Perez-Garcia JM, 2013, J ORNITHOL, V154, P63, DOI 10.1007/s10336-012-0871-x; Maria-Carneiro T, 2013, J THERM BIOL, V38, P41; Melville J, 2001, AUSTRAL ECOL, V26, P660, DOI 10.1046/j.1442-9993.2001.01152.x; Merrill E, 2010, PHILOS T R SOC B, V365, P2279, DOI 10.1098/rstb.2010.0077; Michael DR, 2010, AUSTRAL ECOL, V35, P862, DOI 10.1111/j.1442-9993.2009.02092.x; Miles DB, 2000, EVOLUTION, V54, P1386; Moorcroft PR, 2008, ENCY ECOLOGY, V1, P174; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Pinheiro J. C., 2004, NLME LINEAR NONLINEA, V3, P1; Price-Rees S, 2013, ANIM BIOTELEMETRY, V1, P1; Pusey A.E., 1987, P250; RAUCH N, 1985, BEHAV ECOL SOCIOBIOL, V16, P125, DOI 10.1007/BF00295146; Rauset GR, 2013, OECOLOGIA, V172, P701, DOI 10.1007/s00442-012-2546-y; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Sacchi R, 2010, AMPHIBIA-REPTILIA, V31, P489, DOI 10.1163/017353710X521546; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Sreekar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055935; Sterck EHM, 1997, AM J PRIMATOL, V42, P179, DOI 10.1002/(SICI)1098-2345(1997)42:3<179::AID-AJP2>3.0.CO;2-U; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Uzal A, 2013, EUR J WILDLIFE RES, V59, P563, DOI 10.1007/s10344-013-0705-z; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Wang M, 2007, ECOL MODEL, V205, P397, DOI 10.1016/j.ecolmodel.2007.03.003; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zschokke S, 2002, CAN J ZOOL, V80, P2014, DOI [10.1139/z02-183, 10.1139/Z02-183]	63	28	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96992	10.1371/journal.pone.0096992	http://dx.doi.org/10.1371/journal.pone.0096992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835073	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800024
J	Pang, C; Jia, LL; Hou, XH; Gao, X; Liu, W; Bao, YQ; Jia, WP				Pang, Can; Jia, Lili; Hou, Xuhong; Gao, Xin; Liu, Wei; Bao, Yuqian; Jia, Weiping			The Significance of Screening for Microvascular Diseases in Chinese Community-Based Subjects with Various Metabolic Abnormalities	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERNATIONAL-DIABETES-FEDERATION; MACROVASCULAR COMPLICATIONS; INCREASED PREVALENCE; RISK-FACTORS; POPULATION; MICROALBUMINURIA; RETINOPATHY; ALBUMINURIA; SIGNS	Background: To assess the association of albuminuria and retinopathy with metabolic syndrome (MetS) and the related metabolic components defined by various criteria in Chinese community-based subjects. Methods: A total of 3240 Chinese subjects were recruited from urban communities and classified into subgroups with isolated or concomitant state of the two microvascular diseases. MetS was defined according to the standard of International Diabetes Federation, the National Cholesterol Education Program's Adult Treatment Panel III and Chinese Diabetes Society (CDS), separately. Albuminuria was defined as an elevated morning urine albumin-to-creatinine ratio. Retinopathy were identified with nonmydriatic retinal photographs according to the Diabetic Retinopathy Disease Severity Scale. Logistic regression was performed to analyze the contributive risk factors. Results: The subgroup of isolated retinopathy was the oldest (P<0.05), with higher blood pressure (P<0.001) and larger waist circumference (P<0.05). After adjusting for age, sex and other metabolic components, individuals with blood pressure over 130/85 mmHg were prone to have isolated albuminuria (OR: 1.51, P = 0.0001); while individuals with fasting plasma glucose over 5.6 mmol/L were in high risk of retinopathy concomitant with albuminria (OR: 3.04, P = 0.006). Larger waist circumference was a potential risk factors for isolated albuminuria and isolated retinopathy, though not significant after further adjustment of other metabolic components. The risk for albuminuria and retinopathy increased with the aggregation of three or more metabolic components. However, the MetS per se did not have synergic effect and only the MetS defined by CDS remained as a risk factor. Conclusions: Albuminuria and retinopathy were highly associated with accumulated metabolic abnormalities including sub-clinical elevated blood pressure and elevated fasting plasma glucose.	[Pang, Can; Hou, Xuhong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Dept Endocrinol & Metab,Shanghai Clin Ctr Metab D, Shanghai 200030, Peoples R China; [Jia, Lili] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Liu, Wei] Shanghai Jiao Tong Univ, Affiliated Renji Hosp, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Dept Endocrinol & Metab,Shanghai Clin Ctr Metab D, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012		Drug Innovation Program of National Science and Technology Project [2011ZX09307-001-02]; Integrated Control Project of chronic diseases from Shanghai Hospital Development Center [SHDC12012302]; Training Program for Young Clinician from Shanghai Municipal Health Bureau [[2012]114]	Drug Innovation Program of National Science and Technology Project; Integrated Control Project of chronic diseases from Shanghai Hospital Development Center; Training Program for Young Clinician from Shanghai Municipal Health Bureau	This study was supported by Drug Innovation Program of National Science and Technology Project (No. 2011ZX09307-001-02), Integrated Control Project of chronic diseases from Shanghai Hospital Development Center (No. SHDC12012302) and Training Program for Young Clinician from Shanghai Municipal Health Bureau (No. [2012]114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2006, ISR MED ASSOC J, V8, P378; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bonadonna RC, 2006, DIABETES CARE, V29, P2701, DOI 10.2337/dc06-0942; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; DAVIS JE, 1978, DIABETES, V27, P102, DOI 10.2337/diabetes.27.2.102; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; group C.D.S.M.S.R.C, 2004, CHIN J DIABETES, V12, P151, DOI [10.3321/j.issn:1006-6187.2004.03.002, DOI 10.3321/J.ISSN:1006-6187.2004.03.002]; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hanai K, 2008, DIABETES RES CLIN PR, V79, P318, DOI 10.1016/j.diabres.2007.08.032; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Iwasaki T, 2008, DIABETES RES CLIN PR, V79, P427, DOI [10.1016/j.diabres.2007.10.035, 10.1016/j.diabres.2007.06.014]; Jia W P, 2002, Obes Rev, V3, P157; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Jiang LP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-118; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P161, DOI 10.1136/bjo.2007.127449; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Kshirsagar AV, 2008, AM J CARDIOL, V101, P401, DOI 10.1016/j.amjcard.2007.08.041; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P4458, DOI 10.1167/iovs.09-4939; Lu B, 2007, DIABETES RES CLIN PR, V75, P184, DOI 10.1016/j.diabres.2006.06.024; Nakamura M, 2004, INTERNAL MED, V43, P919, DOI 10.2169/internalmedicine.43.919; Pang C, 2012, DIABETES-METAB RES, V28, P276, DOI 10.1002/dmrr.1307; Raman R, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-67; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P1167, DOI 10.1093/ndt/gfp591; van der Velde M, 2012, NEPHROL DIAL TRANSPL, V27, P2275, DOI 10.1093/ndt/gfr634; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97928	10.1371/journal.pone.0097928	http://dx.doi.org/10.1371/journal.pone.0097928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835219	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800085
J	Zhao, C; Ji, NJ; Zhang, BL; Sun, P; Feng, WP; Wei, J; Chang, YQ				Zhao, Chong; Ji, Nanjing; Zhang, Binglong; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing			Effects of Covering Behavior and Exposure to a Predatory Crab Charybdis japonica on Survival and HSP70 Expression of Juvenile Sea Urchins Strongylocentrotus intermedius	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS; CARASSIUS-AURATUS; STRESS-PROTEINS; SWIMMING CRAB; RADIATION; GENE; RECRUITMENT; SETTLEMENT; MORTALITY; ABUNDANCE	Predation is a complex process among predator, prey and environment. Juvenile sea urchins are more susceptible to predators than adults, which affects community structure. Behavior is involved in anti-predator responses by changes in the expression of anti-predator responsive genes. Here, we investigated the effects of exposure to a predatory crab Charybdis japonica and covering behavior on survival and HSP70 expression of juvenile sea urchins Strongylocentrotus intermedius. C. japonica consumed large numbers of juvenile S. intermedius in 12 hours with a mortality of 34.17 +/- 11.43%. Covering behavior did not significantly reduce predation. Exposure to C. japonica did not significantly upregulate HSP70 expression of juvenile S. intermedius in 12 hours. Covering behavior showed no significant regulative effect on the gene expression of HSP70 of juvenile S. intermedius exposed to C. japonica for 12 hours. The results indicate that the anti-predator function of covering behavior is limited and that HSP70 expression does not appear to play an important role in the anti-predator process of S. intermedius.	[Zhao, Chong; Ji, Nanjing; Zhang, Binglong; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhao, Chong] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Ocean University of China	Chang, YQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	changlab@hotmail.com			Chinese National 863 Project [2012AA10A412]	Chinese National 863 Project(National High Technology Research and Development Program of China)	This work was supported by the Chinese National 863 Project (2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NL, 2001, MAR ECOL PROG SER, V213, P87, DOI 10.3354/meps213087; Agatsuma Y, 2001, FISHERIES SCI, V67, P1181, DOI 10.1046/j.1444-2906.2001.00379.x; Agatsuma Y, 2013, DEV AQUAC FISH SCI, V38, P437, DOI 10.1016/B978-0-12-396491-5.00028-9; Amsler CD, 1999, MAR ECOL PROG SER, V183, P105, DOI 10.3354/meps183105; Bacher S, 2005, FUNCT ECOL, V19, P263, DOI 10.1111/j.1365-2435.2005.00954.x; Bonaventura R, 2006, MAR BIOL, V149, P79, DOI 10.1007/s00227-005-0213-0; Briffa M, 2000, ANIM BEHAV, V59, P159, DOI 10.1006/anbe.1999.1273; Chang Y. Q., 2004, BIOL RES BREEDING SE, P217; Clemente S, 2013, MAR BIOL, V160, P579, DOI 10.1007/s00227-012-2114-3; Crook AC, 2003, MAR ECOL-P S Z N I, V24, P275, DOI 10.1046/j.1439-0485.2003.00846.x; DOUGLAS CA, 1976, PAC SCI, V30, P83; Duffy JE, 2001, MARINE COMMUNITY ECOLOGY, P131; Dumont CP, 2007, ANIM BEHAV, V73, P979, DOI 10.1016/j.anbehav.2006.11.008; Frost AJ, 2013, ANIM BEHAV, V85, P1199, DOI 10.1016/j.anbehav.2013.03.006; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Jennings LB, 2010, MAR BIOL, V157, P307, DOI 10.1007/s00227-009-1318-7; Jiang WM, 1998, MAR FISH RES, V19, P54; Kagawa N, 2002, ZOOL SCI, V19, P735, DOI 10.2108/zsj.19.735; Kagawa N, 1999, FISH PHYSIOL BIOCHEM, V21, P103, DOI 10.1023/A:1007785707501; Kawai T, 1996, FISHERIES SCI, V62, P317, DOI 10.2331/fishsci.62.317; LAWRENCE JM, 1976, NATURE, V262, P490, DOI 10.1038/262490a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez S, 1998, MAR ECOL PROG SER, V172, P239, DOI 10.3354/meps172239; Matranga V, 2002, CELL MOL BIOL, V48, P345; Mesa MG, 2002, NORTHWEST SCI, V76, P118; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Osovitz CJ, 2005, J EXP MAR BIOL ECOL, V327, P134, DOI 10.1016/j.jembe.2005.06.011; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Pawson DL, 2013, DEEP-SEA RES PT II, V92, P207, DOI 10.1016/j.dsr2.2013.01.023; Pearse JS, 2006, SCIENCE, V314, P940, DOI 10.1126/science.1131888; Richner H, 2000, MAR ECOL PROG SER, V205, P307, DOI 10.3354/meps205307; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V365, P59, DOI 10.1016/j.jembe.2008.07.041; Shang Y C., 2005, ETHOLOGY, P168; Sigg JE, 2007, J MAR BIOL ASSOC UK, V87, P1257, DOI 10.1017/S0025315407055865; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Slos S, 2009, ECOL ENTOMOL, V34, P297, DOI 10.1111/j.1365-2311.2008.01077.x; Smith PJ, 2003, NEW ZEAL J MAR FRESH, V37, P753, DOI 10.1080/00288330.2003.9517205; Sorensen JG, 2011, CAN J ZOOL, V89, P1249, DOI 10.1139/Z11-105; Sudo H, 2008, FISH RES, V89, P49, DOI 10.1016/j.fishres.2007.08.012; Verling E, 2002, MAR BIOL, V140, P391, DOI 10.1007/s002270100689; Williams JL, 2006, BEHAV ECOL, V17, P586, DOI 10.1093/beheco/ark003; Yu Zong-he, 2010, Marine Sciences (Beijing), V34, P62; Zhao C, 2013, MAR FRESHW BEHAV PHY, V46, P337, DOI 10.1080/10236244.2013.834119; Zhou Zun-Chun, 2008, Yichuan, V30, P1453, DOI 10.3724/SP.J.1005.2008.01453	47	9	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97840	10.1371/journal.pone.0097840	http://dx.doi.org/10.1371/journal.pone.0097840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837036	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800075
J	Johansson, D; Laursen, F; Ferno, A; Fosseidengen, JE; Klebert, P; Stien, LH; Vagseth, T; Oppedal, F				Johansson, David; Laursen, Frida; Ferno, Anders; Fosseidengen, Jan Erik; Klebert, Pascal; Stien, Lars Helge; Vagseth, Tone; Oppedal, Frode			The Interaction between Water Currents and Salmon Swimming Behaviour in Sea Cages	PLOS ONE			English	Article							ATLANTIC SALMON; SITE SELECTION; SALAR L.; PERFORMANCE; FISH	Positioning of sea cages at sites with high water current velocities expose the fish to a largely unknown environmental challenge. In this study we observed the swimming behaviour of Atlantic salmon (Salmo salar L.) at a commercial farm with tidal currents altering between low, moderate and high velocities. At high current velocities the salmon switched from the traditional circular polarized group structure, seen at low and moderate current velocities, to a group structure where all fish kept stations at fixed positions swimming against the current. This type of group behaviour has not been described in sea cages previously. The structural changes could be explained by a preferred swimming speed of salmon spatially restricted in a cage in combination with a behavioural plasticity of the fish.	[Johansson, David; Laursen, Frida; Fosseidengen, Jan Erik; Stien, Lars Helge; Vagseth, Tone; Oppedal, Frode] Inst Marine Res, Matredal, Norway; [Laursen, Frida; Ferno, Anders] Univ Bergen, Dept Biol, Bergen, Norway; [Klebert, Pascal] Sintef Fisheries & Aquaculture, Trondheim, Norway	Institute of Marine Research - Norway; University of Bergen; SINTEF	Johansson, D (corresponding author), Inst Marine Res, Matredal, Norway.	davidjo@imr.no	klebert, pascal/DSX-4164-2022	Oppedal, Frode/0000-0001-8625-0331	Research Council of Norway [207116/E40]; Norwegian Ministry of Fisheries	Research Council of Norway(Research Council of Norway); Norwegian Ministry of Fisheries	The study was supported by Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906) grant no. 207116/E40 and by the Norwegian Ministry of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetti DD, 2010, MAR TECHNOL SOC J, V44, P22, DOI 10.4031/MTSJ.44.3.11; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Crawley M.J., 2007, R BOOK, P627, DOI [10.1002/9780470515075.ch19, DOI 10.1002/9780470515075.CH19]; Deitch EJ, 2006, J EXP BIOL, V209, P1310, DOI 10.1242/jeb.02105; Dempster T, 2009, AQUACULTURE, V288, P254, DOI 10.1016/j.aquaculture.2008.12.003; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Fore M, 2009, AQUACULTURE, V288, P196, DOI 10.1016/j.aquaculture.2008.11.031; Fredheim A, 2009, BASICS, P914, DOI 10.1533/9781845696474.6.914; Gansel LC, 2012, J OFFSHORE MECH ARCT, V134, DOI 10.1115/1.4003695; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Holmer M, 2010, AQUACULT ENV INTERAC, V1, P57, DOI 10.3354/aei00007; Johansson D, 2007, AQUACULTURE, V265, P271, DOI 10.1016/j.aquaculture.2006.12.047; JUELL JE, 1995, REV FISH BIOL FISHER, V5, P320, DOI 10.1007/BF00043005; Klebert P, 2013, OCEAN ENG, V58, P260, DOI 10.1016/j.oceaneng.2012.11.006; Lijalad M, 2009, AQUACULTURE, V290, P145, DOI 10.1016/j.aquaculture.2009.01.039; Loverich GF, 1997, OPEN OCEAN AQUACULTU, P131; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Perez OM, 2003, AQUACULT ENG, V29, P1, DOI 10.1016/S0144-8609(03)00031-1; Remen M, 2012, AQUACULTURE, V326, P148, DOI 10.1016/j.aquaculture.2011.11.036; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; SUTTERLIN AM, 1979, J FISH RES BOARD CAN, V36, P948, DOI 10.1139/f79-132	22	62	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97635	10.1371/journal.pone.0097635	http://dx.doi.org/10.1371/journal.pone.0097635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830443	Green Published, gold			2022-12-25	WOS:000336789500089
J	Johnson, JE; Johnson, FB				Johnson, Jay E.; Johnson, F. Brad			Methionine Restriction Activates the Retrograde Response and Confers Both Stress Tolerance and Lifespan Extension to Yeast, Mouse and Human Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; CELLULAR SENESCENCE; GENE-EXPRESSION; AGING PRIMATES; TRANSFER-RNA; DWARF MICE; KAPPA-B; RESISTANCE; TOR	A methionine-restricted diet robustly improves healthspan in key model organisms. For example, methionine restriction reduces age-related pathologies and extends lifespan up to 45% in rodents. However, the mechanisms underlying these benefits remain largely unknown. We tested whether the yeast chronological aging assay could model the benefits of methionine restriction, and found that this intervention extends lifespan when enforced by either dietary or genetic approaches, and furthermore, that the observed lifespan extension is due primarily to reduced acid accumulation. In addition, methionine restriction-induced lifespan extension requires the activity of the retrograde response, which regulates nuclear gene expression in response to changes in mitochondrial function. Consistent with an involvement of stress-responsive retrograde signaling, we also found that methionine-restricted yeast are more stress tolerant than control cells. Prompted by these findings in yeast, we tested the effects of genetic methionine restriction on the stress tolerance and replicative lifespans of cultured mouse and human fibroblasts. We found that such methionine-restricted mammalian cells are resistant to numerous cytotoxic stresses, and are substantially longer-lived than control cells. In addition, similar to yeast, the extended lifespan of methionine-restricted mammalian cells is associated with NF kappa B-mediated retrograde signaling. Overall, our data suggest that improved stress tolerance and extension of replicative lifespan may contribute to the improved healthspan observed in methionine-restricted rodents, and also support the possibility that manipulation of the pathways engaged by methionine restriction may improve healthspan in humans.	[Johnson, Jay E.; Johnson, F. Brad] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [P01-AG031862, R01-AG021521]; NATIONAL INSTITUTE ON AGING [R01AG021521, P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (http://www.nih.gov/)grants P01-AG031862 and R01-AG021521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Albertini E, 2012, AGING-US, V4, P664, DOI 10.18632/aging.100491; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Brachmann CB, 1998, YEAST, V14, P115; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; FESNEAU C, 1975, BIOCHIMIE, V57, P49, DOI 10.1016/S0300-9084(75)80109-X; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Guaragnella N, 2013, BBA-MOL CELL RES, V1833, P2765, DOI 10.1016/j.bbamcr.2013.07.017; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hinojosa CA, 2012, EXP GERONTOL, V47, P958, DOI 10.1016/j.exger.2012.08.013; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hwang GW, 2007, BIOCHEM BIOPH RES CO, V363, P873, DOI 10.1016/j.bbrc.2007.09.064; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Jazwinski SM, 2000, ANN NY ACAD SCI, V908, P21; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang JC, 2000, FASEB J, V14, P2135; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KJELLINS.K, 1969, J BACTERIOL, V100, P679; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; McCarty MF, 2009, MED HYPOTHESES, V72, P125, DOI 10.1016/j.mehy.2008.07.044; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; ORENTREICH N, 1993, J NUTR, V123, P269; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Sanchez-Roman I, 2013, EXP GERONTOL, V48, P1030, DOI 10.1016/j.exger.2013.02.021; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; SINGH A, 1974, J BACTERIOL, V118, P911, DOI 10.1128/JB.118.3.911-918.1974; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Welch AZ, 2013, MOL BIOL CELL, V24, P115, DOI 10.1091/mbc.E12-07-0524; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wu P, 1998, GENE, V220, P109, DOI 10.1016/S0378-1119(98)00330-8; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079319	64	62	64	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97729	10.1371/journal.pone.0097729	http://dx.doi.org/10.1371/journal.pone.0097729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830393	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500107
J	Kaminski, L; Eichler, J				Kaminski, Lina; Eichler, Jerry			Haloferax volcanii N-Glycosylation: Delineating the Pathway of dTDP-rhamnose Biosynthesis	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; UDP-L-RHAMNOSE; PROTEIN GLYCOSYLATION; DIPHOSPHATE 4-KETO-6-DEOXY-D-GLUCOSE; CARBOHYDRATE-METABOLISM; ENZYMATIC SYNTHESIS; MEVALONATE PATHWAY; D-GLUCOSE; ARCHAEA; IDENTIFICATION	In the halophilic archaea Haloferax volcanii, the surface (S)-layer glycoprotein can be modified by two distinct N-linked glycans. The tetrasaccharide attached to S-layer glycoprotein Asn-498 comprises a sulfated hexose, two hexoses and a rhamnose. While Agl11-14 have been implicated in the appearance of the terminal rhamnose subunit, the precise roles of these proteins have yet to be defined. Accordingly, a series of in vitro assays conducted with purified Agl11-Agl14 showed these proteins to catalyze the stepwise conversion of glucose-1-phosphate to dTDP-rhamnose, the final sugar of the tetrasaccharide glycan. Specifically, Agl11 is a glucose-1-phosphate thymidylyltransferase, Agl12 is a dTDP-glucose-4,6-dehydratase and Agl13 is a dTDP-4-dehydro-6-deoxy-glucose-3,5-epimerase, while Agl14 is a dTDP-4-dehydrorhamnose reductase. Archaea thus synthesize nucleotide-activated rhamnose by a pathway similar to that employed by Bacteria and distinct from that used by Eukarya and viruses. Moreover, a bioinformatics screen identified homologues of agl11-14 clustered in other archaeal genomes, often as part of an extended gene cluster also containing aglB, encoding the archaeal oligosaccharyltransferase. This points to rhamnose as being a component of N-linked glycans in Archaea other than Hfx. volcanii.	[Kaminski, Lina; Eichler, Jerry] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Eichler, J (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	jeichler@bgu.ac.il	EICHLER, JERRY/F-2351-2012	EICHLER, JERRY/0000-0001-9409-8026	Israel Science Foundation [8/11]; U. S. Army Research Office [W911NF-11-1-520]; Negev-Zin Associates Scholarship	Israel Science Foundation(Israel Science Foundation); U. S. Army Research Office; Negev-Zin Associates Scholarship	J.E. is supported by the Israel Science Foundation (grant 8/11) and the U. S. Army Research Office (W911NF-11-1-520). L.K. is the recipient of a Negev-Zin Associates Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, J BACTERIOL, V190, P3140, DOI 10.1128/JB.00056-08; Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Benelli D, 2011, BIOCHEM SOC T, V39, P89, DOI 10.1042/BST0390089; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Christendat D, 2000, J BIOL CHEM, V275, P24608, DOI 10.1074/jbc.C000238200; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; GLASER L, 1961, J BIOL CHEM, V236, P1795; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2010, ARCHAEA, V2010, DOI 10.1155/2010/315108; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; KAMSTEEG J, 1978, FEBS LETT, V91, P281, DOI 10.1016/0014-5793(78)81192-2; Kuntz C, 1997, GLYCOBIOLOGY, V7, P897, DOI 10.1093/glycob/7.7.897; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; Maki M, 2004, GLYCOBIOLOGY, V14, p1R, DOI 10.1093/glycob/cwh040; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; MELO A, 1968, J BIOL CHEM, V243, P1475; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; OKAZAKI R, 1962, J BIOL CHEM, V237, P3014; PAZUR JH, 1961, J BIOL CHEM, V236, P1780; Phillips G, 2010, J BIOL CHEM, V285, P12706, DOI 10.1074/jbc.M110.102236; Plavner N, 2008, J BACTERIOL, V190, P8045, DOI 10.1128/JB.01200-08; Sakuraba H, 2004, CHEM REC, V3, P281, DOI 10.1002/tcr.10066; Sato T, 2011, CURR OPIN MICROBIOL, V14, P307, DOI 10.1016/j.mib.2011.04.014; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; SNIPES CE, 1977, J BIOL CHEM, V252, P8113; SPROTT GD, 1983, J BIOL CHEM, V258, P4026; Teramoto M., 2012, ADV APPL BIOTECHNOLO, DOI [10.5772/29196, DOI 10.5772/29196]; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Wang JF, 2009, PLANT PHYSIOL BIOCH, V47, P86, DOI 10.1016/j.plaphy.2008.10.011; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200	51	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97441	10.1371/journal.pone.0097441	http://dx.doi.org/10.1371/journal.pone.0097441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831810	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500059
J	Frosch, C; Kraus, RHS; Angst, C; Allgower, R; Michaux, J; Teubner, J; Nowak, C				Frosch, Christiane; Kraus, Robert H. S.; Angst, Christof; Allgoewer, Rainer; Michaux, Johan; Teubner, Jana; Nowak, Carsten			The Genetic Legacy of Multiple Beaver Reintroductions in Central Europe	PLOS ONE			English	Article							CASTOR-FIBER; EURASIAN BEAVER; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; COMPUTER-PROGRAM; AMERICAN BEAVER; CONSERVATION; CANADENSIS; SOFTWARE; BRITAIN	The comeback of the Eurasian beaver (Castor fiber) throughout western and central Europe is considered a major conservation success. Traditionally, several subspecies are recognised by morphology and mitochondrial haplotype, each linked to a relict population. During various reintroduction programs in the 20th century, beavers from multiple source localities were released and now form viable populations. These programs differed in their reintroduction strategies, i.e., using pure subspecies vs. mixed source populations. This inhomogeneity in management actions generated ongoing debates regarding the origin of present beaver populations and appropriate management plans for the future. By sequencing of the mitochondrial control region and microsatellite genotyping of 235 beaver individuals from five selected regions in Germany, Switzerland, Luxembourg, and Belgium we show that beavers from at least four source origins currently form admixed, genetically diverse populations that spread across the study region. While regional occurrences of invasive North American beavers (n = 20) were found, all but one C. fiber bore the mitochondrial haplotype of the autochthonous western Evolutionary Significant Unit (ESU). Considering this, as well as the viability of admixed populations and the fact that the fusion of different lineages is already progressing in all studied regions, we argue that admixture between different beaver source populations should be generally accepted.	[Frosch, Christiane; Kraus, Robert H. S.; Nowak, Carsten] Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany; [Frosch, Christiane; Kraus, Robert H. S.; Nowak, Carsten] Nat Hist Museum, Gelnhausen, Germany; [Angst, Christof] Ctr Suisse Cartog Faune CSCF, Neuchatel, Switzerland; [Allgoewer, Rainer] Buro Okosyst Forsch, Muhlacker, Germany; [Michaux, Johan] Inst Zool, Unite Rech Zoogeog, Liege, Belgium; [Teubner, Jana] Nat Schutzstat Zippelsforde, Zippelsforde, Germany; [Nowak, Carsten] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Frosch, C (corresponding author), Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany.	cfrosch@senckenberg.de	Nowak, Carsten/A-4466-2014; Kraus, Robert/F-1188-2011	Nowak, Carsten/0000-0002-3139-1951; Kraus, Robert/0000-0002-8743-7082	Regierungsprasidium Darmstadt, Hesse, Germany; Johanna Samel-Stiftung; Frankfurt Zoological Society; Leibniz Association [SAW-2011-SGN-3]; Hesse's LOEWE excellence initiative	Regierungsprasidium Darmstadt, Hesse, Germany; Johanna Samel-Stiftung; Frankfurt Zoological Society; Leibniz Association; Hesse's LOEWE excellence initiative	This study was financially supported by the Regierungsprasidium Darmstadt, Hesse, Germany. CF received funding from the Johanna Samel-Stiftung and the Frankfurt Zoological Society. RHSK was funded by grant SAW-2011-SGN-3 from the Leibniz Association. Additional funding comes from Hesse's LOEWE excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2002, GENETICS, V160, P1217; Bartel M, 2012, WILDTIER INFORMATION; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; Dewas M, 2012, MAMMAL REV, V42, P144, DOI 10.1111/j.1365-2907.2011.00196.x; Djoschkin WW, 1972, BIBER ALTEN NEUEN WE, P437; Dolch D, 2002, NATURSCHUTZ LANDSCHA, V11, P220; Ducroz JF, 2005, J MAMMAL, V86, P1059, DOI 10.1644/1545-1542(2005)86[1059:GVAPSO]2.0.CO;2; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; Enserink M, 2006, SCIENCE, V314, P746, DOI 10.1126/science.314.5800.746; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frosch C, 2011, EUR J WILDLIFE RES, V57, P679, DOI 10.1007/s10344-010-0486-6; Gippoliti S, 2007, INT ZOO YB, V41; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Halley Duncan J., 2003, Lutra, V46, P91; Halley DJ, 2011, MAMMAL REV, V41, P40, DOI 10.1111/j.1365-2907.2010.00167.x; Heidecke D., 1986, HERCYNIA NF LEIPZIG, V22, P146; Hermann N, 2013, J NAT CONSERV, V21, P125, DOI 10.1016/j.jnc.2012.11.008; Herr Jan, 2009, Lutra, V52, P123; Horn S, 2014, MOL ECOL, V23, P1717, DOI 10.1111/mec.12691; Horn Susanne, 2010, Artenschutzreport, V26, P72; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014622; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAVROV L S, 1973, Zoologicheskii Zhurnal, V52, P734; Linnell JDC, 2009, REINTRODUCTION TOP O; Macdonald DW, 1995, MAMMAL REV, V25, P161, DOI 10.1111/j.1365-2907.1995.tb00443.x; McEwing R, 2014, EUR J WILDLIFE RES, V60, P547, DOI 10.1007/s10344-014-0803-6; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nolet BA, 1996, BIOL CONSERV, V75, P125, DOI 10.1016/0006-3207(95)00063-1; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Parker H, 2012, WILDLIFE BIOL, V18, P354, DOI 10.2981/12-007; Pelz-Serrano K, 2009, MOL ECOL RESOUR, V9, P551, DOI 10.1111/j.1755-0998.2008.02364.x; Piechocki R., 1977, Bzitrage Jagd-Wildforsch., V10, P332; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Saveljev Alexander, 2002, Acta Zoologica Lituanica, V12, P397; Schwab G, 2002, EUROPEAN BEAVER NEW, P51; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiere N., 2002, MOL ECOL NOTES, V10, P1046, DOI DOI 10.1046/J.1471-8286.2002.00228.X-I2; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x	52	34	35	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97619	10.1371/journal.pone.0097619	http://dx.doi.org/10.1371/journal.pone.0097619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827835	Green Published, gold			2022-12-25	WOS:000336857400112
J	Haack, RA; Britton, KO; Brockerhoff, EG; Cavey, JF; Garrett, LJ; Kimberley, M; Lowenstein, F; Nuding, A; Olson, LJ; Turner, J; Vasilaky, KN				Haack, Robert A.; Britton, Kerry O.; Brockerhoff, Eckehard G.; Cavey, Joseph F.; Garrett, Lynn J.; Kimberley, Mark; Lowenstein, Frank; Nuding, Amelia; Olson, Lars J.; Turner, James; Vasilaky, Kathryn N.			Effectiveness of the International Phytosanitary Standard ISPM No. 15 on Reducing Wood Borer Infestation Rates in Wood Packaging Material Entering the United States	PLOS ONE			English	Article							EMERALD ASH BORER; HEAT-TREATMENT; EXOTIC BARK; AMBROSIA BEETLES; COLEOPTERA; ESTABLISHMENT; INVASIONS; IMPACTS; FORESTS; INSECT	Numerous bark- and wood-infesting insects have been introduced to new countries by international trade where some have caused severe environmental and economic damage. Wood packaging material (WPM), such as pallets, is one of the high risk pathways for the introduction of wood pests. International recognition of this risk resulted in adoption of International Standards for Phytosanitary Measures No. 15 (ISPM15) in 2002, which provides treatment standards for WPM used in international trade. ISPM15 was originally developed by members of the International Plant Protection Convention to "practically eliminate" the risk of international transport of most bark and wood pests via WPM. The United States (US) implemented ISPM15 in three phases during 2005-2006. We compared pest interception rates of WPM inspected at US ports before and after US implementation of ISPM15 using the US Department of Agriculture AQIM (Agriculture Quarantine Inspection Monitoring) database. Analyses of records from 2003-2009 indicated that WPM infestation rates declined 36-52% following ISPM15 implementation, with results varying in statistical significance depending on the selected starting parameters. Power analyses of the AQIM data indicated there was at least a 95% chance of detecting a statistically significant reduction in infestation rates if they dropped by 90% post-ISPM15, but the probability fell as the impact of ISPM15 lessened. We discuss several factors that could have reduced the apparent impact of ISPM15 on lowering WPM infestation levels, and suggest ways that ISPM15 could be improved. The paucity of international interception data impeded our ability to conduct more thorough analyses of the impact of ISPM15, and demonstrates the need for well-planned sampling programs before and after implementation of major phytosanitary policies so that their effectiveness can be assessed. We also present summary data for bark- and wood-boring insects intercepted on WPM at US ports during 1984-2008.	[Haack, Robert A.] US Forest Serv, USDA, No Res Stn, Lansing, MI USA; [Britton, Kerry O.] US Forest Serv, USDA, Arlington, VA USA; [Brockerhoff, Eckehard G.] Scion NZ Forest Res Inst, Christchurch, New Zealand; [Cavey, Joseph F.] US Anim & Plant Hlth Inspect Serv, USDA, Plant Hlth Programs, Natl Identificat Serv, Riverdale, MD USA; [Garrett, Lynn J.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Plant Hlth Sci & Technol, Raleigh, NC USA; [Kimberley, Mark] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Lowenstein, Frank] New England Forestry Fdn, Littleton, MA USA; [Nuding, Amelia] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Olson, Lars J.] Univ Maryland, College Pk, MD 20742 USA; [Turner, James] AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand; [Vasilaky, Kathryn N.] Columbia Univ, Earth Inst, New York, NY USA; [Vasilaky, Kathryn N.] Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Scion; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University System of Maryland; University of Maryland College Park; AgResearch - New Zealand; Columbia University; Columbia University	Haack, RA (corresponding author), US Forest Serv, USDA, No Res Stn, Lansing, MI USA.	rhaack@fs.fed.us	Brockerhoff, Eckehard Gustav/C-1528-2009; Turner, James Alan/AAU-9221-2020	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Turner, James Alan/0000-0003-4396-3280	Nature Conservancy; National Science Foundation [EF-0553768]; University of California Santa Barbara; State of California; New Zealand Foundation for Research and Technology [C02X0501, C04X0302]	Nature Conservancy; National Science Foundation(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; New Zealand Foundation for Research and Technology(New Zealand Foundation for Research, Science and Technology)	The Working Group "Effects of trade policy on management of non-native forest pests and pathogens" was supported by a grant from The Nature Conservancy to the National Center for Ecological Analysis and Synthesis, which is a Center funded by the National Science Foundation (Grant #EF-0553768), the University of California Santa Barbara, and the State of California. Partial funding was provided by the New Zealand Foundation for Research and Technology through contracts C02X0501 (Better Border Biosecurity) and C04X0302 (Forest Biosecurity and Protection) to the author EGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Bulman L. S., 1992, New Zealand Journal of Forestry Science, V22, P32; Bulman L. S., 1998, New Zealand Journal of Forestry Science, V28, P335; Costello C, 2003, AM J AGR ECON, V85, P964, DOI 10.1111/1467-8276.00500; Cross David J., 1991, New Zealand Journal of Forestry Science, V21, P235; Deacon JW, 2006, FUNGAL BIOL-UK; Evans HF, 2007, ALIEN INVASIVE SPECI, P149; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Goebel PC, 2010, J ECON ENTOMOL, V103, P597, DOI 10.1603/EC09264; Haack R.A., 1987, P449; Haack R. A., 2011, Bulletin OEPP, V41, P39, DOI 10.1111/j.1365-2338.2010.02432.x; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack RA, 1997, J FOREST, V95, P11; Haack RA, 2009, J ECON ENTOMOL, V102, P1075, DOI 10.1603/029.102.0328; Haack RA, 2013, CABI INVASIVE SER, P48, DOI 10.1079/9781845938291.0048; Haack Robert A., 2003, Integrated Pest Management Reviews, V6, P253, DOI 10.1023/A:1025715200538; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Horridge M, 2008, EXERCISES CONTRIBUTI; International Plant Protection Convention, 2006, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2012, INT STAND PHYT MEAS; International Plant Protection Convention, 2011, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2009, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2013, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2002, PUBL UN FAO, V15; International Plant Protection Convention, 2001, INT STAND PHYT MEAS; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Leal I, 2010, BCX419 NAT RES CAN C; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCullouch DG, 2007, J ECON ENTOMOL, V100, P1304, DOI 10.1603/0022-0493(2007)100[1304:EOCGAH]2.0.CO;2; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Mushrow L, 2004, FOREST CHRON, V80, P224, DOI 10.5558/tfc80224-2; Myers SW, 2009, J ECON ENTOMOL, V102, P2048, DOI 10.1603/029.102.0605; National Research Council, 2002, PRED INV NON PLANTS; Nzokou P, 2008, FOREST PROD J, V58, P68; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Ramsfield TD, 2010, CAN J PLANT PATHOL, V32, P368, DOI 10.1080/07060661.2010.499269; Salvage R, 1999, NAT STAK TIMB PEST C; Sanchez-Salinas PF, 2007, THESIS U TALCA CHILE; SAS Institute, 2008, SAS STAT 9 2 US GUID; Smith RS., 1991, USE HEAT TREATMENT E; Sobek S, 2011, AGR FOREST ENTOMOL, V13, P333, DOI 10.1111/j.1461-9563.2011.00523.x; Strutt A, 2013, FOREST POLICY ECON, V27, P54, DOI 10.1016/j.forpol.2012.11.003; Tubajika KM, 2008, P SUDD OAK DEATH 3 S, P477; U.S. Department of Agriculture, 2011, AGR QUAR INSP MON AQ; United States Census Bureau, 2012, TRAD GOODS MEX; United States Department of Agriculture, 2013, WOOD PACK MAT; United States Department of Agriculture Animal and Plant Health Inspection Service, 2004, FED REGISTER, V69, P55719; United States Department of Agriculture Animal and Plant Health Inspection Service, 2014, PPQ MAN AGR CLEAR 03; United States Department of Agriculture Animal and Plant Health Inspection Service, 1998, FED REGISTER, V63, P50100; United States Department of Agriculture Animal and Plant Health Inspection Service, 2003, IMP SOL WOOD PACK MA; US Government Accountability Office, 2006, GAO06353; Viljoen J, 2002, STOCK TAKE TIMBER TR; Williams F., 2010, EC COST INVASIVE NON; Zahid MI, 2008, AUSTRAL FOR, V71, P287, DOI 10.1080/00049158.2008.10675047	60	103	110	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96611	10.1371/journal.pone.0096611	http://dx.doi.org/10.1371/journal.pone.0096611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827724	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400031
J	Jagga, Z; Gupta, D				Jagga, Zeenia; Gupta, Dinesh			Supervised Learning Classification Models for Prediction of Plant Virus Encoded RNA Silencing Suppressors	PLOS ONE			English	Article							VIRAL SUPPRESSORS; PROTEIN; INTERFERENCE; STRATEGY; SIZE	Viral encoded RNA silencing suppressor proteins interfere with the host RNA silencing machinery, facilitating viral infection by evading host immunity. In plant hosts, the viral proteins have several basic science implications and biotechnology applications. However in silico identification of these proteins is limited by their high sequence diversity. In this study we developed supervised learning based classification models for plant viral RNA silencing suppressor proteins in plant viruses. We developed four classifiers based on supervised learning algorithms: J48, Random Forest, LibSVM and Naive Bayes algorithms, with enriched model learning by correlation based feature selection. Structural and physicochemical features calculated for experimentally verified primary protein sequences were used to train the classifiers. The training features include amino acid composition; auto correlation coefficients; composition, transition, and distribution of various physicochemical properties; and pseudo amino acid composition. Performance analysis of predictive models based on 10 fold cross-validation and independent data testing revealed that the Random Forest based model was the best and achieved 86.11% overall accuracy and 86.22% balanced accuracy with a remarkably high area under the Receivers Operating Characteristic curve of 0.95 to predict viral RNA silencing suppressor proteins. The prediction models for plant viral RNA silencing suppressors can potentially aid identification of novel viral RNA silencing suppressors, which will provide valuable insights into the mechanism of RNA silencing and could be further explored as potential targets for designing novel antiviral therapeutics. Also, the key subset of identified optimal features may help in determining compositional patterns in the viral proteins which are important determinants for RNA silencing suppressor activities. The best prediction model developed in the study is available as a freely accessible web server pVsupPred at http://bioinfo.icgeb.res.in/pvsup/.	[Jagga, Zeenia; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Facil, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Gupta, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Facil, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Gupta, Dinesh/C-1079-2009; Gupta, Dinesh/AAW-4243-2020	Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology (DBT, India); University Grants Commission (UGC, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India); University Grants Commission (UGC, India)(University Grants Commission, India)	The authors thank the Department of Biotechnology (DBT, India) for the grant for "Bioinformatics Infrastructure Facility" at ICGEB, New Delhi. ZJ acknowledges the University Grants Commission (UGC, India) for the Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bortolamiol D, 2008, PLANT SIGNAL BEHAV, V3, P657, DOI 10.4161/psb.3.9.5758; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Japkowicz N, 2000, IC-AI'2000: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 1-III, P111; Jiang L, 2012, SCI CHINA LIFE SCI, V55, P109, DOI 10.1007/s11427-012-4279-x; Karjee Sumona, 2008, V442, P187, DOI 10.1007/978-1-59745-191-8_14; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Quinlan JR, 1993, C4 5 PROGRAMS MACHIN; Rahman J, 2012, APPL BIOCHEM BIOTECH, V167, P758, DOI 10.1007/s12010-012-9702-z; Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346; Rauschhuber C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01363; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; WITTEN IH, 2005, DATA MINING PRACTICA; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Yasser E-M, 2005, WLSVM INTEGRATING LI	44	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97446	10.1371/journal.pone.0097446	http://dx.doi.org/10.1371/journal.pone.0097446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828116	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400096
J	Shearer, AG; Altman, T; Rhee, CD				Shearer, Alexander G.; Altman, Tomer; Rhee, Christine D.			Finding Sequences for over 270 Orphan Enzymes	PLOS ONE			English	Article							METABOLIC-ACTIVITIES; DATABASE; RESOURCE; GENE; IDENTIFICATION; GENOMICS; UNIPROT; LIVER; ACID	Despite advances in sequencing technology, there are still significant numbers of well-characterized enzymatic activities for which there are no known associated sequences. These `orphan enzymes' represent glaring holes in our biological understanding, and it is a top priority to reunite them with their coding sequences. Here we report a methodology for resolving orphan enzymes through a combination of database search and literature review. Using this method we were able to reconnect over 270 orphan enzymes with their corresponding sequence. This success points toward how we can systematically eliminate the remaining orphan enzymes and prevent the introduction of future orphan enzymes.	[Shearer, Alexander G.; Rhee, Christine D.] Clover Collect, Mountain View, CA 94041 USA; [Altman, Tomer] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Shearer, AG (corresponding author), Clover Collect, Mountain View, CA 94041 USA.	agshearer@clovercollective.com	Altman, Tomer/P-8089-2019	Altman, Tomer/0000-0002-6521-5454	National Institute of General Medical Sciences [GM086755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086755] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant GM086755 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; BARNES S, 1989, J LIPID RES, V30, P529; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; BEEDLE AS, 1974, BIOCHEM J, V139, P205, DOI 10.1042/bj1390205; Caspi R, 2013, COMMUNICATION; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; Devoid Scott, 2013, Methods Mol Biol, V985, P17, DOI 10.1007/978-1-62703-299-5_2; Ferrer L, 2011, BIOINFORMATICS, V27, P2478, DOI 10.1093/bioinformatics/btr428; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Koivistoinen OM, 2008, FEBS J, V275, P2482, DOI 10.1111/j.1742-4658.2008.06392.x; Lee TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-170; Lespinet O, 2005, SCIENCE, V307, P42; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; Li LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081956; Liang CG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat043; Liberal R, 2013, BIOINFORMATICS, V29, P154, DOI 10.1093/bioinformatics/btt236; Mao XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051252; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moss GP, NAME CLASSIFY YOUR E; O'Donovan C, 2011, METHODS MOL BIOL, V694, P25, DOI 10.1007/978-1-60761-977-2_2; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ramkissoon KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084508; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; SCHLESINGER M, 1961, J BIOL CHEM, V236, P2421; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Smith AAT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002540; Thomas P, 2012, NUCLEIC ACIDS RES, V40, pW585, DOI 10.1093/nar/gks563; Yamada T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.13	34	14	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97250	10.1371/journal.pone.0097250	http://dx.doi.org/10.1371/journal.pone.0097250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826896	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400066
J	Hsu, HM; Chu, CH; Wang, YT; Lee, Y; Wei, SY; Liu, HW; Ong, SJ; Chen, CP; Tai, JH				Hsu, Hong-Ming; Chu, Chien-Hsin; Wang, Ya-Ting; Lee, Yu; Wei, Shu-Yi; Liu, Hsing-Wei; Ong, Shiou-Jeng; Chen, Chinpan; Tai, Jung-Hsiang			Regulation of Nuclear Translocation of the Myb1 Transcription Factor by TvCyclophilin 1 in the Protozoan Parasite Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; HUMAN-IMMUNODEFICIENCY-VIRUS; CIS-TRANS ISOMERASES; DNA-BINDING DOMAIN; AP65-1 GENE; HUMAN CYCLOPHILIN; ANKYRIN REPEAT; PROTEIN; IRON; PROMOTER	In Trichomonas vaginalis, a Myb1 protein was previously demonstrated to repress transcription of an iron-inducible ap65-1 gene. In this study, a human cyclophilin A homologue, TvCyclophilin 1 (TvCyP1), was identified as a Myb1-binding protein using a bacterial two-hybrid library screening system. The recombinant TvCyP1 exhibited typical peptidyl-prolyl isomerase activity with k(cat)/K-m of similar to 7.1 mu M-1 s(-1). In a pulldown assay, the His-tagged Myb1 interacted with a GST-TvCyP1 fusion protein, which had an enzymatic proficiency half that of recombinant TvCyP1. Both the enzymatic proficiency of GST-TvCyP1 and its binding to His-Myb1 were eliminated by mutation of Arg(63) in the catalytic motif or inhibited by cyclosporin A. TvCyP1 was primarily localized to the hydrogenosomes by immunofluorescence assay, but it was also co-purified with Myb1 in certain vesicle fractions from differential and gradient centrifugations. Transgenic cells overexpressing HA-TvCyP1 had a higher level of nuclear Myb1 but a much lower level of Myb1 associated with the vesicles than control and those overexpressing HA-TvCyP1(R63A). Myb1 was detected at a much higher level in the HA-TvCyP1 protein complex than in the HA-TvCyP1(R63A) protein complex immunoprecipitated from P15 and P100, but not S100, fractions of postnuclear lysates. A TvCyP1-binding motif, (105)YGPKWNK(111), was identified in Myb1 in which Gly(106) and Pro(107) were essential for its binding to TvCyP1. Mutation of Gly(106) and Pro(107), respectively, in HA-Myb1 resulted in cytoplasmic retention and elevated nuclear translocation of the overexpressed protein. These results suggest that TvCyP1 may induce the release of Myb1 that is restrained to certain cytoplasmic vesicles prior to its nuclear translocation.	[Chu, Chien-Hsin; Wang, Ya-Ting; Ong, Shiou-Jeng; Tai, Jung-Hsiang] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 11529, Taiwan; [Hsu, Hong-Ming; Chu, Chien-Hsin; Lee, Yu; Liu, Hsing-Wei; Tai, Jung-Hsiang] Acad Sinica, Inst Biomed Sci, Div Infect Dis & Immunol, Taipei 11529, Taiwan; [Wei, Shu-Yi; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Div Struct Biol, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Tai, JH (corresponding author), Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan.	taijh@gate.sinica.edu.tw	Tai, Jung-Hsiang/S-7019-2018; Chen, Chinpan/O-4202-2018; Chu, Chu/T-6038-2019	HSU, HONG-MING/0000-0002-7579-5106; Chu, Chien-Hsin/0000-0002-5490-8378	National Science Council [NSC101-2320-B-001-026]; Institute of Biomedical Sciences, Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC101-2320-B-001-026 and the Institute of Biomedical Sciences, Academia Sinica.	ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Beltran NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065148; Bergholtz S, 2001, NUCLEIC ACIDS RES, V29, P3546, DOI 10.1093/nar/29.17.3546; Berriman M, 1998, BIOCHEM J, V334, P437, DOI 10.1042/bj3340437; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; Chou CF, 1996, BIOTECHNIQUES, V20, P790; Chu CH, 2011, EUKARYOT CELL, V10, P1607, DOI 10.1128/EC.05177-11; Dietrich L, 2001, J VIROL, V75, P4721, DOI 10.1128/JVI.75.10.4721-4733.2001; Dornan J, 1999, J BIOL CHEM, V274, P34877, DOI 10.1074/jbc.274.49.34877; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; Garcia AF, 2003, MOL MICROBIOL, V47, P1207, DOI 10.1046/j.1365-2958.2003.03366.x; Garcia AF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-116; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Harlow E., 1988, ANTIBODIES LAB MANUA, P55; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hsu HM, 2012, EUKARYOT CELL, V11, P1441, DOI 10.1128/EC.00190-12; Hsu HM, 2009, EUKARYOT CELL, V8, P362, DOI 10.1128/EC.00317-08; Jiang I, 2011, NUCLEIC ACIDS RES, V39, P8992, DOI 10.1093/nar/gkr558; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lou YC, 2009, NUCLEIC ACIDS RES, V37, P2381, DOI 10.1093/nar/gkp097; Meza-Cervantez P, 2011, MICROBIOL-SGM, V157, P3469, DOI 10.1099/mic.0.053033-0; Moreno-Brito V, 2005, CELL MICROBIOL, V7, P245, DOI 10.1111/j.1462-5822.2004.00455.x; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mundodi V, 2004, MOL MICROBIOL, V53, P1099, DOI 10.1111/j.1365-2958.2004.04192.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ong SJ, 2007, J BIOL CHEM, V282, P6716, DOI 10.1074/jbc.M610484200; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; Ong SJ, 2004, MOL MICROBIOL, V52, P1721, DOI 10.1111/j.1365-2958.2004.04088.x; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Piotukh K, 2005, J BIOL CHEM, V280, P23668, DOI 10.1074/jbc.M503405200; SCHONBRUNNER ER, 1991, J BIOL CHEM, V266, P3630; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Torres-Romero JC, 2009, INFECT GENET EVOL, V9, P1065, DOI 10.1016/j.meegid.2009.06.003; Tsai CD, 2002, J BIOL CHEM, V277, P5153, DOI 10.1074/jbc.M110234200; Vajdos FE, 1997, PROTEIN SCI, V6, P2297; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wei SY, 2012, NUCLEIC ACIDS RES, V40, P449, DOI 10.1093/nar/gkr707; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x	53	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19120	19136		10.1074/jbc.M114.549410	http://dx.doi.org/10.1074/jbc.M114.549410			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831011	Green Published, hybrid			2022-12-25	WOS:000339062900042
J	Al Baqlani, SA; Sy, BT; Ratsch, BA; Al Naamani, K; Al Awaidy, S; Al Busaidy, S; Pauli, G; Bock, CT				Al Baqlani, Said Ali; Bui Tien Sy; Ratsch, Boris A.; Al Naamani, Khalid; Al Awaidy, Salah; Al Busaidy, Suleiman; Pauli, Georg; Bock, C. -Thomas			Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman	PLOS ONE			English	Article							SURFACE-ANTIGEN VARIANTS; CLINICAL-SIGNIFICANCE; DRUG-RESISTANT; MUTATIONS; MUTANTS; INFECTION; PREVALENCE; PROTEIN; UPDATE; SUBGENOTYPES	Background: Hepatitis B virus (HBV) infection is a major global health burden with distinct geographic public health significance. Oman is a country with intermediate HBV carrier prevalence; however, little is known about the incidence of HBV variants in circulation. We investigated the HBV genotype distribution, the occurrence of antiviral resistance, and HBV surface antigen (HBsAg) escape mutations in HBsAg-positive patients in Oman. Methods: Serum samples were collected from 179 chronically HBV-infected patients enrolled in various gastroenterology clinics in Oman. HBV genotypes were determined by sequencing and phylogenetic analysis. Mutations in the HBV polymerase and the HBsAg gene were characterized by mutational analysis. Results: HBV genotypes D (130/170; 76.47%) and A (32/170; 18.28%) are predominant in Oman. The HBV genotypes C and E were less frequent (each 1.18%), while the HBV genotypes B, G, F, and H were not detected. Four patients revealed HBV genotype mixtures (HBV-A/D and D/C). The analyses of vaccine escape mutations yield that 148/170 (87.06%) HBV sequences were wild type. 22/170 (12.94%) HBV sequences showed mutations in the "a'' determinant of the HBsAg domain. Two patients showed the described HBV vaccine escape mutation sP120T. 8/146 (5.48%) HBV isolates harbored mutations in the HBV polymerase known to confer resistance against antiviral therapy. Especially the lamivudine resistance mutations rtL180M/rtM204V and rtM204I were detected. Conclusion: This study shows the distribution of HBV genotypes, therapy resistance, and vaccine escape mutations in HBV-infected patients in Oman. Our findings will have a major impact on therapy management and diagnostics of chronic HBV infections in Oman to control HBV infection in this intermediate HBV-endemic country.	[Al Baqlani, Said Ali; Al Busaidy, Suleiman] Minist Hlth, Cent Publ Hlth Lab, Muscat, Oman; [Bui Tien Sy; Ratsch, Boris A.; Pauli, Georg; Bock, C. -Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Bui Tien Sy] Vietnam Mil Med Univ, Hanoi, Vietnam; [Bui Tien Sy] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Al Naamani, Khalid] Minist Def, Armed Forces Hosp, Muscat, Oman; [Al Awaidy, Salah] Minist Hlth, Off Undersecretary Hlth Affairs, Muscat, Oman	Robert Koch Institute; Eberhard Karls University of Tubingen	Bock, CT (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	bockC@rki.de	Awaidy, Salah Al/AAF-5884-2020; Bock, C.-Thomas/A-3518-2012	Awaidy, Salah Al/0000-0001-5112-3893; Ratsch, Boris/0000-0003-0478-1652; Bock, C.-Thomas/0000-0002-2773-486X	Vietnam Ministry of Education and Training, Vietnam [322]	Vietnam Ministry of Education and Training, Vietnam	BT Sy was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Awaidy S, 2006, J INFECTION, V52, P202, DOI 10.1016/j.jinf.2005.05.006; Al Awaidy ST, 2013, AM J TROP MED HYG, V89, P811, DOI 10.4269/ajtmh.13-0333; Amini-Bavil-Olyaee S, 2005, J MED VIROL, V76, P318, DOI 10.1002/jmv.20362; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bartholomeusz A, 2001, HEPATOLOGY, V34, P432, DOI 10.1053/jhep.2001.26764; Baxa DM, 2013, J HEPATOL, V58, P212, DOI 10.1016/j.jhep.2012.09.014; Blitz L, 1998, J CLIN MICROBIOL, V36, P648, DOI 10.1128/JCM.36.3.648-651.1998; Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015; Brunetto MR, 2013, J HEPATOL; CARMAN WF, 1995, LANCET, V345, P1406, DOI 10.1016/S0140-6736(95)92599-6; Carman WF, 1997, HEPATOLOGY, V26, P1658, DOI 10.1002/hep.510260640; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Cassidy A, 2011, EXPERT REV VACCINES, V10, P1709, DOI [10.1586/ERV.11.151, 10.1586/erv.11.151]; Chang MH, 2014, RECENT RESULTS CANC, V193, P75, DOI 10.1007/978-3-642-38965-8_5; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Cooksley WGE, 2010, J VIRAL HEPATITIS, V17, P601, DOI 10.1111/j.1365-2893.2010.01326.x; Degertekin B, 2009, CURR OPIN GASTROEN, V25, P180, DOI 10.1097/MOG.0b013e328324f478; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Ghany MG, 1998, HEPATOLOGY, V27, P213, DOI 10.1002/hep.510270133; Hannoun C, 2002, J INFECT DIS, V186, P752, DOI 10.1086/342599; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Kaminski G, 2006, MED PRIN PRACT, V15, P368, DOI 10.1159/000094271; Kao JH, 2002, J GASTROEN HEPATOL, V17, P643, DOI 10.1046/j.1440-1746.2002.02737.x; Kao JH, 2005, LANCET, V366, P1337, DOI 10.1016/S0140-6736(05)67544-7; Khedive A, 2013, J VIRAL HEPATITIS, V20, P494, DOI 10.1111/jvh.12045; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lok ASF, 2009, GASTROEN CLIN BIOL, V33, P911, DOI 10.1016/j.gcb.2009.06.001; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Mohammadnejad L, 2012, ARCH IRAN MED, V15, P446, DOI 012157/AIM.0014; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; Sallam TA, 2004, J MED VIROL, V73, P23, DOI 10.1002/jmv.20056; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Saudy N, 2003, J MED VIROL, V70, P529, DOI 10.1002/jmv.10427; Shi YH, 2012, JPN J INFECT DIS, V65, P476, DOI 10.7883/yoken.65.476; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Sunbul M, 2005, WORLD J GASTROENTERO, V11, P1976, DOI 10.3748/wjg.v11.i13.1976; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP1556; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Tujios SR, 2013, CURR OPIN GASTROEN, V29, P250, DOI 10.1097/MOG.0b013e32835ff1e9; Weber B, 2005, J CLIN VIROL, V32, P102, DOI 10.1016/j.jcv.2004.10.008; Westland C, 2003, GASTROENTEROLOGY, V125, P107, DOI 10.1016/S0016-5085(03)00700-5; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97759	10.1371/journal.pone.0097759	http://dx.doi.org/10.1371/journal.pone.0097759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835494	Green Published, gold			2022-12-25	WOS:000339614800067
J	Mulders, WHAM; Barry, KM; Robertson, D				Mulders, Wilhelmina H. A. M.; Barry, Kristin M.; Robertson, Donald			Effects of Furosemide on Cochlear Neural Activity, Central Hyperactivity and Behavioural Tinnitus after Cochlear Trauma in Guinea Pig	PLOS ONE			English	Article							NOISE-INDUCED TINNITUS; AUDITORY BRAIN-STEM; ACOUSTIC TRAUMA; HEARING-LOSS; INFERIOR COLLICULUS; ELECTRICAL-ACTIVITY; GENE-EXPRESSION; ROUND-WINDOW; NUCLEUS; RATS	Cochlear trauma causes increased spontaneous activity (hyperactivity) to develop in central auditory structures, and this has been suggested as a neural substrate for tinnitus. Using a guinea pig model we have previously demonstrated that for some time after cochlear trauma, central hyperactivity is dependent on peripheral afferent drive and only later becomes generated intrinsically within central structures. Furosemide, a loop diuretic, reduces spontaneous firing of auditory afferents. We investigated in our guinea pig model the efficacy of furosemide in reducing 1) spontaneous firing of auditory afferents, using the spectrum of neural noise (SNN) from round window recording, 2) hyperactivity in inferior colliculus, using extracellular single neuron recordings and 3) tinnitus at early time-points after cochlear trauma. Tinnitus was assessed using gap prepulse inhibition of acoustic startle (GPIAS). Intraperitoneal furosemide, but not saline, caused a marked decrease in both SNN and central hyperactivity. Intracochlear perfusion with furosemide similarly reversed central hyperactivity. In animals in which GPIAS measurements suggested the presence of tinnitus (reduced GPIAS), this could be reversed with an intraperitoneal injection with furosemide but not saline. The results are consistent with furosemide reducing central hyperactivity and behavioural signs of tinnitus by acting peripherally to decrease spontaneous firing of auditory afferents. The data support the notion that hyperactivity may be involved in the generation of tinnitus and further suggest that there may be a therapeutic window after cochlear trauma using drug treatments that target peripheral spontaneous activity.	[Mulders, Wilhelmina H. A. M.; Barry, Kristin M.; Robertson, Donald] Univ Western Australia, Sch Anat Physiol & Human Biol, Auditory Lab, Crawley, WA, Australia	University of Western Australia	Mulders, WHAM (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Auditory Lab, Crawley, WA, Australia.	helmy.mulders@uwa.edu.au		Barry, Kristin/0000-0003-3177-6146; Barry, Kristin/0000-0002-1601-0997	Royal National Institute for Deaf People (UK) [G55]; Medical Health and Research Infrastructure Fund; University of Western Australia; RNID [G55] Funding Source: researchfish	Royal National Institute for Deaf People (UK); Medical Health and Research Infrastructure Fund; University of Western Australia; RNID	Supported by grants from the Royal National Institute for Deaf People (UK) G55, the Medical Health and Research Infrastructure Fund (WA) and The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini Dario, 2004, Int Tinnitus J, V10, P91; Andersson G, 2004, J CLIN PSYCHOL, V60, P171, DOI 10.1002/jclp.10243; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Cesarani Antonio, 2002, Int Tinnitus J, V8, P111; DAVIS M, 1974, J COMP PHYSIOL PSYCH, V87, P571, DOI 10.1037/h0036985; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Faraday MM, 2000, PHARMACOL BIOCHEM BE, V66, P375, DOI 10.1016/S0091-3057(00)00212-4; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Ingham NJ, 2006, EUR J NEUROSCI, V24, P2515, DOI 10.1111/j.1460-9568.2006.05134.x; JOHNSTONE JR, 1979, J ACOUST SOC AM, V65, P254, DOI 10.1121/1.382244; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; McMahon CM, 2002, HEARING RES, V173, P134, DOI 10.1016/S0378-5955(02)00281-2; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Mrena R, 2009, INT J AUDIOL, V48, P394, DOI 10.1080/14992020902777225; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, NEUROSCIENCE, V192, P753, DOI 10.1016/j.neuroscience.2011.06.046; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Mulders WHAM, 2010, J NEUROSCI, V30, P9578, DOI 10.1523/JNEUROSCI.2289-10.2010; NAKAI Y, 1982, ACTA OTO-LARYNGOL, V94, P37, DOI 10.3109/00016488209128887; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Patuzzi RB, 2004, HEARING RES, V190, P87, DOI 10.1016/S0378-5955(03)00405-2; Risey, 1995, Int Tinnitus J, V1, P99; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robertson D, 2013, HEARING RES, V295, P124, DOI 10.1016/j.heares.2012.02.002; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; RYBAK LP, 1982, HEARING RES, V7, P223, DOI 10.1016/0378-5955(82)90015-6; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Vio MM, 2005, DRUG DISCOV TODAY, V10, P1263, DOI 10.1016/S1359-6446(05)03594-4; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z	55	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97948	10.1371/journal.pone.0097948	http://dx.doi.org/10.1371/journal.pone.0097948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835470	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800090
J	Singh, A; Haris, M; Cai, KJ; Kogan, F; Hariharan, H; Reddy, R				Singh, Anup; Haris, Mohammad; Cai, Kejia; Kogan, Feliks; Hariharan, Hari; Reddy, Ravinder			High Resolution T1 rho Mapping of In Vivo Human Knee Cartilage at 7T	PLOS ONE			English	Article							HIGH-FIELD MRI; ARTICULAR-CARTILAGE; 1.5 TESLA; 3 T; T-1-RHO; QUANTIFICATION; OSTEOARTHRITIS; COMPENSATION; ARTIFACTS; ECHO	Purpose: Spin lattice relaxation time in rotating frame (T1 rho) mapping of human knee cartilage has shown promise in detecting biochemical changes during osteoarthritis. Due to higher field strength, MRI at 7T has advantages in term of SNR compared to clinical MR scanners and this can be used to increase in image resolution. Objective of current study was to evaluate the feasibility of high resolution T1 rho mapping of in vivo human knee cartilage at 7T MR scanner. Materials and Methods: In this study we have used a T1 rho prepared GRE pulse sequence for obtaining high resolution (in plan resolution = 0.2 mm(2)) T1 rho MRI of human knee cartilage at 7T. The effect of a global and localized reference frequency and reference voltage setting on B-0, B-1 and T1 rho maps in cartilage was evaluated. Test-retest reliability results of T1 rho values from asymptomatic subjects as well as T1 rho maps from abnormal cartilage of two human subjects are presented. These results are compared with T1 rho MRI data obtained from 3T. Results: Our approach enabled acquisition of 3D-T1 rho data within allowed SAR limits at 7T. SNR of cartilage on T1 rho weighted images was greater than 90. Off-resonance effects present in the cartilage B-0, B-1 and T1 rho maps obtained using global shim and reference frequency and voltage setting, were reduced by the proposed localized reference frequency and voltage setting. T1 rho values of cartilage obtained with the localized approach were reproducible. Abnormal knee cartilage showed elevated T1 rho values in affected regions. T1 rho values at 7T were significantly lower (p<0.05) compared to those obtained at 3T. Conclusion: In summary, by using proposed localized frequency and voltage setting approach, high-resolution 3D-T1 rho maps of in vivo human knee cartilage can be obtained in clinically acceptable scan times (<30 min) and SAR constraints, which provides the ability to characterize cartilage molecular integrity.	[Singh, Anup; Haris, Mohammad; Cai, Kejia; Kogan, Feliks; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, CMROI, Philadelphia, PA 19104 USA; [Singh, Anup] Indian Inst Technol Delhi, Ctr Biomed Engn, Delhi, India; [Haris, Mohammad] Sidra Med & Res Ctr, Res Branch, Doha, Qatar; [Cai, Kejia] Univ Illinois, Chicago, IL USA	University of Pennsylvania; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Sidra Medical & Research Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Singh, A (corresponding author), Univ Penn, Dept Radiol, CMROI, Philadelphia, PA 19104 USA.	anups.minhas@gmail.com	Kogan, Feliks/AAH-5814-2019	Reddy, Ravinder/0000-0003-4580-2392; Haris, Mohammad/0000-0002-4945-2935; Kogan, Feliks/0000-0003-0580-7308; Singh, Anup/0000-0001-6744-8326	NIAMS [NIH-R01AR45404]; NIH-NIBIB [P41EB015893]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was performed at an NIH-NIBIB supported Biomedical Technology Research Center (P41EB015893) and was supported by NIAMS grant NIH-R01AR45404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella SVS, 2004, MAGN RESON MED, V52, P1103, DOI 10.1002/mrm.20241; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Borthakur A, 2004, J MAGN RESON IMAGING, V19, P403, DOI 10.1002/jmri.20016; Borthakur A, 2003, J MAGN RESON IMAGING, V17, P730, DOI 10.1002/jmri.10296; Chang G, 2012, J MAGN RESON IMAGING, V35, P441, DOI 10.1002/jmri.23506; Cohen ZA, 1999, OSTEOARTHR CARTILAGE, V7, P95, DOI 10.1053/joca.1998.0165; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; Goto H, 2012, EUR J RADIOL, V81, pE796, DOI 10.1016/j.ejrad.2012.03.022; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Pakin SK, 2006, J MAGN RESON IMAGING, V24, P1357, DOI 10.1002/jmri.20733; Pakin SK, 2006, ACAD RADIOL, V13, P1135, DOI 10.1016/j.acra.2006.06.007; Redfield AG, 1955, PHYS REV, V98, P13; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Regatte RR, 2004, ACAD RADIOL, V11, P741, DOI 10.1016/j.acra.2004.03.051; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250; Wang N, 2012, MAGN RESON MATER PHY, V25, P297, DOI 10.1007/s10334-011-0288-1; Wheaton AJ, 2005, MAGNET RESON MED, V54, P1087, DOI 10.1002/mrm.20678; Wheaton AJ, 2004, MAGNET RESON MED, V52, P1453, DOI 10.1002/mrm.20268; Witschey WRT, 2008, J MAGN RESON IMAGING, V28, P744, DOI 10.1002/jmri.21444; Witschey WRT, 2007, MAGN RESON MED, V57, P2, DOI 10.1002/mrm.21134; Witschey WRT, 2010, MAGN RESON MED, V63, P1376, DOI 10.1002/mrm.22272; Witschey WRT, 2009, MAGN RESON MED, V62, P993, DOI 10.1002/mrm.22092; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	27	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97486	10.1371/journal.pone.0097486	http://dx.doi.org/10.1371/journal.pone.0097486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830386	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500067
J	Youcef, G; Olivier, A; L'Huillier, CPJ; Labat, C; Fay, R; Tabcheh, L; Toupance, S; Rodriguez-Gueant, RM; Bergerot, D; Jaisser, F; Lacolley, P; Zannad, F; Vallar, L; Pizard, A				Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Fay, Renaud; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Bergerot, Damien; Jaisser, Frederic; Lacolley, Patrick; Zannad, Faiez; Vallar, Laurent; Pizard, Anne			Simultaneous Characterization of Metabolic, Cardiac, Vascular and Renal Phenotypes of Lean and Obese SHHF Rats	PLOS ONE			English	Article							ARTERIAL STIFFNESS; RISK-FACTORS; HEART; MODEL; EXPRESSION; RESISTANCE; RECEPTOR	Individuals with metabolic syndrome (MetS) are prone to develop heart failure (HF). However, the deleterious effects of MetS on the continuum of events leading to cardiac remodeling and subsequently to HF are not fully understood. This study characterized simultaneously MetS and cardiac, vascular and renal phenotypes in aging Spontaneously Hypertensive Heart Failure lean (SHHF+/? regrouping and (+/cp) rats) and obese (SHHFcp/cp, "cp" defective mutant allele of the leptin receptor gene) rats. We aimed to refine the milestones and their onset during the progression from MetS to HF in this experimental model We found that SHHFcp/cp but not SHHF+/? rats developed dyslipidemia, as early as 1.5 months of age. This early alteration in the lipidic profile was detectable concomitantly to impaired renal function (polyuria, proteinuria but no glycosuria) and reduced carotid distensibility as compared to SHHF+/? rats. By 3 months of age SHHFcp/cp animals developed severe obesity associated with dislipidemia and hypertension defining the onset of MetS. From 6 months of age, SHHF+/? rats developed concentric left ventricular hypertrophy (LVH) while SHHFcp/cp rats developed eccentric LVH apparent from progressive dilation of the LV dimensions. By 14 months of age only SHHFcp/cp rats showed significantly higher central systolic blood pressure and a reduced ejection fraction resulting in systolic dysfunction as compared to SHHF+/?. In summary, the metabolic and hemodynamic mechanisms participating in the faster decline of cardiac functions in SHHFcp/cp rats are established long before their physiological consequences are detectable. Our results suggest that the molecular mechanisms triggered within the first three months after birth of SHHFcp/cp rats should be targeted preferentially by therapeutic interventions in order to mitigate the later HF development.	[Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Toupance, Simon; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] UMRS U1116 Inserm, Vandoeuvre Les Nancy, France; [Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] Federat Rech 3209, Nancy, France; [Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] Univ Lorraine, Nancy, France; [Youcef, Gina; Vallar, Laurent] Ctr Rech Publ Sante, Genom Res Unit, Strassen, Luxembourg; [Olivier, Arnaud; Fay, Renaud; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Jaisser, Frederic; Lacolley, Patrick; Zannad, Faiez] CHU Nancy, Nancy, France; [Olivier, Arnaud; Fay, Renaud; Toupance, Simon; Jaisser, Frederic; Zannad, Faiez; Pizard, Anne] CIC 1433, Vandoeuvre Les Nancy, France; [Tabcheh, Lina] UMR 7365 CNRS, Vandoeuvre Les Nancy, France; [Rodriguez-Gueant, Rosa-Maria] U954 Inserm, Vandoeuvre Les Nancy, France; [Bergerot, Damien] HEGP, PARCC, CIC 9201, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Luxembourg Institute of Health; CHU de Nancy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pizard, A (corresponding author), UMRS U1116 Inserm, Vandoeuvre Les Nancy, France.	anne.pizard@inserm.fr	Labat, Carlos/F-7492-2010; Zannad, Faiez/K-4649-2019; Jaisser, Frederic/P-4287-2017; Lacolley, Patrick/G-3118-2013; Pizard, Anne CM/P-4754-2016	Labat, Carlos/0000-0002-5275-3405; Jaisser, Frederic/0000-0001-9051-1901; Pizard, Anne CM/0000-0003-2705-6365; Toupance, Simon/0000-0001-7441-567X; Vallar, Laurent/0000-0002-4404-1010	Inserm; Region Lorraine; "Comite Lorrain" of the "Fondation pour la Recherche Medicale";  [261409]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Lorraine(Region Grand-Est); "Comite Lorrain" of the "Fondation pour la Recherche Medicale"(Region Grand-Est); 	Dr A. Pizard acknowledges Inserm, Region Lorraine, the "Comite Lorrain" of the "Fondation pour la Recherche Medicale" and FP7-HEALTH-2010 # 261409 MEDIA program for their financial supports to carry this project. G. Youcef is supported by a salary fellowship from AFR PhD grants, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altschuld RA, 2003, PROG EXP CARDIOL, V5, P67; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Aroor AR, 2012, HEART FAIL CLIN, V8, P609, DOI 10.1016/j.hfc.2012.06.005; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; Bountioukos M, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.031; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; De Pergola G, 2013, ENDOCR METAB IMMUNE; Ebong IA, 2013, OBESITY SILVER SPRIN; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Friedman JE, 1997, HORM METAB RES, V29, P214, DOI 10.1055/s-2007-979024; Greenhouse DD, 1990, FRONTIERS DIABETES 3, VVIII, P375; Griffin KA, 2007, AM J PHYSIOL-RENAL, V293, pF1605, DOI 10.1152/ajprenal.00511.2006; HASS GJ, 1995, AM HEART J, V130, P806, DOI 10.1016/0002-8703(95)90081-0; Heyen JRR, 2002, AM J PHYSIOL-HEART C, V283, pH1775, DOI 10.1152/ajpheart.00305.2002; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; Horwich TB, 2010, J AM COLL CARDIOL, V55, P283, DOI 10.1016/j.jacc.2009.07.029; HOVERSLAND RC, 1992, INT J OBESITY, V16, P977; Ingelsson E, 2005, J AM COLL CARDIOL, V46, P2054, DOI 10.1016/j.jacc.2005.07.059; Kim SH, 1998, YONSEI MED J, V39, P453, DOI 10.3349/ymj.1998.39.5.453; Lacolley P, 2002, CIRCULATION, V106, P2848, DOI 10.1161/01.CIR.0000039328.33137.6C; Lazzarini V, 2013, EUR J HEART FAIL; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Masson S, 2011, EUR J CLIN INVEST, V41, P1330, DOI 10.1111/j.1365-2362.2011.02548.x; McCune SA, 1990, ILAR J, V32, P23; McCune SA, 1990, FRONTIERS DIABETES R, V6, P397; McCune SA, 1995, LESSONS ANIMAL DIABE, P255; MEIER DA, 1995, OBES RES, V3, P465, DOI 10.1002/j.1550-8528.1995.tb00176.x; Przybylski R, 2010, NUTR METAB CARDIOVAS, V20, P641, DOI 10.1016/j.numecd.2009.07.009; Radin MJ, 2003, MOL CELL BIOCHEM, V242, P57, DOI 10.1023/A:1021181527060; RADIN MJ, 1992, J CARDIOVASC PHARM, V19, P464, DOI 10.1097/00005344-199203000-00026; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; Simpson CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026573; Sloboda N, 2012, J GERONTOL A-BIOL, V67, P927, DOI 10.1093/gerona/glr236; Van Berendoncks An M, 2011, Curr Heart Fail Rep, V8, P113, DOI 10.1007/s11897-011-0056-6	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96452	10.1371/journal.pone.0096452	http://dx.doi.org/10.1371/journal.pone.0096452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831821	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500021
J	Zhu, W; Gao, YF; Chang, CF; Wan, JR; Zhu, SS; Wang, J				Zhu, Wei; Gao, Yufeng; Chang, Che-Feng; Wan, Jie-ru; Zhu, Shan-shan; Wang, Jian			Mouse Models of Intracerebral Hemorrhage in Ventricle, Cortex, and Hippocampus by Injections of Autologous Blood or Collagenase	PLOS ONE			English	Article							TUFTSIN FRAGMENT 1-3; TAIL SUSPENSION TEST; BRAIN-INJURY; RECOGNITION MEMORY; RAT MODEL; MICE; STROKE; EDEMA; INFLAMMATION; MECHANISMS	Intracerebral hemorrhage (ICH) is a devastating condition. Existing preclinical ICH models focus largely on striatum but neglect other brain areas such as ventricle, cortex, and hippocampus. Clinically, however, hemorrhagic strokes do occur in these other brain regions. In this study, we established mouse hemorrhagic models that utilize stereotactic injections of autologous whole blood or collagenase to produce ventricular, cortical, and hippocampal injury. We validated and characterized these models by histology, immunohistochemistry, and neurobehavioral tests. In the intraventricular hemorrhage (IVH) model, C57BL/6 mice that received unilateral ventricular injections of whole blood demonstrated bilateral ventricular hematomas, ventricular enlargement, and brain edema in the ipsilateral cortex and basal ganglia at 72 h. Unilateral injections of collagenase (150 U/ml) caused reproducible hematomas and brain edema in the frontal cortex in the cortical ICH (c-ICH) model and in the hippocampus in the hippocampal ICH (h-ICH) model. Immunostaining revealed cellular inflammation and neuronal death in the periventricular regions in the IVH brain and in the perihematomal regions in the c-ICH and h-ICH brains. Locomotor abnormalities measured with a 24-point scoring system were present in all three models, especially on days 1, 3, and 7 post-ICH. Locomotor deficits measured by the wire-hanging test were present in models of IVH and c-ICH, but not h-ICH. Interestingly, mice in the c-ICH model demonstrated emotional abnormality, as measured by the tail suspension test and forced swim test, whereas h-ICH mice exhibited memory abnormality, as measured by the novel object recognition test. All three ICH models generated reproducible brain damage, brain edema, inflammation, and consistent locomotor deficits. Additionally, the c-ICH model produced emotional deficits and the h-ICH model produced cognitive deficits. These three models closely mimic human ICH and should be useful for investigating the pathophysiology of ICH in ventricle, cortex, and hippocampus and for evaluating potential therapeutic strategies.	[Zhu, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Emergency Med, Wuhan 430074, Hubei, Peoples R China; [Zhu, Wei; Gao, Yufeng; Chang, Che-Feng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Wan, Jie-ru] IIT, Coll Sci, Dept Biol Sci, Chicago, IL 60616 USA; [Zhu, Shan-shan] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Illinois Institute of Technology; Johns Hopkins University	Wang, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	jwang79@jhmi.edu	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X; Chang, Che-Feng/0000-0002-3211-1739	AHA [13GRNT15730001]; NIH [K01AG031926, R01NS078026, R01AT007317]; National Center for Complementary & Integrative Health [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031926] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by AHA 13GRNT15730001, NIH K01AG031926, R01NS078026, and R01AT007317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Kleinig TJ, 2009, BRAIN RES, V1287, P164, DOI 10.1016/j.brainres.2009.06.077; Krafft PR, 2012, INT J STROKE, V7, P398, DOI 10.1111/j.1747-4949.2012.00838.x; Lan X, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-98; Liesz Arthur, 2011, Exp Transl Stroke Med, V3, P11, DOI 10.1186/2040-7378-3-11; Lockridge A, 2013, BEHAV BRAIN RES, V246, P168, DOI 10.1016/j.bbr.2013.02.032; Lodhia KR, 2006, ACTA NEUROCHIR SUPPL, V96, P207; MacLellan CL, 2012, J CEREBR BLOOD F MET, V32, P612, DOI 10.1038/jcbfm.2012.8; Masuda T, 2010, BRAIN RES, V1355, P228, DOI 10.1016/j.brainres.2010.07.101; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Renard CE, 2004, PROG NEURO-PSYCHOPH, V28, P1255, DOI 10.1016/j.pnpbp.2004.06.010; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Song S, 2008, ACTA NEUROCHIR SUPPL, V105, P13; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang J, 2008, BRAIN RES, V1222, P214, DOI 10.1016/j.brainres.2008.05.058; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580	48	66	69	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97423	10.1371/journal.pone.0097423	http://dx.doi.org/10.1371/journal.pone.0097423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831292	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500056
J	Chung, TW; Choi, HJ; Kim, SJ; Kwak, CH; Song, KH; Jin, UH; Chang, YC; Chang, HW; Lee, YC; Ha, KT; Kim, CH				Chung, Tae-Wook; Choi, Hee-Jung; Kim, Seok-Jo; Kwak, Choong-Hwan; Song, Kwon-Ho; Jin, Un-Ho; Chang, Young-Chae; Chang, Hyeun Wook; Lee, Young-Choon; Ha, Ki-Tae; Kim, Cheorl-Ho			The Ganglioside GM3 Is Associated with Cisplatin-Induced Apoptosis in Human Colon Cancer Cells	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; ACTIVATION; DEATH; 12-LIPOXYGENASE; EXPRESSION; INDUCTION; SYNTHASE; KINASE; DNA	Cisplatin (cis-diamminedichloroplatinum, CDDP) is a well-known chemotherapeutic agent for the treatment of several cancers. However, the precise mechanism underlying apoptosis of cancer cells induced by CDDP remains unclear. In this study, we show mechanistically that CDDP induces GM3-mediated apoptosis of HCT116 cells by inhibiting cell proliferation, and increasing DNA fragmentation and mitochondria-dependent apoptosis signals. CDDP induced apoptosis within cells through the generation of reactive oxygen species (ROS), regulated the ROS-mediated expression of Bax, Bcl-2, and p53, and induced the degradation of the poly (ADP-ribosyl) polymerase (PARP). We also checked expression levels of different gangliosides in HCT116 cells in the presence or absence of CDDP. Interestingly, among the gangliosides, CDDP augmented the expression of only GM3 synthase and its product GM3. Reduction of the GM3 synthase level through ectopic expression of GM3 small interfering RNA (siRNA) rescued HCT116 cells from CDDP-induced apoptosis. This was evidenced by inhibition of apoptotic signals by reducing ROS production through the regulation of 12-lipoxigenase activity. Furthermore, the apoptotic sensitivity to CDDP was remarkably increased in GM3 synthase-transfected HCT116 cells compared to that in controls. In addition, GM3 synthase-transfected cells treated with CDDP exhibited an increased accumulation of intracellular ROS. These results suggest the CDDP-induced oxidative apoptosis of HCT116 cells is mediated by GM3.	[Chung, Tae-Wook; Choi, Hee-Jung; Kim, Seok-Jo; Kwak, Choong-Hwan; Song, Kwon-Ho; Jin, Un-Ho; Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Lab, Suwon, Kyunggi Do, South Korea; [Choi, Hee-Jung; Ha, Ki-Tae] Pusan Natl Univ, Sch Korean Med, Div Appl Med, Yangsan, Gyeongsangnam D, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Taegu, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Taegu, South Korea; [Chang, Hyeun Wook] Yeungnam Univ, Fac Pharm, Kyungsan, South Korea; [Lee, Young-Choon] Dong A Univ, Fac Med Biotechnol, Pusan, South Korea	Sungkyunkwan University (SKKU); Pusan National University; Catholic University of Daegu; Catholic University of Daegu; Yeungnam University; Dong A University	Ha, KT (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Appl Med, Yangsan, Gyeongsangnam D, South Korea.	hagis@pusan.ac.kr; chkimbio@skku.edu	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714; Chung, Tae-Wook/0000-0001-5243-5020	Basic Science Research Program through National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of Korea [NRF-2013R1A1A2005387]; Personalized Tumor Engineering Research Center grant [2008-062611]	Basic Science Research Program through National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of Korea; Personalized Tumor Engineering Research Center grant	The present study has been supported by the Basic Science Research Program through National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) of Korea (NRF-2013R1A1A2005387) and Personalized Tumor Engineering Research Center grant (2008-062611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL SK, 1983, J HISTOCHEM CYTOCHEM, V31, P307, DOI 10.1177/31.2.6300219; BABA A, 1989, J BIOL CHEM, V264, P15790; Basu S, 2004, GLYCOCONJUGATE J, V20, P563; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; BRIGHTMAN AO, 1992, BIOCHIM BIOPHYS ACTA, V1105, P109, DOI 10.1016/0005-2736(92)90168-L; Burger KNJ, 1999, BBA-BIOMEMBRANES, V1419, P43, DOI 10.1016/S0005-2736(99)00052-8; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Choi HJ, 2003, FEBS LETT, V555, P204, DOI 10.1016/S0014-5793(03)01227-4; Choudhary S, 2013, BIOCHEM BIOPH RES CO, V436, P325, DOI 10.1016/j.bbrc.2013.05.102; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Chung TW, 2005, GLYCOBIOLOGY, V15, P233, DOI 10.1093/glycob/cwh156; d'Azzo A, 2006, CELL DEATH DIFFER, V13, P404, DOI 10.1038/sj.cdd.4401834; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Dent P, 2001, CLIN CANCER RES, V7, P775; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fujimoto Y, 2005, J NEURO-ONCOL, V71, P99, DOI 10.1007/s11060-004-9602-3; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Gershenson DM, 2007, J CLIN ONCOL, V25, P2938, DOI 10.1200/JCO.2007.10.8738; GRUNICKE H, 1992, PHARMACOL THERAPEUT, V55, P1, DOI 10.1016/0163-7258(92)90027-W; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Hakomori SI, 1998, ANN NY ACAD SCI, V845, P1, DOI 10.1111/j.1749-6632.1998.tb09657.x; Iaffaioli RV, 2007, ANN ONCOL, V18, P153, DOI 10.1093/annonc/mdm246; Iwamori M, 2005, GLYCOCONJUGATE J, V22, P119, DOI 10.1007/s10719-005-0363-9; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kiura K, 1998, ANTICANCER RES, V18, P2957; Kopp HG, 2006, DRUGS, V66, P641, DOI 10.2165/00003495-200666050-00005; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; Levin S, 1999, TOXICOL PATHOL, V27, P484, DOI 10.1177/019262339902700419; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Ma R, 2003, GLYCOCONJUGATE J, V20, P319, DOI 10.1023/B:GLYC.0000033628.39302.ae; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; MASUDA H, 1994, BIOCHEM BIOPH RES CO, V203, P1175, DOI 10.1006/bbrc.1994.2306; McNeish IA, 2003, EXP CELL RES, V286, P186, DOI 10.1016/S0014-4827(03)00073-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moore DH, 2006, CURR OPIN ONCOL, V18, P516, DOI 10.1097/01.cco.0000239893.21161.51; Nakatsuji Y, 2001, EXP NEUROL, V168, P290, DOI 10.1006/exnr.2000.7602; Nojiri H, 2002, CANCER DETECT PREV, V26, P114, DOI 10.1016/S0361-090X(02)00033-8; Noll ENE, 2001, EXP NEUROL, V168, P300, DOI 10.1006/exnr.2000.7603; Ozeki Y, 1999, BRIT J PHARMACOL, V128, P1699, DOI 10.1038/sj.bjp.0702976; Razzaque MS, 1999, HISTOCHEM CELL BIOL, V111, P359, DOI 10.1007/s004180050368; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; RUBIN E, 1992, CANCER RES, V52, P878; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Wang P, 2006, CELL SIGNAL, V18, P1528, DOI 10.1016/j.cellsig.2005.12.004; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Watanabe R, 2002, CANCER RES, V62, P3850; Zhang YM, 2006, J BIOL CHEM, V281, P9460, DOI 10.1074/jbc.M510650200	56	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e92786	10.1371/journal.pone.0092786	http://dx.doi.org/10.1371/journal.pone.0092786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829158	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400005
J	Santiago, JJ; McNaughton, LJ; Koleini, N; Ma, X; Bestvater, B; Nickel, BE; Fandrich, RR; Wigle, JT; Freed, DH; Arora, RC; Kardami, E				Santiago, Jon-Jon; McNaughton, Leslie J.; Koleini, Navid; Ma, Xin; Bestvater, Brian; Nickel, Barbara E.; Fandrich, Robert R.; Wigle, Jeffrey T.; Freed, Darren H.; Arora, Rakesh C.; Kardami, Elissavet			High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; UNCONVENTIONAL PROTEIN SECRETION; LEFT-VENTRICULAR DYSFUNCTION; HUMAN PERICARDIAL FLUID; ANGIOTENSIN-II; FACTOR FGF-2; CARDIOVASCULAR-DISEASE; HYPERTROPHIC RESPONSE; NUCLEAR-LOCALIZATION; BIOLOGICAL FUNCTIONS	Fibroblast growth factor 2 (FGF-2) is a multifunctional protein synthesized as high (Hi-) and low (Lo-) molecular weight isoforms. Studies using rodent models showed that Hi-and Lo-FGF-2 exert distinct biological activities: after myocardial infarction, rat Lo-FGF-2, but not Hi-FGF-2, promoted sustained cardioprotection and angiogenesis, while Hi-FGF-2, but not Lo-FGF-2, promoted myocardial hypertrophy and reduced contractile function. Because there is no information regarding Hi-FGF-2 in human myocardium, we undertook to investigate expression, regulation, secretion and potential tissue remodeling-associated activities of human cardiac (atrial) Hi-FGF-2. Human patient-derived atrial tissue extracts, as well as pericardial fluid, contained Hi-FGF-2 isoforms, comprising, respectively, 53%(+/-20 SD) and 68% (+/-25 SD) of total FGF-2, assessed by western blotting. Human atrial tissue-derived primary myofibroblasts (hMFs) expressed and secreted predominantly Hi-FGF-2, at about 80% of total. Angiotensin II (Ang II) up-regulated Hi-FGF-2 in hMFs, via activation of both type 1 and type 2 Ang II receptors; the ERK pathway; and matrix metalloprotease-2. Treatment of hMFs with neutralizing antibodies selective for human Hi-FGF-2 (neu-Ab(Hi-FGF-2)) reduced accumulation of proteins associated with fibroblast-tomyofibroblast conversion and fibrosis, including a-smooth muscle actin, extra-domain A fibronectin, and procollagen. Stimulation of hMFs with recombinant human Hi-FGF-2 was significantly more potent than Lo-FGF-2 in upregulating inflammation-associated proteins such as pro-interleukin-1 beta and plasminogen-activator-inhibitor-1. Culture media conditioned by hMFs promoted cardiomyocyte hypertrophy, an effect that was prevented by neu-Ab (Hi-FGF-2) in vitro. In conclusion, we have documented that Hi-FGF-2 represents a substantial fraction of FGF-2 in human cardiac (atrial) tissue and in pericardial fluid, and have shown that human Hi-FGF-2, unlike Lo-FGF-2, promotes deleterious (pro-fibrotic, proinflammatory, and pro-hypertrophic) responses in vitro. Selective targeting of Hi-FGF-2 production may, therefore, reduce pathological remodelling in the human heart.	[Santiago, Jon-Jon; McNaughton, Leslie J.; Koleini, Navid; Ma, Xin; Bestvater, Brian; Nickel, Barbara E.; Fandrich, Robert R.; Wigle, Jeffrey T.; Freed, Darren H.; Arora, Rakesh C.; Kardami, Elissavet] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp Res Ctr, Winnipeg, MB, Canada; [Ma, Xin; Fandrich, Robert R.; Kardami, Elissavet] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Santiago, Jon-Jon; Koleini, Navid; Kardami, Elissavet] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Wigle, Jeffrey T.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Freed, Darren H.; Arora, Rakesh C.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Kardami, E (corresponding author), Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp Res Ctr, Winnipeg, MB, Canada.	ekardami@sbrc.ca	Koleini, Navid/AAA-1204-2020; Wigle, Jeffrey/G-2005-2014	Koleini, Navid/0000-0003-3021-3894; Freed, Darren/0000-0002-6239-1444; Kardami, Elissavet/0000-0002-3198-8432; Wigle, Jeffrey/0000-0002-4985-7684	Canadian Institutes for Health Research [FRN74733]; National Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Manitoba	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Manitoba	This work was funded through an operating research grant granted by the Canadian Institutes for Health Research to Elissavet Kardami (FRN74733). Jon-Jon Santiago's salary was provided by a studentship award by the National Sciences and Engineering Research Council of Canada, and Leslie McNaughton's salary by a studentship from the Heart and Stroke Foundation of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadie R, 2010, J NUTR, V140, P1438, DOI 10.3945/jn.110.123091; Aranguiz-Urroz P, 2009, AM J HYPERTENS, V22, P569, DOI 10.1038/ajh.2009.32; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Boldt A, 2006, BASIC RES CARDIOL, V101, P261, DOI 10.1007/s00395-005-0571-2; Bommer William J, 2008, Prev Cardiol, V11, P215, DOI 10.1111/j.1751-7141.2008.00004.x; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Burstein B, 2008, CIRCULATION, V117, P1630, DOI 10.1161/CIRCULATIONAHA.107.748053; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Corda S, 1997, CIRC RES, V81, P679; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Ding L, 2002, J BIOL CHEM, V277, P31056, DOI 10.1074/jbc.M203658200; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Doble BW, 2004, J CELL SCI, V117, P507, DOI 10.1242/jcs.00889; DOBLE BW, 1990, BIOCHEM BIOPH RES CO, V173, P1116, DOI 10.1016/S0006-291X(05)80901-5; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Fujita M, 1998, Angiogenesis, V2, P105, DOI 10.1023/A:1009062712441; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Hinescu ME, 2006, J CELL MOL MED, V10, P243, DOI 10.1111/j.1582-4934.2006.tb00306.x; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; Iwakura A, 2000, HEART VESSELS, V15, P112, DOI 10.1007/PL00007264; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Jiang ZS, 2007, J MOL CELL CARDIOL, V42, P222, DOI 10.1016/j.yjmcc.2006.09.002; Kardami E, 2004, CARDIOVASC RES, V63, P458, DOI 10.1016/j.cardiores.2004.04.024; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; Liao SY, 2010, J MOL CELL CARDIOL, V48, P1245, DOI 10.1016/j.yjmcc.2010.01.014; Liao S, 2009, DEV DYNAM, V238, P249, DOI 10.1002/dvdy.21677; Ma X, 2007, J CELL PHYSIOL, V213, P690, DOI 10.1002/jcp.21139; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Pasumarthi KBS, 1996, CIRC RES, V78, P126, DOI 10.1161/01.RES.78.1.126; Pellieux C, 2001, J CLIN INVEST, V108, P1843, DOI 10.1172/JCI200113627; Piotrowicz RS, 1999, J CELL PHYSIOL, V178, P144, DOI 10.1002/(SICI)1097-4652(199902)178:2<144::AID-JCP3>3.0.CO;2-Z; Piotrowicz RS, 2001, J BIOL CHEM, V276, P3963, DOI 10.1074/jbc.M004868200; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Santiago JJ, 2011, CARDIOVASC RES, V89, P139, DOI 10.1093/cvr/cvq261; Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280; Schultz JE, 1999, J CLIN INVEST, V104, P709, DOI 10.1172/JCI7315; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; Srisakuldee W, 2009, CARDIOVASC RES, V83, P672, DOI 10.1093/cvr/cvp142; Stroth U, 2000, MOL BRAIN RES, V78, P175, DOI 10.1016/S0169-328X(00)00093-0; Tanaka T, 1998, J AM COLL CARDIOL, V31, P399, DOI 10.1016/S0735-1097(97)00482-8; Tholozan FMD, 2007, MOL BIOL CELL, V18, P4222, DOI 10.1091/mbc.E06-05-0416; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tsutsumi Y, 1998, CIRC RES, V83, P1035, DOI 10.1161/01.RES.83.10.1035; Turner N, 2013, VASCUL PHARM; Vagner S, 1996, J CELL BIOL, V135, P1391, DOI 10.1083/jcb.135.5.1391; Valtink M, 2012, INVEST OPHTH VIS SCI, V53, P3207, DOI 10.1167/iovs.12-9423; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yu PJ, 2008, ONCOGENE, V27, P2594, DOI 10.1038/sj.onc.1210899; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Zhang SL, 1999, LAB INVEST, V79, P395	70	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97281	10.1371/journal.pone.0097281	http://dx.doi.org/10.1371/journal.pone.0097281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827991	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400074
J	Adachi, K; Nakamura, R; Osada, Y; Senba, M; Tamada, K; Hamano, S				Adachi, Keishi; Nakamura, Risa; Osada, Yoshio; Senba, Masachika; Tamada, Koji; Hamano, Shinjiro			Involvement of IL-18 in the Expansion of Unique Hepatic T Cells with Unconventional Cytokine Profiles during Schistosoma mansoni Infection	PLOS ONE			English	Article							LIVER-INJURY; IFN-GAMMA; NKT CELLS; TH2 POLARIZATION; IMMUNE-RESPONSE; GENE-EXPRESSION; TH1/TH2 BALANCE; B-VIRUS; RECEPTOR; INTERLEUKIN-18	Infection with schistosomes invokes severe fibrotic granulomatous responses in the liver of the host. Schistosoma mansoni infection induces dramatic fluctuations in Th1 or Th2 cytokine responses systemically; Th1 reactions are provoked in the early phase, whilst Th2 responses become dominant after oviposition begins. In the liver, various unique immune cells distinct from those of conventional immune competent organs or tissues exist, resulting in a unique immunological environment. Recently, we demonstrated that S. mansoni infection induces unique CD4(+) T cell populations exhibiting unconventional cytokine profiles in the liver of mice during the period between Th1- and Th2-phases, which we term the transition phase. They produce both IFN-gamma and IL-4 or both IFN-gamma and IL-13 simultaneously. Moreover, T cells secreting triple cytokines IFN-gamma, IL-13 and IL-4 were also induced. We term these cells Multiple Cytokine Producing Hepatic T cells (MCPHT cells). During the transition phase, when MCPHT cells increase, IL-18 secretion was up-regulated in the liver and sera. In S. mansoni-infected IL-18-deficient mice, expansion of MCPHT cells was curtailed. Thus our data suggest that IL-18 produced during S. mansoni infection play a role in the expansion of MCPHT cells.	[Adachi, Keishi; Nakamura, Risa; Hamano, Shinjiro] Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Adachi, Keishi; Hamano, Shinjiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Osada, Yoshio] Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Kitakyushu, Fukuoka 807, Japan; [Senba, Masachika] Nagasaki Univ, Dept Pathol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 755, Japan	Nagasaki University; Nagasaki University; University of Occupational & Environmental Health - Japan; Nagasaki University; Yamaguchi University	Hamano, S (corresponding author), Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	shinjiro@nagasaki-u.ac.jp	adachi, keishi/AAT-7471-2020; Hamano, Shinjiro/A-7932-2011	Hamano, Shinjiro/0000-0003-3881-8337	JSPS KAKENHI [24790402, 25670204]; Health Labour Sciences Research Grant [H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014]; Global COE Program, Nagasaki University; MEXT; Grants-in-Aid for Scientific Research [25670204] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Global COE Program, Nagasaki University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research Number 24790402 (to K.A.), 25670204 (to S.H.), (http://www.jsps.go.jp/english/e-grants/index.html), a Health Labour Sciences Research Grant (H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014 to S.H.) (http://www.mhlw.go.jp/english/), and the Global COE Program, Nagasaki University, supported by MEXT (to S.H.) (http://www-sdc.med.nagasaki-u.ac.jp/gcoe/activities/publication/200901_e.html, http://www.jsps.go.jp/english/e-globalcoe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Adachi K, 2004, INT IMMUNOL, V16, P787, DOI 10.1093/intimm/dxh080; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Adachi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082698; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hayashi N, 1999, J IMMUNOL, V163, P6702; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Infante-Duarte C, 1999, SPRINGER SEMIN IMMUN, V21, P317, DOI 10.1007/s002810050070; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Mallevaey T, 2006, J IMMUNOL, V176, P2476, DOI 10.4049/jimmunol.176.4.2476; Mallevaey T, 2007, INFECT IMMUN, V75, P2171, DOI 10.1128/IAI.01178-06; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakahira M, 2011, INT IMMUNOL, V23, P761, DOI 10.1093/intimm/dxr087; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osada Y, 2005, PARASITOL INT, V54, P29, DOI 10.1016/j.parint.2004.08.004; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Sareneva T, 2000, J IMMUNOL, V165, P1933, DOI 10.4049/jimmunol.165.4.1933; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shimokawa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082025; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tsutsui H, 2000, IMMUNOL REV, V174, P192, DOI 10.1034/j.1600-0528.2002.017418.x; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96042	10.1371/journal.pone.0096042	http://dx.doi.org/10.1371/journal.pone.0096042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824897	gold, Green Published, Green Submitted			2022-12-25	WOS:000336369200009
J	Kurth, F; Duprez, W; Premkumar, L; Schembri, MA; Fairlie, DP; Martin, JL				Kurth, Fabian; Duprez, Wilko; Premkumar, Lakshmanane; Schembri, Mark A.; Fairlie, David P.; Martin, Jennifer L.			Crystal Structure of the Dithiol Oxidase DsbA Enzyme from Proteus Mirabilis Bound Non-covalently to an Active Site Peptide Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; OXIDOREDUCTASE DSBA; CLINICAL ISOLATE; REDOX PROPERTIES; RESISTANCE; VIRULENCE; MUTANTS	The disulfide bond forming DsbA enzymes and their DsbB interaction partners are attractive targets for development of antivirulence drugs because both are essential for virulence factor assembly in Gram-negative pathogens. Here we characterize PmDsbA from Proteus mirabilis, a bacterial pathogen increasingly associated with multidrug resistance. PmDsbA exhibits the characteristic properties of a DsbA, including an oxidizing potential, destabilizing disulfide, acidic active site cysteine, and dithiol oxidase catalytic activity. We evaluated a peptide, PWATCDS, derived from the partner protein DsbB and showed by thermal shift and isothermal titration calorimetry that it binds to PmDsbA. The crystal structures of PmDsbA, and the active site variant PmDsbAC30S were determined to high resolution. Analysis of these structures allows categorization of PmDsbA into the DsbA class exemplified by the archetypal Escherichia coli DsbA enzyme. We also present a crystal structure of PmDsbAC30S in complex with the peptide PWATCDS. The structure shows that the peptide binds non-covalently to the active site CXXC motif, the cis-Pro loop, and the hydrophobic groove adjacent to the active site of the enzyme. This high-resolution structural data provides a critical advance for future structure-based design of non-covalent peptidomimetic inhibitors. Such inhibitors would represent an entirely new antibacterial class that work by switching off the DSB virulence assembly machinery.	[Kurth, Fabian; Duprez, Wilko; Premkumar, Lakshmanane; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld 4067, Australia; [Schembri, Mark A.; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4067, Australia	University of Queensland; University of Queensland	Martin, JL (corresponding author), Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld 4067, Australia.	j.martin@imb.uq.edu.au	Schembri, Mark A/C-7262-2009; Fairlie, David P/F-8865-2014; Martin, Jennifer L./A-6039-2010	Schembri, Mark A/0000-0003-4863-9260; Fairlie, David P/0000-0002-7856-8566; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council Australian Laureate Fellowship [FL0992138]; Australian Research Council Future Fellowship [FT100100662]; National Health and Medical Research Council Senior Principal Research Fellowship [1027369]; Honorary National Health and Medical Research Council [455829]	Australian Research Council Australian Laureate Fellowship(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Honorary National Health and Medical Research Council	Supported through an Australian Research Council Australian Laureate Fellowship FL0992138 to J. L. M.; Supported by an Australian Research Council Future Fellowship FT100100662.; Supported by National Health and Medical Research Council Senior Principal Research Fellowship 1027369.; Supported by Australian Research Council Australian Laureate Fellowship FL0992138 and Honorary National Health and Medical Research Council Research Fellowship 455829. To whom correspondence should be addressed. E-mail: j.martin@imb.uq.edu.au.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COETZEE JN, 1975, J GEN MICROBIOL, V87, P173, DOI 10.1099/00221287-87-1-173; COETZEE JN, 1960, J GEN MICROBIOL, V23, P445, DOI 10.1099/00221287-23-3-445; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRANKLIN TJ, 1973, J BACTERIOL, V115, P235, DOI 10.1128/JB.115.1.235-242.1973; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guay DRP, 2008, DRUGS, V68, P1169, DOI 10.2165/00003495-200868090-00002; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HITCHINGS GH, 1973, J INFECT DIS, V128, pS433, DOI 10.1093/infdis/128.Supplement_3.S433; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jacobsen SM, 2011, VIRULENCE, V2, P460, DOI 10.4161/viru.2.5.17783; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MEHTAR S, 1991, J ANTIMICROB CHEMOTH, V28, P612, DOI 10.1093/jac/28.4.612; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; OHNISHI K, 1987, J BACTERIOL, V169, P1485, DOI 10.1128/jb.169.4.1485-1488.1987; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; SABATH LD, 1969, NEW ENGL J MED, V280, P91, DOI 10.1056/NEJM196901092800208; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Sperling LJ, 2013, J PHYS CHEM B, V117, P6052, DOI 10.1021/jp400795d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tibbetts R, 2008, J CLIN MICROBIOL, V46, P3080, DOI 10.1128/JCM.00979-08; Totsika M, 2012, CURR DRUG TARGETS, V13, P1386, DOI 10.2174/138945012803530206; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460	74	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19810	19822		10.1074/jbc.M114.552380	http://dx.doi.org/10.1074/jbc.M114.552380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24831013	Green Published, hybrid			2022-12-25	WOS:000339326800052
J	Xu, F; Kotarba, AE; Ou-Yang, MH; Fu, Z; Davis, J; Smith, SO; Van Nostrand, WE				Xu, Feng; Kotarba, AnnMarie E.; Ou-Yang, Ming-Hsuan; Fu, Ziao; Davis, Judianne; Smith, Steven O.; Van Nostrand, William E.			Early-onset Formation of Parenchymal Plaque Amyloid Abrogates Cerebral Microvascular Amyloid Accumulation in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; DUTCH-TYPE; BEHAVIORAL DEFICITS; HUMAN BRAIN; HEMORRHAGE; ANGIOPATHY; PATHOLOGY	The fibrillar assembly and deposition of amyloid beta (A beta) protein, a key pathology of Alzheimer disease, can occur in the form of parenchymal amyloid plaques and cerebral amyloid angiopathy (CAA). Familial forms of CAA exist in the absence of appreciable parenchymal amyloid pathology. The molecular interplay between parenchymal amyloid plaques and CAA is unclear. Here we investigated how early-onset parenchymal amyloid plaques impact the development of microvascular amyloid in transgenic mice. Tg-5xFAD mice, which produce non-mutated human A beta and develop early-onset parenchymal amyloid plaques, were bred to Tg-SwDI mice, which produce familial CAA mutant human A beta and develop cerebral microvascular amyloid. The bigenic mice presented with an elevated accumulation of A beta and fibrillar amyloid in the brain compared with either single transgenic line. Tg-SwDI/Tg-5xFAD mice were devoid of microvascular amyloid, the prominent pathology of Tg-SwDI mice, but exhibited larger parenchymal amyloid plaques compared with Tg-5xFAD mice. The larger parenchymal amyloid deposits were associated with a higher loss of cortical neurons and elevated activated microglia in the bigenic Tg-SwDI/Tg-5xFAD mice. The periphery of parenchymal amyloid plaques was largely composed of CAA mutant A beta. Non-mutated A beta fibril seeds promoted CAA mutant A beta fibril formation in vitro. Further, intrahippocampal administration of biotin-labeled CAA mutant A beta peptide accumulated on and adjacent to pre-existing parenchymal amyloid plaques in Tg-5xFAD mice. These findings indicate that early-onset parenchymal amyloid plaques can serve as a scaffold to capture CAA mutant A beta peptides and prevent their accumulation in cerebral microvessels.	[Xu, Feng; Kotarba, AnnMarie E.; Ou-Yang, Ming-Hsuan; Davis, Judianne; Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA; [Fu, Ziao; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-089, Stony Brook, NY 11794 USA.	William.VanNostrand@sbumed.org	Smith, Steven/HDM-9496-2022; Fu, Ziao/K-8758-2017	Fu, Ziao/0000-0001-5036-1945	National Institutes of Health [AG033209, AG027317]; Alzheimer's Association [IIRG-09-15254]; NATIONAL INSTITUTE ON AGING [R21AG033209, R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033209 (to W. E. V. N.) and AG027317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-09-15254 and by a gift from the Cowles Charitable Trust.	Allen N, 2014, NEUROPATH APPL NEURO, V40, P136, DOI 10.1111/nan.12070; Attems J, 2004, ACTA NEUROPATHOL, V107, P83, DOI 10.1007/s00401-003-0796-9; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; BAKKER E, 1991, AM J HUM GENET, V49, P518; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DAVISSALINAS J, 1994, J BIOL CHEM, V269, P22623; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harkness KAC, 2004, EUR J NEUROL, V11, P59, DOI 10.1046/j.1351-5101.2003.00707.x; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Herzig MC, 2009, AM J PATHOL, V174, P722, DOI 10.2353/ajpath.2009.080790; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWAI M, 1993, BRAIN RES, V623, P142, DOI 10.1016/0006-8993(93)90021-E; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Long JM, 1998, J NEUROSCI METH, V84, P101, DOI 10.1016/S0165-0270(98)00100-9; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McCarter JF, 2013, ACTA NEUROPATHOL, V126, P179, DOI 10.1007/s00401-013-1137-2; Melchor JP, 2000, J NEUROCHEM, V74, P2209, DOI 10.1046/j.1471-4159.2000.0742209.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Monro OR, 2002, NEUROBIOL AGING, V23, P405, DOI 10.1016/S0197-4580(01)00317-7; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Nilsson KPR, 2010, J NEUROSCI, V30, P12094, DOI 10.1523/JNEUROSCI.2417-10.2010; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Oshima K, 2008, INT J CLIN EXP PATHO, V1, P403; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; Richard E, 2010, J NEUROPATH EXP NEUR, V69, P1158, DOI 10.1097/NEN.0b013e3181fab558; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; ROZEMULLER AJM, 1993, AM J PATHOL, V142, P1449; Rozemuller AJM, 2005, CNS NEUROL DISORD-DR, V4, P223, DOI 10.2174/1568007054038229; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Thal DR, 2002, J NEUROPATH EXP NEUR, V61, P282, DOI 10.1093/jnen/61.3.282; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verbeek MM, 1997, J NEUROCHEM, V68, P1135; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WATTENDORFF AR, 1995, J NEUROL NEUROSUR PS, V58, P699, DOI 10.1136/jnnp.58.6.699; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043; Xu F, 2012, J ALZHEIMERS DIS, V31, P359, DOI 10.3233/JAD-2012-120421; Xu WJ, 2014, J ALZHEIMERS DIS, V38, P621, DOI 10.3233/JAD-130758; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2006, NEUROREPORT, V17, P1735, DOI 10.1097/01.wnr.0000239958.53072.14; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	75	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17895	17908		10.1074/jbc.M113.536565	http://dx.doi.org/10.1074/jbc.M113.536565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24828504	Green Published, hybrid			2022-12-25	WOS:000338018100050
J	Laurence, M; Hatzis, C; Brash, DE				Laurence, Martin; Hatzis, Christos; Brash, Douglas E.			Common Contaminants in Next-Generation Sequencing That Hinder Discovery of Low-Abundance Microbes	PLOS ONE			English	Article							PROSTATE-CANCER; SAMPLES; FUNGAL; DNA	Unbiased high-throughput sequencing of whole metagenome shotgun DNA libraries is a promising new approach to identifying microbes in clinical specimens, which, unlike other techniques, is not limited to known sequences. Unlike most sequencing applications, it is highly sensitive to laboratory contaminants as these will appear to originate from the clinical specimens. To assess the extent and diversity of sequence contaminants, we aligned 57 "1000 Genomes Project'' sequencing runs from six centers against the four largest NCBI BLAST databases, detecting reads of diverse contaminant species in all runs and identifying the most common of these contaminant genera (Bradyrhizobium) in assembled genomes from the NCBI Genome database. Many of these microorganisms have been reported as contaminants of ultrapure water systems. Studies aiming to identify novel microbes in clinical specimens will greatly benefit from not only preventive measures such as extensive UV irradiation of water and cross-validation using independent techniques, but also a concerted effort to sequence the complete genomes of common contaminants so that they may be subtracted computationally.	[Laurence, Martin] Shipshaw Labs, Montreal, PQ, Canada; [Hatzis, Christos] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University; Yale University	Brash, DE (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	douglas.brash@yale.edu	Hatzis, Christos/M-3867-2015	Hatzis, Christos/0000-0002-8120-2290	NIH Skin Cancer SPORE [5P50CA121974]; Yale University; Shipshaw Labs Inc.; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	NIH Skin Cancer SPORE; Yale University; Shipshaw Labs Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DEB is supported by NIH Skin Cancer SPORE grant 5P50CA121974, CH was supported by Yale University, and ML was supported by Shipshaw Labs Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No patents, products in development or marketed products are related to the findings reported in this paper. These affiliations do not alter the authors adherence to PLOS ONE Policies on sharing data and materials. The Leif Microbiome Analyzer is a commercial product of Shipshaw labs.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Duncan CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-22; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Percudani R, 2013, BIOINFORM BIOL INSIG, V7, P55, DOI 10.4137/BBI.S11064; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Stott-Miller M, 2013, PROSTATE, V73, P1803, DOI 10.1002/pros.22719; Sutcliffe S, 2014, PROSTATE, V74, P569, DOI 10.1002/pros.22778	18	186	190	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97876	10.1371/journal.pone.0097876	http://dx.doi.org/10.1371/journal.pone.0097876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837716	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800079
J	Jenni-Eiermann, S; Jenni, L; Smith, S; Costantini, D				Jenni-Eiermann, Susanne; Jenni, Lukas; Smith, Shona; Costantini, David			Oxidative Stress in Endurance Flight: An Unconsidered Factor in Bird Migration	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE ACTIVITY; ANTIOXIDANT CAPACITY; SKELETAL-MUSCLE; REACTIVE OXYGEN; EXERCISE; PROTEIN; TISSUES; PASSERINES; MECHANISMS; INTENSITY	Migrating birds perform extraordinary endurance flights, up to 200 h non-stop, at a very high metabolic rate and while fasting. Such an intense and prolonged physical activity is normally associated with an increased production of reactive oxygen and nitrogen species (RONS) and thus increased risk of oxidative stress. However, up to now it was unknown whether endurance flight evokes oxidative stress. We measured a marker of oxidative damage (protein carbonyls, PCs) and a marker of enzymatic antioxidant capacity (glutathione peroxidase, GPx) in the European robin (Erithacus rubecula), a nocturnal migrant, on its way to the non-breeding grounds. Both markers were significantly higher in European robins caught out of their nocturnal flight than in conspecifics caught during the day while resting. Independently of time of day, both markers showed higher concentrations in individuals with reduced flight muscles. Adults had higher GPx concentrations than first-year birds on their first migration. These results show for the first time that free-flying migrants experience oxidative stress during endurance flight and up-regulate one component of antioxidant capacity. We discuss that avoiding oxidative stress may be an overlooked factor shaping bird migration strategies, e. g. by disfavouring long nonstop flights and an extensive catabolism of the flight muscles.	[Jenni-Eiermann, Susanne; Jenni, Lukas] Swiss Ornithol Inst, Sempach, Switzerland; [Smith, Shona; Costantini, David] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Costantini, David] Univ Antwerp, Dept Biol, Antwerp, Belgium	Swiss Ornithological Institute; University of Glasgow; University of Antwerp	Jenni-Eiermann, S (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	susi.jenni@vogelwarte.ch		Jenni-Eiermann, Susanne/0000-0002-0610-3428; Costantini, David/0000-0002-8140-8790	Swiss Ornithological Institute	Swiss Ornithological Institute	The study was financed by the Swiss Ornithological Institute which is a private foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RG, 1992, J NUTR, V122, P631, DOI 10.1093/jn/122.suppl_3.631; Bairlein F., 1995, MANUAL FIELD METHODS; Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1; Beer-Ljubic B, 2012, ARCH TIERZUCHT, V55, P485, DOI 10.5194/aab-55-485-2012; Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458; Bolshakov CV, 2007, ANIM BEHAV, V74, P855, DOI 10.1016/j.anbehav.2006.10.024; CALLOW M, 1986, EUR J APPL PHYSIOL O, V55, P654, DOI 10.1007/BF00423212; CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856; Costantini D, 2007, COMP BIOCHEM PHYS C, V144, P363, DOI 10.1016/j.cbpc.2006.11.005; Costantini D, 2013, J EXP BIOL, V216, P2213, DOI 10.1242/jeb.083154; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; de Farias JM, 2013, HORM METAB RES, V45, P190, DOI 10.1055/s-0032-1323740; Falsone K, 2009, HORM BEHAV, V56, P548, DOI 10.1016/j.yhbeh.2009.09.009; FINLEY JW, 1991, BIOL TRACE ELEM RES, V29, P181, DOI 10.1007/BF03032676; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Guglielmo CG, 2002, AM J PHYSIOL-REG I, V282, pR1405, DOI 10.1152/ajpregu.00267.2001; Halliwell B., 2007, FREE RADICALS BIOL M; Jackson MJ, 2007, J APPL PHYSIOL, V102, P1664, DOI 10.1152/japplphysiol.01102.2006; Jenni L., 1984, Ornithologische Beobachter, V81, P183; JENNI L, 1992, ORNIS SCAND, V23, P251, DOI 10.2307/3676646; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni L, 2000, AM J PHYSIOL-REG I, V278, pR1182, DOI 10.1152/ajpregu.2000.278.5.R1182; Jenni L., 1994, BIOL MOULT BIRDS; Jenni-Eiermann Susanne, 2012, P171; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Komenda-Zehnder S, 2010, J AVIAN BIOL, V41, P434, DOI 10.1111/j.1600-048X.2010.04891.x; Kvist A, 2001, NATURE, V413, P730, DOI 10.1038/35099556; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liechti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3554; Margonis K, 2007, FREE RADICAL BIO MED, V43, P901, DOI 10.1016/j.freeradbiomed.2007.05.022; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rey B, 2008, AM J PHYSIOL-REG I, V295, pR92, DOI 10.1152/ajpregu.00271.2007; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Schwilch R, 2002, J EXP BIOL, V205, P687; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Sureda A, 2009, BRIT J SPORT MED, V43, P186, DOI 10.1136/bjsm.2007.043943; Szkudelski T, 2004, J PHYSIOL BIOCHEM, V60, P1, DOI 10.1007/BF03168215; Vazquez-Medina JP, 2011, J EXP BIOL, V214, P2903, DOI 10.1242/jeb.057935	50	77	78	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97650	10.1371/journal.pone.0097650	http://dx.doi.org/10.1371/journal.pone.0097650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830743	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336789500093
J	Park, IH; Geno, KA; Sherwood, LK; Nahm, MH; Beall, B				Park, In Ho; Geno, K. Aaron; Sherwood, Logan K.; Nahm, Moon H.; Beall, Bernard			Population-Based Analysis of Invasive Nontypeable Pneumococci Reveals That Most Have Defective Capsule Synthesis Genes	PLOS ONE			English	Article							SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; SEROTYPE; DISEASE; LOCUS; MUTATIONS; CONJUNCTIVITIS; IDENTIFICATION; OUTBREAK	Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates. While most pneumococci express a capsular polysaccharide, nontypeable pneumococci are sometimes isolated. Carriage nontypeables tend to encode novel surface proteins in place of a capsular polysaccharide synthetic locus, the cps locus. In contrast, capsular polysaccharide is believed to be indispensable for invasive pneumococcal disease, and nontypeables from population-based invasive pneumococcal disease surveillance have not been extensively characterized. We received 14,328 invasive pneumococcal isolates through the Active Bacterial Core surveillance program during 2006-2009. Isolates that were nontypeable by Quellung serotyping were characterized by PCR serotyping, sequence analyses of the cps locus, and multilocus sequence typing. Eighty-eight isolates were Quellung-nontypeable (0.61%). Of these, 79 (89.8%) contained cps loci. Twenty-two nontypeables exhibited serotype 8 cps loci with defects, primarily within wchA. Six of the remaining nine isolates contained previously-described aliB homologs in place of cps loci. Multilocus sequence typing revealed that most nontypeables that lacked capsular biosynthetic genes were related to established non-encapsulated lineages. Thus, invasive pneumococcal disease caused by nontypeable pneumococcus remains rare in the United States, and while carriage nontypeables lacking cps loci are frequently isolated, such nontypeable are extremely rare in invasive pneumococcal disease. Most invasive nontypeable pneumococci possess defective cps locus genes, with an over-representation of defective serotype 8 cps variants.	[Park, In Ho; Geno, K. Aaron; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sherwood, Logan K.; Beall, Bernard] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Beall, B (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.	bbeall@cdc.gov		Geno, Aaron/0000-0002-0799-4189; Nahm, Moon/0000-0002-6922-1042	Centers for Disease Control and Prevention; National Institutes of Health [AI-31473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI031473, R01AI031473] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention and the National Institutes of Health (AI-31473 to MHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Buck JM, 2006, PEDIATR INFECT DIS J, V25, P906, DOI 10.1097/01.inf.0000238143.96607.ec; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; James DBA, 2012, J BACTERIOL, V194, P6479, DOI 10.1128/JB.01135-12; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Keller LE, 2013, INFECT IMMUN, V81, P173, DOI 10.1128/IAI.00755-12; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Martin M, 2003, NEW ENGL J MED, V348, P1112, DOI 10.1056/NEJMoa022521; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Morona JK, 1999, J BACTERIOL, V181, P3599, DOI 10.1128/JB.181.11.3599-3605.1999; Munoz R, 1999, J BACTERIOL, V181, P6214; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Waite RD, 2003, MICROBIOL-SGM, V149, P497, DOI 10.1099/mic.0.26011-0; Waite RD, 2001, MOL MICROBIOL, V42, P1223, DOI 10.1046/j.1365-2958.2001.02674.x; Wang L, 1996, J BACTERIOL, V178, P2598, DOI 10.1128/jb.178.9.2598-2604.1996; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11	37	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97825	10.1371/journal.pone.0097825	http://dx.doi.org/10.1371/journal.pone.0097825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831650	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500120
J	Ashfaq, M; Hebert, PDN; Mirza, JH; Khan, AM; Zafar, Y; Mirza, MS				Ashfaq, Muhammad; Hebert, Paul D. N.; Mirza, Jawwad H.; Khan, Arif M.; Zafar, Yusuf; Mirza, M. Sajjad			Analyzing Mosquito (Diptera: Culicidae) Diversity in Pakistan by DNA Barcoding	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; STEGOMYIA AEGYPTI L.; WEST NILE VIRUS; ANNULARIS COMPLEX; GENETIC DIVERSITY; SPECIES COMPLEX; ANOPHELES; VECTOR; IDENTIFICATION; MITOCHONDRIAL	Background: Although they are important disease vectors mosquito biodiversity in Pakistan is poorly known. Recent epidemics of dengue fever have revealed the need for more detailed understanding of the diversity and distributions of mosquito species in this region. DNA barcoding improves the accuracy of mosquito inventories because morphological differences between many species are subtle, leading to misidentifications. Methodology/Principal Findings: Sequence variation in the barcode region of the mitochondrial COI gene was used to identify mosquito species, reveal genetic diversity, and map the distribution of the dengue-vector species in Pakistan. Analysis of 1684 mosquitoes from 491 sites in Punjab and Khyber Pakhtunkhwa during 2010-2013 revealed 32 species with the assemblage dominated by Culex quinquefasciatus (61% of the collection). The genus Aedes (Stegomyia) comprised 15% of the specimens, and was represented by six taxa with the two dengue vector species, Ae. albopictus and Ae. aegypti, dominant and broadly distributed. Anopheles made up another 6% of the catch with An. subpictus dominating. Barcode sequence divergence in conspecific specimens ranged from 0-2.4%, while congeneric species showed from 2.3-17.8% divergence. A global haplotype analysis of disease-vectors showed the presence of multiple haplotypes, although a single haplotype of each dengue-vector species was dominant in most countries. Geographic distribution of Ae. aegypti and Ae. albopictus showed the later species was dominant and found in both rural and urban environments. Conclusions: As the first DNA-based analysis of mosquitoes in Pakistan, this study has begun the construction of a barcode reference library for the mosquitoes of this region. Levels of genetic diversity varied among species. Because of its capacity to differentiate species, even those with subtle morphological differences, DNA barcoding aids accurate tracking of vector populations.	[Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mirza, Jawwad H.; Khan, Arif M.; Mirza, M. Sajjad] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Zafar, Yusuf] Pakistan Atom Energy Commiss, Islamabad, Pakistan	University of Guelph; Pakistan Institute of Engineering & Applied Science; Pakistan Atomic Energy Commission	Ashfaq, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	mashfaq@uoguelph.ca	Ashfaq, Muhammad/J-4723-2019; Hebert, Paul DN/C-4161-2013; zafar, YUSUF/F-5154-2015	Ashfaq, Muhammad/0000-0003-1351-4126; Hebert, Paul DN/0000-0002-3081-6700; 	Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC [106106-001]; Government of Canada through Genome Canada; Ontario Genomics Institute	Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This research was enabled by grant 106106-001, Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC. Sequence analysis was enabled by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of iBOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar M. S., 2012, Dengue Bulletin, V36, P87; Alam MT, 2007, PARASITOL RES, V100, P943, DOI 10.1007/s00436-006-0375-9; Amerasinghe FP, 2002, J MED ENTOMOL, V39, P28, DOI 10.1603/0022-2585-39.1.28; Anderson JR, 2005, GENETICS, V169, P1529, DOI 10.1534/genetics.104.033639; Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; ASLAMKHAN M, 1971, Mosquito Systematics News Letter, V3, P147; Atrie B, 1999, ANN ENTOMOL SOC AM, V92, P243, DOI 10.1093/aesa/92.2.243; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644; Bass Chris, 2010, Malar Res Treat, V2010, P190434, DOI 10.4061/2010/190434; Beebe NW, 2005, COMMUN DIS INTELL, V29, P299; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Dhananjeyan KJ, 2010, TROP BIOMED, V27, P47; Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Harbach R.E., 1988, Contributions of the American Entomological Institute, V24, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hemmerter S, 2009, MOL PHYLOGENET EVOL, V50, P317, DOI 10.1016/j.ympev.2008.11.016; Ilahi I., 2013, International Journal of Innovation and Applied Studies, V2, P454; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kang D, 2013, MOL ECOL RESOUR, V13, P369, DOI 10.1111/1755-0998.12083; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Kumar NP, 2013, MOL ECOL RESOUR, V13, P354, DOI 10.1111/1755-0998.12076; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Low VL, 2014, MED VET ENTOMOL, V28, P157, DOI 10.1111/mve.12022; Manonmani A, 2001, ACTA TROP, V78, P3, DOI 10.1016/S0001-706X(00)00154-6; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Muhammad Mukhtar, 2011, Dengue Bulletin, V35, P99; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Naeem-Ullah U, 2010, PAK J AGR SCI, V47, P124; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; PANT C, 1987, INSECT SCI APPL, V8, P655, DOI 10.1017/S174275840002275X; Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609; Pollitt LC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-440; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Proft J, 1999, PARASITOL RES, V85, P837, DOI 10.1007/s004360050642; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56; Rasheed SB, 2013, MED VET ENTOMOL, V27, P430, DOI 10.1111/mve.12001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; REISEN W K, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P587; REISEN WK, 1982, T ROY SOC TROP MED H, V76, P437, DOI 10.1016/0035-9203(82)90131-6; Santos J. M. M. dos, 2011, Open Tropical Medicine Journal, V4, P11, DOI 10.2174/1874315301104010011; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Shakoor Muhammad T, 2012, WHO South East Asia J Public Health, V1, P229, DOI 10.4103/2224-3151.207018; Sharma AK, 2010, ACTA TROP, V116, P89, DOI 10.1016/j.actatropica.2010.06.003; Sharma AK, 2013, J MOSQUITO RES, V3, P58; Shepard JJ, 2006, J MED ENTOMOL, V43, P443, DOI 10.1603/0022-2585(2006)43[443:MPAERA]2.0.CO;2; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.27; Stark K, 2012, EUROSURVEILLANCE, V17, P2; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Surendran SN, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-239; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Walton C, 1999, BIOL J LINN SOC, V68, P241, DOI 10.1111/j.1095-8312.1999.tb01168.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang GY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051764, 10.1371/journal.pone.0039700, 10.1371/journal.pone.0047051]; Werblow A, 2013, PARASITOL RES, V112, P2495, DOI 10.1007/s00436-013-3418-z; Wilkerson RC, 2004, J MED ENTOMOL, V41, P392, DOI 10.1603/0022-2585-41.3.392; ZAVORTINK TJ, 1990, J AM MOSQUITO CONTR, V6, P593	90	81	90	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97268	10.1371/journal.pone.0097268	http://dx.doi.org/10.1371/journal.pone.0097268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827460	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400069
J	Gomes, PDFC; Panel, N; Laine, E; Pascutti, PG; Solary, E; Tchertanov, L				Figueiredo Celestino Gomes, Priscila Da Silva; Panel, Nicolas; Laine, Elodie; Pascutti, Pedro Geraldo; Solary, Eric; Tchertanov, Luba			Differential Effects of CSF-1R D802V and KIT D816V Homologous Mutations on Receptor Tertiary Structure and Allosteric Communication	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; STRUCTURE PREDICTION SERVER; TYROSINE KINASE-ACTIVITY; GENERALIZED BORN MODEL; GROWTH-FACTOR RECEPTOR; LOCAL FEATURE ANALYSIS; MOLECULAR-DYNAMICS; C-FMS; SIGNAL-TRANSDUCTION; STATISTICAL-THEORY	The colony stimulating factor-1 receptor (CSF-1R) and the stem cell factor receptor KIT, type III receptor tyrosine kinases (RTKs), are important mediators of signal transduction. The normal functions of these receptors can be compromised by gain-of-function mutations associated with different physiopatological impacts. Whereas KIT D816V/H mutation is a well-characterized oncogenic event and principal cause of systemic mastocytosis, the homologous CSF-1R D802V has not been identified in human cancers. The KIT D816V oncogenic mutation triggers resistance to the RTK inhibitor Imatinib used as first line treatment against chronic myeloid leukemia and gastrointestinal tumors. CSF-1R is also sensitive to Imatinib and this sensitivity is altered by mutation D802V. Previous in silico characterization of the D816V mutation in KIT evidenced that the mutation caused a structure reorganization of the juxtamembrane region (JMR) and facilitated its departure from the kinase domain (KD). In this study, we showed that the equivalent CSF-1R D802V mutation does not promote such structural effects on the JMR despite of a reduction on some key H-bonds interactions controlling the JMR binding to the KD. In addition, this mutation disrupts the allosteric communication between two essential regulatory fragments of the receptors, the JMR and the A-loop. Nevertheless, the mutation-induced shift towards an active conformation observed in KIT D816V is not observed in CSF-1R D802V. The distinct impact of equivalent mutation in two homologous RTKs could be associated with the sequence difference between both receptors in the native form, particularly in the JMR region. A local mutation-induced perturbation on the A-loop structure observed in both receptors indicates the stabilization of an inactive non-inhibited form, which Imatinib cannot bind.	[Figueiredo Celestino Gomes, Priscila Da Silva; Panel, Nicolas; Laine, Elodie; Tchertanov, Luba] Ecole Normale Super, Lab Biol & Pharmacol, Cachan, France; [Figueiredo Celestino Gomes, Priscila Da Silva; Pascutti, Pedro Geraldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Solary, Eric] Inst Gustave Roussy, Villejuif, France; [Solary, Eric] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Tchertanov, Luba] Ecole Normale Super, Ctr Math & Leurs Applicat, Cachan, France	UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio de Janeiro; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Tchertanov, L (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol, Cachan, France.	Luba.Tchertanov@lbpa.ens-cachan.fr	, Tchertanov/CAF-3310-2022; Laine, Elodie/AAW-7458-2021; Pascutti, Pedro/AAP-7752-2020	Laine, Elodie/0000-0003-4870-6304; Pascutti, Pedro/0000-0002-5454-560X; da Silva Figueiredo Celestino Gomes, Priscila/0000-0001-7370-9596; Solary, Eric/0000-0002-8629-1341	Ecole Normale Superieure (ENS) de Cachan; Centre National de la Recherche Scientifique (CNRS); French State Agency for Innovation (OSEO); Fondation de France; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ligue Nationale Contre le Cancer (equipe labellisee)	Ecole Normale Superieure (ENS) de Cachan; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French State Agency for Innovation (OSEO); Fondation de France(Fondation de France); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ligue Nationale Contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer)	This work was supported by Ecole Normale Superieure (ENS) de Cachan, Centre National de la Recherche Scientifique (CNRS), the French State Agency for Innovation (OSEO), Fondation de France and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). ES team is supported by the Ligue Nationale Contre le Cancer (equipe labellisee). The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Allain A, 2014, FARADAY DISCUSS, V169, P303, DOI 10.1039/c4fd00024b; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Batista PR, 2010, PHYS CHEM CHEM PHYS, V12, P2850, DOI 10.1039/b919148h; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOU V, 1988, PROTEIN ENG, V2, P185, DOI 10.1093/protein/2.3.185; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frost MJ, 2002, MOL CANCER THER, V1, P1115; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GLOVER HR, 1995, ONCOGENE, V11, P1347; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; He Y., 2012, E HLTH TELECOMM SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046900; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Laine E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002068; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Li SQ, 2003, J BIOL CHEM, V278, P26007, DOI 10.1074/jbc.M302425200; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meyers MJ, 2010, BIOORG MED CHEM LETT, V20, P1543, DOI 10.1016/j.bmcl.2010.01.078; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morley GM, 1999, ONCOGENE, V18, P3076, DOI 10.1038/sj.onc.1202646; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Pardanani A, 2013, AM J HEMATOL, V88, P612, DOI 10.1002/ajh.23459; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Penev PS, 1996, NETWORK-COMP NEURAL, V7, P477, DOI 10.1088/0954-898X/7/3/002; PERAHIA D, 1995, COMPUT CHEM, V19, P241, DOI 10.1016/0097-8485(95)00011-G; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; ROSNET O, 1993, CRIT REV ONCOGENESIS, V4, P595; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Roussel MF, 2003, CELL CYCLE, V2, P5, DOI 10.4161/cc.2.1.295; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swords R, 2012, LEUKEMIA, V26, P2176, DOI 10.1038/leu.2012.114; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taylor JR, 2006, ONCOGENE, V25, P147, DOI 10.1038/sj.onc.1209007; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wan SZ, 2011, J COMPUT CHEM, V32, P2843, DOI 10.1002/jcc.21866; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zhang ZY, 2006, PROTEINS, V64, P391, DOI 10.1002/prot.20983	88	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97519	10.1371/journal.pone.0097519	http://dx.doi.org/10.1371/journal.pone.0097519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828813	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400105
J	Iihara, K; Nishimura, K; Kada, A; Nakagawara, J; Ogasawara, K; Ono, J; Shiokawa, Y; Aruga, T; Miyachi, S; Nagata, I; Toyoda, K; Matsuda, S; Miyamoto, Y; Suzuki, A; Ishikawa, KB; Kataoka, H; Nakamura, F; Kamitani, S				Iihara, Koji; Nishimura, Kunihiro; Kada, Akiko; Nakagawara, Jyoji; Ogasawara, Kuniaki; Ono, Junichi; Shiokawa, Yoshiaki; Aruga, Toru; Miyachi, Shigeru; Nagata, Izumi; Toyoda, Kazunori; Matsuda, Shinya; Miyamoto, Yoshihiro; Suzuki, Akifumi; Ishikawa, Koichi B.; Kataoka, Hiroharu; Nakamura, Fumiaki; Kamitani, Satoru			Effects of Comprehensive Stroke Care Capabilities on In-Hospital Mortality of Patients with Ischemic and Hemorrhagic Stroke: J-ASPECT Study	PLOS ONE			English	Article							GUIDELINES-STROKE; RECOMMENDATIONS; CONSCIOUSNESS; MULTICENTER; PERFORMANCE; VALIDATION; OUTCOMES; CENTERS; SYSTEM; ATTACK	Background: The effectiveness of comprehensive stroke center (CSC) capabilities on stroke mortality remains uncertain. We performed a nationwide study to examine whether CSC capabilities influenced in-hospital mortality of patients with ischemic and hemorrhagic stroke. Methods and Results: Of the 1,369 certified training institutions in Japan, 749 hospitals responded to a questionnaire survey regarding CSC capabilities that queried the availability of personnel, diagnostic techniques, specific expertise, infrastructure, and educational components recommended for CSCs. Among the institutions that responded, data on patients hospitalized for stroke between April 1, 2010 and March 31, 2011 were obtained from the Japanese Diagnosis Procedure Combination database. In-hospital mortality was analyzed using hierarchical logistic regression analysis adjusted for age, sex, level of consciousness on admission, comorbidities, and the number of fulfilled CSC items in each component and in total. Data from 265 institutions and 53,170 emergency-hospitalized patients were analyzed. Mortality rates were 7.8% for patients with ischemic stroke, 16.8% for patients with intracerebral hemorrhage (ICH), and 28.1% for patients with subarachnoid hemorrhage (SAH). Mortality adjusted for age, sex, and level of consciousness was significantly correlated with personnel, infrastructural, educational, and total CSC scores in patients with ischemic stroke. Mortality was significantly correlated with diagnostic, educational, and total CSC scores in patients with ICH and with specific expertise, infrastructural, educational, and total CSC scores in patients with SAH. Conclusions: CSC capabilities were associated with reduced in-hospital mortality rates, and relevant aspects of care were found to be dependent on stroke type.	[Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; [Nishimura, Kunihiro; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Kada, Akiko] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Nakagawara, Jyoji] Natl Cerebral & Cardiovasc Ctr, Integrat Stroke Imaging Ctr, Suita, Osaka, Japan; [Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan; [Ono, Junichi] Chiba Cardiovasc Ctr, Ichihara, Chiba, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Dept Neurosurg, Mitaka, Tokyo, Japan; [Aruga, Toru] Showa Univ Hosp, Tokyo, Japan; [Miyachi, Shigeru] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4648601, Japan; [Nagata, Izumi] Nagasaki Univ, Dept Neurosurg, Nagasaki 852, Japan; [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Kitakyushu, Fukuoka 807, Japan; [Suzuki, Akifumi] Res Inst Brain & Blood Vessels, Akita 0100874, Japan; [Ishikawa, Koichi B.] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Tokyo 104, Japan; [Kataoka, Hiroharu] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Nakamura, Fumiaki; Kamitani, Satoru] Univ Tokyo, Dept Publ Hlth, Tokyo, Japan	Kyushu University; National Cerebral & Cardiovascular Center - Japan; Nagoya Medical Center; National Cerebral & Cardiovascular Center - Japan; Iwate Medical University; Kyorin University; Showa University; Nagoya University; Nagasaki University; National Cerebral & Cardiovascular Center - Japan; University of Occupational & Environmental Health - Japan; National Cancer Center - Japan; National Cerebral & Cardiovascular Center - Japan; University of Tokyo	Iihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan.	kiihara@ns.med.kyushu-u.ac.jp	Kataoka, Hiroharu/GPT-3596-2022; Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845; Kamitani, Satoru/0000-0001-7188-2141; Matsuda, Shinya/0000-0002-8472-8909	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid from the Ministry of Health, Labour, and Welfare of Japan (Principal Investigator: Koji Iihara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Ali SF, 2013, STROKE, V44, P3148, DOI 10.1161/STROKEAHA.113.002493; [Anonymous], 2007, NEA, V70, P4; [Anonymous], 2011, VITAL STAT JAPAN; Cramer SC, 2012, STROKE, V43, P1089, DOI 10.1161/STROKEAHA.111.635334; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; OHTA T, 1986, J NEUROSURG, V64, P420, DOI 10.3171/jns.1986.64.3.0420; Ohta T, 1974, No Shinkei Geka, V2, P623; Qureshi AI, 2013, J STROKE CEREBROVASC, V22, P661, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.015; Qureshi AI, 2012, CEREBROVASC DIS EXTR, V2, P1, DOI 10.1159/000335097; Reeves MJ, 2010, STROKE, V41, P1573, DOI 10.1161/STROKEAHA.109.577171; Saposnik G, 2009, STROKE, V40, P3321, DOI 10.1161/STROKEAHA.109.554907; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Seghieri C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-170; Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873; Smith EE, 2010, NEUROLOGY, V75, P456, DOI 10.1212/WNL.0b013e3181ebdd8d; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; TEASDALE G, 1974, LANCET, V2, P81; Weimar C, 2006, J NEUROL NEUROSUR PS, V77, P601, DOI 10.1136/jnnp.2005.081117; Yasunaga H, 2005, INT HEART J, V46, P855, DOI 10.1536/ihj.46.855	26	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96819	10.1371/journal.pone.0096819	http://dx.doi.org/10.1371/journal.pone.0096819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828409	gold, Green Submitted, Green Published			2022-12-25	WOS:000336857400039
J	Klomp, A; Vaclavu, L; Meerhoff, GF; Reneman, L; Lucassen, PJ				Klomp, Anne; Vaclavu, Lena; Meerhoff, Gideon F.; Reneman, Liesbeth; Lucassen, Paul J.			Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; DENTATE GYRUS; MAJOR DEPRESSION; PROGENITOR CELLS; RAPHE NUCLEI; SEROTONIN; STRESS; AGE	The antidepressant drug fluoxetine (Prozac) has been increasingly prescribed to children and adolescents with depressive disorders despite a lack of thorough understanding of its therapeutic effects in the paediatric population and of its putative neurodevelopmental effects. Within the framework of PRIOMEDCHILD ERA-NET, we investigated; a) effects of chronic fluoxetine treatment on adult hippocampal neurogenesis, a structural readout relevant for antidepressant action and hippocampal development; b) effects on tryptophan hydroxylase (TPH) expression, a measure of serotonin synthesis; c) whether treatment effects during adolescence differed from treatment at an adult age, and d) whether they were subregion-specific. Stereological quantification of the number of proliferating (Ki-67+) cells and of the number of young migratory neurons (doublecortin+), revealed a significant age-by-treatment interaction effect, indicating that fluoxetine affects both proliferation and neurogenesis in adolescent-treated rats differently than it does in adult-treated rats. In terms of subregional differences, fluoxetine enhanced proliferation mainly in the dorsal parts of the hippocampus, and neurogenesis in both the suprapyramidal and infrapyramidal blades of the dentate gyrus in adolescent-treated rats, while no such differences were seen in adult-treated rats. Fluoxetine exerted similar age-by-treatment interaction effects on TPH cells mainly in the ventral portion of the dorsal raphe nucleus. We conclude that fluoxetine exerts divergent effects on structural plasticity and serotonin synthesis in adolescent versus adult-treated rats. These preliminary data indicate a differential sensitivity of the adolescent brain to this drug and thus warrant further research into their behavioural and translational aspects. Together with recent related findings, they further call for caution in prescribing these drugs to the adolescent population.	[Vaclavu, Lena; Meerhoff, Gideon F.; Lucassen, Paul J.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Klomp, Anne; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Lucassen, PJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.	P.J.Lucassen@uva.nl	Lucassen, Paul/ABA-3113-2020; Václavů, Lena/AAX-5212-2020; Vaclavu, Lena/AAE-9192-2021	Lucassen, Paul/0000-0001-9708-9133; Václavů, Lena/0000-0001-8617-7752; Reneman, Liesbeth/0000-0002-5912-9971	PRIOMEDCHILD ERA-NET; Academic Medical Center (ePOD project); HersenStichting Nederland; ISAO	PRIOMEDCHILD ERA-NET; Academic Medical Center (ePOD project); HersenStichting Nederland; ISAO	LR and PJL are supported by PRIOMEDCHILD ERA-NET. LR is supported by the Academic Medical Center (ePOD project). PJL is further supported by the HersenStichting Nederland and ISAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2004, INT J DEV NEUROSCI, V22, P423, DOI 10.1016/j.ijdevneu.2004.06.002; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Balu DT, 2010, EXP CLIN PSYCHOPHARM, V18, P71, DOI 10.1037/a0017295; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Baudry A, 2011, CURR OPIN NEUROBIOL, V21, P858, DOI 10.1016/j.conb.2011.03.005; Beasley CM, 2000, J CLIN PSYCHIAT, V61, P722, DOI 10.4088/JCP.v61n1003; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Bouet V, 2012, PSYCHOPHARMACOLOGY, V221, P329, DOI 10.1007/s00213-011-2580-1; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Choi MR, 2012, J CHEM NEUROANAT, V43, P96, DOI 10.1016/j.jchemneu.2012.01.001; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Cowen DS, 2008, BRAIN RES, V1228, P14, DOI 10.1016/j.brainres.2008.06.059; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dygalo NN, 2006, PHARMACOL BIOCHEM BE, V85, P220, DOI 10.1016/j.pbb.2006.08.004; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Guirado R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-5; Hansen F, 2011, NEUROSCI LETT, V499, P59, DOI 10.1016/j.neulet.2011.05.032; Hanson ND, 2011, PSYCHONEUROENDOCRINO, V36, P1520, DOI 10.1016/j.psyneuen.2011.04.006; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Hodes GE, 2009, NEUROSCIENCE, V163, P609, DOI 10.1016/j.neuroscience.2009.06.057; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Kapornai K, 2008, CURR OPIN PSYCHIATR, V21, P1, DOI 10.1097/YCO.0b013e3282f25b01; Klomp A, 2012, NEUROIMAGE, V59, P218, DOI 10.1016/j.neuroimage.2011.07.082; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; MacGillivray L, 2010, NEUROSCIENCE, V171, P407, DOI 10.1016/j.neuroscience.2010.08.055; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Marlatt Michael W, 2013, Curr Top Behav Neurosci, V15, P313, DOI 10.1007/7854_2012_237; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Nollet M, 2012, NEUROPSYCHOPHARMACOL, V37, P2210, DOI 10.1038/npp.2012.70; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Paizanis E, 2010, INT J NEUROPSYCHOPH, V13, P759, DOI 10.1017/S1461145709990514; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Pineyro G, 1999, PHARMACOL REV, V51, P533; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Rind HB, 2000, NEUROSCIENCE, V101, P665, DOI 10.1016/S0306-4522(00)00402-4; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sass A, 2012, BEHAV BRAIN RES, V228, P169, DOI 10.1016/j.bbr.2011.12.006; Satvat E, 2012, NEUROPHARMACOLOGY, V62, P1627, DOI 10.1016/j.neuropharm.2011.11.025; Scharfman HE, 2002, J COMP NEUROL, V454, P424, DOI 10.1002/cne.10449; Schoenfeld Timothy J, 2013, Curr Top Behav Neurosci, V15, P139, DOI 10.1007/7854_2012_233; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tamamaki N, 1997, EXP BRAIN RES, V116, P250, DOI 10.1007/PL00005753; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Tordera RM, 2002, EUR J PHARMACOL, V442, P63, DOI 10.1016/S0014-2999(02)01504-2; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Von Frijtag JC, 2002, DEV PSYCHOBIOL, V41, P58, DOI 10.1002/dev.10057; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13; Wenthur CJ, 2014, ACS CHEM NEUROSCI, V5, P14, DOI 10.1021/cn400186j; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19	73	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97603	10.1371/journal.pone.0097603	http://dx.doi.org/10.1371/journal.pone.0097603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827731	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400111
J	Koss, MJ; Hoffmann, J; Nguyen, N; Pfister, M; Mischak, H; Mullen, W; Husi, H; Rejdak, R; Koch, F; Jankowski, J; Krueger, K; Bertelmann, T; Klein, J; Schanstra, JP; Siwy, J				Koss, Michael Janusz; Hoffmann, Janosch; Nguyen, Nauke; Pfister, Marcel; Mischak, Harald; Mullen, William; Husi, Holger; Rejdak, Robert; Koch, Frank; Jankowski, Joachim; Krueger, Katharina; Bertelmann, Thomas; Klein, Julie; Schanstra, Joost P.; Siwy, Justyna			Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration	PLOS ONE			English	Article							AQUEOUS-HUMOR; PROTEINS; NEOVASCULARIZATION; RHEOPHERESIS; TRANSFERRIN; EXPRESSION; BIOMARKERS; DISCOVERY; FLUID	Background: There is absence of specific biomarkers and an incomplete understanding of the pathophysiology of exudative age-related macular degeneration (AMD). Methods and Findings: Eighty-eight vitreous samples (73 from patients with treatment naive AMD and 15 control samples from patients with idiopathic floaters) were analyzed with capillary electrophoresis coupled to mass spectrometry in this retrospective case series to define potential candidate protein markers of AMD. Nineteen proteins were found to be upregulated in vitreous of AMD patients. Most of the proteins were plasma derived and involved in biological (ion) transport, acute phase inflammatory reaction, and blood coagulation. A number of proteins have not been previously associated to AMD including alpha-1-antitrypsin, fibrinogen alpha chain and prostaglandin H2-D isomerase. Alpha-1-antitrypsin was validated in vitreous of an independent set of AMD patients using Western blot analysis. Further systems biology analysis of the data indicated that the observed proteomic changes may reflect upregulation of immune response and complement activity. Conclusions: Proteome analysis of vitreous samples from patients with AMD, which underwent an intravitreal combination therapy including a core vitrectomy, steroids and bevacizumab, revealed apparent AMD-specific proteomic changes. The identified AMD-associated proteins provide some insight into the pathophysiological changes associated with AMD.	[Koss, Michael Janusz; Nguyen, Nauke; Koch, Frank] Goethe Univ Frankfurt, Dept Ophthalmol, D-60054 Frankfurt, Germany; [Koss, Michael Janusz; Pfister, Marcel] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Koss, Michael Janusz] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Hoffmann, Janosch; Mischak, Harald; Klein, Julie; Schanstra, Joost P.; Siwy, Justyna] Mosa Diagnost, Hannover, Germany; [Mischak, Harald; Mullen, William; Husi, Holger] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Rejdak, Robert] Lublin Univ, Dept Gen Ophthalmol, Lublin, Poland; [Jankowski, Joachim; Krueger, Katharina; Siwy, Justyna] Charite, Dept Nephrol Endocrinol & Transplantat Med, D-13353 Berlin, Germany; [Bertelmann, Thomas] Philipps Univ, Dept Ophthalmol, Marburg, Germany; [Schanstra, Joost P.] Inst Cardiovasc & Metab Dis, INSERM, U1048, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France	Goethe University Frankfurt; Doheny Eye Institute; Ruprecht Karls University Heidelberg; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Koss, MJ (corresponding author), Goethe Univ Frankfurt, Dept Ophthalmol, D-60054 Frankfurt, Germany.	Michael.koss@me.com	Klein, Julie/ABE-2622-2020; Mullen, William/GWC-8078-2022; Klein, Julie/M-7088-2017; Schanstra, Joost P/X-7724-2018	Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Schanstra, Joost P/0000-0002-7471-372X; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306; Mullen, William/0000-0002-5685-1563; Rejdak, Robert/0000-0003-3321-2723	Adolf Messer Stiftung in Konigstein, Hessen, Germany	Adolf Messer Stiftung in Konigstein, Hessen, Germany	The study was financed in part by the Adolf Messer Stiftung in Konigstein, Hessen, Germany; No additional external funding was received for this study. http://www.adolf-messer-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Augustin AJ, 2007, RETINA-J RET VIT DIS, V27, P133, DOI 10.1097/IAE.0b013e3180323de7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Boehm N, 2012, BRAIN BEHAV IMMUN, V26, P96, DOI 10.1016/j.bbi.2011.07.241; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6443, DOI 10.1167/iovs.11-7409; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Cryan LM, 2008, PROTEOM CLIN APPL, V2, P762, DOI 10.1002/prca.200780094; Ecker SM, 2012, MOL VIS, V18, P1658; Ecker SM, 2011, MOL VIS, V17, P2856; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kim SJ, 2006, CURR EYE RES, V31, P231, DOI 10.1080/02713680600557030; Kim TW, 2012, J PROTEOME RES, V11, P4034, DOI 10.1021/pr300080s; Kisic B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/467130; Klingel R, 2002, THER APHER, V6, P271, DOI 10.1046/j.1526-0968.2002.00418.x; Klingel R, 2010, THER APHER DIAL, V14, P276, DOI 10.1111/j.1744-9987.2010.00807.x; Koch FH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1599, DOI 10.1001/archophthalmol.2011.341; Koss MJ, 2010, OPHTHALMOLOGICA, V224, P72, DOI 10.1159/000235724; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Noma H, 2008, EYE, V22, P42, DOI 10.1038/sj.eye.6702498; Pfister M, 2012, OPHTHALMOLOGE Z DTSC; Spaide RF, 2006, AM J OPHTHALMOL, V141, P149, DOI 10.1016/j.ajo.2005.07.025; Stefansson E, 2006, ACTA OPHTHALMOL SCAN, V84, P718, DOI 10.1111/j.1600-0420.2006.00778.x; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Walia S, 2010, SEMIN OPHTHALMOL, V25, P289, DOI 10.3109/08820538.2010.518912; Wohlrab W, 2004, HYALURONSAEURE HAUT; Wysokinski D, 2013, EXP EYE RES, V106, P14, DOI 10.1016/j.exer.2012.10.003; Yamane K, 2003, MOL CELL PROTEOMICS, V2, P1177, DOI 10.1074/mcp.M300038-MCP200; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	42	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96895	10.1371/journal.pone.0096895	http://dx.doi.org/10.1371/journal.pone.0096895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828575	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336857400043
J	Qin, SS; Li, Q; Zhou, J; Liu, ZJ; Su, N; Wilson, J; Lu, ZM; Deng, DJ				Qin, Sisi; Li, Qiang; Zhou, Jing; Liu, Zhao-jun; Su, Na; Wilson, James; Lu, Zhe-ming; Deng, Dajun			Homeostatic Maintenance of Allele-Specific p16 Methylation in Cancer Cells Accompanied by Dynamic Focal Methylation and Hydroxymethylation	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ORAL EPITHELIAL DYSPLASIA; ABERRANT DNA METHYLATION; DE-NOVO METHYLATION; CPG ISLAND; MALIGNANT-TRANSFORMATION; PROMOTER METHYLATION; LUNG-CANCER; DEMETHYLATION; PROGRESSION	Aim: p16 Methylation frequently occurs in carcinogenesis. While it has been hypothesized that the p16 methylation states are dynamically maintained in cancer cells, direct evidence supporting this hypothesis has not been available until now. Methods: A fusion cell model was established which reprogrammed the native DNA methylation pattern of the cells. The methylation status of the p16 alleles was then repeatedly quantitatively analyzed in the fusion monoclonal, parental cancer cell lines (p16-completely methylated-AGS and unmethylated-MGC803), and HCT116 non-fusion cell using DHPLC and bisulfite sequencing. Histone methylation was analyzed using chromatin immuno-precipitation (ChIP)-PCR. P16 expression status was determined using immuno-staining and RT-PCR. Results: The methylation status for the majority of the p16 alleles was stably maintained in the fusion monoclonal cells after up to 60 passages. Most importantly, focal de novo methylation, demethylation, and hydroxymethylation were consistently observed within about 27% of the p16 alleles in the fusion monoclones, but not the homozygously methylated or unmethylated parental cells. Furthermore, subclones of the monoclones consistently maintained the same p16 methylation pattern. A similar phenomenon was also observed using the p16 hemi-methylated HCT116 non-fusion cancer cell line. Interestingly, transcription was not observed in p16 alleles that were hydroxymethylated with an antisense-strand-specific pattern. Also, the levels of H3K9 and H3K4 trimethylation in the fusion cells were found to be slightly lower than the parental AGS and MGC803 cells, respectively. Conclusion: The present study provides the first direct evidence confirming that the methylation states of p16 CpG islands is not only homeostatically maintained, but also accompanied by a dynamic process of transient focal methylation, demethylation, and hydroxymethylation in cancer cells.	[Qin, Sisi; Li, Qiang; Zhou, Jing; Liu, Zhao-jun; Su, Na; Lu, Zhe-ming; Deng, Dajun] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China; [Wilson, James] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA USA	Peking University; University System of Georgia; Augusta University	Lu, ZM (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China.	zheminglu@163.com; dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; 	National Natural Science Foundation of China [31261140372, 81171900]; National Basic Research Program of China [2011CB504201, 2010CB529303]; Beijing Natural Science Foundation of China [7122033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work is supported by National Natural Science Foundation of China [Grant 31261140372 and 81171900], National Basic Research Program of China [Grant 2011CB504201 and 2010CB529303], and Beijing Natural Science Foundation of China [Grant 7122033]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2003, MUTAT RES-GEN TOX EN, V535, P73, DOI 10.1016/S1383-5718(02)00288-7; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharyya S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt601; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Deng DJ, 2013, CHINESE SCI BULL, V58, P1, DOI 10.1007/s11434-012-5578-0; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Deng DJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.3.e13; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hall GL, 2008, CANCER EPIDEM BIOMAR, V17, P2174, DOI 10.1158/1055-9965.EPI-07-2867; HERMAN JG, 1995, CANCER RES, V55, P4525; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li Q, 2010, PLOS ONE, V5; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lu ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035928; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Pan K, 2003, HUM MUTAT, V22, P388, DOI 10.1002/humu.10271; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Thomson JP, 2013, NUCLEIC ACIDS RES, V41, P5639, DOI 10.1093/nar/gkt232; WANG KH, 1983, ACTA BIOL EXP SINICA, V16, P257; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang BZ, 2012, HUM GENE THER, V23, P1071, DOI 10.1089/hum.2012.070	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97785	10.1371/journal.pone.0097785	http://dx.doi.org/10.1371/journal.pone.0097785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828678	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400123
J	Guo, G; Kang, Q; Zhu, X; Chen, Q; Wang, X; Chen, Y; Ouyang, J; Zhang, L; Tan, H; Chen, R; Huang, S; Chen, JL				Guo, G.; Kang, Q.; Zhu, X.; Chen, Q.; Wang, X.; Chen, Y.; Ouyang, J.; Zhang, L.; Tan, H.; Chen, R.; Huang, S.; Chen, J-L			A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; STEM-CELLS; NORMAL HEMATOPOIESIS; MOLECULAR PATHWAYS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; MESSENGER-RNAS; C-MYC; CANCER; PTEN	Aberrant expression of long noncoding RNAs (lncRNAs) is associated with various human cancers. However, the role of lncRNAs in Bcr-Abl-mediated chronic myeloid leukemia (CML) is unknown. In this study, we performed a comprehensive analysis of lncRNAs in human CML cells using an lncRNA cDNA microarray and identified an lncRNA termed lncRNA-BGL3 that acted as a key regulator of Bcr-Abl-mediated cellular transformation. Notably, we observed that lncRNA-BGL3 was highly induced in response to disruption of Bcr-Abl expression or by inhibiting Bcr-Abl kinase activity in K562 cells and leukemic cells derived from CML patients. Ectopic expression of lncRNA-BGL3 sensitized leukemic cells to undergo apoptosis and inhibited Bcr-Abl-induced tumorigenesis. Furthermore, transgenic (TG) mice expressing lncRNA-BGL3 were generated. We found that TG expression of lncRNA-BGL3 alone in mice was sufficient to impair primary bone marrow transformation by Bcr-Abl. Interestingly, we identified that lncRNA-BGL3 was a target of miR-17, miR-93, miR-20a, miR-20b, miR-106a and miR-106b, microRNAs that repress mRNA of phosphatase and tensin homolog (PTEN). Further experiments demonstrated that lncRNA-BGL3 functioned as a competitive endogenous RNA for binding these microRNAs to cross-regulate PTEN expression. Additionally, our experiments have begun to address the mechanism of how lncRNA-BGL3 is regulated in the leukemic cells and showed that Bcr-Abl repressed lncRNA-BGL3 expression through c-Myc-dependent DNA methylation. Taken together, these results reveal that Bcr-Abl-mediated cellular transformation critically requires silence of tumor-suppressor lncRNA-BGL3 and suggest a potential strategy for the treatment of Bcr-Abl-positive leukemia.	[Guo, G.; Kang, Q.; Zhu, X.; Wang, X.; Chen, Y.; Ouyang, J.; Chen, J-L] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhu, X.] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Chen, Q.] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China; [Zhang, L.] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Zhang, L.] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Tan, H.] Guangzhou Med Univ, Affiliated Hosp 1, Ctr Oncol & Hematol, Guangzhou, Guangdong, Peoples R China; [Chen, R.] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Huang, S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Anhui University; Fujian Agriculture & Forestry University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangzhou Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, West Beichen Rd, Beijing 100101, Peoples R China.	chenjl@im.ac.cn	Huang, Shile/I-1632-2019; Chen, Runsheng/S-9834-2017; Chen, Ji-Long/AAJ-2134-2021	Huang, Shile/0000-0002-3239-1072; Chen, Runsheng/0000-0001-6049-8347; Chen, Ji-Long/0000-0002-4274-0563; Ouyang, Jing/0000-0002-4592-2688; Guo, Guijie/0000-0002-9031-1915	National Key Technologies Research and Development Program of China [2013ZX10004-611]; National Basic Research Program (973) of China [2014CB541804]; Intramural grant of the Chinese Academy of Sciences [KJZD-EW-L01-3]; Natural Science Foundation of China [81171943, U1305212]; Hundreds of Talents Program of Chinese Academy of Sciences	National Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Basic Research Program (973) of China(National Basic Research Program of China); Intramural grant of the Chinese Academy of Sciences; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundreds of Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Dr Paul B Rothman from the School of Medicine, The Johns Hopkins University for valuable discussions. This work was supported by the National Key Technologies Research and Development Program of China (2013ZX10004-611), National Basic Research Program (973) of China (2014CB541804), Intramural grant of the Chinese Academy of Sciences (KJZD-EW-L01-3), Natural Science Foundation of China (81171943, U1305212) and Hundreds of Talents Program of Chinese Academy of Sciences 2009-2014 to J-LC.	Barcelona SL, 2005, PEDIATR ANESTH, V15, P716, DOI 10.1111/j.1460-9592.2005.01548.x; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chan CM, 2013, NUCLEIC ACIDS RES, V41, P9663, DOI 10.1093/nar/gkt761; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Chen Y, 2010, LEUKEMIA, V24, P1545, DOI 10.1038/leu.2010.143; Chen YY, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-21; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; de Giorgio A, 2013, MOL CELL BIOL, V33, P3976, DOI 10.1128/MCB.00683-13; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P756, DOI 10.1038/nbt0710-756b; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heuston Elisabeth F., 2011, Frontiers in Genetics, V2, P94, DOI 10.3389/fgene.2011.00094; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lu D, 2012, HYPERTENSION, V60, P81, DOI 10.1161/HYPERTENSIONAHA.112.191478; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mishra A, 2012, CANCER CELL, V22, P645, DOI 10.1016/j.ccr.2012.09.009; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qiu XX, 2012, NEOPLASIA, V14, P547, DOI 10.1596/neo.12230; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang KC, 2011, J INVEST DERMATOL, V131, pS63; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang S, 2012, J BIOL CHEM, V287, P9804, DOI 10.1074/jbc.M111.312959; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027	55	121	142	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1768	1779		10.1038/onc.2014.131	http://dx.doi.org/10.1038/onc.2014.131			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24837367				2022-12-25	WOS:000352158000004
J	Siamer, S; Guillas, I; Shimobayashi, M; Kunz, C; Hall, MN; Barny, MA				Siamer, Sabrina; Guillas, Isabelle; Shimobayashi, Mitsugu; Kunz, Caroline; Hall, Michael N.; Barny, Marie-Anne			Expression of the Bacterial Type III Effector DspA/E in Saccharomyces cerevisiae Down-regulates the Sphingolipid Biosynthetic Pathway Leading to Growth Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEWARTII SUBSP STEWARTII; CHAIN FATTY-ACIDS; HRP GENE-CLUSTER; ERWINIA-AMYLOVORA; CELL-DEATH; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; SERINE PALMITOYLTRANSFERASE; CERAMIDE SYNTHESIS; CATALYTIC SUBUNIT	Erwinia amylovora, the bacterium responsible for fire blight, relies on a type III secretion system and a single injected effector, DspA/E, to induce disease in host plants. DspA/E belongs to the widespread AvrE family of type III effectors that suppress plant defense responses and promote bacterial growth following infection. Ectopic expression of DspA/E in plant or in Saccharomyces cerevisiae is toxic, indicating that DspA/E likely targets a cellular process conserved between yeast and plant. To unravel the mode of action of DspA/E, we screened the Euroscarf S. cerevisiae library for mutants resistant to DspA/E-induced growth arrest. The most resistant mutants (Delta sur4,Delta fen1,Delta ipt1,Delta skn1,Delta csg1, Delta csg2,Delta orm1, and Delta orm2) were impaired in the sphingolipid biosynthetic pathway. Exogenously supplied sphingolipid precursors such as the long chain bases (LCBs) phytosphingosine and dihydrosphingosine also suppressed the DspA/E-induced yeast growth defect. Expression of DspA/E in yeast down-regulated LCB biosynthesis and induced a rapid decrease in LCB levels, indicating that serine palmitoyltransferase (SPT), the first and rate-limiting enzyme of the sphingolipid biosynthetic pathway, was repressed. SPT down-regulation was mediated by dephosphorylation and activation of Orm proteins that negatively regulate SPT. A Delta cdc55 mutation affecting Cdc55-PP2A protein phosphatase activity prevented Orm dephosphorylation and suppressed DspA/E-induced growth arrest.	[Siamer, Sabrina; Barny, Marie-Anne] Univ Paris 06, INRA UMR1392, IEES, F-75252 Paris, France; [Guillas, Isabelle] Univ Paris 06, Sorbonne Univ, UMR1166, INSERM,Pitie Salpetriere Univ Hosp, F-75013 Paris, France; [Siamer, Sabrina; Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Kunz, Caroline] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Kunz, Caroline] Museum Natl Hist Nat, UMR7245, F-75005 Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Basel; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Barny, MA (corresponding author), Univ Paris 06, INRA UMR1392, IEES, Bat A-7eme Etage Case 237,7 Quai St Bernard, F-75252 Paris, France.	barny@agroparistech.fr		marie-anne, barny/0000-0002-2005-1388; Guillas, Isabelle/0000-0002-6073-0529; Hall, Michael N/0000-0002-2998-0757; Shimobayashi, Mitsugu/0000-0002-6936-0990	Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant; Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship; European Molecular Biology Organization	Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant(French National Research Agency (ANR)); Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by the Agence Nationale de la Recherche Jeune Chercheur DspCellDeath grant.; Recipient of a Contrat Jeune Scientifique "Institut National de la Recherche Agronomique" Ph.D. fellowship and a European Molecular Biology Organization short term fellowship.	Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Bach L, 2011, J CELL SCI, V124, P3223, DOI 10.1242/jcs.074575; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARNY MA, 1990, MOL MICROBIOL, V4, P777, DOI 10.1111/j.1365-2958.1990.tb00648.x; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016; Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212; Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Degrave A, 2013, MOL PLANT PATHOL, V14, P506, DOI 10.1111/mpp.12022; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dietrich CR, 2008, PLANT J, V54, P284, DOI 10.1111/j.1365-313X.2008.03420.x; Dutton MF, 1996, PHARMACOL THERAPEUT, V70, P137, DOI 10.1016/0163-7258(96)00006-X; Frederick RD, 2001, MOL PLANT MICROBE IN, V14, P1213, DOI 10.1094/MPMI.2001.14.10.1213; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Mor H, 2001, MOL PLANT MICROBE IN, V14, P431, DOI 10.1094/MPMI.2001.14.3.431; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Oh CS, 2007, MOL PLANT PATHOL, V8, P255, DOI [10.1111/j.1364-3703.2007.00390.x, 10.1111/j.1364-3703.2007.00390.X]; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Saucedo-Garcia M, 2011, NEW PHYTOL, V191, P943, DOI 10.1111/j.1469-8137.2011.03727.x; Shi LH, 2007, CELL RES, V17, P1030, DOI 10.1038/cr.2007.100; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siamer S, 2011, FEBS OPEN BIO, V1, P23, DOI 10.1016/j.fob.2011.11.001; Siamer S, 2013, FEMS MICROBIOL LETT, V342, P54, DOI 10.1111/1574-6968.12108; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Voynova NS, 2012, BIOCHEM J, V447, P103, DOI 10.1042/BJ20120712; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	60	16	17	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18466	18477		10.1074/jbc.M114.562769	http://dx.doi.org/10.1074/jbc.M114.562769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828506	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000338042000043
J	Li, GL; Su, H; Zhou, ZJ; Yao, W				Li, Genlai; Su, Hao; Zhou, Zhenjin; Yao, Wen			Identification of the Porcine G Protein-Coupled Receptor 41 and 43 Genes and Their Expression Pattern in Different Tissues and Development Stages	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; GASTROINTESTINAL-TRACT; ADIPOSE-TISSUE; GUT MICROBIOTA; HUMAN COLON; GPR43; PROPIONATE; ADIPOGENESIS; FERMENTATION	Short-chain fatty acids (SCFAs) are not only an important energy source, but they also play a regulatory role in various physiological processes in humans and rodents. Current studies, mostly in humans and rodents, have revealed that SCFAs acted as endogenous ligands for G protein-coupled receptor GPR41 and GPR43. Whether proteins similar to human GPR41 and GPR43 mediate the regulatory effects of SCFAs in swine remains unclear to date. The aims of this study were to determine whether GPR41 and GPR43 genes are expressed in porcine different tissues; and whether the expression of GPR41 and GPR43 is tissue-specific and/or time-associated. The alignment results showed that pig chromosome 6 contained GPR41 and GPR43 genes. Reverse transcription polymerase chain reaction (RT-PCR) indicated that GPR41 and GPR43 were expressed in porcine various tissues. The 2218 bp and 1908 bp nucleotide sequence representing the full-length cDNA sequence of porcine GPR41 and GPR43 was obtained from the ileum and spleen using rapid amplification of cDNA ends (RACE), which were capable of encoding 335 and 329 amino acid sequences, respectively. The structure prediction revealed that porcine GPR41 and GPR43 proteins had seven putative trans-membrane domains. The real-time PCR results indicated that GPR41 and GPR43 were expressed throughout the developmental stages in a tissue-specific and time-associated manner. GPR41 and GPR43 were most highly expressed in the ileum (P < 0.01) and the spleen (P < 0.01), respectively. Western blot results showed that porcine GPR41 and GPR43 proteins were expressed in a variety of porcine tissues, including the spleen, ileum, colon, and adipose tissue. In situ GPR41 and GPR43 immunoreactivities were observed through immunohistochemistry in the spleen, ileum, colon, and adipose tissue. In conclusion, the pig genome encoded GPR41 and GPR43 genes, and these two genes were detected in a variety of porcine tissues and expressed in tissue-specific and time-associated manner.	[Li, Genlai; Su, Hao; Zhou, Zhenjin; Yao, Wen] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China; [Yao, Wen] Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs	Yao, W (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China.	yaowen67jp@njau.edu.cn			National Natural Science Foundation of China [31072035]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Novus International	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Novus International	National Natural Science Foundation of China (No.: 31072035), Special Fund for Agro-scientific Research in the Public Interest (No.: 201003011), and Novus International. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; ANDERSON DB, 1973, J LIPID RES, V14, P160; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bourdu S, 2005, GASTROENTEROLOGY, V128, P1996, DOI 10.1053/j.gastro.2005.03.082; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; BUGAUT M, 1993, ANNU REV NUTR, V13, P217, DOI 10.1146/annurev.nu.13.070193.001245; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; FARNINGHAM DAH, 1993, BRIT J NUTR, V70, P37, DOI 10.1079/BJN19930103; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Gilbert ER, 2008, J NUTR, V138, P262, DOI 10.1093/jn/138.2.262; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hou Zengmiao, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1361; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LUNDBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4471, DOI 10.1073/pnas.79.14.4471; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCBURNEY MI, 1993, J NUTR, V123, P721, DOI 10.1093/jn/123.4.721; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Wang A, 2009, J DAIRY SCI, V92, P2696, DOI 10.3168/jds.2009-2037; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; YEN JT, 1991, J ANIM SCI, V69, P2001, DOI 10.2527/1991.6952001x	31	41	41	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97342	10.1371/journal.pone.0097342	http://dx.doi.org/10.1371/journal.pone.0097342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840136	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600025
J	Gao, YQ; Liu, CS; Ding, YM; Sun, C; Zhang, RB; Xian, M; Zhao, G				Gao, Yongqiang; Liu, Changshui; Ding, Yamei; Sun, Chao; Zhang, Rubing; Xian, Mo; Zhao, Guang			Development of Genetically Stable Escherichia coli Strains for Poly(3-Hydroxypropionate) Production	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CONSTRUCTION; EXPRESSION; 3-HYDROXYPROPIONATE; BIOSYNTHESIS; PURIFICATION; INSERTIONS; CHROMOSOME; POLYESTERS; VECTORS	Poly(3-hydroxypropionate) (P3HP) is a biodegradable and biocompatible thermoplastic. In our previous study, a pathway for P3HP production was constructed in recombinant Esecherichia coli. Seven exogenous genes in P3HP synthesis pathway were carried by two plasmid vectors. However, the P3HP production was severely suppressed by strain instability due to plasmid loss. In this paper, two strategies, chromosomal gene integration and plasmid addiction system (PAS) based on amino acid anabolism, were applied to construct a genetically stable strain. Finally, a combination of those two methods resulted in the best results. The resultant strain carried a portion of P3HP synthesis genes on chromosome and the others on plasmid, and also brought a tyrosine-auxotrophy based PAS. In aerobic fed-batch fermentation, this strain produced 25.7 g/L P3HP from glycerol, about 2.5-time higher than the previous strain with two plasmids. To the best of our knowledge, this is the highest P3HP production from inexpensive carbon sources.	[Gao, Yongqiang; Liu, Changshui; Sun, Chao; Zhang, Rubing; Xian, Mo; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biobased Mat, Qingdao, Peoples R China; [Gao, Yongqiang; Liu, Changshui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xian, Mo; Zhao, Guang] Collaborat Innovat Ctr Marine Biomass Fibers Mat, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Xian, M (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biobased Mat, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn; zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013; GAO, YQ/AAD-8468-2022	zhao, guang/0000-0003-0002-5972; Gao, Yongqiang/0000-0002-5871-8651; ding, yamei/0000-0002-8972-9468	100-Talent Project of CAS; Natural Science Foundation of Shandong Province [ZR2013EMZ002]; National Natural Science Foundation of China [21206185, 21376255]; Qingdao Sci-Tech Development Programme [12-1-4-9-(3)-jch]	100-Talent Project of CAS; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao Sci-Tech Development Programme	This research was financially supported by the 100-Talent Project of CAS (for GZ), Natural Science Foundation of Shandong Province (ZR2013EMZ002), National Natural Science Foundation of China (21206185, 21376255), and Qingdao Sci-Tech Development Programme (12-1-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreessen B, 2010, APPL ENVIRON MICROB, V76, P4919, DOI 10.1128/AEM.01015-10; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BURNS DT, 1991, FRESEN J ANAL CHEM, V340, P53, DOI 10.1007/BF00324392; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Green PR, 2002, BIOMACROMOLECULES, V3, P208, DOI 10.1021/bm015620m; Ichikawa M, 1996, MACROMOL CHEM PHYS, V197, P2467, DOI 10.1002/macp.1996.021970811; Jones KL, 1998, BIOTECHNOL BIOENG, V59, P659, DOI 10.1002/(SICI)1097-0290(19980920)59:6<659::AID-BIT1>3.3.CO;2-1; Koma D, 2012, APPL MICROBIOL BIOT, V93, P815, DOI 10.1007/s00253-011-3735-z; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Kroll J, 2009, METAB ENG, V11, P168, DOI 10.1016/j.ymben.2009.01.007; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Meng DC, 2012, METAB ENG, V14, P317, DOI 10.1016/j.ymben.2012.04.003; Ohta K, 1990, J BACTERIOL, V57, P893; Peredelchuk MY, 1997, GENE, V187, P231, DOI 10.1016/S0378-1119(96)00760-3; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; SAMPATHKUMAR P, 1982, BIOCHIM BIOPHYS ACTA, V702, P204, DOI 10.1016/0167-4838(82)90504-0; Shen HY, 2005, ANAL CHIM ACTA, V535, P33, DOI 10.1016/j.aca.2004.12.027; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Wang Q, 2013, BIORESOURCE TECHNOL, V131, P548, DOI 10.1016/j.biortech.2013.01.096; Wang ZJ, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-34; WOJCIK K, 1993, ACTA MICROBIOL POL, V42, P127; ZABRISKIE DW, 1986, ENZYME MICROB TECH, V8, P706, DOI 10.1016/0141-0229(86)90157-2; Zhou Q, 2011, METAB ENG, V13, P777, DOI 10.1016/j.ymben.2011.10.002	29	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97845	10.1371/journal.pone.0097845	http://dx.doi.org/10.1371/journal.pone.0097845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837211	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800076
J	O'Brien, HD; Williams, SH				O'Brien, Haley D.; Williams, Susan H.			Using Biplanar Fluoroscopy to Guide Radiopaque Vascular Injections: A New Method for Vascular Imaging	PLOS ONE			English	Article							SYSTEM; VISUALIZATION; VENTILATION; KINEMATICS; ANATOMY; HEAD	Studying vascular anatomy, especially in the context of relationships with hard tissues, is of great interest to biologists. Vascular studies have provided significant insight into physiology, function, phylogenetic relationships, and evolutionary patterns. Injection of resin or latex into the vascular system has been a standard technique for decades. There has been a recent surge in popularity of more modern methods, especially radiopaque latex vascular injection followed by CT scanning and digital "dissection.'' This technique best displays both blood vessels and bone, and allows injections to be performed on cadaveric specimens. Vascular injection is risky, however, because it is not a standardizable technique, as each specimen is variable with regard to injection pressure and timing. Moreover, it is not possible to view the perfusion of injection medium throughout the vascular system of interest. Both data and rare specimens can therefore be lost due to poor or excessive perfusion. Here, we use biplanar video fluoroscopy as a technique to guide craniovascular radiopaque latex injection. Cadaveric domestic pigs (Sus scrofa domestica) and white-tailed deer (Odocoileus virginianus) were injected with radiopaque latex under guidance of fluoroscopy. This method was found to enable adjustments, in real-time, to the rate, location, and pressure at which latex is injected in order to avoid data and specimen loss. In addition to visualizing the injection process, this technique can be used to determine flow patterns, and has facilitated the development of consistent markers for complete perfusion.	[O'Brien, Haley D.] Ohio Univ, Dept Biol Sci, Grad Program Ecol & Evolutionary Biol, Athens, OH 45701 USA; [Williams, Susan H.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Ohio University; Ohio University	O'Brien, HD (corresponding author), Ohio Univ, Dept Biol Sci, Grad Program Ecol & Evolutionary Biol, Athens, OH 45701 USA.	ho128009@ohio.edu		Williams, Susan/0000-0003-4167-678X; O'Brien, Haley/0000-0002-8758-6571	National Science Foundation [DBI-0922988]; Ohio Board of Regents, Ohio University; Heritage College; American Society of Mammalogists; Ohio University Student Enhancement Award; Ohio University Graduate Student Senate Original Work Grant	National Science Foundation(National Science Foundation (NSF)); Ohio Board of Regents, Ohio University; Heritage College; American Society of Mammalogists; Ohio University Student Enhancement Award; Ohio University Graduate Student Senate Original Work Grant	Support for this project was provided by a National Science Foundation grant (DBI-0922988), the Ohio Board of Regents, Ohio University (ohio.edu) and the Heritage College of Osteopathic (oucom.ohiou.edu) Medicine to SHW. Support was also provided by the American Society of Mammalogists Grants-In-Aid of Research (mammalsociety.org), the Ohio University Student Enhancement Award (ohio.edu), and the Ohio University Graduate Student Senate Original Work Grant (ohio.edu/gss) to HDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F., 1849, GENUINE WORKS HIPPOC; BALDWIN BA, 1963, J ANAT, V97, P203; Bamel S S, 1975, Anat Anz, V137, P440; BRAINERD EL, 1993, BIOL J LINN SOC, V49, P163, DOI 10.1006/bijl.1993.1028; BRAINERD EL, 1989, SCIENCE, V246, P1593, DOI 10.1126/science.246.4937.1593; Breasted J.H., 1930, E SMITH SURG PAPYRUS; BUGGE J, 1963, ACTA ANAT, V54, P177, DOI 10.1159/000142445; Caputa M, 2004, J THERM BIOL, V29, P691, DOI 10.1016/j.jtherbio.2004.08.079; Carlisle A, 1800, COMMUNICATIONS, V90, P98; CARLTON C, 1977, ANAT REC, V189, P91, DOI 10.1002/ar.1091890107; Costidis A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00243; DANIEL PM, 1953, PHILOS T ROY SOC B, V237, P173, DOI 10.1098/rstb.1953.0003; FOLKOW LP, 1988, J ZOOL, V216, P417, DOI 10.1111/j.1469-7998.1988.tb02439.x; Geisler J. H., 1998, EMERGENCE WHALES EVO; Holliday CM, 2006, ANAT REC PART A, V288A, P1031, DOI 10.1002/ar.a.20374; Keefe DF, 2008, COMPUT GRAPH FORUM, V27, P863, DOI 10.1111/j.1467-8659.2008.01218.x; Khoury Amal, 2007, Am J Orthop (Belle Mead NJ), V36, P582; KILGORE DL, 1976, J COMP PHYSIOL, V110, P209, DOI 10.1007/BF00689309; KRUGER RA, 1979, RADIOLOGY, V130, P49, DOI 10.1148/130.1.49; Kruger RA, 1978, INVEST RADIOL, V14, P279; Lawson MA, 1991, P SOC PHOTO-OPT INS, V256, P1445; Lesbre MF-X, 1903, ARCH MUSEUM HIST NAT, V8, P1; MacPhee R. D. E., 1986, COMP PRIM B, V1, P219; Massimini DF, 2009, THESIS MIT CAMBRIDGE; Meinertz T, 1969, Mikroskopie, V25, P227; MIDTGARD U, 1984, J MORPHOL, V179, P135, DOI 10.1002/jmor.1051790203; Mitchell G, 2008, J THEOR BIOL, V252, P98, DOI 10.1016/j.jtbi.2008.01.017; Nickel R., 1963, ZENTRALBL VET A, V10, P89, DOI [10.1111/j.1439-0442.1963.tb00009.x, DOI 10.1111/J.1439-0442.1963.TB00009.X]; O'Donoghue CH, 1921, PHILOS T R SOC LON B, V210, P175, DOI 10.1098/rstb.1921.0006; Sedlmayr JC, 2002, ANAT RECORD, V267, P330, DOI 10.1002/ar.10133; SUCKLING JA, 1969, NATURE, V221, P379, DOI 10.1038/221379a0; TAYEB M. A. F., 1951, BRIT VET JOUR, V107, P147; Villavicencio AT, 2005, J SPINAL DISORD TECH, V18, P369, DOI 10.1097/01.bsd.0000168511.67189.64; Wible J.R., 1986, Journal of Vertebrate Paleontology, V6, P313; Wible JR, 1984, THESIS DUKE U; Wible JR, 1983, PALAEONTOL POLON, V28, P281; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; You BM, 2001, IEEE T MED IMAGING, V20, P514, DOI 10.1109/42.929617; Zangerl R, 1989, PALEOTECHNIQUES SPEC, P156	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97940	10.1371/journal.pone.0097940	http://dx.doi.org/10.1371/journal.pone.0097940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835249	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800088
J	Rubinstein, NJ; Anderson, AJ; Ma-Wyatt, A; Walland, MJ; McKendrick, AM				Rubinstein, Nikki J.; Anderson, Andrew J.; Ma-Wyatt, Anna; Walland, Mark J.; McKendrick, Allison M.			The Effects of Ageing and Visual Field Loss on Pointing to Visual Targets	PLOS ONE			English	Article							FEEDBACK-CONTROL; GLAUCOMA; EYE; INFORMATION; ECCENTRICITY; LOCALIZATION; IMPAIRMENT; PRECISION; MOVEMENTS; VERNIER	Purpose: To investigate the effect of ageing on visuomotor function and subsequently evaluate the effect of visual field loss on such function in older adults. Methods: Two experiments were performed: 1) to determine the effect of ageing on visual localisation and subsequent pointing precision, and 2) to determine the effect of visual field loss on these outcome measures. For Experiment 1, we measured visual localisation and pointing precision radially at visual eccentricities of 5, 10 and 15 degrees in 25 older (60-72 years) and 25 younger (20-31 years) adults. In the pointing task, participants were asked to point to a target on a touchscreen at a natural pace that prioritised accuracy of the touch. In Experiment 2, a subset of these tasks were performed at 15 degrees eccentricity under both monocular and binocular conditions, by 8 glaucoma (55-76 years) and 10 approximately age-matched controls (61-72 years). Results: Visual localisation and pointing precision was unaffected by ageing (p>0.05) and visual field loss (p>0.05), although movement time was increased in glaucoma (p = 0.01). Conclusion: Visual localisation and pointing precision to high contrast stimuli within the central 15 degrees of vision are unaffected by ageing. Even in the presence of significant visual field loss, older adults with glaucoma are able perform such tasks with reasonable precision provided the target can be perceived and movement time is not restricted.	[Rubinstein, Nikki J.; Anderson, Andrew J.; McKendrick, Allison M.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Ma-Wyatt, Anna] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Walland, Mark J.] Victoria Parade Eye Consultants, Fitzroy, Vic, Australia	University of Melbourne; University of Adelaide	McKendrick, AM (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	allisonm@unimelb.edu.au	McKendrick, Allison M/A-2114-2008	McKendrick, Allison/0000-0003-1972-1222; Anderson, Andrew/0000-0001-7015-0061	Australian Research Council Future Fellowship [ARC FT0990930, ARC FT120100407]	Australian Research Council Future Fellowship(Australian Research Council)	Funded by Australian Research Council Future Fellowship to author AMM (ARC FT0990930) and AJA (ARC FT120100407), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM JJ, 1993, ACTA PSYCHOL, V84, P135, DOI 10.1016/0001-6918(93)90024-L; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Coats RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047222; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Folstein MF., 2000, MINIMENTAL STATE EXA; Garcia-Suarez L, 2004, VISION RES, V44, P1039, DOI 10.1016/j.visres.2003.11.018; Gegenfurtner KR, 2007, J VISION, V7, DOI 10.1167/7.5.11; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Hardy LH., 1937, AM ACAD OPHTHALMOL O, V30, P491; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; KALESNYKAS RP, 1994, VISION RES, V34, P517, DOI 10.1016/0042-6989(94)90165-1; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Latham K, 1998, CURR EYE RES, V17, P1010, DOI 10.1076/ceyr.17.10.1010.5237; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Li RW-H, 2003, J VIS, V3, P353; Ma-Wyatt A, 2007, EXP BRAIN RES, V179, P55, DOI 10.1007/s00221-006-0767-1; Ma-Wyatt A, 2006, VISION RES, V46, P4675, DOI 10.1016/j.visres.2006.08.009; McKendrick AM, 2002, INVEST OPHTH VIS SCI, V43, P1393; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PROTEAU L, 1994, J GERONTOL, V49, pP100, DOI 10.1093/geronj/49.3.P100; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rand MK, 2011, BEHAV BRAIN RES, V219, P39, DOI 10.1016/j.bbr.2010.12.008; Rossit S, 2008, EXP BRAIN RES, V185, P1, DOI 10.1007/s00221-007-1126-6; Sarlegna FR, 2006, NEUROSCI LETT, V403, P309, DOI 10.1016/j.neulet.2006.05.003; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Simmerman J S, 1984, J Am Optom Assoc, V55, P50; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; WARABI T, 1986, EXP NEUROL, V92, P686, DOI 10.1016/0014-4886(86)90309-2; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiecek E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00472	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97190	10.1371/journal.pone.0097190	http://dx.doi.org/10.1371/journal.pone.0097190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836047	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800030
J	Alsiary, R; Bruning-Richardson, A; Bond, J; Morrison, EE; Wilkinson, N; Bell, SM				Alsiary, Rawiah; Bruening-Richardson, Anke; Bond, Jacquelyn; Morrison, Ewan E.; Wilkinson, Nafisa; Bell, Sandra M.			Deregulation of Microcephalin and ASPM Expression Are Correlated with Epithelial Ovarian Cancer Progression	PLOS ONE			English	Article							ABNORMAL SPINDLE-LIKE; CENTROSOMAL PROTEIN; CELL PROLIFERATION; MUTATIONS; GENE; ENCODES; PATHWAY; BIOLOGY; KINASE; RING	Mutations in the MCPH1 (Microcephalin) and ASPM (abnormal spindle-like microcephaly associated) genes cause primary microcephaly. Both are centrosomal associated proteins involved in mitosis. Microcephalin plays an important role in DNA damage response and ASPM is required for correct division of proliferative neuro-epithelial cells of the developing brain. Reduced MCPH1 mRNA expression and ASPM mRNA over-expression have been implicated in the development of human carcinomas. Epithelial ovarian cancer (EOC) is characterised by highly aneuploid tumours. Previously we have reported low Microcephalin and high ASPM protein levels and associations with clinico-pathological parameters in malignant cells from ascitic fluids. To confirm these previous findings on a larger scale Microcephalin and ASPM expression levels and localisations were evaluated by immunohistochemistry in two cohorts; a training set of 25 samples and a validation set of 322 EOC tissue samples. Results were correlated to the associated histopathological data. In normal ovarian tissues the Microcephalin nuclear staining pattern was consistently strong. In the cancer tissues, we identified low nuclear Microcephalin expression in high grade and advanced stage tumours (p<0.0001 and p = 0.0438 respectively). ASPM had moderate to high nuclear and low to moderate cytoplasmic expression in normal tissue. Cytoplasmic ASPM expression decreased with tumour grade and stage in the serous subtype of EOC (p = 0.023 and p = 0.011 respectively). Cytoplasmic ASPM increased with tumour stage in the endometrioid subtype (p = 0.023). Increasing tumour invasiveness (T3) and lymph node involvement (N1) also correlated with a decrease in cytoplasmic ASPM in EOC (p = 0.02 and p = 0.04 respectively). We have validated previous findings of deregulated expression of Microcephalin and ASPM in EOC by confirming associations for low nuclear Microcephalin levels and high cytoplasmic ASPM levels in a larger scale tumour tissue study. Microcephalin and ASPM may prove useful biomarkers in EOC.	[Alsiary, Rawiah; Bond, Jacquelyn; Morrison, Ewan E.; Bell, Sandra M.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Bruening-Richardson, Anke] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Wilkinson, Nafisa] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; Saint James's University Hospital; University of Leeds	Bell, SM (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	medsmb@leeds.ac.uk		Bruning-Richardson, Anke/0000-0002-9862-9805; Bell, Sandra/0000-0002-3022-9864	Yorkshire Cancer Research [L328]; University of Leeds; Saudi Arabian Ministry of Higher Education; Wellbeing of Women	Yorkshire Cancer Research; University of Leeds; Saudi Arabian Ministry of Higher Education; Wellbeing of Women(Wellbeing of Women (WoW))	This work and Dr. Bruning-Richardson were funded by Yorkshire Cancer Research [L328] to Drs Morrison, Bond and Bell. The University of Leeds supports Dr. Bell, Dr Bond and Dr. Morrison. Dr. Alsiary by a scholarship from the Saudi Arabian Ministry of Higher Education, Dr. Wilkinson by Leeds Teaching Hospitals NHS Trust. Dr. Wilkinson holds funding from Wellbeing of Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Aicardi J, 1998, DIS NERVOUS SYSTEM C, P90; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Bhattacharya N, 2013, ANN SURG ONCOL, V20, pS424, DOI 10.1245/s10434-012-2715-6; Bikeye SNN, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-1; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Drozdov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035510; Ferlay J, 2008, CANC INCIDENCE MORTA; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Genin A, 2012, HUM MOL GENET, V21, P5306, DOI 10.1093/hmg/dds386; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Hagemann C, 2008, ONCOL REP, V20, P301, DOI 10.3892/or_00000007; Hermanek P, 2001, CME J GYNECOLOGIC ON, V2, P267; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jo YH, 2013, GENE, V517, P184, DOI 10.1016/j.gene.2012.12.088; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Peyre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012932; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rhoads A, 2005, ETHN DIS S5, V15; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Wang WY, 2013, GASTROENTEROLOGY, V145, P1110, DOI 10.1053/j.gastro.2013.07.040; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	44	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97059	10.1371/journal.pone.0097059	http://dx.doi.org/10.1371/journal.pone.0097059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830737	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500032
J	Kerr, KA; Christy, JH; Joly-Lopez, Z; Luque, J; Collin, R; Guichard, F				Kerr, Kecia A.; Christy, John H.; Joly-Lopez, Zoe; Luque, Javier; Collin, Rachel; Guichard, Frederic			Reproducing on Time When Temperature Varies: Shifts in the Timing of Courtship by Fiddler Crabs	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTIVE SIGNIFICANCE; BEHAVIORAL THERMOREGULATION; WARMING WORLD; UCA; PHENOLOGY; CYCLES; RESPONSES; PATTERNS; RELEASE	Many species reproduce when conditions are most favorable for the survival of young. Numerous intertidal fish and invertebrates release eggs or larvae during semilunar, large amplitude, nocturnal tides when these early life stages are best able to escape predation by fish that feed near the shore during the day. Remarkably, some species, including the fiddler crabs Uca terpsichores and Uca deichmanni, maintain this timing throughout the year as temperature, and thus the rate of embryonic development, vary. The mechanisms that allow such precision in the timing of the production of young are poorly known. A preliminary study suggested that when temperature decreases, U. terpsichores mate earlier in the tidal amplitude cycle such that larvae are released at the appropriate time. We tested this idea by studying the timing of courtship in U. terpsichores and U. deichmanni as temperature varied annually during two years, at 5 locations that differed in the temperature of the sediment where females incubate their eggs. Uca terpsichores courted earlier at locations where sediment temperature declined seasonally but not where sediment temperature remained elevated throughout the year. In contrast, clear shifts in courtship timing were not observed for U. deichmanni despite variation in sediment temperature. We discuss other mechanisms by which this species may maintain reproductive timing. These two species are likely to be affected differently by changes in the frequency and intensity of cold periods that are expected to accompany climate change.	[Kerr, Kecia A.; Joly-Lopez, Zoe; Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Kerr, Kecia A.; Christy, John H.; Luque, Javier; Collin, Rachel] Smithsonian Trop Res Inst, Panama City, Panama; [Kerr, Kecia A.; Collin, Rachel; Guichard, Frederic] McGill Univ, McGill STRI Neotrop Environm Opt NEO, Montreal, PQ, Canada; [Luque, Javier] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	McGill University; Smithsonian Institution; Smithsonian Tropical Research Institute; McGill University; University of Alberta	Kerr, KA (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	kecia.kerr@mail.mcgill.ca	Collin, Rachel/Q-7100-2019; Guichard, Frederic/B-6188-2015; Collin, Rachel/G-2001-2010	Collin, Rachel/0000-0001-5103-4460; Guichard, Frederic/0000-0002-7369-482X; Luque, Javier/0000-0002-4391-5951	Society of Integrative and Comparative Biology; McGill Neotropical Environment Option; Natural Sciences and Engineering Research Council of Canada; Quebec- Ocean	Society of Integrative and Comparative Biology; McGill Neotropical Environment Option; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec- Ocean	This work was funded by a Society of Integrative and Comparative Biology Grant-in-Aid of Research to K. K.; a McGill Neotropical Environment Option Grant-in-Aid of Research to K.K.; the Natural Sciences and Engineering Research Council of Canada (Research grant to F.G. and PGSD to K.K.); and Quebec- Ocean funding of F.G. and K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoh K, 2002, ENVIRON BIOL FISH, V64, P379, DOI 10.1023/A:1016177512353; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bertram DF, 2001, PROG OCEANOGR, V49, P283, DOI 10.1016/S0079-6611(01)00027-1; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; BROWN SK, 1985, J EXP MAR BIOL ECOL, V90, P27, DOI 10.1016/0022-0981(85)90072-3; Burgess SC, 2011, J EXP BIOL, V214, P2329, DOI 10.1242/jeb.054718; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chapperon C, 2011, FUNCT ECOL, V25, P1040, DOI 10.1111/j.1365-2435.2011.01859.x; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Christopher CE, 2008, J CRUSTACEAN BIOL, V28, P328, DOI 10.1651/0278-0372(2008)028[0328:ITHCOF]2.0.CO;2; Christy JH, 2003, REV CHIL HIST NAT, V76, P177; CHRISTY JH, 1982, BIOL BULL, V163, P251, DOI 10.2307/1541264; CHRISTY JH, 1978, SCIENCE, V199, P453, DOI 10.1126/science.199.4327.453; Christy JH, 2002, BEHAV ECOL, V13, P366, DOI 10.1093/beheco/13.3.366; Christy JH, 2001, BEHAVIOUR, V138, P1065, DOI 10.1163/156853901753287145; Christy JH, 2011, INTEGR COMP BIOL, V51, P62, DOI 10.1093/icb/icr013; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Dale RK, 2007, ESTUAR COAST SHELF S, V72, P283, DOI 10.1016/j.ecss.2006.10.024; Danilowicz BS, 1995, B MAR SCI, V57, P624; Derivera CE, 2005, ANIM BEHAV, V70, P289, DOI 10.1016/j.anbehav.2004.10.027; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FOSTER SA, 1987, MAR BIOL, V95, P333, DOI 10.1007/BF00409563; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Georges A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P18, DOI 10.1086/425200; Ghalambor Cameron K., 2010, P90; Gimenez L, 2011, J EXP MAR BIOL ECOL, V400, P227, DOI 10.1016/j.jembe.2011.02.036; Gouhier TC, 2013, CONDUCT UNIVARIATE B; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; JOHNSON RALPH GORDON, 1965, LIMNOL OCEANOGR, V10, P114; Kahn AT, 2013, BEHAV ECOL, V24, P906, DOI 10.1093/beheco/art017; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kellmeyer K, 2001, J EXP MAR BIOL ECOL, V260, P169, DOI 10.1016/S0022-0981(01)00259-3; Kerr KA, 2014, MAR ECOL PROG SER, V503, P99, DOI 10.3354/meps10735; Kerr KA, 2012, MAR ECOL PROG SER, V459, P1, DOI 10.3354/meps09832; Kokita T, 2000, MAR ECOL PROG SER, V199, P263, DOI 10.3354/meps199263; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Les HL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P105, DOI 10.1086/590263; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Milner RNC, 2010, BEHAV ECOL, V21, P311, DOI 10.1093/beheco/arp196; Morgan SG, 1996, MAR ECOL PROG SER, V139, P105, DOI 10.3354/meps139105; Morgan SG, 2011, MAR ECOL PROG SER, V425, P103, DOI 10.3354/meps08969; Murai M, 2005, ANIM BEHAV, V70, P1093, DOI 10.1016/j.anbehav.2005.02.019; Nakasone Y, 1998, J CRUSTACEAN BIOL, V18, P70, DOI 10.2307/1549522; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PICCOLO MC, 1993, ESTUAR COAST SHELF S, V36, P345, DOI 10.1006/ecss.1993.1021; Pike DA, 2012, FUNCT ECOL, V26, P469, DOI 10.1111/j.1365-2435.2011.01946.x; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; R Core Development Team, 2011, R LANG ENV STAT COMP; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rombough PJ, 1996, GLOBAL WARMING IMPLI, P177; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Skov MW, 2005, ECOLOGY, V86, P1164, DOI 10.1890/04-0917; SMITH WK, 1973, PHYSIOL ZOOL, V46, P186, DOI 10.1086/physzool.46.3.30155601; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Thurman CL, 2004, BIOL RHYTHM RES, V35, P43, DOI 10.1080/09291010412331313232; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918; Weaver A, 2002, J CRUSTACEAN BIOL, V22, P429, DOI 10.1651/0278-0372(2002)022[0429:HROUTE]2.0.CO;2; WILSON K, 1983, ESTUAR COAST SHELF S, V17, P581, DOI 10.1016/0272-7714(83)90010-0; Windsor A, 2005, J THERM BIOL, V30, P37, DOI 10.1016/j.jtherbio.2004.06.006; Yamahira K, 1997, MAR ECOL PROG SER, V155, P239, DOI 10.3354/meps155239; ZUCKER N, 1983, MAR BEHAV PHYSIOL, V10, P57, DOI 10.1080/10236248309378606; ZUCKER N, 1974, AM MIDL NAT, V91, P224, DOI 10.2307/2424524; ZUCKER N, 1978, BIOL BULL, V155, P410, DOI 10.2307/1540961	79	19	19	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97593	10.1371/journal.pone.0097593	http://dx.doi.org/10.1371/journal.pone.0097593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832079	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500083
J	Rong, WN; Chen, X; Zhao, KX; Liu, YN; Liu, XX; Ha, SP; Liu, WZ; Kang, XL; Sheng, XL; Zhao, C				Rong, Weining; Chen, Xue; Zhao, Kanxing; Liu, Yani; Liu, Xiaoxing; Ha, Shaoping; Liu, Wenzhou; Kang, Xiaoli; Sheng, Xunlun; Zhao, Chen			Novel and Recurrent MYO7A Mutations in Usher Syndrome Type 1 and Type 2	PLOS ONE			English	Article							MYOSIN-VIIA GENE; SYNDROME-TYPE-II; RETINITIS-PIGMENTOSA; READ ALIGNMENT; MOTOR DOMAIN; LONG ISOFORM; SYNDROME 1B; DEAFNESS; PROTEIN; PRODUCT	Usher syndrome (USH) is a group of disorders manifested as retinitis pigmentosa and bilateral sensorineural hearing loss, with or without vestibular dysfunction. Here, we recruited three Chinese families affected with autosomal recessive USH for detailed clinical evaluations and for mutation screening in the genes associated with inherited retinal diseases. Using targeted next-generation sequencing (NGS) approach, three new alleles and one known mutation in MYO7A gene were identified in the three families. In two families with USH type 1, novel homozygous frameshift variant p.Pro194Hisfs*13 and recurrent missense variant p. Thr165Met were demonstrated as the causative mutations respectively. Crystal structural analysis denoted that p.Thr165Met would very likely change the tertiary structure of the protein encoded by MYO7A. In another family affected with USH type 2, novel biallelic mutations in MYO7A, c.[1343+1G>A];[2837T>G] or p.[?];[Met946Arg], were identified with clinical significance. Because MYO7A, to our knowledge, has rarely been correlated with USH type 2, our findings therefore reveal distinguished clinical phenotypes associated with MYO7A. We also conclude that targeted NGS is an effective approach for genetic diagnosis for USH, which can further provide better understanding of genotype-phenotype relationship of the disease.	[Rong, Weining; Liu, Yani; Ha, Shaoping; Liu, Wenzhou; Sheng, Xunlun] Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China; [Chen, Xue; Liu, Xiaoxing; Zhao, Chen] Nanjing Med Univ, Dept Ophthalmol, State Key Lab Reprod Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Chen, Xue] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Zhao, Kanxing] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Kang, Xiaoli] Shanghai Jiao Tong Univ, Dept Ophthalmol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Chen] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Nanjing Medical University; Chinese University of Hong Kong; Tianjin Medical University; Shanghai Jiao Tong University; Sun Yat Sen University	Sheng, XL (corresponding author), Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China.	shengxunlun@163.com; dr.zhaochen@gmail.com			National Key Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81222009, 81170856, 81160124, 81260154, 81170867]; Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program [BK2012046]; Jiangsu Province's Key Provincial Talents Program [RC201149]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates [CXZZ13_05]; Applied Research Program of the Science and Technology Commission Foundation of Tianjin [013111411]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province's Key Provincial Talents Program; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates; Applied Research Program of the Science and Technology Commission Foundation of Tianjin; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Key Basic Research Program of China (973 Program, 2013CB967500); National Natural Science Foundation of China (81222009, 81170856, 81160124, 81260154, and 81170867); Thousand Youth Talents Program of China (to CZ); Jiangsu Outstanding Young Investigator Program (BK2012046); Jiangsu Province's Key Provincial Talents Program (RC201149); the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (to CZ); Jiangsu Province's Scientific Research Innovation Program for Postgraduates (CXZZ13_05 to XC); Applied Research Program of the Science and Technology Commission Foundation of Tianjin (013111411 to KZ); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chen X, 2014, HUM MOL GENET; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; DAHL SP, 1993, J MED GENET, V30, P843, DOI 10.1136/jmg.30.10.843; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gibbs D, 2010, INVEST OPHTH VIS SCI, V51, P1130, DOI 10.1167/iovs.09-4032; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Jaijo T, 2011, CLIN GENET, V79, P282, DOI 10.1111/j.1399-0004.2010.01454.x; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kambara T, 1999, J BIOL CHEM, V274, P16400, DOI 10.1074/jbc.274.23.16400; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu F, 2013, MOL VIS, V19, P695; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207; Wolfrum U, 2003, ADV EXP MED BIOL, V533, P133; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Yan D, 2009, J HUM GENET, V54, P732, DOI 10.1038/jhg.2009.107; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zhang X, 2013, EYE, V27, P1204, DOI 10.1038/eye.2013.137; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3	60	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97808	10.1371/journal.pone.0097808	http://dx.doi.org/10.1371/journal.pone.0097808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831256	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500118
J	Sarvari, M; Kocsis, P; Deli, L; Gajari, D; David, S; Pozsgay, Z; Hegedus, N; Tihanyi, K; Liposits, Z				Sarvari, Miklos; Kocsis, Pal; Deli, Levente; Gajari, David; David, Szabolcs; Pozsgay, Zsofia; Hegedus, Nikolett; Tihanyi, Karoly; Liposits, Zsolt			Ghrelin Modulates the fMRI BOLD Response of Homeostatic and Hedonic Brain Centers Regulating Energy Balance in the Rat	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; VENTRAL TEGMENTAL AREA; GROWTH-HORMONE; MESSENGER-RNA; ENDOCANNABINOID SYSTEM; NUCLEUS-ACCUMBENS; FEMALE RATS; GHS-R; REWARD; HYPOTHALAMUS	The orexigenic gut-brain peptide, ghrelin and its G-protein coupled receptor, the growth hormone secretagogue receptor 1a (GHS-R1A) are pivotal regulators of hypothalamic feeding centers and reward processing neuronal circuits of the brain. These systems operate in a cooperative manner and receive a wide array of neuronal hormone/transmitter messages and metabolic signals. Functional magnetic resonance imaging was employed in the current study to map BOLD responses to ghrelin in different brain regions with special reference on homeostatic and hedonic regulatory centers of energy balance. Experimental groups involved male, ovariectomized female and ovariectomized estradiol-replaced rats. Putative modulation of ghrelin signaling by endocannabinoids was also studied. Ghrelin-evoked effects were calculated as mean of the BOLD responses 30 minutes after administration. In the male rat, ghrelin evoked a slowly decreasing BOLD response in all studied regions of interest (ROI) within the limbic system. This effect was antagonized by pretreatment with GHS-R1A antagonist JMV2959. The comparison of ghrelin effects in the presence or absence of JMV2959 in individual ROIs revealed significant changes in the prefrontal cortex, nucleus accumbens of the telencephalon, and also within hypothalamic centers like the lateral hypothalamus, ventromedial nucleus, paraventricular nucleus and suprachiasmatic nucleus. In the female rat, the ghrelin effects were almost identical to those observed in males. Ovariectomy and chronic estradiol replacement had no effect on the BOLD response. Inhibition of the endocannabinoid signaling by rimonabant significantly attenuated the response of the nucleus accumbens and septum. In summary, ghrelin can modulate hypothalamic and mesolimbic structures controlling energy balance in both sexes. The endocannabinoid signaling system contributes to the manifestation of ghrelin's BOLD effect in a region specific manner. In females, the estradiol milieu does not influence the BOLD response to ghrelin.	[Sarvari, Miklos; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Kocsis, Pal; Deli, Levente; Gajari, David; David, Szabolcs; Pozsgay, Zsofia; Hegedus, Nikolett; Tihanyi, Karoly] Gedeon Richter Chem Works Ltd, Preclin Imaging Ctr, Budapest, Hungary; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gedeon Richter Chemistry Works	Sarvari, M (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	sarvari@koki.hu	David, Szabolcs/A-1628-2018; Liposits, Zsolt/K-8145-2019	David, Szabolcs/0000-0003-0316-3895; Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K100722]; National Development Agency of Hungary [NFU-BONUS-HU08/2-2011-0006]; European Community [245009]	National Science Foundation of Hungary; National Development Agency of Hungary; European Community(European Commission)	This research was supported by the National Science Foundation of Hungary (OTKA K100722) and the National Development Agency of Hungary (NFU-BONUS-HU08/2-2011-0006). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Cano SC, 2012, CNS DRUGS, V26, P281, DOI 10.2165/11599890-000000000-00000; Carlini VP, 2010, PEPTIDES, V31, P1190, DOI 10.1016/j.peptides.2010.02.021; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cummings DE, 2007, ADDICT BIOL, V12, P1, DOI 10.1111/j.1369-1600.2007.00053.x; DAHLSTRO.A, 1964, ACTA PHYSIOL SCAND, V62, P485, DOI 10.1111/j.1748-1716.1964.tb10446.x; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Farkas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078178; GPaC Watson, 1998, RAT BRAIN STEREOTAXI; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Harrold JA, 2008, BRAIN RES, V1196, P59, DOI 10.1016/j.brainres.2007.12.055; Helmling S, 2006, DRUG NEWS PERSPECT, V19, P13, DOI 10.1358/dnp.2006.19.1.965870; Horvath TL, 2012, MOL METAB, V1, P79, DOI 10.1016/j.molmet.2012.08.003; Horvath TL, 2003, CURR TOP MED CHEM, V3, P921, DOI 10.2174/1568026033452230; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jones RB, 2012, GUT, V61, P1543, DOI 10.1136/gutjnl-2011-301323; Jung KM, 2012, CELL METAB, V15, P299, DOI 10.1016/j.cmet.2012.01.021; Kanoski SE, 2013, BIOL PSYCHIAT, V73, P915, DOI 10.1016/j.biopsych.2012.07.002; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kocsis P, 2013, BRAIN RES BULL, V99, P34, DOI 10.1016/j.brainresbull.2013.09.008; Kojima M, 2002, CURR OPIN PHARMACOL, V2, P665, DOI 10.1016/S1471-4892(02)00220-5; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kojima M, 2013, ENDOCR DEV, V25, P1, DOI 10.1159/000346036; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Kroemer NB, 2013, ADDICT BIOL, V18, P855, DOI 10.1111/j.1369-1600.2012.00489.x; Kuo YT, 2007, J NEUROSCI, V27, P12341, DOI 10.1523/JNEUROSCI.2391-07.2007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Menyhert J, 2006, BRAIN RES, V1125, P31, DOI 10.1016/j.brainres.2006.09.048; Menzies JRW, 2013, ENDOCR DEV, V25, P101, DOI 10.1159/000346058; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Olszewski PK, 2003, PEPTIDES, V24, P597, DOI 10.1016/S0196-9781(03)00105-0; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Romero-Pico A, 2013, NEUROPSYCHOPHARMACOL, V38, P1296, DOI 10.1038/npp.2013.28; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Seoane LM, 2000, EUR J ENDOCRINOL, V143, pR7, DOI 10.1530/eje.0.143R007; Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI 10.1172/JCI0213300; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Vengeliene V, 2013, ADDICT BIOL, V18, P897, DOI 10.1111/adb.12114; Wellman PJ, 2008, REGUL PEPTIDES, V146, P33, DOI 10.1016/j.regpep.2007.07.007; Wellman PJ, 2012, ADDICT BIOL, V17, P908, DOI 10.1111/j.1369-1600.2011.00392.x; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	73	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97651	10.1371/journal.pone.0097651	http://dx.doi.org/10.1371/journal.pone.0097651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830778	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000336789500094
J	Zhang, P; Tang, M; Zhong, T; Lin, Y; Zong, T; Zhong, CX; Zhang, BP; Ren, M; Kuang, HB				Zhang, Peng; Tang, Min; Zhong, Ting; Lin, Yan; Zong, Teng; Zhong, Chengxue; Zhang, BaoPing; Ren, Min; Kuang, HaiBin			Expression and Function of Kisspeptin during Mouse Decidualization	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; PROLACTIN-RELATED PROTEIN; SIGNALING PATHWAY; RECEPTOR GPR54; KISS-1; TROPHOBLAST; PREGNANCY; IMPLANTATION; TAMOXIFEN; PLACENTA	Background: Plasma kisspeptin levels dramatically increased during the first trimester of human pregnancy, which is similar to pregnancy specific glycoprotein-human chorionic gonadotropin. However, its particular role in the implantation and decidualization has not been fully unraveled. Here, the study was conducted to investigate the expression and function of kisspeptin in mouse uterus during early pregnancy and decidualization. Methodology/Principal Findings: Quantitative PCR results demonstrated that Kiss1 and GPR54 mRNA levels showed dynamic increase in the mouse uterus during early pregnancy and artificially induced decidualization in vivo. KISS-1 and GPR54 proteins were spatiotemporally expressed in decidualizing stromal cells in intact pregnant females, as well as in pseudopregnant mice undergoing artificially induced decidualization. In the ovariectomized mouse uterus, the expression of Kiss1 mRNA was upregulated after progesterone or/and estradiol treatment. Moreover, in a stromal cell culture model, the expression of Kiss1 and GPR54 mRNA gradually rise with the progression of stromal cell decidualization, whereas the attenuated expression of Kiss1 using small interfering RNA approaches significantly blocked the progression of stromal cell decidualization. Conclusion: our results demonstrated that Kiss1/GPR54 system was involved in promoting uterine decidualization during early pregnancy in mice.	[Zhang, Peng; Zhong, Ting; Zong, Teng; Zhong, Chengxue; Zhang, BaoPing; Ren, Min; Kuang, HaiBin] Nanchang Univ, Sch Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Tang, Min] Nanchang Univ, Sch Med, Dept Cell Biol, Nanchang, Jiangxi, Peoples R China; [Lin, Yan] Hosp Jixi Prov People, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China; [Zhong, Ting] Gannan Med Univ, Affiliated Hosp 1, Dept Reprod Med, Ganzhou, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Gannan Medical University	Kuang, HB (corresponding author), Nanchang Univ, Sch Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China.	kuanghaibin@ncu.edu.cn		Kuang, haibin/0000-0003-4711-5449	National Natural Science Foundation of China [31260248, 81270668, 30960118, 30760071]; 555 project of Jiangxi Province Gan Po Excellence; Foundation of the Education Department of Jiangxi Province [GJJ12071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 555 project of Jiangxi Province Gan Po Excellence; Foundation of the Education Department of Jiangxi Province	This work was supported by the National Natural Science Foundation of China (31260248, 81270668, 30960118 and 30760071) and The 555 project of Jiangxi Province Gan Po Excellence and the Foundation of the Education Department of Jiangxi Province (GJJ12071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dhillo WS, 2006, AM J PHYSIOL-ENDOC M, V291, pE878, DOI 10.1152/ajpendo.00555.2005; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GU Y, 1994, ENDOCRINOLOGY, V135, P1422, DOI 10.1210/en.135.4.1422; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Klinge CM, 2002, ENDOCRINOLOGY, V143, P853, DOI 10.1210/en.143.3.853; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Peng J, 2013, FERTIL STERIL, V99, P1436, DOI 10.1016/j.fertnstert.2012.12.008; Prasad M, 2005, GYNECOL ONCOL, V96, P25, DOI 10.1016/j.ygyno.2004.08.046; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Reynolds RM, 2009, REPRODUCTION, V138, P1, DOI 10.1530/REP-09-0026; Roseweir AK, 2009, HUM REPROD UPDATE, V15, P203, DOI 10.1093/humupd/dmn058; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Tena-Sempere M, 2006, NEUROENDOCRINOLOGY, V83, P275, DOI 10.1159/000095549; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; Ushizawa K, 2010, MOL CELL ENDOCRINOL, V323, P277, DOI 10.1016/j.mce.2010.03.008; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Zhang L, 2009, CELL TISSUE RES, V338, P413, DOI 10.1007/s00441-009-0884-9; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	31	37	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97647	10.1371/journal.pone.0097647	http://dx.doi.org/10.1371/journal.pone.0097647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830702	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500092
J	Cardenas-Morales, L; Gron, G; Sim, EJ; Stingl, JC; Kammer, T				Cardenas-Morales, Lizbeth; Groen, Georg; Sim, Eun-Jin; Stingl, Julia C.; Kammer, Thomas			Neural Activation in Humans during a Simple Motor Task Differs between BDNF Polymorphisms	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; CORTICAL EXCITABILITY; FINGER MOVEMENTS; HUMAN-MEMORY; PLASTICITY; BRAIN; CORTEX; HANDEDNESS; STIMULATION	The BDNF Val66Met polymorphism has been linked to decreased synaptic plasticity involved in motor learning tasks. We investigated whether individual differences in this polymorphism may promote differences in neural activity during a two-alternative forced-choice motor performance. In two separate sessions, the BOLD signal from 22 right-handed healthy men was measured during button presses with the left and right index finger upon visual presentation of an arrow. 11 men were Val66Val carriers (ValVal group), the other 11 men carried either the Val66Met or the Met66Met polymorphism (Non-ValVal group). Reaction times, resting and active motor thresholds did not differ between ValVal and Non-ValVal groups. Compared to the ValVal group the Non-ValVal group showed significantly higher BOLD signals in the right SMA and motor cingulate cortex during motor performance. This difference was highly consistent for both hands and across all four sessions. Our finding suggests that this BDNF polymorphism may not only influence complex performance during motor learning but is already associated with activation differences during rather simple motor tasks. The higher BOLD signal observed in Non-ValVal subjects suggests the presence of cumulative effects of the polymorphism on the motor system, and may reflect compensatory functional activation mediating equal behavioral performance between groups.	[Cardenas-Morales, Lizbeth; Groen, Georg; Sim, Eun-Jin; Kammer, Thomas] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany; [Cardenas-Morales, Lizbeth] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Cardenas-Morales, Lizbeth] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Stingl, Julia C.] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Stingl, Julia C.] Fed Inst Drugs & Med Devices, Res Dept, Bonn, Germany	Ulm University; Max Planck Society; University of Cologne; Ulm University	Kammer, T (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	thomas.kammer@uni-ulm.de	Stingl, Julia C./ABA-7201-2020; Kammer, Thomas/K-2168-2012	Stingl, Julia C./0000-0002-1566-8156; Kammer, Thomas/0000-0002-2769-5645; Gron, Georg/0000-0002-0282-3575				Abler B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054447; Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Banner H, 2011, EUR J NEUROSCI, V33, P968, DOI 10.1111/j.1460-9568.2010.07550.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Cardenas-Morales L, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht1023, DOI 10.1093/CERCOR/BHT1023]; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Desai NS, 1999, LEARN MEMORY, V6, P284; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Mastroeni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057957; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Mori F, 2011, J NEUROPHYSIOL, V106, P1637, DOI 10.1152/jn.00318.2011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearson-Fuhrhop KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061197; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; RAO SM, 1995, NEUROLOGY, V45, P919, DOI 10.1212/WNL.45.5.919; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7; Ziemann U, 1998, J NEUROSCI, V18, P1115	36	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96722	10.1371/journal.pone.0096722	http://dx.doi.org/10.1371/journal.pone.0096722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828051	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400035
J	Kim, J; Nagami, S; Lee, KH; Park, SJ				Kim, Juri; Nagami, Sara; Lee, Kyu-Ho; Park, Soon-Jung			Characterization of Microtubule-Binding and Dimerization Activity of Giardia lamblia End-Binding 1 Protein	PLOS ONE			English	Article							STRUCTURAL BASIS; PLUS-END; EB1; INTESTINALIS; DYNAMICS; TRACKING; TUBULIN; GENE; LOCALIZATION; INTERPHASE	End-binding 1 (EB1) proteins are evolutionarily conserved components of microtubule (MT) plus-end tracking protein that regulate MT dynamics. Giardia lamblia, with two nuclei and cytoskeletal structures, requires accurate MT distribution for division. In this study, we show that a single EB1 homolog gene of G. lamblia regulates MT dynamics in mitosis. The haemagglutinin-tagged G. lamblia EB1 (GlEB1) localizes to the nuclear envelopes and median bodies, and is transiently present in mitotic spindles of dividing cells. Knockdown of GlEB1 expression using the morpholinos-based anti-EB1 oligonucleotides, resulted in a significant defect in mitosis of Giardia trophozoites. The MT-binding assays using recombinant GlEB1 (rGlEB1) proteins demonstrated that rGlEB1(102-238), but not rGlEB1(1-184), maintains an MT-binding ability comparable with that of the full length protein, rGlEB1(1-238). Size exclusion chromatography showed that rGlEB1 is present as a dimer formed by its C-terminal domain and a disulfide bond. In vitro-mutagenesis of GlEB1 indicated that an intermolecular disulfide bond is made between cysteine #13 of the two monomers. Complementation assay using the BIM1 knockout mutant yeast, the yeast homolog of mammalian EB1, indicated that expression of the C13S mutant GlEB1 protein cannot rescue the mitotic defect of the BIM1 mutant yeast. These results suggest that dimerization of GlEB1 via the 13th cysteine residues plays a role during mitosis in Giardia.	[Kim, Juri; Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea; [Kim, Juri; Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Nagami, Sara; Lee, Kyu-Ho] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Nagami, Sara; Lee, Kyu-Ho] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Sogang University	Park, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea.	sjpark615@yuhs.ac		Kim, Juri/0000-0001-8270-7584; Park, Soon-Jung/0000-0002-0423-1944	National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea [2009-0078120, 2012R1A1A2004874]	National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea	This work was supported by the Basic Science Research Programs (No. 2009-0078120 and No. 2012R1A1A2004874) through the National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bae SS, 2009, EXP PARASITOL, V122, P11, DOI 10.1016/j.exppara.2009.01.005; Ban R, 2009, J BIOL CHEM, V284, P28367, DOI 10.1074/jbc.M109.000273; Beihauer JD, 1997, J CELL BIOL, V139, P717; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hofstetrova K, 2010, EXP PARASITOL, V124, P159, DOI 10.1016/j.exppara.2009.09.004; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; KANE AV, 1991, J PARASITOL, V77, P974, DOI 10.2307/3282752; Kang K, 2010, PARASITOL RES, V106, P723, DOI 10.1007/s00436-009-1687-3; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim J, 2006, PARASITOL RES, V98, P138, DOI 10.1007/s00436-005-0040-8; Kim J, 2008, PARASITOL INT, V57, P465, DOI 10.1016/j.parint.2008.05.008; Kim J, 2008, PARASITOL RES, V103, P1459, DOI 10.1007/s00436-008-1131-0; Kim J, 2009, KOREAN J PARASITOL, V47, P287, DOI 10.3347/kjp.2009.47.3.287; Komaki S, 2010, J CELL SCI, V123, P451, DOI 10.1242/jcs.062703; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nohynkova E, 2000, EUR J CELL BIOL, V79, P438, DOI 10.1078/0171-9335-00066; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; Svard S, 2011, METHODS MOL BIOL, V761, P201, DOI 10.1007/978-1-61779-182-6_13; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97850	10.1371/journal.pone.0097850	http://dx.doi.org/10.1371/journal.pone.0097850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828878	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400125
J	Komers, R; Xu, B; Fu, Y; McClelland, A; Kantharidis, P; Mittal, A; Cohen, HT; Cohen, DM				Komers, Radko; Xu, Bei; Fu, Yi; McClelland, Aaron; Kantharidis, Phillip; Mittal, Amit; Cohen, Herbert T.; Cohen, David M.			Transcriptome-Based Analysis of Kidney Gene Expression Changes Associated with Diabetes in OVE26 Mice, in the Presence and Absence of Losartan Treatment	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; THIOREDOXIN-INTERACTING PROTEIN; TISSUE GROWTH-FACTOR; ANGIOTENSIN-RECEPTOR BLOCKADE; LOW-DENSITY-LIPOPROTEIN; HIPPEL-LINDAU-DISEASE; ER STRESS; ENDOTHELIAL DYSFUNCTION; METABOLIC SYNDROME; OXIDATIVE-STRESS	Diabetes is among the most common causes of end-stage renal disease, although its pathophysiology is incompletely understood. We performed next-generation sequencing-based transcriptome analysis of renal gene expression changes in the OVE26 murine model of diabetes (age 15 weeks), relative to non-diabetic control, in the presence and absence of short-term (seven-day) treatment with the angiotensin receptor blocker, losartan (n = 3-6 biological replicates per condition). We detected 1438 statistically significant changes in gene expression across conditions. Of the 638 genes dysregulated in diabetes relative to the non-diabetic state, >70% were down-regulation events. Unbiased functional annotation of genes up-and down-regulated by diabetes strongly associated (p<1x10(-8)) with terms for oxidative stress and for endoplasmic reticulum stress/protein folding. Most of the individual gene products up-or down-regulated with diabetes were unaffected by losartan treatment; however, of the gene products dysregulated in diabetes and influenced by losartan treatment, the vast majority of changes were in the direction of amelioration rather than exacerbation of the diabetic dysregulation. This group of losartan-protected genes associated strongly with annotation terms for endoplasmic reticulum stress, heat shock proteins, and chaperone function, but not oxidative stress; therefore, the losartan-unaffected genes suggest avenues for additional therapeutic opportunity in diabetes. Interestingly, the gene product most highly upregulated by diabetes (>52-fold), encoded by the cationic amino acid transporter Slc7a12, and the gene product most highly downregulated by diabetes (>99%) - encoded by the "pseudogene" Gm6300 - are adjacent in the murine genome, are members of the SLC7 gene family, and are likely paralogous. Therefore, diabetes activates a near-total genetic switch between these two paralogs. Other individual-level changes in gene expression are potentially relevant to diabetic pathophysiology, and novel pathways are suggested. Genes unaffected by diabetes alone but exhibiting increased renal expression with losartan produced a signature consistent with malignant potential.	[Komers, Radko; Xu, Bei; Fu, Yi; Cohen, David M.] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA; [Komers, Radko; Xu, Bei; Fu, Yi; Cohen, David M.] Portland VA Med Ctr, Portland, OR USA; [Mittal, Amit; Cohen, Herbert T.] Boston Univ, Sch Med, Nephrol Sect, Boston, MA 02118 USA; [McClelland, Aaron; Kantharidis, Phillip] Baker IDI Heart & Diabet Inst, Diabet Div, JDRF Danielle Alberti Mem Ctr Diabet Complicat, Melbourne, Vic, Australia	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Boston University; Baker Heart and Diabetes Institute	Cohen, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA.	cohend@ohsu.edu			National Institutes of Health; Department of Veterans Affairs; American Diabetes Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association)	This work was supported by grants from the National Institutes of Health, the Department of Veterans Affairs, and the American Diabetes Association (to DMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2013, CURR OPIN LIPIDOL, V24, P313, DOI 10.1097/MOL.0b013e3283630cf0; Arumugam S, 2012, TOXICOLOGY, V291, P139, DOI 10.1016/j.tox.2011.11.008; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bindra RS, 2002, CANCER RES, V62, P3014; Blondeau JP, 2002, GENE, V286, P241, DOI 10.1016/S0378-1119(02)00435-3; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; Chakraborty S, 2009, J AM SOC HYPERTENS, V3, P119, DOI 10.1016/j.jash.2008.11.002; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chen GZ, 2012, AM J PHYSIOL-ENDOC M, V303, pE563, DOI 10.1152/ajpendo.00591.2011; Chen GZ, 2011, PROSTAG OTH LIPID M, V96, P63, DOI 10.1016/j.prostaglandins.2011.06.009; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Feng YX, 2005, CELL PHYSIOL BIOCHEM, V16, P237, DOI 10.1159/000089849; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Gao X, 2010, BIOCHEM BIOPH RES CO, V399, P31, DOI 10.1016/j.bbrc.2010.07.027; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; Hu WK, 2012, EXP DIABETES RES, DOI 10.1155/2012/507986; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Knoll KE, 2005, PHYSIOL GENOMICS, V21, P222, DOI 10.1152/physiolgenomics.00231.2004; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Lakshmanan AP, 2011, EUR J PHARM SCI, V44, P627, DOI 10.1016/j.ejps.2011.10.009; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; LIANES P, 1994, J NATL CANCER I, V86, P1325, DOI 10.1093/jnci/86.17.1325; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lokman FE, 2011, J NEPHROL, V24, P778, DOI 10.5301/JN.2011.6382; Lopes-Virella MF, 2008, DIABETES CARE, V31, P2006, DOI 10.2337/dc08-0659; Mathew R, 2005, AM J PHYSIOL-RENAL, V289, pF911, DOI 10.1152/ajprenal.00037.2005; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Miyajima A, 2002, CANCER RES, V62, P4176; Miyamoto S, 2012, DIABETES, V61, P897, DOI 10.2337/db11-0402; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Park IS, 1998, AM J KIDNEY DIS, V32, P1000, DOI 10.1016/S0272-6386(98)70075-7; Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2; Reisman SA, 2012, J AM SOC NEPHROL, V23, P1663, DOI 10.1681/ASN.2012050457; Riser BL, 2001, RENAL FAILURE, V23, P459, DOI 10.1081/JDI-100104729; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Ritz E, 2013, MED CLIN N AM, V97, P19, DOI 10.1016/j.mcna.2012.10.008; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; SHOPLAND DR, 1991, JNCI-J NATL CANCER I, V83, P1142, DOI 10.1093/jnci/83.16.1142; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tanaka N, 2012, BRIT J CANCER, V106, P290, DOI 10.1038/bjc.2011.565; Teo KK, 2013, J HYPERTENS, V31, P1532, DOI 10.1097/HJH.0b013e328362b7fa; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukamoto Y, 1996, J CLIN INVEST, V98, P1930, DOI 10.1172/JCI118994; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Wu J, 2013, J ENDOCRINOL INVEST, V36, P453, DOI 10.3275/8764; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Xu JX, 2010, AM J PHYSIOL-RENAL, V299, pF487, DOI 10.1152/ajprenal.00018.2010; Yang L, 2011, NEPHRON EXP NEPHROL, V119, pE8, DOI 10.1159/000324407; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zatyka M, 2002, CANCER RES, V62, P3803; Zheng SR, 2011, NEPHRON EXP NEPHROL, V119, pE21, DOI 10.1159/000327586; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	99	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96987	10.1371/journal.pone.0096987	http://dx.doi.org/10.1371/journal.pone.0096987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827579	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400050
J	Kupz, A; Curtiss, R; Bedoui, S; Strugnell, RA				Kupz, Andreas; Curtiss, Roy, III; Bedoui, Sammy; Strugnell, Richard A.			In Vivo IFN-gamma Secretion by NK Cells in Response to Salmonella Typhimurium Requires NLRC4 Inflammasomes	PLOS ONE			English	Article							MEMORY CD8(+) T; HOST-DEFENSE; INFECTION; ADULTS; MICE	Natural killer (NK) cells are a critical part of the innate immune defense against viral infections and for the control of tumors. Much less is known about how NK cells contribute to anti-bacterial immunity. NK cell-produced interferon gamma (IFN-gamma) contributes to the control of early exponential replication of bacterial pathogens, however the regulation of these events remains poorly resolved. Using a mouse model of invasive Salmonellosis, here we report that the activation of the intracellular danger sensor NLRC4 by Salmonella-derived flagellin within CD11c(+) cells regulates early IFN-gamma secretion by NK cells through the provision of interleukin 18 (IL-18), independently of Toll-like receptor (TLR)-signaling. Although IL18-signalling deficient NK cells improved host protection during S. Typhimurium infection, this increased resistance was inferior to that provided by wild-type NK cells. These findings suggest that although NLRC4 inflammasome-driven secretion of IL-18 serves as a potent activator of NK cell mediated IFN-gamma secretion, IL18-independent NK cell-mediated mechanisms of IFN-gamma secretion contribute to in vivo control of Salmonella replication.	[Kupz, Andreas; Bedoui, Sammy; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Curtiss, Roy, III] Arizona State Univ, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Kupz, Andreas] Max Planck Inst Infect Biol, Berlin, Germany; [Kupz, Andreas] James Cook Univ, Queensland Trop Hlth Alliance Res Lab, Cairns, Qld, Australia	University of Melbourne; Arizona State University; Arizona State University-Tempe; Max Planck Society; James Cook University	Kupz, A (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	kupz@mpiib-berlin.mpg.de	Kupz, Andreas/J-3844-2014	Strugnell, Richard/0000-0003-0614-5641; BEDOUI, SAMMY/0000-0002-7443-0543; Kupz, Andreas/0000-0002-9259-7873	National Health and Medical Research Council of Australia (NHMRC) [APP606788, APP628464, APP1052764, R01AI60557]; Bill and Melinda Gates Foundation [37863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Health and Medical Research Council of Australia (NH&MRC) https://www.nhmrc.gov.au/ [Program Grant: Fighting Infection, exploiting host-pathogen interactions APP606788 to R.A.S., Career Development Award APP628464 to S. B., CJ Martin Biomedical Early Career Fellowship APP1052764 to A.K.]; and IH R01AI60557 and Bill and Melinda Gates Foundation Grant no. 37863 to R. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Hess J, 1996, J IMMUNOL, V156, P3321; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Pegram HJ, 2008, J IMMUNOL, V181, P3449, DOI 10.4049/jimmunol.181.5.3449; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029	16	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97418	10.1371/journal.pone.0097418	http://dx.doi.org/10.1371/journal.pone.0097418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827856	Green Published, Green Accepted, gold			2022-12-25	WOS:000336857400092
J	Rodovalho, CD; Lyra, ML; Ferro, M; Bacci, M				Rodovalho, Cynara de Melo; Lyra, Mariana Lucio; Ferro, Milene; Bacci, Mauricio, Jr.			The Mitochondrial Genome of the Leaf-Cutter Ant Atta laevigata: A Mitogenome with a Large Number of Intergenic Spacers	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC UTILITY; APIS-MELLIFERA; DNA-SEQUENCE; HYMENOPTERA; ORGANIZATION; EVOLUTION; ANNOTATION; VISUALIZATION; POLYMORPHISM	In this paper we describe the nearly complete mitochondrial genome of the leaf-cutter ant Atta laevigata, assembled using transcriptomic libraries from Sanger and Illumina next generation sequencing (NGS), and PCR products. This mitogenome was found to be very large (18,729 bp), given the presence of 30 non-coding intergenic spacers (IGS) spanning 3,808 bp. A portion of the putative control region remained unsequenced. The gene content and organization correspond to that inferred for the ancestral pancrustacea, except for two tRNA gene rearrangements that have been described previously in other ants. The IGS were highly variable in length and dispersed through the mitogenome. This pattern was also found for the other hymenopterans in particular for the monophyletic Apocrita. These spacers with unknown function may be valuable for characterizing genome evolution and distinguishing closely related species and individuals. NGS provided better coverage than Sanger sequencing, especially for tRNA and ribosomal subunit genes, thus facilitating efforts to fill in sequence gaps. The results obtained showed that data from transcriptomic libraries contain valuable information for assembling mitogenomes. The present data also provide a source of molecular markers that will be very important for improving our understanding of genomic evolutionary processes and phylogenetic relationships among hymenopterans.	[Rodovalho, Cynara de Melo; Ferro, Milene; Bacci, Mauricio, Jr.] UNESP Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil; [Rodovalho, Cynara de Melo] FIOCRUZ Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Lyra, Mariana Lucio] UNESP Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Bacci, Mauricio, Jr.] UNESP Univ Estadual Paulista, Dept Bioquim & Microbiol, Sao Paulo, Brazil	Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Universidade Estadual Paulista	Bacci, M (corresponding author), UNESP Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil.	mbacci@rc.unesp.br	Lyra, Mariana Lucio/O-6405-2014; Bacci, Mauricio/C-4960-2013	Lyra, Mariana Lucio/0000-0002-7863-4965; Bacci, Mauricio/0000-0002-5619-1411; Rodovalho, Cynara/0000-0002-4927-0672; Ferro, Milene/0000-0002-3960-9062	FAPESP [2011/06367-8, 11/50226-0]; CNPq [311562/2012-4, 487639/2012-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESP 2011/06367-8, FAPESP 11/50226-0, CNPq 311562/2012-4, and CNPq 487639/2012-0 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos N., 1998, GUIA PRATICO FORMIGA; AVISE JC, 1995, CONSERV BIOL, V9, P686, DOI 10.1046/j.1523-1739.1995.09030686.x; Bacci M, 2009, MOL PHYLOGENET EVOL, V51, P427, DOI 10.1016/j.ympev.2008.11.005; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Borgmeier T, 1950, MEMORIAS I O CRUZ, V48; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2006, GENOME, V49, P752, DOI 10.1139/G06-030; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Chiotis M, 2000, MOL PHYLOGENET EVOL, V17, P108, DOI 10.1006/mpev.2000.0821; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; CROZIER RH, 1993, GENETICS, V133, P97; Delabie Jacques H.C., 1998, Agrotropica, V9, P49; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durham AM, 2005, BIOINFORMATICS, V21, P2812, DOI 10.1093/bioinformatics/bti424; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emblem A, 2012, GENE, V506, P344, DOI 10.1016/j.gene.2012.06.040; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; Fowler H.G., 1986, P123; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; Gotzek D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-300; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hasegawa E, 2011, MYRMECOL NEWS, V15, P85; Hernandez J. V., 1995, Anais da Sociedade Entomologica do Brasil, V24, P287; Holldobler B., 1990, pi; Hong MY, 2008, GENES GENOM, V30, P307; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HYMAN BC, 1988, GENETICS, V120, P707; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kaltenpoth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032826; Keller L, 1998, INSECT SOC, V45, P235, DOI 10.1007/s000400050084; Klopfstein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069344; Kronauer DJC, 2004, MOL PHYLOGENET EVOL, V32, P416, DOI 10.1016/j.ympev.2004.03.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mao M, 2012, GENOME, V55, P194, DOI [10.1139/G2012-005, 10.1139/g2012-005]; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Rambaut A., 2007, TRACER V1 4; Rodovalho Cynara M., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-203; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vasconcelos HL, 1997, J TROP ECOL, V13, P357, DOI 10.1017/S0266467400010567; Viana LR, 2004, NEOTROP ENTOMOL, V33, P391, DOI 10.1590/S1519-566X2004000300019; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang AR, 2013, MITOCHONDR DNA, V24, P208, DOI 10.3109/19401736.2012.744986; Wei SJ, 2015, MITOCHONDR DNA, V26, P157, DOI 10.3109/19401736.2013.819501; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2010, MOL BIOL REP, V37, P1931, DOI 10.1007/s11033-009-9640-1; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zanetti R, 2008, CIENC AGROTEC, V32, P1313, DOI 10.1590/S1413-70542008000400043; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang C, 2008, ACTA BIOCH BIOPH SIN, V40, P7, DOI 10.1111/j.1745-7270.2008.00375.x	81	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97117	10.1371/journal.pone.0097117	http://dx.doi.org/10.1371/journal.pone.0097117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828084	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400055
J	Schnitzler, A; Arnold, C; Cornille, A; Bachmann, O; Schnitzler, C				Schnitzler, Annik; Arnold, Claire; Cornille, Amandine; Bachmann, Olivier; Schnitzler, Christophe			Wild European Apple (Malus sylvestris (L.) Mill.) Population Dynamics: Insight from Genetics and Ecology in the Rhine Valley. Priorities for a Future Conservation Programme	PLOS ONE			English	Article							DOMESTICATED APPLE; SOFTWARE; HISTORY; FORESTS; BORKH.; TREES	The increasing fragmentation of forest habitats and the omnipresence of cultivars potentially threaten the genetic integrity of the European wild apple (Malus sylvestris (L.) Mill). However, the conservation status of this species remains unclear in Europe, other than in Belgium and the Czech Republic, where it has been declared an endangered species. The population density of M. sylvestris is higher in the forests of the upper Rhine Valley (France) than in most European forests, with an unbalanced age-structure, an overrepresentation of adults and a tendency to clump. We characterize here the ecology, age-structure and genetic diversity of wild apple populations in the Rhine Valley. We use these data to highlight links to the history of this species and to propose guidelines for future conservation strategies. In total, 255 individual wild apple trees from six forest stands (five floodplain forests and one forest growing in drier conditions) were analysed in the field, collected and genotyped on the basis of data for 15 microsatellite markers. Genetic analyses showed no escaped cultivars and few hybrids with the cultivated apple. Excluding the hybrids, the genetically "pure" populations displayed high levels of genetic diversity and a weak population structure. Age-structure and ecology studies of wild apple populations identified four categories that were not randomly distributed across the forests, reflecting the history of the Rhine forest over the last century. The Rhine wild apple populations, with their ecological strategies, high genetic diversity, and weak traces of crop-to-wild gene flow associated with the history of these floodplain forests, constitute candidate populations for inclusion in future conservation programmes for European wild apple.	[Schnitzler, Annik] Univ Lorraine, CNRS, UMR 7360, LIEC, Metz, France; [Arnold, Claire] Univ Lausanne, Unictr, Lausanne, Switzerland; [Cornille, Amandine] CNRS, UMR 8079, F-91405 Orsay, France; [Cornille, Amandine] Univ Paris 11, UMR 8079, Orsay, France; [Bachmann, Olivier] Univ Neuchatel, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland; [Arnold, Claire] Univ Neuchatel, Lab Soil & Vegetat, CH-2000 Neuchatel, Switzerland; [Schnitzler, Christophe] Univ Strasbourg, Sport Sci Fac, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Lausanne; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Neuchatel; University of Neuchatel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schnitzler, A (corresponding author), Univ Lorraine, CNRS, UMR 7360, LIEC, Metz, France.	annik.schnitzler@univ-lorraine.fr	Arnold, Claire/AAC-7330-2022	Arnold, Claire/0000-0002-1179-0728				Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE; CAMPBELL CS, 1991, SYST BOT, V16, P333, DOI 10.2307/2419284; Carbiener R., 1970, Vegetation, V20, P97, DOI 10.1007/BF01965530; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Coart E, 2003, MOL ECOL, V12, P845, DOI 10.1046/j.1365-294X.2003.01778.x; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Diekmann M, 1994, ACTA PHYTOGEOGR SUIC, V80; Dister E, 1983, VERH ZOOL BOT GES OS, V123, P13; Dzhangaliev A. D., 2003, Horticultural Reviews, V29, P305, DOI 10.1002/9780470650868.ch3; Ellenberg H., 1988, VEGETATION ECOLOGY C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Falinski J.B., 1986, GEOBOTANY, V8, P1; Forsline PL, 2002, HORTICULTURAL REV, V29, P1; Gehu JM, 1974, FORETS ACIDIPHILES, P133; GRAUDAL L, 1995, FOREST ECOL MANAG, V73, P117, DOI 10.1016/0378-1127(94)03497-K; Hardtle W, 1996, TUEXENIA, V16, P25; Harrison N, 2011, NAT GENET, V43, P1043, DOI 10.1038/ng.935; Horvat I., 1974, VEGETATION SUDOSTEUR, V4; JANSSENS GA, 1995, THEOR APPL GENET, V91, P691, DOI 10.1007/BF00223298; Kleinschmit J, 1998, NOBL HARDW NETW IPGR, P51; Kugler H., 1970, BLUTENOKOLOGIE; Larsen AS, 2006, TREE GENET GENOMES, V2, P86, DOI 10.1007/s11295-005-0030-0; Linder R, 1959, B SOC BOT FR, V106, P131; Oldeman R. A. A., 1990, FORESTS; Paul P, 1979, REV GEOGR EST, V3-4, P273; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piegay H, 2001, DYNAMIQUE CONT SEDIE, P1; Pritchard JK, 2000, GENETICS, V155, P945; Rameau JC, 1975, FORETS ACIDIPHILES, P319; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SCHNITZLER A, 1995, J VEG SCI, V6, P479, DOI 10.2307/3236346; SCHNITZLER A, 1994, FOREST ECOL MANAG, V68, P385, DOI 10.1016/0378-1127(94)90059-0; Schnitzler A, 2008, FLOODPLAIN FORESTS T, P442; Schnitzler A, 2006, B ASS AMIS JARDIN BO, V2, P57; Schnitzler A, 2006, FOREST ECOL MANAG, V236, P12, DOI 10.1016/j.foreco.2006.05.060; Sissingh G, 1975, FORETS ACIDIPHILES, P363; Stephan BR, 2003, EUFORGEN TECHNICAL G; Striedter K., 1988, THESIS U DUSSELDORF; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tremolieres M, 1998, B ECOL, V22, P317; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wagner I, 1996, MITT DTSCH DENDROL G, V82, P87; Walter JM, 1979, ACTA OECOL, V14, P345	45	18	21	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96596	10.1371/journal.pone.0096596	http://dx.doi.org/10.1371/journal.pone.0096596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827575	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400030
J	Truong, TN; Li, H; Hong, YK; Chen, L				Truong, Tan N.; Li, Hannah; Hong, Young-Kwon; Chen, Lu			Novel Characterization and Live Imaging of Schlemm's Canal Expressing Prox-1	PLOS ONE			English	Article							LYMPHATIC VESSELS; ENDOTHELIAL-CELLS; EYE; VASCULATURE; INDUCTION; MARKERS; SYSTEM; LYVE-1; MOUSE; GENE	Schlemm's canal is an important structure of the conventional aqueous humor outflow pathway and is critically involved in regulating the intraocular pressure. In this study, we report a novel finding that prospero homeobox protein 1 (Prox-1), the master control gene for lymphatic development, is expressed in Schlemm's canal. Moreover, we provide a novel in vivo method of visualizing Schlemm's canal using a transgenic mouse model of Prox-1-green fluorescent protein (GFP). The anatomical location of Prox-1+ Schlemm's canal was further confirmed by in vivo gonioscopic examination and ex vivo immunohistochemical analysis. Additionally, we show that the Schlemm's canal is distinguishable from typical lymphatic vessels by lack of lymphatic vessel endothelial hyaluronan receptor (LYVE-1) expression and absence of apparent sprouting reaction when inflammatory lymphangiogenesis occurred in the cornea. Taken together, our findings offer new insights into Schlemm's canal and provide a new experimental model for live imaging of this critical structure to help further our understanding of the aqueous humor outflow. This may lead to new avenues toward the development of novel therapeutic intervention for relevant diseases, most notably glaucoma.	[Truong, Tan N.; Chen, Lu] Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA; [Truong, Tan N.; Li, Hannah; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Berkeley, CA 94720 USA; [Truong, Tan N.; Li, Hannah; Chen, Lu] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chen, Lu] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Chen, Lu] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Southern California; University of Southern California; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Chen, L (corresponding author), Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA.	chenlu@berkeley.edu			National Institutes of Health; University of California at Berkeley; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported in part by research grants from National Institutes of Health and the University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Birke K, 2010, INVEST OPHTH VIS SCI, V51, P344, DOI 10.1167/iovs.08-3307; Camelo S, 2006, INVEST OPHTH VIS SCI, V47, P1039, DOI 10.1167/iovs.05-1041; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Chen L, 2009, LYMPHOLOGY, V42, P66; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foets B., 1992, GRAEFES ARCH CLIN EX, V30, P269; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grimaldo S, 2011, INVEST OPHTH VIS SCI, V52, P4808, DOI 10.1167/iovs.10-6580; HAMANAKA T, 1992, EXP EYE RES, V55, P479, DOI 10.1016/0014-4835(92)90121-8; Heimark RL, 2002, CURR EYE RES, V25, P299, DOI 10.1076/ceyr.25.5.299.13495; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Perkumas KM, 2012, EXP EYE RES, V96, P82, DOI 10.1016/j.exer.2011.12.017; Ramos RF, 2007, J GLAUCOMA, V16, P391, DOI 10.1097/IJG.0b013e3180654ac6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Smith RS, 2002, MOL VIS, V8, P26; Tam ALC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/42/425101; Truong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021918; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yucel YH, 2009, EXP EYE RES, V89, P810, DOI 10.1016/j.exer.2009.08.010; Yuen D, 2011, CELL RES, V21, P1745, DOI 10.1038/cr.2011.178	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e98245	10.1371/journal.pone.0098245	http://dx.doi.org/10.1371/journal.pone.0098245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827370	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400128
J	Ambrogi, F; Fornili, M; Boracchi, P; Trerotola, M; Relli, V; Simeone, P; La Sorda, R; Lattanzio, R; Querzoli, P; Pedriali, M; Piantelli, M; Biganzoli, E; Alberti, S				Ambrogi, Federico; Fornili, Marco; Boracchi, Patrizia; Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Querzoli, Patrizia; Pedriali, Massimo; Piantelli, Mauro; Biganzoli, Elia; Alberti, Saverio			Trop-2 Is a Determinant of Breast Cancer Survival	PLOS ONE			English	Article							CELL-SURFACE GLYCOPROTEIN; DNA METHYLATION PREVENTS; HUMAN CARCINOMAS; P53 STATUS; EXPRESSION; OVEREXPRESSION; PROGNOSIS; ANTIGENS; GENE	Trop-2 is a calcium signal transducer that drives tumor growth. Anti-Trop-2 antibodies with selective reactivity versus Trop-2 maturation stages allowed to identify two different pools of Trop-2, one localized in the cell membrane and one in the cytoplasm. Of note, membrane-localized/functional Trop-2 was found to be differentially associated with determinants of tumor aggressiveness and distinct breast cancer subgroups. These findings candidated Trop-2 states to having an impact on cancer progression. We tested this model in breast cancer. A large, consecutive human breast cancer case series (702 cases; 8 years median follow-up) was analyzed by immunohistochemistry with anti-Trop-2 antibodies with selective reactivity for cytoplasmic-retained versus functional, membrane-associated Trop-2. We show that membrane localization of Trop-2 is an unfavorable prognostic factor for overall survival (1+ versus 0 for all deaths: hazard ratio, 1.63; P = 0.04), whereas intracellular Trop-2 has a favorable impact on prognosis, with an adjusted hazard ratio for all deaths of 0.48 (high versus low; P = 0.003). A corresponding impact of intracellular Trop-2 was found on disease relapse (high versus low: hazard ratio, 0.51; P = 0.004). Altogether, we demonstrate that the Trop-2 activation states are critical determinants of tumor progression and are powerful indicators of breast cancer patients survival.	[Ambrogi, Federico; Fornili, Marco; Boracchi, Patrizia; Biganzoli, Elia] Univ Milan, Dept Clin Sci & Community Hlth, Unit Med Stat Biometry & Bioinformat Giulio A Mac, Milan, Italy; [Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro; Alberti, Saverio] Univ G dAnnunzio, Fdn G DAnnunzio, Dept Biomed Sci, Unit Canc Pathol, Chieti, Italy; [Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro; Alberti, Saverio] Univ G dAnnunzio, Fdn G DAnnunzio, CeSI, Chieti, Italy; [La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro] Univ G DAnnunzio, CeSI, MediaPharma Srl, Chieti, Italy; [Querzoli, Patrizia; Pedriali, Massimo] Univ Ferrara, Dept Expt & Diagnost Med, Surg Pathol Sect, I-44100 Ferrara, Italy; [Biganzoli, Elia] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy; [Alberti, Saverio] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci Physiol & Physio, Chieti, Italy; [Alberti, Saverio] Oncoxx Biotech Srl, Chieti, Italy	University of Milan; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Ferrara; Fondazione IRCCS Istituto Nazionale Tumori Milan; G d'Annunzio University of Chieti-Pescara	Alberti, S (corresponding author), Univ G dAnnunzio, Fdn G DAnnunzio, Dept Biomed Sci, Unit Canc Pathol, Chieti, Italy.	s.alberti@unich.it	Biganzoli, Elia/J-1678-2012; Alberti, Saverio/M-4511-2014; Lattanzio, Rossano/K-1927-2018; Patrizia, Boracchi/AAB-8851-2019; Simeone, Pasquale/K-7549-2016; Fornili, Marco/AAJ-7660-2021; Trerotola, Marco/J-9015-2016; Ambrogi, Federico/D-4294-2015	Biganzoli, Elia/0000-0003-1202-5873; Alberti, Saverio/0000-0002-4647-6042; Lattanzio, Rossano/0000-0001-9803-4476; Simeone, Pasquale/0000-0003-4430-480X; Trerotola, Marco/0000-0003-1855-7002; QUERZOLI, Patrizia/0000-0003-2873-8894; boracchi, patrizia/0000-0001-8506-2005; Pedriali, Massimo/0000-0003-3113-7352; Ambrogi, Federico/0000-0001-9358-011X; Fornili, Marco/0000-0002-5713-3926	Fondazione of the Cassa di Risparmio della Provincia di Chieti; EU NoE Biopattern [FP6-2002-IST-1, 508803]; Oncoxx Biotech, Compagnia di San Paolo; Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Association for Cancer Research (AIRC, Italy)	Fondazione of the Cassa di Risparmio della Provincia di Chieti; EU NoE Biopattern; Oncoxx Biotech, Compagnia di San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Fondazione of the Cassa di Risparmio della Provincia di Chieti, the EU NoE Biopattern (FP6-2002-IST-1 no. 508803), Oncoxx Biotech, Compagnia di San Paolo, the Italian Ministry of Health (RicOncol RF-EMR-2006-361866), and the Italian Association for Cancer Research (AIRC, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; ALBERTI S, 1988, P NATL ACAD SCI USA, V85, P8391, DOI 10.1073/pnas.85.22.8391; ALBERTI S, 1992, HYBRIDOMA, V11, P539, DOI 10.1089/hyb.1992.11.539; Alberti S, 2012, JPN J CLIN ONCOL, V42, P1128, DOI 10.1093/jjco/hys159; Ambrogi F, 2006, CLIN CANCER RES, V12, P781, DOI 10.1158/1078-0432.CCR-05-0763; Ambrogi F, 2013, BREAST CANC CANC CLI, V2, P41; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Biganzoli E, 2003, ANN ONCOL, V14, P1484, DOI 10.1093/annonc/mdg422; Biganzoli E, 2010, CURR BREAST CANCER R, V2, P96, DOI 10.1007/s12609-010-0013-5; Biganzoli E, 2011, JPN J CLIN ONCOL, V41, P172, DOI 10.1093/jjco/hyq227; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Cimoli G, 2004, BBA-REV CANCER, V1705, P103, DOI 10.1016/j.bbcan.2004.10.001; Duffy MJ, 2006, CRIT REV CL LAB SCI, V43, P325, DOI 10.1080/10408360600739218; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; HELLEMANS P, 1995, BRIT J CANCER, V72, P354, DOI 10.1038/bjc.1995.338; KLEIN CE, 1990, J INVEST DERMATOL, V95, P74, DOI 10.1111/1523-1747.ep12873988; Lin H, 2012, EXP MOL PATHOL; LIPINSKI M, 1981, P NATL ACAD SCI-BIOL, V78, P5147, DOI 10.1073/pnas.78.8.5147; MAKUCH RW, 1982, J CHRON DIS, V35, P437, DOI 10.1016/0021-9681(82)90058-3; Marubini E, 1995, ANAL SURVIVAL DATA C; Mirza AN, 2002, ANN SURG, V235, P10, DOI 10.1097/00000658-200201000-00003; Querzoli P, 2010, BRIT J CANCER, V103, P1835, DOI 10.1038/sj.bjc.6605991; Ripani E, 1998, INT J CANCER, V76, P671; SCHON MP, 1993, INT J CANCER, V55, P988, DOI 10.1002/ijc.2910550619; Spizzo G, 2002, INT J CANCER, V98, P883, DOI 10.1002/ijc.10270; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Tinari N, 2006, CLIN CANCER RES, V12, P1501, DOI 10.1158/1078-0432.CCR-05-0978; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785	32	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96993	10.1371/journal.pone.0096993	http://dx.doi.org/10.1371/journal.pone.0096993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824621	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200046
J	Anbalagan, S; Hesse, RA; Hause, BM				Anbalagan, Srivishnupriya; Hesse, Richard A.; Hause, Ben M.			First Identification and Characterization of Porcine Enterovirus G in the United States	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; WILD BOARS; PICORNAVIRUSES; RECOMBINATION; TESCHOVIRUSES; FEATURES; VIRUS; PIGS	Porcine enterovirus G (EV-G) is a member of the family Picornavirdae, genus Enterovirus. To date, eleven EV-G types (EV-G1 through EV-G11) have been identified in pigs from Asia and Europe however they have never been reported in North America. In this study, we isolated and characterized the complete genome of NP/2013/USA, an EV-G from a porcine diarrhea sample from the United States. The complete genome consists of 7,390 nucleotides excluding the 39 poly(A) tail, and has an open reading frame that encodes a 2,169 amino acid polyprotein. NP/2013/USA was most similar at the nucleotide (84%) and amino acid (95%) level to the HM131607, an EV-G1 type isolated from China in 2012.	[Anbalagan, Srivishnupriya; Hause, Ben M.] Newport Labs Inc, Worthington, MN 56187 USA; [Hesse, Richard A.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Hause, BM (corresponding author), Newport Labs Inc, Worthington, MN 56187 USA.	bhause@newportlabs.com			Newport Laboratories	Newport Laboratories	This work was funded by Newport Laboratories who, in consultation with the collaborating authors, contributed to the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; Anbalagan S, 2013, J GEN VIROL; AUERBACH J, 1994, J VET MED B, V41, P277, DOI 10.1111/j.1439-0450.1994.tb00228.x; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; Boros A, 2012, ARCH VIROL, V157, P981, DOI 10.1007/s00705-012-1255-5; Boros A, 2011, INFECT GENET EVOL, V11, P1096, DOI 10.1016/j.meegid.2011.04.003; Buitrago D, 2010, J VET DIAGN INVEST, V22, P763, DOI 10.1177/104063871002200519; Chen Q, 2013, J CLIN MICROBIOL; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32; KNOWLES NJ, 1979, ARCH VIROL, V62, P201, DOI 10.1007/BF01317552; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; La Rosa G, 2006, J VET MED B, V53, P257, DOI 10.1111/j.1439-0450.2006.00955.x; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Moon HJ, 2012, J VIROL, V86, P10250, DOI 10.1128/JVI.01548-12; Nguyen DV, 2013, J GEN VIROL; Palmquist JM, 2002, J VET DIAGN INVEST, V14, P476, DOI 10.1177/104063870201400605; Prodelalova J, 2012, INFECT GENET EVOL, V12, P1447, DOI 10.1016/j.meegid.2012.04.025; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Sozzi E, 2010, TRANSBOUND EMERG DIS, V57, P434, DOI 10.1111/j.1865-1682.2010.01170.x; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yang SX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-99; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zhang W, 2012, J VIROL, V86, P7008, DOI 10.1128/JVI.00711-12	27	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97517	10.1371/journal.pone.0097517	http://dx.doi.org/10.1371/journal.pone.0097517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824640	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200126
J	Krakowiak, MS; Noto, JM; Piazuelo, MB; Hardbower, DM; Romero-Gallo, J; Delgado, A; Chaturvedi, R; Correa, P; Wilson, KT; Peek, RM				Krakowiak, M. S.; Noto, J. M.; Piazuelo, M. B.; Hardbower, D. M.; Romero-Gallo, J.; Delgado, A.; Chaturvedi, R.; Correa, P.; Wilson, K. T.; Peek, R. M., Jr.			Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization	ONCOGENE			English	Article							EXPRESSION; ACTIVATION; MATRILYSIN; RESPONSES; CANCER; MMP-7; HOST	Helicobacter pylori is the strongest risk factor for the development of gastric cancer. Although the specific mechanisms by which this pathogen induces carcinogenesis have not been fully elucidated, high-expression interleukin (IL)-1 beta alleles are associated with increased gastric cancer risk among H. pylori-infected persons. In addition, loss of matrix metalloproteinase 7 (MMP7) increases mucosal inflammation in mouse models of epithelial injury, and we have shown that gastric inflammation is increased in H. pylori-infected MMP7(-/-) C57BL/6 mice. In this report, we define mechanisms that underpin such responses and extend these results into a genetic model of MMP7 deficiency and gastric cancer. Wild-type (WT) or MMP7(-/-) C57BL/6 mice were challenged with broth alone as an uninfected control or the H. pylori strain PMSS1. All H. pylori-challenged mice were successfully colonized. As expected, H. pylori-infected MMP7(-/-) C57BL/6 mice exhibited a significant increase in gastric inflammation compared with uninfected or infected WT C57BL/6 animals. Loss of MMP7 resulted in M1 macrophage polarization within H. pylori-infected stomachs, as assessed by Luminex technology and immunohistochemistry, and macrophages isolated from infected MMP7-deficient mice expressed significantly higher levels of the M1 macrophage marker IL-1 beta compared with macrophages isolated from WT mice. To extend these findings into a model of gastric cancer, hypergastrinemic WT INS-GAS or MMP7(-/-) INS-GAS mice were challenged with H. pylori strain PMSS1. Consistent with findings in the C57BL/6 model, H. pylori-infected MMP7-deficient INS-GAS mice exhibited a significant increase in gastric inflammation compared with either uninfected or infected WT INS-GAS mice. In addition, the incidence of gastric hyperplasia and dysplasia was significantly increased in H. pylori-infected MMP7(-/-) INS-GAS mice compared with infected WT INS-GAS mice, and loss of MMP7 promoted M1 macrophage polarization. These results suggest that MMP7 exerts a restrictive role on H. pylori-induced gastric injury and the development of premalignant lesions by suppressing M1 macrophage polarization.	[Krakowiak, M. S.; Wilson, K. T.; Peek, R. M., Jr.] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Nashville, TN 37232 USA; [Noto, J. M.; Piazuelo, M. B.; Hardbower, D. M.; Romero-Gallo, J.; Delgado, A.; Chaturvedi, R.; Correa, P.; Wilson, K. T.; Peek, R. M., Jr.] Vanderbilt Univ, Div Gastroenterol, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Hardbower, D. M.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Wilson, K. T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Peek, RM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, 2215 Garland Ave,MRB 4 1030C, Nashville, TN 37232 USA.	richard.peek@vanderbilt.edu		Wilson, Keith/0000-0003-4421-1830	Department of Veterans Affairs [T32CA009592, F32CA153539, T32GM008554, K01AT007324, P01CA028842, R01DK053620, 1I01BX001453];  [R01DK058587];  [R01CA077955];  [P30DK058404];  [P01CA116087]; NATIONAL CANCER INSTITUTE [R01CA190612, R01CA077955, P01CA028842, F32CA153539, T32CA009592, P01CA116087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, P30DK058404, R01DK053620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by T32CA009592 (MSK), F32CA153539 (JMN), T32GM008554 (DMH), K01AT007324 (RC), P01CA028842 (KTW and PC), R01DK053620 and 1I01BX001453 from the Department of Veterans Affairs (KTW), R01DK058587, R01CA077955, P30DK058404 and P01CA116087 (RMP).	Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chung WC, 2010, GASTRIC CANCER, V13, P162, DOI 10.1007/s10120-010-0552-5; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Ogden SR, 2010, CANCER RES, V70, P30, DOI 10.1158/0008-5472.CAN-09-2899; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Quante M, 2013, GASTROENTEROLOGY, V145, P63, DOI 10.1053/j.gastro.2013.03.052; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Senota A, 1998, CLIN EXP METASTAS, V16, P313; Sierra JC, 2013, AM J PHYSIOL-GASTR L, V305, pG196, DOI 10.1152/ajpgi.00495.2012; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	23	27	27	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1865	1871		10.1038/onc.2014.135	http://dx.doi.org/10.1038/onc.2014.135			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24837365	Green Accepted			2022-12-25	WOS:000352158000013
J	Tschumi, M; Schaub, M; Arlettaz, R				Tschumi, Matthias; Schaub, Michael; Arlettaz, Raphael			Territory Occupancy and Parental Quality as Proxies for Spatial Prioritization of Conservation Areas	PLOS ONE			English	Article							BREEDING PERFORMANCE; POPULATION; SETTLEMENT; FECUNDITY; BIRD; AGE	In order to maximize their fitness, individuals aim at choosing territories offering the most appropriate combination of resources. As population size fluctuates in time, the frequency of breeding territory occupancy reflects territory quality. We investigated the relationships between the frequency of territory occupancy (2002-2009) vs. habitat characteristics, prey abundance, reproductive success and parental traits in hoopoes Upupa epops L., with the objective to define proxies for the delineation of conservation priority areas. We predicted that the distribution of phenotypes is despotic and sought for phenotypic characteristics expressing dominance. Our findings support the hypothesis of a despotic distribution. Territory selection was non-random: frequently occupied territories were settled earlier in the season and yielded higher annual reproductive success, but the frequency of territory occupancy could not be related to any habitat characteristics. Males found in frequently occupied territories showed traits expressing dominance (i.e. larger body size and mass, and older age). In contrast, morphological traits of females were not related to the frequency of territory occupancy, suggesting that territory selection and maintenance were essentially a male's task. Settlement time in spring, reproductive success achieved in a given territory, as well as phenotypic traits and age of male territory holders reflected territory quality, providing good proxies for assessing priority areas for conservation management.	[Tschumi, Matthias; Schaub, Michael; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Schaub, Michael] Swiss Ornithol Inst, Sempach, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Sion, Switzerland	University of Bern; Swiss Ornithological Institute; Swiss Ornithological Institute	Tschumi, M (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	matthias.tschumi@agroscope.admin.ch	Arlettaz, Raphaël/O-2182-2016; Tschumi, Matthias/H-6010-2019	Arlettaz, Raphaël/0000-0001-6360-5339; Tschumi, Matthias/0000-0002-7991-7780; Schaub, Michael/0000-0003-2745-0557	Division of Conservation Biology (University of Bern); Swiss Ornithological Institute	Division of Conservation Biology (University of Bern); Swiss Ornithological Institute	The study has been jointly funded by the Division of Conservation Biology (University of Bern) and the Swiss Ornithological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arlettaz R, 2000, CONSERVATION HUPPE F; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Botsch Y, 2012, AUK, V129, P283, DOI 10.1525/auk.2012.11079; Brambilla M, 2013, ORNIS FENNICA, V90, P50; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Dafond L, 2008, THESIS U ZURICH; ESRI, 2008, ARCGIS 9 X; Ferrer M, 2006, J ANIM ECOL, V75, P111, DOI 10.1111/j.1365-2656.2005.01026.x; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; FRANCIS CM, 1986, AUK, V103, P548; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Germain RR, 2014, ECOLOGY, V95, P436, DOI 10.1890/13-0467.1; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Keller V., 2010, ROTE LISTE BRUTVOGEL; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; LANYON SM, 1986, CONDOR, V88, P206, DOI 10.2307/1368917; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martinez JA, 2008, IBIS, V150, P223, DOI 10.1111/j.1474-919X.2007.00774.x; Mermod M, 2009, IBIS, V151, P731, DOI 10.1111/j.1474-919X.2009.00956.x; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; R Core Team, 2012, R LANG ENV STAT COMP; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Serrano D, 2007, AM NAT, V169, pE53, DOI 10.1086/510598; Tagmann-Ioset A, 2012, ACTA OECOL, V39, P25, DOI 10.1016/j.actao.2011.11.003; Tregenza T., 1995, Advances in Ecological Research, V26, P253, DOI 10.1016/S0065-2504(08)60067-7; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	36	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97679	10.1371/journal.pone.0097679	http://dx.doi.org/10.1371/journal.pone.0097679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836965	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800060
J	Bley, AS; Correa, JCF; Dos Reis, AC; Rabelo, NDD; Marchetti, PH; Lucareli, PRG				Bley, Andre Serra; Ferrari Correa, Joao Carlos; Dos Reis, Amir Curcio; Dos Anjos Rabelo, Nayra Deise; Marchetti, Paulo Henrique; Garcia Lucareli, Paulo Roberto			Propulsion Phase of the Single Leg Triple Hop Test in Women with Patellofemoral Pain Syndrome: A Biomechanical Study	PLOS ONE			English	Article							LOWER-EXTREMITY KINEMATICS; MUSCLE-ACTIVATION; HIP STRENGTH; JOINT KINEMATICS; KNEE KINEMATICS; VERTICAL JUMP; FEMALES; MECHANICS; PERSPECTIVE; PRESSURES	Asymmetry in the alignment of the lower limbs during weight-bearing activities is associated with patellofemoral pain syndrome (PFPS), caused by an increase in patellofemoral (PF) joint stress. High neuromuscular demands are placed on the lower limb during the propulsion phase of the single leg triple hop test (SLTHT), which may influence biomechanical behavior. The aim of the present cross-sectional study was to compare kinematic, kinetic and muscle activity in the trunk and lower limb during propulsion in the SLTHT using women with PFPS and pain free controls. The following measurements were made using 20 women with PFPS and 20 controls during propulsion in the SLTHT: kinematics of the trunk, pelvis, hip, and knee; kinetics of the hip, knee and ankle; and muscle activation of the gluteus maximus (GM), gluteus medius (GMed), biceps femoris (BF) and vastus lateralis (VL). Differences between groups were calculated using three separate sets of multivariate analysis of variance for kinematics, kinetics, and electromyographic data. Women with PFPS exhibited ipsilateral trunk lean; greater trunk flexion; greater contralateral pelvic drop; greater hip adduction and internal rotation; greater ankle pronation; greater internal hip abductor and ankle supinator moments; lower internal hip, knee and ankle extensor moments; and greater GM, GMed, BL, and VL muscle activity. The results of the present study are related to abnormal movement patterns in women with PFPS. We speculated that these findings constitute strategies to control a deficient dynamic alignment of the trunk and lower limb and to avoid PF pain. However, the greater BF and VL activity and the extensor pattern found for the hip, knee, and ankle of women with PFPS may contribute to increased PF stress.	[Bley, Andre Serra; Ferrari Correa, Joao Carlos; Dos Reis, Amir Curcio; Dos Anjos Rabelo, Nayra Deise; Garcia Lucareli, Paulo Roberto] Univ Nove de Julho, Human Mot Anal Lab, Dept Rehabil Sci, Sao Paulo, Brazil; [Marchetti, Paulo Henrique] Univ Metodista Piracicaba, UNIMEP, Post Grad Program Human Movement Sci, Sao Paulo, Brazil; [Marchetti, Paulo Henrique] Fac Phys Educ YMCA, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Metodista de Piracicaba	Lucareli, PRG (corresponding author), Univ Nove de Julho, Human Mot Anal Lab, Dept Rehabil Sci, Sao Paulo, Brazil.	paulolucareli@uninove.br	Correa, Joao/D-9312-2015; Lucareli, Paulo Roberto Garcia/D-3965-2009	Correa, Joao/0000-0002-8642-9814; Lucareli, Paulo Roberto Garcia/0000-0002-7148-575X				Aminaka N, 2011, J ELECTROMYOGR KINES, V21, P645, DOI 10.1016/j.jelekin.2011.03.007; Augustsson J, 2006, SCAND J MED SCI SPOR, V16, P111, DOI 10.1111/j.1600-0838.2005.00446.x; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Barton CJ, 2013, BRIT J SPORT MED, V47, P207, DOI 10.1136/bjsports-2012-090953; Barton CJ, 2009, GAIT POSTURE, V30, P405, DOI 10.1016/j.gaitpost.2009.07.109; Bizzini M, 2003, J ORTHOP SPORT PHYS, V33, P4, DOI 10.2519/jospt.2003.33.1.4; Blache Y, 2013, SCAND J MED SCI SPOR, V23, pe121, DOI 10.1111/sms.12042; Blackburn JT, 2009, J ATHL TRAINING, V44, P174, DOI 10.4085/1062-6050-44.2.174; Bolgla LA, 2008, J ORTHOP SPORT PHYS, V38, P12, DOI 10.2519/jospt.2008.2462; Bolgla LA, 2011, INT J SPORTS PHYS TH, V6, P285; Brechter JH, 2002, GAIT POSTURE, V16, P115, DOI 10.1016/S0966-6362(02)00090-5; Cates W, 2009, CLIN SPORT MED, V28, P63, DOI 10.1016/j.csm.2008.09.003; Collado H, 2010, CLIN SPORT MED, V29, P379, DOI 10.1016/j.csm.2010.03.012; Coventry E, 2006, CLIN BIOMECH, V21, P1090, DOI 10.1016/j.clinbiomech.2006.07.004; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; da Cunha RA, 2013, J ORTHOP SPORT PHYS, V43, P332, DOI 10.2519/jospt.2013.4228; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Draper CE, 2012, J ORTHOP RES, V30, P209, DOI 10.1002/jor.21523; Earl JE, 2007, J ORTHOP SPORT PHYS, V37, P245, DOI 10.2519/jospt.2007.2202; Elias JJ, 2011, CLIN BIOMECH, V26, P841, DOI 10.1016/j.clinbiomech.2011.03.016; Fitzgerald GK, 2001, J ORTHOP SPORT PHYS, V31, P588, DOI 10.2519/jospt.2001.31.10.588; Fukuda TY, 2012, J ORTHOP SPORT PHYS, V42, P823, DOI 10.2519/jospt.2012.4184; Halabchi Farzin, 2013, Asian J Sports Med, V4, P85, DOI 10.5812/asjsm.34488; Hamilton RT, 2008, J ATHL TRAINING, V43, P144, DOI 10.4085/1062-6050-43.2.144; Hara M, 2008, HUM MOVEMENT SCI, V27, P636, DOI 10.1016/j.humov.2008.04.001; Hara M, 2006, J BIOMECH, V39, P2503, DOI 10.1016/j.jbiomech.2005.07.030; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Ireland ML, 2003, J ORTHOP SPORT PHYS, V33, P671, DOI 10.2519/jospt.2003.33.11.671; Jacobs CA, 2007, J ATHL TRAINING, V42, P76; Jeon HS, 2001, J ORTHOP SPORT PHYS, V31, P122, DOI 10.2519/jospt.2001.31.3.122; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kaya D, 2011, KNEE SURG SPORT TR A, V19, P242, DOI 10.1007/s00167-010-1290-2; Lankhorst NE, 2012, J ORTHOP SPORT PHYS, V42, P81, DOI 10.2519/jospt.2012.3803; Lee TQ, 2003, J ORTHOP SPORT PHYS, V33, P686, DOI 10.2519/jospt.2003.33.11.686; Lephart SM, 2002, CLIN ORTHOP RELAT R, P162; Li G, 2004, J ORTHOP RES, V22, P801, DOI 10.1016/j.orthres.2003.11.011; Macrum E, 2012, J SPORT REHABIL, V21, P144, DOI 10.1123/jsr.21.2.144; Nakagawa TH, 2012, J ORTHOP SPORT PHYS, V42, P491, DOI 10.2519/jospt.2012.3987; Nakagawa TH, 2012, MED SCI SPORT EXER, V44, P1747, DOI 10.1249/MSS.0b013e318256903a; Pappas E, 2012, SPORTS HEALTH, V4, P115, DOI 10.1177/1941738111432097; Petschnig R, 1998, J ORTHOP SPORT PHYS, V28, P23, DOI 10.2519/jospt.1998.28.1.23; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P639, DOI 10.2519/jospt.2003.33.11.639; Salsich GB, 2012, J ORTHOP SPORT PHYS, V42, P1017, DOI 10.2519/jospt.2012.4231; Souza RB, 2010, J ORTHOP SPORT PHYS, V40, P277, DOI 10.2519/jospt.2010.3215; Souza RB, 2009, J ORTHOP SPORT PHYS, V39, P12, DOI 10.2519/jospt.2009.2885; Thomee R, 1999, SPORTS MED, V28, P245, DOI 10.2165/00007256-199928040-00003; Willson JD, 2008, CLIN BIOMECH, V23, P203, DOI 10.1016/j.clinbiomech.2007.08.025; Willson JD, 2009, J SPORT REHABIL, V18, P76, DOI 10.1123/jsr.18.1.76; Witvrouw E, 2014, BRIT J SPORT MED, V48, P411, DOI 10.1136/bjsports-2014-093450	52	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97606	10.1371/journal.pone.0097606	http://dx.doi.org/10.1371/journal.pone.0097606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830289	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500085
J	Toda, H; Boku, S; Nakagawa, S; Inoue, T; Kato, A; Takamura, N; Song, N; Nibuya, M; Koyama, T; Kusumi, I				Toda, Hiroyuki; Boku, Shuken; Nakagawa, Shin; Inoue, Takeshi; Kato, Akiko; Takamura, Naoki; Song, Ning; Nibuya, Masashi; Koyama, Tsukasa; Kusumi, Ichiro			Maternal Separation Enhances Conditioned Fear and Decreases the mRNA Levels of the Neurotensin Receptor 1 Gene with Hypermethylation of This Gene in the Rat Amygdala	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ROSTRAL VENTROMEDIAL MEDULLA; ANXIETY DISORDERS; PROTEIN-SYNTHESIS; CENTRAL NUCLEUS; MEMORY; EXTINCTION; MECHANISMS; EXPRESSION; RECONSOLIDATION	Stress during postnatal development is associated with an increased risk for depression, anxiety disorders, and substance abuse later in life, almost as if mental illness is able to be programed by early life stressors. Recent studies suggest that such "programmed" effects can be caused by epigenetic regulation. With respect to conditioned fear, previous studies have indicated that early life stress influences its development in adulthood, whereas no potential role of epigenetic regulation has been reported. Neurotensin (NTS) is an endogenous neuropeptide that has receptors densely located in the amygdala and hippocampus. Recently, NTS systems have constituted an emerging target for the treatment of anxiety. The aim of the present work is to clarify whether the NTS system is involved in the disturbance of conditioned fear in rats stressed by maternal separation (MS). The results showed that MS enhanced freezing behaviors in fear-conditioned stress and reduced the gene expression of NTS receptor (NTSR) 1 but not of NTS or NTSR2 in the amygdalas of adult rats. The microinjection of a NTSR1 antagonist into the amygdala increased the percentage of freezing in conditioned fear, whereas the microinjection of NTSR1 agonist decreased freezing. These results suggest that NTSR1 in the amygdala may play a role in the effects of MS on conditioned fear stress in adult rats. Moreover, MS increased DNA methylation in the promoter region of NTSR1 in the amygdala. Taken together, MS may leave epigenetic marks in the NTSR1 gene in the amygdala, which may enhance conditioned fear in adulthood. The MS-induced alternations of DNA methylation in the promoter region of NTSR1 in the amygdala may be associated with vulnerability to the development of anxiety disorders and depression in adulthood.	[Toda, Hiroyuki; Nibuya, Masashi] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Toda, Hiroyuki; Nakagawa, Shin; Inoue, Takeshi; Kato, Akiko; Song, Ning; Koyama, Tsukasa; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Boku, Shuken] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Takamura, Naoki] Dainippon Sumitomo Pharma Co Ltd, Pharmaceut Labs, Osaka, Japan; [Song, Ning] China Med Univ, Hosp 1, Dept Psychiat, Shenyang, Peoples R China	National Defense Medical College - Japan; Hokkaido University; Yeshiva University; Albert Einstein College of Medicine; Dainippon Sumitomo Pharmaceutical Company; China Medical University	Nakagawa, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	snakaga@med.hokudai.ac.jp	Inoue, Takeshi/D-7431-2012; Boku, Shuken/H-2776-2017; Inoue, Takeshi/X-8057-2019	Inoue, Takeshi/0000-0001-5248-1289; Nibuya, Masashi/0000-0002-8292-2302	JSPS KAKENHI [18591269, 24791248]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 18591269 (Shin Nakagawa) and 24791248 (Hiroyuki Toda). http://kaken.nii.ac.jp/d/r/60360905.ja.html http://research-er.jp/researchers/view/00610677/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa B, 2009, PSYCHONEUROENDOCRINO; Alexander MJ, 1998, J COMP NEUROL, V402, P475; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; Binder EB, 2001, PHARMACOL REV, V53, P453; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Buhler AV, 2008, PAIN, V135, P280, DOI 10.1016/j.pain.2007.06.010; Buhler AV, 2005, PAIN, V114, P285, DOI 10.1016/j.pain.2004.12.031; CARTER RB, 1991, PAIN, V47, P211, DOI 10.1016/0304-3959(91)90207-E; Classen CC, 2005, TRAUMA VIOLENCE ABUS, V6, P103, DOI 10.1177/1524838005275087; CLINESCHMIDT BV, 1979, EUR J PHARMACOL, V54, P129, DOI 10.1016/0014-2999(79)90415-1; Cougle JR, 2010, PSYCHIAT RES, V177, P150, DOI 10.1016/j.psychres.2009.03.008; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Erabi K, 2007, INT J NEUROPSYCHOPH, V10, P369, DOI 10.1017/S1461145706006675; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Hashimoto S, 1996, PSYCHOPHARMACOLOGY, V123, P182, DOI 10.1007/BF02246175; Hatzinger M, 1996, NEUROENDOCRINOLOGY, V64, P349, DOI 10.1159/000127138; Holly EN, 2011, EUR NEUROPSYCHOPHARM; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Inoue T, 2004, EUR J PHARMACOL, V497, P311, DOI 10.1016/j.ejphar.2004.06.061; INOUE T, 1993, PHARMACOL BIOCHEM BE, V44, P371, DOI 10.1016/0091-3057(93)90476-A; Inoue T, 2006, ANN REPORT PHARMACOP, V38, P23; Inoue T, 2011, PROG NEURO-PSYCHOPH, V35, P1810, DOI 10.1016/j.pnpbp.2011.09.002; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KAHN D, 1980, ENDOCRINOLOGY, V107, P47, DOI 10.1210/endo-107-1-47; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kawano KI, 2008, SYNAPSE, V62, P259, DOI 10.1002/syn.20487; Lang AJ, 2008, BEHAV MED, V33, P125, DOI 10.3200/BMED.33.4.125-136; Laszlo K, 2012, BEHAV BRAIN RES, V226, P597, DOI 10.1016/j.bbr.2011.08.041; Laszlo K, 2010, BEHAV BRAIN RES, V210, P280, DOI 10.1016/j.bbr.2010.02.038; Laszlo K, 2010, BEHAV BRAIN RES, V208, P430, DOI 10.1016/j.bbr.2009.12.022; Li XB, 2006, EUR J PHARMACOL, V532, P74, DOI 10.1016/j.ejphar.2005.12.008; Maeno H, 1996, MOL BRAIN RES, V40, P97; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Matsumoto M, 2008, PHARMACOL BIOCHEM BE, V89, P247, DOI 10.1016/j.pbb.2007.12.017; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nishith P, 2000, J ABNORM PSYCHOL, V109, P20, DOI 10.1037/0021-843X.109.1.20; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; PAXINOS G, 1997, RAT BRAIN STREOTAXIC; Petrie KA, 2004, NEUROPSYCHOPHARMACOL, V29, P1878, DOI 10.1038/sj.npp.1300494; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Prus AJ, 2014, PROG NEURO-PSYCHOPH, V49, P78, DOI 10.1016/j.pnpbp.2013.11.011; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rakyan VK, 2001, BIOCHEM J, V356, P1, DOI 10.1042/0264-6021:3560001; Rao U, 2008, BIOL PSYCHIAT, V64, P521, DOI 10.1016/j.biopsych.2008.05.012; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roussy G, 2008, J NEUROCHEM, V105, P1100, DOI 10.1111/j.1471-4159.2007.05205.x; Roussy G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-38; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Sarrett P, 2002, J BIOL CHEM, V277, P36233, DOI 10.1074/jbc.M202586200; Schechter DS, 2013, DEV PSYCHOBIOL; Shilling PD, 2008, PHARMACOL BIOCHEM BE, V90, P748, DOI 10.1016/j.pbb.2008.05.025; Stevenson CW, 2009, BEHAV BRAIN RES; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Wise LA, 2001, LANCET, V358, P881, DOI 10.1016/S0140-6736(01)06072-X; Yamada D, 2010, PHARM BIOCH BEHAV; Yamada M, 1998, LIFE SCI, V62, pPL375; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629	69	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97421	10.1371/journal.pone.0097421	http://dx.doi.org/10.1371/journal.pone.0097421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831231	Green Published, gold			2022-12-25	WOS:000336789500055
J	Vilasi, S; Carrotta, R; Mangione, MR; Campanella, C; Librizzi, F; Randazzo, L; Martorana, V; Gammazza, AM; Ortore, MG; Vilasi, A; Pocsfalvi, G; Burgio, G; Corona, D; Piccionello, AP; Zummo, G; Bulone, D; de Macario, EC; Macario, AJL; San Biagio, PL; Cappello, F				Vilasi, Silvia; Carrotta, Rita; Mangione, Maria Rosalia; Campanella, Claudia; Librizzi, Fabio; Randazzo, Loredana; Martorana, Vincenzo; Gammazza, Antonella Marino; Ortore, Maria Grazia; Vilasi, Annalisa; Pocsfalvi, Gabriella; Burgio, Giosalba; Corona, Davide; Piccionello, Antonio Palumbo; Zummo, Giovanni; Bulone, Donatella; de Macario, Everly Conway; Macario, Alberto J. L.; San Biagio, Pier Luigi; Cappello, Francesco			Human Hsp60 with Its Mitochondrial Import Signal Occurs in Solution as Heptamers and Tetradecamers Remarkably Stable over a Wide Range of Concentrations	PLOS ONE			English	Article							CHAPERONIN PROTEIN HSP60; GROEL; HEAT-SHOCK-PROTEIN-60; COMPLEX; CANCER; CHAPERONOPATHIES; RECONSTITUTION; IDENTIFICATION; LOCALIZATION; AGGREGATION	It has been established that Hsp60 can accumulate in the cytosol in various pathological conditions, including cancer and chronic inflammatory diseases. Part or all of the cytosolic Hsp60 could be naive, namely, bear the mitochondrial import signal (MIS), but neither the structure nor the in solution oligomeric organization of this cytosolic molecule has still been elucidated. Here we present a detailed study of the structure and self-organization of naive cytosolic Hsp60 in solution. Results were obtained by different biophysical methods (light and X ray scattering, single molecule spectroscopy and hydrodynamics) that all together allowed us to assay a wide range of concentrations of Hsp60. We found that Naive Hsp60 in aqueous solution is assembled in very stable heptamers and tetradecamers at all concentrations assayed, without any trace of monomer presence.	[Vilasi, Silvia; Carrotta, Rita; Mangione, Maria Rosalia; Librizzi, Fabio; Randazzo, Loredana; Martorana, Vincenzo; Piccionello, Antonio Palumbo; Bulone, Donatella; San Biagio, Pier Luigi; Cappello, Francesco] CNR, Inst Biophys, Palermo, Italy; [Campanella, Claudia; Gammazza, Antonella Marino; Zummo, Giovanni; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Campanella, Claudia; Gammazza, Antonella Marino; Macario, Alberto J. L.; Cappello, Francesco] Euro Mediterranean Inst Sci & Technol, Palermo, Italy; [Ortore, Maria Grazia] Marche Polytech Univ, Dept Life & Environm Sci, Ancona, Italy; [Ortore, Maria Grazia] Marche Polytech Univ, Natl Interuniv Consortium Phys Sci Matter, Ancona, Italy; [Vilasi, Annalisa; Pocsfalvi, Gabriella] CNR, Inst Biosci & Bioresources, Naples, Italy; [Burgio, Giosalba; Corona, Davide; Piccionello, Antonio Palumbo] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de Macario, Everly Conway; Macario, Alberto J. L.] Columbus Ctr, Inst Marine & Environm Technol, Baltimore, MD USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Palermo; Marche Polytechnic University; Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Palermo; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	San Biagio, PL (corresponding author), CNR, Inst Biophys, Palermo, Italy.	pierluigi.sanbiagio@cnr.it	Pocsfalvi, Gabriella/C-4948-2015; Gammazza, Antonella Marino/AAV-3123-2020; ortore, maria grazia/A-8530-2008; bulone, donatella/AAB-6116-2022; Randazzo, Loredana Antonella/P-3070-2018; Ortore, Maria Grazia/AAC-2869-2019; Librizzi, Fabio/L-9187-2015; ortore, maria grazia/H-7635-2015; Piccionello, Antonio Palumbo/V-6634-2017; Cappello, Francesco/F-9153-2012	Pocsfalvi, Gabriella/0000-0001-6065-3853; ortore, maria grazia/0000-0002-2719-6184; bulone, donatella/0000-0002-5841-9133; Randazzo, Loredana Antonella/0000-0002-9424-3665; Librizzi, Fabio/0000-0003-4900-382X; ortore, maria grazia/0000-0002-2719-6184; Piccionello, Antonio Palumbo/0000-0003-4402-5798; VILASI, SILVIA/0000-0002-9926-7199; Mangione, Maria Rosalia/0000-0002-3466-2569; Marino Gammazza, Antonella/0000-0002-1683-3803; SAN BIAGIO, PIER LUIGI/0000-0002-4622-7361; Martorana, Vincenzo/0000-0001-7092-6077; Carrotta, Rita/0000-0003-4628-2819; Cappello, Francesco/0000-0001-9288-1148	Italian grant FIRB "Future in research" [RBFR12SIPT MIND]; Euro-Mediterranean Institute of Science and Technology (Italy)	Italian grant FIRB "Future in research"; Euro-Mediterranean Institute of Science and Technology (Italy)	This work has been supported by Italian grant FIRB "Future in research" RBFR12SIPT MIND: "Multidisciplinary Investigations for the development of Neuro-protective Drugs". FC and AJLM were partially supported by Euro-Mediterranean Institute of Science and Technology (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CHAPERONOPATHIES DIS; Arai M, 2003, PROTEIN SCI, V12, P672, DOI 10.1110/ps.0233603; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Burgio G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000089; Campanella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042008; Cappello F, 2014, EXPERT OPIN THER TAR, V18, P185, DOI 10.1517/14728222.2014.856417; Cappello F, 2013, CURR PHARM DESIGN, V19, P452, DOI 10.2174/138161213804143653; Cappello F, 2011, METHODS MOL BIOL, V787, P245, DOI 10.1007/978-1-61779-295-3_18; Carrotta R, 2012, BBA-GEN SUBJECTS, V1820, P124, DOI 10.1016/j.bbagen.2011.11.010; Carrotta R, 2012, J PHYS CHEM B, V116, P14700, DOI 10.1021/jp307417x; Cechetto JD, 2000, J HISTOCHEM CYTOCHEM, V48, P45, DOI 10.1177/002215540004800105; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; Corsale C, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/244103; David Sabrina, 2013, Front Biosci (Elite Ed), V5, P768; Desmetz C, 2008, J PROTEOME RES, V7, P3830, DOI 10.1021/pr800130d; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; GOROVITS B, 1995, J BIOL CHEM, V270, P2061, DOI 10.1074/jbc.270.5.2061; Guinier A., 1955, SMALL ANGLE SCATTERI; Gupta S, 2005, J CELL MOL MED, V9, P51, DOI 10.1111/j.1582-4934.2005.tb00336.x; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; HUTCHINSON EG, 1989, EMBO J, V8, P1485, DOI 10.1002/j.1460-2075.1989.tb03532.x; Inobe T, 2008, BIOPHYS J, V94, P1392, DOI 10.1529/biophysj.107.114710; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; JINDAL S, 1989, MOL CELL BIOL, V9, P2279, DOI 10.1128/MCB.9.5.2279; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Macario AJL, 1999, MICROBIOL MOL BIOL R, V63, P923, DOI 10.1128/MMBR.63.4.923-967.1999; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1998, BIOCHEMISTRY-MOSCOW+, V63, P374; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Nisemblat S, 2014, ACTA CRYSTALLOGR F, V70, P116, DOI 10.1107/S2053230X1303389X; Ortore MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061904; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pace A, 2013, CURR PHARM DESIGN, V19, P2757, DOI 10.2174/1381612811319150011; Parnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050318; Parnas A, 2009, J BIOL CHEM, V284, P28198, DOI 10.1074/jbc.M109.031997; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pusey PN, 2002, N-HOLLAND D, P3; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Soltys BJ, 1998, MITOCHONDRIAL MOL CH, P69; SQUIRE PG, 1968, BIOCHEMISTRY-US, V7, P4261, DOI 10.1021/bi00852a018; STEPANEK P, 1993, DYNAMIC LIGHT SCATTE; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; YBARRA J, 1995, J BIOL CHEM, V270, P22962, DOI 10.1074/jbc.270.39.22962; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	67	43	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97657	10.1371/journal.pone.0097657	http://dx.doi.org/10.1371/journal.pone.0097657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830947	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500096
J	David, M; Sahay, D; Mege, F; Descotes, F; Leblanc, R; Ribeiro, J; Clezardin, P; Peyruchaud, O				David, Marion; Sahay, Debashish; Mege, Florence; Descotes, Francoise; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier			Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA(1)) Activation in Human Breast and Prostate Cancers	PLOS ONE			English	Article							BONE METASTASES; NEUROPATHIC PAIN; EPITHELIAL-CELLS; GENE-EXPRESSION; AUTOTAXIN; PROTEIN; ANTAGONIST; FIBROSIS; PROMOTES; SUBTYPE	Lysophosphatidic acid (LPA) is a natural bioactive lipid with growth factor-like functions due to activation of a series of six G protein-coupled receptors (LPA(1-6)). LPA receptor type 1 (LPA(1)) signaling influences the pathophysiology of many diseases including cancer, obesity, rheumatoid arthritis, as well as lung, liver and kidney fibrosis. Therefore, LPA(1) is an attractive therapeutic target. However, most mammalian cells co-express multiple LPA receptors whose co-activation impairs the validation of target inhibition in patients because of missing LPA receptor-specific biomarkers. LPA(1) is known to induce IL-6 and IL-8 secretion, as also do LPA(2) and LPA(3). In this work, we first determined the LPA induced early-gene expression profile in three unrelated human cancer cell lines expressing different patterns of LPA receptors (PC3: LPA(1,2,3,6); MDA-MB-231: LPA(1,2); MCF-7: LPA(2,6)). Among the set of genes upregulated by LPA only in LPA(1)-expressing cells, we validated by QPCR and ELISA that upregulation of heparin-binding EGF-like growth factor (HB-EGF) was inhibited by LPA(1-3) antagonists (Ki16425, Debio0719). Upregulation and downregulation of HB-EGF mRNA was confirmed in vitro in human MDA-B02 breast cancer cells stably overexpressing LPA(1) (MDA-B02/LPA(1)) and downregulated for LPA(1) (MDA-B02/shLPA(1)), respectively. At a clinical level, we quantified the expression of LPA(1) and HB-EGF by QPCR in primary tumors of a cohort of 234 breast cancer patients and found a significantly higher expression of HB-EGF in breast tumors expressing high levels of LPA(1). We also generated human xenograph prostate tumors in mice injected with PC3 cells and found that a five-day treatment with Ki16425 significantly decreased both HB-EGF mRNA expression at the primary tumor site and circulating human HB-EGF concentrations in serum. All together our results demonstrate that HB-EGF is a new and relevant biomarker with potentially high value in quantifying LPA(1) activation state in patients receiving anti-LPA(1) therapies.	[David, Marion] Fac Med Toulouse, INSERM, U1037, F-31073 Toulouse, France; [David, Marion] Inst Claudius Regaud, Toulouse, France; [Sahay, Debashish; Mege, Florence; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] INSERM, U1033, F-69008 Lyon, France; [Sahay, Debashish; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] Univ Lyon 1, F-69622 Villeurbanne, France; [Sahay, Debashish; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] Fac Med Lyon Est, Lyon, France; [Mege, Florence] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France; [Descotes, Francoise] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon	Peyruchaud, O (corresponding author), INSERM, U1033, F-69008 Lyon, France.	Olivier.peyruchaud@inserm.fr	Clezardin, Philippe/M-8071-2014; Sahay, Debashish/U-7130-2019	Clezardin, Philippe/0000-0003-0149-4463; Sahay, Debashish/0000-0002-4473-6402; Leblanc, Raphael/0000-0002-1976-9587; Peyruchaud, Olivier/0000-0002-5393-4945	INSERM; Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer; French Association pour la Recherche sur le Cancer ARC; ARC; Seventh Framework Programme (FP7) [264817-BONE-NET]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer; French Association pour la Recherche sur le Cancer ARC(Fondation ARC pour la Recherche sur le Cancer); ARC(Australian Research Council); Seventh Framework Programme (FP7)(European Commission)	This study was supported by grants from the INSERM (OP and PC), the Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer, and the French Association pour la Recherche sur le Cancer ARC (OP). MD is a recipient of a fellowship from ARC. DS is a recipient of a fellowship from the Seventh Framework Programme (FP7/2007-2013) under agreement n o 264817-BONE-NET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Cabello-Verrugio C, 2011, CELL SIGNAL, V23, P449, DOI 10.1016/j.cellsig.2010.10.019; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi KU, 2010, INT J CANC; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; David M, 2014, J BIOL CHEM; David M, 2012, INT J ONCOL, V40, P1133, DOI 10.3892/ijo.2011.1309; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Fukushima N, 2007, NEUROCHEM INT, V50, P302, DOI 10.1016/j.neuint.2006.09.008; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marshall JC, 2012, J NATL CANC I; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Umata T, 2001, J BIOL CHEM, V276, P30475, DOI 10.1074/jbc.M103673200; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Xue JX, 2010, ONCOL REP, V24, P1515, DOI 10.3892/or_00001013; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	42	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97771	10.1371/journal.pone.0097771	http://dx.doi.org/10.1371/journal.pone.0097771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828490	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400121
J	Pluskal, T; Ueno, M; Yanagida, M				Pluskal, Tomas; Ueno, Masaru; Yanagida, Mitsuhiro			Genetic and Metabolomic Dissection of the Ergothioneine and Selenoneine Biosynthetic Pathway in the Fission Yeast, S. pombe, and Construction of an Overproduction System	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL RESPONSES; SEXUAL-DIFFERENTIATION; REGULATORY NETWORK; ORGANIC SELENIUM; PROTEIN; EXPRESSION; ENCODES; COPPER; CELLS; ROLES	Ergothioneine is a small, sulfur-containing metabolite (229 Da) synthesized by various species of bacteria and fungi, which can accumulate to millimolar levels in tissues or cells (e.g. erythrocytes) of higher eukaryotes. It is commonly marketed as a dietary supplement due to its proposed protective and antioxidative functions. In this study we report the genes forming the two-step ergothioneine biosynthetic pathway in the fission yeast, Schizosaccharomyces pombe. We identified the first gene, egt1(+) (SPBC1604.01), by sequence homology to previously published genes from Neurospora crassa and Mycobacterium smegmatis. We showed, using metabolomic analysis, that the Delta egt1 deletion mutant completely lacked ergothioneine and its precursors (trimethyl histidine/hercynine and hercynylcysteine sulfoxide). Since the second step of ergothioneine biosynthesis has not been characterized in eukaryotes, we examined four putative homologs (Nfs1/SPBC21D10.11c, SPAC11D3.10, SPCC777.03c, and SPBC660.12c) of the corresponding mycobacterial enzyme EgtE. Among deletion mutants of these genes, only one (Delta SPBC660.12c, designated Delta egt2) showed a substantial decrease in ergothioneine, accompanied by accumulation of its immediate precursor, hercynylcysteine sulfoxide. Ergothioneine-deficient strains exhibited no phenotypic defects during vegetative growth or quiescence. To effectively study the role of ergothioneine, we constructed an egt1(+) overexpression system by replacing its native promoter with the nmt1(+) promoter, which is inducible in the absence of thiamine. We employed three versions of the nmt1 promoter with increasing strength of expression and confirmed corresponding accumulations of ergothioneine. We quantified the intracellular concentration of ergothioneine in S. pombe (0.3, 157.4, 41.6, and up to 1606.3 mu M in vegetative, nitrogen-starved, glucose-starved, and egt1(+)-overexpressing cells, respectively) and described its gradual accumulation under long-term quiescence. Finally, we demonstrated that the ergothioneine pathway can also synthesize selenoneine, a selenium-containing derivative of ergothioneine, when the culture medium is supplemented with selenium. We further found that selenoneine biosynthesis involves a novel intermediate compound, hercynylselenocysteine.	[Pluskal, Tomas; Yanagida, Mitsuhiro] Grad Univ OIST, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa, Japan; [Pluskal, Tomas; Ueno, Masaru] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima, Hiroshima 724, Japan	Okinawa Institute of Science & Technology Graduate University; Hiroshima University	Yanagida, M (corresponding author), Grad Univ OIST, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa, Japan.	myanagid@gmail.com	Pluskal, Tomáš/C-6247-2012; Ueno, Masaru/G-3990-2019	Pluskal, Tomáš/0000-0002-6940-3006; 	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was funded by the Okinawa Institute of Science and Technology Promotion Corporation (until October 2011) and Okinawa Institute of Science and Technology Graduate University (from November 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANMU D, 1991, ARCH BIOCHEM BIOPHYS, V288, P10, DOI 10.1016/0003-9861(91)90158-F; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Bello MH, 2012, FUNGAL GENET BIOL, V49, P160, DOI 10.1016/j.fgb.2011.12.007; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; GENGHOF DS, 1970, J BACTERIOL, V103, P475, DOI 10.1128/JB.103.2.475-478.1970; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; HARTMAN PE, 1990, METHOD ENZYMOL, V186, P310; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LEONE E, 1951, NATURE, V168, P205, DOI 10.1038/168205b0; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markova NG, 2009, FREE RADICAL BIO MED, V46, P1168, DOI 10.1016/j.freeradbiomed.2009.01.021; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MELVILLE DB, 1954, J BIOL CHEM, V206, P221; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Shimanuki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078545; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shires TK, 1997, COMP BIOCHEM PHYS C, V117, P117, DOI 10.1016/S0742-8413(96)00223-X; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yamashita M, 2013, BIOL TRACE ELEM RES, V156, P36, DOI 10.1007/s12011-013-9846-x; Yamashita Yumiko, 2010, World J Biol Chem, V1, P144, DOI 10.4331/wjbc.v1.i5.144; Yamashita Y, 2010, J BIOL CHEM, V285, P18134, DOI 10.1074/jbc.C110.106377; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhu BZ, 2011, CHEM RES TOXICOL, V24, P30, DOI 10.1021/tx100214t	53	64	74	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97774	10.1371/journal.pone.0097774	http://dx.doi.org/10.1371/journal.pone.0097774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828577	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400122
J	Qin, J; Fang, N; Lou, JN; Zhang, WJ; Xu, SQ; Liu, HL; Fang, Q; Wang, Z; Liu, J; Men, XL; Peng, L; Chen, L				Qin, Jun; Fang, Ni; Lou, Jinning; Zhang, Wenjian; Xu, Shiqing; Liu, Honglin; Fang, Qing; Wang, Zai; Liu, Jiang; Men, Xiuli; Peng, Liang; Chen, Li			TRB3 Is Involved in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis via the Protein Kinase C delta Pathway	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TRIBBLES HOMOLOG; INSULIN-RESISTANCE; ER STRESS; PKC-DELTA; ACTIVATION; DEATH; DROSOPHILA; PHOSPHORYLATION; MORPHOGENESIS	Chronic exposure to free fatty acids (FFAs) may induce beta cell apoptosis in type 2 diabetes. However, the precise mechanism by which FFAs trigger b cell apoptosis is still unclear. Tribbles homolog 3 (TRB3) is a pseudokinase inhibiting Akt, a key mediator of insulin signaling, and contributes to insulin resistance in insulin target tissues. This paper outlined the role of TRB3 in FFAs-induced INS-1 beta cell apoptosis. TRB3 was promptly induced in INS-1 cells after stimulation by FFAs, and this was accompanied by enhanced INS-1 cell apoptosis. The overexpression of TRB3 led to exacerbated apoptosis triggered by FFAs in INS-1-derived cell line and the subrenal capsular transplantation animal model. In contrast, cell apoptosis induced by FFAs was attenuated when TRB3 was knocked down. Moreover, we observed that activation and nuclear accumulation of protein kinase C (PKC) delta was enhanced by upregulation of TRB3. Preventing PKC delta nuclear translocation and PKC delta selective antagonist both significantly lessened the pro-apoptotic effect. These findings suggest that TRB3 was involved in lipoapoptosis of INS-1 beta cell, and thus could be an attractive pharmacological target in the prevention and treatment of T2DM.	[Qin, Jun; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Fang, Ni; Lou, Jinning; Zhang, Wenjian; Xu, Shiqing; Liu, Honglin; Fang, Qing; Wang, Zai; Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Liu, Jiang] China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Men, Xiuli] North China Coal Med Univ, Dept Pathophysiol, Tangshan, Peoples R China	Shandong University; China-Japan Friendship Hospital; China-Japan Friendship Hospital; North China University of Science & Technology	Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.	pengliang8028@163.com; chenli3@medmail.com.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Nature Science Foundation of China [81200616, 81370943]; Beijing Natural Science Foundation of China [7122160]; National Basic Research Program of China [2012CB966402]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; Key New Drug Creation & Manufacturing Program [2011ZX09102-010-03]; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2014-QNYC-A-05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Medical and Health Science and Technology Development Projects of Shandong Province; Key New Drug Creation & Manufacturing Program; China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This work was supported by grants from National Nature Science Foundation of China (81200616 & 81370943), Beijing Natural Science Foundation of China (7122160), National Basic Research Program of China (2012CB966402), Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), Key New Drug Creation & Manufacturing Program (2011ZX09102-010-03) and China-Japan Friendship Hospital Youth Science and Technology Excellence Project (2014-QNYC-A-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Carpenter L, 2002, DIABETES, V51, P317, DOI 10.2337/diabetes.51.2.317; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Cheng Q, 2011, J MOL ENDOCRINOL, V47, P13, DOI 10.1530/JME-10-0106; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Han YQ, 1997, J BIOL CHEM, V272, P9825; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Hu XR, 2005, J MOL ENDOCRINOL, V35, P73, DOI 10.1677/jme.1.01764; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nicoletti-Carvalho JE, 2010, J ENDOCRINOL, V206, P183, DOI 10.1677/JOE-09-0356; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Peng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049258; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Ranta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028828; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Tang M, 2008, CELL MOL LIFE SCI, V65, P2924, DOI 10.1007/s00018-008-8255-3; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zhou YD, 2012, HUM MOL GENET, V21, P196, DOI 10.1093/hmg/ddr454	45	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96089	10.1371/journal.pone.0096089	http://dx.doi.org/10.1371/journal.pone.0096089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824999	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200010
J	Wang, QG; Bao, DC; Guo, YL; Lu, JM; Lu, ZJ; Xu, YZ; Zhang, KH; Liu, HB; Meng, HJ; Jiang, MX; Qiao, XJ; Huang, HD				Wang, Qinggang; Bao, Dachuan; Guo, Yili; Lu, Junmeng; Lu, Zhijun; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie; Jiang, Mingxi; Qiao, Xiujuan; Huang, Handong			Species Associations in a Species-Rich Subtropical Forest Were Not Well-Explained by Stochastic Geometry of Biodiversity	PLOS ONE			English	Article							SPATIAL ASSOCIATIONS	The stochastic dilution hypothesis has been proposed to explain species coexistence in species-rich communities. The relative importance of the stochastic dilution effects with respect to other effects such as competition and habitat filtering required to be tested. In this study, using data from a 25-ha species-rich subtropical forest plot with a strong topographic structure at Badagongshan in central China, we analyzed overall species associations and fine-scale species interactions between 2,550 species pairs. The result showed that: (1) the proportion of segregation in overall species association analysis at 2 m neighborhood in this plot followed the prediction of the stochastic dilution hypothesis that segregations should decrease with species richness but that at 10 m neighborhood was higher than the prediction. (2) The proportion of no association type was lower than the expectation of stochastic dilution hypothesis. (3) Fine-scale species interaction analyses using Heterogeneous Poisson processes as null models revealed a high proportion (47%) of significant species effects. However, the assumption of separation of scale of this method was not fully met in this plot with a strong fine-scale topographic structure. We also found that for species within the same families, fine-scale positive species interactions occurred more frequently and negative ones occurred less frequently than expected by chance. These results suggested effects of environmental filtering other than species interaction in this forest. (4) We also found that arbor species showed a much higher proportion of significant fine-scale species interactions (66%) than shrub species (18%). We concluded that the stochastic dilution hypothesis only be partly supported and environmental filtering left discernible spatial signals in the spatial associations between species in this species-rich subtropical forest with a strong topographic structure.	[Wang, Qinggang; Bao, Dachuan; Guo, Yili; Lu, Junmeng; Lu, Zhijun; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie; Jiang, Mingxi; Qiao, Xiujuan; Huang, Handong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Wang, Qinggang; Guo, Yili; Lu, Junmeng; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie] Univ Chinese Acad Sci, Life Sci Coll, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, MX (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.	mxjiang@wbgcas.cn	; , Xiujuan/M-6966-2013	Lu, Zhijun/0000-0002-9688-3025; , Xiujuan/0000-0003-4647-399X	National Natural Science Foundation of China [31070465, 31200329]; Chinese Forest Biodiversity Monitoring Network [29200931131101919]; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Forest Biodiversity Monitoring Network; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Natural Science Foundation of China (Grant no. 31070465 and 31200329) and Chinese Forest Biodiversity Monitoring Network (29200931131101919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Clements F.E., 1916, PLANT SUCCESSION ANA; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diamond J.M., 1975, P342; Diggle P., 2003, STAT ANAL SPATIAL PO; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Lan GY, 2012, PLOS ONE, V7, DOI [10.1371/annotation/974531b0-9da4-4575-b3d1-955b0163fde0, 10.1371/journal.pone.0046074]; Lieberman M, 2007, OIKOS, V116, P377, DOI 10.1111/j.2006.0030-1299.15370.x; Liu B, 1983, J CENTRAL S FORESTRY, V3, P141; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LOTWICK HW, 1982, J ROY STAT SOC B MET, V44, P406; Luo ZR, 2012, J PLANT ECOL, V5, P346, DOI 10.1093/jpe/rtr048; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Perry GLW, 2009, OIKOS, V118, P161, DOI 10.1111/j.1600-0706.2008.16947.x; Perry GLW, 2014, OIKOS, V123, P99, DOI 10.1111/j.1600-0706.2013.00400.x; PIELOU EC, 1962, J ECOL, V50, P357, DOI 10.2307/2257448; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; R Development Core Team, 2012, R LANG ENV STAT COMP; Stoll P., 2000, GEOMETRY ECOLOGICAL, P11, DOI DOI 10.1017/CBO9780511525537.003; Stoyan D., 1994, FRACTALS RANDOM SHAP; Tilman D., 1982, Monographs in Population Biology, pi; Tofts R, 2000, P ROY SOC B-BIOL SCI, V267, P363, DOI 10.1098/rspb.2000.1010; Ulrich W, 2010, ECOL RES, V25, P375, DOI 10.1007/s11284-009-0661-y; Volkov I, 2009, P NATL ACAD SCI USA, V106, P13854, DOI 10.1073/pnas.0903244106; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Weiher E, 1999, ECOLOGICAL ASSEBLY R; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252	42	5	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97300	10.1371/journal.pone.0097300	http://dx.doi.org/10.1371/journal.pone.0097300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824996	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200089
J	Wu, BY; Gong, DH; Xu, B; He, QP; Liu, ZH; Ji, DX				Wu, Buyun; Gong, Dehua; Xu, Bin; He, Qunpeng; Liu, Zhihong; Ji, Daxi			Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HEPARIN-INDUCED THROMBOCYTOPENIA; RENAL-REPLACEMENT THERAPY; RISK; CARE; PREVALENCE; ARGATROBAN; ANDROGEN; FAILURE; SEPSIS	Background: A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). We aim to investigate the incidence of decreased platelet count and related risk factors in patients receiving CRRT. Methods: In this retrospective study, we screened all patients receiving continuous veno-venous hemofiltration (CWH) at Jinling Hospital between November 2008 and October 2012. The patients were included who received uninterrupted CVVH for more than 72 h and had records of blood test for 4 consecutive days after ruling out pre-existing conditions that may affect the platelet count. Platelet counts before and during CVVH, illness severity, CVVH settings, and outcomes were analyzed. Results: The study included 125 patients. During the 3-day CVVH, 44.8% and 16% patients had a mild decline (20-49.9%) and severe decline (>= 50%) in the platelet count, respectively; 37.6% and 16.0% patients had mild thrombocytopenia (platelet count 50.1-100x10(9)/L) and severe thrombocytopenia (platelet count <= 50x10(9)/L), respectively. Patients with a severe decline in the platelet count had a significantly lower survival rate than patients without a severe decline in the platelet count (35.0% versus 59.0%, P = 0.012), while patients with severe thrombocytopenia had a survival rate similar to those without severe thrombocytopenia (45.0% versus 57.1%, P = 0.308). Female gender, older age, and longer course of the disease were independent risk factors for a severe decline in the platelet count. Conclusions: A decline in the platelet count and thrombocytopenia are quite common in patients receiving CVVH. The severity of the decline in the platelet count rather than the absolute count during CVVH may be associated with hospital mortality. Knowing the risk factors for a severe decline in the platelet count may allow physicians to prevent such an outcome.	[Wu, Buyun; Gong, Dehua; Xu, Bin; He, Qunpeng; Liu, Zhihong; Ji, Daxi] Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ji, DX (corresponding author), Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	dr_jdx@163.com		Wu, Buyun/0000-0002-4874-9171; Liu, Zhi-Hong/0000-0001-6093-0726	Natural Science Foundation of China [81070608]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 81070608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatri A, 2012, THROMB RES, V129, P426, DOI 10.1016/j.thromres.2011.11.041; Ben Hamida C, 2003, INTENS CARE MED, V29, P756, DOI 10.1007/s00134-003-1727-x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Hui P, 2011, CHEST, V139, P271, DOI 10.1378/chest.10-2243; Joannidis M, 2007, CRIT CARE, V11, DOI 10.1186/cc5937; Junqueira DRG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007557.pub2; Kiaii M, 2011, JAMA-J AM MED ASSOC, V306, P1679, DOI 10.1001/jama.2011.1499; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Li SJ, 2007, STEROIDS, V72, P875, DOI 10.1016/j.steroids.2007.07.007; Link A, 2008, CRIT CARE, V12, DOI 10.1186/cc6998; Liu SX, 2010, BLOOD PURIFICAT, V29, P375, DOI 10.1159/000314649; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; Mulder J, 2003, INT J ARTIF ORGANS, V26, P906, DOI 10.1177/039139880302601006; Palsson R, 1999, KIDNEY INT, V55, P1991, DOI 10.1046/j.1523-1755.1999.00444.x; Post JB, 2010, AM J KIDNEY DIS, V55, pE25, DOI 10.1053/j.ajkd.2009.10.059; RONCO C, 1995, CRIT CARE MED, V23, P99, DOI 10.1097/00003246-199501000-00018; Ronco C, 2004, BLOOD PURIFICAT, V22, P164, DOI 10.1159/000074937; Saugel B, 2010, CRIT CARE, V14, DOI 10.1186/cc9024; Strauss R, 2002, CRIT CARE MED, V30, P1765, DOI 10.1097/00003246-200208000-00015; Tolwani A, 2012, NEW ENGL J MED, V367, P2505, DOI 10.1056/NEJMct1206045; Valente C, 2013, CLINICS, V68, P803, DOI 10.6061/clinics/2013(06)13; WATTEL E, 1994, BRIT J HAEMATOL, V87, P205, DOI 10.1111/j.1365-2141.1994.tb04895.x	27	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97286	10.1371/journal.pone.0097286	http://dx.doi.org/10.1371/journal.pone.0097286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824815	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200086
J	Zhou, JZ; Riquelme, MA; Gao, X; Ellies, LG; Sun, LZ; Jiang, JX				Zhou, J. Z.; Riquelme, M. A.; Gao, X.; Ellies, L. G.; Sun, L. Z.; Jiang, J. X.			Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis	ONCOGENE			English	Article							HUMAN-TUMOR-CELLS; RECEPTORS; SURVIVAL; ATP; 5'-TRIPHOSPHATE; HEMICHANNELS; ACTIVATION; MECHANISMS; MIGRATION; MODELS	Extracellular ATP has been shown to either inhibit or promote cancer growth and migration; however, the mechanism underlying this discrepancy remained elusive. Here we demonstrate the divergent roles of ATP and adenosine released by bone osteocytes on breast cancers. We showed that conditioned media (CM) collected from osteocytes treated with alendronate (AD), a bisphosphonate drug, inhibited the migration of human breast cancer MDA-MB-231 cells. Removal of the extracellular ATP by apyrase in CM abolished this effect, suggesting the involvement of ATP. ATP exerted its inhibitory effect through the activation of purinergic P2X receptor signaling in breast cancer cells evidenced by the attenuation of the inhibition by an antagonist, oxidized ATP, as well as knocking down P2X7 with small interfering RNA (siRNA), and the inhibition of migration by an agonist, BzATP. Intriguingly, ATP had a biphasic effect on breast cancer cells-lower dosage inhibited but higher dosage promoted its migration. The stimulatory effect on migration was blocked by an adenosine receptor antagonist, MRS1754, ARL67156, an ecto-ATPase inhibitor, and A(2A) receptor siRNA, suggesting that in contrast to ATP, adenosine, a metabolic product of ATP, promoted migration of breast cancer cells. Consistently, non-hydrolyzable ATP, ATP gamma S, only inhibited but did not promote cancer cell migration. ATP also had a similar inhibitory effect on the Py8119 mouse mammary carcinoma cells; however, adenosine had no effect owing to the absence of the A(2A) receptor. Consistently, ATP.S inhibited, whereas adenosine promoted anchorage-independent growth of MDA-MB-231 cells. Our in vivo xenograft study showed a significant delay of tumor growth with the treatment of ATP gamma S. Moreover, the extent of bone metastasis in a mouse intratibial model was significantly reduced with the treatment of ATP gamma S. Together, our results suggest the distinct roles of ATP and adenosine released by osteocytes and the activation of corresponding receptors P2X7 and A(2A) signaling on breast cancer cell growth, migration and bone metastasis.	[Zhou, J. Z.; Riquelme, M. A.; Gao, X.; Jiang, J. X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Ellies, L. G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Sun, L. Z.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sun, L. Z.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015; , LuZhe/AAW-4095-2021	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	Welch Foundation [AQ-1507]; National Institutes of Health [EY012085, ES022057, CA118182]; NCI Cancer Center Support grant [2 P30 CA054174-17]; NATIONAL CANCER INSTITUTE [P30CA054174, K22CA118182] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022057] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Sumin Gu, Dr Sweta Mishra and Dr Tanuka Biswas for technical assistance. The work was supported by the Welch Foundation grant AQ-1507 and National Institutes of Health grant EY012085 to JXJ, ES022057 to L-ZS, CA118182 to LGE and the NCI Cancer Center Support grant 2 P30 CA054174-17 to Cancer Therapy and Research Center.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Agteresch HJ, 2003, ANTI-CANCER DRUG, V14, P639, DOI 10.1097/00001813-200309000-00009; Agteresch HJ, 2000, EUR J CLIN PHARMACOL, V56, P49, DOI 10.1007/s002280050719; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Beijer S, 2009, ANTI-CANCER DRUG, V20, P625, DOI 10.1097/CAD.0b013e32832d4f22; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Brown Sue A, 2007, Curr Osteoporos Rep, V5, P120; Burnstock G, 2008, J PHYSIOL-LONDON, V586, P3307, DOI 10.1113/jphysiol.2008.155903; Campbell JP, 2012, JOVE-J VIS EXP, DOI 10.3791/4260; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kohno N, 2008, INT J CLIN ONCOL, V13, P18, DOI 10.1007/s10147-007-0726-2; Kretschmann KL, 2012, CANCER METAST REV, V31, P579, DOI 10.1007/s10555-012-9378-4; Leth-Larsen R, 2009, MOL CELL PROTEOMICS, V8, P1436, DOI 10.1074/mcp.M800061-MCP200; Matsuo K, 2009, CURR OPIN NEPHROL HY, V18, P292, DOI 10.1097/MNH.0b013e32832b75f1; Mishra S, 2011, PROSTATE, V71, P1441, DOI 10.1002/pros.21361; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; RAPAPORT E, 1983, CANCER RES, V43, P4402; RAPAPORT E, 1988, EUR J CANCER CLIN ON, V24, P1491, DOI 10.1016/0277-5379(88)90340-9; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Salvestrini V, 2012, BLOOD, V119, P217, DOI 10.1182/blood-2011-07-370775; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Shabbir M, 2009, INT J UROL, V16, P143, DOI 10.1111/j.1442-2042.2008.02207.x; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; Welch D. R., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P30; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Woodhouse EC, 1998, BIOCHEM BIOPH RES CO, V246, P888, DOI 10.1006/bbrc.1998.8714; Zhang W, 2011, BIOCHEM PHARMACOL, V82, P411, DOI 10.1016/j.bcp.2011.05.009; Zhi XL, 2007, CLIN EXP METASTAS, V24, P439, DOI 10.1007/s10585-007-9081-y	35	69	73	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1831	1842		10.1038/onc.2014.113	http://dx.doi.org/10.1038/onc.2014.113			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24837364	Green Accepted			2022-12-25	WOS:000352158000010
J	Lu, W; Khatri, L; Ziff, EB				Lu, Wei; Khatri, Latika; Ziff, Edward B.			Trafficking of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor (AMPA) Receptor Subunit GluA2 from the Endoplasmic Reticulum Is Stimulated by a Complex Containing Ca2+/Calmodulin-activated Kinase II (CaMKII) and PICK1 Protein and by Release of Ca2+ from Internal Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; GLUR2; NEURONS; DOMAIN; LTP; PHOSPHORYLATION; PERMEABILITY; STARGAZIN	The GluA2 subunit of the AMPA receptor (AMPAR) dominantly blocks AMPAR Ca2+ permeability, and its trafficking to the synapse regulates AMPAR-dependent synapse Ca2+ permeability. Here we show that GluA2 trafficking from the endoplasmic reticulum (ER) to the plasma membrane of cultured hippocampal neurons requires Ca2+ release from internal stores, the activity of Ca2+/calmodulin activated kinase II (CaMKII), and GluA2 interaction with the PDZ protein, PICK1. We show that upon Ca2+ release from the ER via the IP3 and ryanodine receptors, CaMKII that is activated enters a complex that contains PICK1, dependent upon the PICK1 BAR (Bin-amphiphysin- Rvs) domain, and that interacts with the GluA2 C-terminal domain and stimulates GluA2 ER exit and surface trafficking. This study reveals a novel mechanism of regulation of trafficking of GluA2-containing receptors to the surface under the control of intracellular Ca2+ dynamics and CaMKII activity.	[Lu, Wei; Khatri, Latika; Ziff, Edward B.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA	New York University	Ziff, EB (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Sch Med, 550 First Ave, New York, NY 10016 USA.	edward.ziff@nyumc.org	Lu, Wei/S-5617-2018	Lu, Wei/0000-0001-6668-8432; Ziff, Edward/0000-0001-7389-8649	National Institutes of Health [R01NS061920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS061920 (NINDS; to E. B. Z.).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chung HJ, 2000, J NEUROSCI, V20, P7258; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	50	29	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19218	19230		10.1074/jbc.M113.511246	http://dx.doi.org/10.1074/jbc.M113.511246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24831007	hybrid, Green Published			2022-12-25	WOS:000339062900049
J	Matsuda, S; Kominato, K; Koide-Yoshida, S; Miyamoto, K; Isshiki, K; Tsuji, A; Yuasa, K				Matsuda, Shinya; Kominato, Kyohei; Koide-Yoshida, Shizuyo; Miyamoto, Kenji; Isshiki, Kinuka; Tsuji, Akihiko; Yuasa, Keizo			PCTAIRE Kinase 3/Cyclin-dependent Kinase 18 Is Activated through Association with Cyclin A and/or Phosphorylation by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK COMPLEXES; SUBSTRATE-SPECIFICITY; DEPENDENT KINASES; NUCLEAR-LOCALIZATION; CANCER; ACTIN; PATHWAYS; OOCYTES; BINDING; FAMILY	PCTAIRE kinase 3 (PCTK3)/cyclin-dependent kinase 18 (CDK18) is an uncharacterized member of the CDK family because its activator(s) remains unidentified. Here we describe the mechanisms of catalytic activation of PCTK3 by cyclin A2 and cAMP-dependent protein kinase (PKA). Using a pulldown experiment with HEK293T cells, cyclin A2 and cyclin E1 were identified as proteins that interacted with PCTK3. An in vitro kinase assay using retinoblastoma protein as the substrate showed that PCTK3 was specifically activated by cyclin A2 but not by cyclin E1, although its activity was lower than that of CDK2. Furthermore, immunocytochemistry analysis showed that PCTK3 colocalized with cyclin A2 in the cytoplasm and regulated cyclin A2 stability. Amino acid sequence analysis revealed that PCTK3 contained four putative PKA phosphorylation sites. In vitro and in vivo kinase assays showed that PCTK3 was phosphorylated by PKA at Ser(12), Ser(66), and Ser(109) and that PCTK3 activity significantly increased via phosphorylation at Ser(12) by PKA even in the absence of cyclin A2. In the presence of cyclin A2, PCTK3 activity was comparable to CDK2 activity. We also found that PCTK3 knockdown in HEK293T cells induced polymerized actin accumulation in peripheral areas and cofilin phosphorylation. Taken together, our results provide the first evidence for the mechanisms of catalytic activation of PCTK3 by cyclin A2 and PKA and a physiological function of PCTK3.	[Matsuda, Shinya; Kominato, Kyohei; Koide-Yoshida, Shizuyo; Miyamoto, Kenji; Isshiki, Kinuka; Tsuji, Akihiko; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 7708506, Japan	Tokushima University	Yuasa, K (corresponding author), Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, 2-1 Minamijosanjima, Tokushima 7708506, Japan.	yuasa@bio.tokushima-u.ac.jp		Matsuda, Shinya/0000-0002-0169-1347	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. Y.).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cole AR, 2009, NEUROSIGNALS, V17, P288, DOI 10.1159/000231895; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Eyers PA, 2005, J BIOL CHEM, V280, P24339, DOI 10.1074/jbc.M412442200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Graeser R, 2002, J CELL SCI, V115, P3479; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Hirose T, 2000, EUR J BIOCHEM, V267, P2113, DOI 10.1046/j.1432-1327.2000.01218.x; Horton LE, 1997, ONCOGENE, V14, P491, DOI 10.1038/sj.onc.1200851; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu F, 2001, AM J PHYSIOL-LUNG C, V280, pL1309, DOI 10.1152/ajplung.2001.280.6.L1309; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MARIDOR G, 1993, J CELL SCI, V106, P535; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nadella KS, 2009, EMBO REP, V10, P599, DOI 10.1038/embor.2009.58; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shehata SN, 2012, CELL SIGNAL, V24, P2085, DOI 10.1016/j.cellsig.2012.06.018; Shibuya EK, 2003, CELL CYCLE, V2, P39, DOI 10.4161/cc.2.1.291; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Yamochi T, 2001, BIOCHEM BIOPH RES CO, V286, P1045, DOI 10.1006/bbrc.2001.5493; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Yuasa K, 2011, CELL SIGNAL, V23, P1179, DOI 10.1016/j.cellsig.2011.03.005; Zacksenhaus E, 1999, BBA-MOL CELL RES, V1451, P288, DOI 10.1016/S0167-4889(99)00103-2	51	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18387	18400		10.1074/jbc.M113.542936	http://dx.doi.org/10.1074/jbc.M113.542936			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831015	hybrid, Green Published			2022-12-25	WOS:000338042000037
J	Xia, B; Liu, YL; Li, W; Brice, AR; Dominy, BN; Cao, WG				Xia, Bo; Liu, Yinling; Li, Wei; Brice, Allyn R.; Dominy, Brian N.; Cao, Weiguo			Specificity and Catalytic Mechanism in Family 5 Uracil DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; EUBACTERIUM THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-DYNAMICS; ACTIVE-SITE; ENZYME MUTY; SUBSTRATE PROPERTIES; ADENINE GLYCOSYLASE	UDGb belongs to family 5 of the uracil DNA glycosylase (UDG) superfamily. Here, we report that family 5 UDGb from Thermus thermophilus HB8 is not only a uracil DNA glycosyase acting on G/U, T/U, C/U, and A/U base pairs, but also a hypoxanthine DNA glycosylase acting on G/I, T/I, and A/I base pairs and a xanthine DNA glycosylase acting on all double-stranded and single-stranded xanthine-containing DNA. Analysis of potentials of mean force indicates that the tendency of hypoxanthine base flipping follows the order of G/I> T/I, A/I> C/I, matching the trend of hypoxanthine DNA glycosylase activity observed in vitro. Genetic analysis indicates that family 5 UDGb can also act as an enzyme to remove uracil incorporated into DNA through the existence of dUTP in the nucleotide pool. Mutational analysis coupled with molecular modeling and molecular dynamics analysis reveals that although hydrogen bonding to O-2 of uracil underlies the UDG activity in a dissociative fashion, Tth UDGb relies on multiple catalytic residues to facilitate its excision of hypoxanthine and xanthine. This study underscores the structural and functional diversity in the UDG superfamily.	[Xia, Bo; Li, Wei; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, South Carolina Expt Stn, Clemson, SC 29634 USA; [Liu, Yinling; Brice, Allyn R.; Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, Rm 049 Life Sci Facil,190 Collings St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; South Carolina Experiment Station [SC-1700274, 6233]; Department of Defense [W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Experiment Station; Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141. This work was also supported by South Carolina Experiment Station Grant SC-1700274 (technical contribution No. 6233), Department of Defense Grant W81XWH-10-1-0385, and National Science Foundation Career Award MCB-0953783 (to B. N. D.).	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Brinkmeyer MK, 2012, CHEM BIOL, V19, P276, DOI 10.1016/j.chembiol.2011.11.011; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunk E, 2012, J AM CHEM SOC, V134, P8608, DOI 10.1021/ja301714j; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong L, 2008, DNA REPAIR, V7, P1962, DOI 10.1016/j.dnarep.2008.08.006; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Francis AW, 2003, J AM CHEM SOC, V125, P16235, DOI 10.1021/ja0374426; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kosaka H, 2007, J MOL BIOL, V373, P839, DOI 10.1016/j.jmb.2007.08.022; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; KUMAR VD, 1992, BIOCHEMISTRY-US, V31, P1541, DOI 10.1021/bi00120a035; Lee HW, 2011, J BIOL CHEM, V286, P31282, DOI 10.1074/jbc.M111.249524; Lee HW, 2010, J BIOL CHEM, V285, P41483, DOI 10.1074/jbc.M110.150003; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Malshetty VS, 2010, MICROBIOL-SGM, V156, P940, DOI 10.1099/mic.0.034363-0; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Matsubara M, 2004, NUCLEIC ACIDS RES, V32, P5291, DOI 10.1093/nar/gkh859; McCann JAB, 2008, J AM CHEM SOC, V130, P5789, DOI 10.1021/ja711363s; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; Michelson AZ, 2012, J AM CHEM SOC, V134, P19839, DOI 10.1021/ja309082k; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poznanski J, 2003, NUCLEOS NUCLEOT NUCL, V22, P249, DOI 10.1081/NCN-120021425; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Sakai T, 2008, DNA REPAIR, V7, P663, DOI 10.1016/j.dnarep.2008.01.006; Sandigursky M, 1999, CURR BIOL, V9, P531, DOI 10.1016/S0960-9822(99)80237-1; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Srinath T, 2007, DNA REPAIR, V6, P1517, DOI 10.1016/j.dnarep.2007.05.001; Starkuviene V, 2002, NUCLEIC ACIDS RES, V30, P2097, DOI 10.1093/nar/30.10.2097; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; TAYLOR AF, 1982, J BACTERIOL, V151, P351, DOI 10.1128/JB.151.1.351-357.1982; Wanner RM, 2009, J BACTERIOL, V191, P6312, DOI 10.1128/JB.00613-09; WARNER HR, 1981, J BACTERIOL, V145, P687, DOI 10.1128/JB.145.2.687-695.1981; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wright PM, 1999, J BIOL CHEM, V274, P29011, DOI 10.1074/jbc.274.41.29011; ZOLTEWICZ JA, 1970, J AM CHEM SOC, V92, P1741, DOI 10.1021/ja00709a055	61	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18413	18426		10.1074/jbc.M114.567354	http://dx.doi.org/10.1074/jbc.M114.567354			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24838246	hybrid, Green Published			2022-12-25	WOS:000338042000039
J	Babuin, MF; Campestre, MP; Rocco, R; Bordenave, CD; Escaray, FJ; Antonelli, C; Calzadilla, P; Garriz, A; Serna, E; Carrasco, P; Ruiz, OA; Menendez, AB				Florencia Babuin, Maria; Paula Campestre, Maria; Rocco, Ruben; Bordenave, Cesar D.; Escaray, Francisco J.; Antonelli, Cristian; Calzadilla, Pablo; Garriz, Andres; Serna, Eva; Carrasco, Pedro; Ruiz, Oscar A.; Menendez, Ana B.			Response to Long-Term NaHCO3-Derived Alkalinity in Model Lotus japonicus Ecotypes Gifu B-129 and Miyakojima MG-20: Transcriptomic Profiling and Physiological Characterization	PLOS ONE			English	Article							CARBONIC-ANHYDRASE ACTIVITY; GENE-EXPRESSION; PLASMA-MEMBRANE; CHLOROPHYLL FLUORESCENCE; PUCCINELLIA-TENUIFLORA; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; CDNA MICROARRAY; PLANT-CELLS	The current knowledge regarding transcriptomic changes induced by alkalinity on plants is scarce and limited to studies where plants were subjected to the alkaline salt for periods not longer than 48 h, so there is no information available regarding the regulation of genes involved in the generation of a new homeostatic cellular condition after long-term alkaline stress. Lotus japonicus is a model legume broadly used to study many important physiological processes including biotic interactions and biotic and abiotic stresses. In the present study, we characterized phenotipically the response to alkaline stress of the most widely used L. japonicus ecotypes, Gifu B-129 and MG-20, and analyzed global transcriptome of plants subjected to 10 mM NaHCO3 during 21 days, by using the Affymetrix Lotus japonicus GeneChip (R). Plant growth assessment, gas exchange parameters, chlorophyll a fluorescence transient (OJIP) analysis and metal accumulation supported the notion that MG-20 plants displayed a higher tolerance level to alkaline stress than Gifu B-129. Overall, 407 and 459 probe sets were regulated in MG-20 and Gifu B-129, respectively. The number of probe sets differentially expressed in roots was higher than that of shoots, regardless the ecotype. Gifu B-129 and MG-20 also differed in their regulation of genes that could play important roles in the generation of a new Fe/Zn homeostatic cellular condition, synthesis of plant compounds involved in stress response, protein-degradation, damage repair and root senescence, as well as in glycolysis, gluconeogenesis and TCA. In addition, there were differences between both ecotypes in the expression patterns of putative transcription factors that could determine distinct arrangements of flavonoid and isoflavonoid compounds. Our results provided a set of selected, differentially expressed genes deserving further investigation and suggested that the L. japonicus ecotypes could constitute a useful model to search for common and distinct tolerance mechanisms to long-term alkaline stress response in plants.	[Florencia Babuin, Maria; Paula Campestre, Maria; Rocco, Ruben; Bordenave, Cesar D.; Escaray, Francisco J.; Antonelli, Cristian; Calzadilla, Pablo; Garriz, Andres; Ruiz, Oscar A.; Menendez, Ana B.] Univ Nacl Gen San Martin, Inst Tecnol Chascomus, Inst Invest Biotechnol, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Chascomus, Argentina; [Serna, Eva] Univ Valencia, Unidad Cent Invest Med INCLIVA, Valencia, Spain; [Carrasco, Pedro] Univ Valencia, Dept Bioquim & Biol Vegetal, Valencia, Spain; [Menendez, Ana B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	University of Valencia; University of Valencia; University of Buenos Aires	Menendez, AB (corresponding author), Univ Nacl Gen San Martin, Inst Tecnol Chascomus, Inst Invest Biotechnol, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Chascomus, Argentina.	anamen@bg.fcen.uba.ar	Bordenave, César Daniel/AAB-5407-2021; Calzadilla, Pablo/AAY-6108-2021; Carrasco, Pedro/P-3333-2014; serna, eva/Z-1433-2019	Bordenave, César Daniel/0000-0002-5582-4942; Carrasco, Pedro/0000-0001-7900-6146; serna, eva/0000-0002-2968-3349; Escaray, Francisco Jose/0000-0001-7413-3541	Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs [2034, 1611]	Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs	This work was supported by grants from the Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs 2034 and 1611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia J, 2011, PLANT PHYSIOL BIOCH, V49, P471, DOI 10.1016/j.plaphy.2011.01.026; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Aglawe S. B., 2012, Physiology and Molecular Biology of Plants, V18, P287, DOI 10.1007/s12298-012-0135-5; Alam SM., 1999, HDB PLANT CROP STRES, V2, P51; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; BARAKIVA A, 1969, J HORTIC SCI BIOTECH, V44, P359, DOI 10.1080/00221589.1969.11514318; Bordenave CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083199; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Calatayud A, 2001, ENVIRON POLLUT, V115, P283, DOI 10.1016/S0269-7491(01)00101-4; Callard D, 1996, PLANT PHYSIOL, V112, P705, DOI 10.1104/pp.112.2.705; Chen LS, 2004, J AM SOC HORTIC SCI, V129, P738, DOI 10.21273/JASHS.129.5.0738; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho CW, 2009, BIOL PLANTARUM, V53, P461, DOI 10.1007/s10535-009-0086-z; Coudert Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-387; Paz RC, 2012, J PLANT GROWTH REGUL, V31, P448, DOI 10.1007/s00344-011-9254-4; Dannenhoffer JM, 1997, PLANTA, V201, P405, DOI 10.1007/s004250050083; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Diaz P, 2010, NEW PHYTOL, V188, P1001, DOI 10.1111/j.1469-8137.2010.03440.x; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Escaray FJ, 2012, PLANT SCI, V182, P121, DOI 10.1016/j.plantsci.2011.03.016; Field B, 2006, PLANT MOL BIOL, V60, P717, DOI 10.1007/s11103-005-5547-y; Ge Y, 2011, FUNCT INTEGR GENOMIC, V11, P369, DOI 10.1007/s10142-010-0191-2; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Gonzalez-Moreno S, 2008, REB, V27, P119, DOI DOI 10.1093/JXB/ERT208; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Hashiguchi M, 2011, INTERDISCIPLINARY BI, V3, P4; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Escudero-Almanza DJ, 2012, CHIL J AGR RES, V72, P140, DOI 10.4067/S0718-58392012000100022; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Kim J, 2006, FEBS LETT, V580, P5251, DOI 10.1016/j.febslet.2006.08.050; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; LICHTENTHALER FW, 1987, CARBOHYD RES, V164, P1, DOI 10.1016/0008-6215(87)80114-3; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; NIELSEN KA, 2005, CYTOCHROME P450 STRU, P553; Nikolic M, 2007, FUNCT PLANT BIOL, V34, P402, DOI 10.1071/FP07022; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Paolocci F, 2011, J EXP BOT, V62, P1189, DOI 10.1093/jxb/erq344; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Pietrini F, 2005, AGR ECOSYST ENVIRON, V106, P189, DOI 10.1016/j.agee.2004.10.007; Prakash JSS, 2003, INDIAN J BIOCHEM BIO, V40, P160; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; READ SM, 1983, PLANTA, V158, P119, DOI 10.1007/BF00397704; Rengel Z, 1995, J PLANT PHYSIOL, V147, P251, DOI 10.1016/S0176-1617(11)81513-0; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Roosta HR, 2011, J PLANT NUTR, V34, P717, DOI 10.1080/01904167.2011.540687; Rowley ER, 2011, PLANT ABIOTIC STRESS, P346; SACHS MM, 1986, ANNU REV PLANT PHYS, V37, P363, DOI 10.1146/annurev.pp.37.060186.002051; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tanji KK, 1996, AGR SALINITY ASSESSM; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; Wang YC, 2008, PLANT MOL BIOL REP, V26, P241, DOI 10.1007/s11105-008-0037-4; Wang YC, 2007, PLANT PHYSIOL BIOCH, V45, P567, DOI 10.1016/j.plaphy.2007.05.006; Wang YC, 2007, J PLANT PHYSIOL, V164, P78, DOI 10.1016/j.jplph.2005.12.006; Yoshida K, 2010, PLANT CELL PHYSIOL, V51, P912, DOI 10.1093/pcp/pcq067; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zocchi G, 2007, J EXP BOT, V58, P993, DOI 10.1093/jxb/erl259	85	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97106	10.1371/journal.pone.0097106	http://dx.doi.org/10.1371/journal.pone.0097106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835559	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800028
J	Thompson, MJ; Timmermans, MJTN				Thompson, Martin J.; Timmermans, Martijn J. T. N.			Characterising the Phenotypic Diversity of Papilio dardanus Wing Patterns Using an Extensive Museum Collection	PLOS ONE			English	Article							THEORETICAL GENETICS; BATESIAN MIMICRY; EVOLUTION; BROWN; POLYTROPHUS; DIVERGENCE; DOMINANCE; GENOME	The history of 20th Century evolutionary biology can be followed through the study of mimetic butterflies. From the initial findings of discontinuous polymorphism through the debates regarding the evolution of mimicry and the step-size of evolutionary change, to the studies on supergene evolution and molecular characterisation of butterfly genomes, mimetic butterflies have been at the heart of evolutionary thought for over 100 years. During this time, few species have received as much attention and in-depth study as Papilio dardanus. To assist all aspects of mimicry research, we present a complete data-derived overview of the extent of polymorphism within this species. Using historical samples permanently held by the NHM London, we document the extent of phenotypic variation and characterise the diversity present in each of the subspecies and how it varies across Africa. We also demonstrate an association between "imperfect" mimetic forms and the transitional race formed in the area where Eastern and Western African populations meet around Lake Victoria. We present a novel portal for access to this collection, www.mimeticbutterflies.org, allowing remote access to this unique repository. It is hoped that this online resource can act as a nucleus for the sharing and dissemination of other collections databases and imagery connected with mimetic butterflies.	[Thompson, Martin J.; Timmermans, Martijn J. T. N.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Thompson, Martin J.] Univ Cambridge, Dept Zool, Cambridge, England; [Timmermans, Martijn J. T. N.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England	Natural History Museum London; University of Cambridge; Imperial College London	Thompson, MJ (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	martt@nhm.ac.uk			NERC [NE/I021578/1]; Entomology department of the NHM London; Natural Environment Research Council [NE/I021578/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Entomology department of the NHM London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC (www.nerc.ac.uk). MJT is funded by a NERC studentship and MJTNT by a NERC Postdoctoral Fellowship (NE/I021578/1). Part of this work was funded by the former Entomology department of the NHM London (www.nhm.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Bernardi G., 1985, Bulletin de la Societe Entomologique de France, V90, P1106; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; Carpenter G. D. H., 1948, Proceedings of the Royal Entomological Society of London (B), V17, P11; Carpenter G. D. H, 1933, MIMICRY; Carroll SB, 2011, SCIENCE, V333, P1100, DOI 10.1126/science.1211025; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P325, DOI 10.1016/S0022-5193(75)80083-X; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P283, DOI 10.1016/S0022-5193(75)80081-6; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; Clark R, 2009, MOL ECOL, V18, P3872, DOI 10.1111/j.1365-294X.2009.04259.x; CLARKE C A, 1991, Journal of the Lepidopterists' Society, V45, P222; CLARKE C. A., 1960, HEREDITY, V14, P73, DOI 10.1038/hdy.1960.6; CLARKE CA, 1963, EVOLUTION, V17, P404, DOI 10.2307/2407091; CLARKE CA, 1962, GENETICS, V47, P909; CLARKE CA, 1959, GENETICS, V44, P1347; CLARKE CA, 1960, GENETICS, V45, P683; CLARKE CA, 1960, GENETICS, V45, P439; Cohen A, 2002, NOTES REC ROY SOC, V56, P206, DOI 10.1098/rsnr.2002.0179; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Davis FR, 2009, T AM PHILOS SOC, V99, P221; Dobzhansky T., 1937; ESRI, 2011, ARCMAP 10; FISHER R. A., 1927, TRANS ENT SOC LONDON, V75, P269; Fisher R.A., 1930, GENETICAL THEORY NAT; Fisher RA, 1930, AM NAT, V64, P385, DOI 10.1086/280325; FORD E, 1964, ECOLOGICAL GENETICS; Ford E. B., 1936, Transactions of the Royal Entomological Society of London, V85, P435; Ford E. B., 1931, MENDELISM EVOLUTION; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; GOLDSCHMIDT RB, 1945, Q REV BIOL, V20, P205, DOI 10.1086/394883; Grimaldi David, 2005, pi; Jordan K., 1905, Zeitschrift fuer Wissenschaftliche Zoologie, Vlxxxiii, P151; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Larsen TB, 1990, BUTTERFLIES KENYA TH; Le Cerf F., 1924, Bulletin of the Hill Museum Witley, V1, P369; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Nijhout H. F., 1991, DEV EVOLUTION BUTTER; Nijhout HF, 2003, EVOL DEV, V5, P579, DOI 10.1046/j.1525-142X.2003.03063.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Poulton E. B., 1924, Journal of the East Africa and Uganda Natural History Society Nairobi no, V20, P4; Punnett, 1905, MENDELISM; Punnett R.C., 1915, MIMICRY BUTTERFLIES; Thompson MJ, 2014, HEREDITY, V113, P1, DOI 10.1038/hdy.2014.20; Trimen R., 1869, Transactions of the Linnean Society of London, Vvol. xxvi, P497; TRIMEN R, 1874, T ENTOMOLOGICAL SOC, V22, P137; Turner J. R. G., 1963, Transactions of the Royal Entomological Society of London, V115, P239; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; TURNER JRG, 1979, P NATL ACAD SCI USA, V76, P1924, DOI 10.1073/pnas.76.4.1924; United States Geological Survey, 2009, AFR IS	56	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96815	10.1371/journal.pone.0096815	http://dx.doi.org/10.1371/journal.pone.0096815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837717	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339614800021
J	Cantera, R; Ferreiro, MJ; Aransay, AM; Barrio, R				Cantera, Rafael; Jose Ferreiro, Maria; Maria Aransay, Ana; Barrio, Rosa			Global Gene Expression Shift during the Transition from Early Neural Development to Late Neuronal Differentiation in Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EARLY BRAIN-DEVELOPMENT; NEUROMUSCULAR-JUNCTION; POSTEMBRYONIC NEUROBLASTS; TRANSCRIPTOME ANALYSIS; PATTERN; EMBRYOGENESIS; PATHWAY; GROWTH; GLIA	Regulation of transcription is one of the mechanisms involved in animal development, directing changes in patterning and cell fate specification. Large temporal data series, based on microarrays across the life cycle of the fly Drosophila melanogaster, revealed the existence of groups of genes which expression increases or decreases temporally correlated during the life cycle. These groups of genes are enriched in different biological functions. Here, instead of searching for temporal coincidence in gene expression using the entire genome expression data, we searched for temporal coincidence in gene expression only within predefined catalogues of functionally related genes and investigated whether a catalogue's expression profile can be used to generate larger catalogues, enriched in genes necessary for the same function. We analyzed the expression profiles from genes already associated with early neurodevelopment and late neurodifferentiation, at embryonic stages 16 and 17 of Drosophila life cycle. We hypothesized that during this interval we would find global downregulation of genes important for early neuronal development together with global upregulation of genes necessary for the final differentiation of neurons. Our results were consistent with this hypothesis. We then investigated if the expression profile of gene catalogues representing particular processes of neural development matched the temporal sequence along which these processes occur. The profiles of genes involved in patterning, neurogenesis, axogenesis or synaptic transmission matched the prediction, with largest transcript values at the time when the corresponding biological process takes place in the embryo. Furthermore, we obtained catalogues enriched in genes involved in temporally matching functions by performing a genome-wide systematic search for genes with their highest expression levels at the corresponding embryonic intervals. These findings imply the use of gene expression data in combination with known biological information to predict the involvement of functionally uncharacterized genes in particular biological events.	[Cantera, Rafael] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Cantera, Rafael; Jose Ferreiro, Maria] IIBCE, Montevideo, Uruguay; [Maria Aransay, Ana] CIC bioGUNE, Derio, Spain; [Maria Aransay, Ana] CIBERehd, Derio, Spain; [Barrio, Rosa] CIC bioGUNE, Derio, Spain	Stockholm University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Cantera, R (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	rcantera@zoologi.su.se; rbarrio@cicbiogune.es	Barrio, Rosa/F-8712-2011; Aransay, Ana M./F-8086-2011	Barrio, Rosa/0000-0002-9663-0669; Aransay, Ana M./0000-0002-8271-612X	Tryggers Foundation; Spanish MICINN [BFU2011-25986]; Consolider Program [CSD2007-00825120]; Department of Education of the Basque Government [PI2012/42]; Department of Industry of the Basque Government [PI2012/42]; Bizkaia County	Tryggers Foundation; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider Program(Spanish Government); Department of Education of the Basque Government; Department of Industry of the Basque Government; Bizkaia County	RC thanks the Tryggers Foundation for their support. RB thanks the Spanish MICINN (BFU2011-25986) and the Consolider Program (CSD2007-00825120), the Departments of Education and Industry of the Basque Government (PI2012/42), and the Bizkaia County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhein B, 2006, DEV BIOL, V296, P545, DOI 10.1016/j.ydbio.2006.04.460; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Baines RA, 2006, SEMIN CELL DEV BIOL, V17, P12, DOI 10.1016/j.semcdb.2005.11.003; Baines RA, 1998, J NEUROSCI, V18, P4673; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Blauth K, 2010, INT REV CEL MOL BIO, V283, P93, DOI 10.1016/S1937-6448(10)83003-5; BROADIE KS, 1993, J NEUROSCI, V13, P144; CANAL I, 1986, J NEUROGENET, V3, P293, DOI 10.3109/01677068609106856; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dorfman R, 2001, DEVELOPMENT, V128, P965; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Ferreiro MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-483; Kassahn KS, 2011, INTEGR BIOL-UK, V3, P522, DOI 10.1039/c0ib00062k; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; MAROY P, 1988, J INSECT PHYSIOL, V34, P633, DOI 10.1016/0022-1910(88)90071-6; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Minidorff EN, 2007, GENETICS, V176, P2247, DOI 10.1534/genetics.107.072819; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; Papatsenko I, 2010, BIOINFORMATICS, V26, P2731, DOI 10.1093/bioinformatics/btq513; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 2013, J CELL SCI, V126, P2331, DOI 10.1242/jcs.126912; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rolls MM, 2011, DEV NEUROBIOL, V71, P419, DOI 10.1002/dneu.20836; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P217, DOI 10.1016/S0074-7742(06)75010-3; SINK H, 1991, DEVELOPMENT, V112, P307; Soustelle L, 2007, NEURON GLIA BIOL, V3, P5, DOI 10.1017/S1740925X07000464; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; Technau GM, 2008, ADV EXP MED BIOL, pv; Truman James W., 1993, P1245; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsachaki M, 2012, DEV DYNAM, V241, P40, DOI 10.1002/dvdy.22738; Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yuva-Aydemir Y, 2011, J NEUROSCI, V31, P7005, DOI 10.1523/JNEUROSCI.0459-11.2011	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97703	10.1371/journal.pone.0097703	http://dx.doi.org/10.1371/journal.pone.0097703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830291	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500105
J	Ding, GY; Gao, L; Li, XW; Zhou, MG; Liu, QY; Ren, HY; Jiang, BF				Ding, Guoyong; Gao, Lu; Li, Xuewen; Zhou, Maigeng; Liu, Qiyong; Ren, Hongyan; Jiang, Baofa			A Mixed Method to Evaluate Burden of Malaria Due to Flooding and Waterlogging in Mengcheng County, China: A Case Study	PLOS ONE			English	Article							CASE-CROSSOVER; AIR-POLLUTION; EL-NINO; METEOROLOGICAL FACTORS; CLIMATIC VARIABLES; SEEKING BEHAVIOR; RAPID ASSESSMENT; TRANSMISSION; EXPOSURE; RISK	Background: Malaria is a highly climate-sensitive vector-borne infectious disease that still represents a significant public health problem in Huaihe River Basin. However, little comprehensive information about the burden of malaria caused by flooding and waterlogging is available from this region. This study aims to quantitatively assess the impact of flooding and waterlogging on the burden of malaria in a county of Anhui Province, China. Methods: A mixed method evaluation was conducted. A case-crossover study was firstly performed to evaluate the relationship between daily number of cases of malaria and flooding and waterlogging from May to October 2007 in Mengcheng County, China. Stratified Cox models were used to examine the lagged time and hazard ratios (HRs) of the risk of flooding and waterlogging on malaria. Years lived with disability (YLDs) of malaria attributable to flooding and waterlogging were then estimated based on the WHO framework of calculating potential impact fraction in the Global Burden of Disease study. Results: A total of 3683 malaria were notified during the study period. The strongest effect was shown with a 25-day lag for flooding and a 7-day lag for waterlogging. Multivariable analysis showed that an increased risk of malaria was significantly associated with flooding alone [adjusted hazard ratio (AHR) = 1.467, 95% CI = 1.257, 1.713], waterlogging alone (AHR = 1.879, 95% CI = 1.696, 2.121), and flooding and waterlogging together (AHR = 2.926, 95% CI = 2.576, 3.325). YLDs per 1000 of malaria attributable to flooding alone, waterlogging alone and flooding and waterlogging together were 0.009 per day, 0.019 per day and 0.022 per day, respectively. Conclusion: Flooding and waterlogging can lead to higher burden of malaria in the study area. Public health action should be taken to avoid and control a potential risk of malaria epidemics after these two weather disasters.	[Ding, Guoyong; Gao, Lu; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Ding, Guoyong] Taishan Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tai An, Shandong, Peoples R China; [Ding, Guoyong; Gao, Lu; Li, Xuewen; Liu, Qiyong; Jiang, Baofa] Shandong Univ, Climate Change & Hlth Ctr, Jinan 250100, Shandong, Peoples R China; [Li, Xuewen] Shandong Univ, Sch Publ Hlth, Dept Environm & Hlth, Jinan 250100, Shandong, Peoples R China; [Zhou, Maigeng] China CDC, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ren, Hongyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China.	bjiang@sdu.edu.cn	Zhou, Maigeng/HCH-7703-2022	Li, Xuewen/0000-0003-0841-8658	National Basic Research Program of China (973 Program) [2012CB955502]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaya SW, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2019; Ahmed F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963525; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; [Anonymous], 1995, ECOSYST HEALLTH; [Anonymous], WHO ENV BURDEN DIS S; [Anonymous], 2011, METEOROL ENV SCI; [Anonymous], YB METEROROLOGICAL D; [Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], CHIN AGR DIS INF DAT; [Anonymous], 2011, ANN DISASTER STAT RE; [Anonymous], 2000, ACTA TROP; [Anonymous], FLOOD COMM DIS FACT; [Anonymous], J TROPICAL MED; Barati M, 2012, ASIAN PAC J TROP MED, V5, P789, DOI 10.1016/S1995-7645(12)60145-X; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bezirtzoglou C, 2011, ANAEROBE, V17, P337, DOI 10.1016/j.anaerobe.2011.05.016; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; CEDENO JEM, 1986, DISASTERS, V10, P107, DOI 10.1111/j.1467-7717.1986.tb00575.x; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Duo-quan Wang, 2013, PLoS One, V8, pe68766, DOI 10.1371/journal.pone.0068766; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686; Garg A, 2009, ENVIRON MANAGE, V43, P779, DOI 10.1007/s00267-008-9242-z; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; GUERI M, 1986, DISASTERS, V10, P118, DOI 10.1111/j.1467-7717.1986.tb00577.x; Harrison BA, 2009, J AM MOSQUITO CONTR, V25, P265, DOI 10.2987/08-5754.1; Hashizume M, 2006, PUBLIC HEALTH, V120, P444, DOI 10.1016/j.puhe.2005.11.007; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Kondo Hisayoshi, 2002, Prehosp Disaster Med, V17, P126; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Lee JT, 1999, ENVIRON HEALTH PERSP, V107, P633, DOI 10.2307/3434454; Li XL, 2007, T ROY SOC TROP MED H, V101, P299, DOI 10.1016/j.trstmh.2006.05.011; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373; MATHUR K K, 1992, Indian Journal of Malariology, V29, P1; McCarthy MC, 1996, J MED VIROL, V48, P141, DOI 10.1002/(SICI)1096-9071(199602)48:2&lt;141::AID-JMV4&gt;3.0.CO;2-9; Mouchet J, 1996, LANCET, V348, P1735, DOI 10.1016/S0140-6736(05)65860-6; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Pawar A. B., 2008, Journal of Vector Borne Diseases, V45, P325; RUSSAC PA, 1986, DISASTERS, V10, P112, DOI 10.1111/j.1467-7717.1986.tb00576.x; Saenz R, 1995, Prehosp Disaster Med, V10, P154; Shen Y.Z., 2006, J PATHOG BIOL, V4, P301; Sidley P, 2000, BRIT MED J, V320, P669, DOI 10.1136/bmj.320.7236.669; TELLERIA AV, 1986, DISASTERS, V10, P88, DOI 10.1111/j.1467-7717.1986.tb00574.x; Theander TG, 1998, T ROY SOC TROP MED H, V92, P589, DOI 10.1016/S0035-9203(98)90775-1; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wang S, 2011, EPIDEMIOLOGY, V22, P568, DOI 10.1097/EDE.0b013e31821d09cd; Wang SV, 2011, AM J EPIDEMIOL, V174, P118, DOI 10.1093/aje/kwr038; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WOODRUFF BA, 1990, DISASTERS, V14, P151, DOI 10.1111/j.1467-7717.1990.tb01056.x; Yang GJ, 2010, GEOSPATIAL HEALTH, V5, P11, DOI 10.4081/gh.2010.183; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337	61	22	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97520	10.1371/journal.pone.0097520	http://dx.doi.org/10.1371/journal.pone.0097520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24830808	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500074
J	Kuwahara, A; Sakai, H; Xu, YJ; Itoh, Y; Hirabayashi, Y; Gotoh, Y				Kuwahara, Atsushi; Sakai, Hiroshi; Xu, Yuanjiang; Itoh, Yasuhiro; Hirabayashi, Yusuke; Gotoh, Yukiko			Tcf3 Represses Wnt-beta-Catenin Signaling and Maintains Neural Stem Cell Population during Neocortical Development	PLOS ONE			English	Article							REGULATES NEURONAL DIFFERENTIATION; WNT/BETA-CATENIN; FATE DETERMINATION; PRECURSOR CELLS; N-MYC; TARGET; SPECIFICATION; TRANSCRIPTION; PROLIFERATION; NEUROGENESIS	During mouse neocortical development, the Wnt-beta-catenin signaling pathway plays essential roles in various phenomena including neuronal differentiation and proliferation of neural precursor cells (NPCs). Production of the appropriate number of neurons without depletion of the NPC population requires precise regulation of the balance between differentiation and maintenance of NPCs. However, the mechanism that suppresses Wnt signaling to prevent premature neuronal differentiation of NPCs is poorly understood. We now show that the HMG box transcription factor Tcf3 (also known as Tcf7l1) contributes to this mechanism. Tcf3 is highly expressed in undifferentiated NPCs in the mouse neocortex, and its expression is reduced in intermediate neuronal progenitors (INPs) committed to the neuronal fate. We found Tcf3 to be a repressor of Wnt signaling in neocortical NPCs in a reporter gene assay. Tcf3 bound to the promoter of the proneural bHLH gene Neurogenin1 (Neurog1) and repressed its expression. Consistent with this, Tcf3 repressed neuronal differentiation and increased the self-renewal activity of NPCs. We also found that Wnt signal stimulation reduces the level of Tcf3, and increases those of Tcf1 (also known as Tcf7) and Lef1, positive mediators of Wnt signaling, in NPCs. Together, these results suggest that Tcf3 antagonizes Wnt signaling in NPCs, thereby maintaining their undifferentiated state in the neocortex and that Wnt signaling promotes the transition from Tcf3-mediated repression to Tcf1/Lef1-mediated enhancement of Wnt signaling, constituting a positive feedback loop that facilitates neuronal differentiation.	[Kuwahara, Atsushi; Sakai, Hiroshi; Xu, Yuanjiang; Itoh, Yasuhiro; Hirabayashi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Signaling, Tokyo, Japan	University of Tokyo	Hirabayashi, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Signaling, Tokyo, Japan.	yhira@iam.u-tokyo.ac.jp	Kuwahara, Atsushi/ABB-5872-2021	Kuwahara, Atsushi/0000-0003-2418-7853; Ito, Yasuhiro/0000-0001-8590-9122; Hirabayashi, Yusuke/0000-0003-3950-6781	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22123003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT, by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Medina R, 2009, DEVELOPMENT, V136, P3301, DOI 10.1242/dev.041772; Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bain J, 2007, BIOCH J, V408; Cadigan KM, COLD SPRING HARB PER, V4; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Choe Y, DEV NEUROSCI; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Ferrell JE, 2002, CURRENT OPINION CELL, V14; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Gribble SL, 2009, DEVELOPMENT, V136, P781, DOI 10.1242/dev.027995; Harrison-Uy SJ, 2012, COLD SPRING HARBOR P, V4; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hovanes K, 2001, NATURE GENETICS, V28; Hovanes K, 2000, NUCL ACIDS RES, V28; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kratochwil K, 2002, GENES DEV, V16; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lange C, 2011, NEUROSCIENCE LETT, V488; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Li TWH, 2006, MOL CELLULAR BIOL, V26; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Murray JT, 2004, BIOCH J, V384; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Nguyen H, 2009, NATURE GENETICS, V41; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Solberg N, 2012, MOL CELLULAR BIOCH, V365; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theodorou E, 2009, GENE DEV, V23, P575, DOI 10.1101/gad.1772509; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Wray J, 2011, NATURE CELL BIOL, V13; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yi F, 2011, NATURE CELL BIOL, V13; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhong J, 2011, DEVELOPMENT, V138; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	70	52	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94408	10.1371/journal.pone.0094408	http://dx.doi.org/10.1371/journal.pone.0094408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832538	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500004
J	Luiz, DP; Santos, CD; Bonetti, AM; Brandeburgo, MAM				Luiz, Denis Prudencio; Santos Junior, Celio Dias; Bonetti, Ana Maria; Manfredi Brandeburgo, Malcom Antonio			Tollip or Not Tollip: What Are the Evolving Questions behind It?	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; LEGIONELLA-PNEUMOPHILA; RECOMBINANT SEQUENCES; PROTEIN; SERVER; SELECTION; MODELS; IMMUNOSENESCENCE; IDENTIFICATION; INTERLEUKIN-1	Tollip plays an important role in the interleukin-1 receptor IL-1R and Toll pathways. As a modulator of the immune pathway, it indirectly controls the amount of antimicrobial peptides. This could indicate a vital step in maintaining animal immune systems and preventing infection. Evolutionary questions are crucial to understanding the conservation and functioning of the biochemical pathways like the Tollip-mediated one. Through an analysis of 36 sequences of the Tollip protein from different animal taxa, downloaded from Kyoto Encyclopedia of Genes and Genomes (KEGG) databank, we inferred diverse evolutionary parameters, such as molecular selection and structure conservation, by analyzing residue by residue, beyond the canonical parameters to this type of study, as maximum likelihood trees. We found that Tollip presented different trends in its evolving history. In primates, the protein is becoming more unstable, just the opposite is observed in the arthropod group. The most interesting finding was the concentration of positively selected residues at amino terminal ends. Some observed topological incongruences in maximum likelihood trees of complete and curated Tollip data sets could be explained through horizontal transfers, evidenced by recombination detection. These results suggest that there is more to be researched and understood about this protein.	[Luiz, Denis Prudencio; Santos Junior, Celio Dias; Bonetti, Ana Maria; Manfredi Brandeburgo, Malcom Antonio] Univ Fed Uberlandia, Genet Lab, Genet & Biochem Inst, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Luiz, DP (corresponding author), Univ Fed Uberlandia, Genet Lab, Genet & Biochem Inst, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	prudenis@yahoo.com.br	Santos-Júnior, Célio D./F-5580-2013; Bonetti, Ana/V-3811-2019	Santos-Júnior, Célio D./0000-0002-1974-1736; 	funding agency: CAPES; funding agency: CNPq; funding agency: FAPEMIG; funding agency: FAU/UFU	funding agency: CAPES; funding agency: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); funding agency: FAPEMIG; funding agency: FAU/UFU	This work was supported by the following funding agencies: CAPES, CNPq, FAPEMIG, FAU/UFU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Azurmendi HF, 2010, MOL CELLS, V30, P581, DOI 10.1007/s10059-010-0145-5; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Coscolla M, 2006, ENVIRON MICROBIOL, V8, P1056, DOI 10.1111/j.1462-2920.2006.00997.x; Costa J, 2010, ENVIRON MICROBIOL, V12, P2711, DOI 10.1111/j.1462-2920.2010.02240.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Galperin MY, 2012, NUCLEIC ACIDS RES, V40, pD1, DOI 10.1093/nar/gkr1196; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ishihara S, 2009, J GASTROENTEROL, V44, P1097, DOI 10.1007/s00535-009-0141-8; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kimura MA, 1985, NEUTRAL THEORY MOL E; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Maddison DR, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1668.1.4; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mount D, 2002, BIOINFORMATICS SEQUE, P480; Muller L, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-12; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Schimming TT, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-3; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; SMITH JM, 1992, J MOL EVOL, V34, P126; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; Wren JD, 2008, BIOINFORMATICS, V24, P2127, DOI 10.1093/bioinformatics/btn464; Yang Z, 2007, HDB STAT GENETICS, P381; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZUCKERKANDL EMILE, 1965, P97	70	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97219	10.1371/journal.pone.0097219	http://dx.doi.org/10.1371/journal.pone.0097219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828816	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400064
J	Putz, K; Trathan, PN; Pedrana, J; Collins, MA; Poncet, S; Luthi, B				Puetz, Klemens; Trathan, Phil N.; Pedrana, Julieta; Collins, Martin A.; Poncet, Sally; Luethi, Benno			Post-Fledging Dispersal of King Penguins (Aptenodytes patagonicus) from Two Breeding Sites in the South Atlantic	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; WINTER MIGRATION; FALKLAND ISLANDS; FORAGING AREAS; SPHENISCUS-MAGELLANICUS; EUDYPTES-CHRYSOCOME; SATELLITE TRACKING; MACQUARIE ISLAND; DIVING BEHAVIOR; HABITAT	Most studies concerning the foraging ecology of marine vertebrates are limited to breeding adults, although other life history stages might comprise half the total population. For penguins, little is known about juvenile dispersal, a period when individuals may be susceptible to increased mortality given their naive foraging behaviour. Therefore, we used satellite telemetry to study king penguin fledglings (n = 18) from two sites in the Southwest Atlantic in December 2007. The two sites differed with respect to climate and proximity to the Antarctic Polar Front (APF), a key oceanographic feature generally thought to be important for king penguin foraging success. Accordingly, birds from both sites foraged predominantly in the vicinity of the APF. Eight king penguins were tracked for periods greater than 120 days; seven of these (three from the Falkland Islands and four from South Georgia) migrated into the Pacific. Only one bird from the Falkland Islands moved into the Indian Ocean, visiting the northern limit of the winter pack-ice. Three others from the Falkland Islands migrated to the eastern coast of Tierra del Fuego before travelling south. Derived tracking parameters describing their migratory behaviour showed no significant differences between sites. Nevertheless, generalized linear habitat modelling revealed that juveniles from the Falkland Islands spent more time in comparatively shallow waters with low sea surface temperature, sea surface height and chlorophyll variability. Birds from South Georgia spent more time in deeper waters with low sea surface temperature and sea surface height, but high concentrations of chlorophyll. Our results indicate that inexperienced king penguins, irrespective of the location of their natal site in relation to the position of the APF, develop their foraging skills progressively over time, including specific adaptations to the environment around their prospective breeding site.	[Puetz, Klemens] Antarctic Res Trust, Bremervorde, Germany; [Trathan, Phil N.; Collins, Martin A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Pedrana, Julieta] CONICET INTA, Balcarce, Argentina; [Luethi, Benno] Antarctic Res Trust Switzerland, Forch, Switzerland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Putz, K (corresponding author), Antarctic Res Trust, Bremervorde, Germany.	puetz@antarctic-research.de	Collins, Martin A/J-8560-2017; , Martin/ABE-6728-2020	Puetz, Klemens/0000-0003-1375-2669; pedrana, julieta/0000-0002-0908-7865	Britta Labhard Co.; Charlotte Fritz Lehmann; Zoo Zurich; Vontobel-Stiftung; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Britta Labhard Co.; Charlotte Fritz Lehmann; Zoo Zurich; Vontobel-Stiftung; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Antarctic Research Trust is grateful to all who have contributed to this project, in particular the following sponsors of individual penguins: Roland Amstutz, Lesley Baxter, Ruth & Walter Egli, Katharina Heckers, Rita & Guido Heule, Ursula & Urs Hurlimann, Britta Labhard & Co., Charlotte & Fritz Lehmann, Hans-Ulrich Schneebeli, Marcel Schonenberger, Dagmar Schultz, Ulrike Stimmel, Barbel Strehmel, Vontobel-Stiftung, Sylke Wicker, Elisabeth Zellweger and Zoo Zurich. The authors wish to acknowledge use of the Maptool program, a product of SEATURTLE.ORG, for analysis and graphics in this article (information is available at www.seaturtle.org). The editor and the reviewers provided highly valuable comments that have been essential for improving the text, tables and figures.	Ainley D.G., 1991, Journal of Marine Systems, V2, P111, DOI 10.1016/0924-7963(91)90017-O; Alderman R, 2010, MAR ECOL PROG SER, V405, P271, DOI 10.3354/meps08590; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Amo L, 2013, MAR ECOL PROG SER, V474, P277, DOI 10.3354/meps10081; BANNASCH R, 1994, J EXP BIOL, V194, P83; Bannasch R, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P141; Berthold P, 1996, CONTROL BIRD MIGRATI; BirdLife International, 2004, GLOB PROC TRACK WORK; Biuw M, 2010, ANTARCT SCI, V22, P157, DOI 10.1017/S0954102009990605; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boersma PD, 2002, AQUAT CONSERV, V12, P63, DOI 10.1002/aqc.477; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; Bost CA, 2004, MAR ECOL PROG SER, V283, P293, DOI 10.3354/meps283293; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Bost CA, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P7; Burger J, 1980, BEHAV MARINE BIRDS; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; Cherel Y, 2002, POLAR BIOL, V25, P898, DOI 10.1007/s00300-002-0419-2; CHEREL Y, 1993, POLAR BIOL, V13, P355; Chiaradia Andre, 2005, Polar Bioscience, V18, P46; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; *CLS SERV ARG, 1996, US MAN; Clutton-Brock T. H., 1988, REPROD SUCCESS; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; DRENT RH, 1980, ARDEA, V68, P225; Eastman J. R., 2009, IDRISI TAIGA; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Harrell FE, 2001, REGRESSION MODELING; Huin N, 2008, FALKLAND ISLAND SEAB; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Juares MA, 2013, ANTARCT SCI; KNOX GA, 1994, BIOL SO OCEAN; Kooyman GL, 2007, AQUAT CONSERV, V17, pS37, DOI 10.1002/aqc.930; Kooyman GL, 1996, NATURE, V383, P397, DOI 10.1038/383397a0; LANCRAFT TM, 1991, POLAR BIOL, V11, P157; Le Vaillant M, 2012, J EXP BIOL, V215, P3685, DOI 10.1242/jeb.071175; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maslennikov V.V., 1993, Antarktika, V32, P86; McCullagh P, 1989, GEN LINEAR MODELS; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Moore GJ, 1999, POLAR BIOL, V21, P376, DOI 10.1007/s003000050376; Murtaugh PA, 1996, ECOL APPL, V6, P132, DOI 10.2307/2269559; Olsson O, 1997, POLAR BIOL, V18, P161, DOI 10.1007/s003000050172; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PETERSON RG, 1989, J GEOPHYS RES-OCEANS, V94, P10817, DOI 10.1029/JC094iC08p10817; Petry MV, 2013, POLAR BIOL, V36, P603, DOI 10.1007/s00300-012-1277-1; Piatkowski U, 2001, FISH RES, V52, P79, DOI 10.1016/S0165-7836(01)00232-6; Pistorius PA, 2012, ANTARCT SCI, V24, P435, DOI 10.1017/S0954102012000302; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2000, IBIS, V142, P614, DOI 10.1111/j.1474-919X.2000.tb04461.x; Putz K, 2005, MAR BIOL, V147, P281, DOI 10.1007/s00227-005-1577-x; Putz K, 1998, ECOLOGY, V79, P1905, DOI 10.2307/176698; Putz K, 2003, J AVIAN BIOL, V34, P139, DOI 10.1034/j.1600-048X.2003.03100.x; Putz K, 2002, AQUAT CONSERV, V12, P75, DOI 10.1002/aqc.478; Putz K, 2002, MAR ECOL PROG SER, V240, P273, DOI 10.3354/meps240273; Putz K., 1999, Marine Ornithology, V27, P77; Putz K, 2002, CONDOR, V104, P528, DOI 10.1650/0010-5422(2002)104[0528:SATVIT]2.0.CO;2; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; R Core Team, 2022, R LANG ENV STAT COMP; Riotte-Lambert L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1434; Rodhouse PG, 1998, MAR ECOL PROG SER, V168, P13, DOI 10.3354/meps168013; Sakamoto Y., 1986, AKAIKE INFORM CRITER; SANDERS S, 2006, IMPORTANT BIRD AREAS; Scheffer A, 2010, MAR ECOL PROG SER, V465, P281; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Shillinger GL, 2012, MAR ECOL PROG SER, V457, P165, DOI 10.3354/meps09816; Thiebot JB, 2014, ENDANGER SPECIES RES, V23, P263, DOI 10.3354/esr00564; Thiebot JB, 2013, ANTARCT SCI, V25, P536, DOI 10.1017/S0954102012001198; Thiebot JB, 2011, ANTARCT SCI, V23, P117, DOI 10.1017/S0954102010000957; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; Trebilco R, 2008, BIOL CONSERV, V141, P2942, DOI 10.1016/j.biocon.2008.07.027; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2005, J ANIM ECOL, V74, P285, DOI 10.1111/j.1365-2656.2005.00922.x; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wienecke B, 2006, POLAR BIOL, V29, P424, DOI 10.1007/s00300-005-0074-5; Wienecke B, 2010, MAR ECOL PROG SER, V410, P269, DOI 10.3354/meps08629; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; Williams T.D., 1995, PENGUINS; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	88	18	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97164	10.1371/journal.pone.0097164	http://dx.doi.org/10.1371/journal.pone.0097164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828545	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400062
J	Rehn, M; Carnahan, A; Merk, H; Kuhlmann-Berenzon, S; Galanis, I; Linde, A; Nyren, O				Rehn, Moa; Carnahan, AnnaSara; Merk, Hanna; Kuhlmann-Berenzon, Sharon; Galanis, Ilias; Linde, Annika; Nyren, Olof			Evaluation of an Internet-Based Monitoring System for Influenza-Like Illness in Sweden	PLOS ONE			English	Article							GENERAL-POPULATION; SURVEILLANCE; NETHERLANDS; EXPERIENCE	To complement traditional influenza surveillance with data on disease occurrence not only among care-seeking individuals, the Swedish Institute for Communicable Disease Control (SMI) has tested an Internet-based monitoring system (IMS) with self-recruited volunteers submitting weekly on-line reports about their health in the preceding week, upon weekly reminders. We evaluated IMS acceptability and to which extent participants represented the Swedish population. We also studied the agreement of data on influenza-like illness (ILI) occurrence from IMS with data from a previously evaluated population-based system (PBS) with an actively recruited random sample of the population who spontaneously report disease onsets in real-time via telephone/Internet, and with traditional general practitioner based sentinel and virological influenza surveillance, in the 2011-2012 and 2012-2013 influenza seasons. We assessed acceptability by calculating the participation proportion in an invited IMS-sample and the weekly reporting proportion of enrolled self-recruited IMS participants. We compared distributions of socio-demographic indicators of self-recruited IMS participants to the general Swedish population using chi-square tests. Finally, we assessed the agreement of weekly incidence proportions (%) of ILI in IMS and PBS with cross-correlation analyses. Among 2,511 invited persons, 166 (6.6%) agreed to participate in the IMS. In each season, 2,552 and 2,486 self-recruited persons participated in the IMS respectively. The weekly reporting proportion among self-recruited participants decreased from 87% to 23% (2011-2012) and 82% to 45% (2012-2013). Women, highly educated, and middle-aged persons were overrepresented among self-recruited IMS participants (p, 0.01). IMS (invited and self-recruited) and PBS weekly incidence proportions correlated strongest when no lags were applied (r = 0.71 and r = 0.69, p, 0.05). This evaluation revealed socio-demographic misrepresentation and limited compliance among the self-recruited IMS participants. Yet, IMS offered a reasonable representation of the temporal ILI pattern in the community overall during the 2011-2012 and 2012-2013 influenza seasons and could be a simple tool for collecting community-based ILI data.	[Rehn, Moa; Carnahan, AnnaSara; Merk, Hanna; Kuhlmann-Berenzon, Sharon; Galanis, Ilias; Linde, Annika] Publ Hlth Agcy Sweden, Solna, Sweden; [Rehn, Moa] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Merk, Hanna; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control; Karolinska Institutet	Rehn, M (corresponding author), Publ Hlth Agcy Sweden, Solna, Sweden.	moa.rehn@folkhalsomyndigheten.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196	European Commission Seventh Framework Programme [EPIWORK 231807]; Swedish Institute for Communicable Disease Control; European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control (ECDC); Swedish Institute for Communicable Disease Control (SMI)	European Commission Seventh Framework Programme(European Commission); Swedish Institute for Communicable Disease Control; European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control (ECDC); Swedish Institute for Communicable Disease Control (SMI)	This study was supported by the European Commission Seventh Framework Programme (grant number EPIWORK 231807) (http://cordis. europa.eu/fp7/home_en.html) and the Swedish Institute for Communicable Disease Control (http://smi.se/). The first author is a fellow of the European Programme for Intervention Epidemiology Training (EPIET). The fellowship is funded by the European Centre for Disease Prevention and Control (ECDC) and the Swedish Institute for Communicable Disease Control (SMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010; Bethlehem J., 2009, APPL SURVEY METHODS; Bexelius C, 2010, EUR J EPIDEMIOL, V25, P693, DOI 10.1007/s10654-010-9484-y; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Carstensen B, 2010, COMP CLIN MEASUREMEN; Chatfield C., 2004, ANAL TIME SERIES INT; European Center for Disease control (ECDC), 2013, EISN INFL SURV; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; German R R, 2001, MMWR Recomm Rep, V50, P1; German RR, 2001, MMWR RECOMM REP, V50, pCE31; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; Merk H, 2013, THESIS KAROLINSKA I; Merk H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061644; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Porta M, 2008, DICT EPIDEMIOLOGY; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Statistic Sweden (SCB), 2013, UND LEVN DAT INT AND; Swedish Institute for Communicable Disease Control (SMI), 2013, INFL SWED SEAS 2011; Swedish Institute for Communicable Disease Control (SMI), 2013, INFL SWED SEAS 2012; Swedish Institute for Communicable Disease Control (SMI), 2013, WEEKL REP LAB CONF R; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; van Noort S P, 2007, Euro Surveill, V12, pE5; Vandendijck Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064156	24	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96740	10.1371/journal.pone.0096740	http://dx.doi.org/10.1371/journal.pone.0096740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824806	gold, Green Published, Green Submitted			2022-12-25	WOS:000336369200029
J	Wagner, D; Newbury, S; Kass, P; Hurley, K				Wagner, Denae; Newbury, Sandra; Kass, Philip; Hurley, Kate			Elimination Behavior of Shelter Dogs Housed in Double Compartment Kennels	PLOS ONE			English	Article							ANIMAL SHELTERS; CATS; ADOPTION; STRESS	For animals in confinement housing the housing structure has tremendous potential to impact well being. Dogs in animal shelters are often housed in one of two types of confinement housing - single kennels and rooms or double compartment kennels and rooms most often separated by a guillotine door. This study examines the effect of housing on the location of elimination behavior in dogs housed in double compartment kennels were the majority of the dogs were walked daily. One side of the kennel contained the food, water and bed and the other side was empty and available except during cleaning time. Location of urination and defecation was observed daily for 579 dogs housed in indoor double compartment kennels for a total of 4440 days of observation. There were 1856 days (41.9%) when no elimination was noted in the kennel. Feces, urine or both were observed in the kennel on 2584 days (58.1%). When elimination occurred in the kennel the probability of fecal elimination on the opposite side of the bed/food/water was 72.5% (95% CI 69.05% to 75.69%). The probability of urination on the opposite side of the bed/food/water was 77.4% (95% CI 74.33% to 80.07%). This study demonstrates the strong preference of dogs to eliminate away from the area where they eat, drink and sleep. Double compartment housing not only allows this - it allows staff the ability to provide safe, efficient, humane daily care and confers the added benefits of reducing risks for disease transmission for the individual dog as well as the population.	[Wagner, Denae; Newbury, Sandra; Hurley, Kate] Univ Calif Davis, Sch Vet Med, Koret Shelter Med Program, Davis, CA 95616 USA; [Kass, Philip] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wagner, D (corresponding author), Univ Calif Davis, Sch Vet Med, Koret Shelter Med Program, Davis, CA 95616 USA.	dcwagner@ucdavis.edu			Koret Foundation; Koret Shelter Medicine Program	Koret Foundation; Koret Shelter Medicine Program	The research was done through the Koret Shelter Medicine Program, which receives funding through the Koret Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisko JJ, 1976, COMMUNICATION CHEM S, P283; Baege B, 1933, HUNDEFORSCH, VI, P3; Fantuzzi JM, 2010, J APPL ANIM WELF SCI, V13, P174, DOI 10.1080/10888700903583467; GOURKOW N, 2001, THESIS U BRIT COLUMB; HART BL, 1992, J PARASITOL, V78, P256, DOI 10.2307/3283472; Hediger H, 1944, PSYCHOL, VIII, P170; Kessler MR, 1999, ANIM WELFARE, V8, P15; Kry K, 2007, ANIM WELFARE, V16, P375; Lord LK, 2008, JAVMA-J AM VET MED A, V233, P1715, DOI 10.2460/javma.233.11.1715; Menzel RM, 1937, WELPE UMWELT; Newbury S, 2010, GUIDELINES STANDARDS; Ottway DS, 2003, ANIM WELFARE, V12, P173; Ross S., 1948, BEHAVIOUR, V2, P144; Salman M. D., 2000, Journal of Applied Animal Welfare Science, V3, P93, DOI 10.1207/S15327604JAWS0302_2; Uexkull JVaS E G., 1931, Z HUNDEFORSCHUNG, VI, P55; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wirant SC, 2004, APPL ANIM BEHAV SCI, V85, P335, DOI 10.1016/j.applanim.2003.09.012	17	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96254	10.1371/journal.pone.0096254	http://dx.doi.org/10.1371/journal.pone.0096254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825357	gold, Green Published			2022-12-25	WOS:000336369200012
J	Desai, AJ; Harikumar, KG; Miller, LJ				Desai, Aditya J.; Harikumar, Kaleeckal G.; Miller, Laurence J.			A Type 1 Cholecystokinin Receptor Mutant That Mimics the Dysfunction Observed for Wild Type Receptor in a High Cholesterol Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SELECTIVE CCK1R AGONISTS; CONSERVED DRY MOTIF; HAMSTER OVARY CELLS; MEMBRANE CHOLESTEROL; MOLECULAR-BASIS; IMIDAZOLE CARBOXAMIDES; HUMAN GALLBLADDERS; II-RECEPTOR; A RECEPTORS	Cholecystokinin (CCK) stimulates the type 1 CCK receptor (CCK1R) to elicit satiety after a meal. Agonists with this activity, although potentially useful for treatment of obesity, can also have side effects and toxicities of concern, making the development of an intrinsically inactive positive allosteric modulator quite attractive. Positive allosteric modulators also have the potential to correct the defective receptor-G protein coupling observed in the high membrane cholesterol environment described in metabolic syndrome. Current model systems to study CCK1R in such an environment are unstable and expensive to maintain. We now report that the Y140A mutation within a cholesterol-binding motif and the conserved, class A G protein-coupled receptor-specific (E/D) RY signature sequence results in ligand binding and activity characteristics similar to wild type CCK1R in a high cholesterol environment. This is true for natural CCK, as well as ligands with distinct chemistries and activity profiles. Additionally, the Y140A construct also behaved like CCK1R in high cholesterol in regard to its internalization, sensitivity to a nonhydrolyzable GTP analog, and anisotropy of a bound fluorescent CCK analog. Chimeric CCK1R/CCK2R constructs that systematically changed the residues in the allosteric ligand-binding pocket were studied in the presence of Y140A. This established increased importance of unique residues within TM3 and reduced the importance of TM2 for binding in the presence of this mutation, with the agonist trigger likely pulled away from its Leu(356) target on TM7. The distinct conformation of this intramembranous pocket within Y140A CCK1R provides an opportunity to normalize this by using a small molecule allosteric ligand, thereby providing safe and effective correction of the coupling defect in metabolic syndrome.	[Desai, Aditya J.; Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Miller, LJ (corresponding author), Mayo Clin, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu			National Institutes of Health [DK032878]; Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032878, R01DK032878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK032878. This work was also supported by the Mayo Clinic.	Akgun E, 2009, J MED CHEM, V52, P2138, DOI 10.1021/jm801439x; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Beglinger C, 2001, AM J PHYSIOL-REG I, V280, pR1149, DOI 10.1152/ajpregu.2001.280.4.R1149; BEHAR J, 1989, GASTROENTEROLOGY, V97, P1479, DOI 10.1016/0016-5085(89)90392-2; Berger R, 2008, BIOORG MED CHEM LETT, V18, P4833, DOI 10.1016/j.bmcl.2008.07.083; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cawston EE, 2012, J BIOL CHEM, V287, P18618, DOI 10.1074/jbc.M111.335646; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chen Q, 1997, GASTROENTEROLOGY, V113, P930, DOI 10.1016/S0016-5085(97)70189-6; Chen Q, 1999, GASTROENTEROLOGY, V116, P678, DOI 10.1016/S0016-5085(99)70190-3; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Desai Aditya J, 2012, Front Endocrinol (Lausanne), V3, P123, DOI 10.3389/fendo.2012.00123; Dong MQ, 2005, BIOCHEMISTRY-US, V44, P6693, DOI 10.1021/bi050130q; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harikumar KG, 2006, J BIOL CHEM, V281, P27072, DOI 10.1074/jbc.M605098200; Harikumar KG, 2013, J BIOL CHEM, V288, P21082, DOI 10.1074/jbc.M113.480715; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; Harikumar KG, 2005, J BIOL CHEM, V280, P1044, DOI 10.1074/jbc.M409480200; HOSHI H, 1993, AM J PHYSIOL, V265, pG1177, DOI 10.1152/ajpgi.1993.265.6.G1177; Jordan J, 2008, CLIN PHARMACOL THER, V83, P281, DOI 10.1038/sj.clpt.6100272; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; KISSILEFF HR, 1981, AM J CLIN NUTR, V34, P154, DOI 10.1093/ajcn/34.2.154; KOPIN AS, 1995, J BIOL CHEM, V270, P5019, DOI 10.1074/jbc.270.10.5019; KOPIN AS, 1994, ANN NY ACAD SCI, V713, P67, DOI 10.1111/j.1749-6632.1994.tb44053.x; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; LIN CW, 1991, MOL PHARMACOL, V39, P346; Miller LJ, 2002, PHARMACOL TOXICOL, V91, P282, DOI 10.1034/j.1600-0773.2002.910603.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pang L, 1999, BIOCHEMISTRY-US, V38, P12003, DOI 10.1021/bi990227a; Potter RM, 2012, J LIPID RES, V53, P137, DOI 10.1194/jlr.M020065; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; REHFELD JF, 1978, J BIOL CHEM, V253, P4022; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Seres I, 2006, J MEMBRANE BIOL, V214, P91, DOI 10.1007/s00232-006-0020-7; Sherrill RG, 2001, BIOORG MED CHEM LETT, V11, P1145, DOI 10.1016/S0960-894X(01)00164-0; SMITH GP, 1985, ANN NY ACAD SCI, V448, P417, DOI 10.1111/j.1749-6632.1985.tb29936.x; Smith JP, 2014, AM J PHYSIOL-GASTR L, V306, pG91, DOI 10.1152/ajpgi.00301.2013; Xiao ZL, 2000, AM J PHYSIOL-GASTR L, V278, pG251, DOI 10.1152/ajpgi.2000.278.2.G251; Xiao ZL, 1999, AM J PHYSIOL-GASTR L, V276, pG1401, DOI 10.1152/ajpgi.1999.276.6.G1401; YU PR, 1995, AM J PHYSIOL-GASTR L, V269, pG659, DOI 10.1152/ajpgi.1995.269.5.G659; Yu PR, 1996, AM J PHYSIOL-GASTR L, V271, pG56, DOI 10.1152/ajpgi.1996.271.1.G56; Zhu C, 2008, BIOORG MED CHEM LETT, V18, P4393, DOI 10.1016/j.bmcl.2008.06.057; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	54	18	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18314	18326		10.1074/jbc.M114.570200	http://dx.doi.org/10.1074/jbc.M114.570200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24825903	Green Published, hybrid			2022-12-25	WOS:000338042000031
J	Mullin, BH; Mamotte, C; Prince, RL; Wilson, SG				Mullin, Benjamin H.; Mamotte, Cyril; Prince, Richard L.; Wilson, Scott G.			Influence of ARHGEF3 and RHOA Knockdown on ACTA2 and Other Genes in Osteoblasts and Osteoclasts	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CELL-LINES; SUGGESTIVE LINKAGE; PROMOTER ACTIVITY; MASS; OSTEOPOROSIS; WOMEN; ACTIN; TWIN; DIFFERENTIATION	Osteoporosis is a common bone disease that has a strong genetic component. Genome-wide linkage studies have identified the chromosomal region 3p14-p22 as a quantitative trait locus for bone mineral density (BMD). We have previously identified associations between variation in two related genes located in 3p14-p22, ARHGEF3 and RHOA, and BMD in women. In this study we performed knockdown of these genes using small interfering RNA (siRNA) in human osteoblast-like and osteoclast-like cells in culture, with subsequent microarray analysis to identify genes differentially regulated from a list of 264 candidate genes. Validation of selected findings was then carried out in additional human cell lines/cultures using quantitative real-time PCR (qRT-PCR). The qRT-PCR results showed significant down-regulation of the ACTA2 gene, encoding the cytoskeletal protein alpha 2 actin, in response to RHOA knockdown in both osteoblast-like (P<0.001) and osteoclast-like cells (P = 0.002). RHOA knockdown also caused up-regulation of the PTH1R gene, encoding the parathyroid hormone 1 receptor, in Saos-2 osteoblast-like cells (P<0.001). Other findings included down-regulation of the TNFRSF11B gene, encoding osteoprotegerin, in response to ARHGEF3 knockdown in the Saos-2 and hFOB 1.19 osteoblast-like cells (P = 0.003-0.02), and down-regulation of ARHGDIA, encoding the Rho GDP dissociation inhibitor alpha, in response to RHOA knockdown in osteoclast-like cells (P<0.001). These studies identify ARHGEF3 and RHOA as potential regulators of a number of genes in bone cells, including TNFRSF11B, ARHGDIA, PTH1R and ACTA2, with influences on the latter evident in both osteoblast-like and osteoclast-like cells. This adds further evidence to previous studies suggesting a role for the ARHGEF3 and RHOA genes in bone metabolism.	[Mullin, Benjamin H.; Prince, Richard L.; Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Mullin, Benjamin H.; Mamotte, Cyril] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA, Australia; [Mullin, Benjamin H.; Mamotte, Cyril] Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Bentley, WA, Australia; [Mullin, Benjamin H.; Prince, Richard L.; Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Wilson, Scott G.] Kings Coll London, Twin & Genet Epidemiol Res Unit, London, England	University of Western Australia; Curtin University; Curtin University; University of Western Australia; University of London; King's College London	Mullin, BH (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia.	Benjamin.Mullin@uwa.edu.au	Mamotte, Cyril/AAF-9603-2020; Mullin, Benjamin/H-5493-2014	Mullin, Benjamin/0000-0003-0743-770X; Wilson, Scott/0000-0002-0357-1373; Mamotte, Cyril/0000-0003-1831-3921	Arthritis Australia [0402067]; Curtin University	Arthritis Australia; Curtin University	This study was supported by Arthritis Australia (Grant 0402067) and Curtin University Postgraduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2005, J BONE MINER RES, V20, P67, DOI 10.1359/JBMR.041015; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilbe G, 1996, BONE, V19, P437, DOI 10.1016/S8756-3282(96)00254-2; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Deng HW, 2000, J BONE MINER RES, V15, P1243, DOI 10.1359/jbmr.2000.15.7.1243; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; EVANS RA, 1988, ANN INTERN MED, V109, P870, DOI 10.7326/0003-4819-109-11-870; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; FLICKER L, 1995, J BONE MINER RES, V10, P1607; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Illumina, 2007, ILL TECHN B PUB; Illumina, 2008, ILL TECHN B PUB; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Lee YH, 2006, J HUM GENET, V51, P480, DOI 10.1007/s10038-006-0390-9; LOWIK CWGM, 1989, BIOCHEM BIOPH RES CO, V162, P1546, DOI 10.1016/0006-291X(89)90851-6; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Mullin BH, 2008, AM J HUM GENET, V82, P1262, DOI 10.1016/j.ajhg.2008.04.016; Mullin BH, 2009, BONE, V45, P387, DOI 10.1016/j.bone.2009.04.254; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pautke C, 2004, ANTICANCER RES, V24, P3743; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Prince RL, 1997, OSTEOPOROSIS INT, V7, P150, DOI 10.1007/BF03194362; Radeff JM, 2004, J BONE MINER RES, V19, P1882, DOI 10.1359/JBMR.040806; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Wang J, 2010, J CELL BIOCH; Wilkins TD, 1996, TRENDS MICROBIOL, V4, P49, DOI 10.1016/0966-842X(96)81508-3; Wilson SG, 2003, AM J HUM GENET, V72, P144, DOI 10.1086/345819; Wynne F, 2003, CALCIFIED TISSUE INT, V72, P651, DOI 10.1007/s00223-002-2086-2; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	46	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98116	10.1371/journal.pone.0098116	http://dx.doi.org/10.1371/journal.pone.0098116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840563	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600108
J	Wang, YJ; Koster, K; Lummer, M; Ragg, H				Wang, Yunjie; Koester, Katharina; Lummer, Martina; Ragg, Hermann			Origin of Serpin-Mediated Regulation of Coagulation and Blood Pressure	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; SERINE-PROTEASE INHIBITOR; ANGIOTENSIN-II; THROMBIN; EVOLUTION; RECEPTOR; ACTIVATION; ROLES; LAMPREY; SYSTEM	Vertebrates evolved an endothelium-lined hemostatic system and a pump-driven pressurized circulation with a finely-balanced coagulation cascade and elaborate blood pressure control over the past 500 million years. Genome analyses have identified principal components of the ancestral coagulation system, however, how this complex trait was originally regulated is largely unknown. Likewise, little is known about the roots of blood pressure control in vertebrates. Here we studied three members of the serpin superfamily that interfere with procoagulant activity and blood pressure of lampreys, a group of basal vertebrates. Angiotensinogen from these jawless fish was found to fulfill a dual role by operating as a highly selective thrombin inhibitor that is activated by heparin-related glycosaminoglycans, and concurrently by serving as source of effector peptides that activate type 1 angiotensin receptors. Lampreys, uniquely among vertebrates, thus use angiotensinogen for interference with both coagulation and osmo- and pressure regulation. Heparin cofactor II from lampreys, in contrast to its paralogue angiotensinogen, is preferentially activated by dermatan sulfate, suggesting that these two serpins affect different facets of thrombin's multiple roles. Lampreys also express a lineage-specific serpin with anti-factor Xa activity, which demonstrates that another important procoagulant enzyme is under inhibitory control. Comparative genomics suggests that orthologues of these three serpins were key components of the ancestral hemostatic system. It appears that, early in vertebrate evolution, coagulation and osmo-and pressure regulation crosstalked through antiproteolytically active angiotensinogen, a feature that was lost during vertebrate radiation, though in gnathostomes interplay between these traits is effective.	[Wang, Yunjie; Koester, Katharina; Ragg, Hermann] Univ Bielefeld, Fac Technol, D-33615 Bielefeld, Germany; [Lummer, Martina] Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Ragg, H (corresponding author), Univ Bielefeld, Fac Technol, D-33615 Bielefeld, Germany.	hermann.ragg@uni-bielefeld.de			Bielefeld University	Bielefeld University	This work was supported by Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bentele C, 2006, BIOCHEM J, V395, P449, DOI 10.1042/BJ20051947; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Brinkmeyer S, 2004, EUR J BIOCHEM, V271, P4275, DOI 10.1111/j.1432-1033.2004.04367.x; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; Doolittle RF, 2013, EVOLUTION VERTEBRATE, P142; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Evans AN, 2010, COMP BIOCHEM PHYS B, V157, P423, DOI 10.1016/j.cbpb.2010.09.006; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Han X, 2000, BLOOD, V96, P3049; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Huang PH, 2007, INT J CARDIOL, V114, P152, DOI 10.1016/j.ijcard.2005.12.009; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Ikeda Y, 2012, J BIOL CHEM, V287, P34256, DOI 10.1074/jbc.M112.353532; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; Oley M, 2004, FEBS LETT, V577, P165, DOI 10.1016/j.febslet.2004.10.003; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Ponczek MB, 2012, J MOL EVOL, V74, P319, DOI 10.1007/s00239-012-9509-0; Pulakat L, 2004, BIOCHEM BIOPH RES CO, V319, P1138, DOI 10.1016/j.bbrc.2004.05.092; RAGG H, 1990, J BIOL CHEM, V265, P5211; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Salzet M, 2001, BRAIN RES REV, V36, P35, DOI 10.1016/S0165-0173(01)00063-7; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Siller-Matula JM, 2011, THROMB HAEMOSTASIS, V106, P1020, DOI 10.1160/TH10-11-0711; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; Wei MC, 2010, ANAL CHEM, V82, P6303, DOI 10.1021/ac100797t; Wong MKS, 2011, J ENDOCRINOL, V209, P127, DOI 10.1530/JOE-10-0422; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97879	10.1371/journal.pone.0097879	http://dx.doi.org/10.1371/journal.pone.0097879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840053	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600085
J	Dumont, AO; Goursaud, S; Desmet, N; Hermans, E				Dumont, Amelie O.; Goursaud, Stephanie; Desmet, Nathalie; Hermans, Emmanuel			Differential Regulation of Glutamate Transporter Subtypes by Pro-Inflammatory Cytokine TNF-alpha in Cortical Astrocytes from a Rat Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NEUROLOGICAL DISORDERS; DISEASE PROGRESSION; FAMILIAL ALS; EXPRESSION; BRAIN; GLAST; EAAT2; TRANSCRIPTION	Dysregulation of the astroglial glutamate transporters GLAST and GLT-1 has been implicated in several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) where a loss of GLT-1 protein expression and activity is reported. Furthermore, the two principal C-terminal splice variants of GLT-1 (namely GLT-1a and GLT-1b) show altered expression ratio in animal models of this disease. Considering the putative link between inflammation and excitotoxicity, we have here characterized the influence of TNF-alpha on glutamate transporters in cerebral cortical astrocyte cultures from wild-type rats and from a rat model of ALS (hSOD1(G93A)). Contrasting with the down-regulation of GLAST, a 72 h treatment with TNF-alpha substantially increased the expression of GLT-1a and GLT-1b in both astrocyte cultures. However, as the basal level of GLT-1a appeared considerably lower in hSOD1(G93A) astrocytes, its up-regulation by TNF-alpha was insufficient to recapitulate the expression observed in wild-type astrocytes. Also the glutamate uptake activity after TNF-alpha treatment was lower for hSOD1(G93A) astrocytes as compared to wild-type astrocytes. In the presence of the protein synthesis inhibitor cycloheximide, TNF-alpha did not influence GLT-1 isoform expression, suggesting an active role of dynamically regulated protein partners in the adaptation of astrocytes to the inflammatory environment. Confirming the influence of inflammation on the control of glutamate transmission by astrocytes, these results shed light on the regulation of glutamate transporter isoforms in neurodegenerative disorders.	[Dumont, Amelie O.; Goursaud, Stephanie; Desmet, Nathalie; Hermans, Emmanuel] Catholic Univ Louvain, Inst Neurosci, Grp Neuropharmacol, B-1200 Brussels, Belgium	Universite Catholique Louvain	Hermans, E (corresponding author), Catholic Univ Louvain, Inst Neurosci, Grp Neuropharmacol, B-1200 Brussels, Belgium.	emmanuel.hermans@uclouvain.be	Hermans, Emmanuel/A-1654-2015; Hermans, Emmanuel/V-3040-2019		DIANE research program of the Belgian Walloon Region Ministry (DGTRE); Association belge pour les maladies neuromusculaires (ABMM); Ministry of Scientific Policy (Belgium) [ARC 10/15-026]	DIANE research program of the Belgian Walloon Region Ministry (DGTRE); Association belge pour les maladies neuromusculaires (ABMM); Ministry of Scientific Policy (Belgium)	This work was supported by the DIANE research program of the Belgian Walloon Region Ministry (DGTRE), by the Association belge pour les maladies neuromusculaires (ABMM) and by a grant of Ministry of Scientific Policy (Belgium, ARC 10/15-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Aoki M, 2005, NEUROPATHOLOGY, V25, P365, DOI 10.1111/j.1440-1789.2005.00611.x; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Berger JV, 2012, NEUROSCIENCE, V205, P29, DOI 10.1016/j.neuroscience.2011.12.044; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Cereda C, 2008, J NEUROIMMUNOL, V194, P123, DOI 10.1016/j.jneuroim.2007.10.028; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dumont AO, 2013, NEUROCHEM INT; Focant MC, 2011, NEUROCHEM INT; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Goursaud S, 2011, FASEB J, V25, P3674, DOI 10.1096/fj.11-182337; Goursaud S, 2009, NEUROCHEM INT, V55, P28, DOI 10.1016/j.neuint.2009.02.003; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hensley K, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-2; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Korn T, 2005, FASEB J, V19, P1878, DOI 10.1096/fj.05-3748fje; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Martinez-Villarreal J, 2012, GLIA; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; McCombe PA, 2011, CURR MOL MED, V11, P246; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Ramirez-Sotelo G, 2007, NEUROCHEM RES, V32, P73, DOI 10.1007/s11064-006-9227-3; Rodriguez-Kern A, 2003, NEUROCHEM INT, V43, P363, DOI 10.1016/S0197-0186(03)00023-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Sogaard R, 2013, J BIOL CHEM; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tilleux S, 2008, J NEUROCHEM, V105, P2224, DOI 10.1111/j.1471-4159.2008.05305.x; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Tilleux S, 2009, NEUROCHEM INT, V55, P35, DOI 10.1016/j.neuint.2008.12.021; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Zelenaia OA, 2000, J NEUROCHEM, V75, P2252, DOI 10.1046/j.1471-4159.2000.0752252.x	44	25	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97649	10.1371/journal.pone.0097649	http://dx.doi.org/10.1371/journal.pone.0097649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836816	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800059
J	Spriggs, EL; Christin, PA; Edwards, EJ				Spriggs, Elizabeth L.; Christin, Pascal-Antoine; Edwards, Erika J.			C-4 Photosynthesis Promoted Species Diversification during the Miocene Grassland Expansion	PLOS ONE			English	Article							GREAT-PLAINS; PHYLOGENETIC ANALYSES; DOMINATED HABITATS; ISOTOPIC EVIDENCE; PANICEAE POACEAE; EVOLUTION; GENUS; PANICOIDEAE; GRASSES; SPREAD	Identifying how organismal attributes and environmental change affect lineage diversification is essential to our understanding of biodiversity. With the largest phylogeny yet compiled for grasses, we present an example of a key physiological innovation that promoted high diversification rates. C-4 photosynthesis, a complex suite of traits that improves photosynthetic efficiency under conditions of drought, high temperatures, and low atmospheric CO2, has evolved repeatedly in one lineage of grasses and was consistently associated with elevated diversification rates. In most cases there was a significant lag time between the origin of the pathway and subsequent radiations, suggesting that the 'C-4 effect' is complex and derives from the interplay of the C-4 syndrome with other factors. We also identified comparable radiations occurring during the same time period in C-3 Pooid grasses, a diverse, cold-adapted grassland lineage that has never evolved C-4 photosynthesis. The mid to late Miocene was an especially important period of both C-3 and C-4 grass diversification, coincident with the global development of extensive, open biomes in both warm and cool climates. As is likely true for most "key innovations'', the C-4 effect is context dependent and only relevant within a particular organismal background and when particular ecological opportunities became available.	[Spriggs, Elizabeth L.; Christin, Pascal-Antoine; Edwards, Erika J.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Spriggs, EL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	elizabeth.spriggs@yale.edu	Christin, Pascal-Antoine/A-6634-2013	Christin, Pascal-Antoine/0000-0001-6292-8734	National Science Foundation grant [IOS0843231]; Marie Curie IOF fellowship [252568]	National Science Foundation grant(National Science Foundation (NSF)); Marie Curie IOF fellowship(European Commission)	This work was supported by National Science Foundation grant IOS0843231 to EJE and a Marie Curie IOF 252568 fellowship to PAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bess EC, 2006, SYST BOT, V31, P656, DOI 10.1600/036364406779695898; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Catalan P, 2004, MOL PHYLOGENET EVOL, V31, P517, DOI 10.1016/j.ympev.2003.08.025; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cerros-Tlatilpa R, 2011, AM J BOT, V98, P1868, DOI 10.3732/ajb.1100103; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Christin PA, 2014, SYST BIOL, V63, P153, DOI 10.1093/sysbio/syt072; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Clayton WD, 2006, ONLINE WORLD GRASS F; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; Donoghue MJ, 2005, PALEOBIOLOGY, V31, P77, DOI 10.1666/0094-8373(2005)031[0077:KICASM]2.0.CO;2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; Galley C, 2007, EVOLUTION, V61, P864, DOI 10.1111/j.1558-5646.2007.00067.x; Gillespie LJ, 2008, BOTANY, V86, P938, DOI 10.1139/B08-076; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jacobs Surrey, 2007, Aliso, V23, P349; Jiang H, 2009, J ARID ENVIRON, V73, P765, DOI 10.1016/j.jaridenv.2009.03.011; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; Labandeir CC, 2011, ENTOMOL AM-NY, V117, P9, DOI 10.1664/10-RA-011.1; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Marazzi B, 2010, EVOLUTION, V64, P3570, DOI 10.1111/j.1558-5646.2010.01086.x; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Morrone O, 2001, NOVON, V11, P429, DOI 10.2307/3393155; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2007, TAXON, V56, P521, DOI 10.1002/tax.562023; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Palazzesi L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2299; Passey BH, 2009, EARTH PLANET SC LETT, V277, P443, DOI 10.1016/j.epsl.2008.11.008; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; QUADE J, 1995, J HUM EVOL, V28, P373, DOI 10.1006/jhev.1995.1029; QUADE J, 1994, PALAEOGEOGR PALAEOCL, V108, P41, DOI 10.1016/0031-0182(94)90021-3; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Salamin N, 2004, PHYLOGENETIC SUPERTR; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sede SM, 2009, SYST BOT, V34, P684, DOI 10.1600/036364409790139655; Sede SM, 2009, TAXON, V58, P365, DOI 10.1002/tax.582004; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Still CJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P286, DOI 10.1111/geb.12121; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stromberg CAE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2508; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; Vamosi SM, 2005, EVOL ECOL RES, V7, P567; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	74	69	70	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97722	10.1371/journal.pone.0097722	http://dx.doi.org/10.1371/journal.pone.0097722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835188	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800065
J	Lee, SH; Lee, JH; Asahara, T; Kim, YS; Jeong, HC; Ahn, Y; Jung, JS; Kwon, SM				Lee, Sang Hun; Lee, Jun Hee; Asahara, Takayuki; Kim, Yong Sook; Jeong, Hae Chang; Ahn, Youngkeun; Jung, Jin Sup; Kwon, Sang-Mo			Genistein Promotes Endothelial Colony-Forming Cell (ECFC) Bioactivities and Cardiac Regeneration in Myocardial Infarction	PLOS ONE			English	Article							PROGENITOR CELLS; BONE-MARROW; POSTNATAL VASCULOGENESIS; ESTROGEN; TRANSPLANTATION; ISCHEMIA; HEART; NEOVASCULARIZATION; ANGIOGENESIS; DYSFUNCTION	Although stem cell-mediated treatment of ischemic diseases offers significant therapeutic promise, the limitation in the therapeutic efficacy of transplanted stem cells in vivo because of poor engraftment remains a challenge. Several strategies aimed at improving survival and engraftment of stem cells in the ischemic myocardium have been developed, such as cell transplantation in combination with growth factor delivery, genetic modification of stem cells, and/or cell therapy using scaffolds. To improve therapeutic efficacy, we investigated the effects of genistein on the engraftment of transplanted ECFCs in an acute myocardial ischemia model. Results: We found that genistein treatment enhanced ECFCs' migration and proliferation, which was accompanied by increases in the expression of ILK, alpha-parvin, F-actin, and phospholylation of ERK 1/2 signaling. Transplantation of genistein-stimulates ECFCs (GS-ECFCs) into myocardial ischemic sites in vivo induced cellular proliferation and secretion of angiogenic cytokines at the ischemic sites and thereby enhanced neovascularization and decreased myocardial fibrosis as well as improved cardiac function, as shown by echocardiography. Taken together, these data suggest that pretreatment of ECFCs with genistein prior to transplantation can improve the regenerative potential in ischemic tissues, providing a novel strategy in adult stem cell therapy for ischemic diseases.	[Lee, Sang Hun] Soonchunhyang Univ, Seoul Hosp Seoul, Med Sci Res Inst, Seoul, South Korea; [Lee, Sang Hun; Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol,Med Res Inst, Yangsan, South Korea; [Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Immunoregulatory Therapeut Grp,Brain Busan Projec, Yangsan, South Korea; [Asahara, Takayuki] RIKEN Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Kim, Yong Sook] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju, South Korea; [Jeong, Hae Chang; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju, South Korea; [Jung, Jin Sup] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, Gyeongnam, South Korea; [Lee, Sang Hun] Soonchunhyang Univ Asan, Dept Med Biosci, Asan, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Soonchunhyang University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Institute for Biomedical Research & Innovation (IBRI); RIKEN; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Pusan National University; Pusan National University Hospital; Soonchunhyang University; Tokai University	Kwon, SM (corresponding author), Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol,Med Res Inst, Yangsan, South Korea.	smkwon323@hotmail.com	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966	National Research Foundation (NRF) - Korean government (MEST) [2007-0052078, 2010-0020260, 2011-0009610]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A110374]	National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a National Research Foundation (NRF) grant funded by the Korean government (MEST) (2007-0052078, 2010-0020260, 2011-0009610) and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A110374). The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Allred CD, 2001, CANCER RES, V61, P5045; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Bolego C, 2010, FASEB J, V24, P2262, DOI 10.1096/fj.09-139220; Deodato B, 1999, BRIT J PHARMACOL, V128, P1683, DOI 10.1038/sj.bjp.0702973; Fischer KM, 2011, CIRC RES, V108, P960, DOI 10.1161/CIRCRESAHA.110.237156; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Kremastinos DT, 2000, ATHEROSCLEROSIS, V150, P81, DOI 10.1016/S0021-9150(99)00389-5; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Murasawa S, 2002, CIRCULATION, V106, P1133, DOI 10.1161/01.CIR.0000027584.85865.B4; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Ridopoulos I, 1997, CIRCULATION, V95, P1505; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sellke FW, 1996, SURGERY, V120, P182, DOI 10.1016/S0039-6060(96)80286-8; Squadrito F, 2000, CARDIOVASC RES, V45, P454, DOI 10.1016/S0008-6363(99)00359-4; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044; Zuba-Surma EK, 2011, J CELL MOL MED, V15, P1319, DOI 10.1111/j.1582-4934.2010.01126.x	35	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96155	10.1371/journal.pone.0096155	http://dx.doi.org/10.1371/journal.pone.0096155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830850	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500014
J	Pitzonka, L; Ullas, S; Chinnam, M; Povinelli, BJ; Fisher, DT; Golding, M; Appenheimer, MM; Nemeth, MJ; Evans, S; Goodrich, DW				Pitzonka, Laura; Ullas, Sumana; Chinnam, Meenalakshmi; Povinelli, Benjamin J.; Fisher, Daniel T.; Golding, Michelle; Appenheimer, Michelle M.; Nemeth, Michael J.; Evans, Sharon; Goodrich, David W.			The Thoc1 Encoded Ribonucleoprotein Is Required for Myeloid Progenitor Cell Homeostasis in the Adult Mouse	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; TRANSCRIPTION ELONGATION; COMPLEX; GENE; TREX; IDENTIFICATION; CONTRIBUTES; MACHINERY; PROTEINS; DOMAIN	Co-transcriptionally assembled ribonucleoprotein (RNP) complexes are critical for RNA processing and nuclear export. RNPs have been hypothesized to contribute to the regulation of coordinated gene expression, and defects in RNP biogenesis contribute to genome instability and disease. Despite the large number of RNPs and the importance of the molecular processes they mediate, the requirements for individual RNP complexes in mammalian development and tissue homeostasis are not well characterized. THO is an evolutionarily conserved, nuclear RNP complex that physically links nascent transcripts with the nuclear export apparatus. THO is essential for early mouse embryonic development, limiting characterization of the requirements for THO in adult tissues. To address this shortcoming, a mouse strain has been generated allowing inducible deletion of the Thoc1 gene which encodes an essential protein subunit of THO. Bone marrow reconstitution was used to generate mice in which Thoc1 deletion could be induced specifically in the hematopoietic system. We find that granulocyte macrophage progenitors have a cell autonomous requirement for Thoc1 to maintain cell growth and viability. Lymphoid lineages are not detectably affected by Thoc1 loss under the homeostatic conditions tested. Myeloid lineages may be more sensitive to Thoc1 loss due to their relatively high rate of proliferation and turnover.	[Pitzonka, Laura; Ullas, Sumana; Chinnam, Meenalakshmi; Goodrich, David W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Povinelli, Benjamin J.; Fisher, Daniel T.; Golding, Michelle; Appenheimer, Michelle M.; Nemeth, Michael J.; Evans, Sharon] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Goodrich, DW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	david.goodrich@roswellpark.org			Roswell Park Alliance Foundation; National Blood Foundation; University at Buffalo Mark Diamond Fund [SU 11-14]; Public Health Service grants from the National Institutes of Health [CA125665, CA79765, AI082039]; National Cancer Institute [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082039] Funding Source: NIH RePORTER	Roswell Park Alliance Foundation; National Blood Foundation; University at Buffalo Mark Diamond Fund; Public Health Service grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Roswell Park Alliance Foundation (B.J.P., M. G., M.J.N., D. W. G.), the National Blood Foundation (B.J.P., M.G., M.J.N.), University at Buffalo Mark Diamond Fund grant SU 11-14 (L. P.), and Public Health Service grants CA125665 (D.W.G.), CA79765 (S.S.E.) and AI082039 (S.S.E.) from the National Institutes of Health. Institutional core facilities utilized in this work were supported by National Cancer Institute grant P30 CA016056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Furumizu C, 2010, RNA, V16, P1809, DOI 10.1261/rna.2265710; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pitzonka L, 2013, MOL CELL BIOL, V33, P3505, DOI 10.1128/MCB.00751-13; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Saran S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-51; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Song F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057995; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tran DDH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.409; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Wang XL, 2007, GENESIS, V45, P32, DOI 10.1002/dvg.20262; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006	40	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97628	10.1371/journal.pone.0097628	http://dx.doi.org/10.1371/journal.pone.0097628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830368	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500087
J	Romer, D; Roces, F				Roemer, Daniela; Roces, Flavio			Nest Enlargement in Leaf-Cutting Ants: Relocated Brood and Fungus Trigger the Excavation of New Chambers	PLOS ONE			English	Article							ATTA-VOLLENWEIDERI FOREL; INTERNAL STRUCTURE; ADAPTIVE VALUE; COLONY GROWTH; 1893 HYM; HYMENOPTERA; ARCHITECTURE; FORMICIDAE; BEHAVIOR; SIZE	During colony growth, leaf-cutting ants enlarge their nests by excavating tunnels and chambers housing their fungus gardens and brood. Workers are expected to excavate new nest chambers at locations across the soil profile that offer suitable environmental conditions for brood and fungus rearing. It is an open question whether new chambers are excavated in advance, or will emerge around brood or fungus initially relocated to a suitable site in a previously-excavated tunnel. In the laboratory, we investigated the mechanisms underlying the excavation of new nest chambers in the leaf-cutting ant Acromyrmex lundi. Specifically, we asked whether workers relocate brood and fungus to suitable nest locations, and to what extent the relocated items trigger the excavation of a nest chamber and influence its shape. When brood and fungus were exposed to unfavorable environmental conditions, either low temperatures or low humidity, both were relocated, but ants clearly preferred to relocate the brood first. Workers relocated fungus to places containing brood, demonstrating that subsequent fungus relocation spatially follows the brood deposition. In addition, more ants aggregated at sites containing brood. When presented with a choice between two otherwise identical digging sites, but one containing brood, ants' excavation activity was higher at this site, and the shape of the excavated cavity was more rounded and chamber-like. The presence of fungus also led to the excavation of rounder shapes, with higher excavation activity at the site that also contained brood. We argue that during colony growth, workers preferentially relocate brood to suitable locations along a tunnel, and that relocated brood spatially guides fungus relocation and leads to increased digging activity around them. We suggest that nest chambers are not excavated in advance, but emerge through a self-organized process resulting from the aggregation of workers and their density-dependent digging behavior around the relocated brood and fungus.	[Roemer, Daniela; Roces, Flavio] Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol Zool 2, D-97070 Wurzburg, Germany	University of Wurzburg	Romer, D (corresponding author), Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol Zool 2, D-97070 Wurzburg, Germany.	daniela.roemer@uni-wuerzburg.de		Romer, Daniela/0000-0002-7437-2195; Roces, Flavio/0000-0001-9258-3079	German Research Foundation (DFG) [SFB 554/TP E1]; German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was partially supported by funds from the German Research Foundation (DFG, grant SFB 554/TP E1). This publication was funded by the German Research Foundation ( DFG) and the University of Wuerzburg in the funding program Open Access Publishing. There were no further external or internal funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, INSECT SOC, V48, P404, DOI 10.1007/PL00001798; Armitage SAO, 2012, EVOLUTION, V66, P1966, DOI 10.1111/j.1558-5646.2011.01568.x; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2010, INSECT SOC, V57, P267, DOI 10.1007/s00040-010-0081-6; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bonetto AA, 1959, HORMIGAS CORTADOERAS, P77; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Camargo RS, 2011, INSECT SOC, V58, P17, DOI 10.1007/s00040-010-0110-5; Cassill D, 2002, INSECT SOC, V49, P158, DOI 10.1007/s00040-002-8296-9; Clark RM, 2014, BEHAV ECOL SOCIOBIOL, V68, P163, DOI 10.1007/s00265-013-1632-4; Camargo Roberto da Silva, 2004, Rev. Árvore, V28, P309, DOI 10.1590/S0100-67622004000200017; DENEUBOURG JL, 1995, J INSECT BEHAV, V8, P417, DOI 10.1007/BF01995316; Diehl-Fleig E., 1992, P51; Fowler H.G., 1986, P18; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; Frohle K, 2012, J EXP BIOL, V215, P1642, DOI 10.1242/jeb.066217; Frohle K, 2009, THESIS; Frohle K., 2009, INSECT NEST HUMAN AR, P95; Holldobler B., 1990, pi; Jacoby M., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P129; Jacoby M., 1960, Zeitschrift fuer Angewandte Entomologie, V46, P34; Jacoby M., 1937, Revista de Entomologia Rio de Janeiro, V7, P416; Jacoby M, 1953, Z ANGEW ENTOMOL, V34, P145; Jacoby M, 1936, REV ENTOMOLOGIA, V6, P120; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Lapointe SL, 1998, ENVIRON ENTOMOL, V27, P636, DOI 10.1093/ee/27.3.636; Lopes JFS, 2005, INSECT SOC, V52, P333, DOI 10.1007/s00040-005-0816-y; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Minter NJ, 2012, J R SOC INTERFACE, V9, P586, DOI 10.1098/rsif.2011.0377; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; MOSER JOHN C., 1963, ANN ENTOMOL SOC AMER, V56, P286, DOI 10.1093/aesa/56.3.286; NAVARRO JG, 1985, BIOTROPICA, V17, P347, DOI 10.2307/2388602; Pereira da Silva V., 1981, REV BRASIL ENTOMOL, V25, P87; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Ritter N, 2009, J MATH IMAGING VIS, V35, P117, DOI 10.1007/s10851-009-0158-x; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; Lopes JFS, 2011, SOCIOBIOLOGY, V58, P593; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Sudd J. H., 1969, Zeitschrift fuer Tierpsychologie, V26, P257; Toffin E, 2010, P ROY SOC B-BIOL SCI, V277, P2617, DOI 10.1098/rspb.2010.0176; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; Verza SS, 2007, INSECT SOC, V54, P303, DOI 10.1007/s00040-007-0943-8; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; Wetterer JK, 1998, FLA ENTOMOL, V81, P61, DOI 10.2307/3495996; Zolessi LC., 1978, REV FAC HUMAN CIENC, V1, P9	58	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97872	10.1371/journal.pone.0097872	http://dx.doi.org/10.1371/journal.pone.0097872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830633	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500130
J	Coulon, M; Henry, L; Perret, A; Cousillas, H; Hausberger, M; George, I				Coulon, Marion; Henry, Laurence; Perret, Audrey; Cousillas, Hugo; Hausberger, Martine; George, Isabelle			Assessing Video Presentations as Environmental Enrichment for Laboratory Birds	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; EUROPEAN STARLINGS; STEREOTYPIC BEHAVIOR; DOMESTIC CHICKS; RHESUS-MONKEYS; STIMULATION; WELFARE; IMAGES; RESPONSES; MALES	The aim of the present study was to investigate the effects of video presentations of natural landscapes on European starlings' (Sturnus vulgaris) stereotypic behaviours (SBs) and other abnormal repetitive behaviours (ARBs) and to evaluate the impact of past experience by comparing wild-caught and hand-reared starlings' reactions. Ten wild-caught and five hand-reared starlings were presented 1-hour videos of landscapes twice a day for five successive days, while a control group of eight wild-caught and four hand-reared starlings was presented a grey screen for the same amount of time. The analysis of the starlings' behaviour revealed that the video presentations of landscapes appeared to have a positive but limited and experience-dependent effect on starlings' SBs and other ARBs compared to the controls. Indeed, whereas video presentations seemed to modulate high rates of SBs and ARBs, they did not appear to be enriching enough to prevent the emergence or the development of SBs and ARBs in an impoverished environment. They even appeared to promote a particular type of SB (somersaulting) that is thought to be linked to escape motivation. The fact that this effect was observed in hand-reared starlings suggests that videos of landscapes could elicit motivation to escape even in birds that never experienced outdoor life. These results highlight the importance of investigating stereotypic behaviour both quantitatively and qualitatively in order to provide crucial clues on animal welfare.	[Coulon, Marion; Henry, Laurence; Perret, Audrey; Cousillas, Hugo; Hausberger, Martine; George, Isabelle] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	isabelle.george@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French ANR (Agence Nationale pour la Recherche) [ANR-09-Blanc-0319-01]; University of Rennes 1; French CNRS	French ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); University of Rennes 1; French CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by a grant of the French ANR (Agence Nationale pour la Recherche) entitled "Intermodalite et imitation: aspects comportementaux et neuronaux (etude chez le bebe et les oiseaux)" (ANR-09-Blanc-0319-01). All authors are supported by the University of Rennes 1 and by the French CNRS. Audrey Perret is a doctoral fellow of the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Bird CD, 2008, ANIM BEHAV, V76, P679, DOI 10.1016/j.anbehav.2008.04.014; Bloomsmith MA, 1990, LAB ANIM, V19, P42; Brilot BO, 2009, BEHAV PROCESS, V82, P256, DOI 10.1016/j.beproc.2009.07.003; Clarke CH, 2000, APPL ANIM BEHAV SCI, V67, P97, DOI 10.1016/S0168-1591(99)00107-0; Clarke CH, 2000, APPL ANIM BEHAV SCI, V66, P107, DOI 10.1016/S0168-1591(99)00071-4; Feenders G, 2012, DEV PSYCHOBIOL, V54, P773, DOI 10.1002/dev.20623; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019074; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017466; Fureix C., 2011, ISRN Zoology, V2011, P271209, DOI 10.5402/2011/271209; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; George Isabelle, 2011, Frontiers in Behavioral Neuroscience, V4, P1, DOI 10.3389/fnbeh.2010.00193; Harris LD, 1999, CONTEMP TOP LAB ANIM, V38, P48; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Henry L, 2008, CR BIOL, V331, P526, DOI 10.1016/j.crvi.2008.04.005; Henry L, 2013, J COMP PSYCHOL, V127, P1, DOI 10.1037/a0029975; Jones RB, 1996, APPL ANIM BEHAV SCI, V48, P81, DOI 10.1016/0168-1591(95)01003-3; KEIPER RR, 1969, ANIM BEHAV, V17, P114, DOI 10.1016/0003-3472(69)90119-5; Lee Grace H., 2011, Laboratory Primate Newsletter, V50, P7; Maddocks SA, 2002, J AVIAN BIOL, V33, P103, DOI 10.1034/j.1600-048X.2002.330117.x; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Odberg F., 1978, P 1 WORLD C ETH APPL, P475; ONEILL P, 1989, HOUSING CARE PSYCHOL, P135; Ophir AG, 2003, ANIM BEHAV, V66, P369, DOI 10.1006/anbe.2003.2229; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; Swaddle JP, 2006, ANIM BEHAV, V72, P161, DOI 10.1016/j.anbehav.2005.12.005; Wells DL, 2006, APPL ANIM BEHAV SCI, V100, P327, DOI 10.1016/j.applanim.2005.12.003; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002	34	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96949	10.1371/journal.pone.0096949	http://dx.doi.org/10.1371/journal.pone.0096949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827457	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400049
J	Myojo, M; Nagata, D; Fujita, D; Kiyosue, A; Takahashi, M; Satonaka, H; Morishita, Y; Akimoto, T; Nagai, R; Komuro, I; Hirata, Y				Myojo, Masahiro; Nagata, Daisuke; Fujita, Daishi; Kiyosue, Arihiro; Takahashi, Masao; Satonaka, Hiroshi; Morishita, Yoshiyuki; Akimoto, Tetsu; Nagai, Ryozo; Komuro, Issei; Hirata, Yasunobu			Telmisartan Activates Endothelial Nitric Oxide Synthase via Ser1177 Phosphorylation in Vascular Endothelial Cells	PLOS ONE			English	Article							ANGIOTENSIN RECEPTOR BLOCKERS; REPERFUSION INJURY; P38 MAPK; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; PATHWAY; AKT; PROLIFERATION; MYOCARDIUM	Because endothelial nitric oxide synthase (eNOS) has anti-inflammatory and anti-arteriosclerotic functions, it has been recognized as one of the key molecules essential for the homeostatic control of blood vessels other than relaxation of vascular tone. Here, we examined whether telmisartan modulates eNOS function through its pleiotropic effect. Administration of telmisartan to mice significantly increased the phosphorylation level of eNOS (Ser1177) in the aortic endothelium, but administration of valsartan had no effect. Similarly, telmisartan treatment of human umbilical vein endothelial cells significantly increased the phosphorylation levels of AMP-activated protein kinase (Thr172) and eNOS and the concentration of intracellular guanosine 3',5'-cyclic monophosphate (cGMP). Furthermore, pretreatment with a p38 mitogen-activated protein kinase (p38 MAPK) inhibitor suppressed the increased phosphorylation level of eNOS and intracellular cGMP concentration. These data show that telmisartan increases eNOS activity through Ser1177 phosphorylation in vascular endothelial cells mainly via p38 MAPK signaling.	[Myojo, Masahiro; Fujita, Daishi; Kiyosue, Arihiro; Takahashi, Masao; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Nagata, Daisuke; Morishita, Yoshiyuki; Akimoto, Tetsu] Jichi Med Univ, Dept Nephrol, Shimotsuke, Tochigi, Japan; [Satonaka, Hiroshi] Dokkyo Med Univ, Dept Cardiol & Nephrol, Mibu, Tochigi, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	University of Tokyo; Jichi Medical University; Dokkyo Medical University; Jichi Medical University	Nagata, D (corresponding author), Jichi Med Univ, Dept Nephrol, Shimotsuke, Tochigi, Japan.	nagatad@jichi.ac.jp		Vacca, Giovanni/0000-0002-0864-1887; Takahashi, Masao/0000-0002-3799-2256	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590823, 17659229]; Sankyo Foundation of Life Science; Fugaku Trust for Medical Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Fugaku Trust for Medical Research	This study was supported by Grants-in-Aid #22590823 (to DN) and #17659229 (to Y.H.), Core Research for Evolutional Science and Technology (to Y.H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Sankyo Foundation of Life Science (to D.N.), and by a Research Grant from the Fugaku Trust for Medical Research (to D.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anter E, 2004, J BIOL CHEM, V279, P46637, DOI 10.1074/jbc.M405547200; Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Benson SC, 2008, J HYPERTENS, V26, P973, DOI 10.1097/HJH.0b013e3282f56ba5; Birnbaum Y, 2005, CARDIOVASC RES, V65, P345, DOI 10.1016/j.cardiores.2004.10.018; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Fischer MJE, 1996, INFLAMM RES, V45, P564, DOI 10.1007/BF02342228; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Giles TD, 2007, REV CARDIOVASC MED, V8, pS14; Gonon AT, 2007, BASIC RES CARDIOL, V102, P80, DOI 10.1007/s00395-006-0613-4; Grossini E, 2009, BRIT J PHARMACOL, V156, P250, DOI 10.1111/j.1476-5381.2008.00024.x; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Kan WH, 2008, AM J PHYSIOL-HEART C, V294, pH2627, DOI 10.1152/ajpheart.91444.2007; Kawano H, 2003, J AM SOC NEPHROL, V14, P584, DOI 10.1097/01.ASN.0000050415.97942.2F; Kjeldsen SE, 2004, AM HEART J, V148, P747, DOI 10.1016/j.ahj.2004.04.037; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; Pitt B, 2002, AM J HYPERTENS, V15, p22S, DOI 10.1016/S0895-7061(01)02275-0; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Wolfrum S, 2004, J CARDIOVASC PHARM, V44, P348, DOI 10.1097/01.fjc.0000137162.14735.30; Yamaguchi K, 2014, CIRC J, V78, P240, DOI 10.1253/circj.CJ-13-0741; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zhu M, 2006, CARDIOVASC RES, V72, P152, DOI 10.1016/j.cardiores.2006.06.027	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96948	10.1371/journal.pone.0096948	http://dx.doi.org/10.1371/journal.pone.0096948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827148	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400048
J	Zhao, YL; Wang, DY; Zong, L; Zhao, FF; Guan, LP; Zhang, P; Shi, W; Lan, L; Wang, HY; Li, Q; Han, B; Yang, L; Jin, X; Wang, J; Wang, J; Wang, QJ				Zhao, Yali; Wang, Dayong; Zong, Liang; Zhao, Feifan; Guan, Liping; Zhang, Peng; Shi, Wei; Lan, Lan; Wang, Hongyang; Li, Qian; Han, Bing; Yang, Ling; Jin, Xin; Wang, Jian; Wang, Jun; Wang, Qiuju			A Novel DFNA36 Mutation in TMC1 Orthologous to the Beethoven (Bth) Mouse Associated with Autosomal Dominant Hearing Loss in a Chinese Family	PLOS ONE			English	Article							GENE FAMILY; HAIR-CELLS; DEAFNESS; CHANNEL; MECHANOTRANSDUCTION; ALIGNMENT; MODEL	Mutations in the transmembrane channel-like gene 1 (TMC1) can cause both DFNA36 and DFNB7/11 hearing loss. More than thirty DFNB7/11 mutations have been reported, but only three DFNA36 mutations were reported previously. In this study, we found a large Chinese family with 222 family members showing post-lingual, progressive sensorineural hearing loss which were consistent with DFNA36 hearing loss. Auditory brainstem response (ABR) test of the youngest patient showed a special result with nearly normal threshold but prolonged latency, decreased amplitude, and the abnormal waveform morphology. Exome sequencing of the proband found four candidate variants in known hearing loss genes. Sanger sequencing in all family members found a novel variant c. 1253T> A (p. M418K) in TMC1 at DFNA36 that co-segregated with the phenotype. This mutation in TMC1 is orthologous to the mutation found in the hearing loss mouse model named Bth ten years ago. In another 51 Chinese autosomal dominant hearing loss families, we screened the segments containing the dominant mutations of TMC1 and no functional variants were found. TMC1 is expressed in the hair cells in inner ear. Given the already known roles of TMC1 in the mechanotransduction in the cochlea and its expression in inner ear, our results may provide an interesting perspective into its function in inner ear.	[Zhao, Yali; Wang, Dayong; Zong, Liang; Zhao, Feifan; Shi, Wei; Lan, Lan; Wang, Hongyang; Li, Qian; Han, Bing; Wang, Qiuju] Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Otolaryngol, Beijing, Peoples R China; [Zhao, Yali] Capital Med Univ, Beijing Inst Otorhinolaryngol, Beijing Tongren Hosp, Beijing, Peoples R China; [Guan, Liping; Zhang, Peng; Jin, Xin; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Yang, Ling] BGI Tianjin, Tianjin, Peoples R China; [Jin, Xin] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); South China University of Technology	Wang, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Otolaryngol, Beijing, Peoples R China.	wqcr@263.net	Jin, Xin/ABF-1329-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Key Basic Research Program of China [2014CB943001]; National Natural Science Foundation of China [81120108009]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants of the National Key Basic Research Program of China, No. 2014CB943001, the National Natural Science Foundation of China, Major Project, No. 81120108009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Hildebrand MS, 2010, ANN OTO RHINOL LARYN, V119, P830, DOI 10.1177/000348941011901207; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Hilgert N, 2009, J HUM GENET, V54, P188, DOI 10.1038/jhg.2009.1; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kitajiri S, 2007, CLIN GENET, V71, P148, DOI 10.1111/j.1399-0004.2007.00739.x; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mazzoli M., 2003, AUDIOL MED, V1, P148, DOI [10.1080/16513860301713, DOI 10.1080/16513860301713]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Christian G, 2005, Hum Mutat, V25, P100, DOI 10.1002/humu.9302; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Yang T, 2010, CLIN GENET, V77, P395, DOI 10.1111/j.1399-0004.2009.01338.x	27	12	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97064	10.1371/journal.pone.0097064	http://dx.doi.org/10.1371/journal.pone.0097064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827932	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400053
J	Zhou, ML; Zhang, Q; Wang, JY				Zhou, Miaolei; Zhang, Qi; Wang, Jingyuan			Feedforward-Feedback Hybrid Control for Magnetic Shape Memory Alloy Actuators Based on the Krasnosel'skii-Pokrovskii Model	PLOS ONE			English	Article							HYSTERESIS	As a new type of smart material, magnetic shape memory alloy has the advantages of a fast response frequency and outstanding strain capability in the field of microdrive and microposition actuators. The hysteresis nonlinearity in magnetic shape memory alloy actuators, however, limits system performance and further application. Here we propose a feedforward-feedback hybrid control method to improve control precision and mitigate the effects of the hysteresis nonlinearity of magnetic shape memory alloy actuators. First, hysteresis nonlinearity compensation for the magnetic shape memory alloy actuator is implemented by establishing a feedforward controller which is an inverse hysteresis model based on Krasnosel'skii-Pokrovskii operator. Secondly, the paper employs the classical Proportion Integration Differentiation feedback control with feedforward control to comprise the hybrid control system, and for further enhancing the adaptive performance of the system and improving the control accuracy, the Radial Basis Function neural network self-tuning Proportion Integration Differentiation feedback control replaces the classical Proportion Integration Differentiation feedback control. Utilizing self-learning ability of the Radial Basis Function neural network obtains Jacobian information of magnetic shape memory alloy actuator for the on-line adjustment of parameters in Proportion Integration Differentiation controller. Finally, simulation results show that the hybrid control method proposed in this paper can greatly improve the control precision of magnetic shape memory alloy actuator and the maximum tracking error is reduced from 1.1% in the open-loop system to 0.43% in the hybrid control system.	[Zhou, Miaolei; Zhang, Qi; Wang, Jingyuan] Jilin Univ, Coll Commun Engn, Changchun 130023, Peoples R China	Jilin University	Zhou, ML (corresponding author), Jilin Univ, Coll Commun Engn, Changchun 130023, Peoples R China.	zml@jlu.edu.cn			National Natural Science Foundation of China [51105170]; Program of Science and Technology Development Plan of Jilin province of China [201105015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Science and Technology Development Plan of Jilin province of China	This research is supported by National Natural Science Foundation of China (Grant No.: 51105170), and Program of Science and Technology Development Plan of Jilin province of China (Grant No.: 201105015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KK, 2008, MECHATRONICS, V18, P141, DOI 10.1016/j.mechatronics.2007.10.008; Al Janaideh M, 2013, PHYSICA B, V430, P95, DOI 10.1016/j.physb.2013.07.002; Brown PJ, 2007, J MAGN MAGN MATER, V310, P2755, DOI 10.1016/j.jmmm.2006.10.1037; Ding YL, 2011, APPL MECH MATER, V44-47, P3100, DOI 10.4028/www.scientific.net/AMM.44-47.3100; Dunand DC, 2011, ADV MATER, V23, P216, DOI 10.1002/adma.201002753; Gauthier JY, 2008, SENSOR ACTUAT A-PHYS, V141, P536, DOI 10.1016/j.sna.2007.10.012; Ge P, 1996, IEEE T CONTR SYST T, V4, P209, DOI 10.1109/87.491195; [葛锁良 Ge Suoliang], 2011, [合肥工业大学学报. 自然科学版, Journal of Hefei University of Technology. Natural Science], V34, P1489; Gu GY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3470117; Han Aiguo, 2005, Journal of Huazhong University of Science and Technology, V33, P4; Karaca HE, 2009, ADV FUNCT MATER, V19, P983, DOI 10.1002/adfm.200801322; Krenke T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466770; Lechevin N, 2005, P AMER CONTR CONF, P3019, DOI 10.1109/ACC.2005.1470434; Liu L, 2012, IEEE T IND INFORM; Luo H. Y., 2010, SHAPE MEMORY ALLOYS, P61; Nascimento MMSF, 2009, MATER DESIGN, V30, P551, DOI 10.1016/j.matdes.2008.05.062; Nespoli A, 2010, SENSOR ACTUAT A-PHYS, V158, P149, DOI 10.1016/j.sna.2009.12.020; Nguyen BK, 2009, IEEE T CONTR SYST T, V17, P434, DOI 10.1109/TCST.2008.924580; Pereira C, 2000, CONTROL ENG PRACT, V8, P3, DOI 10.1016/S0967-0661(99)00130-6; [曲东升 Qu Dongsheng], 2002, [压电与声光, Plezoelectrics and Acoustooptics], V24, P354; Riccardi L, 2012, MECHATRONICS, V22, P568, DOI 10.1016/j.mechatronics.2011.12.004; Rosenbaum S, 2010, IEEE T MAGN, V46, P3984, DOI 10.1109/TMAG.2010.2071391; Ru CH, 2009, CONTROL ENG PRACT, V17, P1107, DOI 10.1016/j.conengprac.2009.04.013; TAO G, 1995, IEEE T AUTOMAT CONTR, V40, P200, DOI 10.1109/9.341778; Tellinen J, 2002, P 8 INT C ACT BREM G, P566; Ullakko K, 1996, J MATER ENG PERFORM, V5, P405, DOI 10.1007/BF02649344; Visone C, 2010, IEEE T MAGN, V46, P1848, DOI 10.1109/TMAG.2010.2042040; Wang FX, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS, P579; Wang YF, 2006, THESIS CONCORDIA U M; Xiao Mei Sui, 2010, 2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), P661, DOI 10.1109/BICTA.2010.5645203; [杨林 YANG Lin], 2006, [计算机仿真, Computer Simulation], V23, P270; Zhou ML, 2013, J CENT SOUTH UNIV, V20, P1214, DOI 10.1007/s11771-013-1604-x; Zhou Miaolei, 2013, ScientificWorldJournal, V2013, P865176, DOI 10.1155/2013/865176; Zi Ye, 2012, Proceedings 2012 Japan-Egypt Conference on Electronics, Communications and Computers (JEC-ECC), P97, DOI 10.1109/JEC-ECC.2012.6186964	34	15	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97086	10.1371/journal.pone.0097086	http://dx.doi.org/10.1371/journal.pone.0097086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828010	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400054
J	Gorgolewski, KJ; Lurie, D; Urchs, S; Kipping, JA; Craddock, RC; Milham, MP; Margulies, DS; Smallwood, J				Gorgolewski, Krzysztof J.; Lurie, Dan; Urchs, Sebastian; Kipping, Judy A.; Craddock, R. Cameron; Milham, Michael P.; Margulies, Daniel S.; Smallwood, Jonathan			A Correspondence between Individual Differences in the Brain's Intrinsic Functional Architecture and the Content and Form of Self-Generated Thoughts	PLOS ONE			English	Article							LOW-FREQUENCY FLUCTUATION; SURFACE-BASED ANALYSIS; METAANALYTIC EVIDENCE; PREFRONTAL CORTEX; EXECUTIVE-CONTROL; DEFAULT NETWORK; CEREBRAL-CORTEX; WORKING-MEMORY; MIND; CONNECTIVITY	Although neural activity often reflects the processing of external inputs, intrinsic fluctuations in activity have been observed throughout the brain. These may relate to patterns of self-generated thought that can occur while not performing goal-driven tasks. To understand the relationship between self-generated mental activity and intrinsic neural fluctuations, we developed the New York Cognition Questionnaire (NYC-Q) to assess the content and form of an individual's experiences during the acquisition of resting-state fMRI data. The data were collected as a part of the Nathan Kline Rockland Enhanced sample. We decomposed NYC-Q scores using exploratory factor analysis and found that self-reported thoughts clustered into distinct dimensions of content (future related, past related, positive, negative, and social) and form (words, images, and specificity). We used these components to perform an individual difference analysis exploring how differences in the types of self-generated thoughts relate to whole brain measures of intrinsic brain activity (fractional amplitude of low frequency fluctuations, regional homogeneity, and degree centrality). We found patterns of self-generated thoughts related to changes that were distributed across a wide range of cortical areas. For example, individuals who reported greater imagery exhibited greater low frequency fluctuations in a region of perigenual cingulate cortex, a region that is known to participate in the so-called default-mode network. We also found certain forms of thought were associated with other areas, such as primary visual cortex, the insula, and the cerebellum. For example, individuals who reported greater future thought exhibited less homogeneous neural fluctuations in a region of lateral occipital cortex, a result that is consistent with the claim that particular types of self-generated thought depend on processes that are decoupled from sensory processes. These data provide evidence that self-generated thought is a heterogeneous category of experience and that studying its content can be helpful in understanding brain dynamics.	[Gorgolewski, Krzysztof J.; Urchs, Sebastian; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany; [Kipping, Judy A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Lurie, Dan; Craddock, R. Cameron; Milham, Michael P.] Child Mind Inst, New York, NY USA; [Craddock, R. Cameron; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Smallwood, Jonathan] Univ York, Dept Psychol, Hesslington, Yorks, England	Max Planck Society; Max Planck Society; Nathan Kline Institute for Psychiatric Research; University of York - UK	Gorgolewski, KJ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany.	krzysztof.gorgolewski@gmail.com	Milham, Michael P/K-9501-2014; Smallwood, Jonathan/ABE-8365-2020; Gorgolewski, Krzysztof Jacek/A-7883-2010; Craddock, Cameron/P-1980-2014; Milham, Michael P./Y-3160-2019; Margulies, Daniel/L-4719-2016	Gorgolewski, Krzysztof Jacek/0000-0003-3321-7583; Craddock, Cameron/0000-0002-4950-1303; Urchs, Sebastian/0000-0001-5504-8579; Lurie, Daniel/0000-0001-8012-6399; Smallwood, Jonathan/0000-0002-7298-2459; Margulies, Daniel/0000-0002-8880-9204				Allen M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00743; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrews-Hanna JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00900; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baird B, J COGN NEUROSCI; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Barron E, 2011, PSYCHOL SCI, V22, P596, DOI 10.1177/0956797611404083; Baumann O, 2012, NEUROIMAGE, V61, P805, DOI 10.1016/j.neuroimage.2012.03.044; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Chen AC, 2013, P NATL ACAD SCI US; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Diaz JL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00739; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franklin MS, 2013, PSYCHON B REV; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Gilden D, 1995, AIDS RES HUM RETRO S, V267, P4; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Kalisch R, 2014, NEUROSCI BIOBEHAV R, V42, P1, DOI 10.1016/j.neubiorev.2014.02.002; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kosslyn S, 1988, AIDS RES HUM RETRO S; Kuhn S., 2013, HUM BRAIN MAPP; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Matthews G., 1999, PERSONALITY PSYCHOL, V7, P335, DOI DOI 10.1177/154193120404801107; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morin A, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.331; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Preminger S, 2011, NEUROIMAGE, V54, P1692, DOI 10.1016/j.neuroimage.2010.08.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Revelle W., 2013, PSYCH PROCEDURES PSY; Ruby FJM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00962; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Rummel J, 2014, PSYCHON B REV; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033706; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00425; Stawarczyk D, 2013, CONSCIOUS COGN, V22, P442, DOI 10.1016/j.concog.2013.01.012; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; ten Berge JMF, 1999, LINEAR ALGEBRA APPL, V289, P311, DOI 10.1016/S0024-3795(97)10007-6; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	103	104	105	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97176	10.1371/journal.pone.0097176	http://dx.doi.org/10.1371/journal.pone.0097176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824880	Green Published, gold, Green Accepted			2022-12-25	WOS:000336369200068
J	Yang, M; Eyers, F; Xiang, Y; Guo, M; Young, IG; Rosenberg, HF; Foster, PS				Yang, Ming; Eyers, Fiona; Xiang, Yang; Guo, Man; Young, Ian G.; Rosenberg, Helene F.; Foster, Paul S.			Expression Profiling of Differentiating Eosinophils in Bone Marrow Cultures Predicts Functional Links between MicroRNAs and Their Target mRNAs	PLOS ONE			English	Article							PERIPHERAL-BLOOD EOSINOPHILS; HEMATOPOIETIC STEM-CELLS; MAST-CELLS; PROLIFERATION; INTERLEUKIN-5; IMMUNITY; MIR-196A; TRANSCRIPTION; DEFICIENCY; CHEMOKINE	Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate complex transcriptional networks underpin immune responses. However, little is known about the specific miRNA networks that control differentiation of specific leukocyte subsets. In this study, we profiled miRNA expression during differentiation of eosinophils from bone marrow (BM) progenitors (bmEos), and correlated expression with potential mRNA targets involved in crucial regulatory functions. Profiling was performed on whole BM cultures to document the dynamic changes in miRNA expression in the BM microenvironment over the differentiation period. miRNA for network analysis were identified in BM cultures enriched in differentiating eosinophils, and chosen for their potential ability to target mRNA of factors that are known to play critical roles in eosinophil differentiation pathways or cell identify. Methodology/Principal Findings: We identified 68 miRNAs with expression patterns that were up-or down-regulated 5-fold or more during bmEos differentiation. By employing TargetScan and MeSH databases, we identified 348 transcripts involved in 30 canonical pathways as potentially regulated by these miRNAs. Furthermore, by applying miRanda and Ingenuity Pathways Analysis (IPA), we identified 13 specific miRNAs that are temporally associated with the expression of IL-5R alpha and CCR3 and 14 miRNAs associated with the transcription factors GATA-1/2, PU.1 and C/EBP epsilon. We have also identified 17 miRNAs that may regulate the expression of TLRs 4 and 13 during eosinophil differentiation, although we could identify no miRNAs targeting the prominent secretory effector, eosinophil major basic protein. Conclusions/Significance: This is the first study to map changes in miRNA expression in whole BM cultures during the differentiation of eosinophils, and to predict functional links between miRNAs and their target mRNAs for the regulation of eosinophilopoiesis. Our findings provide an important resource that will promote the platform for further understanding of the role of these non-coding RNAs in the regulation of eosinophil differentiation and function.	[Yang, Ming; Eyers, Fiona; Foster, Paul S.] Univ Newcastle, Fac Hlth, Ctr Asthma & Resp Dis, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Yang, Ming; Eyers, Fiona; Foster, Paul S.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Xiang, Yang; Guo, Man] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Bioscience, Canberra, ACT 2601, Australia; [Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Central South University; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yang, M (corresponding author), Univ Newcastle, Fac Hlth, Ctr Asthma & Resp Dis, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia.	Ming.Yang@newcastle.edu.au; Paul.Foster@newcastle.edu.au	Foster, Paul/G-5057-2013	, Paul/0000-0002-0827-8299	National Health and Medical Research Council of Australia; Australian Research Council; Cooperative Research Centre for Asthma and Airways; National Institute of Allergy and Infectious Diseases Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000942, ZIAAI000941] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Institute of Allergy and Infectious Diseases Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the National Health and Medical Research Council of Australia, the Australian Research Council, the Cooperative Research Centre for Asthma and Airways and National Institute of Allergy and Infectious Diseases Division of Intramural Research. The funding bodies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bettigole SE, 2013, 8 BIENN S INT EOS SO; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Dyer KD, 2011, J IMMUNOL METHODS, V369, P91, DOI 10.1016/j.jim.2011.04.009; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Furumoto Y, 2011, BLOOD, V118, P5466, DOI 10.1182/blood-2010-09-309955; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HALLGREN R, 1985, CLIN EXP IMMUNOL, V59, P539; HER E, 1991, J CLIN INVEST, V88, P1982, DOI 10.1172/JCI115524; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Hu YL, 2010, NUCLEIC ACIDS RES, V38, P5472, DOI 10.1093/nar/gkq337; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kampe M, 2012, INFLAMMATION, V35, P230, DOI 10.1007/s10753-011-9309-5; Kashiyama K, 2012, J INVEST DERMATOL, V132, P1597, DOI 10.1038/jid.2012.22; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Lee JJ, 2012, J ALLERGY CLIN IMMUN, V130, P572, DOI 10.1016/j.jaci.2012.07.025; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Liu C, 2013, BLOOD; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Melo RCN, 2013, ALLERGY, V68, P274, DOI 10.1111/all.12103; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; MERTENS AV, 1993, CLIN EXP ALLERGY, V23, P868, DOI 10.1111/j.1365-2222.1993.tb00266.x; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Persson CGA, 1997, TRENDS PHARMACOL SCI, V18, P465; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Plotz SG, 2001, BLOOD, V97, P235, DOI 10.1182/blood.V97.1.235; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Shinkai A, 1999, J IMMUNOL, V163, P1602; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Wong CK, 2013, IMMUNOBIOLOGY, V218, P255, DOI 10.1016/j.imbio.2012.05.019; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839	81	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97537	10.1371/journal.pone.0097537	http://dx.doi.org/10.1371/journal.pone.0097537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824797	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200128
J	Desai, LP; Zhou, Y; Estrada, AV; Ding, Q; Cheng, GJ; Collawn, JF; Thannickal, VJ				Desai, Leena P.; Zhou, Yong; Estrada, Aida V.; Ding, Qiang; Cheng, Guangjie; Collawn, James F.; Thannickal, Victor J.			Negative Regulation of NADPH Oxidase 4 by Hydrogen Peroxide-inducible Clone 5 (Hic-5) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; GROWTH-FACTOR-BETA; ALPHA-B-CRYSTALLIN; PREMATURE SENESCENCE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; BINDING-PROTEIN; IN-VITRO; CELLS; HSP27	Hydrogen peroxide-inducible clone 5 (Hic-5) is a focal adhesion adaptor protein induced by the profibrotic cytokine TGF-beta 1. We have demonstrated previously that TGF-beta 1 induces myofibroblast differentiation and lung fibrosis by activation of the reactive oxygen species-generating enzyme NADPH oxidase 4 (Nox4). Here we investigated a potential role for Hic-5 in regulating Nox4, myofibroblast differentiation, and senescence. In normal human diploid fibroblasts, TGF-beta 1 induces Hic-5 expression in a delayed manner relative to the induction of Nox4 and myofibroblast differentiation. Hic-5 silencing induced constitutive Nox4 expression and enhanced TGF-beta 1 inducible Nox4 levels. The induction of constitutive Nox4 protein in Hic-5-silenced cells was independent of transcription and translation and controlled by the ubiquitin-proteasomal system. Hic-5 associates with the ubiquitin ligase Cbl-c and the ubiquitin-binding protein heat shock protein 27 (HSP27). The interaction of these proteins is required for the ubiquitination of Nox4 and for maintaining low basal levels of this reactive oxygen species-generating enzyme. Our model suggests that TGF-beta 1-induced Hic-5 functions as a negative feedback mechanism to limit myofibroblast differentiation and senescence by promoting the ubiquitin-proteasomal system-mediated degradation of Nox4. Together, these studies indicate that endogenous Hic-5 suppresses senescence and profibrotic activities of myofibroblasts by down-regulating Nox4 protein expression. Additionally, these are the first studies, to our	[Desai, Leena P.; Zhou, Yong; Estrada, Aida V.; Ding, Qiang; Cheng, Guangjie; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Collawn, James F.] Univ Alabama Birmingham, Div Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, 1900 Univ Blvd,THT 429, Birmingham, AL 35294 USA.	vjthan@uab.edu		Cheng, Guangjie/0000-0002-9368-379X; Collawn, James/0000-0002-2528-2759	National Institutes of Health [T32 HL105346, P01 HL114470]; NATIONAL CANCER INSTITUTE [P50CA101955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105346, R01HL085324, P01HL114470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL105346 (to L. P. D.) and P01 HL114470 (to V. J. T.).	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Bahta AW, 2008, J INVEST DERMATOL, V128, P1088, DOI 10.1038/sj.jid.5701147; Bai GX, 2014, GENE, V540, P62, DOI 10.1016/j.gene.2014.02.026; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Du Y, 2009, INT J ORAL SCI, V1, P72, DOI 10.4248/ijos.08020; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Ito H, 2002, J BIOCHEM, V131, P593, DOI 10.1093/oxfordjournals.jbchem.a003139; Jia YF, 2001, J BIOL CHEM, V276, P39911, DOI 10.1074/jbc.M103510200; Kato K, 2011, INT J MOL MED, V27, P423, DOI 10.3892/ijmm.2011.595; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Komatsuda A, 1999, NEPHROL DIAL TRANSPL, V14, P1385, DOI 10.1093/ndt/14.6.1385; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liu TG, 2007, AM J RESP CELL MOL, V37, P507, DOI 10.1165/rcmb.2007-0077OC; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Peshavariya H, 2009, ANTIOXID REDOX SIGN, V11, P2399, DOI [10.1089/ars.2009.2579, 10.1089/ARS.2009.2579]; Ryan PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049428; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Sun Y, 2011, EXP LUNG RES, V37, P568, DOI 10.3109/01902148.2011.619627; Takahashi-Horiuchi Y, 2008, TOHOKU J EXP MED, V214, P221, DOI 10.1620/tjem.214.221; Thannickal VJ, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S23; Thannickal VJ, 2013, BIOGERONTOLOGY, V14, P609, DOI 10.1007/s10522-013-9451-6; Thannickal VJ, 2010, INT J BIOCHEM CELL B, V42, P1398, DOI 10.1016/j.biocel.2010.05.010; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Vidyasagar A, 2013, KIDNEY INT, V83, P84, DOI 10.1038/ki.2012.336; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zhang J, 2000, MOL CARCINOGEN, V27, P177, DOI 10.1002/(SICI)1098-2744(200003)27:3<177::AID-MC4>3.3.CO;2-J	43	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18270	18278		10.1074/jbc.M114.562249	http://dx.doi.org/10.1074/jbc.M114.562249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831009	Green Published, hybrid			2022-12-25	WOS:000338042000027
J	Gould, CJ; Chesarone-Cataldo, M; Alioto, SL; Salin, B; Sagot, I; Goode, BL				Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Salin, Benedicte; Sagot, Isabelle; Goode, Bruce L.			Saccharomyces cerevisiae Kelch Proteins and Bud14 Protein Form a Stable 520-kDa Formin Regulatory Complex That Controls Actin Cable Assembly and Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST CYTOKINESIS; FISSION YEAST; POLARIZED GROWTH; MICROTUBULAR CYTOSKELETON; ORGANELLE SEGREGATION; CRYSTAL-STRUCTURE; FAMILY PROTEIN; HUMAN KEAP1; MYOSIN-V; DYNAMICS	Formins perform essential roles in actin assembly and organization in vivo, but they also require tight regulation of their activities to produce properly functioning actin structures. Saccharomyces cerevisiae Bud14 is one member of an emerging class of formin regulators that target the FH2 domain to inhibit actin polymerization, but little is known about how these regulators are themselves controlled in vivo. Kelch proteins are critical for cell polarity and morphogenesis in a wide range of organisms, but their mechanistic roles in these processes are still largely undefined. Here, we report that S. cerevisiae Kelch proteins, Kel1 and Kel2, associate with Bud14 in cell extracts to form a stable 520-kDa complex with an apparent stoichiometry of 2: 2: 1 Bud14/Kel1/Kel2. Using pairwise combinations of GFP-and red fluorescent protein-tagged proteins, we show that Kel1, Kel2, and Bud14 interdependently co-localize at polarity sites. By analyzing single, double, and triple mutants, we show that Kel1 and Kel2 function in the same pathway as Bud14 in regulating Bnr1-mediated actin cable formation. Loss of any component of the complex results in long, bent, and hyper-stable actin cables, accompanied by defects in secretory vesicle traffic during polarized growth and septum formation during cytokinesis. These observations directly link S. cerevisiae Kelch proteins to the control of formin activity, and together with previous observations made for S. pombe homologues tea1p and tea3p, they have broad implications for understanding Kelch function in other systems.	[Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Gould, Christopher J.; Chesarone-Cataldo, Melissa; Alioto, Salvatore L.; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Salin, Benedicte; Sagot, Isabelle] Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Salin, Benedicte; Sagot, Isabelle] CNRS, UMR5095, Bordeaux, France	Brandeis University; Brandeis University; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu			National Institutes of Health [GM083137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, T32GM007122, R01GM083137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083137 (to B. G.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Adams JC, 1998, EMBO J, V17, P4964, DOI 10.1093/emboj/17.17.4964; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bretscher A, 2003, J CELL BIOL, V160, P811, DOI 10.1083/jcb.200301035; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone-Cataldo M, 2011, DEV CELL, V21, P217, DOI 10.1016/j.devcel.2011.07.004; Cullen PJ, 2002, EUKARYOT CELL, V1, P884, DOI 10.1128/EC.1.6.884-894.2002; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Gao L, 2010, MOL BIOL CELL, V21, P1253, DOI 10.1091/mbc.E09-10-0861; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Guthrie C, 1991, GUIDE YEAST GENETICS; Hara T, 2004, MOL BIOL CELL, V15, P1172, DOI 10.1091/mbc.E03-07-0531; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hofken T, 2002, EMBO J, V21, P4851, DOI 10.1093/emboj/cdf481; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Kim IF, 1999, GENE, V228, P73, DOI 10.1016/S0378-1119(99)00006-2; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Li XC, 2004, ACTA CRYSTALLOGR D, V60, P2346, DOI 10.1107/S0907444904024825; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Ohta Y, 2010, INT J ONCOL, V36, P427, DOI 10.3892/ijo_00000516; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; RODRIGUEZ JR, 1990, CELL MOTIL CYTOSKEL, V17, P301, DOI 10.1002/cm.970170405; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schott DH, 2002, J CELL BIOL, V156, P35, DOI 10.1083/jcb.200110086; Schuyler SC, 2002, METHOD ENZYMOL, V351, P150; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Snaith HA, 2005, NAT CELL BIOL, V7, P450, DOI 10.1038/ncb0505-450; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Velichkova M, 2003, CELL MOTIL CYTOSKEL, V56, P109, DOI 10.1002/cm.10138; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	61	17	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18290	18301		10.1074/jbc.M114.548719	http://dx.doi.org/10.1074/jbc.M114.548719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828508	Green Published, hybrid			2022-12-25	WOS:000338042000029
J	Iyirhiaro, GO; Zhang, Y; Estey, C; O'Hare, MJ; Safarpour, F; Parsanejad, M; Wang, SZ; Abdel-Messih, E; Callaghan, SM; During, MJ; Slack, RS; Park, DS				Iyirhiaro, Grace O.; Zhang, Yi; Estey, Carmen; O'Hare, Michael J.; Safarpour, Farzaneh; Parsanejad, Mohammad; Wang, Suzi; Abdel-Messih, Elizabeth; Callaghan, Steve M.; During, Matthew J.; Slack, Ruth S.; Park, David S.			Regulation of Ischemic Neuronal Death by E2F4-p130 Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR E2F1; DNA-DAMAGE; INDEPENDENT FUNCTIONS; FOCAL ISCHEMIA; MICE LACKING; APOPTOSIS; SURVIVAL; P130; ACTIVATION	Inappropriate activation of cell cycle proteins, in particular cyclin D/Cdk4, is implicated in neuronal death induced by various pathologic stresses, including DNA damage and ischemia. Key targets of Cdk4 in proliferating cells include members of the E2F transcription factors, which mediate the expression of cell cycle proteins as well as death-inducing genes. However, the presence of multiple E2F family members complicates our understanding of their role in death. We focused on whether E2F4, an E2F member believed to exhibit crucial control over the maintenance of a differentiated state of neurons, may be critical in ischemic neuronal death. We observed that, in contrast to E2F1 and E2F3, which sensitize to death, E2F4 plays a crucial protective role in neuronal death evoked by DNA damage, hypoxia, and global ischemic insult both in vitro and in vivo. E2F4 occupies promoter regions of proapoptotic factors, such as B-Myb, under basal conditions. Following stress exposure, E2F4-p130 complexes are lost rapidly along with the presence of E2F4 at E2F-containing B-Myb promoter sites. In contrast, the presence of E2F1 at B-Myb sites increases with stress. Furthermore, B-Myb and C-Myb expression increases with ischemic insult. Taken together, we propose a model by which E2F4 plays a protective role in neurons from ischemic insult by forming repressive complexes that prevent prodeath factors such as Myb from being expressed.	[Iyirhiaro, Grace O.; Zhang, Yi; Estey, Carmen; O'Hare, Michael J.; Safarpour, Farzaneh; Parsanejad, Mohammad; Wang, Suzi; Abdel-Messih, Elizabeth; Callaghan, Steve M.; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med & Neurosci, Ottawa, ON K1H 8M5, Canada; [During, Matthew J.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Ottawa; University System of Ohio; Ohio State University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	During, Matthew/AAC-1388-2020	Park, David/0000-0002-4490-3784; Slack, Ruth/0000-0002-1552-2835	Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Center for Stroke Recovery; Neuroscience Canada/Krembil Foundation; Queen Elizabeth II Graduate Scholarships in Science and Technology award	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Center for Stroke Recovery; Neuroscience Canada/Krembil Foundation; Queen Elizabeth II Graduate Scholarships in Science and Technology award	This work was supported by grants from the Heart and Stroke Foundation of Canada, the Heart and Stroke Foundation of Ontario, the Canadian Institutes of Health Research, the Center for Stroke Recovery, and the Neuroscience Canada/Krembil Foundation (to D. S. P.).; Recipient of a Heart and Stroke Foundation of Canada doctoral award and the Queen Elizabeth II Graduate Scholarships in Science and Technology award.; Heart and Stroke Foundation of Canada scholar and recipient of the Heart and Stroke Foundation of Canada Career Investigator award. To whom correspondence should be addressed: Dept. of Cellular and Molecular Medicine, Neuroscience, University of Ottawa, 451 Smyth Rd., Ottawa, ON K1H 8M5, Canada. Tel.: 613-562-5800, ext.8816; Fax: 613-562-5403; E-mail: dpark@uottawa.ca.	Baldi A, 1997, CLIN CANCER RES, V3, P1691; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kusek JC, 2001, BRAIN RES BULL, V54, P187, DOI 10.1016/S0361-9230(00)00447-0; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Schwartz EI, 2007, CELL CYCLE, V6, P318, DOI 10.4161/cc.6.3.3752; Smith RA, 2003, MOL BRAIN RES, V116, P70, DOI 10.1016/S0169-328X(03)00253-5; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yuan ZM, 2011, NEUROSCI LETT, V499, P164, DOI 10.1016/j.neulet.2011.05.045; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18202	18213		10.1074/jbc.M114.574145	http://dx.doi.org/10.1074/jbc.M114.574145			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24828495	Green Published, hybrid			2022-12-25	WOS:000338042000022
J	Kanero, J; Imai, M; Okuda, J; Okada, H; Matsuda, T				Kanero, Junko; Imai, Mutsumi; Okuda, Jiro; Okada, Hiroyuki; Matsuda, Tetsuya			How Sound Symbolism Is Processed in the Brain: A Study on Japanese Mimetic Words	PLOS ONE			English	Article							CORRESPONDENCES; REPRESENTATIONS; PERCEPTION; MOTOR; SHAPE	Sound symbolism is the systematic and non-arbitrary link between word and meaning. Although a number of behavioral studies demonstrate that both children and adults are universally sensitive to sound symbolism in mimetic words, the neural mechanisms underlying this phenomenon have not yet been extensively investigated. The present study used functional magnetic resonance imaging to investigate how Japanese mimetic words are processed in the brain. In Experiment 1, we compared processing for motion mimetic words with that for non-sound symbolic motion verbs and adverbs. Mimetic words uniquely activated the right posterior superior temporal sulcus (STS). In Experiment 2, we further examined the generalizability of the findings from Experiment 1 by testing another domain: shape mimetics. Our results show that the right posterior STS was active when subjects processed both motion and shape mimetic words, thus suggesting that this area may be the primary structure for processing sound symbolism. Increased activity in the right posterior STS may also reflect how sound symbolic words function as both linguistic and non-linguistic iconic symbols.	[Kanero, Junko] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Imai, Mutsumi] Keio Univ Shonan Fujisawa, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Okuda, Jiro] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Kita Ku, Kyoto 603, Japan; [Okada, Hiroyuki] Tamagawa Univ, Coll Engn, Dept Mech Syst, Machida, Tokyo, Japan; [Matsuda, Tetsuya] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Keio University; Kyoto Sangyo University	Matsuda, T (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	tetsuya@lab.tamagawa.ac.jp	Kanero, Junko/Y-1603-2019; Okada, HIroyuki/AAN-8999-2020	Kanero, Junko/0000-0003-1009-5333; 	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi [15300088, 21300301]; MEXT [23120003]; MEXT Global Center of Excellence (GCOE) program; Grants-in-Aid for Scientific Research [24659546, 26580078, 25330176] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Global Center of Excellence (GCOE) program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi grant to MI (#15300088) and to TM (#21300301), MEXT Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making to MI (#23120003), and MEXT Global Center of Excellence (GCOE) program awarded to Tamagawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Kimi, 2009, THESIS KOBE U KOBE; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bodomo Adams B., 2006, SEL P 35 ANN C AFR L, P203; Childs G.T., 1994, SOUND SYMBOLISM, P178; Diffloth Gurard., 1972, CHICAGO LINGUISTIC S, V8, P440; Enfield NJ, 2005, ANNU REV ANTHROPOL, V34, P181, DOI 10.1146/annurev.anthro.34.081804.120406; Fernald A, 2000, PHONETICA, V57, P242, DOI 10.1159/000028477; Firth J. R., 1935, PAPERS LINGUISTICS 1, P34; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hashimoto T, 2006, NEUROIMAGE, V31, P1762, DOI 10.1016/j.neuroimage.2006.02.019; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Hinton L., 1994, SOUND SYMBOLISM; Holmes AP, 1997, NEUROIMAGE, V5, pS480; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Iwasaki N., 2007, JAPANESE LANGUAGE ED, V17, P53; Iwasaki Noriko, 2007, APPLYING THEORY RES, P2; Jakobson R., 1979, SOUND SHAPE LANGUAGE; Kable JW, 2005, J COGNITIVE NEUROSCI, V17, P1855, DOI 10.1162/089892905775008625; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Kemmerer D, 2008, COGN NEUROPSYCHOL, V25, P601, DOI 10.1080/02643290802247052; Kita S, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P206, DOI 10.1142/9789814295222_0027; Kohler W., 1929, GESTALT PSYCHOL; Kovic V, 2010, COGNITION, V114, P19, DOI 10.1016/j.cognition.2009.08.016; Lee J-S, 1992, THESIS INDIANA U BLO; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Ono M., 2007, NIHONGO ONOMATOPOEIA; Osaka N, 2004, BEHAV BRAIN RES, V153, P123, DOI 10.1016/j.bbr.2003.11.013; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Pelphrey KA, 2003, NEUROPSYCHOLOGIA, V41, P156, DOI 10.1016/S0028-3932(02)00146-X; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Saussure F. de., 1983, COURSE GEN LINGUISTI; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Thierry G, 2003, NEURON, V38, P499, DOI 10.1016/S0896-6273(03)00199-5; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Watson Richard L., 2001, IDEOPHONES, P385, DOI DOI 10.1075/TSL.44.29WAT; WE Mok, 2001, THESIS U HAWAII HONO	44	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97905	10.1371/journal.pone.0097905	http://dx.doi.org/10.1371/journal.pone.0097905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840874	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600090
J	Ogier, JM; Carpinelli, MR; Arhatari, BD; Symons, RCA; Kile, BT; Burt, RA				Ogier, Jacqueline M.; Carpinelli, Marina R.; Arhatari, Benedicta D.; Symons, R. C. Andrew; Kile, Benjamin T.; Burt, Rachel A.			CHD7 Deficiency in "Looper", a New Mouse Model of CHARGE Syndrome, Results in Ossicle Malformation, Otosclerosis and Hearing Impairment	PLOS ONE			English	Article							INNER-EAR; GENE-EXPRESSION; MUTATIONS; MECHANISMS; DEFECTS; MICE; NEUROGENESIS; FEATURES	CHARGE syndrome is a rare human disorder caused by mutations in the gene encoding chromodomain helicase DNA binding protein 7 (CHD7). Characteristics of CHARGE are varied and include developmental ear and hearing anomalies. Here we report a novel mouse model of CHD7 dysfunction, termed Looper. The Looper strain harbours a nonsense mutation (c.5690C>A, p. S1897X) within the Chd7 gene. Looper mice exhibit many of the clinical features of the human syndrome, consistent with previously reported CHARGE models, including growth retardation, facial asymmetry, vestibular defects, eye anomalies, hyperactivity, ossicle malformation, hearing loss and vestibular dysfunction. Looper mice display an otosclerosis-like fusion of the stapes footplate to the cochlear oval window and blepharoconjunctivitis but not coloboma. Looper mice are hyperactive and have vestibular dysfunction but do not display motor impairment.	[Ogier, Jacqueline M.; Carpinelli, Marina R.; Burt, Rachel A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Carpinelli, Marina R.; Burt, Rachel A.] HEARing Cooperat Res Ctr, Parkville, Vic, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.; Burt, Rachel A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Kile, Benjamin T.; Burt, Rachel A.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Burt, Rachel A.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Arhatari, Benedicta D.] La Trobe Univ, Dept Phys, ARC Ctr Excellence Coherent X Ray Sci, Bundoora, Vic 3083, Australia; [Symons, R. C. Andrew] Royal Melbourne Hosp, Dept Ophthalmol, Parkville, Vic 3050, Australia	Murdoch Children's Research Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University; Royal Melbourne Hospital	Burt, RA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	rachel.burt@mcri.edu.au	Ogier, Jackie/HCH-4868-2022; Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Symons, Robert Charles Andrew/C-2040-2017; Burt, Rachel/I-7874-2012; Administrator, CMSS/E-3491-2015	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Symons, Robert Charles Andrew/0000-0002-8104-881X; Burt, Rachel/0000-0001-8827-8266; Ogier, Jacqueline/0000-0002-7468-4009; Carpinelli, Marina/0000-0001-5115-7831	HEARing CRC - Cooperative Research Centres Program - an Australian Government Initiative; Garnett Passe and Rodney Williams Memorial Foundation; Australian Government's National Health and Medical Research Council [461219, 1016647]; Sylvia and Charles Viertel Foundation; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant	HEARing CRC - Cooperative Research Centres Program - an Australian Government Initiative; Garnett Passe and Rodney Williams Memorial Foundation; Australian Government's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the HEARing CRC, established and supported under the Cooperative Research Centres Program - an Australian Government Initiative; the Garnett Passe and Rodney Williams Memorial Foundation (fellowship to MRC); the Australian Government's National Health and Medical Research Council (Program Grants 461219 and 1016647, and a fellowship to BTK); the Sylvia and Charles Viertel Foundation (fellowship to BTK); the Victorian State Government's Operational Infrastructure Support Program; the Australian Government's NHMRC IRIISS; and a National Collaborative Research Infrastructure Strategy grant to the Australian Phenomics Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2000, EUR J PEDIATR, V159, P569, DOI 10.1007/s004319900409; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergman JEH, 2012, HUM MUTAT, V33, P1251, DOI 10.1002/humu.22106; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Carpinelli MR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.100; Carpinelli MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067479; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Chordekar S, 2012, HEARING RES, V283, P180, DOI 10.1016/j.heares.2011.10.004; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Graham JM, 2005, AM J MED GENET A, V133A, P240, DOI 10.1002/ajmg.a.30543; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2012, MECH DEVELOP, V129, P308, DOI 10.1016/j.mod.2012.06.002; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Issekutz KA, 2005, AM J MED GENET A, V133A, P309, DOI 10.1002/ajmg.a.30560; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jiang X, 2012, AM J PATHOL, V181, P626, DOI 10.1016/j.ajpath.2012.05.006; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lenz DR, 2010, AUDIOL MED, V8, P110; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Nishina S, 2012, AM J MED GENET A, V158A, P514, DOI 10.1002/ajmg.a.34400; Pau H, 2004, OTOL NEUROTOL, V25, P707, DOI 10.1097/00129492-200409000-00010; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Puc J, 2011, NAT GENET, V43, P505, DOI 10.1038/ng.843; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; Toriello H. V., 2004, HEREDITARY HEARING L; van den Akker PC, 2011, HUM MUTAT, V32, P1100, DOI 10.1002/humu.21551; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5	38	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97559	10.1371/journal.pone.0097559	http://dx.doi.org/10.1371/journal.pone.0097559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840056	Green Published, gold			2022-12-25	WOS:000340948600045
J	Ban, JB; Fan, XW; Huang, Q; Li, BF; Chen, C; Zhang, HC; Xu, SQ				Ban, Jin-Bao; Fan, Xiao-Wu; Huang, Qi; Li, Bin-Feng; Chen, Chen; Zhang, Hua-Chuan; Xu, Shun-Qing			Mono-(2-Ethylhexyl) Phthalate Induces Injury in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; LIPID-PEROXIDATION; INDUCED APOPTOSIS; EXPOSURE; INDUCTION; TOXICITY; STRESS; FAMILY; DEATH; BAX	Mono-(2-ethylhexyl) phthalate (MEHP), the active metabolite of di-(2-ethylhexyl) phthalate (DEHP), is a widespread environmental contaminant and has been proved to have potential adverse effects on the reproductive system, carcinogenicity, liver, kidney and developmental toxicities. However, the effect of MEHP on vascular system remains unclear. The main purpose of this study was to evaluate the cytotoxic effects of MEHP on human umbilical endothelial cells (HUVEC) and its possible molecular mechanism. HUVEC cells were treated with MEHP (0, 6.25, 12.5, 25,50 and 100 mu M), and the cellular apoptosis and mitochondrial membrane potential as well as intracellular reactive oxygen species were determined. In present study, MEHP induced a dose-dependent cell injury in HUVEC cell via an apoptosis pathway as characterized by increased percentage of sub-G1, activation of caspase-3, -8and -9, and increased ratio of Bax/bcl-2 mRNA and protein expression as well as cytochrome C releasing. In addition, there was obvious oxidative stress, represented by decreased glutathione level, increased malondialdehyde level and superoxide dismutase activity. N-Acetylcysteine, as an antioxidant that is a direct reactive oxygen species scavenger, could effectively block MEHP-induced reactive oxygen species generation, mitochondrial membrane potential loss and cell apoptosis. These data indicated that MEHP induced apoptosis in HUVEC cells through a reactive oxygen species-mediated mitochondria-dependent pathway.	[Ban, Jin-Bao; Fan, Xiao-Wu; Huang, Qi; Li, Bin-Feng; Chen, Chen; Zhang, Hua-Chuan] Huazhong Univ Sci & Technol, Dept Gen Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xu, Shun-Qing] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, Q (corresponding author), Huazhong Univ Sci & Technol, Dept Gen Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	huangqi6699@gmail.com; xuscience@hotmail.com			National Program on Key Basic Research Project of China (973 Program) [2012CB722401]; National Natural Science Foundation of China [81030051, 21177046]; R&D Special Fund for Public Welfare Industry (Environment) [200909102]; National Science & Technology Pillar Program during the 12th Five-year Plan Period of China [2012BAI 32B03]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); R&D Special Fund for Public Welfare Industry (Environment); National Science & Technology Pillar Program during the 12th Five-year Plan Period of China	This work was supported by the National Program on Key Basic Research Project of China (973 Program) (2012CB722401), the National Natural Science Foundation of China (81030051, 21177046), the R&D Special Fund for Public Welfare Industry (Environment) (200909102), and the National Science & Technology Pillar Program during the 12th Five-year Plan Period of China (2012BAI 32B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2007, CEREBELLUM, V6, P308, DOI 10.1080/14734220601142878; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Chen JH, 2006, FOOD CHEM TOXICOL, V44, P567, DOI 10.1016/j.fct.2005.09.004; Chen TA, 2011, TOXICOL LETT, V201, P34, DOI 10.1016/j.toxlet.2010.12.002; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Erkekoglu P, 2010, TOXICOL APPL PHARM, V248, P52, DOI 10.1016/j.taap.2010.07.016; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011; Mates J M, 1999, Front Biosci, V4, pD339; National Toxicology Program, 1982, Natl Toxicol Program Tech Rep Ser, V212, P1; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304, DOI 10.1002/jlb.43.4.304; Sadowska AM, 2007, PULM PHARMACOL THER, V20, P9, DOI 10.1016/j.pupt.2005.12.007; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schelman WR, 2004, MOL BRAIN RES, V128, P160, DOI 10.1016/j.molbrainres.2004.06.011; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; TOMASZEWSKI KE, 1990, TOXICOLOGY, V65, P49, DOI 10.1016/0300-483X(90)90078-U; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015901; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei ZZ, 2012, TOXICOL LETT, V212, P212, DOI 10.1016/j.toxlet.2012.05.023; Yang JS, 2009, FOOD CHEM TOXICOL, V47, P171, DOI 10.1016/j.fct.2008.10.032; Yoshioka Y, 2006, J IMMUNOL, V176, P4675, DOI 10.4049/jimmunol.176.8.4675	34	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97607	10.1371/journal.pone.0097607	http://dx.doi.org/10.1371/journal.pone.0097607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836450	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800057
J	Den Hartigh, RJR; Gernigon, C; Van Yperen, NW; Marin, L; Van Geert, PLC				Den Hartigh, Ruud J. R.; Gernigon, Christophe; Van Yperen, Nico W.; Marin, Ludovic; Van Geert, Paul L. C.			How Psychological and Behavioral Team States Change during Positive and Negative Momentum	PLOS ONE			English	Article							QUESTIONNAIRE SUR LAMBIANCE; COUNTERFACTUAL THINKING; PHASE-TRANSITIONS; DYNAMICS; COORDINATION; SPORT; SATISFACTION; EXPERIENCE; COHESION; VELOCITY	In business and sports, teams often experience periods of positive and negative momentum while pursuing their goals. However, researchers have not yet been able to provide insights into how psychological and behavioral states actually change during positive and negative team momentum. In the current study we aimed to provide these insights by introducing an experimental dynamical research design. Rowing pairs had to compete against a virtual opponent on rowing ergometers, while a screen in front of the team broadcasted the ongoing race. The race was manipulated so that the team's rowing avatar gradually progressed (positive momentum) or regressed (negative momentum) in relation to the victory. The participants responded verbally to collective efficacy and task cohesion items appearing on the screen each minute. In addition, effort exertion and interpersonal coordination were continuously measured. Our results showed negative psychological changes (perceptions of collective efficacy and task cohesion) during negative team momentum, which were stronger than the positive changes during positive team momentum. Moreover, teams' exerted efforts rapidly decreased during negative momentum, whereas positive momentum accompanied a more variable and adaptive sequence of effort exertion. Finally, the interpersonal coordination was worse during negative momentum than during positive momentum. These results provide the first empirical insights into actual team momentum dynamics, and demonstrate how a dynamical research approach significantly contributes to current knowledge on psychological and behavioral processes.	[Den Hartigh, Ruud J. R.; Van Yperen, Nico W.; Van Geert, Paul L. C.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Den Hartigh, Ruud J. R.; Gernigon, Christophe] Univ Montpellier I, Fac Sport & Phys Educ Sci, Epsylon Lab, Montpellier, France; [Marin, Ludovic] Univ Montpellier I, Fac Sport & Phys Educ Sci, Movement Hlth Lab M2H, Montpellier, France	University of Groningen; Universite de Montpellier; Universite de Montpellier	Den Hartigh, RJR (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	j.r.den.hartigh@rug.nl	Van Yperen, Nico W./C-2341-2012	Van Yperen, Nico W./0000-0003-2116-8841; Gernigon, Christophe/0000-0002-3233-7551; Den Hartigh, Ruud/0000-0002-0094-8307; Marin, Ludovic/0000-0002-9040-8012	French Doctoral School "Human Movement Sciences" [463]	French Doctoral School "Human Movement Sciences"	The research reported in the article was supported by a PhD grant of the French Doctoral School "Human Movement Sciences" (463). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER P, 1978, URBAN LIFE, V7, P153, DOI 10.1177/089124167800700202; Adler P., 1981, MOMENTUM THEORY SOCI; Arrow H., 2000, SMALL GROUPS COMPLEX; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A, 1997, SELF EFFICACY EXERCI; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323, 10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323]; Briki W, 2014, MOTIV EMOTION, V38, P263, DOI 10.1007/s11031-013-9372-3; Briki W, 2014, PSYCHOL SPORT EXERC, V15, P216, DOI 10.1016/j.psychsport.2013.11.006; Briki W, 2013, PSYCHOL SPORT EXERC, V14, P389, DOI 10.1016/j.psychsport.2012.11.009; Briki W, 2012, INT J SPORT PSYCHOL, V43, P365, DOI 10.7352/IJSP2012.43.365; Buton F, 2007, SMALL GR RES, V38, P235, DOI 10.1177/1046496407300476; Carron A. V., 1998, GROUP DYNAMICS SPORT, V2nd; Carron A.V., 1998, ADV SPORT EXERCISE P, V213
226; Carron AV, 2002, J SPORT SCI, V20, P119, DOI 10.1080/026404102317200828; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Cornelius A, 1997, PERCEPT MOTOR SKILL, V84, P475, DOI 10.2466/pms.1997.84.2.475; Eisler L, 1998, J SPORT EXERCISE PSY, V20, P311; Feltz DL, 1998, J APPL PSYCHOL, V83, P557, DOI 10.1037/0021-9010.83.4.557; Gernigon C, 2010, J SPORT EXERCISE PSY, V32, P377, DOI 10.1123/jsep.32.3.377; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Heuze JP, 2002, J SPORT EXERCISE PSY, V24, P42, DOI 10.1123/jsep.24.1.42; HSEE CK, 1994, J EXP SOC PSYCHOL, V30, P96, DOI 10.1006/jesp.1994.1005; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Jones MI, 2008, J APPL SPORT PSYCHOL, V20, P57, DOI 10.1080/10413200701784841; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 1982, JUDGMENT UNCERTAINTY, P201, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477, 10.1017/CBO9780511809477.015]; Kelso S., 1995, DYNAMIC PATTERNS SEL; Lawrence JW, 2002, J APPL SOC PSYCHOL, V32, P788, DOI 10.1111/j.1559-1816.2002.tb00242.x; Lee JC, 2008, IEEE PERVAS COMPUT, V7, P39, DOI 10.1109/MPRV.2008.53; Markman KD, 2007, PERS SOC PSYCHOL B, V33, P800, DOI 10.1177/0146167207301026; Markman KD, 2007, THINK REASONING, V13, P188, DOI 10.1080/13546780600927157; McGrath JE, 2000, PERS SOC PSYCHOL REV, V4, P95, DOI 10.1207/S15327957PSPR0401_8; MEDVEC VH, 1995, J PERS SOC PSYCHOL, V69, P603, DOI 10.1037/0022-3514.69.4.603; Medvec VH, 1997, J PERS SOC PSYCHOL, V72, P1284, DOI 10.1037/0022-3514.72.6.1284; Miller S, 1991, SPORT PSYCHOL, V5, P211, DOI DOI 10.1123/TSP.5.3.211; Moesch K, 2012, SPORT PSYCHOL, V26, P435, DOI 10.1123/tsp.26.3.435; Nowak A., 1998, DYNAMICAL SOCIAL PSY; Perreault S, 1998, J SPORT EXERCISE PSY, V20, P421, DOI 10.1123/jsep.20.4.421; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Stanimirovic R, 2004, J SPORT EXERCISE PSY, V2, P43, DOI DOI 10.1080/1612197X.2004.9671732; Taylor J, 1994, J APPL SPORT PSYCHOL, V6, P51, DOI DOI 10.1080/10413209408406465; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Todman JB., 2001, SINGLE CASE SMALL N; Van Geert P., 2012, DYNAMICAL SYSTEMS AP, P43; Van Geert P., 1994, DYNAMIC SYSTEMS DEV; van Geert P., 2009, CHAOS COMPLEXITY PSY, P242; van Geert P, 2011, CHILD DEV PERSPECT, V5, P273, DOI 10.1111/j.1750-8606.2011.00197.x; vanGeert P, 1997, PSYCHOL INQ, V8, P143, DOI 10.1207/s15327965pli0802_11	54	33	33	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97887	10.1371/journal.pone.0097887	http://dx.doi.org/10.1371/journal.pone.0097887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24838238	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800082
J	Krasner, NM; Ido, Y; Ruderman, NB; Cacicedo, JM				Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.			Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANTIDIABETIC DRUG; OXIDATIVE STRESS; BINDING PROTEIN; TNF-ALPHA; DYSFUNCTION; EXENATIDE; THERAPIES; INCRETIN; ADHESION	Liraglutide is a glucagon-like peptide-1 (GLP-1) mimetic used for the treatment of Type 2 diabetes. Similar to the actions of endogenous GLP-1, liraglutide potentiates the post-prandial release of insulin, inhibits glucagon release and increases satiety. Recent epidemiological studies and clinical trials have suggested that treatment with GLP-1 mimetics may also diminish the risk of cardiovascular disease in diabetic patients. The mechanism responsible for this effect has yet to be determined; however, one possibility is that they might do so by a direct effect on vascular endothelium. Since low grade inflammation of the endothelium is an early event in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD), we determined the effects of liraglutide on inflammation in cultured human aortic endothelial cells (HAECs). Liraglutide reduced the inflammatory responses to TNF alpha and LPS stimulation, as evidenced by both reduced protein expression of the adhesion molecules VCAM-1 and E-Selectin, and THP-1 monocyte adhesion. This was found to result from increased cell Ca2+ and several molecules sensitive to Ca2+ with known anti inflammatory actions in endothelial cells, including CaMKK beta, CaMKI, AMPK, eNOS and CREB. Treatment of the cells with STO-609, a CaMKK inhibitor, diminished both the activation of AMPK, CaMKI and the inhibition of TNF alpha and LPS-induced monocyte adhesion by liraglutide. Likewise, expression of an shRNA against AMPK nullified the anti-inflammatory effects of liraglutide. The results indicate that liraglutide exerts a strong anti-inflammatory effect on HAECs. They also demonstrate that this is due to its ability to increase intracellular Ca2+ and activate CAMKK beta, which in turn activates AMPK.	[Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.] Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit, Boston, MA 02118 USA; [Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.] Boston Univ, Sch Med, Endocrinol Sect, Boston, MA 02118 USA; [Krasner, Nadia M.] Boston Univ, Sch Med, Dept Med, Program Nutr & Metab, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Krasner, NM (corresponding author), Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit, Boston, MA 02118 USA.	nadiakrasner@gmail.com; cacicedo@bu.edu		/0000-0001-8417-9754	NIH/NHLBI [PO1 HL068758]; NIH/NIDDK [R24 DK094749]; Takeda Pharmaceuticals; NHLBI [HL07969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK094749] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NHLBI Program Project Grant PO1 HL068758 and NIH/NIDDK R24 Seed Grant R24 DK094749 and funding from Takeda Pharmaceuticals. NMK was supported by NHLBI T32 training grant HL07969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2012, J PHARMACOL SCI, V120, P121, DOI 10.1254/jphs.12108FP; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; Chen C, 2013, INFLAMMATION, V36, P309, DOI 10.1007/s10753-012-9548-0; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; CULLINAN CA, 1994, CELL CALCIUM, V15, P391, DOI 10.1016/0143-4160(94)90014-0; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; Damdindorj B, 2012, FEBS LETT, V586, P2555, DOI 10.1016/j.febslet.2012.06.034; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Flint A, 2011, ADV THER, V28, P213, DOI 10.1007/s12325-010-0110-x; Forst T, 2012, DIABETIC MED, V29, P1115, DOI 10.1111/j.1464-5491.2012.03589.x; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016; Horton ES, 2010, DIABETES CARE, V33, P1759, DOI 10.2337/dc09-2062; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kelly CJ, 2012, NUTR CLIN PRACT, V27, P215, DOI 10.1177/0884533611434934; Koska J, 2010, DIABETES CARE, V33, P1028, DOI 10.2337/dc09-1961; Krasner N, 2011, GLUCAGON LIKE PEPTID; KREYMANN B, 1987, LANCET, V2, P1300; Kwan HY, 2009, CLIN EXP PHARMACOL P, V36, P857, DOI 10.1111/j.1440-1681.2009.05199.x; Lee W, 2013, INFLAMMATION, V36, P94, DOI 10.1007/s10753-012-9523-9; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu HB, 2008, J ENDOCRINOL, V196, P57, DOI 10.1677/JOE-07-0387; Marso SP, 2011, DIABETES VASC DIS RE, V8, P237, DOI 10.1177/1479164111408937; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Nakamura K, 2012, ARTERIOSCL THROM VAS, V32, P2670, DOI 10.1161/ATVBAHA.112.254946; Nauck M, 2003, DIABETES, V52, pA128; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Niswender K, 2013, DIABETES OBES METAB, V15, P42, DOI 10.1111/j.1463-1326.2012.01673.x; Nordisk N, 2014, PRODUCT MONOGRAPH; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Ou HC, 2012, J VASC SURG, V55, P1104, DOI 10.1016/j.jvs.2011.10.011; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Read PA, 2012, HEART, V98, P408, DOI 10.1136/hrt.2010.219345; Russell-Jones D, 2009, MOL CELL ENDOCRINOL, V297, P137, DOI 10.1016/j.mce.2008.11.018; Schisano B, 2012, REGUL PEPTIDES, V174, P46, DOI 10.1016/j.regpep.2011.11.008; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; van Can J, 2013, INT J OBESE; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022; Yamamizu K, 2011, CIRC J, V75, P253, DOI 10.1253/circj.CJ-10-0915	58	107	115	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97554	10.1371/journal.pone.0097554	http://dx.doi.org/10.1371/journal.pone.0097554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835252	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800050
J	Faner, R; Gonzalez, N; Cruz, T; Kalko, SG; Agusti, A				Faner, Rosa; Gonzalez, Nuria; Cruz, Tamara; Graciela Kalko, Susana; Agusti, Alvar			Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect	PLOS ONE			English	Article							FAMILIAL AGGREGATION; NATURAL-HISTORY; SEX; EXPRESSION; RISK; COPD; SUSCEPTIBILITY; INFECTION; APOPTOSIS; CLONING	Background: Tobacco smoking is the main risk factor of chronic obstructive pulmonary disease (COPD) but not all smokers develop the disease. An abnormal pulmonary and systemic inflammatory response to smoking is thought to play a major pathogenic role in COPD, but this has never been tested directly. Methods: We studied the systemic biomarker and leukocyte transcriptomic response (Affymetrix microarrays) to smoking exposure in 10 smokers with COPD and 10 smokers with normal spirometry. We also studied 10 healthy never smokers (not exposed to smoking) as controls. Because some aspects of COPD may differ in males and females, and the inflammatory response to other stressors (infection) might be different in man and women, we stratified participant recruitment by sex. Differentially expressed genes were validated by q-PCR. Ontology enrichment was evaluated and interaction networks inferred. Results: Principal component analysis identified sex differences in the leukocyte transcriptomic response to acute smoking. In both genders, we identified genes that were differentially expressed in response to smoking exclusively in COPD patients (COPD related signature) or smokers with normal spirometry (Smoking related signature), their ontologies and interaction networks. Conclusions: The use of an experimental intervention (smoking exposure) to investigate the transcriptomic response of peripheral leukocytes in COPD is a step beyond the standard case-control transcriptomic profiling carried out so far, and has facilitated the identification of novel COPD and Smoking expression related signatures which differ in males and females.	[Faner, Rosa; Gonzalez, Nuria; Cruz, Tamara; Agusti, Alvar] Fundacio Privada Clin Recerca Biomed, Barcelona, Spain; [Faner, Rosa; Cruz, Tamara; Agusti, Alvar] IDIBAPS, Barcelona, Spain; [Faner, Rosa; Agusti, Alvar] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Graciela Kalko, Susana] IDIBAPS, Bioinformat Core Facil, Barcelona, Spain; [Agusti, Alvar] Univ Barcelona, Hosp Clin, Thorax Inst, Barcelona, Spain; [Agusti, Alvar] FISIB, Mallorca, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Agusti, A (corresponding author), Fundacio Privada Clin Recerca Biomed, Barcelona, Spain.	alvar.agusti@clinic.ub.es	Garcia-Navarro, Alvar Agusti/F-4474-2015; Cruz, Tamara/AAH-8835-2019	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Cruz, Tamara/0000-0002-6362-6348; Faner, Rosa/0000-0002-8159-0115; Kalko, Susana/0000-0002-6701-0233	Mutua Madrilena [PI041966/2012]; Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS) [10/00523]; SEPAR [133/2011]	Mutua Madrilena; Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); SEPAR	Supported, in part, by Mutua Madrilena PI041966/2012, Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve 2011, Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS) 10/00523, SEPAR 133/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Aryal S, 2013, TRANSL RES, V162, P208, DOI 10.1016/j.trsl.2013.04.003; Bahr TM, 2013, AM J RESP CELL MOL B; Bailey SL, 2008, CHROMOSOMA, V117, P367, DOI 10.1007/s00412-008-0155-7; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Bhattacharya Soumyaroop, 2011, J Clin Bioinforma, V1, P12, DOI 10.1186/2043-9113-1-12; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016021; DeMeo DL, 2004, THORAX, V59, P396, DOI 10.1136/thx.2003.012856; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dransfield MT, 2007, CHEST; Eisenreichi A, 2013, ONCOL REP, V30, P462, DOI 10.3892/or.2013.2413; Erbel R, 2008, ATHEROSCLEROSIS, V197, P662, DOI 10.1016/j.atherosclerosis.2007.02.031; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gawron A, 2012, CANCER CAUSE CONTROL, V23, P1729, DOI 10.1007/s10552-012-9959-0; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lang F, 2013, EXPERT OPIN INV DRUG, V22, P701, DOI 10.1517/13543784.2013.778971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomas DA, 2001, RESP RES, V2, P20, DOI 10.1186/rr34; LUO Y, 1995, MOL CELL BIOL, V15, P4115; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Menon R, 2012, J AUTOIMMUN, V38, pJ144, DOI 10.1016/j.jaut.2011.11.004; Park SK, 2010, LUNG CANCER, V68, P20, DOI 10.1016/j.lungcan.2009.05.017; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Ryter Stefan W, 2010, Expert Rev Respir Med, V4, P573, DOI 10.1586/ers.10.61; Ryu Jeong-Seon, 2011, Korean Journal of Internal Medicine, V26, P427, DOI 10.3904/kjim.2011.26.4.427; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Silverman EK, 2000, CHEST, V117, p273S, DOI 10.1378/chest.117.5_suppl_1.273S; Smoot M, 2011, BIOINFORMATICS, V27, P1030, DOI 10.1093/bioinformatics/btr045; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Zeng HH, 2012, EUR REV MED PHARMACO, V16, P711; Zhu JH, 2000, CIRCULATION, V102, P2491, DOI 10.1161/01.CIR.102.20.2491	46	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97491	10.1371/journal.pone.0097491	http://dx.doi.org/10.1371/journal.pone.0097491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830457	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500069
J	Shekoofa, A; Emam, Y; Shekoufa, N; Ebrahimi, M; Ebrahimie, E				Shekoofa, Avat; Emam, Yahya; Shekoufa, Navid; Ebrahimi, Mansour; Ebrahimie, Esmaeil			Determining the Most Important Physiological and Agronomic Traits Contributing to Maize Grain Yield through Machine Learning Algorithms: A New Avenue in Intelligent Agriculture	PLOS ONE			English	Article							KERNEL WATER RELATIONS; PLANT-GROWTH; WEIGHT; NITROGEN	Prediction is an attempt to accurately forecast the outcome of a specific situation while using input information obtained from a set of variables that potentially describe the situation. They can be used to project physiological and agronomic processes; regarding this fact, agronomic traits such as yield can be affected by a large number of variables. In this study, we analyzed a large number of physiological and agronomic traits by screening, clustering, and decision tree models to select the most relevant factors for the prospect of accurately increasing maize grain yield. Decision tree models (with nearly the same performance evaluation) were the most useful tools in understanding the underlying relationships in physiological and agronomic features for selecting the most important and relevant traits (sowing date-location, kernel number per ear, maximum water content, kernel weight, and season duration) corresponding to the maize grain yield. In particular, decision tree generated by C&RT algorithm was the best model for yield prediction based on physiological and agronomical traits which can be extensively employed in future breeding programs. No significant differences in the decision tree models were found when feature selection filtering on data were used, but positive feature selection effect observed in clustering models. Finally, the results showed that the proposed model techniques are useful tools for crop physiologists to search through large datasets seeking patterns for the physiological and agronomic factors, and may assist the selection of the most important traits for the individual site and field. In particular, decision tree models are method of choice with the capability of illustrating different pathways of yield increase in breeding programs, governed by their hierarchy structure of feature ranking as well as pattern discovery via various combinations of features.	[Shekoofa, Avat] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Emam, Yahya; Ebrahimie, Esmaeil] Shiraz Univ, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Shekoufa, Navid] Amirkabir Univ Technol, Dept Comp Engn & Informat Technol, Tehran, Iran; [Ebrahimi, Mansour] Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of North Carolina; North Carolina State University; Shiraz University; Amirkabir University of Technology; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Dept Crop Prod & Plant Breeding, Shiraz, Iran.	esmaeil.ebrahimie@adelaide.edu.au	Emam, Yahya/X-2090-2019; Shekoofa, Avat/ABE-4326-2020; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Emam, Yahya/0000-0002-7113-8168; Shekoofa, Avat/0000-0002-4309-9026; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567	Shiraz University	Shiraz University	This study was supported by the grant (AGR-emam) of Shiraz University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahand M., 2010, INT J MANAGEMENT INF, V14, P57; [Anonymous], ASIAN J HLTH INFO SC; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Brown G, 1996, KERNEL DRY WEIGHT LO; Dancey D, 2007, IEEE T SYST MAN CY B, V37, P794, DOI 10.1109/TSMCB.2007.895334; Drummond ST, 2003, T ASAE, V46, P5, DOI 10.13031/2013.12541; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; Fischer KS., 1984, PHYS TROPICAL FIELD; Fischer RA, 2011, CROP PASTURE SCI, V62, P95, DOI 10.1071/CP10344; Gambin BL, 2006, FIELD CROP RES, V95, P316, DOI 10.1016/j.fcr.2005.04.002; Gambin BL, 2008, AUST J AGR RES, V59, P280, DOI 10.1071/AR07275; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gautam R, 2006, BIOSYST ENG, V95, P359, DOI 10.1016/j.biosystemseng.2006.07.007; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Hammann F, 2009, CURR DRUG METAB, V10, P339, DOI 10.2174/138920009788499021; JONES RJ, 1983, CROP SCI, V23, P129, DOI 10.2135/cropsci1983.0011183X002300010038x; Khanna-Chopra R, 1998, EUR J AGRON, V9, P101, DOI 10.1016/S1161-0301(98)00028-8; Lauer JG, 1999, AGRON J, V91, P834, DOI 10.2134/agronj1999.915834x; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Matsumoto K, 1998, LECT NOTES ARTIF INT, V1532, P439; Melchiori RJM, 2008, FIELD CROP RES, V108, P198, DOI 10.1016/j.fcr.2008.05.003; Nielsen RL, 2002, AGRON J, V94, P549; Roddick J. F., 2001, Temporal, Spatial, and Spatio-Temporal Data Mining. First International Workshop, TSDM 2000. Revised Papers (Lecture Notes in Artificial Intelligence Vol.2007), P147; Sala RG, 2007, FIELD CROP RES, V101, P19, DOI 10.1016/j.fcr.2006.09.004; Schulze FH, 2005, WATER SCI TECHNOL, V52, P21, DOI 10.2166/wst.2005.0279; Shekoofa A, 2012, ARCH AGRON SOIL SCI, V58, P777, DOI 10.1080/03650340.2010.546788; Shekoofa A, 2011, AUST J CROP SCI, V5, P162; Shekoofa A, 2011, ANN M FUND LIF SOIL; Shekoofa A, 2011, 11 AS MAIZ C NOV 7 1; Shekoofa A, 2010, THESIS SHIRAZ U SHIR; Sinclair TR, 2010, AGRON J, V102, P475, DOI 10.2134/agronj2009.0195; Subedi KD, 2005, CROP SCI, V45, P2246, DOI 10.2135/cropsci2004.0653; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Wang YY, 2008, INT J REMOTE SENS, V29, P2993, DOI 10.1080/01431160701442070; Ye XF, 2009, PHARMACOEPIDEM DR S, V18, P154, DOI 10.1002/pds.1695	40	41	43	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97288	10.1371/journal.pone.0097288	http://dx.doi.org/10.1371/journal.pone.0097288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830330	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500046
J	Taylor, SE; Morganti-Kossmann, C; Lifshitz, J; Ziebell, JM				Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.			Rod Microglia: A Morphological Definition	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CELL-DEATH; RAT; ACTIVATION; MOUSE; PHYSIOLOGY; RESPONSES; SENSOR; MICE; CNS	Brain microglial morphology relates to function, with ramified microglia surveying the micro-environment and amoeboid microglia engulfing debris. One subgroup of microglia, rod microglia, have been observed in a number of pathological conditions, however neither a function nor specific morphology has been defined. Historically, rod microglia have been described intermittently as cells with a sausage-shaped soma and long, thin processes, which align adjacent to neurons. More recently, our group has described rod microglia aligning end-to-end with one another to form trains adjacent to neuronal processes. Confusion in the literature regarding rod microglia arises from some reports referring to the sausage-shaped cell body, while ignoring the spatial distribution of processes. Here, we systematically define the morphological characteristics of rod microglia that form after diffuse brain injury in the rat, which differ morphologically from the spurious rod microglia found in uninjured sham. Rod microglia in the diffuse-injured rat brain show a ratio of 1.79 +/- 0.03 cell length: cell width at day 1 post-injury, which increases to 3.35 +/- 0.05 at day 7, compared to sham (1.17 +/- 0.02). The soma length: width differs only at day 7 post-injury (2.92 +/- 0.07 length: width), compared to sham (2.49 +/- 0.05). Further analysis indicated that rod microglia may not elongate in cell length but rather narrow in cell width, and retract planar (side) processes. These morphological characteristics serve as a tool for distinguishing rod microglia from other morphologies. The function of rod microglia remains enigmatic; based on morphology we propose origins and functions for rod microglia after acute neurological insult, which may provide biomarkers or therapeutic targets.	[Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85006 USA; [Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Taylor, Samuel E.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Dept Psychol, Neurosci Program, Tempe, AZ 85287 USA	Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; University of Bath; Arizona State University; Arizona State University-Tempe	Ziebell, JM (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85006 USA.	jmziebell@email.arizona.edu	Ziebell, Jenna/Y-4496-2019	Morganti-Kossmann, Cristina/0000-0002-0807-2063; Ziebell, Jenna/0000-0003-2497-4347	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS065052]; Mission Support Fund at Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065052] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mission Support Fund at Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052 and the Mission Support Fund at Phoenix Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GRAEBER MB, 1994, NEUROPATH APPL NEURO, V20, P178; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lambertsen KL, 2011, J NEUROPATH EXP NEUR, V70, P481, DOI 10.1097/NEN.0b013e31821db3aa; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; OHNO M, 1992, DEV BRAIN RES, V67, P37, DOI 10.1016/0165-3806(92)90023-P; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Spielmeyer W, 1922, HISTOPATHOLOGIE NERV; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Taylor SE, 2013, CURRENT PROTOCOLS ES; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wierzba-Bobrowicz T, 2002, FOLIA NEUROPATHOL, V40, P125; Wirenfeldt M, 2009, NEUROBIOL DIS, V34, P432, DOI 10.1016/j.nbd.2009.02.015; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	39	77	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97096	10.1371/journal.pone.0097096	http://dx.doi.org/10.1371/journal.pone.0097096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830807	gold, Green Submitted, Green Published			2022-12-25	WOS:000336789500034
J	de Zwaan, M; Muller, A; Allison, KC; Brahler, E; Hilbert, A				de Zwaan, Martina; Mueller, Astrid; Allison, Kelly C.; Braehler, Elmar; Hilbert, Anja			Prevalence and Correlates of Night Eating in the German General Population	PLOS ONE			English	Article							OBESE	Recently, night eating syndrome (NES) was included into the DSM-5 as an example of "Other Specified Feeding and Eating Disorders." The study provides insight into the population prevalence of NES using a large representative German population sample (n = 2,460) with a wide age range (14-85 years). The prevalence of NES was 1.1% using a cut-off on the Night Eating Questionnaire (NEQ) of 25. A positive screening for NES was positively associated with depression and anxiety, eating disorder psychopathology, and body weight.	[de Zwaan, Martina; Mueller, Astrid] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Allison, Kelly C.] Univ Penn, Ctr Weight & Eating Disorders, Perelman Sch Med, Philadelphia, PA 19104 USA; [Braehler, Elmar] Univ Leipzig, Med Ctr, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Braehler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Hilbert, Anja] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany	Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; Leipzig University; Johannes Gutenberg University of Mainz; Leipzig University	de Zwaan, M (corresponding author), Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany.	dezwaan.martina@mh-hannover.de	Braehler, Elmar/C-6535-2009; Allison, Kelly C./O-4174-2019	Braehler, Elmar/0000-0002-2648-2728; Allison, Kelly C./0000-0002-9807-0220	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research [01EO1001]	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research was supported by internal funds by the Department of Medical Psychology and Medical Sociology at the University of Leipzig. AH was supported by grant 01EO1001 from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Kelly C, 2008, Eat Behav, V9, P62, DOI 10.1016/j.eatbeh.2007.03.007; Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Berner LA, 2013, PSYCHOL RES BEHAV MA, V6, P1, DOI 10.2147/PRBM.S31929; de Zwaan M, 2006, INT J EAT DISORDER, V39, P224, DOI 10.1002/eat.20246; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Gallant AR, 2012, OBES REV, V13, P528, DOI 10.1111/j.1467-789X.2011.00975.x; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lundgren JD, 2006, AM J PSYCHIAT, V163, P156, DOI 10.1176/appi.ajp.163.1.156; Lundgren JD, 2010, PSYCHIAT RES, V175, P233, DOI 10.1016/j.psychres.2008.10.027; Meule A., 2012, OBESITY FACTS, V5, P21; Rand CSW, 1997, INT J EAT DISORDER, V22, P65, DOI 10.1002/(SICI)1098-108X(199707)22:1&lt;65::AID-EAT8&gt;3.0.CO;2-0; Striegel-Moore RH, 2005, INT J EAT DISORDER, V37, P200, DOI 10.1002/eat.20128; STUNKARD AJ, 1955, AM J MED, V19, P78, DOI 10.1016/0002-9343(55)90276-X; Tholin S, 2009, OBESITY, V17, P1050, DOI 10.1038/oby.2008.676; Vander Wal JS, 2012, CLIN PSYCHOL REV, V32, P49, DOI 10.1016/j.cpr.2011.11.001	18	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97667	10.1371/journal.pone.0097667	http://dx.doi.org/10.1371/journal.pone.0097667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828066	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400115
J	Fnais, N; Gomes, T; Mahoney, J; Alissa, S; Mamdani, M				Fnais, Naif; Gomes, Tara; Mahoney, James; Alissa, Sami; Mamdani, Muhammad			Temporal Trend of Carpal Tunnel Release Surgery: A Population-Based Time Series Analysis	PLOS ONE			English	Article							GENERAL-POPULATION; PREVALENCE; DIAGNOSIS; CARE	Background: Carpal tunnel release (CTR) is among the most common hand surgeries, although little is known about its pattern. In this study, we aimed to investigate temporal trends, age and gender variation and current practice patterns in CTR surgeries. Methods: We conducted a population-based time series analysis among over 13 million residents of Ontario, who underwent operative management for carpal tunnel syndrome (CTS) from April 1, 1992 to March 31, 2010 using administrative claims data. Results: The primary analysis revealed a fairly stable procedure rate of approximately 10 patients per 10,000 population per year receiving CTRs without any significant, consistent temporal trend (p = 0.94). Secondary analyses revealed different trends in procedure rates according to age. The annual procedure rate among those age >75 years increased from 22 per 10,000 population at the beginning of the study period to over 26 patients per 10,000 population (p < 0.01) by the end of the study period. CTR surgical procedures were approximately two-fold more common among females relative to males (64.9% vs. 35.1 respectively; p < 0.01). Lastly, CTR procedures are increasingly being conducted in the outpatient setting while procedures in the inpatient setting have been declining steadily - the proportion of procedures performed in the outpatient setting increased from 13% to over 30% by 2010 (p < 0.01). Conclusion: Overall, CTR surgical-procedures are conducted at a rate of approximately 10 patients per 10,000 population annually with significant variation with respect to age and gender. CTR surgical procedures in ambulatory-care facilities may soon outpace procedure rates in the in-hospital setting.	[Fnais, Naif] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Gomes, Tara] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gomes, Tara; Mamdani, Muhammad] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mahoney, James] St Michaels Hosp, Div Plast & Reconstruct Surg, Toronto, ON M5B 1W8, Canada; [Alissa, Sami] Univ Toronto, Div Plast & Reconstruct Surg, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad] St Michaels Hosp, Li KaShing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	King Saud University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Mamdani, M (corresponding author), St Michaels Hosp, Appl Hlth Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	mamdanim@smh.ca		Gomes, Tara/0000-0002-1468-1965	King Saud University - Li Ka Shing Knowledge Institute Collaborative Program; Institute for Clinical Evaluative Sciences (ICES); Ontario MOHLTC	King Saud University - Li Ka Shing Knowledge Institute Collaborative Program; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the King Saud University - Li Ka Shing Knowledge Institute Collaborative Program (http://ksu-lkski.org/) and the Institute for Clinical Evaluative Sciences (ICES; www.ices.on.ca), which is funded by an annual grant from the Ontario MOHLTC (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omran M, 2003, J VASC SURG, V38, P289, DOI 10.1016/S0741-5214(03)00273-8; [Anonymous], CARP TUNN REL DET; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bell CM, 2006, ARCH INTERN MED, V166, P2525, DOI 10.1001/archinte.166.22.2525; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; Concannon MJ, 2000, PLAST RECONSTR SURG, V105, P1662, DOI 10.1097/00006534-200004050-00010; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; Fajardo M, 2012, J HAND SURG-AM, V37A, P1599, DOI 10.1016/j.jhsa.2012.04.035; Gelfman R, 2009, NEUROLOGY, V72, P33, DOI 10.1212/01.wnl.0000338533.88960.b9; Graham B, 2008, J BONE JOINT SURG AM, V90A, P2587, DOI 10.2106/JBJS.G.01362; Katims J J, 1989, ASAIO Trans, V35, P280; KATZ JN, 1990, J RHEUMATOL, V17, P1495; Kerwin G, 1996, HAND CLIN, V12, P243; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P263, DOI 10.1136/jnnp.2005.066696; Leblanc Martin R, 2007, Hand (N Y), V2, P173, DOI 10.1007/s11552-007-9043-5; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; LISS GM, 1992, AM J IND MED, V22, P395, DOI 10.1002/ajim.4700220312; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; National Institute for Occupational Safety and Health (NIOSH), 1997, DHHS NIOSH PUBLICATI, V97; *ONT MIN HLTH, 1992, SCHED BEN PHYS SERV; Palmer DH, 1995, AAOS INSTR COURS LEC, V44, P167; Pindyck RS, 1998, ECONOMETRIC MODELS E, P463; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Roh YH, 2010, J HAND SURG-AM, V35A, P1410, DOI 10.1016/j.jhsa.2010.05.020; SPINNER RJ, 1989, MAYO CLIN PROC, V64, P829, DOI 10.1016/S0025-6196(12)61756-X; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; Szabo, 1994, J Am Acad Orthop Surg, V2, P115; Witt JC, 2004, MUSCLE NERVE, V29, P515, DOI 10.1002/mus.20019	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97499	10.1371/journal.pone.0097499	http://dx.doi.org/10.1371/journal.pone.0097499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828486	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400102
J	Harper, DM; Alexander, NM; Ahern, DA; Comes, JC; Smith, MS; Heutinck, MA; Handley, SM				Harper, Diane Medved; Alexander, Natalie Marya; Ahern, Debra Ann; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin			Women Have a Preference for Their Male Partner to Be HPV Vaccinated	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ACCEPTABILITY; ADOLESCENTS; KNOWLEDGE; ATTITUDES; CHILDREN; PARENTS; LATINO; IMPACT; BOYS	Background: Peer influence and social networking can change female adolescent and young adult behavior. Peer influence on preferences for male human papillomavirus (HPV) vaccination has not been documented. The primary aim of this study was to determine if women had preferences about male sexual partner HPV vaccination receipt. Methods and Findings: A prospective survey of women 18-26 years of age was conducted at an urban university student health clinic. Education about the two HPV vaccines, cervical cancer and genital warts was provided. Women self-reported their demographic and medical history data, as well as their own preferences for HPV vaccine and their preferences for their male partner HPV vaccine using a 5 point Likert scale. 601 women, mean age of 21.5 years (SD 2.4), participated between 2011 and 2012. Nearly 95% of respondents were heterosexual; condoms and contraceptives were used in over half of the population. Regardless of the woman's vaccination status, women had significantly higher (strongly agree/agree) preferences for the male partner being vaccinated with HPV4 than not caring if he was vaccinated (63.6% vs. 13.1%, p<0.001). This preference was repeated for sexual risk factors and past reproductive medical history. Women who received HPV4 compared to those choosing HPV2 had a significantly lower proportion of preferences for not caring if the male partner was vaccinated (13% vs. 22%, p = 0.015). Conclusions: Women preferred a HPV vaccinated male partner. Peer messaging might change the male HPV vaccination uptake.	[Harper, Diane Medved] Univ Missouri Kansas City Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Harper, Diane Medved; Ahern, Debra Ann] Univ Missouri Kansas City Sch Med, Dept Community & Family Med, Kansas City, MO USA; [Harper, Diane Medved] Univ Missouri Kansas City Sch Med, Dept Obstet & Gynecol, Kansas City, MO USA; [Alexander, Natalie Marya] Kansas City Univ Med & Biosci, Dept Family Med, Kansas City, MO USA; [Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin] Univ Missouri, Univ Missouri Kansas City Student Hlth & Wellness, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri Kansas City Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; Ali MM, 2011, J DEV BEHAV PEDIATR, V32, P563, DOI 10.1097/DBP.0b013e318231cf03; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Daley MF, 2006, PEDIATRICS, V118, P2280, DOI 10.1542/peds.2006-1946; Dishion TJ, 2005, J ABNORM CHILD PSYCH, V33, P395, DOI 10.1007/s10802-005-3579-z; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Drolet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067072; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Gerend MA, 2009, SEX TRANSM DIS, V36, P58, DOI 10.1097/OLQ.0b013e31818606fc; Harper D. M., 2010, J VACCINES VACCIN, V1, P107, DOI [10.4172/2157-7560.1000107, DOI 10.4172/2157-7560.1000107]; Harper DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088493; Heitmann ER, 2012, CURR OBSTET GYNECOL, V1, P95, DOI 10.1007/s13669-012-0017-4; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; LEIGH WA, 2002, REPROD HLTH AFRICAN, P1; Licht AS, 2010, SEX TRANSM INFECT, V86, P74, DOI 10.1136/sti.2009.037705; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Ogilvie GS, 2008, SEX TRANSM INFECT, V84, P318, DOI 10.1136/sti.2007.029389; Oteng B, 2011, SEX TRANSM INFECT, V87, P52, DOI 10.1136/sti.2009.041392; Reiter PL, 2010, SEX TRANSM INFECT, V86, P241, DOI 10.1136/sti.2009.039065; Rice E, 2011, PREV SCI, V12, P80, DOI 10.1007/s11121-010-0191-4; Richmond MJ, 2012, PREV SCI, V13, P267, DOI 10.1007/s11121-011-0261-2; Riedesel J M, 2005, J Pediatr Adolesc Gynecol, V18, P391, DOI 10.1016/j.jpag.2005.09.004; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Shen-Gunther J, 2011, GYNECOL ONCOL, V123, P272, DOI 10.1016/j.ygyno.2011.07.094; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; StatSoft Inc, 2010, STATISTICA DAT AN SO; Watts LA, 2009, GYNECOL ONCOL, V112, P577, DOI 10.1016/j.ygyno.2008.12.010; Wong LP, 2010, EUR J OBSTET GYN R B, V148, P90, DOI 10.1016/j.ejogrb.2009.10.002; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97119	10.1371/journal.pone.0097119	http://dx.doi.org/10.1371/journal.pone.0097119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828237	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400056
J	Garmendia, J; Viadas, C; Calatayud, L; Mell, JC; Marti-Lliteras, P; Euba, B; Llobet, E; Gil, C; Bengoechea, JA; Redfield, RJ; Linares, J				Garmendia, Junkal; Viadas, Cristina; Calatayud, Laura; Mell, Joshua Chang; Marti-Lliteras, Pau; Euba, Begona; Llobet, Enrique; Gil, Carmen; Antonio Bengoechea, Jose; Redfield, Rosemary J.; Linares, Josefina			Characterization of Nontypable Haemophilus influenzae Isolates Recovered from Adult Patients with Underlying Chronic Lung Disease Reveals Genotypic and Phenotypic Traits Associated with Persistent Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS PATIENTS; MEMBRANE PROTEIN P2; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; RESPIRATORY-TRACT; BIOFILM FORMATION; STRUCTURAL-CHARACTERIZATION; EPITHELIAL-CELLS; LIPID-A	Nontypable Haemophilus influenzae (NTHi) has emerged as an important opportunistic pathogen causing infection in adults suffering obstructive lung diseases. Existing evidence associates chronic infection by NTHi to the progression of the chronic respiratory disease, but specific features of NTHi associated with persistence have not been comprehensively addressed. To provide clues about adaptive strategies adopted by NTHi during persistent infection, we compared sequential persistent isolates with newly acquired isolates in sputa from six patients with chronic obstructive lung disease. Pulse field gel electrophoresis (PFGE) identified three patients with consecutive persistent strains and three with new strains. Phenotypic characterisation included infection of respiratory epithelial cells, bacterial self-aggregation, biofilm formation and resistance to antimicrobial peptides (AMP). Persistent isolates differed from new strains in showing low epithelial adhesion and inability to form biofilms when grown under continuous-flow culture conditions in microfermenters. Self-aggregation clustered the strains by patient, not by persistence. Increasing resistance to AMPs was observed for each series of persistent isolates; this was not associated with lipooligosaccharide decoration with phosphorylcholine or with lipid A acylation. Variation was further analyzed for the series of three persistent isolates recovered from patient 1. These isolates displayed comparable growth rate, natural transformation frequency and murine pulmonary infection. Genome sequencing of these three isolates revealed sequential acquisition of single-nucleotide variants in the AMP permease sapC, the heme acquisition systems hgpB, hgpC, hup and hxuC, the 3-deoxy-D-manno-octulosonic acid kinase kdkA, the long-chain fatty acid transporter ompP1, and the phosphoribosylamine glycine ligase purD. Collectively, we frame a range of pathogenic traits and a repertoire of genetic variants in the context of persistent infection by NTHi.	[Garmendia, Junkal; Viadas, Cristina; Euba, Begona; Gil, Carmen] CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain; [Garmendia, Junkal; Calatayud, Laura; Marti-Lliteras, Pau; Euba, Begona; Llobet, Enrique; Antonio Bengoechea, Jose; Linares, Josefina] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Garmendia, Junkal; Marti-Lliteras, Pau; Llobet, Enrique; Antonio Bengoechea, Jose] Fdn Invest Sanitaria Illes Balears, Lab Microbial Pathogenesis, Bunyola, Spain; [Calatayud, Laura; Linares, Josefina] Univ Barcelona, Dept Microbiol, IDIBELL, Univ Hosp Bellvitge, Barcelona, Spain; [Mell, Joshua Chang; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Mell, Joshua Chang] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Antonio Bengoechea, Jose] CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of British Columbia; Drexel University; Consejo Superior de Investigaciones Cientificas (CSIC)	Garmendia, J (corresponding author), CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain.	juncal.garmendia@unavarra.es	Gil, Carmen/K-3759-2017; Liñares, Josefina/N-9450-2014; Garmendia, Juncal/G-4360-2011	Gil, Carmen/0000-0002-8867-4442; Garmendia, Juncal/0000-0002-7440-2737; Bengoechea, Jose/0000-0002-9677-8751	U. S. National Institutes of Health - ISCIII [5F32AI084427, PS09/00130]; Ministerio Economia y Competitividad (MINECO) [SAF2012-31166]; Dpto. Salud Gobierno Navarra [359/2012]; Ministerio Educacion PRX [12/00191, PS09/01904]; Canadian Institutes of Health Research; CIBERES is an initiative from ISCIII, Spain.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI084427] Funding Source: NIH RePORTER	U. S. National Institutes of Health - ISCIII; Ministerio Economia y Competitividad (MINECO); Dpto. Salud Gobierno Navarra; Ministerio Educacion PRX; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIBERES is an initiative from ISCIII, Spain.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JCM was supported by a postdoctoral fellowship from the U. S. National Institutes of Health (5F32AI084427). This work has been funded by grants from ISCIII PS09/00130, Ministerio Economia y Competitividad (MINECO) SAF2012-31166, Dpto. Salud Gobierno Navarra 359/2012, and Ministerio Educacion PRX 12/00191 to JG, PS09/01904 to JL, and Canadian Institutes of Health Research grant to RJR. CIBERES is an initiative from ISCIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Aussel L, 2000, FEBS LETT, V465, P87, DOI 10.1016/S0014-5793(99)01722-6; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cardines R, 2012, INT J MED MICROBIOL, V302, P45, DOI 10.1016/j.ijmm.2011.08.003; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chikhi R, 2013, BIOINFORMATICS; Chin CL, 2005, AM J RESP CRIT CARE, V172, P85, DOI 10.1164/rccm.200412-1687OC; Cholon DM, 2008, INFECT IMMUN, V76, P4463, DOI 10.1128/IAI.00499-08; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Clark SE, 2013, MOL MICROBIOL, V88, P603, DOI 10.1111/mmi.12214; Coutinho CP, 2011, INFECT IMMUN, V79, P2950, DOI 10.1128/IAI.01366-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dixon K, 2007, J BACTERIOL, V189, P511, DOI 10.1128/JB.00815-06; Domenech A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059027; Evans ME, 1999, ANN PHARMACOTHER, V33, P960, DOI 10.1345/aph.18426; Garmendia J, 2012, EUR RESPIR J, V39, P467, DOI 10.1183/09031936.00061911; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Hawdon NA, 2010, FEMS IMMUNOL MED MIC, V59, P207, DOI 10.1111/j.1574-695X.2010.00693.x; Hermsen ED, 2003, INFECT DIS CLIN N AM, V17, P545, DOI 10.1016/S0891-5520(03)00058-8; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hiltke TJ, 2003, J INFECT DIS, V188, P114, DOI 10.1086/375724; Hiltke TJ, 2002, J INFECT DIS, V185, P627, DOI 10.1086/339362; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lerner CG, 2005, ANTIMICROB AGENTS CH, V49, P2767, DOI 10.1128/AAC.49.7.2767-2777.2005; Li H, 2013, ARXIV13033997V3991QB; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lindner B, 2000, METH MOL B, V145, P311; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; Marti-Lliteras P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021133; Mason KM, 2011, J BACTERIOL, V193, P2527, DOI 10.1128/JB.01313-10; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; McCrea KW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-286; Mell JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002151; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Mikhail I, 2005, ANAL BIOCHEM, V340, P303, DOI 10.1016/j.ab.2005.02.020; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Morey P, 2013, INFECT IMMUN, V81, P4100, DOI 10.1128/IAI.00492-13; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025923; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Oertelt C, 2001, EUR J BIOCHEM, V268, P554, DOI 10.1046/j.1432-1327.2001.01891.x; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poje Grant, 2003, Methods Mol Med, V71, P57; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; Puig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082515; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Roson B, 2000, CLIN INFECT DIS, V31, P869, DOI 10.1086/318151; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Sekhar S, 2009, J MED MICROBIOL, V58, P1428, DOI 10.1099/jmm.0.010355-0; Sethi S, 2004, AM J RESP CRIT CARE, V169, P448, DOI 10.1164/rccm.200308-1181OC; Sethi S, 2010, EUR RESPIR J, V35, P1209, DOI 10.1183/09031936.00081409; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Starner TD, 2002, INFECT IMMUN, V70, P5287, DOI 10.1128/IAI.70.9.5287-5289.2002; Szelestey BR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003709; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wayne P., 2010, CLIN LAB STANDARDS I; Wayne P., 2006, METHODS DILUTION ANT; Webb DC, 1999, PROTEIN EXPRES PURIF, V15, P1, DOI 10.1006/prep.1998.0990; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6	85	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97020	10.1371/journal.pone.0097020	http://dx.doi.org/10.1371/journal.pone.0097020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824990	Green Published, gold			2022-12-25	WOS:000336369200051
J	Khan, NA; Aziz, S; Khan, NA				Khan, Najeeb Alam; Aziz, Shahnila; Khan, Nadeem Alam			Numerical Simulation for the Unsteady MHD Flow and Heat Transfer of Couple Stress Fluid over a Rotating Disk	PLOS ONE			English	Article							OLDROYD-B FLUID; VISCOUS DISSIPATION; VARIABLE PROPERTIES; FIELD; CONE; HALL	The present work is devoted to study the numerical simulation for unsteady MHD flow and heat transfer of a couple stress fluid over a rotating disk. A similarity transformation is employed to reduce the time dependent system of nonlinear partial differential equations (PDEs) to ordinary differential equations (ODEs). The Runge-Kutta method and shooting technique are employed for finding the numerical solution of the governing system. The influences of governing parameters viz. unsteadiness parameter, couple stress and various physical parameters on velocity, temperature and pressure profiles are analyzed graphically and discussed in detail.	[Khan, Najeeb Alam; Aziz, Shahnila; Khan, Nadeem Alam] Univ Karachi, Dept Math Sci, Karachi, Pakistan	University of Karachi	Khan, NA (corresponding author), Univ Karachi, Dept Math Sci, Karachi, Pakistan.	njbalam@yahoo.com	Khan, Najeeb Alam/Q-2160-2019; Khan, Najeeb Alam/AAM-3168-2021	Khan, Najeeb Alam/0000-0001-6242-0658				Ariel PD, 2002, Z ANGEW MATH MECH, V82, P235, DOI 10.1002/1521-4001(200204)82:4<235::AID-ZAMM235>3.0.CO;2-L; Bellout H, 2013, Z ANGEW MATH PHYS, V64, P83, DOI 10.1007/s00033-012-0221-0; Chamkha AJ, 2012, CHEM ENG COMMUN, V199, P122, DOI 10.1080/00986445.2011.575907; Dehghan M, 2009, COMPUT PHYS COMMUN, V180, P1458, DOI 10.1016/j.cpc.2009.03.007; Dehghan M, 2009, APPL NUMER MATH, V59, P1043, DOI 10.1016/j.apnum.2008.05.001; Dinarvand S, 2010, NONLINEAR ANAL-REAL, V11, P1159, DOI 10.1016/j.nonrwa.2009.02.009; Fang T, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2823572; Farooq M, 2011, HEAT TRANSF RES, V42, P737, DOI 10.1615/HeatTransRes.2012000996; Hayat T, 2009, CHAOS SOLITON FRACT, V39, P840, DOI 10.1016/j.chaos.2007.01.067; Jamil M, 2013, THERM SCI, V17, P997, DOI 10.2298/TSCI110731140J; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan I, 2012, TRANSPORT POROUS MED, V91, P49, DOI 10.1007/s11242-011-9832-8; Khan NA, 2013, ENG COMPUTATION, V30, P399, DOI 10.1108/02644401311314358; Kumar SK, 1987, 321 WINTHR COLL DEP; Lorrain P., 2006, MAGNETO FLUID DYNAMI; Maleque KA, 2005, J HEAT TRANS-T ASME, V127, P1406, DOI 10.1115/1.2098860; Ming CY, 2011, INT COMMUN HEAT MASS, V38, P280, DOI 10.1016/j.icheatmasstransfer.2010.11.013; Nadeem S, 2013, J TAIWAN INST CHEM E, V44, P596, DOI 10.1016/j.jtice.2013.01.007; Osalusi E, 2008, INT COMMUN HEAT MASS, V35, P413, DOI 10.1016/j.icheatmasstransfer.2007.09.002; Osalusi E, 2007, INT COMMUN HEAT MASS, V34, P1017, DOI 10.1016/j.icheatmasstransfer.2007.05.009; Ram P, 2013, RESULTS PHYS, V3, P55, DOI 10.1016/j.rinp.2013.03.002; Ramzan M, 2013, EUROPE PHY J, V128, P1; Rashidi MM, 2012, COMPUT FLUIDS, V54, P1, DOI 10.1016/j.compfluid.2011.08.001; Rashidi MM, 2014, THERM SCI, V18, pS527, DOI 10.2298/TSCI120301155R; Rashidi MM, 2009, NONLINEAR ANAL-REAL, V10, P2346, DOI 10.1016/j.nonrwa.2008.04.018; Sreenadh S., 2011, ADV APPL SCI RES, V2, P215; STOKES VK, 1966, PHYS FLUIDS, V9, P1709, DOI 10.1063/1.1761925; Takhar HS, 2002, INT J THERM SCI, V41, P147, DOI 10.1016/S1290-0729(01)01292-3; Turkyilmazoglu M, 2012, INT J HEAT MASS TRAN, V55, P6959, DOI 10.1016/j.ijheatmasstransfer.2012.05.089; Turkyilmazoglu M, 2012, APPL THERM ENG, V35, P127, DOI 10.1016/j.applthermaleng.2011.10.014; Wiesche SAD, 2007, INT J THERM SCI, V46, P745, DOI 10.1016/j.ijthermalsci.2006.10.013	31	31	32	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95423	10.1371/journal.pone.0095423	http://dx.doi.org/10.1371/journal.pone.0095423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835274	Green Submitted, Green Published, gold			2022-12-25	WOS:000339614800007
J	Martin, JW; Chilton-MacNeill, S; Koti, M; van Wijnen, AJ; Squire, JA; Zielenska, M				Martin, Jeffrey W.; Chilton-MacNeill, Susan; Koti, Madhuri; van Wijnen, Andre J.; Squire, Jeremy A.; Zielenska, Maria			Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR RUNX2; HIGH-GRADE OSTEOSARCOMA; CELL-CYCLE KINASES; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; CHROMOSOMAL INSTABILITY; PROTEIN EXPRESSION; PROGNOSTIC-FACTORS; TUMOR-SUPPRESSOR; COPY NUMBER	Osteosarcoma is the most common malignancy of bone, and occurs most frequently in children and adolescents. Currently, the most reliable technique for determining a patients' prognosis is measurement of histopathologic tumor necrosis following pre-operative neo-adjuvant chemotherapy. Unfavourable prognosis is indicated by less than 90% estimated necrosis of the tumor. Neither genetic testing nor molecular biomarkers for diagnosis and prognosis have been described for osteosarcomas. We used the novel nanoString mRNA digital expression analysis system to analyse gene expression in 32 patients with sporadic paediatric osteosarcoma. This system used specific molecular barcodes to quantify expression of a set of 17 genes associated with osteosarcoma tumorigenesis. Five genes, from this panel, which encoded the bone differentiation regulator RUNX2, the cell cycle regulator CDC5L, the TP53 transcriptional inactivator MDM2, the DNA helicase RECQL4, and the cyclin-dependent kinase gene CDK4, were differentially expressed in tumors that responded poorly to neo-adjuvant chemotherapy. Analysis of the signalling relationships of these genes, as well as other expression markers of osteosarcoma, indicated that gene networks linked to RB1, TP53, PI3K, PTEN/Akt, myc and RECQL4 are associated with osteosarcoma. The discovery of these networks provides a basis for further experimental studies of role of the five genes (RUNX2, CDC5L, MDM2, RECQL4, and CDK4) in differential response to chemotherapy.	[Martin, Jeffrey W.; Chilton-MacNeill, Susan; Zielenska, Maria] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Squire, Jeremy A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Koti, Madhuri] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Squire, Jeremy A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, SP, Brazil; [Squire, Jeremy A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mayo Clinic; Mayo Clinic; McMaster University; Queens University - Canada; Queens University - Canada; Universidade de Sao Paulo; Universidade de Sao Paulo	Squire, JA (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	jsquireinsp@gmail.com	van Wijnen, Andre J./AAG-3578-2019; Squire, Jeremy A/A-9352-2012	van Wijnen, Andre J./0000-0002-4458-0946; Squire, Jeremy A/0000-0002-9863-468X	Canadian Cancer Society [CCRI-020247]; National Institutes of Health [AR049069]	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Canadian Cancer Society through grant CCRI-020247. Additional support was provided by National Institutes of Health grant AR049069 (to AvW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Dujardin F, 2011, MODERN PATHOL, V24, P624, DOI 10.1038/modpathol.2010.229; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Gallaher B, 2000, CELL MOL BIOL, V46, P79; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Kelly AD, 2013, GENOME MED, V5, DOI 10.1186/gm406; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Kyriazoglou AI, 2012, CANCER GENET-NY, V205, P332, DOI 10.1016/j.cancergen.2012.04.011; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Maire G, 2009, NEOPLASIA, V11, P260, DOI 10.1593/neo.81384; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Mohseny AB, 2010, GENE CHROMOSOME CANC, V49, P1095, DOI 10.1002/gcc.20817; Namlos Heidi M., 2012, Sarcoma, V2012, P639038, DOI 10.1155/2012/639038; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sato N, 2000, ANTICANCER RES, V20, P837; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Selvarajah S, 2008, CYTOGENET GENOME RES, V122, P5, DOI 10.1159/000151310; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; Wang ZX, 2010, BONE, V47, P445, DOI 10.1016/j.bone.2010.05.027; Won KY, 2009, TUMORI J, V95, P311; Wunder JS, 2005, J CLIN ONCOL, V23, P1483, DOI 10.1200/JCO.2005.04.074; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Yoshida A, 2012, AM J SURG PATHOL, V36, P423, DOI 10.1097/PAS.0b013e31824230d0; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	60	65	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95843	10.1371/journal.pone.0095843	http://dx.doi.org/10.1371/journal.pone.0095843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835790	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800010
J	Riar, AK; Narasimhan, M; Rathinam, ML; Vedpathak, D; Mummidi, S; Henderson, GI; Mahimainathan, L				Riar, Amanjot Kaur; Narasimhan, Madhusudhanan; Rathinam, Mary Latha; Vedpathak, Dhanashree; Mummidi, Srinivas; Henderson, George I.; Mahimainathan, Lenin			Ethanol-Induced Transcriptional Activation of Programmed Cell Death 4 (Pdcd4) Is Mediated by GSK-3 beta Signaling in Rat Cortical Neuroblasts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; FETAL ALCOHOL SYNDROME; SYNTHASE KINASE 3-BETA; NF-KAPPA-B; GENE-EXPRESSION; PRENATAL EXPOSURE; BETA-CATENIN; TRANSLATION INITIATION; PROTEIN TRANSLATION; BINDING	Ingestion of ethanol (ETOH) during pregnancy induces grave abnormalities in developing fetal brain. We have previously reported that ETOH induces programmed cell death 4 (PDCD4), a critical regulator of cell growth, in cultured fetal cerebral cortical neurons (PCNs) and in the cerebral cortex in vivo and affect protein synthesis as observed in Fetal Alcohol Spectrum Disorder (FASD). However, the mechanism which activates PDCD4 in neuronal systems is unclear and understanding this regulation may provide a counteractive strategy to correct the protein synthesis associated developmental changes seen in FASD. The present study investigates the molecular mechanism by which ethanol regulates PDCD4 in cortical neuroblasts, the immediate precursor of neurons. ETOH treatment significantly increased PDCD4 protein and transcript expression in spontaneously immortalized rat brain neuroblasts. Since PDCD4 is regulated at both the post-translational and post-transcriptional level, we assessed ETOH's effect on PDCD4 protein and mRNA stability. Chase experiments demonstrated that ETOH does not significantly impact either PDCD4 protein or mRNA stabilization. PDCD4 promoter-reporter assays confirmed that PDCD4 is transcriptionally regulated by ETOH in neuroblasts. Given a critical role of glycogen synthase kinase 3 beta (GSK-3 beta) signaling in regulating protein synthesis and neurotoxic mechanisms, we investigated the involvement of GSK-3 beta and showed that multifunctional GSK-3 beta was significantly activated in response to ETOH in neuroblasts. In addition, we found that ETOH-induced activation of PDCD4 was inhibited by pharmacologic blockade of GSK-3 beta using inhibitors, lithium chloride (LiCl) and SB-216763 or siRNA mediated silencing of GSK-3 beta. These results suggest that ethanol transcriptionally upregulates PDCD4 by enhancing GSK-3 beta signaling in cortical neuroblasts. Further, we demonstrate that canonical Wnt-3a/GSK-3 beta signaling is involved in regulating PDCD4 protein expression. Altogether, we provide evidence that GSK-3 beta/PDCD4 network may represent a critical modulatory point to manage the protein synthetic anomalies and growth aberrations of neural cells seen in FASD.	[Riar, Amanjot Kaur; Narasimhan, Madhusudhanan; Rathinam, Mary Latha; Vedpathak, Dhanashree; Henderson, George I.; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79409 USA; [Narasimhan, Madhusudhanan; Henderson, George I.; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, South Plains Alcohol & Addict Res Ctr, Lubbock, TX 79409 USA; [Mummidi, Srinivas] South Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Mummidi, Srinivas] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Mahimainathan, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79409 USA.	lenin.mahimainathan@ttuhsc.edu	Mummidi, Srinivas/H-3335-2017	Mummidi, Srinivas/0000-0002-4068-6380	National Institutes of Health Research Project Grant Program [RO1 AA010114]; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [1I01BX000975]; NIH [RO1AI043279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	National Institutes of Health Research Project Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by RO1 AA010114 (National Institutes of Health Research Project Grant Program) to George I. Henderson. SM is supported by grants awarded by the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (1I01BX000975) and by RO1AI043279 (NIH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Anthony B, 2008, ALCOHOL ALCOHOLISM, V43, P261, DOI 10.1093/alcalc/agm166; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Carter JJ, 2008, ACTA NEUROPATHOL, V116, P303, DOI 10.1007/s00401-008-0377-z; Cash AC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-4; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Chen G, 2009, NEUROTOX RES, V15, P321, DOI 10.1007/s12640-009-9036-y; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coles CD, 1997, ALCOHOL CLIN EXP RES, V21, P150, DOI 10.1111/j.1530-0277.1997.tb03743.x; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P220, DOI 10.1097/00000374-200002000-00013; CUSSO R, 1989, ALCOHOL ALCOHOLISM, V24, P291, DOI 10.1093/oxfordjournals.alcalc.a044915; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; DUMAS RM, 1994, NEUROTOXICOL TERATOL, V16, P605, DOI 10.1016/0892-0362(94)90038-8; Elliott EJ, 2008, ARCH DIS CHILD, V93, P732, DOI 10.1136/adc.2007.120220; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; GUERRI C, 1990, NEUROCHEM RES, V15, P559, DOI 10.1007/BF00966217; Guerri C, 1998, ALCOHOL CLIN EXP RES, V22, P304, DOI 10.1111/j.1530-0277.1998.tb03653.x; Handa RK, 2000, METAB BRAIN DIS, V15, P211, DOI 10.1007/BF02674530; Hanlon SE, 2004, CURR OPIN GENET DEV, V14, P697, DOI 10.1016/j.gde.2004.09.008; HENDERSON GI, 1995, ALCOHOL CLIN EXP RES, V19, P714, DOI 10.1111/j.1530-0277.1995.tb01572.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jegou S, 2012, ANN NEUROL, V72, P952, DOI 10.1002/ana.23699; JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; KOTCH LE, 1995, TERATOLOGY, V52, P128, DOI 10.1002/tera.1420520304; Leupold JH, 2012, BIOSCIENCE REP, V32, P281, DOI 10.1042/BSR20110045; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; Luo J, 2009, MOL NEUROBIOL, V40, P108, DOI 10.1007/s12035-009-8075-y; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Mason Stephen, 2012, Int J Proteomics, V2012, P867141, DOI 10.1155/2012/867141; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Matsuhashi S, 2007, EXP DERMATOL, V16, P179, DOI 10.1111/j.1600-0625.2006.00531.x; Mattson SN, 1998, ALCOHOL CLIN EXP RES, V22, P279, DOI 10.1111/j.1530-0277.1998.tb03651.x; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; MILLER MW, 1991, ALCOHOL CLIN EXP RES, V15, P229, DOI 10.1111/j.1530-0277.1991.tb01861.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MUNOZ A, 1993, J CELL BIOL, V121, P423, DOI 10.1083/jcb.121.2.423; Narasimhan M, 2013, ALCOHOL CLIN EXP RES, V37, P96, DOI 10.1111/j.1530-0277.2012.01850.x; Nunez SC, 2011, ALCOHOL RES HEALTH, V34, P121; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schneider Mary L, 2005, Alcohol Clin Exp Res, V29, P1685, DOI 10.1097/01.alc.0000179409.80370.25; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Smartt HJM, 2012, GUT, V61, P1306, DOI 10.1136/gutjnl-2011-300817; Substance Abuse and Mental Health Services Administration (SAMHSA). The National Survey on Drug Use and Health (NSDUH), 2013, NAT SURV DRUG US HLT; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Vikhreva PN, 2012, DOKL BIOCHEM BIOPHYS, V442, P49, DOI 10.1134/S1607672912010176; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; Waby JS, 2008, CURR GENOMICS, V9, P301, DOI 10.2174/138920208785133244; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Yamada Y, 2005, J CRANIOFAC SURG, V16, P1055, DOI 10.1097/01.scs.0000183470.31202.c9; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Young MR, 2010, MOL INTERV, V10, P76, DOI 10.1124/mi.10.2.5; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	78	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98080	10.1371/journal.pone.0098080	http://dx.doi.org/10.1371/journal.pone.0098080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837604	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800102
J	Nguyen, KA; Hamzeh-Cognasse, H; Sebban, M; Fromont, E; Chavarin, P; Absi, L; Pozzetto, B; Cognasse, F; Garraud, O				Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Sebban, Marc; Fromont, Elisa; Chavarin, Patricia; Absi, Lena; Pozzetto, Bruno; Cognasse, Fabrice; Garraud, Olivier			A Computerized Prediction Model of Hazardous Inflammatory Platelet Transfusion Outcomes	PLOS ONE			English	Article							ACUTE LUNG INJURY; SOLUBLE CD40 LIGAND; SINGLE-NEEDLE PLATELETPHERESIS; COAT-DERIVED PLATELETS; IN-VITRO; ADDITIVE SOLUTIONS; TRIMA ACCEL; STORAGE; BLOOD; CD154	Background: Platelet component (PC) transfusion leads occasionally to inflammatory hazards. Certain BRMs that are secreted by the platelets themselves during storage may have some responsibility. Methodology/Principal Findings: First, we identified non-stochastic arrangements of platelet-secreted BRMs in platelet components that led to acute transfusion reactions (ATRs). These data provide formal clinical evidence that platelets generate secretion profiles under both sterile activation and pathological conditions. We next aimed to predict the risk of hazardous outcomes by establishing statistical models based on the associations of BRMs within the incriminated platelet components and using decision trees. We investigated a large (n = 65) series of ATRs after platelet component transfusions reported through a very homogenous system at one university hospital. Herein, we used a combination of clinical observations, ex vivo and in vitro investigations, and mathematical modeling systems. We calculated the statistical association of a large variety (n = 17) of cytokines, chemokines, and physiologically likely factors with acute inflammatory potential in patients presenting with severe hazards. We then generated an accident prediction model that proved to be dependent on the level (amount) of a given cytokine-like platelet product within the indicated component, e. g., soluble CD40-ligand (>289.5 pg/109 platelets), or the presence of another secreted factor (IL-13, >0). We further modeled the risk of the patient presenting either a febrile non-hemolytic transfusion reaction or an atypical allergic transfusion reaction, depending on the amount of the chemokine MIP-1 alpha (<20.4 or >20.4 pg/109 platelets, respectively). Conclusions/Significance: This allows the modeling of a policy of risk prevention for severe inflammatory outcomes in PC transfusion.	[Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Pozzetto, Bruno; Cognasse, Fabrice; Garraud, Olivier] Univ Lyon, GIMAP, EA3064, St Etienne, France; [Sebban, Marc; Fromont, Elisa] CNRS, UMR 5516, Lab Hubert Curien, St Etienne, France; [Chavarin, Patricia; Absi, Lena; Cognasse, Fabrice; Garraud, Olivier] EFS Auvergne Loire, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet	Garraud, O (corresponding author), Univ Lyon, GIMAP, EA3064, St Etienne, France.	Olivier.garraud@efs.sante.fr	Cognasse, Fabrice/Z-4401-2019	POZZETTO, Bruno/0000-0002-2603-8467; Fromont, Elisa/0000-0003-0133-3491	National and Regional Blood Bank; EFS Auvergne-Loire, France; Association "Les Amis de Remi," Savigneux, France; French National Agency for Drug Safety and Health Products (ANSM)	National and Regional Blood Bank; EFS Auvergne-Loire, France; Association "Les Amis de Remi," Savigneux, France; French National Agency for Drug Safety and Health Products (ANSM)	Financial support was received through grants from the National and Regional Blood Bank, EFS Auvergne-Loire, France, the Association "Les Amis de Remi," Savigneux, France, and the French National Agency for Drug Safety and Health Products (ANSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Adda R, 2012, RAPPORT ACTIVITE HEM, P1; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; [Anonymous], 2011, INT HAEM NETW PROP S; Apelseth TO, 2006, TRANSFUSION, V46, P800, DOI 10.1111/j.1537-2995.2006.00800.x; Blumberg N, 2003, TRANSFUSION, V43, P291, DOI 10.1046/j.1537-2995.2003.t01-2-00362.x; Blumberg N, 2009, IMMUNOL RES; Blumberg N, 2006, TRANSFUSION, V46, P1813, DOI 10.1111/j.1537-2995.2006.00979.x; Blumberg N, 2012, LANCET, V380, P1287, DOI 10.1016/S0140-6736(12)60983-0; Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Burgstaler EA, 2004, TRANSFUSION, V44, P1612, DOI 10.1111/j.0041-1132.2004.04129.x; Chavarin P, 2011, VOX SANG, V100, P247, DOI 10.1111/j.1423-0410.2010.01389.x; Cognasse F, 2008, TRANSFUSION, V48, P809, DOI 10.1111/j.1537-2995.2008.01655.x; Cognasse F, 2006, TRANSFUSION, V46, P1184, DOI 10.1111/j.1537-2995.2006.00869.x; Cognasse F, 2009, TRANSFUSION, V49, P91, DOI 10.1111/j.1537-2995.2008.01931.x; Cognasse F, 2008, BLOOD, V112, P4779, DOI 10.1182/blood-2008-05-157578; Connor RI, 1996, J VIROL, V70, P5306, DOI 10.1128/JVI.70.8.5306-5311.1996; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Fontana S, 2006, TRANSFUSION, V46, P2004, DOI 10.1111/j.1537-2995.2006.01009.x; Garraud O, 2012, TRANSFUS CLIN BIOL, V19, P104, DOI 10.1016/j.tracli.2012.02.004; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Hamzeh-Cognasse H, 2013, TRANSFUSION; Heddle N M, 1999, Curr Opin Hematol, V6, P420, DOI 10.1097/00062752-199911000-00012; Kaufman J, 2007, J THROMB HAEMOST, V5, P788, DOI 10.1111/j.1538-7836.2007.02412.x; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nguyen KA, 2012, BLOOD TRANSFUS, P1; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Park JW, 2013, TRANSFUSION, V53, P637, DOI 10.1111/j.1537-2995.2012.03777.x; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Refaai MA, 2011, THROMB RES, V127, P287, DOI 10.1016/j.thromres.2010.10.012; Sahler J, 2012, TRANSFUS CLIN BIOL, V19, P98, DOI 10.1016/j.tracli.2012.02.003; Sahler Julie, 2011, Drug Discov Today Dis Mech, V8, pe9; Sandgren P, 2007, VOX SANG, V93, P27, DOI 10.1111/j.1423-0410.2007.00912.x; Sandgren P, 2010, VOX SANG, V99, P341, DOI 10.1111/j.1423-0410.2010.01364.x; Sandgren P, 2013, TRANSFUSION; Sandgren P, 2008, TRANSFUSION, V48, P688, DOI 10.1111/j.1537-2995.2007.01593.x; Sayah DM, 2012, CRIT CARE CLIN, V28, P363, DOI 10.1016/j.ccc.2012.04.001; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Tinegate H, 2012, BRIT J HAEMATOL, V159, P143, DOI 10.1111/bjh.12017; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Tung JP, 2012, CRIT CARE, V16, DOI 10.1186/cc11178; Vlahou A, 2003, J BIOMED BIOTECHNOL, P308, DOI 10.1155/S1110724303210032; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x	49	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97082	10.1371/journal.pone.0097082	http://dx.doi.org/10.1371/journal.pone.0097082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830754	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500033
J	Neubauer, S; Dolgova, O; Prag, G; Borriss, R; Makarewicz, O				Neubauer, Svetlana; Dolgova, Olga; Praeg, Gregory; Borriss, Rainer; Makarewicz, Oliwia			Substitutional Analysis of the C-Terminal Domain of AbrB Revealed Its Essential Role in DNA-Binding Activity	PLOS ONE			English	Article							STATE REGULATOR ABRB; BACILLUS-AMYLOLIQUEFACIENS FZB45; CATABOLITE REPRESSION; TRANSCRIPTION FACTORS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; TRANSPORT OPERON; PROMOTER REGION; GENE-EXPRESSION; SUBTILIS	The global transition state regulator AbrB controls more than 100 genes of the Bacillus relatives and is known to interact with varying DNA-sequences. The DNA-binding domain of the AbrB-like proteins was proposed to be located exclusively within the amino-terminal ends. However, the recognition of DNA, and specificity of the binding mechanism, remains elusive still in view of highly differing recognition sites. Here we present a substitutional analysis to examine the role of the carboxy-terminal domain of AbrB from Bacillus subtilis and Bacillus amyloliquefaciens. Our results demonstrate that the carboxy-terminal domains of AbrB affect the DNA-binding properties of the tetrameric AbrB. Most likely, the C-termini are responsible for the cooperative character observed for AbrB interaction with some DNA targets like tycA and phyC.	[Neubauer, Svetlana; Dolgova, Olga; Praeg, Gregory; Borriss, Rainer; Makarewicz, Oliwia] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Makarewicz, Oliwia] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany	Humboldt University of Berlin; Friedrich Schiller University of Jena	Makarewicz, O (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	oliwia.makarewicz@med.uni-jena.de	Borriss, Rainer/C-5026-2012	Borriss, Rainer/0000-0003-3726-1004; Makarewicz, Oliwia/0000-0002-4404-1862	Deutsche Forschungsgemeinschaft, DFG [BO 1113/9-1]; German Ministry for Education and Research, BMBF [01EO1002, 01KI1204]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft, DFG (grant BO 1113/9-1 to R. B.) and partially by the German Ministry for Education and Research, BMBF (grants 01EO1002 and 01KI1204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asen I, 2009, J MOL BIOL, V386, P962, DOI 10.1016/j.jmb.2008.10.061; Benson LM, 2002, ANAL BIOCHEM, V306, P222, DOI 10.1006/abio.2002.5704; Bobay BG, 2005, FEBS LETT, V579, P5669, DOI 10.1016/j.febslet.2005.09.045; Bobay BG, 2004, BIOCHEMISTRY-US, V43, P16106, DOI 10.1021/bi048399h; Cavanagh J, 2002, BIOCHEMISTRY-US, V41, P7859, DOI 10.1021/bi0202225; Chumsakul O, 2010, NUCL ACIDS RES; Coles M, 2005, STRUCTURE, V13, P919, DOI 10.1016/j.str.2005.03.017; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; FISHER SH, 1994, J BACTERIOL, V176, P1903, DOI 10.1128/jb.176.7.1903-1912.1994; FRIEDRICH K, 1988, FEBS LETT, V229, P197, DOI 10.1016/0014-5793(88)80826-3; FURBASS R, 1991, FEBS LETT, V287, P153, DOI 10.1016/0014-5793(91)80038-5; FURBASS R, 1991, MOL GEN GENET, V225, P347; HAHN J, 1995, J BACTERIOL, V177, P3601, DOI 10.1128/jb.177.12.3601-3605.1995; Hamoen LW, 2003, FEMS MICROBIOL LETT, V218, P299, DOI 10.1111/j.1574-6968.2003.tb11532.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Makarewicz O, 2008, J BACTERIOL, V190, P6467, DOI 10.1128/JB.00430-08; MARAHIEL MA, 1993, MOL MICROBIOL, V7, P631, DOI 10.1111/j.1365-2958.1993.tb01154.x; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Neubauer S, 2012, MOL GENET GENOMICS, V287, P111, DOI 10.1007/s00438-011-0666-4; Olson AL, 2013, BIOCHEM BIOPH RES CO, V431, P253, DOI 10.1016/j.bbrc.2012.12.124; Phillips ZEV, 2001, FEMS MICROBIOL LETT, V203, P207, DOI 10.1016/S0378-1097(01)00347-0; Qian Q, 2002, FEMS MICROBIOL LETT, V211, P219, DOI 10.1016/S0378-1097(02)00679-1; Sambrook J., 2002, MOL CLONING LAB MANU; Shafikhani SH, 2002, J BACTERIOL, V184, P564, DOI 10.1128/JB.184.2.564-571.2002; SLACK FJ, 1991, MOL MICROBIOL, V5, P1915, DOI 10.1111/j.1365-2958.1991.tb00815.x; STRAUCH MA, 1989, MOL MICROBIOL, V3, P1203, DOI 10.1111/j.1365-2958.1989.tb00270.x; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; STRAUCH MA, 1995, J BACTERIOL, V177, P6727, DOI 10.1128/jb.177.23.6727-6731.1995; STRAUCH MA, 1995, J BACTERIOL, V177, P6999, DOI 10.1128/jb.177.23.6999-7002.1995; STRAUCH MA, 1995, MOL GEN GENET, V246, P756, DOI 10.1007/BF00290723; STRAUCH MA, 1995, J BACTERIOL, V177, P4532, DOI 10.1128/jb.177.15.4532-4536.1995; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; Sullivan DM, 2008, STRUCTURE, V16, P1702, DOI 10.1016/j.str.2008.08.014; Uyar E, 2009, J BACTERIOL, V191, P2388, DOI 10.1128/JB.01594-08; Xu K, 1996, J BIOL CHEM, V271, P2621, DOI 10.1074/jbc.271.5.2621; Xu K, 1996, MOL MICROBIOL, V19, P145, DOI 10.1046/j.1365-2958.1996.358882.x; Xu K, 2001, J BACTERIOL, V183, P4094, DOI 10.1128/JB.183.13.4094-4098.2001; Yao F, 2005, J BACTERIOL, V187, P6354, DOI 10.1128/JB.187.18.6354-6362.2005; ZUBER P, 1987, J BACTERIOL, V169, P2223, DOI 10.1128/jb.169.5.2223-2230.1987	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97254	10.1371/journal.pone.0097254	http://dx.doi.org/10.1371/journal.pone.0097254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832089	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500043
J	Thomas, SF; Rooks, P; Rudin, F; Atkinson, S; Goddard, P; Bransgrove, R; Mason, PT; Allen, MJ				Thomas, Simon F.; Rooks, Paul; Rudin, Fabian; Atkinson, Sov; Goddard, Paul; Bransgrove, Rachel; Mason, Paul T.; Allen, Michael J.			The Bactericidal Effect of Dendritic Copper Microparticles, Contained in an Alginate Matrix, on Escherichia coli	PLOS ONE			English	Article							NANOPARTICLES; RESPONSES	Although the bactericidal effect of copper has been known for centuries, there is a current resurgence of interest in the use of this element as an antimicrobial agent. During this study the use of dendritic copper microparticles embedded in an alginate matrix as a rapid method for the deactivation of Escherichia coli ATCC 11775 was investigated. The copper/alginate produced a decrease in the minimum inhibitory concentration from free copper powder dispersed in the media from 0.25 to 0.065 mg/ml. Beads loaded with 4% Cu deactivated 99.97% of bacteria after 90 minutes, compared to a 44.2% reduction in viability in the equivalent free copper powder treatment. There was no observed loss in the efficacy of this method with increasing bacterial loading up to 10(6) cells/ml, however only 88.2% of E. coli were deactivated after 90 minutes at a loading of 10(8) cells/ml. The efficacy of this method was highly dependent on the oxygen content of the media, with a 4.01% increase in viable bacteria observed under anoxic conditions compared to a>99% reduction in bacterial viability in oxygen tensions above 50% of saturation. Scanning electron micrographs (SEM) of the beads indicated that the dendritic copper particles sit as discrete clusters within a layered alginate matrix, and that the external surface of the beads has a scale-like appearance with dendritic copper particles extruding. E. coli cells visualised using SEM indicated a loss of cellular integrity upon Cu bead treatment with obvious visible blebbing. This study indicates the use of microscale dendritic particles of Cu embedded in an alginate matrix to effectively deactivate E. coli cells and opens the possibility of their application within effective water treatment processes, especially in high particulate waste streams where conventional methods, such as UV treatment or chlorination, are ineffective or inappropriate.	[Thomas, Simon F.; Rudin, Fabian; Mason, Paul T.] Plymouth Martine Lab Applicat Ltd, Plymouth, Devon, England; [Rooks, Paul; Atkinson, Sov; Bransgrove, Rachel; Allen, Michael J.] Plymouth Marine Lab, Plymouth, Devon, England; [Goddard, Paul] Prot Technol Ltd, Manchester, Lancs, England	Plymouth Marine Laboratory	Allen, MJ (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	mija@pml.ac.uk	Rudin, Fabian S/B-5877-2015; Allen, Michael J/C-1248-2011	Rudin, Fabian S/0000-0003-4539-3074; Allen, Michael J/0000-0001-8504-7171; Thomas, Simon/0000-0002-8474-1230	Bill & Melinda Gates Foundation [OPP1044451, OPP1095464]; NERC [pml010009, pml010002] Funding Source: UKRI; Natural Environment Research Council [pml010009, pml010002] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants awarded to MJA from the Bill & Melinda Gates Foundation (OPP1044451, OPP1095464). The findings and conclusions contained within are those of the author(s) and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarghouthi M, 2000, INT J PHARM, V206, P23, DOI 10.1016/S0378-5173(00)00470-1; Anal AK, 2003, DRUG DEV IND PHARM, V29, P713, DOI 10.1081/DDC-120021320; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Besser JM, 2007, ENVIRON TOXICOL CHEM, V26, P1657, DOI 10.1897/06-571R.1; Chen YG, 2012, ENVIRON SCI TECHNOL, V46, P12452, DOI 10.1021/es302646q; Diaz-Visurraga J, 2012, INT J NANOMED, V7, P3597, DOI 10.2147/IJN.S32648; Dolwet HHA, 1985, J TRACE ELEM MED BIO, V2; Faundez G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-19; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; GORDON AS, 1994, CAN J MICROBIOL, V40, P408, DOI 10.1139/m94-067; HARWOOD VJ, 1994, APPL ENVIRON MICROB, V60, P1749, DOI 10.1128/AEM.60.6.1749-1753.1994; Held KD, 1996, RADIAT RES, V145, P542, DOI 10.2307/3579272; Holt JG, 2010, BERGEYS MANUAL DETER; Jorge MB, 2013, AQUAT TOXICOL, V126, P137, DOI 10.1016/j.aquatox.2012.10.014; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Lin YSE, 2002, APPL ENVIRON MICROB, V68, P2711, DOI 10.1128/AEM.68.6.2711-2715.2002; Liu YS, 2009, RADIAT PHYS CHEM, V78, P251, DOI 10.1016/j.radphyschem.2009.01.003; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Santo CE, 2012, MICROBIOLOGYOPEN, V1, P46, DOI 10.1002/mbo3.2; Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Xu Q, 2014, OPT EXPRESS, V22, pA301, DOI 10.1364/OE.22.00A301	23	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96225	10.1371/journal.pone.0096225	http://dx.doi.org/10.1371/journal.pone.0096225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831035	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500015
J	Bezabhe, WM; Chalmers, L; Bereznicki, LR; Peterson, GM; Bimirew, MA; Kassie, DM				Bezabhe, Woldesellassie M.; Chalmers, Leanne; Bereznicki, Luke R.; Peterson, Gregory M.; Bimirew, Mekides A.; Kassie, Desalew M.			Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia	PLOS ONE			English	Article							STIGMA; ART; POPULATION; OUTCOMES; UGANDA	Background: Antiretroviral therapy (ART) has been life saving for hundreds of thousands of Ethiopians. With increased availability of ART in recent years, achievement of optimal adherence and patient retention are becoming the greatest challenges in the management of HIV/AIDS in Ethiopia. However, few studies have explored factors influencing medication adherence to ART and retention in follow-up care among adult Ethiopian HIV-positive patients, especially in the Amhara region of the country, where almost one-third of the country's ART is prescribed. The aim of this qualitative study was to collect such data from patients and healthcare providers in the Amhara region of Ethiopia. Methods: Semi-structured interviews were conducted with 24 patients, of whom 11 had been lost to follow-up and were non-persistent with ART. In addition, focus group discussions were performed with 15 ART nurses and 19 case managers. All interviews and focus groups were audio-recorded, transcribed, and coded for themes and patterns in Amharic using a grounded theory approach. The emergent concepts and categories were translated into English. Results: Economic constraints, perceived stigma and discrimination, fasting, holy water, medication side effects, and dissatisfaction with healthcare services were major reasons for patients being non-adherent and lost to follow-up. Disclosure of HIV status, social support, use of reminder aids, responsibility for raising children, improved health on ART, and receiving education and counseling emerged as facilitators of adherence to ART. Conclusions: Improving adherence and retention requires integration of enhanced treatment access with improved job and food security. Healthcare providers need to be supported to better equip patients to cope with the issues associated with ART. Development of social policies and cooperation between various agencies are required to facilitate optimal adherence to ART, patient retention, and improved patient outcomes.	[Bezabhe, Woldesellassie M.; Chalmers, Leanne; Bereznicki, Luke R.; Peterson, Gregory M.] Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas 7001, Australia; [Bezabhe, Woldesellassie M.] Bahir Dar Univ, Coll Med & Hlth Sci, Gojjam, Ethiopia; [Bimirew, Mekides A.] Felege Hiwot Hosp, Dept Internal Med, Gojjam, Ethiopia; [Kassie, Desalew M.] Gondar Univ Hosp, Dept Internal Med, Gondar, Ethiopia	University of Tasmania; Bahir Dar University	Bezabhe, WM (corresponding author), Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas 7001, Australia.	mwoldesellassie@yahoo.com		Chalmers, Leanne/0000-0002-2477-2190; Peterson, Gregory/0000-0002-6764-3882; Bezabhe, Woldesellassie/0000-0002-3028-6949; Bereznicki, Luke/0000-0003-3974-3437	Tasmanian School of Pharmacy, University of Tasmania	Tasmanian School of Pharmacy, University of Tasmania	The study was financially supported by the Tasmanian School of Pharmacy, University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeneye A K, 2006, World Health Popul, V8, P46; Amhara HIV/AIDS Prevention and Control Coordination Office (HAPCO), 2013, HIV FACTS FIG; Aspeling HE, 2008, INT J NURS PRACT, V14, P3, DOI 10.1111/j.1440-172X.2007.00659.x; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bezabhe WM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003559; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; Ethiopian Central Statistical Agency, 2012, POP 2011; Federal HIV/AIDS Prevention and Control Office (HAPCO), 2012, COUNTR PROGR REP HIV; Finocchario-Kessler S, 2011, AIDS PATIENT CARE ST, V25, P103, DOI 10.1089/apc.2010.0319; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Gonzalez JS, 2007, ANN BEHAV MED, V34, P46, DOI 10.1007/BF02879920; Gusdal AK, 2011, AIDS CARE, V23, P657, DOI 10.1080/09540121.2010.532531; Gusdal AK, 2009, AIDS CARE, V21, P1381, DOI 10.1080/09540120902883119; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Kuschminder K, 2012, PROFILING ETHIOPIAN; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Lima V, 2009, SOC SCI MED, V68, P1044, DOI 10.1016/j.socscimed.2008.12.043; Malcolm A., 1998, CRITICAL PUBLIC HLTH, V8, P347, DOI [10.1080/09581599808402920, DOI 10.1080/09581599808402920]; Mamo W, 2012, ISRN AIDS; Mengistu Zuriyash, 2012, Ethiop Med J, V50, P355; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Murphy DA, 2011, J CONSULT CLIN PSYCH, V79, P203, DOI 10.1037/a0022896; Musumari PM, 2013, AIDS CARE; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Negash T, 2013, J ASSOC NURSE AIDS C, V24, P530, DOI 10.1016/j.jana.2012.11.004; Olley BO, 2006, AIDS CARE, V18, P1025, DOI 10.1080/09540120600568756; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Palar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061935; Patel Sangita, 2012, Indian J Sex Transm Dis AIDS, V33, P107, DOI 10.4103/0253-7184.102119; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Peltzer K, 2011, AIDS CARE, V23, P60, DOI 10.1080/09540121.2010.498864; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Portelli MS, 2012, ASIA PAC J PUBLIC HL; Rathavuth Hong VM, 2008, FACTORS ASS PREVALEN; Rotberg RI, 2013, WASH QUART, V36, P111, DOI 10.1080/0163660X.2013.751651; Saether ST, 2007, TROP MED INT HEALTH, V12, P999, DOI 10.1111/j.1365-3156.2007.01879.x; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Vyankandondera J, 2013, AIDS CARE; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2013, AIDS; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197; Yakasai AM, 2011, TROP DOCT, V41, P233, DOI 10.1258/td.2011.110130	56	105	108	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97353	10.1371/journal.pone.0097353	http://dx.doi.org/10.1371/journal.pone.0097353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828585	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400082
J	Drake, A; Rock, CA; Quinlan, SP; Martin, M; Green, DJ				Drake, Anna; Rock, Christine A.; Quinlan, Sam P.; Martin, Michaela; Green, David J.			Wind Speed during Migration Influences the Survival, Timing of Breeding, and Productivity of a Neotropical Migrant, Setophaga petechia	PLOS ONE			English	Article							SPRING ARRIVAL; POPULATION LIMITATION; REPRODUCTIVE SUCCESS; SEXUAL SELECTION; WINTERING AREAS; MARKED ANIMALS; BIRD MIGRATION; NORTH-AMERICA; CLIMATE; SONGBIRD	Over the course of the annual cycle, migratory bird populations can be impacted by environmental conditions in regions separated by thousands of kilometers. We examine how climatic conditions during discrete periods of the annual cycle influence the demography of a nearctic-neotropical migrant population of yellow warblers (Setophaga petechia), that breed in western Canada and overwinter in Mexico. We demonstrate that wind conditions during spring migration are the best predictor of apparent annual adult survival, male arrival date, female clutch initiation date and, via these timing effects, annual productivity. We find little evidence that conditions during the wintering period influence breeding phenology and apparent annual survival. Our study emphasizes the importance of climatic conditions experienced by migrants during the migratory period and indicates that geography may play a role in which period most strongly impacts migrant populations.	[Drake, Anna; Rock, Christine A.; Quinlan, Sam P.; Martin, Michaela; Green, David J.] Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Drake, A (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada.	aedrake@sfu.ca	Green, David J/B-5096-2012		Fish and Wildlife Compensation Program [WSI4639]; Environment Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN261899]; NSERC	Fish and Wildlife Compensation Program; Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research support came from The Fish and Wildlife Compensation Program (WSI4639) (www.bchydro.com/bcrp), core funding to the CWE provided by Environment Canada (www.sfu.ca/biology/wildberg), a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to D.J.G. (RGPIN261899) and NSERC fellowships to A.D., C.R., S.Q. and M.M. (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERSTAM T, 1979, ORNIS SCAND, V10, P76, DOI 10.2307/3676347; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; BAILLIE SR, 1992, IBIS, V134, P120; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Caso M, 2007, P NATL ACAD SCI USA, V104, P10530, DOI 10.1073/pnas.0701862104; Drake A, 2013, J AVIAN BIOL, V44, P321, DOI 10.1111/j.1600-048X.2013.05828.x; Dugger KM, 2004, CONDOR, V106, P744, DOI 10.1650/7632; Ebird, 2013, EBIRD ONL DAT BIRD D; Erni B, 2005, BEHAV ECOL, V16, P732, DOI 10.1093/beheco/ari046; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Felix Rodney K. Jr., 2008, Studies in Avian Biology, V37, P126; Gauthreaux SA, 1980, P 17 INT ORN C, V17, P517; Giorgi F, 2001, GEOPHYS RES LETT, V28, P3317, DOI 10.1029/2001GL013150; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Hutto R.L., 1980, P181; Kelly JF, 2005, CONDOR, V107, P197, DOI 10.1650/7805; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leeper DA, 1998, J N AM BENTHOL SOC, V17, P54, DOI 10.2307/1468051; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Macmynowski DP, 2007, GLOBAL CHANGE BIOL, V13, P2239, DOI 10.1111/j.1365-2486.2007.01448.x; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mazerolle DF, 2011, ECOSCIENCE, V18, P18, DOI 10.2980/18-1-3345; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Nott MP, 2002, GLOBAL ECOL BIOGEOGR, V11, P333, DOI 10.1046/j.1466-822X.2002.00296.x; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Pyle P., 1997, IDENTIFICATION GUI 1; Renton K, 2004, AUK, V121, P1214, DOI 10.1642/0004-8038(2004)121[1214:CVNPAR]2.0.CO;2; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; Rock CA, 2013, CAN J ZOOL, V91, P505, DOI 10.1139/cjz-2013-0014; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 2005, CONDOR, V107, P212, DOI 10.1650/7807; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1	46	48	48	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97152	10.1371/journal.pone.0097152	http://dx.doi.org/10.1371/journal.pone.0097152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828427	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400059
J	Zhang, Z; Wei, SG; Gui, HS; Yuan, ZY; Li, SB				Zhang, Zhe; Wei, Shuguang; Gui, Hongsheng; Yuan, Zuyi; Li, Shengbin			The Contribution of Genetic Diversity to Subdivide Populations Living in the Silk Road of China	PLOS ONE			English	Article							9 STR LOCI; ETHNIC-GROUPS; ORIGIN; REGION; DNA; MTDNA; TREES	There are several indigenous ethnic populations along the silk road in the Northwest of China that display clear differences in culture and social customs, perhaps as a result of geographic isolation and different linguistic traditions. However, extensive trade and other interactions probably facilitated the admixture of different gene pools between these populations over the last two millennia. To further explore the evolutionary relationships of the 13 ethnic populations residing in Northwest China and to reveal the features of population admixture, the 9 most-commonly employed CODIS loci (D3S1358, TH01, D5S818, D13S317, D7S820, CSF1PO, vWA, TPOX, FGA) were selected for genotyping and further analysis. Phylogenetic tree and principal component analysis revealed clear pattern of population differentiation between 4 populations living in Sinkiang Uighur Autonomous Region and other 9 populations dwelled in the upper regions of Silk Road. R matrix regression showed high-level gene flow and population admixture dose exist among these ethic populations in the Northwest region of China. Furthermore, the Mantel test suggests that larger percent of genetic variance (21.58% versus 2.3%) can be explained by geographic isolation than linguistic barriers, which matched with the contribution of geographic factors to other world populations.	[Zhang, Zhe; Yuan, Zuyi; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Gene Related Dis, Xian, Shaanxi, Peoples R China; [Zhang, Zhe; Wei, Shuguang; Gui, Hongsheng; Yuan, Zuyi; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med & Forens, Natl Minist Hlth Forens Sci, Key Lab, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yuan, ZY (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Gene Related Dis, Xian, Shaanxi, Peoples R China.	zuyiyuan@mail.xjtu.edu.cn; shbinlee@mail.xjtu.edu.cn	Gui, Hongsheng/D-1063-2013	Gui, Hongsheng/0000-0002-0460-7446; Yuan, Zuyi/0000-0002-4141-0298	National Foundation (Ministry of Science and Technology, P.R. of China) [2013FY114300]	National Foundation (Ministry of Science and Technology, P.R. of China)	This research was supported by the National Foundation (2013FY114300; Ministry of Science and Technology, P.R. of China; http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbasak BS, 2001, FORENSIC SCI INT, V123, P227, DOI 10.1016/S0379-0738(01)00532-1; Ayub Q, 2003, AM J PHYS ANTHROPOL, V122, P259, DOI 10.1002/ajpa.10234; Barbujani G, 1997, AM J HUM GENET, V61, P1011, DOI 10.1086/301620; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Budowle B, 1999, J FORENSIC SCI, V44, P1277; Budowle B, 2001, J FORENSIC SCI, V46, P453; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Chen LK, 1999, ZHONGGUO MINZUSHI GA; Chen T, 2006, FORENSIC SCI INT, V157, P218, DOI 10.1016/j.forsciint.2005.03.015; Chen T, 2004, FORENSIC SCI INT, V146, P53, DOI 10.1016/j.forsciint.2004.04.004; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Du R., 1993, ETHNIC GROUPS CHINA; Harpending HC., 1982, BIOCH ASPECTS EVOLUT; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; LI HJ, 1990, HUM GENET, V86, P231; Ma Yin, 1994, CHINAS MINORITY NATL; National Bureau of Statistics PRoC, 2010, TAB NAT 2010 POP CEN; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Perez-Lezaun A, 1996, HUM GENET, V99, P1; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reddy BM, 2001, HUM BIOL, V73, P57; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Takezaki N, 2008, GENETICS, V178, P385, DOI 10.1534/genetics.107.081505; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang XH, 2002, FORENSIC SCI INT, V129, P214, DOI 10.1016/S0379-0738(02)00227-X; Wei YL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-42; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Xiao FX, 2004, EUR J HUM GENET, V12, P301, DOI 10.1038/sj.ejhg.5201097; [薛付忠 Xue Fuzhong], 2005, [人类学学报, Acta Anthropologica Sinica], V24, P221; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2000, GENES GENET SYST, V75, P173, DOI 10.1266/ggs.75.173; Yuan Hong FY, 2004, CHINESE J FORENSIC M, V19, P290; Zhou RX, 2007, J HUM GENET, V52, P584, DOI 10.1007/s10038-007-0155-0	42	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97344	10.1371/journal.pone.0097344	http://dx.doi.org/10.1371/journal.pone.0097344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828511	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400081
J	Fortunato, MJ; Ball, CE; Hollinger, K; Patel, NB; Modi, JN; Rajasekaran, V; Nonneman, DJ; Ross, JW; Kennedy, EJ; Selsby, JT; Beedle, AM				Fortunato, Marisa J.; Ball, Charlotte E.; Hollinger, Katrin; Patel, Niraj B.; Modi, Jill N.; Rajasekaran, Vedika; Nonneman, Dan J.; Ross, Jason W.; Kennedy, Eileen J.; Selsby, Joshua T.; Beedle, Aaron M.			Development of Rabbit Monoclonal Antibodies for Detection of Alpha-Dystroglycan in Normal and Dystrophic Tissue	PLOS ONE			English	Article							GLYCOPROTEIN COMPLEX; MUSCLE-FIBERS; LAMININ; GLYCOSYLATION; DISRUPTION; DEFICIENCY; EXPRESSION; MEMBRANE; ISOFORMS	Alpha-dystroglycan requires a rare O-mannose glycan modification to form its binding epitope for extracellular matrix proteins such as laminin. This functional glycan is disrupted in a cohort of muscular dystrophies, the secondary dystroglycanopathies, and is abnormal in some metastatic cancers. The most commonly used reagent for detection of alpha-dystroglycan is mouse monoclonal antibody IIH6, but it requires the functional O-mannose structure for recognition. Therefore, the ability to detect alpha-dystroglycan protein in disease states where it lacks the full O-mannose glycan has been limited. To overcome this hurdle, rabbit monoclonal antibodies against the alpha-dystroglycan C-terminus were generated. The new antibodies, named 5-2, 29-5, and 45-3, detect alpha-dystroglycan from mouse, rat and pig skeletal muscle by Western blot and immunofluorescence. In a mouse model of fukutin-deficient dystroglycanopathy, all antibodies detected low molecular weight alpha-dystroglycan in disease samples demonstrating a loss of functional glycosylation. Alternately, in a porcine model of Becker muscular dystrophy, relative abundance of alpha-dystroglycan was decreased, consistent with a reduction in expression of the dystrophin-glycoprotein complex in affected muscle. Therefore, these new rabbit monoclonal antibodies are suitable reagents for alpha-dystroglycan core protein detection and will enhance dystroglycan-related studies.	[Fortunato, Marisa J.; Kennedy, Eileen J.; Beedle, Aaron M.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Ball, Charlotte E.; Patel, Niraj B.; Modi, Jill N.; Rajasekaran, Vedika] Univ Georgia, Ctr Undergrad Res, Athens, GA 30602 USA; [Hollinger, Katrin; Ross, Jason W.; Selsby, Joshua T.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Nonneman, Dan J.] USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Iowa State University; United States Department of Agriculture (USDA)	Beedle, AM (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	beedlea@uga.edu	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677; Selsby, Joshua/0000-0003-3797-7539	University of Georgia College of Pharmacy; National Institutes of Health [R21NS079603, R21RR030232]; NATIONAL CANCER INSTITUTE [K22CA154600] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR030232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079603] Funding Source: NIH RePORTER	University of Georgia College of Pharmacy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Georgia College of Pharmacy (AMB) and by funds from the National Institutes of Health R21NS079603 (JTS) and R21RR030232 (JWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; DiBlasi C, 1996, ACTA NEUROPATHOL, V92, P369; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esser AK, 2013, J BIOL CHEM, V288, P2132, DOI 10.1074/jbc.M112.432807; Geis T, 2013, NEUROGENETICS, V14, P205, DOI 10.1007/s10048-013-0374-9; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; Hollinger K, 2014, FASEB J, V28, P1600, DOI 10.1096/fj.13-241141; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jimenez-Mallebrera C, 2003, EUR J PAEDIATR NEURO, V7, P129, DOI 10.1016/S1090-3798(03)00042-4; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Martin LT, 2007, HUM PATHOL, V38, P1657, DOI 10.1016/j.humpath.2007.03.025; MATSUMURA K, 1994, NEUROMUSCULAR DISORD, V4, P115, DOI 10.1016/0960-8966(94)90002-7; McGlone J., 2010, GUIDE CARE USE AGR A, V3rd; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nonneman DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-233; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Pavoni E, 2005, FEBS LETT, V579, P493, DOI 10.1016/j.febslet.2004.10.111; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	31	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97567	10.1371/journal.pone.0097567	http://dx.doi.org/10.1371/journal.pone.0097567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824861	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200129
J	Takacs, P; Bihari, P; Eros, T; Specziar, A; Szivak, I; Biro, P; Csoma, E				Takacs, Peter; Bihari, Peter; Eros, Tibor; Specziar, Andras; Szivak, Ildiko; Biro, Peter; Csoma, Eszter			Genetic Heterogeneity Reveals On-Going Speciation and Cryptic Taxonomic Diversity of Stream-Dwelling Gudgeons (Teleostei, Cyprinidae) in the Middle Danubian Hydrosystem (Hungary)	PLOS ONE			English	Article							GOBIO-GOBIO; MOLECULAR PHYLOGENY; CENTRAL-EUROPE; GENUS GOBIO; MITOCHONDRIAL; POPULATIONS; SOFTWARE; DIFFERENTIATION; MODEL; FISH	Although stream-dwelling gudgeons (Cyprinidae, genus: Gobio) are widespread in Central Europe, the taxonomy of this group and the distribution of its species are still unexplored in detail. The aims of our study are to ascertain taxonomic composition and distribution of the former Gobio gobio superspecies in the inner area of the Carpathian Basin. Since the presence of cryptic species is suspected in this area, we examined the taxonomic and phylogenetic relationships of Central European Gobio taxa by sequencing the mitochondrial DNA control region (mtCR). Additionally, we characterized the genetic structure of 27 stream-dwelling gudgeon populations of this area by Amplified Fragment Length Polymorphism (AFLP). Results of mtCR analysis proved the presence of three species already known as G. obtusirostris (dominant in NW-Hungary), G. gobio (sporadic) and G. carpathicus (sporadic). Additionally, the analysis revealed the existence of one doubtful taxon, G. sp1 (dominant in NE-Hungary), and a new isolated haplogroup (dominant in SW-Hungary). Although Network analysis showed significant detachment among haplogroups, their genetic distances were quite small. Therefore Bayesian phylogenetic analysis showed weak nodal support for the branching pattern both for newly described haplotypes, and for the already accepted species. AFLP data showed distinct population structure and a clear pattern of isolation was revealed by distance of stocks. At the same time, level of separation was not affected by the altitudinal position of sites. Moreover we found three major clusters of populations which were separated according to hydrographic regions, and corresponded to the findings of mtCR analysis. Our results suggest the on-going speciation of gudgeons in the Carpathian Basin, however the separation of haplogroups seems to only be an intermediate phase. The discovered natural pattern seems to be only slightly influenced by anthropogenic impacts. Additionally our results put into question the suitability of the recently accepted within Gobio genus taxonomy.	[Takacs, Peter; Eros, Tibor; Specziar, Andras; Szivak, Ildiko; Biro, Peter] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrozool, Tihany, Hungary; [Bihari, Peter] MTA Biol Res Ctr, Inst Genet, Szeged, Hungary; [Csoma, Eszter] Univ Debrecen, Dept Med Microbiol, H-4012 Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Debrecen	Takacs, P (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrozool, Tihany, Hungary.	takacs.peter@okologia.mta.hu	Specziár, András/N-5656-2019; Biro, Peter/CAJ-0232-2022; Takács, Péter/A-8082-2016; Eros, Tibor/I-1671-2019	Specziár, András/0000-0001-6341-636X; Biro, Peter/0000-0002-2855-4991; Takács, Péter/0000-0001-5247-7597; 	Hungarian Scientific Research Fund [OTKA-NKTH CNK 80140]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the Hungarian Scientific Research Fund (OTKA-NKTH CNK 80140). "The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript''.	Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; Arthofer W, 2010, MOL ECOL RESOUR, V10, P385, DOI 10.1111/j.1755-0998.2009.02751.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Banarescu PM, 1999, FRESHWATER FISHES EU, V5/I, P81, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A026036; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barluenga M, 2005, MOL ECOL, V14, P1229, DOI 10.1111/j.1365-294X.2005.02468.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Cooke GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048800; Coyne JA, 2004, SPECIATION; Doadrio I., 2004, Graellsia, V60, P107; Drummond A. J., 2011, GENEIOUS V5 4; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gabris Gy, 2007, FOLDRAJZI ERTESITO, V56, P39; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Rodriguez C, 2007, MOL PHYLOGENET EVOL, V43, P111, DOI 10.1016/j.ympev.2006.10.022; Hanfling B, 1998, HEREDITY, V80, P110; Harka A, 2004, MAGYARORSZAG HALFAUN, P269; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Herman O, 1887, MAGYAR HALASZAT KONY, P847; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kottelat M, 2005, CYBIUM, V29, P211; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson ER, 2012, FRESHWATER BIOL, V57, P1823, DOI 10.1111/j.1365-2427.2012.02841.x; Laszloffy W, 1982, TISZA, P610; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Maric S, 2012, HYDROBIOLOGIA, V691, P225, DOI 10.1007/s10750-012-1076-2; Maric S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-2; Martonne Erdos K, 2004, MAGYARORSZAG TERMESZ, P245; MAYR E, 1948, ADV GENET, V2, P205, DOI 10.1016/S0065-2660(08)60469-1; Mendel J, 2005, FOLIA ZOOL, V54, P13; Mendel J, 2012, MOL ECOL RES, V12, P972, DOI DOI 10.1111/J.1755-0998.2012.03173.X; Mendel J, 2008, MOL PHYLOGENET EVOL, V47, P1061, DOI 10.1016/j.ympev.2008.03.005; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Naseka A.M., 2006, Zoosystematica Rossica, V15, P185; NEI M, 1974, GENETICS, V76, P379; Neilson ME, 2011, DIVERS DISTRIB, V17, P688, DOI 10.1111/j.1472-4642.2011.00762.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nowak M, 2011, 1 INT C FISH DIV CA, P48; Nowak Michal, 2011, Archives of Polish Fisheries, V19, P37; Nowak Michal, 2008, AACL Bioflux, V1, P27; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Pontin DR, 2012, HYDROBIOLOGIA, V686, P91, DOI 10.1007/s10750-011-0994-8; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2009, DOCUMENTATION STRUCT; Rambaut A, 2009, TRACER VERSION 1 5; Rundell RJ, 2004, MOL PHYLOGENET EVOL, V31, P246, DOI 10.1016/j.ympev.2003.07.014; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Sanda R, 2005, FOLIA ZOOL, V54, P73; Schreiber A, 2002, HEREDITY, V89, P163, DOI 10.1038/sj.hdy.6800109; Sediva A, 2008, MOL ECOL, V17, P1277, DOI 10.1111/j.1365-294X.2007.03656.x; Sikhegyi F., 2002, EGU S MUELLER SPECIA, V3, P203; Slechtova V, 2005, FOLIA ZOOL, V54, P25; Sumegi P, 2008, DOC PRAEHIST, V35, P33, DOI 10.4312/dp.35.3; Takacs P, 2008, ACTA ZOOL ACAD SCI H, V54, P289; Takacs P, 2012, ANN LIMNOL-INT J LIM, V48, P53; Takacs Peter, 2011, Ecology of Lake Balaton, V1, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turan D, 2012, ZOOTAXA, P56, DOI 10.11646/zootaxa.3257.1.4; Vasil'eva ED, 2005, J ICHTHYOL+, V4, P730; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Wachter GA, 2012, MOL ECOL, V21, P4983, DOI 10.1111/j.1365-294X.2012.05758.x; Watanabe K, 2000, ICHTHYOL RES, V47, P43, DOI 10.1007/BF02674312; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Zickovich JM, 2007, FRESHWATER BIOL, V52, P1982, DOI 10.1111/j.1365-2427.2007.01822.x; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	79	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97278	10.1371/journal.pone.0097278	http://dx.doi.org/10.1371/journal.pone.0097278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824751	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200085
J	Tavares, LDC; Zanon, G; Weber, AD; Neto, AT; Mostardeiro, CP; Da Cruz, IBM; Oliveira, RM; Ilha, V; Dalcol, II; Morel, AF				Tavares, Luciana de C.; Zanon, Graciane; Weber, Andreia D.; Neto, Alexandre T.; Mostardeiro, Clarice P.; Da Cruz, Ivana B. M.; Oliveira, Raul M.; Ilha, Vinicius; Dalcol, Ionara I.; Morel, Ademir F.			Structure-Activity Relationship of Benzophenanthridine Alkaloids from Zanthoxylum rhoifolium Having Antimicrobial Activity	PLOS ONE			English	Article							OXIDATIVE STRESS; CHELERYTHRINE; FUROQUINOLINE; SANGUINARINE; ANTIMALARIAL; CHELIDONINE; FAGARONINE; GENERATION	Zanthoxylum rhoifolium (Rutaceae) is a plant alkaloid that grows in South America and has been used in Brazilian traditional medicine for the treatment of different health problems. The present study was designed to evaluate the antimicrobial activity of the steam bark crude methanol extract, fractions, and pure alkaloids of Z. rhoifolium. Its stem bark extracts exhibited a broad spectrum of antimicrobial activity, ranging from 12.5 to 100 mu g/mL using bioautography method, and from 125 to 500 mu g/mL in the microdilution bioassay. From the dichloromethane basic fraction, three furoquinoline alkaloids (1-3), and nine benzophenanthridine alkaloids (4-12) were isolated and the antimicrobial activity of the benzophenanthridine alkaloids is discussed in terms of structure-activity relationships. The alkaloid with the widest spectrum of activity was chelerythrine (10), followed by avicine (12) and dihydrochelerythrine (4). The minimal inhibitory concentrations of chelerythrine, of 1.50 mu g/mL for all bacteria tested, and between 3.12 and 6.25 mu g/mL for the yeast tested, show this compound to be a more powerful antimicrobial agent when compared with the other active alkaloids isolated from Z. rhoifolium. To verify the potential importance of the methylenedioxy group (ring A) of these alkaloids, chelerythrine was selected to represent the remainder of the benzophenanthridine alkaloids isolated in this work and was subjected to a demethylation reaction giving derivative 14. Compared to chelerythrine, the derivative (14) was less active against the tested bacteria and fungi. Kinetic measurements of the bacteriolytic activities of chelerythrine against the bacteria Bacillus subtilis (Gram-positive) and Escherichia coli (Gram-negative) were determined by optical density based on real time assay, suggesting that its mechanism of action is not bacteriolytic. The present study did not detect hemolytic effects of chelerythrine on erythrocytes and found a protective effect considering the decrease in TBARS and AOPP (advanced oxidized protein products) levels when compared to the control group.	[Tavares, Luciana de C.; Zanon, Graciane; Weber, Andreia D.; Neto, Alexandre T.; Ilha, Vinicius; Dalcol, Ionara I.; Morel, Ademir F.] Univ Fed Santa Maria, Ctr Res Nat Prod NPPN, BR-97119900 Santa Maria, RS, Brazil; [Mostardeiro, Clarice P.; Da Cruz, Ivana B. M.; Oliveira, Raul M.; Dalcol, Ionara I.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Pharmacol, BR-97119900 Santa Maria, RS, Brazil; [Da Cruz, Ivana B. M.] Univ Fed Santa Maria, Grad Program Toxicol Biochem, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Morel, AF (corresponding author), Univ Fed Santa Maria, Ctr Res Nat Prod NPPN, BR-97119900 Santa Maria, RS, Brazil.	afmorel@base.ufsm.br	da Cruz, Ivana BM/G-4329-2012; Ilha, Vinicius/E-1690-2013; Dalcol, Ionara/AAN-4140-2020	da Cruz, Ivana BM/0000-0003-3008-6899; Ilha, Vinicius/0000-0003-2555-4731; 	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX	The authors thank CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX for financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAMMA A, 1979, PHYTOCHEMISTRY, V18, P1417, DOI 10.1016/0031-9422(79)83044-7; BARRET Y, 1992, PHYTOTHER RES, V6, P59, DOI 10.1002/ptr.2650060202; BASCO LK, 1994, ANTIMICROB AGENTS CH, V38, P1169, DOI 10.1128/AAC.38.5.1169; FANG SD, 1993, J ORG CHEM, V58, P5025, DOI 10.1021/jo00071a001; Fernandes CC, 2009, J BRAZIL CHEM SOC, V20, P379, DOI 10.1590/S0103-50532009000200025; Freitas FFBP, 2011, J ETHNOPHARMACOL, V137, P700, DOI 10.1016/j.jep.2011.06.026; Gehrke ITS, 2013, J ETHNOPHARMACOL, V148, P486, DOI 10.1016/j.jep.2013.04.043; Gonzaga WDA, 2003, PLANTA MED, V69, P371, DOI 10.1055/s-2003-38882; HAMBURGER MO, 1987, J NAT PROD, V50, P19, DOI 10.1021/np50049a003; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Jullian V, 2006, J ETHNOPHARMACOL, V106, P348, DOI 10.1016/j.jep.2006.01.011; Kemeny-Beke A, 2006, CANCER LETT, V237, P67, DOI 10.1016/j.canlet.2005.05.037; KHALID SA, 1982, J NAT PROD, V45, P343, DOI 10.1021/np50021a017; Kim J, 2005, J CELL BIOCHEM, V94, P39, DOI 10.1002/jcb.20276; Lehtinen J, 2006, J MICROBIOL METH, V66, P381, DOI 10.1016/j.mimet.2006.01.002; LENFELD J, 1981, PLANTA MED, V43, P161, DOI 10.1055/s-2007-971493; Mazzanti G, 2009, J ETHNOPHARMACOL, V126, P518, DOI 10.1016/j.jep.2009.09.004; MESSMER WM, 1972, J PHARM SCI-US, V61, P1858, DOI 10.1002/jps.2600611145; Miao F, 2011, NAT PROD RES, V25, P863, DOI 10.1080/14786419.2010.482055; Moura NF, 1998, FITOTERAPIA, V69, P271; Moura NF, 1997, PHYTOCHEMISTRY, V46, P443; Navarro V, 1999, J ETHNOPHARMACOL, V66, P223, DOI 10.1016/S0378-8741(98)00182-2; NCCLS: National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS CLSI; NCCLS: National Committee for Clinical Laboratory Standards, 2002, M7A5 NCCLS CLSI; Nissanka APK, 2001, PHYTOCHEMISTRY, V56, P857, DOI 10.1016/S0031-9422(00)00402-7; Nyangulu JM, 2005, BIOORG MED CHEM LETT, V15, P2007, DOI 10.1016/j.bmcl.2005.02.074; ODEBIYI OO, 1979, PLANTA MED, V36, P204, DOI 10.1055/s-0028-1097271; de Oliveira S, 2008, CLIN HEMORHEOL MICRO, V39, P363, DOI 10.3233/CH-2008-1101; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Parlakpinar H, 2006, CELL BIOCHEM FUNCT, V24, P41, DOI 10.1002/cbf.1182; Pereira SS, 2010, J ETHNOPHARMACOL, V129, P227, DOI 10.1016/j.jep.2010.03.009; RAHALISON L, 1991, PHYTOCHEM ANALYSIS, V2, P199, DOI 10.1002/pca.2800020503; Schiar VPP, 2009, CHEM-BIOL INTERACT, V177, P28, DOI 10.1016/j.cbi.2008.10.007; Selmeci L, 2005, CLIN CHEM LAB MED, V43, P294, DOI 10.1515/CCLM.2005.050; Taylor PW, 2013, INT J ANTIMICROB AG, V42, P195, DOI 10.1016/j.ijantimicag.2013.05.004; Tillequin Francois, 2007, Phytochemistry Reviews, V6, P65, DOI 10.1007/s11101-006-9010-8; TINWA M, 1974, J PHARM SCI-US, V63, P1476, DOI 10.1002/jps.2600630935; Wansi JD, 2010, PHYTOTHER RES, V24, P775, DOI 10.1002/ptr.2894; Weber AD, 2009, PLANTA MED, V75, P979; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yang XJ, 2012, MOLECULES, V17, P13026, DOI 10.3390/molecules171113026	41	27	33	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97000	10.1371/journal.pone.0097000	http://dx.doi.org/10.1371/journal.pone.0097000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824737	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200047
J	Venter, G; Oerlemans, FTJJ; Willemse, M; Wijers, M; Fransen, JAM; Wieringa, B				Venter, Gerda; Oerlemans, Frank T. J. J.; Willemse, Marieke; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be			NAMPT-Mediated Salvage Synthesis of NAD(+) Controls Morphofunctional Changes of Macrophages	PLOS ONE			English	Article							ACTIN STRESS FIBERS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHARMACOLOGICAL INHIBITION; TYROSINE PHOSPHORYLATION; RESPIRATORY BURST; CREATINE-KINASE; CELL-ADHESION; RHO; ACTIVATION; LPS	Functional morphodynamic behavior of differentiated macrophages is strongly controlled by actin cytoskeleton rearrangements, a process in which also metabolic cofactors ATP and NAD(H) (i.e. NAD(+) and NADH) and NADP(H) (i.e. NADP(+) and NADPH) play an essential role. Whereas the link to intracellular ATP availability has been studied extensively, much less is known about the relationship between actin cytoskeleton dynamics and intracellular redox state and NAD(+)-supply. Here, we focus on the role of nicotinamide phosphoribosyltransferase (NAMPT), found in extracellular form as a cytokine and growth factor, and in intracellular form as one of the key enzymes for the production of NAD(+) in macrophages. Inhibition of NAD(+) salvage synthesis by the NAMPT-specific drug FK866 caused a decrease in cytosolic NAD(+) levels in RAW 264.7 and Maf-DKO macrophages and led to significant downregulation of the glycolytic flux without directly affecting cell viability, proliferation, ATP production capacity or mitochondrial respiratory activity. Concomitant with these differential metabolic changes, the capacity for phagocytic ingestion of particles and also substrate adhesion of macrophages were altered. Depletion of cytoplasmic NAD(+) induced cell-morphological changes and impaired early adhesion in phagocytosis of zymosan particles as well as spreading performance. Restoration of NAD(+) levels by NAD(+), NMN, or NADP(+) supplementation reversed the inhibitory effects of FK866. We conclude that direct coupling to local, actin-based, cytoskeletal dynamics is an important aspect of NAD(+)'s cytosolic role in the regulation of morphofunctional characteristics of macrophages.	[Venter, Gerda; Oerlemans, Frank T. J. J.; Willemse, Marieke; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Wieringa, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Wieringa, Berend/A-5346-2011; Wijers-Rouw, Mietske/G-4456-2016; Fransen, Jack/E-8924-2010	Wieringa, Berend/0000-0001-9192-8020; Fransen, Jack/0000-0002-0571-7639; Venter, Gerda/0000-0002-8043-2203	Radboud University Medical Centre	Radboud University Medical Centre	Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	ALBINA JE, 1993, AM J PHYSIOL, V264, pC1594, DOI 10.1152/ajpcell.1993.264.6.C1594; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; CIFARELLI A, 1979, RES EXP MED, V174, P197, DOI 10.1007/BF01851332; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Hahn EL, 2000, SHOCK, V13, P253, DOI 10.1097/00024382-200004000-00001; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Hasmann M, 2003, CANCER RES, V63, P7436; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Hung R-J, 2011, AIDS RES HUM RETR S1; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330; Kotas ME, 2013, ADIPOCYTE, V2, P113, DOI 10.4161/adip.23437; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Malam Z, 2011, J IMMUNOL, V186, P6474, DOI 10.4049/jimmunol.1003706; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; PARADISI F, 1979, Ricerca in Clinica e in Laboratorio, V9, P47; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RASCHKE WC, 1975, J NATL CANCER I, V54, P1249, DOI 10.1093/jnci/54.5.1249; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schilling E, 2011, INNATE IMMUN, V0, P1; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; van Horssen R, 2013, CELL MOL LIFE SCI, P1; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262	96	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97378	10.1371/journal.pone.0097378	http://dx.doi.org/10.1371/journal.pone.0097378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824795	Green Submitted, gold, Green Published			2022-12-25	WOS:000336369200105
J	Yamashita, H; Suzuki, G; Kai, S; Hayashibara, T; Koike, K				Yamashita, Hiroshi; Suzuki, Go; Kai, Sayaka; Hayashibara, Takeshi; Koike, Kazuhiko			Establishment of Coral-Algal Symbiosis Requires Attraction and Selection	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; GENUS SYMBIODINIUM; ACROPORA CORALS; REEF; ZOOXANTHELLAE; ACQUISITION; LARVAE; ONSET; IDENTIFICATION; FLEXIBILITY	Coral reef ecosystems are based on coral-zooxanthellae symbiosis. During the initiation of symbiosis, majority of corals acquire their own zooxanthellae (specifically from the dinoflagellate genus Symbiodinium) from surrounding environments. The mechanisms underlying the initial establishment of symbiosis have attracted much interest, and numerous field and laboratory experiments have been conducted to elucidate this establishment. However, it is still unclear whether the host corals selectively or randomly acquire their symbionts from surrounding environments. To address this issue, we initially compared genetic compositions of Symbiodinium within naturally settled about 2-week-old Acropora coral juveniles (recruits) and those in the adjacent seawater as the potential symbiont source. We then performed infection tests using several types of Symbiodinium culture strains and apo-symbiotic (does not have Symbiodinium cells yet) Acropora coral larvae. Our field observations indicated apparent preference toward specific Symbiodinium genotypes (A1 and D1-4) within the recruits, despite a rich abundance of other Symbiodinium in the environmental population pool. Laboratory experiments were in accordance with this field observation: Symbiodinium strains of type A1 and D1-4 showed higher infection rates for Acropora larvae than other genotype strains, even when supplied at lower cell densities. Subsequent attraction tests revealed that three Symbiodinium strains were attracted toward Acropora larvae, and within them, only A1 and D1-4 strains were acquired by the larvae. Another three strains did not intrinsically approach to the larvae. These findings suggest the initial establishment of corals-Symbiodinium symbiosis is not random, and the infection mechanism appeared to comprise two steps: initial attraction step and subsequent selective uptake by the coral.	[Yamashita, Hiroshi; Suzuki, Go; Kai, Sayaka; Hayashibara, Takeshi] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan	Japan Fisheries Research & Education Agency (FRA); Hiroshima University	Yamashita, H (corresponding author), Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan.	hyamashita@fra.affrc.go.jp	Koike, Kazuhiko/A-3392-2019	Kazuhiko, Koike/0000-0001-5380-5839	Ministry of Education, Culture, Sports, Science and Technology of Japan [21310011, 24570028]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 21310011) and (C) (No. 24570028) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Cumbo VR, 2013, CORAL REEFS, V32, P111, DOI 10.1007/s00338-012-0951-7; FITT WK, 1985, J PHYCOL, V21, P62; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Harii S, 2009, MAR BIOL, V156, P1203, DOI 10.1007/s00227-009-1162-9; Hayashibara T, 2004, CORAL REEFS, V23, P406, DOI 10.1007/s00338-004-0406-x; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hollingsworth L. L., 2006, P 10 INT COR REEF S, P99; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; Jimbo M, 2013, J EXP MAR BIOL ECOL, V439, P129, DOI 10.1016/j.jembe.2012.10.022; Jimbo M, 2010, FISHERIES SCI, V76, P355, DOI 10.1007/s12562-009-0204-z; KINZIE RA, 1974, J EXP MAR BIOL ECOL, V15, P335, DOI 10.1016/0022-0981(74)90054-9; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MONTGOMERY MK, 1995, MAR BIOL, V124, P147, DOI 10.1007/BF00349156; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; R Core Team, 2012, R LANG ENV STAT COMP; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Suzuki G, 2012, CORAL REEFS, V31, P535, DOI 10.1007/s00338-011-0865-9; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Yamashita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006303; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004	43	38	40	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97003	10.1371/journal.pone.0097003	http://dx.doi.org/10.1371/journal.pone.0097003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824794	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200048
J	Yang, TT; Zhang, X; Wang, M; Zhang, J; Huang, F; Cai, J; Zhang, Q; Mao, F; Zhu, W; Qian, H; Xu, WR				Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong			Activation of Mesenchymal Stem Cells by Macrophages Prompts Human Gastric Cancer Growth through NF-kappa B Pathway	PLOS ONE			English	Article							FACTOR EXPRESSION; TRANSITION; INFLAMMATION; CYTOKINES; DRIVES	Accumulating evidence indicate that macrophages activate mesenchymal stem cells (MSCs) to acquire pro-inflammatory phenotype. However, the role of MSCs activated by macrophages in gastric cancer remains largely unknown. In this study, we found that MSCs were activated by macrophages to produce increased levels of inflammatory cytokines. Cell colony formation and transwell migration assays revealed that supernatants from the activated MSCs could promote both gastric epithelial cell and gastric cancer cell proliferation and migration. In addition, the expression of epithelial-mesenchymal transition (EMT), angiogenesis, and stemness-related genes was increased in activated MSCs. The phosphorylated forms of NF-kappa B, ERK and STAT3 in gastric cells were increased by active MSCs. Inhibition of NF-kappa B activation by PDTC blocked the effect of activated MSCs on gastric cancer cells. Co-injection of activated MSCs with gastric cancer cells could accelerate gastric cancer growth. Moreover, human peripheral blood monocytes derived macrophages also activated MSCs to prompt gastric cancer cell proliferation and migration. Taken together, our findings suggest that MSCs activated by macrophage acquire pro-inflammatory phenotype and prompt gastric cancer growth in an NF-kappa B-dependent manner, which provides new evidence for the modulation of MSCs by tumor microenvironment and further insight to the role of stromal cells in gastric carcinogenesis and cancer progression.	[Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong] Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China; [Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong] Jiangsu Univ, Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Qian, H (corresponding author), Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China.	lstmmmlst@163.com; icls@ujs.edu.cn	cai, jie/HHS-0606-2022	Qian, Hui/0000-0002-0098-3196	Major Research Plan of the National Natural Science Foundation of China [91129718]; National Natural Science Foundation of China [81302119, 81201660, 81071421]; Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities [SJK2013-10]; Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation [BL2012055]; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program [LJ201117]; Natural Science Foundation of the Jiangsu Province [BK2012709, BK20130540]; Doctoral Program Foundation of State Education Ministry [20113227110011]; Jiangsu Province for Natural Scicence Research in Colleges and Universities [13KJB320001]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities; Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program; Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Doctoral Program Foundation of State Education Ministry; Jiangsu Province for Natural Scicence Research in Colleges and Universities	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (Grant No. 91129718), the National Natural Science Foundation of China (Grant no. 81302119, 81201660, 81071421), Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities (Grant no. SJK2013-10), Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation (Grant no.BL2012055), Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program (Grant no.LJ201117), the Natural Science Foundation of the Jiangsu Province (Grant no.BK2012709, BK20130540), Doctoral Program Foundation of State Education Ministry (Grant no. 20113227110011), Jiangsu Province for Natural Scicence Research in Colleges and Universities (13KJB320001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035036; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Cao HL, 2009, CANCER LETT, V274, P61, DOI 10.1016/j.canlet.2008.08.036; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fiaschi T, 2013, CELL CYCLE, V12, P1791, DOI 10.4161/cc.24902; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gordon GM, 2009, J CELL PHYSIOL, V221, P402, DOI 10.1002/jcp.21869; Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698; He HJ, 2006, J BIOL CHEM, V281, P31369, DOI 10.1074/jbc.M603762200; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Maeda K, 1999, CANCER, V86, P566, DOI 10.1002/(SICI)1097-0142(19990815)86:4<566::AID-CNCR4>3.0.CO;2-1; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Morales C, 2014, CANCER RES, V74, P446, DOI 10.1158/0008-5472.CAN-13-1677; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Qiao C, 2008, CELL BIOL INT, V32, P8, DOI 10.1016/j.cellbi.2007.08.002; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Ray A, 2010, MOL CANCER RES, V8, P1261, DOI 10.1158/1541-7786.MCR-10-0212; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shih CH, 2009, EUR J PHARMACOL, V618, P70, DOI 10.1016/j.ejphar.2009.07.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Tsuboi K, 2014, ONCOL REP, V31, P57, DOI 10.3892/or.2013.2842; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	40	31	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97569	10.1371/journal.pone.0097569	http://dx.doi.org/10.1371/journal.pone.0097569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824968	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200130
J	Gudmundsson, M; Kim, S; Wu, M; Ishida, T; Momeni, MH; Vaaje-Kolstad, G; Lundberg, D; Royant, A; Stahlberg, J; Eijsink, VGH; Beckham, GT; Sandgren, M				Gudmundsson, Mikael; Kim, Seonah; Wu, Miao; Ishida, Takuya; Momeni, Majid Hadadd; Vaaje-Kolstad, Gustav; Lundberg, Daniel; Royant, Antoine; Stahlberg, Jerry; Eijsink, Vincent G. H.; Beckham, Gregg T.; Sandgren, Mats			Structural and Electronic Snapshots during the Transition from a Cu(II) to Cu(I) Metal Center of a Lytic Polysaccharide Monooxygenase by X-ray Photoreduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS V583; GLYCOSIDE HYDROLASE FAMILY; BINDING PROTEIN CBP21; ACTIVE-SITE; LIGNOCELLULOSIC BIOMASS; MACROMOLECULAR CRYSTALS; DENSITY FUNCTIONALS; SERRATIA-MARCESCENS; CELLULOSE; MODEL	Lytic polysaccharide monooxygenases (LPMOs) are a recently discovered class of enzymes that employ a copper-mediated, oxidative mechanism to cleave glycosidic bonds. The LPMO catalytic mechanism likely requires that molecular oxygen first binds to Cu(I), but the oxidation state in many reported LPMO structures is ambiguous, and the changes in the LPMO active site required to accommodate both oxidation states of copper have not been fully elucidated. Here, a diffraction data collection strategy minimizing the deposited x-ray dose was used to solve the crystal structure of a chitin-specific LPMO from Enterococcus faecalis (EfaCBM33A) in the Cu(II)-bound form. Subsequently, the crystalline protein was photoreduced in the x-ray beam, which revealed structural changes associated with the conversion from the initial Cu(II)-oxidized form with two coordinated water molecules, which adopts a trigonal bipyramidal geometry, to a reduced Cu(I) form in a T-shaped geometry with no coordinated water molecules. A comprehensive survey of Cu(II) and Cu(I) structures in the Cambridge Structural Database unambiguously shows that the geometries observed in the least and most reduced structures reflect binding of Cu(II) and Cu(I), respectively. Quantum mechanical calculations of the oxidized and reduced active sites reveal little change in the electronic structure of the active site measured by the active site partial charges. Together with a previous theoretical investigation of a fungal LPMO, this suggests significant functional plasticity in LPMO active sites. Overall, this study provides molecular snapshots along the reduction process to activate the LPMO catalytic machinery and provides a general method for solving LPMO structures in both copper oxidation states.	[Gudmundsson, Mikael; Wu, Miao; Ishida, Takuya; Momeni, Majid Hadadd; Lundberg, Daniel; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Kim, Seonah; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Ishida, Takuya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Vaaje-Kolstad, Gustav; Stahlberg, Jerry; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, NO-1432 As, Norway; [Royant, Antoine] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38042 Grenoble, France; [Royant, Antoine] European Synchrotron Radiat Facil, F-38000 Grenoble, France	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Tokyo; Norwegian University of Life Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 15013 Denver West Pkwy,MS 3322, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; mats.sandgren@slu.se	Royant, Antoine/G-3684-2012; Lundberg, Daniel/K-2263-2015; Daniel Lundberg, BA/I-5714-2019; Momeni, Majid Haddad/AAB-1857-2021; Stahlberg, Jerry/D-4163-2013	Royant, Antoine/0000-0002-1919-8649; Daniel Lundberg, BA/0000-0001-9507-7614; Momeni, Majid Haddad/0000-0001-9653-1380; Sandgren, Mats/0000-0002-2358-4534; Vaaje-Kolstad, Gustav/0000-0002-3077-8003; Gudmundsson, Mikael/0000-0002-8095-4423; Stahlberg, Jerry/0000-0003-4059-8580	Faculty for Natural Resources and Agriculture; Swedish University of Agricultural Sciences; research program MicroDrivE-Microbially Derived Energy; U.S. Department of Energy BioEnergy Technologies Office; National Science Foundation XSEDE Grant through the Texas Advanced Computing Center [MCB090159]; Norwegian Research Council [214138, 214613]	Faculty for Natural Resources and Agriculture; Swedish University of Agricultural Sciences; research program MicroDrivE-Microbially Derived Energy; U.S. Department of Energy BioEnergy Technologies Office(United States Department of Energy (DOE)); National Science Foundation XSEDE Grant through the Texas Advanced Computing Center; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences, the research program MicroDrivE-Microbially Derived Energy, U.S. Department of Energy BioEnergy Technologies Office and National Science Foundation XSEDE Grant MCB090159 (to G. T. B. and S. K.) (through the Texas Advanced Computing Center), and Grants 214138 and 214613 from the Norwegian Research Council (to G. V.-K. and V. G. H. E.).	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bohle LA, 2011, FEMS MICROBIOL LETT, V325, P123, DOI 10.1111/j.1574-6968.2011.02419.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casella L, 1996, INORG CHEM, V35, P1101, DOI 10.1021/ic950392o; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Dechancie J, 2007, PROTEIN SCI, V16, P1851, DOI 10.1110/ps.072963707; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liao RZ, 2013, J PHYS CHEM B, V117, P3954, DOI 10.1021/jp311705s; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; SORRELL TN, 1994, INORG CHIM ACTA, V218, P103, DOI 10.1016/0020-1693(93)03792-9; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	59	72	75	0	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18782	18792		10.1074/jbc.M114.563494	http://dx.doi.org/10.1074/jbc.M114.563494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24828494	hybrid, Green Published			2022-12-25	WOS:000339062900014
J	Santra, M; Zhang, ZG; Yang, J; Santra, S; Santra, S; Chopp, M; Morris, DC				Santra, Manoranjan; Zhang, Zheng Gang; Yang, James; Santra, Sutapa; Santra, Soumi; Chopp, Michael; Morris, Daniel C.			Thymosin beta 4 Up-regulation of MicroRNA-146a Promotes Oligodendrocyte Differentiation and Suppression of the Toll-like Proinflammatory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL DIFFERENTIATION; INNATE IMMUNE-RESPONSES; BETA(4) MESSENGER-RNA; GENE-EXPRESSION; C-JUN; BRAIN; MYELINATION; KROX-20; RAT; STROKE	Thymosin beta 4 (T beta 4), a G-actin-sequestering peptide, improves neurological outcome in rat models of neurological injury. Tissue inflammation results from neurological injury, and regulation of the inflammatory response is vital for neurological recovery. The innate immune response system, which includes the Toll-like receptor (TLR) proinflammatory signaling pathway, regulates tissue injury. We hypothesized that T beta 4 regulates the TLR proinflammatory signaling pathway. Because oligodendrogenesis plays an important role in neurological recovery, we employed an in vitro primary rat embryonic cell model of oligodendrocyte progenitor cells (OPCs) and a mouse N20.1 OPC cell line to measure the effects of T beta 4 on the TLR pathway. Cells were grown in the presence of T beta 4, ranging from 25 to 100 ng/ml (RegeneRx Biopharmaceuticals Inc., Rockville, MD), for 4 days. Quantitative real-time PCR data demonstrated that T beta 4 treatment increased expression of microRNA-146a (miR-146a), a negative regulator the TLR signaling pathway, in these two cell models. Western blot analysis showed that T beta 4 treatment suppressed expression of IL-1 receptor-associated kinase 1 (IRAK1) and tumor necrosis factor receptor-associated factor 6 (TRAF6), two proinflammatory cytokines of the TLR signaling pathway. Transfection of miR-146a into both primary rat embryonic OPCs and mouse N20.1 OPCs treated with T beta 4 demonstrated an amplification of myelin basic protein (MBP) expression and differentiation of OPC into mature MBPexpressing oligodendrocytes. Transfection of anti-miR-146a nucleotides reversed the inhibitory effect of T beta 4 on IRAK1 and TRAF6 and decreased expression of MBP. These data suggest that T beta 4 suppresses the TLR proinflammatory pathway by upregulating miR-146a.	[Santra, Manoranjan; Zhang, Zheng Gang; Santra, Sutapa; Santra, Soumi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Yang, James] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Morris, Daniel C.] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 West Grand Blvd,CFP 2, Detroit, MI 48202 USA.	morris@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institutes of Health [R01 AG038648, R01 NS075156, R01 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038648, R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG038648 (to D. M.), R01 NS075156 (to Z. G.), and R01 AG037506 (to M. C.). The Henry Ford Health Systems have a Material Transfer Agreement with RegeneRx Biopharmaceuticals Inc. (Rockville, MD). United States Provisional Patent 61/163,556 has been filed for use of T beta 4 in neurological injury.	Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Butcher J, 2009, J NEUROSCI, V29, P5365, DOI 10.1523/JNEUROSCI.5976-08.2009; Carpintero P, 1999, NEUROSCIENCE, V90, P1433, DOI 10.1016/S0306-4522(98)00494-1; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Dong JH, 2005, NEUROREPORT, V16, P1629, DOI 10.1097/01.wnr.0000183326.21241.48; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hannappel E, 2007, ANN NY ACAD SCI, V1112, P21, DOI 10.1196/annals.1415.018; Hossain S, 2012, GLIA, V60, P1130, DOI 10.1002/glia.22340; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Izadi H, 2007, INFECT IMMUN, V75, P5027, DOI 10.1128/IAI.00492-07; Kim Y, 2006, BRAIN RES, V1085, P177, DOI 10.1016/j.brainres.2006.01.065; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Morris DC, 2010, ANN NY ACAD SCI, V1194, P112, DOI 10.1111/j.1749-6632.2010.05469.x; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920; Paez PM, 2004, GLIA, V46, P207, DOI 10.1002/glia.20001; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; Santra M, 2012, GLIA, V60, P1826, DOI 10.1002/glia.22400; Santra M, 2011, CANCER SCI, V102, P1350, DOI 10.1111/j.1349-7006.2011.01952.x; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vartiainen N, 1996, NEUROREPORT, V7, P1613, DOI 10.1097/00001756-199607080-00017; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	43	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19508	19518		10.1074/jbc.M113.529966	http://dx.doi.org/10.1074/jbc.M113.529966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24828499	hybrid, Green Published			2022-12-25	WOS:000339326800026
J	Ehrensberger, KM; Corkins, ME; Choi, SY; Bird, AJ				Ehrensberger, Kate M.; Corkins, Mark E.; Choi, Sangyong; Bird, Amanda J.			The Double Zinc Finger Domain and Adjacent Accessory Domain from the Transcription Factor Loss of Zinc Sensing 1 (Loz1) Are Necessary for DNA Binding and Zinc Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; TRANSITION; HELIX	The Loz1 transcription factor from Schizosaccharomyces pombe plays an essential role in zinc homeostasis by repressing target gene expression in zinc-replete cells. To determine how Loz1 function is regulated by zinc, we employed a genetic screen to isolate mutants with impaired zinc-dependent gene expression and analyzed Loz1 protein truncations to map a minimal zinc-responsive domain. In the screen, we isolated 36 new loz1 alleles. 27 of these alleles contained mutations resulting in the truncation of the Loz1 protein. The remaining nine alleles contained point mutations leading to an amino acid substitution within a C-terminal double zinc finger domain. Further analysis of two of these substitutions revealed that they disrupted Loz1 DNA activity in vitro. By analyzing Loz1 protein truncations, we found that the last 96 amino acids of Loz1 was the smallest region that was able to confer partial zinc-dependent repression in vivo. This 96-amino acid region contains the double zinc finger domain and an accessory domain that enhances DNA binding. These results were further supported by the findings that MtfA, a transcription factor from Aspergillus nidulans that contains a related double zinc finger, is unable to complement loz1 Delta, whereas a chimera of MtfA containing the Loz1 accessory domain is able to complement loz1 Delta. Together, our studies indicate that the double zinc finger domain and adjacent accessory domain preceding zinc finger 1 are necessary for DNA binding and zinc-dependent repression.	[Ehrensberger, Kate M.; Corkins, Mark E.; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Choi, Sangyong; Bird, Amanda J.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Ehrensberger, Kate M.; Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Human Sci, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050				Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Clemens S, 2002, J BIOL CHEM, V277, P18215, DOI 10.1074/jbc.M201031200; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Dutnall RN, 1996, STRUCTURE, V4, P599, DOI 10.1016/S0969-2126(96)00064-0; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Frey AG, 2012, MICROBIOLOGYOPEN, V1, P105, DOI 10.1002/mbo3.8; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Kamashev DE, 2000, J BIOL CHEM, V275, P36056, DOI 10.1074/jbc.M001691200; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Ramamoorthy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074122; Shimizu M, 2001, J BIOL CHEM, V276, P37680, DOI 10.1074/jbc.M105342200; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1	26	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18087	18096		10.1074/jbc.M114.551333	http://dx.doi.org/10.1074/jbc.M114.551333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24831008	Green Published, hybrid			2022-12-25	WOS:000338042000012
J	Laughery, JM; Knowles, DP; Schneider, DA; Bastos, RG; McElwain, TF; Suarez, CE				Laughery, Jacob M.; Knowles, Donald P.; Schneider, David A.; Bastos, Reginaldo G.; McElwain, Terry F.; Suarez, Carlos E.			Targeted Surface Expression of an Exogenous Antigen in Stably Transfected Babesia bovis	PLOS ONE			English	Article							REACTIVE ANTIBODIES; CATTLE; VACCINATION; PROTEIN; GENE; COLOCALIZATION; INFECTION; PEPTIDES; VACCINES; CLONING	Babesia bovis is a tick-borne intraerythocytic protozoan responsible for acute disease in cattle which can be controlled by vaccination with attenuated B. bovis strains. Emerging B. bovis transfection technologies may increase the usefulness of these live vaccines. One use of transfected B. bovis parasites may be as a vaccine delivery platform. Previous transfection methods for B. bovis were limited by single expression sites and intracellular expression of transfected antigens. This study describes a novel transfection system in which two exogenous genes are expressed: one for selection and the other for a selected antigen designed to be delivered to the surface of the parasites. The strategy for duplicating the number of transfected genes was based on the use of the putative bidirectional promoter of the B. bovis 1.4 Kb ef-1 alpha intergenic region. The ability of this region to regulate two independent expression sites was demonstrated using a luciferase assay on transiently transfected B. bovis parasites and then incorporated into a stable transfection plasmid to control independent expression of the selectable marker GFP-BSD and another gene of interest. A chimeric gene was synthetized using sequences from the protective B-cell epitopes of Rhipicephalus microplus tick antigen Bm86 along with sequences from the surface exposed B. bovis major surface antigen-1. This chimeric gene was then cloned into the additional expression site of the transfection plasmid. Transfection of the B. bovis Mo7 strain with this plasmid resulted in stable insertion into the ef-1 alpha locus and simultaneous expression of both exogenous genes. Expression of the Bm86 epitopes on the surface of transfected merozoites was demonstrated using immunofluorescence analyses. The ability to independently express multiple genes by the inclusion of a bidirectional promoter and the achievement of surface expression of foreign epitopes advances the potential of transfected B. bovis as a future vaccine delivery platform.	[Laughery, Jacob M.; Knowles, Donald P.; Bastos, Reginaldo G.; McElwain, Terry F.; Suarez, Carlos E.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Knowles, Donald P.; Schneider, David A.; Suarez, Carlos E.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [McElwain, Terry F.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University	Suarez, CE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA.	ces@vetmed.wsu.edu	Schneider, David/A-2833-2010	Schneider, David/0000-0001-9659-6731	United States Department of Agriculture-Agriculture Research Service Current Research Information System Project [5348-32000-028-00D]; United States Agency for International Development Grant [PCE-G-0098-00043-00]; USDA [SCA58-5348-7-528, 5348-32000-028-055]	United States Department of Agriculture-Agriculture Research Service Current Research Information System Project; United States Agency for International Development Grant(United States Agency for International Development (USAID)); USDA(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture-Agriculture Research Service Current Research Information System Project No. 5348-32000-028-00D, United States Agency for International Development Grant PCE-G-0098-00043-00, and USDA (SCA58-5348-7-528) agreement 5348-32000-028-055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Berens SJ, 2005, INFECT IMMUN, V73, P7180, DOI 10.1128/IAI.73.11.7180-7189.2005; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Bram RA, 2002, J MED ENTOMOL, V39, P405, DOI 10.1603/0022-2585-39.3.405; Brown WC, 1999, PARASITOL TODAY, V15, P275, DOI 10.1016/S0169-4758(99)01471-4; Canales M, 2009, VACCINE, V27, P7244, DOI 10.1016/j.vaccine.2009.09.123; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de la Fuente J, 1999, GENET ANAL-BIOMOL E, V15, P143, DOI 10.1016/S1050-3862(99)00018-2; de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9; De la Fuente J., 1995, RECOMBINANT VACCINES, P177; de Leon AAP, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-36; de Waal DT, 2006, VET PARASITOL, V138, P88, DOI 10.1016/j.vetpar.2006.01.042; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Florin-Christensen M, 2002, INFECT IMMUN, V70, P2039; HINES SA, 1989, MOL BIOCHEM PARASIT, V37, P1, DOI 10.1016/0166-6851(89)90096-0; HINES SA, 1992, MOL BIOCHEM PARASIT, V55, P85, DOI 10.1016/0166-6851(92)90129-8; LeRoith T, 2006, INFECT IMMUN, V74, P3663, DOI 10.1128/IAI.00032-06; LEVY MG, 1980, SCIENCE, V207, P1218, DOI 10.1126/science.7355284; Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085; PALMER DA, 1982, PARASITOLOGY, V84, P567, DOI 10.1017/S0031182000052835; Patarroyo JH, 2002, VET IMMUNOL IMMUNOP, V88, P163, DOI 10.1016/S0165-2427(02)00154-X; RAND KN, 1989, P NATL ACAD SCI USA, V86, P9657, DOI 10.1073/pnas.86.24.9657; RODRIGUEZ M, 1994, J BIOTECHNOL, V33, P135, DOI 10.1016/0168-1656(94)90106-6; RODRIGUEZ SD, 1983, INFECT IMMUN, V42, P15, DOI 10.1128/IAI.42.1.15-18.1983; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2012, MOL BIOCHEM PARASIT, V185, P52, DOI 10.1016/j.molbiopara.2012.05.003; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2000, INFECT IMMUN, V68, P6865, DOI 10.1128/IAI.68.12.6865-6870.2000; Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1023/B:APPA.0000049223.92326.02; Willadsen P, 2004, PARASITOLOGY, V129, pS367, DOI 10.1017/S0031182003004657	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97890	10.1371/journal.pone.0097890	http://dx.doi.org/10.1371/journal.pone.0097890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840336	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600087
J	Cheng, C; Wan, F; Liu, L; Zeng, FQ; Xing, SA; Wu, XF; Chen, XP; Zhu, ZH				Cheng, Chao; Wan, Feng; Liu, Lian; Zeng, Fuqing; Xing, Shi'an; Wu, Xiaofei; Chen, Xuepan; Zhu, Zhaohui			Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma	PLOS ONE			English	Article							GLOBAL GENE REGULATOR; GASTRIC-CANCER; TUMOR PROGRESSION; PROGNOSTIC VALUE; BLADDER-CANCER; GROWTH-FACTOR; UP-REGULATION; EXPRESSION; CHROMATIN; METASTASIS	Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of SATB1 in RCC remains unclear. With the combination of immunohistochemistry, western blotting, immunofluorescence, qRT-PCR, and cell proliferation, migration and invasion assays, we found that levels of SATB1 mRNA and protein were dramatically increased in human ccRCC tissues (P<0.001 for both), and upregulation of SATB1 was significantly associated with depth of invasion (P<0.001), lymph node status (P = 0.001) and TNM stage (P = 0.009). SATB1 knockdown inhibited the proliferation, migration and invasion of 786-O cells, whereas SATB1 overexpression promoted the growth and aggressive phenotype of ACHN cells in vitro. Furthermore, SATB1 expression was positively correlated with ZEB2 expression (P = 0.013), and inversely linked to levels of SATB2 and E-cadherin (P = 0.005 and P<0.001, respectively) in ccRCC tissues. Our data provide a basis for the concept that overexpression of SATB1 may play a critical role in the acquisition of an aggressive phenotype for RCC cells through EMT, providing new insights into the significance of SATB1 in invasion and metastasis of ccRCC, which may contribute to fully elucidating the exact mechanism of development and progression of RCC.	[Cheng, Chao; Wan, Feng; Zeng, Fuqing; Wu, Xiaofei; Chen, Xuepan; Zhu, Zhaohui] Huazhong Univ Sci & Technol, Dept Urol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Liu, Lian] Huazhong Univ Sci & Technol, Canc Ctr Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xing, Shi'an] Huazhong Univ Sci & Technol, Cent Lab, Tongji Med Coll, Union Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhu, ZH (corresponding author), Huazhong Univ Sci & Technol, Dept Urol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	zhuzhaohui316@sina.com						Basso M, 2010, UROL ONCOL-SEMIN ORI, V28, P121, DOI 10.1016/j.urolonc.2009.04.015; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056241; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Chu SH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-149; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Han B, 2013, TUMOR BIOL, V34, P2943, DOI 10.1007/s13277-013-0857-1; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lane BR, 2007, J UROLOGY, V178, P429, DOI 10.1016/j.juro.2007.03.106; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Maloney EK, 2003, CANCER RES, V63, P5073; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053527; Tang HW, 2008, CANCER INVEST, V26, P60, DOI 10.1080/07357900701519279; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Xue YJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	31	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97406	10.1371/journal.pone.0097406	http://dx.doi.org/10.1371/journal.pone.0097406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835085	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800044
J	Han, PF; Fan, JQ; Liu, Y; Cuthbertson, AGS; Yan, SQ; Qiu, BL; Ren, SX				Han, Pengfei; Fan, Jiqiao; Liu, Yu; Cuthbertson, Andrew G. S.; Yan, Shaoqiao; Qiu, Bao-Li; Ren, Shunxiang			RNAi-Mediated Knockdown of Serine Protease Inhibitor Genes Increases the Mortality of Plutella xylostella Challenged by Destruxin A	PLOS ONE			English	Article							NEEM-BASED INSECTICIDES; MANDUCA-SEXTA SERPIN-4; METARHIZIUM-ANISOPLIAE; PROTEINASE COMPLEXES; DIAMONDBACK MOTH; IMMUNE-RESPONSE; ACTIVATION; IDENTIFICATION; LEPIDOPTERA; DEFENSE	Destruxin A is a mycotoxin that is secreted by entomopathogenic fungi which has a broad-spectrum insecticidal effect. Previous transcript and protein profiling analysis showed that destruxin A has significant effects on the expression of serine protease inhibitor genes (serpin-2, 4, 5) in the larvae of Plutella xylostella. In the current study, we aimed to understand the role of serpins under application of destruxin A. We obtained two full-length cDNA sequences of P. xylostella serpins, named serpin-4 and serpin-5, and cloned the serpin-2 gene whose full-length has already been published. Phylogenetic analysis indicated that these two serpin genes were highly clustered with other serpins associated with the immune response in other insects. The temporal and spatial expression of serpin-2, serpin-4 and serpin-5 were determined to be the highest in the fat body and hemolymph of 4th larval stage using qRT-PCR and western blot detection techniques. RNA interference (RNAi) mediated knockdown of P. xylostella serpin genes was carried out by microinjection of double-stranded RNA (dsRNA). The expression levels of serpins decreased significantly after RNAi. Results showed that the depletion of serpins induced cecropins expression, increased phenoloxidase (PO) activity, body melanization and mortality in the larvae of P. xylostella under the same lethal concentration of destruxin A. The superimposed effects of serpins RNAi were similar with the destruxin A treatment upon mortality of P. xylostella larvae. We discovered for the first time that serpins play indispensable role in P. xylostella when challenged by destruxin A and deduced the possible function mechanism of destruxin A. Our findings are conducive to fully understanding the potential insecticidal mechanism of destruxin A and constitute a well-defined potential molecular target for novel insecticides.	[Han, Pengfei; Fan, Jiqiao; Liu, Yu; Yan, Shaoqiao; Qiu, Bao-Li; Ren, Shunxiang] South China Agr Univ, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China; [Cuthbertson, Andrew G. S.] Food & Environm Res Agcy, Sand Hutton, N Yorkshire, England	South China Agricultural University; Food & Environment Research Agency	Qiu, BL (corresponding author), South China Agr Univ, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China.	baileyqiu@scau.edu.cn; shxren@scau.edu.cn		Cuthbertson, Andrew/0000-0003-1914-8796	National Basic Research Program of China [2013CB127604]; Guangdong Province Natural Science Foundation in Key Projects [S2012020010951]	National Basic Research Program of China(National Basic Research Program of China); Guangdong Province Natural Science Foundation in Key Projects	This work was supported by National Basic Research Program of China (2013CB127604) and Guangdong Province Natural Science Foundation in Key Projects (S2012020010951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; Ahmad N, 2012, CROP PROT, V34, P18, DOI 10.1016/j.cropro.2011.12.010; Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Amiri-Besheli B, 2000, MYCOL RES, V104, P447, DOI 10.1017/S095375629900146X; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Bandani AR, 2001, BBA-BIOMEMBRANES, V1510, P367, DOI 10.1016/S0005-2736(00)00370-9; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butt TM, 2009, RAPID COMMUN MASS SP, V23, P1426, DOI 10.1002/rcm.4018; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Christen JM, 2012, INSECT BIOCHEM MOLEC, V42, P946, DOI 10.1016/j.ibmb.2012.09.008; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Feeroza Khalique, 2005, Pakistan Journal of Biological Sciences, V8, P475, DOI 10.3923/pjbs.2005.475.478; Gan H, 2001, INSECT BIOCHEM MOLEC, V31, P887, DOI 10.1016/S0965-1748(01)00034-0; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Hu QB, 2009, TOXICON, V53, P115, DOI 10.1016/j.toxicon.2008.10.019; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KANOST MR, 1995, INSECT BIOCHEM MOLEC, V25, P285, DOI 10.1016/0965-1748(94)00067-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Liang GM, 2003, CROP PROT, V22, P333, DOI 10.1016/S0261-2194(02)00175-8; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Lira SP, 2006, J ANTIBIOT, V59, P553, DOI 10.1038/ja.2006.76; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Nappi AJ, 2001, ADV EXP MED BIOL, V484, P329; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; Ruiz-Sanchez E, 2010, TOXICON, V56, P1043, DOI 10.1016/j.toxicon.2010.07.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sree KS, 2008, PEST MANAG SCI, V64, P119, DOI 10.1002/ps.1480; Suwanchaichinda C, 2013, INSECT BIOCHEM MOLEC, V43, P555, DOI 10.1016/j.ibmb.2013.03.015; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P387, DOI 10.1016/j.ibmb.2003.12.005; Xu YY, 2004, BIOCONTROL SCI TECHN, V14, P713, DOI 10.1080/09583150410001682395; YANG JC, 1994, ENTOMOPHAGA, V39, P397, DOI 10.1007/BF02373045; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	69	25	26	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97863	10.1371/journal.pone.0097863	http://dx.doi.org/10.1371/journal.pone.0097863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837592	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800078
J	Kwon, HM; Lee, KH; Han, BW; Han, MR; Kim, DH; Kim, DE				Kwon, Hyun-Mi; Lee, Kwang Hyun; Han, Byung Woo; Han, Mi Ra; Kim, Dong Ho; Kim, Dong-Eun			An RNA Aptamer That Specifically Binds to the Glycosylated Hemagglutinin of Avian Influenza Virus and Suppresses Viral Infection in Cells	PLOS ONE			English	Article							RECEPTOR-BINDING; MEMBRANE-FUSION; A VIRUS; SELECTION; PROTEIN; INHIBITION; MECHANISMS; EXPRESSION; LIGANDS; REGION	The influenza virus surface glycoprotein hemagglutinin (HA) is responsible for viral attachment to sialic acid-containing host cell receptors and it facilitates the initial stage of viral infection. In the present study, we isolated an RNA aptamer specific to the glycosylated receptor-binding domain of the HA protein (gHA1) after 12 cycles of the systematic evolution of ligands by exponential enrichment procedure (SELEX), and we then investigated if the selected aptamer suppresses viral infection in host cells. Nitrocellulose filter binding and enzyme-linked immunosorbent assay (ELISA) experiments revealed that 1 RNA aptamer, HA12-16, bound specifically to the gHA1 protein. Cell viability assay showed that the HA12-16 RNA aptamer suppressed viral infection in host cells by enhancing cell viability. Immunofluorescence microscopic analysis further demonstrated that the HA12-16 RNA aptamer suppresses viral attachment to host cells by neutralizing the receptor-binding site of influenza virus HA. These results indicate that the isolated RNA aptamer can be developed as an antiviral reagent against influenza through appropriate therapeutic formulation.	[Kwon, Hyun-Mi; Lee, Kwang Hyun; Kim, Dong-Eun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Han, Byung Woo; Han, Mi Ra] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Dong Ho] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea	Konkuk University; Seoul National University (SNU); National Cancer Center - Korea (NCC)	Kim, DE (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	kimde@konkuk.ac.kr	Kim, Dong-Eun/D-8304-2011	Kim, Dong-Eun/0000-0001-6545-8387	National Research Foundation of Korea (NRF) grants - Korea Government (MEST) [2010-0019306]	National Research Foundation of Korea (NRF) grants - Korea Government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea Government (MEST) (2010-0019306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 2008, VIROLOGY, V380, P354, DOI 10.1016/j.virol.2008.08.010; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; Chizmadzhev YA, 2004, BIOELECTROCHEMISTRY, V63, P129, DOI 10.1016/j.bioelechem.2003.10.016; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Gopinath SCB, 2006, J BIOCHEM, V139, P837, DOI 10.1093/jb/mvj095; Jang KJ, 2008, BIOCHEM BIOPH RES CO, V366, P738, DOI 10.1016/j.bbrc.2007.12.020; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; KAWAOKA Y, 1990, VIROLOGY, V179, P759, DOI 10.1016/0042-6822(90)90143-F; KEIL W, 1985, EMBO J, V4, P2711, DOI 10.1002/j.1460-2075.1985.tb03991.x; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; LEVI R, 1995, J VIROL METHODS, V52, P55, DOI 10.1016/0166-0934(94)00137-6; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Perkins AC, 2007, Q J NUCL MED MOL IM, V51, P292; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Tombelli S, 2009, CURR OPIN MOL THER, V11, P179; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang ZM, 2001, J VIROL METHODS, V98, P53, DOI 10.1016/S0166-0934(01)00355-X; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wongphatcharachai M, 2013, J CLIN MICROBIOL, V51, P46, DOI 10.1128/JCM.02118-12; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	28	38	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97574	10.1371/journal.pone.0097574	http://dx.doi.org/10.1371/journal.pone.0097574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835440	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800052
J	Mulcahy, DG; Martinez-Gomez, JE; Aguirre-Leon, G; Cervantes-Pasqualli, JA; Zug, GR				Mulcahy, Daniel G.; Martinez-Gomez, Juan E.; Aguirre-Leon, Gustavo; Cervantes-Pasqualli, Juan A.; Zug, George R.			Rediscovery of an Endemic Vertebrate from the Remote Islas Revillagigedo in the Eastern Pacific Ocean: The Clarion Nightsnake Lost and Found	PLOS ONE			English	Article							CONSERVATION STATUS; HYPSIGLENA-TORQUATA; LIZARD; BIOGEOGRAPHY; TREE	Vertebrates are currently going extinct at an alarming rate, largely because of habitat loss, global warming, infectious diseases, and human introductions. Island ecosystems are particularly vulnerable to invasive species and other ecological disturbances. Properly documenting historic and current species distributions is critical for quantifying extinction events. Museum specimens, field notes, and other archived materials from historical expeditions are essential for documenting recent changes in biodiversity. The Islas Revillagigedo are a remote group of four islands, 700-1100 km off the western coast of mainland Mexico. The islands are home to many endemic plants and animals recognized at the specific-and subspecific-levels, several of which are currently threatened or have already gone extinct. Here, we recount the initial discovery of an endemic snake Hypsiglena ochrorhyncha unaocularus Tanner on Isla Clarion, the later dismissal of its existence, its absence from decades of field surveys, our recent rediscovery, and recognition of it as a distinct species. We collected two novel complete mitochondrial (mt) DNA genomes and up to 2800 base-pairs of mtDNA from several other individuals, aligned these with previously published mt-genome data from samples throughout the range of Hypsiglena, and conducted phylogenetic analyses to infer the biogeographic origin and taxonomic status of this population. We found the Isla Clarion population to be most closely related to populations in the Sonora-Sinaloa state border area of mainland Mexico and Isla Santa Catalina, in the Gulf of California. Based on genetics, morphology, and geographic distributions, we also recognize these two other lineages as distinct species. Our study shows the importance of museum specimens, field notes, and careful surveys to accurately document biodiversity and brings these island endemics (Clarion and Santa Catalina nightsnakes) and mainland population near the Sonora-Sinaloa state border to the attention of conservation biologists currently monitoring biodiversity in these fragile subtropical ecosystems.	[Mulcahy, Daniel G.; Zug, George R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Martinez-Gomez, Juan E.; Aguirre-Leon, Gustavo; Cervantes-Pasqualli, Juan A.] Red Interacc Multitrof, Asociac Civil, Inst Ecol, Xalapa, Veracruz, Mexico	Smithsonian Institution; Smithsonian National Museum of Natural History; Instituto de Ecologia - Mexico	Mulcahy, DG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA.	MulcahyD@si.edu	Martínez-Gómez, Juan Esteban E/F-3585-2010	Martínez-Gómez, Juan Esteban E/0000-0003-2937-8544; Mulcahy, Daniel G./0000-0001-6614-2405	Smithsonian-NMNH; Island Endemics Foundation; INECOL	Smithsonian-NMNH; Island Endemics Foundation; INECOL	This research was funded by Smithsonian-NMNH grants awarded to GRZ and DGM, RW McDiarmid and DGM, and funds by the Island Endemics Foundation and INECOL were awarded to JEMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUD G, 1993, OHIO J SCI, V93, P101; Beebe CW, 1938, ZACA VENTURE; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bogert CM, 1944, B AM MUS NAT HIST, V83, P299; BRATTSTROM B. H., 1955, AMER MIDLAND NAT, V54, P219, DOI 10.2307/2422189; BRATTSTROM BH, 1990, J BIOGEOGR, V17, P177, DOI 10.2307/2845325; Carreno Ana Luisa, 2002, P14; Castaneda MD, 2011, MOL PHYLOGENET EVOL, V61, P784, DOI 10.1016/j.ympev.2011.07.004; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; de Queiroz K, 1998, ENDLESS FORMS, P57; DIXON JR, 1986, SOUTHWEST NAT, V31, P307, DOI 10.2307/3671835; Feldman CR, 2011, MOL PHYLOGENET EVOL, V61, P714, DOI 10.1016/j.ympev.2011.08.008; FROST DR, 1990, HERPETOLOGICA, V46, P87; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hardy L. M., 1969, University of Kansas Publications of the Museum of Natural History, V18, P39; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P2621, DOI 10.1073/pnas.91.7.2621; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jepson P., 2011, FRONT BIOGEOGR, V3, P111; Sigala-Rodriguez JJ, 2009, REV MEX BIODIVERS, V80, P231; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Ladle RJ, 2009, NATURE, V461, P723, DOI 10.1038/461723c; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Martinez-Gomez JE, 2004, BIOL CONSERV, V116, P35, DOI 10.1016/S0006-3207(03)00171-X; Martinez-Gomez JE, 2001, IBIS, V143, P456, DOI 10.1111/j.1474-919X.2001.tb04947.x; Martinez-Gomez JE, 1995, WILSON B, V107, P555; Martinez-Gomez Juan E., 1996, Bird Conservation International, V6, P271; Mendez-Guardado P, 2001, ADV GLOB CHANGE RES, V9, P323; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Mulcahy DG, 2011, COPEIA, P407, DOI 10.1643/CH-10-058; Mulcahy DG, 2009, MOL PHYLOGENET EVOL, V53, P537, DOI 10.1016/j.ympev.2009.05.037; Mulcahy DG, 2006, THESIS; Murphy Robert W., 2002, P181; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Otte D, 2007, T AM ENTOMOL SOC, V133, P453, DOI 10.3157/0002-8320-133.3.453; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Phillips S.J., 2000, NATURAL HIST SONORAN; Reiserer Randall S., 2013, Amphibian & Reptile Conservation, V7, P74; Rodriguez-Robles JA, 1999, COPEIA, P93; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; TANNER WILMER W., 1966, TRANS SAN DIEGO SOC NATUR HIST, V14, P189; Tanner WW, 1944, GREAT BASIN NAT, V5, P25; Zug GR, 2013, REPTILES AND AMPHIBIANS OF THE PACIFIC ISLANDS: A COMPREHENSIVE GUIDE, P1	46	9	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97682	10.1371/journal.pone.0097682	http://dx.doi.org/10.1371/journal.pone.0097682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837300	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800062
J	Dickson, RP; Erb-Downward, JR; Freeman, CM; Walker, N; Scales, BS; Beck, JM; Martinez, FJ; Curtis, JL; Lama, VN; Huffnagle, GB				Dickson, Robert P.; Erb-Downward, John R.; Freeman, Christine M.; Walker, Natalie; Scales, Brittan S.; Beck, James M.; Martinez, Fernando J.; Curtis, Jeffrey L.; Lama, Vibha N.; Huffnagle, Gary B.			Changes in the Lung Microbiome following Lung Transplantation Include the Emergence of Two Distinct Pseudomonas Species with Distinct Clinical Associations	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; RESPIRATORY MICROBIOME; FLUORESCENS; BACTERIAL; COLONIZATION; SEQUENCE; RISK; PCR; AERUGINOSA; EXPOSURE	Background: Multiple independent culture-based studies have identified the presence of Pseudomonas aeruginosa in respiratory samples as a positive risk factor for bronchiolitis obliterans syndrome (BOS). Yet, culture-independent microbiological techniques have identified a negative association between Pseudomonas species and BOS. Our objective was to investigate whether there may be a unifying explanation for these apparently dichotomous results. Methods: We performed bronchoscopies with bronchoalveolar lavage (BAL) on lung transplant recipients (46 procedures in 33 patients) and 26 non-transplant control subjects. We analyzed bacterial communities in the BAL fluid using qPCR and pyrosequencing of 16S rRNA gene amplicons and compared the culture-independent data with the clinical metadata and culture results from these subjects. Findings: Route of bronchoscopy (via nose or via mouth) was not associated with changes in BAL microbiota (p = 0.90). Among the subjects with positive Pseudomonas bacterial culture, P. aeruginosa was also identified by culture-independent methods. In contrast, a distinct Pseudomonas species, P. fluorescens, was often identified in asymptomatic transplant subjects by pyrosequencing but not detected via standard bacterial culture. The subject populations harboring these two distinct pseudomonads differed significantly with respect to associated symptoms, BAL neutrophilia, bacterial DNA burden and microbial diversity. Despite notable differences in culturability, a global database search of UM Hospital Clinical Microbiology Laboratory records indicated that P. fluorescens is commonly isolated from respiratory specimens. Interpretation: We have reported for the first time that two prominent and distinct Pseudomonas species (P. fluorescens and P. aeruginosa) exist within the post-transplant lung microbiome, each with unique genomic and microbiologic features and widely divergent clinical associations, including presence during acute infection.	[Dickson, Robert P.; Erb-Downward, John R.; Freeman, Christine M.; Walker, Natalie; Scales, Brittan S.; Martinez, Fernando J.; Curtis, Jeffrey L.; Lama, Vibha N.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Freeman, Christine M.] Dept Vet Affairs Hlth Care Syst, Res Serv, Ann Arbor, MI USA; [Scales, Brittan S.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Beck, James M.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Beck, James M.] Vet Affairs Eastern Colorado Hlth Care Syst, Med Serv, Denver, CO USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Huffnagle, GB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ghuff@umich.edu	Dickson, Robert/AAU-2949-2020; Huffnagle, Gary B./ABF-1323-2020	Curtis, Jeffrey/0000-0001-5191-4847; Dickson, Robert/0000-0002-6875-4277; Walker, Natalie/0000-0002-7445-3534	National Institutes of Health [T32HL00774921, U01HL098961, R01HL094622, R01HL114447, T32AI007528]; Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114447, R01HL094622, T32HL007287, T32HL007749, U01HL098961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871, T32AI007528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health grants T32HL00774921 (RPD), U01HL098961 (JMB, JLC, GBH), R01HL094622 (VNL), R01HL114447 (GBH, FJM), T32AI007528 (BSS) and the Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs (CMF, JMB, JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baader A, 1887, CORRES BLATT SCHWEIZ, V13, P385; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; BERNSTEIN DI, 1995, CHEST, V108, P636, DOI 10.1378/chest.108.3.636; Borewicz K, 2012, FEMS MICROBIOL LETT; Bossuyt X, 2006, CLIN CHEM, V52, P171, DOI 10.1373/clinchem.2005.058560; Botha P, 2008, TRANSPLANTATION, V85, P771, DOI 10.1097/TP.0b013e31816651de; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Daigle Derek, 2011, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0705s96; Diaz PI, 2013, CLIN VACCINE IMMUNOL, V20, P920, DOI 10.1128/CVI.00734-12; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duncan Michael D, 2005, Proc Am Thorac Soc, V2, P449, DOI 10.1513/pats.200507-073JS; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gershman MD, 2008, CLIN INFECT DIS, V47, P1372, DOI 10.1086/592968; Gottlieb J, 2009, RESP MED, V103, P743, DOI 10.1016/j.rmed.2008.11.015; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Husain Shahid, 2002, Semin Respir Infect, V17, P310, DOI 10.1053/srin.2002.36442; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; INGENITO EP, 1987, J APPL PHYSIOL, V63, P2075, DOI 10.1152/jappl.1987.63.5.2075; Jumpstart Consortium Human Microbiome Project Data Generation Working Group, 2010, HUM MICR CONS 16S 45; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khalifah AP, 2004, AM J RESP CRIT CARE, V170, P181, DOI 10.1164/rccm.200310-1359OC; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Leung RK, 2012, CLIN MICROBIOL INFEC; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lozupone C, 2013, AM J RESP CRIT CARE; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; MORTENSEN JE, 1995, INFECT CONT HOSP EP, V16, P30; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Patel SK, 2013, WORLD J GASTROENTERO, V19, P1056, DOI 10.3748/wjg.v19.i7.1056; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Scarpellini M, 2004, FEMS MICROBIOL LETT, V236, P257, DOI 10.1016/j.femsle.2004.05.043; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Twigg HL, 2013, LANCET RESP MED, V1, P354, DOI 10.1016/S2213-2600(13)70117-6; Vos R, 2008, EUR RESPIR J, V31, P1037, DOI 10.1183/09031936.00128607; Wei B, 2002, INFECT IMMUN, V70, P6567, DOI 10.1128/IAI.70.12.6567-6575.2002; Willner DL, 2013, AM J RESP CRIT CARE; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	49	124	128	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97214	10.1371/journal.pone.0097214	http://dx.doi.org/10.1371/journal.pone.0097214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831685	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500040
J	Dolcino, M; Patuzzo, G; Barbieri, A; Tinazzi, E; Rizzi, M; Beri, R; Argentino, G; Ottria, A; Lunardi, C; Puccetti, A				Dolcino, Marzia; Patuzzo, Giuseppe; Barbieri, Alessandro; Tinazzi, Elisa; Rizzi, Monica; Beri, Ruggero; Argentino, Giuseppe; Ottria, Andrea; Lunardi, Claudio; Puccetti, Antonio			Gene Expression Profiling in Peripheral Blood Mononuclear Cells of Patients with Common Variable Immunodeficiency: Modulation of Adaptive Immune Response following Intravenous Immunoglobulin Therapy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; T-CELLS; ACTIVATION; ANTIBODIES; APOPTOSIS; SUBSET; LEPTIN; CXCR4; CD38; CD4	Background: Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also to an active role in the modulation of the immune response. Common variable immunodeficiency is the most frequent primary immunodeficiency seen in clinical practice. Methods: We have studied the effect of intravenous immunoglobulin replacement in patients with common variable immunodeficiency by evaluating the gene-expression profiles from Affimetrix HG-U133A. Some of the gene array results were validated by real time RT-PCR and by the measurement of circulating cytokines and chemokines by ELISA. Moreover we performed FACS analysis of blood mononuclear cells from the patients enrolled in the study. Results: A series of genes involved in innate and acquired immune responses were markedly up-or down-modulated before therapy. Such genes included CD14, CD36, LEPR, IRF-5, RGS-1, CD38, TNFRSF25, IL-4, CXCR4, CCR3, IL-8. Most of these modulated genes showed an expression similar to that of normal controls after immunoglobulin replacement. Real time RT-PCR of selected genes and serum levels of IL-4, CXCR4 before and after therapy changed accordingly to gene array results. Interestingly, serum levels of IL-8 remained unchanged, as the corresponding gene, before and after treatment. FACS analysis showed a marked decrease of CD8+T cells and an increase of CD4+T cells following treatment. Moreover we observed a marked increase of CD23(-)CD27(-)IgM(-)Ig(-) B cells (centrocytes). Conclusions: Our results are in accordance with previous reports and provide further support to the hypothesis that the benefits of intravenous immunoglobulin therapy are not only related to antibody replacement but also to its ability to modulate the immune response in common variable immunodeficiency.	[Dolcino, Marzia; Puccetti, Antonio] Inst Giannina Gaslini, Dept Immunol, Genoa, Italy; [Patuzzo, Giuseppe; Barbieri, Alessandro; Tinazzi, Elisa; Rizzi, Monica; Beri, Ruggero; Argentino, Giuseppe; Lunardi, Claudio] Univ Verona, Dept Med, I-37100 Verona, Italy; [Ottria, Andrea; Puccetti, Antonio] Univ Genoa, Dept Expt Med, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Puccetti, A (corresponding author), Inst Giannina Gaslini, Dept Immunol, Genoa, Italy.	antonio.puccetti@unige.it	Tinazzi, Elisa/AAB-9450-2020	Argentino, Giuseppe/0000-0002-4747-4655; Ottria, Andrea/0000-0001-8722-3968; PATUZZO, Giuseppe/0000-0001-8011-0004	Italian Ministry of education; Ministero della Sanita	Italian Ministry of education; Ministero della Sanita(Ministry of Health, Italy)	This work was supported by a grant from the Italian Ministry of education and from a grant from Ministero della Sanita (grant recipients: CL and AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RR, 2012, CLIN EXP IMMUNOL, V169, P263, DOI 10.1111/j.1365-2249.2012.04620.x; Bateman EAL, 2012, CLIN EXP IMMUNOL, V170, P202, DOI 10.1111/j.1365-2249.2012.04643.x; Bayry J, 2003, ARTHRITIS RHEUM-US, V48, P3497, DOI 10.1002/art.11346; Bayry J, 2004, BLOOD, V104, P2441, DOI 10.1182/blood-2004-04-1325; Bayry J, 2011, J AUTOIMMUN, V36, P9, DOI 10.1016/j.jaut.2010.09.006; Carvalho KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012652; Dolcino M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/198956; Dolcino M, 2013, IMMUNOL RES, V56, P465, DOI 10.1007/s12026-013-8420-0; FERRER JM, 1995, CLIN EXP IMMUNOL, V102, P286; Gelfand EW, 2013, NEW ENGL J MED, V368, P777, DOI 10.1056/NEJMc1215489; Goldberg AC, 2009, ANN NY ACAD SCI, V1153, P184, DOI 10.1111/j.1749-6632.2008.03971.x; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kaveri SV, 2011, CLIN EXP IMMUNOL, V164, P2, DOI 10.1111/j.1365-2249.2011.04387.x; Kim SY, 2010, BIOCHEM BIOPH RES CO, V394, P562, DOI 10.1016/j.bbrc.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunardi C, 2006, PLOS MED, V3, P94, DOI 10.1371/journal.pmed.0030002; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; Maarschalk-Ellerbroek LJ, 2011, INT J ANTIMICROB AG, V37, P396, DOI 10.1016/j.ijantimicag.2010.11.027; Malvoisin E, 2011, ANAL BIOCHEM, V414, P202, DOI 10.1016/j.ab.2011.03.022; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Paquin-Proulx D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075199; Patuzzo G, 2013, ISRN IMMUNOLOGY; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Rezaei N, 2008, J INVEST ALLERG CLIN, V18, P449; Rezaei N, 2010, IMMUNOBIOLOGY, V215, P81, DOI 10.1016/j.imbio.2009.01.011; Salzer U, 2012, ANN NY ACAD SCI, V1250, P41, DOI 10.1111/j.1749-6632.2011.06377.x; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Scott-Taylor TH, 2004, CLIN EXP IMMUNOL, V138, P484, DOI 10.1111/j.1365-2249.2004.02640.x; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; Sokos DR, 2002, BIOL BLOOD MARROW TR, V8, P117, DOI 10.1053/bbmt.2002.v8.pm11939601; Tinazzi E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3069; Trepanier P, 2012, BLOOD, V120, P2769, DOI 10.1182/blood-2012-07-445007; Vences-Catalan F, 2011, IUBMB LIFE, V63, P840, DOI 10.1002/iub.549; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97571	10.1371/journal.pone.0097571	http://dx.doi.org/10.1371/journal.pone.0097571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831519	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500079
J	Gerard, C; Baudson, N; Ory, T; Louahed, J				Gerard, Catherine; Baudson, Nathalie; Ory, Thierry; Louahed, Jamila			Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses	PLOS ONE			English	Article							T-CELL RESPONSES; INTERFERON-GAMMA; NECROSIS-FACTOR; PHASE-II; IN-VIVO; EXPRESSION; ADJUVANT; PROTEIN; MELANOMA; GROWTH	Purpose: MAGE-A3 is a potential target for immunotherapy due to its tumor-specific nature and expression in several tumor types. Clinical data on MAGE-A3 immunotherapy have raised many questions that can only be addressed by using animal models. In the present study, different aspects of the murine anti-tumor immune responses induced by a recombinant MAGE-A3 protein (recMAGE-A3) in combination with different immunostimulants (AS01, AS02, CpG7909 or AS15) were investigated. Experimental Design and Results: Based on cytokine profile analyses and protection against challenge with MAGE-A3-expressing tumor, the combination recMAGE-A3+AS15 was selected for further experimental work, in particular to study the mechanisms of anti-tumor responses. By using MHC class I-, MHC class II-, perforin-, B-cell- and IFN-gamma- knock-out mice and CD4(+) T cell-, CD8(+) T cell- and NK cell- depleted mice, we demonstrated that CD4(+) T cells and NK cells are the main antitumor effectors, and that IFN-gamma is a major effector molecule. This mouse tumor model also established the need to repeat recMAGE-A3+AS15 injections to sustain efficient anti-tumor responses. Furthermore, our results indicated that the efficacy of tumor rejection by the elicited anti-MAGE-A3 responses depends on the proportion of tumor cells expressing MAGE-A3. Conclusions: The recMAGE-A3+AS15 cancer immunotherapy efficiently induced an antigen-specific, functional and long-lasting immune response able to recognize and eliminate MAGE-A3-expressing tumor cells up to several months after the last immunization in mice. The data highlighted the importance of the immunostimulant to induce a Th1-type immune response, as well as the key role played by IFN-gamma, CD4(+) T cells and NK cells in the anti-tumoral effect.	[Gerard, Catherine; Baudson, Nathalie; Ory, Thierry; Louahed, Jamila] GlaxoSmithKline Vaccines, Rixensart, Belgium	GlaxoSmithKline	Gerard, C (corresponding author), GlaxoSmithKline Vaccines, Rixensart, Belgium.	catherine.gerard@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and publishing of the present manuscript. JL was involved in study supervision at all stages. All authors were involved in study design, review of study reports, data analysis and interpretation. NB and TO conducted the study and were involved in data generation. All authors were involved in drafting and approval of the manuscript.	Atanackovic D, 2004, J IMMUNOL, V172, P3289, DOI 10.4049/jimmunol.172.5.3289; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Hudolin T, 2009, ACTA DERMATOVENER CR, V17, P103; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kruit WHJ, 2013, J CLIN ONCOL, V31, P2413, DOI 10.1200/JCO.2012.43.7111; Lally KM, 2001, INT J CANCER, V93, P841, DOI 10.1002/ijc.1420; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; Lin KY, 1996, CANCER RES, V56, P21; Marchand M, 2003, EUR J CANCER, V39, P70, DOI 10.1016/S0959-8049(02)00479-3; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nierkens S, 2011, CANCER RES, V71, P6428, DOI 10.1158/0008-5472.CAN-11-2154; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Seliger B, 2008, ADV CANCER RES, V101, P249, DOI 10.1016/S0065-230X(08)00407-7; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANPEL A, 1995, IMMUNOL REV, V145, P229, DOI 10.1111/j.1600-065X.1995.tb00084.x; VANPEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4718; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; Vantomme V, 2004, J IMMUNOTHER, V27, P124, DOI 10.1097/00002371-200403000-00006; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Xu XL, 1998, CANCER RES, V58, P2832	49	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94883	10.1371/journal.pone.0094883	http://dx.doi.org/10.1371/journal.pone.0094883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830315	Green Submitted, gold, Green Published			2022-12-25	WOS:000336789500006
J	Hatzirodos, N; Hummitzsch, K; Irving-Rodgers, HF; Rodgers, RJ				Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.			Transcriptome Profiling of the Theca Interna in Transition from Small to Large Antral Ovarian Follicles	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; TUMOR-NECROSIS-FACTOR; GRANULOSA-CELLS; FOLLICULAR DEVELOPMENT; BINDING-PROTEINS; GENE-EXPRESSION; IN-VITRO; STIMULATING-HORMONE; LUTEINIZING-HORMONE; ANDROGEN PRODUCTION	The theca interna layer of the ovarian follicle forms during the antral stage of follicle development and lies adjacent to and directly outside the follicular basal lamina. It supplies androgens and communicates with the granulosa cells and the oocyte by extracellular signaling. To better understand developmental changes in the theca interna, we undertook transcriptome profiling of the theca interna from small (3-5 mm, n = 10) and large (9-12 mm, n = 5) healthy antral bovine follicles, representing a calculated >7-fold increase in the amount of thecal tissue. Principal Component Analysis and hierarchical classification of the signal intensity plots for the arrays showed no clustering of the theca interna samples into groups depending on follicle size or subcategories of small follicles. From the over 23,000 probe sets analysed, only 76 were differentially expressed between large and small healthy follicles. Some of the differentially expressed genes were associated with processes such as myoblast differentiation, protein ubiquitination, nitric oxide and transforming growth factor beta signaling. The most significant pathway affected from our analyses was found to be Wnt signaling, which was suppressed in large follicles via down-regulation of WNT2B and up-regulation of the inhibitor FRZB. These changes in the transcriptional profile could have been due to changes in cellular function or alternatively since the theca interna is composed of a number of different cell types it could have been due to any systematic change in the volume density of any particular cell type. However, our study suggests that the transcriptional profile of the theca interna is relatively stable during antral follicle development unlike that of granulosa cells observed previously. Thus both the cellular composition and cellular behavior of the theca interna and its contribution to follicular development appear to be relatively constant throughout the follicle growth phase examined.	[Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Hummitzsch, Katja/K-6940-2013; Irving-Rodgers, Helen/E-3660-2010; Rodgers, Raymond J/C-3476-2009	Hummitzsch, Katja/0000-0001-5023-2668; 	National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide	This work was supported by the National Health and Medical Research Council of Australia, the Australian Research Council and the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salihi M, 2011, EPIGENETICS-US, V6, P1021, DOI 10.4161/epi.6.8.16064; [Anonymous], 2005, IPA NETW GEN ALG; BAIRD DT, 1981, BIOL REPROD, V24, P1013, DOI 10.1095/biolreprod24.5.1013; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Berisha B, 2000, J ENDOCRINOL, V167, P371, DOI 10.1677/joe.0.1670371; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRUNSWIGSPICKENHEIER B, 1992, ENDOCRINOLOGY, V131, P1445, DOI 10.1210/en.131.3.1445; Castanon BI, 2012, J ANIM SCI, V90, P3789, DOI 10.2527/jas.2011-4696; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; CONTI P, 1991, IMMUNOLOGY, V73, P450; Dassen H, 2007, CELL MOL LIFE SCI, V64, P1009, DOI 10.1007/s00018-007-6553-9; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Glister C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-72; Glister C, 2013, P NATL ACAD SCI USA, V110, pE1426, DOI 10.1073/pnas.1222216110; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Hatzirodos N, 2014, PLOS ONE UNPUB; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hatzirodos N, 2012, MATRIX BIOL, V31, P45, DOI 10.1016/j.matbio.2011.10.002; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2003, REPROD FERT DEVELOP, V15, P241, DOI 10.1071/RD03008; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Irving-Rodgers HF, 2000, J REPROD FERTIL, V118, P221, DOI 10.1530/reprod/118.2.221; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kratzer I, 2012, HISTOCHEM CELL BIOL, V138, P861, DOI 10.1007/s00418-012-1001-9; Lee YS, 2011, AM J PHYSIOL-ENDOC M, V301, pE196, DOI 10.1152/ajpendo.00686.2010; Logan KA, 2002, BIOL REPROD, V66, P906, DOI 10.1095/biolreprod66.4.906; Martelli A, 2009, REPRODUCTION, V137, P45, DOI 10.1530/REP-08-0117; Mazaud-Guittot S, 2011, METHODS MOL BIOL, V763, P223, DOI 10.1007/978-1-61779-191-8_15; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; MONGET P, 1993, ENDOCRINOLOGY, V132, P1438, DOI 10.1210/en.132.4.1438; Newman JW, 2004, ENDOCRINOLOGY, V145, P5097, DOI 10.1210/en.2004-0710; Nguyen HPT, 2012, ENDOCRINOLOGY, V153, P2870, DOI 10.1210/en.2011-1839; Nicholas B, 2002, REPRODUCTION, V124, P439, DOI 10.1530/rep.0.1240439; Oldridge EE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.6; OLESZAK E, 1988, EXP CELL RES, V179, P575, DOI 10.1016/0014-4827(88)90295-9; Orisaka M, 2006, BIOL REPROD, V75, P734, DOI 10.1095/biolreprod.105.050344; Palermo R, 2007, REPROD BIOMED ONLINE, V15, P326, DOI 10.1016/S1472-6483(10)60347-1; Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;55::AID-MRD8&gt;3.0.CO;2-L; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Schams D, 2002, DOMEST ANIM ENDOCRIN, V22, P51, DOI 10.1016/S0739-7240(01)00116-3; Schauser KH, 2001, BIOL REPROD, V65, P1672, DOI 10.1095/biolreprod65.6.1672; Solovyeva EV, 2000, BIOL REPROD, V63, P1214, DOI 10.1095/biolreprod63.4.1214; Stouffer RL, 2001, ARCH MED RES, V32, P567, DOI 10.1016/S0188-4409(01)00323-X; Tajima K, 2007, REPROD BIOMED ONLINE, V15, P591, DOI 10.1016/S1472-6483(10)60392-6; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Wu XM, 2004, MOL ENDOCRINOL, V18, P1509, DOI 10.1210/me.2003-0399; Young JM, 2012, J MOL ENDOCRINOL, V48, P49, DOI 10.1530/JME-11-0134; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	64	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97489	10.1371/journal.pone.0097489	http://dx.doi.org/10.1371/journal.pone.0097489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830430	gold, Green Published			2022-12-25	WOS:000336789500068
J	Tseng, YJ; Chen, RS; Hsu, WY; Hsiao, FJ; Lin, YY				Tseng, Yi-Jhan; Chen, Rou-Shayn; Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang			Reduced Motor Cortex Deactivation in Individuals Who Suffer from Writer's Cramp	PLOS ONE			English	Article							MOVEMENT-BETA-SYNCHRONIZATION; CORTICAL NETWORK; STIMULATION; OSCILLATIONS; DYSTONIA; RHYTHMS; FIELDS; INTEGRATION; RESPONSES	This study investigated the neuromagnetic activities of self-paced finger lifting task and electrical median nerve stimulation in ten writer's cramp patients and fourteen control subjects. The event-related de/synchronizations (ERD/ERS) of beta-band activity levels were evaluated and the somatosensory cortical activity levels were analyzed using equivalent-current dipole modeling. No significant difference between the patients and control subjects was found in the electrical stimulation-induced beta ERS and electrical evoked somatosensory cortical responses. Movement-related beta ERD did not differ between controls and patients. Notably, the amplitude of the beta ERS after termination of finger movement was significantly lower in the patients than in the control subjects. The reduced movement-related beta ERS might reflect an impairment of motor cortex deactivation. In conclusion, a motor dependent dysregulation of the sensorimotor network seems to be involved in the functional impairment of patients with writer's cramp.	[Tseng, Yi-Jhan; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan; [Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tseng, Yi-Jhan; Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Integrated Brain Res Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Rou-Shayn] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Chen, Rou-Shayn] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei City Hospital	Lin, YY (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan.	yylin@vghtpe.gov.tw			Taipei Veterans General Hospital [V96ER3-004, V97ER3-006, VGHUST97-P6-24, V98ER3-002, V98S4-018, V99ER3-006, V101C-023, V102C-101, V102E9-003, V103C-062, V103E9-003]; National Science Council [NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC-98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011 -MY3, NSC-100-2321-B-010-004-MY3, NSC-101-2917-I-010-003, NSC-101-2314-B-010-068-MY3, NSC 102-2628-B-010-008-MY3]; Brain Research Center [102AC-B22, 102AC-B7]; National Yang-Ming University; Ministry of Education, Taipei, Taiwan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Brain Research Center; National Yang-Ming University; Ministry of Education, Taipei, Taiwan	The authors thank all the grants supported by Taipei Veterans General Hospital (V96ER3-004, V97ER3-006, VGHUST97-P6-24, V98ER3-002, V98S4-018, V99ER3-006, V101C-023, V102C-101, V102E9-003, V103C-062, V103E9-003), National Science Council (NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC-98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011 -MY3, NSC-100-2321-B-010-004-MY3, NSC-101-2917-I-010-003, NSC-101-2314-B-010-068-MY3, NSC 102-2628-B-010-008-MY3), and the Brain Research Center (102AC-B22, 102AC-B7), National Yang-Ming University and a grant from Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara-Jimenez W, 2000, NEUROLOGY, V55, P1869, DOI 10.1212/WNL.55.12.1869; Bara-Jimenez W, 2000, ANN NEUROL, V47, P377, DOI 10.1002/1531-8249(200003)47:3<377::AID-ANA16>3.0.CO;2-2; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cassim F, 2001, NEUROREPORT, V12, P3859, DOI 10.1097/00001756-200112040-00051; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Cheyne DL, 2003, COGNITIVE BRAIN RES, V17, P599, DOI 10.1016/S0926-6410(03)00173-3; Contarino MF, 2007, CLIN NEUROPHYSIOL, V118, P2195, DOI 10.1016/j.clinph.2007.07.004; Delmaire C, 2009, ARCH NEUROL-CHICAGO, V66, P502, DOI 10.1001/archneurol.2009.8; FORSS N, 1994, ELECTROEN CLIN NEURO, V92, P510, DOI 10.1016/0168-5597(94)90135-X; Frasson E, 2001, MOVEMENT DISORD, V16, P674, DOI 10.1002/mds.1142; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Hallett M, 2006, HUM MOVEMENT SCI, V25, P454, DOI 10.1016/j.humov.2006.05.004; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hamano T, 1999, CLIN NEUROPHYSIOL, V110, P508, DOI 10.1016/S1388-2457(98)00045-5; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Jankowski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078234; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KAJI R, 1995, ANN NEUROL, V38, P155, DOI 10.1002/ana.410380206; Kakigi R, 2000, PROG NEUROBIOL, V61, P495, DOI 10.1016/S0301-0082(99)00063-5; Levy LM, 2002, ANN NEUROL, V51, P93, DOI 10.1002/ana.10073; Lin YY, 2005, NEUROIMAGE, V25, P1090, DOI 10.1016/j.neuroimage.2004.12.047; Lin YY, 2003, NEUROIMAGE, V20, P909, DOI 10.1016/S1053-8119(03)00387-2; Lin YY, 2000, NEUROIMAGE, V11, P334, DOI 10.1006/nimg.1999.0536; Mauguiere F, 1997, EVOKED POTENTIAL, V104, P281, DOI 10.1016/S0013-4694(97)00006-0; Murase N, 2000, BRAIN, V123, P1813, DOI 10.1093/brain/123.9.1813; Muthukumaraswamy SD, 2013, NEUROIMAGE, V66, P36, DOI 10.1016/j.neuroimage.2012.10.054; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2001, J CLIN NEUROPHYSIOL, V18, P559, DOI 10.1097/00004691-200111000-00006; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Reyns N, 2013, CLIN NEUROPHYSIOL, V124, P761, DOI 10.1016/j.clinph.2012.10.011; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Tamas G, 2003, CLIN NEUROPHYSIOL, V114, P614, DOI 10.1016/S1388-2457(02)00424-8; Tamura Y, 2008, MOVEMENT DISORD, V23, P558, DOI 10.1002/mds.21870; Tecchio F, 2008, NEUROSCIENCE, V154, P563, DOI 10.1016/j.neuroscience.2008.03.045; Toro C, 2000, ANN NEUROL, V47, P456, DOI 10.1002/1531-8249(200004)47:4<456::AID-ANA8>3.3.CO;2-H; Tyvaert L, 2009, SLEEP MED, V10, P1090, DOI 10.1016/j.sleep.2008.11.008; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97561	10.1371/journal.pone.0097561	http://dx.doi.org/10.1371/journal.pone.0097561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831291	gold, Green Published, Green Submitted			2022-12-25	WOS:000336789500078
J	Saino, N; Romano, M; Rubolini, D; Ambrosini, R; Romano, A; Caprioli, M; Costanzo, A; Bazzi, G				Saino, Nicola; Romano, Maria; Rubolini, Diego; Ambrosini, Roberto; Romano, Andrea; Caprioli, Manuela; Costanzo, Alessandra; Bazzi, Gaia			A Trade-Off between Reproduction and Feather Growth in the Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; MOLT STRATEGIES; NUTRITIONAL CONDITION; MIGRATORY BEHAVIOR; STURNUS-VULGARIS; ANNUAL ROUTINES; ANNUAL CYCLE; BROOD SIZE; PTILOCHRONOLOGY; BIRDS	Physiological trade-offs mediated by limiting energy, resources or time constrain the simultaneous expression of major functions and can lead to the evolution of temporal separation between demanding activities. In birds, plumage renewal is a demanding activity, which accomplishes fundamental functions, such as allowing thermal insulation, aerodynamics and socio-sexual signaling. Feather renewal is a very expensive and disabling process, and molt is often partitioned from breeding and migration. However, trade-offs between feather renewal and breeding have been only sparsely studied. In barn swallows (Hirundo rustica) breeding in Italy and undergoing molt during wintering in sub-Saharan Africa, we studied this trade-off by removing a tail feather from a large sample of individuals and analyzing growth bar width, reflecting feather growth rate, and length of the growing replacement feather in relation to the stage in the breeding cycle at removal and clutch size. Growth bar width of females and length of the growing replacement feather of both sexes were smaller when the original feather had been removed after clutch initiation. Importantly, in females both growth bar width and replacement feather length were negatively predicted by clutch size, and more strongly so for large clutches and when feather removal occurred immediately after clutch completion. Hence, we found strong, coherent evidence for a trade-off between reproduction, and laying effort in particular, and the ability to generate new feathers. These results support the hypothesis that the derived condition of molting during wintering in long-distance migrants is maintained by the costs of overlapping breeding and molt.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Romano, Andrea; Caprioli, Manuela; Costanzo, Alessandra; Bazzi, Gaia] Univ Milan, Dept Biosci, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milan; University of Milano-Bicocca	Saino, N (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	nicola.saino@unimi.it	Romano, Andrea/B-3930-2012; Romano, Andrea/A-2780-2017; costanzo, alessandra/AAF-8987-2020; Ambrosini, Roberto/F-3188-2012; Bazzi, Gaia/AAP-9154-2020; Rubolini, Diego/F-2851-2011	Romano, Andrea/0000-0002-0945-6018; costanzo, alessandra/0000-0003-3781-0798; Ambrosini, Roberto/0000-0002-7148-1468; Rubolini, Diego/0000-0003-2703-5783; Saino, Nicola/0000-0002-0230-3967; BAZZI, GAIA/0000-0002-7220-6054				[Anonymous], 2007, RMRSGTR189 USDA FOR; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; BENSCH S, 1985, ORNIS SCAND, V16, P151, DOI 10.2307/3676481; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; Bonier F, 2007, ECOLOGY, V88, P2729, DOI 10.1890/07-0696.1; Clarkson CE, 2011, ECOL INDIC, V11, P1707, DOI 10.1016/j.ecolind.2011.04.019; Cramp S, 1998, COMPLETE BIRDS W PAL; Cyr NE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P452, DOI 10.1086/589547; DAWSON A, 1994, IBIS, V136, P335, DOI 10.1111/j.1474-919X.1994.tb01104.x; DAWSON A, 1982, GEN COMP ENDOCR, V48, P213, DOI 10.1016/0016-6480(82)90019-3; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2006, GEN COMP ENDOCR, V147, P314, DOI 10.1016/j.ygcen.2006.02.001; de la Hera I, 2011, AUK, V128, P321, DOI 10.1525/auk.2011.10181; de la Hera I, 2009, J AVIAN BIOL, V40, P461, DOI 10.1111/j.1600-048X.2008.04689.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; DRENT RH, 1980, ARDEA, V68, P225; Echeverry-Galvis MA, 2012, J EXP BIOL, V215, P1957, DOI 10.1242/jeb.065474; Echeverry-Galvis MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061106; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; GRUBB TC, 1991, AUK, V108, P725, DOI 10.2307/4088120; GRUBB TC, 1989, AUK, V106, P314; Grubb TC, 1998, CONDOR, V100, P753, DOI 10.2307/1369761; Grubb Thomas C. Jr, 1995, Current Ornithology, V12, P89; Hall KSS, 2004, EVOL ECOL, V18, P85, DOI 10.1023/B:EVEC.0000017848.20735.8b; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Jenni L., 1994, BIOL MOULT BIRDS; Johnson EI, 2012, J AVIAN BIOL, V43, P141, DOI 10.1111/j.1600-048X.2011.05574.x; Jovani R, 2012, J AVIAN BIOL, V43, P97, DOI 10.1111/j.1600-048X.2012.05583.x; Jovani R, 2011, J AVIAN BIOL, V42, P1, DOI 10.1111/j.1600-048X.2010.05175.x; Kern MD, 2002, IBIS, V144, P23, DOI 10.1046/j.0019-1019.2001.00010.x; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; LESSELLS CM, 1986, J ANIM ECOL, V55, P669, DOI 10.2307/4747; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MASMAN D, 1988, ARDEA, V76, P64; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Moller AP., 1994, SEXUAL SELECTION BAR; Moreno J, 2001, OECOLOGIA, V129, P492, DOI 10.1007/s004420100767; Murphy Mary E., 1996, P158; MURPHY ME, 1991, AUK, V108, P695, DOI 10.2307/4088109; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; MURPHY ME, 1992, AUK, V109, P676; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Roff Derek A., 1992; Rohwer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011586; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Roulin A, 2008, ANIM BEHAV, V75, P1351, DOI 10.1016/j.anbehav.2007.09.007; Rubolini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048955; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; Saino N, 2013, J ORNITHOL, V154, P537, DOI 10.1007/s10336-012-0924-1; Saino N, 2012, J AVIAN BIOL, V43, P513, DOI 10.1111/j.1600-048X.2012.05622.x; Salewski V, 2004, J ORNITHOL, V145, P109, DOI 10.1007/s10336-004-0020-2; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Sockman KW, 2006, BIOL REV, V81, P629, DOI 10.1017/S1464793106007147; Stearns S.C., 1992, pi; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Svensson E, 1999, BIOL J LINN SOC, V67, P263, DOI 10.1006/bijl.1998.0302; Turner A., 2006, BARN SWALLOW; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Ward S, 1996, PHYSIOL ZOOL, V69, P930, DOI 10.1086/physzool.69.4.30164236; Williams T., 2012, PHYSL ADAPTATIONS BR; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	69	16	17	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96428	10.1371/journal.pone.0096428	http://dx.doi.org/10.1371/journal.pone.0096428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826890	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400026
J	Kang, Q; Srividhya, J; Ipe, J; Pomerening, JR				Kang, Qing; Srividhya, Jeyaraman; Ipe, Joseph; Pomerening, Joseph R.			Evidence toward a Dual Phosphatase Mechanism That Restricts Aurora A (Thr-295) Phosphorylation during the Early Embryonic Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; KINASE AURORA; CENTROSOMAL PROTEIN; A OVEREXPRESSION; MITOTIC EXIT; PHASE ENTRY; IN-VITRO; ACTIVATION; TPX2; PLK1	The mitotic kinase Aurora A(AurA) is regulated by a complex network of factors that includes co-activator binding, autophosphorylation, and dephosphorylation. Dephosphorylation of AurA by PP2A (human, Ser-51; Xenopus, Ser-53) destabilizes the protein, whereas mitotic dephosphorylation of its T-loop (human, Thr-288; Xenopus, Thr-295) by PP6 represses AurA activity. However, AurA(Thr-295) phosphorylation is restricted throughout the early embryonic cell cycle, not just during M-phase, and how Thr-295 is kept dephosphorylated during interphase and whether or not this mechanism impacts the cell cycle oscillator were unknown. Titration of okadaic acid (OA) or fostriecin into Xenopus early embryonic extract revealed that phosphatase activity other than PP1 continuously suppresses AurA(Thr-295) phosphorylation during the early embryonic cell cycle. Unexpectedly, we observed that inhibiting a phosphatase activity highly sensitive to OA caused an abnormal increase in AurA(Thr-295) phosphorylation late during interphase that corresponded with delayed cyclin-dependent kinase 1 (CDK1) activation. AurA(Thr-295) phosphorylation indeed influenced this timing, because AurA isoforms retaining an intact Thr-295 residue further delayed M-phase entry. Using mathematical modeling, we determined that one phosphatase would be insufficient to restrict AurA phosphorylation and regulate CDK1 activation, whereas a dual phosphatase topology best recapitulated our experimental observations. We propose that two phosphatases target Thr-295 of AurA to prevent premature AurA activation during interphase and that phosphorylated AurA(Thr-295) acts as a competitor substrate with a CDK1-activating phosphatase in late interphase. These results suggest a novel relationship between AurA and protein phosphatases during progression throughout the early embryonic cell cycle and shed new light on potential defects caused by AurA overexpression.	[Kang, Qing; Srividhya, Jeyaraman; Ipe, Joseph; Pomerening, Joseph R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Pomerening, JR (corresponding author), Indiana Univ, Dept Biol, 212 S Hawthorne Dr,Rm 043F, Bloomington, IN 47405 USA.	jpomeren@indiana.edu		Pomerening, Joseph/0000-0003-4120-9081; Ipe, Joseph/0000-0002-8362-4403	National Institutes of Health [R01GM086526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086526.	Abe Y, 2010, J CELL SCI, V123, P3978, DOI 10.1242/jcs.076315; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Buck SB, 2003, J AM CHEM SOC, V125, P15694, DOI 10.1021/ja038672n; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; De Luca M, 2006, CELL CYCLE, V5, P296; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; FELIX MA, 1990, EMBO J, V9, P675, DOI 10.1002/j.1460-2075.1990.tb08159.x; Hammond D, 2013, J CELL SCI, V126, P3429, DOI 10.1242/jcs.128397; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Jantscher F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-28; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Krasinska L, 2011, MOL CELL, V44, P437, DOI 10.1016/j.molcel.2011.10.007; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Li CC, 2009, MOL CANCER RES, V7, P678, DOI 10.1158/1541-7786.MCR-08-0483; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Maton G, 2005, J CELL SCI, V118, P2485, DOI 10.1242/jcs.02370; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reboutier D, 2012, J CELL BIOL, V197, P19, DOI 10.1083/jcb.201107134; Roghi C, 1998, J CELL SCI, V111, P557; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Swingle Mark, 2007, V365, P23; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	57	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17480	17496		10.1074/jbc.M113.527622	http://dx.doi.org/10.1074/jbc.M113.527622			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24825897	Green Published, hybrid			2022-12-25	WOS:000338018100016
J	Bauer, EM; Zheng, H; Lotze, MT; Bauer, PM				Bauer, Eileen M.; Zheng, Han; Lotze, Michael T.; Bauer, Philip M.			Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; I INTERFERON; ARTERIAL-HYPERTENSION; PLEXIFORM LESIONS; APOPTOTIC CELLS; IFN-ALPHA; EFFEROCYTOSIS; PHAGOCYTOSIS; DASATINIB; RECEPTOR	Pulmonary hypertension (PH) is a progressive and fatal disease with no cure. Vascular remodeling in PH involves intraluminal growth of endothelial and smooth muscle cells, leading to obliterative vascular lesions. Cell growth in these lesions is quasi-neoplastic, with evidence of monoclonality, apoptosis resistance and cancer-like metabolic derangements. Herein we tested the effect of human interferon alpha 2b (IFN alpha), a pleiotropic cytokine and anti-cancer therapeutic, on the development and progression of PH in the rat SU5416/hypoxia (SUH) model and mouse hypoxia model of the disease. In both models IFN alpha attenuated the development of PH and reversed established PH as assessed by measuring right ventricular systolic pressure and right ventricular hypertrophy. The effect of IFN alpha was dependent on the type I interferon receptor (IFNAR) since mice lacking a subunit of the IFNAR were not protected by IFN alpha. Morphometric analysis of pulmonary aterioles from hypoxic mice or SUH rats showed that IFN alpha inhibited pulmonary vascular remodeling in both models and that IFN alpha reversed remodeling in SUH rats with established disease. Immunohistochemical staining revealed that IFN alpha decreased the number of PCNA and Tunel positive cells in the wall of pulmonary arterioles. In vitro, IFN alpha inhibited proliferation of human pulmonary artery smooth muscle cells and as well as human pulmonary artery endothelial cell proliferation and apoptosis. Together these findings demonstrate that IFN alpha reverses established experimental PH and provide a rationale for further exploration of the use of IFN alpha and other immunotherpies in PH.	[Bauer, Eileen M.; Zheng, Han; Lotze, Michael T.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Bauer, Eileen M.; Lotze, Michael T.] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bauer, EM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	bauerpm@upmc.edu			NIH [R01 HL085134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH R01 HL085134 to PM Bauer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Almagro P, 2002, MEDICINE, V81, P417, DOI 10.1097/00005792-200211000-00002; Banerjee S, 2010, J LEUKOCYTE BIOL, V88, P973, DOI 10.1189/jlb.0510262; Bauer EM, 2012, MOL MED, V18, P1509, DOI 10.2119/molmed.2012.00283; Bauer EM, 2013, J BIOL CHEM, V288, P1365, DOI 10.1074/jbc.M112.434142; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Cao B, 2008, WORLD J GASTROENTERO, V14, P6802, DOI 10.3748/wjg.14.6802; CHEN BDM, 1987, CELL IMMUNOL, V106, P343, DOI 10.1016/0008-8749(87)90177-8; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; Dhillon S, 2010, DIGEST DIS SCI, V55, P1785, DOI 10.1007/s10620-010-1220-7; Dumitrescu D, 2011, EUR RESPIR J, V38, P218, DOI 10.1183/09031936.00154210; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Fruehauf S, 2001, ANN HEMATOL, V80, P308; George PM, 2014, CIRC RES, V114, P677, DOI 10.1161/CIRCRESAHA.114.302221; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Jochmann Nicoline, 2005, Cardiovasc Ultrasound, V3, P26, DOI 10.1186/1476-7120-3-26; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Liang SJ, 2003, CYTOKINE, V23, P190, DOI 10.1016/S1043-4666(03)00226-6; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Mattei D, 2009, BONE MARROW TRANSPL, V43, P967, DOI 10.1038/bmt.2008.415; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Olin J, 2011, BMJ CASE REP 2011 BC, V2011; Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rasheed W, 2009, LEUKEMIA RES, V33, P861, DOI 10.1016/j.leukres.2008.09.026; ROLLAG H, 1984, SCAND J IMMUNOL, V20, P149, DOI 10.1111/j.1365-3083.1984.tb00988.x; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Siddegowda Nagesh Koregala, 2011, Indian J Psychiatry, V53, P239, DOI 10.4103/0019-5545.86815; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; TUDER RM, 1994, AM J PATHOL, V144, P275; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; Voelkel NF, 1995, EUR RESPIR J, V8, P2129, DOI 10.1183/09031936.95.08122129; Wuttge DM, 2013, SCAND J RHEUMATOL, V42, P235, DOI 10.3109/03009742.2012.736532	52	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96720	10.1371/journal.pone.0096720	http://dx.doi.org/10.1371/journal.pone.0096720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837600	Green Accepted, gold, Green Published			2022-12-25	WOS:000339614800020
J	Chen, XF; Zhu, Q; Liu, YQ; Liu, P; Yin, YM; Guo, RH; Lu, KH; Gu, YH; Liu, LK; Wang, JH; Wang, ZX; Roe, OD; Shu, YQ; Zhu, LJ				Chen, Xiaofeng; Zhu, Quan; Liu, Yiqian; Liu, Ping; Yin, Yongmei; Guo, Renhua; Lu, Kaihua; Gu, Yanhong; Liu, Lianke; Wang, Jinghua; Wang, Zhaoxia; Roe, Oluf Dimitri; Shu, Yongqian; Zhu, Lingjun			Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; OPEN-LABEL; 1ST-LINE TREATMENT; CHINESE PATIENTS; MULTICENTER; CHEMOTHERAPY; GEFITINIB; ERLOTINIB; MUTATION; PLACEBO	Background: Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung cancer (NSCLC). This retrospective analysis was performed to assess the efficacy of icotinib on patients with non-small-cell lung cancer (NSCLC). Methods: 82 consecutive patients treated with icotinib as first (n = 24) or second/third line (n = 58) treatment at three hospitals in Nanjing were enrolled into our retrospective research. The Response Evaluation Criteria in Solid Tumors (RECIST) was used to evaluate the tumor responses and the progression-free survival (PFS) and overall survival (OS) was evaluated by the Kaplan-Meier method. Results: Median PFS was 4.0 months (95% CI 2.311-5.689). Median OS was 11.0 months (95% CI 8.537-13.463) in this cohort. Median PFS for first and second/third line were 7.0 months (95% CI 2.151-11.8) and 3.0 months (95% CI 1.042-4.958), respectively. Median OS for first and second/third line were 13.0 months (95% CI 10.305-15.695) and 10.0 months (95% CI 7.295-12.70), respectively. In patients with EGFR mutation (n = 19), icotinib significantly reduced the risk of progression (HR 0.36, 95% CI 0.18-0.70, p = 0.003) and death (HR 0.10, 95% CI 0.02-0.42, p = 0.002) compared with those EGFR status unknown (n = 63). The most common adverse events were acne-like rash (39.0%) and diarrhea (20.7%). Conclusions: Icotinib is active in the treatment of patients with NSCLC both in first or second/third line, especially in those patients harbouring EGFR mutations, with an acceptable adverse event profile.	[Chen, Xiaofeng; Liu, Yiqian; Liu, Ping; Yin, Yongmei; Guo, Renhua; Lu, Kaihua; Gu, Yanhong; Liu, Lianke; Shu, Yongqian; Zhu, Lingjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Quan] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Jinghua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Zhaoxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Roe, Oluf Dimitri] Nord Trondelag Hlth Trust, Levanger Hosp, Canc Clin, Levanger, Norway	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing Medical University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	yongqianshu@126.com; zhulingjun@njmu.edu.cn	Shu, Yongqian/ABD-5698-2021	Roe, Oluf Dimitri/0000-0002-4870-5822	Program for Development of Innovative Research Teams; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center) [BL 2012008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China	Program for Development of Innovative Research Teams; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China	This work was partly supported by the Program for Development of Innovative Research Teams, by Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center, BL 2012008), and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and by Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; De Censi A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.516; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kohrman M, 2012, J CLIN ONCOL, V30; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ren GJ, 2011, CHINESE MED J-PEKING, V124, P19, DOI 10.3760/cma.j.issn.0366-6999.2011.01.005; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi Y, 2013, LANCET ONCOL; Tan FL, 2012, LUNG CANCER, V76, P177, DOI 10.1016/j.lungcan.2011.10.023; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Wang HP, 2011, CHINESE MED J-PEKING, V124, P1933, DOI 10.3760/cma.j.issn.0366-6999.2011.13.003; Wu MN, 2010, LUNG CANCER, V67, P343, DOI 10.1016/j.lungcan.2009.04.011; Yang GD, 2012, ONCOL REP, V27, P2066, DOI 10.3892/or.2012.1741; Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; Zhao QO, 2011, LUNG CANCER, V73, P195, DOI 10.1016/j.lungcan.2010.11.007; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	26	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95897	10.1371/journal.pone.0095897	http://dx.doi.org/10.1371/journal.pone.0095897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836053	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800011
J	Hoefler, D; Nicklas, W; Mauter, P; Pawlita, M; Schmitt, M				Hoefler, Daniela; Nicklas, Werner; Mauter, Petra; Pawlita, Michael; Schmitt, Markus			A Bead-Based Multiplex Assay for the Detection of DNA Viruses Infecting Laboratory Rodents	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBODY-PRODUCTION TEST; BIOLOGICAL-MATERIALS; MINUTE VIRUS; RAT COLONIES; IN-VIVO; MOUSE; MICE; PCR; CONTAMINATION	The Federation of European Laboratory Animal Science Association (FELASA) recommends screening of laboratory rodents and biological materials for a broad variety of bacterial agents, viruses, and parasites. Methods commonly used to date for pathogen detection are neither cost-effective nor time- and animal-efficient or uniform. However, an infection even if silent alters experimental results through changing the animals' physiology and increases inter-individual variability. As a consequence higher numbers of animals and experiments are needed for valid and significant results. We developed a novel high-throughput multiplex assay, called rodent DNA virus finder (rDVF) for the simultaneous identification of 24 DNA viruses infecting mice and rats. We detected all 24 DNA viruses with high specificity and reproducibility. Detection limits for the different DNA viruses varied between 10 and 1000 copies per PCR. The validation of rDVF was done with DNA isolated from homogenised organs amplified by pathogen specific primers in one multiplex PCR. The biotinylated amplicons were detected via hybridisation to specific oligonucleotide probes coupled to spectrally distinct sets of fluorescent Luminex beads. In conclusion, rDVF may have the potential to replace conventional testing and may simplify and improve routine detection of DNA viruses infecting rodents.	[Hoefler, Daniela; Pawlita, Michael; Schmitt, Markus] German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Baden Wurttembe, Germany; [Nicklas, Werner; Mauter, Petra] German Canc Res Ctr, Heidelberg, Baden Wurttembe, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hoefler, D (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Baden Wurttembe, Germany.	d.hoefler@dkfz.de	Waterboer, Tim/G-1252-2010; Schmitt, Markus/B-6410-2008	Schmitt, Markus/0000-0002-7827-6694; Pawlita, Michael/0000-0002-4720-8306				Baker D. G., 2003, NATURAL PATHOGENS LA; Bauer BA, 2004, BIOLOGICALS, V32, P177, DOI 10.1016/j.biologicals.2004.08.004; Berke Z, 2000, LEUKEMIA, V14, P419, DOI 10.1038/sj.leu.2401703; Besselsen DG, 2008, COMPARATIVE MED, V58, P140; BESSELSEN DG, 1995, J CLIN MICROBIOL, V33, P2859, DOI 10.1128/JCM.33.11.2859-2863.1995; BESSELSEN DG, 1995, J CLIN MICROBIOL, V33, P1699, DOI 10.1128/JCM.33.7.1699-1703.1995; Bootz F, 2003, LAB ANIM-UK, V37, P341, DOI 10.1258/002367703103051895; Bootz FO, 2007, ALTEX-ALTERN TIEREXP, V24, P19; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Carty AJ, 2008, ILAR J, V49, P272, DOI 10.1093/ilar.49.3.272; Compton SR, 2001, COMPARATIVE MED, V51, P113; Connole MD, 2000, MED MYCOL, V38, P59, DOI 10.1080/mmy.38.s1.59.65; Henderson KS, 2013, J AM ASSOC LAB ANIM, V52, P763; Jumpertz T, 2011, ANAL BIOCHEM, V408, P64, DOI 10.1016/j.ab.2010.09.011; KILHAM L, 1970, P SOC EXP BIOL MED, V133, P1447; KRAFT V, 1994, LAB ANIM, V28, P1, DOI 10.1258/002367794781065933; Labelle P, 2009, COMPARATIVE MED, V59, P180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenaerts L, 2005, ANTIMICROB AGENTS CH, V49, P4689, DOI 10.1128/AAC.49.11.4689-4699.2005; LEWIS VJ, 1971, LAB ANIM SCI, V21, P203; Livingston RS, 2003, LAB ANIMAL, V32, P44, DOI 10.1038/laban0503-44; Mahabir E, 2004, J VIROL METHODS, V120, P239, DOI 10.1016/j.jviromet.2004.05.006; Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Nicklas W, 1999, BERL MUNCH TIERARZTL, V112, P201; Nicklas W, 1999, LAB ANIM-UK, V33, P39, DOI 10.1258/002367799780639987; Nicklas W., 1993, SCANDANAVIAN J LAB A, V20, P53; PRINGAKERBLOM P, 1993, RES VIROLOGY, V144, P117, DOI 10.1016/S0923-2516(06)80020-8; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2011, CANCER EPIDEM BIOMAR, V20, P1558, DOI 10.1158/1055-9965.EPI-11-0424; Schmitt M, 2010, J MOL MICROB BIOTECH, V19, P204, DOI 10.1159/000321449; Schmitt M, 2010, J VIROL METHODS, V170, P67, DOI 10.1016/j.jviromet.2010.08.020; Shek WR, 2007, MOUSE BIOMEDICAL RES, P731; Szomolanyi-Tsuda E, 2006, J VIROL, V80, P4286, DOI 10.1128/JVI.80.9.4286-4291.2006; van de Ven EMES, 2006, LAB ANIM-UK, V40, P137, DOI 10.1258/002367706776319114; Wan CH, 2006, LAB ANIM-UK, V40, P63, DOI 10.1258/002367706775404408; Wan CH, 2002, J GEN VIROL, V83, P2075, DOI 10.1099/0022-1317-83-8-2075; YAGAMI K, 1995, LAB ANIM SCI, V45, P326; Zenner L, 2000, LAB ANIM-UK, V34, P76, DOI 10.1258/002367700780577957	41	7	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97525	10.1371/journal.pone.0097525	http://dx.doi.org/10.1371/journal.pone.0097525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835244	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800048
J	Wurster, T; Tegtmeyer, R; Borst, O; Rath, D; Geisler, T; Gawaz, M; Bigalke, B				Wurster, Thomas; Tegtmeyer, Roland; Borst, Oliver; Rath, Dominik; Geisler, Tobias; Gawaz, Meinrad; Bigalke, Boris			Platelet Expression of Stromal Cell-Derived Factor-1 Is Associated with the Degree of Valvular Aortic Stenosis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; VONWILLEBRAND-FACTOR; THROMBIN GENERATION; PRACTICE GUIDELINES; AMERICAN-COLLEGE; TASK-FORCE; MECHANISMS; AGGREGATION; ACTIVATION; BIOMARKERS	Background and Purpose: Platelet surface expression of stromal-cell-derived factor-1 (SDF-1) is increased during platelet activation and constitutes an important factor in hematopoetic progenitor cell trafficking at sites of vascular injury and ischemia. Enhanced platelet SDF-1 expression has been reported previously in patients suffering from acute coronary syndrome (ACS). We hypothesized that expression of platelet associated SDF-1 may also be influenced by calcified valvular aortic stenosis (AS). Methods: We consecutively evaluated 941 patients, who were admitted to the emergency department with dyspnea and chest pain. Platelet surface expression of SDF-1 was determined by flow cytometry, AS was assessed using echocardiography and hemodynamic assessment by heart catheterization. A 1:1 propensity score matching was implemented to match 218 cases with 109 pairs adjusting for age, sex, cardiovascular risk factors, and medication including ACE inhibitors, angiotensin receptor blockers, beta blockers, statins, aspirin, clopidogrel, GPIIb/IIIa antagonists, and vitamin K antagonists. Results: Patients with valvular AS showed enhanced platelet SDF-1 expression compared to patients without AS (non-valvular disease, NV) independent of ACS and stable coronary artery disease (SAP) [mean fluorescence intensity (MFI) for ACS (AS vs. NV): 75 +/- 40.4 vs. 39.5 +/- 23.3; P = 0.002; for SAP (AS vs. NV): 54.9 +/- 44.6 vs. 24.3 +/- 11.2; P = 0.008]. Moreover, the degree of AS significantly correlated with SDF-1 platelet surface expression (r = 0.462; P = 0.002). Conclusions: Valvular AS is associated with enhanced platelet-SDF-1 expression; moreover the degree of valvular AS correlates with SDF-1 platelet surface expression. These findings may have clinical implications in the future.	[Wurster, Thomas; Tegtmeyer, Roland; Borst, Oliver; Rath, Dominik; Geisler, Tobias; Gawaz, Meinrad; Bigalke, Boris] Eberhard Karls Univ Tubingen, Med Klin 3, Tubingen, Germany; [Bigalke, Boris] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England	Eberhard Karls University of Tubingen; University of London; King's College London	Wurster, T (corresponding author), Eberhard Karls Univ Tubingen, Med Klin 3, Tubingen, Germany.	thomas.wurster@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020	Borst, Oliver/0000-0003-4002-4085	Deutsche Forschungsgemeinschaft [Klinische Forschergruppe KFO274]; German Cardiac Society (DGK)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cardiac Society (DGK)	This study has been supported by the Deutsche Forschungsgemeinschaft -Klinische Forschergruppe KFO274 "Platelets - Molecular Mechanisms and Translational Implications" to M. G. and the German Cardiac Society (DGK) "molecular imaging of atherosclerotic plaques" to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Aronow WS, 1999, AM J CARDIOL, V83, P599, DOI 10.1016/S0002-9149(98)00922-9; Beckmann E, 2010, J HEART VALVE DIS, V19, P441; Biberthaler P, 1998, EUR J CARDIO-THORAC, V14, P503, DOI 10.1016/S1010-7940(98)00223-1; Blackshear JL, 2013, AM J CARDIOL, V111, P374, DOI 10.1016/j.amjcard.2012.10.015; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chirkov YY, 2006, J HEART VALVE DIS, V15, P28; Chirkov YY, 2002, AM J CARDIOL, V90, P551, DOI 10.1016/S0002-9149(02)02536-5; DEMEYER E, 1995, EUR J PHARM-MOLEC PH, V291, P67; Dimitrow PP, 2008, HEART, V94, DOI 10.1136/hrt.2007.126896; Dimitrow Pawel Petkow, 2009, Atherosclerosis, V204, pe103, DOI 10.1016/j.atherosclerosis.2008.12.029; Gawaz M, 1996, THROMB RES, V83, P341, DOI 10.1016/0049-3848(96)00144-2; Gawaz M, 1999, CIRCULATION, V99, P2; Geisler T, 2012, EUR J RADIOL, V81, pE486, DOI 10.1016/j.ejrad.2011.06.019; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Luszczak J, 2011, BLOOD COAGUL FIBRIN, V22, P473, DOI 10.1097/MBC.0b013e328346c2bb; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Natorska J, 2011, HEART, V97, P2023, DOI 10.1136/hrt.2010.217273; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OBRIEN JR, 1995, BRIT HEART J, V74, P641; PETERSON DM, 1987, BLOOD, V69, P625; Stellos K, 2012, J THROMB HAEMOST, V10, P49, DOI 10.1111/j.1538-7836.2011.04547.x; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Theroux P, 1998, CIRCULATION, V97, P1195, DOI 10.1161/01.CIR.97.12.1195; Waxman DA, 2006, J AM COLL CARDIOL, V48, P1755, DOI 10.1016/j.jacc.2006.05.075; Wurster T, 2013, INT J CARDIOL, V164, P111, DOI 10.1016/j.ijcard.2011.06.082; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97405	10.1371/journal.pone.0097405	http://dx.doi.org/10.1371/journal.pone.0097405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834915	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800043
J	Gomaraschi, M; Ossoli, A; Pozzi, S; Nilsson, P; Cefalu, AB; Averna, M; Kuivenhoven, JA; Hovingh, GK; Veglia, F; Franceschini, G; Calabresi, L				Gomaraschi, Monica; Ossoli, Alice; Pozzi, Silvia; Nilsson, Peter; Cefalu, Angelo B.; Averna, Maurizio; Kuivenhoven, Jan Albert; Hovingh, G. Kees; Veglia, Fabrizio; Franceschini, Guido; Calabresi, Laura			eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CELL-ADHESION MOLECULE-1; SCAVENGER RECEPTOR BI; NITRIC-OXIDE SYNTHASE; CHOLESTEROL EFFLUX; ENDOTHELIAL FUNCTION; ANTIINFLAMMATORY PROPERTIES; INHIBITION; TORCETRAPIB	Mutations in the CETP gene resulting in defective CETP activity have been shown to cause remarkable elevations of plasma HDL-C levels, with the accumulation in plasma of large, buoyant HDL particles enriched in apolipoprotein E. Genetic CETP deficiency thus represents a unique tool to evaluate how structural alterations of HDL impact on HDL atheroprotective functions. Aim of the present study was to assess the ability of HDL obtained from CETP-deficient subjects to protect endothelial cells from the development of endothelial dysfunction. HDL isolated from one homozygous and seven heterozygous carriers of CETP null mutations were evaluated for their ability to down-regulate cytokine-induced cell adhesion molecule expression and to promote NO production in cultured endothelial cells. When compared at the same protein concentration, HDL and HDL3 from carriers proved to be as effective as control HDL and HDL3 in down-regulating cytokine-induced VCAM-1, while carrier HDL2 were more effective than control HDL2 in inhibiting VCAM-1 expression. On the other hand, HDL and HDL fractions from carriers of CETP deficiency were significantly less effective than control HDL and HDL fractions in stimulating NO production, due to a reduced eNOS activating capacity, likely because of a reduced S1P content. In conclusion, the present findings support the notion that genetic CETP deficiency, by affecting HDL particle structure, impacts on HDL vasculoprotective functions. Understanding of these effects might be important for predicting the outcomes of pharmacological CETP inhibition.	[Gomaraschi, Monica; Ossoli, Alice; Pozzi, Silvia; Franceschini, Guido; Calabresi, Laura] Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Nilsson, Peter] Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Cefalu, Angelo B.; Averna, Maurizio] Univ Palermo, Dept Internal Med & Med Specialties, Policlin Paolo Giaccone, Palermo, Italy; [Kuivenhoven, Jan Albert] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Veglia, Fabrizio] Ist Cardiol Monzino, Milan, Italy	University of Milan; Lund University; Skane University Hospital; University of Palermo; Policlinico Paolo Giaccone; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; IRCCS Centro Cardiologico Monzino	Calabresi, L (corresponding author), Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	laura.calabresi@unimi.it	Cefalu', Angelo B/K-9491-2016; Ossoli, Alice/K-5917-2016; Veglia, Fabrizio/K-1958-2016; Gomaraschi, Monica/A-3601-2014; Averna, Maurizio/U-9527-2017	Cefalu', Angelo B/0000-0003-1259-8284; Ossoli, Alice/0000-0002-9902-252X; Veglia, Fabrizio/0000-0002-9378-8874; Gomaraschi, Monica/0000-0003-3082-2120; Averna, Maurizio/0000-0003-3558-9209; Calabresi, Laura/0000-0001-5042-9532; FRANCESCHINI, GUIDO/0000-0003-2687-1771; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Telethon-Italy [GGP08052]; Fondazione Cariplo [2009-2576]; European Community [BM0904]; Netherlands Organisation for Scientific Research [91612122]	Telethon-Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); European Community(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from Telethon-Italy [GGP08052 to M. G.], Fondazione Cariplo [2009-2576 to M. G.], and the European Community [COST Action BM0904]. G. K. H. is a recipient of a Veni grant (91612122) from the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DT, 1998, ARTERIOSCL THROM VAS, V18, P1450, DOI 10.1161/01.ATV.18.9.1450; Baker PW, 1999, J LIPID RES, V40, P345; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bellanger N, 2012, ATHEROSCLEROSIS, V221, P160, DOI 10.1016/j.atherosclerosis.2011.12.027; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Bloomfield D, 2009, AM HEART J, V157, P352, DOI 10.1016/j.ahj.2008.09.022; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; Calabresi L, 2009, ATHEROSCLEROSIS, V205, P506, DOI 10.1016/j.atherosclerosis.2009.01.006; Cefalu AB, 2009, ATHEROSCLEROSIS, V204, P202, DOI 10.1016/j.atherosclerosis.2008.08.031; Chantepie S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049336; Connelly MA, 2010, J CARDIOVASC PHARM, V55, P459, DOI 10.1097/FJC.0b013e3181cf03cb; de Beer MC, 2001, J BIOL CHEM, V276, P15832, DOI 10.1074/jbc.M100228200; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Gomaraschi M, 2007, CIRCULATION, V116, P2165, DOI 10.1161/CIRCULATIONAHA.107.705657; Han S, 2013, BBA-MOL CELL BIOL L, V1831, P825, DOI 10.1016/j.bbalip.2012.12.008; Hermann F, 2009, THROMB RES, V123, P460, DOI 10.1016/j.thromres.2008.06.022; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Luscher TF, 2012, EUR HEART J, V33, P857, DOI 10.1093/eurheartj/ehs019; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Nagano Makoto, 2004, J Atheroscler Thromb, V11, P110; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Noto H, 2003, ATHEROSCLEROSIS, V171, P131, DOI 10.1016/j.atherosclerosis.2003.08.005; Patel S, 2009, ATHEROSCLEROSIS, V204, P424, DOI 10.1016/j.atherosclerosis.2008.07.047; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Rinninger F, 2003, ATHEROSCLEROSIS, V166, P31, DOI 10.1016/S0021-9150(02)00311-8; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Simic B, 2012, EUR HEART J, V33, P1615, DOI 10.1093/eurheartj/ehr348; Stein EA, 2009, AM J CARDIOL, V104, P82, DOI 10.1016/j.amjcard.2009.02.061; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; WARNICK GR, 1978, J LIPID RES, V19, P65; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142	40	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95925	10.1371/journal.pone.0095925	http://dx.doi.org/10.1371/journal.pone.0095925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830642	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500010
J	Heesch, K; Raczkowski, F; Schumacher, V; Hunemoerder, S; Panzer, U; Mittrucker, HW				Heesch, Kira; Raczkowski, Friederike; Schumacher, Valea; Huenemoerder, Stefanie; Panzer, Ulf; Mittruecker, Hans-Willi			The Function of the Chemokine Receptor CXCR6 in the T Cell Response of Mice against Listeria monocytogenes	PLOS ONE			English	Article							EXPRESSION CLONING; IMMUNE-RESPONSES; DENDRITIC CELLS; CUTTING EDGE; LYMPHOCYTES; RECRUITMENT; INDUCTION; SUBSETS; MEMORY; LIGAND	The chemokine receptor CXCR6 is expressed on different T cell subsets and up-regulated following T cell activation. CXCR6 has been implicated in the localization of cells to the liver due to the constitutive expression of its ligand CXCL16 on liver sinusoidal endothelial cells. Here, we analyzed the role of CXCR6 in CD8(+) T cell responses to infection of mice with Listeria monocytogenes. CD8(+) T cells responding to listerial antigens acquired high expression levels of CXCR6. However, deficiency of mice in CXCR6 did not impair control of the L. monocytogenes infection. CXCR6-deficient mice were able to generate listeria-specific CD4(+) and CD8(+) T cell responses and showed accumulation of T cells in the infected liver. In transfer assays, we detected reduced accumulation of listeria-specific CXCR6-deficient CD8(+) T cells in the liver at early time points post infection. Though, CXCR6 was dispensable at later time points of the CD8(+) T cell response. When transferred CD8(+) T cells were followed for extended time periods, we observed a decline in CXCR6-deficient CD8(+) T cells. The manifestation of this cell loss depended on the tissue analyzed. In conclusion, our results demonstrate that CXCR6 is not required for the formation of a T cell response to L. monocytogenes and for the accumulation of T cells in the infected liver but CXCR6 appears to influence long-term survival and tissue distribution of activated cells.	[Heesch, Kira; Raczkowski, Friederike; Schumacher, Valea; Huenemoerder, Stefanie; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Panzer, Ulf] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heesch, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	k.heesch@uke.de; h.mittruecker@uke.de			Deutsche Forschungsgemeinschaft [Klinische Forschergruppe 228, Sonderforschungsbereich 841]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Ulf Panzer: Klinische Forschergruppe 228 (Deutsche Forschungsgemeinschaft) http://kfo228.de/, http://www.dfg.de/. Hans-Willi Mittrucker: Sonderforschungsbereich 841 (Deutsche Forschungsgemeinschaft) http://www.sfb841.de/, http://www.dfg.de/, Klinische Forschergruppe 228 (Deutsche Forschungsgemeinschaft) http://kfo228.de/, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrunategui-Correa V, 2004, CELL IMMUNOL, V227, P109, DOI 10.1016/j.cellimm.2004.02.003; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bjordahl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042635; Boisvert J, 2003, J HEPATOL, V38, P67, DOI 10.1016/S0168-8278(02)00328-8; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Emoto M, 2006, INFECT IMMUN, V74, P5903, DOI 10.1128/IAI.00311-06; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; Goubier A, 2013, J INVEST DERMATOL, V133, P980, DOI 10.1038/jid.2012.404; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Kursar M, 2008, EUR J IMMUNOL, V38, P127, DOI 10.1002/eji.200737142; La Porta CAM, 2012, STEM CELL REV REP, V8, P1282, DOI 10.1007/s12015-012-9383-6; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Loetscher M, 1997, CURR BIOL, V7, P652, DOI 10.1016/S0960-9822(06)00292-2; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Mattarollo SR, 2011, J IMMUNOL, V187, P1601, DOI 10.4049/jimmunol.1100756; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Riedel JH, 2012, J AM SOC NEPHROL, V23, P1987, DOI 10.1681/ASN.2012040394; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Sheikine Y, 2008, ATHEROSCLEROSIS, V197, P487, DOI 10.1016/j.atherosclerosis.2007.11.034; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shields PL, 1999, J IMMUNOL, V163, P6236; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Szalay G, 1999, J IMMUNOL, V162, P6955; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; van der Voort R, 2010, J LEUKOCYTE BIOL, V87, P1029, DOI 10.1189/jlb.0709482; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004; Zhou YH, 1998, J IMMUNOL, V160, P4018	39	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97701	10.1371/journal.pone.0097701	http://dx.doi.org/10.1371/journal.pone.0097701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832098	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500104
J	Higaki, T; Higaki, S; Hirota, M; Hasezawa, S				Higaki, Takumi; Higaki, Shogo; Hirota, Masahiro; Hasezawa, Seiichiro			Radiocesium Distribution in Bamboo Shoots after the Fukushima Nuclear Accident	PLOS ONE			English	Article							RADIONUCLIDES; CHERNOBYL; PLANT; SOIL	The distribution of radiocesium was examined in bamboo shoots, Phyllostachys pubescens, collected from 10 sites located some 41 to 1140 km from the Fukushima Daiichi nuclear power plant, Japan, in the Spring of 2012, 1 year after the Fukushima nuclear accident. Maximum activity concentrations for radiocesium Cs-134 and Cs-137 in the edible bamboo shoot parts, 41 km away from the Fukushima Daiichi plant, were in excess of 15.3 and 21.8 kBq/kg (dry weight basis; 1.34 and 1.92 kBq/kg, fresh weight), respectively. In the radiocesium-contaminated samples, the radiocesium activities were higher in the inner tip parts, including the upper edible parts and the apical culm sheath, than in the hardened culm sheath and underground basal parts. The radiocesium/potassium ratios also tended to be higher in the inner tip parts. The radiocesium activities increased with bamboo shoot length in another bamboo species, Phyllostachys bambusoides, suggesting that radiocesium accumulated in the inner tip parts during growth of the shoots.	[Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan; [Hirota, Masahiro] Shinshu Univ, Res Ctr Human & Environm Sci, Matsumoto, Nagano 390, Japan; [Hasezawa, Seiichiro] Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Shinshu University; Japan Science & Technology Agency (JST)	Higaki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	takumi.higaki@gmail.com	Higaki, Shogo/G-5100-2013; Higaki, Shogo/N-8792-2019; Higaki, Takumi/N-1216-2015	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475; 				Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Higaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034766; Japanese Ministry of Health Labour and Welfare (MHLW), 2012, SUM RAD TEST RES CAR; Japanese Ministry of Health Labour and Welfare (MHLW), 2013, SUM RAD TEST RES CAR; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Kleinhenz V, 2001, ADV AGRON, V74, P99, DOI 10.1016/S0065-2113(01)74032-1; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Merz S, 2013, ENVIRON SCI TECHNOL, V47, P1248, DOI 10.1021/es3037498; MHLW, 2011, DAM SIT MEAS TAK GRE; Niimura N, 2015, J ENVIRON RADIOACTIV, V139, P234, DOI 10.1016/j.jenvrad.2013.12.020; Smolders Erik, 2011, Integrated Environmental Assessment and Management, V7, P379, DOI 10.1002/ieam.236; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Tagami K, 2012, J ENVIRON RADIOACTIV, V111, P65, DOI 10.1016/j.jenvrad.2011.09.017; TOPCUOGLU S, 1992, TOXICOL ENVIRON CHEM, V37, P95, DOI 10.1080/02772249209357858; Wu JS, 2009, J PLANT NUTR, V32, P489, DOI 10.1080/01904160802679958; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yoshihara T, 2013, J ENVIRON RADIOACTIV, V115, P60, DOI 10.1016/j.jenvrad.2012.07.002	19	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97659	10.1371/journal.pone.0097659	http://dx.doi.org/10.1371/journal.pone.0097659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831096	Green Published, gold, Green Submitted			2022-12-25	WOS:000336789500097
J	Khailova, L; Petrie, B; Baird, CH; Rieg, JAD; Wischmeyer, PE				Khailova, Ludmila; Petrie, Benjamin; Baird, Christine H.; Rieg, Jessica A. Dominguez; Wischmeyer, Paul E.			Lactobacillus rhamnosus GG and Bifidobacterium longum Attenuate Lung Injury and Inflammatory Response in Experimental Sepsis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTOR-2; FACTOR-KAPPA-B; DOUBLE-BLIND; NECROTIZING ENTEROCOLITIS; BACTERIAL TRANSLOCATION; ACUTE-PANCREATITIS; GUT ORIGIN; PROBIOTICS	Introduction: Probiotic use to prevent nosocomial gastrointestinal and potentially respiratory tract infections in critical care has shown great promise in recent clinical trials of adult and pediatric patients. Despite well-documented benefits of probiotic use in intestinal disorders, the potential for probiotic treatment to reduce lung injury following infection and shock has not been well explored. Objective: Evaluate if Lactobacillus rhamnosus GG (LGG) or Bifidobacterium longum (BL) treatment in a weanling mouse model of cecal ligation and puncture (CLP) peritonitis will protect against lung injury. Methods: 3 week-old FVB/N mice were orally gavaged with 200 mu l of either LGG, BL or sterile water (vehicle) immediately prior to CLP. Mice were euthanized at 24 h. Lung injury was evaluated via histology and lung neutrophil infiltration was evaluated by myeloperoxidase (MPO) staining. mRNA levels of IL-6, TNF-alpha, MyD88, TLR-4, TLR-2, NFKB (p50/p105) and Cox-2 in the lung analyzed via real-time PCR. TNF-alpha and IL-6 in lung was analyzed via ELISA. Results: LGG and BL treatment significantly improved lung injury following experimental infection and sepsis and lung neutrophil infiltration was significantly lower than in untreated septic mice. Lung mRNA and protein levels of IL-6 and TNF-alpha and gene expression of Cox-2 were also significantly reduced in mice receiving LGG or BL treatment. Gene expression of TLR-2, MyD88 and NFKB (p50/p105) was significantly increased in septic mice compared to shams and decreased in the lung of mice receiving LGG or BL while TLR-4 levels remained unchanged. Conclusions: Treatment with LGG and BL can reduce lung injury following experimental infection and sepsis and is associated with reduced lung inflammatory cell infiltrate and decreased markers of lung inflammatory response. Probiotic therapy may be a promising intervention to improve clinical lung injury following systemic infection and sepsis.	[Khailova, Ludmila; Petrie, Benjamin; Baird, Christine H.; Rieg, Jessica A. Dominguez; Wischmeyer, Paul E.] Univ Colorado, Dept Anesthesiol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Wischmeyer, PE (corresponding author), Univ Colorado, Dept Anesthesiol, Sch Med, Aurora, CO USA.	Paul.Wischmeyer@ucdenver.edu		Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health (NIH) [R01 GM078312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health (NIH) R01 GM078312 to P. Wischmeyer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Aguero G, 2006, NUTRITION, V22, P810, DOI 10.1016/j.nut.2006.03.013; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Anderson RC, 2010, FEMS MICROBIOL LETT, V309, P184, DOI 10.1111/j.1574-6968.2010.02038.x; Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559; Annane D, 2005, CELL, V124, P783; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Arribas B, 2009, BRIT J NUTR, V101, P51, DOI 10.1017/S0007114508986876; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671; BAKER CC, 1983, SURGERY, V94, P331; Bausserman M, 2005, J PEDIAT, V147, P197; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Bitto A, 2012, CRIT CARE, V16, DOI 10.1186/1364-8535-16-R32; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Dahlem P, 2007, PAEDIATR RESPIR REV, V8, P348, DOI 10.1016/j.prrv.2007.03.001; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Drouault-Holowacz S, 2008, GASTROEN CLIN BIOL, V32, P147, DOI 10.1016/j.gcb.2007.06.001; Edelman DA, 2006, J SURG RES, V134, P22, DOI 10.1016/j.jss.2006.03.007; Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Giamarellos-Bourboulis EJ, 2009, J TRAUMA, V67, P815, DOI 10.1097/TA.0b013e31819d979e; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hammerman C, 2004, CLIN PERINATOL, V31, P489, DOI 10.1016/j.clp.2004.04.015; Harb H, 2013, CLIN EXP ALLERGY, V43, P353, DOI 10.1111/cea.12047; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Khailova L, 2013, ANESTHESIOLOGY; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kirkby NS, 2013, BIOCHEM BIOPH RES CO, V438, P249, DOI 10.1016/j.bbrc.2013.07.006; Kono Y, 2011, SURGERY; Kotzampassi K, 2006, WORLD J SURG, V30, P1848, DOI 10.1007/s00268-005-0653-1; Lee YK, 2000, APPL ENVIRON MICROB, V66, P3692, DOI 10.1128/AEM.66.9.3692-3697.2000; Li XH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/354087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukacs SL, 2004, PEDIATR INFECT DIS J, V23, P599, DOI 10.1097/01.inf.0000131633.74921.90; Luyer MD, 2005, INFECT IMMUN, V73, P3686, DOI 10.1128/IAI.73.6.3686-3692.2005; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Matsumoto T, 2008, J APPL MICROBIOL, V104, P672, DOI 10.1111/j.1365-2672.2007.03593.x; McNaught CE, 2005, CLIN NUTR, V24, P211, DOI 10.1016/j.clnu.2004.08.008; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Olah A, 2007, HEPATO-GASTROENTEROL, V54, P590; Pitsouni E, 2009, EUR J CLIN PHARMACOL, V65, P561, DOI 10.1007/s00228-009-0642-7; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Schultz MJ, 2010, CRIT CARE MED, V38, P1506, DOI 10.1097/CCM.0b013e3181d8c473; Shanahan F, 2002, BRIT J NUTR, V88, pS5, DOI 10.1079/BJN2002624; Siempos II, 2010, CRIT CARE MED, V38, P954, DOI 10.1097/CCM.0b013e3181c8fe4b; Singhi SC, 2008, INDIAN J PEDIATR, V75, P621, DOI 10.1007/s12098-008-0119-1; Singleton KD, 2007, AM J PHYSIOL-REG I, V292, pR1839, DOI 10.1152/ajpregu.00755.2006; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tok D, 2007, J TRAUMA, V62, P880, DOI 10.1097/01.ta.0000236019.00650.00; Tsujimoto H, 2005, SHOCK, V23, P39, DOI 10.1097/01.shk.0000145936.31967.d7; Tsujimoto H, 2004, J ENDOTOXIN RES, V10, P229, DOI 10.1179/096805104225005814; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Wang X, 1996, WORLD J SURG, V20, P307; Wang XD, 1996, WORLD J SURG, V20, P299, DOI 10.1007/s002689900048; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Williams DL, 1999, SURGERY, V126, P54, DOI 10.1067/msy.1999.99058; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yu M, 2007, INT IMMUNOPHARMACOL, V7, P1076, DOI 10.1016/j.intimp.2007.04.003; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739; Zhang LN, 2011, EXP TOXICOL PATHOL, V63, P519, DOI 10.1016/j.etp.2010.04.002	77	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97861	10.1371/journal.pone.0097861	http://dx.doi.org/10.1371/journal.pone.0097861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830455	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500129
J	Fujii, J; Kodama, M; Oike, A; Matsuo, Y; Min, MS; Hasebe, T; Ishizuya-Oka, A; Kawakami, K; Nakamura, M				Fujii, Jun; Kodama, Maho; Oike, Akira; Matsuo, Yasuki; Min, Mi-Sook; Hasebe, Takashi; Ishizuya-Oka, Atsuko; Kawakami, Koichi; Nakamura, Masahisa			Involvement of Androgen Receptor in Sex Determination in an Amphibian Species	PLOS ONE			English	Article							FROG RANA-RUGOSA; REVERSED GONADS; LINKED GENE; KEY-FACTOR; CHROMOSOMES; EXPRESSION; MICE; DIFFERENTIATION; DMRT1; MECHANISM	In mice and humans, the androgen receptor (AR) gene, located on the X chromosome, is not known to be involved in sex determination. In the Japanese frog Rana rugosa the AR is located on the sex chromosomes (X, Y, Z and W). Phylogenetic analysis shows that the AR on the X chromosome (X-AR) of the Korean R. rugosa is basal and segregates into two clusters: one containing W-AR of Japanese R. rugosa, the other containing Y-AR. AR expression is twice as high in ZZ (male) compared to ZW (female) embryos in which the W-AR is barely expressed. Higher AR-expression may be associated with male sex determination in this species. To examine whether the Z-AR is involved in sex determination in R. rugosa, we produced transgenic (Tg) frogs carrying an exogenous Z-AR. Analysis of ZW Tg frogs revealed development of masculinized gonads or 'ovotestes'. Expression of CYP17 and Dmrt1, genes known to be activated during normal male gonadal development, were up-regulated in the ZW ovotestis. Testosterone, supplied to the rearing water, completed the female-to-male sex-reversal in the AR-Tg ZW frogs. Here we report that Z-AR is involved in male sex-determination in an amphibian species.	[Fujii, Jun; Kodama, Maho; Oike, Akira; Matsuo, Yasuki; Nakamura, Masahisa] Waseda Univ, Dept Biol, Tokyo, Japan; [Min, Mi-Sook] Seoul Natl Univ, Lab Wildlife Conservat Genet, Seoul, South Korea; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki, Kanagawa, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan	Waseda University; Seoul National University (SNU); Nippon Medical School; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nakamura, M (corresponding author), Waseda Univ, Dept Biol, Tokyo, Japan.	nakamra@waseda.jp	Kawakami, Koichi/AAF-1380-2019	Hasebe, Takashi/0000-0001-7200-8173	Ministry of Education, Science, and Culture of Japan [22370027]; Korean government from the National Research Foundation [NRF-2012R1A1A2040065]; Grants-in-Aid for Scientific Research [25440160] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korean government from the National Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid to MN from the Ministry of Education, Science, and Culture of Japan to MN (No. 22370027) and by the Korean government to M-SM from the National Research Foundation (NRF-2012R1A1A2040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama S, 2003, CYTOGENET GENOME RES, V101, P295, DOI 10.1159/000074352; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; Iwade R, 2008, GEN COMP ENDOCR, V155, P79, DOI 10.1016/j.ygcen.2007.02.032; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; Miura I, 2012, CHROMOSOME RES, V20, P47, DOI 10.1007/s10577-011-9258-8; Nakamura M, 2013, SEX DEV, V7, P104, DOI 10.1159/000339661; Nakamura M, 2010, J EXP ZOOL PART A, V313A, P381, DOI 10.1002/jez.616; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P1; Ogata M, 2002, CYTOGENET GENOME RES, V99, P185, DOI 10.1159/000071592; Sakurai N, 2008, J STEROID BIOCHEM, V112, P5, DOI 10.1016/j.jsbmb.2008.07.002; Saotome K, 2010, J EXP ZOOL PART A, V313A, P452, DOI 10.1002/jez.617; Saotome K, 2010, J EXP ZOOL PART A, V313A, P369, DOI 10.1002/jez.607; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Schmid M., 1991, P393; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Uno Y, 2008, CHROMOSOME RES, V16, P637, DOI 10.1007/s10577-008-1217-7; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yokoyama S, 2009, J EXP ZOOL PART A, V311A, P1	27	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e93655	10.1371/journal.pone.0093655	http://dx.doi.org/10.1371/journal.pone.0093655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826887	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400006
J	Hohwu, L; Li, J; Olsen, J; Sorensen, TIA; Obel, C				Hohwu, Lena; Li, Jiong; Olsen, Jorn; Sorensen, Thorkild I. A.; Obel, Carsten			Severe Maternal Stress Exposure Due to Bereavement before, during and after Pregnancy and Risk of Overweight and Obesity in Young Adult Men: A Danish National Cohort Study	PLOS ONE			English	Article							PRENATAL STRESS; EARLY-LIFE; PERSPECTIVE; REGISTRY; DISEASE; PUBERTY; HEALTH; RATS; BMI	Background: Perinatal stress may programme overweight and obesity. We examined whether maternal pre- and post-natal bereavement was associated with overweight and obesity in young men. Methods: A cohort study was conducted including 119,908 men born from 1976 to 1993 and examined for military service between 2006 and 2011. Among them, 4,813 conscripts were born to mothers bereaved by death of a close relative from 12 months preconception to birth of the child (exposed group). Median body mass index (BMI) and prevalence of overweight and obesity were estimated. Odds ratio of overweight (BMI >= 25 kg/m(2)) and obesity (BMI >= 30 kg/m(2)) were estimated by logistic regression analysis adjusted for maternal educational level. Results: Median BMI was similar in the exposed and the unexposed group but the prevalence of overweight (33.3% versus 30.4%, p = 0.02) and obesity (9.8% versus 8.5%, p = 0.06) was higher in the exposed group. Conscripts exposed 6 to 0 months before conception and during pregnancy had a higher risk of overweight (odds ratio 1.15, 95% confidence interval (CI): 1.03; 1.27 and odds ratio 1.13, 95% CI: 1.03; 1.25, respectively). Conscripts born to mothers who experienced death of the child's biological father before child birth had a two-fold risk of obesity (odds ratio 2.00, 95% CI: 0.93; 4.31). There was no elevated risk in those who experienced maternal bereavement postnatally. Conclusion: Maternal bereavement during the prenatal period was associated with increased risk of overweight or obesity in a group of young male conscripts, and this may possibly be reflected to severe stress exposure early in life. However, not all associations were clear, and further studies are warranted.	[Hohwu, Lena; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Frederiksbjerg Hosp, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen	Hohwu, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark.	lena.hohwu@alm.au.dk	Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; Hohwu, Lena/0000-0002-9887-7745; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	European Research Council [ERC-StG-2010-260242-PROGEURO]; Danish Medical Research Council [09-072986]; Aarhus University, Denmark	European Research Council(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University, Denmark	This work was supported by European Research Council (ERC-StG-2010-260242-PROGEURO to JL; the Danish Medical Research Council (project no. 09-072986)). Lena Hohwu is supported by a full PhD fellowship at Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; Choi JH, 2013, CURR OPIN ENDOCRINOL, V20, P62, DOI 10.1097/MED.0b013e32835b7ec7; Forsvaret, 2013, MEN WOM QUAL UNF ARM; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Ghoorah K, 2014, J STEROID BIOCH MOL; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Goodkin K, 2001, ANONYMOUS HDB BEREAV, P671; Green A, 1996, DAN MED BULL, V43, P464; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Ingstrup KG, 2012, J OBES, V2012, DOI 10.1155/2012/462845; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Li J, 2012, OBESITY FACTS, V5, P881, DOI 10.1159/000345933; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ramasubramanian L, 2013, CHILD CARE HLTH DEV, V39, P134, DOI 10.1111/j.1365-2214.2011.01325.x; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Roy JR, 2009, MED SCI MONITOR, V15, pRA137; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Stenhammar C, 2010, ACTA PAEDIATR, V99, P1205, DOI 10.1111/j.1651-2227.2010.01776.x; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x	37	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97490	10.1371/journal.pone.0097490	http://dx.doi.org/10.1371/journal.pone.0097490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828434	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400101
J	Li, YH; Xu, JT; Gao, KS				Li, Yahe; Xu, Juntian; Gao, Kunshan			Light-Modulated Responses of Growth and Photosynthetic Performance to Ocean Acidification in the Model Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; PHOTOSYSTEM-II; SEAWATER ACIDIFICATION; INORGANIC CARBON; UV-RADIATION; MARINE; PHYTOPLANKTON; PHOTOINHIBITION; CALCIFICATION; EFFICIENCY	Ocean acidification (OA) due to atmospheric CO2 rise is expected to influence marine primary productivity. In order to investigate the interactive effects of OA and light changes on diatoms, we grew Phaeodactylum tricornutum, under ambient (390 ppmv; LC) and elevated CO2 (1000 ppmv; HC) conditions for 80 generations, and measured its physiological performance under different light levels (60 mu mol m(-2) s(-1), LL; 200 mu mol m(-2) s(-1), ML; 460 mu mol m(-2) s(-1), HL) for another 25 generations. The specific growth rate of the HC-grown cells was higher (about 12-18%) than that of the LC-grown ones, with the highest under the ML level. With increasing light levels, the effective photochemical yield of PSII (F-v'/F-m') decreased, but was enhanced by the elevated CO2, especially under the HL level. The cells acclimated to the HC condition showed a higher recovery rate of their photochemical yield of PSII compared to the LC-grown cells. For the HC-grown cells, dissolved inorganic carbon or CO2 levels for half saturation of photosynthesis (K-1/2 DIC or K-1/2 CO2) increased by 11, 55 and 32%, under the LL, ML and HL levels, reflecting a light dependent down-regulation of carbon concentrating mechanisms (CCMs). The linkage between higher level of the CCMs down-regulation and higher growth rate at ML under OA supports the theory that the saved energy from CCMs down-regulation adds on to enhance the growth of the diatom.	[Li, Yahe; Gao, Kunshan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Xu, Juntian] Huaihai Inst Technol, Sch Marine Sci & Technol, Lianyungang, Jiangsu, Peoples R China	Xiamen University; Jiangsu Ocean University	Gao, KS (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	ksgao@xmu.edu.cn	gao, kunshan/G-3374-2010; Xu, Juntian/AAW-4084-2021; Xu, juntian/ABB-8233-2021	Gao, Kunshan/0000-0001-7365-6332	National Basic Research Program of China [2011CB200902]; National Natural Science Foundation [41120164007]; Program for Changjiang Scholars and Innovative Research Team [IRT0941]; SOA [GASI-03-01-02-04]; China-Japan collaboration project from MOST [S2012GR0290]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); SOA; China-Japan collaboration project from MOST	This study was supported by National Basic Research Program of China (2011CB200902), National Natural Science Foundation (41120164007), Program for Changjiang Scholars and Innovative Research Team (IRT0941), SOA (GASI-03-01-02-04), and China-Japan collaboration project from MOST (S2012GR0290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bartual A, 2003, CAN J BOT, V81, P191, DOI [10.1139/B03-013, 10.1139/b03-013]; BEARDALL J, 1991, CAN J BOT, V69, P1146, DOI 10.1139/b91-147; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J., 2013, ALGAE BIOFUELS ENERG, P153; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gao KS, 2009, LIMNOL OCEANOGR, V54, P1855, DOI 10.4319/lo.2009.54.6.1855; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Hoppe CJM, 2014, NEW PHYTOL; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Ihnken S, 2011, PHYCOLOGIA, V50, P182, DOI 10.2216/10-11.1; Janssen Meike, 2001, International Microbiology, V4, P27; Jin P, 2013, PLANT PHYSIOL, V162, P2084, DOI 10.1104/pp.113.219543; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; King AL, 2011, ISME J, V5, P1388, DOI 10.1038/ismej.2010.211; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Li Y, 2012, BIOGEOSCIENCES, V9, P3931, DOI 10.5194/bg-9-3931-2012; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; PERRY MJ, 1981, MAR BIOL, V62, P91, DOI 10.1007/BF00388170; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; SHIRAIWA Y, 1983, PLANT CELL PHYSIOL, V24, P919, DOI 10.1093/oxfordjournals.pcp.a076596; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Strickland J.D.H., 1972, B FISH RES BOARD CAN, V157, P49, DOI DOI 10.1002/IROH.19700550118; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Torstensson A, 2012, POLAR BIOL, V35, P205, DOI 10.1007/s00300-011-1056-4; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Watson RT, 2001, CLIMATE CHANGE 2001, P398, DOI DOI 10.1256/004316502320517344; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Young EB, 2005, CAN J BOT, V83, P917, DOI 10.1139/B05-081	58	18	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96173	10.1371/journal.pone.0096173	http://dx.doi.org/10.1371/journal.pone.0096173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828454	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400022
J	Mi, JX				Mi, Jian-Xun			A Novel Algorithm for Independent Component Analysis with Reference and Methods for Its Applications	PLOS ONE			English	Article							BLIND SEPARATION; CONSTRAINED ICA; UNKNOWN NUMBER; EXTRACTION; REJECTION	This paper presents a stable and fast algorithm for independent component analysis with reference (ICA-R). This is a technique for incorporating available reference signals into the ICA contrast function so as to form an augmented Lagrangian function under the framework of constrained ICA (cICA). The previous ICA-R algorithm was constructed by solving the optimization problem via a Newton-like learning style. Unfortunately, the slow convergence and potential misconvergence limit the capability of ICA-R. This paper first investigates and probes the flaws of the previous algorithm and then introduces a new stable algorithm with a faster convergence speed. There are two other highlights in this paper: first, new approaches, including the reference deflation technique and a direct way of obtaining references, are introduced to facilitate the application of ICA-R; second, a new method is proposed that the new ICA-R is used to recover the complete underlying sources with new advantages compared with other classical ICA methods. Finally, the experiments on both synthetic and real-world data verify the better performance of the new algorithm over both previous ICA-R and other well-known methods.	[Mi, Jian-Xun] Chongqing Univ Posts & Telecommun, Chongqing Key Lab Computat Intelligence, Chongqing, Peoples R China; [Mi, Jian-Xun] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; Chongqing University of Posts & Telecommunications	Mi, JX (corresponding author), Chongqing Univ Posts & Telecommun, Chongqing Key Lab Computat Intelligence, Chongqing, Peoples R China.	mijianxun@gmail.com	Mi, Jianxun/U-3642-2019; Mi, Jianxun/J-9670-2014	Mi, Jianxun/0000-0002-7531-4341	National Nature Science Committee of China [61202276, 61203376]	National Nature Science Committee of China	The funding that has supported the work is from the National Nature Science Committee of China under Grant Nos. 61202276, 61203376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boyd S., 2004, CONVEX OPTIMIZATION; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Cichocki A, 1999, NEUROCOMPUTING, V24, P55, DOI 10.1016/S0925-2312(98)00091-5; Cruces-Alvarez SA, 2004, IEEE T NEURAL NETWOR, V15, P859, DOI 10.1109/TNN.2004.828764; de Moor D., DAISY DATABASE IDENT; DELFOSSE N, 1994, INT CONF ACOUST SPEE, P41; Du K L, 2014, NEURAL NETWORKS STAT, P419; Gibson O, 2002, P 2 EUR MED BIOL ENG, P424; Goldstein JS, 1999, INT CONF ACOUST SPEE, P1357, DOI 10.1109/ICASSP.1999.756232; Golub G. H., 2012, MATRIX COMPUTATIONS; Huang DS, 2007, IEEE T NEURAL NETWOR, V18, P1532, DOI 10.1109/TNN.2007.895910; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A., 2004, INDEPENDENT COMPONEN; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; James CJ, 2003, IEEE T BIO-MED ENG, V50, P1108, DOI 10.1109/TBME.2003.816076; James CJ, 2002, IET C P, P4; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Koldovsky Z, 2006, IEEE T NEURAL NETWOR, V17, P1265, DOI 10.1109/TNN.2006.875991; Leclercq Y, 2009, NEUROIMAGE, V44, P679, DOI 10.1016/j.neuroimage.2008.10.017; Lee TW, 1997, INDEPENDENT COMPONER; Lee WL, 2013, IEEE ENG MED BIO, P7064, DOI 10.1109/EMBC.2013.6611185; Lin QH, 2004, LECT NOTES COMPUT SC, V3173, P755; Lin QH, 2007, INFORM SCIENCES, V177, P1265, DOI 10.1016/j.ins.2006.09.011; Lu W, 2005, IEEE T NEURAL NETWOR, V16, P203, DOI 10.1109/TNN.2004.836795; Milanesi M, 2008, MED BIOL ENG COMPUT, V46, P251, DOI 10.1007/s11517-007-0293-8; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Oja E, 1997, NEUROCOMPUTING, V17, P25, DOI 10.1016/S0925-2312(97)00045-3; Peng C, 2007, NEURAL COMPUT APPL, V16, P581, DOI 10.1007/s00521-007-0100-3; Pham DT, 1997, IEEE T SIGNAL PROCES, V45, P1712, DOI 10.1109/78.599941; Sun TY, 2008, NEUROCOMPUTING, V71, P2271, DOI 10.1016/j.neucom.2007.07.036; Sun ZL, 2011, IEEE T INF FOREN SEC, V6, P360, DOI 10.1109/TIFS.2011.2118207; Sun ZL, 2010, NEUROCOMPUTING, V73, P1013, DOI 10.1016/j.neucom.2009.12.016; Wei L, 2006, NEUROCOMPUTING, V69, P2244, DOI 10.1016/j.neucom.2005.06.021; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Yu X, 2014, NATURAL GRADIENT FLE, P153; Zarzoso V, 2000, COMPUT CARDIOL, V27, P431, DOI 10.1109/CIC.2000.898549; Zhang J, 2013, IEEE IMTC P, P1459; Zhang ZL, 2008, NEUROCOMPUTING, V71, P1669, DOI 10.1016/j.neucom.2007.04.004	42	21	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e93984	10.1371/journal.pone.0093984	http://dx.doi.org/10.1371/journal.pone.0093984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826986	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400007
J	Zhang, GX; Liu, YF; Ni, Y; Meng, ZJ; Lu, T; Li, TL				Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai			Exogenous Calcium Alleviates Low Night Temperature Stress on the Photosynthetic Apparatus of Tomato Leaves	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-I; QUANTUM YIELD; CALMODULIN-BINDING; HYDROGEN-PEROXIDE; D1 PROTEIN; HIGH LIGHT; PHOTOINHIBITION; FLUORESCENCE; ARABIDOPSIS	The effect of exogenous CaCl2 on photosystem I and II (PSI and PSII) activities, cyclic electron flow (CEF), and proton motive force of tomato leaves under low night temperature (LNT) was investigated. LNT stress decreased the net photosynthetic rate (Pn), effective quantum yield of PSII [Y(II)], and photochemical quenching (qP), whereas CaCl2 pretreatment improved Pn, Y(II), and qP under LNT stress. LNT stress significantly increased the non-regulatory quantum yield of energy dissipation [Y(NO)], whereas CaCl2 alleviated this increase. Exogenous Ca2+ enhanced stimulation of CEF by LNT stress. Inhibition of oxidized PQ pools caused by LNT stress was alleviated by CaCl2 pretreatment. LNT stress reduced zeaxanthin formation and ATPase activity, but CaCl2 pretreatment reversed both of these effects. LNT stress caused excess formation of a proton gradient across the thylakoid membrane, whereas CaCl2 pretreatment decreased the said factor under LNT. Thus, our results showed that photoinhibition of LNT-stressed plants could be alleviated by CaCl2 pretreatment. Our findings further revealed that this alleviation was mediated in part by improvements in carbon fixation capacity, PQ pools, linear and cyclic electron transports, xanthophyll cycles, and ATPase activity.	[Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Key Lab Protected Hort Liaoning Prov, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Li, TL (corresponding author), Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China.	tianlaili@126.com	Zhang, Guoxian/AAK-3875-2021		National Natural Science Foundation of China [31301813]; China Agriculture Research System [CARS-25]; 12th Five-Year Support Project of China [2011BAD12B03]; Major Scientific Research Projects of Liaoning Province [2011215003]; Agriculture Science and Technology Development Program of Shenyang [F11092300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; 12th Five-Year Support Project of China; Major Scientific Research Projects of Liaoning Province; Agriculture Science and Technology Development Program of Shenyang	This work was supported by the National Natural Science Foundation of China (Grant No. 31301813), the China Agriculture Research System (Grant No. CARS-25), the 12th Five-Year Support Project of China (Grant No. 2011BAD12B03), the Major Scientific Research Projects of Liaoning Province (Grant No. 2011215003), and the Agriculture Science and Technology Development Program of Shenyang (Grant No. F11092300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2005, PLANT SCI, V169, P559, DOI 10.1016/j.plantsci.2005.05.004; Ai XiZhen, 2006, Scientia Agricultura Sinica, V39, P2063; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Bayer RG, 2012, J EXP BOT, V63, P1713, DOI 10.1093/jxb/err377; Bellamine J, 1997, ACTA PHYSIOL PLANT, V19, P17, DOI 10.1007/s11738-997-0017-6; Busch F, 2009, FUNCT PLANT BIOL, V36, P1016, DOI 10.1071/FP08043; Chen HX, 2007, PHYSIOL PLANTARUM, V129, P386, DOI 10.1111/j.1399-3054.2006.00830.x; Chen LB, 2012, PHOTOSYNTH RES, V112, P141, DOI 10.1007/s11120-012-9750-9; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; DELASRIVAS J, 1992, FEBS LETT, V301, P246, DOI 10.1016/0014-5793(92)80250-K; Dongsansuk A, 2013, PHOTOSYNTHETICA, V51, P13, DOI 10.1007/s11099-012-0070-2; Feng Z, 2010, AGR SCI CHINA, V9, P1777, DOI 10.1016/S1671-2927(09)60276-5; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; Hideg E, 2001, PHYSIOL PLANTARUM, V112, P10, DOI 10.1034/j.1399-3054.2001.1120102.x; Huang Jun, 2012, Yingyong Shengtai Xuebao, V23, P2521; Huang W, 2011, PLANT CELL PHYSIOL, V52, P297, DOI 10.1093/pcp/pcq166; Huang W, 2010, PHOTOSYNTH RES, V103, P175, DOI 10.1007/s11120-010-9539-7; Ioannidis NE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00071; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1374, DOI 10.1016/j.bbabio.2012.03.010; Joliot P, 2013, PHOTOSYNTH RES, V115, P55, DOI 10.1007/s11120-013-9826-1; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Liu YF, 2012, PLANT SCI, V196, P8, DOI 10.1016/j.plantsci.2012.07.005; Liu YF, 2011, J HORTIC SCI BIOTECH, V86, P91, DOI 10.1080/14620316.2011.11512731; Liu YF, 2013, J INTEGR AGR, V12, P2172, DOI [10.1016/S2095-3119(13)60411-6, 10.1016/s2095-3119(13)60411-6]; Mi HL, 2000, PLANT CELL PHYSIOL, V41, P1129, DOI 10.1093/pcp/pcd038; Miyake C, 2004, PLANT CELL PHYSIOL, V45, P1426, DOI 10.1093/pcp/pch163; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Partelli FL, 2011, ENVIRON EXP BOT, V74, P194, DOI 10.1016/j.envexpbot.2011.06.001; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Qi MingFang, 2011, Scientia Agricultura Sinica, V44, P531; Rocha AG, 2012, PROTOPLASMA, V249, P957, DOI 10.1007/s00709-011-0373-3; Savitch LV, 2001, PLANTA, V214, P295, DOI 10.1007/s004250100622; Scheller HV, 2005, PLANTA, V221, P5, DOI 10.1007/s00425-005-1507-7; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209; SCHREIBER U, 1989, PHILOS T ROY SOC B, V323, P241, DOI 10.1098/rstb.1989.0007; Schreiber U., 2008, PAM APPL NOTES, V10, P1; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Shikanai T, 2014, CURR OPIN BIOTECH, V26, P25, DOI 10.1016/j.copbio.2013.08.012; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; Stael S, 2011, FEBS LETT, V585, P517, DOI 10.1016/j.febslet.2011.01.001; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Xu CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068214, 10.1371/journal.pone.0068837]; Yamori W, 2011, PLANT J, V68, P966, DOI 10.1111/j.1365-313X.2011.04747.x; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; [由继红 You Jihong], 2002, [作物学报, Acta Agronomica Sinica], V28, P693; Zhang SP, 2004, PLANT CELL PHYSIOL, V45, P1595, DOI 10.1093/pcp/pch180	61	64	71	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97322	10.1371/journal.pone.0097322	http://dx.doi.org/10.1371/journal.pone.0097322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828275	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400077
J	Sokunbi, MO; Gradin, VB; Waiter, GD; Cameron, GG; Ahearn, TS; Murray, AD; Steele, DJ; Staff, RT				Sokunbi, Moses O.; Gradin, Victoria B.; Waiter, Gordon D.; Cameron, George G.; Ahearn, Trevor S.; Murray, Alison D.; Steele, Douglas J.; Staff, Roger T.			Nonlinear Complexity Analysis of Brain fMRI Signals in Schizophrenia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FRACTAL ANALYSIS; EEG; CONNECTIVITY; PREDICTION; RESPONSES	We investigated the differences in brain fMRI signal complexity in patients with schizophrenia while performing the Cyberball social exclusion task, using measures of Sample entropy and Hurst exponent (H). 13 patients meeting diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) criteria for schizophrenia and 16 healthy controls underwent fMRI scanning at 1.5 T. The fMRI data of both groups of participants were pre-processed, the entropy characterized and the Hurst exponent extracted. Whole brain entropy and H maps of the groups were generated and analysed. The results after adjusting for age and sex differences together show that patients with schizophrenia exhibited higher complexity than healthy controls, at mean whole brain and regional levels. Also, both Sample entropy and Hurst exponent agree that patients with schizophrenia have more complex fMRI signals than healthy controls. These results suggest that schizophrenia is associated with more complex signal patterns when compared to healthy controls, supporting the increase in complexity hypothesis, where system complexity increases with age or disease, and also consistent with the notion that schizophrenia is characterised by a dysregulation of the nonlinear dynamics of underlying neuronal systems.	[Sokunbi, Moses O.; Waiter, Gordon D.; Cameron, George G.; Ahearn, Trevor S.; Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Staff, Roger T.] Aberdeen Royal Infirm, Dept Nucl Med, Aberdeen, Scotland; [Gradin, Victoria B.; Steele, Douglas J.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Gradin, Victoria B.] Univ Republica, Ctr Basic Res Psychol, Montevideo, Uruguay; [Sokunbi, Moses O.] Cardiff Univ, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales; [Sokunbi, Moses O.] Cardiff Univ, Cardiff Sch Med, Inst Psychol Med & Clin Neurosci, MRC,Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	University of Aberdeen; University of Aberdeen; University of Dundee; Universidad de la Republica, Uruguay; Cardiff University; Cardiff University	Sokunbi, MO (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland.	SokunbiMO@cardiff.ac.uk	Staff, Roger T/G-1826-2011; Waiter, Gordon/AAA-1141-2020; Murray, Alison/H-6250-2017; Steele, J Douglas/A-8972-2017; Sokunbi, Moses/AAY-6713-2020; Steele, Douglas/AAB-9889-2019	Staff, Roger T/0000-0003-0620-8673; Murray, Alison/0000-0003-4915-4847; Steele, J Douglas/0000-0002-9822-8753; Steele, Douglas/0000-0002-9822-8753; Sokunbi, Moses/0000-0002-8389-4577; Waiter, Gordon/0000-0002-5313-9845	Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE); ARUK, in Aberdeen, Scotland; SINAPSE; Miller Mckenzie Trust; Chief Scientist Office, Scotland	Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE); ARUK, in Aberdeen, Scotland; SINAPSE; Miller Mckenzie Trust; Chief Scientist Office, Scotland	MOS was supported by a studentship from Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE) and a small grant from the local ARUK, in Aberdeen, Scotland. VBG was supported by a studentship from SINAPSE. The Miller Mckenzie Trust and Chief Scientist Office, Scotland, funded the scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; BASSINGTHWAIGHTE JB, 1995, ANN BIOMED ENG, V23, P491, DOI 10.1007/BF02584449; BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P578, DOI 10.1161/01.RES.65.3.578; Beran J., 1994, STAT LONG MEMORY PRO; BERTOLACCINI M, 1978, IEEE T BIO-MED ENG, V25, P159, DOI 10.1109/TBME.1978.326242; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Eisenberger NI, 2007, EMOTION, V7, P745, DOI 10.1037/1528-3542.7.4.745; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fadili MJ, 2002, NEUROIMAGE, V15, P217, DOI 10.1006/nimg.2001.0955; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; GLENNY RW, 1991, J APPL PHYSIOL, V70, P2351, DOI 10.1152/jappl.1991.70.6.2351; Gomez C, 2011, IEEE ENG MED BIO, P1765, DOI 10.1109/IEMBS.2011.6090504; Gomez C, 2009, ANN BIOMED ENG, V37, P586, DOI 10.1007/s10439-008-9633-6; Gradin VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042608; GRANT PE, 1994, INVEST RADIOL, V29, P16, DOI 10.1097/00004424-199401000-00002; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jeong J, 1998, ELECTROEN CLIN NEURO, V106, P220, DOI 10.1016/S0013-4694(97)00079-5; Jeong J, 2001, J CLIN NEUROPHYSIOL, V18, P58, DOI 10.1097/00004691-200101000-00010; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keil A, 1998, SCHIZOPHR RES, V33, P169, DOI 10.1016/S0920-9964(98)00069-3; Kim WS, 2005, PHYSIOL MEAS, V26, P517, DOI 10.1088/0967-3334/26/4/016; Lake DE, 2002, AM J PHYSIOL-REG I, V283, P52; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2004, PHYSL COMPLEXITY AGI, V2004; Lu S, 2008, IEEE T BIO-MED ENG, V55, P1966, DOI 10.1109/TBME.2008.919870; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pilgram B, 1998, PHYSICA D, V114, P108, DOI 10.1016/S0167-2789(97)00188-7; PRITCHARD WS, 1994, ELECTROEN CLIN NEURO, V91, P118, DOI 10.1016/0013-4694(94)90033-7; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, P47; Robert PH, 1997, PSYCHOL MED, V27, P1287, DOI 10.1017/S0033291797005515; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; SCHEPERS HE, 1992, IEEE ENG MED BIOL, V11, P57, DOI 10.1109/51.139038; Sokunbi MO, 2013, PSYCHIAT RES-NEUROIM, V214, P341, DOI 10.1016/j.pscychresns.2013.10.001; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; ZWEIG MH, 1993, CLIN CHEM, V39, P561	53	77	80	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95146	10.1371/journal.pone.0095146	http://dx.doi.org/10.1371/journal.pone.0095146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824731	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000336369200005
J	Zelenchuk, LV; Hedge, AM; Rowe, PSN				Zelenchuk, Lesya V.; Hedge, Anne-Marie; Rowe, Peter S. N.			PHEX Mimetic (SPR4-Peptide) Corrects and Improves HYP and Wild Type Mice Energy-Metabolism	PLOS ONE			English	Article							PLASMA URIC-ACID; EXTRACELLULAR PHOSPHOGLYCOPROTEIN MEPE; INSULIN-RECEPTOR INHIBITOR; CONTROLS BONE-FORMATION; X-LINKED RICKETS; GLUCOSE-TOLERANCE; ASARM-PEPTIDES; RENAL GLUCONEOGENESIS; PHOSPHATE-METABOLISM; PROXIMAL TUBULE	Context: PHEX or DMP1 mutations cause hypophosphatemic-rickets and altered energy metabolism. PHEX binds to DMP1-ASARM-motif to form a complex with alpha(5)beta(3) integrin that suppresses FGF23 expression. ASARM-peptides increase FGF23 by disrupting the PHEX-DMP1-Integrin complex. We used a 4.2 kDa peptide (SPR4) that binds to ASARM-peptide/motif to study the DMP1-PHEX interaction and to assess SPR4 for the treatment of energy metabolism defects in HYP and potentially other bone-mineral disorders. Design: Subcutaneously transplanted osmotic pumps were used to infuse SPR4-peptide or vehicle (VE) into wild-type mice (WT) and HYP-mice (PHEX mutation) for 4 weeks. Results: SPR4 partially corrected HYP mice hypophosphatemia and increased serum 1.25(OH)(2)D-3. Serum FGF23 remained high and PTH was unaffected. WT-SPR4 mice developed hypophosphatemia and hypercalcemia with increased PTH, FGF23 and 1.25(OH)(2)D-3. SPR4 increased GAPDH HYP-bone expression 60x and corrected HYP-mice hyperglycemia and hypoinsulinemia. HYP-VE serum uric-acid (UA) levels were reduced and SPR4 infusion suppressed UA levels in WT-mice but not HYP-mice. SPR4 altered leptin, adiponectin, and sympathetic-tone and increased the fat mass/weight ratio for HYP and WT mice. Expression of perlipin-2 a gene involved in obesity was reduced in HYP-VE and WT-SPR4 mice but increased in HYP-SPR4 mice. Also, increased expression of two genes that inhibit insulin-signaling, ENPP1 and ESP, occurred with HYP-VE mice. In contrast, SPR4 reduced expression of both ENPP1 and ESP in WT mice and suppressed ENPP1 in HYP mice. Increased expression of FAM20C and sclerostin occurred with HYP-VE mice. SPR4 suppressed expression of FAM20C and sclerostin in HYP and WT mice. Conclusions: ASARM peptides and motifs are physiological substrates for PHEX and modulate osteocyte PHEX-DMP1-alpha(5)beta(3)-integrin interactions and thereby FGF23 expression. These interactions also provide a nexus that regulates bone and energy metabolism. SPR4 suppression of sclerostin and/or sequestration of ASARM-peptides improves energy metabolism and may have utility for treating familial rickets, osteoporosis, obesity and diabetes.	[Zelenchuk, Lesya V.; Hedge, Anne-Marie; Rowe, Peter S. N.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Rowe, PSN (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA.	prowe@kumc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [5R01AR051598-10]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051598] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by a grant to PSNR from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under Award Number 5R01AR051598-10. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2006, NAT CLIN PRACT ENDOC, V2, P694, DOI 10.1038/ncpendmet0367; Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; ALEXANDERBRIDGES M, 1992, ADV ENZYME REGUL, V32, P149; ALLON M, 1992, J AM SOC NEPHROL, V2, P1593; Amling M, 2000, BIOESSAYS, V22, P970; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Azam N, 2003, ENDOCRINOLOGY, V144, P3463, DOI 10.1210/en.2003-0255; Barros NMT, 2013, J BONE MINER RES, V28, P688, DOI 10.1002/jbmr.1766; Bedir A, 2003, JPN HEART J, V44, P527, DOI 10.1536/jhj.44.527; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Billaudel B, 1998, DIABETES METAB, V24, P344; Bonewald L. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P239; Boskey AL, 2010, CALCIFIED TISSUE INT, V86, P42, DOI 10.1007/s00223-009-9313-z; Boudin E, 2013, BONE, V55, P52, DOI 10.1016/j.bone.2013.03.015; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Boukpessi T, 2010, AM J PATHOL, V177, P803, DOI 10.2353/ajpath.2010.091231; Bresler D, 2004, J ENDOCRINOL, V183, pR1, DOI 10.1677/joe.1.05989; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CADE C, 1986, ENDOCRINOLOGY, V119, P84, DOI 10.1210/endo-119-1-84; Campos M, 2003, BIOCHEM J, V373, P271, DOI 10.1042/BJ20030287; CAPPARELLI AW, 1992, ENDOCRINOLOGY, V130, P328, DOI 10.1210/en.130.1.328; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chang MK, 2014, J BONE MINER RES, V29, P29, DOI 10.1002/jbmr.2059; Chen L, 2013, DIABETIC MED, V30, P309, DOI 10.1111/j.1464-5491.2012.03769.x; Civantos Modino Soralla, 2012, Endocrinol Nutr, V59, P533, DOI 10.1016/j.endonu.2012.06.010; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; David V, 2011, AM J PHYSIOL-RENAL, V300, pF783, DOI 10.1152/ajprenal.00304.2010; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; de Lorenzo C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/376454; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; DEFRONZO RA, 1980, NEW ENGL J MED, V303, P1259, DOI 10.1056/NEJM198011273032203; Ditzel J, 2009, DIABETES METAB SYNDR, V2, P173; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Eleftheriadis T, 2013, RENAL FAILURE, V35, P592, DOI 10.3109/0886022X.2013.773836; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Fruehwald-Schultes B, 1999, METABOLISM, V48, P677, DOI 10.1016/S0026-0495(99)90163-4; Fujiwara I, 2003, J BONE MINER RES, V18, P434, DOI 10.1359/jbmr.2003.18.3.434; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Gaucher C, 2009, CELLS TISSUES ORGANS, V189, P219, DOI 10.1159/000151382; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Goltzman D, 2011, J BONE MINER RES, V26, P1997, DOI 10.1002/jbmr.462; Grassi D, 2013, CURR PHARM DESIGN, V19, P2432, DOI 10.2174/1381612811319130011; Haap M, 2006, EUR J CLIN NUTR, V60, P734, DOI 10.1038/sj.ejcn.1602375; Haglin L, 2001, MED HYPOTHESES, V56, P657, DOI 10.1054/mehy.2000.1272; Hale LJ, 2013, CLIN SCI, V124, P351, DOI 10.1042/CS20120378; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; HETTLEMAN BD, 1983, J CLIN INVEST, V72, P582, DOI 10.1172/JCI111006; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; HRUSKA KA, 1995, AM J PHYSIOL-RENAL, V268, pF357, DOI 10.1152/ajprenal.1995.268.3.F357; Hsu YH, 2012, J CLIN ENDOCR METAB, V97, pE1958, DOI 10.1210/jc.2012-1890; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471; Idelevich A, 2013, J BONE MINER RES, V28, P18, DOI 10.1002/jbmr.1812; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jain A, 2004, J CLIN ENDOCR METAB, V89, P4158, DOI 10.1210/jc.2003-032031; Jankowski M, 2011, BIOCHEM BIOPH RES CO, V416, P64, DOI 10.1016/j.bbrc.2011.10.144; Jemtland R, 2011, J BONE MINER RES, V26, P1793, DOI 10.1002/jbmr.396; Johnson RJ, 2010, EVOL ANTHROPOL, V19, P250, DOI 10.1002/evan.20266; Joshi A, 2013, J OSTEOPOROS, V2013, DOI [10.1155/2013/397814, 10.1155/2013/984626]; Kalaitzidis R, 2005, AM J KIDNEY DIS, V45, P851, DOI 10.1053/j.ajkd.2005.01.005; Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Karsenty G, 2001, RECENT PROG HORM RES, V56, P401, DOI 10.1210/rp.56.1.401; Karsenty G, 2011, ANNU REV MED, V62, P323, DOI 10.1146/annurev-med-090710-133426; Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897; KUROKAWA K, 1973, BIOCHIM BIOPHYS ACTA, V313, P17, DOI 10.1016/0304-4165(73)90185-2; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee B., 2013, REV ENDOCR METAB DIS; Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LEVI E, 1992, ENDOCRINOLOGY, V131, P2182, DOI 10.1210/en.131.5.2182; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Makovey J, 2013, BONE, V52, P400, DOI 10.1016/j.bone.2012.10.025; Mangge H, 2013, OBESITY, V21, pE71, DOI 10.1002/oby.20061; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; MASSRY SG, 1991, KIDNEY INT, V40, P662, DOI 10.1038/ki.1991.258; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Mori K, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-53; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Nanes MS, 2013, CURR OPIN ENDOCRINOL, V20, P523, DOI 10.1097/01.med.0000436189.80104.80; Nesbitt T, 1996, ENDOCRINOLOGY, V137, P943, DOI 10.1210/en.137.3.943; NESBITT T, 1995, J BONE MINER RES, V10, P1327; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; Pan WT, 2011, AM J PHYSIOL-ENDOC M, V301, pE901, DOI 10.1152/ajpendo.00087.2011; Paula FJA, 1998, HORM METAB RES, V30, P281, DOI 10.1055/s-2007-978884; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price Sarah, 2011, Nat Rev Rheumatol, V7, P373, DOI 10.1038/nrrheum.2011.84; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; RIFAS L, 1995, CALCIFIED TISSUE INT, V57, P60, DOI 10.1007/BF00298998; Robles-Cervantes JA, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/107904; ROOBOL A, 1973, BIOCHEM J, V134, P157, DOI 10.1042/bj1340157; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; SABINA RL, 1982, BIOCHEM BIOPH RES CO, V109, P649, DOI 10.1016/0006-291X(82)91989-1; Saito T, 2011, BONE; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Santos RD, 2012, ENDOCRINE, V41, P350, DOI 10.1007/s12020-012-9657-4; Sarkar PD, 2012, ARCH PHYSIOL BIOCHEM, V118, P260, DOI 10.3109/13813455.2012.715651; Schwartz AV, 2013, J BONE MINER RES, V28, P1348, DOI 10.1002/jbmr.1865; Sluijs I, 2013, J NUTR, V143, P80, DOI 10.3945/jn.112.167221; Sortica DA, 2011, ARQ BRAS ENDOCRINOL, V55, P677, DOI 10.1590/S0004-27302011000900002; Sritara C, 2013, J CLIN DENSITOM, V16, P336, DOI 10.1016/j.jocd.2012.05.008; Staines KA, 2012, BONE, V51, P418, DOI 10.1016/j.bone.2012.06.022; Staines KA, 2013, J BONE MINER METAB; Stellato D, 2012, INTERN EMERG MED, V7, P5, DOI 10.1007/s11739-011-0642-3; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Tagliabracci A, 2014, PNAS; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Thrailkill KM, 2012, OSTEOPOROSIS INT, V23, P1799, DOI 10.1007/s00198-011-1807-7; Tiosano D, 2011, J BONE MINER RES, V26, P2252, DOI 10.1002/jbmr.431; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; TRAVIS SF, 1971, NEW ENGL J MED, V285, P763, DOI 10.1056/NEJM197109302851402; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; VAUGHN LK, 1986, ENDOCRINOLOGY, V118, P441, DOI 10.1210/endo-118-1-441; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P687, DOI 10.1515/jpem-2012-0064; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Xi W, 2002, HORM METAB RES, V34, P288, DOI 10.1055/s-2002-33256; Xie W, 1999, BIOCHEM J, V343, P393, DOI [10.1042/0264-6021:3430393, 10.1042/bj3430393]; Xie WS, 2000, BIOCHEM J, V352, P227, DOI 10.1042/0264-6021:3520227; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamaguchi T, 2011, ENDOCR J, V58, P613, DOI 10.1507/endocrj.EJ11-0063; Yancovitch A, 2011, J BONE MINER METAB, V29, P621, DOI 10.1007/s00774-011-0260-1; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje; Zhang L, 2013, HUM MOL GENET; ZHOU XJ, 1991, KIDNEY INT, V39, P120, DOI 10.1038/ki.1991.15; Zmuda JM, 2011, OSTEOPOROSIS INT, V22, P1079, DOI 10.1007/s00198-010-1296-0	163	11	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97326	10.1371/journal.pone.0097326	http://dx.doi.org/10.1371/journal.pone.0097326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839967	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600024
J	Bogdanov, P; Corraliza, L; Villena, JA; Carvalho, AR; Garcia-Arumi, J; Ramos, D; Ruberte, J; Simo, R; Hernandez, C				Bogdanov, Patricia; Corraliza, Lidia; Villena, Josep A.; Carvalho, Andrea R.; Garcia-Arumi, Jose; Ramos, David; Ruberte, Jesus; Simo, Rafael; Hernandez, Cristina			The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; APOPTOTIC CELL-DEATH; BARRIER BREAKDOWN; GLUTAMATE RECEPTORS; MULTIFOCAL ERG; MULLER CELLS; EARLY EVENT; RETINOPATHY; EXPRESSION; RAT	Background: To characterize the sequential events that are taking place in retinal neurodegeneration in a murine model of spontaneous type 2 diabetes (db/db mouse). Methods: C57BLKsJ-db/db mice were used as spontaneous type 2 diabetic animal model, and C57BLKsJ-db/+ mice served as the control group. To assess the chronological sequence of the abnormalities the analysis was performed at different ages (8, 16 and 24 weeks). The retinas were evaluated in terms of morphological and functional abnormalities [electroretinography (ERG)]. Histological markers of neurodegeneration (glial activation and apoptosis) were evaluated by immunohistochemistry. In addition glutamate levels and glutamate/aspartate transporter (GLAST) expression were assessed. Furthermore, to define gene expression changes associated with early diabetic retinopathy a transcriptome analyses was performed at 8 week. Furthermore, an additional interventional study to lower blood glucose levels was performed. Results: Glial activation was higher in diabetic than in non diabetic mice in all the stages (p<0.01). In addition, a progressive loss of ganglion cells and a significant reduction of neuroretinal thickness were also observed in diabetic mice. All these histological hallmarks of neurodegeneration were less pronounced at week 8 than at week 16 and 24. Significant ERG abnormalities were present in diabetic mice at weeks 16 and 24 but not at week 8. Moreover, we observed a progressive accumulation of glutamate in diabetic mice associated with an early downregulation of GLAST. Morphological and ERG abnormalities were abrogated by lowering blood glucose levels. Finally, a dysregulation of several genes related to neurotransmission and oxidative stress such as UCP2 were found at week 8. Conclusions: Our results suggest that db/db mouse reproduce the features of the neurodegenerative process that occurs in the human diabetic eye. Therefore, it seems an appropriate model for investigating the underlying mechanisms of diabetes-induced retinal neurodegeneration and for testing neuroprotective drugs.	[Bogdanov, Patricia; Corraliza, Lidia; Simo, Rafael; Hernandez, Cristina] Univ Autonoma Barcelona, Vall dHebron Res Inst, Diabet & Metab Res Unit, E-08193 Barcelona, Spain; [Bogdanov, Patricia; Corraliza, Lidia; Villena, Josep A.; Simo, Rafael; Hernandez, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Villena, Josep A.] Univ Autonoma Barcelona, Vall dHebron Res Inst, Lab Metab & Obes, E-08193 Barcelona, Spain; [Carvalho, Andrea R.; Garcia-Arumi, Jose] Univ Autonoma Barcelona, Vall dHebron Res Inst, Ophthalmol Res Lab, Barcelona, Spain; [Carvalho, Andrea R.; Garcia-Arumi, Jose] Inst Salud Carlos III, Red Temat Invest Oftalmol OFTARED, Madrid, Spain; [Ramos, David; Ruberte, Jesus] Univ Autonoma Barcelona, Fac Vet Sci, Dept Anim Hlth & Anat, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Autonomous University of Barcelona	Hernandez, C (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Diabet & Metab Res Unit, E-08193 Barcelona, Spain.	cristina.hernandez@vhir.org	Villena, Josep A/H-1597-2015; Bogdanov, Patricia/AAF-7831-2021; Ruberte, Jesus/AAS-9240-2021	Bogdanov, Patricia/0000-0003-0669-4958; Hernandez, Cristina/0000-0002-3109-1721; Villena, Josep A/0000-0002-2200-2985; Garcia-Arumi, Jose/0000-0001-8827-1160; Simo Canonge, Rafael/0000-0003-0475-3096; RUBERTE, JESUS/0000-0003-1540-1432	Ministerio de Ciencia e Innovacion [SAF2012-35562]; Ministerio de Economia y Competitividad [PI10/01219, PI13/00603]; European Foundation for the Study of Diabetes (EFSD); Novo-Nordisk	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); European Foundation for the Study of Diabetes (EFSD); Novo-Nordisk(Novo Nordisk)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2012-35562), the Ministerio de Economia y Competitividad (PI10/01219; PI13/00603), the European Foundation for the Study of Diabetes (EFSD), and Novo-Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 1997, ARCH OPHTHALMOL-CHIC, V115, P1161, DOI 10.1001/archopht.1997.01100160331011; Anderson PJB, 2008, CLIN OPHTHALMOL, V2, P801; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barnstable C J, 1993, Curr Opin Neurobiol, V3, P520, DOI 10.1016/0959-4388(93)90050-9; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; Bronson-Castain KW, 2009, RETINA-J RET VIT DIS, V29, P618, DOI 10.1097/IAE.0b013e31819a988b; Carrasco E, 2007, DIABETES CARE, V30, P2902, DOI 10.2337/dc07-0332; Cervantes-Villagrana AR, 2010, CURR EYE RES, V35, P733, DOI 10.3109/02713683.2010.483312; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P4106, DOI 10.1167/iovs.04-0405; Harrison WW, 2011, INVEST OPHTH VIS SCI, V52, P772, DOI 10.1167/iovs.10-5931; Hernandez C, 2013, DIABETES, V62, P2569, DOI 10.2337/db12-0926; HOLOPIGIAN K, 1992, INVEST OPHTH VIS SCI, V33, P2773; Imai H, 2009, DEV OPHTHALMOL, V44, P56, DOI 10.1159/000223946; Ju WK, 2008, MOL VIS, V14, P2629; Ju WK, 2009, INVEST OPHTH VIS SCI, V50, P707, DOI 10.1167/iovs.08-2499; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Klemp K, 2005, INVEST OPHTH VIS SCI, V46, P2620, DOI 10.1167/iovs.04-1254; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lau JCM, 2013, MOL VIS, V19, P1538; Lecleire-Collet A, 2011, INVEST OPHTH VIS SCI, V52, P2861, DOI 10.1167/iovs.10-5960; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Lieth E, 2000, EXP EYE RES, V70, P723, DOI 10.1006/exer.2000.0840; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markowitz Alison J B, 2007, Cellscience, V4, P111; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Ng JS, 2008, INVEST OPHTH VIS SCI, V49, P1622, DOI 10.1167/iovs.07-1157; Ng YK, 2004, BRAIN RES, V1018, P66, DOI 10.1016/j.brainres.2004.05.055; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Santiago AR, 2009, MOL VIS, V15, P1620; Sarthy VP, 2005, GLIA, V49, P184, DOI 10.1002/glia.20097; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Silva KC, 2013, INVEST OPHTH VIS SCI, V54, P1325, DOI 10.1167/iovs.12-10647; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Simo R, 2009, DIABETES CARE, V32, P1556, DOI 10.2337/dc09-0565; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tyrberg M, 2011, DOC OPHTHALMOL, V123, P193, DOI 10.1007/s10633-011-9298-6; Valverde AM, 2013, MOL VIS, V19, P47; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; van Dijk HW, 2011, VISION RES, V51, P224, DOI 10.1016/j.visres.2010.08.024; WACHTMEISTER L, 1987, DOC OPHTHALMOL, V66, P187, DOI 10.1007/BF00145232; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727	64	115	120	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97302	10.1371/journal.pone.0097302	http://dx.doi.org/10.1371/journal.pone.0097302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837086	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800036
J	Cui, H; Liu, XH; Wang, KY; Zhu, CY; Wang, C; Xie, XH				Cui, Hong; Liu, Xiao-hui; Wang, Ke-yong; Zhu, Chun-yan; Wang, Chen; Xie, Xin-hui			Association of Saccade Duration and Saccade Acceleration/Deceleration Asymmetry during Visually Guided Saccade in Schizophrenia Patients	PLOS ONE			English	Article							ALERT SQUIRREL-MONKEY; EYE-MOVEMENTS; BURST NEURONS; PHYSIOLOGY; TRACKING; VELOCITY; ANATOMY	Objective: To examine the difference between schizophrenia patients and normal controls on velocity and acceleration of saccade, by using the basic visually guided saccade (VGS) paradigm. Methods: Eighteen schizophrenia outpatients and fourteen normal controls participated in the VGS task. Multiple indicators, including amplitude, duration, velocity, latency, accuracy rate, acceleration, and deceleration were analyzed. Asymmetric acceleration index (AAI) was introduced to describe the difference between peak acceleration and peak deceleration. The correlation coefficient (R-AD) of AAI and duration was computed to examine the difference between schizophrenia patients and normal controls. Results: No significant difference between patients and normal controls was found on amplitude, duration, latency, and accuracy rate. However, RAD values of schizophrenia patients were significantly lower than the control group. Conclusion: Compared to normal controls, association of saccade duration and saccade acceleration/deceleration asymmetry during visually guided saccade was lower in schizophrenia patients.	[Cui, Hong; Liu, Xiao-hui; Xie, Xin-hui] Chinese Peoples Liberat Army Gen Hosp, Div Med Psychol, Beijing, Peoples R China; [Cui, Hong; Liu, Xiao-hui; Xie, Xin-hui] Med Sch PLA, Beijing, Peoples R China; [Wang, Ke-yong; Wang, Chen; Xie, Xin-hui] Anhui Mental Hlth Ctr, Dept Psychiat, Hefei, Anhui, Peoples R China; [Zhu, Chun-yan; Wang, Chen; Xie, Xin-hui] Anhui Med Univ, Dept Med Psychol, Hefei, Anhui, Peoples R China	Chinese People's Liberation Army General Hospital; Anhui Medical University	Xie, XH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Div Med Psychol, Beijing, Peoples R China.	xxh.med@gmail.com		Xie, Xin-hui/0000-0002-3603-3854	National Science and Technology Pillar Program [2013BAI08B03]; Natural Science Foundation of China [31100812]	National Science and Technology Pillar Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science and Technology Pillar Program (Grant number 2013BAI08B03 http://www.most.gov.cn/) and the Natural Science Foundation of China (Grant number 31100812 http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in data collection, decision to publish, or preparation of manuscript.	ABEL LA, 1988, BIOL PSYCHIAT, V24, P747, DOI 10.1016/0006-3223(88)90250-8; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Diefendorf AR, 1908, BRAIN, V31, P451, DOI 10.1093/brain/31.3.451; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; HOLZMAN PS, 1974, ARCH GEN PSYCHIAT, V31, P143; Horn AKE, 1998, J COMP NEUROL, V392, P413; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; LEVY DL, 1994, SCHIZOPHRENIA BULL, V20, P47, DOI 10.1093/schbul/20.1.47; Qiu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025805; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; STRASSMAN A, 1986, J COMP NEUROL, V249, P337, DOI 10.1002/cne.902490303; STRASSMAN A, 1986, J COMP NEUROL, V249, P358, DOI 10.1002/cne.902490304; VANOPSTAL AJ, 1987, VISION RES, V27, P731, DOI 10.1016/0042-6989(87)90071-X; Zhao Q, 2013, SCHIZOPHRENIA B	18	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97308	10.1371/journal.pone.0097308	http://dx.doi.org/10.1371/journal.pone.0097308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24837253	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800037
J	Fernandez, R; Kvist, S; Lenihan, J; Giribet, G; Ziegler, A				Fernandez, Rosa; Kvist, Sebastian; Lenihan, Jennifer; Giribet, Gonzalo; Ziegler, Alexander			Sine Systemate Chaos? A Versatile Tool for Earthworm Taxonomy: Non-Destructive Imaging of Freshly Fixed and Museum Specimens Using Micro-Computed Tomography	PLOS ONE			English	Article							SPECIES COMPLEX OLIGOCHAETA; MOUSE EMBRYOS; MORPHOLOGY; CT; VISUALIZATION; LUMBRICIDAE; ANATOMY; DNA; MICROTOMOGRAPHY; RECONSTRUCTION	In spite of the high relevance of lumbricid earthworms ('Oligochaeta': Lumbricidae) for soil structure and functioning, the taxonomy of this group of terrestrial invertebrates remains in a quasi-chaotic state. Earthworm taxonomy traditionally relies on the interpretation of external and internal morphological characters, but the acquisition of these data is often hampered by tedious dissections or restricted access to valuable and rare museum specimens. The present state of affairs, in conjunction with the difficulty of establishing primary homologies for multiple morphological features, has led to an almost unrivaled instability in the taxonomy and systematics of certain earthworm groups, including Lumbricidae. As a potential remedy, we apply for the first time a non-destructive imaging technique to lumbricids and explore the future application of this approach to earthworm taxonomy. High-resolution micro-computed tomography (mu CT) scanning of freshly fixed and museum specimens was carried out using two cosmopolitan species, Aporrectodea caliginosa and A. trapezoides. By combining two-dimensional and three-dimensional dataset visualization techniques, we demonstrate that the morphological features commonly used in earthworm taxonomy can now be analyzed without the need for dissection, whether freshly fixed or museum specimens collected more than 60 years ago are studied. Our analyses show that mCT in combination with soft tissue staining can be successfully applied to lumbricid earthworms. An extension of the approach to other families is poised to strengthen earthworm taxonomy by providing a versatile tool to resolve the taxonomic chaos currently present in this ecologically important, but taxonomically neglected group of terrestrial invertebrates.	[Fernandez, Rosa; Kvist, Sebastian; Lenihan, Jennifer; Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ziegler, Alexander] Ziegler Biosolut, Waldshut Tiengen, Germany	Harvard University	Fernandez, R (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA.	rfernandezgarcia@g.harvard.edu	Fernandez, Rosa/AAR-5567-2021; Fernández, Rosa/Q-2294-2016; Giribet, Gonzalo/P-1086-2015	Fernandez, Rosa/0000-0002-4719-6640; Fernández, Rosa/0000-0002-4719-6640; Giribet, Gonzalo/0000-0002-5467-8429; Kvist, Sebastian/0000-0003-3200-6207; Trimble, Jennifer/0000-0002-7480-3645; Ziegler, Alexander/0000-0002-7572-6872	Ramon Areces Foundation; Wenner-Gren Foundations; Helge Ax:son Johnson's Foundation; Deutsche Forschungsgemeinschaft [ZI-1274/1-1, ZI-1274/1-2]; Museum of Comparative Zoology; Department of Invertebrate Zoology	Ramon Areces Foundation; Wenner-Gren Foundations; Helge Ax:son Johnson's Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Museum of Comparative Zoology; Department of Invertebrate Zoology	Funding for RF was provided by the Ramon Areces Foundation, for SK by the Wenner-Gren Foundations and Helge Ax:son Johnson's Foundation, and for AZ by the Deutsche Forschungsgemeinschaft through grants no. ZI-1274/1-1 and ZI-1274/1-2. Research was also supported by internal funds from the Museum of Comparative Zoology and from the Department of Invertebrate Zoology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Bauder JAS, 2013, BIOL J LINN SOC, V110, P291, DOI 10.1111/bij.12134; Baverstock H, 2013, J ANAT, V223, P46, DOI 10.1111/joa.12059; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; Blakemore RJ., 2006, COSMOPOLITAN EARTHWO; Boistel R, 2011, MAR ECOL-EVOL PERSP, V32, P438, DOI 10.1111/j.1439-0485.2011.00442.x; Bouche MB, 1972, LOMBRICIENS FRANCE E; Briones MJI, 1996, CAN J ZOOL, V74, P240, DOI 10.1139/z96-030; Cox PG, 2011, ANAT REC, V294, P1612, DOI 10.1002/ar.21483; Csuzdi C, 2007, ACTA ZOOL ACAD SCI H, V53, P347; Csuzdi C, 2007, EUR J SOIL BIOL, V43, pS19, DOI 10.1016/j.ejsobi.2007.08.005; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Eberhard MJB, 2010, ARTHROPOD STRUCT DEV, V39, P230, DOI 10.1016/j.asd.2010.02.002; Edwards C.A., 2004, EARTHWORM ECOLOGY; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO; Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fender W.M., 1990, P357; Fernandez R, 2012, MOL PHYLOGENET EVOL, V64, P368, DOI 10.1016/j.ympev.2012.04.011; Garwood R, 2009, BIOL LETTERS, V5, P841, DOI 10.1098/rsbl.2009.0464; GATES GE, 1972, T AM PHILOS SOC, V62, P5; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Golding RE, 2009, J MORPHOL, V270, P558, DOI 10.1002/jmor.10699; Haug JT, 2011, J MICROSC-OXFORD, V244, P259, DOI 10.1111/j.1365-2818.2011.03534.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Briones MJI, 2009, SOIL BIOL BIOCHEM, V41, P2257, DOI 10.1016/j.soilbio.2009.07.008; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Kamenz C, 2009, MICRON, V40, P911, DOI 10.1016/j.micron.2009.05.007; Kerbl A, 2013, J EXP MAR BIOL ECOL, V447, P140, DOI 10.1016/j.jembe.2013.02.022; Klussmann-Fricke BJ, 2012, ARTHROPOD STRUCT DEV, V41, P545, DOI 10.1016/j.asd.2012.06.002; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Lavelle P., 2001, SOIL ECOLOGY; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Lenihan J, 2014, GIGASCIENCE DATABASE, DOI [10.5524/100092, DOI 10.5524/100092]; Lenihan J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-6; LJUNGSTROM P-O, 1972, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V99, P1; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Michaelsen W., 1900, Das Tierreich, VLief. x, pUnpaginated; Michalik P, 2013, ZOOKEYS, P101, DOI 10.3897/zookeys.335.6030; Murienne J, 2008, NATURE, V453, P450, DOI 10.1038/453450d; Nickel M, 2006, ZOOMORPHOLOGY, V125, P209, DOI 10.1007/s00435-006-0021-1; OMODEO P, 1991, B ZOOL, V58, P171, DOI 10.1080/11250009109355749; Paredes UM, 2012, J ZOOL SYST EVOL RES, V50, P247, DOI 10.1111/j.1439-0469.2012.00657.x; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Prajapati SI, 2014, MOUSE MOL EMBRYOLOGY, P291; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Richards CS, 2012, FORENSIC SCI INT, V220, P251, DOI 10.1016/j.forsciint.2012.03.012; Saito S, 2012, BRIT J RADIOL, V85, pE973, DOI 10.1259/bjr/13040401; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19; Stephenson J. L, 1930, OLIGOCHAETA; Tahara R, 2013, J ANAT, V223, P297, DOI 10.1111/joa.12081; Tsai HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024935; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Vocking O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072660; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Wilhelm G, 2011, BIOL J LINN SOC, V104, P642, DOI 10.1111/j.1095-8312.2011.01751.x; Wilhelmi AP, 2012, ZOOMORPHOLOGY, V131, P325, DOI 10.1007/s00435-012-0162-3; Ziegler Alexander, 2011, BMC Med, V9, P17, DOI 10.1186/1741-7015-9-17; Ziegler A, 2014, COMPUT ANAL SYNTH DE, P235; Ziegler A, 2012, ZOOSYMPOSIA, V7, P53, DOI 10.11646/zoosymposia.7.1.6; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	74	53	55	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96617	10.1371/journal.pone.0096617	http://dx.doi.org/10.1371/journal.pone.0096617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837238	Green Submitted, gold, Green Published			2022-12-25	WOS:000339614800018
J	Kong, F; Zhen, ZL; Li, JG; Huang, LJ; Wang, X; Song, YY; Liu, J				Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying; Liu, Jia			Sex-Related Neuroanatomical Basis of Emotion Regulation Ability	PLOS ONE			English	Article							HIPPOCAMPAL VOLUME; GENDER-DIFFERENCES; ANTERIOR CINGULATE; LIFE SATISFACTION; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURAL BASES; INTELLIGENCE; AMYGDALA; VALIDITY	Behavioral research has demonstrated that males have a higher capability of regulating their own and others' emotions than females; however, little is known about the sex-specific brain mechanisms involved in emotion regulation ability. In the present study, we used voxel-based morphometry to investigate the neural basis underlying emotion regulation ability in a large sample of young adults. Assessment of emotion regulation ability was performed using the Wong and Law Emotional Intelligence Scale. As expected, males significantly scored higher in emotion regulation ability than females did. More importantly, we found the sex differences in the neuroanatomical basis of emotion regulation ability. Males showed a stronger positive relation between emotion regulation ability and regional gray matter volume (rGMV) in the right dorsolateral prefrontal cortex. In contrast, females demonstrated a stronger positive relation between emotion regulation ability and rGMV in an anatomical cluster that extends from the left brainstem to the left hippocampus, the left amygdala and the insular cortex. The present study provides the first empirical evidence regarding the sex-linked neuroanatomical correlates of emotion regulation ability. These findings may help understand why there is a higher prevalence of affective disorders in females and maladaptive behaviors in males.	[Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022; Kong, Feng/F-3051-2019	Kong, Feng/0000-0002-5571-3994; Liu, Jia/0000-0003-0383-0934; Li, Jingguang/0000-0003-2410-937X	National Natural Science Foundation of China [31230031, 91132703, 30800295, 31100808]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31230031, 91132703, 30800295, 31100808) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelang M, 2006, INTELLIGENCE, V34, P459, DOI 10.1016/j.intell.2006.03.003; [Anonymous], 1997, EMOTIONAL DEV EMOTIO; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bar-On R, 2000, PERS INDIV DIFFER, V28, P1107, DOI 10.1016/S0191-8869(99)00160-9; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Carney MA, 2000, J CONSULT CLIN PSYCH, V68, P788, DOI 10.1037/0022-006X.68.5.788; Craig A, 2009, PERS INDIV DIFFER, V46, P111, DOI 10.1016/j.paid.2008.09.011; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Extremera N, 2007, PERS INDIV DIFFER, V42, P1069, DOI 10.1016/j.paid.2006.09.014; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gray, 2012, MEN ARE MARS WOMEN A; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Iidaka T, 2003, HIPPOCAMPUS, V13, P429, DOI 10.1002/hipo.10059; Jha AP, 2006, BRAIN RES, V1097, P133, DOI 10.1016/j.brainres.2006.02.039; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Killgore WDS, 2012, NEUROREPORT, V23, P551, DOI 10.1097/WNR.0b013e32835446f7; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kong F, 2013, PERS INDIV DIFFER, V54, P197, DOI 10.1016/j.paid.2012.08.028; Kong F, 2012, PERS INDIV DIFFER, V53, P1039, DOI 10.1016/j.paid.2012.07.032; Koven NS, 2011, SOC COGN AFFECT NEUR, V6, P582, DOI 10.1093/scan/nsq084; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Law KS, 2004, J APPL PSYCHOL, V89, P483, DOI 10.1037/0021-9010.89.3.483; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mak AKY, 2009, NEUROPSYCHOLOGIA, V47, P2900, DOI 10.1016/j.neuropsychologia.2009.06.017; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mesulam M, 2000, PRINCIPLES BEHAV COG; Mikolajczak M, 2007, J PERS ASSESS, V88, P338, DOI 10.1080/00223890701333431; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Ortigue S, 2007, NEUROIMAGE, V37, P551, DOI 10.1016/j.neuroimage.2007.05.026; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PTACEK JT, 1994, PERS SOC PSYCHOL B, V20, P421, DOI 10.1177/0146167294204009; Rosso IM, 2005, BIOL PSYCHIAT, V57, P21, DOI 10.1016/j.biopsych.2004.10.027; Saklofske DH, 2003, PERS INDIV DIFFER, V34, P707, DOI 10.1016/S0191-8869(02)00056-9; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shi JQ, 2007, PERS INDIV DIFFER, V43, P377, DOI 10.1016/j.paid.2006.12.012; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Vakili K, 2000, BIOL PSYCHIAT, V47, P1087, DOI 10.1016/S0006-3223(99)00296-6; Van Rooy DL, 2005, PERS INDIV DIFFER, V38, P689, DOI 10.1016/j.paid.2004.05.023; Vrticka P, 2011, NEUROPSYCHOLOGIA, V49, P1067, DOI 10.1016/j.neuropsychologia.2011.02.020; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	73	56	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97071	10.1371/journal.pone.0097071	http://dx.doi.org/10.1371/journal.pone.0097071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835267	gold, Green Submitted, Green Published			2022-12-25	WOS:000339614800026
J	Pearson-Fuhrhop, KM; Dunn, EC; Mortero, S; Devan, WJ; Falcone, GJ; Lee, P; Holmes, AJ; Hollinshead, MO; Roffman, JL; Smoller, JW; Rosand, J; Cramer, SC				Pearson-Fuhrhop, Kristin M.; Dunn, Erin C.; Mortero, Sarah; Devan, William J.; Falcone, Guido J.; Lee, Phil; Holmes, Avram J.; Hollinshead, Marisa O.; Roffman, Joshua L.; Smoller, Jordan W.; Rosand, Jonathan; Cramer, Steven C.			Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression	PLOS ONE			English	Article							VAL(108/158) MET GENOTYPE; RECEPTOR GENE; TARDIVE-DYSKINESIA; SER9GLY POLYMORPHISM; PARKINSONS-DISEASE; ASTERISK-D; ASSOCIATION; PROFILE; COMT; D2	Background: Depression is a common source of human disability for which etiologic insights remain limited. Although abnormalities of monoamine neurotransmission, including dopamine, are theorized to contribute to the pathophysiology of depression, evidence linking dopamine-related genes to depression has been mixed. The current study sought to address this knowledge-gap by examining whether the combined effect of dopamine polymorphisms was associated with depressive symptomatology in both healthy individuals and individuals with depression. Methods: Data were drawn from three independent samples: (1) a discovery sample of healthy adult participants (n = 273); (2) a replication sample of adults with depression (n = 1,267); and (3) a replication sample of healthy adult participants (n = 382). A genetic risk score was created by combining functional polymorphisms from five genes involved in synaptic dopamine availability (COMT and DAT) and dopamine receptor binding (DRD1, DRD2, DRD3). Results: In the discovery sample, the genetic risk score was associated with depressive symptomatology (beta = -0.80, p = 0.003), with lower dopamine genetic risk scores (indicating lower dopaminergic neurotransmission) predicting higher levels of depression. This result was replicated with a similar genetic risk score based on imputed genetic data from adults with depression (beta = -0.51, p = 0.04). Results were of similar magnitude and in the expected direction in a cohort of healthy adult participants (beta = -0.86, p = 0.15). Conclusions: Sequence variation in multiple genes regulating dopamine neurotransmission may influence depressive symptoms, in a manner that appears to be additive. Further studies are required to confirm the role of genetic variation in dopamine metabolism and depression.	[Pearson-Fuhrhop, Kristin M.; Mortero, Sarah; Cramer, Steven C.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Dunn, Erin C.; Devan, William J.; Falcone, Guido J.; Lee, Phil; Smoller, Jordan W.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Dunn, Erin C.; Lee, Phil; Holmes, Avram J.; Roffman, Joshua L.; Smoller, Jordan W.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Dunn, Erin C.; Lee, Phil; Smoller, Jordan W.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Hollinshead, Marisa O.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Rosand, Jonathan] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rosand, Jonathan] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Cramer, Steven C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine	Cramer, SC (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	scramer@uci.edu	Fuhrhop, Kristin Pearson/AAD-5596-2021; Dunn, Erin C./AFM-9511-2022; Falcone, Guido/L-2287-2016; Roffman, Joshua/G-8228-2012	Dunn, Erin C./0000-0003-1413-3229; Falcone, Guido/0000-0002-6407-0302; Roffman, Joshua/0000-0003-4073-532X; Holmes, Avram/0000-0001-6583-803X	NIH [R01 NS058755, 5M011 RR-00827-29]; American Heart Association; Science of Health and Development Initiative at the Center on the Developing Child at Harvard University; NIMH [K24 MH094614, K01MH099232]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000153]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD074722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614, K01MH099232, K99MH101367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Science of Health and Development Initiative at the Center on the Developing Child at Harvard University; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by NIH grants R01 NS058755 (to SCC) and 5M011 RR-00827-29 (to UC Irvine), and a predoctoral fellowship from the American Heart Association (to KMPF). ECD was supported by the Science of Health and Development Initiative at the Center on the Developing Child at Harvard University and JWS was supported by NIMH grant K24 MH094614. The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153. AJH was supported by the NIMH grant K01MH099232. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, MANUAL PROFILES MOOD; Bakker PR, 2006, SCHIZOPHR RES, V83, P185, DOI 10.1016/j.schres.2006.01.010; Berthele A, 2005, NEUROIMAGE, V28, P185, DOI 10.1016/j.neuroimage.2005.05.030; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Calhoon GG, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00168; CICHON S, 1994, HUM MOL GENET, V3, P209, DOI 10.1093/hmg/3.1.209; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Dmitrzak-Weglarz M, 2006, NEUROPSYCHOBIOLOGY, V53, P46, DOI 10.1159/000090703; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dunn EC, 2011, J CHILD PSYCHOL PSYC, V52, P1223, DOI 10.1111/j.1469-7610.2011.02466.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Erro R, 2012, J NEUROL NEUROSURG P; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Gershon AA, 2007, BIOL PSYCHIAT, V61, P145, DOI 10.1016/j.biopsych.2006.05.031; Gilbert DL, 2006, BRAIN, V129, P2038, DOI 10.1093/brain/awl147; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hauser RA, 2009, MOVEMENT DISORD, V24, P2328, DOI 10.1002/mds.22759; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hek K, 2013, BIOL PSYCHIAT; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; Holmes AJ, 2012, J NEUROSCI, V32, P18087, DOI 10.1523/JNEUROSCI.2531-12.2012; Hori H, 2012, SCI WORLD J, DOI 10.1100/2012/372474; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Huang W, 2008, HUM GENET, V123, P133, DOI 10.1007/s00439-007-0453-9; Inoue-Murayama M, 2002, NEUROSCI LETT, V334, P206, DOI 10.1016/S0304-3940(02)01125-4; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Limosin F, 2003, ALCOHOL CLIN EXP RES, V27, P1226, DOI 10.1097/01.ALC.0000081624.57507.87; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lotrich FE, 2011, PSYCHIAT CLIN N AM, V34, P357, DOI 10.1016/j.psc.2011.02.003; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mihara K, 2003, AM J MED GENET B, V117B, P57, DOI 10.1002/ajmg.b.10025; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; NOBLE EP, 1994, MED HYPOTHESES, V42, P257, DOI 10.1016/0306-9877(94)90127-9; O'Tuathaigh CMP, 2012, CNS NEUROL DISORD-DR, V11, P282; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Pearson-Fuhrhop KM, 2013, PLOS ONE IN PRESS; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roffman JL, 2013, SCHIZOPHRENIA BULL, V39, P330, DOI 10.1093/schbul/sbr150; Rush AJ, 2003, AM J PSYCHIAT, V160, P237, DOI 10.1176/appi.ajp.160.2.237; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Savitz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054108; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; STRANGE PG, 1991, TRENDS PHARMACOL SCI, V12, P48, DOI 10.1016/0165-6147(91)90494-D; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Tsai HT, 2010, AM J MED GENET B, V153B, P57, DOI 10.1002/ajmg.b.30946; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; WADDINGTON JL, 1986, BIOCHEM PHARMACOL, V35, P3661, DOI 10.1016/0006-2952(86)90649-0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Woo SI, 2002, PSYCHIAT CLIN NEUROS, V56, P469, DOI 10.1046/j.1440-1819.2002.01038.x; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	78	48	49	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e93772	10.1371/journal.pone.0093772	http://dx.doi.org/10.1371/journal.pone.0093772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834916	Green Published, gold			2022-12-25	WOS:000339614800003
J	Tsuchiya, Y; Pham, U; Hu, WZ; Ohnuma, S; Gout, I				Tsuchiya, Yugo; Pham, Uyen; Hu, Wanzhou; Ohnuma, Shin-ichi; Gout, Ivan			Changes in Acetyl CoA Levels during the Early Embryonic Development of Xenopus laevis	PLOS ONE			English	Article							HISTONE ACETYLATION; TISSUE-EXTRACTS; MALONYL-COA; RAT-LIVER; COENZYME; METABOLISM; CELLS; TRANSCRIPTION; COMMITMENT; HEART	Coenzyme A (CoA) is a ubiquitous and fundamental intracellular cofactor. CoA acts as a carrier of metabolically important carboxylic acids in the form of CoA thioesters and is an obligatory component of a multitude of catabolic and anabolic reactions. Acetyl CoA is a CoA thioester derived from catabolism of all major carbon fuels. This metabolite is at a metabolic crossroads, either being further metabolised as an energy source or used as a building block for biosynthesis of lipids and cholesterol. In addition, acetyl CoA serves as the acetyl donor in protein acetylation reactions, linking metabolism to protein post-translational modifications. Recent studies in yeast and cultured mammalian cells have suggested that the intracellular level of acetyl CoA may play a role in the regulation of cell growth, proliferation and apoptosis, by affecting protein acetylation reactions. Yet, how the levels of this metabolite change in vivo during the development of a vertebrate is not known. We measured levels of acetyl CoA, free CoA and total short chain CoA esters during the early embryonic development of Xenopus laevis using HPLC. Acetyl CoA and total short chain CoA esters start to increase around midblastula transition (MBT) and continue to increase through stages of gastrulation, neurulation and early organogenesis. Pre-MBT embryos contain more free CoA relative to acetyl CoA but there is a shift in the ratio of acetyl CoA to CoA after MBT, suggesting a metabolic transition that results in net accumulation of acetyl CoA. At the whole-embryo level, there is an apparent correlation between the levels of acetyl CoA and levels of acetylation of a number of proteins including histones H3 and H2B. This suggests the level of acetyl CoA may be a factor, which determines the degree of acetylation of these proteins, hence may play a role in the regulation of embryogenesis.	[Tsuchiya, Yugo; Pham, Uyen; Gout, Ivan] UCL, Inst Struct & Mol Biol, London, England; [Hu, Wanzhou; Ohnuma, Shin-ichi] UCL, UCL Inst Ophthalmol, London, England	University of London; Birkbeck University London; University College London; University of London; University College London	Gout, I (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	i.gout@ucl.ac.uk		Ohnuma, Shin-ichi/0000-0002-3305-5126	Association for International Cancer Research [09-0787]; Biotechnology and Biological Sciences Research Council [BB/L010410/1] Funding Source: researchfish; Worldwide Cancer Research [09-0787] Funding Source: researchfish; BBSRC [BB/L010410/1] Funding Source: UKRI	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is funded by the Association for International Cancer Research (www.aicr.org.uk Grant No. 09-0787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED JB, 1969, ANAL BIOCHEM, V29, P293, DOI 10.1016/0003-2697(69)90312-1; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CORKEY BE, 1981, ANAL BIOCHEM, V118, P30, DOI 10.1016/0003-2697(81)90152-4; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Hu WZ, 2013, EXP EYE RES, V116, P109, DOI 10.1016/j.exer.2013.07.021; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shi L, 2013, P NATL ACAD SCI USA, V110, P7318, DOI 10.1073/pnas.1302490110; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WYLIE CC, 1987, DEV BIOL, V119, P496, DOI 10.1016/0012-1606(87)90052-2; Xing SF, 2012, TRENDS PLANT SCI, V17, P423, DOI 10.1016/j.tplants.2012.03.008; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhao S, 2012, SCIENCE, V327, P1000	46	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97693	10.1371/journal.pone.0097693	http://dx.doi.org/10.1371/journal.pone.0097693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831956	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500103
J	Alechine, E; Corach, D				Alechine, Evguenia; Corach, Daniel			High-Throughput Screening for Spermatogenesis Candidate Genes in the AZFc Region of the Y Chromosome by Multiplex Real Time PCR Followed by High Resolution Melting Analysis	PLOS ONE			English	Article							DELETION; MICRODELETIONS; RECOMBINATION; PALINDROMES; EXPRESSION; PROTEIN	Microdeletions in the AZF region of the Y chromosome are among the most frequent genetic causes of male infertility, although the specific role of the genes located in this region is not fully understood. AZFa and AZFb deletions impair spermatogenesis since no spermatozoa are found in the testis. Deletions of the AZFc region, despite being the most frequent in azoospermic patients, do not correlate with spermatogenic failure. Therefore, the aim of this work was to develop a screening method to ascertain the presence of the main spermatogenesis candidate genes located in the AZFc region in the light of the identification of those responsible for spermatogenic failure. DAZ, CDY, BPY2, PRY, GOLGA2LY and CSGP4LY genes were selected on the basis of their location in the AZFc region, testis-only expression, and confirmed or predicted protein codification. AMEL and SRY were used as amplification controls. The identification of Real Time PCR products was performed by High Resolution Melting analysis with SYTO 9 as intercalating dye. The herein described method allows a rapid, simple, low-cost, high-throughput screening for deletions of the main AZFc genes in patients with spermatogenic failure. This provides a strategy that would accelerate the identification of spermatogenesis candidate genes in larger populations of patients with non-obstructive idiopathic azoospermia.	[Alechine, Evguenia; Corach, Daniel] Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Corach, D (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina.	dcorach@yahoo.com		Alechine, Evguenia/0000-0001-6002-3093	National Research Council of Argentina (CONICET) (PIP) [1120110100914]; UBACyT [2011-2014 GC]	National Research Council of Argentina (CONICET) (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT	This work was supported by the National Research Council of Argentina (CONICET) (PIP N o1120110100914) and UBACyT (2011-2014 GC) grants awarded to DC. DC in Principal Research fellow and EA is a Doctoral fellow of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Foresta C, 2001, HUM REPROD, V16, P1543, DOI 10.1093/humrep/16.8.1543; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kozina V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023174; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Kumari A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041488, 10.1371/journal.pone.0041230]; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Noordam MJ, 2011, HUM MOL GENET, V20, P2457, DOI 10.1093/hmg/ddr119; Oklander LI, 2007, MOL ECOL NOTES, V7, P117, DOI 10.1111/j.1471-8286.2006.01529.x; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2000, Methods Mol Biol, V132, P365; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Yang Y, 2010, INT J ANDROL, V33, P745, DOI 10.1111/j.1365-2605.2009.01015.x; Zuccarelli G, 2011, FORENSIC SCI INT-GEN, V5, P105, DOI 10.1016/j.fsigen.2010.08.018	29	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97227	10.1371/journal.pone.0097227	http://dx.doi.org/10.1371/journal.pone.0097227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828879	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400065
J	Lo, CW; Chang, Y; Lee, JL; Tsai, WB; Chen, WS				Lo, Chia-Wen; Chang, Yung; Lee, Jyun-Lin; Tsai, Wei-Bor; Chen, Wen-Shiang			Tertiary-Amine Functionalized Polyplexes Enhanced Cellular Uptake and Prolonged Gene Expression	PLOS ONE			English	Article							IN-VIVO; TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; PLASMID DNA; SKELETAL-MUSCLE; THERAPEUTIC ULTRASOUND; MICROBUBBLE ULTRASOUND; DELIVERY-SYSTEMS; PEI-DNA; POLYETHYLENIMINE	Ultrasound (US) has been found to facilitate the transport of DNA across cell membranes. However, the transfection efficiency is generally low, and the expression duration of the transfected gene is brief. In this study, a tertiary polycation, Poly(2-(dimethylamino) ethyl methacrylate) (PDMAEMA), was used as a carrier for US-mediated gene transfection. Its in-vitro and in-vivo effects on the transfection efficiency and the expression duration were evaluated. A mixture of pCI-neo-luc and PDMAEMA was transfected to cultured cells or mouse muscle by exposure to 1-MHz pulse US. A strong expression of luciferase was found 10 days after the transfection in vitro regardless of US exposure. However, effective transfection only occurred in the US groups in vivo. The transfection ability depended on the weight ratio of PDMAEMA to DNA, and was different for the in-vitro and in-vivo conditions. Lower weight ratios, e.g., 0.25, exhibited better in-vivo expression for at least 45 days.	[Lo, Chia-Wen; Lee, Jyun-Lin; Chen, Wen-Shiang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lo, Chia-Wen; Lee, Jyun-Lin; Chen, Wen-Shiang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan, Taiwan; [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan, Taiwan; [Tsai, Wei-Bor] Natl Taiwan Univ, Dept Chem Engn, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chung Yuan Christian University; Chung Yuan Christian University; National Taiwan University	Chen, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	wenshiang@gmail.com	Wen-shiang, Chen/B-4794-2009; Chang, Yung/B-4788-2011	Wen-shiang, Chen/0000-0003-1488-5164; Tsai, Wei-Bor/0000-0002-2316-5751	National Science Council of the Republic of China [NSC 100-2923-B-002-004-MY3, 100-2923-B-002-003-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC 100-2923-B-002-004-MY3 and 100-2923-B-002-003-MY3 (SonInCaRe ANR-NSC project) from the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Bekeredjian R, 2006, ULTRASCHALL MED, V27, P134, DOI 10.1055/s-2005-858993; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cai JG, 2011, MACROMOLECULES, V44, P2050, DOI 10.1021/ma102498g; Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087; dos Santos T, 2011, SMALL, V7, P3341, DOI 10.1002/smll.201101076; Duvshani-Eshet M, 2007, CANCER GENE THER, V14, P306, DOI 10.1038/sj.cgt.7701015; Duvshani-Eshet M, 2007, MOL CANCER THER, V6, P2371, DOI 10.1158/1535-7163.MCT-07-0019; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Greenleaf WJ, 1998, ULTRASOUND MED BIOL, V24, P587, DOI 10.1016/S0301-5629(98)00003-9; Hayashi S, 2009, CANCER GENE THER, V16, P638, DOI 10.1038/cgt.2008.1; Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609; Kinoshita M, 2007, BIOCHEM BIOPH RES CO, V359, P860, DOI 10.1016/j.bbrc.2007.05.153; Lee JL, 2012, J CONTROL RELEASE, V160, P64, DOI 10.1016/j.jconrel.2012.03.007; Li YS, 2009, CANCER LETT, V273, P62, DOI 10.1016/j.canlet.2008.07.030; Liao ZK, 2012, CANCER GENE THER, V19, P171, DOI 10.1038/cgt.2011.73; Lo CH, 2010, J GENE MED, V12, P423, DOI 10.1002/jgm.1452; Lu QL, 2003, GENE THER, V10, P396, DOI 10.1038/sj.gt.3301913; Mannermaa E, 2005, CURR EYE RES, V30, P345, DOI 10.1080/02713680590934058; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P203, DOI 10.1016/j.jconrel.2005.01.011; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1; Morimoto K, 2003, MOL THER, V7, P254, DOI 10.1016/S1525-0016(02)00053-9; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007; Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Synatschke CV, 2011, BIOMACROMOLECULES, V12, P4247, DOI 10.1021/bm201111d; Taniyama Y, 2002, GENE THER, V9, P372, DOI 10.1038/sj.gt.3301678; vandeWetering P, 1997, J CONTROL RELEASE, V49, P59, DOI 10.1016/S0168-3659(97)00059-X; Verbaan F, 2003, EUR J PHARM SCI, V20, P419, DOI 10.1016/j.ejps.2003.09.005; Wang XH, 2005, RADIOLOGY, V237, P224, DOI 10.1148/radiol.2371040805; Zhang XQ, 2008, J MICROENCAPSUL, V25, P1, DOI 10.1080/02652040701659347 	40	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97627	10.1371/journal.pone.0097627	http://dx.doi.org/10.1371/journal.pone.0097627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827929	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400113
J	Tissier, ML; Williams, TD; Criscuolo, F				Tissier, Mathilde L.; Williams, Tony D.; Criscuolo, Francois			Maternal Effects Underlie Ageing Costs of Growth in the Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							OXIDATIVE STRESS; TELOMERE LENGTH; QUANTITATIVE PCR; SEX-DIFFERENCES; CORTICOSTERONE; YOLK; ESTRADIOL; RATES; AGE; 17-BETA-ESTRADIOL	Maternal effects provide a mechanism to adapt offspring phenotype and optimize the mother's fitness to current environmental conditions. Transferring steroids to the yolk is one way mothers can translate environmental information into potential adaptive signals for offspring. However, maternally-derived hormones might also have adverse effects for offspring. For example, recent data in zebra finch chicks suggested that ageing related-processes (i.e. oxidative stress and telomere loss) were increased after egg-injection of corticosterone (CORT). Still, we have few experimental data describing the effect of maternal effects on the growth-ageing trade-off in offspring. Here, we chronically treated pre-laying zebra finch females (Taeniopygia guttata) with 17-beta-estradiol (E-2) or CORT, and followed offspring growth and cellular ageing rates (oxidative stress and telomere loss). CORT treatment decreased growth rate in male chicks and increased rate of telomere loss in mothers and female offspring. E-2 increased body mass gain in male offspring, while reducing oxidative stress in both sexes but without affecting telomere loss. Since shorter telomeres were previously found to be a proxy of individual lifespan in zebra finches, maternal effects may, through pleiotropic effects, be important determinants of offspring life-expectancy by modulating ageing rate during embryo and post-natal growth.	[Tissier, Mathilde L.; Criscuolo, Francois] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France; [Williams, Tony D.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Simon Fraser University	Tissier, ML (corresponding author), Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France.	mathilde.tissier@iphc.cnrs.fr; francois.criscuolo@iphc.cnrs.fr			Natural Sciences and Engineering Research Council; Centre National de la Recherche Scientifique (CNRS)	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Natural Sciences and Engineering Research Council Discovery Grant funding to TDW. M. Tissier and the present experiment were both partly funded by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Beaulieu M, 2010, P ROY SOC B-BIOL SCI, V277, P1087, DOI 10.1098/rspb.2009.1881; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn, 2006, TELOMERES; Breuner CW, 2000, HORM BEHAV, V37, P23, DOI 10.1006/hbeh.1999.1554; CALOW P, 1982, AM NAT, V120, P416, DOI 10.1086/284001; Casagrande S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1319, DOI 10.1007/s00265-012-1387-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Christians JK, 1999, J EXP BIOL, V202, P2679; Costantini D, 2006, J COMP PHYSIOL B, V176, P329, DOI 10.1007/s00360-005-0055-6; Criscuolo F, 2011, OECOLOGIA, V167, P315, DOI 10.1007/s00442-011-1986-0; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Eng ML, 2013, ENVIRON TOXICOL CHEM, V32, P345, DOI 10.1002/etc.2033; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Harvey S, 2013, GEN COMP ENDOCR, V190, P3, DOI 10.1016/j.ygcen.2013.01.008; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Hayward LS, 2006, GEN COMP ENDOCR, V146, P144, DOI 10.1016/j.ygcen.2005.10.016; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Henriksen R, 2013, GEN COMP ENDOCR, V191, P83, DOI 10.1016/j.ygcen.2013.05.028; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hoogenboom MO, 2012, COMP BIOCHEM PHYS A, V163, P379, DOI 10.1016/j.cbpa.2012.07.002; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kilgas P, 2010, COMP BIOCHEM PHYS B, V157, P288, DOI 10.1016/j.cbpb.2010.07.002; Kim SY, 2010, J EVOLUTION BIOL, V23, P769, DOI 10.1111/j.1420-9101.2010.01942.x; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Kozlowski CP, 2010, GEN COMP ENDOCR, V168, P460, DOI 10.1016/j.ygcen.2010.06.006; Kyo S, 1999, CANCER RES, V59, P5917; Love OP, 2008, HORM BEHAV, V53, P104, DOI 10.1016/j.yhbeh.2007.09.007; Love OP, 2008, AM NAT, V172, pE135, DOI 10.1086/590959; Love OP, 2003, INTEGR COMP BIOL, V43, P838; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Oddie KR, 2000, J ANIM ECOL, V69, P903, DOI 10.1046/j.1365-2656.2000.00438.x; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; Schultner J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2090; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Shipley B, 2004, CAUSE CORRELATION BI; Spencer KA, 2008, GEN COMP ENDOCR, V159, P250, DOI 10.1016/j.ygcen.2008.09.007; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Thierry AM, 2013, THESIS U STRASBOURG; von Engelhardt N, 2004, HORM BEHAV, V45, P306, DOI 10.1016/j.yhbeh.2003.12.009; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Williams TD, 2005, P ROY SOC B-BIOL SCI, V272, P173, DOI 10.1098/rspb.2004.2935; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; You YY, 2009, PROG NAT SCI-MATER, V19, P427, DOI 10.1016/j.pnsc.2008.05.035	65	42	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97705	10.1371/journal.pone.0097705	http://dx.doi.org/10.1371/journal.pone.0097705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828412	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400119
J	Wen, X; Kurtz, I; Paine, ML				Wen, Xin; Kurtz, Ira; Paine, Michael L.			Prevention of the Disrupted Enamel Phenotype in Slc4a4-Null Mice Using Explant Organ Culture Maintained in a Living Host Kidney Capsule	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; COTRANSPORTER NBCE1; METABOLIC-ACIDOSIS; MISSENSE MUTATION; MINERALIZATION; DEFECTS; BONE; HYPOPHOSPHATASIA; AMELOBLASTS; MATURATION	Slc4a4-null mice are a model of proximal renal tubular acidosis ( pRTA). Slc4a4 encodes the electrogenic sodium base transporter NBCe1 that is involved in transcellular base transport and pH regulation during amelogenesis. Patients with mutations in the SLC4A4 gene and Slc4a4-null mice present with dysplastic enamel, amongst other pathologies. Loss of NBCe1 function leads to local abnormalities in enamel matrix pH regulation. Loss of NBCe1 function also results in systemic acidemic blood pH. Whether local changes in enamel pH and/or a decrease in systemic pH are the cause of the abnormal enamel phenotype is currently unknown. In the present study we addressed this question by explanting fetal wild-type and Slc4a4-null mandibles into healthy host kidney capsules to study enamel formation in the absence of systemic acidemia. Mandibular E11.5 explants from NBCe1(-/-) mice, maintained in host kidney capsules for 70 days, resulted in teeth with enamel and dentin with morphological and mineralization properties similar to cultured NBCe1(+/+) mandibles grown under identical conditions. Ameloblasts express a number of proteins involved in dynamic changes in H+/base transport during amelogenesis. Despite the capacity of ameloblasts to dynamically modulate the local pH of the enamel matrix, at least in the NBCe1(-/-) mice, the systemic pH also appears to contribute to the enamel phenotype. Extrapolating these data to humans, our findings suggest that in patients with NBCe1 mutations, correction of the systemic metabolic acidosis at a sufficiently early time point may lead to amelioration of enamel abnormalities.	[Wen, Xin; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Paine, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	paine@usc.edu			National Institutes of Health [DE019629, DK077162]; The Donald T. Sterling Charitable Foundation; Factor Family Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Donald T. Sterling Charitable Foundation; Factor Family Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DE019629 (MLP) and DK077162 (IK) from the National Institutes of Health, and The Donald T. Sterling Charitable Foundation and the Factor Family Foundation (IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; CUNHA GR, 1989, BIOL REPROD, V40, P861, DOI 10.1095/biolreprod40.4.861; Demirci FYK, 2006, MOL VIS, V12, P324; Descroix V, 2010, J DENT RES, V89, P1427, DOI 10.1177/0022034510379603; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Fan YW, 2011, ACTA BIOMATER, V7, P2293, DOI 10.1016/j.actbio.2011.01.028; Fukui N, 2000, ORAL SURG ORAL MED O, V89, P208, DOI 10.1067/moe.2000.103884; Gauvin R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-24; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Hu JCC, 2000, EUR J ORAL SCI, V108, P189, DOI 10.1034/j.1600-0722.2000.108003189.x; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; KOPPANG HS, 1984, SCAND J DENT RES, V92, P489; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kurtz I, 2013, SELDIN GIEBISCHS KID, P1837, DOI DOI 10.1016/B978-0-12-381462-3.00053-7; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lacruz RS, 2010, J BIOL CHEM, V285, P24432, DOI 10.1074/jbc.M110.115188; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; Le Norcy E, 2011, J DENT RES, V90, P1091, DOI 10.1177/0022034511411301; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Masuyama R, 2001, ENDOCRINOLOGY, V142, P494, DOI 10.1210/en.142.1.494; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; McCance RA, 1961, LANCET, V277, P293; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Muller F, 1996, CLIN CHEM, V42, P1855; Nanci A., 2008, 10 CATES ORAL HISTOL; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SPACKMAN T, 1963, OBSTET GYNECOL, V22, P785; Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang XM, 2009, ARCH ORAL BIOL, V54, P1105, DOI 10.1016/j.archoralbio.2009.09.004; Zhang XM, 2009, ARCH ORAL BIOL, V54, P299, DOI 10.1016/j.archoralbio.2009.01.002	42	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97318	10.1371/journal.pone.0097318	http://dx.doi.org/10.1371/journal.pone.0097318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828138	Green Published, gold, Green Submitted			2022-12-25	WOS:000336857400076
J	Wolfe, KJ; Ren, HY; Trepte, P; Cyr, DM				Wolfe, Katie J.; Ren, Hong Yu; Trepte, Philipp; Cyr, Douglas M.			Polyglutamine-Rich Suppressors of Huntingtin Toxicity Act Upstream of Hsp70 and Sti1 in Spatial Quality Control of Amyloid-Like Proteins	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; UBIQUITIN-PROTEASOME SYSTEM; MUTANT HUNTINGTIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; EXPANDED POLYGLUTAMINE; EXPANSION PROTEINS; ALZHEIMERS-DISEASE; CASPASE CLEAVAGE; BODY FORMATION	Protein conformational maladies such as Huntington Disease are characterized by accumulation of intracellular and extracellular protein inclusions containing amyloid-like proteins. There is an inverse correlation between proteotoxicity and aggregation, so facilitated protein aggregation appears cytoprotective. To define mechanisms for protective protein aggregation, a screen for suppressors of nuclear huntingtin (Htt103Q) toxicity was conducted. Nuclear Htt103Q is highly toxic and less aggregation prone than its cytosolic form, so we identified suppressors of cytotoxicity caused by Htt103Q tagged with a nuclear localization signal (NLS). High copy suppressors of Htt103Q-NLS toxicity include the polyQ-domain containing proteins Nab3, Pop2, and Cbk1, and each suppresses Htt toxicity via a different mechanism. Htt103Q-NLS appears to inactivate the essential functions of Nab3 in RNA processing in the nucleus. Function of Pop2 and Cbk1 is not impaired by nuclear Htt103Q, as their respective polyQ-rich domains are sufficient to suppress Htt103Q toxicity. Pop2 is a subunit of an RNA processing complex and is localized throughout the cytoplasm. Expression of just the Pop2 polyQ domain and an adjacent proline-rich stretch is sufficient to suppress Htt103Q toxicity. The proline-rich domain in Pop2 resembles an aggresome targeting signal, so Pop2 may act in trans to positively impact spatial quality control of Htt103Q. Cbk1 accumulates in discrete perinuclear foci and overexpression of the Cbk1 polyQ domain concentrates diffuse Htt103Q into these foci, which correlates with suppression of Htt toxicity. Protective action of Pop2 and Cbk1 in spatial quality control is dependent upon the Hsp70 co-chaperone Sti1, which packages amyloid-like proteins into benign foci. Protein: protein interactions between Htt103Q and its intracellular neighbors lead to toxic and protective outcomes. A subset of polyQ-rich proteins buffer amyloid toxicity by funneling toxic aggregation intermediates to the Hsp70/Sti1 system for spatial organization into benign species.	[Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Trepte, Philipp] Max Delbruck Ctr Mol Med, Berlin, Germany	University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cyr, DM (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	dmcyr@med.unc.edu		Trepte, Philipp/0000-0002-8141-6272; Cyr, Douglas/0000-0002-4928-3414	NIH [R01GM56981, R01GM067785, F31NS074777]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH: R01GM56981, R01GM067785, and F31NS074777. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2009, MOL BIOL CELL; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hobor F, 2011, J BIOL CHEM, V286, P3645, DOI 10.1074/jbc.M110.158774; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Malinovska L, 2012, MOL BIOL CELL; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Robertson AL, 2011, NUCLEIC ACIDS RES, V39, pD272, DOI 10.1093/nar/gkq1100; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Treusch S, 2012, J CELL BIOL, V197, P369, DOI 10.1083/jcb.201108146; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wolfe KJ, 2013, MOL BIOL CELL	77	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95914	10.1371/journal.pone.0095914	http://dx.doi.org/10.1371/journal.pone.0095914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828240	Green Published, gold, Green Accepted			2022-12-25	WOS:000336857400017
J	Xie, L; Chen, JL; Zhang, WZ; Wang, SZ; Zhao, TL; Huang, C; Wang, J; Yang, JF; Yang, YF; Tan, ZP				Xie, Li; Chen, Jin-Lan; Zhang, Wei-Zhi; Wang, Shou-Zheng; Zhao, Tian-Li; Huang, Can; Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping			Rare De Novo Copy Number Variants in Patients with Congenital Pulmonary Atresia	PLOS ONE			English	Article							HEART-DEFECTS; DIHYDROFOLATE-REDUCTASE; FOLATE PATHWAY; GENES; RISK; TETRALOGY; MUTATIONS; ANEURYSMS; GENETICS; DISEASE	Background: Ongoing studies using genomic microarrays and next-generation sequencing have demonstrated that the genetic contributions to cardiovascular diseases have been significantly ignored in the past. The aim of this study was to identify rare copy number variants in individuals with congenital pulmonary atresia (PA). Methods and Results: Based on the hypothesis that rare structural variants encompassing key genes play an important role in heart development in PA patients, we performed high-resolution genome-wide microarrays for copy number variations (CNVs) in 82 PA patient-parent trios and 189 controls with an Illumina SNP array platform. CNVs were identified in 17/82 patients (20.7%), and eight of these CNVs (9.8%) are considered potentially pathogenic. Five de novo CNVs occurred at two known congenital heart disease (CHD) loci (16p13.1 and 22q11.2). Two de novo CNVs that may affect folate and vitamin B-12 metabolism were identified for the first time. A de novo 1-Mb deletion at 17p13.2 may represent a rare genomic disorder that involves mild intellectual disability and associated facial features. Conclusions: Rare CNVs contribute to the pathogenesis of PA (9.8%), suggesting that the causes of PA are heterogeneous and pleiotropic. Together with previous data from animal models, our results might help identify a link between CHD and folate-mediated one-carbon metabolism (FOCM). With the accumulation of high-resolution SNP array data, these previously undescribed rare CNVs may help reveal critical gene(s) in CHD and may provide novel insights about CHD pathogenesis.	[Xie, Li; Chen, Jin-Lan; Zhang, Wei-Zhi; Wang, Shou-Zheng; Zhao, Tian-Li; Huang, Can; Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping] Cent S Univ, Xiangya Hosp 2, State Key Lab Med Genet, Clin Ctr Gene Diag & Therapy, Changsha, Hunan, Peoples R China	Central South University; Central South University	Yang, YF (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	yyf627@163.com; tanzhiping@gmail.com			National High Technology Research and Development Program of China (863 Program) [2011AA02A112]; National Key Technology R&D Program of China [2012BAI09B05]; National Natural Science Foundation of China [81101475, 81370204, 81300072, 81200087]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We appreciate supports from the National High Technology Research and Development Program of China (863 Program) (2011AA02A112 to YYF), the National Key Technology R&D Program of China (2012BAI09B05 to YYF), the National Natural Science Foundation of China (81101475 to TZP, 81370204 to YYF, 81300072 to CJL, and 81200087 to ZWZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amark KM, 2006, J AM COLL CARDIOL, V47, P1448, DOI 10.1016/j.jacc.2005.10.068; Andersen TA, 2014, CELL MOL LIFE SCI, V71, P1327, DOI 10.1007/s00018-013-1430-1; Arrington CB, 2012, CIRC-CARDIOVASC GENE, V5, P175, DOI 10.1161/CIRCGENETICS.111.961797; Bansal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085375; Barc Julien, 2011, J Am Coll Cardiol, V57, P40, DOI 10.1016/j.jacc.2010.08.621; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Cario H, 2011, AM J HUM GENET, V88, P226, DOI 10.1016/j.ajhg.2011.01.007; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Digilio MC, 1996, AM J CARDIOL, V77, P1375, DOI 10.1016/S0002-9149(96)00212-3; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Gelb BD, 2013, CURR OPIN P IN PRESS; Goldmuntz E, 2008, CIRC-CARDIOVASC GENE, V1, P126, DOI 10.1161/CIRCGENETICS.108.796342; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hitz MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002903; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kozyraki R, 2001, J MOL MED, V79, P161, DOI 10.1007/s001090100193; Krepischi-Santos ACV, 2009, CYTOGENET GENOME RES, V125, P1, DOI 10.1159/000218743; Lalani SR, 2013, EUR J HUM GENET, V21, P173, DOI 10.1038/ejhg.2012.155; Lee MS, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-12; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Leonard H, 2000, HEART, V84, P499, DOI 10.1136/heart.84.5.499; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luo C, 2012, AM J MED GENET A, V158A, P1918, DOI 10.1002/ajmg.a.35471; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Rodriguez RMG, 2013, INT J CARDIOL, V167, P768, DOI 10.1016/j.ijcard.2012.03.047; Roos L, 2009, J MED GENET, V46, P703, DOI 10.1136/jmg.2008.065094; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Stover PJ, 2011, ADV NUTR, V2, P325, DOI 10.3945/an.111.000596; Sun SN, 2011, ACTA BIOCH BIOPH SIN, V43, P957, DOI 10.1093/abbs/gmr098; Tang LS, 2004, BIRTH DEFECTS RES A, V70, P449, DOI 10.1002/bdra.20043; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tremblay N, 2011, EUR HEART J, V32, P568, DOI 10.1093/eurheartj/ehq447; Tsaroucha AK, 2008, CLIN EXP MED, V8, P165, DOI 10.1007/s10238-008-0174-y; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815	41	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96471	10.1371/journal.pone.0096471	http://dx.doi.org/10.1371/journal.pone.0096471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826987	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400027
J	Yang, YS; Zhang, F; Tang, DJ; Yang, YH; Zhu, HL				Yang, Yu-Shun; Zhang, Fei; Tang, Dan-Jie; Yang, Yong-Hua; Zhu, Hai-Liang			Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-Diaryl-4,5-Dihydro-1H-Pyrazol-5-yl)Phenol Derivatives as Inhibitors of B-Raf Kinase	PLOS ONE			English	Article							SIGNALING PATHWAY; BRAF INHIBITORS; CANCER; ACTIVATION; MUTATIONS; MELANOMA; TUMORS; GENE	A series of novel 2-(1,3-diaryl- 4,5-dihydro-1H-pyrazol-5-yl)phenol derivatives (C1-C24) have been synthesized. The B-Raf inhibitory activity and anti-proliferation activity of these compounds have been tested. Compound C6 displayed the most potent biological activity against B-Raf(V600E) (IC50 = 0.15 mu M) and WM266.4 human melanoma cell line (GI(50) = 1.75 mu M), being comparable with the positive control (Vemurafenib and Erlotinib) and more potent than our previous best compounds. The docking simulation was performed to analyze the probable binding models and poses while the QSAR model was built to check the previous work as well as to introduce new directions. This work aimed at seeking more potent inhibitors as well as discussing some previous findings. As a result, the introduction of ortho-hydroxyl group on 4,5-dihydro-1H-pyrazole skeleton did reinforce the anti-tumor activity while enlarging the group on N-1 of pyrazoline was also helpful.	[Yang, Yu-Shun; Zhang, Fei; Tang, Dan-Jie; Yang, Yong-Hua; Zhu, Hai-Liang] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yu-Shun] Nanjing Univ, Inst Chem & Biomed Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Yang, YH (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	yangyh@nju.edu.cn; zhuhl@nju.edu.cn		Yang, Yu-Shun/0000-0001-5424-8202	National Natural Science Foundation of China [J1103512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by National Natural Science Foundation of China (No. J1103512'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarifar D, 2003, MOLECULES, V8, P642, DOI 10.3390/80800642; Blackburn C, 2010, BIOORG MED CHEM LETT, V20, P4795, DOI 10.1016/j.bmcl.2010.06.110; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De DYD, 1998, J MED CHEM, V41, P4918, DOI 10.1021/jm980146x; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; El-Azab AS, 2010, EUR J MED CHEM, V45, P4188, DOI 10.1016/j.ejmech.2010.06.013; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P367, DOI 10.1007/s10555-005-1585-9; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Kalinsky K, 2007, EXPERT REV ANTICANC, V7, P715, DOI 10.1586/14737140.7.5.715; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kirkpatrick P, 2004, NAT REV DRUG DISCOV, V3, P299, DOI 10.1038/nrd1364; Latif N, 1983, EGYPT J CHEM, V26, P521; Li CY, 2012, BIOORGAN MED CHEM, V20, P3746, DOI 10.1016/j.bmc.2012.04.047; Li NX, 2007, CURR OPIN INVEST DR, V8, P452; Liu JJ, 2012, BIOORGAN MED CHEM, V20, P6089, DOI 10.1016/j.bmc.2012.08.020; Mathieu S, 2012, J MED CHEM, V55, P2869, DOI 10.1021/jm300016v; Newhouse BJ, 2011, BIOORG MED CHEM LETT, V21, P3488, DOI 10.1016/j.bmcl.2010.12.038; Niculescu-Duvaz D, 2010, BIOORGAN MED CHEM, V18, P6934, DOI 10.1016/j.bmc.2010.06.031; Sommers JA, 2005, CANCER RES, V65, P1223, DOI 10.1158/0008-5472.CAN-03-0231; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu XL, 2003, CANCER RES, V63, P4561; Yang YS, 2012, BIOORGAN MED CHEM, V20, P6048, DOI 10.1016/j.bmc.2012.08.043	26	0	0	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95702	10.1371/journal.pone.0095702	http://dx.doi.org/10.1371/journal.pone.0095702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827980	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400014
J	Moriwaki, S; Suzuki, K; Muramatsu, M; Nomura, A; Inoue, F; Into, T; Yoshiko, Y; Niida, S				Moriwaki, Sawako; Suzuki, Keiko; Muramatsu, Masashi; Nomura, Atsushi; Inoue, Fumihide; Into, Takeshi; Yoshiko, Yuji; Niida, Shumpei			Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice	PLOS ONE			English	Article							INFLAMMATORY MEDIATORS; KAPPA-B; DIFFERENTIATION; FLAVONOIDS; RANKL; BIOAVAILABILITY; ABSORPTION; RAT; TRANSFORMATION; TRANSCRIPTION	Anthocyanins, one of the flavonoid subtypes, are a large family of water-soluble phytopigments and have a wide range of health-promoting benefits. Recently, an anthocyanin-rich compound from blueberries was reported to possess protective property against bone loss in ovariectomized (OVX) animal models. However, the active ingredients in the anthocyanin compound have not been identified. Here we show that delphinidin, one of the major anthocyanidins in berries, is a potent active ingredient in anti-osteoporotic bone resorption through the suppression of osteoclast formation. In vitro examinations revealed that delphinidin treatment markedly inhibited the differentiation of RAW264.7 cells into osteoclasts compared with other anthocyanidins, cyanidin and peonidin. Oral administration of delphinidin significantly prevented bone loss in both RANKL-induced osteoporosis model mice and OVX model mice. We further provide evidence that delphinidin suppressed the activity of NF-kappa B, c-fos, and Nfatc1, master transcriptional factors for osteoclastogenesis. These results strongly suggest that delphinidin is the most potent inhibitor of osteoclast differentiation and will be an effective agent for preventing bone loss in postmenopausal osteoporosis.	[Moriwaki, Sawako; Muramatsu, Masashi; Niida, Shumpei] NCGG, Lab Genom & Prote, Aichi, Japan; [Moriwaki, Sawako; Niida, Shumpei] NCGG, Biobank Omics Unit, Aichi, Japan; [Suzuki, Keiko] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo 142, Japan; [Nomura, Atsushi; Inoue, Fumihide] Nihon Seiyaku Kogyo Co Ltd, Aichi, Japan; [Into, Takeshi] Asahi Univ, Sch Dent, Dept Oral Bacteriol, Div Oral Infect & Hlth Sci, Gifu, Japan; [Yoshiko, Yuji] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan	Showa University; Asahi University; Hiroshima University	Niida, S (corresponding author), NCGG, Lab Genom & Prote, Aichi, Japan.	sniida@ncgg.go.jp			Japan Society for the Promotion of Science (KAKENHI) [20390469, 21791802]; Ministry of Health Labour and Welfare (Health Labour Sciences Research) [H24-Choju-007]; Grants-in-Aid for Scientific Research [23592747] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labour and Welfare (Health Labour Sciences Research)(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Japan Society for the Promotion of Science (KAKENHI Grant No. 20390469 to SN and No. 21791802 to SM) and by Ministry of Health Labour and Welfare (Health Labour Sciences Research Grant No. H24-Choju-007 to SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Hafeez B, 2008, CELL CYCLE, V7, P3320, DOI 10.4161/cc.7.21.6969; Bu SY, 2008, CALCIFIED TISSUE INT, V82, P475, DOI 10.1007/s00223-008-9139-0; Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892; Devareddy L, 2008, J NUTR BIOCHEM, V19, P694, DOI 10.1016/j.jnutbio.2007.09.004; Diel P, 2004, MOL CELL ENDOCRINOL, V221, P21, DOI 10.1016/j.mce.2004.04.006; Einbond LS, 2004, FOOD CHEM, V84, P23, DOI 10.1016/S0308-8146(03)00162-6; Gehlbach SH, 2002, AM J PUBLIC HEALTH, V92, P271, DOI 10.2105/AJPH.92.2.271; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; Hollman PCH, 2004, PHARM BIOL, V42, P74, DOI 10.3109/13880200490893492; Hou DX, 2004, CARCINOGENESIS, V25, P29, DOI 10.1093/carcin/bgg184; Inami K, 2008, ORTHOD WAVES, V67, P150, DOI 10.1016/j.odw.2008.04.003; Karlsen A, 2007, J NUTR, V137, P1951; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Kwon JY, 2007, ANN NY ACAD SCI, V1095, P513, DOI 10.1196/annals.1397.055; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Manach C, 1997, FEBS LETT, V409, P12, DOI 10.1016/S0014-5793(97)00467-5; Matsumoto H, 2001, J AGR FOOD CHEM, V49, P1546, DOI 10.1021/jf001246q; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Mazza G, 2002, J AGR FOOD CHEM, V50, P7731, DOI 10.1021/jf020690l; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737; MIDDLETON E, 1992, BIOCHEM PHARMACOL, V43, P1167, DOI 10.1016/0006-2952(92)90489-6; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wallace TC, 2011, ADV NUTR, V2, P1, DOI 10.3945/an.110.000042; Wattel A, 2004, J CELL BIOCHEM, V92, P285, DOI 10.1002/jcb.20071; Welch A, 2012, J BONE MINER RES, V27, P1872, DOI 10.1002/jbmr.1649; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130	35	69	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97177	10.1371/journal.pone.0097177	http://dx.doi.org/10.1371/journal.pone.0097177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824988	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200069
J	Deas, M; Andrefouet, S; Leopold, M; Guillemot, N				Deas, Marilyn; Andrefouet, Serge; Leopold, Marc; Guillemot, Nicolas			Modulation of Habitat-Based Conservation Plans by Fishery Opportunity Costs: A New Caledonia Case Study Using Fine-Scale Catch Data	PLOS ONE			English	Article							MARINE PROTECTED AREAS; PACIFIC ISLAND COUNTRIES; CORAL-REEF FISHERIES; SOCIOECONOMIC DATA; LOCAL KNOWLEDGE; INFORMATION-SYSTEMS; MANAGEMENT; DESIGN; GIS; SUSTAINABILITY	Numerous threats impact coral reefs and conservation actions are urgently needed. Fast production of marine habitat maps promotes the use of habitat-only conservation plans, where a given percentage of the area of each habitat is set as conservation objectives. However, marine reserves can impact access to fishing grounds and generate opportunity costs for fishers that need to be minimized. In New Caledonia (Southwest Pacific), we used fine-scale fishery catch maps to define nineteen opportunity costs layers (expressed as biomass catch loss) considering i) total catches, ii) target fish families, iii) local marine tenure, and iv) gear type. The expected lower impacts on fishery catch when using the different cost constraints were ranked according to effectiveness in decreasing the costs generated by the habitat-only scenarios. The exercise was done for two habitat maps with different thematic richness. In most cases, habitat conservation objectives remained achievable, but effectiveness varied widely between scenarios and between habitat maps. The results provide practical guidelines for coral reef conservation and management. Habitat-only scenarios can be used to initiate conservation projects with stakeholders but the costs induced by such scenarios can be lowered by up to 50-60% when detailed exhaustive fishery data are used. When using partial data, the gain would be only in the 15-25% range. The best compromises are achieved when using local data.	[Deas, Marilyn; Andrefouet, Serge] CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Noumea, New Caledonia; [Leopold, Marc] CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Port Vila, Vanuatu, New Caledonia; [Leopold, Marc] Fisheries Dept Vanuatu, Port Vila, Vanuatu, New Caledonia	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Andrefouet, S (corresponding author), CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Noumea, New Caledonia.	serge.andrefouet@ird.fr			New Caledonia ZONECO Program; LITEAU French national Program (COGERON Project); Koniambo Nickel SAS mining company; NASA; IRD	New Caledonia ZONECO Program; LITEAU French national Program (COGERON Project); Koniambo Nickel SAS mining company; NASA(National Aeronautics & Space Administration (NASA)); IRD	Data acquisition funded by: New Caledonia ZONECO Program, the LITEAU French national Program (COGERON Project) and the Koniambo Nickel SAS mining company. The Millennium map is a product funded by NASA and the IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Andrefouet S, 2008, J SPAT SCI, V53, P113, DOI 10.1080/14498596.2008.9635140; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Andrefouet S., 2008, ATLAS RECIFS CORALLI; Andrefouet S., 2009, ATLAS W INDIAN OCEAN; Anuchiracheeva S, 2003, OCEAN COAST MANAGE, V46, P1049, DOI 10.1016/j.ocecoaman.2004.01.001; Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2011, J EXP MAR BIOL ECOL, V408, P21, DOI 10.1016/j.jembe.2011.07.023; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Bell, 2011, VULNERABILITY TROPIC; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; David G, 2010, MAR POLLUT BULL, V61, P323, DOI 10.1016/j.marpolbul.2010.06.020; De Freitas DM, 2009, J ENVIRON MANAGE, V90, P2071, DOI 10.1016/j.jenvman.2007.08.026; Guillemot N, 2009, ATLAS PECHE NONPROFE; Guillemot N., 2009, THESIS IRD AGROCAMPU; Guillemot N, 2009, FISH RES, V98, P51, DOI 10.1016/j.fishres.2009.03.013; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Hamel MA, 2010, MAR POLLUT BULL, V60, P1397, DOI 10.1016/j.marpolbul.2010.07.002; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Kronen M, 2012, OCEAN COAST MANAGE, V55, P63, DOI 10.1016/j.ocecoaman.2011.07.011; Leopold M., 2013, VERTIGO, V13, DOI [10.4000/vertigo.13297, DOI 10.4000/VERTIGO.13297]; Leopold M, 2014, ICES J MAR SCI, V71, P1781, DOI 10.1093/icesjms/fst204; NAIDOO R, 2006, TRENDS ECOL EVOL, V21, P7; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; van de Geer C, 2013, MAR POLICY, V39, P248, DOI 10.1016/j.marpol.2012.11.006; Walmsley SF, 2003, ENVIRON CONSERV, V30, P388, DOI 10.1017/S0376892903000407; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	36	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97409	10.1371/journal.pone.0097409	http://dx.doi.org/10.1371/journal.pone.0097409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835216	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800045
J	McBride, SH; McKenzie, JA; Bedrick, BS; Kuhlmann, P; Pasteris, JD; Rosen, V; Silva, MJ				McBride, Sarah H.; McKenzie, Jennifer A.; Bedrick, Bronwyn S.; Kuhlmann, Paige; Pasteris, Jill D.; Rosen, Vicki; Silva, Matthew J.			Long Bone Structure and Strength Depend on BMP2 from Osteoblasts and Osteocytes, but Not Vascular Endothelial Cells	PLOS ONE			English	Article							DISTRACTION OSTEOGENESIS; RAT ULNA; PERIOSTEUM; GENE; DIFFERENTIATION; CALCIFICATION; ANGIOGENESIS; PROGENITORS; EXPRESSION; MOUSE	The importance of bone morphogenetic protein 2 (BMP2) in the skeleton is well known. BMP2 is expressed in a variety of tissues during development, growth and healing. In this study we sought to better identify the role of tissue-specific BMP2 during post-natal growth and to determine if BMP2 knockout affects the ability of terminally differentiated cells to create high quality bone material. We targeted BMP2 knockout to two differentiated cell types known to express BMP2 during growth and healing, early-stage osteoblasts and their progeny (osterix promoted Cre) and vascular endothelial cells (vascular-endothelial-cadherin promoted Cre). Our objectives were to assess post-natal bone growth, structure and strength. We hypothesized that removal of BMP2 from osteogenic and vascular cells (separately) would result in smaller skeletons with inferior bone material properties. At 12 and 24 weeks of age the osteoblast knockout of BMP2 reduced body weight by 20%, but the vascular knockout had no effect. Analysis of bone in the tibia revealed reductions in cortical and cancellous bone size and volume in the osteoblast knockout, but not in the vascular endothelial knockout. Furthermore, forelimb strength testing revealed a 30% reduction in ultimate force at both 12 and 24 weeks in the osteoblast knockout of BMP2, but no change in the vascular endothelial knockout. Moreover, mechanical strength testing of femurs from osteoblast knockout mice demonstrated an increased Young's modulus (greater than 35%) but decreased post-yield displacement (greater than 50%) at both 12 and 24 weeks of age. In summary, the osteoblast knockout of BMP2 reduced bone size and altered mechanical properties at the whole-bone and material levels. Osteoblast-derived BMP2 has an important role in post-natal skeletal growth, structure and strength, while vascular endothelial-derived BMP2 does not.	[McBride, Sarah H.; McKenzie, Jennifer A.; Kuhlmann, Paige; Silva, Matthew J.] Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63130 USA; [McBride, Sarah H.] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA; [Bedrick, Bronwyn S.; Pasteris, Jill D.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Rosen, Vicki] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Harvard University; Harvard School of Dental Medicine	McBride, SH (corresponding author), Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63130 USA.	SMcBrid9@SLU.edu		Pasteris, Jill/0000-0001-7041-6966; Silva, Matthew/0000-0001-7375-4522	Washington University T32 Metabolic Skeletal Disorders Training Program [NIH 1T32AR060719-01]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR050211]; Washington University Musculoskeletal Research Center [NIH P30 AR057235]; Amgen Scholars Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060719, P30AR057235, R01AR050211] Funding Source: NIH RePORTER	Washington University T32 Metabolic Skeletal Disorders Training Program; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington University Musculoskeletal Research Center; Amgen Scholars Program(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the following sources: Washington University T32 Metabolic Skeletal Disorders Training Program (NIH 1T32AR060719-01) (SM), National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) AR050211 (SM, JM, MJS), Washington University Musculoskeletal Research Center (NIH P30 AR057235), and Amgen Scholars Program (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; [Anonymous], METABOLISM, V58, P644; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Colnot C, 2012, J ORTHOP RES, V30, P1869, DOI 10.1002/jor.22181; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Doss MX, 2012, STEM CELL REV REP, V8, P43, DOI 10.1007/s12015-011-9263-5; Feng JS, 2011, CELLS TISSUES ORGANS, V194, P216, DOI 10.1159/000324644; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jacobsen KA, 2008, J BONE MINER RES, V23, P596, DOI [10.1359/jbmr.080103, 10.1359/JBMR.080103]; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Li Z, 2014, AM MINERAL IN PRESS; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Martinez MD, 2010, BONE, V46, P1604, DOI 10.1016/j.bone.2010.02.030; Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017; McGuigan FE, 2007, CALCIFIED TISSUE INT, V81, P254, DOI 10.1007/s00223-007-9054-9; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Medici M, 2006, J BONE MINER RES, V21, P845, DOI [10.1359/jbmr.060306, 10.1359/JBMR.060306]; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nyman JS, 2012, CURR OSTEOPOROS REP, V10, P169, DOI 10.1007/s11914-012-0101-8; Oh JH, 2012, BIOCHEM BIOPH RES CO, V418, P634, DOI 10.1016/j.bbrc.2012.01.064; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; SIMPSON AHRW, 1985, J ANAT, V140, P697; Skinner HCW, 2005, MINERAL MAG, V69, P621, DOI 10.1180/0026461056950275; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Tomlinson RE, 2013, J APP PHYSL; Tomlinson RE, 2013, BONE, V52, P212, DOI 10.1016/j.bone.2012.09.035; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Varanasi SS, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/243465; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Wu LA, 2011, CELL TISSUE RES, V343, P545, DOI 10.1007/s00441-010-1120-3; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Zhang HB, 1996, DEVELOPMENT, V122, P2977	43	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96862	10.1371/journal.pone.0096862	http://dx.doi.org/10.1371/journal.pone.0096862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837969	Green Published, gold, Green Submitted			2022-12-25	WOS:000339614800022
J	Yue, H; Yu, JB; He, JW; Zhang, Z; Fu, WZ; Zhang, H; Wang, C; Hu, WW; Gu, JM; Hu, YQ; Li, M; Liu, YJ; Zhang, ZL				Yue, Hua; Yu, Jin-bo; He, Jin-wei; Zhang, Zeng; Fu, Wen-zhen; Zhang, Hao; Wang, Chun; Hu, Wei-wei; Gu, Jie-mei; Hu, Yun-qiu; Li, Miao; Liu, Yu-juan; Zhang, Zhen-lin			Identification of Two Novel Mutations in the PHEX Gene in Chinese Patients with Hypophosphatemic Rickets/Osteomalacia	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; PEX GENE; FAMILIES; RICKETS; EXPRESSION; FGF23; DMP1	Objective: X-linked dominant hypophosphatemia (XLH) is the most prevalent form of inherited rickets/osteomalacia in humans. The aim of this study was to identify PHEX gene mutations and describe the clinical features observed in 6 unrelated Chinese families and 3 sporadic patients with hypophosphatemic rickets/osteomalacia. Methods: For this study, 45 individuals from 9 unrelated families of Chinese Han ethnicity (including 16 patients and 29 normal phenotype subjects), and 250 healthy donors were recruited. All 22 exons and exon-intron boundaries of the PHEX gene were amplified by polymerase chain reaction (PCR) and directly sequenced. Results: The PHEX mutations were detected in 6 familial and 3 sporadic hypophosphatemic rickets/osteomalacia. Altogether, 2 novel mutations were detected: 1 missense mutation c.1183G>C in exon 11, resulting in p.Gly395Arg and 1 missense mutation c.1751A>C in exon 17, resulting in p.His584Pro. No mutations were found in the 250 healthy controls. Conclusions: Our study increases knowledge of the PHEX gene mutation types and clinical phenotypes found in Chinese patients with XLH, which is important for understanding the genetic basis of XLH. The molecular diagnosis of a PHEX genetic mutation is of great importance for confirming the clinical diagnosis of XLH, conducting genetic counseling, and facilitating prenatal intervention, especially in the case of sporadic patients.	[Yue, Hua; He, Jin-wei; Zhang, Zeng; Fu, Wen-zhen; Zhang, Hao; Wang, Chun; Hu, Wei-wei; Gu, Jie-mei; Hu, Yun-qiu; Li, Miao; Liu, Yu-juan; Zhang, Zhen-lin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Osteoporosis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China; [Yu, Jin-bo] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pediat, Shanghai 200030, Peoples R China; [Zhang, Zeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Osteoporosis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China.	ZZL2002@medmail.com.cn			National Natural ScienceFoundation of China [81000360, 81170803, 81070692, 81370978]; Shanghai Rising-Star Program [11QA1404900]; Academic Leaders in Health Sciences in Shanghai [XBR2011014]	National Natural ScienceFoundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Academic Leaders in Health Sciences in Shanghai	The study was supported by grants from the National Natural ScienceFoundation of China (No. 81000360, 81170803, 81070692, and 81370978), Shanghai Rising-Star Program (No. 11QA1404900), and Academic Leaders in Health Sciences in Shanghai (No XBR2011014). The founder (Prof. Zhen-lin Zhang(with the National Natural Science Foundation of China (81170803 and 81070692) and Academic Leaders in Health Sciences in Shanghai (No XBR2011014) played a role in conceiving, designing, revising the study and data collection as well. The founder (Dr. Hua Yue) with the National Natural Science Foundation of China (No. 81000360) and Shanghai Rising-Star Program (No. 11QA1404900) was responsible for data analysis, writing, and preparation of the manuscript. The founder with the National Natural Science Foundation of China (No. 81370978) had a role in data collection.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albright F, 1937, AM J DIS CHILD, V54, P529; Beck-Nielsen SS, 2012, J HUM GENET, V57, P453, DOI 10.1038/jhg.2012.56; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Clausmeyer S, 2009, CALCIFIED TISSUE INT, V85, P211, DOI 10.1007/s00223-009-9260-8; DAVIES M, 1981, CLIN RHEUM DIS, V7, P595; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Durmaz E, 2013, BONE, V52, P286, DOI 10.1016/j.bone.2012.10.012; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; Francis F, 1997, GENOME RES, V7, P573, DOI 10.1101/gr.7.6.573; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; Jap TS, 2011, CALCIFIED TISSUE INT, V88, P370, DOI 10.1007/s00223-011-9465-5; Kang QL, 2012, BIOCHEM BIOPH RES CO, V423, P793, DOI 10.1016/j.bbrc.2012.06.042; Lo FS, 2006, NEPHRON PHYSIOL, V103, P157, DOI 10.1159/000092916; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Qiu GR, 2010, GENET TEST MOL BIOMA, V14, P385, DOI 10.1089/gtmb.2009.0175; Quarles LD, 2001, J CLIN ENDOCR METAB, V86, P494, DOI 10.1210/jc.86.2.494; Quinlan C, 2012, PEDIATR NEPHROL, V27, P581, DOI 10.1007/s00467-011-2046-z; ROWE PSN, 1994, HUM GENET, V94, P457; Rowe PSN, 1998, CURR OPIN NEPHROL HY, V7, P367, DOI 10.1097/00041552-199807000-00004; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Ruppe MD, 2011, CLIN ENDOCRINOL, V74, P312, DOI 10.1111/j.1365-2265.2010.03919.x; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; Xia WB, 2007, CALCIFIED TISSUE INT, V81, P415, DOI 10.1007/s00223-007-9067-4; Yang LL, 2013, J PEDIATR ENDOCR MET, V26, P1179, DOI 10.1515/jpem-2013-0101; Zhu XW, 2010, J CHILD NEUROL, V25, P842, DOI 10.1177/0883073809350722	30	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97830	10.1371/journal.pone.0097830	http://dx.doi.org/10.1371/journal.pone.0097830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836714	gold, Green Published, Green Submitted			2022-12-25	WOS:000339614800073
J	De Martin, S; Paliuri, G; Belloni, A; Orso, G; Zanarella, E; Stellin, G; Milanesi, O; Basso, G; Ruga, EM; Frasson, C; Gabbia, D; Perdoncin, G; Palatini, P; Bova, S				De Martin, Sara; Paliuri, Giovanna; Belloni, Annasandra; Orso, Genny; Zanarella, Erica; Stellin, Giovanni; Milanesi, Ornella; Basso, Giuseppe; Ruga, Ezia Maria; Frasson, Chiara; Gabbia, Daniela; Perdoncin, Giada; Palatini, Pietro; Bova, Sergio			Expression and Distribution of the Adrenomedullin System in Newborn Human Thymus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE-RELATED PEPTIDE; T-CELL DEVELOPMENT; EPITHELIAL-CELLS; RAT-HEART; CALCITONIN; ANGIOGENESIS; PROLIFERATION; ESTABLISHMENT; LOCALIZATION	Adrenomedullin (AM) is a multifunctional peptide endowed with various biological actions mediated by the interaction with the calcitonin receptor-like receptor (CLR), which couples to the receptor activity-modifying proteins 2 or 3 (RAMP2 or RAMP3) to form the functional plasma membrane receptors AM1 and AM2, respectively. In this study, we investigated for the first time the expression and localization of AM, CLR, RAMP2 and RAMP3 in human thymic tissue from newborns and in primary cultures of thymic epithelial cells (TECs) and thymocytes. Immunohistochemical analysis of thymic tissue showed that both AM and RAMP2 are abundantly expressed in the epithelial cells of medulla and cortex, blood vessels and mastocytes. In contrast, RAMP3 could not be detected. In cultured TECs, double immunofluorescence coupled to confocal microscopy revealed that AM is present in the cytoplasmic compartment, whereas RAMP2 could be detected in the cytoplasm and nucleus, but not in the cell membrane. At variance with RAMP2, CLR was not only present in the nucleus and cytoplasm of TECs, but could also be detected in the cell membrane. The nuclear and cytoplasmic localizations of RAMP2 and CLR and the absence of RAMP2 in the cell membrane were confirmed by western-blot analysis performed on cell fractions. AM, RAMP2 and CLR could also be detected in thymocytes by means of double immunofluorescence coupled to confocal microscopy, although these proteins were not present in the whole thymocyte population. In these cells, AM and RAMP2 were detected in the cytoplasm, whereas CLR could be observed in the cytoplasm and the plasma membrane. In conclusion, our results show that the AM system is widely expressed in human thymus from newborns and suggest that both AM1 receptor components CLR and RAMP2 are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus.	[De Martin, Sara; Paliuri, Giovanna; Gabbia, Daniela; Palatini, Pietro; Bova, Sergio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Belloni, Annasandra; Perdoncin, Giada] Univ Padua, Dept Mol Med, Padua, Italy; [Orso, Genny; Zanarella, Erica] Sci Inst IRCCS Eugenio Medea, Treviso, Italy; [Stellin, Giovanni] Univ Padua, Dept Cardiac Thorac & Vasc Surg, Pediat & Congenital Cardiac Surg Unit, Padua, Italy; [Milanesi, Ornella; Basso, Giuseppe; Ruga, Ezia Maria; Frasson, Chiara] Univ Padua, Dept Pediat, Padua, Italy	University of Padua; University of Padua; IRCCS Eugenio Medea; University of Padua; University of Padua	De Martin, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	sara.demartin@unipd.it	De Martin, Sara/AAC-7396-2022; Gabbia, Daniela/J-9984-2019; Orso, Genny/C-6492-2016	De Martin, Sara/0000-0001-6398-8237; Gabbia, Daniela/0000-0003-2247-8227; Orso, Genny/0000-0002-2959-8806; STELLIN, GIOVANNI/0000-0002-1903-2542; BASSO, GIUSEPPE/0000-0002-2634-9302; Milanesi, Ornella/0000-0002-6875-9297	University of Padova	University of Padova	This work was supported by a grant from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2010, J IMMUNOL, V184, P5949, DOI 10.4049/jimmunol.1000601; Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Bai M, 2008, ANTICANCER RES, V28, P295; Belloni AS, 2006, INT J MOL MED, V17, P709; Belloni AS, 2005, INT J MOL MED, V15, P567; Belloni AS, 2004, INT J MOL MED, V13, P669; Belloni AS, 2003, PEPTIDES, V24, P295, DOI 10.1016/S0196-9781(03)00038-X; Belloni AS, 2001, HISTOL HISTOPATHOL, V16, P1263, DOI 10.14670/HH-16.1263; Bkaily G, 2009, CAN J PHYSIOL PHARM, V87, P108, DOI 10.1139/Y08-115; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Carraro G, 2002, INT J MOL MED, V10, P767; Cheung BMY, 2012, RECENT PATENTS ENDOC, V6, P4, DOI 10.2174/187221412799015263; Consonni A, 2011, MOL CELL NEUROSCI, V48, P151, DOI 10.1016/j.mcn.2011.07.006; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; FERNANDEZ E, 1994, BLOOD, V83, P3245; GALY AHM, 1992, J IMMUNOL, V149, P775; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hay DL, 2003, BRIT J PHARMACOL, V140, P477, DOI 10.1038/sj.bjp.0705472; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Kitamura K, 2012, BIOCHEM BIOPH RES CO, V425, P548, DOI 10.1016/j.bbrc.2012.08.022; Kocemba KA, 2013, LEUKEMIA, V27, P1729, DOI 10.1038/leu.2013.76; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liverani E, 2012, INT IMMUNOPHARMACOL, V14, P75, DOI 10.1016/j.intimp.2012.06.011; Marie JC, 1999, J IMMUNOL, V162, P2103; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; PENIT C, 1989, P NATL ACAD SCI USA, V86, P5547, DOI 10.1073/pnas.86.14.5547; Pleguezuelos O, 2004, FEBS LETT, V577, P249, DOI 10.1016/j.febslet.2004.10.019; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Ribatti D, 2008, PEPTIDES, V29, P1596, DOI 10.1016/j.peptides.2008.05.011; Schwarz N, 2006, J ENDOCRINOL, V190, P505, DOI 10.1677/joe.1.06806; Sexton PM, 2009, DRUG DISCOV TODAY, V14, P413, DOI 10.1016/j.drudis.2008.12.009; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Welsch U, 2002, ACTA HISTOCHEM, V104, P65, DOI 10.1078/0065-1281-00623; Wong LYF, 2005, ENDOCRINOLOGY, V146, P1321, DOI 10.1210/en.2004-1080; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97592	10.1371/journal.pone.0097592	http://dx.doi.org/10.1371/journal.pone.0097592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831942	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500082
J	Ecsedi, S; Hernandez-Vargas, H; Lima, SC; Vizkeleti, L; Toth, R; Lazar, V; Koroknai, V; Kiss, T; Emri, G; Herceg, Z; Adany, R; Balazs, M				Ecsedi, Szilvia; Hernandez-Vargas, Hector; Lima, Sheila C.; Vizkeleti, Laura; Toth, Reka; Lazar, Viktoria; Koroknai, Viktoria; Kiss, Timea; Emri, Gabriella; Herceg, Zdenko; Adany, Roza; Balazs, Margit			DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; PROMOTER METHYLATION; MALIGNANT-MELANOMA; GENOME; CANCER; BRAF; 5-HYDROXYMETHYLCYTOSINE; IDENTIFICATION; EPIGENETICS; MUTATIONS	In melanoma, the presence of promoter related hypermethylation has previously been reported, however, no methylation-based distinction has been drawn among the diverse melanoma subtypes. Here, we investigated DNA methylation changes associated with melanoma progression and links between methylation patterns and other types of somatic alterations, including the most frequent mutations and DNA copy number changes. Our results revealed that the methylome, presenting in early stage samples and associated with the BRAF(V600E) mutation, gradually decreased in the medium and late stages of the disease. An inverse relationship among the other predefined groups and promoter methylation was also revealed except for histologic subtype, whereas the more aggressive, nodular subtype melanomas exhibited hypermethylation as well. The Breslow thickness, which is a continuous variable, allowed for the most precise insight into how promoter methylation decreases from stage to stage. Integrating our methylation results with a high-throughput copy number alteration dataset, local correlations were detected in the MYB and EYA4 genes. With regard to the effects of DNA hypermethylation on melanoma patients' survival, correcting for clinical cofounders, only the KIT gene was associated with a lower overall survival rate. In this study, we demonstrate the strong influence of promoter localized DNA methylation changes on melanoma initiation and show how hypermethylation decreases in melanomas associated with less favourable clinical outcomes. Furthermore, we establish the methylation pattern as part of an integrated apparatus of somatic DNA alterations.	[Ecsedi, Szilvia; Vizkeleti, Laura; Toth, Reka; Lazar, Viktoria; Koroknai, Viktoria; Kiss, Timea; Adany, Roza; Balazs, Margit] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary; [Ecsedi, Szilvia; Vizkeleti, Laura; Adany, Roza; Balazs, Margit] Univ Debrecen, MTA DE Publ Hlth Res Grp, H-4012 Debrecen, Hungary; [Hernandez-Vargas, Hector; Lima, Sheila C.; Herceg, Zdenko] Int Agcy Res Canc, Sect Mech Carcinogenesis, Epigenet Grp, F-69372 Lyon, France; [Emri, Gabriella] Univ Debrecen, Fac Med, Dept Dermatol, H-4012 Debrecen, Hungary	University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Debrecen; World Health Organization; International Agency for Research on Cancer (IARC); University of Debrecen	Balazs, M (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary.	balazs.margit@sph.unideb.hu	Toth, Reka/AAB-1695-2020; Vizkeleti, Laura/T-4416-2017; Lima, Sheila C S/A-9059-2015; Lazar, Vladimir/AAQ-2086-2020	Toth, Reka/0000-0002-6096-1052; Vizkeleti, Laura/0000-0001-6870-3499; Lazar, Viktoria/0000-0002-9778-941X; Hernandez-Vargas, Hector/0000-0001-6045-2103	Hungarian National Research Fund [OTKA K75191]; TAMOP projects; European Union; European Social Fund; National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program [TAMOP 4.2.4.A/2-11-1-2012-0001];  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0031]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP projects; European Union(European Commission); European Social Fund(European Social Fund (ESF)); National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program; ; 	This research was supported by the Hungarian National Research Fund (OTKA K75191), the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and the TAMOP-4.2.2.A-11/1/KONV-2012-0031 projects; the TAMOP projects are co-financed by the European Union and the European Social Fund. Furthermore, the research was realized in the frames of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program." The project was subsidized by the European Union and co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Adjemian JZ, 2009, INT J OCCUP ENV HEAL, V15, P331; Bae JM, 2013, HISTOL HISTOPATHOL; Balazs M, 2011, BREAKTHROUGHS MELANO, P237; Berger MF, 2009, HEMATOL ONCOL CLIN N, V23, P397, DOI 10.1016/j.hoc.2009.03.005; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Christensen BC, 2010, CANCER RES, V70, P5686, DOI 10.1158/0008-5472.CAN-10-0190; Chu SH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-156; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Gerami P, 2012, AM J SURG PATHOL, V36, P808, DOI 10.1097/PAS.0b013e31824b1efd; Gershenwald JE, 2010, ANN SURG ONCOL, V17, P1475, DOI 10.1245/s10434-010-0986-3; Greshock J, 2009, GENE CHROMOSOME CANC, V48, P419, DOI 10.1002/gcc.20651; Hernandez-Vargas H, 2011, EPIGENETICS-US, V6, P429, DOI 10.4161/epi.6.4.14515; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hou P, 2012, CELL CYCLE, V11, P286, DOI 10.4161/cc.11.2.18707; Houseman EA, 2009, BIOINFORMATICS, V25, P1999, DOI 10.1093/bioinformatics/btp364; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Lahtz C, 2010, J INVEST DERMATOL, V130, P620, DOI 10.1038/jid.2009.226; Lazar V, 2012, MELANOMA RES, V22, P202, DOI 10.1097/CMR.0b013e328352dbc8; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lima SCS, 2011, EPIGENETICS-US, V6, P1217, DOI 10.4161/epi.6.10.17199; Liu DX, 2012, BIOCHEM BIOPH RES CO, V425, P45, DOI 10.1016/j.bbrc.2012.07.046; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; Mori T, 2006, CANCER RES, V66, P6692, DOI 10.1158/0008-5472.CAN-06-0801; Rakosy Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054958; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Senetta R, 2012, HISTOPATHOLOGY, V60, P706, DOI 10.1111/j.1365-2559.2011.03984.x; Sigalotti L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-185; Sigalotti L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-56; Song CX, 2011, EPIGENOMICS-UK, V3, P521, DOI [10.2217/epi.11.74, 10.2217/EPI.11.74]; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Thomas NE, 2006, MELANOMA RES, V16, P97, DOI 10.1097/01.cmr.0000215035.38436.87; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van den Hurk K, 2012, BBA-REV CANCER, V1826, P89, DOI 10.1016/j.bbcan.2012.03.011; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Vizkeleti L, 2012, TUMOR BIOL, V33, P2189, DOI 10.1007/s13277-012-0480-6; Wild L, 2010, BBA-REV CANCER, V1806, P50, DOI 10.1016/j.bbcan.2010.03.003; Zhang HT, 2011, INT J MOL SCI, V12, P1505, DOI 10.3390/ijms12031505	44	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96612	10.1371/journal.pone.0096612	http://dx.doi.org/10.1371/journal.pone.0096612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832207	Green Submitted, Green Published, gold			2022-12-25	WOS:000336789500024
J	Kupczik, K; Chattah, NLT				Kupczik, Kornelius; Chattah, Netta Lev-Tov			The Adaptive Significance of Enamel Loss in the Mandibular Incisors of Cercopithecine Primates (Mammalia: Cercopithecidae): A Finite Element Modelling Study	PLOS ONE			English	Article							ANTERIOR TOOTH USE; BEHAVIOR; DIET; INTERFEROMETRY; DENTITION; MOLARS; MICROSTRUCTURE; DEFORMATION; ANTHROPOIDS; ADAPTATION	In several primate groups enamel is reduced or absent from the lingual (tongue) side of the mandibular incisor crowns akin to other placental and marsupial mammalian groups such as rodents, lagomorphs and wombats. Here we investigate the presumed adaptation of crowns with unilateral enamel to the incision of tough foods in cercopithecines, an Old World monkey subfamily, using a simulation approach. We developed and validated a finite element model of the lower central incisor of the rhesus macaque (Macaca mulatta) with labial enamel only to compute three-dimensional displacements and maximum principal stresses on the crown subjected to compressive loads varying in orientation. Moreover, we developed a model of a macaque incisor with enamel present on both labial and lingual aspects, thus resembling the ancestral condition found in the sister taxon, the leaf-eating colobines. The results showed that, concomitant with experimental results, the cercopithecine crown with unilateral enamel bends predominantly towards the inside of the mouth, while displacements decreased when both labial and lingual enamel are present. Importantly, the cercopithecine incisor crown experienced lower maximum principal stress on the lingual side compared to the incisor with enamel on the lingual and labial aspects under non-axial loads directed either towards the inside or outside of the mouth. These findings suggest that cercopithecine mandibular incisors are adapted to a wide range of ingestive behaviours compared to colobines. We conclude that the evolutionary loss of lingual enamel in cercopithecines has conferred a safeguard against crown failure under a loading regime assumed for the ingestion (peeling, scraping) of tough-skinned fruits.	[Kupczik, Kornelius] Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany; [Kupczik, Kornelius] Univ Jena, Inst Spezielle Zool & Evolut Biol, Jena, Germany; [Chattah, Netta Lev-Tov] Israel Natl Police, Dept Identificat & Forens Sci, Jerusalem, Israel	Max Planck Society; Friedrich Schiller University of Jena	Kupczik, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany.	kornelius_kupczik@eva.mpg.de	Kupczik, Kornelius/E-9788-2011	Kupczik, Kornelius/0000-0003-1502-581X	Max Planck Society; Minerva Stiftung	Max Planck Society(Max Planck SocietyFoundation CELLEX); Minerva Stiftung	Funding was provided by the Max Planck Society and the Minerva Stiftung (to NLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K. R., 2008, TECHNIQUE APPL DENT, P349; Agrawal KR, 2003, P ROY SOC B-BIOL SCI, V270, P1277, DOI 10.1098/rspb.2003.2361; AIMI M, 1989, PRIMATES, V30, P261, DOI 10.1007/BF02381312; Anderson PSL, 2012, J R SOC INTERFACE, V9, P1846, DOI 10.1098/rsif.2012.0043; Barak MM, 2009, J STRUCT BIOL, V168, P511, DOI 10.1016/j.jsb.2009.07.019; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069990; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062263; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; BENEFIT BR, 1993, J HUM EVOL, V25, P83, DOI 10.1006/jhev.1993.1041; Benefit Brenda R., 2000, P133, DOI 10.1017/CBO9780511542589.007; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Chattah NLT, 2011, J ANAT, V218, P87, DOI 10.1111/j.1469-7580.2010.01234.x; Chattah NLT, 2009, ADV MATER, V21, P413, DOI 10.1002/adma.200801187; Constantino PJ, 2011, J HUM EVOL, V61, P89, DOI 10.1016/j.jhevol.2011.02.009; CRAIG RG, 1961, J DENT RES, V40, P936, DOI 10.1177/00220345610400051901; Deane A, 2012, AM J PHYS ANTHROPOL, V148, P249, DOI 10.1002/ajpa.21598; DELSON E, 1975, CONTRIB PRIMATOL, V5, P167; Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2; Giannini M, 2004, DENT MATER, V20, P322, DOI 10.1016/S0109-5641(03)00110-6; GILLINGS B, 1961, J DENT RES, V40, P105, DOI 10.1177/00220345610400010201; Hasegawa A, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/659802; Huo B, 2005, J BIOMECH, V38, P587, DOI 10.1016/j.jbiomech.2004.03.028; HYLANDER WL, 1975, SCIENCE, V189, P1095, DOI 10.1126/science.808855; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Lawn BR, 2009, J MECH BEHAV BIOMED, V2, P33, DOI 10.1016/j.jmbbm.2008.05.007; Liu J, 2012, BIOMECH MODEL MECHAN, V11, P35, DOI 10.1007/s10237-011-0291-5; Lucas Peter W., 1994, P173; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Magne P, 1999, J PROSTHET DENT, V81, P345, DOI 10.1016/S0022-3913(99)70279-9; Martin T, 2004, J VERTEBR PALEONTOL, V24, P411, DOI 10.1671/2513; Martin Thomas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V75, P257; RASMUSSEN ST, 1976, J DENT RES, V55, P154, DOI 10.1177/00220345760550010901; Rees JS, 2001, J ORAL REHABIL, V28, P425, DOI 10.1046/j.1365-2842.2001.00686.x; ROSENBERGER AL, 1978, J MAMMAL, V59, P207, DOI 10.2307/1379899; SHELLIS R P, 1979, Scanning Electron Microscopy, P497; SHELLIS RP, 1986, AM J PHYS ANTHROPOL, V71, P103, DOI 10.1002/ajpa.1330710113; SIEBERT J R, 1984, Primates, V25, P507, DOI 10.1007/BF02381672; Spears IR, 1998, AM J PHYS ANTHROPOL, V106, P467, DOI 10.1002/(SICI)1096-8644(199808)106:4<467::AID-AJPA3>3.0.CO;2-G; Spears IR, 1997, J DENT RES, V76, P1690, DOI 10.1177/00220345970760101101; SPEARS IR, 1993, J DENT RES, V72, P1526, DOI 10.1177/00220345930720111101; STRASSER E, 1987, J HUM EVOL, V16, P81, DOI 10.1016/0047-2484(87)90061-3; Thenius E., 1989, ZAHNE GEBISS SAUGETI, P513; UNGAR PS, 1990, AM J PRIMATOL, V20, P43, DOI 10.1002/ajp.1350200107; Ungar PS, 1996, AM J PHYS ANTHROPOL, V100, P101; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V95, P197, DOI 10.1002/ajpa.1330950207; Ungar PS, 1996, AM J PRIMATOL, V38, P145, DOI 10.1002/(SICI)1098-2345(1996)38:2<145::AID-AJP3>3.0.CO;2-Z; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; Wright BW, 2012, AM J PHYS ANTHROPOL, V148, P262, DOI 10.1002/ajpa.22081; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Zaslansky P, 2006, ADV FUNCT MATER, V16, P1925, DOI 10.1002/adfm.200600120; Ziskind D, 2011, J STRUCT BIOL, V174, P23, DOI 10.1016/j.jsb.2010.09.010	52	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97677	10.1371/journal.pone.0097677	http://dx.doi.org/10.1371/journal.pone.0097677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831704	Green Published, gold			2022-12-25	WOS:000336789500101
J	Albino, S; Tabb, KM; Requena, D; Egoavil, M; Pineros-Leano, MF; Zunt, JR; Garcia, PJ				Albino, Sandra; Tabb, Karen M.; Requena, David; Egoavil, Miguel; Pineros-Leano, Maria F.; Zunt, Joseph R.; Garcia, Patricia J.			Perceptions and Acceptability of Short Message Services Technology to Improve Treatment Adherence amongst Tuberculosis Patients in Peru: A Focus Group Study	PLOS ONE			English	Article							MANAGEMENT; ATTITUDES; PHONES; SMS	Background: Tuberculosis (TB) is global health concern and a leading infectious cause of mortality. Reversing TB incidence and disease-related mortality is a major global health priority. Infectious disease mortality is directly linked to failure to adhere to treatments. Using technology to send reminders by short message services have been shown to improve treatment adherence. However, few studies have examined tuberculosis patient perceptions and attitudes towards using SMS technology to increase treatment adherence. In this study, we sought to investigate perceptions related to feasibility and acceptability of using text messaging to improve treatment adherence among adults who were receiving treatment for TB in Callao, Peru. Methods: We conducted focus group qualitative interviews with current TB positive and non-contagious participants to understand the attitudes, perceptions, and feasibility of using short message service (SMS) reminders to improve TB treatment adherence. Subjects receiving care through the National TB Program were recruited through public health centers in Ventanilla, Callao, Peru. In four focus groups, we interviewed 16 patients. All interviews were recorded and transcribed verbatim. Thematic network analysis and codebook techniques were used to analyze data. Results: Three major themes emerged from the data: limits on health literacy and information posed challenges to successful TB treatment adherence, treatment motivation at times facilitated adherence to TB treatment, and acceptability of SMS including positive perceptions of SMS to improve TB treatment adherence. The majority of patients shared considerations about how to effectively and confidentially administer an SMS intervention with TB positive participants. Conclusion: The overall perceptions of the use of SMS were positive and indicated that SMS technology may be an efficient way to transmit motivational texts on treatment, health education information, and simple reminders to increase treatment adherence for low-income TB patients living in Peru.	[Albino, Sandra; Requena, David; Egoavil, Miguel; Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Epidemiol Unit, STD & HIV Sch Publ Hlth & Adm, Lima, Peru; [Tabb, Karen M.; Pineros-Leano, Maria F.] Univ Illinois, Sch Social Work, Urbana, IL USA; [Tabb, Karen M.] Univ Illinois, Ctr Latin Amer & Caribbean Studies, Urbana, IL USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Med Neurol, Seattle, WA USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Zunt, Joseph R.; Garcia, Patricia J.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [Zunt, Joseph R.; Garcia, Patricia J.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA	Universidad Peruana Cayetano Heredia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Epidemiol Unit, STD & HIV Sch Publ Hlth & Adm, Lima, Peru.	patricia.garcia@upch.pe	Zunt, Joseph/ABD-2886-2021; Pineros-Leano, Maria/AAB-5459-2019; Requena, David/AAF-4255-2019; Pineros-Leano, Maria/X-7041-2019	Pineros-Leano, Maria/0000-0001-7057-8316; Egoavil, Miguel S./0000-0002-9065-2576; Requena, David/0000-0002-5968-1133; Albino, Sandra/0000-0002-9992-6158; Tabb Dina, Karen/0000-0002-4722-9502	Fogarty International Center, United States National Institutes of Health [5R25TW007490-02, D43TW008438-0109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007543, R24HD042828] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW007490, D43TW008438] Funding Source: NIH RePORTER	Fogarty International Center, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This article was supported by the following grants: 5R25TW007490-02 and D43TW008438-0109 from the Fogarty International Center, United States National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Fogarty/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailinger RL, 2007, J COMMUN HEALTH NURS, V24, P191, DOI 10.1080/07370010701429637; Alejandria M.M., 2009, ACTA MED PHILIPPINA, V43, P10; Bassett IV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-390; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Bourne C, 2011, SEX TRANSM INFECT, V87, P229, DOI 10.1136/sti.2010.048397; Culqui D, 2005, REV PANAMERICANA SAL, V18; Culqui DR, 2005, REV PANAM SALUD PUBL, V18, P14, DOI 10.1590/S1020-49892005000600003; Curioso WH, 2009, ITS TIME YOUR LIFE S; Deglise C, 2012, J TELEMED TELECARE, V18, P273, DOI 10.1258/jtt.2012.110810; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; DIRESA Callao, 2011, ESTR SAN REG PREV CO; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Hsieh CJ, 2008, J CLIN NURS, V17, P869, DOI 10.1111/j.1365-2702.2006.01924.x; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Lester RT, 2006, AIDS, V20, P2242, DOI 10.1097/QAD.0b013e3280108508; Mittal Chhaya, 2011, Indian J Community Med, V36, P27, DOI 10.4103/0970-0218.80789; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Nglazi MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-566; OSIPTEL, 2013, IND SERV MOB LIN SER; Person AK, 2011, TELEMED E-HEALTH, V17, P189, DOI 10.1089/tmj.2010.0164; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Senbeto M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1222; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Strandbygaard U, 2010, RESP MED, V104, P1236, DOI 10.1016/j.rmed.2010.03.034; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	29	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95770	10.1371/journal.pone.0095770	http://dx.doi.org/10.1371/journal.pone.0095770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828031	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400015
J	Jain, R; Kazmierczak, BI				Jain, Ruchi; Kazmierczak, Barbara I.			A Conservative Amino Acid Mutation in the Master Regulator FleQ Renders Pseudomonas aeruginosa Aflagellate	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; CYSTIC-FIBROSIS PATIENTS; GRAM-NEGATIVE BACTERIA; GENE-EXPRESSION; III SECRETION; TRANSCRIPTIONAL ACTIVATOR; FLAGELLAR NUMBER; READ ALIGNMENT; DNA-SEQUENCES; MOTILITY	Flagellar-based motility plays a critical role in Pseudomonas aeruginosa pathogenesis, influencing both the establishment of bacterial infection and the host's response to the pathogen. Nonetheless, aflagellate clinical strains are often isolated from acutely and chronically infected patients and include the virulent laboratory strain PA103. We determined that PA103's aflagellate phenotype is the result of a single amino acid change (G240V) in the master flagellar regulator, FleQ. This mutation, which lies just outside the Walker B box of FleQ, abrogates the ability of FleQ to positively regulate flagellar gene expression. Reversal of this seemingly conservative amino acid substitution is sufficient to restore swimming motility to PA103, despite the presence of mutations in other flagellar genes of PA103. We also investigated the consequences of restoring flagellar assembly on PA103 virulence. Although a negative correlation between flagellar assembly and Type 3 secretion system (T3SS) expression has been reported previously, we did not observe downregulation of T3SS expression or function in Fla+ PA103. Restoration of flagellar assembly did, however, amplify IL-1 signals measured during murine pulmonary infection and was associated with increased bacterial clearance. These experiments suggest that loss of flagellar motility may primarily benefit PA103 by attenuating pathogen recognition and clearance during acute infection.	[Jain, Ruchi; Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06520 USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University	Kazmierczak, BI (corresponding author), Yale Univ, Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06520 USA.	barbara.kazmierczak@yale.edu		Kazmierczak, Barbara/0000-0002-8162-803X	Brown-Coxe Fellowship; National Institute of Allergy and Infectious Diseases [R01 AI075051, R01 AI081825]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075051, R01AI081825] Funding Source: NIH RePORTER	Brown-Coxe Fellowship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Brown-Coxe Fellowship (R.J.), the National Institute of Allergy and Infectious Diseases (R01 AI075051, R01 AI081825 (B.I.K.)) and a Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award (B.I.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jyot J, 2007, MOL MICROBIOL, V63, P1026, DOI 10.1111/j.1365-2958.2006.05573.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Ledizet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049578; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Li, 2005, Ann Clin Microbiol Antimicrob, V4, P22, DOI 10.1186/1476-0711-4-22; Liu Y, 1996, J MED MICROBIOL, V45, P359, DOI 10.1099/00222615-45-5-359; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; MONTIE TC, 1982, INFECT IMMUN, V35, P281, DOI 10.1128/IAI.35.1.281-288.1982; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Patankar YR, 2013, INFECT IMMUN, V81, P2043, DOI 10.1128/IAI.00054-13; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Schniederberend M, 2013, J BACTERIOL, V195, P1051, DOI 10.1128/JB.02013-12; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith K, 2003, POETRY REV, V93, P5; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; van Ditmarsch D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-140; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wangdi T, 2010, INFECT IMMUN, V78, P4744, DOI 10.1128/IAI.00744-10; Watson AA, 1996, GENE, V172, P163, DOI 10.1016/0378-1119(96)00026-1; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97439	10.1371/journal.pone.0097439	http://dx.doi.org/10.1371/journal.pone.0097439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827992	Green Submitted, gold, Green Published			2022-12-25	WOS:000336857400094
J	Ji, Y; Abrams, N; Zhu, W; Salinas, E; Yu, ZY; Palmer, DC; Jailwala, P; Franco, Z; Roychoudhuri, R; Stahlberg, E; Gattinoni, L; Restifo, NP				Ji, Yun; Abrams, Natalie; Zhu, Wei; Salinas, Eddie; Yu, Zhiya; Palmer, Douglas C.; Jailwala, Parthav; Franco, Zulmarie; Roychoudhuri, Rahul; Stahlberg, Eric; Gattinoni, Luca; Restifo, Nicholas P.			Identification of the Genomic Insertion Site of Pmel-1 TCR alpha and beta Transgenes by Next-Generation Sequencing	PLOS ONE			English	Article							CD8(+) T-CELLS; SUPERIOR ANTITUMOR IMMUNITY; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; TUMOR-REGRESSION; DENDRITIC CELLS; STEM-CELLS; MEMORY; EFFECTOR; ANTIGEN	The pmel-1 T cell receptor transgenic mouse has been extensively employed as an ideal model system to study the mechanisms of tumor immunology, CD8(+) T cell differentiation, autoimmunity and adoptive immunotherapy. The 'zygosity' of the transgene affects the transgene expression levels and may compromise optimal breeding scheme design. However, the integration sites for the pmel-1 mouse have remained uncharacterized. This is also true for many other commonly used transgenic mice created before the modern era of rapid and inexpensive next-generation sequencing. Here, we show that whole genome sequencing can be used to determine the exact pmel-1 genomic integration site, even with relatively "shallow" (8X) coverage. The results were used to develop a validated polymerase chain reaction-based genotyping assay. For the first time, we provide a quick and convenient polymerase chain reaction method to determine the dosage of pmel-1 transgene for this freely and publically available mouse resource. We also demonstrate that next-generation sequencing provides a feasible approach for mapping foreign DNA integration sites, even when information of the original vector sequences is only partially known.	[Ji, Yun; Zhu, Wei; Gattinoni, Luca] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Abrams, Natalie; Salinas, Eddie; Jailwala, Parthav; Stahlberg, Eric] Frederick Natl Lab Canc Res, Adv Biomed Comp Ctr, Frederick, MD USA; [Yu, Zhiya; Palmer, Douglas C.; Franco, Zulmarie; Roychoudhuri, Rahul; Restifo, Nicholas P.] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, Y (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	jiyun@mail.nih.gov; restifo@nih.gov	Abrams, Natalie/AAM-5468-2021; Palmer, Douglas/B-9454-2008; Waldmann, Thomas/AAT-5972-2021; Roychoudhuri, Rahul/A-7442-2010; Ji, Yun/B-7245-2009; Restifo, Nicholas Phillip/M-6549-2019; Abrams, Natalie/F-4845-2011; Restifo, Nicholas Phillip/Z-1614-2019; Gattinoni, Luca/A-2281-2008	Abrams, Natalie/0000-0001-9698-2819; Palmer, Douglas/0000-0001-5018-5734; Waldmann, Thomas/0000-0003-4500-6660; Roychoudhuri, Rahul/0000-0002-5392-1853; Ji, Yun/0000-0001-6340-7009; Abrams, Natalie/0000-0001-9698-2819; Gattinoni, Luca/0000-0003-2239-3282; Restifo, Nicholas P./0000-0003-4229-4580	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010763, ZICBC011532] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2003, GENESIS, V36, P134, DOI 10.1002/gene.10205; Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091; Boni A, 2008, BLOOD, V112, P4746, DOI 10.1182/blood-2008-07-169797; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Byrne KT, 2014, J IMMUNOL; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Cui YZ, 2009, BLOOD, V114, P3831, DOI 10.1182/blood-2009-03-212134; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Diaz-Montero CM, 2008, CANCER IMMUNOL IMMUN, V57, P563, DOI 10.1007/s00262-007-0394-0; DuBose AJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1463; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gattinoni L, 2006, BLOOD, V108, P3818, DOI 10.1182/blood-2006-07-034066; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; He H, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-24; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Johnson LDS, 2010, J IMMUNOL, V184, P5604, DOI 10.4049/jimmunol.1000109; Kaluza KM, 2012, HUM GENE THER, V23, P1054, DOI 10.1089/hum.2012.030; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Saux A, 2010, TRANSGENIC RES, V19, P923, DOI 10.1007/s11248-010-9368-7; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Lou YY, 2004, CANCER RES, V64, P6783, DOI 10.1158/0008-5472.CAN-04-1621; Lu Y, 2014, P NATL ACAD SCI US; Murakami T, 2003, J EXP MED, V198, P1337, DOI 10.1084/jem.20030593; Ohigashi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014391; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Palmer DC, 2004, J IMMUNOL, V173, P7209, DOI 10.4049/jimmunol.173.12.7209; Palmer DC, 2008, P NATL ACAD SCI USA, V105, P8061, DOI 10.1073/pnas.0710929105; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Prins RM, 2008, CANCER IMMUNOL IMMUN, V57, P1279, DOI 10.1007/s00262-008-0461-1; Quatromoni JG, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-127; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez GM, 2013, J INVEST DERMATOL, V133, P2013, DOI 10.1038/jid.2013.86; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rubinstein MP, 2012, J AM COLL SURGEONS, V214, P700, DOI 10.1016/j.jamcollsurg.2011.12.034; Salem ML, 2009, J IMMUNOL, V182, P2030, DOI 10.4049/jimmunol.0801829; Schneider MR, 2005, ANAL BIOCHEM, V344, P1, DOI 10.1016/j.ab.2005.03.035; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vo DD, 2009, CANCER RES, V69, P8693, DOI 10.1158/0008-5472.CAN-09-1456; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Wrzesinski C, 2007, J CLIN INVEST, V117, P492, DOI 10.1172/JCI30414; Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou P, 2014, NATURE	75	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96650	10.1371/journal.pone.0096650	http://dx.doi.org/10.1371/journal.pone.0096650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827921	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400033
J	Li, XP; Treesukosol, Y; Moghadam, A; Smith, M; Ofeldt, E; Yang, DJ; Li, TX; Tamashiro, K; Choi, PQ; Moran, TH; Smith, WW				Li, Xueping; Treesukosol, Yada; Moghadam, Alexander; Smith, Megan; Ofeldt, Erica; Yang, Dejun; Li, Tianxia; Tamashiro, Kellie; Choi, Pique; Moran, Timothy H.; Smith, Wanli W.			Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice	PLOS ONE			English	Article							LACKING CCK-1 RECEPTORS; ALPHA-SYNUCLEIN; MEAL SIZE; OLETF RATS; PARKINSONS-DISEASE; NERVE TRANSECTION; LICKING RESPONSES; OBESITY MODEL; FEEDING RATS; LEWY BODIES	Synphilin-1 is a cytoplasmic protein that has been shown to be involved in the control of energy balance. Previously, we reported on the generation of a human synphilin-1 transgenic mouse model (SP1), in which overexpression of human synphilin-1 resulted in hyperphagia and obesity. Here, behavioral measures in SP1 mice were compared with those of their age-matched controls (NTg) at two time points: when there was not yet a group body weight difference ("pre-obese'') and when SP1 mice were heavier ("obese''). At both time points, meal pattern analyses revealed that SP1 mice displayed higher daily chow intake than non-transgenic control mice. Furthermore, there was an increase in meal size in SP1 mice compared with NTg control mice at the obese stage. In contrast, there was no meal number change between SP1 and NTg control mice. In a brief-access taste procedure, both "pre-obese'' and "obese" SP1 mice displayed concentration-dependent licking across a sucrose concentration range similar to their NTg controls. However, at the pre-obese stage, SP1 mice initiated significantly more trials to sucrose across the testing sessions and licked more vigorously at the highest concentration presented, than the NTg counterparts. These group differences in responsiveness to sucrose were no longer apparent in obese SP1 mice. These results suggest that at the pre-obese stage, the increased trials to sucrose in the SP1 mice reflects increased appetitive behavior to sucrose that may be indicative of the behavioral changes that may contribute to hyperphagia and development of obesity in SP1 mice. These studies provide new insight into synphilin-1 contributions to energy homeostasis.	[Li, Xueping; Yang, Dejun; Li, Tianxia; Smith, Wanli W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Treesukosol, Yada; Moghadam, Alexander; Smith, Megan; Ofeldt, Erica; Tamashiro, Kellie; Choi, Pique; Moran, Timothy H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Moran, TH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	tmoran@jhmi.edu; wsmith@rx.umaryland.edu	Yang, Dejun/L-9865-2016; Aljarah, Ali/Q-7105-2016	Yang, Dejun/0000-0001-5118-0652; Tamashiro, Kellie/0000-0002-9398-8796; Aljarah, Ali/0000-0003-0535-090X	National Institutes of Health [DK083410]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK083410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK083410 to Wanli W. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Azzara AV, 2002, PHYSIOL BEHAV, V77, P411, DOI 10.1016/S0031-9384(02)00883-1; Bi S, 2002, NEUROPEPTIDES, V36, P171, DOI 10.1054/npep.2002.0895; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cottone P, 2013, INT J OBES IN PRESS; DAVIS JD, 1993, AM J PHYSIOL, V265, pR888, DOI 10.1152/ajpregu.1993.265.4.R888; DAVIS JD, 1990, AM J PHYSIOL, V259, pR1228, DOI 10.1152/ajpregu.1990.259.6.R1228; De Jonghe BC, 2005, AM J PHYSIOL-REG I, V288, pR292, DOI 10.1152/ajpregu.00481.2004; DREWNOWSKI A, 1978, PHARMACOL BIOCHEM BE, V9, P619, DOI 10.1016/0091-3057(78)90213-7; Eckel LA, 2004, PHYSIOL BEHAV, V82, P35, DOI 10.1016/j.physbeh.2004.04.023; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Hajnal A, 2005, AM J PHYSIOL-REG I, V289, pR1675, DOI 10.1152/ajpregu.00412.2005; Jiang ES, 2008, CHEM SENSES, V33, P709, DOI 10.1093/chemse/bjn039; Lee MD, 2002, PHARMACOL BIOCHEM BE, V71, P147, DOI 10.1016/S0091-3057(01)00630-X; Lee MD, 2002, PSYCHOPHARMACOLOGY, V164, P49, DOI 10.1007/s00213-002-1162-7; Li X, 2012, INT J OBESITY, V36, P1215, DOI 10.1038/ijo.2011.235; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu J, 2012, INT J OBESITY, V36, P1529, DOI 10.1038/ijo.2012.111; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Smith JC, 2001, APPETITE, V36, P93, DOI 10.1006/appe.2000.0372; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Spector AC, 1996, BEHAV NEUROSCI, V110, P1096; Spector AC, 2009, CURR OPIN NEUROBIOL, V19, P370, DOI 10.1016/j.conb.2009.07.014; STROHMAYER AJ, 1987, APPETITE, V8, P111, DOI 10.1016/S0195-6663(87)80004-1; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Treesukosol Y, 2013, PHYSIOL BEHAV, V110, P109, DOI 10.1016/j.physbeh.2013.01.003; Treesukosol Y, 2011, J NEUROSCI, V31, P13527, DOI 10.1523/JNEUROSCI.2179-11.2011; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Zhu GJ, 2012, PHYSIOL BEHAV, V105, P234, DOI 10.1016/j.physbeh.2011.08.007	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e91449	10.1371/journal.pone.0091449	http://dx.doi.org/10.1371/journal.pone.0091449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829096	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400004
J	Meliopoulos, VA; Kayali, G; Burnham, A; Oshansky, CM; Thomas, PG; Gray, GC; Beck, MA; Schultz-Cherry, S				Meliopoulos, Victoria A.; Kayali, Ghazi; Burnham, Andrew; Oshansky, Christine M.; Thomas, Paul G.; Gray, Gregory C.; Beck, Melinda A.; Schultz-Cherry, Stacey			Detection of Antibodies against Turkey Astrovirus in Humans	PLOS ONE			English	Article							INFECTION; POULTRY; RETROVIRUSES; MORTALITY; CHICKEN; VIRUS	Astroviruses are a leading cause of gastroenteritis in mammals and birds worldwide. Although historically thought to be species-specific, increasing evidence suggests that astroviruses may cross species barriers. In this report, we used enzyme-linked immunosorbent assays to screen sera from three distinct human cohorts involved in influenza studies in Memphis, TN or Chapel Hill, NC, and Midwestern poultry abattoir workers for antibodies to turkey astrovirus type 2 (TAstV-2). Surprisingly, 26% of one cohort's population was TAstV-2 positive as compared to 0 and 8.9% in the other cohorts. This cohort was composed of people with exposure to turkeys in the Midwestern United States including abattoir workers, turkey growers, and non-occupationally exposed participants. The odds of testing positive for antibodies against turkey astrovirus among abattoir workers were approximately 3 times higher than the other groups. These studies suggest that people with contact to turkeys can develop serological responses to turkey astrovirus. Further work is needed to determine if these exposures result in virus replication and/or clinical disease.	[Meliopoulos, Victoria A.; Kayali, Ghazi; Burnham, Andrew; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gray, Gregory C.] Univ Florida, Coll Publ Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Beck, Melinda A.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill	Schultz-Cherry, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	stacey.schultz-cherry@stjude.org	Schultz-Cherry, Stacey/N-2506-2018; Gray, Gregory C./ABF-1298-2020; Thomas, Paul G./H-1063-2018	Thomas, Paul G./0000-0001-7955-0256; Burnham, Andrew/0000-0002-2374-987X; Gray, Gregory/0000-0002-4628-5908	Hartwell Biomedical Foundation; National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID) [HHSN266200700005C]; ALSAC; U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; NIAID [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078090] Funding Source: NIH RePORTER	Hartwell Biomedical Foundation; National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Hartwell Biomedical Foundation, National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID) contract number HHSN266200700005C, ALSAC, the U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (GCG), and NIAID R01 AI068803 (GCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH A, 2013, ASTROVIRUS RES ESSEN, P1; Ulloa JC, 2010, CAN J MICROBIOL, V56, P569, DOI [10.1139/W10-042, 10.1139/w10-042]; Cattoli G, 2005, VET REC, V156, P220; Choudat D, 1996, OCCUP ENVIRON MED, V53, P403, DOI 10.1136/oem.53.6.403; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2012, J VIROL, V86, P13772, DOI 10.1128/JVI.02105-12; Day JM, 2007, AVIAN DIS, V51, P681, DOI 10.1637/0005-2086(2007)51[681:AMRTFT]2.0.CO;2; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; DuBois RM, 2013, J VIROL, V87, P7853, DOI 10.1128/JVI.03139-12; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; JOHNSON ES, 1994, CANCER DETECT PREV, V18, P9; Kayali G, 2011, VECTOR-BORNE ZOONOT, V11, P1453, DOI 10.1089/vbz.2011.0637; Moser LA, 2007, J VIROL, V81, P11937, DOI 10.1128/JVI.00942-07; Netto GF, 2003, OCCUP ENVIRON MED, V60, P784, DOI 10.1136/oem.60.10.784; Oshansky CM, 2013, AM J RESP CRITICAL C; Paich HA, 2013, OBESITY; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Pantin-Jackwood MJ, 2006, VIRUS GENES, V32, P187, DOI 10.1007/s11262-005-6875-3; Rivera R, 2010, J GEN VIROL, V91, P166, DOI 10.1099/vir.0.015222-0; Schultz-Cherry S., 2013, ASTROVIRUS RES ESSEN; Sellers H, 2010, VACCINE, V28, P1253, DOI 10.1016/j.vaccine.2009.11.016; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031	25	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96934	10.1371/journal.pone.0096934	http://dx.doi.org/10.1371/journal.pone.0096934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826893	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400046
J	Newie, I; Sokilde, R; Persson, H; Grabau, D; Rego, N; Kvist, A; von Stedingk, K; Axelson, H; Borg, A; Vallon-Christersson, J; Rovira, C				Newie, Inga; Sokilde, Rolf; Persson, Helena; Grabau, Dorthe; Rego, Natalia; Kvist, Anders; von Stedingk, Kristoffer; Axelson, Hakan; Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos			The HER2-Encoded miR-4728-3p Regulates ESR1 through a Non-Canonical Internal Seed Interaction	PLOS ONE			English	Article							BREAST-CANCER; ESTROGEN-RECEPTOR; CAENORHABDITIS-ELEGANS; TARGET RECOGNITION; MICRORNA TARGETS; BINDING; HER2; EXPRESSION; PREDICTION; IDENTIFICATION	Since the early 1980s remarkable progress has been made in understanding the role of the HER2 locus in carcinogenesis, but many details of its regulatory network are still elusive. We recently reported the finding of 367 new human microRNA (miRNA) genes of which one, mir-4728, is encoded in an intron of the HER2 gene. Here, we confirm that the HER2 oncogene is a bi-functional locus encoding the membrane receptor and a functional miRNA gene. We further show that miR-4728-3p has alternative functionalities depending on the region used for interaction with its target; the canonical seed between nucleotides 2-8 or a novel, more internal seed shifted to nucleotides 6-12. Analysis of public data shows that this internal seed region, although rare compared to the far more abundant canonical 2-8 seed interaction, can also direct targeted down-regulation by other miRNAs. Through the internal seed, miR-4728-3p regulates expression of estrogen receptor alpha, an interaction that would have remained undetected if classic rules for miRNA-target interaction had been applied. In summary, we present here an alternative mode of miRNA regulation and demonstrate this dual function of the HER2 locus, linking the two major biomarkers in breast cancer.	[Newie, Inga; Sokilde, Rolf; von Stedingk, Kristoffer; Axelson, Hakan; Borg, Ake; Rovira, Carlos] BioCare, Strateg Canc Res Program, Lund, Sweden; [Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos] CREATE Hlth, Strateg Ctr Translat Canc Res, Lund, Sweden; [Grabau, Dorthe] Skane Univ Hosp, Dept Pathol, Lund, Sweden; [von Stedingk, Kristoffer; Axelson, Hakan] Lund Univ Canc Ctr, Dept Lab Med, Lund, Sweden; [Newie, Inga; Sokilde, Rolf; Persson, Helena; Rego, Natalia; Kvist, Anders; Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos] Lund Univ Canc Ctr, Dept Pathol & Oncol, Lund, Sweden	Lund University; Skane University Hospital	Rovira, C (corresponding author), BioCare, Strateg Canc Res Program, Lund, Sweden.	Carlos.Rovira@med.lu.se	Søkilde, Rolf/F-5138-2015; Persson, Helena/ABE-5003-2020	Søkilde, Rolf/0000-0003-3010-3599; Vallon-Christersson, Johan/0000-0002-2195-0385; Newie, Inga/0000-0002-6047-6647; Persson, Helena/0000-0002-5187-6446; Kvist, Anders/0000-0002-1358-0695; Rego, Natalia/0000-0001-6944-2825	Swedish National Science Council; Swedish Cancer Society; Gunnar Nilsson Foundation; Berta Kamprads Foundation; BioCare, Lund	Swedish National Science Council; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Foundation; Berta Kamprads Foundation; BioCare, Lund	Support was provided by the Swedish National Science Council, Swedish Cancer Society, Gunnar Nilsson Foundation, Berta Kamprads Foundation, and BioCare, Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lambert NJ, 2011, NUCLEIC ACIDS RES, V39, P4827, DOI 10.1093/nar/gkr077; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mortimer SA, 2013, NUCLEIC ACIDS RES, V41, P4230, DOI 10.1093/nar/gkt075; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Olayioye MA, 2001, BREAST CANCER RES, V3, P385, DOI 10.1186/bcr327; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pinhel I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3145; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zaczek A, 2005, HISTOL HISTOPATHOL, V20, P1005, DOI 10.14670/HH-20.1005	39	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97200	10.1371/journal.pone.0097200	http://dx.doi.org/10.1371/journal.pone.0097200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828673	Green Published, Green Submitted, gold			2022-12-25	WOS:000336857400063
J	Stiburkova, B; Pavlikova, M; Sokolova, J; Kozich, V				Stiburkova, Blanka; Pavlikova, Marketa; Sokolova, Jitka; Kozich, Viktor			Metabolic Syndrome, Alcohol Consumption and Genetic Factors Are Associated with Serum Uric Acid Concentration	PLOS ONE			English	Article							TETRAHYDROFOLATE REDUCTASE GENE; METHYLENETETRAHYDROFOLATE REDUCTASE; RENAL HYPOURICEMIA; URATE TRANSPORTER; RISK-FACTORS; ABCG2 GENE; GOUT; SLC2A9; HYPERURICEMIA; POLYMORPHISM	Objective: Uric acid is the end product of purine metabolism in humans, and increased serum uric acid concentrations lead to gout. The objective of the current study was to identify factors that are independently associated with serum uric acid concentrations in a cohort of Czech control individuals. Methods: The cohort consisted of 589 healthy subjects aged 18-65 years. We studied the associations between the serum uric acid concentration and the following: (i) demographic, anthropometric and other variables previously reported to be associated with serum uric acid concentrations; (ii) the presence of metabolic syndrome and the levels of metabolic syndrome components; and (iii) selected genetic variants of the MTHFR (c.665C>T, c.1286A>C), SLC2A9 (c.844G>A, c.881G>A) and ABCG2 genes (c.421C>A). A backward model selection procedure was used to build two multiple linear regression models; in the second model, the number of metabolic syndrome criteria that were met replaced the metabolic syndrome-related variables. Results: The models had coefficients of determination of 0.59 and 0.53. The serum uric acid concentration strongly correlated with conventional determinants including male sex, and with metabolic syndrome-related variables. In the simplified second model, the serum uric acid concentration positively correlated with the number of metabolic syndrome criteria that were met, and this model retained the explanatory power of the first model. Moderate wine drinking did not increase serum uric acid concentrations, and the urate transporter ABCG2, unlike MTHFR, was a genetic determinant of serum uric acid concentrations. Conclusion: Metabolic syndrome, moderate wine drinking and the c.421C>A variant in the ABCG gene are independently associated with the serum uric acid concentration. Our model indicates that uric acid should be clinically monitored in persons with metabolic syndrome.	[Stiburkova, Blanka] Charles Univ Prague, Inst Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic; Gen Univ Hosp Prague, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Stiburkova, B (corresponding author), Charles Univ Prague, Inst Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic.	blanka.stiburkova@lf1.cuni.cz	Sokolová, Jitka/H-9924-2015; Kozich, Viktor/A-7672-2008; Pavlikova, Marketa/F-4563-2016; Stiburkova, Blanka/N-8824-2013	Sokolová, Jitka/0000-0002-0453-3336; Kozich, Viktor/0000-0001-5820-5277; Pavlikova, Marketa/0000-0003-4314-4357; Stiburkova, Blanka/0000-0003-2465-1476	Czech Republic Ministry of Health [IGA MZ NT/11322-4/2010, RVO VFN64165]	Czech Republic Ministry of Health(Ministry of Health, Czech Republic)	This study was supported by a grant from the Czech Republic Ministry of Health (IGA MZ NT/11322-4/2010 and RVO VFN64165) and by institutional support from a program at Charles University in Prague (PRVOUK-P24/LF1/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alderman M, 1999, Can J Cardiol, V15 Suppl F, p20F; BENGTSSON C, 1974, ACTA MED SCAND, V196, P93; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; De Vera M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1549, DOI 10.1002/art.24193; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Golbahair J, 2007, NUTR METAB CARDIOVAS, V17, P462, DOI 10.1016/j.numecd.2006.02.002; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hollis-Moffatt JE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3356; Hong YS, 2004, J KOREAN MED SCI, V19, P209, DOI 10.3346/jkms.2004.19.2.209; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Itou S, 2009, NUTR RES, V29, P710, DOI 10.1016/j.nutres.2009.10.006; Janosikova B, 2003, MOL GENET METAB, V79, P167, DOI 10.1016/S1096-7192(03)00079-9; Karns R, 2012, ANN HUM GENET, V76, P121, DOI 10.1111/j.1469-1809.2011.00698.x; Kawamoto R, 2001, J HUM GENET, V46, P506, DOI 10.1007/s100380170031; Lwin H, 2006, CIRC J, V70, P83, DOI 10.1253/circj.70.83; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Motti C, 1998, ATHEROSCLEROSIS, V139, P377, DOI 10.1016/S0021-9150(98)00079-3; Nakamura K, 2012, NUTR METAB CARDIOVAS, V22, P989, DOI 10.1016/j.numecd.2011.01.003; NAKASHIMA M, 1992, EUR J CLIN PHARMACOL, V42, P333; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Onat A, 2013, CLIN RHEUMATOL, V32, P1767, DOI 10.1007/s10067-013-2339-7; Phipps-Green AJ, 2010, HUM MOL GENET, V19, P4813, DOI 10.1093/hmg/ddq412; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; Rathmann W, 1998, ANN EPIDEMIOL, V8, P250, DOI 10.1016/S1047-2797(97)00204-4; Stiburkova B, 2013, EUR J HUM GENET, V21, P1067, DOI 10.1038/ejhg.2013.3; Stiburkova B, 2012, ADV CHRONIC KIDNEY D, V19, P372, DOI 10.1053/j.ackd.2012.07.010; Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Tu HP, 2010, ANN RHEUM DIS, V69, P887, DOI 10.1136/ard.2009.113357; Urano W, 2010, ANN RHEUM DIS, V69, P932, DOI 10.1136/ard.2009.111096; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Wingrove CS, 1998, METABOLISM, V47, P435, DOI 10.1016/S0026-0495(98)90056-7; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Yamagishi K, 2010, RHEUMATOLOGY, V49, P1461, DOI 10.1093/rheumatology/keq096; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Zuo M, 2000, J HUM GENET, V45, P257, DOI 10.1007/s100380070037	51	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97646	10.1371/journal.pone.0097646	http://dx.doi.org/10.1371/journal.pone.0097646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827988	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400114
J	Tin, MMY; Economo, EP; Mikheyev, AS				Tin, Mandy Man-Ying; Economo, Evan Philip; Mikheyev, Alexander Sergeyevich			Sequencing Degraded DNA from Non-Destructively Sampled Museum Specimens for RAD-Tagging and Low-Coverage Shotgun Phylogenetics	PLOS ONE			English	Article							DRAFT GENOME; EXTRACTION; DISCOVERY; ANCIENT; COLLECTIONS; DROSOPHILA; COST; AGE	Ancient and archival DNA samples are valuable resources for the study of diverse historical processes. In particular, museum specimens provide access to biotas distant in time and space, and can provide insights into ecological and evolutionary changes over time. However, archival specimens are difficult to handle; they are often fragile and irreplaceable, and typically contain only short segments of denatured DNA. Here we present a set of tools for processing such samples for state-of-the-art genetic analysis. First, we report a protocol for minimally destructive DNA extraction of insect museum specimens, which produced sequenceable DNA from all of the samples assayed. The 11 specimens analyzed had fragmented DNA, rarely exceeding 100 bp in length, and could not be amplified by conventional PCR targeting the mitochondrial cytochrome oxidase I gene. Our approach made these samples amenable to analysis with commonly used next-generation sequencing-based molecular analytic tools, including RAD-tagging and shotgun genome re-sequencing. First, we used museum ant specimens from three species, each with its own reference genome, for RAD-tag mapping. Were able to use the degraded DNA sequences, which were sequenced in full, to identify duplicate reads and filter them prior to base calling. Second, we re-sequenced six Hawaiian Drosophila species, with millions of years of divergence, but with only a single available reference genome. Despite a shallow coverage of 0.37 +/- 0.42 per base, we could recover a sufficient number of overlapping SNPs to fully resolve the species tree, which was consistent with earlier karyotypic studies, and previous molecular studies, at least in the regions of the tree that these studies could resolve. Although developed for use with degraded DNA, all of these techniques are readily applicable to more recent tissue, and are suitable for liquid handling automation.	[Tin, Mandy Man-Ying; Economo, Evan Philip; Mikheyev, Alexander Sergeyevich] Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Mikheyev, AS (corresponding author), Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan.	sasha@homologo.us	Mikheyev, Alexander/E-7999-2013	Mikheyev, Alexander/0000-0003-4369-1019	Okinawa Institute of Science and Technology; Japan Society for the Promotion of Science [13058556]	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by the Okinawa Institute of Science and Technology, and a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research # 13058556 to ASM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045549; Auwera G.A., 2013, CURRENT PROTOCOLS BI; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Favret C, 2005, P ENTOMOL SOC WASH, V107, P469; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hunter SJ, 2008, MOL ECOL RESOUR, V8, P56, DOI 10.1111/j.1471-8286.2007.01879.x; Jansen G, 2009, ZOOL SCR, V38, P527, DOI 10.1111/j.1463-6409.2009.00386.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li TW, 2006, ANAL BIOCHEM, V349, P242, DOI 10.1016/j.ab.2005.11.002; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikheyev AS, 2009, MOL ECOL, V18, P2937, DOI 10.1111/j.1365-294X.2009.04213.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; O'Grady PM, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-6; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiss RA, 2006, QUATERNARY SCI REV, V25, P1877, DOI 10.1016/j.quascirev.2006.01.009; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schmidt WM, 1996, NUCLEIC ACIDS RES, V24, P1789, DOI 10.1093/nar/24.9.1789; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Smit A., REPEATMASKER OPEN 3; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Yue Dongxian, 2008, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0306s84; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	45	100	101	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96793	10.1371/journal.pone.0096793	http://dx.doi.org/10.1371/journal.pone.0096793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828244	Green Submitted, Green Published, gold			2022-12-25	WOS:000336857400037
J	Zhang, L; Dang, RJ; Li, H; Li, P; Yang, YM; Guo, XM; Wang, XY; Fang, NZ; Mao, N; Wen, N; Jiang, XX				Zhang, Lei; Dang, Rui-Jie; Li, Hong; Li, Ping; Yang, Yan-Mei; Guo, Xi-Min; Wang, Xiao-Yan; Fang, Nan-Zhu; Mao, Ning; Wen, Ning; Jiang, Xiao-Xia			SOCS1 Regulates the Immune Modulatory Properties of Mesenchymal Stem Cells by Inhibiting Nitric Oxide Production	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; MACROPHAGE ACTIVATION; MEDIATED IMMUNOSUPPRESSION; NEGATIVE REGULATOR; CYTOKINE; SUPPRESSOR; DIFFERENTIATION; RESPONSES; MARROW	Mesenchymal stem cells (MSCs) have been shown to be highly immunosuppressive and have been employed to treat various immune disorders. However, the mechanisms underlying the immunosuppressive capacity of MSCs are not fully understood. We found the suppressor of cytokine signaling 1 (SOCS1) was induced in MSCs treated with inflammatory cytokines. Knockdown of SOCS1 did not bring much difference on the proliferation and differentiation properties of MSCs. However, MSCs with SOCS1 knockdown exhibited enhanced immunosuppressive capacity, showing as inhibiting T cell proliferation at extremely low ratio (MSC to T) in vitro, significantly promoting tumor growth and inhibiting delayed-type hypersensitivity response in vivo. We further demonstrated that SOCS1 inhibited the immunosuppressive capacity of MSCs by reducing inducible nitric oxide synthase (iNOS) expression. Additionally, we found the significantly lower SOCS1 expression and higher nitric oxide (NO) production in MSCs isolated from synovial fluid of rheumatoid arthritis patients. Collectively, our data revealed a novel role of SOCS1 in regulating the immune modulatory activities of MSCs.	[Zhang, Lei; Li, Hong; Guo, Xi-Min; Wang, Xiao-Yan; Mao, Ning; Jiang, Xiao-Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Lei; Fang, Nan-Zhu] Yanbian Univ, Yanji, Jilin Province, Peoples R China; [Dang, Rui-Jie; Li, Ping; Yang, Yan-Mei; Wen, Ning] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yanbian University; Chinese People's Liberation Army General Hospital	Wen, N (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ning1972@sina.com; smilovxiaoxia@gmail.com			National Natural Science Foundation of China [81271936, 81070393, 81170523, 81170461, 31170926]; Chinese National Key Program on Basic Research [2010CB529904]; National High-Tech Research and Development Program [2011AA020114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Program on Basic Research; National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This study was supported by grants from the National Natural Science Foundation of China (81271936, 81070393, 81170523, 81170461, 31170926), the Chinese National Key Program on Basic Research(2010CB529904) and the National High-Tech Research and Development Program (2011AA020114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chatterjee D, 2012, IMMUNOLOGY, V137, P92; Chinen T, 2006, GASTROENTEROLOGY, V130, P373, DOI 10.1053/j.gastro.2005.10.051; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Hanada T, 2005, J IMMUNOL, V174, P4325, DOI 10.4049/jimmunol.174.7.4325; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jorgensen C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3105; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sahin G, 2006, RHEUMATOL INT, V26, P805, DOI 10.1007/s00296-005-0091-2; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sayama K, 2004, J INVEST DERMATOL, V122, pA132; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x; Yahata Y, 2004, J INVEST DERMATOL, V122, pA2; Yang Yan-Mei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1563, DOI 10.7534/j.issn.1009-2137.2013.06.037; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	36	14	17	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97256	10.1371/journal.pone.0097256	http://dx.doi.org/10.1371/journal.pone.0097256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826993	gold, Green Published, Green Submitted			2022-12-25	WOS:000336857400067
J	Cheng, CM; Tzou, SC; Zhuang, YH; Huang, CC; Kao, CH; Liao, KW; Cheng, TC; Chuang, CH; Hsieh, YC; Tai, MH; Cheng, TL				Cheng, Chiu-Min; Tzou, Shey-Cherng; Zhuang, Ya-Han; Huang, Chien-Chiao; Kao, Chien-Han; Liao, Kuang-Wen; Cheng, Ta-Chun; Chuang, Chih-Hung; Hsieh, Yuan-Chin; Tai, Ming-Hong; Cheng, Tian-Lu			Functional Production of a Soluble and Secreted Single-Chain Antibody by a Bacterial Secretion System	PLOS ONE			English	Article							CIRCOVIRUS TYPE-2 PCV2; ESCHERICHIA-COLI; EXTRACELLULAR PRODUCTION; RECOMBINANT PROTEINS; EXPRESSION; FRAGMENT; FUSION; DISEASES; ANTIGEN; VIRUS	Single-chain variable fragments (scFvs) serve as an alternative to full-length monoclonal antibodies used in research and therapeutic and diagnostic applications. However, when recombinant scFvs are overexpressed in bacteria, they often form inclusion bodies and exhibit loss of function. To overcome this problem, we developed an scFv secretion system in which scFv was fused with osmotically inducible protein Y (osmY), a bacterial secretory carrier protein, for efficient protein secretion. Anti-EGFR scFv (alpha EGFR) was fused with osmY (N- and C-termini) and periplasmic leader sequence (pelB) to generate alpha EGFR-osmY, osmY-alpha EGFR, and pelB-alpha EGFR (control), respectively. In comparison with the control, both the osmY-fused alpha EGFR scFvs were soluble and secreted into the LB medium. Furthermore, the yield of soluble alpha EGFR-osmY was 20-fold higher, and the amount of secreted protein was 250-fold higher than that of osmY-alpha EGFR. In addition, the antigenbinding activity of both the osmY-fused alpha EGFRs was 2-fold higher than that of the refolded pelB-alpha EGFR from inclusion bodies. Similar results were observed with alpha TAG72-osmY and alpha Her2-osmY. These results suggest that the N-terminus of osmY fused with scFv produces a high yield of soluble, functional, and secreted scFv, and the osmY-based bacterial secretion system may be used for the large-scale industrial production of low-cost alpha EGFRprotein.	[Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Tzou, Shey-Cherng; Liao, Kuang-Wen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Zhuang, Ya-Han; Huang, Chien-Chiao; Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Kao, Chien-Han; Cheng, Ta-Chun; Hsieh, Yuan-Chin] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Tai, Ming-Hong; Cheng, Tian-Lu] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Cheng, TL (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	tlcheng@kmu.edu.tw		Hsieh, Yuan Chin/0000-0003-4005-5340; Cheng, Tian-Lu/0000-0002-7263-2766	National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan [NSC101-2325-B-037-001, NSC101-2321-B-037-001, NSC101-2313-B-022-001]; Department of Health, Executive Yuan, Taiwan [DOH100-TD-C-111-002]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan; Department of Health, Executive Yuan, Taiwan; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	This work was supported by grants from the National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan (NSC101-2325-B-037-001, NSC101-2321-B-037-001, NSC101-2313-B-022-001), the Department of Health, Executive Yuan, Taiwan (DOH100-TD-C-111-002) and the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Chi SC, 2003, DIS AQUAT ORGAN, V55, P221, DOI 10.3354/dao055221; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Darwich L, 2012, VIRUS RES, V164, P61, DOI 10.1016/j.virusres.2011.12.003; de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Gamage LNA, 2012, CAN J VET RES, V76, P301; Hu XJ, 2007, PROTEIN EXPRES PURIF, V52, P194, DOI 10.1016/j.pep.2006.08.009; Huang L, 2013, INT J MOL SCI, V14, P19109, DOI 10.3390/ijms140919109; Ilk N, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-6; Intorasoot S, 2007, J VIROL METHODS, V143, P186, DOI 10.1016/j.jviromet.2007.03.008; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Kim H, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.83; Kipriyanov SM, 1996, PROTEIN ENG, V9, P203, DOI 10.1093/protein/9.2.203; Kotzsch A, 2011, PROTEIN SCI, V20, P597, DOI 10.1002/pro.593; Lorberboum-Galski H, 2011, EXPERT OPIN DRUG DEL, V8, P605, DOI 10.1517/17425247.2011.566269; Low KO, 2011, J IND MICROBIOL BIOT, V38, P1587, DOI 10.1007/s10295-011-0949-0; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; Ralph JP, 1999, APPL MICROBIOL BIOT, V52, P70, DOI 10.1007/s002530051489; Reinartz S, 2000, CANCER IMMUNOL IMMUN, V49, P186, DOI 10.1007/s002620000126; Shieh JR, 2005, DIS AQUAT ORGAN, V63, P53, DOI 10.3354/dao063053; Smallshaw JE, 1999, PROTEIN ENG, V12, P623, DOI 10.1093/protein/12.7.623; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zheng ZB, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-37	29	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97367	10.1371/journal.pone.0097367	http://dx.doi.org/10.1371/journal.pone.0097367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824752	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200104
J	Liu, S; Lv, Y; Wan, XR; Li, LM; Hu, B; Li, L				Liu, Shuai; Lv, Yan; Wan, Xiao-Rong; Li, Li-Mei; Hu, Bo; Li, Ling			Cloning and Expression Analysis of cDNAs Encoding ABA 8 '-Hydroxylase in Peanut Plants in Response to Osmotic Stress	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; MOLECULAR-CLONING; DROUGHT TOLERANCE; SWISS-MODEL; KEY ENZYME; ARABIDOPSIS; METABOLISM; PROTEIN; DEHYDRATION	Abscisic acid (ABA) catabolism is one of the determinants of endogenous ABA levels affecting numerous aspects of plant growth and abiotic-stress responses. The major ABA catabolic pathway is triggered by ABA 8 '-hydroxylation catalysed by ABA 8 '-hydroxylase, the cytochrome P450 CYP707A family. In this study, the full-length cDNAs of AhCYP707A1 and AhCYP707A2 were cloned and characterized from peanut. Expression analyses showed that AhCYP707A1 and AhCYP707A2 were expressed ubiquitously in peanut roots, stems, and leaves with different transcript accumulation levels, including the higher expression of AhCYP707A1 in roots. The expression of AhCYP707A2 was significantly up-regulated by 20% PEG6000 or 250 mmol/L NaCl in peanut roots, stems, and leaves, whereas the up-regulation of AhCYP707A1 transcript level by PEG6000 or NaCl was observed only in roots instead of leaves and stems. Due to the osmotic and ionic stresses of high concentration of NaCl to plants simultaneously, low concentration of LiCl (30 mmol/L, at which concentration osmotic status of cells is not seriously affected, the toxicity of Li+ being higher than that of Na+) was used to examine whether the effect of NaCl might be related to osmotic or ionic stress. The results revealed visually the susceptibility to osmotic stress and the resistance to salt ions in peanut seedlings. The significant up-regulation of AhCYP707A1, AhCYP707A2 and AhNCED1 transcripts and endogenous ABA levels by PEG6000 or NaCl instead of LiCl, showed that the osmotic stress instead of ionic stress affected the expression of those genes and the biosynthesis of ABA in peanut. The functional expression of AhCYP707A1 cDNA in yeast showed that the microsomal fractions prepared from yeast cell expressing recombinant AhCYP707A1 protein exhibited the catalytic activity of ABA 8 '-hydroxylase. These results demonstrate that the expressions of AhCYP707A1 and AhCYP707A2 play an important role in ABA catabolism in peanut, particularly in response to osmotic stress.	[Liu, Shuai; Lv, Yan; Li, Li-Mei; Hu, Bo; Li, Ling] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Wan, Xiao-Rong] Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; Zhongkai University of Agriculture & Engineering	Wan, XR (corresponding author), Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	bioxrwan@hotmail.com; liling502@126.com	Wan, Xiaorong/S-1681-2019		National Natural Science Foundation of China [30800077, 31171468]; Guangdong Natural Science Foundation [10251063101000010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was jointly supported by the grants from the National Natural Science Foundation of China (approved Nos. 30800077 and 31171468 granted to XRW and LL, respectively) and Guangdong Natural Science Foundation (approved No. 10251063101000010 granted to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; Hong L, 2013, BIOL PLANTARUM, V57, P56, DOI 10.1007/s10535-012-0236-6; Hu B, 2013, ACTA PHYSIOL PLANT, V35, P1667, DOI 10.1007/s11738-012-1209-2; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Liang JH, 2009, BIOSCI BIOTECH BIOCH, V73, P2103, DOI 10.1271/bbb.90133; Liu CJ, 2003, PLANT J, V36, P471, DOI 10.1046/j.1365-313X.2003.01893.x; Liu X, 2011, BIOSCI BIOTECH BIOCH, V75, P443, DOI 10.1271/bbb.100614; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; PIERCE M, 1981, PLANTA, V153, P156, DOI 10.1007/BF00384097; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suttle JC, 2012, J EXP BOT, V63, P5717, DOI 10.1093/jxb/ers146; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Vallabhaneni R, 2010, ARCH BIOCHEM BIOPHYS, V504, P112, DOI 10.1016/j.abb.2010.07.005; Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wan XR, 2005, DNA SEQUENCE, V16, P217, DOI 10.1080/10425170500129785; Yang SH, 2006, PLANT J, V47, P675, DOI 10.1111/j.1365-313X.2006.02815.x; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; ZEEVAART JAD, 1980, PLANT PHYSIOL, V66, P672, DOI 10.1104/pp.66.4.672; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zheng Y, 2012, ANN BOT-LONDON, V110, P743, DOI 10.1093/aob/mcs133; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	44	26	32	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97025	10.1371/journal.pone.0097025	http://dx.doi.org/10.1371/journal.pone.0097025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825163	Green Published, gold, Green Submitted			2022-12-25	WOS:000336369200052
J	Memish, ZA; Bamgboye, EA; Abuljadayel, N; Smadi, H; Abouzeid, MS; Al Hakeem, RF				Memish, Ziad Ahmed; Bamgboye, Elija Afolabi; Abuljadayel, Naila; Smadi, Hanan; Abouzeid, Mohamed Salamh; Al Hakeem, Rafat Faisal			Incidence of and Risk Factors Associated with Pulmonary and Extra-Pulmonary Tuberculosis in Saudi Arabia (2010-2011)	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; EPIDEMIOLOGY	Setting: National Tuberculosis Program, Department of Public Health, Ministry of Health, Kingdom of Saudi Arabia (KSA). Objective: To summarize data on the incidence of tuberculosis and associated risk factors for cases reported during 2010-2011. Design: Retrospective analysis of routinely collected data through an established national disease notification system of the Ministry of Health in KSA. Results: The estimated incidence of all forms of tuberculosis fell from 15.8/100000 (95% CI: 15.3/100,000-16.3/100,000) in 2010 to 13.8/100,000 (95% CI: 13.4/100,000-14.2/100,000) in 2011. Saudis experienced a decrease from 11.8/100,000 (95% CI: 11.3/100,000 to 12.3/100,000) in 2010 to 9.9/100,000 (95% CI: 9.5/100,000-10.4/100,000) in 2011 while the incidence in non-Saudis declined from 24.7/100,000 (95% CI: 23.6/100,000 to 25.7/100,000) in 2010 to 22.5/100,000 (95% CI: 21.5/100,000 to 23.4/100,000) in 2011. The proportion of Extra Pulmonary TB (EPTB) which increased minimally from 30% in 2010 to 32% in 2011 was higher than global figures and strongly associated with age, sex, nationality and occupation. Conclusion: The current estimated incidence of about 14/100,000 in 2011 is less than half its estimated value of 44/100000 in 1990. Without prejudice to any under-reporting, the KSA appeared to be on the course for TB elimination by 2050 having reached the first milestone set by WHO. The proportion of EPTB remains higher than global figure and age, sex, nationality and occupation were significant independent predictors of EPTB.	[Memish, Ziad Ahmed; Bamgboye, Elija Afolabi; Abuljadayel, Naila; Smadi, Hanan; Abouzeid, Mohamed Salamh; Al Hakeem, Rafat Faisal] Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia; [Memish, Ziad Ahmed] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Bamgboye, Elija Afolabi] Univ Ibadan, Dept Epidemiol & Med Stat, Ibadan, Nigeria	Ministry of Health - Saudi Arabia; Alfaisal University; University of Ibadan	Memish, ZA (corresponding author), Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Kahtani NH, 2003, MANUAL NATL TB CONTR; Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; ALKASSIMI FA, 1993, TUBERCLE LUNG DIS, V74, P254, DOI 10.1016/0962-8479(93)90051-X; Alothman AF, 2011, BMC P S6, V5, P252, DOI 10,1186/1753-6561-5-S6-P252; [Anonymous], SAUD AR INC TUB; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; DUBROW EL, 1976, J AM GERIATR SOC, V24, P481, DOI 10.1111/j.1532-5415.1976.tb03269.x; FAO, 2022, GLOB STRAT DIG HLTH; Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Gunal S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-154; IBM, 1968, STAT PACK SOC SCI SP; Jaryal A, 2011, LUNG INDIA, V28, P263, DOI 10.4103/0970-2113.85687; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Ministry of Health, 1997, MIN HLTH ANN HLTH RE, P46; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Saudi Arabia, 2011, HLTH STAT YB, P103; Waness A, 2011, RESPIROLOGY, V16, P755, DOI 10.1111/j.1440-1843.2011.01988.x; WHO, STOP TUB SAUS AR BEC; World Health Organization, 1994, TECHN CONS M TUB E M; World Health Organization, 2011, WHO REP SAUD AR TUB	24	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95654	10.1371/journal.pone.0095654	http://dx.doi.org/10.1371/journal.pone.0095654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824783	gold, Green Submitted, Green Published			2022-12-25	WOS:000336369200006
J	Zhu, LS; Xing, ZL; Gai, XC; Li, SJ; San, ZH; Wang, XP				Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping			Identification of a Novel Enterovirus E Isolates HY12 from Cattle with Severe Respiratory and Enteric Diseases	PLOS ONE			English	Article							BOVINE ENTEROVIRUSES; CLASSIFICATION; DIVERSITY; ETIOLOGY; VIRUSES; REGION; CALF	In this study, a virus strain designated as HY12 was isolated from cattle with a disease of high morbidity and mortality in Jilin province. Biological and physiochemical properties showed that HY12 isolates is cytopathic with an extremely high infectivity. HY12 is resistant to treatment of organic solvent and acid, and unstable at 60 degrees C for 1 h. Electron microscopy observation revealed the virus is an approximately 22-28 nm in diameter. The complete genome sequence of HY12 consists of 7416 nucleotides, with a typical picornavirus genome organization including a 5'-untranslated region (UTR), a large single ORF encoding a polyprotein of 2176 amino acids, and a 3'-UTR. Phylogenetic analysis clustered HY12 isolates to a new serotype/genotype within the clade of enterovirus E (formerly BEV-A). Alignment analysis revealed a unique insertion of 2 amino acid residues (NF) at the C-terminal of VP1 protein between aa 825 and 826, and several rare mutations in VP1 and VP4 of HY12 isolates in relation to known bovine enterovirus (BEV) strains. This is the first report of an enterovirus E in China, which is potentially associated with an outbreak in cattle with severe respiratory and enteric diseases.	[Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	Jilin Province Scientific and Technology Program [20140204064NY]; program fund of Jilin province for high-level creative and talented individuals	Jilin Province Scientific and Technology Program; program fund of Jilin province for high-level creative and talented individuals	This study is supported by the Key Science and Technology projects from Jilin Province Scientific and Technology Program (20140204064NY); program fund of Jilin province for high-level creative and talented individuals to Xinping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas-Machado U, 2007, VET PATHOL, V44, P110, DOI 10.1354/vp.44-1-110; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; BUCZEK J, 1970, ARCH GES VIRUSFORSCH, V30, P408, DOI 10.1007/BF01258371; BUERKI F, 1962, Pathol Microbiol (Basel), V25, P789; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Dubois E, 2004, INT J FOOD MICROBIOL, V92, P35, DOI 10.1016/j.ijfoodmicro.2003.06.001; DUNNE HW, 1974, J AM VET MED ASSOC, V164, P290; DUNNE HW, 1973, AM J VET RES, V34, P1121; Fong TT, 2005, APPL ENVIRON MICROB, V71, P2070, DOI 10.1128/AEM.71.4.2070-2078.2005; IDE PR, 1970, CANADIAN VET J, V11, P194; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068081; KNOWLES NJ, 1985, ARCH VIROL, V83, P141, DOI 10.1007/BF01309912; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Ley V, 2002, APPL ENVIRON MICROB, V68, P3455, DOI 10.1128/AEM.68.7.3455-3461.2002; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; McCarthy FM, 1999, VET MICROBIOL, V68, P71, DOI 10.1016/S0378-1135(99)00062-0; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; McFERRAN J. B., 1958, Veterinary Record, V70, P999; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MOLL T, 1959, AM J VET RES, V20, P27; Nollens HH, 2009, VET MICROBIOL, V139, P170, DOI 10.1016/j.vetmic.2009.05.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROVOZZO GC, 1965, CORNELL VET, V55, P121; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Straub O C, 1965, Berl Munch Tierarztl Wochenschr, V78, P386; STRAUB O. C., 1964, ARCH GESAMTE VIRUS FORSCH, V14, P272, DOI 10.1007/BF01555099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMAATEN MJ, 1967, AM J VET RES, V28, P677; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; WELDON SL, 1979, J AM VET MED ASSOC, V174, P168; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zell R, 1997, VIRUS RES, V51, P213, DOI 10.1016/S0168-1702(97)00096-8; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zheng T, 2007, ARCH VIROL, V152, P191, DOI 10.1007/s00705-006-0838-4	38	358	389	21	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97730	10.1371/journal.pone.0097730	http://dx.doi.org/10.1371/journal.pone.0097730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	25469875	Green Published, Green Submitted, gold			2022-12-25	WOS:000336789500108
J	Mishra, S; Singh, BR; Singh, A; Keswani, C; Naqvi, AH; Singh, HB				Mishra, Sandhya; Singh, Braj Raj; Singh, Akanksha; Keswani, Chetan; Naqvi, Alim H.; Singh, H. B.			Biofabricated Silver Nanoparticles Act as a Strong Fungicide against Bipolaris sorokiniana Causing Spot Blotch Disease in Wheat	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR BIOSYNTHESIS; PHOTOCATALYTIC ACTIVITY; CULTURE SUPERNATANT; ANTIFUNGAL ACTIVITY; BACTERIA; STRAIN; NANOCOMPOSITE; LIGNIFICATION; PROTECTION	The present study is focused on the extracellular synthesis of silver nanoparticles (AgNPs) using culture supernatant of an agriculturally important bacterium, Serratia sp. BHU-S4 and demonstrates its effective application for the management of spot blotch disease in wheat. The biosynthesis of AgNPs by Serratia sp. BHU-S4 (denoted as bsAgNPs) was monitored by UV-visible spectrum that showed the surface plasmon resonance (SPR) peak at 410 nm, an important characteristic of AgNPs. Furthermore, the structural, morphological, elemental, functional and thermal characterization of bsAgNPs was carried out using the X-ray diffraction (XRD), electron and atomic microscopies, energy dispersive X-ray (EDAX) spectrometer, FTIR spectroscopy and thermogravimetric analyzer (TGA), respectively. The bsAgNPs were spherical in shape with size range of similar to 10 to 20 nm. The XRD and EDAX analysis confirmed successful biosynthesis and crystalline nature of AgNPs. The bsAgNPs exhibited strong antifungal activity against Bipolaris sorokiniana, the spot blotch pathogen of wheat. Interestingly, 2, 4 and 10 mu g/ml concentrations of bsAgNPs accounted for complete inhibition of conidial germination, whereas in the absence of bsAgNPs, conidial germination was 100%. A detached leaf bioassay revealed prominent conidial germination on wheat leaves infected with B. sorokiniana conidial suspension alone, while the germination of conidia was totally inhibited when the leaves were treated with bsAgNPs. The results were further authenticated under green house conditions, where application of bsAgNPs significantly reduced B. sorokiniana infection in wheat plants. Histochemical staining revealed a significant role of bsAgNPs treatment in inducing lignin deposition in vascular bundles. In summary, our findings represent the efficient application of bsAgNPs in plant disease management, indicating the exciting possibilities of nanofungicide employing agriculturally important bacteria.	[Mishra, Sandhya; Singh, Akanksha; Keswani, Chetan; Singh, H. B.] Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India; [Singh, Braj Raj; Naqvi, Alim H.] Aligarh Muslim Univ, ZH Coll Engn & Technol, Dept Appl Phys, Ctr Excellence Mat Sci Nanomat, Aligarh, Uttar Pradesh, India	Banaras Hindu University (BHU); Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Singh, HB (corresponding author), Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India.	hbs1@rediffmail.com	KESWANI, CHETAN/I-4311-2014; De Groot, Annie/B-6221-2013	KESWANI, CHETAN/0000-0002-2786-121X; De Groot, Annie/0000-0001-5911-1459; Singh, Akanksha/0000-0001-7206-3965	NIAID NIH HHS [U19 AI082642] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakshi M, 2014, CURR SCI INDIA, V106, P350; Balaji DS, 2009, COLLOID SURFACE B, V68, P88, DOI 10.1016/j.colsurfb.2008.09.022; Benhamou N, 2000, PHYTOPATHOLOGY, V90, P45, DOI 10.1094/PHYTO.2000.90.1.45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Choi M, 2010, J COLLOID INTERF SCI, V341, P83, DOI 10.1016/j.jcis.2009.09.037; Domiciano GP, 2013, TROP PLANT PATHOL, V38, P258, DOI http://dx.doi.org/10.1590/s1982-56762013005000006; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Gopinath V, 2013, SPECTROCHIM ACTA A, V106, P170, DOI 10.1016/j.saa.2012.12.087; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; HOLT J. G., 1994, BERGEYS MANUAL DETER, P544; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Jensen WA., 1962, BOT HISTOCHEMISTRY P; Jeyaraj M, 2013, J IND ENG CHEM, V19, P1299, DOI 10.1016/j.jiec.2012.12.031; KAMENSKY M, 2003, SOIL BOIL BIOCH, V79, P584; Kanchana A, 2011, DIG J NANOMATER BIOS, V6, P1741; Kasthuri J, 2009, COLLOID SURFACE B, V68, P55, DOI 10.1016/j.colsurfb.2008.09.021; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Khan JA, 2013, SPECTROCHIM ACTA A, V109, P313, DOI 10.1016/j.saa.2013.03.011; Kim SW, 2009, J MICROBIOL BIOTECHN, V19, P760, DOI 10.4014/jmb.0812.649; KLEEMANN W, 1993, INT J MOD PHYS B, V7, P2469, DOI 10.1142/S0217979293002912; Koo SY, 2009, J MICROBIOL BIOTECHN, V19, P1431, DOI 10.4014/jmb.0904.04014; Krishnaraj C, 2012, SPECTROCHIM ACTA A, V93, P95, DOI 10.1016/j.saa.2012.03.002; Kumar CG, 2011, COLLOID SURFACE B, V84, P462, DOI 10.1016/j.colsurfb.2011.01.042; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Lee KJ, 2013, MATER LETT, V105, P128, DOI 10.1016/j.matlet.2013.04.076; Malhotra A, 2013, BIORESOURCE TECHNOL, V142, P727, DOI 10.1016/j.biortech.2013.05.109; Mandal S, 2007, PHYSIOL MOL PLANT P, V71, P201, DOI 10.1016/j.pmpp.2008.02.003; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mehta YR, 1994, MANEJO INTEGRADO ENF, P314; Mishra S, 2012, PLANT GROWTH REGUL, V66, P155, DOI 10.1007/s10725-011-9639-1; MOERSCHBACHER BM, 1990, PLANT PHYSIOL, V93, P465, DOI 10.1104/pp.93.2.465; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012; Navrotsky A, 2000, J NANOPART RES, V2, P321, DOI 10.1023/A:1010007023813; Long NV, 2013, J NANOMATER, V2013, DOI 10.1155/2013/793125; Oves M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059140; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Quester K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077486; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Saari E.E., 1998, HELMINTHOSPORIUM BLI, P37; Sarkar A, 2010, J PROTEOME RES, V9, P4565, DOI 10.1021/pr1002824; Shi HY, 2012, ACTA BIOCH BIOPH SIN, V44, P555, DOI 10.1093/abbs/gms035; Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh RV, 1997, P INT WORKSH HELM BL, P59; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171	53	123	139	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97881	10.1371/journal.pone.0097881	http://dx.doi.org/10.1371/journal.pone.0097881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25111185	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600086
J	Chen, Y; Yang, J; Shu, HZ; Shi, LY; Wu, JS; Luo, LM; Coatrieux, JL; Toumoulin, C				Chen, Yang; Yang, Jian; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine			2-D Impulse Noise Suppression by Recursive Gaussian Maximum Likelihood Estimation	PLOS ONE			English	Article							MEDIAN FILTER; TOMOGRAPHIC RECONSTRUCTION; REMOVAL; DETECTOR; SIMILARITY; ALGORITHM; WEIGHTS	An effective approach termed Recursive Gaussian Maximum Likelihood Estimation (RGMLE) is developed in this paper to suppress 2-D impulse noise. And two algorithms termed RGMLE-C and RGMLE-CS are derived by using spatially-adaptive variances, which are respectively estimated based on certainty and joint certainty & similarity information. To give reliable implementation of RGMLE-C and RGMLE-CS algorithms, a novel recursion stopping strategy is proposed by evaluating the estimation error of uncorrupted pixels. Numerical experiments on different noise densities show that the proposed two algorithms can lead to significantly better results than some typical median type filters. Efficient implementation is also realized via GPU (Graphic Processing Unit)-based parallelization techniques.	[Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Beijing, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine] Ctr Rech Informat Biomed Sino Francais LIA CRIBs, Rennes, France; [Yang, Jian] Beijing Inst Technol, Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Coatrieux, Jean-Louis; Toumoulin, Christine] INSERM, U1099, Rennes, France; [Coatrieux, Jean-Louis; Toumoulin, Christine] Univ Rennes 1, LTSI, Rennes, France	Southeast University - China; Southeast University - China; Beijing Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Luo, LM (corresponding author), Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China.	luo.list@seu.edu.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Basic Research Program of China [2010CB732503]; National Natural Science Foundation [81000636, 81370040]; Natural Science Foundations of Jiangsu Province [BK2011593]; Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	This research was supported by National Basic Research Program of China under grant (2010CB732503), National Natural Science Foundation under grants (81000636, 81370040), and the Project supported by Natural Science Foundations of Jiangsu Province (BK2011593). This work was also supported by the Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1974, J ROY STAT SOC B MET, V36, P99; [Anonymous], NVIDIA CUDATM PROGR; Arce GR, 1998, IEEE T SIGNAL PROCES, V46, P3195, DOI 10.1109/78.735296; Astola J., 1997, FUNDAMENTALS NONLINE; Bovik A., 2000, HDB IMAGE VIDEO PROC; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Cai JF, 2011, INVERSE PROBL IMAG, V2, P187; Chan RH, 2005, IEEE T IMAGE PROCESS, V14, P1479, DOI 10.1109/TIP.2005.852196; Chaudhury KN, 2012, IEEE SIGNAL PROC LET, V19, P745, DOI 10.1109/LSP.2012.2217329; Chen Y, 2008, J MATH IMAGING VIS, V30, P133, DOI 10.1007/s10851-007-0042-5; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, MULTISCALE MODEL SIM, V9, P1399, DOI 10.1137/100814184; Deledalle CA, 2009, IEEE T IMAGE PROCESS, V18, P2661, DOI 10.1109/TIP.2009.2029593; Dong YQ, 2007, IEEE T IMAGE PROCESS, V16, P1112, DOI 10.1109/TIP.2006.891348; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Esakkirajan S, 2011, IEEE SIGNAL PROC LET, V18, P287, DOI 10.1109/LSP.2011.2122333; Harris JW, 1998, HDB MATH COMPUTATION, P824; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Justusson BI, 1981, P 2 DIM DIG SIGN PRO; LEE YH, 1991, IEEE T SIGNAL PROCES, V39, P984, DOI 10.1109/78.80931; Lin CH, 2010, IEEE T IMAGE PROCESS, V19, P2307, DOI 10.1109/TIP.2010.2047906; Ng PE, 2006, IEEE T IMAGE PROCESS, V15, P1506, DOI 10.1109/TIP.2005.871129; Sree PSJ, 2013, SIGNAL IMAGE VIDEO P, V7, P111, DOI 10.1007/s11760-011-0210-3; Srinivasan KS, 2007, IEEE SIGNAL PROC LET, V14, P189, DOI 10.1109/LSP.2006.884018; Takeda H, 2007, IEEE T IMAGE PROCESS, V16, P349, DOI 10.1109/TIP.2006.888330; Ville DVD, 2011, IEEE T IMAGE PROCESS, V20, P2683; Wainwright MJ, ADV NEUROALINFORMATI; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang SQ, 2002, IEEE SIGNAL PROC LET, V9, P360, DOI 10.1109/LSP.2002.805310; Zhang XM, 2009, IEEE SIGNAL PROC LET, V16, P295, DOI 10.1109/LSP.2009.2014293	30	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96386	10.1371/journal.pone.0096386	http://dx.doi.org/10.1371/journal.pone.0096386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836960	Green Published, Green Submitted, gold			2022-12-25	WOS:000339614800016
J	Gai, XP; Wang, HY; Liu, J; Zhai, LM; Liu, S; Ren, TZ; Liu, HB				Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Ren, Tianzhi; Liu, Hongbin			Effects of Feedstock and Pyrolysis Temperature on Biochar Adsorption of Ammonium and Nitrate	PLOS ONE			English	Article							BLACK CARBON; NUTRIENT AVAILABILITY; SOIL; SORPTION; RESIDUE; MANURE; SULFAMETHOXAZOLE; PHOSPHATE; AMENDMENT; DYNAMICS	Biochar produced by pyrolysis of biomass can be used to counter nitrogen (N) pollution. The present study investigated the effects of feedstock and temperature on characteristics of biochars and their adsorption ability for ammonium N (NH4+-N) and nitrate N (NO3--N). Twelve biochars were produced from wheat-straw (W-BC), corn-straw (C-BC) and peanut-shell (P-BC) at pyrolysis temperatures of 400, 500, 600 and 700 degrees C. Biochar physical and chemical properties were determined and the biochars were used for N sorption experiments. The results showed that biochar yield and contents of N, hydrogen and oxygen decreased as pyrolysis temperature increased from 400 degrees C to 700 degrees C, whereas contents of ash, pH and carbon increased with greater pyrolysis temperature. All biochars could sorb substantial amounts of NH4+-N, and the sorption characteristics were well fitted to the Freundlich isotherm model. The ability of biochars to adsorb NH4+-N followed: C-BC. P-BC. W-BC, and the adsorption amount decreased with higher pyrolysis temperature. The ability of C-BC to sorb NH4+-N was the highest because it had the largest cation exchange capacity (CEC) among all biochars (e.g., C-BC400 with a CEC of 38.3 cmol kg(-1) adsorbed 2.3 mg NH4+-N g(-1) in solutions with 50 mg NH4+ L-1). Compared with NH4+-N, none of NO3 -N was adsorbed to biochars at different NO3 concentrations. Instead, some NO3- -N was even released from the biochar materials. We conclude that biochars can be used under conditions where NH4+-N (or NH3) pollution is a concern, but further research is needed in terms of applying biochars to reduce NO3--N pollution.	[Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Liu, Hongbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China; [Liu, Jian] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Ren, Tianzhi] Minist Agr, Inst Agroenvironm Protect, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, HB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China.	liuhongbin@caas.cn	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	National Natural Science Foundation of China [41301311, 41203072]; Special Fund for Agro-scientific Research in the Public Interest [201303095-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	Funding: This study was financially supported by the National Natural Science Foundation of China (41301311), the Special Fund for Agro-scientific Research in the Public Interest (201303095-10), and the National Natural Science Foundation of China (41203072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami A, 2007, J HAZARD MATER, V144, P427, DOI 10.1016/j.jhazmat.2006.10.062; Ahmad M, 2013, BIORESOURCE TECHNOL, V143, P615, DOI 10.1016/j.biortech.2013.06.033; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Ding Y, 2010, WATER AIR SOIL POLL, V213, P47, DOI 10.1007/s11270-010-0366-4; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Gell K, 2011, J HAZARD MATER, V186, P2017, DOI 10.1016/j.jhazmat.2010.12.105; Hollister CC, 2013, J ENVIRON QUAL, V42, P137, DOI 10.2134/jeq2012.0033; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; IFA/IFDC/IPI/PPI/FAO, 2009, FERT US CROP; Ji LL, 2011, ENVIRON SCI TECHNOL, V45, P5580, DOI 10.1021/es200483b; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Knowles OA, 2011, SCI TOTAL ENVIRON, V409, P3206, DOI 10.1016/j.scitotenv.2011.05.011; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Mimmo T, 2014, BIOMASS BIOENERG, V62, P149, DOI 10.1016/j.biombioe.2014.01.004; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Ohe K, 2003, J CHEM ENG JPN, V36, P511, DOI 10.1252/jcej.36.511; Ok YS, 2007, J HAZARD MATER, V147, P91, DOI 10.1016/j.jhazmat.2006.12.046; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038; Sun L, 2013, BIORESOURCE TECHNOL, V140, P406, DOI 10.1016/j.biortech.2013.04.116; Wu WX, 2012, BIOMASS BIOENERG, V47, P268, DOI 10.1016/j.biombioe.2012.09.034; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhai LM, 2014, BIOL FERT SOILS; Zhang AF, 2013, AGR ECOSYST ENVIRON, V173, P37, DOI 10.1016/j.agee.2013.04.001; Zhao XC, 2013, BIORESOURCE TECHNOL, V147, P338, DOI 10.1016/j.biortech.2013.08.042; Zheng H, 2013, ENVIRON POLLUT, V181, P60, DOI 10.1016/j.envpol.2013.05.056; Zheng H, 2013, BIORESOURCE TECHNOL, V130, P463, DOI 10.1016/j.biortech.2012.12.044; Zhu AN, 2005, ENVIRON INT, V31, P904, DOI 10.1016/j.envint.2005.05.038	42	358	389	21	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113888	10.1371/journal.pone.0113888	http://dx.doi.org/10.1371/journal.pone.0113888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469875	Green Published, gold, Green Submitted			2022-12-25	WOS:000349128700050
J	Chen, YK; Han, LZ; Xue, F; Shen, CH; Lu, J; Yang, TH; Zhang, JJ; Xia, Q				Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang			Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ATP-BINDING CASSETTE; RENAL-TRANSPLANTATION; DOSAGE REQUIREMENTS; DOSING REQUIREMENTS; SUBFAMILY B; PHARMACOKINETICS; IMPACT; PHARMACOGENETICS; AGE	Tacrolimus (TAC) is the backbone of an immunosuppressive drug used in most solid organ transplant recipients. A single nucleotide polymorphism (SNP) at position 6986G>A in CYP3A5 has been notably involved in the pharmacokinetic variability of TAC. It is hypothesized that CYP3A5 genotyping in patients may provide a guideline for TAC therapeutic regimen. To further evaluate the impact of CYP3A5 variants in donors and recipients, ABCB1 and ACE SNPs in recipients on TAC disposition, clinical and laboratory data were retrospectively reviewed from 90 pediatric patients with liver transplantation and their corresponding donors after 1 year of transplantation. The recipients with CYP3A5 *1/*1 or *1/*3 required more time to achieve TAC therapeutic range during the induction phase, and needed more upward dose during the late induction and the maintained phases, with lower C/D ratio, compared with those with CYP3A5 *3/*3. And donor CYP3A5 genotypes were found to impact on TAC trough concentrations after liver transplantation. No association between ABCB1 or ACE genotypes and TAC disposition post-transplantation was found. These results strongly suggest that CYP3A5 genotyping both in recipient and donor, not ABCB1 or ACE is necessary for establishing a personalized TAC dosage regimen in pediatric liver transplant patients.	[Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xue, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China.	fengxue6879@163.com; xiaqiang@medmail.com.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Ministry of Public Health [IHECCO8-201213]; Shanghai Science and Technology Committee [12ZR1418300]	National Ministry of Public Health; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This project was supported by National Ministry of Public Health grant (IHECCO8-201213) (http://www.nhfpc.gov.cn/gjhzs/index.shtml) and Shanghai Science and Technology Committee grant (12ZR1418300) (http://www.stcsm.gov.cn/). The funders had roles in study design, data collection and analysis.	Gomez-Bravo MA, 2013, J CLIN PHARMACOL, V53, P1146, DOI 10.1002/jcph.154; Chen DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073405; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; de Wildt SN, 2011, EUR J CLIN PHARMACOL, V67, P1231, DOI 10.1007/s00228-011-1083-7; Ferraris JR, 2011, PEDIATR TRANSPLANT, V15, P525, DOI 10.1111/j.1399-3046.2011.01513.x; Fukudo M, 2006, CLIN PHARMACOL THER, V80, P331, DOI 10.1016/j.clpt.2006.06.008; Gijsen V, 2011, J HEART LUNG TRANSPL, V30, P1352, DOI 10.1016/j.healun.2011.08.001; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; Glowacki F, 2011, NEPHROL DIAL TRANSPL, V26, P3046, DOI 10.1093/ndt/gfr253; Grenda R, 2009, ANN TRANSPL, V14, P18; Hawwa AF, 2011, EXPERT OPIN DRUG SAF, V10, P9, DOI 10.1517/14740338.2010.505600; Hawwa AF, 2009, BRIT J CLIN PHARMACO, V68, P413, DOI 10.1111/j.1365-2125.2009.03461.x; Hesselink DA, 2014, CLIN PHARMACOKINET, V53, P123, DOI 10.1007/s40262-013-0120-3; Hosohata K, 2009, DRUG METAB PHARMACOK, V24, P458, DOI 10.2133/dmpk.24.458; Hosohata K, 2009, DRUG METAB DISPOS, V37, P821, DOI 10.1124/dmd.108.025833; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kausman JY, 2008, PEDIATR TRANSPLANT, V12, P329, DOI 10.1111/j.1399-3046.2007.00821.x; Kim JS, 2005, PEDIATR TRANSPLANT, V9, P162, DOI 10.1111/j.1399-3046.2005.00263.x; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; MacPhee IAM, 2005, TRANSPLANTATION, V79, P499, DOI 10.1097/01.TP.0000151766.73249.12; Min SI, 2010, TRANSPLANTATION, V90, P1394, DOI 10.1097/TP.0b013e3181fa93a4; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Provenzani A, 2009, ANN TRANSPL, V14, P23; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Satoh S, 2008, BRIT J CLIN PHARMACO, V66, P207, DOI 10.1111/j.1365-2125.2008.03188.x; Shilbayeh Sireen, 2013, Saudi J Kidney Dis Transpl, V24, P1125, DOI 10.4103/1319-2442.121268; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Uesugi M, 2013, BIOL PHARM BULL, V36, P1814; Vannaprasaht S, 2013, CLIN THER, V35, P1762, DOI 10.1016/j.clinthera.2013.08.019; Wang WL, 2006, LIVER TRANSPLANT, V12, P775, DOI 10.1002/lt.20709; Xue F, 2010, TRANSPLANTATION, V89, P620, DOI 10.1097/TP.0b013e3181c690fa; Yu SF, 2006, TRANSPLANTATION, V81, P46, DOI 10.1097/01.tp.0000188118.34633.bf	33	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109464	10.1371/journal.pone.0109464	http://dx.doi.org/10.1371/journal.pone.0109464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	24836960	gold, Green Published, Green Submitted			2022-12-25	WOS:000343210300051
